PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Abramson, JZ; Hernandez-Lloreda, MV; Esteban, JA; Colmenares, F; Aboitiz, F; Call, J				Abramson, Jose Z.; Victoria Hernandez-Lloreda, Ma; Esteban, Jose-Antonio; Colmenares, Fernando; Aboitiz, Francisco; Call, Josep			Contextual imitation of intransitive body actions in a Beluga whale (Delphinapterus leucas): A "do as other does" study	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; ANIMALS; MECHANISMS; EVOLUTION; CULTURE; FACULTY; US	Cetaceans are remarkable for exhibiting group-specific behavioral traditions or cultures in several behavioral domains (e.g., calls, behavioral tactics), and the question of whether they can be acquired socially, for example through imitative processes, remains open. Here we used a "Do as other does" paradigm to experimentally study the ability of a beluga to imitate familiar intransitive (body-oriented) actions demonstrated by a conspecific. The participant was first trained to copy three familiar behaviors on command (training phase) and then was tested for her ability to generalize the learned "Do as the other does" command to a different set of three familiar behaviors (testing phase). We found that the beluga (1) was capable of learning the copy command signal "Do what-the-other-does"; (2) exhibited high matching accuracy for trained behaviors (mean = 84% of correct performance) after making the first successful copy on command; (3) copied successfully the new set of three familiar generalization behaviors that were untrained to the copy command (range of first copy = 12 to 35 trials); and (4) deployed a high level of matching accuracy (mean = 83%) after making the first copy of an untrained behavior on command. This is the first evidence of contextual imitation of intransitive (body-oriented) movements in the beluga and adds to the reported findings on production imitation of sounds in this species and production imitation of sounds and motor actions in several cetaceans, especially dolphins and killer whales. Collectively these findings highlight the notion that cetaceans have a natural propensity at skillfully and proficiently matching the sounds and body movements demonstrated by conspecifics, a fitness-enhancing propensity in the context of cooperative hunting and anti-predatory defense tactics, and of alliance formation strategies that have been documented in these species' natural habitats. Future work should determine if the beluga can also imitate novel motor actions.	[Abramson, Jose Z.; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Psiquiatria, Santiago, Chile; [Abramson, Jose Z.; Aboitiz, Francisco] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile; [Abramson, Jose Z.] Univ Playa Ancha, Ctr Estudios Avanzados, Valparaiso, Chile; [Abramson, Jose Z.; Victoria Hernandez-Lloreda, Ma; Colmenares, Fernando] Univ Complutense Madrid, Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain; [Victoria Hernandez-Lloreda, Ma] Univ Complutense Madrid, Fac Psicol, Dept Metodol Ciencias Comportamiento, Campus Somosaguas, Madrid, Spain; [Esteban, Jose-Antonio] Parques Reunidos Valencia SA Oceanog, Res Dept, Valencia, Spain; [Colmenares, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas, Madrid, Spain; [Call, Josep] Univ St Andrews, Sch Psychol & Neurosci, South St, St Andrews, Fife Ky, Scotland; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Deutsch Pl 6, Leipzig, Germany	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Playa Ancha; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; University of St Andrews; Max Planck Society	Abramson, JZ (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Psiquiatria, Santiago, Chile.; Abramson, JZ (corresponding author), Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencia, Santiago, Chile.; Abramson, JZ (corresponding author), Univ Playa Ancha, Ctr Estudios Avanzados, Valparaiso, Chile.; Abramson, JZ (corresponding author), Univ Complutense Madrid, Grp UCM Estudio Comportamiento Anim & Humano, Madrid, Spain.	zabramson@psi.ucm.es	; Zamorano-Abramson, Jose/B-3990-2012	Hernandez-Lloreda, Maria Victoria/0000-0003-0966-7453; Call Balaguer, Josep/0000-0002-8597-8336; Zamorano-Abramson, Jose/0000-0001-7106-6419	Ministerio de Economia y Competitividad, Spain [PSI2011-29016C-02-01, PSI2014-51890-C2-1-P]; Universidad Complutense de Madrid y Banco Santander Central Hispano [GR3/14-940813]; Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT [3140580]; European Research Council [609819]	Ministerio de Economia y Competitividad, Spain; Universidad Complutense de Madrid y Banco Santander Central Hispano; Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); European Research Council(European Research Council (ERC)European Commission)	The research reported in this paper was partly funded by project grants PSI2011-29016C-02-01, PSI2014-51890-C2-1-P (Ministerio de Economia y Competitividad, Spain) http://www. mineco.gob.es/ and UCM-BSCH GR3/14-940813 (Universidad Complutense de Madrid y Banco Santander Central Hispano) to F.C.A post-doctoral scholarship from Fondo Nacional de Desarrollo Cientifico y Tecnologico/FONDECYT No 3140580 awarded to J.ZA. funded his salary. http://www. conicyt.cl/fondecyt. European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant SOMICS agreement no 609819. Dr. Josep Call. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JZ, 2013, ANIM COGN, V16, P11, DOI 10.1007/s10071-012-0546-2; Bates LA, 2010, WIRES COGN SCI, V1, P685, DOI 10.1002/wcs.77; BAUER GB, 1994, PERCEPT MOTOR SKILL, V79, P1307, DOI 10.2466/pms.1994.79.3.1307; Byrne R.W., 1994, P223; Byrne RW, 2009, CURR BIOL, V19, pR111, DOI 10.1016/j.cub.2008.11.027; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; Call J, 2002, FROM ANIM ANIMAT, P211; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; Connor RC, 1998, TRENDS ECOL EVOL, V13, P228, DOI 10.1016/S0169-5347(98)01326-3; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Dean L, 2016, INT ENCY ANTHR; Filatova OA, 2015, BEHAVIOUR, V152, P2001, DOI 10.1163/1568539X-00003317; Fugazza C, 2015, APPL ANIM BEHAV SCI, V171, P146, DOI 10.1016/j.applanim.2015.08.033; Galef BG, 2013, BEHAV PROCESS, V100, P123, DOI 10.1016/j.beproc.2013.07.026; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HAYES KJ, 1952, J COMP PHYSIOL PSYCH, V45, P450, DOI 10.1037/h0053609; Herman LM, 2002, FROM ANIM ANIMAT, P63; Herman Louis M., 2006, P439; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C, 2013, LIFE MIND-PHILOS ISS, P313; Heyes CM, 2000, ADV STUD BEHAV, V29, P215, DOI 10.1016/S0065-3454(08)60106-0; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Huber L, 2009, PHILOS T R SOC B, V364, P2299, DOI 10.1098/rstb.2009.0060; Jaakkola K., 2010, INT J COMP PSYCHOL, V234, P671, DOI DOI 10.1016/J.JEBDP.20; Jaakkola K, 2013, ANIM COGN, V16, P701, DOI 10.1007/s10071-013-0605-3; Janik VM, 2014, CURR OPIN NEUROBIOL, V28, P60, DOI 10.1016/j.conb.2014.06.010; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Miles H. Lyn, 1996, P278; MITCHELL RW, 1993, PRIMATES, V34, P301, DOI 10.1007/BF02382625; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Ridgway S, 2012, CURR BIOL, V22, pR860, DOI 10.1016/j.cub.2012.08.044; Subiaul F, 2010, BEHAV PROCESS, V83, P222, DOI 10.1016/j.beproc.2009.12.002; Tennie C, 2009, ANIM BEHAV, V77, P1491, DOI 10.1016/j.anbehav.2009.03.008; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; Tsukasa M., 2012, INT J COMP PSYCHOL, V25, P195; van Schaik CP, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P623; Vonk J., 2012, OXFORD HDB COMP EVOL, P144; Whitehead H., 2014, CULTURAL LIVES WHALE; Whiten A, 2000, COGNITIVE SCI, V24, P477; Xitco M. J., 1988, THESIS; Yeater D. B., 2010, INT J COMP PSYCHOL, V23, P379; Zentall T.R., 2013, SOCIAL LEARNING PSYC; Zentall TR, 2011, INTERACT STUD, V12, P233, DOI 10.1075/is.12.2.03zen; Zentall TR, 2001, CYBERNET SYST, V32, P53, DOI 10.1080/019697201300001812	49	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178906	10.1371/journal.pone.0178906	http://dx.doi.org/10.1371/journal.pone.0178906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636677	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300020
J	Guillot, C; Martel, N; Berby, F; Bordes, I; Hantz, O; Blanchet, M; Sureau, C; Vaillant, A; Chemin, I				Guillot, Clement; Martel, Nora; Berby, Francoise; Bordes, Isabelle; Hantz, Olivier; Blanchet, Matthieu; Sureau, Camille; Vaillant, Andrew; Chemin, Isabelle			Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes	PLOS ONE			English	Article							AMPHIPATHIC DNA POLYMERS; FIBROBLAST-GROWTH-FACTOR; VIRUS INFECTION; ANTISENSE OLIGONUCLEOTIDES; ANTIVIRAL ACTIVITY; BINDING; MECHANISMS; COMBINATION; LAMIVUDINE	Hepatitis B virus (HBV) infection remains a major public health concern worldwide with 240 million individuals chronically infected and at risk of developing cirrhosis and hepatocellular carcinoma. Current treatments rarely cure chronic hepatitis B infection, highlighting the need for new anti-HBV drugs. Nucleic acid polymers (NAPs) are phosphorothioated oligonucleotides that have demonstrated a great potential to inhibit infection with several viruses. In chronically infected human patients, NAPs administration lead to a decline of blood HBsAg and HBV DNA and to HBsAg seroconversion, the expected signs of functional cure. NAPs have also been shown to prevent infection of duck hepatocytes with the Avihepadnavirus duck hepatitis B virus (DHBV) and to exert an antiviral activity against established DHBV infection in vitro and in vivo. In this study, we investigated the specific anti-HBV antiviral activity of NAPs in the HepaRG human hepatoma cell line and primary cultures of human hepatocytes. NAPs with different chemical features (phosphorothioation, 2'O-methyl ribose, 5-methylcytidine) were assessed for antiviral activity when provided at the time of HBV inoculation or post-inoculation. NAPs dose-dependently inhibited HBV entry in a phosphorothioation-dependent, sequence-independent and size-dependent manner. This inhibition of HBV entry by NAPs was impaired by 2'O-methyl ribose modification. NAP treatment after viral inoculation did not elicit any antiviral activity.	[Guillot, Clement; Martel, Nora; Berby, Francoise; Bordes, Isabelle; Hantz, Olivier; Chemin, Isabelle] Univ Lyon, CNRS, Ctr Rech Cancerol Lyon, INSERM,U1052,UMR5286, Lyon, France; [Blanchet, Matthieu; Vaillant, Andrew] Replicor Inc, Montreal, PQ, Canada; [Sureau, Camille] INTS, Mol Virol Lab, CNRS, INSERM,U1134, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chemin, I (corresponding author), Univ Lyon, CNRS, Ctr Rech Cancerol Lyon, INSERM,U1052,UMR5286, Lyon, France.; Vaillant, A (corresponding author), Replicor Inc, Montreal, PQ, Canada.	availlant@replicor.com; isabelle.chemin@inserm.fr	Chemin, Isabelle/I-3032-2016; Sharma, Ashwani/AAK-3879-2020	Chemin, Isabelle/0000-0002-7188-5489; Sharma, Ashwani/0000-0001-9835-1973; Guillot, Clement/0000-0001-6849-421X; VAILLANT, Andrew/0000-0002-1433-0700	Replicor Inc.	Replicor Inc.	The work was funded by Replicor Inc. The funder provided support in the form of salaries for authors [CG, NM, MB and AV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal S, 1996, TRENDS BIOTECHNOL, V14, P376, DOI 10.1016/0167-7799(96)10053-6; Al-Mahtab M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156667; Bernstein DI, 2008, ANTIMICROB AGENTS CH, V52, P2727, DOI 10.1128/AAC.00279-08; Cardin RD, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-214; Dias N, 2002, MOL CANCER THER, V1, P347; FENNEWALD SM, 1995, J BIOL CHEM, V270, P21718, DOI 10.1074/jbc.270.37.21718; Funk A, 2007, WORLD J GASTROENTERO, V13, P91, DOI 10.3748/wjg.v13.i1.91; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Ghosh S, 2016, J VIRAL HEPAT; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; Guzman EM, 2007, ANTIVIR THER, V12, P1147; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kondo Yasuteru, 2013, ISRN Gastroenterol, V2013, P935295, DOI 10.1155/2013/935295; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee AM, 2008, VIROLOGY, V372, P107, DOI 10.1016/j.virol.2007.10.016; Li JS, 2015, CLIN MOL HEPATOL, V21, P193, DOI 10.3350/cmh.2015.21.3.193; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marcellin P, 2016, GASTROENTEROLOGY, V150, P134, DOI 10.1053/j.gastro.2015.09.043; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Noordeen F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140909; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5299, DOI 10.1128/AAC.01005-13; Noordeen F, 2013, ANTIMICROB AGENTS CH, V57, P5291, DOI 10.1128/AAC.01003-13; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sureau C, 2013, HEPATOLOGY, V57, P985, DOI 10.1002/hep.26125; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Vaillant A, 2006, ANTIMICROB AGENTS CH, V50, P1393, DOI 10.1128/AAC.50.4.1393-1401.2006; Vaillant A, 2016, ANTIVIR RES, V133, P32, DOI 10.1016/j.antiviral.2016.07.004; Zhu DM, 2016, J IMMUNOL, V196, P3079, DOI 10.4049/jimmunol.1502061	35	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179697	10.1371/journal.pone.0179697	http://dx.doi.org/10.1371/journal.pone.0179697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636622	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300051
J	Reinke, LM; Spiegel, M; Plegge, T; Hartleib, A; Nehlmeier, I; Gierer, S; Hoffmann, M; Hofmann-Winkler, H; Winkler, M; Pohlmann, S				Reinke, Lennart Michel; Spiegel, Martin; Plegge, Teresa; Hartleib, Anika; Nehlmeier, Inga; Gierer, Stefanie; Hoffmann, Markus; Hofmann-Winkler, Heike; Winkler, Michael; Poehlmann, Stefan			Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2	PLOS ONE			English	Article							CORONAVIRUS; ENTRY; VIRUS; GLYCOPROTEIN; INHIBITORS; RECEPTOR; FUSION; H7N9	The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV) mediates viral entry into target cells. Cleavage and activation of SARS S by a host cell protease is essential for infectious viral entry and the responsible enzymes are potential targets for antiviral intervention. The type II transmembrane serine protease TMPRSS2 cleaves and activates SARS S in cell culture and potentially also in the infected host. Here, we investigated which determinants in SARS S control cleavage and activation by TMPRSS2. We found that SARS S residue R667, a previously identified trypsin cleavage site, is also required for S protein cleavage by TMPRSS2. The cleavage fragments produced by trypsin and TMPRSS2 differed in their decoration with N-glycans, suggesting that these proteases cleave different SARS S glycoforms. Although R667 was required for SARS S cleavage by TMPRSS2, this residue was dispensable for TMPRSS2-mediated S protein activation. Conversely, residue R797, previously reported to be required for SARS S activation by trypsin, was dispensable for S protein cleavage but required for S protein activation by TMPRSS2. Collectively, these results show that different residues in SARS S control cleavage and activation by TMPRSS2, suggesting that these processes are more complex than initially appreciated.	[Reinke, Lennart Michel; Spiegel, Martin; Plegge, Teresa; Hartleib, Anika; Nehlmeier, Inga; Gierer, Stefanie; Hoffmann, Markus; Hofmann-Winkler, Heike; Winkler, Michael; Poehlmann, Stefan] Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany; [Spiegel, Martin] Med Hsch Brandenburg Theodor Fontane, Inst Mikrobiol & Virol, Senftenberg, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany.	spoehlmann@dpz.eu	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011; Spiegel, Martin/H-7843-2019	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Winkler, Michael/0000-0002-6198-554X	Leibniz Association (Graduate School for Emerging Infec tious Diseases)	Leibniz Association (Graduate School for Emerging Infec tious Diseases)	The study was supported by the Leibniz Association (Graduate School for Emerging Infec tious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Cheng Z, 2015, J INFECT DIS; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hilgenfeld R, 2013, ANTIVIR RES, V100, P286, DOI 10.1016/j.antiviral.2013.08.015; Hofmann H, 2004, TRENDS MICROBIOL, V12, P466, DOI 10.1016/j.tim.2004.08.008; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li WH, 2006, ADV EXP MED BIOL, V581, P209; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Peitsch C, 2014, J VIROL, V88, P282, DOI 10.1128/JVI.01635-13; Plegge T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166013; Poon LLM, 2004, LANCET INFECT DIS, V4, P663, DOI 10.1016/S1473-3099(04)01172-7; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Simmons G, 2013, ANTIVIR RES, V100, P605, DOI 10.1016/j.antiviral.2013.09.028; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	33	52	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179177	10.1371/journal.pone.0179177	http://dx.doi.org/10.1371/journal.pone.0179177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636671	gold, Green Published			2022-12-26	WOS:000404118300029
J	Trattner, C; Parra, D; Elsweiler, D				Trattner, Christoph; Parra, Denis; Elsweiler, David			Monitoring obesity prevalence in the United States through bookmarking activities in online food portals	PLOS ONE			English	Article							DIET QUALITY; CONSUMPTION; ADOLESCENTS; EPIDEMIC; CHILDREN; IMPACT	Studying the impact of food consumption on people's health is a serious matter for its implications on public policy, but it has traditionally been a slow process since it requires information gathered through expensive collection processes such as surveys, census and systematic reviews of research articles. We argue that this process could be supported and hastened using data collected via online social networks. In this work we investigate the relationships between the online traces left behind by users of a large US online food community and the prevalence of obesity in 47 states and 311 counties in the US. Using data associated with the recipes bookmarked over an 9-year period by 144,839 users of the Allrecipes. com food website residing throughout the US, several hierarchical regression models are created to (i) shed light on these relations and (ii) establish their magnitude. The results of our analysis provide strong evidence that bookmarking activities on recipes in online food communities can provide a signal allowing food and health related issues, such as obesity to be better understood and monitored. We discover that higher fat and sugar content in bookmarked recipes is associated with higher rates of obesity. The dataset is complicated, but strong temporal and geographical trends are identifiable. We show the importance of accounting for these trends in the modeling process.	[Trattner, Christoph] MODUL Univ Vienna, Dept New Media Technol, Vienna, Austria; [Parra, Denis] Pontificia Univ Catolica Chile, Dept Ciencia Computac, Santiago, Chile; [Elsweiler, David] Univ Regensburg, Chair Informat Sci I IMSK, Regensburg, Germany	Pontificia Universidad Catolica de Chile; University of Regensburg	Elsweiler, D (corresponding author), Univ Regensburg, Chair Informat Sci I IMSK, Regensburg, Germany.	david.elsweiler@sprachlit.uni-regensburg.de	Parra, Denis/M-2967-2019; Parra, Denis/D-1388-2014	Parra, Denis/0000-0001-9878-8761; Trattner, Christoph/0000-0002-1193-0508; Elsweiler, David/0000-0002-5791-0641	German Research Foundation (DFG) within the funding programme Open Access Publishing; CONICYT [FONDECYT 11150783]	German Research Foundation (DFG) within the funding programme Open Access Publishing(German Research Foundation (DFG)); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The author Denis Parra was supported by CONICYT, project FONDECYT 11150783.	Abbar S, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3197, DOI 10.1145/2702123.2702153; Alaimo K, 1994, Adv Data, P1; [Anonymous], 2007, FSA NUTR FOOD BASED; [Anonymous], 2016, ALLRECIPES FOOD FRIE; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], 2016, HEALTHY EATING INDEX; [Anonymous], 2013, UNCONDITIONAL MULTIL; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Bates D. M., 2010, IME4 MIXED EFFECTS M; Beaglehole R, 2016, MISUNDERSTANING REAL; Bellisle F., 2005, EUFIC REV, V17, P1; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; BRADBURN NM, 1987, SCIENCE, V236, P157, DOI 10.1126/science.3563494; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Buntain C, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P777, DOI 10.1145/2740908.2742469; Centers for Disease Control and Prevention, 2016, CDC 247 SAV LIV PROT; De Choudhury M., 2013, 7 INT AAAI C WEBL SO, P2, DOI DOI 10.1145/1810617.1810626; De Choudhury M., 2016, CHARACTERIZING DIETA; Drewnowski A, 2007, EPIDEMIOL REV, V29, P160, DOI 10.1093/epirev/mxm011; EHSA, 2016, NUTR LAB SOFTW NUTR; Elsweiler D, 2017, P SIGIR 2017; Field A., 2012, DISCOVERING STAT USI; Fried D, 2014, IEEE INT CONF BIG DA, P778, DOI 10.1109/BigData.2014.7004305; Ge M., 2015, P 9 ACM C REC SYST, P333, DOI DOI 10.1145/2792838.2796554; Gillum RF, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-27; Giltinan DM, 1995, NONLINEAR MODELS REP, V62; Grace-Martin K., 2016, INTRACLASS CORRELATI; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Hagan P., 2016, WHY FAT NOT SUGAR IS; Holbrook AL, 2003, PUBLIC OPIN QUART, V67, P79, DOI 10.1086/346010; Howard S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7607; Jacka FN, 2010, AUST NZ J PSYCHIAT, V44, P435, DOI 10.3109/00048670903571598; Kallehave O, 2011, P PINC 2011 WORKSH C; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leslie I., 2016, SUGAR CONSPIRACY; Mejova Y., 2015, P 5 INT C DIG HLTH 2, P51, DOI [10.1145/2750511.2750524, DOI 10.1145/2750511.2750524]; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Newman C., 2013, FAT VS SUGAR WHICH D; Paparrizos J, 2016, P ACM SIGKDD C KNOWL; Paul MJ, 2016, BIOCOMPUT-PAC SYM, P468; Polgreen PM, 2007, CLIN INFECT DIS, V44, P272, DOI 10.1086/510427; Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18; ROZIN P, 1985, ANN NY ACAD SCI, V443, P189, DOI 10.1111/j.1749-6632.1985.tb27073.x; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Said A, 2014, RSWEB RECSYS; Said A, 2014, P RSWEB 14; Scheibehenne B, 2007, APPETITE, V49, P578, DOI 10.1016/j.appet.2007.03.224; Schoen H, 2013, INTERNET RES, V23, P528, DOI 10.1108/IntR-06-2013-0115; Schwartz H. A., 2013, ICWSM; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Strohmaier M, 2014, IEEE INTELL SYST, V29, P84, DOI 10.1109/MIS.2014.80; Trattner C, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P489, DOI 10.1145/3038912.3052573; Trattner C, 2016, ERCIM NEWS, P50; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Tu YK, 2005, BRIT DENT J, V199, P457, DOI 10.1038/sj.bdj.4812743; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; van Dam R, 2007, EUR J CLIN NUTR, V61, pS75, DOI 10.1038/sj.ejcn.1602939; Wagner C, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0036-7; West J.H., 2012, TEMPORAL VARIABILITY; West R., 2013, WWW, P1399; Who J, 2003, WHO TECH REP SER, V916; Williams G, 2009, OBESITY SCI PRACTICE; Yang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150881	65	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179144	10.1371/journal.pone.0179144	http://dx.doi.org/10.1371/journal.pone.0179144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636665	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300026
J	Veach, RA; Liu, Y; Zienkiewicz, J; Wylezinski, LS; Boyd, KL; Wynn, JL; Hawiger, J				Veach, Ruth Ann; Liu, Yan; Zienkiewicz, Jozef; Wylezinski, Lukasz S.; Boyd, Kelli L.; Wynn, James L.; Hawiger, Jacek			Survival, bacterial clearance and thrombocytopenia are improved in polymicrobial sepsis by targeting nuclear transport shuttles	PLOS ONE			English	Article							NF-KAPPA-B; INTERCELLULAR-ADHESION MOLECULE-1; E-SELECTIN; INNATE IMMUNITY; P-SELECTIN; INFLAMMATION; EXPRESSION; APOPTOSIS; IMPORT; SUPPRESSION	The rising tide of sepsis, a leading cause of death in the US and globally, is not adequately controlled by current antimicrobial therapies and supportive measures, thereby requiring new adjunctive treatments. Severe microvascular injury and multiple organ failure in sepsis are attributed to a "genomic storm" resulting from changes in microbial and host genomes encoding virulence factors and endogenous inflammatory mediators, respectively. This storm is mediated by stress-responsive transcription factors that are ferried to the nucleus by nuclear transport shuttles importins/karyopherins. We studied the impact of simultaneously targeting two of these shuttles, importin alpha 5 (Imp alpha 5) and importin beta 1 (Imp beta 1), with a cell-penetrating Nuclear Transport Modifier (NTM) in a mouse model of polymicrobial sepsis. NTM reduced nuclear import of stress-responsive transcription factors nuclear factor kappa B, signal transducer and activator of transcription 1 alpha, and activator protein 1 in liver, which was also protected from sepsis-associated metabolic changes. Strikingly, NTM without antimicrobial therapy improved bacterial clearance in blood, spleen, and lungs, wherein a 700-fold reduction in bacterial burden was achieved while production of proinflammatory cytokines and chemokines in blood plasma was suppressed. Furthermore, NTM significantly improved thrombocytopenia, a prominent sign of microvascular injury in sepsis, inhibited neutrophil infiltration in the liver, decreased L-selectin, and normalized plasma levels of E-selectin and P-selectin, indicating reduced microvascular injury. Importantly, NTM combined with antimicrobial therapy extended the median time to death from 42 to 83 hours and increased survival from 30% to 55% (p = 0.022) as compared to antimicrobial therapy alone. This study documents the fundamental role of nuclear signaling mediated by Imp alpha 5 and Imp beta 1 in the mechanism of polymicrobial sepsis and highlights the potential for targeting nuclear transport as an adjunctive therapy in sepsis management.	[Veach, Ruth Ann; Liu, Yan; Zienkiewicz, Jozef; Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Immunotherapy Program, Nashville, TN 37212 USA; [Veach, Ruth Ann; Liu, Yan; Zienkiewicz, Jozef; Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA; [Zienkiewicz, Jozef; Hawiger, Jacek] Tennessee Valley Hlth Care Syst, Dept Vet Affairs, Nashville, TN 37212 USA; [Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Boyd, Kelli L.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Wynn, James L.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Wynn, James L.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hawiger, J (corresponding author), Vanderbilt Univ, Sch Med, Immunotherapy Program, Nashville, TN 37212 USA.; Hawiger, J (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37212 USA.; Hawiger, J (corresponding author), Tennessee Valley Hlth Care Syst, Dept Vet Affairs, Nashville, TN 37212 USA.; Hawiger, J (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	jack.hawiger@vanderbilt.edu		Veach, Ruth Ann/0000-0003-0038-8802; Wylezinski, Lukasz/0000-0001-6481-8379; Hawiger, Jacek/0000-0003-2721-6859; Wynn, James/0000-0001-7052-4836	NIH [P30DK058404, 2P30CA68485]; Vanderbilt Ingram Cancer Center; Department of Medicine at Vanderbilt University; Vanderbilt University Medical Center lmmunotherapy Program; Vanderbilt Clinical and Translational Science Award (CTSA); VA Merit Review Award [1101BX0022750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM106143] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002750] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center; Department of Medicine at Vanderbilt University; Vanderbilt University Medical Center lmmunotherapy Program; Vanderbilt Clinical and Translational Science Award (CTSA); VA Merit Review Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Scholarships for Flow Cytometry Core services were provided by the Vanderbilt University Medical Center Digestive Disease Research Center, supported by NIH grant P30DK058404, and the Vanderbilt Ingram Cancer Center, supported by NIH grant 2P30CA68485. Additional support was provided by the Department of Medicine at Vanderbilt University, the Vanderbilt University Medical Center lmmunotherapy Program, the Vanderbilt Clinical and Translational Science Award (CTSA), and VA Merit Review Award 1101BX0022750. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Baran-Marszak F, 2004, BLOOD, V104, P2475, DOI 10.1182/blood-2003-10-3508; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Charalambous BM, 2012, CURR OPIN PULM MED, V18, P222, DOI 10.1097/MCP.0b013e328352103b; DAVIS CE, 1974, J EXP MED, V140, P159, DOI 10.1084/jem.140.1.159; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; DiGiandomenico A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110183; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Frazier WJ, 2009, J IMMUNOL, V183, P7411, DOI 10.4049/jimmunol.0804343; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hawiger J, 2011, CRIT CARE, V15, DOI 10.1186/cc10482; Herwig MC, 2013, PATHOBIOLOGY, V80, P245, DOI 10.1159/000347062; Hui P, 2011, CHEST, V139, P271, DOI 10.1378/chest.10-2243; Jung TW, 2014, MOL CELL ENDOCRINOL, V391, P30, DOI 10.1016/j.mce.2014.04.012; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; Kroger C., 2016, GENES-BASEL, P8; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Langley RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005893; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05543; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liu Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000093; Lush CW, 2001, AM J PHYSIOL-GASTR L, V280, pG291, DOI 10.1152/ajpgi.2001.280.2.G291; Opal SM, 2010, INT J ANTIMICROB AG, V36, pS70, DOI 10.1016/j.ijantimicag.2010.11.008; Qiu G, 2001, SHOCK, V16, P425, DOI 10.1097/00024382-200116060-00004; Reddy RC, 2001, INFECT IMMUN, V69, P1394, DOI 10.1128/IAI.69.3.1394-1401.2001; Schroeder M, 2017, GENES-BASEL, P8; Steeber DA, 1999, J IMMUNOL, V163, P2176; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; Veach RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030527; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wallington J, 2008, MOL CELL BIOCHEM, V308, P183, DOI 10.1007/s11010-007-9627-y; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WOLFF SM, 1973, J INFECT DIS, V128, pS259, DOI 10.1093/infdis/128.Supplement_1.S259; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Wynn JL, 2016, P NATL ACAD SCI USA, V113, pE2627, DOI 10.1073/pnas.1515793113; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	50	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179468	10.1371/journal.pone.0179468	http://dx.doi.org/10.1371/journal.pone.0179468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628637	gold, Green Submitted, Green Published			2022-12-26	WOS:000404043100033
J	Ho, SC; Jacob, SA; Tangiisuran, B				Ho, Siew Ching; Jacob, Sabrina Anne; Tangiisuran, Balamurugan			Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study	PLOS ONE			English	Article							PRIMARY-CARE; AFRICAN-AMERICANS; PATIENTS BELIEFS; PATIENT TRUST; MEDICATION; PHYSICIAN; ATTITUDES; THERAPY; HARMFULNESS; EXPERIENCES	Background One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD. Methods Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach. Results A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks. Conclusions Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.	[Ho, Siew Ching; Tangiisuran, Balamurugan] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Jacob, Sabrina Anne] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia; [Tangiisuran, Balamurugan] Univ Sains Malaysia, Natl Poison Ctr, WHO Collaborating Ctr Drug Informat, George Town, Malaysia	Universiti Sains Malaysia; Monash University; Monash University Sunway; Universiti Sains Malaysia	Tangiisuran, B (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.; Tangiisuran, B (corresponding author), Univ Sains Malaysia, Natl Poison Ctr, WHO Collaborating Ctr Drug Informat, George Town, Malaysia.	bala@usm.my	Tangiisuran, Balamurugan/E-2708-2012; Jacob, Sabrina Anne/F-8065-2014	Tangiisuran, Balamurugan/0000-0002-4354-3342; Jacob, Sabrina Anne/0000-0001-8012-7789	Universiti Sains Malaysia	Universiti Sains Malaysia(Universiti Sains Malaysia)	This study was funded by a short-term grant from Universiti Sains Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Kadir A.B., 2011, MALAYSIAN J PSYCHIAT, V20, P1; Abel Willie M, 2013, Front Public Health, V1, P66, DOI 10.3389/fpubh.2013.00066; Aikens JE, 2008, ANN FAM MED, V6, P23, DOI 10.1370/afm.759; Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238; Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11; Alekhya P, 2015, J DEPRESS ANXIETY, V4, P2167; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson C, 2013, RES SOC ADMIN PHARM, V9, P884, DOI 10.1016/j.sapharm.2012.11.002; [Anonymous], 2011, WHY MEDICATIONS GIVE; Ariff Kamil M, 2006, Aust J Rural Health, V14, P2, DOI 10.1111/j.1440-1584.2006.00747.x; Banerjee S., 2013, DEPRESSION RES TREAT, V2013, P12; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Brown C, 2007, GEN HOSP PSYCHIAT, V29, P492, DOI 10.1016/j.genhosppsych.2007.07.007; Bryant A., 2007, INTRO GROUNDED THEOR; Bureau USC, 2010, THE AMERICAN COMMUNI; Chagnon J., 2013, MIGRATION INT 2010 2; Chakraborty K, 2009, SOC PSYCH PSYCH EPID, V44, P482, DOI 10.1007/s00127-008-0468-0; Chong S. T., 2013, ASIAN SOCIAL SCI, V9, P1, DOI [DOI 10.5539/ASS.V9N6P1, DOI 10.5539/ass.v9n6p1]; Chong WW, 2013, PATIENT PREFER ADHER, V7, P813, DOI 10.2147/PPA.S48486; Clatworthy J, 2007, BIPOLAR DISORD, V9, P656, DOI 10.1111/j.1399-5618.2007.00434.x; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; Clifford S, 2006, PHARM WORLD SCI, V28, P165, DOI 10.1007/s11096-006-9026-6; Creswell J. W., 2013, QUALITATIVE INQUIRY; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; Delamater AM, 2006, CLIN DIABETES, V24, P71, DOI 10.2337/diaclin.24.2.71.; Deva MP, 2004, INT REV PSYCHIATR, V16, P167, DOI 10.1080/09540260310001635203; DiBonaventura M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-20; Din RM, 2014, PHARM VALUE ADDED SE; Epstein R., 2007, PATIENT CENTERED COM; Fedrick Francis, 2012, East Afr J Public Health, V9, P90; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Haque A, 2005, J MENT HEALTH, V14, P183, DOI DOI 10.1080/09638230500059997; Hatah E, 2015, PATIENT PREFER ADHER, V9, P589, DOI 10.2147/PPA.S79477; Ho SC, 2016, J AFFECT DISORDERS, V193, P1, DOI 10.1016/j.jad.2015.12.029; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 2004, SOC SCI MED, V59, P1307, DOI 10.1016/j.socscimed.2004.01.009; Hunot Vivien M, 2007, Prim Care Companion J Clin Psychiatry, V9, P91; Institute for Public Health, 2011, NAT HLTH MORB SURV N; Jacob SA, 2015, NEUROPSYCH DIS TREAT, V11, P1339, DOI 10.2147/NDT.S82563; Jacobs AK, 2005, CIRCULATION, V111, P3494, DOI 10.1161/CIRCULATIONAHA.105.166277; Jacobs EA, 2006, J GEN INTERN MED, V21, P642, DOI 10.1111/j.1525-1497.2006.00485.x; Jorm AF, 2005, J AFFECT DISORDERS, V88, P47, DOI 10.1016/j.jad.2005.06.002; Kerse N, 2004, ANN FAM MED, V2, P455, DOI 10.1370/afm.139; Kessing LV, 2005, PSYCHOL MED, V35, P1205, DOI 10.1017/S0033291705004605; Khan MU, 2014, J PHARM BIOALLIED SC, V6, P104, DOI 10.4103/0975-7406.129175; Khan Tahir M, 2010, Ment Health Fam Med, V7, P27; Kim SC, 2008, MIL MED, V173, P85, DOI 10.7205/MILMED.173.1.85; Kramer EJ, 2002, WESTERN J MED, V176, P227; LEVENTHAL H, 1992, COGNITIVE THER RES, V16, P143, DOI 10.1007/BF01173486; Leventhal H, 2003, SELF REGULATION HLTH, P42, DOI DOI 10.1093/RHEUMATOLOGY/KEM060; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Lincoln TM, 2007, SCHIZOPHRENIA BULL, V33, P1324, DOI 10.1093/schbul/sbm002; Lingam R, 2002, ACTA PSYCHIAT SCAND, V105, P164, DOI 10.1034/j.1600-0447.2002.1r084.x; Martin RW, 2008, J RHEUMATOL, V35, P618; Mason M, 2010, COMMUNICATION; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mukhtar F, 2011, CURR PSYCHIATRY REV, V7, P234, DOI 10.2174/157340011797183201; Murata A, 2012, PATIENT PREFER ADHER, V6, P863, DOI 10.2147/PPA.S36295; Na E, 2015, PSYCHIAT CLIN NEUROS, V69, P298, DOI 10.1111/pcn.12272; Nguyen GC, 2009, INFLAMM BOWEL DIS, V15, P1233, DOI 10.1002/ibd.20883; Novick D, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0560-4; Ogedegbe G, 2004, ETHNIC DIS, V14, P3; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pelaez S, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0044-9; Razali SM, 1996, ACTA PSYCHIAT SCAND, V94, P229, DOI 10.1111/j.1600-0447.1996.tb09854.x; Rossom RC, 2016, DEPRESS ANXIETY, V33, P765, DOI 10.1002/da.22532; Sawada N, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-38; Sbaraini A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-128; Schofield P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X567045; Schraufnagel TJ, 2008, FOCUS, V6, P517; Singh JA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4524; Sirey JA, 2010, AM J GERIAT PSYCHIAT, V18, P554, DOI 10.1097/JGP.0b013e3181cdeb7d; Sohal T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136202; Statistics ABo, 2001, POP COMP AS BORN AUS; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Tamburrino Marijo B, 2009, Prim Care Companion J Clin Psychiatry, V11, P205, DOI 10.4088/PCC.08m00694; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van Grieken RA, 2014, J AFFECT DISORDERS, V167, P153, DOI 10.1016/j.jad.2014.05.065; Wasti SP, 2012, J HEALTH POPUL NUTR, V30, P410; WHO, 2001, WORLD HLTH REPORT 20	84	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179290	10.1371/journal.pone.0179290	http://dx.doi.org/10.1371/journal.pone.0179290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614368	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000403280900040
J	Jirak, D; Janacek, J				Jirak, Daniel; Janacek, Jiri			Volume of the crocodilian brain and endocast during ontogeny	PLOS ONE			English	Article								Understanding complex situations and planning difficult actions require a brain of appropriate size. Animal encephalisation provides an indirect information about these abilities. The brain is entirely composed of soft tissue and, as such, rarely fossilises. As a consequence, the brain proportions and morphology of some extinct vertebrates are usually only inferred from their neurocranial endocasts. However, because the morphological configuration of the brain is not fully reflected in the endocast, knowledge of the brain/endocast relationship is essential (especially the ratio of brain volume to endocast volume or the equivalent proportion of interstitial tissue) for studying the endocasts of extinct animals. Here we assess the encephalic volume and structure of modern crocodilians. The results we obtained using ex vivo magnetic resonance imaging reveal how the endoneurocranial cavity and brain compartments of crocodilians change configuration during ontogeny. We conclude that the endocasts of adult crocodilians are elongated and expanded while their brains are more linearly organised. The highest proportion of brain tissue to endocast volume is in the prosencephalon at over 50% in all but the largest animals, whereas the proportion in other brain segments is under 50% in all but the smallest animals and embryos. Our results may enrich the field of palaeontological study by offering more precise phylogenetic interpretations of the neuroanatomic characteristics of extinct vertebrates at various ontogenetic stages.	[Jirak, Daniel] Inst Clin & Expt Med, MR Unit, Dept Diagnost & Intervent Radiol, Prague, Czech Republic; [Jirak, Daniel] Charles Univ Prague, Fac Med 1, Inst Biophys & Informat, Prague, Czech Republic; [Janacek, Jiri] Czech Acad Sci, Inst Physiol, Dept Biomath, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Jirak, D (corresponding author), Inst Clin & Expt Med, MR Unit, Dept Diagnost & Intervent Radiol, Prague, Czech Republic.; Jirak, D (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biophys & Informat, Prague, Czech Republic.	daniel.jirak@ikem.cz	Jirak, Daniel/Q-5357-2017; Jirak, Daniel/AAH-2269-2022; Janacek, Jiri/B-7932-2012; Jirak, Daniel/AFL-9989-2022	Jirak, Daniel/0000-0001-6834-3462; Jirak, Daniel/0000-0001-6834-3462; Janacek, Jiri/0000-0003-0286-4999; Jirak, Daniel/0000-0001-6834-3462	Czech Science Foundation [P302/12/1207, 13-12412S]	Czech Science Foundation(Grant Agency of the Czech Republic)	D.J. and J.J. were funded by the Czech Science Foundation (P302/12/1207). J.J. was also funded by the Czech Science Foundation (13-12412S). We thank Martin Kundrat for providing crocodilian sample collection.	Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Brasier MD, 2016, SPECIAL PUBLICATIONS; Brusatte SL, 2013, B AM MUS NAT HIST, P3; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; De Groof G, 2016, BRAIN STRUCT FUNCT, V221, P1899, DOI 10.1007/s00429-015-1011-1; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Ferguson M.W.J., 1985, Biology of Reptilia, V14, P329; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Hopson JA, 1979, BIOL REPTILIA; Hurlburt G. R., 2013, TYRANNOSAURID PALEOB, P134; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Jirak D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16002; Kawabe S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129939; Kotrotsou A, 2014, MAGN RESON MED, V71, P364, DOI 10.1002/mrm.24661; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; MACE GM, 1981, J ZOOL, V193, P333; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Rogers SW, 1999, ANAT RECORD, V257, P162; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855	20	32	32	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178491	10.1371/journal.pone.0178491	http://dx.doi.org/10.1371/journal.pone.0178491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614349	Green Submitted, Green Published, gold			2022-12-26	WOS:000403280900018
J	Rodrigues, BL; Canto, ACVDS; da Costa, MP; da Silva, FA; Marsico, ET; Conte, CA				Rodrigues, Bruna Leal; Vilhena da Cruz Silva Canto, Anna Carolina; da Costa, Marion Pereira; da Silva, Flavio Alves; Marsico, Eliane Teixeira; Conte-Junior, Carlos Adam			Fatty acid profiles of five farmed Brazilian freshwater fish species from different families	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; BRYCON-CEPHALUS; LIPID PROFILES; MARINE FISH; SHELF-LIFE; TELEOSTEI; OMEGA-3-FATTY-ACIDS; MUSCLE; SEASON	The proximate composition and fatty acid (FA) profiles of five Brazilian freshwater fish species, namely Brycon cephalus (BC), Cichla ocellaris (CO), Prochilodus lineatus (PL), Leporinus friderici (LF) and Pseudoplatystoma corruscans (PCO), were investigated. CO and LF exhibited the highest (p < 0.05) moisture content, as well as one of the lowest (p < 0.05) lipid values, whereas BC presented the lowest (p < 0.05) moisture and, alongside PL, the highest (p < 0.05) lipid content. The predominant FAs in the evaluated fish species were palmitic, oleic, linoleic and docosahexaenoic acids. BC and CO presented high n-3 PUFA content, especially DHA, and demonstrated superior nutritional quality indices compared to the other evaluated fish species. Furthermore, a significant relationship was observed among these species, suggesting they possess similar nutritional lipid values. Thus, BC and CO were proven to be an excellent matrix with relevant lipid quality, desirable for human health.	[Rodrigues, Bruna Leal; Vilhena da Cruz Silva Canto, Anna Carolina; da Costa, Marion Pereira; Marsico, Eliane Teixeira; Conte-Junior, Carlos Adam] Univ Fed Fluminense, Fac Vet, Dept Tecnol Alimentos, Niteroi, RJ, Brazil; [da Costa, Marion Pereira; Conte-Junior, Carlos Adam] Univ Fed Rio de Janeiro, Inst Quim, Programa Ciencia Alimentos, Rio De Janeiro, Brazil; [da Silva, Flavio Alves] Univ Fed Goias, Escola Agron, Setor Engn Alimentos, Jatai, Go, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal de Goias	Rodrigues, BL (corresponding author), Univ Fed Fluminense, Fac Vet, Dept Tecnol Alimentos, Niteroi, RJ, Brazil.	brunaleal@id.uff.br	Marsico, Eliane/AAQ-7766-2021; SILVA, FLAVIO/AAC-6943-2019; Costa, Marion/AAL-1269-2020; Silva, Flávio/ABA-6664-2020; Conte-Junior, Carlos A./J-5815-2014	SILVA, FLAVIO/0000-0002-3619-755X; Costa, Marion/0000-0002-3003-6763; Conte-Junior, Carlos A./0000-0001-6133-5080; Marsico, Eliane/0000-0001-9452-5462	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ, Brazil [E-26/201.185/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil [311361/2013-7, 400136/2014-7, 155693/2016-6, 166186/2015-5, 157525/2015-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES, Brazil [125]; Coordination of Enhancement of People of a Superior Level (CAPES, Brazil) graduate scholarship	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordination of Enhancement of People of a Superior Level (CAPES, Brazil) graduate scholarship	The authors thank the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ, Brazil, http://www.faper.br/ (grant E-26/201.185/2014, CACJ), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil, http://www.cnpq.br/ (grants 311361/2013-7, CACJ; 400136/2014-7, CACJ; 155693/2016-6, BLR; 166186/2015-5, BLR; and 157525/2015-5, ACVCSC), and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES, Brazil, https://www.capes.gov.br/ (grant 125, CAPES/Embrapa 2014, MPC) for financial support. BLR was supported by a Coordination of Enhancement of People of a Superior Level (CAPES, Brazil) graduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1989, PROG FOOD NUTR SCI, V13, P161; Albrecht MP, 2003, STUD NEOTROP FAUNA E, V38, P33, DOI 10.1076/snfe.38.1.33.14033; Almeida NM, 2007, J SCI FOOD AGR, V87, P2596, DOI 10.1002/jsfa.3014; ANDRADE AD, 1995, J AM OIL CHEM SOC, V72, P1207, DOI 10.1007/BF02540990; AOAC, 2012, OFF METH AN AOAC; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOMFIM M.A.D, 2004, REV ELETRONICA NUTRI, V1, P20; Boscolo W.R., 2011, REV BRAS ZOOTECN, V40, P145; Brazilian Health Ministry, MORT IND SPEC MORT R; BUDDINGTON RK, 1987, J PHYSIOL-LONDON, V393, P261, DOI 10.1113/jphysiol.1987.sp016823; Castagnolli N, 1979, FUNDAMENTOS NUTR PEI; Celik M, 2005, FOOD CHEM, V92, P637, DOI 10.1016/j.foodchem.2004.08.026; Chan AS, 2004, J FISH BIOL, V65, P848, DOI 10.1111/j.0022-1112.2004.00495.x; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; Department of Health and Social Security, 1984, REP HLTH SOC SUBJ, V28, P443; *EUR FOOD SAF AUTH, 2009, EFSA J, V1013, P1; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ O; Fernandes CE, 2014, FOOD CHEM, V160, P67, DOI 10.1016/j.foodchem.2014.03.055; Figueiredo-Garutti ML, 2002, COMP BIOCHEM PHYS A, V132, P467, DOI 10.1016/S1095-6433(02)00094-6; Fishery and Aquaculture Country Profiles, 2010, FISH AQ COUNTR PROF; Fishery and Aquaculture Country Profiles, 2013, FISH AQ COUNTR PROF; German DP, 2006, MAR BIOL, V148, P1123, DOI 10.1007/s00227-005-0149-4; Giaquinto PC, 2005, ACTA ETHOL, V8, P65, DOI 10.1007/s10211-005-0001-3; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; HMSO UK, 1994, NUTR ASP CARD DIS; HOFER R, 1981, OECOLOGIA, V48, P342, DOI 10.1007/BF00346492; Huss HH, 1995, FAO FISH TECH PAP, V348, P130; IMO, 2016, GUID DEV SHIP EN EFF; Inhamuns AJ, 2008, FOOD CHEM, V107, P587, DOI 10.1016/j.foodchem.2007.07.032; Inhamuns AJ, 2009, FOOD CHEM, V117, P272, DOI 10.1016/j.foodchem.2009.03.113; Jabeen F, 2011, FOOD CHEM, V125, P991, DOI 10.1016/j.foodchem.2010.09.103; Kishino S, 2002, BIOSCI BIOTECH BIOCH, V66, P2283, DOI 10.1271/bbb.66.2283; Liu JJ, 2015, BRAIN RES, V1597, P220, DOI 10.1016/j.brainres.2014.11.059; Logato PVR, 1998, ANATOMIA FUNCIONAL F; Louly AWOA, 2011, FOOD CHEM, V124, P24, DOI 10.1016/j.foodchem.2010.05.097; Luzia LA, 2003, FOOD CHEM, V83, P93, DOI 10.1016/S0308-8146(03)00054-2; Macdiarmid JI, 2013, P NUTR SOC, V72, P13, DOI 10.1017/S0029665112002893; Mansure AD, 2012, ARQ BRAS CARDIOL, V99, P755; Memon NN, 2011, FOOD CHEM, V126, P405, DOI 10.1016/j.foodchem.2010.10.107; Mert R, 2015, CHIN J OCEANOL LIMN, V33, P70, DOI 10.1007/s00343-015-4025-x; Moreira AB, 2001, J FOOD COMPOS ANAL, V14, P565, DOI 10.1006/jfca.2001.1025; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nachi AM, 1998, ANN SCI NAT ZOOL, V19, P81, DOI 10.1016/S0003-4339(98)80002-6; Novaes J.L.C., 2004, Acta Limnologica Brasiliensia, V16, P41; Osman H, 2001, FOOD CHEM, V73, P55, DOI 10.1016/S0308-8146(00)00277-6; Ozogul Y, 2007, FOOD CHEM, V103, P217, DOI 10.1016/j.foodchem.2006.08.009; Rasoarahona JRE, 2005, FOOD CHEM, V91, P683, DOI 10.1016/j.foodchem.2004.07.001; Rebole A, 2015, FOOD CHEM, V174, P614, DOI 10.1016/j.foodchem.2014.11.072; REIMER G, 1982, J FISH BIOL, V21, P637, DOI 10.1111/j.1095-8649.1982.tb02867.x; Rodrigues BL, 2016, FOOD CONTROL, V60, P596, DOI 10.1016/j.foodcont.2015.09.004; Rotta MA., 2003, ASPECTOS GERAIS DA F; Santos-Silva J, 2002, LIVEST PROD SCI, V77, P187, DOI 10.1016/S0301-6226(02)00059-3; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; STANSBY ME, 1976, MAR FISH REV, V38, P1; Suplicy F. M., 2007, FAO Fisheries Technical Paper, P129; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Ugoala C., 2009, Brazilian Journal of Aquatic Science and Technology, V13, P65; ULBRICHT TLV, 1991, LANCET, V338, P985, DOI 10.1016/0140-6736(91)91846-M; Volpe MG, 2015, LWT-FOOD SCI TECHNOL, V60, P615, DOI 10.1016/j.lwt.2014.08.048; Zhu HY, 2010, J NUTR BIOCHEM, V21, P954, DOI 10.1016/j.jnutbio.2009.07.011	62	26	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178898	10.1371/journal.pone.0178898	http://dx.doi.org/10.1371/journal.pone.0178898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614390	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900023
J	Hinlo, R; Gleeson, D; Lintermans, M; Furlan, E				Hinlo, Rheyda; Gleeson, Dianne; Lintermans, Mark; Furlan, Elise			Methods to maximise recovery of environmental DNA from water samples	PLOS ONE			English	Article							ROOM-TEMPERATURE PRESERVATION; EDNA; BIODIVERSITY; CAPTURE; FILTRATION; ABUNDANCE; HOLOCENE	The environmental DNA (eDNA) method is a detection technique that is rapidly gaining credibility as a sensitive tool useful in the surveillance and monitoring of invasive and threatened species. Because eDNA analysis often deals with small quantities of short and degraded DNA fragments, methods that maximize eDNA recovery are required to increase detectability. In this study, we performed experiments at different stages of the eDNA analysis to show which combinations of methods give the best recovery rate for eDNA. Using Oriental weatherloach (Misgurnus anguillicaudatus) as a study species, we show that various combinations of DNA capture, preservation and extraction methods can significantly affect DNA yield. Filtration using cellulose nitrate filter paper preserved in ethanol or stored in a -20 degrees C freezer and extracted with the Qiagen DNeasy kit outperformed other combinations in terms of cost and efficiency of DNA recovery. Our results support the recommendation to filter water samples within 24hours but if this is not possible, our results suggest that refrigeration may be a better option than freezing for short-term storage (i.e., 3-5 days). This information is useful in designing eDNA detection of low-density invasive or threatened species, where small variations in DNA recovery can signify the difference between detection success or failure.	[Hinlo, Rheyda; Gleeson, Dianne; Lintermans, Mark; Furlan, Elise] Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia	University of Canberra	Hinlo, R (corresponding author), Univ Canberra, Inst Appl Ecol, Bruce, ACT, Australia.	Rheyda.Hinlo@canberra.edu.au		Hinlo, Rheyda/0000-0002-3391-4859; Lintermans, Mark/0000-0003-2369-0932; Furlan, Elise/0000-0002-1642-9819	Invasive Animals Cooperative Research Centre [1.W.2]	Invasive Animals Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This project was funded by the Invasive Animals Cooperative Research Centre through Project 1.W.2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg JJ, 2015, J GREAT LAKES RES; [Anonymous], 2013, INT J ZOOL, DOI DOI 10.1155/2013/174056; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Cabrita E, 2005, CRYOBIOLOGY, V50, P144, DOI 10.1016/j.cryobiol.2004.12.003; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Eichmiller JJ, 2016, MOL ECOL RESOUR, V16, P56, DOI 10.1111/1755-0998.12421; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Fraser L, 2005, REPROD DOMEST ANIM, V40, P530, DOI 10.1111/j.1439-0531.2005.00626.x; Furlan EM, 2016, MOL ECOL RESOUR, V16, P641, DOI 10.1111/1755-0998.12483; Gaillard C., 1998, TECHNICAL TIPS ONLIN, V3, P63, DOI [10.1016/s1366-2120(08)70101-6, DOI 10.1016/S1366-2120(08)70101-6]; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hartman LJ, 2005, MOL CELL PROBE, V19, P51, DOI 10.1016/j.mcp.2004.07.006; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Koster WM, 2002, SCOPING STUDY POTENT; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Liang ZB, 2013, ENVIRON SCI TECHNOL, V47, P9324, DOI 10.1021/es401342b; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Minamoto T, 2016, LIMNOLOGY, V17, P23, DOI 10.1007/s10201-015-0457-4; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Piggott MP, 2016, ECOL EVOL, V6, P2739, DOI 10.1002/ece3.2083; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Renshaw MA, 2015, MOL ECOL RESOUR, V15, P168, DOI 10.1111/1755-0998.12281; Robson HLA, 2016, MOL ECOL RESOUR, V16, P922, DOI 10.1111/1755-0998.12505; Schultz MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141503; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spens J, 2016, METHODS ECOLOGY EVOL; Strand DA, 2011, DIS AQUAT ORGAN, V95, P9, DOI 10.3354/dao02334; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Takahara T, 2015, BIOL CONSERV, V183, P64, DOI 10.1016/j.biocon.2014.11.014; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Thomsen P. F., 2012, PLOS ONE, V7; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Thornton DJ, 1996, MOL BIOTECHNOL, V5, P171, DOI 10.1007/BF02789065; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Turner CR, 2014, BIORXIV; Wegleitner BJ, 2015, CONSERV GENET RESOUR, V7, P789, DOI 10.1007/s12686-015-0483-x; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Willerslev E, 1999, P NATL ACAD SCI USA, V96, P8017, DOI 10.1073/pnas.96.14.8017; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; Yamanaka H, 2016, ECOL RES, V31, P963, DOI 10.1007/s11284-016-1400-9	57	97	106	5	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179251	10.1371/journal.pone.0179251	http://dx.doi.org/10.1371/journal.pone.0179251			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604830	gold, Green Published, Green Submitted			2022-12-26	WOS:000403088400044
J	Nam, SS; Ko, YC; Alouini, MS; Choi, S				Nam, Sung Sik; Ko, Young-Chai; Alouini, Mohamed-Slim; Choi, Seyeong			Statistical analysis on finger replacement schemes for RAKE receivers in the soft handover region with multiple BSs over i.n.d. fading channels	PLOS ONE			English	Article							UNIFIED FRAMEWORK; JOINT STATISTICS; PARTIAL-SUMS; MODEL	A new finger replacement technique which is applicable for RAKE receivers in the soft hand-over region has been proposed and studied under the ideal assumption that the fading is both independent and identically distributed from path to path. To supplement our previous work, we present a general comprehensive framework for the performance assessment of the proposed finger replacement schemes operating over independent but non-identically distributed (i.n.d.) faded paths. To accomplish this object, we derive new closed-form expressions for the target key statistics which are composed of i.n.d. exponential random variables. With these new expressions, the performance analysis of various wireless communication systems over more practical channel environments can be possible.	[Nam, Sung Sik; Ko, Young-Chai] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Alouini, Mohamed-Slim] KAUST, Dept Elect Engn, Thuwal, Makkah Province, Saudi Arabia; [Choi, Seyeong] Wonkwang Univ, Dept Informat & Commun Engn, Jeonbuk, South Korea	Korea University; King Abdullah University of Science & Technology; Wonkwang University	Choi, S (corresponding author), Wonkwang Univ, Dept Informat & Commun Engn, Jeonbuk, South Korea.	sychoi@wku.ac.kr	Alouini, Mohamed-Slim/I-2658-2018	Alouini, Mohamed-Slim/0000-0003-4827-1793	Wonkwang University	Wonkwang University	This paper was supported by Wonkwang University in 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouini MS, 2000, IEEE T COMMUN, V48, P401, DOI 10.1109/26.837044; Annamalai A, 2005, IEEE T COMMUN, V53, P1027, DOI 10.1109/TCOMM.2005.849742; Cassioli D., 2012, 2012 IEEE International Conference on Ultra-Wideband (ICUWB2012), P145, DOI 10.1109/ICUWB.2012.6340429; Choi S, 2008, IEEE T VEH TECHNOL, V57, P2114, DOI 10.1109/TVT.2007.912162; Choi S, 2008, IEEE T WIREL COMMUN, V7, P1152, DOI 10.1109/TWC.2008.060902; Choi S, 2008, IEEE T WIREL COMMUN, V7, P495, DOI 10.1109/TWC.2008.060814; Choi S, 2008, IEEE T COMMUN, V56, P213, DOI 10.1109/TCOMM.2008.060340; Di Renzo M, 2015, IEEE T WIREL COMMUN, V14, P5038, DOI 10.1109/TWC.2015.2431689; Erceg V, 1999, IEEE J SEL AREA COMM, V17, P399, DOI 10.1109/49.753726; HASHEMI H, 1993, IEEE J SEL AREA COMM, V11, P967, DOI 10.1109/49.233210; Kumaravel R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115710; Mo YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142775; Nam SS, 2013, IEEE INT SYMP INFO, P56, DOI 10.1109/ISIT.2013.6620187; Nam SS, 2014, IEEE T SIGNAL PROCES, V62, P4270, DOI 10.1109/TSP.2014.2326624; Nam SS, 2010, IEEE T INFORM THEORY, V56, P5655, DOI 10.1109/TIT.2010.2070271; Papoulis A., 1991, PROBABILITY RANDOM V; Rinaldi C, 2014, IEEE I C ULTRA-WIDEB, P379, DOI 10.1109/ICUWB.2014.6959011; Shang Y., FILOMAT; Shang Y., ASIAN JOURNAL OF MAT; Stegun IA., 1970, HDB MATH FUNCTIONS; Tham ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148625; TURIN GL, 1972, IEEE T VEH TECHNOL, VVT21, P1, DOI 10.1109/T-VT.1972.23492; Yang HC, 2006, IEEE T WIREL COMMUN, V5, P1876, DOI 10.1109/TWC.2006.04595	23	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179126	10.1371/journal.pone.0179126	http://dx.doi.org/10.1371/journal.pone.0179126			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604831	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400029
J	Feng, J; Yang, H; Zhang, Y; Wei, H; Zhu, Z; Zhu, B; Yang, M; Cao, W; Wang, L; Wu, Z				Feng, J.; Yang, H.; Zhang, Y.; Wei, H.; Zhu, Z.; Zhu, B.; Yang, M.; Cao, W.; Wang, L.; Wu, Z.			Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells	ONCOGENE			English	Article							IMMUNE CHECKPOINT BLOCKADE; AEROBIC GLYCOLYSIS; RECEPTOR; PROTEIN; MECHANISM; SURVIVAL; PATHWAY	The clinical success of immunotherapy that inhibits the negative immune regulatory pathway programmed cell death protein 1/PD-1 ligand (PD-1/PD-L1) has initiated a new era in the treatment of metastatic cancer. PD-L1 expression is upregulated in many solid tumors including lung cancer and functions predominantly in lactate-enriched tumor microenvironments. Here, we provided evidence for PD-L1 induction in response to lactate stimulation in lung cancer cells. Lactate-induced PD-L1 induction was mediated by its receptor GPR81. The silencing of GPR81 signaling in lung cancer cells resulted in a decrease in PD-L1 protein levels and functional inactivation of PD-L1 promoter activity. In addition, GPR81-mediated upregulation of PD-L1 in glucose-stimulated lung cancer cells that recapitulates the enhanced glycolysis in vivo was dependent on lactate dehydrogenase A (LDHA). We also demonstrated that activation of GPR81 decreases intracellular cAMP levels and inhibits protein kinase A (PKA) activity, leading to activation of the transcriptional coactivator TAZ. Interaction of TAZ with the transcription factor TEAD was essential for TAZ activation of PD-L1 and induction of its expression. Furthermore, we found that lactate-induced activation of PD-L1 in tumor cells led to reduced production of interferon-gamma and induction of apoptosis of cocultured Jurkat T-cell leukemia cells. Our findings reveal an unexpected role of lactate in contributing to tumor cell protection from cytotoxic T-cell targeting and establishes a direct connection between tumor cell metabolic reprograming and tumor evasion from the immune response.	[Feng, J.; Wang, L.] Wannan Med Coll, Affiliated Hosp 1, Med Oncol, Wuhu, Peoples R China; [Yang, H.] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Ctr & Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Zhang, Y.; Wu, Z.] Wannan Med Coll, Anhui Prov Key Lab Act Biol Macromol Res, Wuhu, Peoples R China; [Wei, H.] Wannan Med Coll, Dept Cent Lab, Wuhu, Peoples R China; [Zhu, Z.] Wannan Med Coll, Sch Pharm, Wuhu, Peoples R China; [Zhu, Z.] Wannan Med Coll, Sch Forens Med, Wuhu, Peoples R China; [Yang, M.; Cao, W.] Wannan Med Coll, Sch Anesthesiol, Wuhu, Peoples R China; [Wang, L.; Wu, Z.] Wannan Med Coll, Sch Preclin Med, 22 Wenchang West Rd, Wuhu 241001, Peoples R China	Wannan Medical College; Tianjin Medical University; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College; Wannan Medical College	Wang, L; Wu, Z (corresponding author), Wannan Med Coll, Sch Preclin Med, 22 Wenchang West Rd, Wuhu 241001, Peoples R China.	lucyyjs@163.com; zwu2ster@163.com		Yang, Hui/0000-0002-3938-9530	National Natural Science Foundation of China [81272359]; Wannan Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wannan Medical College	We thank Dr Hen Wu (Tianjin Lung Cancer Center and Institute, Tianjin Medical University General Hospital) for helping with the correlation analysis in a data set obtained from GEO, and Sean Hackett (Johns Hopkins University) for critical reading and revising of this manuscript. This work was supported by the National Natural Science Foundation of China (81272359 to ZW) and introduction of high-level scientific research start-up fund by Wannan Medical College (to ZW).	Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Kuei C, 2011, MOL PHARMACOL, V80, P848, DOI 10.1124/mol.111.074500; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Lipson EJ, 2015, SEMIN ONCOL, V42, P587, DOI 10.1053/j.seminoncol.2015.05.013; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Roland CL, 2014, CANCER RES, V74, P5301, DOI 10.1158/0008-5472.CAN-14-0319; Shimomura T, 2014, BIOCHEM BIOPH RES CO, V443, P917, DOI 10.1016/j.bbrc.2013.12.100; Topalian SL, 2016, NAT REV CANCER, V16, P275, DOI 10.1038/nrc.2016.36; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Walenta S, 2004, CURR MED CHEM, V11, P2195, DOI 10.2174/0929867043364711; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	26	154	160	10	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5829	5839		10.1038/onc.2017.188	http://dx.doi.org/10.1038/onc.2017.188			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28604752				2022-12-26	WOS:000413292900005
J	Rodionova, IA; Zhang, ZG; Mehla, J; Goodacre, N; Babu, M; Emili, A; Uetz, P; Saier, MH				Rodionova, Irina A.; Zhang, Zhongge; Mehla, Jitender; Goodacre, Norman; Babu, Mohan; Emili, Andrew; Uetz, Peter; Saier, Milton H., Jr.			The phosphocarrier protein HPr of the bacterial phosphotransferase system globally regulates energy metabolism by directly interacting with multiple enzymes in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adenylate kinase (ADK); glycolysis; phosphofructokinase; protein-protein interaction; pyruvate kinase; Histidine phosphocarrier protein; adenylate kinase; glucosamine 6-phosphate deaminase; isomerase	GLUCOSAMINE-6-PHOSPHATE DEAMINASE; ALLOSTERIC ACTIVATION; GLYCOGEN-PHOSPHORYLASE; SUBSTRATE-BINDING; PYRUVATE-KINASE; PHOSPHOENOLPYRUVATE; REPRESSION; PATHOGEN; COMPLEX; DOMAIN	The histidine-phosphorylatable phosphocarrier protein (HPr) is an essential component of the sugar-transporting phosphotransferase system (PTS) in many bacteria. Recent interactome findings suggested that HPr interacts with several carbohydrate-metabolizing enzymes, but whether HPr plays a regulatory role was unclear. Here, we provide evidence that HPr interacts with a large number of proteins in Escherichia coli. We demonstrate HPr-dependent allosteric regulation of the activities of pyruvate kinase (PykF, but not PykA), phosphofructokinase (PfkB, but not PfkA), glucosamine-6-phosphate deaminase (NagB), and adenylate kinase (Adk). HPr is either phosphorylated on a histidyl residue (HPr-P) or non-phosphorylated (HPr). PykF is activated only by non-phosphorylated HPr, which decreases the PykF K-half for phosphoenolpyruvate by 10-fold (from 3.5 to 0.36 mm), thus influencing glycolysis. PfkB activation by HPr, but not by HPr-P, resulted from a decrease in the K-half for fructose-6-P, which likely influences both gluconeogenesis and glycolysis. Moreover, NagB activation by HPr was important for the utilization of amino sugars, and allosteric inhibition of Adk activity by HPr-P, but not by HPr, allows HPr to regulate the cellular energy charge coordinately with glycolysis. These observations suggest that HPr serves as a directly interacting global regulator of carbon and energy metabolism and probably of other physiological processes in enteric bacteria.	[Rodionova, Irina A.; Zhang, Zhongge; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA; [Mehla, Jitender; Goodacre, Norman; Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA; [Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK S4S 0A2, Canada; [Emili, Andrew] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada	University of California System; University of California San Diego; Virginia Commonwealth University; University of Regina; University of Toronto	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, San Diego, CA 92093 USA.	msaier@ucsd.edu	Mohan, Babu P./I-7362-2019; Mehla, Jitender/M-6165-2016; Uetz, Peter/A-7119-2012	Mehla, Jitender/0000-0002-7829-557X; Goodacre, Norman/0000-0003-4995-2822; Saier, Milton/0000-0001-5530-0017; Uetz, Peter/0000-0001-6194-4927	National Institutes of Health [GM109895]; Canadian Institutes of Health Research [MOP-106449, PJT-148831]; Natural Sciences and Engineering Research Council of Canada Grant [DG-20234]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402, R01GM109895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM109895. The interactome data reported in supplemental Table S1 was supported by National Institutes of Health Grant GM109895 as well as the Canadian Institutes of Health Research Grants MOP-106449 (to A. E.) and PJT-148831 (to M. B.) and Natural Sciences and Engineering Research Council of Canada Grant DG-20234 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTAMIRANO MM, 1995, BIOCHEMISTRY-US, V34, P6074, DOI 10.1021/bi00018a010; Alvarez-Anorve LI, 2016, J BACTERIOL, V198, P1610, DOI 10.1128/JB.00870-15; Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010; Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09; Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; BABUL J, 1978, J BIOL CHEM, V253, P4350; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Boel G, 2003, J MOL MICROB BIOTECH, V5, P206, DOI 10.1159/000071072; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Choe M, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43431; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Fawzi NL, 2010, P NATL ACAD SCI USA, V107, P1379, DOI 10.1073/pnas.0909370107; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Jung YS, 2012, J BIOL CHEM, V287, P23819, DOI 10.1074/jbc.M112.371492; Kim HM, 2015, MOL MICROBIOL, V96, P293, DOI 10.1111/mmi.12936; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; Ping J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/628536; Porcheron G, 2016, CURR OPIN MICROBIOL, V30, P98, DOI 10.1016/j.mib.2016.01.008; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; Ravcheev DA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00294; Reichenbach B, 2007, J BACTERIOL, V189, P4603, DOI 10.1128/JB.00236-07; Rodionova IA, 2012, J BACTERIOL, V194, P5552, DOI 10.1128/JB.01136-12; Ryabov Y, 2009, J AM CHEM SOC, V131, P9522, DOI 10.1021/ja902336c; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Saier M. H, 1987, ENZYMES METABOLIC PA; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; SAIER MH, 1976, J BIOL CHEM, V251, P6598; Saier MH, 1996, MICROBIOL-UK, V142, P217, DOI 10.1099/13500872-142-2-217; Schrank TP, 2013, TOP CURR CHEM, V337, P95, DOI 10.1007/128_2012_410; Schwieters CD, 2010, J AM CHEM SOC, V132, P13026, DOI 10.1021/ja105485b; Seok YJ, 1997, J BIOL CHEM, V272, P26511, DOI 10.1074/jbc.272.42.26511; Seok YJ, 2001, J MOL MICROB BIOTECH, V3, P385; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Torres JC, 1997, BIOCHEM J, V327, P675; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Wujak M, 2015, POSTEP HIG MED DOSW, V69, P933, DOI 10.5604/17322693.1165196	44	18	18	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14250	14257		10.1074/jbc.M117.795294	http://dx.doi.org/10.1074/jbc.M117.795294			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28634232	Green Published, hybrid			2022-12-26	WOS:000408439800028
J	Chirivi, J; Danies, G; Sierra, R; Schauer, N; Trenkamp, S; Restrepo, S; Sanjuan, T				Chirivi, Juan; Danies, Giovanna; Sierra, Rocio; Schauer, Nicolas; Trenkamp, Sandra; Restrepo, Silvia; Sanjuan, Tatiana			Metabolomic profile and nucleoside composition of Cordyceps nidus sp nov (Cordycipitaceae): A new source of active compounds	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; ANTIOXIDANT PROPERTIES; BACTERIAL-INFECTIONS; LIGHT WAVELENGTHS; CELL-DEATH; MILITARIS; EVOLUTION; EXTRACT; PHYTOSPHINGOSINE; BIOSYNTHESIS	Cordyceps sensu lato is a genus of arthropod-pathogenic fungi, which have been used traditionally as medicinal in Asia. Within the genus, Ophiocordyceps sinensis is the most coveted and expensive species in China. Nevertheless, harvesting wild specimens has become a challenge given that natural populations of the fungus are decreasing and because large-scale culture of it has not yet been achieved. The worldwide demand for products derived from cultivable fungal species with medicinal properties has increased recently. In this study, we propose a new species, Cordyceps nidus, which parasitizes underground nests of trapdoor spiders. This species is phylogenetically related to Cordyceps militaris, Cordyceps pruinosa, and a sibling species of Cordyceps caloceroides. It is found in tropical rainforests from Bolivia, Brazil, Colombia and Ecuador. We also investigated the medicinal potential of this fungus based on its biochemical properties when grown on four different culture media. The metabolic profile particularly that of nucleosides, in polar and non-polar extracts was determined by UPLC, and then correlated to their antimicrobial activity and total phenolic content. The metabolome showed a high and significant dependency on the substrate used for fungal growth. The mass intensities of nucleosides and derivative compounds were higher in natural culture media in comparison to artificial culture media. Among these compounds, cordycepin was the predominant, showing the potential use of this species as an alternative to O. sinensis. Furthermore, methanol fractions showed antimicrobial activity against gram-positive bacteria, and less than 3.00 mg of gallic acid equivalents per g of dried extract were obtained when assessing its total phenolic content by modified Folin-Ciocalteu method. The presence of polyphenols opens the possibility of further exploring the antioxidant capacity and the conditions that may enhance this characteristic. The metabolic composition and biochemical activity indicate potential use of C. nidus in pharmaceutical applications.	[Chirivi, Juan; Danies, Giovanna; Restrepo, Silvia] Univ Los Andes, Lab Mycol & Plant Dis, Bogota, Colombia; [Chirivi, Juan; Sierra, Rocio; Sanjuan, Tatiana] Univ Los Andes, Prod & Proc Design Grp, Bogota, Colombia; [Schauer, Nicolas; Trenkamp, Sandra] Metabol Discoveries GmbH, Postdam Golm, Germany; [Sanjuan, Tatiana] Univ Antioquia, Lab Taxon & Ecol Hongos, Medellin, Colombia	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); Universidad de Antioquia	Restrepo, S (corresponding author), Univ Los Andes, Lab Mycol & Plant Dis, Bogota, Colombia.; Sanjuan, T (corresponding author), Univ Los Andes, Prod & Proc Design Grp, Bogota, Colombia.; Sanjuan, T (corresponding author), Univ Antioquia, Lab Taxon & Ecol Hongos, Medellin, Colombia.	srestrep@uniancles.edu.co; t_sanjuan@hotmail.com	Sanjuan, Tatiana/U-9807-2019	Sanjuan, Tatiana/0000-0003-1836-4542; Chirivi-Salomon, Juan/0000-0003-2072-7955; Sierra, Rocio/0000-0002-2074-7772	"The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia" [489-2009]; Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis [1204-669-46686]; Metabolomic Discoveries GmbH	"The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia"; Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis; Metabolomic Discoveries GmbH	This work was supported in part from the project "The phylogenetic relationship of Cordyceps in the Insecta Class in the Amazon of Colombia" Code 489-2009 (COLCIENCIAS, Department of Science and Technology of Colombia), and the project Metabolomics de Cordyceps nidus and Cordyceps takaomontana: a bioprospective analysis, code 1204-669-46686 (COLCIENCIAS) to metabolomics analysis and to prepare and publish the manuscript. Metabolomic Discoveries GmbH provides support in the form of salaries for authors NS and ST but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contrubutions" section.	[Anonymous], 2014, ENTEROCOCCI COMMENSA; Buckley LF, 2016, HEART LUNG, V45, P232, DOI 10.1016/j.hrtlng.2016.01.011; Chiechio S, 2006, CURR NEUROPHARMACOL, V4, P233, DOI 10.2174/157015906778019509; Chioza A, 2014, J MYCOL; Chirivi-Salomon JS, 2015, PHYTOTAXA, V234, P63; Clinical and Laboratory Standards Institute (CLSI), 2009, M44A NCCLS, V29; Clinical and Laboratory Standards Institute (CLSI), 2010, M51A NCCLS, V30; CLSI, 2012, PERF STAND ANT DISK, V32; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P2030, DOI 10.1007/s12010-012-9628-5; Dong JZ, 2013, J FOOD BIOCHEM, V37, P578, DOI 10.1111/jfbc.12009; Dong JZ, 2012, APPL BIOCHEM BIOTECH, V166, P1215, DOI 10.1007/s12010-011-9506-6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Elias BC, 2006, MICROBIOL RES, V161, P273, DOI 10.1016/j.micres.2005.10.003; Estcourt LJ, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009733.pub3; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Fong Y. K., 2000, Mycologist, V14, P127, DOI 10.1016/S0269-915X(00)80090-7; Golembiewski J, 2015, J PERIANESTH NURS, V30, P560, DOI 10.1016/j.jopan.2015.09.005; Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987; Guo LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126095; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harvey-Clark C, 2011, ILAR J, V52, P213, DOI 10.1093/ilar.52.2.213; Holliday J, 2008, INT J MED MUSHROOMS, V10, P219, DOI 10.1615/IntJMedMushr.v10.i3.30; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hwang IK, 2008, PLANTA MED, V74, P114, DOI 10.1055/s-2008-1034277; Hyun SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073065; Hyun SH, 2013, J MICROBIOL BIOTECHN, V23, P47, DOI 10.4014/jmb.1208.08058; Jin DQ, 2004, BIOL PHARM BULL, V27, P1126, DOI 10.1248/bpb.27.1126; John VU, 2011, [Frontiers in Biology, 生物学前沿], V6, P357; Johnson D, 2009, MYCOL RES, V113, P279, DOI 10.1016/j.mycres.2008.09.008; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keerti, 2014, ISRN Biochem, V2014, P178498, DOI 10.1155/2014/178498; Kepler RM, 2012, MYCOLOGIA, V104, P182, DOI 10.3852/11-070; Kim Soo-Young, 2010, Mycobiology, V38, P133, DOI 10.4489/MYCO.2010.38.2.133; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kornerup A, 1984, METHUEN HDB COLOUR; KUPPERS H, 1979, ATLAS COLORES; Li C, 2006, J FOOD COMPOS ANAL, V19, P800, DOI 10.1016/j.jfca.2006.04.007; Li SP, 2006, J PHARMACEUT BIOMED, V41, P1571, DOI 10.1016/j.jpba.2006.01.046; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu ZQ, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-61; MAINS E. B., 1954, BULL TORREY BOT CLUB, V81, P492, DOI 10.2307/2481945; Miller MA, 2015, XSEDE 15 P 2015 XSED, V39, P1, DOI [DOI 10.1145/2792745.2792784, 10.1145/2792745.2792784]; Muller Thomas, 2007, Neuropsychiatr Dis Treat, V3, P211, DOI 10.2147/nedt.2007.3.2.211; Nasca C, 2013, P NATL ACAD SCI USA, V110, P4804, DOI 10.1073/pnas.1216100110; Nemeth J, 2015, J ANTIMICROB CHEMOTH, V70, P382, DOI 10.1093/jac/dku379; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; Oh TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090823; Osborn M., 2009, THERAPEUTICS CLIN RI; Palacios I, 2011, FOOD CHEM, V128, P674, DOI 10.1016/j.foodchem.2011.03.085; Park MT, 2005, BLOOD, V105, P1724, DOI 10.1182/blood-2004-07-2938; Park SJ, 2013, METABOLOMICS, V9, P236, DOI 10.1007/s11306-012-0442-4; Pavicic T., 2007, International Journal of Cosmetic Science, V29, P181, DOI 10.1111/j.1467-2494.2007.00378.x; Peng L, 2002, EUR J PHARMACOL, V446, P53, DOI 10.1016/S0014-2999(02)01794-6; Petch, 1924, ANN ROYAL BOT GARDEN, V8, P119; PETCH T., 1933, Transactions of the British Mycological Society, V18, P48; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Sanjuan T, 2014, MYCOLOGIA, V106, P260, DOI 10.3852/106.2.260; Sanjuan TI, 2015, FUNGAL BIOL-UK, V119, P901, DOI 10.1016/j.funbio.2015.06.010; Shcherba VV, 2000, APPL BIOCHEM MICRO+, V36, P491, DOI 10.1007/BF02731896; Shrestha B, 2012, MYCOL PROG, V11, P599, DOI 10.1007/s11557-012-0825-y; Shrivastava T.P., 2013, J PHARM TECH, V6, P44; Sims KA, 2006, PHARMACOTHERAPY, V26, P1745, DOI 10.1592/phco.26.12.1745; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stensrud O, 2005, MYCOL RES, V109, P41, DOI 10.1017/S095375620400139X; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Taylor CP, 2007, EPILEPSY RES, V73, P137, DOI 10.1016/j.eplepsyres.2006.09.008; Tong SS, 2011, J PHARM PHARMACOL, V63, P238, DOI 10.1111/j.2042-7158.2010.01210.x; Tzortzopoulou A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006883.pub2; VanderMolen KM, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-71; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141; WISSEMAN CL, 1954, J BACTERIOL, V67, P662, DOI 10.1128/JB.67.6.662-673.1954; Yang FQ, 2008, J PHARMACEUT BIOMED, V48, P231, DOI 10.1016/j.jpba.2008.05.012; Yu Y, 2015, ACTA PHARM SIN B, V5, P210, DOI 10.1016/j.apsb.2015.01.012; Yuen GJ, 2008, CLIN PHARMACOKINET, V47, P351, DOI 10.2165/00003088-200847060-00001; Zeilinger S., 2015, BIOSYNTHESIS MOL GEN; Zhang YJ, 2014, MOL ECOL, V23, P5337, DOI 10.1111/mec.12940; Zhao J, 2014, J PHARMACEUT BIOMED, V87, P271, DOI 10.1016/j.jpba.2013.04.025	79	15	17	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179428	10.1371/journal.pone.0179428	http://dx.doi.org/10.1371/journal.pone.0179428			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636672	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300036
J	Goyen, KA; Wright, JD; Cunneen, A; Henning, J				Goyen, Kailiea Arianna; Wright, John David; Cunneen, Alexandra; Henning, Joerg			Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?	PLOS ONE			English	Article							TRANSMISSION; OUTBREAKS; DEVELOP; BATS	Hendra virus is a zoonotic paramyxovirus, which causes severe respiratory and neurological disease in horses and humans. Since 2012, the Hendra virus sub-unit G vaccine has been available for horse vaccination in Australia. Uptake of the vaccine has been limited and spillover events of Hendra virus infection in horses continue to occur. We conducted an online, questionnaire-based cross-sectional study of 376 horse owners belonging to a variety of different equestrian clubs in Queensland, Australia, to identify risk factors for non-vaccination against Hendra virus. A total of 43.1% (N = 162) of horse owners indicated that they currently did not vaccinate against Hendra virus infection, while 56.9% (N = 214) currently vaccinated against Hendra virus infection. A total of 52 risk factors were evaluated relating to equestrian activities, horse management, perceived risk and severity of horse and human infection with Hendra virus, side effects of Hendra vaccination, other vaccinations conducted by horse owners and horse owners' attitudes towards veterinarians. The final multivariable logistics regression model identified the following risk factors associated with increased odds of non-vaccination against Hendra virus: 1) perceived low risk (compared to high) of Hendra virus infection to horses (considering the horse owners' location and management practices) or horse owners were unsure about the risk of infection, 2) perceived moderate severity (compared to very severe or severe) of Hendra virus infection in humans, 3) horse owners non-vaccination of their pets, 4) horse owners non-vaccination against strangles disease in horses, 5) handling of more than three horses per week (compared to one horse only) and 6) perceived attitude that veterinarians had a high motivation of making money from Hendra virus vaccination (compared to veterinarians having a low motivation of making money from Hendra virus vaccination). Horse owners were more likely to vaccinate against Hendra virus if horses were used for dressage, show jumping or eventing. The study also identified horse owners' concerns about side-effects and about the lack of evidence on vaccine efficacy.	[Goyen, Kailiea Arianna; Wright, John David; Cunneen, Alexandra; Henning, Joerg] Univ Queensland, Fac Sci, Sch Vet Sci, Gatton, Qld, Australia	University of Queensland	Henning, J (corresponding author), Univ Queensland, Fac Sci, Sch Vet Sci, Gatton, Qld, Australia.	j.henning@uq.edu.au	Wright, John/D-7974-2013; Henning, Joerg/G-8662-2017	Henning, Joerg/0000-0002-0282-1318	University of Queensland, School of Veterinary Science, Bequest [2015000168]	University of Queensland, School of Veterinary Science, Bequest	The project was supported by The University of Queensland, School of Veterinary Science, Bequest (2015000168) and Donation Funds to JH and JDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Broacasting Cooperation, 2015, CONC ALL RISKS HENDR; Australian Pesticides and Veterinary Medicine Authority, 2017, HENDR VIR VACC; Australian Veterinary Association, 2015, VETS CRIT HAT CAMP H; Australian Veterinary Association Ltd, 2017, SUMM ADV EXP REP MAD; Australian Veterinary Association Ltd, 2016, EQ VETS WELC NEW ANN; Australian Veterinary Association Ltd, 2016, HENDR VIR VACC ITS V; Bard AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171380; Broder CC, 2013, ANTIVIR RES, V100, P8, DOI 10.1016/j.antiviral.2013.06.012; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Kung N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080897; LIEFMAN CE, 1981, AUST VET J, V57, P57, DOI 10.1111/j.1751-0813.1981.tb00444.x; Manyweathers J, 2017, TRANSBOUND EMERG DIS, V64, P1898, DOI 10.1111/tbed.12588; Martin G, 2015, J GEN VIROL, V96, P1229, DOI 10.1099/vir.0.000073; Mendez DH, 2012, EMERG INFECT DIS, V18, P83, DOI 10.3201/eid1801.111006; Middleton D, 2014, VET CLIN N AM-EQUINE, V30, P579, DOI 10.1016/j.cveq.2014.08.004; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; Murray PK, 1996, AUST VET J, V74, P214, DOI 10.1111/j.1751-0813.1996.tb15406.x; Peel Alison J, 2016, Infect Ecol Epidemiol, V6, P31658, DOI 10.3402/iee.v6.31658; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Richens IF, 2015, VET REC, V177, P465, DOI 10.1136/vr.103415; Smith I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025275; Taylor M, 2016, RIRDC PUBLICATION, V16/002; Velkov T, 2014, CURR DRUG TARGETS, V15, P103, DOI 10.2174/1389450114888131204163210; Waller AS, 2014, VET CLIN N AM-EQUINE, V30, P591, DOI 10.1016/j.cveq.2014.08.007; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Zahoor Bilal, 2016, Infect Ecol Epidemiol, V6, P31659, DOI 10.3402/iee.v6.31659; Zahoor Bilal A., 2015, Infection Ecology & Epidemiology, V5, P29619, DOI 10.3402/iee.v5.29619	30	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0180062	10.1371/journal.pone.0180062	http://dx.doi.org/10.1371/journal.pone.0180062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636633	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300065
J	Schotthoefer, AM; Schrodi, SJ; Meece, JK; Fritsche, TR; Shukla, SK				Schotthoefer, Anna M.; Schrodi, Steven J.; Meece, Jennifer K.; Fritsche, Thomas R.; Shukla, Sanjay K.			Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-PHAGOCYTOPHILA; UNITED-STATES; MURINE MODEL; T-CELLS; INFECTION; AGENT; IMMUNOPATHOLOGY; CHAFFEENSIS; REGULATOR	Human anaplasmosis (HA) is an emerging tick-borne disease that may present as a mild flu-like illness or a life threatening, sepsis-like condition. Although disease severity is hypothesized to relate to immunopathology and immune dysfunction in humans, studies to directly measure immune responses in infected humans have been very limited. We quantified cytokines in 80 confirmed HA patients using a multiplex chemiluminescence immunoassay system and compared similarly measured responses in 1000 control subjects. Pro-inflammatory cytokines were significantly elevated in HA patients (all seven p<0.0001). Interferon gamma (IFN-gamma) concentrations were particularly high, with average concentrations 7.8 times higher in the HA patients than the controls. A subset of cytokines consisting of IL-1 beta, IL-8, IL-6, TNF-alpha, and IL-10 was also coordinately high and significantly associated with severity of thrombocytopenia in HA patients. Patients with infections in the very acute stage (<= 4 days ill) tended to have the highest IFN-gamma, IL-12p70, and IL-2 levels. Higher concentrations of IL-13 and IL-5 were associated with diarrhea and vomiting. Our findings support a pathophysiological role for a pro-inflammatory response in HA, especially with regard to the modulation of hematopoiesis and subsequent hematopoietic complications.	[Schotthoefer, Anna M.; Schrodi, Steven J.; Meece, Jennifer K.; Shukla, Sanjay K.] Marshfield Clin Fdn Med Res & Educ, Res Inst, Marshfield, WI 54449 USA; [Fritsche, Thomas R.] Marshfield Clin Fdn Med Res & Educ, Marshfield Labs, Marshfield, WI USA; [Fritsche, Thomas R.] Univ Wisconsin La Crosse, Microbiol Dept, La Crosse, WI USA	Marshfield Clinic; Marshfield Clinic; University of Wisconsin System; University of Wisconsin La Crosse	Schotthoefer, AM (corresponding author), Marshfield Clin Fdn Med Res & Educ, Res Inst, Marshfield, WI 54449 USA.	Schotthoefer.Anna@MarshfieldResearch.org	Schrodi, Steven J./O-4288-2019	Schrodi, Steven J./0000-0003-2304-8528	Marshfield Clinic Research Institute; NCATS [UL1TR000427]	Marshfield Clinic Research Institute; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Marshfield Clinic Research Institute. This study also was partly supported by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011 and the National Center for Advancing Translational Sciences (NCATS) grant 9U54TR000021, and now by the NCATS grant UL1TR000427. Funding through generous donors to the Marshfield Clinic and a pilot ICTR grant from UL1TR000427 to SJS was used to support this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; Bakken JS, 1996, JAMA-J AM MED ASSOC, V275, P199, DOI 10.1001/jama.275.3.199; Bamias G, 2015, CURR OPIN GASTROEN, V31, P471, DOI 10.1097/MOG.0000000000000212; Bell CA, 2005, DIAGN MICR INFEC DIS, V53, P301, DOI 10.1016/j.diagmicrobio.2005.06.019; Biggs HM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6502a1; Birkner K, 2008, EUR J IMMUNOL, V38, P3395, DOI 10.1002/eji.200838615; Boushab BM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw200; Choi KS, 2014, J IMMUNOL, V193, P5088, DOI 10.4049/jimmunol.1401381; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dahlgren FS, 2015, AM J TROP MED HYG, V93, P66, DOI 10.4269/ajtmh.15-0122; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Davies RS, 2011, CLIN VACCINE IMMUNOL, V18, P1962, DOI 10.1128/CVI.05034-11; Dieye Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1965; Division of AIDS (DAIDS),, 2014, TABL GRAD SEV AD PED; Dumler JS, 2007, CLIN INFECT DIS, V45, P199, DOI 10.1086/518834; Dumler JS, 2012, FEMS IMMUNOL MED MIC, V64, P13, DOI 10.1111/j.1574-695X.2011.00909.x; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Dumler JS, 2000, CLIN DIAGN LAB IMMUN, V7, P6, DOI 10.1128/CDLI.7.1.6-8.2000; Dupont CD, 2012, SEMIN IMMUNOPATHOL, V34, P793, DOI 10.1007/s00281-012-0339-3; Gallo E, 2012, EUR J IMMUNOL, V42, P2322, DOI 10.1002/eji.201142227; Hochedez P, 2015, EMERG INFECT DIS, V21, P2221, DOI 10.3201/eid2112.141099; Johns JL, 2009, INFECT IMMUN, V77, P4070, DOI 10.1128/IAI.00570-09; KASAHARA T, 1983, J IMMUNOL, V130, P1784; Klein MB, 2000, J INFECT DIS, V182, P200, DOI 10.1086/315641; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Lepidi H, 2000, AM J TROP MED HYG, V62, P29, DOI 10.4269/ajtmh.2000.62.29; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Martin ME, 2001, AM J PATHOL, V158, P1881, DOI 10.1016/S0002-9440(10)64145-4; Massung RF, 2002, EMERG INFECT DIS, V8, P467; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Parvaneh N, 2013, BRIT J HAEMATOL, V162, P573, DOI 10.1111/bjh.12422; Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI DOI 10.1056/NEJM0A1010493; Pusterla N, 1999, J CLIN MICROBIOL, V37, P4042, DOI 10.1128/JCM.37.12.4042-4044.1999; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schotthoefer AM, 2013, J CLIN MICROBIOL, V51, P2147, DOI 10.1128/JCM.00347-13; Schulert GS, 2016, J INFECT DIS, V213, P1180, DOI 10.1093/infdis/jiv550; Scorpio DG, 2005, ANN NY ACAD SCI, V1063, P425, DOI 10.1196/annals.1355.077; Stokes ME, 2000, CATEGORICAL DATA ANA; Talsness Stephen R, 2011, WMJ, V110, P82; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Townsend JL, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv055; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Xiong WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148885; Zhang MC, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0439-2	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179655	10.1371/journal.pone.0179655	http://dx.doi.org/10.1371/journal.pone.0179655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628633	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100044
J	Seo, J; Kim, SM; Jang, M; La Yun, B; Lee, SH; Kim, EK; Kang, E; Park, SY; Moon, WK; Choi, HY; Kim, B				Seo, Jiwoon; Kim, Sun Mi; Jang, Mijung; La Yun, Bo; Lee, Soo Hyun; Kim, Eun-Kyu; Kang, Eunyoung; Park, So Yeon; Moon, Woo Kyung; Choi, Hye Young; Kim, Bohyoung			Ultrasound-guided cable-free 13-gauge vacuum-assisted biopsy of non-mass breast lesions	PLOS ONE			English	Article							CORE-NEEDLE-BIOPSY; CARCINOMA IN-SITU; MICROCALCIFICATIONS	Purpose To compare the outcomes of ultrasound-guided core biopsy for non-mass breast lesions by the novel 13-gauge cable-free vacuum-assisted biopsy (VAB) and by the conventional 14gauge semi-automated core needle biopsy (CCNB). Materials and methods Our institutional review board approved this prospective study, and all patients provided written informed consent. Among 1840 ultrasound-guided percutaneous biopsies performed from August 2013 to December 2014, 145 non-mass breast lesions with suspicious microcalcifications on mammography or corresponding magnetic resonance imaging finding were subjected to 13-gauge VAB or 14-gauge CCNB. We evaluated the technical success rates, average specimen numbers, and tissue sampling time. We also compared the results of percutaneous biopsy and final surgical pathologic diagnosis to analyze the rates of diagnostic upgrade or downgrade. Results Ultrasound-guided VAB successfully targeted and sampled all lesions, whereas CCNB failed to demonstrate calcification in four (10.3%) breast lesions with microcalcification on specimen mammography. The mean sampling time were 238.6 and 170.6 seconds for VAB and CCNB, respectively. No major complications were observed with either method. Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) lesions were more frequently upgraded after CCNB (8/23 and 3/5, respectively) than after VAB (2/26 and 0/4, respectively P = 0.028). Conclusion Non-mass breast lesions were successfully and accurately biopsied using cable-free VAB. The underestimation rate of ultrasound-detected non-mass lesion was significantly lower with VAB than with CCNB.	[Seo, Jiwoon; Kim, Sun Mi; Jang, Mijung; La Yun, Bo; Lee, Soo Hyun] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Eun-Kyu; Kang, Eunyoung] Seoul Natl Univ, Bundang Hosp, Dept Surg, Gyeonggi Do, South Korea; [Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Gyeonggi Do, South Korea; [Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Choi, Hye Young] Gyeongsang Natl Univ Hosp, Dept Radiol, Jinju Si, South Korea; [Kim, Bohyoung] Hankuk Univ Foreign Studies, Div Biomed Engn, Oedae Ro 81, Yongin, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital; Hankuk University Foreign Studies	Kim, SM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	kimsmlms@daum.net		Park, So Yeon/0000-0002-0299-7268	SNUBH Research Fund [02-2014-040]; Technology Innovation Program - Ministry of Trade, Industry and Energy (MOTIE) of Korea [10049785]	SNUBH Research Fund; Technology Innovation Program - Ministry of Trade, Industry and Energy (MOTIE) of Korea	This work has been funded by Grant No. 02-2014-040 from the SNUBH Research Fund. This work was supported by the Technology Innovation Program funded By the Ministry of Trade, Industry and Energy (MOTIE) of Korea (10049785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Technology Innovation Program funded By the Ministry of Trade, Industry and Energy (MOTIE) of Korea (10049785, Development of 'medical equipment using (ionizing or non-ionizing) radiation'-dedicated R&D platform and medical device technology.	Bagnera S, 2013, OPEN J RADIOL, V3, P174; Cassano E, 2007, BREAST CANCER RES TR, V102, P103, DOI 10.1007/s10549-006-9305-x; Cho N, 2005, KOREAN J RADIOL, V6, P102, DOI 10.3348/kjr.2005.6.2.102; Cho N, 2009, ACTA RADIOL, V50, P602, DOI 10.1080/02841850902933107; Choi ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144046; Hatada T, 2000, J AM COLL SURGEONS, V190, P299, DOI 10.1016/S1072-7515(99)00300-2; Helbich T H, 2004, Eur Radiol, V14, P383, DOI 10.1007/s00330-003-2141-z; Jackman RJ, 2001, RADIOLOGY, V218, P497, DOI 10.1148/radiology.218.2.r01fe35497; Kim HS, 2008, KOREAN J RADIOL, V9, P503, DOI 10.3348/kjr.2008.9.6.503; Ko KH, 2015, EUR J RADIOL, V84, P77, DOI 10.1016/j.ejrad.2014.10.010; Memarsadeghi M, 2003, ROFO-FORTSCHR RONTG, V175, P374, DOI 10.1055/s-2003-37822; Park H, 2011, J HIGH ENERGY PHYS, DOI [10.1007/JHEP10(2011)092, 10.1155/2011/485173]; Parker SH, 1997, RADIOGRAPHICS, V17, P1233, DOI 10.1148/radiographics.17.5.9308112; Polom K, 2012, REP PRACT ONCOL RADI, V17, P129, DOI 10.1016/j.rpor.2012.03.008; Schueller G, 2008, EUR RADIOL, V18, P1761, DOI 10.1007/s00330-008-0955-4; Smith DN, 2001, J ULTRAS MED, V20, P43; Soo MS, 2003, AM J ROENTGENOL, V180, P941, DOI 10.2214/ajr.180.4.1800941; Soo MS, 2002, AM J ROENTGENOL, V178, P1007, DOI 10.2214/ajr.178.4.1781007; Suh YJ, 2012, BRIT J RADIOL, V85, pE349, DOI 10.1259/bjr/30974918; Uematsu T, 2007, BREAST J, V13, P624, DOI 10.1111/j.1524-4741.2007.00502.x; Wallis M, 2007, EUR RADIOL, V17, P581, DOI 10.1007/s00330-006-0408-x; Youk JH, 2007, RADIOGRAPHICS, V27, P79, DOI 10.1148/rg.271065029	22	11	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179182	10.1371/journal.pone.0179182	http://dx.doi.org/10.1371/journal.pone.0179182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628656	gold, Green Published, Green Submitted			2022-12-26	WOS:000404043100019
J	Balch, A; Wendelboe, AM; Vesely, SK; Bratzler, DW				Balch, Aubrey; Wendelboe, Aaron M.; Vesely, Sara K.; Bratzler, Dale W.			Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile	PLOS ONE			English	Article							CARE IMPROVEMENT PROJECTS; ANTIMICROBIAL PROPHYLAXIS; PREVENTION; SURGERY; OUTCOMES; DISEASE; HIP	Objective We aimed to measure the association between 2013 guideline concordant prophylactic antibiotic use prior to surgery and infection with Clostridium difficile. Design We conducted a retrospective case-control study by selecting patients who underwent a surgical procedure between January 1, 2012 and December 31, 2013. Setting Large urban community hospital. Patients Cases and controls were patients age 18+ years who underwent an eligible surgery (i.e., colorectal, neurosurgery, vascular/cardiac/thoracic, hysterectomy, abdominal/pelvic and orthopedic surgical procedures) within six months prior to infection diagnosis. Cases were diagnosed with C. difficile infection while controls were not. Methods The primary exposure was receiving (vs. not receiving) the recommended prophylactic antibiotic regimen, based on type and duration. Potential confounders included age, sex, length of hospital stay, comorbidities, type of surgery, and prior antibiotic use. Crude and adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated using logistic regression. Results We enrolled 68 cases and 220 controls. The adjusted OR among surgical patients between developing C. difficile infection and not receiving the recommended prophylactic antibiotic regimen (usually receiving antimicrobial prophylaxis for more than 24 hours) was 6.7 (95% CI: 2.9-15.5). Independent risk factors for developing C. difficile infection included having severe comorbidities, receiving antibiotics within the previous 6 months, and undergoing orthopedic surgery. Conclusions Adherence to the recommended prophylactic antibiotics among surgical patients likely reduces the probability of being case of C. difficile. Antibiotic stewardship should be a priority in strategies to decrease the morbidity, mortality, and costs associated with C. difficile infection.	[Balch, Aubrey; Wendelboe, Aaron M.; Vesely, Sara K.; Bratzler, Dale W.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Wendelboe, AM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Oklahoma City, OK USA.	Aaron-Wendelboe@ouhsc.edu		Wendelboe, Aaron/0000-0002-8670-7730; Bratzler, Dale/0000-0002-8033-7521				Al-Obaydi Waleed, 2010, J Orthop Surg (Hong Kong), V18, P320; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe276, DOI 10.1016/S1473-3099(16)30398-X; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe288, DOI 10.1016/S1473-3099(16)30402-9; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Ban KA, 2017, J AM COLL SURGEONS, V224, P59, DOI 10.1016/j.jamcollsurg.2016.10.029; Bratzler DW, 2006, AM SURGEON, V72, P1010; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Calvert JK, 2014, J UROLOGY, V192, P425, DOI 10.1016/j.juro.2014.02.096; Carignan A, 2008, CLIN INFECT DIS, V46, P1838, DOI 10.1086/588291; Jenkins PJ, 2010, J BONE JOINT SURG BR, V92B, P994, DOI 10.1302/0301-620X.92B7.23412; Jettoo P, 2013, J ORTHOP SURG-HONG K, V21, P323, DOI 10.1177/230949901302100312; Kim MJ, 2012, J KOREAN SURG SOC, V83, P14, DOI 10.4174/jkss.2012.83.1.14; McNulty C, 1997, J ANTIMICROB CHEMOTH, V40, P707, DOI 10.1093/jac/40.5.707; Mukhtar S, 2006, J HOSP INFECT, V64, P93, DOI 10.1016/j.jhin.2006.05.006; O'Connor KA, 2004, QJM-INT J MED, V97, P423, DOI 10.1093/qjmed/hch076; Poeran J, 2016, J THORAC CARDIOV SUR, V151, P589, DOI 10.1016/j.jtcvs.2015.09.090; Sandora TJ, 2016, JAMA PEDIATR, V170, P570, DOI 10.1001/jamapediatrics.2016.0019; Siller-Ruiz M, 2014, REV ESP QUIM, V27, P122; Southern WN, 2010, SURGERY, V148, P24, DOI 10.1016/j.surg.2009.11.021; YEE J, 1991, ARCH SURG-CHICAGO, V126, P241; Zerey Marc, 2007, Surg Infect (Larchmt), V8, P557, DOI 10.1089/sur.2006.062	24	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179117	10.1371/journal.pone.0179117	http://dx.doi.org/10.1371/journal.pone.0179117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622340	gold, Green Submitted, Green Published			2022-12-26	WOS:000403506300014
J	Tang, BP; Xin, ZZ; Liu, Y; Zhang, DZ; Wang, ZF; Zhang, HB; Chai, XY; Zhou, CL; Liu, QN				Tang, Bo-Ping; Xin, Zhao-Zhe; Liu, Yu; Zhang, Dai-Zhen; Wang, Zheng-Fei; Zhang, Hua-Bin; Chai, Xin-Yue; Zhou, Chun-Lin; Liu, Qiu-Ning			The complete mitochondrial genome of Sesarmops sinensis reveals gene rearrangements and phylogenetic relationships in Brachyura	PLOS ONE			English	Article							CRUSTACEA-DECAPODA; RNA GENE; CRAB; SEQUENCE; EVOLUTION; DNA; SELECTION; PATTERNS	Mitochondrial genome (mitogenome) is very important to understand molecular evolution and phylogenetics. Herein, in this study, the complete mitogenome of Sesarmops sinensis was reported. The mitogenome was 15,905 bp in size, and contained 13 protein-coding genes (PCGs), two ribosomal RNA (rRNA) genes, 22 transfer RNA (tRNA) genes, and a control region (CR). The AT skew and the GC skew are both negative in the mitogenomes of S. sinensis. The nucleotide composition of the S. sinensis mitogenome was also biased toward A + T nucleotides (75.7%). All tRNA genes displayed a typical mitochondrial tRNA cloverleaf structure, except for the trnS1 gene, which lacked a dihydroxyuridine arm. S. sinensis exhibits a novel rearrangement compared with the Pancrustacean ground pattern and other Brachyura species. Based on the 13 PCGs, the phylogenetic analysis showed that S. sinensis and Sesarma neglectum were clustered on one branch with high nodal support values, indicating that S. sinensis and S. neglectum have a sister group relationship. The group (S. sinensis + S. neglectum) was sister to (Parasesarmops tripectinis + Metopaulias depressus), suggesting that S. sinensis belongs to Grapsoidea, Sesarmidae. Phylogenetic trees based on amino acid sequences and nucleotide sequences of mitochondrial 13 PCGs using BI and ML respectively indicate that section Eubrachyura consists of four groups clearly. The resulting phylogeny supports the establishment of a separate subsection Potamoida. These four groups correspond to four subsections of Raninoida, Heterotremata, Potamoida, and Thoracotremata.	[Tang, Bo-Ping; Xin, Zhao-Zhe; Liu, Yu; Zhang, Dai-Zhen; Wang, Zheng-Fei; Zhang, Hua-Bin; Chai, Xin-Yue; Zhou, Chun-Lin; Liu, Qiu-Ning] Yancheng Teachers Univ, Sch Ocean & Biol Engn, Jiangsu Prov Key Lab Coastal Wetland Bioresources, Jiangsu Synthet Innovat Ctr Coastal Bioagr,Jiangs, Yancheng, Peoples R China	Yancheng Teachers University	Liu, QN (corresponding author), Yancheng Teachers Univ, Sch Ocean & Biol Engn, Jiangsu Prov Key Lab Coastal Wetland Bioresources, Jiangsu Synthet Innovat Ctr Coastal Bioagr,Jiangs, Yancheng, Peoples R China.	yctu1989@163.com	Wang, Zhengfei/AAJ-1596-2020	Wang, Zhengfei/0000-0003-1918-6282; Liu, Qiu-Ning/0000-0002-9264-019X	National Natural Science Foundation of China [31672267, 31640074]; Natural Science Foundation of Jiangsu Province [BK20160444]; Natural Science Research General Program of Jiangsu Provincial Higher Education Institutions [15KJB240002, 12KJA180009, 16KJA180008]; Jiangsu Provincial Key Laboratory of Coastal Wetland Bioresources and Environmental Protection [JLCBE14006]; Special Guide Fund Project of Agricultural Science and Technology Innovation of Yancheng city [YKN2014022]; Jiangsu Provincial Key Laboratory for Bioresources of Saline Soils [JKLBS2014013, JKLBS2015004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Research General Program of Jiangsu Provincial Higher Education Institutions; Jiangsu Provincial Key Laboratory of Coastal Wetland Bioresources and Environmental Protection; Special Guide Fund Project of Agricultural Science and Technology Innovation of Yancheng city; Jiangsu Provincial Key Laboratory for Bioresources of Saline Soils	This work was supported by the National Natural Science Foundation of China (31672267 and 31640074), the Natural Science Foundation of Jiangsu Province (BK20160444), the Natural Science Research General Program of Jiangsu Provincial Higher Education Institutions (15KJB240002, 12KJA180009 and 16KJA180008), Jiangsu Provincial Key Laboratory of Coastal Wetland Bioresources and Environmental Protection (JLCBE14006), the Special Guide Fund Project of Agricultural Science and Technology Innovation of Yancheng city (YKN2014022), the Jiangsu Provincial Key Laboratory for Bioresources of Saline Soils (JKLBS2014013 and JKLBS2015004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31672267 and 31640074), the Natural Science Foundation of Jiangsu Province (BK20160444), the Natural Science Research General Program of Jiangsu Provincial Higher Education Institutions (15KJB240002, 12KJA180009 and 16KJA180008), Jiangsu Provincial Key Laboratory of Coastal Wetland Bioresources and Environmental Protection (JLCBE14006), the Special Guide Fund Project of Agricultural Science and Technology Innovation of Yancheng city (YKN2014022), the Jiangsu Provincial Key Laboratory for Bioresources of Saline Soils (JKLBS2014013 and JKLBS2015004).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ABELE L G, 1991, Memoirs of the Queensland Museum, V31, P101; [Anonymous], 2001, SCI SERIES; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Bowman T.E., 1982, P1; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Cassone BJ, 2006, MAR BIOL, V149, P213, DOI 10.1007/s00227-005-0197-9; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cui BK, 2011, MYCOL PROG, V10, P267, DOI 10.1007/s11557-010-0697-y; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Gong YJ, 2012, MOL BIOL REP, V39, P2893, DOI 10.1007/s11033-011-1049-y; GUINOT D, 1977, CR ACAD SCI D NAT, V285, P1049; Guinot D, 2013, ZOOTAXA, V3665, P1, DOI 10.11646/zootaxa.3665.1.1; Ji YK, 2014, J CRUSTACEAN BIOL, V34, P494, DOI 10.1163/1937240X-00002252; Juhling F, 2012, NUCLEIC ACIDS RES, V40, P2833, DOI 10.1093/nar/gkr1131; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Ki JS, 2009, COMP BIOCHEM PHYS D, V4, P290, DOI 10.1016/j.cbd.2009.07.002; Kitaura J, 2002, J CRUSTACEAN BIOL, V22, P682, DOI 10.1651/0278-0372(2002)022[0682:MPOGAO]2.0.CO;2; Komai T., 2006, Zootaxa, V1168, P1; Liu QN, 2015, BIOCHEM SYST ECOL, V62, P241, DOI 10.1016/j.bse.2015.09.008; Liu YA, 2010, MOL BIOL REP, V37, P2559, DOI 10.1007/s11033-009-9773-2; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11524; Ma HY, 2013, GENE, V519, P120, DOI 10.1016/j.gene.2013.01.028; Ng NK, 2007, RAFFLES B ZOOL, P233; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski Lars, 2006, BMC Genomics, V7, P1; Rawlings TA, 2003, P NATL ACAD SCI USA, V100, P15700, DOI 10.1073/pnas.2535036100; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 2011, MRBAYES VER IN PRESS; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; Shen X, 2007, GENE, V403, P98, DOI 10.1016/j.gene.2007.06.021; Shi GH, 2015, MAR GENOM, V21, P53, DOI 10.1016/j.margen.2015.02.002; Shi W, 2015, J EVID BASED COMPLEM, V2015, P1, DOI DOI 10.1016/J.0CEAN-ENG.2015.07.064.ISSN; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun HY, 2005, GENE, V349, P207, DOI 10.1016/j.gene.2004.12.036; Tan MH, 2016, MITOCHONDRIAL DNA A, V27, P1275, DOI 10.3109/19401736.2014.945553; Tang BP, 2003, MOL PHYLOGENET EVOL, V29, P309, DOI 10.1016/S1055-7903(03)00112-X; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xing YH, 2016, MITOCHONDRIAL DNA B, V1, P461, DOI 10.1080/23802359.2016.1186509; Yamauchi MM, 2003, GENE, V311, P129, DOI 10.1016/S0378-1119(03)00582-1; Yang JS, 2010, ZOOL SCR, V39, P621, DOI 10.1111/j.1463-6409.2010.00442.x; Yang SL, 2012, FAUNA SINICA INVERTE, V49, P396; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zhang Shu, 2008, Marine Sciences (Beijing), V32, P9	51	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179800	10.1371/journal.pone.0179800	http://dx.doi.org/10.1371/journal.pone.0179800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622362	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300053
J	Paukner, A; Pedersen, EJ; Simpson, EA				Paukner, Annika; Pedersen, Eric J.; Simpson, Elizabeth A.			Testing the arousal hypothesis of neonatal imitation in infant rhesus macaques	PLOS ONE			English	Article							LINEAR MIXED MODELS; TONGUE PROTRUSION; NEWBORN MACAQUES; FACIAL GESTURES; MOVEMENT; PRIMATES; MONKEYS; EXPLORATION; PREFERENCE; BEHAVIORS	Neonatal imitation is the matching of (often facial) gestures by newborn infants. Some studies suggest that performance of facial gestures is due to general arousal, which may produce false positives on neonatal imitation assessments. Here we examine whether arousal is linked to facial gesturing in newborn infant rhesus macaques (Macaca mulatta). We tested 163 infants in a neonatal imitation paradigm in their first postnatal week and analyzed their lipsmacking gestures (a rapid opening and closing of the mouth), tongue protrusion gestures, and yawn responses (a measure of arousal). Arousal increased during dynamic stimulus presentation compared to the static baseline across all conditions, and arousal was higher in the facial gestures conditions than the nonsocial control condition. However, even after controlling for arousal, we found a condition-specific increase in facial gestures in infants who matched lipsmacking and tongue protrusion gestures. Thus, we found no support for the arousal hypothesis. Consistent with reports in human newborns, imitators' propensity to match facial gestures is based on abilities that go beyond mere arousal. We discuss optimal testing conditions to minimize potentially confounding effects of arousal on measurements of neonatal imitation.	[Paukner, Annika] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Poolesville, MD USA; [Pedersen, Eric J.; Simpson, Elizabeth A.] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Pedersen, Eric J.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Miami; University of Colorado System; University of Colorado Boulder	Paukner, A (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Poolesville, MD USA.	pauknera@mail.nih.gov	Simpson, Elizabeth A./H-5479-2019; Paukner, Annika/ABA-3275-2020	Simpson, Elizabeth A./0000-0003-2715-2533; Paukner, Annika/0000-0002-3421-1864; Pedersen, Eric/0000-0003-4692-0577	National Science Foundation [BCS-1653737]; Division of Intramural Research, NICHD	National Science Foundation(National Science Foundation (NSF)); Division of Intramural Research, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Science Foundation (www.nsf.gov BCS-1653737) and the Division of Intramural Research, NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Pier Francesco Ferrari, Stephen Suomi, and all staff, students, and volunteers who helped collect and code the data. This research was supported by the National Science Foundation (www.nsf.gov BCS-1653737) and the Division of Intramural Research, NICHD.	Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; ANISFELD M, 1991, DEV REV, V11, P60, DOI 10.1016/0273-2297(91)90003-7; Argiolas A, 1998, EUR J PHARMACOL, V343, P1, DOI 10.1016/S0014-2999(97)01538-0; Atkins DC, 2013, PSYCHOL ADDICT BEHAV, V27, P166, DOI 10.1037/a0029508; Baenninger R, 1996, PHYSIOL BEHAV, V59, P421, DOI 10.1016/0031-9384(95)02014-4; Bard KA, 2007, ANIM COGN, V10, P233, DOI 10.1007/s10071-006-0062-3; Bertrand M., 1996, BEHAV REPERTOIRE STU; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; COWART BJ, 1981, PSYCHOL BULL, V90, P43, DOI 10.1037/0033-2909.90.1.43; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; EKMAN P, 1976, ENVIRON PSYCH NONVER, V1, P56, DOI 10.1007/BF01115465; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Ferrari PF, 2012, J COGNITIVE NEUROSCI, V24, P1165, DOI 10.1162/jocn_a_00198; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; FIELD TM, 1983, INFANT BEHAV DEV, V6, P485, DOI 10.1016/S0163-6383(83)90316-8; Galef B.G. Jr, 1988, P3; Giganti F, 2002, DEV PSYCHOBIOL, V41, P289, DOI 10.1002/dev.10047; Goy R W, 1972, Recent Prog Horm Res, V28, P707; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HADIDIAN J, 1980, BEHAVIOUR, V75, P133, DOI 10.1163/156853980X00375; Holsti D, 2005, CLIN J PAIN, V21, P491; JACOBSON SW, 1979, CHILD DEV, V50, P425, DOI 10.2307/1129418; Jones SS, 2006, INFANT BEHAV DEV, V29, P126, DOI 10.1016/j.infbeh.2005.08.004; Jones SS, 1996, CHILD DEV, V67, P1952, DOI 10.2307/1131603; Kaburu SSK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34997; KOEPKE JE, 1983, INFANT BEHAV DEV, V6, P97, DOI 10.1016/S0163-6383(83)80012-5; Leone A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04010; Liang AC, 2015, PHYSIOL BEHAV, V140, P38, DOI 10.1016/j.physbeh.2014.11.029; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Meltzoff A. N., 2017, DEV SCI; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; MELTZOFF AN, 1989, DEV PSYCHOL, V25, P954, DOI 10.1037/0012-1649.25.6.954; Messinger DS, 2009, INFANCY, V14, P285, DOI 10.1080/15250000902839963; Mizuno K, 2004, ACTA PAEDIATR, V93, P1640, DOI 10.1080/08035250410023115; Nagy E, 2005, PEDIATR RES, V58, P749, DOI 10.1203/01.PDR.0000180570.28111.D9; Nagy E, 2004, INFANT BEHAV DEV, V27, P54, DOI 10.1016/j.infbeh.2003.06.004; Nagy E, 2014, DEVELOPMENTAL SCI, V17, P841, DOI 10.1111/desc.12163; Nagy E, 2013, DEV PSYCHOL, V49, P1628, DOI 10.1037/a0031127; Nagy E, 2011, INFANT CHILD DEV, V20, P3, DOI 10.1002/icd.683; ORDY JM, 1964, P SOC EXP BIOL MED, V115, P677; Parr LA, 2010, AM J PHYS ANTHROPOL, V143, P625, DOI 10.1002/ajpa.21401; Paukner A, 2014, DEVELOPMENTAL SCI, V17, P833, DOI 10.1111/desc.12207; Paukner A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028848; R Development Core Team, 2014, R LANG ENV STAT COMP; Simpson EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20233; Simpson EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19669; Simpson EA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0289; Simpson EA, 2014, P NATL ACAD SCI USA, V111, P6922, DOI 10.1073/pnas.1402471111; Simpson EA, 2014, DEV PSYCHOBIOL, V56, P864, DOI 10.1002/dev.21146	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178864	10.1371/journal.pone.0178864	http://dx.doi.org/10.1371/journal.pone.0178864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617816	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000403364600015
J	Perycz, M; Krwawicz, J; Bochtler, M				Perycz, Malgorzata; Krwawicz, Joanna; Bochtler, Matthias			A TALE-inspired computational screen for proteins that contain approximate tandem repeats	PLOS ONE			English	Article							DNA-BINDING PROTEINS; SEQUENCE; PREDICTION; COMPLEX; RECOGNITION; SPECIFICITY; BREAKING; BACTERIA; DOMAIN; CODE	TAL (transcription activator-like) effectors (TALEs) are bacterial proteins that are secreted from bacteria to plant cells to act as transcriptional activators. TALEs and related proteins (RipTALs, BurrH, MOrTL1 and MOrTL2) contain approximate tandem repeats that differ in conserved positions that define specificity. Using PERL, we screened similar to 47 million protein sequences for TALE-like architecture characterized by approximate tandem repeats (between 30 and 43 amino acids in length) and sequence variability in conserved positions, without requiring sequence similarity to TALEs. Candidate proteins were scored according to their propensity for nuclear localization, secondary structure, repeat sequence complexity, as well as covariation and predicted structural proximity of variable residues. Biological context was tentatively inferred from co-occurrence of other domains and interactome predictions. Approximate repeats with TALE-like features that merit experimental characterization were found in a protein of chestnut blight fungus, a eukaryotic plant pathogen.	[Perycz, Malgorzata; Krwawicz, Joanna; Bochtler, Matthias] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Perycz, Malgorzata; Krwawicz, Joanna; Bochtler, Matthias] Int Inst Mol & Cell Biol Warsaw, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej	Bochtler, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.; Bochtler, M (corresponding author), Int Inst Mol & Cell Biol Warsaw, Warsaw, Poland.	mbochtler@iimcb.gov.pl	Perycz, Malgorzata/HHN-0050-2022	Perycz, Malgorzata/0000-0003-3154-6594; Bochtler, Matthias/0000-0001-7884-4463	National Science Centre funds [UMO-2011/02/NNZ1/00052]; Norway Grant through the Polish-Norwegian Research Programme [PoI-Nor/207085/65/2013]	National Science Centre funds; Norway Grant through the Polish-Norwegian Research Programme	The research was supported by National Science Centre funds (grant No. UMO-2011/02/NNZ1/00052) issued to MB [https://www.ncn.gov.pI/]. Work of JK was partially supported by the grant (PoI-Nor/207085/65/2013) from Norway Grant through the Polish-Norwegian Research Programme operated by the National Centre for Research and Development(NCBR) [http://www.ncbr.gov.pI/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Birol M, 2014, CURR PROTEIN PEPT SC, V15, P504, DOI 10.2174/1389203715666140221095109; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Lange O, 2015, NUCLEIC ACIDS RES, V43, P10065, DOI 10.1093/nar/gkv1053; de Lange O, 2014, NUCLEIC ACIDS RES, V42, P7436, DOI 10.1093/nar/gku329; de Lange O, 2013, NEW PHYTOL, V199, P773, DOI 10.1111/nph.12324; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Doyle EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082120; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espagne E, 2002, GENETICS, V161, P71; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Harris JL, 2011, AGING-US, V3, P461, DOI 10.18632/aging.100334; Jehl MA, 2011, NUCLEIC ACIDS RES, V39, pD591, DOI 10.1093/nar/gkq1154; Jernigan KK, 2015, PEERJ, V3, DOI 10.7717/peerj.732; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juillerat A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03831; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Li LX, 2013, MOL PLANT, V6, P1318, DOI 10.1093/mp/sst006; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lum G, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nettling M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0767-x; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Stella S, 2014, ACTA CRYSTALLOGR F, V70, P87, DOI 10.1107/S2053230X13033037; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Szurek B, 2002, MOL MICROBIOL, V46, P13, DOI 10.1046/j.1365-2958.2002.03139.x; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	40	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179173	10.1371/journal.pone.0179173	http://dx.doi.org/10.1371/journal.pone.0179173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617832	Green Submitted, gold, Green Published			2022-12-26	WOS:000403364600023
J	Huang, M; Hayward, JJ; Corey, E; Garrison, SJ; Wagner, GR; Krotscheck, U; Hayashi, K; Schweitzer, PA; Lust, G; Boyko, AR; Todhunter, RJ				Huang, Meng; Hayward, Jessica J.; Corey, Elizabeth; Garrison, Susan J.; Wagner, Gabriela R.; Krotscheck, Ursula; Hayashi, Kei; Schweitzer, Peter A.; Lust, George; Boyko, Adam R.; Todhunter, Rory J.			A novel iterative mixed model to remap three complex orthopedic traits in dogs	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; GENOME-WIDE ASSOCIATION; DIPEPTIDYL PEPTIDASE-IV; FRAGMENTED CORONOID PROCESS; MELCHIOR-CLAUSEN DYSPLASIA; CANINE HIP-DYSPLASIA; DEVELOPMENTAL DYSPLASIA; RHEUMATOID-ARTHRITIS; COAT COLOR; MULTIGENERATION FAMILY	Hip dysplasia (HD), elbow dysplasia (ED), and rupture of the cranial (anterior) cruciate ligament (RCCL) are the most common complex orthopedic traits of dogs and all result in debilitating osteoarthritis. We reanalyzed previously reported data: the Norberg angle (a quantitative measure of HD) in 921 dogs, ED in 113 cases and 633 controls, and RCCL in 271 cases and 399 controls and their genotypes at similar to 185,000 single nucleotide polymorphisms. A novel fixed and random model with a circulating probability unification (FarmCPU) function, with marker-based principal components and a kinship matrix to correct for population stratification, was used. A Bonferroni correction at p < 0.01 resulted in a P < 6.96 x10(-8). Six loci were identified; three for HD and three for RCCL. An associated locus at CFA28:34,369,342 for HD was described previously in the same dogs using a conventional mixed model. No loci were identified for RCCL in the previous report but the two loci for ED in the previous report did not reach genome-wide significance using the FarmCPU model. These results were supported by simulation which demonstrated that the FarmCPU held no power advantage over the linear mixed model for the ED sample but provided additional power for the HD and RCCL samples. Candidate genes for HD and RCCL are discussed. When using FarmCPU software, we recommend a resampling test, that a positive control be used to determine the optimum pseudo quantitative trait nucleotide-based covariate structure of the model, and a negative control be used consisting of permutation testing and the identical resampling test as for the non-permuted phenotypes.	[Huang, Meng] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Hayward, Jessica J.; Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Hayward, Jessica J.; Corey, Elizabeth; Garrison, Susan J.; Wagner, Gabriela R.; Boyko, Adam R.; Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Cornell Vet Biobank, Ithaca, NY 14853 USA; [Corey, Elizabeth; Garrison, Susan J.; Krotscheck, Ursula; Hayashi, Kei; Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Schweitzer, Peter A.] Cornell Univ, Biotechnol Resource Ctr, Sequencing Core, Ithaca, NY USA; [Lust, George] Cornell Univ, Baker Inst Anim Hlth, Ithaca, NY USA; [Boyko, Adam R.] Embark Vet Inc, Austin, TX USA	Washington State University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University	Huang, M (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	meng.huang@wsu.edu	Hayward, Jessica/AGW-0493-2022; Hayashi, Kei/K-5885-2018	Garrison, Susan/0000-0001-6760-427X	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; National Geographic Society; NIH [R01 GM103961, R24 GM082910-A1, R24 GM082910-S1]; The American Kennel Club [1445]; Cornell University College of Veterinary Medicine	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; National Geographic Society(National Geographic Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The American Kennel Club; Cornell University College of Veterinary Medicine	This study was made possible by funding support from Zoetis Animal Health, the Cornell University Center for Advanced Technology in Life Science Enterprise, the National Geographic Society, NIH R01 GM103961, NIH R24 GM082910-A1 and R24 GM082910-S1, The American Kennel Club (Grant #1445) and the Cornell University College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor H, 1998, CURR BIOL, V8, P642, DOI 10.1016/S0960-9822(98)70251-9; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Baird AEG, 2014, ANIM GENET, V45, P542, DOI 10.1111/age.12162; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Breur GJ, 2012, GENETICS OF THE DOG, 2ND EDITION, P136, DOI 10.1079/9781845939403.0136; Breur GJ LN, 2012, GENETICS OF ORTHOPED; Cardinet GH, 1997, J AM VET MED ASSOC, V210, P1417; Castelhano MGP, 2009, JAVMA-J AM VET MED A, V234, P75, DOI 10.2460/javma.234.1.75; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Cohn DH, 2003, AM J HUM GENET, V72, P419, DOI 10.1086/346176; Comerford EJ, 2011, VET COMP ORTHOPAED, V24, P91, DOI 10.3415/VCOT-10-04-0055; Comerford EJ, 2004, AM J VET RES, V65, P1136, DOI 10.2460/ajvr.2004.65.1136; Dupuis N, 2015, HUM MOL GENET, V24, P2771, DOI 10.1093/hmg/ddv038; Ehtesham N, 2002, AM J HUM GENET, V71, P947, DOI 10.1086/342669; El Ghouzzi V, 2003, HUM MOL GENET, V12, P357, DOI 10.1093/hmg/ddg029; El Khoury L, 2015, INT J SPORTS MED, V36, P333, DOI 10.1055/s-0034-1390492; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Feldman G, 2010, CLIN ORTHOP RELAT R, V468, P337, DOI 10.1007/s11999-009-1073-6; Feldman GJ, 2013, J BONE MINER RES, V28, P2540, DOI 10.1002/jbmr.1999; Feldman GJ, 2012, J ARTHROPLASTY, V27, P527, DOI 10.1016/j.arth.2011.10.016; Fels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096618; Freedman AH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005851; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; GOTOH H, 1989, CLIN CHEM, V35, P1016; GUTHRIE S, 1992, RES VET SCI, V52, P284, DOI 10.1016/0034-5288(92)90026-X; Hao Z, 2014, J ORTHOP RES, V32, P179, DOI 10.1002/jor.22507; Hayward JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10460; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Hou YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076390; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Li L, 2016, J ORTHOP RES; Liu XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005767; Loder RT, 2015, J CHILD ORTHOP, V9, P93, DOI 10.1007/s11832-015-0636-1; Lyons ML, 2015, J SHOULDER ELB SURG, V24, P1098, DOI 10.1016/j.jse.2015.03.014; Mannion S, 2014, BRIT J SPORT MED, V48, P1640, DOI 10.1136/bjsports-2013-093201; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Montecchiani C, 2016, BRAIN, V139, P73, DOI 10.1093/brain/awv320; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Nielen ALJ, 2001, AM J VET RES, V62, P1198, DOI 10.2460/ajvr.2001.62.1198; Ohnuma K, 2008, TRENDS IMMUNOL, V29, P295, DOI 10.1016/j.it.2008.02.010; Olin J., 2016, ORTHOPEDIC FOUNDATIO; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Phavaphutanon J, 2009, AM J VET RES, V70, P1094, DOI 10.2460/ajvr.70.9.1094; Posthumus M, 2009, AM J; Powers MY, 2005, JAVMA-J AM VET MED A, V227, P1109, DOI 10.2460/javma.2005.227.1109; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahim M, 2014, J ORTHOP RES, V32, P1612, DOI 10.1002/jor.22705; Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386; Sandell LJ, 2012, NAT REV RHEUMATOL, V8, P77, DOI 10.1038/nrrheum.2011.199; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Sedo A, 2005, ARTHRITIS RES THER, V7, P253, DOI 10.1186/ar1852; Sherva R, 2014, ALZHEIMERS DEMENT, V10, P45, DOI 10.1016/j.jalz.2013.01.008; Sromova L, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0707-y; Stepien-Slodkowska M, 2013, BIOL SPORT, V30, P57, DOI [10.5604/20831860.1029823, 10.5604/20831862.1029823]; Takaishi M, 2003, MOL BRAIN RES, V112, P146, DOI 10.1016/S0169-328X(03)00061-5; Temwichitr J, 2010, VET J, V185, P123, DOI 10.1016/j.tvjl.2009.06.022; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Ubbink GJ, 2000, VET REC, V147, P149, DOI 10.1136/vr.147.6.149; Van Hateren N, 2006, DEV DYNAM, V235, P490, DOI 10.1002/dvdy.20612; Verhoeven G, 2012, VET SURG, V41, P10, DOI 10.1111/j.1532-950X.2011.00929.x; Watson C M, 2015, SAMJ, S. Afr. med. j., V105, P558, DOI [10.7196/SAMJnew.7917, 10.7196/SAMJNEW.7917]; Wilke VL, 2009, AM J VET RES, V70, P1013, DOI 10.2460/ajvr.70.8.1013; Wilke VL, 2006, JAVMA-J AM VET MED A, V228, P61, DOI 10.2460/javma.228.1.61; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Zhang Z., 2013, ZHIWU LABORATORY FOR; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	67	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0176932	10.1371/journal.pone.0176932	http://dx.doi.org/10.1371/journal.pone.0176932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614352	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900003
J	Szulc-Dabrowska, L; Struzik, J; Ostrowska, A; Guzera, M; Toka, FN; Bossowska-Nowicka, M; Gierynska, MM; Winnicka, A; Nowak, Z; Niemialtowski, MG				Szulc-Dabrowska, Lidia; Struzik, Justyna; Ostrowska, Agnieszka; Guzera, Maciej; Toka, Felix N.; Bossowska-Nowicka, Magdalena; Gierynska, Malgorzata M.; Winnicka, Anna; Nowak, Zuzanna; Niemialtowski, Marek G.			Functional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; NF-KAPPA-B; MODIFIED VACCINIA VIRUS; MHC CLASS-II; TOLL-LIKE RECEPTORS; CD8(+) T-CELLS; ANTIGEN PRESENTATION; PROTECTIVE IMMUNITY; HUMAN MONKEYPOX; C57BL/6 MICE	Ectromelia virus (ECTV) is an orthopoxvirus responsible for mousepox, a lethal disease of certain strains of mice that is similar to smallpox in humans, caused by variola virus (VARV). ECTV, similar to VARV, exhibits a narrow host range and has co-evolved with its natural host. Consequently, ECTV employs sophisticated and host-specific strategies to control the immune cells that are important for induction of antiviral immune response. In the present study we investigated the influence of ECTV infection on immune functions of murine GM-CSF-derived bone marrow cells (GM-BM), comprised of conventional dendritic cells (cDCs) and macrophages. Our results showed for the first time that ECTV is able to replicate productively in GM-BM and severely impaired their innate and adaptive immune functions. Infected GM-BM exhibited dramatic changes in morphology and increased apoptosis during the late stages of infection. Moreover, GM-BM cells were unable to uptake and process antigen, reach full maturity and mount a proinflammatory response. Inhibition of cytokine/chemokine response may result from the alteration of nuclear translocation of NF-kappa B, IRF3 and IRF7 transcription factors and down-regulation of many genes involved in TLR, RLR, NLR and type I IFN signaling pathways. Consequently, GM-BM show inability to stimulate proliferation of purified allogeneic CD4(+) T cells in a primary mixed leukocyte reaction (MLR). Taken together, our data clearly indicate that ECTV induces immunosuppressive mechanisms in GM-BM leading to their functional paralysis, thus compromising their ability to initiate downstream T-cell activation events.	[Szulc-Dabrowska, Lidia; Struzik, Justyna; Toka, Felix N.; Bossowska-Nowicka, Magdalena; Gierynska, Malgorzata M.; Niemialtowski, Marek G.] Warsaw Univ Life Sci SGGW, Dept Preclin Sci, Fac Vet Med, Warsaw, Poland; [Ostrowska, Agnieszka] Warsaw Univ Life Sci SGGW, Analyt Ctr, Warsaw, Poland; [Guzera, Maciej] Univ Cambridge, Dept Vet Med, Cambridge, England; [Toka, Felix N.] Ross Univ, Dept Biomed Sci, Sch Vet Med, St Kitts, West Indies, St Kitts & Nevi; [Winnicka, Anna] Warsaw Univ Life Sci SGGW, Dept Pathol & Vet Diagnost, Fac Vet Med, Warsaw, Poland; [Nowak, Zuzanna] Warsaw Univ Life Sci SGGW, Fac Anim Sci, Dept Genet & Anim Breeding, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; University of Cambridge; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Szulc-Dabrowska, L (corresponding author), Warsaw Univ Life Sci SGGW, Dept Preclin Sci, Fac Vet Med, Warsaw, Poland.	lidia_szulc@sggw.pl	Nowak-Zyczynska, Zuzanna/GPC-5777-2022; Guzera, Maciej/AAT-6629-2021; Toka, Felix/P-7828-2019	Nowak-Zyczynska, Zuzanna/0000-0002-5907-9943; Toka, Felix/0000-0001-9560-8665; Winnicka, Anna/0000-0001-9918-3430; Struzik, Justyna/0000-0001-9718-7657; Ostrowska, Agnieszka/0000-0001-8781-6106; Szulc-Dabrowska, Lidia/0000-0002-5436-6556	National Science Center in Cracow, Poland [UMLO-2012/05/D/NZ6/02916]; Ministry of Science and Higher Education in Warsaw, Poland [NN401015240]	National Science Center in Cracow, Poland; Ministry of Science and Higher Education in Warsaw, Poland	This work was supported by grant No. UMLO-2012/05/D/NZ6/02916 (to LS-D) from the National Science Center in Cracow, Poland (https://www.ncn.gov.pl/) and grant No. NN401015240 (to FNT) from the Ministry of Science and Higher Education in Warsaw, Poland (http://www.nauka.gov.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Belongia Edward A, 2003, Clin Med Res, V1, P87; BULLER RML, 1986, CURR TOP MICROBIOL, V127, P319; Buries K, 2014, VIROLOGY, V468, P351, DOI 10.1016/j.virol.2014.08.030; Byun MJ, 2007, CELL HOST MICROBE, V2, P306, DOI 10.1016/j.chom.2007.09.002; Byun M, 2009, CELL HOST MICROBE, V6, P422, DOI 10.1016/j.chom.2009.09.012; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; de Brito C, 2011, J IMMUNOL, V186, P1503, DOI 10.4049/jimmunol.1001022; De Smedt T, 2001, J LEUKOCYTE BIOL, V69, P951; DeFaundez IS, 1995, ADV EXP MED BIOL, V378, P257; Deng L, 2006, J VIROL, V80, P9977, DOI 10.1128/JVI.00354-06; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; DiPerna G, 2004, J BIOL CHEM, V279, P36570, DOI 10.1074/jbc.M400567200; Dolega P, 2017, VIRAL IMMUNOL; Drillien R, 2000, VIROLOGY, V268, P471, DOI 10.1006/viro.2000.0203; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Hansen SJ, 2011, VIROLOGY, V412, P411, DOI 10.1016/j.virol.2011.01.024; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Jenne L, 2000, GENE THER, V7, P1575, DOI 10.1038/sj.gt.3301287; Jiang XZ, 2008, INFECT IMMUN, V76, P2392, DOI 10.1128/IAI.01584-07; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Luteijn RD, 2014, J IMMUNOL, V193, P1578, DOI 10.4049/jimmunol.1400964; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McFadden G, 2005, NAT REV MICROBIOL, V3, P201, DOI 10.1038/nrmicro1099; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Montanuy I, 2011, FASEB J, V25, P1960, DOI 10.1096/fj.10-177188; Norbury CC, 2002, NAT IMMUNOL, V3, P265, DOI 10.1038/ni762; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Pascutti MF, 2011, J VIROL, V85, P5532, DOI 10.1128/JVI.02267-10; Rehm KE, 2010, VIROLOGY, V397, P176, DOI 10.1016/j.virol.2009.11.008; Rehm KE, 2009, IMMUNOLOGY, V128, P381, DOI 10.1111/j.1365-2567.2009.03120.x; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Sanderson CM, 1998, J VIROL, V72, P1235, DOI 10.1128/JVI.72.2.1235-1243.1998; Sei JJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004941; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Smith VP, 2000, J VIROL, V74, P8460, DOI 10.1128/JVI.74.18.8460-8471.2000; Stabenow J, 2010, J VIROL, V84, P3909, DOI 10.1128/JVI.02012-09; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Stanford MM, 2007, IMMUNOL CELL BIOL, V85, P93, DOI 10.1038/sj.icb.7100033; Struzik J, 2015, MICROB PATHOGENESIS, V87, P59, DOI 10.1016/j.micpath.2015.07.017; Struzik J, 2015, ARCH VIROL, V160, P2301, DOI 10.1007/s00705-015-2507-y; Szulc-Dabrowska L, 2016, CYTOSKELETON, V73, P396, DOI 10.1002/cm.21308; Szulc-Dazbrowska L, 2013, PATHOG DIS, V68, P105, DOI 10.1111/2049-632X.12054; Thiele F, 2015, J VIROL, V89, P2698, DOI 10.1128/JVI.03244-14; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; van Buuren N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004326; Vidalain PO, 2001, IMMUNOBIOLOGY, V204, P629, DOI 10.1078/0171-2985-00102; Wahid R, 2005, J VIROL, V79, P401, DOI 10.1128/JVI.79.1.401-409.2005; Walsh SR, 2011, EXPERT REV VACCINES, V10, P1221, DOI [10.1586/ERV.11.79, 10.1586/erv.11.79]; Walzer T, 2005, J IMMUNOL, V174, P51, DOI 10.4049/jimmunol.174.1.51; Wang N, 2009, J IMMUNOL, V183, P1542, DOI 10.4049/jimmunol.0802741; Wang Q, 2014, J VIROL, V88, P4853, DOI 10.1128/JVI.02923-13; Yao YX, 2007, CELL IMMUNOL, V246, P92, DOI 10.1016/j.cellimm.2007.06.005; Yates NL, 2007, VIROLOGY, V359, P349, DOI 10.1016/j.virol.2006.09.020	65	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179166	10.1371/journal.pone.0179166	http://dx.doi.org/10.1371/journal.pone.0179166			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604814	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400033
J	Klymenko, Y; Kim, O; Loughran, E; Yang, J; Lombard, R; Alber, M; Stack, MS				Klymenko, Y.; Kim, O.; Loughran, E.; Yang, J.; Lombard, R.; Alber, M.; Stack, M. S.			Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis	ONCOGENE			English	Article							COLLECTIVE CELL-MIGRATION; TYPE-1 MATRIX-METALLOPROTEINASE; N-CADHERIN; CARCINOMA-CELLS; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; SURFACE EPITHELIUM; MALIGNANT-MELANOMA; MESSENGER-RNA; TUMOR-GROWTH	During epithelial ovarian cancer (EOC) progression, intraperitoneally disseminating tumor cells and multicellular aggregates (MCAs) present in ascites fluid adhere to the peritoneum and induce retraction of the peritoneal mesothelial monolayer prior to invasion of the collagen-rich submesothelial matrix and proliferation into macro-metastases. Clinical studies have shown heterogeneity among EOC metastatic units with respect to cadherin expression profiles and invasive behavior; however, the impact of distinct cadherin profiles on peritoneal anchoring of metastatic lesions remains poorly understood. In the current study, we demonstrate that metastasis-associated behaviors of ovarian cancer cells and MCAs are influenced by cellular cadherin composition. Our results show that mesenchymal N-cadherin-expressing (Ncad+) cells and MCAs invade much more efficiently than E-cadherin-expressing (Ecad+) cells. Ncad+ MCAs exhibit rapid lateral dispersal prior to penetration of three-dimensional collagen matrices. When seeded as individual cells, lateral migration and cell-cell junction formation precede matrix invasion. Neutralizing the Ncad extracellular domain with the monoclonal antibody GC-4 suppresses lateral dispersal and cell penetration of collagen gels. In contrast, use of a broad-spectrum matrix metalloproteinase (MMP) inhibitor (GM6001) to block endogenous membrane type 1 matrix metalloproteinase (MT1-MMP) activity does not fully inhibit cell invasion. Using intact tissue explants, Ncad+ MCAs were also shown to efficiently rupture peritoneal mesothelial cells, exposing the submesothelial collagen matrix. Acquisition of Ncad by Ecad+ cells increased mesothelial clearance activity but was not sufficient to induce matrix invasion. Furthermore, co-culture of Ncad+ with Ecad+ cells did not promote a 'leader-follower' mode of collective cell invasion, demonstrating that matrix remodeling and creation of invasive micro-tracks are not sufficient for cell penetration of collagen matrices in the absence of Ncad. Collectively, our data emphasize the role of Ncad in intraperitoneal seeding of EOC and provide the rationale for future studies targeting Ncad in preclinical models of EOC metastasis.	[Klymenko, Y.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN USA; [Klymenko, Y.; Kim, O.; Loughran, E.; Yang, J.; Lombard, R.; Alber, M.; Stack, M. S.] Univ Notre Dame, Harper Canc Res Inst, South Bend, IN USA; [Kim, O.; Alber, M.] Univ Notre Dame, Dept Appl & Computat Math & Stat, 153 Hurley Hall, Notre Dame, IN 46556 USA; [Kim, O.; Alber, M.] Univ Calif Riverside, Dept Math, Riverside, CA USA; [Loughran, E.; Yang, J.; Stack, M. S.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; University of California System; University of California Riverside; University of Notre Dame	Alber, M (corresponding author), Univ Notre Dame, Dept Appl & Computat Math & Stat, 153 Hurley Hall, Notre Dame, IN 46556 USA.; Stack, MS (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Harper Canc Res Inst, A200 Harper Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	malber@nd.edu; sstack@nd.edu	Alber, Mark/AAR-1280-2020; Loughran, Elizabeth/D-6511-2015	Loughran, Elizabeth/0000-0002-7940-3157; /0000-0001-7324-8427	National Institutes of Health/National Cancer Institute [RO1CA109545, RO1CA086984]; Leo and Anne Albert Charitable Trust; Research Like a Champion grant; Walther Cancer Foundation Seeding Research in Cancer grant; NSF [DGE1313583]; University of Notre Dame Integrated Imaging Facility;  [U01-HL116330]; NATIONAL CANCER INSTITUTE [R01CA086984, R01CA109545] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL116330] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leo and Anne Albert Charitable Trust; Research Like a Champion grant; Walther Cancer Foundation Seeding Research in Cancer grant; NSF(National Science Foundation (NSF)); University of Notre Dame Integrated Imaging Facility; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Research Grants RO1CA109545 and RO1CA086984 (both to MSS) from the National Institutes of Health/National Cancer Institute, the Leo and Anne Albert Charitable Trust (to MSS); the Research Like a Champion grant (to YK and RL); the Walther Cancer Foundation Seeding Research in Cancer grant (to OK); NSF DGE1313583 (to EL); U01-HL116330 (to OK and MA) and University of Notre Dame Integrated Imaging Facility. We thank Dr Charles Tessier, Indiana University School of Medicine-South Bend for assistance with second-harmonic-generation imaging microscopy.	ACKERMAN AB, 1984, AM J DERMATOPATH, V6, P63; Afzal S, 1998, HUM PATHOL, V29, P155, DOI 10.1016/S0046-8177(98)90226-X; Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Augustine CK, 2008, CANCER RES, V68, P3777, DOI 10.1158/0008-5472.CAN-07-5949; Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200; BELL CD, 1986, J SURG ONCOL, V31, P39, DOI 10.1002/jso.2930310109; Blaschuk OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0039; Blaschuk OW, 2009, EUR J PHARMACOL, V625, P195, DOI 10.1016/j.ejphar.2009.05.033; Bruney L, 2014, BIOL CHEM, V395, P1221, DOI 10.1515/hsz-2014-0155; Burleson KM, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-6; Burleson KM, 2004, GYNECOL ONCOL, V93, P170, DOI 10.1016/j.ygyno.2003.12.034; Carey SP, 2013, CLIN EXP METASTAS, V30, P615, DOI 10.1007/s10585-013-9565-x; Coffman LG, 2016, TRANSL RES, V175, P92, DOI 10.1016/j.trsl.2016.03.016; Cosgrove BD, 2016, NAT MATER, V15, P1297, DOI [10.1038/NMAT4725, 10.1038/nmat4725]; Davidowitz RA, 2012, JOVE-J VIS EXP, DOI 10.3791/3888; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Davidson B, 2002, MOL CELL ENDOCRINOL, V187, P39, DOI 10.1016/S0303-7207(01)00709-2; Davidson B, 2001, AM J CLIN PATHOL, V115, P517; DAY CL, 1981, ANN SURG, V194, P108, DOI 10.1097/00000658-198107000-00019; Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183; Devemy E, 2008, PEPTIDES, V29, P1853, DOI 10.1016/j.peptides.2008.06.025; Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ellerbroek SM, 2001, J BIOL CHEM, V276, P24833, DOI 10.1074/jbc.M005631200; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Howlader N, 2011, SEER CANC STAT REV 1, P19; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Ilina O, 2009, J CELL SCI, V122, P3203, DOI 10.1242/jcs.036525; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; King SM, 2011, ENDOCR-RELAT CANCER, V18, P627, DOI 10.1530/ERC-11-0107; Klymenko Y, 2017, NEOPLASIA, V19, P549, DOI 10.1016/j.neo.2017.04.002; Labernadie A, 2017, NAT CELL BIOL, V19, P224, DOI 10.1038/ncb3478; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lautscham LA, 2015, BIOPHYS J, V109, P900, DOI 10.1016/j.bpj.2015.07.025; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Liu YY, 2015, CANCER RES, V75, P5046, DOI 10.1158/0008-5472.CAN-15-0706; Marcus CS, 2014, J CANCER, V5, P25, DOI 10.7150/jca.7810; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Mitra AK, 2015, GYNECOL ONCOL, V138, P372, DOI 10.1016/j.ygyno.2015.05.040; Moser TL, 1996, INT J CANCER, V67, P695, DOI 10.1002/(SICI)1097-0215(19960904)67:5<695::AID-IJC18>3.3.CO;2-2; Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151; NIEDBALA MJ, 1985, EXP CELL RES, V160, P499, DOI 10.1016/0014-4827(85)90197-1; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Page DL, 1987, DIAGNOSTIC HISTOPATH; Pasapera AM, 2015, CURR BIOL, V25, P175, DOI 10.1016/j.cub.2014.11.043; Poncelet C, 2010, FERTIL STERIL, V94, P2909, DOI 10.1016/j.fertnstert.2010.04.055; Pradeep S, 2014, CANCER CELL, V26, P77, DOI 10.1016/j.ccr.2014.05.002; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Sadler NM, 2013, AM J BLOOD RES, V3, P271; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shih WT, 2012, J CELL SCI, V125, P3661, DOI 10.1242/jcs.103861; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sodek KL, 2007, BRIT J CANCER, V97, P358, DOI 10.1038/sj.bjc.6603863; Stewart DJ, 2006, J CLIN ONCOL, V24, p124S; Takai N, 2005, CANCER-AM CANCER SOC, V104, P2701, DOI 10.1002/cncr.21533; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; Utton MA, 2001, J NEUROCHEM, V76, P1421, DOI 10.1046/j.1471-4159.2001.00140.x; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Wolf K, 2006, BRIT J DERMATOL, V154, P11, DOI 10.1111/j.1365-2133.2006.07231.x	75	43	44	0	29	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5840	5851		10.1038/onc.2017.171	http://dx.doi.org/10.1038/onc.2017.171			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28628116	Green Accepted, Green Submitted			2022-12-26	WOS:000413292900006
J	Andreozzi, F; Mannino, GC; Mancuso, E; Spiga, R; Perticone, F; Sesti, G				Andreozzi, Francesco; Mannino, Gaia Chiara; Mancuso, Elettra; Spiga, Rosangela; Perticone, Francesco; Sesti, Giorgio			Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLUCOSE-TOLERANCE; KISS-1; GENE; SENSITIVITY; GPR54; METABOLISM; METASTIN; GLUCAGON; PLACENTA	To evaluate if plasma kisspeptin concentrations are associated with insulin secretion, as suggested by recent in vitro studies, independently of confounders. 261 nondiabetic subjects were stratified into tertiles according to kisspeptin values. Insulin secretion was assessed using indexes derived from oral glucose tolerance test (OGTT). After adjusting for age, gender, and BMI, subjects in the highest (tertile 3) kisspeptin group exhibited significantly lower values of insulinogenic index, corrected insulin response (CIR30), and Stumvoll indexes for first-phase and second-phase insulin release as compared with low (tertile 1) or intermediate (tertile 2) kisspeptin groups. Univariate correlations between kisspeptin concentration and metabolic variables showed that kisspeptin concentration was significantly and positively correlated with age, blood pressure, and 2-h post-load glucose, and inversely correlated with BMI, and waist circumference. There was an inverse relationship between kisspeptin levels and OGTT-derived indexes of glucose-stimulated insulin secretion. A multivariable regression analysis in a model including all the variables significantly correlated with kisspeptin concentration showed thar age (I-3 =-0.338, P<0.0001), BMI (I-3 = 0.272, P<0.0001), 2-h post-load glucose ((3 =-0.229, P<0.0001), and kisspeptin ((3 =-0.105, P 0.03) remained associated with insulinogenic index. These factors explained 34.6% of the variance of the insulinogenic index. In conclusion, kisspeptin concentrations are associated with insulin secretion independently of important determinants of glucose homeostasis such as gender, age, adiposity, 2-h post-load glucose, and insulin sensitivity.	[Andreozzi, Francesco; Mannino, Gaia Chiara; Mancuso, Elettra; Spiga, Rosangela; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, CZ, Italy	Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, CZ, Italy.	sesti@unicz.it	Perticone, Francesco/I-4260-2017; Mancuso, Elettra/AAD-5180-2020; Mannino, Gaia C/K-1580-2016; Spiga, Rosangela/AAB-4421-2020; Andreozzi, Francesco/J-4073-2018	Mancuso, Elettra/0000-0002-0562-9196; Mannino, Gaia C/0000-0002-6341-4572; Spiga, Rosangela/0000-0002-3331-6568; Andreozzi, Francesco/0000-0001-9375-1513; Sesti, Giorgio/0000-0002-1618-7688	Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD"	Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD"	The authors received no specific funding for this work, which was supported, in part, by the Foundation for Diabetes Research of the Italian Diabetes Society, through the award of "Fondazione Diabete Ricerca FO.DI.RI.-MSD" scholarships in 2014 and 2015 to Gaia Chiara Mannino. FO.DI.RI. and MSD 2014-2015-Dr. Gaia Chiara Mannino. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Cetkovic A, 2012, ENDOCR RES, V37, P78, DOI 10.3109/07435800.2011.639319; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Fiorentino TV, 2015, NUTR METAB CARDIOVAS, V25, P510, DOI 10.1016/j.numecd.2015.02.007; Gottsch ML, 2009, PEPTIDES, V30, P4, DOI 10.1016/j.peptides.2008.06.016; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hauge-Evans AC, 2006, DIABETOLOGIA, V49, P2131, DOI 10.1007/s00125-006-0343-z; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Hiney JK, 2009, ENDOCRINOLOGY, V150, P376, DOI 10.1210/en.2008-0954; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.3.CO;2-T; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muir AI, 2001, J BIOL CHEM, V276, P28969, DOI 10.1074/jbc.M102743200; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Panidis D, 2006, FERTIL STERIL, V85, P1778, DOI 10.1016/j.fertnstert.2005.11.044; Schwetz TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113020; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Silveira LG, 2010, J CLIN ENDOCR METAB, V95, P2276, DOI 10.1210/jc.2009-2421; Silvestre RA, 2008, J ENDOCRINOL, V196, P283, DOI 10.1677/JOE-07-0454; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Teles MG, 2008, NEW ENGL J MED, V358, P709, DOI 10.1056/NEJMoa073443; Tolson KP, 2016, ENDOCRINOLOGY, V157, P4192, DOI 10.1210/en.2016-1501; Tolson KP, 2014, J CLIN INVEST, V124, P3075, DOI 10.1172/JCI71075; Vikman J, 2009, DIABETES OBES METAB, V11, P197, DOI 10.1111/j.1463-1326.2009.01116.x	28	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179834	10.1371/journal.pone.0179834	http://dx.doi.org/10.1371/journal.pone.0179834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636637	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300057
J	Lake, MP; Bouchard, LS				Lake, Michael P.; Bouchard, Louis-S.			Targeted nanodiamonds for identification of subcellular protein assemblies in mammalian cells	PLOS ONE			English	Article							POLY(PROPYLENE IMINE) DENDRIMERS; NUCLEAR-PORE COMPLEX; QUANTUM DOTS; FLUORESCENT NANODIAMONDS; GOLD NANOPARTICLES; IN-VITRO; ELECTRON-MICROSCOPY; SIRNA DELIVERY; TOXICITY; NUP98	Transmission electron microscopy (TEM) can be used to successfully determine the structures of proteins. However, such studies are typically done ex situ after extraction of the protein from the cellular environment. Here we describe an application for nanodiamonds as targeted intensity contrast labels in biological TEM, using the nuclear pore complex (NPC) as a model macroassembly. We demonstrate that delivery of antibody-conjugated nanodiamonds to live mammalian cells using maltotriose-conjugated polypropylenimine dendrimers results in efficient localization of nanodiamonds to the intended cellular target. We further identify signatures of nanodiamonds under TEM that allow for unambiguous identification of individual nanodiamonds from a resin-embedded, OsO4-stained environment. This is the first demonstration of nanodiamonds as labels for nanoscale TEM-based identification of subcellular protein assemblies. These results, combined with the unique fluorescence properties and biocompatibility of nanodiamonds, represent an important step toward the use of nanodiamonds as markers for correlated optical/electron bioimaging.	[Lake, Michael P.; Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Bouchard, Louis-S.] Univ Calif Los Angeles, Ctr Comprehens Canc, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bouchard, LS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Bouchard, LS (corresponding author), Univ Calif Los Angeles, Ctr Comprehens Canc, Los Angeles, CA 90095 USA.	bouchard@chem.ucla.edu			AFOSR/DARPA QUASAR; Arnold and Mabel Beckman Foundation	AFOSR/DARPA QUASAR; Arnold and Mabel Beckman Foundation	This work was supported by AFOSR/DARPA QUASAR, Arnold and Mabel Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1881, J ROYAL MICROSCOPICA, V1, P388, DOI DOI 10.1111/J.1365-2818.1881.TB05909.X; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Buchser W., 2014, ASSAY GUIDANCE MANUA; Chatel G, 2012, J STRUCT BIOL, V177, P81, DOI 10.1016/j.jsb.2011.11.004; Chen M, 2005, EXP CELL RES, V305, P51, DOI 10.1016/j.yexcr.2004.12.021; Chen M, 2010, J PHYS CHEM LETT, V1, P3167, DOI 10.1021/jz1013278; Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Deerinck TJ, 2008, TOXICOL PATHOL, V36, P112, DOI 10.1177/0192623307310950; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; El-Say K. M., 2011, J APPL PHARM SCI, V01, P29; Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j; Franiak-Pietryga I, 2013, MOL PHARMACEUT, V10, P2490, DOI 10.1021/mp400142p; Franks TM, 2013, TRENDS CELL BIOL, V23, P112, DOI 10.1016/j.tcb.2012.10.013; Frantsuzov P, 2008, NAT PHYS, V4, P519, DOI 10.1038/nphys1001; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Guo ST, 2011, J NANOMATER, V2011, DOI 10.1155/2011/742895; Hirsch PB, 1977, ELECT MICROSCOPY THI; Huang YA, 2014, SCI REP; Ivask A, 2015, CURR TOP MED CHEM, V15, P1914, DOI 10.2174/1568026615666150506150109; Jelezko F, 2001, SINGLE MOL, V2, P255, DOI 10.1002/1438-5171(200112)2:4<255::AID-SIMO255>3.0.CO;2-D; Klajnert B, 2008, CHEM-EUR J, V14, P7030, DOI 10.1002/chem.200800342; Kreyling WG, 2015, NAT NANOTECHNOL, V10, P619, DOI [10.1038/NNANO.2015.111, 10.1038/nnano.2015.111]; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Le Sage D, 2013, NATURE, V496, P486, DOI 10.1038/nature12072; Levy R., 2010, NANO REV; Mahamid J, 2016, SCIENCE, V351, P969, DOI 10.1126/science.aad8857; Mayhew TM, 2011, J ANAT, V219, P647, DOI 10.1111/j.1469-7580.2011.01438.x; Mayhew TM, 2009, ANN ANAT, V191, P153, DOI 10.1016/j.aanat.2008.11.001; Mkandawire M, 2009, J BIOPHOTONICS, V2, P596, DOI 10.1002/jbio.200910002; Moore L, 2013, J DENT RES, V92, P976, DOI 10.1177/0022034513504952; Nagarajan S, 2016, NANOSCALE, V8, P11588, DOI 10.1039/c6nr01908k; Oh E, 2016, NAT NANOTECHNOL, V11, P479, DOI [10.1038/NNANO.2015.338, 10.1038/nnano.2015.338]; Paget V, 2014, NANOTOXICOLOGY, V8, P46, DOI 10.3109/17435390.2013.855828; Rodgers KR, 2016, BIOTECHNOL ADV, V34, P1149, DOI 10.1016/j.biotechadv.2016.07.004; Rothen-Rutishauser B, 2014, NANOMEDICINE-UK, V9, P607, DOI [10.2217/NNM.13.24, 10.2217/nnm.13.24]; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shimkunas RA, 2009, BIOMATERIALS, V30, P5720, DOI 10.1016/j.biomaterials.2009.07.004; SHIUE WK, 1982, J R STAT SOC C-APPL, V31, P130; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Souquere S, 2015, NUCLEUS-PHILA, V6, P326, DOI 10.1080/19491034.2015.1082695; Thiberge S, 2004, P NATL ACAD SCI USA, V101, P3346, DOI 10.1073/pnas.0400088101; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Tuchin V. V., 2015, TISSUE OPTICS LIGHT; Tzeng YK, 2011, ANGEW CHEM INT EDIT, V50, P2262, DOI 10.1002/anie.201007215; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Wingard CJ, 2011, NANOTOXICOLOGY, V5, P531, DOI 10.3109/17435390.2010.530004; Xi GF, 2014, NANOMED-NANOTECHNOL, V10, P381, DOI 10.1016/j.nano.2013.07.013; Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081; Zhang DM, 2009, NANO LETT, V9, P666, DOI 10.1021/nl803054h; Ziemba B, 2014, INT J PHARMACEUT, V461, P391, DOI 10.1016/j.ijpharm.2013.12.011; Ziemba B, 2011, J BIOMED MATER RES A, V99A, P261, DOI 10.1002/jbm.a.33196; Zurbuchen MA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02668	54	15	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179295	10.1371/journal.pone.0179295	http://dx.doi.org/10.1371/journal.pone.0179295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636640	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300031
J	Weaver, KJ; May, CJ; Ellis, BL				Weaver, Kathryn J.; May, Cassandra J.; Ellis, Brian L.			Using a health-rating system to evaluate the usefulness of Caenorhabditis elegans as a model for anthelmintic study	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; GASTROINTESTINAL NEMATODE; CHLORIDE CHANNEL; DOSE ALBENDAZOLE; LOW EFFICACY; IN-VITRO; HOOKWORM; MALARIA; NITAZOXANIDE; MEBENDAZOLE	Soil-transmitted helminths (STHs) are intestinal parasitic nematodes that infect humans, and are transmitted through contaminated soil. These nematodes include the large roundworm (Ascaris lumbricoides), whipworm (Trichuris trichiura), and hookworm (Ancylostoma ceylanicum, Ancylostoma duodenale, and Necator americanus). Nearly 1.5 billion people (-24% of the population) worldwide are infected with at least one species of these parasites, burdening the poor, in particular, children and pregnant women. To combat these diseases, the WHO only recognizes four anthelmintic drugs, including the preferred drug, albendazole, for mass drug administration (MDA). These four drugs have a total of two different mechanisms of action, and, as expected, resistance has been observed. This problem calls for new drugs with different mechanisms of action. Although there is precedence for the use of Caenorhabditis elegans (C. elegans), a free-living nematode, as a model for drug screening and anthelmintic testing, their usefulness for such anthelmintic study is not clear as past research has shown that C. elegans did not show a strong response to albendazole, the MDA drug of choice, in comparison with various STHs under similar treatment. To further examine if C. elegans has the potential to be a good model organism for anthelmintic drug study, we employed a health rating scale in order to tease out potential effects of albendazole, and other anthelmintics, that may have been missed using a binary, dead/alive scale. Using the health-rating scale we found that although the worms may have not been dying, they were sick, showing dose responses to anthelmintic drugs, including albendazole, reinforcing C. elegans as a useful model for anthelmintic study.	[Weaver, Kathryn J.; May, Cassandra J.; Ellis, Brian L.] Bethel Coll, Dept Biol & Chem, Mishawaka, IN 46545 USA		Ellis, BL (corresponding author), Bethel Coll, Dept Biol & Chem, Mishawaka, IN 46545 USA.	brian.ellis@bethelcollege.edu	May, Cassie/ABA-7419-2020; Ellis, Brian L./AAC-6105-2021	Ellis, Brian L./0000-0002-5878-3461; Weaver, Kathryn/0000-0001-8701-4197				Abaza H, 1998, CURR THER RES CLIN E, V59, P116, DOI 10.1016/S0011-393X(98)85006-6; Adegnika AA, 2014, ANTIMICROB AGENTS CH, V58, P2535, DOI 10.1128/AAC.01317-13; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bischof Larry J., 2006, V351, P139; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8485; Cappello M, 2004, PEDIATR INFECT DIS J, V23, P663, DOI 10.1097/01.inf.0000132228.00778.e4; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Davila-Gutierrez CE, 2002, AM J TROP MED HYG, V66, P251, DOI 10.4269/ajtmh.2002.66.251; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; Doroszuk A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp528; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Flohr C, 2007, AM J TROP MED HYG, V76, P732, DOI 10.4269/ajtmh.2007.76.732; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Geary TG, 2001, VET PARASITOL, V101, P371, DOI 10.1016/S0304-4017(01)00562-3; Geary TG, 1999, VET PARASITOL, V84, P275, DOI 10.1016/S0304-4017(99)00042-4; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Holden-Dye Lindy, 2014, WormBook, P1, DOI 10.1895/wormbook.1.143.2; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; HOSONO R, 1978, EXP GERONTOL, V13, P369, DOI 10.1016/0531-5565(78)90047-5; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; HOTEZ PJ, 1989, PEDIATR INFECT DIS J, V8, P516, DOI 10.1097/00006454-198908000-00009; Hu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070702; Hu Y, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000499; Humphries D, 2011, AM J TROP MED HYG, V84, P792, DOI 10.4269/ajtmh.2011.11-0003; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kopp SR, 2008, VET PARASITOL, V152, P284, DOI 10.1016/j.vetpar.2007.12.020; LACEY E, 1988, INT J PARASITOL, V18, P885, DOI 10.1016/0020-7519(88)90175-0; Mathew MD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005058; Neglected Disease Research and Development: The Ebola Effect, 2015, G FIND POL CUR; Office of Extramural Research NIH, 2016, EST FUND VAR RES CON; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Ortiz JJ, 2002, T ROY SOC TROP MED H, V96, P193, DOI 10.1016/S0035-9203(02)90301-9; Paveley RA, 2013, PARASITE IMMUNOL, V35, P302, DOI 10.1111/pim.12037; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Rossignol JF, 1984, AM J TROP MED HYG, V92, P663; Ruiz-Lancheros E, 2011, INT J PARASITOL, V41, P455, DOI 10.1016/j.ijpara.2010.11.009; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Somvanshi VS, 2014, MOL BIOCHEM PARASIT, V193, P1, DOI 10.1016/j.molbiopara.2013.12.002; Soukhathammavong PA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001417; Stepek G, 2005, PARASITOLOGY, V130, P203, DOI 10.1017/S0031182004006225; Stepek G, 2006, INT J EXP PATHOL, V87, P325, DOI 10.1111/j.1365-2613.2006.00495.x; Tambo E, 2015, INFECT DIS POVERTY, V4; Tritten L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001457; Tufts PR, 2014, TUFTS CTR STUD DRUG; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WHO, 2022, SOIL TRANSM HELM INF; WHO, 2016, METR DIS ADJ LIF YEA; Xue J, 2005, EXP PARASITOL, V111, P219, DOI 10.1016/j.exppara.2005.08.002	54	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179376	10.1371/journal.pone.0179376	http://dx.doi.org/10.1371/journal.pone.0179376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632749	gold, Green Published, Green Submitted			2022-12-26	WOS:000404046100024
J	Yan, ZY; Zhao, JL; Gan, L; Zhang, YQ; Guo, R; Cao, XM; Lau, WB; Ma, X; Wang, YJ				Yan, Zheyi; Zhao, Jianli; Gan, Lu; Zhang, Yanqing; Guo, Rui; Cao, Xiaoming; Lau, Wayne Bond; Ma, Xin; Wang, Yajing			CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner	PLOS ONE			English	Article							FACTOR-RELATED PROTEIN-3; PROLIFERATION; ADIPOKINE; MIGRATION	Objectives Diabetic retinopathy (DR) is a severe complication of chronic diabetes. The C1q/TNF-related protein family (CTRPs) has been demonstrated to exert protective effects against obesity and atherosclerosis in animal studies. Heretofore, the association between circulating CTRPs and DR patients has been unexplored. In the current study, we attempt to define this association, as well as the effect of CTRPs upon DR pathophysiology. Design The present investigation is a case control study that enrolled control subjects and type 2 diabetes mellitus (T2DM) patients diagnosed with DR. Serum CTRPs and sVACM-1 were determined by ELISA. Results Serum CTRP3 and CTRP5 levels were markedly decreased in patients with T2DM compared to controls (p<0.05) and inversely associated with T2DM. Furthermore, mutivariate regression and ROC analysis revealed CTRP3 deficiency, not CTRP5, was associated with proliferative diabetic retinopathy (PDR). Spearman's rank correlation assay demonstrated an inverse association between CTRP3 and sVCAM-1. Finally, exogenous CTRP3 administration attenuated high glucose high lipid (HGHL)-induced VCAM-1 production in an AMPK-dependent manner in cultured human retinal microvascular endothelial cells (HRMECs). Conclusion CTRP3 may serve as a novel biomarker for DR severity. CTRP3 may represent a future novel therapeutic against DR, a common ocular complication of diabetes.	[Yan, Zheyi] Shanxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Taiyuan, Shanxi, Peoples R China; [Yan, Zheyi; Zhao, Jianli; Gan, Lu; Zhang, Yanqing; Guo, Rui; Lau, Wayne Bond; Ma, Xin; Wang, Yajing] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA; [Zhao, Jianli; Zhang, Yanqing] Shanxi Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Taiyuan, Shanxi, Peoples R China; [Gan, Lu; Guo, Rui; Ma, Xin; Wang, Yajing] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Cao, Xiaoming] Shanxi Med Univ, Affiliated Hosp 2, Dept Orthoped, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Jefferson University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Wang, YJ (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.; Wang, YJ (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China.	yajing.wang@jefferson.edu		Lau, Wayne Bond/0000-0002-8064-8290	Shanxi Animals' Special Foundation [2015K01]; Shanxi Key Subjects Construction, Innovative Talents of Higher Learning Institutions of Shanxi, American Diabetes Association [1-14-BS-218, 1-17-IBS-297]; Natural Science Foundation of China [81670278, 31322026, 81270185, 81470020]; National Institutes of Health [HL-96686, HL-123404]; American Diabetes Association [1-15-BS-122]	Shanxi Animals' Special Foundation; Shanxi Key Subjects Construction, Innovative Talents of Higher Learning Institutions of Shanxi, American Diabetes Association; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association)	This work was supported by the following grants: Shanxi Animals' Special Foundation 2015K01 (ZY. Yan); Shanxi Key Subjects Construction, Innovative Talents of Higher Learning Institutions of Shanxi, American Diabetes Association 1-14-BS-218, 1-17-IBS-297, Natural Science Foundation of China 81670278, 31322026 (Y. Wang); 81270185, 81470020 (J. Zhao); National Institutes of Health HL-96686, HL-123404, and American Diabetes Association 1-15-BS-122 (X.L. Ma). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Akiyama H, 2013, MOL CELL ENDOCRINOL, V369, P63, DOI 10.1016/j.mce.2013.01.002; Ban B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112931; Castan-Laurell I, 2016, APELIN ENERGY METABO, P353; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; Hernandez C, 2012, CURR DIABETES REP, V12, P329, DOI 10.1007/s11892-012-0284-5; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Kacso IM, 2015, CLIN BIOCHEM, V48, P860, DOI 10.1016/j.clinbiochem.2015.05.013; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Limb GA, 1999, INVEST OPHTH VIS SCI, V40, P2453; Liu GZ, 2015, FREE RADICAL BIO MED, V89, P473, DOI 10.1016/j.freeradbiomed.2015.09.005; Murayama MA, 2014, BIOCHEM BIOPH RES CO, V443, P42, DOI 10.1016/j.bbrc.2013.11.040; Nowak M, 2008, CLIN EXP MED, V8, P159, DOI 10.1007/s10238-008-0173-z; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Omae T, 2015, INVEST OPHTH VIS SCI, V56, P4143, DOI 10.1167/iovs.15-16447; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Rangasamy S, 2012, MIDDLE EAST AFR J OP, V19, P52, DOI 10.4103/0974-9233.92116; Shehzad A, 2012, HORM-INT J ENDOCRINO, V11, P8, DOI 10.1007/BF03401534; Sun XD, 2011, ACTA PHARMACOL SIN, V32, P1543, DOI 10.1038/aps.2011.130; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Vaziri K, 2015, SEMINARS OPHTHALMOLO; Wang SH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00237; World Health Organization, 2014, GLOB DAT VIS IMP 201; Yang WM, 2014, BIOCHEM BIOPH RES CO, V452, P715, DOI 10.1016/j.bbrc.2014.08.145; Yi W, 2012, CIRCULATION, V125, P3159, DOI 10.1161/CIRCULATIONAHA.112.099937; Yoo HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055744; Yoshizawa M, 1998, DIABETES RES CLIN PR, V42, P65, DOI 10.1016/S0168-8227(98)00091-6; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang W, 2016, J DIABETES SCI TECHN; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	35	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178253	10.1371/journal.pone.0178253	http://dx.doi.org/10.1371/journal.pone.0178253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632765	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100005
J	Fania, C; Arosio, B; Capitanio, D; Torretta, E; Gussago, C; Ferri, E; Mari, D; Gelfi, C				Fania, Chiara; Arosio, Beatrice; Capitanio, Daniele; Torretta, Enrica; Gussago, Cristina; Ferri, Evelyn; Mari, Daniela; Gelfi, Cecilia			Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms	PLOS ONE			English	Article							A-I; AMYLOID-BETA; PLASMA; DIAGNOSIS; DEMENTIA	In the diagnosis of Alzheimer's disease (AD) total tau (T-tau), tau phosphorylated at threonine 181 (P-tau181), and the 42 amino acid isoform of alpha beta-amyloid (A beta) are well established surrogate CSF markers. However, there is a constant need for new diagnostic markers to identify the disease at a very early stage. The identification of new molecules for AD diagnosis and monitoring in CSF is hampered by several "confounding" factors including intra-and inter-individual, pre-analytical and analytical variabilities. In an attempt to partially overcome patient's variability and to determine new molecules significantly dysregulated in CSF, we assessed the proteome profile of low molecular weight protein species in CSF and serum of the same patients. CSFs and sera from 36 ADs, 32 iNPHs (idiopathic normal pressure hydrocephalus) and 12 controls were compared by MALDI profiling (non-parametric statistics, CV<20%, AUC>0.750). After protein identification by mass spectrometry, the proteoform composition was assessed by 2-D DIGE/MS. Results indicated that CSF of iNPH can be used as control. Serum and CSF of AD patients shows a specific protein profile compared to iNPH samples. A variation (p<0.01) of Apo A-1 levels in AD, together with a specific dysregulation of Apo A-1 proteoforms was observed. The profiling of CSF and serum of the same patients, suggests that the decrement of total Apo A-1 occurs specifically in CSF. Serum and CSF of AD shows a characteristic Apo A-1 proteoform pattern suggesting it as potential marker which can support the clinical workflow adopted for AD diagnosis and progression.	[Fania, Chiara; Gelfi, Cecilia] IRCCS, Policlin San Donato, UO Prote Clin, San Donato Milanese, MI, Italy; [Arosio, Beatrice; Gussago, Cristina; Ferri, Evelyn; Mari, Daniela] Univ Milan, Geriatr Unit, Dept Med Sci & Community Hlth, Milan, Italy; [Arosio, Beatrice; Mari, Daniela] IRCCS, Osped Maggiore Policlin, Fdn Ca Granda, Milan, Italy; [Capitanio, Daniele; Torretta, Enrica; Gelfi, Cecilia] Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy; Univ Milan, Nutr Sci, Milan, Italy	IRCCS Policlinico San Donato; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan	Gelfi, C (corresponding author), IRCCS, Policlin San Donato, UO Prote Clin, San Donato Milanese, MI, Italy.; Gelfi, C (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Segrate, MI, Italy.	cecilia.gelfi@unimi.it	Capitanio, Daniele/J-9976-2018; Mari, Daniela/K-5663-2016; CAPITANIO, DANIELE/AAC-4059-2019; Ferri, Evelyn/ABF-3654-2020; torretta, enrica/I-8793-2012	Capitanio, Daniele/0000-0001-7701-728X; Mari, Daniela/0000-0002-6950-0789; CAPITANIO, DANIELE/0000-0001-7701-728X; torretta, enrica/0000-0002-6374-3325; Ferri, Evelyn/0000-0002-7423-3793; Arosio, Beatrice/0000-0002-0615-3580; Gussago, Cristina/0000-0002-2708-3112; Fania, Chiara/0000-0003-3949-8769	Ministero dell'Istruzione, dell'Universita e della Ricerca [FIRB RBRN07BMCT]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was funded by Ministero dell'Istruzione, dell'Universita e della Ricerca [award number FIRB RBRN07BMCT to Cecilia Gelfi]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baynes JW, 2014, CLIN CHEM LAB MED, V52, P1, DOI 10.1515/cclm-2013-0551; Beynon RJ, 2005, NAT METHODS, V2, P587, DOI 10.1038/NMETH774; BRESLOW JL, 1982, P NATL ACAD SCI-BIOL, V79, P6861, DOI 10.1073/pnas.79.22.6861; Catherman AD, 2014, BIOCHEM BIOPH RES CO, V445, P683, DOI 10.1016/j.bbrc.2014.02.041; Chandramouli K., 2009, HUMAN GENOMICS PROTE, V2009; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Fania C, 2015, CLIN CHIM ACTA, V439, P42, DOI 10.1016/j.cca.2014.10.003; Fania C, 2011, ELECTROPHORESIS, V32, P1715, DOI 10.1002/elps.201100134; Fania C, 2009, ELECTROPHORESIS, V30, P2193, DOI 10.1002/elps.200800800; Gallia GL, 2006, NAT CLIN PRACT NEURO, V2, P375, DOI 10.1038/ncpneuro0237; Gharavi NM, 2007, ARTERIOSCL THROM VAS, V27, P1346, DOI 10.1161/ATVBAHA.107.141283; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Hye A, 2014, ALZHEIMERS DEMENT, V10, P799, DOI 10.1016/j.jalz.2014.05.1749; Karantzoulis S, 2011, EXPERT REV NEUROTHER, V11, P1579, DOI [10.1586/ERN.11.155, 10.1586/ern.11.155]; Karp NA, 2005, J PROTEOME RES, V4, P1867, DOI 10.1021/pr050084g; Karp Natasha A, 2007, Proteomics, V7 Suppl 1, P42, DOI 10.1002/pmic.200700683; Kingwell Katie, 2013, Nat Rev Neurol, V9, P420, DOI 10.1038/nrneurol.2013.134; Lazarus J, 2015, J ALZHEIMERS DIS, V44, P175, DOI 10.3233/JAD-141314; Lefterov I, 2010, J BIOL CHEM, V285, P36945, DOI 10.1074/jbc.M110.127738; Lehallier B, 2016, JAMA NEUROL, V73, P203, DOI 10.1001/jamaneurol.2015.3135; Lewczuk P, 2015, J ALZHEIMERS DIS, V43, P183, DOI 10.3233/JAD-140771; Mateos-Caceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millan J, 2009, VASC HEALTH RISK MAN, V5, P757; Minjarez B, 2016, J PROTEOMICS, V139, P103, DOI 10.1016/j.jprot.2016.03.022; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Nofer Jerzy-Roch, 2005, Expert Rev Cardiovasc Ther, V3, P1071, DOI 10.1586/14779072.3.6.1071; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Paula-Lima AC, 2009, INT J BIOCHEM CELL B, V41, P1361, DOI 10.1016/j.biocel.2008.12.003; Relkin Norman, 2005, Neurosurgery, V57, pS4; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Saczynski JS, 2007, AM J EPIDEMIOL, V165, P985, DOI 10.1093/aje/kwm027; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; Song F, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-5; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; SUEHIRO T, 1993, CLIN CHEM, V39, P60	37	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179280	10.1371/journal.pone.0179280	http://dx.doi.org/10.1371/journal.pone.0179280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628634	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100025
J	Sampath, R; Cummins, NW; Natesampillai, S; Bren, GD; Chung, TD; Baker, J; Henry, K; Pagliuzza, A; Badley, AD				Sampath, Rahul; Cummins, Nathan W.; Natesampillai, Sekar; Bren, Gary D.; Chung, Thomas D.; Baker, Jason; Henry, Keith; Pagliuzza, Amelie; Badley, Andrew D.			Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells	PLOS ONE			English	Article								HIV persists because a reservoir of latently infected CD4 T cells do not express viral proteins and are indistinguishable from uninfected cells. One approach to HIV cure suggests that reactivating HIV will activate cytotoxic pathways; yet when tested in vivo, reactivating cells do not die sufficiently to reduce cell-associated HIV DNA levels. We recently showed that following reactivation from latency, HIV infected cells generate the HIV specific cytotoxic protein Casp8p41 which is produced by HIV protease cleaving procaspase 8. However, cell death is prevented, possibly due to low procaspase 8 expression. Here, we tested whether increasing procaspase 8 levels in CD4 T cells will produce more Casp8p41 following HIV reactivation, causing more reactivated cells to die. Screening 1277 FDA approved drugs identified 168 that increased procaspase 8 expression by at least 1.7-fold. Of these 30 were tested for anti-HIV effects in an acute HIVIIIb infection model, and 9 drugs at physiologic relevant levels significantly reduced cell-associated HIV DNA. Primary CD4 T cells from ART suppressed HIV patients were treated with one of these 9 drugs and reactivated with aCD3/aCD28. Four drugs significantly increased Casp8p41 levels following HIV reactivation, and decreased total cell associated HIV DNA levels (flurbiprofen: p = 0.014; doxycycline: p = 0.044; indomethacin: p = 0.025; bezafibrate: P = 0.018) without effecting the viability of uninfected cells. Thus procaspase 8 levels can be increased pharmacologically and, in the context of HIV reactivation, increase Casp8p41 causing death of reactivating cells and decreased HIV DNA levels. Future studies will be required to define the clinical utility of this or similar approaches.	[Sampath, Rahul; Cummins, Nathan W.; Natesampillai, Sekar; Bren, Gary D.; Badley, Andrew D.] Mayo Clin Rochester, Div Infect Dis, Rochester, MN 55905 USA; [Chung, Thomas D.; Badley, Andrew D.] Mayo Clin Rochester, Off Translat Practice, Rochester, MN 55905 USA; [Baker, Jason] Univ Minnesota, Div Infect Dis, Minneapolis, MN USA; [Henry, Keith] Hennepin Cty Med Ctr, HIV Program, Minnneapolis, MN USA; [Pagliuzza, Amelie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center; Universite de Montreal	Badley, AD (corresponding author), Mayo Clin Rochester, Div Infect Dis, Rochester, MN 55905 USA.; Badley, AD (corresponding author), Mayo Clin Rochester, Off Translat Practice, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	Sampath, Rahul/J-7234-2019	Sampath, Rahul/0000-0002-1653-1653; Badley, Andrew/0000-0001-7796-7680	National Center for Advancing Translational Sciences (NCATS), component of the National Institutes of Health (NIH) [KL2 TR000136]; National Institute of Allergy and Infectious Diseases [R01 AI110173, R01 AI120698]; Division of Infectious Diseases, Mayo Clinic Rochester; Minneapolis Medical Research Foundation (MMRF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120698, R01AI110173] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), component of the National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Infectious Diseases, Mayo Clinic Rochester; Minneapolis Medical Research Foundation (MMRF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible by CTSA Grant Number KL2 TR000136 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH); grant numbers R01 AI110173 and R01 AI120698 from the National Institute of Allergy and Infectious Diseases; and by funding from the Division of Infectious Diseases, Mayo Clinic Rochester and the Minneapolis Medical Research Foundation (MMRF). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NIH, Mayo Clinic or University of Minnesota.		0	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179327	10.1371/journal.pone.0179327	http://dx.doi.org/10.1371/journal.pone.0179327			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628632	gold, Green Submitted, Green Published			2022-12-26	WOS:000404043100028
J	Jenkins, JMA; Thompson, FR; Faaborg, J				Jenkins, Julianna M. A.; Thompson, Frank R., III; Faaborg, John			Species-specific variation in nesting and postfledging resource selection for two forest breeding migrant songbirds	PLOS ONE			English	Article							OVENBIRDS SEIURUS-AUROCAPILLA; HABITAT SELECTION; HOME-RANGE; LAND BIRDS; NEW-WORLD; SURVIVAL; POPULATION; MOVEMENTS; FRAGMENTS; PATTERNS	Habitat selection is a fundamental component of community ecology, population ecology, and evolutionary biology and can be especially important to species with complex annual habitat requirements, such as migratory birds. Resource preferences on the breeding grounds may change during the postfledging period for migrant songbirds, however, the degree to which selection changes, timing of change, and whether all or only a few species alter their resource use is unclear. We compared resource selection for nest sites and resource selection by postfledging juvenile ovenbirds (Seiurus aurocapilla) and Acadian flycatchers (Empidonax virescens) followed with radio telemetry in Missouri mature forest fragments from 2012-2015. We used Bayesian discrete choice modeling to evaluate support for local vegetation characteristics on the probability of selection for nest sites and locations utilized by different ages of postfledging juveniles. Patterns of resource selection variation were species-specific. Resource selection models indicated that Acadian flycatcher habitat selection criteria were similar for nesting and dependent postfledging juveniles and selection criteria diverged when juveniles became independent from adults. After independence, flycatcher resource selection was more associated with understory foliage density. Ovenbirds differed in selection criteria between the nesting and postfledging periods. Fledgling ovenbirds selected areas with higher densities of understory structure compared to nest sites, and the effect of foliage density on selection increased as juveniles aged and gained independence. The differences observed between two sympatric forest nesting species, in both the timing and degree of change in resource selection criteria over the course of the breeding season, illustrates the importance of considering species-specific traits and postfledging requirements when developing conservation efforts, especially when foraging guilds or prey bases differ. We recommend that postfledging habitat selection be considered in future conservation efforts dealing with Neotropical migrants and other forest breeding songbirds.	[Jenkins, Julianna M. A.] Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA; [Thompson, Frank R., III] US Forest Serv, Northern Res Stn, Columbia, MO USA; [Faaborg, John] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Jenkins, Julianna M. A.] US Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service	Jenkins, JMA (corresponding author), Univ Missouri, Sch Nat Resources, Columbia, MO 65211 USA.; Jenkins, JMA (corresponding author), US Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA.	juliannajenkins@fs.fed.us		Jenkins, Julianna/0000-0002-6290-0018	USDA Forest Service Northern Research Station; University of Missouri; Audubon Society of Missouri graduate research scholarship; University of Missouri's conservation biology fellowship;  [14-CR-11242311-064]	USDA Forest Service Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service); University of Missouri; Audubon Society of Missouri graduate research scholarship; University of Missouri's conservation biology fellowship; 	This study was funded by a research joint venture agreement 14-CR-11242311-064 between the USDA Forest Service Northern Research Station and the University of Missouri. The manuscript was officially reviewed by the USDA Forest Service Northern Research Station, which resulted in no changes to the manuscript. Additional funding came from the Audubon Society of Missouri graduate research scholarship (http:// mobirds.org/ASM/Scholarship.aspx) and the University of Missouri's conservation biology fellowship (http://www.conservbionissouri.edu/ fellowship.php); these funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akresh ME, 2009, CONDOR, V111, P756, DOI 10.1525/cond.2009.080059; Anders AD, 1998, AUK, V115, P349, DOI 10.2307/4089193; Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Ausprey IJ, 2011, AUK, V128, P293, DOI 10.1525/auk.2011.10158; Bakermans MH, 2006, AUK, V123, P368, DOI 10.1642/0004-8038(2006)123[368:SHUOAF]2.0.CO;2; Berkeley LI, 2007, AUK, V124, P396, DOI 10.1642/0004-8038(2007)124[396:PSAMID]2.0.CO;2; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burke A. D., 2013, THESIS; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; Chandler CC, 2012, FOREST ECOL MANAG, V264, P1, DOI 10.1016/j.foreco.2011.09.018; Cohen EB, 2004, AUK, V121, P404, DOI 10.1642/0004-8038(2004)121[0404:SHUAMO]2.0.CO;2; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Cox WA, 2014, J WILDLIFE MANAGE, V78, P183, DOI 10.1002/jwmg.670; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 2 2; Estrella A, 1998, J BUS ECON STAT, V16, P198, DOI 10.2307/1392575; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Faaborg J, 2010, ECOL MONOGR, V80, P3, DOI 10.1890/09-0395.1; Hersek MJ, 2002, AUK, V119, P240, DOI 10.1642/0004-8038(2002)119[0240:BHCPOO]2.0.CO;2; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Jenkins JMA, 2017, J WILDLIFE MANAGE, V81, P144, DOI 10.1002/jwmg.21171; Jenkins JMA, 2016, CONDOR, V118, P583, DOI 10.1650/CONDOR-16-30.1; Jirinec V, 2016, AUK, V133, P1, DOI 10.1642/AUK-15-76.1; Keller JK, 2003, FOREST ECOL MANAG, V174, P541, DOI 10.1016/S0378-1127(02)00074-9; Kellner K, 2015, WRAPPER RJAGS STREAM; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; Martin TE, 2009, ANN NY ACAD SCI, V1168, P201, DOI 10.1111/j.1749-6632.2009.04577.x; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; McFadden Daniel., 1978, SPATIAL INTERACTION, VVol. 3, P75; Moorman CE, 2012, WILSON J ORNITHOL, V124, P31, DOI 10.1676/11-020.1; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Peterson SM, 2015, CONDOR, V117, P386, DOI 10.1650/CONDOR-14-124.1; Plummer M., 2015, RJAGS BAYESIAN GRAPH; Porneluzi P., 2011, BIRDS N AM; Porneluzi PA, 1999, CONSERV BIOL, V13, P1151, DOI 10.1046/j.1523-1739.1999.98455.x; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; RCoreTeam, 2015, R LANG ENV STAT COMP; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Rush SA, 2008, AUK, V125, P183, DOI 10.1525/auk.2008.125.1.183; Streby HM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00187.1; Streby HM, 2013, CONDOR, V115, P403, DOI 10.1525/cond.2013.110178; Streby HM, 2012, WILSON J ORNITHOL, V124, P620, DOI 10.1676/12-001.1; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P404, DOI 10.2193/0022-541X(2006)70[404:ABREDM]2.0.CO;2; Thompson FR, 2007, IBIS; VanHorn MA, 1995, AUK, V112, P98; Vitz AC, 2011, CONDOR, V113, P400, DOI 10.1525/cond.2011.100023; Vitz AC, 2010, AUK, V127, P364, DOI 10.1525/auk.2010.09048; West P. W., 2009, TREE FOREST MEASUREM, DOI [DOI 10.1007/978-3-540-95966-3, 10.1007/978-3-540-95966-3]; White JD, 2005, CONDOR, V107, P388, DOI 10.1650/7606; Whitehead DR, 2002, BIRDS N AM	50	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179524	10.1371/journal.pone.0179524	http://dx.doi.org/10.1371/journal.pone.0179524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614414	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900060
J	Martinelli, AG; Kammerer, CF; Melo, TP; Neto, VDP; Ribeiro, AM; Da-Rosa, AAS; Schultz, CL; Soares, MB				Martinelli, Agustin G.; Kammerer, Christian F.; Melo, Tomaz P.; Paes Neto, Voltaire D.; Ribeiro, Ana Maria; Da-Rosa, Atila A. S.; Schultz, Cesar L.; Soares, Marina Bento			The African cynodont Aleodon (Cynodontia, Probainognathia) in the Triassic of southern Brazil and its biostratigraphic significance	PLOS ONE			English	Article							SANTA-MARIA FORMATION; GRANDE-DO-SUL; TRAVERSODONTID CYNODONT; ISCHIGUALASTO FORMATION; PHYLOGENETIC-RELATIONSHIPS; DIVERSITY PATTERNS; FUNCTIONAL-ANATOMY; CHANARES FORMATION; BEAUFORT GROUP; CUYO BASIN	In this contribution we report the first occurrence of the enigmatic African probainognathian genus Aleodon in the Middle-early Late Triassic of several localities from the state of Rio Grande do Sul in southern Brazil. Aleodon is unusual among early probainognathians in having transversely-expanded postcanine teeth, similar to those of gomphodont cynognathians. This genus was previously known from the Manda Beds of Tanzania and the upper Omingonde Formation of Namibia. The Brazilian record of this genus is based upon multiple specimens representing different ontogenetic stages, including three that were previously referred to the sectorial-toothed probainognathian Chiniquodon theotonicus. We propose a new species of Aleodon (A. cromptoni sp. nov.) based on the specimens from Brazil. Additionally, we tentatively refer one specimen from the upper Omingonde Formation of Namibia to this new taxon, strengthening biostratigraphic correlations between these strata. Inclusion of A. cromptoni in a phylogenetic analysis of eucynodonts recovers it as the sister-taxon of A. brachyrhamphus within the family Chiniquodontidae. The discovery of numerous specimens of Aleodon among the supposedly monospecific Chiniquodon samples of Brazil raises concerns about chiniquodontid alpha taxonomy, particularly given the extremely broad geographic distribution of Chiniquodon. The discovery of Brazilian Aleodon and new records of the traversodontid Luangwa supports the hypothesis that at least two subzones can be recognized in the Dinodontosaurus Assemblage Zone.	[Martinelli, Agustin G.; Melo, Tomaz P.; Paes Neto, Voltaire D.; Schultz, Cesar L.; Soares, Marina Bento] Univ Fed Rio Grande do Sul, Agron, Lab Paleontol Vertebrados, Dept Paleontol & Estratig,Inst Geociencias, Porto Alegre, RS, Brazil; [Kammerer, Christian F.] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Ribeiro, Ana Maria] Museu Ciencias Nat Fundacao Zoobot Rio Grande Sul, Secao Paleontol, Porto Alegre, RS, Brazil; [Da-Rosa, Atila A. S.] Univ Fed Santa Maria, Dept Geociencias, Lab Estratig & Paleobiol, Santa Maria, RS, Brazil	Universidade Federal do Rio Grande do Sul; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Universidade Federal de Santa Maria (UFSM)	Martinelli, AG (corresponding author), Univ Fed Rio Grande do Sul, Agron, Lab Paleontol Vertebrados, Dept Paleontol & Estratig,Inst Geociencias, Porto Alegre, RS, Brazil.	agustin_martinelli@yahoo.com.ar	Melo, Tomaz Panceri/AFV-5804-2022; Martinelli, Agustin G./D-4632-2015; Soares, Marina Bento/M-9477-2017; DaRosa, Atila A. S./E-1926-2013; DaRosa, Atila/Q-6884-2019; Soares, Marina/AAN-8513-2020; Ribeiro, Ana Maria/O-3345-2017; Schultz, Cesar/I-4127-2013; Melo, Tomaz P/I-5304-2017	Melo, Tomaz Panceri/0000-0002-6203-560X; Soares, Marina Bento/0000-0002-8393-2406; DaRosa, Atila A. S./0000-0003-4074-0794; Soares, Marina/0000-0002-8393-2406; Ribeiro, Ana Maria/0000-0003-4167-8558; Schultz, Cesar/0000-0001-7121-0409; Melo, Tomaz P/0000-0002-6203-560X; Martinelli, Agustin/0000-0003-4489-0888	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Paleontological Society International Research Program (PaISIRP) - Sepkoski Grant	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Paleontological Society International Research Program (PaISIRP) - Sepkoski Grant	This work is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Paleontological Society International Research Program (PaISIRP) - Sepkoski Grant (2016) to AGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Claudio Bortolas, Elaine G. Della Pace, and Cassia A. H. Schalemberger (SMED-Mata RS) for access and loan of the holotype of Aleodon cromptoni housed at the Museu Padre Daniel Cargnin (Mata, RS, Brazil) and for their kindness during our (AGM, CFK) visit. Carlos Nunes Rodrigues and Belarmino Stefanello have helped with historical data on the Sangas in the municipality of Candelaria. For field work assistance at Vale Verde locality we thank Marcel Lacerda, Morgan Guignard, and Tiago Raugust. Most of the photographs of Aleodon specimens from the UFRGS were skillfully taken by Luiz Flavio Lopes (UFRGS). We thank Fernando Abdala, Sergio Dias-da-Silva, Lucas Fiorelli, Julia Desojo, Martin Ezcurra, Max Langer, Martin Hechenleitner, Jeremias Taborda, Marcelo de la Fuente, Jorge Ferigolo, Ricardo Bertoni, Federico Agnolin, Marcel Lacerda, Elisabete Dassie, Heitor Francischini, and Ana Zavattieri for taxonomic and/or biostratigraphic discussions. For access to collections we acknowledge Sandra Chapman (NHMUK), Pamela Gill (NHMUK), Pip Brewer (NHMUK), Mathew Lowe (UMZC), Carlos Nunes Rodrigues (MMACR), Marco Brandalise de Andrade (MCP), Carolina Hoffmann (MCP), Tania Dutra (UNISINOS), Gabriela Correa (UNISINOS), Jaime Powell (PVL), Rodrigo Gonzalez (PVL), and Rodrigo Machado (MCT). This work is supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Paleontological Society International Research Program (PalSIRP)-Sepkoski Grant (2016) to AGM. Finally, we appreciate the comments and suggestions of the Academic Editor Matt Friedman and the reviewers Christian Sidor and Jorg Frobisch, which greatly improved the MS.	Abdala F., 2004, Palaeontologia Africana, V40, P11; Abdala F, 2005, J VERTEBR PALEONTOL, V25, P192, DOI 10.1671/0272-4634(2005)025[0192:CFTUBF]2.0.CO;2; Abdala F, 2003, ZOOL J LINN SOC-LOND, V139, P529, DOI 10.1111/j.1096-3642.2003.00096.x; Abdala F, 2002, PALAEONTOLOGY, V45, P1151, DOI 10.1111/1475-4983.00280; Abdala F., 2009, Palaeontologia Africana, V44, P83; Abdala F, 2001, NEUES JAHRB GEOL P-M, P669; Abdala F, 2013, GONDWANA RES, V23, P1151, DOI 10.1016/j.gr.2012.07.011; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abdala F, 2009, J VERTEBR PALEONTOL, V29, P837, DOI 10.1671/039.029.0303; Abdala Fernando, 1996, Ameghiniana, V33, P115; Arcucci A, 1998, J VERTEBR PALEONTOL, V18, P228, DOI 10.1080/02724634.1998.10011046; Avila JN, 2006, GEOL SOC AM BULL, V118, P1088, DOI 10.1130/B25893.1; Barberena M.C., 1981, PESQUISAS, V14, P181; Barberena M. C., 1981, PESQUISAS, V14, P149; Barberena M.C., 1977, PESQUISAS, V7, P111; BARBERENA MC, 1985, NATL GEOGR RES, V1, P5; Barberena MC, 1974, THESIS; Barberena MC, 1978, PESQUISAS, V9; BATTAIL B, 1991, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V13, P17; Bertoni-Machado Cristina, 2008, Pesquisas em Geociencias, V35, P57; Bonaparte J., 1973, ACT 5 C GEOL ARG, V5, P93; BONAPARTE J F, 1982, Journal of Vertebrate Paleontology, V2, P362; Bonaparte J.F., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P599; Bonaparte J. F., 1966, Ameghiniana, V4, P243; BONAPARTE J F, 1972, Ameghiniana, V9, P343; Bonaparte JF., 1966, ACTA GEOLOGICA LILLO, V8, P95; Bonaparte JF, 1967, COLOQUIO MAR DEL PLA, V1969, P283; Bonaparte JF, 2000, B ACAD NACL CIENCIAS, V64, P147; Bonaparte JF., 1967, NUEVA EVIDENCIA DE V, P273; Bonaparte JF, 2015, PROTOMAMIFEROS Y MAM; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2001, Bulletin of the Museum of Comparative Zoology, V156, P59; Pavanatto AEB, 2016, HIST BIOL, V28, P978, DOI 10.1080/08912963.2015.1070148; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Broili F, 1934, ZUR OSTEOLOGIE DES K, P95; Cisneros JC, 2004, P ROY SOC B-BIOL SCI, V271, P1541, DOI 10.1098/rspb.2004.2748; CROMPTON A. W., 1955, PROC ZOOL SOC LONDON, V125, P617; Crompton A.W., 1972, B BRIT MUS NAT HIST, V21, P29; da Rosa Atila Augusto Stock, 2005, Geociencias (Sao Paulo), V24, P115; Da Rosa Atila Augusto Stock, 2004, Revista Brasileira de Paleontologia, V7, P289; Da-Rosa AAS, 2015, J S AM EARTH SCI, V61, P108, DOI 10.1016/j.jsames.2014.10.008; Damiani RJ, 2003, J VERTEBR PALEONTOL, V23, P54, DOI 10.1671/0272-4634(2003)23[54:NMTFTC]2.0.CO;2; Dassie ECG, 2014, THESIS; De Oliveira TV, 2011, ZOOTAXA, P19; de Oliveira TV, 2009, REV BRAS PALEONTOLOG, V12, P113, DOI 10.4072/rbp.2009.2.02; Desojo JB, 2011, ZOOL J LINN SOC-LOND, V161, P839, DOI 10.1111/j.1096-3642.2010.00655.x; Dias-da-Silva S, 2011, REV BRAS PALEONTOLOG, V14, P157, DOI 10.4072/rbp.2011.2.04; Domeier M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008495; Dornelles IF., 1992, THESIS; Dornelles Jose Eduardo Figueiredo, 1995, Comunicacoes do Museu de Ciencias e Tecnologia UBEA-PUCRS Serie Ciencias da Terra, V1, P63; DRYSDALL AR, 1963, MEMOIR GEOLOGICAL SU, V1, P1; Ezcurra MD, 2015, AMEGHINIANA, V52, P391, DOI 10.5710/AMGH.28.04.2015.2867; Faurie S., 1974, Annals S Afr Mus, V65, P337; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fiorelli LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep03348; Flynn JJ, 2000, J VERTEBR PALEONTOL, V20, P422, DOI 10.1671/0272-4634(2000)020[0422:NTSEFT]2.0.CO;2; Franca MAG, 2011, NATURWISSENSCHAFTEN, V98, P389, DOI 10.1007/s00114-011-0782-3; Gaetano LC, 2012, J VERTEBR PALEONTOL, V32, P1411, DOI 10.1080/02724634.2012.697086; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; GOW CE, 1980, PROC R SOC SER B-BIO, V208, P461, DOI 10.1098/rspb.1980.0063; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; GRINE F E, 1977, Palaeontologia Africana, V20, P123; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hancox P. J., 2000, ZENTRALBLATT GEOLOGI, V1998, P1285; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Hanich D, 2013, XXIII CONGRESSO BRAS, P234; Hopson J.A., 1991, P635; HOPSON J A, 1984, Palaeontologia Africana, V25, P181; HOPSON J A, 1972, Palaeontologia Africana, V14, P71; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Hopson JA, 2014, VERTEBR PALEOBIOL PA, P233, DOI 10.1007/978-94-007-6841-3_14; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Hsiou Annie, 2002, Revista Brasileira de Paleontologia, V3, P48; Huene F, 1942, LIEFERUNGEN 3 4 PSEU, P161; Huene F.von., 1938, NOVA ACTA LEOPOLDINA, V6, P83; Huene Fv, 1936, ERGEBNISSE DER SAURI, P83; Huene Fv, 1935, LIEFERUNG 1 ANOMODON, P1; Kammerer CF, 2008, J VERTEBR PALEONTOL, V28, P445, DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0.CO;2; Kammerer Christian F., 2012, Fieldiana-Life and Earth Sciences, V5, P112; Kammerer CF, 2010, J VERTEBR PALEONTOL, V30, P1889, DOI 10.1080/02724634.2010.520784; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; KEMP TS, 1980, J ZOOL, V191, P193; KEMP TS, 1975, NATURE, V254, P415, DOI 10.1038/254415a0; KEYSER A W, 1973, South African Journal of Science, V69, P113; Keyser AW, 1973, PALAEONTOLOGIA AFRIC, V16, P1; Kischlat EE., 2000, PALEONTOLOGIA RIO GR, P398; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Lacerda M, PEER J, V4, pe1622; Lacerda MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118563; Langer Max C., 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P201; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Liu J, 2014, VERTEBR PALEOBIOL PA, P255, DOI 10.1007/978-94-007-6841-3_15; Liu Jun, 2008, REVISTA BRASILEIRA DE PALEONTOLOGIA, V11, P27; Lucas S. G., 2001, ALBERTIANA, V26, P13; LUCAS SG, 1993, J PALEONTOL, V67, P318, DOI 10.1017/S0022336000032285; Lucas Spencer G., 2002, Bulletin of the New Mexico Museum of Natural History and Science, V21, P131; MACHADO Monica S, 1992, THESIS; Maisch MW, 2001, NEUES JAHRB GEOL P-A, V220, P127, DOI 10.1127/njgpa/220/2001/127; Marsicano CA, 2016, P NATL ACAD SCI USA, V113, P509, DOI 10.1073/pnas.1512541112; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, 2008, MALARGUE, P67; Martinelli AG, 2015, V CONGRESO LATINOAME, P64; Martinelli AG, 2016, CONTRIB MUS ARG CIEN, V6, P183; Martinelli AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162945; Martinelli AG, 2009, J VERTEBR PALEONTOL, V29, P852, DOI 10.1671/039.029.0315; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2013, REV BRAS PALEONTOLOG, V16, P61, DOI 10.4072/rbp.2013.1.05; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P285, DOI 10.1080/02724634.1996.10011315; Mastrantonio BM, 2013, GEOL SOC SPEC PUBL, V379, P425, DOI 10.1144/SP379.10; Mattar L.C.B., 1989, AN ACAD BRAS CIENC, V61, P319; Melo TP, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.1002562; Monti Mariana, 2016, Lat. Am. j. sedimentol. basin anal., V23, P1; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Oliveira T.V., 2011, PALAEONTOL Z, V85, P67, DOI DOI 10.1007/S12542-010-0078-5; Oliveira TV, 2010, ZOOTAXA, V2382, P1; Ottone EG, 2014, J S AM EARTH SCI, V56, P186, DOI 10.1016/j.jsames.2014.08.008; Peecook BR, 2013, J VERTEBR PALEONTOL, V33, P1127, DOI 10.1080/02724634.2013.755991; Peruzzo Cibele Schwanke, 1995, Anais da Academia Brasileira de Ciencias, V67, P175; Philipp R.P., 2013, AN 8 S INT TECT 14 S, P154; Pinheiro FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22817; Price L.I., 1947, B DIVISAO GEOLOGIA M, V122, P7; Raugust T., 2014, THESIS; Raugust T, 2013, GEOL SOC SPEC PUBL, V379, P303, DOI 10.1144/SP379.22; Reichel M, 2009, PALAEONTOLOGY, V52, P229, DOI 10.1111/j.1475-4983.2008.00824.x; Roberto-da-Silva L., 2009, PALAEONTOLOGIA DESTA, P23; Rogers RR, 2001, PALAIOS, V16, P461, DOI 10.2307/3515563; Romer A. S., 1944, Bulletin of the Museum of Comparative Zoology, V93, P463; Romer A.S., 1973, Breviora, VNo. 407, P1; Romer A.S., 1973, Breviora, VNo. 401, P1; Romer A. S., 1969, Breviora, VNo. 332, P1; Romer A.S., 1969, BREVIORA, V333, P1; Romer AS, 1973, XX SUMMARY BREVIORA, V413, P1; Rubidge, 1995, BIOSTRATIGRAPHIC SER, V1, P40; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1865; Sa-Teixeira AM, 1982, COMUNICACOES MUSEU C, V24, P1; Schultz C. L., 2000, REV BRASILEIRA GEOCI, V30, P491; Schultz C. L., 1995, COMUNICACOES MUSEU C, V1, P25; Schultz Cesar Leandro, 1990, Paula-Coutiana, V4, P35; Schultz CL, 2016, PALAEONTOL Z, V90, P593, DOI 10.1007/s12542-016-0307-7; Schultz CL, 2005, T GEOBIOL, V23, P123; Seeley HG, 1894, PHILOS T R SOC B, V185, P1029; Shishkin MA, 1995, 6 S MES TERR EC BIOT, P39; Sidor CA, 2001, EVOLUTION, V55, P1419; Sidor CA., 2011, AMEGHINIANA, V48, pR113; Sidor C, 2009, J VERTEBR PALEONTOL, V29, p181A; Sidor C, 2008, J VERTEBR PALEONTOL, V28, p142A; Sidor CA, 2014, J VERTEBR PALEONTOL, V34, P793, DOI 10.1080/02724634.2014.837472; Smith R.M.H., 2011, AMEGHINIANA SUPLEMEN, V48, pR35; Smith RM, 2016, J VERTEBR PALEONT 20, P227; Smith RMH, 2002, PALAIOS, V17, P249, DOI 10.1669/0883-1351(2002)017<0249:CFEAVT>2.0.CO;2; Soares MB, 2014, AN ACAD BRAS CIENC, V86, P1673, DOI 10.1590/0001-3765201420140455; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Spalletti LA, 2008, GEOL ACTA, V6, P267; Stipanicic PN, 2007, AMEGHINIANA, V44, P759; Stockley G.M., 1932, Q J GEOL SOC LOND, V88, P610, DOI DOI 10.1016/S0031-0182(03)00230-X; Sues HD, 2016, P NATL ACAD SCI USA, V113, P480, DOI 10.1073/pnas.1523058113; TEIXEIRA AMS, 1987, PAULA COUTIANA, V1, P39; Teixeira AMS, 1995, THESIS; Teixeira AMS, 1979, THESIS; VALENCIO DA, 1975, EARTH PLANET SC LETT, V26, P319, DOI 10.1016/0012-821X(75)90007-2; Vega-Dias Cristina, 2005, Revista Brasileira de Paleontologia, V8, P221; Wopfner H, 2002, J AFR EARTH SCI, V34, P167, DOI 10.1016/S0899-5362(02)00016-7; Wynd BM, 2016, J VERTEBR PALEONT SU, V36, p254A; Zavattieri AM, 2007, AMEGHINIANA, V44, P133; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	168	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							0177948	10.1371/journal.pone.0177948	http://dx.doi.org/10.1371/journal.pone.0177948			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614355	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900010
J	Lin, SY; Hsu, WH; Lin, CC; Lin, CL; Tsai, CH; Kao, CH				Lin, Shih-Yi; Hsu, Wu-Huei; Lin, Cheng-Chieh; Lin, Cheng-Li; Tsai, Chung-Hao; Kao, Chia-Hung			Effect of acute pancreatitis on the risk of developing osteoporosis: A nationwide cohort study	PLOS ONE			English	Article							POPULATION-BASED COHORT; BONE HEALTH; ASSOCIATION; DIAGNOSIS; DISEASES	Purpose Chronic exocrine pancreatic insufficiency can lead to osteoporosis. However, the incidence and risk of osteoporosis after acute inflammation of pancreas remained known. Thus, we conducted a population-based cohort study to clarify the association between acute pancreatitis (AP) and osteoporosis. Methods Patients newly diagnosed with AP with index date between 2000 and 2011 were identified from the National Health Insurance Research Database. Osteoporosis were defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes. We applied age-, sex-, and comorbidities-adjusted variable Cox proportional hazard models for assessing the association between AP and osteoporosis. Moreover, these models were used to adjust for the influences of patient characteristics and comorbidities. Results In this study, 4,016 patients were included in the AP cohort (males, 67.9%; mean age, 51.8 years) and 4,016 matched controls in the non-AP cohort. After a mean follow-up period of 4.97 and 5.21 years in the AP and non-AP cohorts, respectively, the incidence of osteoporosis was 8.22 per 1000 person-years in the AP cohort. The AP cohort had a higher risk [adjusted hazard ratio (aHR) = 1.27, 95% confidence interval (CI) = 1.02-1.58] of osteoporosis than did the non-AP cohort. The risk of osteoporosis was highest in the female patients of the AP cohort (aHR = 2.26, 95% CI = 1.85-2.76) and patients aged 50-64 years (aHR = 4.14, 95% CI = 3.13-5.47). Conclusion AP patients are at a risk of osteoporosis, especially female gender and age 50-64 years. Those with >3 episodes of AP had highest significant risk of developing osteoporosis.	[Lin, Shih-Yi; Hsu, Wu-Huei; Lin, Cheng-Chieh; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Lin, Shih-Yi] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Shih-Yi] China Med Univ Hosp, Kidney Inst, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Dept Chest, Taichung, Taiwan; [Lin, Cheng-Chieh] China Med Univ Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Tsai, Chung-Hao] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw	Lin, Cheng-Chieh/P-2564-2015	Lin, Cheng-Chieh/0000-0002-9625-6216	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [(MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST105-2325-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported by the grants from the Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence, (MOHW105-TDU-B-212-133019); China Medical University Hospital and the Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); the NRPB Stroke Clinical Trial Consortium (MOST105-2325-B-039-003); the Tseng-Lien Lin Foundation, Taichung, Taiwan; the Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bhatia M, 2007, REGUL PEPTIDES, V138, P40, DOI 10.1016/j.regpep.2006.08.006; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Chen CH, 2016, OSTEOPOROSIS INT, V27, P2117, DOI 10.1007/s00198-016-3510-1; Chen SJ, 2015, QJM-INT J MED, V108, P633, DOI 10.1093/qjmed/hcv012; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Duggan SN, 2015, AM J GASTROENTEROL, V110, P336, DOI 10.1038/ajg.2014.430; Dujsikova H, 2008, PANCREATOLOGY, V8, P583, DOI 10.1159/000159845; Fisic E, 2013, GASTROENT RES PRACT, V2013, DOI DOI 10.1155/2013/282645; Guda Nalini M, 2011, Curr Gastroenterol Rep, V13, P140, DOI 10.1007/s11894-011-0176-x; Guda NM, 2015, PANCREAPEDIA EXOCRIN; Haaber AB, 2000, INT J PANCREATOL, V27, P21, DOI 10.1385/IJGC:27:1:21; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Hu WS, 2016, INT J CARDIOL, V220, P768, DOI 10.1016/j.ijcard.2016.06.084; Ionescu AA, 2003, EUR RESPIR J, V22, p64S, DOI 10.4137/CCRPM.S22803; Jeremiah MP, 2015, AM FAM PHYSICIAN, V92, P261; Lee CWS, 2016, ENDOCRINE, V52, P86, DOI 10.1007/s12020-015-0756-x; Lee CWS, 2015, MAYO CLIN PROC, V90, P63, DOI 10.1016/j.mayocp.2014.11.009; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Li HM, 2017, AM J MED, V130, P54, DOI 10.1016/j.amjmed.2016.07.017; Malmstrom ML, 2012, PANCREAS, V41, P271, DOI 10.1097/MPA.0b013e3182240552; Martinez-Moneo E, 2016, PANCREATOLOGY, V16, P988, DOI 10.1016/j.pan.2016.09.008; Pearson DA, 2007, NUTR CLIN PRACT, V22, P517, DOI 10.1177/0115426507022005517; Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669; Shen HN, 2012, PANCREAS, V41, P696, DOI 10.1097/MPA.0b013e31823db941; Shen HN, 2012, DIABETES CARE, V35, P1061, DOI 10.2337/dc11-1925; Shen HN, 2011, PANCREAS, V40, P10, DOI 10.1097/MPA.0b013e3181f7e750; Siris E, 2014, OSTEOPOROSIS INT, V25, P1439, DOI 10.1007/s00198-014-2655-z; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; Swezey RL, 1999, J RHEUMATOL, V26, P2642; Tsai MS, 2015, INT J CLIN PRACT, V69, P235, DOI 10.1111/ijcp.12526; Wactawski-Wende J, 2001, Ann Periodontol, V6, P197, DOI 10.1902/annals.2001.6.1.197; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126	32	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179358	10.1371/journal.pone.0179358	http://dx.doi.org/10.1371/journal.pone.0179358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604838	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400047
J	Welner, DH; Shin, D; Tomaleri, GP; DeGiovanni, AM; Tsai, AYL; Tran, HM; Hansen, SF; Green, DT; Scheller, HV; Adams, PD				Welner, Ditte Hededam; Shin, David; Tomaleri, Giovani P.; DeGiovanni, Andy M.; Tsai, Alex Yi-Lin; Tran, Huu M.; Hansen, Sara Fasmer; Green, Derek T.; Scheller, Henrik V.; Adams, Paul D.			Plant cell wall glycosyltransferases: High-throughput recombinant expression screening and general requirements for these challenging enzymes	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; UDP-ARABINOFURANOSE; PROTEIN EXPRESSION; COMPLEX-FORMATION; ARABINOPYRANOSE; MUTASE	Molecular characterization of plant cell wall glycosyltransferases is a critical step towards understanding the biosynthesis of the complex plant cell wall, and ultimately for efficient engineering of biofuel and agricultural crops. The majority of these enzymes have proven very difficult to obtain in the needed amount and purity for such molecular studies, and recombinant cell wall glycosyltransferase production efforts have largely failed. A daunting number of strategies can be employed to overcome this challenge, including optimization of DNA and protein sequences, choice of expression organism, expression conditions, co-expression partners, purification methods, and optimization of protein solubility and stability. Hence researchers are presented with thousands of potential conditions to test. Ultimately, the subset of conditions that will be sampled depends on practical considerations and prior knowledge of the enzyme(s) being studied. We have developed a rational approach to this process. We devise a pipeline comprising in silico selection of targets and construct design, and high-throughput expression screening, target enrichment, and hit identification. We have applied this pipeline to a test set of Arabidopsis thaliana cell wall glycosyltransferases known to be challenging to obtain in soluble form, as well as to a library of cell wall glycosyltransferases from other plants including agricultural and biofuel crops. The screening results suggest that recombinant cell wall glycosyltransferases in general have a very low soluble: insoluble ratio in lysates from heterologous expression cultures, and that co-expression of chaperones as well as lysis buffer optimization can increase this ratio. We have applied the identified preferred conditions to Reversibly Glycosylated Polypeptide 1 from Arabidopsis thaliana, and processed this enzyme to near-purity in unprecedented milligram amounts.The obtained preparation of Reversibly Glycosylated Polypeptide 1 has the expected arabinopyranose mutase and autoglycosylation activities.	[Welner, Ditte Hededam; Shin, David; Tomaleri, Giovani P.; DeGiovanni, Andy M.; Tsai, Alex Yi-Lin; Tran, Huu M.; Hansen, Sara Fasmer; Scheller, Henrik V.; Adams, Paul D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Welner, Ditte Hededam; Shin, David; Tomaleri, Giovani P.; DeGiovanni, Andy M.; Adams, Paul D.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Tsai, Alex Yi-Lin; Hansen, Sara Fasmer; Scheller, Henrik V.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Tran, Huu M.] Sandia Natl Labs, Biol & Engn Sci Ctr, Livermore, CA USA; [Welner, Ditte Hededam] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Green, Derek T.] Star Lane Ctr, Casper, WY USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Sandia National Laboratories; Technical University of Denmark	Welner, DH (corresponding author), Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Welner, DH (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Welner, DH (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	diwel@dtu.dk	Scheller, Henrik/AAH-4770-2020; Adams, Paul David/A-1977-2013	Scheller, Henrik/0000-0002-6702-3560; Adams, Paul David/0000-0001-9333-8219; Welner, Ditte Hededam/0000-0001-9297-4133	Office of Science, Office of Biological and Environmental Research, of the United States' Department of Energy [DE-ACO2-05CH11231]; Carlsberg Foundation	Office of Science, Office of Biological and Environmental Research, of the United States' Department of Energy; Carlsberg Foundation(Carlsberg Foundation)	This work conducted by the Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research, of the United States' Department of Energy under contract no. DE-ACO2-05CH11231. SFH was supported by a fellowship from the Carlsberg Foundation.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; De Pino V, 2007, PLANTA, V226, P335, DOI 10.1007/s00425-007-0485-3; Delgado IJ, 1998, PLANT PHYSIOL, V116, P1339, DOI 10.1104/pp.116.4.1339; Derman AI, 1993, J BIOL CHEM, V274, P21499; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Drakakaki G, 2006, PLANT PHYSIOL, V142, P1480, DOI 10.1104/pp.106.086363; Eudes A, 2011, APPL MICROBIOL BIOT, V89, P989, DOI 10.1007/s00253-010-2939-y; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hansen SF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00059; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Konishi T, 2010, BIOSCI BIOTECH BIOCH, V74, P191, DOI 10.1271/bbb.90619; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Langeveld SMJ, 2002, PLANT PHYSIOL, V129, P278, DOI 10.1104/pp.010720; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Levin JM, 1997, PROTEIN ENG, V10, P771, DOI 10.1093/protein/10.7.771; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lindwall G, 2000, PROTEIN ENG, V13, P67, DOI 10.1093/protein/13.1.67; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marin Monica, 2008, Biotechnology Journal, V3, P1047, DOI 10.1002/biot.200800089; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Oikawa A, 2013, TRENDS PLANT SCI, V18, P49, DOI 10.1016/j.tplants.2012.07.002; Parsons HT, 2012, PLANT PHYSIOL, V159, P12, DOI 10.1104/pp.111.193151; Rasala BA, 2015, PHOTOSYNTH RES, V123, P227, DOI 10.1007/s11120-014-9994-7; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Rost B, 1996, METHOD ENZYMOL, V266, P525; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Wu ZL, 2011, GLYCOBIOLOGY, V21, P727, DOI 10.1093/glycob/cwq187	41	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0177591	10.1371/journal.pone.0177591	http://dx.doi.org/10.1371/journal.pone.0177591			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598995	Green Published, gold			2022-12-26	WOS:000402992000004
J	Gocher, AM; Azabdaftari, G; Euscher, LM; Dai, SH; Karacosta, LG; Franke, TF; Edelman, AM				Gocher, Angela M.; Azabdaftari, Gissou; Euscher, Lindsey M.; Dai, Shuhang; Karacosta, Loukia G.; Franke, Thomas F.; Edelman, Arthur M.			Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; calmodulin (CaM); ovarian cancer; phosphorylation; protein kinase	ANDROGEN RECEPTOR; MOLECULAR-CLONING; PROSTATE-CANCER; CYCLIN D1; PATHWAY ACTIVATION; PHOSPHORYLATION; BETA; PROGRESSION; INHIBITION; SURVIVAL	Hyperactivation of Akt is associated with oncogenic changes in the growth, survival, and chemoresistance of cancer cells. The PI3K/phosphoinositide-dependent kinase (PDK) 1 pathway represents the canonical mechanism for phosphorylation of Akt at its primary activation site, Thr-308. We observed that Ca2+/calmodulin (CaM)-dependent protein kinase kinase 2 () (CaMKK2) is highly expressed in high-grade serous ovarian cancer, and we investigated its role in Akt activation in ovarian cancer (OVCa) cell lines (OVCAR-3, SKOV-3, and Caov-3). Knockdown or pharmacological inhibition of CaMKK2 produced phenotypes expected of Akt inhibition, including reductions in cell growth and cell viability and in the regulation of Akt downstream targets involved in G(1)/S transition and apoptosis. CaMKK2 knockdown or inhibition decreased Akt phosphorylation at Thr-308 and Ser-473 to extents similar to those of PDK1 knockdown or PI3K inhibition. Combined CaMKK2 and PDK1 knockdown or CaMKK and PI3K inhibition, respectively, produced additive effects on p-Akt and cell growth, consistent with direct Akt phosphorylation by CaMKK2. This conclusion was supported by the absence of effects of CaMKK2 knockdown/inhibition on alternative means of activating Akt via p-Akt Thr-450, p-PDK1 Ser-241, or p-IRS1 Ser-636/639. Recombinant CaMKK2 directly activated recombinant Akt by phosphorylation at Thr-308 in a Ca2+/CaM-dependent manner. In OVCa cells, p-Akt Thr-308 was significantly inhibited by intracellular Ca-i(2+) chelation or CaM inhibition. Ionomycin-induced Ca2+ influx promoted p-Akt, an effect blocked by PDK1, and/or CaMKK2, siRNAs, and by PI3K and/or CaMKK inhibitors. CaMKK2 knockdown potentiated the effects of the chemotherapeutic drugs carboplatin and PX-866 to reduce proliferation and survival of OVCa cells.	[Gocher, Angela M.; Euscher, Lindsey M.; Dai, Shuhang; Karacosta, Loukia G.; Edelman, Arthur M.] SUNY Bffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Azabdaftari, Gissou] Roswell Pk Canc Inst, Dept Pathol & Lab Med, Buffalo, NY 14263 USA; [Franke, Thomas F.] NYU, Sch Med, Dept Psychiat Biochem & Mol Pharmacol, New York, NY 10016 USA	Roswell Park Cancer Institute; New York University	Edelman, AM (corresponding author), SUNY Bffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	aedelman@buffalo.edu		Dai, Shuhang/0000-0001-9607-0684	Mark Diamond Research Fund [SU-15-04]; University at Buffalo Foundation; Department of Defense [OC150368]; National Institutes of Health [OD018340]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018340] Funding Source: NIH RePORTER	Mark Diamond Research Fund; University at Buffalo Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Mark Diamond Research Fund SU-15-04 (to A. M. G.), University at Buffalo Foundation and Department of Defense Grant OC150368 (to A. M. E.), and by National Institutes of Health Grant OD018340 (to T. F. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Alvero Ayesha B., 2008, V414, P79; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Bast RC, 2012, CANCER DISCOV, V2, P16, DOI 10.1158/2159-8290.CD-11-0323; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dai CL, 2013, J BIOL CHEM, V288, P23875, DOI 10.1074/jbc.M112.445148; Davis A, 2014, GYNECOL ONCOL, V133, P624, DOI 10.1016/j.ygyno.2014.02.038; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Edelman AM, 1996, J BIOL CHEM, V271, P10806, DOI 10.1074/jbc.271.18.10806; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Franke TF, 2000, METHOD ENZYMOL, V322, P400; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gocher A. M., 2013, THESIS; Hanrahan AJ, 2012, CANCER DISCOV, V2, P56, DOI 10.1158/2159-8290.CD-11-0170; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ihle NT, 2004, MOL CANCER THER, V3, P763; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Kahl CR, 2004, J BIOL CHEM, V279, P15411, DOI 10.1074/jbc.M312543200; Karacosta LG, 2016, PROSTATE, V76, P294, DOI 10.1002/pros.23121; Karacosta LG, 2012, J BIOL CHEM, V287, P24832, DOI 10.1074/jbc.M112.370783; KIKUCHI Y, 1990, GYNECOL ONCOL, V39, P199, DOI 10.1016/0090-8258(90)90432-K; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Rodriguez-Mora OG, 2005, CANCER RES, V65, P5408, DOI 10.1158/0008-5472.CAN-05-0271; Schmitt JM, 2012, J CELL BIOCHEM, V113, P1514, DOI 10.1002/jcb.24020; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu J, 2007, HIPPOCAMPUS, V17, P525, DOI 10.1002/hipo.20289; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	67	57	57	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14188	14204		10.1074/jbc.M117.778464	http://dx.doi.org/10.1074/jbc.M117.778464			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28634229	Green Published, hybrid			2022-12-26	WOS:000408439800023
J	Tan, S; Ding, KS; Chong, QY; Zhao, JS; Liu, Y; Shao, YY; Zhang, YY; Yu, Q; Xiong, ZR; Zhang, WJ; Zhang, M; Li, GP; Li, XN; Kong, XJ; Ahmad, A; Wu, ZS; Wu, Q; Zhao, XD; Lobie, PE; Zhu, T				Tan, Sheng; Ding, Keshuo; Chong, Qing-Yun; Zhao, Junsong; Liu, Yuan; Shao, Yunying; Zhang, Yuanyuan; Yu, Qing; Xiong, Zirui; Zhang, Weijie; Zhang, Min; Li, Gaopeng; Li, Xiaoni; Kong, Xiangjun; Ahmad, Akhlaq; Wu, Zhengsheng; Wu, Qiang; Zhao, Xiaodong; Lobie, Peter E.; Zhu, Tao			Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; ENDOCRINE RESISTANCE; GENE-EXPRESSION; MECHANISMS; MICRORNAS; HER-2; STABILITY; THERAPY	Tamoxifen-resistant (TAMR) estrogen receptor-positive (ER+) breast cancer is characterized by elevated Erb-B2 receptor tyrosine kinase 2 (ERBB2) expression. However, the underlying mechanisms responsible for the increased ERBB2 expression in the TAMR cells remain poorly understood. Herein, we reported that the ERBB2 expression is regulated at the post-transcriptional level by miR26a/b and the RNA-binding protein human antigen R (HuR), both of which associate with the 3'-UTR of the ERBB2 transcripts. We demonstrated that miR26a/b inhibits the translation of ERBB2 mRNA, whereas HuR enhances the stability of the ERBB2 mRNA. InTAMRER+ breast cancer cells with elevated ERBB2 expression, we observed a decrease in the level of miR26a/b and an increase in the level of HuR. The forced expression of miR26a/b or the depletion of HuR decreased ERBB2 expression in the TAMR cells, resulting in the reversal of tamoxifen resistance. In contrast, the inactivation of miR26a/b or forced expression of HuR decreased tamoxifen responsiveness of the parental ER+ breast cancer cells. We further showed that the increase in HuR expression in the TAMR ER+ breast cancer cells is attributable to an increase in the HuR mRNA isoform with shortened 3'-UTR, which exhibits increased translational activity. This shortening of the HuR mRNA 3'-UTR via alternative polyadenylation (APA) was observed to be dependent on cleavage stimulation factor subunit 2 (CSTF2/CstF-64), which is up-regulated in the TAMR breast cancer cells. Taken together, we have characterized a model in which the interplay between miR26a/b and HuR post-transcriptionally up-regulates ERBB2 expression in TAMR ER+ breast cancer cells.	[Tan, Sheng; Ding, Keshuo; Zhao, Junsong; Liu, Yuan; Shao, Yunying; Zhang, Yuanyuan; Yu, Qing; Xiong, Zirui; Zhang, Weijie; Zhang, Min; Li, Gaopeng; Li, Xiaoni; Kong, Xiangjun; Ahmad, Akhlaq; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Tan, Sheng; Yu, Qing; Zhang, Weijie; Zhang, Min; Li, Xiaoni; Kong, Xiangjun; Zhu, Tao] Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Ding, Keshuo; Wu, Zhengsheng; Wu, Qiang] Anhui Med Univ, Dept Pathol, Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Chong, Qing-Yun; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Chong, Qing-Yun; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Hlth Syst, Natl Canc Inst Singapore, Singapore 119074, Singapore; [Zhao, Xiaodong] Shanghai Jiao Tong Univ, Sch Biomed Engn, BioID Ctr, Shanghai 200240, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Grad Sch Shenzhen, Tsinghua Berkeley Shenzhen Inst TBSI, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; National University of Singapore; National University of Singapore; National University of Singapore; Shanghai Jiao Tong University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.; Zhu, T (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018; tan, sheng/GSN-2599-2022; zhang, yuanyuan/GYA-4428-2022; Ahmad, Akhlaq/GVS-1598-2022	Xiong, Zirui Ray/0000-0003-4311-3200; Zhang, Weijie/0000-0002-6462-6067	National Key R&D Program of China [2016 YFC1302305]; National Natural Science Foundation of China [81672609, 81472494, 81672615]; Specialized Research Fund for the Doctoral Program of Higher Education [20133402120032, 20133420120006]; CAS Grant [XDA01040410]; Cancer Science Institute of Singapore through National Research Foundation; Ministry of Education of Singapore; National Medical Research Council of Singapore [R-713-000-163-511, R-713-000-206-511]; Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant [2015VBA031]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); CAS Grant; Cancer Science Institute of Singapore through National Research Foundation(National Research Foundation, Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); National Medical Research Council of Singapore(National Medical Research Council, Singapore); Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant	This work was supported by the National Key R&D Program of China (Grant 2016 YFC1302305); the National Natural Science Foundation of China Grants (81672609, 81472494, and 81672615); the Specialized Research Fund for the Doctoral Program of Higher Education (20133402120032 and 20133420120006); the CAS Grant XDA01040410, the Cancer Science Institute of Singapore through grants from the National Research Foundation and Ministry of Education of Singapore and grants from the National Medical Research Council of Singapore (R-713-000-163-511 and R-713-000-206-511). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Chinese Academy of Sciences President's International Fellowship Initiative (PIFI) Grant 2015VBA031. To whom correspondence may be addressed: Cancer Science Institute of Singapore, National University of Singapore, Centre for Translational Medicine MD6, #11-01K, 14 Medical Dr., Singapore 117599. Tel.: 65-66011046; E-mail: csipel@nus.edu.sg.	Al-Ahmadi W, 2013, J PATHOL, V230, P28, DOI 10.1002/path.4178; Al-Ahmadi W, 2009, NUCLEIC ACIDS RES, V37, P3612, DOI 10.1093/nar/gkp223; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bhat-Nakshatri P, 2009, NUCLEIC ACIDS RES, V37, P4850, DOI 10.1093/nar/gkp500; BORG A, 1994, CANCER LETT, V81, P137, DOI 10.1016/0304-3835(94)90194-5; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chu I, 2005, CANCER RES, V65, P18; Dai WJ, 2012, NUCLEIC ACIDS RES, V40, P787, DOI 10.1093/nar/gkr783; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dowsett M, 2001, ENDOCR-RELAT CANCER, V8, P191, DOI 10.1677/erc.0.0080191; Dowsett M, 2001, CANCER RES, V61, P8452; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Egeland NG, 2015, INT J MOL SCI, V16, P24243, DOI 10.3390/ijms161024243; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Epis MR, 2011, J BIOL CHEM, V286, P41442, DOI 10.1074/jbc.M111.301481; Erson-Bensan AE, 2016, MOL CANCER RES, V14, P507, DOI 10.1158/1541-7786.MCR-15-0489; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hostetter C, 2008, CANCER BIOL THER, V7, P1498, DOI 10.4161/cbt.7.9.6490; Hostetter CL, 2009, CANCER LETT, V275, P178, DOI 10.1016/j.canlet.2008.10.005; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jansen MPHM, 2012, BREAST CANCER RES TR, V133, P937, DOI 10.1007/s10549-011-1877-4; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Jin K, 2015, CANCER DISCOV, V5, P944, DOI 10.1158/2159-8290.CD-15-0090; Kang H, 2013, INT J MOL SCI, V14, P17204, DOI 10.3390/ijms140817204; Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kotta-Loizou I, 2016, NEOPLASIA, V18, P674, DOI 10.1016/j.neo.2016.09.002; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li CS, 2009, AAPS J, V11, P747, DOI 10.1208/s12248-009-9145-9; Li S, 2012, NUCLEIC ACIDS RES, V40, P884, DOI 10.1093/nar/gkr715; Lipton A, 2005, CANCER, V104, P257, DOI 10.1002/cncr.21202; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mehta A, 2006, GENE DEV, V20, P939, DOI 10.1101/gad.1388706; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Proudfoot NJ, 2011, GENE DEV, V25, P1770, DOI 10.1101/gad.17268411; Pryzbylkowski P, 2008, BREAST CANCER RES TR, V111, P15, DOI 10.1007/s10549-007-9751-0; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Tan S, 2011, FEBS LETT, V585, P2229, DOI 10.1016/j.febslet.2011.05.042; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Tominaga K, 2011, MOL CELL BIOL, V31, P4219, DOI 10.1128/MCB.05955-11; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yuan Z, 2010, HISTOL HISTOPATHOL, V25, P1331, DOI 10.14670/HH-25.1331; Zhuang R, 2013, NUCLEIC ACIDS RES, V41, P7905, DOI 10.1093/nar/gkt565; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	68	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13551	13564		10.1074/jbc.M117.780973	http://dx.doi.org/10.1074/jbc.M117.780973			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28637868	Green Published, hybrid			2022-12-26	WOS:000407942400027
J	Verissimo, AF; Khalfaoui-Hassani, B; Hwang, J; Steimle, S; Selamoglu, N; Sanders, C; Khatchikian, CE; Daldal, F				Verissimo, Andreia F.; Khalfaoui-Hassani, Bahia; Hwang, Josephine; Steimle, Stefan; Selamoglu, Nur; Sanders, Carsten; Khatchikian, Camilo E.; Daldal, Fevzi			The thioreduction component CcmG confers efficiency and the heme ligation component CcmH ensures stereo-specificity during cytochrome c maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CCMG; APOCYTOCHROME-C; RHODOBACTER-CAPSULATUS; THIOREDOXIN REDUCTASE; CATALYTIC MECHANISM; BIOGENESIS DEFECT; NULL MUTANTS; DISULFIDE; PROTEIN; SYSTEM	In many Gram-negative bacteria, including Rhodobacter capsulatus, cytochrome c maturation (Ccm) is carried out by a membrane-integral machinery composed of nine proteins (CcmA to I). During this process, the periplasmic thiol-disulfide oxidoreductase DsbA is thought to catalyze the formation of a disulfide bond between the Cys residues at the apocytochrome c heme-binding site (CXXCH). Subsequently, a Ccm-specific thioreductive pathway involving CcmG and CcmH reduces this disulfide bond to allow covalent heme ligation. Currently, the sequence of thioredox reactions occurring between these components and apocytochrome c and the identity of their active Cys residues are unknown. In this work, we first investigated protein-protein interactions among the apocytochrome c, CcmG, and the heme-ligation components CcmF, CcmH, and CcmI. We found that they all interact with each other, forming a CcmFGHI-apocytochrome c complex. Using purified wildtype CcmG, CcmH, and apocytochrome c, as well as their respective Cys mutant variants, we determined the rates of thiol-disulfide exchange reactions between selected pairs of Cys residues from these proteins. We established that CcmG can efficiently reduce the disulfide bond of apocytochrome c and also resolve a mixed disulfide bond formed between apocytochrome c and CcmH. We further show that Cys-45 of CcmH and Cys-34 of apocytochrome c are most likely to form this mixed disulfide bond, which is consistent with the stereo-specificity of the heme-apocytochrome c ligation reaction. We conclude that CcmG confers efficiency, and CcmH ensures stereo-specificity during Ccm and present a comprehensive model for thioreduction reactions that lead to heme-apocytochrome c ligation.	[Verissimo, Andreia F.; Khalfaoui-Hassani, Bahia; Hwang, Josephine; Steimle, Stefan; Selamoglu, Nur; Daldal, Fevzi] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sanders, Carsten] Univ Kutztown, Dept Phys Sci, Kutztown, PA 19530 USA; [Khatchikian, Camilo E.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Pennsylvania; University of Texas System; University of Texas El Paso	Daldal, F (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu			Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy [DOE DE-FG02-91ER20052]; National Institutes of Health [GM 382375];  [G12MD007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038237] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported primarily by the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of Department of Energy Grant DOE DE-FG02-91ER20052 (to F. D.) and in part by the National Institutes of Health Grants GM 38237 (to F. D.), which supported the production of mutant proteins, and Grant 5G12MD007592 (to C. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja U, 2008, FEBS LETT, V582, P2779, DOI 10.1016/j.febslet.2008.07.007; Aitken A., 2002, PROTEIN PROTOCOLS HD, P595, DOI DOI 10.1385/1-59259-169-8:595; Allen JWA, 2003, J BIOL CHEM, V278, P52075, DOI 10.1074/jbc.M307196200; Ang SK, 2014, BIOCHEM J, V460, P199, DOI 10.1042/BJ20131540; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Cheng ZY, 2011, CHEM REV, V111, P5768, DOI 10.1021/cr100006x; Cho SH, 2009, J BIOL CHEM, V284, P11416, DOI 10.1074/jbc.M900651200; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Deshmukh M, 2000, MOL MICROBIOL, V35, P123, DOI 10.1046/j.1365-2958.2000.01683.x; Deshmukh M, 2003, J BACTERIOL, V185, P3361, DOI 10.1128/JB.185.11.3361-3372.2003; Deshmukh M, 2002, MOL MICROBIOL, V46, P1069, DOI 10.1046/j.1365-2958.2002.03212.x; Di Matteo A, 2007, J BIOL CHEM, V282, P27012, DOI 10.1074/jbc.M702702200; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Di Silvio E, 2013, BBA-PROTEINS PROTEOM, V1834, P1554, DOI 10.1016/j.bbapap.2013.04.027; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Fabianek RA, 1999, ARCH MICROBIOL, V171, P92, DOI 10.1007/s002030050683; Gao T, 2007, J BACTERIOL, V189, P6253, DOI 10.1128/JB.00656-07; Inaba K, 2008, BBA-MOL CELL RES, V1783, P520, DOI 10.1016/j.bbamcr.2007.11.006; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mavridou DAI, 2013, IUBMB LIFE, V65, P209, DOI 10.1002/iub.1123; Mavridou DAI, 2012, J BIOL CHEM, V287, P2342, DOI 10.1074/jbc.M111.313692; Meyer EH, 2005, P NATL ACAD SCI USA, V102, P16113, DOI 10.1073/pnas.0503473102; Monika EM, 1997, J MOL BIOL, V271, P679, DOI 10.1006/jmbi.1997.1227; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Netto LES, 2016, FREE RADICAL RES, V50, P206, DOI 10.3109/10715762.2015.1120864; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rozhkova A, 2007, J MOL BIOL, V367, P1162, DOI 10.1016/j.jmb.2006.12.033; San Francisco B., 2014, MOL MICROBIOL, V91, P996; Sanders C, 2000, BBA-BIOENERGETICS, V1459, P131, DOI 10.1016/S0005-2728(00)00122-5; Sanders C, 2005, J BACTERIOL, V187, P4245, DOI 10.1128/JB.187.12.4245-4256.2005; Sanders C, 2008, J BIOL CHEM, V283, P29715, DOI 10.1074/jbc.M805413200; Sanders C, 2007, J BACTERIOL, V189, P789, DOI 10.1128/JB.01441-06; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Setterdahl AT, 2000, BIOCHEMISTRY-US, V39, P10172, DOI 10.1021/bi000663t; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Turkarslan S, 2008, MOL MICROBIOL, V70, P652, DOI 10.1111/j.1365-2958.2008.06441.x; Vasas A, 2015, NITRIC OXIDE-BIOL CH, V46, P93, DOI 10.1016/j.niox.2014.12.003; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Verissimo AF, 2015, J BIOL CHEM, V290, P16989, DOI 10.1074/jbc.M115.652818; Verissimo AF, 2014, BBA-BIOENERGETICS, V1837, P989, DOI 10.1016/j.bbabio.2014.03.003; Verissimo AF, 2013, J BIOL CHEM, V288, P6272, DOI 10.1074/jbc.M112.440024; Verissimo AF, 2011, J BIOL CHEM, V286, P40452, DOI 10.1074/jbc.M111.277764; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099; Zheng XM, 2012, BBA-PROTEINS PROTEOM, V1824, P1394, DOI 10.1016/j.bbapap.2012.06.017	52	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13154	13167		10.1074/jbc.M117.794586	http://dx.doi.org/10.1074/jbc.M117.794586			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28634234	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000407465300007
J	Bethge, P; Carta, S; Lorenzo, DA; Egolf, L; Goniotaki, D; Madisen, L; Voigt, FF; Chen, JL; Schneider, B; Ohkura, M; Nakai, J; Zeng, HK; Aguzzi, A; Helmchen, F				Bethge, Philipp; Carta, Stefano; Lorenzo, Dayra A.; Egolf, Ladan; Goniotaki, Despoina; Madisen, Linda; Voigt, Fabian F.; Chen, Jerry L.; Schneider, Bernard; Ohkura, Masamichi; Nakai, Junichi; Zeng, Hongkui; Aguzzi, Adriano; Helmchen, Fritjof			An R-CaMP1.07 reporter mouse for cell-typespecific expression of a sensitive red fluorescent calcium indicator	PLOS ONE			English	Article							IMAGING NEURAL ACTIVITY; TRANSGENIC MICE; PROJECTION NEURONS; CA2+ INDICATORS; GENE-EXPRESSION; CRE-RECOMBINASE; DRIVER LINES; PROTEINS; CORTEX; REORGANIZATION	Genetically encoded calcium indicators (GECIs) enable imaging of in vivo brain cell activity with high sensitivity and specificity. In contrast to viral infection or in utero electroporation, indicator expression in transgenic reporter lines is induced noninvasively, reliably, and homogenously. Recently, Cre/tTA-dependent reporter mice were introduced, which provide high-level expression of green fluorescent GECIs in a cell-type-specific and inducible manner when crossed with Cre and tTA driver mice. Here, we generated and characterized the first red-shifted GECI reporter line of this type using R-CaMP1.07, a red fluorescent indicator that is efficiently two-photon excited above 1000 nm. By crossing the new R-CaMP1.07 reporter line to Cre lines driving layer-specific expression in neocortex we demonstrate its high fidelity for reporting action potential firing in vivo, long-term stability over months, and versatile use for functional imaging of excitatory neurons across all cortical layers, especially in the previously difficult to access layers 4 and 6.	[Bethge, Philipp; Carta, Stefano; Lorenzo, Dayra A.; Egolf, Ladan; Voigt, Fabian F.; Chen, Jerry L.; Helmchen, Fritjof] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Carta, Stefano; Lorenzo, Dayra A.; Goniotaki, Despoina; Voigt, Fabian F.; Aguzzi, Adriano; Helmchen, Fritjof] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Carta, Stefano; Lorenzo, Dayra A.; Goniotaki, Despoina; Voigt, Fabian F.; Aguzzi, Adriano; Helmchen, Fritjof] ETH, Zurich, Switzerland; [Goniotaki, Despoina; Aguzzi, Adriano] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland; [Madisen, Linda; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Schneider, Bernard] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lausanne, Switzerland; [Ohkura, Masamichi; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama, Japan; [Chen, Jerry L.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Allen Institute for Brain Science; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Saitama University; Boston University	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.; Helmchen, F (corresponding author), Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland.; Helmchen, F (corresponding author), ETH, Zurich, Switzerland.	helmchen@hifo.uzh.ch	Ohkura, Masamichi/J-6976-2012; Nakai, Junichi/GQZ-6415-2022; Goniotaki, Despoina/AAP-5931-2021; Schneider, Bernard/H-6168-2011; Helmchen, Fritjof/A-6255-2008	Aguzzi, Adriano/0000-0002-0344-6708; Ohkura, Masamichi/0000-0002-3659-7780; Schneider, Bernard/0000-0001-5485-8748; Voigt, Fabian/0000-0002-7108-2176; Chen, Jerry/0000-0002-7409-7859; Helmchen, Fritjof/0000-0002-8867-9569; Goniotaki, Despoina/0000-0003-2120-8858	Swiss National Science Foundation [31003A-149858]; Sinergia [CRSII3_147660]; U.S. BRAIN Initiative (NIH) [1U01NS090475-01]; Human Frontier Science Program (HFSP); CandDoc Forschungskredit of the University of Zurich; Regional Innovation Cluster Program; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT; Japan Agency for Medical Research and Development (AMED); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090475] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26282217] Funding Source: KAKEN	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; U.S. BRAIN Initiative (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP)(Human Frontier Science Program); CandDoc Forschungskredit of the University of Zurich; Regional Innovation Cluster Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Swiss National Science Foundation (31003A-149858; F.H.; and Sinergia grant CRSII3_147660; A.A., F.H., and B.S.; www.snf.ch), the U.S. BRAIN Initiative (NIH grant 1U01NS090475-01; F.H.; VAPAV.braininitiative.nih.gov), an Human Frontier Science Program (HFSP; www.hfsp.org) postdoctoral fellowship (P.B.), and a CandDoc Forschungskredit of the University of Zurich (D.A. L.; wvivi.uzh.ch). This work was also partially supported by the Regional Innovation Cluster Program (City Area Type, Central Saitama Area) (J. N.), Grants-in-Aid KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT; www.mext.go.dp) and the Japan Society for the Promotion of Science (JSPS; www.isps.go.ip) (M.O., J.N.) and the program for Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from MEXT and the Japan Agency for Medical Research and Development (AMED; www.amed.go.jp) (J.N.). H. Z. and L.M. thank the founders of the Allen Institute (www.alleninstitute.org), Paul G. Allen and Jody Allen, for their vision, encouragement, and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2012, NATURE, V490, P219, DOI 10.1038/nature11529; Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Briggs F, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.003.2010; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Carandini M, 2015, J NEUROSCI, V35, P53, DOI 10.1523/JNEUROSCI.0594-14.2015; Chen JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14679; Chen JL, 2015, NAT NEUROSCI, V18, P1101, DOI 10.1038/nn.4046; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chen Q, 2012, NEURON, V76, P297, DOI 10.1016/j.neuron.2012.07.011; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collot M, 2015, ELIFE, V4, DOI 10.7554/eLife.05808; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Empson RM, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12468; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grienberger C, 2012, NEURON, V73, P862, DOI 10.1016/j.neuron.2012.02.011; Gschwend O, 2015, NAT NEUROSCI, V18, P1474, DOI 10.1038/nn.4089; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/nphoton.2012.336, 10.1038/NPHOTON.2012.336]; Huang ZJ, 2013, ANNU REV NEUROSCI, V36, P183, DOI 10.1146/annurev-neuro-062012-170307; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Inoue M, 2015, NAT METHODS, V12, P893, DOI 10.1038/nmeth0915-893b; Issa JB, 2014, NEURON, V83, P944, DOI 10.1016/j.neuron.2014.07.009; Kim TH, 2016, CELL REP, V17, P3385, DOI 10.1016/j.celrep.2016.12.004; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Lutcke H, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00009; Ma Y, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0360; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Margolis DJ, 2012, NAT NEUROSCI, V15, P1539, DOI 10.1038/nn.3240; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Murakami T, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00020; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ohkura M, 2012, PLOS ONE, V7, pe3993; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Sato M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125354; Shen Y, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.031203; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Stirman JN, 2016, NAT BIOTECHNOL, V34, P857, DOI 10.1038/nbt.3594; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tischbirek C, 2015, P NATL ACAD SCI USA, V112, P11377, DOI 10.1073/pnas.1514209112; Vanni MP, 2014, J NEUROSCI, V34, P15931, DOI 10.1523/JNEUROSCI.1818-14.2014; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wu J., 2014, NAT COMMUN, V5; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Xie YC, 2016, J NEUROSCI, V36, P1261, DOI 10.1523/JNEUROSCI.2744-15.2016; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	69	24	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179460	10.1371/journal.pone.0179460	http://dx.doi.org/10.1371/journal.pone.0179460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640817	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800033
J	Viljakainen, HT; Koistinen, HA; Tervahartiala, T; Sorsa, T; Andersson, S; Makitie, O				Viljakainen, Heli T.; Koistinen, Heikki A.; Tervahartiala, Taina; Sorsa, Timo; Andersson, Sture; Makitie, Outi			Metabolic milieu associates with impaired skeletal characteristics in obesity	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; FRACTURE RISK; LEPTIN; INFLAMMATION; TURNOVER; WOMEN; SENSITIVITY	High leptin concentration, low-grade inflammation, and insulin resistance often coexist in obese subjects; this adverse metabolic milieu may be the main culprit for increased fracture risk and impaired bone quality seen in patients with type 2 diabetes. We examined the associations of leptin, hs (high sensitivity)-CRP and insulin resistance with bone turnover markers (BTMs) and bone characteristics in 55 young obese adults (median BMI 40 kg/m(2)) and 65 non-obese controls. Mean age of the subjects was 19.5 +/- 2.5 years (mean +/- SD). Concentrations of leptin, adiponectin, hs-CRP, MMP-8 and TIMP-1, fasting plasma glucose and insulin (to calculate HOMA), BTMs (BAP, P1NP, CTX-1, and TRAC5b) were measured. Bone characteristics were determined with pQCT at radius and tibia, and with DXA for central sites. Leptin, hs-CRP and HOMA correlated inversely with BTMs: the partial coefficients were 1.5-1.9 fold higher in males than in females. After adjusting for age, BMI, and other endocrine factors, leptin displayed an independent effect in males on radial bone mass (p = 0.019), tibial trabecular density (p = 0.025) and total hip BMD (p = 0.043), with lower densities in males with high leptin. In females, the model adjusting for age, BMI, and other endocrine factors, revealed that hs-CRP had independent effects on radial bone mass (p = 0.034) and lumbar spine BMD (p = 0.016), women with high hs-CRP having lower values. Partial correlations of adiponectin and TIMP-1 with bone characteristics were discrepant; MMP-8 showed no associations. In conclusion, in young obese adults and their controls, leptin, hs-CRP and HOMA associate inversely with BTMs and bone characteristics. Leptin appears to be the key independent effector in males, whereas hs-CRP displayed a predominant role in females.	[Viljakainen, Heli T.; Andersson, Sture; Makitie, Outi] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Viljakainen, Heli T.; Koistinen, Heikki A.; Tervahartiala, Taina; Sorsa, Timo; Andersson, Sture; Makitie, Outi] Helsinki Univ Hosp, Helsinki, Finland; [Viljakainen, Heli T.; Makitie, Outi] Folkhalsan Res Ctr, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr Endocrinol, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Helsinki, Finland; [Tervahartiala, Taina; Sorsa, Timo] Univ Helsinki, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Sorsa, Timo] Karolinska Inst, Div Periodontol, Dept Dent Med, Huddinge, Sweden; [Makitie, Outi] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Makitie, Outi] Karolinska Univ Hosp, Clin Genet, Stockholm, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; University of Helsinki; University of Helsinki; University of Helsinki; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Viljakainen, HT (corresponding author), Univ Helsinki, Childrens Hosp, Helsinki, Finland.; Viljakainen, HT (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Viljakainen, HT (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.	heli.viljakainen@helsinki.fi	Koistinen, Heikki/J-7313-2016	Koistinen, Heikki/0000-0001-7870-070X	Academy of Finland [277843, 258753]; Sigrid Juselius Foundation; Foundation for Pediatric Research; Folkhalsan Research Foundation; Novo Nordisk Foundation; Swedish Research Council; Swedish Childhood Cancer Foundation; Ahokas Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Helsinki University Hospital research funds; Novo Nordisk Fonden [NNF16OC0021322] Funding Source: researchfish	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Folkhalsan Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Ahokas Foundation; Finska Lakaresallskapet; Liv och Halsa Foundation; Helsinki University Hospital research funds; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by funds from the Academy of Finland (grant number 277843, 258753), Sigrid Juselius Foundation, Foundation for Pediatric Research, Folkhalsan Research Foundation, Novo Nordisk Foundation, Swedish Research Council, Swedish Childhood Cancer Foundation, Ahokas Foundation, Finska Lakaresallskapet, and Liv och Halsa Foundation, and Helsinki University Hospital research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Abhari S, 2013, BONE, V56, P67, DOI 10.1016/j.bone.2013.05.009; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Berglundh S, 2015, OSTEOPOROSIS INT, V26, P727, DOI 10.1007/s00198-014-2951-7; Cohen A, 2013, J CLIN ENDOCR METAB, V98, P2562, DOI 10.1210/jc.2013-1047; Dahl K, 2015, BONE, V72, P65, DOI 10.1016/j.bone.2014.11.012; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, P594, DOI 10.1210/jc.2014-3199; Dimitri P, 2011, BONE, V48, P189, DOI 10.1016/j.bone.2010.09.034; Gaudio A, 2014, DIABETES VASC DIS RE, V11, P48, DOI 10.1177/1479164113510923; Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901; Gursoy UK, 2010, J CLIN PERIODONTOL, V37, P487, DOI 10.1111/j.1600-051X.2010.01563.x; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Hind K, 2010, J CLIN DENSITOM, V13, P413, DOI 10.1016/j.jocd.2010.06.002; Hribal ML, 2014, CURR PHARM DESIGN, V20, P609, DOI 10.2174/13816128113199990016; Kindler JM, 2016, J CLIN ENDOCR METAB, V101, P198, DOI 10.1210/jc.2015-3451; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Laurent MR, 2016, OSTEOPOROSIS INT, V27, P3227, DOI 10.1007/s00198-016-3656-x; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Lee HS, 2015, EXP CLIN ENDOCR DIAB, V123, P604, DOI 10.1055/s-0035-1559795; Legiran S, 2012, CLIN CASES MINER BON, V9, P145; Lorentzon M, 2006, J BONE MINER RES, V21, P1871, DOI 10.1359/JBMR.060814; Lucas R, 2012, CLIN ENDOCRINOL, V77, P665, DOI 10.1111/j.1365-2265.2012.04430.x; Nagase H, 2003, BIOCHEM SOC SYMP, V70, P201, DOI 10.1042/bss0700201; Oei L, 2014, OSTEOPOROSIS INT, V25, P1247, DOI 10.1007/s00198-013-2578-0; Paganelli M, 2007, INFLAMM BOWEL DIS, V13, P416, DOI 10.1002/ibd.20039; Parajuli A, 2015, BONE, V81, P152, DOI 10.1016/j.bone.2015.07.012; Pollock NK, 2015, MOL CELL ENDOCRINOL, V410, P52, DOI 10.1016/j.mce.2015.03.016; Potikanond S, 2016, J ENDOCRINOL, V228, P85, DOI 10.1530/JOE-15-0333; Romagnoli E, 2016, ENDOCRINE, V54, P342, DOI 10.1007/s12020-016-0857-1; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Shanbhogue VV, 2016, LANCET DIABETES ENDO, V4, P159, DOI 10.1016/S2213-8587(15)00283-1; Sherk VD, 2011, J CLIN DENSITOM, V14, P321, DOI 10.1016/j.jocd.2011.03.010; Viljakainen HT, 2015, CALCIFIED TISSUE INT, V97, P364, DOI 10.1007/s00223-015-0031-4; Viljakainen H, 2014, J CLIN ENDOCR METAB, V99, P2155, DOI 10.1210/jc.2013-3097; Viljakainen HT, 2011, BONE, V48, P212, DOI 10.1016/j.bone.2010.09.022; Weinhold B, 1997, BIOCHEM J, V327, P425, DOI 10.1042/bj3270425	36	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179660	10.1371/journal.pone.0179660	http://dx.doi.org/10.1371/journal.pone.0179660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640843	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800048
J	Choi, J; Rho, MJ; Kim, Y; Yook, IH; Yu, H; Kim, DJ; Choi, Y				Choi, Jingyun; Rho, Mi Jung; Kim, Yejin; Yook, In Hye; Yu, Hwanjo; Kim, Dai-Jin; Choi, Young			Smartphone dependence classification using tensor factorization	PLOS ONE			English	Article							ADDICTION	Excessive smartphone use causes personal and social problems. To address this issue, we sought to derive usage patterns that were directly correlated with smartphone dependence based on usage data. This study attempted to classify smartphone dependence using a data-driven prediction algorithm. We developed a mobile application to collect smartphone usage data. A total of 41,683 logs of 48 smartphone users were collected from March 8, 2015, to January 8, 2016. The participants were classified into the control group (SUC) or the addiction group (SUD) using the Korean Smartphone Addiction Proneness Scale for Adults (S-Scale) and a face-to-face offline interview by a psychiatrist and a clinical psychologist (SUC = 23 and SUD = 25). We derived usage patterns using tensor factorization and found the following six optimal usage patterns: 1) social networking services (SNS) during daytime, 2) web surfing, 3) SNS at night, 4) mobile shopping, 5) entertainment, and 6) gaming at night. The membership vectors of the six patterns obtained a significantly better prediction performance than the raw data. For all patterns, the usage times of the SUD were much longer than those of the SUC. From our findings, we concluded that usage patterns and membership vectors were effective tools to assess and predict smartphone dependence and could provide an intervention guideline to predict and treat smartphone dependence based on usage data.	[Choi, Jingyun; Yu, Hwanjo] Pohang Univ Sci & Technol, Dept Comp Sci & Engn, Pohang, South Korea; [Rho, Mi Jung; Yook, In Hye; Choi, Young] Catholic Univ Korea, Dept Med Informat, Coll Med, Seoul, South Korea; [Kim, Yejin] Pohang Univ Sci & Technol, Dept Creat IT Engn, Pohang, South Korea; [Kim, Dai-Jin] Catholic Univ Korea, Seoul St Marys Hosp, Dept Psychiat, Coll Med, Seoul, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Seoul St. Mary's Hospital	Choi, Y (corresponding author), Catholic Univ Korea, Dept Med Informat, Coll Med, Seoul, South Korea.; Kim, DJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Psychiat, Coll Med, Seoul, South Korea.	kdj922@chollian.net; iychoi@catholic.ac.kr		Yook, In Hye/0000-0003-0264-171X	ICT R&D program of MSIP/IITP [B0101-15-0307]; Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M3C4A7033344]; National Research Foundation of Korea - Korean Government [2014M3C7A1062893]	ICT R&D program of MSIP/IITP; Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was partly supported by the ICT R&D program of MSIP/IITP B0101-15-0307 "Basic Software Research in Human-level Lifelong Machine Learning" , Next-Generation Information Computing Development Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2012M3C4A7033344) and the National Research Foundation of Korea Grant funded by the Korean Government (No. 2014M3C7A1062893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOL-BBDO Mobile Research, 2012, 7 SHAD MOB HIDD MOT; Bader B.W., 2015, MATLAB TENSOR TOOLBO; Billieux J, 2007, APPL COGNITIVE PSYCH, V21, P527, DOI 10.1002/acp.1289; Ho JC, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P115, DOI 10.1145/2623330.2623658; Ho JC, 2014, J BIOMED INFORM, V52, P199, DOI 10.1016/j.jbi.2014.07.001; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Kim Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159788; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lee H, 2014, J MED SYST, V38, DOI 10.1007/s10916-013-0001-1; Lee H, 2007, INT J NEURAL SYST, V17, P305, DOI 10.1142/S0129065707001159; Lee SJ, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6120440; Li YF, 2010, IEEE INT C BIOINFORM, P438, DOI 10.1109/BIBM.2010.5706606; Mok JY, 2014, NEUROPSYCH DIS TREAT, V10, P817, DOI 10.2147/NDT.S59293; Park N, 2012, CYBERPSYCH BEH SOC N, V15, P491, DOI 10.1089/cyber.2011.0580; Samaha M, 2016, COMPUT HUM BEHAV, V57, P321, DOI 10.1016/j.chb.2015.12.045; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P38; Shin K., 2011, SEOUL KOREAN NATL IN, V24, P231; Takao M, 2009, CYBERPSYCHOL BEHAV, V12, P501, DOI 10.1089/cpb.2009.0022; Wang YC, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1265, DOI 10.1145/2783258.2783395; Yoo S, 2006, ANXIETY MOOD, V2, P50	21	12	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0177629	10.1371/journal.pone.0177629	http://dx.doi.org/10.1371/journal.pone.0177629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636614	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300005
J	Park, SH; Won, HJ; Kim, SY; Shin, YM; Kim, PN; Yoon, SM; Park, JH; Kim, JH				Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun; Yoon, Sang Min; Park, Jin-hong; Kim, Jong Hoon			Efficacy and safety of ultrasound-guided implantation of fiducial markers in the liver for stereotactic body radiation therapy	PLOS ONE			English	Article							FOCAL HEPATIC-LESIONS; HEPATOCELLULAR-CARCINOMA; PERCUTANEOUS BIOPSY; RADIOTHERAPY; DISEASE; RADIOSURGERY; SONOGRAPHY; CYBERKNIFE; ABLATION	Objective Stereotactic body radiation therapy (SBRT) for the treatment of a malignancy in the liver requires the perilesional implantation of fiducial markers for lesion detection. The purpose of this study is to evaluate the efficacy and safety of ultrasound (US)-guided marker implantation for SBRT. Methods We retrospectively reviewed 299, US-guided, intrahepatic fiducial markers implanted in 101 patients between November 2013 and September 2014. SBRT-planning CT images were analyzed to determine the technical success of the implantation, the mean distance between the tumor margin and the marker, with the ideal location of fiducials defined as the distance between a marker and a tumor less than 3 cm and the distance between markers greater than 2 cm according to the tumor conspicuity seen on gray-scale US and the artifact obscuring tumor margins. We also evaluated procedure-related major and minor complications. Results Technical success was achieved in 291 (97.3%) fiducial marker implantations. The mean distance between the tumor and the marker was 3.1 cm (S. D., 2.1 cm; range, 0-9.5 cm). Of 101 patients, 72 lesions (71.3%, 2.2 +/- 1.0 cm; range, 0-3.0 cm) had fiducial markers located in an ideal location. The ideal location of fiducials was more common in visible lesions than in poorly conspicuous lesions (90.2% vs. 52.0%, P < 0.001). Seventeen markers (5.8%) developed beam-hardening artifacts obscuring the tumor margins. There were no major complications, although 12 patients (11.9%) developed minor complications. Conclusions US-guided implantation of fiducial markers in the liver is an effective and safe procedure with only rare complications.	[Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun] Univ Ulsan, Coll Med, Div Abdominal Radiol, Asan Med Ctr,Dept Radiol, Seoul, South Korea; [Park, So Hyun; Won, Hyung Jin; Kim, So Yeon; Shin, Yong Moon; Kim, Pyo Nyun] Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea; [Park, So Hyun] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Yoon, Sang Min; Park, Jin-hong; Kim, Jong Hoon] Univ Ulsan, Coll Med, Dept Radiat Oncol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Gachon University; University of Ulsan	Won, HJ (corresponding author), Univ Ulsan, Coll Med, Div Abdominal Radiol, Asan Med Ctr,Dept Radiol, Seoul, South Korea.; Won, HJ (corresponding author), Univ Ulsan, Coll Med, Res Inst Radiol, Asan Med Ctr, Seoul, South Korea.	hjwon@amc.seoul.kr		Park, So Hyun/0000-0001-9935-2863; Park, Jin-hong/0000-0002-1088-0174				Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Chang SD, 2001, STEREOT FUNCT NEUROS, V76, P204, DOI 10.1159/000066719; Cheng JCH, 2002, INT J RADIAT ONCOL, V54, P156, DOI 10.1016/S0360-3016(02)02915-2; Das IJ, 1996, RADIOTHER ONCOL, V38, P61, DOI 10.1016/0167-8140(95)01674-0; Dawson LA, 2000, J CLIN ONCOL, V18, P2210, DOI 10.1200/JCO.2000.18.11.2210; Facciuto ME, 2012, J SURG ONCOL, V105, P692, DOI 10.1002/jso.22104; Kim JH, 2012, KOREAN J RADIOL, V13, P307, DOI 10.3348/kjr.2012.13.3.307; Kothary N, 2009, AM J ROENTGENOL, V192, P1090, DOI 10.2214/AJR.08.1399; Kothary N, 2009, J VASC INTERV RADIOL, V20, P235, DOI 10.1016/j.jvir.2008.09.026; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Lee MW, 2014, ULTRASONOGRAPHY, V33, P227, DOI 10.14366/usg.14021; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Liu C-H, 2015, J MED SCI, V35, P92; Masuzaki R, 2011, J GASTROEN HEPATOL, V26, P759, DOI 10.1111/j.1440-1746.2010.06559.x; Minami Y, 2011, WORLD J GASTROENTERO, V17, P4952, DOI 10.3748/wjg.v17.i45.4952; Oldrini G, 2015, DIAGN INTERV IMAG, V96, P589, DOI 10.1016/j.diii.2014.01.010; Park HJ, 2013, J ULTRAS MED, V32, P1557, DOI 10.7863/ultra.32.9.1557; Sacks David, 2003, J Vasc Interv Radiol, V14, pS199; Wu W, 2006, AM J ROENTGENOL, V187, P752, DOI 10.2214/AJR.05.0535; Xu ZY, 2006, INT J RADIAT ONCOL, V65, P189, DOI 10.1016/j.ijrobp.2005.11.034; Yoon SH, 2010, EUR RADIOL, V20, P2047, DOI 10.1007/s00330-010-1757-z	21	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179676	10.1371/journal.pone.0179676	http://dx.doi.org/10.1371/journal.pone.0179676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636658	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300048
J	Islam, FMA				Islam, Fakir M. Amirul			Accuracy and reliability of retinal photo grading for diabetic retinopathy: Remote graders from a developing country and standard retinal photo grader in Australia	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; EYE	Background To evaluate the accuracy and reliability of fundus retinal photos graded by local graders in Bangladesh with those graded by an expert at the Centre for Eye Research Australia (CERA) in the context of mass scale diabetic retinopathy (DR) screening in Bangladesh. Methods A population-based cross-sectional study of 3,104 adults identified 213 (7.2%) eligible patients with diabetes of age >= 40 years in 2012-2013. Retinal photographs were collected using a non-mydriatic digital fundus retinal camera and a two-field imaging protocol. The photos were graded by two remote graders (G1 and G2) who were trained by a retinal specialist (RS) in Bangladesh, by the RS himself, and by a Centre for Eye Research Australia (CERA) grader. The local graders up skilled their grading ability by comparing 30% of the photos graded by the CERA grader with their own grades. Learning from that exercise was applied to the remaining 70% of photos, which were re-graded. Reliability and accuracy of grading amongst the graders were reported using cross tabulation, inter-and intra-grader reliability, and with sensitivity and specificity. Results Of 122 eyes from 61 patients, the mild (R1) DR was estimated to be 14 to 25%, pre-proliferative (R2) DR 4-8%, and proliferative (R3) DR 0.8 to 1.6%, whereas 25%, 8%, 18%, and 15% were found to be ungradable by CERA, RS, G1, and G2, respectively. Of 8 (6.6%) eyes identified as R2 by the CERA grader, 5 (63%), 3 (38%) and 3 (38%) were correctly classified as R2, whereas the rest were classified either as R1 or R3 but none were classified as no DR (R0) or ungradable by the RS, G1 and G2, respectively. After getting experience reviewing the 30% test set graded by the CERA grader, the local graders graded moderate and severe DR with 100% accuracy. After excluding ungradable photos, the sensitivity (specificity) relative to the CERA grader was 82% (88%) before and 80% (93%) after training for G1 and 56% (87%) before and 77% (90%) after training for G2. In case of maculopathy, the CERA grader reported 11.2% eyes with maculopathy, which included 100% of the 4.9% by RS, 6.6% by G1, and 7.4% by G2. Conclusions Local graders in Bangladesh are able to grade retinal photos with high accuracy if the DR is at least of a moderate level. With appropriate training and experience, local graders have the ability to contribute significantly to the grading of millions of retinal photos, which required grading in resource-poor countries.	[Islam, Fakir M. Amirul] Swinburne Univ Technol, Fac Hlth Arts & Design, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic, Australia; [Islam, Fakir M. Amirul] ORCD, Dariapur, Narail, Bangladesh	Swinburne University of Technology	Islam, FMA (corresponding author), Swinburne Univ Technol, Fac Hlth Arts & Design, Dept Stat Data Sci & Epidemiol, Hawthorn, Vic, Australia.; Islam, FMA (corresponding author), ORCD, Dariapur, Narail, Bangladesh.	fislam@swin.edu.au	Islam, Fakir M Amirul/P-6665-2015	Islam, Fakir M Amirul/0000-0003-3897-3302				Adal KM, 2015, INVEST OPHTH VIS SCI, V56, P1805, DOI 10.1167/iovs.14-15949; Akhter A, 2013, OPHTHAL EPIDEMIOL, V20, P220, DOI 10.3109/09286586.2013.809770; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Awan H, 2014, ASIA-PAC J OPHTHALMO, V3, P74, DOI 10.1097/APO.0000000000000037; Chakrabarti R, 2015, BANGLADESH J MED SCI, V14, P367, DOI 10.3329/bjms.v14i4.25767; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, INVEST OPHTH VIS SCI, V48, P1018, DOI 10.1167/iovs.06-0978; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Friedman DS, 2011, AM J OPHTHALMOL, V151, P192, DOI 10.1016/j.ajo.2010.10.014; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Islam FMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133043; Islam FMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110368; Islam FM, 2015, J DIABETES; Organization. WH, 2012, SIT AN VIS 2020 WHO; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Resnikoff S, 2012, BRIT J OPHTHALMOL, V96, P783, DOI 10.1136/bjophthalmol-2011-301378; Saquib N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-434; Shorliff K, 2006, PRACT DIAB INT, V23; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; W.H.O, 2014, DIABETES; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; World Health Organization, 2005, PREV BLINDN DIAB MEL; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	25	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179310	10.1371/journal.pone.0179310	http://dx.doi.org/10.1371/journal.pone.0179310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632764	Green Published, gold			2022-12-26	WOS:000404046100020
J	Nelson, SK; Steber, CM				Nelson, Sven K.; Steber, Camille M.			Transcriptional mechanisms associated with seed dormancy and dormancy loss in the gibberellin-insensitive sly1-2 mutant of Arabidopsis thaliana	PLOS ONE			English	Article							INDUCED PEPTIDE TRANSPORTER; FALSE DISCOVERY RATE; DELLA PROTEIN SLR1; ABSCISIC-ACID; NITRIC-OXIDE; MOLECULAR-MECHANISM; FLORAL DEVELOPMENT; BARLEY ALEURONE; LOW-TEMPERATURE; MESSENGER-RNA	While widespread transcriptome changes were previously observed with seed dormancy loss, this study specifically characterized transcriptional changes associated with the increased seed dormancy and dormancy loss of the gibberellin (GA) hormone-insensitive sleepy1-2 (sly1-2) mutant. The SLY1 gene encodes the F-box subunit of an SCF E3 ubiquitin ligase needed for GA-triggered proteolysis of DELLA repressors of seed germination. DELLA over-accumulation in sly1-2 seeds leads to increased dormancy that can be rescued without DELLA protein destruction either by overexpression of the GA receptor, GA-INSENSITIVE DWARF1b (GID1b-OE) (74% germination) or by extended dry after-ripening (11 months, 51% germination). After-ripening of sly1 resulted in different transcriptional changes in early versus late Phase II of germination that were consistent with the processes known to occur. Approximately half of the transcriptome changes with after-ripening appear to depend on SLY1-triggered DELLA proteolysis. Given that many of these SLY1/GA-dependent changes are genes involved in protein translation, it appears that GA signaling increases germination capacity in part by activating translation. While sly1-2 after-ripening was associated with transcript-level changes in 4594 genes over two imbibition timepoints, rescue of sly1-2 germination by GID1b-OE was associated with changes in only 23 genes. Thus, a big change in sly1-2 germination phenotype can occur with relatively little change in the global pattern of gene expression during the process of germination. Most GID1b-OE-responsive transcripts showed similar changes with after-ripening in early Phase II of imbibition, but opposite changes with after-ripening by late Phase II. This suggests that GID1b-OE stimulates germination early in imbibition, but may later trigger negative feedback regulation.	[Nelson, Sven K.; Steber, Camille M.] Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA; [Steber, Camille M.] USDA ARS, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA; [Steber, Camille M.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Nelson, Sven K.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA	Washington State University; United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Steber, CM (corresponding author), Washington State Univ, Mol Plant Sci Program, Pullman, WA 99164 USA.; Steber, CM (corresponding author), USDA ARS, Wheat Hlth Genet & Qual Res Unit, Pullman, WA 99164 USA.; Steber, CM (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	csteber@wsu.edu	Nelson, Sven/H-8806-2019	Nelson, Sven/0000-0002-2409-1176; Steber, Camille/0000-0001-6255-7670	National Science Foundation (NSF) [0850981]; USDA-ARS project [424575]	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); USDA-ARS project	This work was supported by National Science Foundation (NSF) Award 0850981 to CMS (https://www.nsf.gov/funding/pgm_summ.jsp? pims _id=501087), and USDA-ARS project 424575 to CMS (http://www.ars.usda.gov/pacific-west-area/pullman-wa/whgq/).; We thank the members of the Steber lab, A. Hauvermale, S. Martinez, K. Tuttle, and T. Harris, for helpful suggestions about the research and manuscript. Thanks are also due to M. Neff, H. Hellmann, A. McCubbin, and P. Okubara for helpful comments on the manuscript. This research was funded by National Science Foundation (NSF) Award 0850981 and USDA-ARS project 424575 (to C.M.S.).	Abbruzzetti S, 2011, IUBMB LIFE, V63, P1094, DOI 10.1002/iub.546; Alabadi D, 2008, PLANT J, V53, P324, DOI 10.1111/j.1365-313X.2007.03346.x; Alkhalfioui F, 2007, PLANT PHYSIOL, V144, P1559, DOI 10.1104/pp.107.098103; Arenas-Mena C, 1999, PLANT MOL BIOL, V40, P355, DOI 10.1023/A:1006219315562; Ariizumi T, 2008, PLANT CELL, V20, P2447, DOI 10.1105/tpc.108.058487; Ariizumi T, 2007, PLANT CELL, V19, P791, DOI 10.1105/tpc.106.048009; Ariizumi T, 2013, PLANT PHYSIOL, V162, P2125, DOI 10.1104/pp.113.219451; Ariizumi T, 2011, PLANT SIGNAL BEHAV, V6, P831, DOI 10.4161/psb.6.6.15164; Ariizumi T, 2011, PLANT PHYSIOL, V155, P765, DOI 10.1104/pp.110.166272; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bai MY, 2012, NAT CELL BIOL, V14, P810, DOI 10.1038/ncb2546; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bassel GW, 2008, PLANT PHYSIOL, V147, P143, DOI 10.1104/pp.107.110841; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentsink L, 2006, P NATL ACAD SCI USA, V103, P17042, DOI 10.1073/pnas.0607877103; Bernhardt A, 2010, PLANTA, V232, P555, DOI 10.1007/s00425-010-1195-9; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Borisjuk L, 2009, NEW PHYTOL, V182, P17, DOI 10.1111/j.1469-8137.2008.02752.x; Borrell A, 2002, PLANT MOL BIOL, V50, P249, DOI 10.1023/A:1016084615014; Bush DS, 1996, PLANTA, V199, P89, DOI 10.1007/BF00196885; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Carrera E, 2008, PLANT J, V53, P214, DOI 10.1111/j.1365-313X.2007.03331.x; Carrera E, 2007, PLANT PHYSIOL, V143, P1669, DOI 10.1104/pp.107.096057; CHEAH KSE, 1978, NATURE, V272, P593, DOI 10.1038/272593a0; Chen H, 2008, PLANT SIGNAL BEHAV, V3, P986, DOI 10.4161/psb.6185; Chiang GCK, 2011, MOL ECOL, V20, P3336, DOI 10.1111/j.1365-294X.2011.05181.x; Chiba Y, 2015, J PLANT RES, V128, P679, DOI 10.1007/s10265-015-0710-2; Corner EJH, 1964, THE LIFE OF PLANTS; COSGROVE D J, 1989, Planta (Heidelberg), V177, P121, DOI 10.1007/BF00392162; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; Dekkers BJW, 2016, FRONT PLANT SCI FRON, V7, P479; Dill A, 2004, PLANT CELL, V16, P1392, DOI 10.1105/tpc.020958; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; FENG S, 2008, COORDINATED REGULATI, V475, P479, DOI DOI 10.1038/NATURE06448; Finch-Savage WE, 2007, PLANT J, V51, P60, DOI 10.1111/j.1365-313X.2007.03118.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Gallego-Bartolome J, 2010, MOL BIOL EVOL, V27, P1247, DOI 10.1093/molbev/msq012; Gao F, 2012, PLANT BIOTECHNOL J, V10, P465, DOI 10.1111/j.1467-7652.2012.00682.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GILROY S, 1994, PLANT PHYSIOL, V104, P1185, DOI 10.1104/pp.104.4.1185; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Guan QM, 2013, MOL PLANT, V6, P386, DOI 10.1093/mp/sss119; Gubler F, 2002, PLANT PHYSIOL, V129, P191, DOI 10.1104/pp.010918; Hauvermale AL, 2015, PLANT CELL PHYSIOL, V56, P1773, DOI 10.1093/pcp/pcv084; Hauvermale AL, 2012, PLANT PHYSIOL, V160, P83, DOI 10.1104/pp.112.200956; Hirano K, 2012, PLANT J, V71, P443, DOI 10.1111/j.1365-313X.2012.05000.x; Hirano K, 2010, PLANT CELL, V22, P2680, DOI 10.1105/tpc.110.075549; HOLM S, 1979, SCAND J STAT, V6, P65; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; Iuchi S, 2007, PLANT J, V50, P958, DOI 10.1111/j.1365-313X.2007.03098.x; Jacobsen JV, 2013, PLANTA, V238, P121, DOI 10.1007/s00425-013-1878-0; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Karim S, 2005, J MOL MODEL, V11, P226, DOI 10.1007/s00894-005-0257-6; Karim S, 2007, PLANTA, V225, P1431, DOI 10.1007/s00425-006-0451-5; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; Lai LM, 2012, BIOINFORMATICS, V28, P2291, DOI 10.1093/bioinformatics/bts421; Lau OS, 2010, CURR OPIN PLANT BIOL, V13, P571, DOI 10.1016/j.pbi.2010.07.001; Lee KP, 2010, P NATL ACAD SCI USA, V107, P19108, DOI 10.1073/pnas.1012896107; Lee Y, 2002, PLANT PHYSIOL, V130, P1396, DOI 10.1104/pp.008888; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livne S, 2014, PLANT CELL PHYSIOL, V55, P1727, DOI 10.1093/pcp/pcu104; Lozano-Juste J, 2011, PLANT PHYSIOL, V156, P1410, DOI 10.1104/pp.111.177741; Marin-de la Rosa N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005337; McCubbin AG, 2004, PLANT J, V39, P206, DOI 10.1111/j.1365-313X.2004.02121.x; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Mortensen SA, 2011, FEBS LETT, V585, P1929, DOI 10.1016/j.febslet.2011.04.077; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Nelson SK, 2016, ANNU PLANT REV, V49, P153, DOI 10.1002/9781119210436.ch6; Nishizawa-Yokoi A, 2009, BIOSCI BIOTECH BIOCH, V73, P890, DOI 10.1271/bbb.80809; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Oh E, 2004, PLANT CELL, V16, P3045, DOI 10.1105/tpc.104.025163; Oh E, 2006, PLANT J, V47, P124, DOI 10.1111/j.1365-313X.2006.02773.x; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Penfield S, 2006, CURR BIOL, V16, P2366, DOI 10.1016/j.cub.2006.10.057; Penfield S, 2012, PHILOS T R SOC B, V367, P291, DOI 10.1098/rstb.2011.0186; Preston J, 2009, PLANT CELL PHYSIOL, V50, P1786, DOI 10.1093/pcp/pcp121; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Qi TC, 2014, PLANT CELL, V26, P1118, DOI 10.1105/tpc.113.121731; R Core Team, 2021, R LANGUAGE ENV STAT; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Rubinovich L, 2010, PLANT J, V64, P1018, DOI 10.1111/j.1365-313X.2010.04390.x; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Sirova J, 2011, PLANT SCI, V181, P560, DOI 10.1016/j.plantsci.2011.03.014; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steber CM, 1998, GENETICS, V149, P509; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tejedor-Cano J, 2010, PLANT CELL ENVIRON, V33, P1408, DOI 10.1111/j.1365-3040.2010.02159.x; Telfer A, 1997, DEVELOPMENT, V124, P645; Thiel J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-48; Toh S, 2012, PLANT SIGNAL BEHAV, V7, P556, DOI 10.4161/psb.19839; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2008, PLANT CELL, V20, P2437, DOI 10.1105/tpc.108.061648; Vlieghe K, 2003, J CELL SCI, V116, P4249, DOI 10.1242/jcs.00715; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamamoto Y, 2010, PLANT CELL, V22, P3589, DOI 10.1105/tpc.110.074542; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yilmaz A, 2011, NUCLEIC ACIDS RES, V39, pD1118, DOI 10.1093/nar/gkq1120; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x; Zhiponova MK, 2014, P NATL ACAD SCI USA, V111, P2824, DOI 10.1073/pnas.1400203111	124	12	13	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179143	10.1371/journal.pone.0179143	http://dx.doi.org/10.1371/journal.pone.0179143			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628628	Green Submitted, gold, Green Published			2022-12-26	WOS:000404043100018
J	Velo, E; Bongiorno, G; Kadriaj, P; Myrseli, T; Crilly, J; Lika, A; Mersini, K; Di Muccio, T; Bino, S; Gramiccia, M; Gradoni, L; Maroli, M				Velo, Enkelejda; Bongiorno, Gioia; Kadriaj, Perparim; Myrseli, Teita; Crilly, James; Lika, Aldin; Mersini, Kujtim; Di Muccio, Trentina; Bino, Silvia; Gramiccia, Marina; Gradoni, Luigi; Maroli, Michele			The current status of phlebotomine sand flies in Albania and incrimination of Phlebotomus neglectus (Diptera, Psychodidae) as the main vector of Leishmania infantum	PLOS ONE			English	Article							SANDFLIES DIPTERA; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; RETROSPECTIVE ANALYSIS; NATURAL INFECTION; IDENTIFICATION; FOCUS; ZYMODEME; REGION; ISLAND	The incidence of visceral leishmaniasis (VL) in Albania is higher than in other countries of southern Europe, however the role of local sand fly species in the transmission of Leishmania infantum was not addressed conclusively. In 2006, a country-wide collection of sand flies performed in 14 sites selected based on recent occurrence of VL cases showed that Phlebotomus neglectus was by far the most prevalent species (95.6%). Furthermore, 15% of pools made from 422 P. neglectus females tested positive for Leishmania sp. genomic DNA. In the same year, Culicoides trapping was performed for bluetongue disease surveillance in 91 sites of southern Albania, targeting livestock farms regardless recent occurrence of VL in the surveyed areas. In 35 sites where sand flies were collected along with midges, Phlebotomus perfiliewi was the most prevalent among the Phlebotomus species identified, however search for leishmanial DNA in females of this species was unsuccessful. In 2011, sand flies were trapped in 4 sites of north Albania characterized by high VL incidence, and females were dissected to search for Leishmania infections. Both P. neglectus and P. tobbi were collected at high densities. Two positive specimens were detected from a sample of 64 P. neglectus trapped in one site (3.1%). Parasites were successfully cultured from one specimen and characterized as belonging to Leishmania infantum zymodeme MON-1, the only zymodeme so far identified as the agent of human and canine leishmaniasis in the country. Altogether our studies indicate that P. neglectus is the main leishmaniasis vector in Albania.	[Velo, Enkelejda; Kadriaj, Perparim; Myrseli, Teita; Bino, Silvia] Inst Publ Hlth, Dept Control Infect Dis, Tirana, Albania; [Bongiorno, Gioia; Di Muccio, Trentina; Gramiccia, Marina; Gradoni, Luigi; Maroli, Michele] Ist Super Sanita, MIPI Dept, Unit Vector Borne Dis & Int Hlth, Rome, Italy; [Crilly, James; Lika, Aldin; Mersini, Kujtim] Food Safety & Vet Inst, Dept Anim Hlth, Tirana, Albania	Istituto Superiore di Sanita (ISS)	Velo, E (corresponding author), Inst Publ Hlth, Dept Control Infect Dis, Tirana, Albania.	keladikolli@yahoo.com	DI MUCCIO, TRENTINA/C-4967-2016; Mersini, Kujtim/B-6393-2019; Gradoni, Luigi/C-4962-2016	DI MUCCIO, TRENTINA/0000-0001-6452-8902; Mersini, Kujtim/0000-0001-8520-3373; Velo, Enkelejda/0000-0001-7283-2541	Institute of Public Health, Tirana; EU grant [FP7-261504 EDENext]; World Health Organization, Office in Albania, Consulting Research Service [2011/170992-0]	Institute of Public Health, Tirana; EU grant(European Commission); World Health Organization, Office in Albania, Consulting Research Service	This work has been funded by the Institute of Public Health, Tirana and partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext471 (http://www.edenext.eu). The contents of this publication are the responsibility of the authors and do not necessarily reflect the views of the European Commission. MM was supported by a grant of the World Health Organization, Office in Albania, Consulting Research Service 2011/170992-0.	Adhami J, 2000, REV MJEKSORE, V1, P60; ADLER S, 1957, ANNU REV ENTOMOL, V2, P203, DOI 10.1146/annurev.en.02.010157.001223; Adler S, 1935, PROC R SOC SER B-BIO, V116, P516, DOI 10.1098/rspb.1935.0007; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], TRAVAUX MUSEUM NATL, V51, P185; Bosnic S, 2006, ACTA TROP, V99, P42, DOI 10.1016/j.actatropica.2006.06.009; Cani E., 2001, REV VET, V5, P81; CHANIOTIS B, 1994, ANN TROP MED PARASIT, V88, P659, DOI 10.1080/00034983.1994.11812918; Farkas R, 2011, VECTOR-BORNE ZOONOT, V11, P823, DOI 10.1089/vbz.2010.0186; Garifallou A., 1989, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V163, P1011; Gramiccia M, 2003, ANN TROP MED PARASIT, V97, P65, DOI 10.1179/000349803225002543; Ivovic V, 2004, ANN TROP MED PARASIT, V98, P425, DOI 10.1179/000349804225003352; Killick-Kendrick R., 1991, Parassitologia (Rome), V33, P335; LEGER N, 1988, T ROY SOC TROP MED H, V82, P419, DOI 10.1016/0035-9203(88)90145-9; Leger N, 2000, PARASITE, V7, P143, DOI 10.1051/parasite/2000072143; LEGER N, 1991, ANN PARASIT HUM COMP, V66, P33, DOI 10.1051/parasite/199166133; LEGER N, 1987, B SOC PATHOL EXOT, V80, P252; LEGER N, 1983, ANN PARASIT HUM COMP, V58, P611, DOI 10.1051/parasite/1983586611; Lewis D.J., 1982, Bulletin of the British Museum (Natural History) Entomology, V45, P121; Alcover MM, 2012, PARASITOL RES, V111, P515, DOI 10.1007/s00436-012-2863-4; Maroli M., 2002, Parassitologia (Rome), V44, P103; Maroli M, 2013, MED VET ENTOMOL, V27, P123, DOI 10.1111/j.1365-2915.2012.01034.x; MAROLI M, 1987, T ROY SOC TROP MED H, V81, P596, DOI 10.1016/0035-9203(87)90420-2; MAROLI M, 1994, ACTA TROP, V57, P333, DOI 10.1016/0001-706X(94)90079-5; Ozbel Y, 2016, ACTA TROP, V155, P89, DOI 10.1016/j.actatropica.2015.12.018; Ozbel Y, 2011, J VECTOR ECOL, V36, pS99, DOI 10.1111/j.1948-7134.2011.00118.x; Petrela R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000814; Rastgeldi S, 2005, P 5 INT S PHLEB SAND, V82, P121; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Svobodova M, 2009, INT J PARASITOL, V39, P251, DOI 10.1016/j.ijpara.2008.06.016; Theodor O., 1958, FLIEGEN PALAEARKTISC, V9c, P1; Tsachev I, 2007, TURK J VET ANIM SCI, V31, P73; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; Velo E, 2005, PARASITE, V12, P45, DOI 10.1051/parasite/2005121045; Velo E, 2003, T ROY SOC TROP MED H, V97, P288, DOI 10.1016/S0035-9203(03)90145-3; ZIVKOVIC V, 1982, ACTA VET-BEOGRAD, V32, P295	36	12	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179118	10.1371/journal.pone.0179118	http://dx.doi.org/10.1371/journal.pone.0179118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628627	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100017
J	Boucheham, A; Sommard, V; Zehraoui, F; Boualem, A; Batouche, M; Bendahmane, A; Israeli, D; Tahi, F				Boucheham, Anouar; Sommard, Vivien; Zehraoui, Farida; Boualem, Adnane; Batouche, Mohamed; Bendahmane, Abdelhafid; Israeli, David; Tahi, Fariza			IpiRId: Integrative approach for piRNA prediction using genomic and epigenomic data	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; MICRORNA PRECURSOR IDENTIFICATION; NONCODING RNAS; CLASSIFICATION; CLUSTERS; DISTANCE; BIOGENESIS; DISCOVERY; TESTES; MODEL	Many computational tools have been proposed during the two last decades for predicting piRNAs, which are molecules with important role in post-transcriptional gene regulation. However, these tools are mostly based on only one feature that is generally related to the sequence. Discoveries in the domain of piRNAs are still in their beginning stages, and recent publications have shown many new properties. Here, we propose an integrative approach for piRNA prediction in which several types of genomic and epigenomic properties that can be used to characterize these molecules are examined. We reviewed and extracted a large number of piRNA features from the literature that have been observed experimentally in several species. These features are represented by different kernels, in a Multiple Kernel Learning based approach, implemented within an object-oriented framework. The obtained tool, called IpiRId, shows prediction results that attain more than 90% of accuracy on different tested species (human, mouse and fly), outperforming all existing tools. Besides, our method makes it possible to study the validity of each given feature in a given species. Finally, the developed tool is modular and easily extensible, and can be adapted for predicting other types of ncRNAs. The IpiRId software and the user-friendly web-based server of our tool are now freely available to academic users at: https://evryrna.ibisc.univ-evry.fr/evryrna/.	[Boucheham, Anouar; Sommard, Vivien; Zehraoui, Farida; Tahi, Fariza] Univ Paris Saclay, IBISC, Univ Evry, Evry, France; [Sommard, Vivien; Boualem, Adnane; Bendahmane, Abdelhafid] Univ Paris Saclay, Univ Paris Diderot, Univ Paris Sud,Univ Evry,Sorbone Paris Cite, Inst Plant Sci Paris Saclay,IPS2,INRA,CNRS, Orsay, France; [Boucheham, Anouar] Constantine Univ 3, Fac ISCA, Constantine, Algeria; [Boucheham, Anouar; Batouche, Mohamed] Constantine Univ 2, Coll NTIC, Constantine, Algeria; [Israeli, David] Univ Evry Paris Saclay, Inserm INTEGRARE U951, Evry, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Tahi, F (corresponding author), Univ Paris Saclay, IBISC, Univ Evry, Evry, France.	fariza.tahi@univ-evry.fr	Boualem, Adnane/ABC-5019-2021	Boualem, Adnane/0000-0003-4428-6496; Bendahmane, Abdelhafid/0000-0003-3246-868X; Batouche, Mohamed/0000-0002-2456-7859; Israeli, David/0000-0003-2762-2195				Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; BETEL D, 2007, PLOS COMPUT BIOL, V3; Boucheham Anouar, 2015, International Journal of Computational Biology and Drug Design, V8, P251, DOI 10.1504/IJCBDD.2015.072075; Boucheham A, 2015, LECT N BIOINFORMAT, V9044, P301, DOI 10.1007/978-3-319-16480-9_30; Brayet J, 2014, BIOINFORMATICS, V30, pI364, DOI 10.1093/bioinformatics/btu441; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hirano T, 2014, RNA, V20, P1223, DOI 10.1261/rna.045310.114; Jaakkola T, 1999, Proc Int Conf Intell Syst Mol Biol, P149; Jain A., 2012, P 18 ACM SIGKDD INT, P750, DOI [DOI 10.1145/2339530.2339648, 10.1145/2339530.2339648]; Kim J, 2012, ILAR J, V53, P232, DOI 10.1093/ilar.53.3-4.232; Kozomara A., 2013, NUCLEIC ACIDS RES; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Le Thomas A, 2014, GENOME BIOL, V15, DOI 10.1186/gb4154; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, MOL BIOSYST, V11, P1194, DOI 10.1039/c5mb00050e; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Liu XQ, 2014, MOL BIOSYST, V10, P3075, DOI 10.1039/c4mb00447g; Makarova JA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1161, DOI 10.1134/S0006297907110016; Menor MS, 2015, INT J MOL SCI, V16, P1466, DOI 10.3390/ijms16011466; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rose NR, 2014, BBA-GENE REGUL MECH, V1839, P1362, DOI 10.1016/j.bbagrm.2014.02.007; Shpiz S, 2011, NUCLEIC ACIDS RES, V39, P8703, DOI 10.1093/nar/gkr552; Solda G, 2009, BRIEF BIOINFORM, V10, P475, DOI 10.1093/bib/bbp022; Tafer H, 2008, BIOINFORMATICS, V24, P2657, DOI 10.1093/bioinformatics/btn193; Tempel S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks146; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tran VDT, 2015, RNA, V21, P775, DOI 10.1261/rna.043612.113; Vourekas A, 2015, GENE DEV, V29, P617, DOI 10.1101/gad.254631.114; Wang K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0419-6; Wang W, 2014, MOL CELL, V56, P708, DOI 10.1016/j.molcel.2014.10.016; Weick EM, 2014, DEVELOPMENT, V141, P3458, DOI 10.1242/dev.094037; Wu KP, 2009, PATTERN RECOGN, V42, P710, DOI 10.1016/j.patcog.2008.08.030; Xuan P, 2011, BIOINFORMATICS, V27, P1368, DOI 10.1093/bioinformatics/btr153; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yamanaka S, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-22; Yu BW, 2015, CELL RES, V25, P525, DOI 10.1038/cr.2015.10; Zhang P, 2014, DATABASE THE JOURNAL, V2014; Zhang Y, 2011, BIOINFORMATICS, V27, P771, DOI 10.1093/bioinformatics/btr016	42	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179787	10.1371/journal.pone.0179787	http://dx.doi.org/10.1371/journal.pone.0179787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622364	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300052
J	Kohno, M; Ikeda, T; Hashimoto, R; Izumi, Y; Watanabe, M; Horinouchi, H; Sakai, H; Kobayashi, K; Iwazaki, M				Kohno, Mitsutomo; Ikeda, Tatsuhiko; Hashimoto, Ryo; Izumi, Yotaro; Watanabe, Masazumi; Horinouchi, Hirohisa; Sakai, Hiromi; Kobayashi, Koichi; Iwazaki, Masayuki			Acute 40% exchange-transfusion with hemoglobin-vesicles in a mouse pneumonectomy model	PLOS ONE			English	Article							ARTIFICIAL OXYGEN CARRIER; HUMAN SERUM-ALBUMIN; HEMORRHAGIC-SHOCK; RAT MODEL; BLOOD SUBSTITUTES; RESUSCITATION; FLUID; MICE	Objectives Hemoglobin vesicles (HbVs) function as a red blood cell (RBC) substitute and are composed of purified hemoglobin encapsulated in a phospholipid bilayer membrane. The performance of HbVs as a substitute for RBC transfusions was examined in a mouse model of pneumonectomy following acute 40% exchange-transfusion with HbVs. Methods Before performing left pneumonectomies, 40% of the blood volume of mice was replaced with a) lactated Ringer's solution (control), b) 5% recombinant human serum albumin (rHSA), c) mouse RBCs shed in rHSA (mRBCs/rHSA), or d) HbV suspended in rHSA (HbV/rHSA). We compared postoperative a) survival, b) functional recovery, and c) histopathological, immunohistochemical, and inflammatory responses among the study groups. Results In the HbV/rHSA and mRBC/rHSA groups, all mice survived >= 7 days after pneumonectomy, whereas 100% of the control mice died within a few h and 50% of mice in the rHSA group died within 24 h after pneumonectomy. Immunohistochemical staining for hypoxia-inducible factor-1 alpha showed that hepatic and renal hypoxic injuries were prominently mitigated by HbV and mRBCs. Conclusions The oxygen-carrying performance of HbV was similar to that of mRBCs, even with impaired lung functions following pneumonectomy. HbV infusion did not interfere with the recovery from surgical injury. In the near future, HbVs could be used clinically as a substitute for the perioperative transfusion of RBCs, when or where donated RBCs are not immediately available.	[Kohno, Mitsutomo; Hashimoto, Ryo; Iwazaki, Masayuki] Tokai Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Isehara, Kanagawa, Japan; [Ikeda, Tatsuhiko; Watanabe, Masazumi; Kobayashi, Koichi] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan; [Izumi, Yotaro] Saitama Med Univ, Saitama Med Ctr, Dept Gen Thorac Surg, Kawagoe, Saitama, Japan; [Horinouchi, Hirohisa] Saitama City Hosp, Dept Gen Thorac Surg, Saitama, Japan; [Sakai, Hiromi] Nara Med Univ, Sch Med, Dept Chem, Kashihara, Nara, Japan	Tokai University; Keio University; Saitama Medical University; Nara Medical University	Kohno, M (corresponding author), Tokai Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Isehara, Kanagawa, Japan.	kohno@1993.jukuin.keio.ac.jp	Sakai, Hiromi/J-2529-2019	Sakai, Hiromi/0000-0002-0681-3032	Japan Society for the Promotion of Science and Health Labour Sciences Research Grant from Ministry of Health, Labour and Welfare, Japan [22591575]	Japan Society for the Promotion of Science and Health Labour Sciences Research Grant from Ministry of Health, Labour and Welfare, Japan	This study was supported, in part, by a grant-in-aid for Scientific Research (C) #22591575 (M.K.) from the Japan Society for the Promotion of Science and Health Labour Sciences Research Grant (H.S.) from The Ministry of Health, Labour and Welfare, Japan.	Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; CHANG TMS, 1992, BIOMAT ARTIF CELL IM, V20, P159, DOI 10.3109/10731199209119634; Izumi Y, 1997, ASAIO J, V43, P289, DOI 10.1097/00002480-199707000-00006; Kohno M, 2012, THORAC CARDIOV SURG, V60, P124, DOI 10.1055/s-0030-1271011; Ministry of Health Labour and Welfare Japan, 2014, P BLOOD DON PROM COM; Nogami Y, 2008, ANN SURG, V248, P310, DOI 10.1097/SLA.0b013e3181820c80; Sakai H, 2000, AM J PHYSIOL-HEART C, V279, pH908, DOI 10.1152/ajpheart.2000.279.3.H908; Sakai H, 2006, TRANSFUSION, V46, P339, DOI 10.1111/j.1537-2995.2006.00727.x; Sakai H, 1996, BIOTECHNOL PROGR, V12, P119, DOI 10.1021/bp950068w; Sakai H, 2000, BIOCONJUGATE CHEM, V11, P425, DOI 10.1021/bc990173h; Sakai H, 2004, BIOMATERIALS, V25, P4317, DOI 10.1016/j.biomaterials.2003.11.005; Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22; Sakai H, 2001, AM J PATHOL, V159, P1079, DOI 10.1016/S0002-9440(10)61783-X; Sakai H, 2009, SHOCK, V31, P507, DOI 10.1097/SHK.0b013e318188f83d; Seishi Y, 2012, SHOCK, V38, P153, DOI 10.1097/SHK.0b013e31825ad7cf; Taguchi K, 2009, DRUG METAB DISPOS, V37, P1456, DOI 10.1124/dmd.109.027094; Taguchi K, 2009, J CONTROL RELEASE, V136, P232, DOI 10.1016/j.jconrel.2009.02.009; Tajima Atsushi, 2008, Interact Cardiovasc Thorac Surg, V7, P1114, DOI 10.1510/icvts.2007.170456; Tsuchida E, 1995, ARTIFICIAL RED CELLS, P20; WINSLOW RM, 1995, NAT MED, V1, P1212, DOI 10.1038/nm1195-1212; Yamamoto M, 2012, ARTIF CELL BLOOD SUB, V40, P179, DOI 10.3109/10731199.2011.637929; Yamazaki M, 2006, CIRCULATION, V114, pI220, DOI 10.1161/CIRCULATIONAHA.105.000562	22	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178724	10.1371/journal.pone.0178724	http://dx.doi.org/10.1371/journal.pone.0178724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622333	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300007
J	da Silveira, JC; Andrade, GM; del Collado, M; Sampaio, RV; Sangalli, JR; Silva, LA; Pinaffi, FVL; Jardim, IB; Cesar, MC; Nogueira, MFG; Cesar, ASM; Coutinho, LL; Pereira, RW; Perecin, F; Meirelles, FV				da Silveira, Juliano C.; Andrade, Gabriella M.; del Collado, Maite; Sampaio, Rafael V.; Sangalli, Juliano R.; Silva, Luciano A.; Pinaffi, Fabio V. L.; Jardim, Izabelle B.; Cesar, Marcelo C.; Nogueira, Marcelo F. G.; Cesar, Aline S. M.; Coutinho, Luiz L.; Pereira, Rinaldo W.; Perecin, Felipe; Meirelles, Flavio V.			Supplementation with small-extracellular vesicles from ovarian follicular fluid during in vitro production modulates bovine embryo development	PLOS ONE			English	Article							RNA; MICRORNAS; OOCYTE; MOUSE; CELLS; GENE; COMPETENCE; BLASTOCYST; PROTEINS; EXOSOMES	Pregnancy success results from the interaction of multiple factors, among them are folliculogenesis and early embryonic development. Failure during these different processes can lead to difficulties in conception. Alternatives to overcome these problems are based on assisted reproductive techniques. Extracellular vesicles are cell-secreted vesicles present in different body fluids and contain bioactive materials, such as messenger RNA, microRNAs (miRNAs), and proteins. Thus, our hypothesis is that extracellular vesicles from follicular fluid from 3-6 mm ovarian follicles can modulate bovine embryo development in vitro. To test our hypothesis follicular fluid from bovine ovaries was aspirated and small-extracellular vesicles (<200 nm) were isolated for further analysis. Additionally, small-extracellular vesicles (EVs) were utilized for functional experiments investigating their role in modulating messenger RNA, microRNA as well as global DNA methylation and hydroxymethylation levels of bovine blastocysts. EVs from 3-6 mm follicles were used for RNA-seq and miRNA analysis. Functional annotation analysis of the EVs transcripts revealed messages related to chromatin remodeling and transcriptional regulation. EVs treatment during oocyte maturation and embryo development causes changes in blastocyst rates, as well as changes in the transcription levels of genes related to embryonic metabolism and development. Supplementation with EVs from 3-6 mm follicles during oocyte maturation and early embryo development (until the 4-cell stage) increased the levels of bta-miR-631 (enriched in EVs from 3-6 mm follicles) in embryos. Interestingly, the addition of EVs from 3-6 mm follicles induced changes in global DNA methylation and hydroxymethylation levels compared to embryos produced by the standard in vitro production system. Our results indicate that the supplementation of culture media with EVs isolated from the follicular fluid of 3-6 mm follicles during oocyte maturation and early embryo development can partially modify metabolic and developmental related genes as well as miRNA and global DNA methylation and hydroxymethylation, suggesting that EVs play an important role during oocyte maturation and early embryo development in vitro.	[da Silveira, Juliano C.; Andrade, Gabriella M.; del Collado, Maite; Sampaio, Rafael V.; Sangalli, Juliano R.; Silva, Luciano A.; Pinaffi, Fabio V. L.; Jardim, Izabelle B.; Cesar, Marcelo C.; Perecin, Felipe; Meirelles, Flavio V.] Univ Sao Paulo, Dept Vet Med, Sao Paulo, Brazil; [Nogueira, Marcelo F. G.] Univ Sao Paulo State, Dept Biol Sci, Sao Paulo, Brazil; [Cesar, Aline S. M.; Coutinho, Luiz L.] Univ Sao Paulo, Dept Anim Sci, Luiz de Queiroz Coll Agr, Sao Paulo, Brazil; [Pereira, Rinaldo W.] Univ Catolica Brasilia, Dept Biotechnol, Brasilia, DF, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Catolica de Brasilia	da Silveira, JC (corresponding author), Univ Sao Paulo, Dept Vet Med, Sao Paulo, Brazil.	julianodasilveira@usp.br	Pereira, Rinaldo W/B-9255-2011; Meirelles, Flavio V/B-5048-2010; Perecin, Felipe/C-7268-2012; Sampaio, Rafael RVS/B-5354-2013; Coutinho, Luiz L/C-8455-2012; Cesar, Marcelo C/C-9149-2012; Coutinho, Luiz/P-5233-2019; Silva, Luciano A/G-6925-2012; Andrade, Gabriella M/F-9881-2012; Da Silveira, Juliano/AAH-9784-2020; del Collado, Maite/M-4870-2015; Cesar, Aline Silva Mello/E-6887-2014; Silveira, Juliano C/B-3086-2013; Nogueira, Marcelo Fábio Gouveia/D-9801-2012; Sangalli, Juliano Rodrigues/C-1834-2013; CTC USP, CEPID 13 18/J-8951-2014	Pereira, Rinaldo W/0000-0003-3704-2848; Meirelles, Flavio V/0000-0003-0372-4920; Perecin, Felipe/0000-0003-2009-5863; Sampaio, Rafael RVS/0000-0002-8227-8510; Coutinho, Luiz L/0000-0002-7266-8881; Cesar, Marcelo C/0000-0001-9077-1535; Coutinho, Luiz/0000-0002-7266-8881; Silva, Luciano A/0000-0002-9545-179X; Andrade, Gabriella M/0000-0002-8095-3738; Da Silveira, Juliano/0000-0002-4796-6393; del Collado, Maite/0000-0002-4098-4855; Cesar, Aline Silva Mello/0000-0001-9921-214X; Silveira, Juliano C/0000-0002-4796-6393; Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; CTC USP, CEPID 13 18/0000-0002-7123-9524	FAPESP [2012/50533-2, 2013/08135-2, 2014/21034-3, 2013/10473-3, 2014/22887-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from FAPESP (grant 2012/50533-2; grant 2013/08135-2; grant 2014/21034-3; grant 2013/10473-3 and grant 2014/22887-0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alminana C, 2015, ANIM REPROD, V12, P366; Anckaert E, 2015, REPROD FERT DEVELOP, V27, P739, DOI 10.1071/RD14333; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; da Silveira JC, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-44; da Silveira JC, 2015, REPROD FERT DEVELOP, V27, P897, DOI 10.1071/RD14452; da Silveira JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093252; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; el Hajj N, 2013, FERTIL STERIL, V99, P632, DOI 10.1016/j.fertnstert.2012.12.044; Fair T, 2003, ANIM REPROD SCI, V78, P203, DOI 10.1016/S0378-4320(03)00091-5; FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225; Gilbert I, 2012, REPRODUCTION, V143, P735, DOI 10.1530/REP-11-0460; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hung WT, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132977; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Li W, 2014, REPROD FERTIL DEV; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Macabelli CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093287; Macaulay AD, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119867; Macaulay AD, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.114.127571; Mendonca AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142072; Ohshima K, 2014, PROTEOMICS, V14, P2297, DOI 10.1002/pmic.201300477; Patel OV, 2007, REPRODUCTION, V133, P95, DOI 10.1530/rep.1.01123; Portela VM, 2010, FERTIL STERIL, V93, P2050, DOI 10.1016/j.fertnstert.2009.01.151; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sang Q, 2013, J CLIN ENDOCR METAB, V98, P3068, DOI 10.1210/jc.2013-1715; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sohel MMH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078505; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vogel R, 2016, A STANDARDIZED METHO, V1, P1; Wang HW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100511; Williams CR, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0956-2; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yanagimachi R, 2012, J REPROD DEVELOP, V58, P25, DOI 10.1262/jrd.11-015; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Zhang Y, 2013, J BIOL CHEM, V288, P23659, DOI 10.1074/jbc.M113.475608	46	61	62	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179451	10.1371/journal.pone.0179451	http://dx.doi.org/10.1371/journal.pone.0179451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617821	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600038
J	Mohr, T; Haudek-Prinz, V; Slany, A; Grillari, J; Micksche, M; Gerner, C				Mohr, Thomas; Haudek-Prinz, Verena; Slany, Astrid; Grillari, Johannes; Micksche, Michael; Gerner, Christopher			Proteome profiling in IL-1 beta and VEGF-activated human umbilical vein endothelial cells delineates the interlink between inflammation and angiogenesis	PLOS ONE			English	Article							GENE ONTOLOGY; SECRETOME; MECHANISMS; EXPRESSION; INSIGHTS; DISEASE; BINDING	Endothelial cells represent major effectors in inflammation and angiogenesis, processes that drive a multitude of pathological states such as atherosclerosis and cancer. Both inflammation and angiogenesis are interconnected with each other in the sense that many proinflammatory proteins possess proangiogenic properties and vice versa. To elucidate this interplay further, we present a comparative proteome study of inflammatory and angiogenic activated endothelial cells. HUVEC were stimulated with interleukin 1-beta and VEGF, respectively. Cultured primary cells were fractionated into secreted, cytoplasmic and nuclear protein fractions and processed for subsequent LC-MS/MS analysis. Obtained protein profiles were filtered for fraction-specific proteins to address potential cross fractional contamination, subjected to comparative computational biology analysis ( GO-Term enrichment analysis, weighted gene co-expression analysis) and compared to published mRNA profiles of IL-1 beta respectively VEGF stimulated HUVEC. GO Term enrichment analysis and comparative pathway analysis revealed features such as NOD and NfkB signaling for inflammatory activated HUVEC and VEGF and ErB signaling for VEGF-activated HUVEC with potential crosstalk via map kinases MAP2K2. Weighted protein co-expression network analysis revealed several potential hub genes so far not associated with driver function in inflammation or angiogenesis such as HSPG2, ANXA3, and GPI. "Classical" inflammation or angiogenesis markers such as IL6, CXCL8 or CST1 were found in a less central position within the co-expression networks. In conclusion, this study reports a framework for the computational biology based analysis of proteomics data applied to cytoplasmic, nucleic and extracellular fractions of quiescent, inflammatory and angiogenic activated HUVEC. Novel potential hub genes relevant for these processes were successfully identified.	[Mohr, Thomas; Slany, Astrid; Micksche, Michael] Med Univ Vienna, Dept Med, Inst Canc Res, Vienna, Austria; [Mohr, Thomas] ScienceConsult DI Thomas Mohr KG, Guntramsdorf, Austria; [Haudek-Prinz, Verena; Slany, Astrid; Gerner, Christopher] Univ Vienna, Dept Analyt Chem, Fac Chem, Vienna, Austria; [Grillari, Johannes] BOKU Univ Life Sci, Dept Biotechnol, Christian Doppler Lab Biotechnol Skin Aging, Vienna, Austria; [Grillari, Johannes] Evercyte GmbH, Vienna, Austria	Medical University of Vienna; University of Vienna	Mohr, T (corresponding author), Med Univ Vienna, Dept Med, Inst Canc Res, Vienna, Austria.; Mohr, T (corresponding author), ScienceConsult DI Thomas Mohr KG, Guntramsdorf, Austria.	thomas.mohr@mohrkeg.co.at	Mohr, Thomas/AAN-1180-2020; Grillari, Johannes/B-2967-2011	Mohr, Thomas/0000-0002-1933-847X; Grillari, Johannes/0000-0001-5474-6332; Gerner, Christopher/0000-0003-4964-0642; Slany, Astrid/0000-0002-2217-5800				Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; Althubiti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.489; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AUGUSTIN HG, 1994, BIOESSAYS, V16, P901, DOI 10.1002/bies.950161208; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Belinky Frida, 2015, Database (Oxford), V2015, DOI 10.1093/database/bav006; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boersma YL, 2014, ACTA CRYSTALLOGR D, V70, P3320, DOI 10.1107/S1399004714022767; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Bruneel A, 2003, PROTEOMICS, V3, P714, DOI 10.1002/pmic.200300409; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carpentier G., 2012, IMAGEJ NEWS, V5; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Ferrington DA, 2012, PROG MOL BIOL TRANSL, V109, P75, DOI 10.1016/B978-0-12-397863-9.00003-1; Gilsdorf JR, INDUCTION PROINFLAMM; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Gonzalez-Cabrero Jesus, 2007, Methods Mol Biol, V357, P181; Gopinathan G, 2015, CANCER RES, V75, P3098, DOI 10.1158/0008-5472.CAN-15-1227; Grillari J, 2000, EXP GERONTOL, V35, P187, DOI 10.1016/S0531-5565(00)00080-2; Griss J, 2011, PROTEOMICS, V11, P1000, DOI 10.1002/pmic.201000507; Gundacker N, 2006, ELECTROPHORESIS, V27, P2712, DOI 10.1002/elps.200500964; Gundacker NC, 2009, J PROTEOME RES, V8, P2799, DOI 10.1021/pr8011039; Haudek VJ, 2009, J PROTEOME RES; Haudek-Prinz VJ, 2012, J PROTEOMICS, V76, P150, DOI 10.1016/j.jprot.2012.07.012; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jeong JK, 2013, TRENDS ENDOCRIN MET, V24, P61, DOI 10.1016/j.tem.2012.11.001; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffmann A, 2009, BIOINFORMATICS, V25, P2092, DOI 10.1093/bioinformatics/btp354; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Mohr T, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-231; Mundel TM, 2007, MICROVASC RES, V74, P85, DOI 10.1016/j.mvr.2007.05.005; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Packiriswamy N, 2015, GENES IMMUN, V16, P367, DOI 10.1038/gene.2015.26; Park HJ, 2008, J PROTEOME RES, V7, P1138, DOI 10.1021/pr7007237; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sadun A, 2015, ACTA OPHTHALMOL, V93, DOI 10.1111/j.1755-3768.2015.0131; Schweighofer B, 2007, CLIN HEMORHEOL MICRO, V37, P57; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Slany A, 2016, MOL CELL PROTEOMICS; Slany A, 2009, ELECTROPHORESIS, V30, P1306, DOI 10.1002/elps.200800440; Snelgrove RJ, 2010, SCIENCE, V330, P90, DOI 10.1126/science.1190594; Suehiro J, 2014, J BIOL CHEM, V289, P29044, DOI 10.1074/jbc.M114.555235; Tanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027922; Tunica DG, 2009, PROTEOMICS, V9, P4991, DOI 10.1002/pmic.200900065; Wang YX, 2011, AM J PHYSIOL-CELL PH, V301, pC695, DOI 10.1152/ajpcell.00322.2010	66	57	58	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179065	10.1371/journal.pone.0179065	http://dx.doi.org/10.1371/journal.pone.0179065			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617818	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600021
J	Franck, JA; Smeets, RJEM; Seelen, HAM				Franck, Johan Anton; Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria			Changes in arm-hand function and arm-hand skill performance in patients after stroke during and after rehabilitation	PLOS ONE			English	Article							CLINICALLY IMPORTANT DIFFERENCE; UPPER-LIMB RECOVERY; UPPER-EXTREMITY; MOTOR RECOVERY; ABILHAND QUESTIONNAIRE; INTERRATER RELIABILITY; OUTCOME MEASURES; SURVIVORS; THERAPY; IMPAIRMENT	Background Arm-hand rehabilitation programs applied in stroke rehabilitation frequently target specific populations and thus are less applicable in heterogeneous patient populations. Besides, changes in arm-hand function (AHF) and arm-hand skill performance (AHSP) during and after a specific and well-described rehabilitation treatment are often not well evaluated. Method This single-armed prospective cohort study featured three subgroups of stroke patients with either a severely, moderately or mildly impaired AHF. Rehabilitation treatment consisted of a Concise_ Arm_ and_ hand_ Rehabilitation_ Approach_ in_ Stroke (CARAS). Measurements at function and activity level were performed at admission, clinical discharge, 3, 6, 9 and 12 months after clinical discharge. Results Eighty-nine stroke patients (M/F:63/23; mean age: 57.6yr (+/-10.6); post-stroke time: 29.8 days (+/-20.1)) participated. All patients improved on AHF and arm-hand capacity during and after rehabilitation, except on grip strength in the severely affected subgroup. Largest gains occurred in patients with a moderately affected AHF. As to self-perceived AHSP, on average, all subgroups improved over time. A small percentage of patients declined regarding self-perceived AHSP post-rehabilitation. Conclusions A majority of stroke patients across the whole arm-hand impairment severity spectrum significantly improved on AHF, arm-hand capacity and self-perceived AHSP. These were maintained up to one year post-rehabilitation. Results may serve as a control condition in future studies.	[Franck, Johan Anton] Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands; [Franck, Johan Anton; Seelen, Henk Alexander Maria] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands; [Smeets, Rob Johannes Elise Marie; Seelen, Henk Alexander Maria] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Maastricht, Netherlands	Maastricht University	Franck, JA (corresponding author), Adelante Rehabil Ctr, Dept Brain Injury Rehabil, Hoensbroek, Netherlands.; Franck, JA (corresponding author), Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands.	h.franck@adelante-zorggroep.nl	Smeets, Rob JEM/D-1522-2011	Smeets, Rob JEM/0000-0002-9503-366X				Arya KN, 2012, TOP STROKE REHABIL, V19, P193, DOI 10.1310/tsr1903-193; Arya KN, 2011, TOP STROKE REHABIL, V18, P599, DOI 10.1310/tsr18s01-599; Ashford S, 2008, J REHABIL MED, V40, P787, DOI 10.2340/16501977-0276; Barker RN, 2005, DISABIL REHABIL, V27, P1213, DOI 10.1080/09638280500075717; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Combs SA, 2010, DISABIL REHABIL, V32, P669, DOI 10.3109/09638280903242716; De Weerdt WJG., 1985, PHYSIOTHER CAN, V37, P65, DOI DOI 10.3138/PTC.37.2.065; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Franck J.A., 2015, OPEN J OCCUP THER, V3, P10, DOI [10.15453/2168-6408.1164, DOI 10.15453/2168-6408.1164]; French B, 2009, STROKE; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Hamilton G. F., 1994, STIMULUS, V13, P164; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Harris-Love ML, 2016, NEUROREHAB NEURAL RE, V30, P328, DOI 10.1177/1545968315594886; Hayward K, 2010, DISABIL REHABIL, V32, P1973, DOI 10.3109/09638288.2010.481027; Hsieh CL, 1998, AGE AGEING, V27, P107, DOI 10.1093/ageing/27.2.107; Jang SH, 2003, NEUROREPORT, V14, P137, DOI 10.1097/00001756-200301200-00025; Kwah LK, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040053; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Kwakkel G, 2015, OXFORD TXB NEUROREHA; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lemmens RJM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-21; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; McDonnell MN, 2007, NEUROREHAB NEURAL RE, V21, P435, DOI 10.1177/1545968307300437; Mirbagheri MM, 2008, ARCH PHYS MED REHAB, V89, P1507, DOI 10.1016/j.apmr.2008.02.017; Morris JH, 2008, ARCH PHYS MED REHAB, V89, P1237, DOI 10.1016/j.apmr.2007.11.039; Oujamaa L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P269, DOI 10.1016/j.rehab.2008.10.003; Penta M, 2001, STROKE, V32, P1627, DOI 10.1161/01.STR.32.7.1627; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Platz T, 2005, CLIN REHABIL, V19, P714, DOI 10.1191/0269215505cr904oa; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Reenen ETKV, 2009, DISABIL REHABIL, V31, P1338, DOI 10.1080/09638280902846855; Salter K, 2005, DISABIL REHABIL, V27, P191, DOI 10.1080/09638280400008537; Smania N, 2007, STROKE, V38, P1088, DOI 10.1161/01.STR.0000258077.88064.a3; Sullivan KJ, 2011, STROKE, V42, P427, DOI 10.1161/STROKEAHA.110.592766; Timmermans AAA, 2009, DISABIL REHABIL, V31, P1344, DOI 10.1080/09638280902823664; Timmermans AAA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-1; Twisk JWR, 2003, APPL LONGITUDINAL DA; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; Verbunt JA, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-7; WADE DT, 1985, J NEUROL NEUROSUR PS, V48, P7, DOI 10.1136/jnnp.48.1.7; Wallace AC, 2010, CLIN REHABIL, V24, P471, DOI 10.1177/0269215509358944; Wang TN, 2011, ARCH PHYS MED REHAB, V92, P1086, DOI 10.1016/j.apmr.2011.01.020; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Winstein CJ, 2006, TXB NEURAL REPAIR RE; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	51	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179453	10.1371/journal.pone.0179453	http://dx.doi.org/10.1371/journal.pone.0179453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614403	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900054
J	Hubot, N; Lucas, CH; Piraino, S				Hubot, Nathan; Lucas, Cathy H.; Piraino, Stefano			Environmental control of asexual reproduction and somatic growth of Aurelia spp. (Cnidaria, Scyphozoa) polyps from the Adriatic Sea	PLOS ONE			English	Article							COMMON JELLYFISH; MOON JELLYFISH; AURITA; TEMPERATURE; BLOOMS; RATES; LAKES	Polyps of two moon jellyfish species, Aurelia coerulea and A. relicta, from two Adriatic Sea coastal habitats were incubated under multiple combinations of temperature (14, 21 degrees C), salinity (24, 37 ppt) and food regime (9.3, 18.6, 27.9 mu g C ind(-1) week(-1)) to comparatively assess how these factors may influence major asexual reproduction processes in the two species. Both species exhibited a shared pattern of budding mode (Directly Budded Polyps: DBP; Stolonal Budded Polyps: SBP), with DBP favoured under low food supply (9.3 mu g C ind(-1) week(-1)) and low temperature (14 E C), and SBP dominant under high temperature (21 E C). However, A. coerulea showed an overall higher productivity than A. relicta, in terms of budding and podocyst production rates. Further, A. coerulea exhibited a wide physiological plasticity across different temperatures and salinities as typical adaptation to ecological features of transitional coastal habitats. This may support the hypothesis that the invasion of A. coerulea across coastal habitats worldwide has been driven by shellfish aquaculture, with scyphistoma polyps and resting stages commonly found on bivalve shells. On the contrary, A. relicta appears to be strongly stenovalent, with cold, marine environmental optimal preferences (salinity 37 ppt, T ranging 14-19 degrees C), corroborating the hypothesis of endemicity within the highly peculiar habitat of the Mljet lake. By exposing A. relicta polyps to slightly higher temperature (21 E C), a previously unknown developmental mode was observed, by the sessile polyp regressing into a dispersive, temporarily unattached and tentacle-less, non-feeding stage. This may allow A. relicta polyps to escape climatic anomalies associated to warming of surface layers and deepening of isotherms, by moving into deeper, colder layers. Overall, investigations on species-specific eco-physiological and ontogenetic potentials of polyp stages may contribute to clarify the biogeographic distribution of jellyfish and the phylogenetic relationships among evolutionary related sister clades.	[Hubot, Nathan] Brussels Free Univ, Brussels, Belgium; [Lucas, Cathy H.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali DiSTeBA, Lecce, Italy; [Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare, Rome, Italy	NERC National Oceanography Centre; University of Southampton; University of Salento; CoNISMa	Lucas, CH (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England.; Piraino, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali DiSTeBA, Lecce, Italy.; Piraino, S (corresponding author), Consorzio Nazl Interuniv Sci Mare, Rome, Italy.	cathy.lucas@noc.soton.ac.uk; stefano.piraino@unisalento.it	Piraino, Stefano/J-5234-2012	Piraino, Stefano/0000-0002-8752-9390; Hubot, Nathan/0000-0001-6917-2255	European Union [I-A/1.3/098, 266445, 678193]	European Union(European Commission)	SP has received funding from the European Union's projects MED-JELLYRISK (grant n. I-A/1.3/098 - ENPI CBCMED programme), VECTORS (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, grant n. 266445, FP7th programme), and CERES (Climate Change and European Aquatic Resources, grant n. 678193, Horizon 2020 programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, SESSILE ORG, DOI DOI 10.4282/SOSJ.20.69; Arai MN, 2001, HYDROBIOLOGIA, V451, P69, DOI 10.1023/A:1011840123140; Belmonte G, 2011, ITAL J ZOOL, V78, P370, DOI 10.1080/11250003.2011.561261; Benovic A, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64s1197; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; Boero F., 2016, EXPLAINING OCEAN WAR, P213, DOI DOI 10.2305/IUCN.CH.2016.08.EN; Bosch-Belmar M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154239; DAmico P., 2016, JELLYFISH ECOLOGY DI; Dawson MN, 2015, BIOL INVASIONS, V17, P851, DOI 10.1007/s10530-014-0732-z; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Dawson MN, 2003, MAR BIOL, V143, P369, DOI 10.1007/s00227-003-1070-3; Dawson MN, 2001, GEOGRAPHIC VARIATION; De Donno A, 2014, INT J ENV RES PUB HE, V11, P2488, DOI 10.3390/ijerph110302488; Doyle Thomas K., 2014, P105; Evjemo JO, 1999, J EXP MAR BIOL ECOL, V242, P273, DOI 10.1016/S0022-0981(99)00104-5; Fuchs B, 2014, CURR BIOL, V24, P263, DOI 10.1016/j.cub.2013.12.003; Gambill M, 2014, J EXP MAR BIOL ECOL, V459, P17, DOI 10.1016/j.jembe.2014.05.005; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Holst S, 2012, HYDROBIOLOGIA, V690, P127, DOI 10.1007/s10750-012-1043-y; Kinne O., 1966, Netherlands Journal of Sea Research, V3, P222, DOI 10.1016/0077-7579(66)90013-5; Kogovsek T, 2012, ACTA ADRIAT, V53, P233; Liu WC, 2009, HYDROBIOLOGIA, V616, P247, DOI 10.1007/s10750-008-9597-4; Lucas Cathy H., 2014, P129; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Malej A, 2007, MAR BIOL, V151, P827, DOI 10.1007/s00227-006-0503-1; Pascual M, 2014, MAR ECOL; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Pyron RA, 2015, BIOL REV, V90, P1248, DOI 10.1111/brv.12154; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Scorrano S., 2016, ZOOL J LINN SOC; Shoji J, 2009, SCI MAR, V73, P191, DOI 10.3989/scimar.2009.73s1191; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; Wang N, 2015, HYDROBIOLOGIA, V754, P125, DOI 10.1007/s10750-014-1978-2; Willcox S, 2007, J EXP MAR BIOL ECOL, V353, P107, DOI 10.1016/j.jembe.2007.09.006	42	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178482	10.1371/journal.pone.0178482	http://dx.doi.org/10.1371/journal.pone.0178482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614409	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000403280900017
J	Karve, SS; Pradhan, S; Ward, DV; Weiss, AA				Karve, Sayali S.; Pradhan, Suman; Ward, Doyle V.; Weiss, Alison A.			Intestinal organoids model human responses to infection by commensal and Shiga toxin producing Escherichia coli	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; HOST-RANGE; IN-VITRO; O157-H7; BIOCONDUCTOR; PERSISTENCE; EXPRESSION; RESISTANCE; BACTERIA; TISSUE	Infection with Shiga toxin (Stx) producing Escherichia coli O157: H7 can cause the potentially fatal complication hemolytic uremic syndrome, and currently only supportive therapy is available. Lack of suitable animal models has hindered study of this disease. Induced human intestinal organoids (iHIOs), generated by in vitro differentiation of pluripotent stem cells, represent differentiated human intestinal tissue. We show that iHIOs with addition of human neutrophils can model E. coli intestinal infection and innate cellular responses. Commensal and O157: H7 introduced into the iHIO lumen replicated rapidly achieving high numbers. Commensal E. coli did not cause damage, and were completely contained within the lumen, suggesting defenses, such as mucus production, can constrain non-pathogenic strains. Some O157: H7 initially co-localized with cellular actin. Loss of actin and epithelial integrity was observed after 4 hours. O157: H7 grew as filaments, consistent with activation of the bacterial SOS stress response. SOS is induced by reactive oxygen species (ROS), and O157: H7 infection increased ROS production. Transcriptional profiling (RNAseq) demonstrated that both commensal and O157: H7 upregulated genes associated with gastrointestinal maturation, while infection with O157: H7 upregulated inflammatory responses, including interleukin 8 (IL-8). IL-8 is associated with neutrophil recruitment, and infection with O157: H7 resulted in recruitment of human neutrophils into the iHIO tissue.	[Karve, Sayali S.; Pradhan, Suman; Weiss, Alison A.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA; [Ward, Doyle V.] Univ Massachusetts, Sch Med, Ctr Microbiome Res, Worcester, MA USA; [Ward, Doyle V.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA	University System of Ohio; University of Cincinnati; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Weiss, AA (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45220 USA.	alison.weiss@uc.edu		Weiss, Alison/0000-0002-4726-8376; Pradhan, Suman/0000-0002-9596-8190	National Institutes of Health [R21A1115003, R01-A1064893, U01-A1075498, U19-A1116491]; CCTST (Center for Clinical and Translational Science and Training) [1UL1TR001425-01]; NIDDK [P30 DK078392]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115003, U19AI116491, U01AI075498, R01AI064893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCTST (Center for Clinical and Translational Science and Training); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (https://prolectreporter.nih.goyv/reporter.cfm) Grants R21A1115003, R01-A1064893, U01-A1075498, U19-A1116491, to AAW. Core support was obtained from the CCTST (Center for Clinical and Translational Science and Training, for Advancing Translational Sciences Award Number 1UL1TR001425-01) and by NIDDK P30 DK078392 (Pluripotent Stem Cell and Organoid Core and Live Microscopy Core) of the Digestive Disease Research Core Center in Cincinnati. Biodefense and Emerging Infections Research Resources Repository (BEI, https.//www.beiresources.org/) provided purified Stx2a and antibodies to Stx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank James Wells, Christopher Mayhew and Amy Pitstick from the Pluripotent Stem Cell and Organoid Core, Cincinnati Children's Hospital Medical Center, and Chet Closson from the University of Cincinnati Live Microscopy Core for their valuable input. We also acknowledge the support from CCTST (Center for Clinical and Translational Science and Training, for Advancing Translational Sciences Award Number 1UL1TR001425-01) and by NIDDK P30 DK078392 (Pluripotent Stem Cell and Organoid Core and Live Microscopy Core) of the Digestive Disease Research Core Center in Cincinnati. We thank the Biodefense and Emerging Infectious Diseases Research Resources Repository for providing purified Stx2a protein and antibodies.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Canny GO, 2008, INFECT IMMUN, V76, P3360, DOI 10.1128/IAI.00187-08; Chong YW, 2007, MICROBIOL-SGM, V153, P794, DOI 10.1099/mic.0.2006/003178-0; Du AP, 2012, DEV BIOL, V365, P175, DOI 10.1016/j.ydbio.2012.02.024; Dundas S, 2001, CLIN INFECT DIS, V33, P923, DOI 10.1086/322598; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211; Finkbeiner SR, 2015, STEM CELL REP, V4, P1140, DOI 10.1016/j.stemcr.2015.04.010; Gamage SD, 2003, INFECT IMMUN, V71, P3107, DOI 10.1128/IAI.71.6.3107-3115.2003; Gamage SD, 2006, INFECT IMMUN, V74, P1977, DOI 10.1128/IAI.74.3.1977-1983.2006; Gamage SD, 2004, INFECT IMMUN, V72, P7131, DOI 10.1128/IAI.72.12.7131-7139.2004; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Horvath DJ, 2011, MICROBES INFECT, V13, P426, DOI 10.1016/j.micinf.2010.12.004; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; In JG, 2016, NAT REV GASTRO HEPAT, V13, P633, DOI 10.1038/nrgastro.2016.142; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; McGannon CM, 2010, ANTIMICROB AGENTS CH, V54, P3790, DOI 10.1128/AAC.01783-09; Melton-Celsa A, 2011, RICIN SHIGA TOXINS, P67; Mody RK, 2015, J PEDIATR-US, V166, P1022, DOI 10.1016/j.jpeds.2014.12.064; Morelle S, 2005, MOL MICROBIOL, V55, P853, DOI 10.1111/j.1365-2958.2004.04426.x; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pellino CA, 2016, J BACTERIOL, V198, P1621, DOI 10.1128/JB.00918-15; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Shimizu T, 2011, GENE, V478, P1, DOI 10.1016/j.gene.2011.01.006; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Ward DV, 2016, CELL REP; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010	41	82	83	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178966	10.1371/journal.pone.0178966	http://dx.doi.org/10.1371/journal.pone.0178966			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614372	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900027
J	Evju, O; Pozo, JM; Frangi, AF; Mardal, KA				Evju, Oyvind; Pozo, Jose M.; Frangi, Alejandro F.; Mardal, Kent-Andre			Robustness of common hemodynamic indicators with respect to numerical resolution in 38 middle cerebral artery aneurysms	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; UNRUPTURED INTRACRANIAL ANEURYSMS; WALL SHEAR-STRESS; TRANSITIONAL FLOW; CAROTID SIPHON; NAVIER-STOKES; RUPTURE RISK; ASPECT RATIO; VELOCITY; SOLVER	Background Using computational fluid dynamics (CFD) to compute the hemodynamics in cerebral aneurysms has received much attention in the last decade. The usability of these methods depends on the quality of the computations, highlighted in recent discussions. The purpose of this study is to investigate the convergence of common hemodynamic indicators with respect to numerical resolution. Methods 38 middle cerebral artery bifurcation aneurysms were studied at two different resolutions (one comparable to most studies, and one finer). Relevant hemodynamic indicators were collected from two of the most cited studies, and were compared at the two refinements. In addition, correlation to rupture was investigated. Results Most of the hemodynamic indicators were very well resolved at the coarser resolutions, correlating with the finest resolution with a correlation coefficient > 0.95. The oscillatory shear index (OSI) had the lowest correlation coefficient of 0.83. A logarithmic Bland-Altman plot revealed noticeable variations in the proportion of the aneurysm under low shear, as well as in spatial and temporal gradients not captured by the correlation alone. Conclusion Statistically, hemodynamic indicators agree well across the different resolutions studied here. However, there are clear outliers visible in several of the hemodynamic indicators, which suggests that special care should be taken when considering individual assessment.	[Evju, Oyvind; Mardal, Kent-Andre] Simula Res Lab, Ctr Biomed Comp, Oslo, Norway; [Pozo, Jose M.; Frangi, Alejandro F.] Univ Sheffield, Dept Elect & Elect Engn, Ctr Computat & Imaging Simulat Technol Biomed CIS, Sheffield, S Yorkshire, England; [Mardal, Kent-Andre] Univ Oslo, Dept Math, Oslo, Norway	University of Sheffield; University of Oslo	Mardal, KA (corresponding author), Simula Res Lab, Ctr Biomed Comp, Oslo, Norway.; Mardal, KA (corresponding author), Univ Oslo, Dept Math, Oslo, Norway.	kent-and@math.uio.no	Pozo, Jose M/M-7604-2016; Frangi, Alejandro F/C-6500-2008; Mardal, Kent-Andre/G-8296-2018	Pozo, Jose M/0000-0002-0759-3510; Frangi, Alejandro F/0000-0002-2675-528X; Mardal, Kent-Andre/0000-0002-4946-1110	Norwegian Research Council [179578, 251237]; European Union Sixth Framework Programme [IST-2005-027703]	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Union Sixth Framework Programme(European Commission)	This work was funded by Norwegian Research Council grant 179578, http://www forskningsradet.no (OE, KAM); Norwegian Research Council grant 251237, http://www. forskningsradet.no (OE, KAM). This work was partially funded from the European Union Sixth Framework Programme (FP6) in the context of the Integrated Project @neurIST: Integrated Biomedical Informatics for the Management of Cerebral Aneurysms (IST-2005-027703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bogunovic H, 2011, MED PHYS, V38, P210, DOI 10.1118/1.3515749; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Evju O, 2013, J BIOMECH, V46, P2802, DOI 10.1016/j.jbiomech.2013.09.004; Hodis S, 2012, J BIOMECH, V45, P2907, DOI 10.1016/j.jbiomech.2012.07.030; Hoi Y, 2011, CHARACTERIZATION VOL, V31, P291, DOI [10.1088/0967-3334/31/3/002, DOI 10.1088/0967-3334/31/3/002]; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Jain K, 2016, COMPUT FLUIDS, V127, P36, DOI 10.1016/j.compfluid.2015.12.011; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; Kallmes DF, 2012, AM J NEURORADIOL, V33, P395, DOI 10.3174/ajnr.A2993; Khan MO, 2015, AM J NEURORADIOL, V36, P1310, DOI 10.3174/ajnr.A4263; Lauric A, 2011, ANN BIOMED ENG, V39, P1457, DOI 10.1007/s10439-010-0241-x; Logg A., 2012, AUTOMATED SOLUTION D; Millan RD, 2007, IEEE T MED IMAGING, V26, P1270, DOI 10.1109/TMI.2007.901008; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Mortensen M, 2015, COMPUT PHYS COMMUN, V188, P177, DOI 10.1016/j.cpc.2014.10.026; Qian Y, 2011, AM J NEURORADIOL, V32, P1948, DOI 10.3174/ajnr.A2655; Raghavan ML, 2005, J NEUROSURG, V102, P355, DOI 10.3171/jns.2005.102.2.0355; Retarekar R., 2012, HEMODYNAMICS AND NAT; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Schneiders JJ, 2014, AM J NEURORADIOL, V35, P1358, DOI 10.3174/ajnr.A3866; Schubert T, 2011, AM J NEURORADIOL, V32, P1107, DOI 10.3174/ajnr.A2426; SHERMAN TF, 1981, J GEN PHYSIOL, V78, P431, DOI 10.1085/jgp.78.4.431; SIMO JC, 1994, COMPUT METHOD APPL M, V111, P111, DOI 10.1016/0045-7825(94)90042-6; Steinman DA, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023382; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Valen-Sendstad K, 2014, AM J NEURORADIOL, V35, P536, DOI 10.3174/ajnr.A3793; Valen-Sendstad K, 2015, ANN BIOMED ENG, V43, P1422, DOI 10.1007/s10439-015-1288-5; Valen-Sendstad K, 2014, J BIOMECH, V47, P3210, DOI 10.1016/j.jbiomech.2014.04.018; Valen-Sendstad K, 2013, J BIOMECH, V46, P402, DOI 10.1016/j.jbiomech.2012.10.042; Valen-Sendstad K, 2011, J BIOMECH, V44, P2826, DOI 10.1016/j.jbiomech.2011.08.015; Valencia C, 2010, IEEE ENG MED BIO, P6046, DOI 10.1109/IEMBS.2010.5627610; Ventikos Y, 2014, AM J NEURORADIOL, V35, P544, DOI 10.3174/ajnr.A3894; Villa-Uriol MC, 2011, INTERFACE FOCUS, V1, P308, DOI 10.1098/rsfs.2010.0033; Weir B, 2003, J NEUROSURG, V99, P447, DOI 10.3171/jns.2003.99.3.0447; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276; Xiang JP, 2015, J NEUROINTERV SURG, V7, P490, DOI 10.1136/neurintsurg-2014-011218; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923	41	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0177566	10.1371/journal.pone.0177566	http://dx.doi.org/10.1371/journal.pone.0177566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609457	Green Published, gold, Green Accepted			2022-12-26	WOS:000403274700003
J	Hooper, KM; Kong, WM; Ganea, D				Hooper, Kirsten Mary; Kong, Weimin; Ganea, Doina			Prostaglandin E2 inhibits Tr1 cell differentiation through suppression of c-Maf	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; CUTTING EDGE; TRANSCRIPTION FACTOR; HELPER-CELLS; RECEPTOR; IL-27; TH17; E-2; INTERLEUKIN-27	Prostaglandin E2 (PGE2), a major lipid mediator abundant at inflammatory sites, acts as a proinflammatory agent in models of inflammatory/autoimmune diseases by promoting CD4 Th1/Th17 differentiation. Regulatory T cells, including the IL-10 producing Tr1 cells counterbalance the proinflammatory activity of effector Th1/Th17 cells. Tr1 cell differentiation and function are induced by IL-27, and depend primarily on sustained expression of c-Maf in addition to AhR and Blimp-1. In agreement with the in vivo proinflammatory role of PGE2, here we report for the first time that PGE2 inhibits IL-27-induced differentiation and IL-10 production of murine CD4(+)CD49b(+)LAG-3(+)Foxp3(-)Tr1 cells. The inhibitory effect of PGE2 was mediated through EP4 receptors and induction of cAMP, leading to a significant reduction in c-Maf expression. Although PGE2 reduced IL-21 production in differentiating Tr1 cells, its inhibitory effect on Tr1 differentiation and c-Maf expression also occurred independent of IL-21 signaling. PGE2 did not affect STAT1/3 activation, AhR expression and only marginally reduced Egr-2/Blimp-1 expression. The effect of PGE2 on CD4(+)CD49b(+)LAG-3(+)Tr1 differentiation was not associated with either induction of Foxp3 or IL-17 production, suggesting a lack of transdifferentiation into Foxp3(+) Treg or effector Th17 cells. We recently reported that PGE2 inhibits the expression and production of IL-27 from activated conventional dendritic cells (cDC) in vivo and in vitro. The present study indicates that PGE2 also reduces murine Tr1 differentiation and function directly by acting on IL-27-differentiating Tr1 cells. Together, the ability of PGE2 to inhibit IL-27 production by cDC, and the direct inhibitory effect on Tr1 differentiation mediated through reduction in c-Maf expression, represent a new mechanistic perspective for the proinflammatory activity of PGE2.	[Hooper, Kirsten Mary; Kong, Weimin; Ganea, Doina] Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Kong, Weimin] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Kong, Weimin] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Ganea, D (corresponding author), Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	dganea@temple.edu		Ganea, Doina/0000-0003-2032-8743	National Institutes of Health [R01AI047325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was funded by National Institutes of Health grant R01AI047325 (https://www.nih.gov) to DG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Batten M, 2008, J IMMUNOL, V180, P2752, DOI 10.4049/jimmunol.180.5.2752; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Boomer JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002436; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Brockmann L, 2017, J IMMUNOL, V198, P1130, DOI 10.4049/jimmunol.1601045; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Carrier Y, 2012, EUR J IMMUNOL, V42, P1393, DOI 10.1002/eji.201142162; Chen HY, 2009, PROSTAG LEUKOTR ESS, V80, P195, DOI 10.1016/j.plefa.2009.01.006; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gagliani N, 2013, NAT MED, V19, P739, DOI 10.1038/nm.3179; Gagliani N, 2010, DIABETES, V59, P433, DOI 10.2337/db09-1168; Gregori S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00593; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Harizi H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/683405; Heinemann C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4770; Hilkens CMU, 1996, J IMMUNOL, V156, P1722; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hooper KM, 2017, J IMMUNOL, V198, P1521, DOI 10.4049/jimmunol.1601073; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Iwasaki Y, 2013, EUR J IMMUNOL, V43, P1063, DOI 10.1002/eji.201242942; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Jia XY, 2014, INT IMMUNOPHARMACOL, V23, P163, DOI 10.1016/j.intimp.2014.08.024; Kalinski P, 1997, J IMMUNOL, V159, P28; Kawahara K, 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI 10.1016/j.bbalip.2014.07.008; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Konya V, 2013, PHARMACOL THERAPEUT, V138, P485, DOI 10.1016/j.pharmthera.2013.03.006; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Lefrancois L, 2001, CURRENT PROTOCOLS IN, V3; Liu WX, 2013, PROSTAG LEUKOTR ESS, V89, P335, DOI 10.1016/j.plefa.2013.08.006; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Meka RR, 2015, AUTOIMMUN REV, V14, P1131, DOI 10.1016/j.autrev.2015.08.001; Neumann C, 2014, J EXP MED, V211, P1807, DOI 10.1084/jem.20131548; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pot C, 2011, SEMIN IMMUNOL, V23, P438, DOI 10.1016/j.smim.2011.08.003; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Rodriguez M, 2014, MOL PHARMACOL, V85, P187, DOI 10.1124/mol.113.089573; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2014, CURR TOP MICROBIOL, V380, P39, DOI 10.1007/978-3-662-43492-5_3; Rosas LE, 2006, AM J PATHOL, V168, P158, DOI 10.2353/ajpath.2006.050013; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakata D, 2010, IUBMB LIFE, V62, P591, DOI 10.1002/iub.356; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Sawant DV, 2014, IMMUNOL REV, V259, P173, DOI 10.1111/imr.12173; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Shi Q, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/685043; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Vasanthakumar A, 2013, EUR J IMMUNOL, V43, P882, DOI 10.1002/eji.201343479; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wang H, 2011, IMMUNOL LETT, V136, P21, DOI 10.1016/j.imlet.2010.11.007; Wu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023618; Yao CC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2684; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Yoo JK, 2002, J IMMUNOL, V169, P3637, DOI 10.4049/jimmunol.169.7.3637; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0; Yoshida H, 2008, INT J BIOCHEM CELL B, V40, P2379, DOI 10.1016/j.biocel.2008.05.020; Zeng HY, 2015, CELL MOL IMMUNOL, V12, P566, DOI 10.1038/cmi.2015.44	73	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179184	10.1371/journal.pone.0179184	http://dx.doi.org/10.1371/journal.pone.0179184			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604806	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400034
J	Tai, HR; Wang, XB; Zhou, J; Han, XJ; Fang, TT; Gong, H; Huang, N; Chen, HH; Qin, JQ; Yang, M; Wei, XW; Yang, L; Xiao, HY				Tai, Haoran; Wang, Xiaobo; Zhou, Jiao; Han, Xiaojuan; Fang, Tingting; Gong, Hui; Huang, Ning; Chen, Honghan; Qin, Jianqiong; Yang, Ming; Wei, Xiawei; Yang, Li; Xiao, Hengyi			Protein kinase C beta activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation	FASEB JOURNAL			English	Article						FTO; mTOR; phosphorylation; adipogenesis	FTO GENE; PKC-BETA; DIABETIC COMPLICATIONS; ADULT OBESITY; PROLIFERATION; DIFFERENTIATION; OVEREXPRESSION; CHILDHOOD; CANCER; CELLS	Protein kinase C beta (PKC beta) is a serine-threonine kinase associated with obesity and diabetic complications; its activation contributes to weight gain, and deletion of its gene results in resistance to genetic- and diet-induced obesity. Fat mass and obesity-associated (FTO) protein is a recently identified RNA demethylase, and its overexpression in mice leads to increased body weight as well as fat mass. Although sharing some features in anabolism regulation, PKC beta and FTO have not been investigated together; therefore, their relationship has not been established. We report that PKC beta positively regulates FTO on the posttranslation level, evidenced by the facts that PKC beta activation contributes to high-glucose-induced FTO up-regulation, and overexpression of PKC beta suppresses ubiquitin-proteasome degradation of FTO, whereas PKC beta inactivation acts in the opposite manner. It was also found that PKC beta can phosphorylate FTO on threonine, and this phosphorylation requires both catalytic and regulatory domains of PKC beta. Moreover, PKC beta inhibition can suppress 3T3-L1 cell differentiation in normal and FTO-overexpressing cells but not in FTO-silenced or -inhibited cells. We propose that PKC beta acts to suppress the degradation of FTO protein and reveals the associated role of PKC beta and FTO in adipogenesis, suggesting a new pathway that affects the development of obesity and metabolic diseases.-Tai, H., Wang, X., Zhou, J., Han, X., Fang, T., Gong, H., Huang, N., Chen, H., Qin, J., Yang, M., Wei, X., Yang, L., Xiao, H. Protein kinase C beta activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation.	[Tai, Haoran; Wang, Xiaobo; Zhou, Jiao; Han, Xiaojuan; Fang, Tingting; Gong, Hui; Huang, Ning; Chen, Honghan; Qin, Jianqiong; Yang, Ming; Wei, Xiawei; Yang, Li; Xiao, Hengyi] Sichuan Univ, State Key Lab Biotherapy, Collaborat Innovat Ctr Biotherapy, Lab Aging Res,Ctr Gerontol & Geriatr,West China H, Chengdu, Sichuan, Peoples R China	Sichuan University	Xiao, HY (corresponding author), West China Hosp, 1 Keyuan 4 Rd,Gaopneg Ave, Chengdu 610041, Sichuan, Peoples R China.	hengyix@scu.edu.cn	Tai, Haoran/S-2807-2018		National Key Research and Development Program [2016YFC1200203]; National Natural Science Foundation of China [81273224]; National 973 Basic Research Programs of China [2013CB967204]	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Programs of China	The authors thank Noel G. Morgan and Dr. Mark A. Russell (University of Exeter, Exeter, United Kingdom) for providing the FTO-HA plasmid, Caiguang Yang (Chinese Academy of Sciences, Shanghai, China) for providing the recombinant FTO protein, and Yuquan Wei, Canhua Huang, and Jie Zhang (Sichuan University) for continuous support. This work was supported by National Key Research and Development Program Grant 2016YFC1200203 (to H.X.), National Natural Science Foundation of China Grant 81273224 (to H.X.), and National 973 Basic Research Programs of China Grant 2013CB967204 (to H.X). The authors declare no conflicts of interest.	Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Basson MD, 2015, MOL ONCOL, V9, P513, DOI 10.1016/j.molonc.2014.10.008; Chen BE, 2012, J AM CHEM SOC, V134, P17963, DOI 10.1021/ja3064149; Chen XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151056; Cheung MK, 2013, INT J OBESITY, V37, P744, DOI 10.1038/ijo.2012.77; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; El Osta M, 2014, FASEB J, V28, P495, DOI 10.1096/fj.13-230557; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jiao Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020102; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Lei SQ, 2013, DIABETES, V62, P2318, DOI 10.2337/db12-1391; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Loraine YC, 2015, MOL METAB, V4, P287, DOI 10.1016/j.molmet.2015.01.011; Lutzny G, 2013, CANCER CELL, V23, P77, DOI 10.1016/j.ccr.2012.12.003; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Mehta NK, 2014, BBA-MOL CELL BIOL L, V1841, P1491, DOI 10.1016/j.bbalip.2014.07.011; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Merkestein M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097162; Pavan C, 2010, PHARMACOGENOMICS J, V10, P408, DOI 10.1038/tpj.2009.67; Poritsanos NJ, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.15; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Russell MA, 2011, CLIN SCI, V120, P403, DOI 10.1042/CS20100416; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Tan AH, 2015, INT J CLIN EXP PATHO, V8, P13405; Zhang MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133788; Zhang ZB, 2012, CANCER LETT, V319, P89, DOI 10.1016/j.canlet.2011.12.033; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhu YP, 2016, ONCOL REP, V35, P2391, DOI 10.3892/or.2016.4613	39	16	16	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4396	4406		10.1096/fj.201601159RR	http://dx.doi.org/10.1096/fj.201601159RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626026				2022-12-26	WOS:000413397400018
J	Yu, ZX; Ruter, DL; Kushner, EJ; Bautch, VL				Yu, Zhixian; Ruter, Dana L.; Kushner, Erich J.; Bautch, Victoria L.			Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells	FASEB JOURNAL			English	Article						vasculature; tumor microenvironment; proliferation; blood vessel sprouting	BLOOD-VESSEL FORMATION; CENTRIOLE DUPLICATION; CANCER-CELLS; CELLULAR SENESCENCE; EXTRA CENTROSOMES; IN-VIVO; CYCLE; INSTABILITY; PATHWAY; P53	Tumor blood vessels support tumor growth and progression. Centrosomes are microtubule organization centers in cells, and often up to 30% of tumor endothelial cells (ECs) acquire excess (>2) centrosomes. Although excess centrosomes can lead to aneuploidy and chromosome instability in tumor cells, how untransformed ECs respond to excess centrosomes is poorly understood. We found that the frequency of primary human ECs with excess centrosomes was quickly reduced in a p53-dependent manner. Excess centrosomes in ECs were associated with p53 phosphorylation at Ser33, increased p21 levels, and decreased cell proliferation and expression of senescence markers, but independent of DNA damage and apoptosis. Aspects of the senescence-associated phenotype were also observed in mouse ECs that were isolated from tumors with excess centrosomes. Primary ECs with excess centrosomes in vascular sprouts also had elevated Ser33 p53 phosphorylation and expressed senescence markers. Our work demonstrates that nontransformed ECs respond differently to excess centrosomes than do most tumor cellsthey undergo senescence in vascular sprouts and vessels, which suggests that pathologic outcomes of centrosome overduplication depend on the transformation status of cells.-Yu, Z., Ruter, D. L., Kushner, E. J., Bautch, V. L. Excess centrosomes induce p53-dependent senescence without DNA damage in endothelial cells.	[Yu, Zhixian; Ruter, Dana L.; Kushner, Erich J.; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Dept Biol, 503 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, 503 Fordham Hall,CB 3280, Chapel Hill, NC 27599 USA.	bautch@med.unc.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL43174, HL116719]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043174, R01HL116719] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL43174 and HL116719 (to V.L.B.). The authors thank members of the V.L.B. laboratory for constructive discussions and for comments on the manuscript. Z.Y. and V.L.B. are members of the Curriculum in Genetics and Molecular Biology at the University of North Carolina at Chapel Hill. The authors declare no conflicts of interest.	Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12; Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Arquint C, 2016, BIOCHEM SOC T, V44, P1253, DOI 10.1042/BST20160116; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao R, 2015, J GERONTOL A-BIOL, V70, P701, DOI 10.1093/gerona/glu019; GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawabe T, 2004, MOL CANCER THER, V3, P513; Kuo LJ, 2008, IN VIVO, V22, P305; Kushner EJ, 2016, MOL BIOL CELL, V27, P1911, DOI 10.1091/mbc.E15-09-0645; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Mariotti Massimo, 2006, Immun Ageing, V3, P4, DOI 10.1186/1742-4933-3-4; McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Nakatsu Martin N, 2007, J Vis Exp, P186, DOI 10.3791/186; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; RING D, 1982, J CELL BIOL, V94, P549, DOI 10.1083/jcb.94.3.549; Roberts DM, 2004, AM J PATHOL, V164, P1531, DOI 10.1016/S0002-9440(10)63711-X; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Sluder G, 1997, J CELL SCI, V110, P421; Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; te Poele RH, 2002, CANCER RES, V62, P1876; Terzi MY, 2016, MOL BIOL REP, V43, P1213, DOI 10.1007/s11033-016-4065-0; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Warboys CM, 2014, ARTERIOSCL THROM VAS, V34, P985, DOI 10.1161/ATVBAHA.114.303415; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yasutis KM, 2013, CELL CYCLE, V12, P1501, DOI 10.4161/cc.24637; Yeo EJ, 2000, EXP GERONTOL, V35, P553, DOI 10.1016/S0531-5565(00)00108-X; Yu ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168334	53	5	5	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4295	4304		10.1096/fj.201601320R	http://dx.doi.org/10.1096/fj.201601320R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626028	Green Published, Green Submitted			2022-12-26	WOS:000413397400010
J	Sun, Q; Zhao, Y; Yang, YX; Yang, X; Li, MH; Xu, X; Wen, D; Wang, JS; Zhang, JF				Sun, Qi; Zhao, Yue; Yang, Yunxia; Yang, Xiao; Li, Minghui; Xu, Xi; Wen, Dan; Wang, Junsong; Zhang, Jianfa			Loss of the clock protein PER2 shortens the erythrocyte life span in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; clock gene; energy metabolism; erythrocyte; Na; K plus -ATPase	RED-BLOOD-CELL; HEMOLYTIC-ANEMIA; BONE-MARROW; GENE-EXPRESSION; IN-VIVO; CIRCADIAN VARIATIONS; PEROXIREDOXIN-II; OXIDATIVE-STRESS; MEMBRANE; ATPASE	Cell proliferation and release from the bone marrow have been demonstrated to be controlled by circadian rhythms in both humans and mice. However, it is unclear whether local circadian clocks in the bone marrow influence physiological functions and life span of erythrocytes. Here, we report that loss of the clock gene Per2 significantly decreased erythrocyte life span. Mice deficient in Per2 were more susceptible to acute stresses in the erythrocytes, becoming severely anemic upon phenylhydrazine, osmotic, and H2O2 challenges. H-1 NMR-based metabolomics analysis revealed that the Per2 depletion causes significant changes in metabolic profiles of erythrocytes, including increased lactate and decreased ATP levels compared with wild-type mice. The lower ATP levels were associated with hyperfunction of Na+/K+-ATPase activity in Per2-null erythrocytes, and inhibition of Na+/K+-ATPase activity by ouabain efficiently rescued ATP levels. Per2-null mice displayed increased levels of Na+/K+-ATPase 1 (ATP1A1) in the erythrocyte membrane, and transfection of Per2 cDNA into the erythroleukemic cell line TF-1 inhibited Atp1a1 expression. Furthermore, we observed that PER2 regulates Atp1a1 transcription through interacting with trans-acting transcription factor 1 (SP1). Our findings reveal that Per2 function in the bone marrow is required for the regulation of life span in circulating erythrocytes.	[Sun, Qi; Zhao, Yue; Yang, Yunxia; Yang, Xiao; Li, Minghui; Xu, Xi; Wen, Dan; Wang, Junsong; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, 200 Xiaolingwei, Nanjing 210094, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, 200 Xiaolingwei, Nanjing 210094, Jiangsu, Peoples R China.	jfzhang@mail.njust.edu.cn	Zhao, Yue/AAJ-4026-2021	Zhao, Yue/0000-0003-2869-5257; Li, Minghui/0000-0003-4643-2303	973 Program of China [2013CB945203]; National Science Foundation of China [31671220, 31471111]	973 Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program of China Grant 2013CB945203 and National Science Foundation of China Grants 31671220 and 31471111. The authors declare that they have no conflicts of interest with the contents of this article.	Antonelou MH, 2010, BLOOD TRANSFUS-ITALY, V8, pS39, DOI 10.2450/2010.007S; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Bae K, 2006, MOL CELLS, V22, P275; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACK JA, 1979, AM J HUM GENET, V31, P300; CASTANO JG, 1979, J BIOL CHEM, V254, P5576; Chakravarty S, 2011, CELL MOL BIOL, V57, P80, DOI 10.1170/T905; Chen YG, 2000, BIOCHEM BIOPH RES CO, V276, P724, DOI 10.1006/bbrc.2000.3536; Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111; Cho J, 2015, CELL DEATH DIFFER, V22, P1437, DOI 10.1038/cdd.2014.230; CLARK RH, 1969, SCIENCE, V166, P236, DOI 10.1126/science.166.3902.236; De Franceschi L, 2005, BLOOD, V106, P1454, DOI 10.1182/blood-2005-01-0368; DESANCHEZ VC, 1983, LIFE SCI, V33, P1057, DOI 10.1016/0024-3205(83)90661-6; DESFORGES JF, 1965, NEW ENGL J MED, V273, P1310, DOI 10.1056/NEJM196512092732405; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; ELUWA EO, 1987, BIOCHEM MED METAB B, V38, P142, DOI 10.1016/0885-4505(87)90073-9; ETIEMBLE J, 1976, HUM GENET, V31, P83, DOI 10.1007/BF00270403; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; GANZONI AM, 1971, J CLIN INVEST, V50, P1373, DOI 10.1172/JCI106619; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; Hartley PS, 2009, BRIT J HAEMATOL, V146, P185, DOI 10.1111/j.1365-2141.2009.07722.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hortle E, 2016, BLOOD, V128, P1290, DOI 10.1182/blood-2015-09-666834; Huang YX, 2011, J CELL MOL MED, V15, P2634, DOI 10.1111/j.1582-4934.2011.01310.x; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kedzierska K, 2005, BIOL TRACE ELEM RES, V107, P21, DOI 10.1385/BTER:107:1:021; KEITT AS, 1969, J CLIN INVEST, V48, P1997, DOI 10.1172/JCI106165; LAERUM CD, 1988, CHRONOBIOL INT, V5, P19, DOI 10.3109/07420528809078549; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Leitch JM, 2007, AM J PHYSIOL-CELL PH, V292, pC974, DOI 10.1152/ajpcell.00335.2006; LUTHRA MG, 1982, BLOOD, V60, P1332; MAGNANI M, 1983, MECH AGEING DEV, V22, P295, DOI 10.1016/0047-6374(83)90084-2; Mairbaurl H, 2000, AM J PHYSIOL-CELL PH, V279, pC1621, DOI 10.1152/ajpcell.2000.279.5.C1621; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; NEWSOMETABATABAI R, 1984, COMP BIOCHEM PHYS A, V78, P779, DOI 10.1016/0300-9629(84)90633-9; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; Pasqualetti P, 1988, Quad Sclavo Diagn, V24, P89; PETERS LL, 2001, HEMATOPOIESIS DEV AP, P582; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; REINILA M, 1982, ANAL BIOCHEM, V124, P19, DOI 10.1016/0003-2697(82)90214-7; Robledo RF, 2008, BLOOD, V112, P4298, DOI 10.1182/blood-2008-05-156000; Sandoval S, 2012, BLOOD, V120, P155, DOI 10.1182/blood-2011-05-357418; Smaaland Rune, 1995, In Vivo (Attiki), V9, P379; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; SUPLOTOV SN, 1986, LAB DELO, P459; SUZUKI M, 1992, COMP BIOCHEM PHYS B, V103, P859, DOI 10.1016/0305-0491(92)90205-6; Swoyer J, 1987, Prog Clin Biol Res, V227A, P281; SYLLMRAPOPORT I, 1965, DEUT MED WOCHENSCHR, V90, P290, DOI 10.1055/s-0028-1111334; TALANSKY BE, 1987, J REPROD FERTIL, V79, P447, DOI 10.1530/jrf.0.0790447; TOZZICIANCARELLI MG, 1992, CELL MOL BIOL, V38, P303; Tsinkalovsky O, 2005, EXP HEMATOL, V33, P100, DOI 10.1016/j.exphem.2004.09.007; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vokurkova M, 2016, PHYSIOL RES, V65, P91, DOI 10.33549/physiolres.933326; VORGER P, 1985, COMP BIOCHEM PHYS A, V82, P221, DOI 10.1016/0300-9629(85)90730-3; Wang SB, 2010, J BIOL CHEM, V285, P19976, DOI 10.1074/jbc.M110.102467; Weber YG, 2008, J CLIN INVEST, V118, P2157, DOI 10.1172/JCI34438; Wei HS, 2016, NEURON, V91, P851, DOI 10.1016/j.neuron.2016.07.016; Wood PA, 2008, MOL CANCER RES, V6, P1786, DOI 10.1158/1541-7786.MCR-08-0196; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yamasaki M, 2009, J PARASITOL, V95, P1532, DOI 10.1645/GE-2036.1; Yerer MB, 2006, CLIN HEMORHEOL MICRO, V35, P143; Yokoyama U, 1971, Nihon Shonika Gakkai Zasshi, V75, P341; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhao Y, 2012, FEBS LETT, V586, P1306, DOI 10.1016/j.febslet.2012.03.034; Zhao Y, 2011, THROMB RES, V127, P122, DOI 10.1016/j.thromres.2010.11.025; Zidova Z, 2014, CELL PHYSIOL BIOCHEM, V34, P2221, DOI 10.1159/000369665	68	9	9	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12679	12690		10.1074/jbc.M117.783985	http://dx.doi.org/10.1074/jbc.M117.783985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28607147	Green Published, hybrid			2022-12-26	WOS:000406636900031
J	Rizal, G; Karki, S; Thakur, V; Wanchana, S; Alonso-Cantabrana, H; Dionora, J; Sheehy, JE; Furbank, R; von Caemmerer, S; Quick, WP				Rizal, Govinda; Karki, Shanta; Thakur, Vivek; Wanchana, Samart; Alonso-Cantabrana, Hugo; Dionora, Jacque; Sheehy, John E.; Furbank, Robert; von Caemmerer, Susanne; Quick, William Paul			A sorghum (Sorghum bicolor) mutant with altered carbon isotope ratio	PLOS ONE			English	Article							PROTEIN FAMILIES; DISCRIMINATION; GENE; PANTHER; KINASE; TOOL; RECOGNITION; GROWTH	Recent efforts to engineer C-4 photosynthetic traits into C-3 plants such as rice demand an understanding of the genetic elements that enable C-4 plants to outperform C-3 plants. As a part of the C-4 Rice Consortium's efforts to identify genes needed to support C-4 photosynthesis, EMS mutagenized sorghum populations were generated and screened to identify genes that cause a loss of C-4 function. Stable carbon isotope ratio (delta C-13) of leaf dry matter has been used to distinguishspecies with C-3 and C-4 photosynthetic pathways. Here, we report the identification of a sorghum (Sorghum bicolor) mutant with a low delta C-13 characteristic. A mutant (named Mut33) with a pale phenotype and stunted growth was identified from an EMS treated sorghum M-2 population. The stable carbon isotope analysis of the mutants showed a decrease of C-13 uptake capacity. The noise of random mutation was reduced by crossing the mutant and its wildtype (WT). The back-cross (BC1F1) progenies were like the WT parent in terms of C-13 values and plant phenotypes. All the BC1F2 plants with low delta C-13 died before they produced their 6 th leaf. Gas exchange measurements of the low delta C-13 sorghum mutants showed a higher CO2 compensation point (25.24 mu mol CO2. mol(-1) air) and the maximum rate of photosynthesis was less than 5 mu mol.m(-2). s(-1). To identify the genetic determinant of this trait, four DNA pools were isolated; two each from normal and low delta C-13 BC1F2 mutant plants. These were sequenced using an Illumina platform. Comparison of allele frequency of the single nucleotide polymorphisms (SNPs) between the pools with contrasting phenotype showed that a locus in Chromosome 10 between 57,941,104 and 59,985,708 bps had an allele frequency of 1. There were 211 mutations and 37 genes in the locus, out of which mutations in 9 genes showed non-synonymous changes. This finding is expected to contribute to future research on the identification of the causal factor differentiating C-4 from C-3 species that can be used in the transformation of C-3 to C-4 plants.	[Rizal, Govinda; Karki, Shanta; Thakur, Vivek; Wanchana, Samart; Dionora, Jacque; Sheehy, John E.; Quick, William Paul] IRRI, Rice Ctr C4, Los Banos, Laguna, Philippines; [Karki, Shanta] Govt Nepal, Minist Agr Dev, Kathmandu, Nepal; [Thakur, Vivek] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Alonso-Cantabrana, Hugo; Furbank, Robert; von Caemmerer, Susanne] Australian Natl Univ, Res Sch Biol, Div Plant Sci, Australian Res Council Ctr Excellence Translat Ph, Acton, ACT, Australia; [Sheehy, John E.; Quick, William Paul] Univ Sheffield, Sheffield, S Yorkshire, England; [Rizal, Govinda] Beldangi 2,Extension E3-25, Jhapa, Nepal	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Australian National University; University of Sheffield	Quick, WP (corresponding author), IRRI, Rice Ctr C4, Los Banos, Laguna, Philippines.; Quick, WP (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.	w.p.quick@irri.org	Furbank, Robert T/A-1884-2010; von Caemmerer, Susanne/C-9317-2009; Wanchana, Samart/AAF-5773-2020; Karki, Shanta/AAO-2373-2021	Furbank, Robert T/0000-0001-8700-6613; Alonso-Cantabrana, Hugo/0000-0002-5462-5861; Wanchana, Samart/0000-0002-5459-3425; Rizal, Govinda/0000-0002-6245-1996	Bill and Melinda Gates Foundation; UKAID (UK); IRRI; International Rice Research Institute (IRRI); Australian National University (ANU)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UKAID (UK); IRRI; International Rice Research Institute (IRRI)(CGIAR); Australian National University (ANU)(Australian National University)	The research on C4 rice is funded by Bill and Melinda Gates Foundation, UKAID (UK) and IRRI to Dr William Paul Quick, International Rice Research Institute (IRRI) and Dr Robert Furbank, Dr Susanne von Caemmerer, Australian National University (ANU).	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Alonso-Cantabrana H, 2016, J EXP BOT, V67, P3109, DOI 10.1093/jxb/erv555; Contreras-Cornejo HA, 2015, MOL PLANT MICROBE IN, V28, P701, DOI 10.1094/MPMI-01-15-0005-R; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burdiak P, 2015, J EXP BOT, V66, P3325, DOI 10.1093/jxb/erv143; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Chen ZX, 2001, PLANT PHYSIOL, V126, P473, DOI 10.1104/pp.126.2.473; Collins NC, 1998, MOL PLANT MICROBE IN, V11, P968, DOI 10.1094/MPMI.1998.11.10.968; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dievart A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-367; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gresset S, 2014, PLANT PHYSIOL, V164, P131, DOI 10.1104/pp.113.224816; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; HENDERSON SA, 1992, AUST J PLANT PHYSIOL, V19, P263, DOI 10.1071/PP9920263; HUBICK KT, 1990, PLANT PHYSIOL, V92, P534, DOI 10.1104/pp.92.2.534; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; KU SB, 1980, PLANTA, V147, P277, DOI 10.1007/BF00379833; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ling QH, 2011, PHOTOSYNTH RES, V107, P209, DOI 10.1007/s11120-010-9606-0; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitchell AJ, 2016, BIOCHEM, V56, P441; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Pengelly JJL, 2010, J EXP BOT, V61, P4109, DOI 10.1093/jxb/erq226; Rizal G, 2015, PLANT J, V84, P257, DOI 10.1111/tpj.13007; Rizal G, 2014, CROP SCI, V54, P520, DOI 10.2135/cropsci2013.07.0471; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz HR, 1996, VITIS, V35, P169; Sun CW, 2009, PLANT PHYSIOL, V150, P879, DOI 10.1104/pp.109.137240; Sun CW, 2001, PLANT CELL, V13, P2053, DOI 10.1105/tpc.13.9.2053; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; von Caemmerer S, 2014, J EXP BOT, V65, P3459, DOI 10.1093/jxb/eru127; VONCAEMMERER S, 1992, PLANT CELL ENVIRON, V15, P1063; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang P, 2013, PLANT J, V75, P656, DOI 10.1111/tpj.12229; Zeinalov Yuzeir, 1999, Bulgarian Journal of Plant Physiology, V25, P26	48	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179567	10.1371/journal.pone.0179567	http://dx.doi.org/10.1371/journal.pone.0179567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640841	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000404135800040
J	Guo, L; Zhou, LL; Gao, Q; Zhang, AJ; Wei, J; Hong, DT; Chu, YK; Duan, XG; Zhang, Y; Xu, GX				Guo, Le; Zhou, Linlin; Gao, Qian; Zhang, Aijun; Wei, Jun; Hong, Dantong; Chu, Yuankui; Duan, Xiangguo; Zhang, Ying; Xu, Guangxian			MicroRNA-144-3p inhibits autophagy activation and enhances Bacillus Calmette-Guerin infection by targeting ATG4a in RAW264.7 macrophage cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; INNATE; DIFFERENTIATION; PROLIFERATION; DEGRADATION; MIR-144-3P; PATHWAYS; ROLES; BCG	MicroRNAs (miRNAs) are small noncoding nucleotides that play major roles in the response of host immune cells. Autophagy plays a key role in activating the antimicrobial host defense against Mycobacterium tuberculosis (M. tuberculosis). Whether miRNAs specifically influence the activation of macrophage autophagy during M. tuberculosis infection is largely unknown. In the present study, we demonstrate that Mycobacterium bovis Bacillus Calmette-Guerin (BCG) infection of macrophages leads to increased expression of miR-144-3p, which targets autophagy-related gene 4a (ATG4a), to inhibit autophagy activation and antimicrobial responses to BCG. Overexpression of miR-144-3p significantly decreased both mRNA and protein levels of ATG4a, inhibited the formation of autophagosomes in RAW264.7 cells and increased intracellular survival of BCG. However, transfection with miR-144-3p inhibitor led to an increase in ATG4a levels, accelerated the autophagic response in macrophages, and decreased BCG survival in macrophages. The experimental results of this study reveal a novel role of miR-144-3p in inhibiting autophagy activation by targeting ATG4a and enhancing BCG infection, and provide potential targets for developing improved treatment.	[Guo, Le; Wei, Jun; Xu, Guangxian] Ningxia Med Univ, Gen Hosp, Ningxia Key Lab Clin & Pathogen Microbiol, Yinchuan, Peoples R China; [Guo, Le; Zhou, Linlin; Gao, Qian; Zhang, Aijun; Wei, Jun; Hong, Dantong; Chu, Yuankui; Duan, Xiangguo; Xu, Guangxian] Ningxia Med Univ, Sch Clin Med, Dept Med Lab, Yinchuan, Peoples R China; [Zhou, Linlin] North China Univ Sci & Technol, Clin Lab, Affiliated Hosp, Tangshan, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Ningxia Medical University; Ningxia Medical University; North China University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Xu, GX (corresponding author), Ningxia Med Univ, Sch Clin Med, Dept Med Lab, Yinchuan, Peoples R China.	xuguangxian@nxmu.edu.cn			National Natural Science Foundation of China [31472168, 31160494]; Clinical Laboratory Diagnosis Creative Group Open Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Laboratory Diagnosis Creative Group Open Project	This work was funded by the National Natural Science Foundation of China (No. 31472168; No. 31160494) and the 2013 Clinical Laboratory Diagnosis Creative Group Open Project.	Araya J, 2013, INTERNAL MED, V52, P2295, DOI 10.2169/internalmedicine.52.1118; Baena A, 2009, TISSUE ANTIGENS, V74, P189, DOI 10.1111/j.1399-0039.2009.01301.x; Betin VMS, 2013, AUTOPHAGY, V9, P881, DOI 10.4161/auto.24172; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095716; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen SS, 2015, CELL PHYSIOL BIOCHEM, V35, P997, DOI 10.1159/000369755; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Fenton M J, 1998, Curr Opin Hematol, V5, P72, DOI 10.1097/00062752-199801000-00012; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Frankel LB, 2011, EMBO J, V30, P4628, DOI 10.1038/emboj.2011.331; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Guo L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00134; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Hossain MM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/179174; Hu YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094997; Huang C, 2016, FEBS LETT, V590, P795, DOI 10.1002/1873-3468.12112; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jo EK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00097; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kanayama M, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00047; Kim JK, 2015, J IMMUNOL, V194, P5355, DOI 10.4049/jimmunol.1402557; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li K, 2016, MOL CELLS; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Liu F, 2015, TUMOUR BIOL; Liu HY, 2016, CELL MOL BIOL, V62, P87; Lv Y, 2016, INT J INFECT DIS, V43, P68, DOI 10.1016/j.ijid.2015.12.014; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rosenberger CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006305; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Song L, 2014, J CELL MOL MED, V18, P2266, DOI 10.1111/jcmm.12380; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Wang JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003697; Zhang SY, 2016, ONCOTARGET, V7, P11637, DOI 10.18632/oncotarget.7025	51	38	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179772	10.1371/journal.pone.0179772	http://dx.doi.org/10.1371/journal.pone.0179772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636635	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300054
J	Jourdan, M; Robert, N; Cren, M; Thibaut, C; Duperray, C; Kassambara, A; Cogne, M; Tarte, K; Klein, B; Moreaux, J				Jourdan, Michel; Robert, Nicolas; Cren, Mailys; Thibaut, Coraline; Duperray, Christophe; Kassambara, Alboukadel; Cogne, Michel; Tarte, Karin; Klein, Bernard; Moreaux, Jerome			Characterization of human FCRL4-positive B cells	PLOS ONE			English	Article							EXPRESSION; FCRL4; RECEPTORS; TISSUE; POPULATION; GENERATION; MECHANISM; PROMOTES; IRTA1; TAIL	FCRL4 is an immunoregulatory receptor that belongs to the Fc receptor-like (FCRL) family. In healthy individuals, FCRL4 is specifically expressed by memory B cells (MBCs) localized in sub-epithelial regions of lymphoid tissues. Expansion of FCRL4+ B cells has been observed in blood and other tissues in various infectious and autoimmune disorders. Currently, the mechanisms involved in pathological FCRL4+ B cell generation are actively studied, but they remain elusive. As in vivo FCRL4+ cells are difficult to access and to isolate, here we developed a culture system to generate in vitro FCRL4+ B cells from purified MBCs upon stimulation with soluble CD40 ligand and/or CpG DNA to mimic T-cell dependent and/or T cell independent activation, respectively. After 4 days of stimulation, FCRL4+ B cells represented 17% of all generated cells. Transcriptomic and phenotypic analyses of in vitro generated FCRL4+ cells demonstrated that they were closely related to FCRL4+ tonsillar MBCs. They strongly expressed inhibitory receptor genes, as observed in exhausted FCRL4+ MBCs from blood samples of HIV-infected individuals with high viremia. In agreement, cell cycle genes were significantly downregulated and the number of cell divisions was two-fold lower in in vitro generated FCRL4+ than FCRL4- cells. Finally, due to their reduced proliferation and differentiation potential, FCRL4+ cells were less prone to differentiate into plasma cells, differently from FCRL4- cells. Our in vitro model could be of major interest for studying the biology of normal and pathological FCRL4+ cells.	[Jourdan, Michel; Thibaut, Coraline; Kassambara, Alboukadel; Klein, Bernard; Moreaux, Jerome] UM, CNRS, UMR 9002, Inst Human Genet, Montpellier, France; [Robert, Nicolas; Kassambara, Alboukadel; Klein, Bernard; Moreaux, Jerome] CHU Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France; [Cren, Mailys] INSERM, U1040, Montpellier, France; [Duperray, Christophe] Montpellier Rio Imaging, Cytometry IRB, Montpellier, France; [Cogne, Michel] Univ Limoges, CNRS UMR 7276, Limoges, France; [Tarte, Karin] CHU Rennes, Pole Cellules & Tissus, Rennes, France; [Tarte, Karin] INSERM, U917, Rennes, France; [Klein, Bernard; Moreaux, Jerome] Univ Montpellier I, UFR Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Moreaux, J (corresponding author), UM, CNRS, UMR 9002, Inst Human Genet, Montpellier, France.; Moreaux, J (corresponding author), CHU Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France.; Moreaux, J (corresponding author), Univ Montpellier I, UFR Med, Montpellier, France.	jerome.moreaux@igh.cnrs.fr	tarte, karin/GXV-1815-2022; Duperray, Christophe/P-6922-2017; cogné, michel/D-7370-2015; J, Moreaux/ABA-2974-2021; moreaux, jerome/HGA-5649-2022	tarte, karin/0000-0002-6809-917X; cogné, michel/0000-0002-8519-4427; J, Moreaux/0000-0002-5717-3207; 	Institut National du Cancer [2012-109/087437, PLBIO15-256]; Conseil Regional Languedoc Roussillon [R14026FF]; Fondation de France [201400047510]; Institut Thematigue Multi-organismes Cancer (MMTT); SIRIC Montpellier [INCa-DGOS-Inserm 6045]	Institut National du Cancer(Institut National du Cancer (INCA) France); Conseil Regional Languedoc Roussillon(Region Occitanie); Fondation de France(Fondation de France); Institut Thematigue Multi-organismes Cancer (MMTT); SIRIC Montpellier	This work was supported by Institut National du Cancer (2012-109/087437 and PLBIO15-256), Conseil Regional Languedoc Roussillon (R14026FF), Fondation de France (201400047510), Institut Thematigue Multi-organismes Cancer (MM&TT) and SIRIC Montpellier (INCa-DGOS-Inserm 6045).	Amara K, 2017, J AUTOIMMUN; Bernard NJ, 2014, NAT REV RHEUMATOL, V10, DOI [10.1038/nrrheum.2014.170, 10.1038/nrrheum.2014.60, 10.1038/nrrheum.2014.166, 10.1038/nrrheum.2014.72, 10.1038/nrrheum.2014.180, 10.1038/nrrheum.2014.141, 10.1038/nrrheum.2014.25, 10.1038/nrrheum.2014.88, 10.1038/nrrheum.2013.187, 10.1038/nrrheum.2013.207, 10.1038/nrrheum.2014.96]; Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Ehrhardt GRA, 2003, P NATL ACAD SCI USA, V100, P13489, DOI 10.1073/pnas.1935944100; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falini B, 2003, BLOOD, V102, P3684, DOI 10.1182/blood-2003-03-0750; Hartmann G, 2000, J IMMUNOL, V164, P944, DOI 10.4049/jimmunol.164.2.944; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Johrens K, 2005, HAEMATOLOGICA, V90, P1070; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Jourdan M, 2016, ONCOTARGET, V7, P28096, DOI 10.18632/oncotarget.8581; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Jourdan M, 2009, BLOOD, V114, P5173, DOI 10.1182/blood-2009-07-235960; Kardava L, 2011, J CLIN INVEST, V121, P2614, DOI 10.1172/JCI45685; Kassambara A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004077; Laffleur B, 2014, ONCOTARGET, V5, P1118, DOI 10.18632/oncotarget.1546; Maecker HT, 2004, CYTOM PART A, V62A, P169, DOI 10.1002/cyto.a.20092; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; Polson AG, 2006, INT IMMUNOL, V18, P1363, DOI 10.1093/intimm/dxl069; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sohn HW, 2011, BLOOD, V118, P6332, DOI 10.1182/blood-2011-05-353102; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wilson TJ, 2012, J IMMUNOL, V188, P4741, DOI 10.4049/jimmunol.1102651; Yeo L, 2015, ANN RHEUM DIS, V74, P928, DOI 10.1136/annrheumdis-2013-204116; Zeng Z, 2012, CLIN RHEUMATOL, V31, P1449, DOI 10.1007/s10067-012-2028-y	37	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179793	10.1371/journal.pone.0179793	http://dx.doi.org/10.1371/journal.pone.0179793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636654	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300055
J	Walker, F; Bucker, B; Anderson, NC; Schreij, D; Theeuwes, J				Walker, Francesco; Bucker, Berno; Anderson, Nicola C.; Schreij, Daniel; Theeuwes, Jan			Looking at paintings in the Vincent Van Gogh Museum: Eye movement patterns of children and adults	PLOS ONE			English	Article							ATTENTION; SALIENCY; CAPTURE; OVERT	In the present study, we examined the eye movement behaviour of children and adults looking at five Van Gogh paintings in the Van Gogh Museum, Amsterdam. The goal of the study was to determine the role of top-down and bottom-up attentional processes in the first stages of participants' aesthetic experience. Bottom-up processes were quantified by determining a salience map for each painting. Top-down processing was manipulated by first allowing participants to view the paintings freely, then providing background information about each painting, and then allowing them to view the paintings a second time. The salience analysis showed differences between the eye movement behaviour of children and adults, and differences between the two phases. In the children, the first five fixations during the free viewing phase were strongly related to visually salient features of the paintings- indicating a strong role for bottom-up factors. In the second phase, after children had received background information, top-down factors played a more prominent role. By contrast, adults' observed patterns were similar in both phases, indicating that bottom-up processes did not play a major role when they viewed the paintings. In the second phase, children and adults both spent more time looking at regions that were mentioned in the background information. This effect was greater for adults than for children, confirming the notion that adults, when viewing paintings, rely much more on top-down processing than children.	[Walker, Francesco; Bucker, Berno; Anderson, Nicola C.; Schreij, Daniel; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Walker, Francesco] Univ Twente, Ctr Transport Studies, Enschede, Netherlands; [Anderson, Nicola C.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Vrije Universiteit Amsterdam; University of Twente; University of British Columbia	Walker, F (corresponding author), Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands.; Walker, F (corresponding author), Univ Twente, Ctr Transport Studies, Enschede, Netherlands.	francesco.walker89@gmail.com	Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721	European Research Council (ERC) advancedgrant [ERC-2012-AdG 323413]	European Research Council (ERC) advancedgrant(European Research Council (ERC))	This research was supported by a European Research Council (ERC) advancedgrant [ERC-2012-AdG 323413] to Jan Theeuwes.	Acik A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00207; Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Belke B., 2006, PSYCHOL SCI, V48, P115; Brieber D, 2015, ACTA PSYCHOL, V154, P36, DOI 10.1016/j.actpsy.2014.11.004; Brieber D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099019; Carbon CC, 2017, I-PERCEPTION, V8, DOI 10.1177/2041669517694184; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Devue C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034598; Findlay J. M., 2003, ACTIVE VISION PSYCHO; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Fuchs I, 2011, COGN COMPUT, V3, P25, DOI 10.1007/s12559-010-9062-3; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Heidenreich SM, 2011, EMPIR STUD ARTS, V29, P51, DOI 10.2190/EM.29.1.d; Henry C. K., 1992, VISUAL ARTS RES, P82; Ho-Phuoc T, 2010, COGN COMPUT, V2, P344, DOI 10.1007/s12559-010-9078-8; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kassner M, 2014, PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP'14 ADJUNCT), P1151, DOI 10.1145/2638728.2641695; Land M. F., 1994, NATURE; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Locher P., 1999, EMPIR STUD ARTS, V17, P121, DOI DOI 10.2190/R1WN-TAF2-376D-EFUH; Locher P. J., 2006, PSYCHOL SCI, V48, P106, DOI DOI 10.1198/016214504000000683; Locher PJ, 2001, PERCEPTION, V30, P449, DOI 10.1068/p3008; Madden DJ, 2007, NEUROBIOL AGING, V28, P459, DOI 10.1016/j.neurobiolaging.2006.01.005; Madden DJ, 2004, ADV CELL AGING GERON, V15, P41; Massaro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037285; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Pihko E, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00094; Quian Quiroga R., 2011, ADV CLIN NEUROSCIENC, V11, P15; Quiroga RQ, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00098; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Risko EF, 2012, COGNITION, V122, P86, DOI 10.1016/j.cognition.2011.08.014; Silvia PJ, 2013, EMPIR STUD ARTS, V31, P107, DOI 10.2190/EM.31.1.f; Smith J., 2001, EMPIRICAL STUDIES AR, V19, P229, DOI [10.2190/5MQM-59JH-X21R-JN5J, DOI 10.2190/5MQM-59JH-X21R-JN5J]; Smith JK, 1993, ISSUES MEASUREMENT E; Smith LF, 2017, PSYCHOL AESTHET CREA, V11, P77, DOI 10.1037/aca0000049; Swami V, 2013, PSYCHOL AESTHET CREA, V7, P285, DOI 10.1037/a0030965; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Underwood G, 2006, Q J EXP PSYCHOL, V59, P1931, DOI 10.1080/17470210500416342; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; ZANGEMEISTER WH, 1995, NEUROPSYCHOLOGIA, V33, P1009, DOI 10.1016/0028-3932(95)00014-T	46	35	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178912	10.1371/journal.pone.0178912	http://dx.doi.org/10.1371/journal.pone.0178912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636664	Green Submitted, gold, Green Published			2022-12-26	WOS:000404118300021
J	Hall, JA; McElwee, MK; Freedman, JH				Hall, Julie A.; McElwee, Matthew K.; Freedman, Jonathan H.			Identification of ATF-7 and the insulin signaling pathway in the regulation of metallothionein in C. elegans suggests roles in aging and reactive oxygen species	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; AGE-1 PI3 KINASE; OXIDATIVE STRESS; TRANSCRIPTION FACTORS; PROTEIN-KINASES; TRANSGENIC MICE; ACTIVATION; GENES; P38; DIFFERENTIATION	It has been proposed that aging results from the lifelong accumulation of intracellular damage via reactions with reactive oxygen species (ROS). Metallothioneins are conserved cysteine- rich proteins that function as efficient ROS scavengers and may affect longevity. To better understand mechanisms controlling metallothionein expression, the regulatory factors and pathways that controlled cadmium-inducible transcription of the C. elegans metallothionein gene, mtl-1, were identified. The transcription factor ATF-7 was identified in both ethylmethanesulfonate mutagenesis and candidate gene screens. PMK-1 and members of the insulin signaling pathway, PDK-1 and AKT-1/2, were also identified as mtl-1 regulators. Genetic and previous results support a model for the regulation of cadmium-inducible mtl-1 transcription based on the derepression of the constitutively active transcription factor ELT2. In addition, knockdown of the mammalian homologs of PDK1 and ATF7 in HEK293 cells resulted in changes in metallothionein expression, suggesting that this pathway was evolutionarily conserved. The insulin signaling pathway is known to influence the aging process; however, various factors responsible for affecting the aging phenotype are unknown. Identification of portions of the insulin signaling pathway as regulators of metallothionein expression supports the hypothesis that longevity is affected by the expression of this efficient ROS scavenger.	[Hall, Julie A.; Freedman, Jonathan H.] NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [McElwee, Matthew K.; Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Hall, Julie A.] Lincoln Mem Univ, Dept Biol, Harrogate, TN 37752 USA; [McElwee, Matthew K.] Univ Minnesota, Internal Med, Minneapolis, MN USA; [Freedman, Jonathan H.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Minnesota System; University of Minnesota Twin Cities; University of Louisville	Hall, JA (corresponding author), NIEHS, Biomol Screening Branch, Div Natl Toxicol Program, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.; Hall, JA (corresponding author), Lincoln Mem Univ, Dept Biol, Harrogate, TN 37752 USA.	julie.hall02@lmunet.edu		McElwee, Matthew/0000-0003-1659-6112	NIH, National Institute of Environmental Health Sciences [Z01ES102045, Z01ES102046]	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported [in part] by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01ES102045 and Z01ES102046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; BAUMAN JW, 1991, TOXICOL APPL PHARM, V110, P347, DOI 10.1016/S0041-008X(05)80017-1; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Boyd WA, 2010, TOXICOL APPL PHARM, V245, P153, DOI 10.1016/j.taap.2010.02.014; Braithwaite EK, 2010, J BIOCHEM MOL TOXIC, V24, P330, DOI 10.1002/jbt.20342; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; Cipriano C, 2006, BIOGERONTOLOGY, V7, P357, DOI 10.1007/s10522-006-9050-x; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Dalton TP, 1996, J BIOL CHEM, V271, P26233, DOI 10.1074/jbc.271.42.26233; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Flibotte S, 2010, GENETICS, V185, P431, DOI 10.1534/genetics.110.116616; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Fuhrman LE, 2008, PLOS ONE, P3; Gami MS, 2006, AGING CELL, V5, P31, DOI 10.1111/j.1474-9726.2006.00188.x; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Hall J, 2012, TOXICOL SCI, V128, P418, DOI 10.1093/toxsci/kfs166; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Hockner M, 2015, BIOCHEM BIOPH RES CO, V460, P537, DOI 10.1016/j.bbrc.2015.03.065; Hung JJ, 1998, J BIOL CHEM, V273, P31924, DOI 10.1074/jbc.273.48.31924; Jin KL, 2010, AGING DIS, V1, P72; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Khanna N, 1997, ARCH ENVIRON CON TOX, V32, P110, DOI 10.1007/s002449900162; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; LAZO JS, 1995, J BIOL CHEM, V270, P5506, DOI 10.1074/jbc.270.10.5506; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Liu J., 2009, TOXICOL APPL PHARM, V238, P209; Maekawa T, 2010, MOL CELL BIOL, V30, P613, DOI 10.1128/MCB.00685-09; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Malavolta M, 2008, REJUV RES, V11, P455, DOI 10.1089/rej.2008.0679; Malavolta M, 2012, REJUV RES, V15, P140, DOI 10.1089/rej.2011.1261; McDonald J.H., 2014, HDB BIOL STAT; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; Pulak Rock, 2006, V351, P275; Quevedo C, 2007, CURR BIOL, V17, P286, DOI 10.1016/j.cub.2006.12.038; Reis RJS, 2009, BBA-GEN SUBJECTS, V1790, P1075, DOI 10.1016/j.bbagen.2009.05.011; Sarin S, 2010, GENETICS, V185, P417, DOI 10.1534/genetics.110.116319; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Shivers RP, 2010, PLOS GENET, P6; SLICE LW, 1990, J BIOL CHEM, V265, P256; Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Swindell WR, 2011, AGEING RES REV, V10, P132, DOI 10.1016/j.arr.2010.09.007; Takahashi S, 2015, MOL MED REP, V12, P795, DOI 10.3892/mmr.2015.3459; THOMAS JP, 1986, BIOCHIM BIOPHYS ACTA, V884, P448, DOI 10.1016/0304-4165(86)90195-9; THORNALLEY PJ, 1985, BIOCHIM BIOPHYS ACTA, V827, P36, DOI 10.1016/0167-4838(85)90098-6; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; WILLIAMS PL, 1988, TOXICOL IND HEALTH, V4, P469, DOI 10.1177/074823378800400406; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Zeitoun-Ghandour S, 2011, MOL BIOSYST, V7, P2397, DOI 10.1039/c1mb05114h	59	10	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0177432	10.1371/journal.pone.0177432	http://dx.doi.org/10.1371/journal.pone.0177432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632756	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100003
J	Kammoun, HL; Allen, TL; Henstridge, DC; Kraakman, MJ; Peijs, L; Rose-John, S; Febbraio, MA				Kammoun, Helene L.; Allen, Tamara Louise; Henstridge, Darren Colin; Kraakman, Michael James; Peijs, Lone; Rose-John, Stefan; Febbraio, Mark Anthony			Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; CIRCULATING INTERLEUKIN-6; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LIVER STEATOSIS; IL-6; INFLAMMATION; BLOCKADE; RECEPTOR	Non-alcoholic steatohepatitis (NASH) is a liver disease with the potential to lead to cirrhosis and hepatocellular carcinoma. Interleukin-6 (IL-6) has been implicated in the pathogenesis of NASH, with the so-called IL-6 'trans-signaling' cascade being responsible for the pro-inflammatory actions of this cytokine. We aimed to block IL-6 'trans-signaling', using a transgenic mouse that overexpresses human soluble glycoprotein130 (sgp130Fc Tg mice) fed a commonly used dietary model of inducing NASH (methionine and choline deficient-diet; MCD diet) and hypothesized that markers of NASH would be ameliorated in such mice. Sgp130Fc Tg and littermate control mice were fed a MCD or control diet for 4 weeks. The MCD diet induced many hallmarks of NASH including hepatomegaly, steatosis, and liver inflammation. However, in contrast with other mouse models and, indeed, human NASH, the MCD diet model did not increase the mRNA or protein expression of IL-6. Not surprisingly, therefore, markers of MCD diet-induced NASH were unaffected by sgp130Fc transgenic expression. While the MCD diet model induces many pathophysiological markers of NASH, it does not induce increased IL-6 expression in the liver, a key hallmark of human NASH. We, therefore, caution the use of the MCD diet as a viable mouse model of NASH.	[Kammoun, Helene L.; Allen, Tamara Louise; Henstridge, Darren Colin; Kraakman, Michael James; Peijs, Lone; Febbraio, Mark Anthony] Baker Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia; [Kammoun, Helene L.] Monash Univ, Immunol Dept, Melbourne, Vic, Australia; [Rose-John, Stefan] Christian Albrechts Univ Kiel, Dept Biochem, Kiel, Germany; [Febbraio, Mark Anthony] Garvan Inst, Cellular & Mol Metab, Sydney, NSW, Australia	Monash University; University of Kiel; Garvan Institute of Medical Research	Kammoun, HL (corresponding author), Baker Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic, Australia.; Kammoun, HL (corresponding author), Monash Univ, Immunol Dept, Melbourne, Vic, Australia.	helene.kammoun@bakeridi.edu.au	Febbraio, Mark/AAE-9632-2019; Peijs, Lone/P-7161-2018; Rose-John, Stefan/A-7998-2010	Peijs, Lone/0000-0002-7953-1976; Rose-John, Stefan/0000-0002-7519-3279; Febbraio, Mark/0000-0002-9296-4418; Kraakman, Michael/0000-0002-5755-0447	National Health & Medical Research Council of Australia [APP1041760, APP1021168]; Deutsche Forschungsgemeinschaft [SFB654, SFB841, SFB877]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by a Project Grant (APP1041760) and a Senior Research Fellowship (APP1021168) from the National Health & Medical Research Council of Australia (https://www.nhmrc.gov.au/) awarded to MAF. The work of S.R.-J. was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/en) (SFB654, project C5; SFB841, project C1; SFB877, project A1 and the Cluster of Excellence "Inflammation at Interfaces"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Project Grant (APP1041760) and a Senior Research Fellowship (APP1021168) from the National Health & Medical Research Council of Australia awarded to MAF. The work of S.R.-J. was supported by the Deutsche Forschungsgemeinschaft (SFB654, project C5; SFB841, project C1; SFB877, project A1 and the Cluster of Excellence "Inflammation at Interfaces").	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Aleksandrova K, 2014, HEPATOLOGY, V60, P858, DOI 10.1002/hep.27016; Barranco Caroline, 2016, Nat Rev Rheumatol, V12, P436, DOI 10.1038/nrrheum.2016.104; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Coulon S, 2012, CYTOKINE, V59, P442, DOI 10.1016/j.cyto.2012.05.001; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Garcia-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kammoun HL, 2014, REV ENDOCR METAB DIS, V15, P31, DOI 10.1007/s11154-013-9274-4; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Min HK, 2015, AM J PHYSIOL-GASTR L, V308, pG794, DOI 10.1152/ajpgi.00390.2014; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Schmidt-Arras D, 2016, J HEPATOL; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang Zhi-Gang, 2016, World J Gastrointest Pathophysiol, V7, P17, DOI 10.4291/wjgp.v7.i1.17; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yamaguchi K, 2010, LAB INVEST, V90, P1169, DOI 10.1038/labinvest.2010.75	35	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179099	10.1371/journal.pone.0179099	http://dx.doi.org/10.1371/journal.pone.0179099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632778	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000404046100011
J	Tao, J; Zhang, Y; Zuo, XY; Hong, RY; Li, H; Liu, X; Huang, WP; Cao, ZB; Zhang, YH				Tao, Jia; Zhang, Yu; Zuo, Xiaoyuan; Hong, Renyun; Li, Hui; Liu, Xing; Huang, Weiping; Cao, Zubing; Zhang, Yunhai			DOT1L inhibitor improves early development of porcine somatic cell nuclear transfer embryos	PLOS ONE			English	Article							PIG CLONING EFFICIENCY; PREIMPLANTATION DEVELOPMENT; DONOR CELLS; STEM-CELLS; TRICHOSTATIN; METHYLATION; EXPRESSION; DIFFERENTIATION; COMPETENCE; GENE	Incomplete epigenetic reprogramming of the genome of donor cells causes poor early and full-term developmental efficiency of somatic cell nuclear transfer (SCNT) embryos. Previous research indicate that inhibition of the histone H3 K79 methyltransferase DOT1L, using a selective pharmacological inhibitor EPZ004777 (EPZ), significantly improved reprogramming efficiency during the generation of mouse induced pluripotent stem cells. However, the roles of DOT1L in porcine nuclear transfer-mediated cellular reprogramming are not yet known. Here we showed that DOT1L inhibition via 0.5 nM EPZ treatment for 12 or 24 h significantly enhanced the blastocyst rate of SCNT embryos and dramatically reduced the level of H3K79me2 during SCNT 1-cell embryonic development. Additionally, H3K79me2 level in the EPZ-treated SCNT embryos was similar to that in in vitro fertilized embryos, suggesting that DOT1L-mediated H3K79me2 is a reprogramming barrier to early development of porcine SCNT embryos. qRT-PCR analysis further demonstrated that DOT1L inactivation did not change the expression levels of DOT1L itself but increased the expression levels of POU5F1, LIN28, SOX2, CDX2 and GATA4 associated with pluripotency and early cell differentiation. In conclusion, DOT1L inhibitor improved early developmental efficiency of porcine SCNT embryos probably via inducing the increased expression of genes important for pluripotency and lineage specification.	[Tao, Jia; Zhang, Yu; Zuo, Xiaoyuan; Hong, Renyun; Li, Hui; Liu, Xing; Huang, Weiping; Cao, Zubing; Zhang, Yunhai] Anhui Agr Univ, Coll Anim Sci & Technol, Anhui Prov Key Lab Local Livestock & Poultry Gene, Hefei, Anhui, Peoples R China; [Zhang, Yu] Univ Copenhagen, Dept Vet Clin & Anim Sci, Fac Hlth & Med Sci, Gronnegardsvej 7, Frederiksberg C, Denmark	Anhui Agricultural University; University of Copenhagen	Cao, ZB (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Anhui Prov Key Lab Local Livestock & Poultry Gene, Hefei, Anhui, Peoples R China.	zubingcao@ahau.edu.cn	Zhang, Yunhai/O-4453-2014; Zhang, Yu/M-4249-2017	Zhang, Yunhai/0000-0001-9721-5910; Zhang, Yu/0000-0002-5592-111X	National Natural Science Foundation of China [31272442]; National Transgenic New Species Breeding Program of China [2014ZX08006-01B]; Anhui Provincial Natural Science Foundation [1708085QC55]; Startup Foundation of Anhui Agricultural University for Talented Scholar [YJ2016-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic New Species Breeding Program of China; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Startup Foundation of Anhui Agricultural University for Talented Scholar	This work was supported by the National Natural Science Foundation of China (31272442), National Transgenic New Species Breeding Program of China (2014ZX08006-01B), Anhui Provincial Natural Science Foundation (1708085QC55) and Startup Foundation of Anhui Agricultural University for Talented Scholar (YJ2016-10).	Akiyama T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002279; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Fu L, 2012, THERIOGENOLOGY, V78, P1929, DOI 10.1016/j.theriogenology.2012.07.017; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huang JJ, 2016, REPRODUCTION, V151, P39, DOI 10.1530/REP-15-0460; Jin JX, 2013, THERIOGENOLOGY, V80, P630, DOI 10.1016/j.theriogenology.2013.06.006; Jin L, 2017, MOL REPROD DEV; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Loi P, 2016, TRENDS BIOTECHNOL, V34, P791, DOI 10.1016/j.tibtech.2016.03.008; Maalouf WE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-11; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Ooga M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113258; Sepulveda-Rincon LP, 2016, THERIOGENOLOGY, V86, P91, DOI 10.1016/j.theriogenology.2016.04.022; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yin XJ, 2002, BIOL REPROD, V67, P442, DOI 10.1095/biolreprod67.2.442; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao JG, 2010, CELL REPROGRAM, V12, P75, DOI 10.1089/cell.2009.0038	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179436	10.1371/journal.pone.0179436	http://dx.doi.org/10.1371/journal.pone.0179436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632762	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100028
J	Matsuzaki, K; Katakura, M; Sugimoto, N; Hara, T; Hashimoto, M; Shido, O				Matsuzaki, Kentaro; Katakura, Masanori; Sugimoto, Naotoshi; Hara, Toshiko; Hashimoto, Michio; Shido, Osamu			Neural progenitor cell proliferation in the hypothalamus is involved in acquired heat tolerance in long-term heat-acclimated rats	PLOS ONE			English	Article							TRANSIENT EXPRESSION; STEM-CELLS; NEUROGENESIS; NEURONS; ACTIVATION; BRAIN; DIFFERENTIATION; SHOCK; THERMOREGULATION; DOUBLECORTIN	Constant exposure to moderate heat facilitates progenitor cell proliferation and neuronal differentiation in the hypothalamus of heat-acclimated (HA) rats. In this study, we investigated neural phenotype and responsiveness to heat in HA rats' hypothalamic newborn cells. Additionally, the effect of hypothalamic neurogenesis on heat acclimation in rats was evaluated. Male Wistar rats (5 weeks old) were housed at an ambient temperature (T-a) of 32 degrees C for 6 days (STHA) or 40 days (LTHA), while control (CN) rats were kept at a T-a of 24 degrees C for 6 days (STCN) or 40 days (LTCN). Bromodeoxyuridine (BrdU) was intraperitoneally injected daily for five consecutive days (50 mg/kg/day) after commencing heat exposure. The number of hypothalamic BrdU-immunopositive (BrdU+) cells in STHA and LTHA rats was determined immunohistochemically in brain samples and found to be significantly greater than those in respective CN groups. In LTHA rats, approximately 32.6% of BrdU+ cells in the preoptic area (POA) of the anterior hypothalamus were stained by GAD67, a GABAergic neuron marker, and 15.2% of BrdU+ cells were stained by the glutamate transporter, a glutamatergic neuron marker. In addition, 63.2% of BrdU+ cells in the POA were immunolabeled with c-Fos. Intracerebral administration of the mitosis inhibitor, cytosine arabinoside (AraC), interfered with the proliferation of neural progenitor cells and acquired heat tolerance in LTHA rats, whereas the selected ambient temperature was not changed. These results demonstrate that heat exposure generates heat responsive neurons in the POA, suggesting a pivotal role in autonomic thermoregulation in long-term heat-acclimated rats.	[Matsuzaki, Kentaro; Katakura, Masanori; Sugimoto, Naotoshi; Hara, Toshiko; Hashimoto, Michio; Shido, Osamu] Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane, Japan; [Katakura, Masanori] Josai Univ, Fac Pharmaceut Sci, Dept Nutr Physiol, Sakado, Saitama, Japan; [Sugimoto, Naotoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Physiol, Kanazawa, Ishikawa, Japan	Shimane University; Josai University; Kanazawa University	Matsuzaki, K (corresponding author), Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane, Japan.	matuzaki@med.shimane-u.ac.jp		Matsuzaki, Kentaro/0000-0002-5942-8840	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24590300, 15K08209]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant-in-Aid for Scientific Research (C) 24590300 and 15K08209.; This study was supported by The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant-in-Aid for Scientific Research (C) 24590300 and 15K08209. The authors would like to thank Enago for the English language review.	Armstrong LE, 2002, REV NEUROSCIENCE, V13, P271; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Bath KG, 2012, DEV PSYCHOBIOL, V54, P578, DOI 10.1002/dev.20546; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; BRAVO R, 1986, EXP CELL RES, V163, P287, DOI 10.1016/0014-4827(86)90059-5; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CARLISLE HJ, 1969, J COMP PHYSIOL PSYCH, V69, P391, DOI 10.1037/h0028170; CARLISLE HJ, 1966, NATURE, V209, P1324, DOI 10.1038/2091324a0; Ceccatelli S, 2004, TOXICOL LETT, V149, P59, DOI 10.1016/j.toxlet.2003.12.060; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; DUFF GW, 1982, YALE J BIOL MED, V55, P437; Garrett AT, 2009, EUR J APPL PHYSIOL, V107, P659, DOI 10.1007/s00421-009-1182-7; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Han SI, 2002, FEBS LETT, V515, P141, DOI 10.1016/S0014-5793(02)02459-6; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Horowitz M, 1999, AM J PHYSIOL-REG I, V277, pR47, DOI 10.1152/ajpregu.1999.277.1.R47; Horowitz M, 2016, J APPL PHYSIOL, V120, P702, DOI 10.1152/japplphysiol.00552.2015; KANOSUE K, 1994, AM J PHYSIOL, V267, pR283, DOI 10.1152/ajpregu.1994.267.1.R283; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Matsuzaki K, 2006, NEUROSCI LETT, V400, P230, DOI 10.1016/j.neulet.2006.02.077; Matsuzaki Kentaro, 2015, Temperature (Austin), V2, P418, DOI 10.1080/23328940.2015.1044635; Matsuzaki K, 2015, J COMP NEUROL, V523, P1190, DOI 10.1002/cne.23732; Matsuzaki K, 2009, PFLUG ARCH EUR J PHY, V458, P661, DOI 10.1007/s00424-009-0654-2; Migaud M, 2010, EUR J NEUROSCI, V32, P2042, DOI 10.1111/j.1460-9568.2010.07521.x; Morrison Shaun F, 2016, F1000Res, V5, DOI 10.12688/f1000research.7958.1; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura Kazuhiro, 2015, Temperature (Austin), V2, P352, DOI 10.1080/23328940.2015.1070944; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; NAKAYAMA T, 1985, JPN J PHYSIOL, V35, P375, DOI 10.2170/jjphysiol.35.375; Omori H, 2014, NEUROSCI RES, V79, P13, DOI 10.1016/j.neures.2013.11.005; Osaka T, 2012, NEUROSCIENCE, V226, P156, DOI 10.1016/j.neuroscience.2012.08.048; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Pierau FK, 1994, ADV PHAR SC, P31; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Reyes JH, 2008, J NEUROSCI, V28, P12622, DOI 10.1523/JNEUROSCI.0563-08.2008; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; SanzRodriguez C, 1997, NEUROSCI LETT, V223, P141, DOI 10.1016/S0304-3940(97)13412-7; Shido Osamu, 2015, Temperature (Austin), V2, P362, DOI 10.1080/23328940.2015.1076591; Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731; Sugimoto N, 1999, PFLUG ARCH EUR J PHY, V438, P766, DOI 10.1007/s004240051104; Sugimoto N, 2016, NAUNYN SCHMIEDEBERGS; Sugimoto N, 2014, CELL BIOCHEM BIOPHYS, V70, P301, DOI 10.1007/s12013-014-9912-9; Sugimoto N, 2012, CELL PHYSIOL BIOCHEM, V30, P450, DOI 10.1159/000339038; Tamura M, 1999, J BIOL CHEM, V274, P20693, DOI 10.1074/jbc.274.29.20693; Tokizawa K, 2012, J PHYS FITNESS SPORT, V1, P343; Umschweif G, 2014, J CEREBR BLOOD F MET, V34, P1381, DOI 10.1038/jcbfm.2014.93; Werner L, 2012, ENDOCRINOLOGY, V153, P2655, DOI 10.1210/en.2011-1760; WILLIAMS CG, 1967, J APPL PHYSIOL, V22, P21, DOI 10.1152/jappl.1967.22.1.21; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yoshida K, 2005, NEUROSCIENCE, V133, P1039, DOI 10.1016/j.neuroscience.2005.03.044; Yu SH, 2016, J NEUROSCI, V36, P5034, DOI 10.1523/JNEUROSCI.0213-16.2016	55	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178787	10.1371/journal.pone.0178787	http://dx.doi.org/10.1371/journal.pone.0178787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628625	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100009
J	Sun, M; Zhang, ZQ; Ma, CY; Chen, SH; Chen, XJ				Sun, Min; Zhang, Zhiqiang; Ma, Chiyuan; Chen, Suihua; Chen, Xinjian			Quantitative analysis of retinal layers on three-dimensional spectral-domain optical coherence tomography for pituitary adenoma	PLOS ONE			English	Article							NERVE-FIBER LAYER; VISUAL-FIELD RECOVERY; CHIASMAL COMPRESSION; ATTENUATION COEFFICIENT; PROGNOSTIC VALUE; GANGLION-CELLS; OCT; GLAUCOMA; THICKNESS; IMAGES	Purpose To quantitatively investigate the characteristics of eyes with pituitary adenoma presented by three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) using three common indices, including thickness, optical intensity ratio, and optical intensity attenuation coefficient (OIAC). Methods The SD-OCT database of 38 patients with pituitary adenoma and 39 normal controls were included in the study. Quadrantal and average measurements of thickness, optical intensity ratio, and OIAC were calculated for macular retinal nerve fiber layer (mRNFL), ganglion cell layer (GCL) combined with inner plexiform layer (IPL) (GCIPL) and/or the collective ganglion cell complex (GCC). The parameters of patients and controls were compared by unpaired t-test and Mann-Whitney U-test. The relationships between the optical intensity ratio and the thickness of mRNFL and GCIPL were evaluated by Pearson's correlation. Diagnostic performances of these indices were assessed using receiver operating characteristic (ROC) analysis. Results Significant decreases in thickness existed in the mRNFL and nasal GCC of patients compared with controls (p-values of 0.000 to 0.039). Optical intensity ratios in the relevant retinal layers of patients were almost all lower than those of controls. In patients, optical intensities were increased in the mRNFL but decreased in the GCIPL along with an increase of retinal thicknesses. The OIAC measurements were significantly higher in the upper quadrants and global average of the mRNFL in patients. The areas under the ROC curves (AUC) obtained by global average mRNFL thickness was significantly greater than that of the global average OIAC in the mRNFL (p = 0.0265). Conclusions Thicknesses of the mRNFL and nasal GCC were significantly decreased in the retinas of patients with pituitary adenoma compared with controls. The differences of the optical intensity ratio and OIAC between patients and controls were not all statistically significant. Thickness was more sensitive than optical characteristics indices in distinguishing pituitary adenoma from controls.	[Sun, Min; Chen, Xinjian] Soochow Univ, Sch Elect & Informat Engn, Suzhou, Jiangsu, Peoples R China; [Sun, Min] Huaian Vocat Coll Informat Technol, Dept Elect Engn, Huaian, Jiangsu, Peoples R China; [Zhang, Zhiqiang] Nanjing Mil Command, Dept Med Imaging, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China; [Ma, Chiyuan] Nanjing Mil Command, Dept Neurosurg, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China; [Chen, Suihua] Nanjing Mil Command, Dept Ophthalmol, Nanjing Gen Hosp, Nanjing, Jiangsu, Peoples R China	Soochow University - China; Nanjing General Hospital; Nanjing General Hospital; Nanjing General Hospital	Chen, XJ (corresponding author), Soochow Univ, Sch Elect & Informat Engn, Suzhou, Jiangsu, Peoples R China.	xjchen@suda.edu.cn		Chen, Xinjian/0000-0002-0871-293X	National Basic Research Program of China (973 Program) [2014CB748600]; National Natural Science Foundation of China (NSFC) [81371629, 81401472, 61401294, 61401293, 61622114]; Natural Science Foundation of the Jiangsu Province [BK20140052]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported in part by the National Basic Research Program of China (973 Program) under Grant 2014CB748600 (http://www.nsfc.gov.cn/, XC) and in part by the National Natural Science Foundation of China (NSFC) under Grants 81371629, 81401472, 61401294, 61401293, 61622114 (http://www.nsfc.gov.cn/, XC), and in part by Natural Science Foundation of the Jiangsu Province under Grant BK20140052 (http://www.jstd.gov.cn/, XC).	Akashi A, 2014, INVEST OPHTH VIS SCI, V55, P4667, DOI 10.1167/iovs.14-14766; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; BERGLAND R, 1969, J NEUROSURG, V31, P327, DOI 10.3171/jns.1969.31.3.0327; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P6846, DOI 10.1167/iovs.13-12062; Cioffi George A, 2005, Trans Am Ophthalmol Soc, V103, P592; Danesh-Meyer HV, 2006, INVEST OPHTH VIS SCI, V47, P4827, DOI 10.1167/iovs.06-0327; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Garcia Garrido M, 2014, PLOS ONE, V9; Garcia T, 2014, J NEUROSURG, V121, P165, DOI 10.3171/2014.2.JNS131767; Gould TJ, 1996, J NEURO-OPHTHALMOL, V16, P199; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kerrison JB, 2000, AM J OPHTHALMOL, V130, P813, DOI 10.1016/S0002-9394(00)00539-0; Kok PHB, 2009, INVEST OPHTH VIS SCI, V50, P787, DOI 10.1167/iovs.08-2364; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McIlwaine GG, 2005, J NEURO-OPHTHALMOL, V25, P40, DOI 10.1097/00041327-200503000-00011; Monteiro MLR, 2010, EYE, V24, P1382, DOI 10.1038/eye.2010.48; Monteiro MLR, 2014, INVEST OPHTH VIS SCI, V55, P3328, DOI 10.1167/iovs.14-14118; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P8527, DOI 10.1167/iovs.11-8034; Moon CH, 2011, INVEST OPHTH VIS SCI, V52, P7966, DOI 10.1167/iovs.11-7450; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Neudorfer M, 2012, INVEST OPHTH VIS SCI, V53, P3104, DOI 10.1167/iovs.11-8700; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Pons ME, 2000, ARCH OPHTHALMOL-CHIC, V118, P1044, DOI 10.1001/archopht.118.8.1044; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Shi F, 2015, IEEE T MED IMAGING, V34, P441, DOI 10.1109/TMI.2014.2359980; Tudor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093916; van der Meer FJ, 2010, LASER MED SCI, V25, P259, DOI 10.1007/s10103-009-0723-y; van der Schoot J, 2012, INVEST OPHTH VIS SCI, V53, P2424, DOI 10.1167/iovs.11-8436; Ventura LM, 2009, DOC OPHTHALMOL, V118, P155, DOI 10.1007/s10633-008-9143-8; Vermeer KA, 2012, INVEST OPHTH VIS SCI, V53, P6102, DOI 10.1167/iovs.12-9933	31	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179532	10.1371/journal.pone.0179532	http://dx.doi.org/10.1371/journal.pone.0179532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628662	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100035
J	Wagner, F; Laun, FB; Kuder, TA; Mlynarska, A; Maier, F; Faust, J; Demberg, K; Lindemann, L; Rivkin, B; Nagel, AM; Ladd, ME; Maier-Hein, K; Bickelhaupt, S; Bach, M				Wagner, Friedrich; Laun, Frederik B.; Kuder, Tristan A.; Mlynarska, Anna; Maier, Florian; Faust, Jonas; Demberg, Kerstin; Lindemann, Linus; Rivkin, Boris; Nagel, Armin M.; Ladd, Mark E.; Maier-Hein, Klaus; Bickelhaupt, Sebastian; Bach, Michael			Temperature and concentration calibration of aqueous polyvinylpyrrolidone (PVP) solutions for isotropic diffusion MRI phantoms	PLOS ONE			English	Article							SELF-DIFFUSION; QUALITY-CONTROL; FIBER-TRACKING; TENSOR; WATER; VALIDATION; QUANTIFICATION; REPEATABILITY; VARIABILITY; PRINCIPLES	To use the "apparent diffusion coefficient" (D-app) as a quantitative imaging parameter, wellsuited test fluids are essential. In this study, the previously proposed aqueous solutions of polyvinylpyrrolidone (PVP) were examined and temperature calibrations were obtained. For example, at a temperature of 20 degrees C, D-app ranged from 1.594 (95% CI: 1.593, 1.595) mu m(2)/ms to 0.3326 (95% CI: 0. 3304, 0.3348) mu m(2)/ms for PVP-concentrations ranging from 10% (w/w) to 50% (w/w) using K30 polymer lengths. The temperature dependence of Dapp was found to be so strong that a negligence seems not advisable. The temperature dependence is descriptively modelled by an exponential function exp(c(2) (T-20 degrees C)) and the determined c(2) values are reported, which can be used for temperature calibration. For example, we find the value 0.02952 K-1 for 30% (w/ w) PVP-concentration and K30 polymer length. In general, aqueous PVP solutions were found to be suitable to produce easily applicable and reliable D-app-phantoms.	[Wagner, Friedrich; Laun, Frederik B.; Kuder, Tristan A.; Maier, Florian; Faust, Jonas; Demberg, Kerstin; Lindemann, Linus; Rivkin, Boris; Nagel, Armin M.; Ladd, Mark E.; Bach, Michael] German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany; [Laun, Frederik B.; Nagel, Armin M.] Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Mlynarska, Anna; Bickelhaupt, Sebastian] German Canc Res Ctr, Radiol, Heidelberg, Germany; [Maier-Hein, Klaus] German Canc Res Ctr, Med & Biol Informat, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Bach, M (corresponding author), German Canc Res Ctr, Med Phys Radiol, Heidelberg, Germany.	m.bach@dkfz.de	Laun, Frederik Bernd/O-4810-2016; Maier-Hein, Klaus Hermann/AAF-8487-2020; Kuder, Tristan Anselm/AAF-2136-2019; Nagel, Armin M/C-4671-2016	Laun, Frederik Bernd/0000-0002-9269-5609; Maier-Hein, Klaus Hermann/0000-0002-6626-2463; Kuder, Tristan Anselm/0000-0001-6439-8124; Nagel, Armin M/0000-0003-0948-1421; Bach, Michael/0000-0003-4275-7936; Ladd, Mark/0000-0002-4128-9440	Deutsche Forschungsgemeinschaft (DFG) [LA 2804/1-3]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support by the Deutsche Forschungsgemeinschaft (DFG) is gratefully acknowledged (grant number LA 2804/1-3).	Antunes J, 2016, TRANSL ONCOL, V9, P155, DOI 10.1016/j.tranon.2016.01.008; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Bach M, 2014, MAGN RESON MED, V71, P1108, DOI 10.1002/mrm.24774; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Benjamini D, 2016, J MAGN RESON, V271, P40, DOI 10.1016/j.jmr.2016.08.004; Benjamini D, 2014, J MAGN RESON, V246, P36, DOI 10.1016/j.jmr.2014.06.017; Chenevert TL, 2011, J MAGN RESON IMAGING, V34, P983, DOI 10.1002/jmri.22363; Delakis I, 2004, PHYS MED BIOL, V49, P1409, DOI 10.1088/0031-9155/49/8/003; Farrher E, 2012, MAGN RESON IMAGING, V30, P518, DOI 10.1016/j.mri.2011.12.012; Fieremans E, 2008, PHYS MED BIOL, V53, P5405, DOI 10.1088/0031-9155/53/19/009; Fieremans E, 2008, J MAGN RESON, V190, P189, DOI 10.1016/j.jmr.2007.10.014; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Freitag MT, 2016, RADIOLOGE, V56, P137, DOI 10.1007/s00117-015-0066-6; Fritzsche KH, 2010, NEUROIMAGE, V51, P242, DOI 10.1016/j.neuroimage.2010.02.007; Fukuzaki M, 1999, P 7 ANN M ISMRM PHIL; Giannelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086280; Giannotti E, 2015, EUR J RADIOL, V84, P1729, DOI 10.1016/j.ejrad.2015.05.032; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; Hellerbach A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070343; Holz M, 2000, PHYS CHEM CHEM PHYS, V2, P4740, DOI 10.1039/b005319h; Horkay F, 2012, INVENTORSPHANTOM DIF; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK., 2011, DIFFUSION MRI THEORY; Kasper E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114543; Keenan KE, 2016, J MAGN RESON IMAGING, V44, P846, DOI 10.1002/jmri.25237; Keenan KE, 2016, J MAGN RESON IMAGING; Komlosh ME, 2017, J MAGN RESON, V275, P19, DOI 10.1016/j.jmr.2016.11.017; Komlosh ME, 2011, J MAGN RESON, V208, P128, DOI 10.1016/j.jmr.2010.10.014; KRYNICKI K, 1978, FARADAY DISCUSS, V66, P199, DOI 10.1039/dc9786600199; Kuder TA, 2012, MAGN RESON MED, V67, P1401, DOI 10.1002/mrm.23133; Laubach HJ, 1998, J MAGN RESON IMAGING, V8, P1349, DOI 10.1002/jmri.1880080627; Laun FB, 2011, RADIOLOGE, V51, P170, DOI 10.1007/s00117-010-2057-y; Laun FB, 2009, MAGN RESON MATER PHY, V22, P151, DOI 10.1007/s10334-008-0159-6; Laun FB, 2009, MAGN RESON IMAGING, V27, P541, DOI 10.1016/j.mri.2008.08.011; Lorenz R, 2008, APPL MAGN RESON, V33, P419, DOI 10.1007/s00723-008-0087-7; Malyarenko D, 2013, J MAGN RESON IMAGING, V37, P1238, DOI 10.1002/jmri.23825; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Moussavi-Biugui A, 2011, MAGN RESON MED, V65, P190, DOI 10.1002/mrm.22602; Mulkern RV, 2015, ACAD RADIOL, V22, P363, DOI 10.1016/j.acra.2014.10.006; Perrin M, 2005, PHILOS T R SOC B, V360, P881, DOI 10.1098/rstb.2005.1650; Pierpaoli C., 2009, P 17 ANN M ISMRM HON; Pullens P, 2015, P 23 ANN M ISMRM TOR; Pullens P, 2010, J MAGN RESON IMAGING, V32, P482, DOI 10.1002/jmri.22243; Rathi Y, 2014, MED IMAGE ANAL, V18, P1143, DOI 10.1016/j.media.2014.06.003; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Spees WM, 2012, MAGN RESON MED, V68, P319, DOI 10.1002/mrm.23201; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Taouli B, 2016, J MAGN RESON IMAGING; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Teipel SJ, 2010, J ALZHEIMERS DIS, V22, P507, DOI 10.3233/JAD-2010-100234; Tofts PS, 2000, MAGN RESON MED, V43, P368, DOI 10.1002/(SICI)1522-2594(200003)43:3<368::AID-MRM8>3.0.CO;2-B; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; von dem Hagen EAH, 2002, MAGN RESON MED, V48, P454, DOI 10.1002/mrm.10250; Yanasak N, 2006, MAGN RESON IMAGING, V24, P1349, DOI 10.1016/j.mri.2006.08.001; Yanasak NE, 2009, MED PHYS, V36, P1875, DOI 10.1118/1.3110670; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010	59	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179276	10.1371/journal.pone.0179276	http://dx.doi.org/10.1371/journal.pone.0179276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628638	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100022
J	McConnell, MW; Fitzpatrick, MJ				McConnell, Murray W.; Fitzpatrick, Mark J.			'Foraging' for a place to lay eggs: A genetic link between foraging behaviour and oviposition preferences	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DROSOPHILA-MELANOGASTER LARVAE; NATURAL VARIATION; SUCROSE RESPONSIVENESS; SITE SELECTION; POLYMORPHISM; CHOICE; PKG; EXPRESSION; STRATEGIES	Gravid female arthropods in search of egg-laying substrates embark on foraging-like forays: they survey the environment assessing multiple patches, tasting each with their tarsi and proboscis, and then, if interested, they deposit an egg (or eggs). In fruit flies, Drosophila melanogaster, allelic variation in the foraging gene (for) underlies the rover/sitter foraging behaviour polymorphism. Rover flies (for(R)) are more active foragers (both within and between food patches) compared to sitters (for(s)). In nematodes, Caenorhabditis elegans, a mutation in egl-4, the ortholog of for, leads to aberrations in egg laying. Given this and the notion that females may 'forage' for a place to oviposit, we hypothesized that for may underlie egg-laying decisions in the fruit fly. Indeed, when given a choice between patches of low- and high-nutrient availability, rovers lay significantly more eggs on the low-nutrient patches than sitters and also a sitter mutant (for(s2)). We confirm the role of for by inducing rover-like oviposition preferences in a sitter fly using the transgenic overexpression of for-mRNA in the nervous system.	[McConnell, Murray W.; Fitzpatrick, Mark J.] Univ Toronto, Dept Biol Sci, Integrat Behav & Neurosci Grp, Toronto, ON, Canada; [McConnell, Murray W.; Fitzpatrick, Mark J.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Fitzpatrick, Mark J.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Fitzpatrick, MJ (corresponding author), Univ Toronto, Dept Biol Sci, Integrat Behav & Neurosci Grp, Toronto, ON, Canada.; Fitzpatrick, MJ (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.; Fitzpatrick, MJ (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	mark.fitzpatrick@utoronto.ca	Fitzpatrick, Mark J/A-3414-2008	Fitzpatrick, Mark/0000-0003-3484-4327	Natural Sciences and Engineering Research Council (NSERC) of Canada; University of Toronto Connaught Start-Up Grant	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto Connaught Start-Up Grant	This research was funded by a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant to and a University of Toronto Connaught Start-Up Grant to MJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 1989, LAB HDB; Battesti M, 2015, BEHAV ECOL SOCIOBIOL, V69, P83, DOI 10.1007/s00265-014-1820-x; Belay AT, 2007, J COMP NEUROL, V504, P570, DOI 10.1002/cne.21466; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; CHESS KF, 1985, EVOLUTION, V39, P869, DOI 10.1111/j.1558-5646.1985.tb00428.x; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; DEBELLE JS, 1987, HEREDITY, V59, P73, DOI 10.1038/hdy.1987.98; DEBELLE JS, 1989, GENETICS, V123, P157; DEBELLE JS, 1993, GENOME, V36, P94, DOI 10.1139/g93-013; DELSOLAR E, 1966, AM NAT, V100, P127, DOI 10.1086/282406; Doak P, 2006, ECOLOGY, V87, P395, DOI 10.1890/05-0647; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Edelsparre AH, 2014, ECOL LETT, V17, P333, DOI 10.1111/ele.12234; Feil R, 2005, REV NEUROSCIENCE, V16, P23; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fitzpatrick MJ, 2005, CAN J ZOOL, V83, P368, DOI 10.1139/Z05-027; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Ingram KK, 2005, MOL ECOL, V14, P813, DOI 10.1111/j.1365-294X.2005.02450.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Janz N, 2005, OIKOS, V109, P535, DOI 10.1111/j.0030-1299.2005.13817.x; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kaun KR, 2007, LEARN MEMORY, V14, P342, DOI 10.1101/lm.505807; Keesey IW, 2016, J CHEM ECOL, V42, P739, DOI 10.1007/s10886-016-0737-4; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; MANGEL M, 1989, J EVOLUTION BIOL, V2, P157, DOI 10.1046/j.1420-9101.1989.2030157.x; Mansourian S, 2016, CURR BIOL, V26, P2762, DOI 10.1016/j.cub.2016.07.065; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PARSONS PA, 1977, EXPERIENTIA, V33, P898, DOI 10.1007/BF01951269; PEREIRA HS, 1995, GENETICS, V141, P263; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; PYLE DW, 1976, AM NAT, V110, P181, DOI 10.1086/283057; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; RODRIGUEZ L, 1992, J EVOLUTION BIOL, V5, P61, DOI 10.1046/j.1420-9101.1992.5010061.x; Scheiner R, 2004, LEARN MEMORY, V11, P303, DOI 10.1101/lm.71604; Schwartz NU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037910; Sheeba V, 1998, J BIOSCIENCE, V23, P93, DOI 10.1007/BF02703000; SOKOLOWSKI MB, 1985, J INSECT PHYSIOL, V31, P857, DOI 10.1016/0022-1910(85)90103-9; SOKOLOWSKI MB, 1980, BEHAV GENET, V10, P291, DOI 10.1007/BF01067774; SOKOLOWSKI MB, 1981, BEHAV GENET, V11, P612; SOKOLOWSKI MB, 1984, ANIM BEHAV, V32, P645, DOI 10.1016/S0003-3472(84)80139-6; TAKAMURA T, 1980, JPN J GENET, V55, P91, DOI 10.1266/jjg.55.91; Temussi PA, 2009, TRENDS BIOCHEM SCI, V34, P296, DOI 10.1016/j.tibs.2009.02.005; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Tobback J, 2011, ARCH INSECT BIOCHEM, V76, P30, DOI 10.1002/arch.20401; TRENT C, 1983, GENETICS, V104, P619; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Zar JH, 1999, BIOSTATISTICAL ANAL	57	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179362	10.1371/journal.pone.0179362	http://dx.doi.org/10.1371/journal.pone.0179362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622389	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300027
J	Imani, G; Boyemb, F; Lewis, S; Nabahungu, NL; Calders, K; Zapfack, L; Riera, B; Balegamire, C; Cuni-Sanchez, A				Imani, Gerard; Boyemb, Faustin; Lewis, Simon; Nabahungu, Nsharwasi Leon; Calders, Kim; Zapfack, Louis; Riera, Bernard; Balegamire, Clarisse; Cuni-Sanchez, Aida			Height-diameter allometry and above ground biomass in tropical montane forests: Insights from the Albertine Rift in Africa	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; CARBON STOCKS; ALTITUDINAL GRADIENT; TREE ALLOMETRY; NATIONAL-PARK; MOUNTAINS; GROWTH; KAHUZI; SOIL; MAP	Tropical montane forests provide an important natural laboratory to test ecological theory. While it is well-known that some aspects of forest structure change with altitude, little is known on the effects of altitude on above ground biomass (AGB), particularly with regard to changing height-diameter allometry. To address this we investigate (1) the effects of altitude on height-diameter allometry, (2) how different height-diameter allometric models affect above ground biomass estimates; and (3) how other forest structural, taxonomic and environmental attributes affect above ground biomass using 30 permanent sample plots (1-ha; all trees >= 10 cm diameter measured) established between 1250 and 2600 m asl in Kahuzi Biega National Park in eastern Democratic Republic of Congo. Forest structure and species composition differed with increasing altitude, with four forest types identified. Different height-diameter allometric models performed better with the different forest types, as trees got smaller with increasing altitude. Above ground biomass ranged from 168 to 290 Mg ha(-1), but there were no significant differences in AGB between forests types, as tree size decreased but stem density increased with increasing altitude. Forest structure had greater effects on above ground biomass than forest diversity. Soil attributes (K and acidity, pH) also significantly affected above ground biomass. Results show how forest structural, taxonomic and environmental attributes affect above ground biomass in African tropical montane forests. They particularly highlight that the use of regional height-diameter models introduces significant biases in above ground biomass estimates, and that different height-diameter models might be preferred for different forest types, and these should be considered in future studies.	[Imani, Gerard] Univ Officielle Bukavu, Biol Dept, Bukavu, DEM REP CONGO; [Imani, Gerard; Boyemb, Faustin] Univ Kisangani, Plant Dept, Kisangani, DEM REP CONGO; [Lewis, Simon; Calders, Kim; Cuni-Sanchez, Aida] UCL, Dept Geog, London, England; [Lewis, Simon] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Nabahungu, Nsharwasi Leon] Int Inst Trop Agr, Soil Lab, Kalambo Site, Kalambo, DEM REP CONGO; [Calders, Kim] Natl Phys Lab, Earth Observat Climate & Opt Grp, Teddington, Middx, England; [Zapfack, Louis] Univ Yaounde I, Plant Biol & Physiol Dept, Yaounde, Cameroon; [Riera, Bernard] Museum Natl Hist Nat, Lab Ecol Nat, Brunoy, France; [Balegamire, Clarisse] Ctr Rech Sci Nat Lwiro, Lwiro, DEM REP CONGO	University of London; University College London; University of Leeds; National Physical Laboratory - UK; University of Yaounde I; Museum National d'Histoire Naturelle (MNHN)	Imani, G (corresponding author), Univ Officielle Bukavu, Biol Dept, Bukavu, DEM REP CONGO.; Imani, G (corresponding author), Univ Kisangani, Plant Dept, Kisangani, DEM REP CONGO.	imanigerard2006@yahoo.fr	RIERA, Bernard/ABG-1318-2020	RIERA, Bernard/0000-0002-5320-9671; balegamire, clarisse/0000-0003-4557-5863; Calders, Kim/0000-0002-4562-2538	FCCC (Appui a l'UNIKIS: "Forets et Changement Climatique au Congo") - European Commission; European Research Council	FCCC (Appui a l'UNIKIS: "Forets et Changement Climatique au Congo") - European Commission; European Research Council(European Research Council (ERC)European Commission)	The present work has been financially supported by the FCCC project (Appui a l'UNIKIS: "Forets et Changement Climatique au Congo") funded by the European Commission, implemented by the Center for International Forestry Research in partnership with University of Kisangani (UNIKIS) and Synergies Development (RSD) for logistical support. Simon Lewis is supported by the European Research Council. This funder had a role only in study design, data collection and soil analysis.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amani C, 2008, ANN FS SCI APPLIQUEE, V1, P1; [Anonymous], 2010, PLAN GEN GESTION PAR; Arcangeli C, 2014, FORESTRY, V87, P177, DOI 10.1093/forestry/cpt041; Avitabile V, 2016, GLOBAL CHANGE BIOL, V22, P1406, DOI 10.1111/gcb.13139; Avitabile Valerio, 2011, Carbon Balance Manag, V6, P7, DOI 10.1186/1750-0680-6-7; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Banin L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1179, DOI 10.1111/j.1466-8238.2012.00778.x; Basabose AK, 2002, AM J PRIMATOL, V58, P1, DOI 10.1002/ajp.10049; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; Bruijnzeel LA, 2011, TROPICAL MONTANE CLO, P137; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chisholm RA, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12132; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; Dewitte O, 2013, GEODERMA, V211, P138, DOI 10.1016/j.geoderma.2013.07.007; Dinerstein E, 2013, CONSERV BIOL, V27, P14, DOI 10.1111/j.1523-1739.2012.01959.x; Djomo AN, 2010, FOREST ECOL MANAG, V260, P1873, DOI 10.1016/j.foreco.2010.08.034; Dossa GGO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067720; Eggleston HS, 2006, 4 IPCC IGES NAT GREE, P20; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Fayolle A, 2016, FOREST ECOL MANAG, V374, P42, DOI 10.1016/j.foreco.2016.04.033; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Feldpausch TR, 2011, BIOGEOSCIENCES, V8, P1081, DOI 10.5194/bg-8-1081-2011; Fischer E, 1996, ERDWISSENSCHAFTLICHE; Fischer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123300; Fujii K, 2014, ECOL RES, V29, P371, DOI 10.1007/s11284-014-1144-3; Gibbs HK, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045023; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Godo G., 1990, CAH ORSTOM, V25, P423; Grau O, 2017, SCI REP-UK, V7, DOI 10.1038/srep45017; Griscom BW, 2006, J TROP ECOL, V22, P587, DOI 10.1017/S0266467406003361; GRUBB PJ, 1977, ANNU REV ECOL SYST, V8, P83, DOI 10.1146/annurev.es.08.110177.000503; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Hue N V, 2004, TESTING YOUR SOIL WH, P1; Imani G., 2016, J BIODIVERS ENVIRON, V8, P134; Imani MG, 2016, EUR SCI J, V12, P88; Imani MG, SOIL VARIAB IN PRESS; Kearsley E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3269; Larjavaara M, 2013, METHODS ECOL EVOL, V4, P793, DOI 10.1111/2041-210X.12071; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Ledo A, 2016, ECOL APPL, V26, P2374, DOI 10.1002/eap.1450; Ledo A, 2016, J ECOL, V104, P1819, DOI 10.1111/1365-2745.12635; Leuschner C., 2013, ECOSYSTEM SERVICES B, V221, P117, DOI DOI 10.1007/978-3-642-38137-9_10; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Lewis SL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0295; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lovett JC, 2006, AFR J ECOL, V44, P478, DOI 10.1111/j.1365-2028.2006.00660.x; Mangambu J, 2013, THESIS; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchard Edward Ta, 2013, Carbon Balance Manag, V8, P10, DOI 10.1186/1750-0680-8-10; Molto Q, 2014, BIOGEOSCIENCES, V11, P3121, DOI 10.5194/bg-11-3121-2014; Motsara M., 2008, GUIDE LAB ESTABLISHM; Mugasha WA, 2013, SOUTH FORESTS, V75, P221, DOI 10.2989/20702620.2013.824672; Munishi PKT, 2004, J TROP FOR SCI, V16, P78; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Paul KI, 2016, GLOBAL CHANGE BIOL, V22, P2106, DOI 10.1111/gcb.13201; Pearl R, 1920, P NATL ACAD SCI USA, V6, P275, DOI 10.1073/pnas.6.6.275; Pecrot A, 1962, PUBLICATIO INEAC, V97; Pelletier J, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024005; Pierlot R, 1966, STRUCTURE COMPOSITIO; Pinheiro J, 2020, R PACKAGE VERSION 31; Ploton P, 2016, BIOGEOSCIENCES, V13, P1571, DOI 10.5194/bg-13-1571-2016; Plumptre A.J., 2009, PROTECTED AREAS GOVE; Plumptre AJ, 2003, BIODIVERSITY ALBERTI, P1543; Plumptre AJ, 2007, BIOL CONSERV, V134, P178, DOI 10.1016/j.biocon.2006.08.021; Poorter L, 2015, GLOBAL ECOL BIOGEOGR, V24, P1314, DOI 10.1111/geb.12364; Qian J, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0728-3; Quesada CA, 2012, BIOGEOSCIENCES, V9, P2203, DOI 10.5194/bg-9-2203-2012; R Development Core Team R, 2008, LANG ENV STAT COMP; Rejou-Mechain M, 2014, BIOGEOSCIENCES, V11, P6827, DOI 10.5194/bg-11-6827-2014; Rutishauser E, 2013, FOREST ECOL MANAG, V307, P219, DOI 10.1016/j.foreco.2013.07.013; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Shirima DD, 2015, BASIC APPL ECOL, V16, P239, DOI 10.1016/j.baae.2014.11.008; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Sullivan MJP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39102; Swai G., 2014, Journal of Ecology and the Natural Environment, V6, P90; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Unger M, 2012, OECOLOGIA, V170, P263, DOI 10.1007/s00442-012-2295-y; Wang Y, 1998, CAN J FOREST RES, V28, P1171, DOI 10.1139/cjfr-28-8-1171; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Wurzburger N, 2015, ECOLOGY, V96, P2137, DOI 10.1890/14-1362.1; Yamagiwa J, 2005, INT J PRIMATOL, V26, P1345, DOI 10.1007/s10764-005-8856-8; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]; Zeide B, 2001, EL BIENN S SILV RES, P463	95	23	24	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179653	10.1371/journal.pone.0179653	http://dx.doi.org/10.1371/journal.pone.0179653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617841	Green Published, gold			2022-12-26	WOS:000403364600053
J	Zamuner, AR; Porta, A; Andrade, CP; Forti, M; Marchi, A; Furlan, R; Barbic, F; Catai, AM; Silva, E				Zamuner, Antonio Roberto; Porta, Alberto; Andrade, Carolina Pieroni; Forti, Meire; Marchi, Andrea; Furlan, Raffaello; Barbic, Franca; Catai, Aparecida Maria; Silva, Ester			The degree of cardiac baroreflex involvement during active standing is associated with the quality of life in fibromyalgia patients	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AUTONOMIC CARDIOVASCULAR CONTROL; EXPERIMENTAL PAIN STIMULATION; ARTERIAL-PRESSURE; PERIOD; RESPIRATION; DYSFUNCTION; CAUSALITY; RESPONSES; WOMEN	Fibromyalgia syndrome (FMS) is a rheumatologic disorder characterized by chronic widespread pain, fatigue and other symptoms. Baroreflex dysfunction has been observed in women with FMS. However, it is unknown whether the limited involvement of the baroreflex control during an orthostatic stimulus has some impact on the quality of life of the FMS patient. Therefore, the aim of the study is evaluate the relationship between the quality of life of the FMS patient and indexes of the cardiovascular autonomic control as estimated from spontaneous fluctuations of heart period (HP) and systolic arterial pressure (SAP). We enrolled 35 women with FMS (age: 48.8 +/- 8.9 years; body mass index: 29.3 +/- 4.3 Kg/m(2)). The electrocardiogram, non-invasive finger blood pressure and respiratory activity were continuously recorded during 15 minutes at rest in supine position (REST) and in orthostatic position during active standing (STAND). Traditional cardiovascular autonomic control markers were assessed along with a Granger causality index assessing the strength of the causal relation from SAP to HP (CRSAP -> HP) and measuring the degree of involvement of the cardiac baroreflex. The impact of FMS on quality of life was quantified by the fibromyalgia impact questionnaire (FIQ) and visual analog score for pain (VAS pain). No significant linear association was found between FIQ scores and the traditional cardiovascular indexes both at REST and during STAND (p > 0.05). However, a negative relationship between CRSAP -> HP during STAND and FIQ score was found (r = -0.56, p < 0.01). Similar results were found with VAS pain. In conclusion, the lower the degree of cardiac baroreflex involvement during STAND in women with FMS, the higher the impact of FMS on the quality of life, thus suggesting that Granger causality analysis might be clinically helpful in assessing the state of the FMS patient.	[Zamuner, Antonio Roberto; Andrade, Carolina Pieroni; Forti, Meire; Catai, Aparecida Maria; Silva, Ester] Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, SP, Brazil; [Zamuner, Antonio Roberto] Univ Sagrado Coracao, Dept Phys Therapy, Bauru, Brazil; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy; [Marchi, Andrea] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [Furlan, Raffaello; Barbic, Franca] Humanitas Univ, Humanitas Res Hosp, Internal Med, Rozzano, Italy	Universidade Federal de Sao Carlos; Universidade do Sagrado Coracao; University of Milan; IRCCS Policlinico San Donato; Polytechnic University of Milan; Humanitas University; IRCCS Humanitas Research Hospital	Zamuner, AR (corresponding author), Univ Fed Sao Carlos, Dept Phys Therapy, Sao Carlos, SP, Brazil.; Zamuner, AR (corresponding author), Univ Sagrado Coracao, Dept Phys Therapy, Bauru, Brazil.	beto.zam@gmail.com	Catai, Aparecida Maria/G-4612-2012; Furlan, Raffaello/AAH-3167-2021; Zamunér, Antonio Roberto/F-3552-2016; Barbic, Franca/GLV-2669-2022; Barbic, Franca/S-2183-2019	Furlan, Raffaello/0000-0001-5209-6786; Zamunér, Antonio Roberto/0000-0002-7480-3047; Barbic, Franca/0000-0002-8283-1988	Sao Paulo Research Foundation (FAPESP) [2011/22122-5, 2015/08445-7]; National Council for Scientific and Technological Development (CNPq) [307187/2013-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Grant 2011/22122-5, Sao Paulo Research Foundation (FAPESP); Grant 2015/08445-7, Sao Paulo Research Foundation (FAPESP) to ARZ; Grant no 307187/2013-6, National Council for Scientific and Technological Development (CNPq) to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASELLI G, 1994, MED BIOL ENG COMPUT, V32, P143, DOI 10.1007/BF02518911; Bennett R, 2005, CLIN EXP RHEUMATOL, V23, pS154; BouHolaigah I, 1997, CLIN EXP RHEUMATOL, V15, P239; Bruehl S, 2005, CLIN J PAIN, V21, P147, DOI 10.1097/00002508-200503000-00006; Cohen H, 2000, SEMIN ARTHRITIS RHEU, V29, P217, DOI 10.1016/S0049-0172(00)80010-4; Figueroa A, 2008, CLIN PHYSIOL FUNCT I, V28, P49, DOI 10.1111/j.1475-097X.2007.00776.x; Furlan R, 2005, J RHEUMATOL, V32, P1787; GRANGER CWJ, 1980, J ECON DYN CONTROL, V2, P329, DOI 10.1016/0165-1889(80)90069-X; Jones KD, 2012, CLIN RHEUMATOL, V31, P1205, DOI 10.1007/s10067-012-1996-2; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Marques Amélia Pasqual, 2006, Rev. Bras. Reumatol., V46, P24, DOI 10.1590/S0482-50042006000100006; Martinez-Lavin M, 2000, SEMIN ARTHRITIS RHEU, V29, P197, DOI 10.1016/S0049-0172(00)80008-6; Martinez-Lavin M, 1998, ARTHRITIS RHEUM-US, V41, P1966, DOI 10.1002/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O; Martinez-Lavin M, 2002, RHEUM DIS CLIN N AM, V28, P379, DOI 10.1016/S0889-857X(01)00015-1; Nollo G, 2005, AM J PHYSIOL-HEART C, V288, pH1777, DOI 10.1152/ajpheart.00594.2004; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; Porta A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0161; Porta A, 2013, J APPL PHYSIOL, V115, P1032, DOI 10.1152/japplphysiol.00537.2013; Porta A, 2012, IEEE T BIO-MED ENG, V59, P832, DOI 10.1109/TBME.2011.2180379; Porta A, 2011, AM J PHYSIOL-REG I, V300, pR378, DOI 10.1152/ajpregu.00553.2010; del Paso GAR, 2012, J PSYCHOSOM RES, V72, P87, DOI 10.1016/j.jpsychores.2011.09.011; del Paso GAR, 2011, J PSYCHOSOM RES, V70, P125, DOI 10.1016/j.jpsychores.2010.09.012; del Paso GAR, 2010, PSYCHOSOM MED, V72, P462, DOI 10.1097/PSY.0b013e3181da91f1; Rose MS, 2000, J CLIN EPIDEMIOL, V53, P1209, DOI 10.1016/S0895-4356(00)00257-2; Soderstrom T., 1988, SYSTEM IDENTIFICATIO; Staud Roland, 2008, Curr Rheumatol Rep, V10, P463; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Zamuner AR, 2015, CLIN EXP RHEUMATOL, V33, pS53; Zamuner AR, 2015, AM J PHYSIOL-REG I, V309, pR79, DOI 10.1152/ajpregu.00012.2015	30	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179500	10.1371/journal.pone.0179500	http://dx.doi.org/10.1371/journal.pone.0179500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614420	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900058
J	Horodyska, J; Hamill, RM; Varley, PF; Reyer, H; Wimmers, K				Horodyska, Justyna; Hamill, Ruth M.; Varley, Patrick F.; Reyer, Henry; Wimmers, Klaus			Genome-wide association analysis and functional annotation of positional candidate genes for feed conversion efficiency and growth rate in pigs	PLOS ONE			English	Article							L-SELECTIN; DIVERGENT SELECTION; TRAITS; LINKAGE; MICE; POLYMORPHISMS; RESTRICTION; EXPRESSION; RECEPTORS; TISSUES	Feed conversion efficiency is a measure of how well an animal converts feed into live weight and it is typically expressed as feed conversion ratio (FCR). FCR and related traits like growth rate (e.g. days to 110 kg-D110) are of high interest for animal breeders, farmers and society due to implications on animal performance, feeding costs and environmental sustainability. The objective of this study was to identify genomic regions associated with FCR and D110 in pigs. A total of 952 terminal line boars, showing an individual variation in FCR, were genotyped using 60K SNP-Chips. Markers were tested for associations with estimated breeding values (EBV) for FCR and D110. For FCR, the largest number of associated SNPs was located on chromosomes 4 (30 SNPs), 1 (25 SNPs), X (15 SNPs) and 6 (12 SNPs). The most prominent genomic regions for D110 were identified on chromosomes 15 (10 SNPs), 1 and 4 (both 9 SNPs). The most significantly associated SNPs for FCR and D110 mapped 129.8 Kb from METTL11B (chromosome 4) and 32Kb from MBD5 (chromosome 15), respectively. A list of positional genes, closest to significantly associated SNPs, was used to identify enriched pathways and biological functions related to the QTL for both traits. A number of candidate genes were significantly overrepresented in pathways of immune cell trafficking, lymphoid tissue structure, organ morphology, endocrine system function, lipid metabolism, and energy production. After resequencing the coding region of selected positional and functional candidate genes, six SNPs were genotyped in a subset of boars. SNPs in PRKDC, SELL, NR2E1 and AKRIC3 showed significant associations with EBVs for FCR/D110. The study revealed a number of chromosomal regions and candidate genes affecting FCR/D110 and pointed to corresponding biological pathways related to lipid metabolism, olfactory reception, and also immunological status.	[Horodyska, Justyna; Hamill, Ruth M.] TEAGASC, Food Res Ctr, Dublin, Ireland; [Horodyska, Justyna; Reyer, Henry; Wimmers, Klaus] Inst Genome Biol, Leibniz Inst Farm Anim Biol FBN, Dummerstorf, Germany; [Varley, Patrick F.] Hermitage Genet, Kilkenny, Ireland; [Wimmers, Klaus] Univ Rostock, Fac Agr & Environm Sci, Rostock, Germany	Teagasc; Forschungsinstitut fur Nutztierbiologie (FBN); University of Rostock	Reyer, H (corresponding author), Inst Genome Biol, Leibniz Inst Farm Anim Biol FBN, Dummerstorf, Germany.	reyer@fbn-dummerstorf.de	Wimmers, Klaus/AAF-9434-2020; Hamill, Ruth M/G-3336-2017	Hamill, Ruth M/0000-0002-7230-6709; Wimmers, Klaus/0000-0002-9523-6790; Horodyska, Justyna/0000-0001-5788-2516	European Union [311794]; Hermitage Genetics	European Union(European Commission); Hermitage Genetics	This project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration as part of the ECO-FCE project under grant agreement No. 311794. Hermitage Genetics is a partner of the ECO-FCE project and did not provide own funds for conducting this research. Hermitage Genetics, provided support in the form of salaries for authors [PV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aime P, 2014, FRONTIERS BEHAV NEUR, V8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker D, 2013, PLOS ONE, P8; Benod C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099440; Bergen AW, 2003, MOL PSYCHIATR, V8, P397, DOI 10.1038/sj.mp.4001318; Bosse M., 2014, NAT COMMUN, V5; Brown KMO, 2007, BIOL PSYCHIAT, V61, P367, DOI 10.1016/j.biopsych.2006.04.007; Cepica S, 2003, J ANIM BREED GENET, V120, P28, DOI 10.1046/j.0931-2668.2003.00421.x; Christie BR, 2006, NEUROSCIENCE, V137, P1031, DOI 10.1016/j.neuroscience.2005.08.091; Cottam DR, 2002, OBES SURG, V12, P230, DOI 10.1381/096089202762552674; Cox DG, 2006, HUM HERED, V61, P10, DOI 10.1159/000091787; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; de Oliveira PSN, 2014, BMC GENET, P15; Do DN, 2013, J ANIM SCI, V91, P4069, DOI 10.2527/jas.2012-6197; Do DN, 2014, FRONT GENET, V5; Du YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047358; Duthie C, 2008, ANIM GENET, V39, P130, DOI 10.1111/j.1365-2052.2007.01689.x; Do DN, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-27; Ekine CC, 2014, G3-GENES GENOM GENET, V4, P341, DOI 10.1534/g3.113.008706; FERRELL CL, 1985, J ANIM SCI, V61, P725, DOI 10.2527/jas1985.613725x; Gabarrou JF, 2000, BRIT J NUTR, V83, P645, DOI 10.1017/S0007114500000829; Gondret F, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2438-3; Gonzalez-Muniesa P, 2013, INT J MOL SCI, V14, P17238, DOI 10.3390/ijms140917238; Gregersen VR, 2012, BMC GENOMICS, P13; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Jafarikia M, 2015, MOL BIOL REP, V42, P1391, DOI 10.1007/s11033-015-3917-3; Jiang L, 2014, BMC GENOMICS, P15; Jiao S, 2014, J ANIM SCI, V92, P2846, DOI 10.2527/jas.2014-7337; Khazen D, 2009, EUR J GASTROEN HEPAT, V21, P167, DOI 10.1097/MEG.0b013e32830e6fc8; Kretowski A, 2000, IMMUNOL LETT, V74, P225, DOI 10.1016/S0165-2478(00)00259-5; Kumar RA, 2008, AM J MED GENET B, V147B, P880, DOI 10.1002/ajmg.b.30696; Kwon DY, 2014, EMBO MOL MED, V6, P993, DOI 10.15252/emmm.201404324; Lefaucheur L, 2011, J ANIM SCI, V89, P996, DOI 10.2527/jas.2010-3493; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Luo WZ, 2012, INT J BIOL SCI, V8, P580, DOI 10.7150/ijbs.3614; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; NELSON RM, 1992, COLD SPRING HARB SYM, V57, P271, DOI 10.1101/SQB.1992.057.01.032; Njoku C. P., 2015, Slovak Journal of Animal Science, V48, P16; Onteru SK, 2013, PLOS ONE, V8; Patience F. J, 2015, J ANIMAL SCI BIOTECH, P6; Raffler NA, 2005, DRUG DISCOV TODAY, V2, P213, DOI [10.1016/j.ddstr.2005.08.012, DOI 10.1016/J.DDSTR.2005.08.012]; Rakhshandeh A, 2012, J ANIM SCI, V90, P233, DOI 10.2527/jas.53976; Roberts NE, 2003, CAN VET J, V44, P31; Sahana G, 2013, J ANIM SCI, V91, P1041, DOI 10.2527/jas.2012-5643; Saintilan R, 2013, J ANIM SCI, V91, P2542, DOI 10.2527/jas.2012-5687; Svensson PA, 2008, CELL MOL BIOL LETT, V13, P599, DOI 10.2478/s11658-008-0025-6; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Vigors S, 2014, ADSA ASAS CSAS JOINT; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; Walz K, 2014, RARE DIS, V2, DOI 10.4161/2167549X.2014.967151; Wang HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00134; White DL, 2014, GASTROENTEROLOGY, V146, pS968; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; YANG XD, 1993, P NATL ACAD SCI USA, V90, P10494, DOI 10.1073/pnas.90.22.10494; Yilmaz Zeynep, 2015, Adv Genomics Genet, V5, P131; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu YJ, 2001, CANCER RES, V61, P1820; Yue G, 2003, J ANIM BREED GENET, V120, P45, DOI 10.1046/j.0931-2668.2003.00423.x	60	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0173482	10.1371/journal.pone.0173482	http://dx.doi.org/10.1371/journal.pone.0173482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604785	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400001
J	Ulrich, D; Le Teuff, I; Huberlant, S; Carteron, P; Letouzey, V; de Tayrac, R				Ulrich, Daniela; Le Teuff, Isabelle; Huberlant, Stephanie; Carteron, Patrick; Letouzey, Vincent; de Tayrac, Renaud			A preclinical evaluation of polypropylene/polylacticacid hybrid meshes for fascial defect repair using a rat abdominal hernia model	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; SOFT-TISSUE REINFORCEMENT; POLY(LACTIC ACID) MESH; INCISIONAL HERNIA; VAGINAL SURGERY; HOST RESPONSE; COLLAGEN; BIOCOMPATIBILITY; COMPLICATIONS; DEGRADATION	Objectives Synthetic mesh surgery for both abdominal and urogenital hernia repair is often unsatisfactory in the long-term due to postoperative complications. We hypothesized that a semi-degradable mesh hybrid may provide more appropriate biocompatibility with comparable mechanical properties. The aim was to compare its in vivo biocompatibility with a commercial polypropylene (PP) mesh. Methods 72 rats were randomly allocated to either our new composite mesh (monofilament PP mesh knitted with polylactic-acid-fibers (PLA)) or to a commercially available PP mesh that was used as a control. 15, 90, and 180 days after implantation into the rat abdomen mesh tissue complexes were analysed for erosion, contraction, foreign body reaction, tissue integration and biomechanical properties. Results No differences were seen in regard to clinical parameters including erosion, contraction or infection rates between the two groups. Biomechanical properties including breaking load, stiffness and deformation did not show any significant differences between the different materials at any timepoint. Macrophage staining did not reveal any significant differences between the two groups or between timepoints either. In regard to collagen I there was significantly less collagen I in the PP group compared to the PP/PLA group at day 180. Collagen III did not show any significant differences at any timepoint between the two groups. Conclusion A PP/PLA hybrid mesh, leaving a low amount of PP after PLA degradation seems to have comparable biomechanical properties like PP at 180 days due to enhanced collagen production without significant differences in erosion, contraction, herniation or infection rates.	[Ulrich, Daniela; Le Teuff, Isabelle; Huberlant, Stephanie; Letouzey, Vincent; de Tayrac, Renaud] Med Univ Nimes, 4 Rue Prof Robert Debre, Nimes, France; [Ulrich, Daniela] Med Univ Graz, Auenbruggerpl 14, Graz, Austria; [Carteron, Patrick] Aspide Med, 246 Allee Lavoisier, La Talaudiere, France	Medical University of Graz	Ulrich, D (corresponding author), Med Univ Nimes, 4 Rue Prof Robert Debre, Nimes, France.; Ulrich, D (corresponding author), Med Univ Graz, Auenbruggerpl 14, Graz, Austria.	Daniela.ulrich@medunigraz.at	Gold, Daniela/ABE-4818-2020	Gold, Daniela/0000-0002-7196-454X				Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Ahonen-Siirtola M, 2015, SCAND J SURG, V104, P66, DOI 10.1177/1457496914534208; Alvarez J, 2013, Minerva Ginecol, V65, P53; Garcia-Urena MA, 2007, AM J SURG, V193, P538, DOI 10.1016/j.amjsurg.2006.06.045; Barski Dimitri, 2014, Surg Technol Int, V24, P217; Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228; Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543; Boennelycke M, 2011, INT UROGYNECOL J, V22, P191, DOI 10.1007/s00192-010-1257-3; Butters M, 2007, BRIT J SURG, V94, P562, DOI 10.1002/bjs.5733; Cassar K, 2002, BRIT J SURG, V89, P534, DOI 10.1046/j.1365-2168.2002.02083.x; de Tayrac R, 2010, EUR SURG RES, V44, P102, DOI 10.1159/000277933; de Tayrac R, 2008, J BIOMED MATER RES B, V85B, P529, DOI 10.1002/jbm.b.30976; de Tayrac R, 2007, INT UROGYNECOL J, V18, P1007, DOI 10.1007/s00192-006-0270-z; de Tayrac R, 2007, INT UROGYNECOL J, V18, P513, DOI 10.1007/s00192-006-0176-9; Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Hunskaar S, EPIDEMIOLOGY URINARY, P255; Konstantinovic ML, 2007, INT UROGYNECOL J, V18, P619, DOI 10.1007/s00192-006-0202-y; Lim YN, 2007, INT UROGYNECOL J, V18, P1053, DOI 10.1007/s00192-006-0290-8; Maher C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub6; Mamy L, 2011, INT UROGYNECOL J, V22, P47, DOI 10.1007/s00192-010-1245-7; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y; Sailes FC, 2011, J AM COLL SURGEONS, V212, P119, DOI 10.1016/j.jamcollsurg.2010.08.021; Stanford EJ, 2012, INT UROGYNECOL J, V23, P19, DOI 10.1007/s00192-011-1584-z; Ulrich D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050044; Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091	28	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179246	10.1371/journal.pone.0179246	http://dx.doi.org/10.1371/journal.pone.0179246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598983	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000031
J	Tuohetahuntila, M; Molenaar, MR; Spee, B; Brouwers, JF; Wubbolts, R; Houweling, M; Yan, C; Du, H; VanderVen, BC; Vaandrager, AB; Helms, JB				Tuohetahuntila, Maidina; Molenaar, Martijn R.; Spee, Bart; Brouwers, Jos F.; Wubbolts, Richard; Houweling, Martin; Yan, Cong; Du, Hong; VanderVen, Brian C.; Vaandrager, Arie B.; Helms, J. Bernd			Lysosome-mediated degradation of a distinct pool of lipid droplets during hepatic stellate cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatic stellate cell (HSC); lipase; lipid droplet; lipolysis; retinoid; vitamin A	LIPASE-DEFICIENT MICE; ACID LIPASE; RAT-LIVER; RETINYL ESTER; STORAGE DISEASE; AUTOPHAGY; TURNOVER; MACROPHAGES; HOMEOSTASIS; INHIBITORS	Activation of hepatic stellate cells (HSCs) is a critical step in the development of liver fibrosis. During activation, HSCs lose their lipid droplets (LDs) containing triacylglycerols (TAGs), cholesteryl esters, and retinyl esters (REs). We previously provided evidence for the presence of two distinct LD pools, a preexisting and a dynamic LD pool. Here we investigate the mechanisms of neutral lipid metabolism in the preexisting LD pool. To investigate the involvement of lysosomal degradation of neutral lipids, we studied the effect of lalistat, a specific lysosomal acid lipase (LAL/Lipa) inhibitor on LD degradation in HSCs during activation in vitro. The LAL inhibitor increased the levels of TAG, cholesteryl ester, and RE in both rat and mouse HSCs. Lalistat was less potent in inhibiting the degradation of newly synthesized TAG species as compared with a more general lipase inhibitor orlistat. Lalistat also induced the presence of RE-containing LDs in an acidic compartment. However, targeted deletion of the Lipa gene in mice decreased the liver levels of RE, most likely as the result of a gradual disappearance of HSCs in livers of Lipa(-/-) mice. Lalistat partially inhibited the induction of activation marker -smooth muscle actin (-SMA) in rat and mouse HSCs. Our data suggest that LAL/Lipa is involved in the degradation of a specific preexisting pool of LDs and that inhibition of this pathway attenuates HSC activation.	[Tuohetahuntila, Maidina; Molenaar, Martijn R.; Brouwers, Jos F.; Wubbolts, Richard; Houweling, Martin; Vaandrager, Arie B.; Helms, J. Bernd] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Yalelaan 2, NL-3584 CM Utrecht, Netherlands; [Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands; [Yan, Cong; Du, Hong] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [VanderVen, Brian C.] Cornell Univ, Dept Microbiol & Immunol, Vet Med Ctr C5 181, Ithaca, NY 14853 USA	Utrecht University; Utrecht University; Indiana University System; Indiana University Bloomington; Cornell University	Helms, JB (corresponding author), Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Yalelaan 2, NL-3584 CM Utrecht, Netherlands.	J.B.Helms@uu.nl	Brouwers, Jos F/AAH-1444-2019; Wubbolts, Richard/ABH-6667-2020	Brouwers, Jos F/0000-0003-2924-3279; Wubbolts, Richard/0000-0001-8661-7594; Molenaar, Martijn/0000-0001-5221-608X; Vaandrager, Arie/0000-0001-9394-9239	seventh framework program of the EU-funded "LipidomicNet" project [202272]; NATIONAL CANCER INSTITUTE [R01CA152099] Funding Source: NIH RePORTER	seventh framework program of the EU-funded "LipidomicNet" project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the seventh framework program of the EU-funded "LipidomicNet" project (proposal number 202272). The authors declare that they have no conflicts of interest with the contents of this article.	Ajat M, 2017, BBA-MOL CELL BIOL L, V1862, P176, DOI 10.1016/j.bbalip.2016.10.013; Anderson RA, 1999, MOL GENET METAB, V68, P333, DOI 10.1006/mgme.1999.2904; AzaisBraesco V, 1995, BBA-LIPID LIPID MET, V1259, P271, DOI 10.1016/0005-2760(95)00173-5; Bains M, 2009, J BIOL CHEM, V284, P20398, DOI 10.1074/jbc.M109.011791; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3566; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Du H, 1998, HUM MOL GENET, V7, P1347, DOI 10.1093/hmg/7.9.1347; Du H, 2001, J LIPID RES, V42, P489; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Grumet L, 2016, J BIOL CHEM, V291, P17977, DOI 10.1074/jbc.M116.724054; Hamilton J, 2012, CLIN CHIM ACTA, V413, P1207, DOI 10.1016/j.cca.2012.03.019; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kluwe J, 2011, GUT, V60, P1260, DOI 10.1136/gut.2010.209551; Long AP, 2012, TRAFFIC, V13, P705, DOI 10.1111/j.1600-0854.2012.01339.x; Mello T, 2008, BIOCHEM BIOPH RES CO, V374, P460, DOI 10.1016/j.bbrc.2008.07.024; MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Ouimet M, 2011, CELL METAB, V13, P655, DOI 10.1016/j.cmet.2011.03.023; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Pirazzi C, 2014, HUM MOL GENET, V23, P4077, DOI 10.1093/hmg/ddu121; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Robinet P, 2013, ARTERIOSCL THROM VAS, V33, P903, DOI 10.1161/ATVBAHA.112.301041; Rosenbaum AI, 2010, J MED CHEM, V53, P5281, DOI 10.1021/jm100499s; Rosenbaum AI, 2009, BBA-MOL CELL BIOL L, V1791, P1155, DOI 10.1016/j.bbalip.2009.08.005; Schreiber R, 2012, BBA-MOL CELL BIOL L, V1821, P113, DOI 10.1016/j.bbalip.2011.05.001; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Sun Y, 2014, MOL GENET METAB, V112, P229, DOI 10.1016/j.ymgme.2014.04.006; Testerink N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034945; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; Tuohetahuntila M, 2016, J LIPID RES, V57, P1162, DOI 10.1194/jlr.M066415; Tuohetahuntila M, 2015, BBA-MOL CELL BIOL L, V1851, P220, DOI 10.1016/j.bbalip.2014.12.003; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; VanderVen BC, 2010, CYTOM PART A, V77A, P751, DOI 10.1002/cyto.a.20911; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; YAMAMOTO K, 1983, CELL TISSUE RES, V233, P45; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang ZL, 2017, REDOX BIOL, V11, P322, DOI 10.1016/j.redox.2016.12.021	42	34	35	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12436	12448		10.1074/jbc.M117.778472	http://dx.doi.org/10.1074/jbc.M117.778472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615446	Green Published, hybrid			2022-12-26	WOS:000406636900009
J	Yang, Z; Ding, X; Liu, J; Duan, P; Si, L; Wan, BH; Tu, P				Yang, Zhi; Ding, Xun; Liu, Jiang; Duan, Peng; Si, Lian; Wan, Binghua; Tu, Ping			Associations between anthropometric parameters and lipid profiles in Chinese individuals with age >= 40 years and BMI < 28kg/m(2)	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC ABNORMALITIES; WAIST CIRCUMFERENCE; CHOLESTEROL LEVELS; FAT DISTRIBUTION; OBESITY; RISK; PREDICTORS; MEN; ADIPOSITY	Background Lipid abnormalities are associated with overweight and obesity. Some simple anthropometric measurements such as body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHpR), and waist-to-height ratio (WHtR), may link to increased risk of dyslipidemia. However, diverse results were found in different population studies. We focused on the associations between these measurements and dyslipidemia in non-obese (BMI < 28kg/m(2)) population aged more than 40 years. Methods and findings Cross-sectional study of 4185 non-obese adults aged more than 40 years was conducted in Nanchang, Jiangxi province, China. Questionnaire, anthropometric and laboratory tests were conducted. The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) criteria were used to define high total cholesterol (TC), high low-density lipoprotein cholesterol (LDL-C), low high-density lipoprotein cholesterol (HDL-C), hypertriglyceridemia and dyslipidemia. The overall prevalence of high TC, high LDL-C, low HDL-C, hypercholesterolemia, hypertriglyceridemia and dyslipidemia were 15.68%, 27.98%, 20.12%, 44.01%, 21.98% and 49.06% respectively. Multiple logistic regressions showed only BMI (per quartile increment) increased risks for prevalent high LDL-C, low HDL-C, hypercholesterolemia, hypertriglyceridemia, and dyslipidemia. Regardless of sex, age and prevalent metabolic syndrome, increasing BMI was persistently independent risk factor for having low HDL-C, hypercholesterolemia and dyslipidemia, however was not associated with high TC. Conclusions In non-obese Chinese population aged more than 40 years, increasing BMI may better identify the prevalent dyslipidemia than other anthropometric measurements. However, due to the different meanings, both BMI and WC should be measured and monitored for metabolic risk assessment.	[Yang, Zhi; Ding, Xun; Liu, Jiang; Duan, Peng; Si, Lian; Wan, Binghua; Tu, Ping] Third Hosp Nanchang, Nanchang Key Lab Diabet, Nanchang, Jiangxi, Peoples R China; [Yang, Zhi; Ding, Xun; Liu, Jiang; Duan, Peng; Si, Lian; Wan, Binghua; Tu, Ping] Third Hosp Nanchang, Dept Endocrinol & Metab, Nanchang, Jiangxi, Peoples R China		Tu, P (corresponding author), Third Hosp Nanchang, Nanchang Key Lab Diabet, Nanchang, Jiangxi, Peoples R China.; Tu, P (corresponding author), Third Hosp Nanchang, Dept Endocrinol & Metab, Nanchang, Jiangxi, Peoples R China.	tuping8877@126.com			International Exchange and Cooperation Center of National Health and Family Planning Commission of the People's Republic of China [2009103]; Health and Family Planning Commission of Jiangxi Province [2010-26]; Jiangxi Medical Association [2013-8]; Jiangxi Committee of Science and Technology [20133ACI90016]; Health and Family Planning Commission of Nanchang City, Jiangxi Province [2010-27, 2010-38, 2011-6, 2011-33]	International Exchange and Cooperation Center of National Health and Family Planning Commission of the People's Republic of China; Health and Family Planning Commission of Jiangxi Province; Jiangxi Medical Association; Jiangxi Committee of Science and Technology; Health and Family Planning Commission of Nanchang City, Jiangxi Province	This study was supported by grants from International Exchange and Cooperation Center of National Health and Family Planning Commission of the People's Republic of China (Number 2009103, Recipient: Weiping Jia), Health and Family Planning Commission of Jiangxi Province (Number 2010-26, Recipient: Ping Tu), Jiangxi Medical Association (Number 2013-8, Recipient: Ping Tu), Jiangxi Committee of Science and Technology (Number 20133ACI90016, Recipient: Ping Tu), Health and Family Planning Commission of Nanchang City, Jiangxi Province (Number 2010-27, 2010-38, 2011-6 and 2011-33, Recipient: Ping Tu).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Hadaegh F, 2006, EXP CLIN ENDOCR DIAB, V114, P310, DOI 10.1055/s-2006-924123; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He Y, 2007, DIABETES CARE, V30, P2128, DOI 10.2337/dc06-2402; Ho JS, 2009, AM J CARDIOL, V104, P943, DOI 10.1016/j.amjcard.2009.05.047; Holl RW, 2011, INT J PEDIATR OBES, V6, P53, DOI 10.3109/17477166.2011.604325; Hou XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059145; Hou XH, 2016, J AM COLL CARDIOL, V68, P1599, DOI 10.1016/j.jacc.2016.07.737; Hsieh SD, 2010, METABOLISM, V59, P834, DOI 10.1016/j.metabol.2009.09.032; Huang Y, 2009, J DIABETES, V1, P57, DOI 10.1111/j.1753-0407.2008.00006.x; Jeong SK, 2005, J KOREAN MED SCI, V20, P7, DOI 10.3346/jkms.2005.20.1.7; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Lu M, 2006, J INTERN MED, V260, P442, DOI 10.1111/j.1365-2796.2006.01706.x; Rodgers A, 1998, LANCET, V352, P1801; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Schneider HJ, 2006, LANCET, V367, P1052, DOI 10.1016/S0140-6736(06)68462-6; Schwab KO, 2009, PEDIATR DIABETES, V10, P184, DOI 10.1111/j.1399-5448.2008.00469.x; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Takami R, 2001, DIABETES CARE, V24, P1248, DOI 10.2337/diacare.24.7.1248; Tulloch-Reid MK, 2003, DIABETES CARE, V26, P2556, DOI 10.2337/diacare.26.9.2556; Wannamethee SG, 2005, AM J CLIN NUTR, V81, P1313; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104361; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83; Zhu YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149392	27	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178343	10.1371/journal.pone.0178343	http://dx.doi.org/10.1371/journal.pone.0178343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632766	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100007
J	Wang, YR; Li, JH; Xiong, K; Chen, ZJ; Zheng, CP; Tan, Y; Cong, YG				Wang, Yiran; Li, Jianhua; Xiong, Kun; Chen, Zhijin; Zheng, Chunping; Tan, Yong; Cong, Yanguang			Elimination of persistent vaccine bacteria of Salmonella enterica serovar Typhimurium in the guts of immunized mice by inducible expression of truncated YncE	PLOS ONE			English	Article							III SECRETION SYSTEM; PHOP-PHOQ; COLONIZATION RESISTANCE; BIOLOGICAL CONTAINMENT; PSEUDOMONAS-PUTIDA; VIRULENCE; DELIVERY; GENES; IMMUNOGENICITY; VOLUNTEERS	Orally administered vaccine bacteria usually persist for a period of time in the intestinal tracts of immunized individuals, and are excreted in feces to the environment resulting in a potential biosafety issue. The releasing risk can be minimized by immediate elimination of the persistent vaccine bacteria once adequate protective immune responses have been elicited by the vaccine bacteria. In a previous study, inducible expression of truncated yncE gene (yncE*) was found lethal to host bacteria. This feature has an application potential in biosafety control. Here, we assessed the efficacy of YncE* in eliminating an attenuated strain of Salmonella enterica serovar Typhimurium in a mouse model. To this end, a pBAD-derived plasmid containing yncE* under the control of the Ara promoter was transformed into Delta phoPQ mutant of S. Typhimurium. Our data show that the induced expression of yncE* in the presence of arabinose eliminated the vaccine bacteria both in vitro and in vivo. BALB/c mice with or without streptomycin-pretreatment were used to assess the efficacy of YncE* in vivo. Oral administration of 500 mu l of 20% arabinose at 24 h postvaccination removed the vaccine bacteria from the guts of the tested mice without streptomycin-pretreatment. For streptomycin- pretreated mice, which were colonized with higher levels of Salmonella, an additional gavage of arabinose was required to completely eliminate the vaccine bacteria in the guts of the tested mice. The orally administered arabinose did not affect the persistence of bacteria that had penetrated the intestinal mucosa of the immunized mice. Furthermore, there was no significant difference in the protection rate between the routine immunization and the immunization with the arabinose treatment. The results indicate that the yncE* element improves the biosafety of the bacterial vaccine, and can be taken in consideration in future design of live bacterial vaccines.	[Wang, Yiran; Xiong, Kun; Chen, Zhijin; Zheng, Chunping; Tan, Yong; Cong, Yanguang] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Li, Jianhua] 88 Hosp PLA, Orthopaed Ctr PLA, Tai An, Shandong, Peoples R China	Army Medical University	Cong, YG (corresponding author), Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China.	ygcong@hotmail.com	wang, yixuan/GXW-2866-2022; LI, JIAN/GRY-2197-2022; wang, yi/GVT-8516-2022; li, jian/GSE-0245-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yin/HCI-9352-2022	Cong, Yanguang/0000-0001-6630-6078	national natural science foundation of China [31500116]; scientific and technological research project of Chongqing [cstc2012gg-yyjs10057]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); scientific and technological research project of Chongqing	This study was supported by the national natural science foundation of China (31500116) to KX and a scientific and technological research project of Chongqing (cstc2012gg-yyjs10057) to YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the national natural science foundation of China (31500116) and a scientific and technological research project of Chongqing (cstc2012gg-yyjs10057).	Adams P, 2001, PROTEOMICS, V1, P597, DOI 10.1002/1615-9861(200104)1:4<597::AID-PROT597>3.0.CO;2-P; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Aziz MA, 2007, BIOESSAYS, V29, P591, DOI 10.1002/bies.20580; Baba-Dikwa A, 2008, ACTA CRYSTALLOGR F, V64, P966, DOI 10.1107/S1744309108029515; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; BEJ AK, 1992, J IND MICROBIOL, V10, P79, DOI 10.1007/BF01583839; Charles Richelle C, 2013, PLoS Negl Trop Dis, V7, pe2335, DOI 10.1371/journal.pntd.0002335; Dalebroux ZD, 2014, CURR OPIN MICROBIOL, V17, P106, DOI 10.1016/j.mib.2013.12.005; Davison John, 2002, Environmental Biosafety Research, V1, P9, DOI 10.1051/ebr:2002001; DIAZ E, 1994, MOL MICROBIOL, V13, P855, DOI 10.1111/j.1365-2958.1994.tb00477.x; El Ghany MA, 2007, INFECT IMMUN, V75, P1835, DOI 10.1128/IAI.01655-06; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; GALAN JE, 1989, MICROB PATHOGENESIS, V6, P433, DOI 10.1016/0882-4010(89)90085-5; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hindle Z, 2002, INFECT IMMUN, V70, P3457, DOI 10.1128/IAI.70.7.3457-3467.2002; HOHMANN AW, 1978, INFECT IMMUN, V22, P763, DOI 10.1128/IAI.22.3.763-770.1978; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Kagawa W, 2011, ACTA CRYSTALLOGR D, V67, P1045, DOI 10.1107/S0907444911045033; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; KNUDSEN S, 1995, APPL ENVIRON MICROB, V61, P985, DOI 10.1128/AEM.61.3.985-991.1995; Kotton CN, 2006, VACCINE, V24, P6216, DOI 10.1016/j.vaccine.2006.05.094; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Li J, 2015, CURR MICROBIOL; Lin IYC, 2015, VACCINES-BASEL, V3, P940, DOI 10.3390/vaccines3040940; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MOLIN S, 1993, ANNU REV MICROBIOL, V47, P139, DOI 10.1146/annurev.micro.47.1.139; Moriel DG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00326-16; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Ronchel MC, 1998, APPL ENVIRON MICROB, V64, P4904; Simon Anna J, 2016, F1000Res, V5, DOI 10.12688/f1000research.8365.1; TACKET CO, 1991, J INFECT DIS, V163, P901, DOI 10.1093/infdis/163.4.901; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Viret JF, 2004, VACCINE, V22, P2457, DOI 10.1016/j.vaccine.2003.12.033; Wright O, 2013, MICROBIOL-SGM, V159, P1221, DOI 10.1099/mic.0.066308-0; Xiong K, 2015, INT J MED MICROBIOL, V305, P563, DOI 10.1016/j.ijmm.2015.07.004; Xiong K, 2012, FEMS MICROBIOL LETT, V328, P70, DOI 10.1111/j.1574-6968.2011.02481.x; Yuki Y, 2009, EXPERT REV VACCINES, V8, P1083, DOI [10.1586/erv.09.61, 10.1586/ERV.09.61]	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179649	10.1371/journal.pone.0179649	http://dx.doi.org/10.1371/journal.pone.0179649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628661	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100042
J	Ward, TA; McHugh, PJ; Durant, ST				Ward, Thomas A.; McHugh, Peter J.; Durant, Stephen T.			Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; DOUBLE-STRAND BREAKS; NONPOLYPOSIS COLORECTAL-CANCER; OKAZAKI FRAGMENT MATURATION; NUCLEOTIDE EXCISION-REPAIR; STALLED REPLICATION FORKS; INTERSTRAND CROSS-LINKS; SACCHAROMYCES-CEREVISIAE; MICROSATELLITE INSTABILITY; HOMOLOGOUS RECOMBINATION	Flap endonuclease 1 (FEN1) is a structure selective endonuclease required for proficient DNA replication and the repair of DNA damage. Cellularly active inhibitors of this enzyme have previously been shown to induce a DNA damage response and, ultimately, cell death. High- throughput screens of human cancer cell-lines identify colorectal and gastric cell-lines with microsatellite instability (MSI) as enriched for cellular sensitivity to N-hydroxyurea series inhibitors of FEN1, but not the PARP inhibitor olaparib or other inhibitors of the DNA damage response. This sensitivity is due to a synthetic lethal interaction between FEN1 and MRE11A, which is often mutated in MSI cancers through instabilities at a poly(T) microsatellite repeat. Disruption of ATM is similarly synthetic lethal with FEN1 inhibition, suggesting that disruption of FEN1 function leads to the accumulation of DNA double-strand breaks. These are likely a result of the accumulation of aberrant replication forks, that accumulate as a consequence of a failure in Okazaki fragment maturation, as inhibition of FEN1 is toxic in cells disrupted for the Fanconi anemia pathway and post-replication repair. Furthermore, RAD51 foci accumulate as a consequence of FEN1 inhibition and the toxicity of FEN1 inhibitors increases in cells disrupted for the homologous recombination pathway, suggesting a role for homologous recombination in the resolution of damage induced by FEN1 inhibition. Finally, FEN1 appears to be required for the repair of damage induced by olaparib and cisplatin within the Fanconi anemia pathway, and may play a role in the repair of damage associated with its own disruption.	[Ward, Thomas A.; Durant, Stephen T.] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Oncol Biosci, Alderley Pk, Macclesfield, Cheshire, England; [Ward, Thomas A.; McHugh, Peter J.] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Dept Oncol, Oxford, England; [Durant, Stephen T.] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Oncol Biosci, Cambridge, England; [Ward, Thomas A.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Radiat Biol & Therapy Grp, Leeds, W Yorkshire, England	AstraZeneca; University of Oxford; AstraZeneca; Saint James's University Hospital; University of Leeds	Ward, TA; Durant, ST (corresponding author), AstraZeneca, Innovat Med & Early Dev Biotech Unit, Oncol Biosci, Alderley Pk, Macclesfield, Cheshire, England.; Ward, TA (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med, Dept Oncol, Oxford, England.; Durant, ST (corresponding author), AstraZeneca, Innovat Med & Early Dev Biotech Unit, Oncol Biosci, Cambridge, England.; Ward, TA (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Canc & Pathol, Radiat Biol & Therapy Grp, Leeds, W Yorkshire, England.	t.a.ward@leeds.ac.uk; stephen.durant@astrazeneca.com	Ward, Thomas/O-8002-2019	Ward, Thomas/0000-0003-0937-4554; McHugh, Peter/0000-0002-8679-4627	Cancer Research UK Programme Grant [CA9047/A10111]; AstraZeneca Postdoctoral Research Program; AstraZeneca	Cancer Research UK Programme Grant(Cancer Research UK); AstraZeneca Postdoctoral Research Program; AstraZeneca(AstraZeneca)	Work performed in the laboratory of PJM was supported by Cancer Research UK Programme Grant CA9047/A10111 (http://science.cancerresearchuk.org/). Work performed by TAW at AstraZeneca Pharmaceuticals was funded by the AstraZeneca Postdoctoral Research Program. AstraZeneca provided financial support in the form of salaries and research materials for TAW and STD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P1326, DOI 10.1016/j.molonc.2014.04.009; Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Algasaier SI, 2016, J BIOL CHEM; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Barber LJ, 2005, MOL CELL BIOL, V25, P2297, DOI 10.1128/MCB.25.6.2297-2309.2005; Becker JR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005659; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Boch J, 2011, NAT BIOTECHNOL, V29, P135, DOI 10.1038/nbt.1767; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Cerbinskaite A, 2012, CANCER TREAT REV, V38, P89, DOI 10.1016/j.ctrv.2011.04.015; Daee DL, 2007, MOL CELL BIOL, V27, P102, DOI 10.1128/MCB.01167-06; Daee Danielle L, 2012, Genome Integr, V3, P7, DOI 10.1186/2041-9414-3-7; Daee DL, 2012, J BIOL CHEM, V287, P26563, DOI 10.1074/jbc.M112.369918; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Dovrat D, 2014, P NATL ACAD SCI USA, V111, P14118, DOI 10.1073/pnas.1321349111; Duan WR, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00368; Durant ST, 2012, J CANCER, V3, P67, DOI 10.7150/jca.3965; Exell JC, 2016, NAT CHEM BIOL; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Grasby JA, 2012, TRENDS BIOCHEM SCI, V37, P74, DOI 10.1016/j.tibs.2011.10.003; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hopfner KP, 2014, BIOESSAYS, V36, P1170, DOI 10.1002/bies.201400102; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Jaiswal AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123808; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Kim HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082769; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; KOI M, 1994, CANCER RES, V54, P4308; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Koppensteiner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100041; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Lachaud C, 2016, SCIENCE, V351, P846, DOI 10.1126/science.aad5634; Lam JS, 2006, BJU INT, V98, P445, DOI 10.1111/j.1464-410X.2006.06224.x; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Lawes DA, 2003, EUR J SURG ONCOL, V29, P201, DOI 10.1053/ejso.2002.1399; Li HR, 2004, CANCER RES, V64, P4760, DOI 10.1158/0008-5472.CAN-04-0975; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Matsuzaki Y, 2002, NUCLEIC ACIDS RES, V30, P3273, DOI 10.1093/nar/gkf440; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McHugh PJ, 2012, CELL CYCLE, V11, P3739, DOI 10.4161/cc.21727; McHugh PJ, 2000, MOL CELL BIOL, V20, P3425, DOI 10.1128/MCB.20.10.3425-3433.2000; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; McWhirter C, 2013, J BIOMOL SCREEN, V18, P567, DOI 10.1177/1087057113476551; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Moreau S, 2001, GENETICS, V159, P1423; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066379; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Paull TT, 2015, ANNU REV BIOCHEM, V84, P711, DOI 10.1146/annurev-biochem-060614-034335; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Pizzolato J, 2015, J BIOL CHEM, V290, P22602, DOI 10.1074/jbc.M115.663666; Porter-Goff ME, 2009, MOL BIOL CELL, V20, P2096, DOI 10.1091/mbc.E08-09-0986; Qian LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082666; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shen BH, 2005, BIOESSAYS, V27, P717, DOI 10.1002/bies.20255; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; Shibata Y, 2002, J BIOL CHEM, V277, P746, DOI 10.1074/jbc.M109461200; Singh P, 2008, MOL CANCER RES, V6, P1710, DOI 10.1158/1541-7786.MCR-08-0269; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Stodola JL, 2016, NAT STRUCT MOL BIOL; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tadi SK, 2015, MOL BIOL CELL; Takahata C, 2015, CARCINOGENESIS, V36, P841, DOI 10.1093/carcin/bgv078; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Tumey LN, 2005, BIOORG MED CHEM LETT, V15, P277, DOI 10.1016/j.bmcl.2004.10.086; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WAGA S, 1994, J BIOL CHEM, V269, P10923; Ward TA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002884; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Wheeler JMD, 1999, P NATL ACAD SCI USA, V96, P10296, DOI 10.1073/pnas.96.18.10296; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yang JH, 2007, GENE, V393, P110, DOI 10.1016/j.gene.2007.01.025; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	103	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179278	10.1371/journal.pone.0179278	http://dx.doi.org/10.1371/journal.pone.0179278			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628639	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100024
J	da Cunha, M; Pais, SV; Bugalhao, JN; Mota, LJ				da Cunha, Maria; Pais, Sara V.; Bugalhao, Joana N.; Mota, Luis Jaime			The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; YERSINIA-ENTEROCOLITICA; TRANSLOCATED PROTEIN; INC PROTEINS; PLASMID; IDENTIFICATION; VIRULENCE; INFECTION; SYSTEM; GENES	Chlamydia trachomatis is a human bacterial pathogen causing ocular and genital infections. It multiplies exclusively within an intracellular membrane-bound vacuole, the inclusion, and uses a type III secretion system to manipulate host cells by injecting them with bacterially encoded effector proteins. In this work, we characterized the expression and subcellular localization in infected host cells of the C. trachomatis CT142, CT143, and CT144 proteins, which we previously showed to be type III secretion substrates. Transcriptional analyses in C. trachomatis confirmed the prediction that ct142, ct143 and ct144 are organized in an operon and revealed that their expression is likely driven by the main a factor, 666. In host cells infected by C. trachomatis, production of CT142 and CT143 could be detected by immunoblotting from 20-26 h post-infection. Immunofluorescence microscopy of infected cells revealed that from 20 h post-infection CT143 appeared mostly as globular structures outside of the bacterial cells but within the lumen of the inclusion. Furthermore, immunofluorescence microscopy of cells infected by C. trachomatis strains carrying plasmids producing CT142, CT143, or CT144 under the control of the ct142 promoter and with a C-terminal double hemagglutinin (2HA) epitope tag revealed that CT142-2HA, CT143-2HA or CT144-2HA showed an identical localization to chromosomally-encoded CT143. Moreover, CT142-2HA or CT144-2HA and CT143 produced by the same bacteria co-localized in the lumen of the inclusion. Overall, these data suggest that the CT142, CT143, and CT144 type III secretion substrates are secreted into the lumen of the inclusion where they might form a protein complex.	[da Cunha, Maria; Pais, Sara V.; Bugalhao, Joana N.; Mota, Luis Jaime] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, UCIBIO REQUIMTE, Caparica, Portugal; [da Cunha, Maria; Mota, Luis Jaime] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Mota, LJ (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, UCIBIO REQUIMTE, Caparica, Portugal.; Mota, LJ (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.	ljmota@fct.unl.pt	Mota, Luis/B-9497-2008	Mota, Luis/0000-0002-5592-8397; Bugalhao, Joana/0000-0002-0823-3541; Paiva Raposo Da Cunha, Maria/0000-0002-6453-7785; Pais, Sara/0000-0003-2392-0451	Fundacao para a Ciencia e a Tecnologia (FCT) [ERA-PTG/0005/2010]; Unidade de Ciencias Biomoleculares Aplicadas (UCIBIO); national funds from FCT [UID/Multi/04378/2013]; European Regional Development Fund (ERDF) under the PT2020 Partnership Agreement [POCI-01-0145-FEDER-007728]; FCT [SFRH/BD/62728/2009, PD/BD/52210/2013, PD/BD/128214/2016, PD/00133/2012]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Unidade de Ciencias Biomoleculares Aplicadas (UCIBIO); national funds from FCT(Portuguese Foundation for Science and Technology); European Regional Development Fund (ERDF) under the PT2020 Partnership Agreement; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) through grant ERA-PTG/0005/2010 (in the frame of ERA-NET PathoGenoMics) to LJM and by Unidade de Ciencias Biomoleculares Aplicadas (UCIBIO), which is financed by national funds from FCT (UID/Multi/04378/2013) and co-financed by the European Regional Development Fund (ERDF) under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007728). MdC was supported by PhD fellowship SFRH/BD/62728/2009 from FCT. SVP and JNB hold PhD fellowships PD/BD/52210/2013 and PD/BD/128214/2016, respectively, within the scope of the PhD program Molecular Biosciences (PD/00133/2012) funded by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Bannantine JP, 1998, MOL MICROBIOL, V28, P1017, DOI 10.1046/j.1365-2958.1998.00867.x; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; Chellas-Gery B, 2007, CELL MICROBIOL, V9, P2417, DOI 10.1111/j.1462-5822.2007.00970.x; Chen Y, 2014, NANO ENERGY, V10, P1, DOI 10.1016/j.nanoen.2014.08.016; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; da Cunha M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-40; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Diepold A, 2014, FEMS MICROBIOL REV, V38, P802, DOI 10.1111/1574-6976.12061; Dumoux M, 2015, J CELL SCI, V128, P3420, DOI 10.1242/jcs.169318; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Engstrom P, 2013, J BACTERIOL, V195, P4221, DOI 10.1128/JB.00506-13; Ferreira R, 2013, MICROBIOL RES, V168, P333, DOI 10.1016/j.micres.2013.02.001; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Fischer A, 2017, ELIFE, V6, DOI 10.7554/eLife.21465; Furtado AR, 2013, CELL MICROBIOL, V15, P2064, DOI 10.1111/cmi.12171; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gehre L, 2016, ELIFE, V5, DOI 10.7554/eLife.12552; GORDON FB, 1965, J INFECT DIS, V115, P186, DOI 10.1093/infdis/115.2.186; Ho TD, 2005, INFECT IMMUN, V73, P905, DOI 10.1128/IAI.73.2.905-911.2005; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hovis KM, 2013, PATHOG DIS, V69, P213, DOI 10.1111/2049-632X.12070; Hower S, 2009, MOL MICROBIOL, V72, P1423, DOI 10.1111/j.1365-2958.2009.06732.x; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Jorgensen I, 2008, INFECT IMMUN, V76, P3940, DOI 10.1128/IAI.00632-08; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Lu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068764; Martinez-Argudo I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052179; Mathews S, 2006, CHLAMYDIA GENOMICS P, P133; Mehlitz A, 2010, J CELL BIOL, V190, P143, DOI 10.1083/jcb.200909095; MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Mueller KE, 2016, MBIO, V7, DOI 10.1128/mBio.01817-15; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Nguyen BD, 2013, JOVE-J VIS EXP, DOI 10.3791/50636; Nordfelth R, 2005, INFECT IMMUN, V73, P3104, DOI 10.1128/IAI.73.5.3104-3114.2005; O'Connell CM, 2016, MICROB CELL, V3, P390, DOI 10.15698/mic2016.09.525; Olivares-Zavaleta N, 2010, VACCINE, V28, P1454, DOI 10.1016/j.vaccine.2009.11.073; Pais SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056292; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; PETERSON EM, 1990, PLASMID, V23, P144, DOI 10.1016/0147-619X(90)90033-9; Prantner D, 2008, INFECT IMMUN; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Sigar IM, 2014, PATHOG DIS, V70, P61, DOI 10.1111/2049-632X.12086; Sixt BS, 2017, CELL HOST MICROBE, V21, P113, DOI 10.1016/j.chom.2016.12.002; Slepenkin A, 2007, INFECT IMMUN, V75, P3478, DOI 10.1128/IAI.00023-07; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subtil A, 2005, MOL MICROBIOL, V56, P1636, DOI 10.1111/j.1365-2958.2005.04647.x; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Taylor HR, 2014, LANCET; Taylor-Brown A, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu009; Vromman F, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00123; Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15; Wang D, 2011, J BIOL CHEM, V286, P29922, DOI 10.1074/jbc.M111.233858; Wolf K, 2006, MOL MICROBIOL, V61, P1543, DOI 10.1111/j.1365-2958.2006.05347.x; Wolf K, 2009, CELL MICROBIOL, V11, P769, DOI 10.1111/j.1462-5822.2009.01290.x; Yates WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080287; Zhong GM, 2017, TRENDS MICROBIOL, V25, P141, DOI 10.1016/j.tim.2016.09.006	71	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178856	10.1371/journal.pone.0178856	http://dx.doi.org/10.1371/journal.pone.0178856			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622339	Green Submitted, gold, Green Published			2022-12-26	WOS:000403506300011
J	Romero-Olivares, AL; Allison, SD; Treseder, KK				Romero-Olivares, Adriana L.; Allison, Steven D.; Treseder, Kathleen K.			Decomposition of recalcitrant carbon under experimental warming in boreal forest	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; CLIMATE-CHANGE; TEMPERATURE SENSITIVITY; PLANT-TISSUE; FEEDBACKS; FUNGI; GRASSLAND; ECOSYSTEM; DYNAMICS; LIGNIN	Over the long term, soil carbon (C) storage is partly determined by decomposition rate of carbon that is slow to decompose (i.e., recalcitrant C). According to thermodynamic theory, decomposition rates of recalcitrant C might differ from those of non-recalcitrant C in their sensitivities to global warming. We decomposed leaf litter in a warming experiment in Alaskan boreal forest, and measured mass loss of recalcitrant C (lignin) vs. non-recalcitrant C (cellulose, hemicellulose, and sugars) throughout 16 months. We found that these C fractions responded differently to warming. Specifically, after one year of decomposition, the ratio of recalcitrant C to non-recalcitrant C remaining in litter declined in the warmed plots compared to control. Consistent with this pattern, potential activities of enzymes targeting recalcitrant C increased with warming, relative to those targeting non-recalcitrant C. Even so, mass loss of individual C fractions showed that non-recalcitrant C is preferentially decomposed under control conditions whereas recalcitrant C losses remain unchanged between control and warmed plots. Moreover, overall mass loss was greater under control conditions. Our results imply that direct warming effects, as well as indirect warming effects (e.g. drying), may serve to maintain decomposition rates of recalcitrant C compared to non recalcitrant C despite negative effects on overall decomposition.	[Romero-Olivares, Adriana L.; Allison, Steven D.; Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Allison, Steven D.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Romero-Olivares, AL (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	alromer1@uci.edu	Romero-Olivares, Adriana/V-6534-2018; Treseder, Kathleen K/E-5148-2011; Allison, Steven D./E-2978-2010	Romero-Olivares, Adriana/0000-0003-0287-3043; Treseder, Kathleen K/0000-0003-2847-6935; Allison, Steven D./0000-0003-4629-7842	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT), UC-MEXUS [216015]; American Association of University Women (AAUW) (International Fellowship); National Science Foundation [DEB-1256896, DEB-1457160, EAR-1411942]; Division Of Earth Sciences [1411942] Funding Source: National Science Foundation	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT), UC-MEXUS; American Association of University Women (AAUW) (International Fellowship); National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT), UC-MEXUS (scholarship no. 216015), and American Association of University Women (AAUW) (International Fellowship) to ALR-O and National Science Foundation grants DEB-1256896, DEB-1457160, and EAR-1411942.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Allison SD, 2007, SOIL BIOL BIOCHEM, V39, P1878, DOI 10.1016/j.soilbio.2007.02.001; Allison SD, 2011, FUNGAL ECOL, V4, P362, DOI 10.1016/j.funeco.2011.01.003; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Aravantinos-Zafiris G., 1994, Lebensmittel-Wissenschaft and Technologie, V27, P468, DOI 10.1006/fstl.1994.1094; Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Bradford MA, 2016, NAT CLIM CHANGE, V6, P751, DOI [10.1038/NCLIMATE3071, 10.1038/nclimate3071]; Bronson DR, 2008, GLOBAL CHANGE BIOL, V14, P856, DOI 10.1111/j.1365-2486.2007.01508.x; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; DeAngelis KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00104; German DP, 2012, GLOBAL CHANGE BIOL, V18, P1468, DOI 10.1111/j.1365-2486.2011.02615.x; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; HANSEN J, 1975, ANAL BIOCHEM, V68, P87, DOI 10.1016/0003-2697(75)90682-X; Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; HUDSON HJ, 1968, NEW PHYTOL, V67, P837, DOI 10.1111/j.1469-8137.1968.tb06399.x; IPCC, 2014, IPCC 2014 CLIMATE CH; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Kleber M, 2010, ENVIRON CHEM, V7, P320, DOI 10.1071/EN10006; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; PARTON WJ, 1988, BIOGEOCHEMISTRY, V5, P109, DOI 10.1007/BF02180320; Pold G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00480; Pries CEH, 2013, J GEOPHYS RES-BIOGEO, V118, P1133, DOI 10.1002/jgrg.20089; R Core Development Team, 2009, R LANG ENV STAT COMP; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Stokstad E, 2004, SCIENCE, V304, P1618, DOI 10.1126/science.304.5677.1618; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Talbot JM, 2012, BIOGEOCHEMISTRY, V108, P279, DOI 10.1007/s10533-011-9599-6; Theander O, 1995, J AOAC INT, V78, P1030; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Treseder KK, 2016, GLOBAL CHANGE BIOL, V22, P3395, DOI 10.1111/gcb.13238; Treseder KK, 2004, ECOL APPL, V14, P1826, DOI 10.1890/03-5133; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI DOI 10.1128/MMBR.00041-14; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Verburg PSJ, 1999, BIOL FERT SOILS, V28, P271, DOI 10.1007/s003740050493; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; Xu WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06512	45	21	21	10	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179674	10.1371/journal.pone.0179674	http://dx.doi.org/10.1371/journal.pone.0179674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622366	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300049
J	Arredondo, JJ; Vivar, J; Laine-Menendez, S; Martinez-Morentin, L; Cervera, M				Arredondo, Juan J.; Vivar, Jorge; Laine-Menendez, Sara; Martinez-Morentin, Leticia; Cervera, Margarita			CF2 transcription factor is involved in the regulation of Mef2 RNA levels, nuclei number and muscle fiber size	PLOS ONE			English	Article							GENE-EXPRESSION; DROSOPHILA EMBRYOGENESIS; SOMATIC MUSCULATURE; CELL FATES; TROPONIN-T; MYOGENESIS; MESODERM; D-MEF2; SPECIFICATION; MELANOGASTER	CF2 and Mef2 influence a variety of developmental muscle processes at distinct stages of development. Nevertheless, the exact nature of the CF2-Mef2 relationship and its effects on muscle building remain yet to be resolved. Here, we explored the regulatory role of CF2 in the Drosophila embryo muscle formation. To address this question and not having proper null CF2 mutants we exploited loss or gain of function strategies to study the contribution of CF2 to Mef2 transcription regulation and to muscle formation. Our data point to CF2 as a factor involved in the regulation of muscle final size and/or the number of nuclei present in each muscle. This function is independent of its role as a Mef2 collaborative factor in the transcriptional regulation of muscle-structural genes. Although Mef2 expression patterns do not change, reductions or increases in parallel in CF2 and Mef2 transcript abundance were observed in interfered and overexpressed CF2 embryos. Since CF2 expression variations yield altered Mef2 expression levels but with correct spatio-temporal Mef2 expression patterns, it can be concluded that only the mechanism controlling expression levels is de-regulated. Here, it is proposed that CF2 regulates Mef2 expression through a Feedforward Loop circuit.	[Arredondo, Juan J.; Cervera, Margarita] Univ Autonoma Madrid, UAM CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, C Arzobispo Morcillo 4, Madrid, Spain; Univ Autonoma Madrid, Fac Med, Ctr Invest Biomed Red CIBERER, C Arzobispo Morcillo 4, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Arredondo, JJ; Cervera, M (corresponding author), Univ Autonoma Madrid, UAM CSIC, Inst Invest Biomed Alberto Sols, Dept Bioquim, C Arzobispo Morcillo 4, Madrid, Spain.	juan.arredondo@uam.es; margarita.cervera@uam.es	Arredondo, Juan/L-2404-2013; Perez, Claudio A/F-3560-2015	Arredondo, Juan/0000-0002-6784-0990; Perez, Claudio A/0000-0002-5484-4159; , Sara/0000-0001-6048-624X	Ministerio de Economia y Competitividad espanol (MINECO) [BFU2010-19551]	Ministerio de Economia y Competitividad espanol (MINECO)	This work was supported by Ministerio de Economia y Competitividad espanol (MINECO) BFU2010-19551 to MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abmayr SM, 1998, CURR TOP DEV BIOL, V38, P35; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Arredondo JJ, 2001, J BIOL CHEM, V276, P8278, DOI 10.1074/jbc.M009302200; Bagni C, 2002, MECH DEVELOP, V117, P265, DOI 10.1016/S0925-4773(02)00176-4; BATE M, 1990, DEVELOPMENT, V110, P791; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carmena A, 1998, GENE DEV, V12, P304, DOI 10.1101/gad.12.3.304; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; Dobi KC, 2015, WIRES DEV BIOL, V4, P357, DOI 10.1002/wdev.182; Elgar SJ, 2008, P NATL ACAD SCI USA, V105, P918, DOI 10.1073/pnas.0711255105; Fujioka M, 2005, CIRC RES, V97, P1108, DOI 10.1161/01.RES.0000191546.08532.B2; Gajewski KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010713; Garcia-Zaragoza E, 2008, MECH DEVELOP, V125, P617, DOI 10.1016/j.mod.2008.03.003; Ghanim M, 2006, BIOTECHNIQUES, V41, P414, DOI 10.2144/000112267; Gunthorpe D, 1999, DEV BIOL, V215, P130, DOI 10.1006/dbio.1999.9449; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; Kelly KK, 2002, MECH DEVELOP, V110, P39, DOI 10.1016/S0925-4773(01)00586-X; LILLY B, 1994, P NATL ACAD SCI USA, V91, P5662, DOI 10.1073/pnas.91.12.5662; Lin MH, 1997, DEV BIOL, V182, P240, DOI 10.1006/dbio.1996.8484; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mantrova EY, 1998, GENE DEV, V12, P1166; Marco-Ferreres R, 2005, BIOCHEM J, V386, P145, DOI 10.1042/BJ20041240; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Mas JA, 2004, MOL BIOL CELL, V15, P1931, DOI 10.1091/mbc.e03-10-0729; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; Paululat A, 1999, MECH DEVELOP, V83, P17, DOI 10.1016/S0925-4773(99)00029-5; RANGANAYAKULU G, 1995, DEV BIOL, V171, P169, DOI 10.1006/dbio.1995.1269; Ruiz-Gomez M, 1998, INT J DEV BIOL, V42, P283; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schulman VK, 2015, WIRES DEV BIOL, V4, P313, DOI 10.1002/wdev.180; SKEATH JB, 1992, GENE DEV, V6, P2606, DOI 10.1101/gad.6.12b.2606; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Tanaka KKK, 2008, MOL CELL BIOL, V28, P1616, DOI 10.1128/MCB.01169-07; TAYLOR MV, 1995, MECH DEVELOP, V50, P29, DOI 10.1016/0925-4773(94)00323-F; Ward EJ, 2000, MECH DEVELOP, V96, P233, DOI 10.1016/S0925-4773(00)00389-0	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179194	10.1371/journal.pone.0179194	http://dx.doi.org/10.1371/journal.pone.0179194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617826	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600024
J	Hsu, KC; Wang, FS				Hsu, Kai-Cheng; Wang, Feng-Sheng			Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; SYSTEMS BIOLOGY; PERSONALIZED MEDICINE; 2-HIT HYPOTHESIS; DRUG DISCOVERY; ENZYME TARGETS; SCHIZOPHRENIA; BIOMARKERS; DYSFUNCTION; PSYCHIATRY	Precision medicine considers an individual's unique physiological characteristics as strongly influential in disease vulnerability and in response to specific therapies. Predicting an individual's susceptibility to developing an illness, making an accurate diagnosis, maximizing therapeutic effects, and minimizing adverse effects for treatment are essential in precision medicine. We introduced model-based precision medicine optimization approaches, including pathogenesis, biomarker detection, and drug target discovery, for treating presynaptic dopamine overactivity. Three classes of one-hit and two-hit enzyme defects were detected as the causes of disease states by the optimization approach of pathogenesis. The cluster analysis and support vector machine was used to detect optimal biomarkers in order to discriminate the accurate etiology from three classes of disease states. Finally, the fuzzy decision-making method was employed to discover common and specific drug targets for each classified disease state. We observed that more accurate diagnoses achieved higher satisfaction grades and dosed fewer enzyme targets to treat the disease. Furthermore, satisfaction grades for common drugs were lower than for specific ones, but common drugs could simultaneously treat several disease states that had different etiologies.	[Hsu, Kai-Cheng] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Neurol, Huwei Township, Yunlin, Taiwan; [Wang, Feng-Sheng] Natl Chung Cheng Univ, Dept Chem Engn, Chiayi, Taiwan	National Taiwan University; National Taiwan University Hospital; National Chung Cheng University	Wang, FS (corresponding author), Natl Chung Cheng Univ, Dept Chem Engn, Chiayi, Taiwan.	chmfsw@ccu.edu.tw			Ministry of Science of Technology, Taiwan, ROC [MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, MOST105-2627-M-194-001]; Ministry of Science and Technology of Taiwan [MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, MOST105-2627-M-194-001]	Ministry of Science of Technology, Taiwan, ROC; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was financially supported by the Ministry of Science of Technology, Taiwan, ROC (https://www.most.gov.tw/) through grants MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001, and MOST105-2627-M-194-001, grant recipient Prof. Feng-Sheng Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from Ministry of Science and Technology of Taiwan (Grant MOST103-2221-E-194-045-MY3, MOST104-2627-B-194-001 and MOST105-2627-M-194-001), is highly appreciated.	Alawieh A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00187; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Avila-Rojas H, 2016, INVEST CLIN, V57, P217; Barbolosi D, 2016, NAT REV CLIN ONCOL, V13, P242, DOI 10.1038/nrclinonc.2015.204; Baumeister Alan A, 2002, J Hist Neurosci, V11, P265, DOI 10.1076/jhin.11.3.265.10391; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bishop C. M, 2006, PATTERN RECOGNITION; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Feigenson KA, 2014, NEUROSCI BIOBEHAV R, V38, P72, DOI 10.1016/j.neubiorev.2013.11.006; Friedman J, 2001, SPRINGER SERIES STAT, V10; Gillani Z, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0395-x; Gnanadesikan R., 1982, UTILITAS MATH A, V21A, P75; Guillen-Gosalbez G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-386; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Hsu KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164589; Hsu KC, 2013, BIOINFORMATICS, V29, P3191, DOI 10.1093/bioinformatics/btt564; Hsu KC, 2010, COMPUT BIOL MED, V40, P823, DOI 10.1016/j.compbiomed.2010.08.005; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kraemer HC, 2002, AM J GERIAT PSYCHIAT, V10, P653, DOI 10.1176/appi.ajgp.10.6.653; Lewandowski KE, 2007, HARVARD REV PSYCHIAT, V15, P233, DOI 10.1080/10673220701650409; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Lyon GJ, 2011, SCHIZOPHRENIA BULL, V37, P108, DOI 10.1093/schbul/sbp010; Materi W, 2007, DRUG DISCOV TODAY, V12, P295, DOI 10.1016/j.drudis.2007.02.013; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; McGowan S, 2004, ARCH GEN PSYCHIAT, V61, P134, DOI 10.1001/archpsyc.61.2.134; McLachlan G J, 1992, Stat Methods Med Res, V1, P27, DOI 10.1177/096228029200100103; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Molero P, 2007, PHARMACOGENOMICS J, V7, P418, DOI 10.1038/sj.tpj.6500441; Montine TJ, 2015, J EXP MED, V212, P601, DOI 10.1084/jem.20150656; Nemeroff CB, 2013, BMC MED, V11, DOI [10.1186/1741-7015-11-202, 10.1186/1741-7015-11-132]; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Pontil M, 1998, IEEE T PATTERN ANAL, V20, P637, DOI 10.1109/34.683777; Qi Z, 2008, PHARMACOPSYCHIATRY, V41, pS89, DOI 10.1055/s-2008-1080936; Qi Z, 2010, PHARMACOPSYCHIATRY, V43, pS50, DOI 10.1055/s-0030-1248317; Qi Z, 2011, HANDBOOK OF SCHIZOPHRENIA SPECTRUM DISORDERS, VOL 1, P305, DOI 10.1007/978-94-007-0837-2_14; Qi Z, 2009, SYNAPSE, V63, P1133, DOI 10.1002/syn.20686; Qi Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002444; Quinn L, 2003, FUNCTIONAL OUTCOMES; REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651; SEEMAN P, 1993, ARCH NEUROL-CHICAGO, V50, P1093, DOI 10.1001/archneur.1993.00540100078020; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Seeman P, 2006, SYNAPSE, V60, P319, DOI 10.1002/syn.20303; Stone JA, 2010, J CLIN PHARMACOL, V50, p20S, DOI 10.1177/0091270010377628; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tretter F, 2012, METHODS MOL BIOL, V829, P567, DOI 10.1007/978-1-61779-458-2_36; Vapnik V., 2013, NATURE STAT LEARNING; Vera J, 2007, BIOINFORMATICS, V23, P2281, DOI 10.1093/bioinformatics/btm326; Vera J, 2010, COMPUT OPER RES, V37, P1427, DOI 10.1016/j.cor.2009.02.021; Voit EO, 2012, FIRST COURSE SYSTEMS; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Woods AG, 2012, J CELL MOL MED, V16, P1184, DOI 10.1111/j.1582-4934.2012.01543.x; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328	62	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179575	10.1371/journal.pone.0179575	http://dx.doi.org/10.1371/journal.pone.0179575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614410	Green Submitted, Green Published, gold			2022-12-26	WOS:000403280900063
J	Schreiber, U; Mayer, C; Schmitz, OJ; Rosendahl, P; Bronja, A; Greule, M; Keppler, F; Mulder, I; Sattler, T; Scholer, HF				Schreiber, Ulrich; Mayer, Christian; Schmitz, Oliver J.; Rosendahl, Pia; Bronja, Amela; Greule, Markus; Keppler, Frank; Mulder, Ines; Sattler, Tobias; Schoeler, Heinz F.			Organic compounds in fluid inclusions of Archean quartz-Analogues of prebiotic chemistry on early Earth	PLOS ONE			English	Article							DETRITAL ZIRCONS; ORIGIN; CRUST	The origin of life is still an unsolved mystery in science. Hypothetically, prebiotic chemistry and the formation of protocells may have evolved in the hydrothermal environment of tectonic fault zones in the upper continental crust, an environment where sensitive molecules are protected against degradation induced e.g. by UV radiation. The composition of fluid inclusions in minerals such as quartz crystals which have grown in this environment during the Archean period might provide important information about the first organic molecules formed by hydrothermal synthesis. Here we present evidence for organic compounds which were preserved in fluid inclusions of Archean quartz minerals from Western Australia. We found a variety of organic compounds such as alkanes, halocarbons, alcohols and aldehydes which unambiguously show that simple and even more complex prebiotic organic molecules have been formed by hydrothermal processes. Stable-isotope analysis confirms that the methane found in the inclusions has most likely been formed from abiotic sources by hydrothermal chemistry. Obviously, the liquid phase in the continental Archean crust provided an interesting choice of functional organic molecules. We conclude that organic substances such as these could have made an important contribution to prebiotic chemistry which might eventually have led to the formation of living cells.	[Schreiber, Ulrich] Univ Duisburg Essen, Dept Geol, Univ Str 5, Essen, Germany; [Mayer, Christian] Univ Duisburg Essen, CeNIDE, Fac Chem, Univ Str 5, Essen, Germany; [Schmitz, Oliver J.; Rosendahl, Pia; Bronja, Amela] Univ Duisburg Essen, Appl Analyt Chem, Fac Chem, Univ Str 5, Essen, Germany; [Greule, Markus; Keppler, Frank; Mulder, Ines; Sattler, Tobias; Schoeler, Heinz F.] Heidelberg Univ, Inst Earth Sci, Neuenheimer Feld 234-236, Heidelberg, Germany; [Keppler, Frank; Schoeler, Heinz F.] Heidelberg Univ, Heidelberg Ctr Environm HCE, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mayer, C (corresponding author), Univ Duisburg Essen, CeNIDE, Fac Chem, Univ Str 5, Essen, Germany.	christian.mayer@uni-due.de	Schmitz, Oliver J/G-5615-2014; Keppler, Frank/F-4401-2012; Mayer, Christian/D-2144-2019; Mulder, Ines/ACL-4606-2022	Keppler, Frank/0000-0003-2766-8812; Schmitz, Oliver/0000-0003-2184-1207; Greule, Markus/0000-0002-9958-8371	DFG (German Science Foundation) [KE 884/81]; German Science Foundation (DFG) [763]	DFG (German Science Foundation)(German Research Foundation (DFG)); German Science Foundation (DFG)(German Research Foundation (DFG))	F. Keppler and M. Greule were supported by the DFG (German Science Foundation KE 884/81). I. Mulder, T. Saltier and H. F. Scholer are grateful for the financial support of the German Science Foundation (DFG Research Unit 763). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATURE CHEM, V5, P349; Baechmann K, 1990, PHYS CHEM BEHAV ATMO; Berndt ME, 1996, GEOLOGY, V24, P351, DOI 10.1130/0091-7613(1996)024<0351:ROCDSO>2.3.CO;2; Cavosie AJ, 2004, PRECAMBRIAN RES, V135, P251, DOI 10.1016/j.precamres.2004.09.001; Clayden J., 2012, ORGANIC CHEM; Etiope G, 2013, REV GEOPHYS, V51, P276, DOI 10.1002/rog.20011; Frische M, 2006, ENVIRON SCI POLLUT R, V13, P406, DOI 10.1065/espr2006.01.291; Galimov EM, 2006, GEOCHEM INT+, V44, P1, DOI 10.1134/S0016702906010010; Gribble GW, 2003, HANDB ENVIRON CHEM, V3, P1; Harrison TM, 2008, EARTH PLANET SC LETT, V268, P476, DOI 10.1016/j.epsl.2008.02.011; Jordan A, 2003, HANDB ENVIRON CHEM, V3, P121; Jordan A, 2000, ENVIRON SCI TECHNOL, V34, P1122, DOI 10.1021/es990838q; Keppler F, 2012, NATURE, V486, P93, DOI 10.1038/nature11203; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Mayer C, 2015, ORIGINS LIFE EVOL B, V45, P139, DOI 10.1007/s11084-015-9411-z; Mulder I, 2013, CHEM GEOL, V358, P148, DOI 10.1016/j.chemgeo.2013.09.003; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Muller B, 1999, EUR J INORG CHEM, P129; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Patai S, 1964, ALKENES, V1; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schreiber U, 2012, ORIGINS LIFE EVOL B, V42, P47, DOI 10.1007/s11084-012-9267-4; Trevors JT, 2011, INT J MOL SCI, V12, P1650, DOI 10.3390/ijms12031650; Ueno Y, 2006, NATURE, V440, P516, DOI 10.1038/nature04584; WACHTERSHAUSER G, 1988, MICROBIOL REV, V52, P452; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	27	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0177570	10.1371/journal.pone.0177570	http://dx.doi.org/10.1371/journal.pone.0177570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614348	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900005
J	Kendra, PE; Owens, D; Montgomery, WS; Narvaez, TI; Bauchan, GR; Schnell, EQ; Tabanca, N; Carrillo, D				Kendra, Paul E.; Owens, David; Montgomery, Wayne S.; Narvaez, Teresa I.; Bauchan, Gary R.; Schnell, Elena Q.; Tabanca, Nurhayat; Carrillo, Daniel			alpha-Copaene is an attractant, synergistic with quercivorol, for improved detection of Euwallacea nr. fornicatus (Coleoptera: Curculionidae: Scolytinae)	PLOS ONE			English	Article							REDBAY AMBROSIA BEETLE; ANASTREPHA-SUSPENSA DIPTERA; SOUTHEASTERN UNITED-STATES; ESSENTIAL OIL LURES; XYLEBORUS-GLABRATUS; RAFFAELEA-LAURICOLA; SYMBIOTIC FUNGUS; LAUREL WILT; ELECTROANTENNOGRAM RESPONSES; AVOCADO	The tea shot-hole borer, Euwallacea fornicatus Eichhoff, is an ambrosia beetle endemic to Asia and a pest of commercial tea, Camellia sinensis (L.) Kuntze. Recently, a complex of species morphologically similar to E. fornicatus has been recognized, which includes new pests established in Israel and the USA, both in California and Florida. Collectively termed E. nr. fornicatus, these cryptic species carry symbiotic Fusarium spp. fungi, some of which cause dieback disease in susceptible hosts, which include avocado, Persea americana Miller. Due to the threat to this economically important crop, research was initiated to evaluate efficacy of kairomone-based lures for detection of the beetle in Florida (termed the Florida tea shot hole borer, FL-TSHB). A series of field tests were conducted in 2016 in commercial avocado groves known to have FL-TSHB at various population levels. All tests evaluated lures containing quercivorol (p-menth-2-en-1-ol) and alpha-copaene, presented separately and in combination; and one test evaluated effect of trap type on beetle captures. In addition, electroantennography (EAG) was used to quantify female olfactory responses to lure emissions. This study identified (-)-alpha-copaene as a new attractant for FL-TSHB, equivalent in efficacy to quercivorol (the standard lure for Euwallacea detection in the USA); however, the combination of lures captured significantly more FL-TSHB than either lure alone. This combination resulted in synergistic attraction at two field sites and additive attraction at a third site. Sticky panel traps captured more FL-TSHB than comparably-baited Lindgren funnel traps. Females engaged in host-seeking flight from 11:00 to 16:00 hr (EST), with peak numbers observed between 12:00 and 13:00 hr. EAG analyses confirmed olfactory chemoreception of both kairomones, with a higher response elicited with the combination of volatiles. Results indicate that detection of pest E. nr. fornicatus in Florida can be improved by using a two-component lure consisting of p-menth-2-en-1-ol and (-)-alpha-copaene.	[Kendra, Paul E.; Owens, David; Montgomery, Wayne S.; Narvaez, Teresa I.; Schnell, Elena Q.; Tabanca, Nurhayat] ARS, USDA, Subtrop Hort Res Stn, Miami, FL 33158 USA; [Bauchan, Gary R.] ARS, USDA, Beltsville Area Res Ctr, Electron & Confocal Microscopy Unit, Beltsville, MD USA; [Carrillo, Daniel] Univ Florida, Ctr Trop Res & Educ, Homestead, FL 33031 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Kendra, PE (corresponding author), ARS, USDA, Subtrop Hort Res Stn, Miami, FL 33158 USA.	paul.kendra@ars.usda.gov	Bauchan, Gary/ABH-3800-2020	Carrillo, Daniel/0000-0003-2291-1844; Bauchan, Gary/0000-0003-3060-7666	United States Department of Agriculture, Agricultural Research Service (USDA-ARS); U.S. Department of Energy (DOE); U.S. Department of Agriculture (USDA); DOE [DE-SC0014664]	United States Department of Agriculture, Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE))	This research was supported by the United States Department of Agriculture, Agricultural Research Service (USDA-ARS) Appropriated Funds (Mitigation of the Invasive Pest Threat from the American Tropics and Subtropics) and by an appointment to the ARS Research Participation agreement between the U.S. Department of Energy (DOE) and the U.S. Department of Agriculture (USDA). ORISE is managed by ORAU under DOE contract number DE-SC0014664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosia beetles JE., 2012, FLA ENTOMOL, V95, P573; [Anonymous], 2014, AC TECHN WORKSH XYL; Atkinson TH, 2013, ZOOTAXA, V3669, P96, DOI 10.11646/zootaxa.3669.1.10; Bolton SJ, 2014, J NAT HIST, V48, P1359, DOI 10.1080/00222933.2013.859318; Brar GS, 2012, FLA ENTOMOL, V95, P1003, DOI 10.1653/024.095.0428; Campbell AS, 2017, PHYTOPATHOLOGY, V107, P70, DOI 10.1094/PHYTO-02-16-0072-R; Carrillo D, 2014, PLANT PATHOL, V63, P54, DOI 10.1111/ppa.12073; Carrillo D, 2016, INSECTS, V7, DOI 10.3390/insects7040055; Carrillo D, 2015, FLA ENTOMOL, V98, P780, DOI 10.1653/024.098.0258; Commodity trade statistics database (UN Comtrade), 2016, AV EXP ISR; DANTHANARAYANA W, 1968, Tea Quarterly, V39, P61; Garcia-Avila CD, 2016, FLA ENTOMOL, V99, P555, DOI 10.1653/024.099.0335; Eskalen A, 2012, PLANT DIS, V96, P1070, DOI 10.1094/PDIS-03-12-0276-PDN; Eskalen A., 2016, FUSARIUM DIEBACK PSH; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Freeman S, 2013, MYCOLOGIA, V105, P1595, DOI 10.3852/13-066; Freeman S, 2014, AC TECHN WORKSH XYL; Guillen L, 2016, ENTOMOL EXP APPL, V160, P251, DOI 10.1111/eea.12483; Haack Robert A., 2003, Integrated Pest Management Reviews, V6, P253, DOI 10.1023/A:1025715200538; Hanula JL, 2008, J ECON ENTOMOL, V101, P1276, DOI 10.1603/0022-0493(2008)101[1276:BAHAOR]2.0.CO;2; Harrington TC, 2008, MYCOTAXON, V104, P399; Hughes M.A., 2015, PLANT HLTH PROG, V16, P174, DOI DOI 10.1094/PHP-RP-15-0017; Hulcr J, 2011, J CHEM ECOL, V37, P1374, DOI 10.1007/s10886-011-0046-x; Hulcr J, 2011, P ROY SOC B-BIOL SCI, V278, P2866, DOI 10.1098/rspb.2011.1130; Inch S, 2012, BOTANY, V90, P627, DOI [10.1139/B2012-015, 10.1139/b2012-015]; Kashiwagi T, 2006, BIOSCI BIOTECH BIOCH, V70, P2544, DOI 10.1271/bbb.60211; Kendra P. E., 2013, American Journal of Plant Sciences, V4, P727; Kendra P. E., 2015, 53 ANN M ENT SOC AM; Kendra PE, 2016, J ECON ENTOMOL, V109, P2428, DOI 10.1093/jee/tow214; Kendra PE, 2016, J PEST SCI, V89, P427, DOI 10.1007/s10340-015-0708-5; Kendra PE, 2014, J PEST SCI, V87, P681, DOI 10.1007/s10340-014-0561-y; Kendra PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102086; Kendra PE, 2012, ENVIRON ENTOMOL, V41, P1597, DOI 10.1603/EN12164; Kendra PE, 2012, FLA ENTOMOL, V95, P513, DOI 10.1653/024.095.0244; Kendra PE, 2012, J ECON ENTOMOL, V105, P659, DOI 10.1603/EC11398; Kendra PE, 2011, J CHEM ECOL, V37, P932, DOI 10.1007/s10886-011-9998-0; Kendra PE, 2011, FLA ENTOMOL, V94, P123, DOI 10.1653/024.094.0201; Kendra PE, 2009, ENVIRON ENTOMOL, V38, P1259, DOI 10.1603/022.038.0437; Kendra PE, 2005, ENVIRON ENTOMOL, V34, P584, DOI 10.1603/0046-225X-34.3.584; Kuhns EH, 2014, J CHEM ECOL, V40, P355, DOI 10.1007/s10886-014-0427-z; Kuhns EH, 2014, AGR FOREST ENTOMOL, V16, P87, DOI 10.1111/afe.12037; Lynch SC, 2016, MYCOLOGIA, V108, P313, DOI 10.3852/15-063; Martini X, 2015, J CHEM ECOL, V41, P613, DOI 10.1007/s10886-015-0595-5; Mayfield AE, 2013, ENVIRON ENTOMOL, V42, P743, DOI 10.1603/EN12341; Mendel Z, 2012, PHYTOPARASITICA, V40, P235, DOI 10.1007/s12600-012-0223-7; Miller DR, 2009, J CHEM ECOL, V35, P435, DOI 10.1007/s10886-009-9613-9; Niogret J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073601; Niogret J, 2011, FLA ENTOMOL, V94, P1010, DOI 10.1653/024.094.0439; Niogret J, 2011, J CHEM ECOL, V37, P483, DOI 10.1007/s10886-011-9953-0; O'Donnell K, 2015, FUNGAL GENET BIOL, V82, P277, DOI 10.1016/j.fgb.2014.10.014; OSTMARK H E, 1968, Florida Entomologist, V51, P155, DOI 10.2307/3493549; Ploetz RC, 2017, PLANT HLTH PROG, V18, P51, DOI 10.1094/PHP-12-16-0070-RP; Ploetz RC, 2017, J ECON ENTOMOL, V110, P347, DOI 10.1093/jee/tow292; Ploetz RC, 2017, FORESTS, V8, DOI 10.3390/f8020048; Rabaglia R. J., 2002, AM BEETLES, P792; Rabaglia RJ, 2006, ANN ENTOMOL SOC AM, V99, P1034, DOI 10.1603/0013-8746(2006)99[1034:ROAXCC]2.0.CO;2; SIAP-SAGARPA. Produccion Agriocola Ciclo: Perennes 2014, 2014, PROD AGR CICL PER 20; Stouthamer R, 2017, AGR FOREST ENTOMOL, V18; Systat Software, 2010, SIGMAPLOT 11 2 US GU; United States Department of Agriculture, NONC FRUITS NUTS 201; United States Department of Agriculture Forest Service, 2016, LAUR WILT DISTR MAP; Vega FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085860	63	49	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179416	10.1371/journal.pone.0179416	http://dx.doi.org/10.1371/journal.pone.0179416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609448	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700036
J	Ye, A; Kim, H; Kim, J				Ye, An; Kim, Hana; Kim, Joomyeong			PEG3 control on the mammalian MSL complex	PLOS ONE			English	Article							IMPRINTED DOMAIN; GENE; METHYLATION; VISUALIZATION; ACETYLATION; BINDING; PROTEIN; MOF	Peg3 (paternally expressed gene 3) encodes a DNA-binding protein that functions as a transcriptional repressor. Recent studies revealed that PEG3 binds to Msl1 (male-specific lethal 1) and Msl3, the two main components of the MSL complex. In the current study, we investigated potential roles of Peg3 in controlling its downstream genes through H4K16ac, the histone modification by the MSL complex. According to the results, complete removal of PEG3 resulted in up-regulation of Msl1 and Msl3, and subsequently an increase in the global levels of H4K16ac, confirming PEG3 as a transcriptional repressor for MSL during mammalian development. Genome-wide analyses further revealed that about 10% of the entire gene catalogue was affected in the MEF cells lacking PEG3, displaying the increased levels of H4K16ac in their promoter regions. The expression levels of a small subset of the affected genes were up-regulated in the MEF cells lacking PEG3. Interestingly, three Hox clusters also exhibited changes in the levels of H4K16ac, suggesting potential roles of PEG3 and MSL in the regulation of Hox clusters. Overall, the current study reports that Peg3 may control its downstream genes through mammalian MSL.	[Ye, An; Kim, Hana; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526	National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).; We would like to thank Maheshi Dassanayake at LSU and Alvaro Hernandez at Univ of Illinois for their help in NGS runs. We also thank Dr. Hongzhi He for his help in deriving MEF cells, and also the members of JooKim Lab for the detailed suggestions for the manuscript. This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074).	Chelmicki T, 2014, ELIFE, V3, DOI 10.7554/eLife.02024; Denizot AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006053; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; He H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167541; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lubelsky Y, 2014, GENOME RES, V24, P1102, DOI 10.1101/gr.160010.113; Lucchesi J. C., 2015, COLD SPRING HARB PER, V7; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shimazaki N, 2014, INT J HEMATOL, V100, P230, DOI 10.1007/s12185-014-1637-4; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Thomas T, 2008, MOL CELL BIOL, V28, P5093, DOI 10.1128/MCB.02202-07; Williamson EA, 2012, PROG MOL BIOL TRANSL, V110, P207, DOI 10.1016/B978-0-12-387665-2.00008-0; Ye A, 2016, EPIGENETICS-US, V11, P889, DOI 10.1080/15592294.2016.1255385; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zhou XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030340	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178363	10.1371/journal.pone.0178363	http://dx.doi.org/10.1371/journal.pone.0178363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609438	Green Published, Green Submitted, gold			2022-12-26	WOS:000403274700006
J	Haase, R; Potthoff, SA; Meyer-Schwesinger, C; Frosch, C; Wiech, T; Panzer, U; Konigshausen, E; Stegbauer, J; Sellin, L; Rump, LC; Quack, I; Woznowski, M				Haase, Raphael; Potthoff, Sebastian Alexander; Meyer-Schwesinger, Catherine; Frosch, Clara; Wiech, Thorsten; Panzer, Ulf; Koenigshausen, Eva; Stegbauer, Johannes; Sellin, Lorenz; Rump, Lars Christian; Quack, Ivo; Woznowski, Magdalena			A novel in vivo method to quantify slit diaphragm protein abundance in murine proteinuric kidney disease	PLOS ONE			English	Article							NEPHRIN ENDOCYTOSIS; PODOCYTES; PROGRESSION; INTEGRITY; DYNAMIN; MODEL	Injury of the glomerular filter causes proteinuria by disrupting the sensitive interplay of the glomerular protein network. To date, studies of the expression and trafficking of glomerular proteins have been mostly limited to in vitro or histologic studies. Here, we report a novel in vivo biotinylation assay that allows the quantification of surface expression of glomerular proteins in mice. Kidneys were perfused in situ with biotin before harvest. Afterwards glomeruli were isolated and lyzed. The protein of interest was separated by immunoprecipitation and the amount of surface-expressed protein was quantified by Western blot analysis with streptavidin staining. As proof-of-concept, we examined the presence of nephrin in the slit diaphragm in two well-established murine models of proteinuric kidney disease: nephrotoxic nephritis and adriamycin nephropathy. In proteinuric animals, significantly less nephrin was detected in the slit diaphragm. When proteinuria decreased once again during the course of disease, the amount of surface nephrin returned to the baseline. Our present results suggest that our assay is a valuable tool to study the glomerular filter in proteinuric kidney diseases. Note that the assay is not limited to proteins expressed in the slit diaphragm, and all surface proteins that are accessible to biotin perfusion and immunoprecipitation qualify for this analysis.	[Haase, Raphael; Potthoff, Sebastian Alexander; Frosch, Clara; Koenigshausen, Eva; Stegbauer, Johannes; Sellin, Lorenz; Rump, Lars Christian; Quack, Ivo; Woznowski, Magdalena] Heinrich Heine Univ, Med Fac, Dept Nephrol, Dusseldorf, Germany; [Meyer-Schwesinger, Catherine; Panzer, Ulf] Univ Hosp Eppendorf, Med Clin 3, Hamburg, Germany; [Wiech, Thorsten] Univ Hosp Eppendorf, Inst Pathol, Hamburg, Germany	Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Quack, I (corresponding author), Heinrich Heine Univ, Med Fac, Dept Nephrol, Dusseldorf, Germany.	ivo.quack@med.uni-duesseldorf.de	Stegbauer, Johannes/L-7461-2013; Wiech, Thorsten/ABA-3632-2020	Wiech, Thorsten/0000-0003-4053-1474	Deutsche Forschungsgemeinschaft [WO1811/2-1, QU280/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de/) WO1811/2-1 to MW and QU280/3-1 to IQ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSMANN KJM, 1985, VIRCHOWS ARCH A, V406, P285, DOI 10.1007/BF00704298; Babayeva S, 2013, J BIOL CHEM, V288, P24035, DOI 10.1074/jbc.M113.452904; Babayeva S, 2011, AM J PHYSIOL-RENAL, V300, pF549, DOI 10.1152/ajprenal.00566.2009; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Hiromura K, 2001, KIDNEY INT, V60, P2235, DOI 10.1046/j.1523-1755.2001.00057.x; Inoue K, 2015, AM J PHYSIOL-RENAL, V309, pF398, DOI 10.1152/ajprenal.00136.2015; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P636, DOI 10.1111/j.1751-7176.2009.00184.x; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Pereira WD, 2015, INFLAMM RES, V64, P287, DOI 10.1007/s00011-015-0813-1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Satoh D, 2014, J BIOCHEM, V156, P115, DOI 10.1093/jb/mvu022; Soda K, 2013, CURR OPIN NEPHROL HY, V22, P432, DOI 10.1097/MNH.0b013e3283624820; Soda K, 2012, J CLIN INVEST, V122, P4401, DOI 10.1172/JCI65289; Sussman AN, 2009, AM J PATHOL, V174, P1827, DOI 10.2353/ajpath.2009.080464; Swiatecka-Urban A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00032; Taniguchi Y, 2012, AM J PHYSIOL-RENAL, V302, pF1161, DOI 10.1152/ajprenal.00614.2011; Teng B, 2016, DIABETES; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tsai WC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003013; Waters AM, 2012, J AM SOC NEPHROL, V23, P27, DOI 10.1681/ASN.2011010027; Yan K, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013297.11876.5B	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179217	10.1371/journal.pone.0179217	http://dx.doi.org/10.1371/journal.pone.0179217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604827	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400039
J	Jakic, B; Buszko, M; Cappellano, G; Wick, G				Jakic, Bojana; Buszko, Maja; Cappellano, Giuseppe; Wick, Georg			Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ENDOTHELIAL-CELL APOPTOSIS; HEAT-SHOCK-PROTEIN-60 EXPRESSION; OXIDATIVE STRESS; T-LYMPHOCYTES; PLASMA SODIUM; DIETARY SALT; ATHEROSCLEROSIS; RECEPTOR; COMPLEX	Atherosclerosis is the leading cause of death in the world. We have previously shown that expression of heat shock protein 60 (HSP60) on the surface of endothelial cells is the main cause of initiating the disease as it acts as a T cell auto-antigen and can be triggered by classical atherosclerosis risk factors, such as infection (e.g. Chlamydia pneumoniae), chemical stress (smoking, oxygen radicals, drugs), physical insult (heat, shear blood flow) and inflammation (inflammatory cytokines, lipopolysaccharide, oxidized low density lipoprotein, advanced glycation end products). In the present study, we show that increasing levels of sodium chloride can also induce an increase in intracellular and surface expression of HSP60 protein in human umbilical vein endothelial cells. In addition, we found that elevated sodium induces apoptosis.	[Jakic, Bojana; Buszko, Maja; Cappellano, Giuseppe; Wick, Georg] Med Univ Innsbruck, Bioctr, Div Expt Pathophysiol & Immunol, Lab Autoimmun, Innsbruck, Austria	Medical University of Innsbruck	Jakic, B (corresponding author), Med Univ Innsbruck, Bioctr, Div Expt Pathophysiol & Immunol, Lab Autoimmun, Innsbruck, Austria.	bojana.jakic@i-med.ac.at	Jakic, Bojana/AAR-8584-2020; Cappellano, Giuseppe/ABE-4980-2020	Jakic, Bojana/0000-0002-2339-5928; Cappellano, Giuseppe/0000-0001-5193-4688	Tiroler Wissenschaftfonds [UNI-0404/1395]; Osterreischische Nationalbank [15953]	Tiroler Wissenschaftfonds; Osterreischische Nationalbank	B.J. received a grant from the Tiroler Wissenschaftfonds, grant no: UNI-0404/1395. Website: https.//www.tirol.gv.at/bildung/wissenschaftsfords/. B.J. received a donation from the Lore and Udo Saldow donation. G.W. received a grant from Osterreischische Nationalbank, grant no 15953. Website: https://www.oenb.at/Ueber-Uns/Forschungsfuerderung/Jubilaeumsfonds.html. The funders and donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman G.L., 1990, CLIN METHODS HIST PH, V3; Afek A, 2000, J AUTOIMMUN, V14, P115, DOI 10.1006/jaut.1999.0351; Almanzar G, 2012, J AUTOIMMUN, V39, P441, DOI 10.1016/j.jaut.2012.07.006; Amberger A, 1997, CELL STRESS CHAPERON, V2, P94, DOI 10.1379/1466-1268(1997)002<0094:CEOIVE>2.3.CO;2; ANDERTON SM, 1993, EUR J IMMUNOL, V23, P33, DOI 10.1002/eji.1830230107; Ando K, 2012, ANN MED, V44, pS119, DOI 10.3109/07853890.2012.671538; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Bavisotto CC, 2017, J INORG BIOCHEM, V170, P8, DOI 10.1016/j.jinorgbio.2017.02.004; Campanella C, 2009, INT J IMMUNOGENET, V36, P73, DOI 10.1111/j.1744-313X.2008.00819.x; Campanella C, 2008, EUR J HISTOCHEM, V52, P221; Campanella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042008; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Cicconi R, 2004, MOL CELL BIOCHEM, V259, P1, DOI 10.1023/B:MCBI.0000021335.52162.51; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; DeMeester SL, 1997, ARCH SURG-CHICAGO, V132, P1283; DeMeester SL, 2001, FASEB J, V15, P270, DOI 10.1096/fj.00-0170hyp; Dmitrieva NI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128870; FISCH P, 1990, J EXP MED, V171, P1567, DOI 10.1084/jem.171.5.1567; Gammazza AM, 2014, CELL STRESS CHAPERON, V19, P343, DOI 10.1007/s12192-013-0460-9; Gammazza AM, 2012, CELL MOL NEUROBIOL, V32, P943, DOI 10.1007/s10571-011-9789-8; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Grundtman C, 2015, ATHEROSCLEROSIS, V242, P303, DOI 10.1016/j.atherosclerosis.2015.06.044; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hamilton EW, 2001, PLANT PHYSIOL, V126, P1266, DOI 10.1104/pp.126.3.1266; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; He FJ, 2012, ANN MED, V44, pS127, DOI 10.3109/07853890.2012.660495; Hochleitner BW, 2000, ARTERIOSCL THROM VAS, V20, P617, DOI 10.1161/01.ATV.20.3.617; Kennedy D, 2014, IUBMB LIFE, V66, P327, DOI 10.1002/iub.1274; Ketelhuth DFJ, 2016, CIRC RES, V118, P668, DOI 10.1161/CIRCRESAHA.115.306427; Kimura T, 2015, AUTOIMMUNITY, V48, P152, DOI 10.3109/08916934.2014.1003641; KLEINDIENST R, 1993, AM J PATHOL, V142, P1927; Knoflach M, 2007, ATHEROSCLEROSIS, V195, P333, DOI 10.1016/j.atherosclerosis.2006.09.021; Kopp C, 2013, HYPERTENSION, V61, P635, DOI 10.1161/HYPERTENSIONAHA.111.00566; Kosova K, 2013, INT J MOL SCI, V14, P6757, DOI 10.3390/ijms14046757; Kreutmayer S, 2013, CELL STRESS CHAPERON, V18, P259, DOI 10.1007/s12192-012-0378-7; Kreutmayer SB, 2011, J MOL CELL CARDIOL, V51, P777, DOI 10.1016/j.yjmcc.2011.07.003; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; O'Donnell M, 2015, CIRC RES, V116, P1046, DOI 10.1161/CIRCRESAHA.116.303771; Oberleithner H, 2012, ANN MED, V44, pS143, DOI 10.3109/07853890.2011.653397; Oberleithner H, 2011, PFLUG ARCH EUR J PHY, V462, P519, DOI 10.1007/s00424-011-0999-1; Onat D, 2011, CURR DIABETES REP, V11, P193, DOI 10.1007/s11892-011-0182-2; Pfister G, 2005, J CELL SCI, V118, P1587, DOI 10.1242/jcs.02292; Pircher A, ENDOTHELIAL CELL MET; Pockley AG, 2002, J HYPERTENS, V20, P1815, DOI 10.1097/00004872-200209000-00027; Pons H, 2013, AM J PHYSIOL-RENAL, V304, pF289, DOI 10.1152/ajprenal.00517.2012; Powe NR, 2016, JAMA-J AM MED ASSOC, V315, P2173, DOI 10.1001/jama.2016.5985; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Selli ME, 2017, INT J OBESITY, V41, P348, DOI 10.1038/ijo.2016.216; SINGH B, 1992, DNA CELL BIOL, V11, P489, DOI 10.1089/dna.1992.11.489; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Vilasi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097657; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; Wang JH, 1997, AM J PHYSIOL-CELL PH, V272, pC1543, DOI 10.1152/ajpcell.1997.272.5.C1543; WHO, 2012, SODIUM INTAKE FOR AD; Wick C, 2016, CELL STRESS CHAPERON, V21, P201, DOI 10.1007/s12192-015-0659-z; Wick G, 2014, NAT REV CARDIOL, V11, P516, DOI 10.1038/nrcardio.2014.91; Wick MC, 2008, CELL STRESS CHAPERON, V13, P275, DOI 10.1007/s12192-008-0044-2; XU QB, 1994, CIRC RES, V75, P1078, DOI 10.1161/01.RES.75.6.1078; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1; ZUGEL U, 1995, EUR J IMMUNOL, V25, P451, DOI 10.1002/eji.1830250222	75	28	29	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179383	10.1371/journal.pone.0179383	http://dx.doi.org/10.1371/journal.pone.0179383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604836	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400050
J	Aguilar, D; Pinart, M; Koppelman, GH; Saeys, Y; Nawijn, MC; Postma, DS; Akdis, M; Auffray, C; Ballereau, S; Benet, M; Garcia-Aymerich, J; Gonzalez, JR; Guerra, S; Keil, T; Kogevinas, M; Lambrecht, B; Lemonnier, N; Melen, E; Sunyer, J; Valenta, R; Valverde, S; Wickman, M; Bousquet, J; Oliva, B; Anto, JM				Aguilar, Daniel; Pinart, Mariona; Koppelman, Gerard H.; Saeys, Yvan; Nawijn, Martijn C.; Postma, Dirkje S.; Akdis, Muebeccel; Auffray, Charles; Ballereau, Stephane; Benet, Marta; Garcia-Aymerich, Judith; Ramon Gonzalez, Juan; Guerra, Stefano; Keil, Thomas; Kogevinas, Manolis; Lambrecht, Bart; Lemonnier, Nathanael; Melen, Erik; Sunyer, Jordi; Valenta, Rudolf; Valverde, Sergi; Wickman, Magnus; Bousquet, Jean; Oliva, Baldo; Anto, Josep M.			Computational analysis of multimorbidity between asthma, eczema and rhinitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INNATE LYMPHOID-CELLS; ALLERGIC RHINITIS; ATOPIC-DERMATITIS; NETWORK MEDICINE; COMORBIDITY; MEDALL; METAANALYSIS; MECHANISMS; GENES	Background The mechanisms explaining the co-existence of asthma, eczema and rhinitis (allergic multimorbidity) are largely unknown. We investigated the mechanisms underlying multimorbidity between three main allergic diseases at a molecular level by identifying the proteins and cellular processes that are common to them. Methods An in silico study based on computational analysis of the topology of the protein interaction network was performed in order to characterize the molecular mechanisms of multimorbidity of asthma, eczema and rhinitis. As a first step, proteins associated to either disease were identified using data mining approaches, and their overlap was calculated. Secondly, a functional interaction network was built, allowing to identify cellular pathways involved in allergic multimorbidity. Finally, a network-based algorithm generated a ranked list of newly predicted multimorbidity-associated proteins. Results Asthma, eczema and rhinitis shared a larger number of associated proteins than expected by chance, and their associated proteins exhibited a significant degree of interconnectedness in the interaction network. There were 15 pathways involved in the multimorbidity of asthma, eczema and rhinitis, including IL4 signaling and GATA3-related pathways. A number of proteins potentially associated to these multimorbidity processes were also obtained. Conclusions These results strongly support the existence of an allergic multimorbidity cluster between asthma, eczema and rhinitis, and suggest that type 2 signaling pathways represent a relevant multimorbidity mechanism of allergic diseases. Furthermore, we identified new candidates contributing to multimorbidity that may assist in identifying new targets for multimorbid allergic diseases.	[Aguilar, Daniel; Pinart, Mariona; Garcia-Aymerich, Judith; Ramon Gonzalez, Juan; Guerra, Stefano; Kogevinas, Manolis; Anto, Josep M.] ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Aguilar, Daniel; Oliva, Baldo] Univ Pompeu Fabra, Dept Ciencies Experimentals La Salut, Struct Bioinformat Grp, Barcelona, Spain; [Aguilar, Daniel; Pinart, Mariona; Benet, Marta; Garcia-Aymerich, Judith; Ramon Gonzalez, Juan; Guerra, Stefano; Kogevinas, Manolis; Sunyer, Jordi; Oliva, Baldo] CIBER Epidemiol Salud PUbl CIBERESP, Barcelona, Spain; [Pinart, Mariona; Kogevinas, Manolis; Anto, Josep M.] IMIM, Barcelona, Spain; [Koppelman, Gerard H.; Nawijn, Martijn C.; Postma, Dirkje S.; Lambrecht, Bart] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, Groningen, Netherlands; [Koppelman, Gerard H.; Nawijn, Martijn C.; Postma, Dirkje S.; Lambrecht, Bart] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Saeys, Yvan] VIB, Inflammat Res Ctr, Ghent, Belgium; [Saeys, Yvan] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium; [Nawijn, Martijn C.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Lab Allergol & Pulm Dis, Groningen, Netherlands; [Akdis, Muebeccel] Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Akdis, Muebeccel] Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland; [Auffray, Charles; Ballereau, Stephane; Lemonnier, Nathanael] CNRS, EISBM, Lyon, France; [Guerra, Stefano] Arizona Resp Ctr, Tucson, AZ USA; [Keil, Thomas] Charite, Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Lambrecht, Bart] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands; [Melen, Erik; Wickman, Magnus] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Melen, Erik; Wickman, Magnus] Sachs Childrens Hosp, Stockholm, Sweden; [Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Valenta, Rudolf] Med Univ Vienna, Christian Doppler Lab Allergy Res, Vienna, Austria; [Valverde, Sergi] Univ Pompeu Fabra, ICREA Complex Syst Lab, Barcelona, Spain; [Valverde, Sergi] UPF, CSIC, Inst Biol Evolutiva, Barcelona, Spain; [Bousquet, Jean] Hop Arnaud Villeneuve Univ Hosp, Montpellier, France; [Bousquet, Jean] INSERM, Montpellier, France	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Groningen; University of Groningen; University of Groningen; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University Hospital; University of Groningen; Swiss Institute of Allergy & Asthma Research; Centre National de la Recherche Scientifique (CNRS); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National & Kapodistrian University of Athens; Erasmus University Rotterdam; Erasmus MC; Karolinska Institutet; Medical University of Vienna; Medical University of Vienna; ICREA; Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Aguilar, D (corresponding author), ISGlobal, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.	daniel.aguilar@upf.edu	Lemonnier, Nathanael/K-5393-2016; Valverde, Sergi/J-3275-2012; Koppelman, Gerard/AAG-9187-2020; Lambrecht, Bart N/K-2484-2014; Gonzalez, Juan R/B-7860-2018; Pinart Gilberga, Mariona/GLS-8842-2022; Sunyer, Jordi/G-6909-2014; J, Garcia-Aymerich/G-6867-2014; Saeys, Yvan/C-1311-2009; Bousquet, Jean/O-4221-2019; Anto, J M/H-2676-2014; Ballereau, Stephane/AAM-4883-2020; Kogevinas, Manolis/C-3918-2017; Akdis, Cezmi/AAV-4844-2020	Lemonnier, Nathanael/0000-0002-3994-8697; Valverde, Sergi/0000-0002-2150-9610; Lambrecht, Bart N/0000-0003-4376-6834; Gonzalez, Juan R/0000-0003-3267-2146; Pinart Gilberga, Mariona/0000-0002-8223-1325; Sunyer, Jordi/0000-0002-2602-4110; J, Garcia-Aymerich/0000-0002-7097-4586; Saeys, Yvan/0000-0002-0415-1506; Anto, J M/0000-0002-4736-8529; Ballereau, Stephane/0000-0002-8479-3110; Kogevinas, Manolis/0000-0002-9605-0461; Akdis, Cezmi/0000-0001-8020-019X; Nawijn, Martijn/0000-0003-3372-6521; Aguilar, Daniel/0000-0001-7520-4508; Koppelman, Gerard/0000-0001-8567-3252; Valenta, Rudolf/0000-0001-5944-3365; Bousquet, Jean/0000-0002-4061-4766; Benet Mora, Marta/0000-0001-9600-3510	Spanish Ministry of Science and Innovation (MICINN) [BIO2011-22568]; Mechanisms of the Development of ALLergy (MeDALL) within the EU under the Health Cooperation Work Programme of the Seventh Framework programme [261357]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Mechanisms of the Development of ALLergy (MeDALL) within the EU under the Health Cooperation Work Programme of the Seventh Framework programme	This work was supported by the Spanish Ministry of Science and Innovation (MICINN) grant BIO2011-22568, and by Mechanisms of the Development of ALLergy (MeDALL), a collaborative project done within the EU under the Health Cooperation Work Programme of the Seventh Framework programme (grant agreement number 261357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki S, 2016, INT IMMUNOL, V28, P65, DOI 10.1093/intimm/dxv055; Alase A, 2012, BRIT J DERMATOL, V167, P1386, DOI 10.1111/j.1365-2133.2012.11140.x; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Apter AJ, 2015, J ALLERGY CLIN IMMUN, V135, P46, DOI 10.1016/j.jaci.2014.10.050; Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barnes PJ, 2008, CURR MOL MED, V8, P330, DOI 10.2174/156652408785160952; Barnes PJ, 2009, AM J RESP CELL MOL, V41, P631, DOI 10.1165/rcmb.2009-0220TR; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Bousquet J, 2015, ALLERGY, V70, P1062, DOI 10.1111/all.12637; Bousquet J, 2011, ALLERGY, V66, P596, DOI 10.1111/j.1398-9995.2010.02534.x; Bousquet J, 2016, ALLERGY; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Brietzke E, 2012, MED HYPOTHESES, V78, P601, DOI 10.1016/j.mehy.2012.01.036; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; Chanez P, 1999, AM J RESP CRIT CARE, V159, P588, DOI 10.1164/ajrccm.159.2.9801022; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Deza M. M., 2009, ENCY DISTANCES; Doherty TA, 2014, J ALLERGY CLIN IMMUN, V133, P1203, DOI 10.1016/j.jaci.2013.12.1086; FISCHER GF, 1992, HUM IMMUNOL, V33, P259, DOI 10.1016/0198-8859(92)90333-I; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fontaine JF, 2011, NUCLEIC ACIDS RES, V39, pW455, DOI 10.1093/nar/gkr246; Garcia-Aymerich J, 2015, ALLERGY, V70, P973, DOI 10.1111/all.12640; Gluck J, 2012, INFLAMM RES, V61, P547, DOI 10.1007/s00011-012-0443-9; Grotenboer NS, 2013, J ALLERGY CLIN IMMUN, V131, P856, DOI 10.1016/j.jaci.2012.11.028; Guay C, 2006, CURR TOP MED CHEM, V6, P393, DOI 10.2174/156802606776287054; Guney E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043557; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hopper JL, 2012, J ALLERGY CLIN IMMUN, V130, P1117, DOI 10.1016/j.jaci.2012.08.003; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kontou PI, 2016, GENE, V590, P68, DOI 10.1016/j.gene.2016.05.044; Koppelman GH, 2011, CURR OPIN ALLERGY CL, V11, P414, DOI 10.1097/ACI.0b013e32834a9573; Kovacic MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023714; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Krug N, 2015, NEW ENGL J MED, V372, P1987, DOI 10.1056/NEJMoa1411776; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liu AH, 2016, J ALLERGY CLIN IMMUN, V138, P1042, DOI 10.1016/j.jaci.2016.06.060; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Marenholz I, 2013, CURR OPIN ALLERGY CL, V13, P478, DOI 10.1097/ACI.0b013e328364e8f7; MARSH DG, 1979, P NATL ACAD SCI USA, V76, P2903, DOI 10.1073/pnas.76.6.2903; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McCormack T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054945; McIntire JJ, 2003, NATURE, V425, P576, DOI 10.1038/425576a; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nabe T, 2014, J PHARMACOL SCI, V126, P85, DOI 10.1254/jphs.14R12CP; Nishimura D, 2001, BIOTECH SOFTW INTERN, P117, DOI [10.1089/152791601750294344, DOI 10.1089/152791601750294344]; Oiso N, 2000, BRIT J DERMATOL, V142, P1003, DOI 10.1046/j.1365-2133.2000.03485.x; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Piro RM, 2012, HUM GENET, V131, P1811, DOI 10.1007/s00439-012-1206-y; Portelli MA, 2014, FASEB J, V28, P923, DOI 10.1096/fj.13-240879; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randhawa V, 2012, OMICS, V16, P513, DOI 10.1089/omi.2011.0160; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Salimi M, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-18; Saluja R, 2015, CLIN TRANSL ALLERGY, V5, DOI 10.1186/s13601-015-0076-5; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sharma A, 2015, HUM MOL GENET; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Simpson EL, 2012, CURR DERMATOL REP, V1, P29, DOI 10.1007/s13671-011-0003-5; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Soriano JB, 1997, AM J RESP CRIT CARE, V156, P1394, DOI 10.1164/ajrccm.156.5.9701064; Sotiropoulou G, 2012, TRENDS PHARMACOL SCI, V33, P623, DOI 10.1016/j.tips.2012.09.005; Turinsky AL, 2014, METHODS MOL BIOL, V1091, P315, DOI 10.1007/978-1-62703-691-7_22; Turinsky AL, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq026; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vladich FD, 2005, J CLIN INVEST, V115, P747, DOI 10.1172/JCI200522818; Wang K, 2010, CELL, V142, P351, DOI 10.1016/j.cell.2010.07.025; Wollenberg A, 2013, ALLERGY, V68, P1509, DOI 10.1111/all.12324; Yan L, 2000, PHARMACOGENETICS, V10, P261, DOI 10.1097/00008571-200004000-00007; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang ML, 2011, AM J HUM GENET, V88, P755, DOI 10.1016/j.ajhg.2011.05.006; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	88	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179125	10.1371/journal.pone.0179125	http://dx.doi.org/10.1371/journal.pone.0179125			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598986	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000026
J	Cheung, RTH; An, WW; Au, IPH; Zhang, JH; Chan, ZYS; Man, A; Lau, FOY; Lam, MKY; Lau, KK; Leung, CY; Tsang, NW; Sze, LKY; Lam, GWK				Cheung, Roy T. H.; An, Winko W.; Au, Ivan P. H.; Zhang, Janet H.; Chan, Zoe Y. S.; Man, Alfred; Lau, Fannie O. Y.; Lam, Melody K. Y.; Lau, K. K.; Leung, C. Y.; Tsang, N. W.; Sze, Louis K. Y.; Lam, Gilbert W. K.			Measurement agreement between a newly developed sensing insole and traditional laboratory-based method for footstrike pattern detection in runners	PLOS ONE			English	Article							GROUND REACTION FORCES; FOOT-STRIKE PATTERNS; LANDING PATTERN; GAIT; BAREFOOT; STRESS	This study introduced a novel but simple method to continuously measure footstrike patterns in runners using inexpensive force sensors. Two force sensing resistors were firmly affixed at the heel and second toe of both insoles to collect the time signal of foot contact. A total of 109 healthy young adults (42 males and 67 females) were recruited in this study. They ran on an instrumented treadmill at 0 degrees, +10 degrees, and -10 degrees inclinations and attempted rearfoot, midfoot, and forefoot landings using real time visual biofeedback. Intra-step strike index and onset time difference between two force sensors were measured and analyzed with univariate linear regression. We analyzed 25,655 footfalls and found that onset time difference between two sensors explained 80-84% of variation in the prediction model of strike index (R-squared = 0.799-0.836, p<0.001). However, the time windows to detect footstrike patterns on different surface inclinations were not consistent. These findings may allow laboratory-based gait retraining to be implemented in natural running environments to aid in both injury prevention and performance enhancement.	[Cheung, Roy T. H.; An, Winko W.; Au, Ivan P. H.; Zhang, Janet H.; Chan, Zoe Y. S.; Man, Alfred; Lau, Fannie O. Y.; Lam, Melody K. Y.; Lau, K. K.; Leung, C. Y.; Tsang, N. W.] Hong Kong Polytech Univ, Dept Rehabil Sci, Gait & Mot Anal Lab, Hong Kong, Hong Kong, Peoples R China; [Sze, Louis K. Y.] Persona Surg Modelling, Hong Kong, Hong Kong, Peoples R China; [Lam, Gilbert W. K.] Li Ning Sports Sci Res Ctr, Beijing, Peoples R China	Hong Kong Polytechnic University	Cheung, RTH (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Gait & Mot Anal Lab, Hong Kong, Hong Kong, Peoples R China.	Roy.Cheung@polyu.edu.hk	; Lam, Wing Kai/W-4265-2018	Au, Ivan Pui Hung/0000-0003-0633-2113; Cheung, Roy/0000-0001-7990-3007; An, Winko Wenkang/0000-0002-0621-1680; Lam, Wing Kai/0000-0001-8692-2206; CHEUNG, Roy Tsz Hei/0000-0002-0288-7755	Innovation and Technology Fund [ITP/085/15TI]; Innovation and Technology Commission; Government of the HKSAR	Innovation and Technology Fund; Innovation and Technology Commission; Government of the HKSAR	This study is a government funded research project (Innovation and Technology Fund (Project number ITP/085/15TI), Innovation and Technology Commission, The Government of the HKSAR) (You may refer to the funder's homepage at www.itf.gov.hk). However, the funding body did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries (In this study, the funder support Mr. Alfred Man (Man A.) in the form of salaries) and/or research materials. We also declare that the previously submitted statements relating to the author contributions are correct and accurate.	Agresta C, 2015, J ORTHOP SPORT PHYS, V45, P576, DOI 10.2519/jospt.2015.5823; Almeida MO, 2015, J ORTHOP SPORT PHYS, V45, P738, DOI 10.2519/jospt.2015.6019; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; An W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/240153; Breine B, 2016, J SPORTS SCI, P1; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; Chen TL, 2016, CLIN BIOMECH, V33, P49, DOI 10.1016/j.clinbiomech.2016.02.013; Cheung RTH, 2011, J ORTHOP SPORT PHYS, V41, P914, DOI 10.2519/jospt.2011.3771; Cheung RT, 2016, SPORTS BIOMECH, V4, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1080/14763141.2016.1226381; Clermont CA, 2016, GAIT POSTURE, V50, P126, DOI 10.1016/j.gaitpost.2016.08.024; Davis IS, 2016, PHYS MED REH CLIN N, V27, P339, DOI 10.1016/j.pmr.2015.09.002; Eskofier B.M., 2013, P 2013 IEEE INT C BO, P1, DOI 10.1109/BSN.2013.6575457; Hsu CY, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081156; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Lyght M, 2016, J APPL BIOMECH, V32, P365, DOI 10.1123/jab.2015-0183; Tseh W, 2008, J SPORT SCI MED, V7, P91; van der Worp H, 2016, BRIT J SPORT MED, V50, P450, DOI 10.1136/bjsports-2015-094924; Zhang JH, 2016, GAIT POSTURE, V46, P53, DOI 10.1016/j.gaitpost.2016.02.002	18	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0175724	10.1371/journal.pone.0175724	http://dx.doi.org/10.1371/journal.pone.0175724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599003	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000001
J	Gao, XP; Zhao, L; Zhuang, JG; Zang, N; Xu, FD				Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi			Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation	FASEB JOURNAL			English	Article						SIDS; cardiorespiratory activity; I-Ks	SUDDEN-INFANT-DEATH; SENSORY NEURONS; CIGARETTE-SMOKE; NEONATAL-RATS; REFLEX APNEA; DECEREBRATE PIGLETS; RESPIRATORY CONTROL; POTASSIUM CURRENTS; BREATHING PATTERN; HYPOXIA	Maternal cigarette smoke, including prenatal nicotinic exposure (PNE), is responsible for sudden infant death syndrome (SIDS). The fatal events of SIDS are characterized by severe bradycardia and life-threatening apneas. Although activation of transient receptor potential vanilloid 1 (TRPV1) of superior laryngeal C fibers (SLCFs) could induce bradycardia and apnea and has been implicated in SIDS pathogenesis, how PNE affects the SLCF-mediated cardiorespiratory responses remains unexplored. Here, we tested the hypothesis that PNE would aggravate the SLCF-mediated apnea and bradycardia via up-regulating TRPV1 expression and excitation of laryngeal C neurons in the nodose/jugular (N/J) ganglia. To this end, we compared the following outcomes between control and PNE rat pups at postnatal days 11-14: 1) the cardiorespiratory responses to intralaryngeal application of capsaicin (10 mu g/ml, 50 mu l), a selective stimulant for TRPV1 receptors, in anesthetized preparation; 2) immunoreactivity and mRNA of TRPV1 receptors of laryngeal sensory C neurons in the N/J ganglia retrogradely traced by 1,1-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; and 3) TRPV1 currents and electrophysiological characteristics of these neurons by using whole-cell patch-clamp technique in vitro. Our results showed that PNE markedly prolonged the apneic response and exacerbated the bradycardic response to intralaryngeal perfusion of capsaicin, which was associated with up-regulation of TRPV1 expression in laryngeal C neurons. In addition, PNE increased the TRPV1 currents, depressed the slow delayed rectifier potassium currents, and increased the resting membrane potential of these neurons. Our results suggest that PNE is capable of aggravating the SLCF-mediated apnea and bradycardia through TRPV1 sensitization and neuronal excitation, which may contribute to the pathogenesis of SIDS.-Gao, X., Zhao, L., Zhuang, J., Zang, N., Xu, F. Prenatal nicotinic exposure prolongs superior laryngeal C-fiber-mediated apnea and bradycardia through enhancing neuronal TRPV1 expression and excitation.	[Gao, Xiuping; Zhao, Lei; Zhuang, Jianguo; Zang, Na; Xu, Fadi] Lovelace Resp Res Inst, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA	Lovelace Respiratory Research Institute	Xu, FD (corresponding author), Lovelace Resp Res Inst, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	fxu@lrri.org			U.S. National Institutes of Health, National Heart, Lung and Blood Institute [HL-107462, HL-119683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119683, R01HL107462] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Ellen Blake (Lovelace Respiratory Research Institute) for editing the manuscript. This study was supported by U.S. National Institutes of Health, National Heart, Lung and Blood Institute Grants HL-107462 and HL-119683. The authors declare no conflicts of interest.	Abu-Shaweesh JM, 2001, J APPL PHYSIOL, V90, P1570, DOI 10.1152/jappl.2001.90.4.1570; Adams EJ, 1998, PEDIATRICS, V102, P1445, DOI 10.1542/peds.102.6.1445; Anand U, 2006, NEUROSCI LETT, V399, P51, DOI 10.1016/j.neulet.2006.01.046; Ballanyi Klaus, 2004, Current Neuropharmacology, V2, P221, DOI 10.2174/1570159043476828; BENOWITZ NL, 1984, CLIN PHARMACOL THER, V35, P499, DOI 10.1038/clpt.1984.67; BOGGS DF, 1982, J APPL PHYSIOL, V53, P455, DOI 10.1152/jappl.1982.53.2.455; Campos M, 2009, CLIN EXP PHARMACOL P, V36, P1205, DOI 10.1111/j.1440-1681.2009.05214.x; Chen H, 2005, EUR J NEUROSCI, V22, P380, DOI 10.1111/j.1460-9568.2005.04229.x; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Daley KC, 2004, CURR OPIN PEDIATR, V16, P227; DOWNING SE, 1975, PEDIATRICS, V55, P640; Duy PM, 2010, EXP PHYSIOL, V95, P774, DOI 10.1113/expphysiol.2010.052647; Evans AR, 1999, J PHYSIOL-LONDON, V516, P163, DOI 10.1111/j.1469-7793.1999.163aa.x; FAGENHOLZ SA, 1979, AM J PHYSIOL, V237, pR10, DOI 10.1152/ajpregu.1979.237.1.R10; Fregosi RF, 2008, RESP PHYSIOL NEUROBI, V164, P80, DOI 10.1016/j.resp.2008.05.008; Gu QH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00065; Guntheroth WG, 2001, PEDIATRICS, V107, P693, DOI 10.1542/peds.107.4.693; GUNTHEROTH WG, 1975, J CLIN INVEST, V56, P1371, DOI 10.1172/JCI108217; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P1544, DOI 10.1164/rccm.200204-289OC; Hafstrom O, 2002, AM J RESP CRIT CARE, V166, P92, DOI 10.1164/rccm.2107082; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harper RM, 2000, RESP PHYSIOL, V119, P123, DOI 10.1016/S0034-5687(99)00107-3; Hayakawa T, 2014, J CHEM NEUROANAT, V55, P18, DOI 10.1016/j.jchemneu.2013.11.001; Hishida N, 1997, J VET MED SCI, V59, P499, DOI 10.1292/jvms.59.499; Hu YM, 2010, AM J PHYSIOL-LUNG C, V299, pL483, DOI 10.1152/ajplung.00111.2010; Huang YH, 2004, RESP PHYSIOL NEUROBI, V143, P1, DOI 10.1016/j.resp.2004.07.002; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; JIANG C, 1994, EXP BRAIN RES, V100, P407, DOI 10.1007/BF02738401; Jost N, 2007, ANN NONINVAS ELECTRO, V12, P64, DOI 10.1111/j.1542-474X.2007.00140.x; Kalra R, 2002, J PHARMACOL EXP THER, V302, P935, DOI 10.1124/jpet.302.3.935; KASHIBA H, 1995, MOL BRAIN RES, V30, P158, DOI 10.1016/0169-328X(94)00249-E; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; LANIER B, 1983, OTOLARYNG HEAD NECK, V91, P597, DOI 10.1177/019459988309100602; LEE JC, 1977, AM J PHYSIOL, V233, pR30, DOI 10.1152/ajpregu.1977.233.1.R30; Lee LY, 2013, PULM PHARMACOL THER, V26, P491, DOI 10.1016/j.pupt.2013.03.010; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; Lin YJ, 2013, J APPL PHYSIOL, V114, P361, DOI 10.1152/japplphysiol.00977.2012; Liu BY, 2015, J APPL PHYSIOL, V118, P635, DOI 10.1152/japplphysiol.00717.2014; Liu BY, 2013, PULM PHARMACOL THER, V26, P364, DOI 10.1016/j.pupt.2013.01.010; LUCK W, 1985, DEV PHARMACOL THERAP, V8, P384, DOI 10.1159/000457063; MU XJ, 1993, J NEUROSCI, V13, P4029; Mutoh T, 2000, J VET MED SCI, V62, P665, DOI 10.1292/jvms.62.665; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; Pendlebury JD, 2008, AM J RESP CRIT CARE, V177, P1255, DOI 10.1164/rccm.200711-1739OC; Potenzieri C, 2012, J PHYSIOL-LONDON, V590, P5449, DOI 10.1113/jphysiol.2012.237115; Saareks V, 2000, J PHYSIOL PHARMACOL, V51, P631; SANTAMBROGIO G, 1995, RESP PHYSIOL, V102, P1, DOI 10.1016/0034-5687(95)00048-I; Shea AK, 2008, NICOTINE TOB RES, V10, P267, DOI 10.1080/14622200701825908; St-Hilaire M, 2007, J APPL PHYSIOL, V102, P1429, DOI 10.1152/japplphysiol.00977.2006; St-John WM, 1999, NEUROSCI LETT, V267, P206, DOI 10.1016/S0304-3940(99)00364-X; Stephan-Blanchard E, 2013, RESP PHYSIOL NEUROBI, V185, P110, DOI 10.1016/j.resp.2012.06.023; Stephenson R, 2001, J PHYSIOL-LONDON, V536, P225, DOI 10.1111/j.1469-7793.2001.00225.x; Varro A, 2000, J PHYSIOL-LONDON, V523, P67, DOI 10.1111/j.1469-7793.2000.00067.x; Wang RR, 2008, J PERINAT MED, V36, P161, DOI 10.1515/JPM.2008.022; WENNERGREN G, 1989, ACTA PAEDIATR SCAND, V78, P11, DOI 10.1111/j.1651-2227.1989.tb10879.x; Wong-Riley MTT, 2013, RESP PHYSIOL NEUROBI, V185, P156, DOI 10.1016/j.resp.2012.05.026; Xia L, 2013, RESP PHYSIOL NEUROBI, V186, P109, DOI 10.1016/j.resp.2013.01.004; Xia LX, 2008, J APPL PHYSIOL, V104, P269, DOI 10.1152/japplphysiol.00721.2007; Xia LX, 2008, RESP PHYSIOL NEUROBI, V164, P358, DOI 10.1016/j.resp.2008.08.002; Xu F, 2003, J APPL PHYSIOL, V94, P1446, DOI 10.1152/japplphysiol.00767.2002; Yoshida Yoshikazu, 2000, American Journal of Medicine, V108, p51S, DOI 10.1016/S0002-9343(99)00342-3; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang ZX, 2013, RESP PHYSIOL NEUROBI, V186, P164, DOI 10.1016/j.resp.2013.01.006; Zhao L, 2016, TOXICOL SCI, V153, P103, DOI 10.1093/toxsci/kfw108; Zhao L, 2016, TOXICOL APPL PHARM, V303, P58, DOI 10.1016/j.taap.2016.05.008; Zhao L, 2016, TOXICOL APPL PHARM, V290, P107, DOI 10.1016/j.taap.2015.10.023; Zhuang JG, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12023; Zhuang JG, 2015, AM J PHYSIOL-LUNG C, V308, pL922, DOI 10.1152/ajplung.00241.2014	70	8	8	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4325	4334		10.1096/fj.201700163R	http://dx.doi.org/10.1096/fj.201700163R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28615326	Green Published			2022-12-26	WOS:000413397400012
J	Liebsch, F; Aurousseau, MRP; Bethge, T; McGuire, H; Scolari, S; Herrmann, A; Blunck, R; Bowie, D; Multhaup, G				Liebsch, Filip; Aurousseau, Mark R. P.; Bethge, Tobias; McGuire, Hugo; Scolari, Silvia; Herrmann, Andreas; Blunck, Rikard; Bowie, Derek; Multhaup, Gerd			Full-length cellular beta-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; INFLUENZA-VIRUS HEMAGGLUTININ; WILSON-DISEASE; ALZHEIMERS-DISEASE; CLEAVING ENZYME; BACE1; SEQUENCE; DOMAIN; MODEL; MICE	The beta-secretase (BACE1) initiates processing of the amyloid precursor protein (APP) into A beta peptides, which have been implicated as central players in the pathology of Alzheimer disease. BACE1 has been described as a copper-binding protein and its oligomeric state as being monomeric, dimeric, and/or multimeric, but the native cellular stoichiometry has remained elusive. Here, by using single-molecule fluorescence and in vitro cross-linking experiments with photo-activatable unnatural amino acids, we show that full-length BACE1, independently of its subcellular localization, exists as trimers in human cells. We found that trimerization requires the BACE1 transmembrane sequences (TMSs) and cytoplasmic domains, with residues Ala(463) and Cys(466) buried within the trimer interface of the sulfur-rich core of the TMSs. Our 3D model predicts that the sulfur-rich core of the trimeric BACE1 TMS is accessible to metal ions, but copper ions did not trigger trimerization. The results of functional assays of endogenous BACE1 suggest that it has a role in intracellular copper compartmentalization by transferring cytosolic copper to intracellular compartments, while leaving the overall cellular copper concentration unaltered. Adding to existing physiological models, our results provide novel insight into the atypical interactions between copper and BACE1 and into its non-enzymatic activities. In conclusion, therapeutic Alzheimer disease prevention strategies aimed at decreasing BACE1 protein levels should be regarded with caution, because adverse effects in copper homeostasis may occur.	[Liebsch, Filip; Bowie, Derek; Multhaup, Gerd] McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada; [Aurousseau, Mark R. P.; Bowie, Derek; Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Bethge, Tobias] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [McGuire, Hugo; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Scolari, Silvia; Herrmann, Andreas] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Bethge, Tobias] Kantonsspital Aarau, Inst Lab Med, CH-5001 Aarau, Switzerland	McGill University; McGill University; Free University of Berlin; Universite de Montreal; Humboldt University of Berlin; Kantonsspital Aarau AG (KSA)	Multhaup, G (corresponding author), McGill Univ, Integrated Program Neurosci, Montreal, PQ H3G 0B1, Canada.; Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Liebsch, Filip/AAL-3327-2020; Blunck, Rikard/AAM-3078-2020	Liebsch, Filip/0000-0002-0955-8065; Blunck, Rikard/0000-0003-4484-2907	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 04774-15]; Canada Foundation for Innovation (CFI); Canada Research Chairs (CRC) Program; International Copper Association; Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Canadian Institutes of Health Research (CIHR); Fonds de recherche du Quebec, Sante (FRQS); CIHR; Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC [DG 327201-2012]; CIHR [MOP 136894]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC) Program(Canada Research Chairs); International Copper Association; Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec, Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec - Nature et technologies (FRQNT); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN 04774-15, the Canada Foundation for Innovation (CFI), Canada Research Chairs (CRC) Program, and the International Copper Association (to G. M.), Studienstiftung des Deutschen Volkes and Groupe de Recherche Axe sur la Structure des Proteines (GRASP) Ph. D. fellowships (to F.L.), operating grants from the Canadian Institutes of Health Research (CIHR) (to D. B.), and the Fonds de recherche du Quebec, Sante (FRQS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Banting and Best graduate fellowship from the CIHR.; Supported by a Fonds de recherche du Quebec - Nature et technologies (FRQNT) doctoral research grant.; Supported by NSERC Grant DG 327201-2012 and CIHR Grant MOP 136894.	Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Banci L, 2010, CELL MOL LIFE SCI, V67, P2563, DOI 10.1007/s00018-010-0330-x; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Engel S, 2010, BIOCHEM J, V425, P567, DOI 10.1042/BJ20091388; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Gitlin JD, 2003, GASTROENTEROLOGY, V125, P1868, DOI 10.1053/j.gastro.2003.05.010; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Haas KL, 2011, J AM CHEM SOC, V133, P4427, DOI 10.1021/ja108890c; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Johnston JM, 2011, BIOCHEMISTRY-US, V50, P1682, DOI 10.1021/bi101474v; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kandalepas PC, 2012, J NEUROCHEM, V120, P55, DOI 10.1111/j.1471-4159.2011.07512.x; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Lutsenko S, 2016, METALLOMICS, V8, P840, DOI [10.1039/c6mt00176a, 10.1039/C6MT00176A]; Lutsenko S, 2008, BIOCHEM SOC T, V36, P1233, DOI 10.1042/BST0361233; McGuire H, 2012, J BIOL CHEM, V287, P35912, DOI 10.1074/jbc.M112.402057; MENKES JH, 1962, PEDIATRICS, V29, P764; Meyer LA, 2001, J BIOL CHEM, V276, P36857, DOI 10.1074/jbc.M105361200; Munter LM, 2013, J AM CHEM SOC, V135, P19354, DOI 10.1021/ja410812r; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nie L, 2011, J AM CHEM SOC, V133, P6177, DOI 10.1021/ja106894g; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; Polishchuk EV, 2014, DEV CELL, V29, P686, DOI 10.1016/j.devcel.2014.04.033; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Scolari S, 2009, J BIOL CHEM, V284, P15708, DOI 10.1074/jbc.M900437200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Vetrivel KS, 2011, J BIOL CHEM, V286, P26166, DOI 10.1074/jbc.M111.260471; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Voigt P, 2005, J BIOL CHEM, V280, P5121, DOI 10.1074/jbc.M413104200; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Zhao YJ, 2012, J BIOL CHEM, V287, P11141, DOI 10.1074/jbc.M111.330209	48	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13258	13270		10.1074/jbc.M117.779165	http://dx.doi.org/10.1074/jbc.M117.779165			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637867	Green Published, hybrid			2022-12-26	WOS:000407465300015
J	Tsukamoto, H; Chen, IS; Kubo, Y; Furutani, Y				Tsukamoto, Hisao; Chen, I-Shan; Kubo, Yoshihiro; Furutani, Yuji			A ciliary opsin in the brain of a marine annelid zooplankton is ultraviolet-sensitive, and the sensitivity is tuned by a single amino acid residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						brain; G protein-coupled receptor (GPCR); molecular evolution; photobiology; rhodopsin; ultraviolet-visible spectroscopy (UV-Vis spectroscopy)	PHOTORECEPTOR CELL; RHODOPSIN; PIGMENT; DROSOPHILA; VISION; LIGHT; GENE; EXPRESSION; RECEPTOR; DYNAMICS	Ciliary opsins were classically thought to function only in vertebrates for vision, but they have also been identified recently in invertebrates for non-visual photoreception. Larvae of the annelid Platynereis dumerilii are used as a zooplankton model, and this zooplankton species possesses a vertebrate-type ciliary opsin (named c-opsin) in the brain. Platynereis c-opsin is suggested to relay light signals for melatonin production and circadian behaviors. Thus, the spectral and biochemical characteristics of this c-opsin would be directly related to non-visual photoreception in this zooplankton model. Here we demonstrate that the c-opsin can sense UV to activate intracellular signaling cascades and that it can directly bind exogenous all-trans-retinal. These results suggest that this c-opsin regulates circadian signaling in a UV-dependent manner and that it does not require a supply of 11-cis-retinal for photoreception. Avoidance of damaging UV irradiation is a major cause of large-scale daily zooplankton movement, and the observed capability of the c-opsin to transmit UV signals and bind all-trans-retinal is ideally suited for sensing UV radiation in the brain, which presumably lacks enzymes producing 11-cis-retinal. Mutagenesis analyses indicated that a unique amino acid residue (Lys-94) is responsible for c-opsin-mediated UV sensing in the Platynereis brain. We therefore propose that acquisition of the lysine residue in the c-opsin would be a critical event in the evolution of Platynereis to enable detection of ambient UV light. In summary, our findings indicate that the c-opsin possesses spectral and biochemical properties suitable for UV sensing by the zooplankton model.	[Tsukamoto, Hisao; Furutani, Yuji] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan; [Tsukamoto, Hisao; Furutani, Yuji] Grad Univ Adv Studies, SOKENDAI, Dept Struct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Chen, I-Shan; Kubo, Yoshihiro] Grad Univ Adv Studies, SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Chen, I-Shan; Kubo, Yoshihiro] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Tsukamoto, H (corresponding author), Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	tsukamoh@ims.ac.jp	Chen, I-Shan/ABG-2914-2021; Furutani, Yuji/J-8337-2019	Chen, I-Shan/0000-0003-3204-3921; Furutani, Yuji/0000-0001-5284-8773; Kubo, Yoshihiro/0000-0001-6707-0837	JSPS KAKENHI Grants [25840122, 17K15109, 26708002]; Uehara Memorial Foundation; Center for the Promotion of Integrated Sciences of SOKENDAI; Cooperative Study Program of the National Institute for Physiological Sciences	JSPS KAKENHI Grants; Uehara Memorial Foundation(Uehara Memorial Foundation); Center for the Promotion of Integrated Sciences of SOKENDAI; Cooperative Study Program of the National Institute for Physiological Sciences	This work was supported by JSPS KAKENHI Grants 25840122 and 17K15109 (to H. T.) and 26708002 (to Y. F.), the Uehara Memorial Foundation, the Center for the Promotion of Integrated Sciences of SOKENDAI, and the Cooperative Study Program of the National Institute for Physiological Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	ALLDREDGE AL, 1980, J EXP MAR BIOL ECOL, V44, P133, DOI 10.1016/0022-0981(80)90150-1; Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; Baumgartner W, 1999, BIOPHYS J, V77, P1980, DOI 10.1016/S0006-3495(99)77039-6; Bianchi D, 2013, NAT GEOSCI, V6, P545, DOI 10.1038/NGEO1837; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Brandon CS, 2017, J MOL EVOL, V84, P12, DOI 10.1007/s00239-016-9777-1; Brierley AS, 2014, CURR BIOL, V24, pR1074, DOI 10.1016/j.cub.2014.08.054; Chen IS, 2014, J PHYSIOL-LONDON, V592, P1237, DOI 10.1113/jphysiol.2013.269803; Conzelmann M, 2011, P NATL ACAD SCI USA, V108, pE1174, DOI 10.1073/pnas.1109085108; Cronin TW, 2016, J EXP BIOL, V219, P2790, DOI 10.1242/jeb.128769; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; EAKIN RM, 1979, AM ZOOL, V19, P647; Fasick JI, 2002, BIOCHEMISTRY-US, V41, P6860, DOI 10.1021/bi0200413; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Friedmann D, 2015, CURR BIOL, V25, P69, DOI 10.1016/j.cub.2014.10.055; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; FUKADA Y, 1990, BIOCHEMISTRY-US, V29, P3133, DOI 10.1021/bi00464a033; Futahashi R, 2015, P NATL ACAD SCI USA, V112, pE1247, DOI 10.1073/pnas.1424670112; Gartner W., 2000, HDB BIOL PHYS, V3, P297; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; Guhmann M, 2015, CURR BIOL, V25, P2265, DOI 10.1016/j.cub.2015.07.017; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; HUBBARD R, 1953, J GEN PHYSIOL, V36, P415, DOI 10.1085/jgp.36.3.415; HUBBARD R, 1958, J GEN PHYSIOL, V41, P501, DOI 10.1085/jgp.41.3.501; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Kato M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163925; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kitamoto J, 2000, J EXP BIOL, V203, P2887; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0174-9; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Menzel R., 1979, HDB SENSORY PHYSL, V7 / 6 / 6, P503, DOI DOI 10.1007/978-3-642-66999-6_9; METHFESSEL C, 1986, PFLUG ARCH EUR J PHY, V407, P577, DOI 10.1007/BF00582635; MONTELL C, 1987, J NEUROSCI, V7, P1558; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Ni JD, 2017, NATURE, V545, P340, DOI 10.1038/nature22325; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; Randel N, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0042; Randel N, 2014, ELIFE, V3, DOI 10.7554/eLife.02730; Randel N, 2013, INTEGR COMP BIOL, V53, P7, DOI 10.1093/icb/ict046; Rhode SC, 2001, NATURE, V412, P69, DOI 10.1038/35083567; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; Salcedo E, 2003, J NEUROSCI, V23, P10873; Sato KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146275; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Schippers KJ, 2014, CELL, V159, P9, DOI 10.1016/j.cell.2014.09.004; SMITH KC, 1990, J COMP PHYSIOL A, V166, P597; Sugihara T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161215; Tada T, 2009, P NATL ACAD SCI USA, V106, P17457, DOI 10.1073/pnas.0903839106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Tosches MA, 2014, CELL, V159, P46, DOI 10.1016/j.cell.2014.07.042; Townson SM, 1998, J NEUROSCI, V18, P2412; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H., 2014, EVOLUTION VISUAL NON, P219, DOI DOI 10.1007/978-1-4614-4355-1_7; Tsukamoto H, 2015, J BIOL CHEM, V290, P27176, DOI 10.1074/jbc.M115.666305; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Velarde RA, 2005, INSECT BIOCHEM MOLEC, V35, P1367, DOI 10.1016/j.ibmb.2005.09.001; Wang XY, 2012, J NEUROSCI, V32, P3485, DOI 10.1523/JNEUROSCI.5350-11.2012; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Williamson CE, 2011, LIMNOL OCEANOGR, V56, P1603, DOI 10.4319/lo.2011.56.5.1603; Yamashita T, 2014, J BIOL CHEM, V289, P3991, DOI 10.1074/jbc.M113.514075; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; ZUKER CS, 1987, J NEUROSCI, V7, P1550	76	15	15	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12971	12980		10.1074/jbc.M117.793539	http://dx.doi.org/10.1074/jbc.M117.793539			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623234	Green Published, hybrid			2022-12-26	WOS:000407220100025
J	Aberdam, E; Petit, I; Sangari, L; Aberdam, D				Aberdam, Edith; Petit, Isabelle; Sangari, Linda; Aberdam, Daniel			Induced pluripotent stem cell-derived limbal epithelial cells (LiPSC) as a cellular alternative for in vitro ocular toxicity testing	PLOS ONE			English	Article							DIFFERENTIATION; IRRITATION; MODEL; EXPRESSION; CHEMICALS	Induced pluripotent stem cells hold great potential to produce unlimited amount of differentiated cells as cellular source for regenerative medicine but also for in vitro drug screening and cytotoxicity tests. Ocular toxicity testing is mandatory to evaluate the risks of drugs and cosmetic products before their application to human patients by preventing eye irritation or insult. Since the global ban to use animals, many human-derived alternatives have been proposed, from ex-vivo enucleated postmortem cornea, primary corneal cell culture and immortalized corneal epithelial cell lines. All of them share limitations for their routine use. Using an improved protocol, we derived limbal epithelial cells from human induced pluripotent stem cells, named LiPSC, that are able to be passaged and differentiate further into corneal epithelial cells. Comparative RT-qPCR, immunofluorescence staining, flow cytometry analysis and zymography assays demonstrate that LiPSC are morphologically and molecularly similar to the adult stem cells. Moreover, contrary to HCE, LiPSC and primary limbal cells display similarly sensitive to cytotoxicity treatment among passages. Our data strongly suggest that LiPSC could become a powerful alternative cellular model for cosmetic and drug tests.	[Aberdam, Daniel] INSERM, U976, Paris, France; Univ Paris Diderot, Hop St Louis, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Aberdam, D (corresponding author), INSERM, U976, Paris, France.	daniel.aberdam@inserm.fr	Petit, isabelle/AAF-5620-2020; Aberdam, Daniel/G-3299-2013	Petit, isabelle/0000-0002-9782-0683; Aberdam, Daniel/0000-0002-4019-5418	Agence Nationale pour la Recherche [ANR-Emergence 11-EMMA-023, ANR-13-PRTS-0001]; The competitiveness cluster MEDICEN; INSERM; Universite Paris-Diderot	Agence Nationale pour la Recherche(French National Research Agency (ANR)); The competitiveness cluster MEDICEN; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris-Diderot	This study was supported by the Agence Nationale pour la Recherche (ANR-Emergence 11-EMMA-023 and ANR-13-PRTS-0001); The competitiveness cluster MEDICEN; INSERM; and Universite Paris-Diderot.	Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Ahmad S, 2007, STEM CELLS, V25, P1145, DOI 10.1634/stemcells.2006-0516; Alepee N, 2016, TOXICOL IN VITRO, V31, P43, DOI 10.1016/j.tiv.2015.11.012; Araki-Sasaki K., 1995, INVEST OPHTH VIS SCI, V6, P614; Cheng CC, 2009, J CELL SCI, V122, P4473, DOI 10.1242/jcs.054791; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Erbani J, 2016, STEM CELL REV; Kaluzhny Y, 2011, ATLA-ALTERN LAB ANIM, V39, P339, DOI 10.1177/026119291103900409; Katoh M, 2013, TOXICOL IN VITRO, V27, P2184, DOI 10.1016/j.tiv.2013.08.008; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Mikhailova A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14684; Mikhailova A, 2014, STEM CELL REP, V2, P219, DOI 10.1016/j.stemcr.2013.12.014; Miyashita H, 2013, STEM CELL TRANSL MED, V2, P758, DOI 10.5966/sctm.2012-0156; Petit I, 2012, STEM CELL RES, V8, P134, DOI 10.1016/j.scr.2011.09.003; Ronkko S, 2016, DRUG DELIV TRANSL RE, V6, P660, DOI 10.1007/s13346-016-0330-y; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Wilson SL, 2015, TOXICOLOGY, V327, P32, DOI 10.1016/j.tox.2014.11.003	21	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179913	10.1371/journal.pone.0179913	http://dx.doi.org/10.1371/journal.pone.0179913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640863	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800082
J	Ambrosius, W; Michalak, S; Kazmierski, R; Andrzejewska, N; Kozubski, W				Ambrosius, Wojciech; Michalak, Slawomir; Kazmierski, Radoslaw; Andrzejewska, Natalia; Kozubski, Wojciech			Predictive value of serum transthyretin for outcome in acute ischemic stroke	PLOS ONE			English	Article							NUTRITIONAL-STATUS; CEREBRAL-ISCHEMIA; LOW PREALBUMIN; BRAIN; MECHANISMS; MORTALITY; SEVERITY; PROTEINS; DISEASE	Introduction The impact of choroid plexus with its blood cerebrospinal fluid barrier in the ischemic stroke pathology is poorly explored. Transthyretin (TTR) is a protein synthesized in liver and just in choroid plexus. Objectives The current study was designed to assess the prognostic value of serum TTR for functional outcome (at the time of hospital discharge) and long-term (one-year) overall mortality in ischemic stroke patients. Patients and methods We conducted a prospective observational study. Patients (n = 81) with acute (< 24 hours of symptoms onset) ischemic stroke consecutively admitted to Stroke Unit were included. An unfavorable outcome was defined as a modified Rankin Scale (mRS) score > 3. The relationships between serum TTR levels and clinical outcome were analyzed using multivariate analysis. One-year mortality was analyzed by Kaplan Meier survival curves stratified by mean value of TTR. Results Compared with patients with mRS <3, patients with an unfavorable outcome at hospital discharge had significantly lower TTR levels on admission (P< 0.0001). In non -survivals serum TTR levels were significantly lower compared with patients who survive one year of observation (P 0.009). Using multivariate analysis, transthyretin emerged as an independent predictor for unfavorable outcome at the day of hospital discharge (adjusted odds ratio = 0.96; 95% CI: 0.9-0.99, P <0.05). A one-year mortality of patients with the lower TTR levels was significantly higher than in patients with TTR levels above mean value (P= 0.02). Conclusions Serum level of TTR at admission was a predictor of functional outcome after ischemic stroke and was also associated with one-year mortality in stroke survivals.	[Ambrosius, Wojciech; Kozubski, Wojciech] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Michalak, Slawomir] Poznan Univ Med Sci, Dept Neurochem & Neuropathol, Poznan, Poland; [Kazmierski, Radoslaw; Andrzejewska, Natalia] Poznan Univ Med Sci, Ludwik Bierkowski Hosp, Dept Neurol & Cerebrovasc Disorders, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Ambrosius, W (corresponding author), Poznan Univ Med Sci, Dept Neurol, Poznan, Poland.	wambrosius@ump.edu.pl	Ambrosius, Wojciech/AGL-7764-2022	Kozubski, Wojciech/0000-0003-2777-261X; Ambrosius, Wojciech/0000-0002-8018-9776				Adams HP, 2015, STROKE, V46, pE114, DOI 10.1161/STROKEAHA.114.007773; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ambrosius W, 2011, EXP CLIN ENDOCR DIAB, V119, P139, DOI 10.1055/s-0030-1267918; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Chertow GM, 2005, KIDNEY INT, V68, P2794, DOI 10.1111/j.1523-1755.2005.00751.x; Delpont B, 2016, EUR NEUROL, V76, P125, DOI 10.1159/000449055; Dennis M, 2003, STROKE, V34, P1450, DOI 10.1161/01.STR.0000074037.49197.8C; Devoto G, 2006, CLIN CHEM, V52, P2281, DOI 10.1373/clinchem.2006.080366; DICKSON PW, 1987, J BIOL CHEM, V262, P13907; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Ennis SR, 2006, J CEREBR BLOOD F MET, V26, P675, DOI 10.1038/sj.jcbfm.9600224; Fleming CE, 2009, PROG NEUROBIOL, V89, P266, DOI 10.1016/j.pneurobio.2009.07.007; Furlan JC, 2014, EUR J NEUROL, V21, P215, DOI 10.1111/ene.12233; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao C, 2011, CLIN EXP MED, V11, P49, DOI 10.1007/s10238-010-0103-8; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; Kassem NA, 2006, AM J PHYSIOL-REG I, V291, pR1310, DOI 10.1152/ajpregu.00789.2005; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Keep RF, 2005, BLOOD-CEREBROSPINAL FLUID BARRIER, P345; Lee KH, 2016, KIDNEY RES CLIN PRAC, V35, P169, DOI 10.1016/j.krcp.2016.06.002; Lourenco P, 2014, HEART, V100, P1780, DOI 10.1136/heartjnl-2014-305747; Ma LL, 2016, CLIN CHIM ACTA, V458, P63, DOI 10.1016/j.cca.2016.04.023; Ma YH, 2012, J NEUROSCI RES, V90, P1873, DOI 10.1002/jnr.23088; Prapunpoj P, 2009, FEBS J, V276, P5330, DOI 10.1111/j.1742-4658.2009.07243.x; Richardson SJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00066; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Shen HC, 2011, ARCH GERONTOL GERIAT, V53, pE149, DOI 10.1016/j.archger.2010.08.001; Ye S, 2017, INT J NEUROSCI, V127, P601, DOI 10.1080/00207454.2016.1218874	30	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179806	10.1371/journal.pone.0179806	http://dx.doi.org/10.1371/journal.pone.0179806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636639	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300056
J	Gonzalez-Rocha, G; Munoz-Cartes, G; Canales-Aguirre, CB; Lima, CA; Dominguez-Yevenes, M; Bello-Toledo, H; Hernandez, CE				Gonzalez-Rocha, Gerardo; Munoz-Cartes, Gabriel; Canales-Aguirre, Cristian B.; Lima, Celia A.; Dominguez-Yevenes, Mariana; Bello-Toledo, Helia; Hernandez, Cristian E.			Diversity structure of culturable bacteria isolated from the Fildes Peninsula (King George Island, Antarctica): A phylogenetic analysis perspective	PLOS ONE			English	Article							SP-NOV.; PROKARYOTIC DIVERSITY; HETEROTROPHIC BACTERIA; ENVIRONMENT-SELECTS; COMMUNITY STRUCTURE; NICHE CONSERVATISM; MICROBIAL MATS; ROSS SEA; TERRESTRIAL; GENE	It has been proposed that Antarctic environments select microorganisms with unique biochemical adaptations, based on the tenet 'Everything is everywhere, but, the environment selects' by Baas-Becking. However, this is a hypothesis that has not been extensively evaluated. This study evaluated the fundamental prediction contained in this hypothesis-in the sense that species are structured in the landscape according to their local habitats-, using as study model the phylogenetic diversity of the culturable bacteria of Fildes Peninsula (King George Island, Antarctica). Eighty bacterial strains isolated from 10 different locations in the area, were recovered. Based on phylogenetic analysis of 16S rRNA gene sequences, the isolates were grouped into twenty-six phylotypes distributed in three main clades, of which only six are exclusive to Antarctica. Results showed that phylotypes do not group significantly by habitat type; however, local habitat types had phylogenetic signal, which support the phylogenetic niche conservatism hypothesis and not a selective role of the environment like the Baas-Becking hypothesis suggests. We propose that, more than habitat selection resulting in new local adaptations and diversity, local historical colonization and species sorting (i.e. differences in speciation and extinction rates that arise by interaction of species level traits with the environment) play a fundamental role on the culturable bacterial diversity in Antarctica.	[Gonzalez-Rocha, Gerardo; Munoz-Cartes, Gabriel; Lima, Celia A.; Dominguez-Yevenes, Mariana; Bello-Toledo, Helia] Univ Concepcion, Fac Ciencias Biol, Dept Microbiol, Lab Invest & Agentes Antibacteriano, Concepcion, Chile; [Canales-Aguirre, Cristian B.; Hernandez, Cristian E.] Univ Concepcion, Fac Ciencias Nat Oceanog, Dept Zool, Lab Ecol Evolutiva Filoinformat, Concepcion, Chile; [Canales-Aguirre, Cristian B.] Univ Los Lagos, Ctr Imar, Camino Chinquihue 6 km, Puerto Montt, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Los Lagos	Hernandez, CE (corresponding author), Univ Concepcion, Fac Ciencias Nat Oceanog, Dept Zool, Lab Ecol Evolutiva Filoinformat, Concepcion, Chile.	cristianhernand@udec.cl	Gonzalez-Rocha, Gerardo E/M-3610-2014; Hernández, Cristián E./AAS-1286-2020; Hernández, Cristián E./GLS-1111-2022; Lima, Celia A/F-9206-2017; Bello-Toledo, H/AAA-2387-2022; Gonzalez-Rocha, Gerardo/AAP-1793-2021	Gonzalez-Rocha, Gerardo E/0000-0003-2351-1236; Hernández, Cristián E./0000-0002-9811-2881; Hernández, Cristián E./0000-0002-9811-2881; Bello-Toledo, H/0000-0002-9277-4681; Gonzalez-Rocha, Gerardo/0000-0003-2351-1236; Lima, Celia/0000-0002-4697-034X	Institute Antartico Chileno INACH [G-03-07, T-17-08]; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [1140692, 1170815]; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT POSDOCTORADO [3150456]; INACH [G-03-07, RT-17-08]; FONDECYT [1140692, 1170815, 3150456]	Institute Antartico Chileno INACH; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT POSDOCTORADO; INACH; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was financed by Institute Antartico Chileno INACH No G-03-07 (http//www. inach.cl/inachi) to MD-Y; Institute Antartico Chileno INACH No T-17-08 (http://www.inach.cl/inach/) to GG-R; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT No 1140692 and 1170815 (http://www.conicyt.cl/fondecyt/) to CEHU and Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT POSDOCTORADO No 3150456 (http://www.conicyt.cl/fondecyt/) to CBC-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To the Chilean Antarctic Institute (INACH) for the logistic support provided during our stay in the Research Base "Profesor Julio Escudero". This research was founded by INACH RT-17-08 and G-03-07. Authors are very grateful to Dra. Patricia Virano for assistance by the previous version of the map. CEHU is grateful to funding from FONDECYT grant 1140692 and 1170815, CCA was funded by FONDECYT grant 3150456.	Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Benmalek Y, 2010, INT J SYST EVOL MICR, V60, P1876, DOI 10.1099/ijs.0.008631-0; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bottos EM, 2008, ENVIRON MICROBIOL, V10, P950, DOI 10.1111/j.1462-2920.2007.01516.x; Brambilla E, 2001, EXTREMOPHILES, V5, P23, DOI 10.1007/s007920000169; Chong CW, 2009, POLAR BIOL, V32, P853, DOI 10.1007/s00300-009-0585-6; Chong CW, 2013, EXTREMOPHILES, V17, P733, DOI 10.1007/s00792-013-0555-3; Chong CW, 2009, POLAR BIOL, V32, P1571, DOI 10.1007/s00300-009-0656-8; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Convey P, 2008, BIOL REV, V83, P103, DOI 10.1111/j.1469-185X.2008.00034.x; Correa-Llanten DN, 2012, J MICROBIOL, V50, P374, DOI 10.1007/s12275-012-2029-1; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DiCello F, 1996, MINERVA BIOTECNOL, V8, P126; DiCello F, 1997, RES MICROBIOL, V148, P237, DOI 10.1016/S0923-2508(97)85244-8; Dieser M, 2010, ARCT ANTARCT ALP RES, V42, P396, DOI 10.1657/1938-4246-42.4.396; Fondi M, 2016, GENOME BIOL EVOL, V8, P1388, DOI 10.1093/gbe/evw077; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hernandez CE, 2013, METHODS ECOL EVOL, V4, P401, DOI 10.1111/2041-210X.12033; Hu WG, 2016, EXTREMOPHILES, V20, P337, DOI 10.1007/s00792-016-0825-y; Hubbell Stephen P., 2001, V32, pi; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Humphry DR, 2001, INT J SYST EVOL MICR, V51, P1235, DOI 10.1099/00207713-51-4-1235; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Jing HM, 2010, AQUAT MICROB ECOL, V61, P191, DOI 10.3354/ame01450; Klassen JL, 2011, EXTREMOPHILES, V15, P45, DOI 10.1007/s00792-010-0336-1; Leibold MA, 2015, ECOLOGY, V96, P3227, DOI 10.1890/14-2354.1; Lopatina A, 2016, FRONTIERS MICROBIOLO, P7; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Rojas JL, 2009, MAR GENOM, V2, P33, DOI 10.1016/j.margen.2009.03.005; Luria CM, 2014, MARINE BACTERIAL ARC; Mannisto MK, 2000, INT J SYST EVOL MICR, V50, P1731, DOI 10.1099/00207713-50-5-1731; McCammon SA, 1998, INT J SYST BACTERIOL, V48, P1405, DOI 10.1099/00207713-48-4-1405; Metje M, 2007, ENVIRON MICROBIOL, V9, P954, DOI 10.1111/j.1462-2920.2006.01217.x; Michaud L, 2004, FEMS MICROBIOL LETT, V230, P63, DOI 10.1016/S0378-1097(03)00857-7; Mojib N, 2009, DIVERSITY BACTERIAL; Moreno-Pino M, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw088; Moroenyane I, 2016, MICROB ECOL, V72, P313, DOI 10.1007/s00248-016-0761-5; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nogi Y, 2005, SYST APPL MICROBIOL, V28, P310, DOI 10.1016/j.syapm.2005.01.001; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peeters K, 2012, POLAR BIOL, V35, P543, DOI 10.1007/s00300-011-1100-4; Peeters K, 2011, FEMS MICROBIOL LETT, V321, P130, DOI 10.1111/j.1574-6968.2011.02326.x; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Reysenbach AL, 2000, EXTREMOPHILES, V4, P61, DOI 10.1007/s007920050008; Romanenko LA, 2005, INT J SYST EVOL MICR, V55, P919, DOI 10.1099/ijs.0.63176-0; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Shivaji S, 2013, RES MICROBIOL, V164, P70, DOI 10.1016/j.resmic.2012.09.001; Shivaji S, 2011, RES MICROBIOL, V162, P191, DOI 10.1016/j.resmic.2010.09.020; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tytgat B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097564; Van Trappen S, 2002, SYST APPL MICROBIOL, V25, P603, DOI 10.1078/07232020260517742; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P769, DOI 10.1099/ijs.0.03056-0; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vrba E, 1982, EVOLUTION TRENDS MOD, P239; VRBA ES, 1980, S AFR J SCI, V76, P61; Wang NF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01188; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Winter C, 2013, ISME J, V7, P1507, DOI 10.1038/ismej.2013.56; Wong CMVL, 2011, POL POLAR RES, V32, P3, DOI 10.2478/v10183-011-0003-y; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xiao X, 2007, ANTARCT SCI, V19, P11, DOI 10.1017/S095410200700003X; Xin YJ, 2011, POLAR BIOL, V34, P1501, DOI 10.1007/s00300-011-1009-y; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Yergeau E, 2007, FEMS MICROBIOL ECOL, V59, P436, DOI 10.1111/j.1574-6941.2006.00200.x; Zhang DC, 2006, INT J SYST EVOL MICR, V56, P2921, DOI 10.1099/ijs.0.64564-0; Zhu F, 2003, INT J SYST EVOL MICR, V53, P853, DOI 10.1099/ijs.0.02310-0	78	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179390	10.1371/journal.pone.0179390	http://dx.doi.org/10.1371/journal.pone.0179390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632790	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100026
J	Granata, V; Fusco, R; Catalano, O; Avallone, A; Palaia, R; Botti, G; Tatangelo, F; Granata, F; Cascella, M; Izzo, F; Petrillo, A				Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Avallone, Antonio; Palaia, Raffaele; Botti, Gerardo; Tatangelo, Fabiana; Granata, Francesco; Cascella, Marco; Izzo, Francesco; Petrillo, Antonella			Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases	PLOS ONE			English	Article							PREOPERATIVE EVALUATION; BILIARY OBSTRUCTION; HEPATOCELLULAR-CARCINOMA; MR CHOLANGIOGRAPHY; HELICAL CT; CHOLANGIOCARCINOMA; TRACT	Purpose We compared diagnostic performance of Magnetic Resonance (MR), Computed Tomography (CT) and Ultrasound (US) with (CEUS) and without contrast medium to identify peribiliary metastasis. Methods We identified 35 subjects with histological proven peribiliary metastases who underwent CEUS, CT and MR study. Four radiologists evaluated the presence of peribiliary lesions, using a 4-point confidence scale. Echogenicity, density and T1-Weigthed (T1-W), T2-W and Diffusion Weighted Imaging (DWI) signal intensity as well as the enhancement pattern during contrast studies on CEUS, CT and MR so as hepatobiliary-phase on MRI was assessed. Results All lesions were detected by MR. CT detected 8 lesions, while US/CEUS detected one lesion. According to the site of the lesion, respect to the bile duct and hepatic parenchyma: 19 (54.3%) were periductal, 15 (42.8%) were intra-periductal and 1 (2.8%) was periductal-intrahepatic. According to the confidence scale MRI had the best diagnostic performance to assess the lesion. CT obtained lower diagnostic performance. There was no significant difference in MR signal intensity and contrast enhancement among all metastases (p>0.05).There was no significant difference in CT density and contrast enhancement among all metastases (p>0.05). Conclusions MRI is the method of choice for biliary tract tumors but it does not allow a correct differential diagnosis among different histological types of metastasis. The presence of biliary tree dilatation without hepatic lesions on CT and US/CEUS study may be an indirect sign of peribiliary metastases and for this reason the patient should be evaluated by MRI.	[Granata, Vincenza; Fusco, Roberta; Catalano, Orlando; Petrillo, Antonella] Ist Nazl Tumori IRCCS Fdn G Pascale, Div Radiol, Naples, Italy; [Avallone, Antonio] Ist Nazl Tumori IRCCS Fdn G Pascale, Div Abdominal Oncol, Naples, Italy; [Palaia, Raffaele; Izzo, Francesco] Ist Nazl Tumori IRCCS Fdn G Pascale, Div Hepatobiliary Surg Oncol, Naples, Italy; [Botti, Gerardo; Tatangelo, Fabiana] Ist Nazl Tumori IRCCS Fdn G Pascale, Div Diagnost Pathol, Naples, Italy; [Granata, Francesco] Univ Cassino & Southern Lazio, Dept Civil & Mech Engn, Cassino, Italy; [Cascella, Marco] Ist Nazl Tumori IRCCS Fdn G Pascale, Div Anesthesia Endoscopy & Cardiol, Naples, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; University of Cassino; IRCCS Fondazione Pascale	Fusco, R (corresponding author), Ist Nazl Tumori IRCCS Fdn G Pascale, Div Radiol, Naples, Italy.	r.fusco@istitutotumori.na.it	Fusco, Roberta/I-4062-2018; GRANATA, Francesco/AFV-6410-2022; Granata, Vincenza/K-6733-2016; Petrillo, Antonella/J-5450-2018; Granata, Francesco/P-5197-2014; cascella, Marco/N-1316-2018; Tatangelo, Fabiana/AAA-8413-2020; Izzo, Francesco/P-3042-2019; Avallone, Antonio/K-4662-2016	Fusco, Roberta/0000-0002-0469-9969; GRANATA, Francesco/0000-0002-2268-6600; Granata, Vincenza/0000-0002-6601-3221; Petrillo, Antonella/0000-0003-2465-5370; cascella, Marco/0000-0002-5236-3132; Tatangelo, Fabiana/0000-0002-9943-6079; Izzo, Francesco/0000-0003-3093-5408; Avallone, Antonio/0000-0001-6188-5664; Botti, Gerardo/0000-0002-6287-733X				Avallone A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2102-y; Bartolotta TV, 2010, RADIOL MED, V115, P714, DOI 10.1007/s11547-010-0506-3; Bernatik T, 2001, J ULTRAS MED, V20, P509; BISMUTH H, 1975, SURG GYNECOL OBSTET, V140, P170; Campani R, 1998, RADIOLOGY, V209P, P232; Choi KS, 2015, AM J ROENTGENOL, V205, P789, DOI 10.2214/AJR.14.14089; Chung WS, 2011, J MAGN RESON IMAGING, V34, P345, DOI 10.1002/jmri.22671; Chung YE, 2008, EUR RADIOL, V18, P2182, DOI 10.1007/s00330-008-1006-x; Corona-Villalobos CP, 2014, SURG ONCOL CLIN N AM, V23, P189, DOI 10.1016/j.soc.2013.10.002; Corvino A, 2015, ULTRASOUND MED BIOL, V41, P1301, DOI 10.1016/j.ultrasmedbio.2014.12.667; El Fattach H, 2015, EUR J RADIOL, V84, P1444, DOI 10.1016/j.ejrad.2015.05.003; Granata V, 2013, GASTROENT RES PRACT, V2013; Granata V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3918292; Granata V, 2016, RADIOL MED, V121, P122, DOI 10.1007/s11547-015-0582-5; Granata V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142876; Granata V, 2015, ABDOM IMAGING, V40, P2364, DOI 10.1007/s00261-015-0488-7; Gwon DI, 2012, ACTA RADIOL, V53, P422, DOI 10.1258/ar.2012.110703; Izzo F, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0006-0; Mittal PK, 2015, ABDOM IMAGING, V40, P1520, DOI 10.1007/s00261-014-0300-0; Moon SG, 2003, ABDOM IMAGING, V28, P45, DOI 10.1007/s00261-001-0191-8; Neri E, 2016, EUR RADIOL, V26, P921, DOI 10.1007/s00330-015-3900-3; NESBIT GM, 1988, AM J ROENTGENOL, V151, P933, DOI 10.2214/ajr.151.5.933; Park MJ, 2014, RADIOLOGY, V270, P768, DOI 10.1148/radiol.13130009; POPP JW, 1979, ANN INTERN MED, V91, P568, DOI 10.7326/0003-4819-91-4-568; Ringe KL, 2015, BEST PRACT RES CL GA, V29, P253, DOI 10.1016/j.bpg.2015.02.004; Ryoo I, 2010, INVEST RADIOL, V45, P217, DOI 10.1097/RLI.0b013e3181d2eeb1; Sun HY, 2013, J MAGN RESON IMAGING, V38, P138, DOI 10.1002/jmri.23957; Tillich M, 1998, AM J ROENTGENOL, V171, P651, DOI 10.2214/ajr.171.3.9725291; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Westwood M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17090; Zech CJ, 2004, EUR RADIOL, V14, P1174, DOI 10.1007/s00330-004-2327-z	31	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179951	10.1371/journal.pone.0179951	http://dx.doi.org/10.1371/journal.pone.0179951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632786	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100054
J	Pai, SC; Kung, PT; Chou, WY; Kuo, T; Tsai, WC				Pai, Szu-Chi; Kung, Pei-Tseng; Chou, Wen-Yu; Kuo, Tsunghuai; Tsai, Wen-Chen			Survival and medical utilization of children and adolescents with prolonged ventilatordependent and associated factors	PLOS ONE			English	Article							TERM MECHANICAL VENTILATION; OUTCOMES; CARE; COST	Over the course of a year, more than 20,000 patients in Taiwan require prolonged mechanical ventilation (PMV). Data from the National Health Insurance Research Database for patients between 2005 and 2011 were used to conduct a retrospective analysis on ventilator dependence. The study subjects were PMV patients aged <17 years in Taiwan. A multiple regression model employing general estimating equations was applied to investigate the factors affecting the use of medical resources by children and adolescent PMV patients. A Cox proportional hazard model was incorporated to explore the factors affecting the survival of these patients. Data were collected for a total of 1,019 children and adolescent PMV patients in Taiwan. The results revealed that the average number of outpatient visits per subject was 32.1 times per year, whereas emergency treatments averaged 1.56 times per year per subject and hospitalizations averaged 160.8 days per year per subject. Regarding average annual medical costs, hospitalizations accounted for the largest portion at NT $821,703 per year per subject, followed by outpatient care at NT$123,136 per year per subject and emergency care at NT$3,806 per year per subject. The demographic results indicated that the patients were predominately male (61.24%), with those under 1 year of age accounting for the highest percentage (36.38%). According to the Kaplan D Meier curve, the 1-year and 5-year mortality rates of the patients were approximately 32% and 47%, respectively. The following factors affecting the survival rate were considered: age, the Charlson Comorbidity Index (CCI), diagnosis type necessitating ventilator use, and whether an invasive ventilator was used. This study investigated the use of medical resources and the survival rates of children and adolescent PMV patients. The findings of this study can serve as a reference for the National Health Insurance Administration in promoting its future integrated pilot projects on ventilator dependency.	[Pai, Szu-Chi; Chou, Wen-Yu; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Pai, Szu-Chi] Show Chwan Mem Hosp, Dept Resp Therapy, Changhua, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Hlth Adm, Taichung, Taiwan; [Kuo, Tsunghuai] Show Chwan Mem Hosp, Dept Chest Med, Changhua, Taiwan	China Medical University Taiwan; Show Chwan Memorial Hospital; Asia University Taiwan; Show Chwan Memorial Hospital	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789	China Medical University [CMU103-ASIA-23, DOH102-NH-9009]; Asia University; Ministry of Health and Welfare, Taiwan; National Health Insurance Administration, Taiwan	China Medical University(China Medical University); Asia University; Ministry of Health and Welfare, Taiwan; National Health Insurance Administration, Taiwan	This study was supported by grants (CMU103-ASIA-23, DOH102-NH-9009) from China Medical University, Asia University and the Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants (CMU103-ASIA-23, DOH102-NH-9009) from China Medical University, Asia University and the National Health Insurance Administration, Taiwan. We are grateful for use of the National Health Insurance Research Database.	Baldwin MR, 2013, CHEST, V143, P910, DOI 10.1378/chest.12-1668; Benneyworth BD, 2011, PEDIATRICS, V127, pE1533, DOI 10.1542/peds.2010-2026; Damuth E, 2015, LANCET RESP MED, V3, P544, DOI 10.1016/S2213-2600(15)00150-2; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edwards J. D., 2010, J PEDIAT, V157; Estenssoro E, 2005, CHEST, V127, P598, DOI 10.1378/chest.127.2.598; Fakharian Atefeh, 2013, Tanaffos, V12, P6; Frengley JD, 2014, J AM GERIATR SOC, V62, P1, DOI 10.1111/jgs.12597; Hsia SH, 2012, PEDIATR NEONATOL, V53, P304, DOI 10.1016/j.pedneo.2012.07.005; Lin MS, 2013, RESP CARE, V58, P517, DOI 10.4187/respcare.01530; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lone NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10117; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; McDougall CM, 2013, ARCH DIS CHILD, V98, P660, DOI 10.1136/archdischild-2012-303062; National Health Insurance Administration Ministry of Health and Welfare, 2013, REG GOV EX NAT HLTH; National Health Insurance Administration Ministry of Health and Welfare, 2016, UN HLTH COV TAIW; National Health Insurance Administration Ministry of Health and Welfare, 2012, BUS IMPL REP FEBR; National Health Insurance Administration Ministry of Health and Welfare, 2014, ABSTR STAT AN NAT A; National Health Insurance Administration Ministry of Health and Welfare, 2006, EST VENT INT DEL SYS; National Health Insurance Administration Ministry of Health and Welfare. The National Health Insur- ance Statistics, 2010, ABSTR STAT AN 3 ST A, V4; National Health Insurance Administration Ministry of Health and Welfare. The National Health Insurance Statistics, 2014, NAT HLTH INS STAT B, V4; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Racca F, 2011, MINERVA ANESTESIOL, V77, P892; Tung HP, 2009, J TAIWAN EMERG MED, V11, pS14; Wallis C, 2011, ARCH DIS CHILD, V96, P998, DOI 10.1136/adc.2010.192864	25	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179274	10.1371/journal.pone.0179274	http://dx.doi.org/10.1371/journal.pone.0179274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628663	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100021
J	Uitterdijk, A; Groenendijk, BCW; Gorsse-Bakker, C; Panasewicz, A; Sneep, S; Tempel, D; de Kamp, EHV; Merkus, D; van der Giessen, WJ; Duncker, DJ				Uitterdijk, Andre; Groenendijk, Bianca C. W.; Gorsse-Bakker, Charlotte; Panasewicz, Anna; Sneep, Stefan; Tempel, Dennie; de Kamp, Esther H. van; Merkus, Daphne; van der Giessen, Willem J.; Duncker, Dirk J.			Time course of VCAM-1 expression in reperfused myocardial infarction in swine and its relation to retention of intracoronary administered bone marrow-derived mononuclear cells	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; PROGENITOR CELLS; INFLAMMATORY RESPONSE; ADHESION MOLECULES; CD34(+) CELLS; E-SELECTIN; DELIVERY; INJECTION; THERAPY; SIZE	Background Intracoronary infusion of autologous bone marrow-derived mononuclear cells (BMMNC), after acute myocardial infarction (AMI), has been shown to improve myocardial function. However, therapeutic efficacy is limited, possibly because cell retention rates are low, suggesting that optimization of cell retention might increase therapeutic efficacy. Since retention of injected BMMNC is observed only within infarcted, but not remote, myocardium, we hypothesized that adhesion molecules on activated endothelium following reperfusion are essential. Consequently, we investigated the role of vascular cell adhesion molecule 1 (VCAM-1) in BMMNC retention in swine undergoing reperfused AMI produced by 120 min of percutaneous left circumflex coronary occlusion. Methods and results VCAM-1 expression in the infarct and remote region was quantified at 1, 3, 7, 14, and 35 days, post-reperfusion (n >= 6 swine per group). Since expression levels were significantly higher at 3 days (2.41 +/- 0.62%) than at 7 days (0.98 +/- 0.28%; p<0.05), we compared the degree of cell retention at those time points in a follow-up study, in which an average of 43.10(6) autologous BMMNCs were infused intracoronary at 3, or 7 days, post-reperfusion (n = 6 swine per group) and retention was histologically quantified one hour after intracoronary infusion of autologous BMMNCs. Although VCAM-1 expression correlated with retention of BMMNC within each time point, overall BMMNC retention was similar at day 3 and day 7 (2.3 +/- 1.3% vs. 3.1 +/- 1.4%, p = 0.72). This was not due to the composition of infused bone marrow cell fractions (analyzed with flow cytometry; n = 5 per group), as cell composition of the infused BMMNC fractions was similar. Conclusion These findings suggest that VCAM-1 expression influences to a small degree, but is not the principal determinant of, BMMNC retention.	[Uitterdijk, Andre; Groenendijk, Bianca C. W.; Gorsse-Bakker, Charlotte; Panasewicz, Anna; Sneep, Stefan; Tempel, Dennie; de Kamp, Esther H. van; Merkus, Daphne; van der Giessen, Willem J.; Duncker, Dirk J.] Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Duncker, DJ (corresponding author), Erasmus MC, Dept Cardiol, Rotterdam, Netherlands.	d.duncker@erasmusmc.nl	Merkus, Daphne/AAN-4459-2020; Merkus, Daphne/C-6539-2011	Merkus, Daphne/0000-0002-4852-831X; Uitterdijk, Andre/0000-0003-1331-9259	Ministry of Economic Affairs and the Province of South Holland (Pieken in de Delta Program)	Ministry of Economic Affairs and the Province of South Holland (Pieken in de Delta Program)	This work was supported by the Ministry of Economic Affairs and the Province of South Holland (Pieken in de Delta Program; 3Binding Project to Willem J. van der Giessen and Dirk J. Duncker).; The authors gratefully acknowledge funding by the Ministry of Economic Affairs and the Province of South Holland (Pieken in de Delta Program; 3Binding Project to WJG and DJD), and gratefully acknowledge Prof. Dr. Dorian Haskard, Vascular Sciences Section, National Heart and Lung Institute, Imperial College London, for providing the VCAM-1 antibody.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Assmus B, 2014, EUR HEART J, V35, P1275, DOI 10.1093/eurheartj/ehu062; Blann AD, 2003, EUR HEART J, V24, P2166, DOI 10.1016/j.ehj.2003.08.021; Blocklet D, 2006, STEM CELLS, V24, P333, DOI 10.1634/stemcells.2005-0201; Cason BA, 1997, ANESTHESIOLOGY, V87, P1182, DOI 10.1097/00000542-199711000-00023; Dedobbeleer C, 2009, J CARDIOVASC PHARM, V53, P480, DOI 10.1097/FJC.0b013e3181a7b572; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Doyle B, 2007, J NUCL MED, V48, P1708, DOI 10.2967/jnumed.107.042838; Duncker DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1189, DOI 10.1152/ajpheart.1996.270.4.H1189; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Goussetis E, 2006, STEM CELLS, V24, P2279, DOI 10.1634/stemcells.2005-0589; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Hong SJ, 2014, CATHETER CARDIO INTE, V83, pE17, DOI 10.1002/ccd.24659; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Keith MCL, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0503-8; Kerner T, 2001, CRIT CARE, V5, P145, DOI 10.1186/cc1014; Ly HQ, 2009, EUR HEART J, V30, P2861, DOI 10.1093/eurheartj/ehp322; Macias C, 2003, REV ESP CARDIOL, V56, P137, DOI 10.1157/13043219; McColgan P, 2011, STEM CELL REV REP, V7, P1031, DOI 10.1007/s12015-011-9260-8; Moelker AD, 2006, EUR HEART J, V27, P3057, DOI 10.1093/eurheartj/ehl401; Moreira RD, 2011, ARQ BRAS CARDIOL, V97, P420; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Musialek P, 2013, CIRC-CARDIOVASC IMAG, V6, P320, DOI 10.1161/CIRCIMAGING.112.979633; Musialek P, 2011, J NUCL CARDIOL, V18, P104, DOI 10.1007/s12350-010-9326-z; OLIVETTI G, 1990, CIRC RES, V67, P23, DOI 10.1161/01.RES.67.1.23; Penicka M, 2005, CIRCULATION, V112, pE63, DOI 10.1161/CIRCULATIONAHA.104.496133; Ruparelia N, 2013, INFLAMM RES, V62, P515, DOI 10.1007/s00011-013-0605-4; Silva SA, 2009, CELL TRANSPLANT, V18, P343, DOI 10.3727/096368909788534951; Suefuji H, 2000, AM HEART J, V140, P243, DOI 10.1067/mhj.2000.107544; Tossios P, 2008, EUR HEART J, V29, P1911, DOI 10.1093/eurheartj/ehn218; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; Uitterdijk A, 2015, AM J PHYSIOL-HEART C, V309, pH396, DOI 10.1152/ajpheart.00698.2014; Uitterdijk A, 2013, AM J PHYSIOL-HEART C, V305, pH1104, DOI 10.1152/ajpheart.00447.2013; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178779	10.1371/journal.pone.0178779	http://dx.doi.org/10.1371/journal.pone.0178779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628621	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100008
J	Leongomez, JD; Mileva, VR; Little, AC; Roberts, SC				Leongomez, Juan David; Mileva, Viktoria R.; Little, Anthony C.; Roberts, S. Craig			Perceived differences in social status between speaker and listener affect the speaker's vocal characteristics	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; VOICE PITCH; MENS VOICES; DOMINANCE; CUES; ATTRACTIVENESS; SIGNALS; INDUSTRIAL; EVOLUTION; PRESTIGE	Non-verbal behaviours, including voice characteristics during speech, are an important way to communicate social status. Research suggests that individuals can obtain high social status through dominance (using force and intimidation) or through prestige (by being knowledgeable and skilful). However, little is known regarding differences in the vocal behaviour of men and women in response to dominant and prestigious individuals. Here, we tested within-subject differences in vocal parameters of interviewees during simulated job interviews with dominant, prestigious, and neutral employers (targets), while responding to questions which were classified as introductory, personal, and interpersonal. We found that vocal modulations were apparent between responses to the neutral and high-status targets, with participants, especially those who perceived themselves as low in dominance, increasing fundamental frequency (F0) in response to the dominant and prestigious targets relative to the neutral target. Self-perceived prestige, however, was less related to contextual vocal modulations than self-perceived dominance. Finally, we found that differences in the context of the interview questions participants were asked to respond to (introductory, personal, interpersonal), also affected their vocal parameters, being more prominent in responses to personal and interpersonal questions. Overall, our results suggest that people adjust their vocal parameters according to the perceived social status of the listener as well as their own self-perceived social status.	[Leongomez, Juan David; Mileva, Viktoria R.; Little, Anthony C.; Roberts, S. Craig] Univ Stirling, Fac Nat Sci, Stirling, Scotland; [Leongomez, Juan David] Univ El Bosque, Fac Psicol, Lab Anal Comportamiento Humano, Bogota, Colombia; [Little, Anthony C.] Univ Bath, Dept Psychol, Bath, Avon, England	University of Stirling; Universidad El Bosque; University of Bath	Leongomez, JD (corresponding author), Univ Stirling, Fac Nat Sci, Stirling, Scotland.; Leongomez, JD (corresponding author), Univ El Bosque, Fac Psicol, Lab Anal Comportamiento Humano, Bogota, Colombia.	jleongomez@unbosque.edu.co	Roberts, Craig/E-6919-2011; Leongómez, Juan David/D-2885-2011; Little, Anthony/W-2732-2019	Roberts, Craig/0000-0002-9641-6101; Leongómez, Juan David/0000-0002-0092-6298; Little, Anthony/0000-0001-9100-1903	Universidad El Bosque, Vicerrectory of Research [PCI2015-8207]; COLCIENCIAS, the Colombian Administrative Department of Science, Technology and Innovation; University of Stirling; Natural Sciences and Engineering Research Council of Canada	Universidad El Bosque, Vicerrectory of Research; COLCIENCIAS, the Colombian Administrative Department of Science, Technology and Innovation(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); University of Stirling; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	JDL was supported by Universidad El Bosque, Vicerrectory of Research under Grant No. PCI2015-8207 (http://www.uelbosque.edu.co/), and COLCIENCIAS, the Colombian Administrative Department of Science, Technology and Innovation (http://www.colciencias.gov.co/home). VRM was supported by the University of Stirling (https:// wwwstir.ac.uk/) and the Natural Sciences and Engineering Research Council of Canada (http:// www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2002, SURGERY, V132, P5, DOI 10.1067/msy.2002.124733; Bailey DH, 2011, EVOL HUM BEHAV, V32, P138, DOI 10.1016/j.evolhumbehav.2010.08.004; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bryant GA, 2009, BIOL LETTERS, V5, P12, DOI 10.1098/rsbl.2008.0507; Burriss RP, 2007, ARCH SEX BEHAV, V36, P377, DOI 10.1007/s10508-006-9136-1; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Cheng JT, 2013, J PERS SOC PSYCHOL, V104, P103, DOI 10.1037/a0030398; Cheng JT, 2010, EVOL HUM BEHAV, V31, P334, DOI 10.1016/j.evolhumbehav.2010.02.004; Collias N. E., 1960, ANIMAL SOUNDS COMMUN, P368; Collins SA, 2000, ANIM BEHAV, V60, P773, DOI 10.1006/anbe.2000.1523; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; DELANEY HD, 1981, MULTIVAR BEHAV RES, V16, P105, DOI 10.1207/s15327906mbr1601_6; Feinberg DR, 2008, EVOL ANTHROPOL, V17, P112, DOI 10.1002/evan.20166; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Frowd CD., 2004, ACM T APPL PERCEPT, V1, P19, DOI [10.1145/1008722.1008725, DOI 10.1145/1008722.1008725]; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hill AK, 2013, EVOL HUM BEHAV, V34, P334, DOI 10.1016/j.evolhumbehav.2013.05.004; Hodges-Simeon CR, 2014, BEHAV ECOL, V25, P984, DOI 10.1093/beheco/aru081; Hodges-Simeon CR, 2011, ARCH SEX BEHAV, V40, P551, DOI 10.1007/s10508-010-9625-0; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; HOLM S, 1979, SCAND J STAT, V6, P65; Hopcroft RL, 2006, EVOL HUM BEHAV, V27, P104, DOI 10.1016/j.evolhumbehav.2005.07.004; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Kempe V, 2013, HUM NATURE-INT BIOS, V24, P461, DOI 10.1007/s12110-013-9183-y; KUDO H, 1987, PRIMATES, V28, P289, DOI 10.1007/BF02381013; Leongomez JD, 2014, EVOL HUM BEHAV, V35, P489, DOI 10.1016/j.evolhumbehav.2014.06.008; Mayew WJ, 2013, EVOL HUM BEHAV, V34, P243, DOI 10.1016/j.evolhumbehav.2013.03.001; Mulac A, 1996, HEALTH COMMUN, V8, P199, DOI 10.1207/s15327027hc0803_2; Pinker S., 1997, MIND WORKS; Pipitone RN, 2008, EVOL HUM BEHAV, V29, P268, DOI 10.1016/j.evolhumbehav.2008.02.001; Puts DA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2830; Puts DA, 2013, HORM BEHAV, V63, P13, DOI 10.1016/j.yhbeh.2012.11.007; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Roder S, 2013, EVOL PSYCHOL-US, V11, P392; Schneider BA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00474; Sell A, 2010, P ROY SOC B-BIOL SCI, V277, P3509, DOI 10.1098/rspb.2010.0769; Taylor A., 2011, USING GLM PROCEDURE; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Tusing KJ, 2000, HUM COMMUN RES, V26, P148, DOI 10.1093/hcr/26.1.148; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Watkins CD, 2010, BEHAV ECOL, V21, P943, DOI 10.1093/beheco/arq091; Wheatley JR, 2014, EVOL HUM BEHAV, V35, P264, DOI 10.1016/j.evolhumbehav.2014.02.006; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Xu Y, 2013, RADIAT ONCOL, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0062397; Young MJ., 2004, COMMUNICATION REPORT, V17, P49, DOI [10.1080/08934210409389373, DOI 10.1080/08934210409389373]	49	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179407	10.1371/journal.pone.0179407	http://dx.doi.org/10.1371/journal.pone.0179407			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614413	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900049
J	Jin, YM; Schaffer, AA; Sherry, ST; Feolo, M				Jin, Yumi; Schaffer, Alejandro A.; Sherry, Stephen T.; Feolo, Michael			Quickly identifying identical and closely related subjects in large databases using genotype data	PLOS ONE			English	Article							PAIRWISE RELATEDNESS; ASSOCIATION; INFERENCE; PLINK	Genome- wide association studies (GWAS) usually rely on the assumption that different samples are not from closely related individuals. Detection of duplicates and close relatives becomes more difficult both statistically and computationally when one wants to combine datasets that may have been genotyped on different platforms. The dbGaP repository at the National Center of Biotechnology Information (NCBI) contains datasets from hundreds of studies with over one million samples. There are many duplicates and closely related individuals both within and across studies from different submitters. Relationships between studies cannot always be identified by the submitters of individual datasets. To aid in curation of dbGaP, we developed a rapid statistical method called Genetic Relationship and Fingerprinting (GRAF) to detect duplicates and closely related samples, even when the sets of genotyped markers differ and the DNA strand orientations are unknown. GRAF extracts genotypes of 10,000 informative and independent SNPs from genotype datasets obtained using different methods, and implements quick algorithms that enable it to find all of the duplicate pairs from more than 880,000 samples within and across dbGaP studies in less than two hours. In addition, GRAF uses two statistical metrics called All Genotype Mismatch Rate (AGMR) and Homozygous Genotype Mismatch Rate (HGMR) to determine subject relationships directly from the observed genotypes, without estimating probabilities of identity by descent (IBD), or kinship coefficients, and compares the predicted relationships with those reported in the pedigree files. We implemented GRAF in a freely available C++ program of the same name. In this paper, we describe the methods in GRAF and validate the usage of GRAF on samples from the dbGaP repository. Other scientists can use GRAF on their own samples and in combination with samples downloaded from dbGaP.	[Jin, Yumi; Schaffer, Alejandro A.; Sherry, Stephen T.; Feolo, Michael] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Jin, YM (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	jinyu@ncbi.nlm.nih.gov	Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Sherry, Stephen/0000-0002-7982-076X	Intramural Research Program of the National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888, ZIALM000097] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine.; This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. The authors thank Dr. Masato Kimura for his helpful discussions about the algorithms. We are also grateful to the dbGaP curators for testing and using GRAF.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson AD, 2007, GENETICS, V176, P421, DOI 10.1534/genetics.106.063149; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen WM, 2016, 66 ANN M AM SOC HUM; Choi Y, 2009, GENET EPIDEMIOL, V33, P668, DOI 10.1002/gepi.20418; Conomos MP, 2016, AM J HUM GENET, V98, P127, DOI 10.1016/j.ajhg.2015.11.022; Day-Williams AG, 2011, GENET EPIDEMIOL, V35, P360, DOI 10.1002/gepi.20584; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; He D, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014420074; Hindorff LA, 2016, CATALOG PUBLISHED GE; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Jin Y, 2014, 22 ANN INT C INT SYS; Jin Y, 2014, 64 ANN M AM SOC HUM; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085437; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; LYNCH M, 1988, MOL BIOL EVOL, V5, P584; Lynch M, 1999, GENETICS, V152, P1753; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; Milligan BG, 2003, GENETICS, V163, P1153; Morrison J, 2013, GENET EPIDEMIOL, V37, P635, DOI 10.1002/gepi.21737; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REISER B, 1987, COMPUT STAT DATA AN, V5, P59, DOI 10.1016/0167-9473(87)90008-9; Staples J, 2016, AM J HUM GENET, V99, P154, DOI 10.1016/j.ajhg.2016.05.020; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Sun Lei, 2012, Methods Mol Biol, V850, P47, DOI 10.1007/978-1-61779-555-8_4; Sun Lei, 2012, Methods Mol Biol, V850, P25, DOI 10.1007/978-1-61779-555-8_3; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wang JL, 2002, GENETICS, V160, P1203; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179106	10.1371/journal.pone.0179106	http://dx.doi.org/10.1371/journal.pone.0179106			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609482	Green Submitted, Green Published, gold			2022-12-26	WOS:000403274700021
J	Beigelman-Aubry, C; Peguret, N; Stuber, M; Delacoste, J; Belmondo, B; Lovis, A; Simons, J; Long, O; Grant, K; Berchier, G; Rohner, C; Bonanno, G; Coppo, S; Schwitter, J; Ozsahin, M; Qanadli, S; Meuli, R; Bourhis, J				Beigelman-Aubry, Catherine; Peguret, Nicolas; Stuber, Matthias; Delacoste, Jean; Belmondo, Bastien; Lovis, Alban; Simons, Julien; Long, Olivier; Grant, Kathleen; Berchier, Gregoire; Rohner, Chantal; Bonanno, Gabriele; Coppo, Simone; Schwitter, Juerg; Ozsahin, Mahmut; Qanadli, Salah; Meuli, Reto; Bourhis, Jean			Chest-MRI under pulsatile flow ventilation: A new promising technique	PLOS ONE			English	Article							FREQUENCY PERCUSSIVE VENTILATION; TUMORS	Objectives Magnetic resonance imaging (MRI) of the chest has long suffered from its sensitivity to respiratory and cardiac motion with an intrinsically low signal to noise ratio and a limited spatial resolution. The purpose of this study was to perform chest MRI under an adapted non invasive pulsatile flow ventilation system (high frequency percussive ventilation, HFPV (R)) allowing breath hold durations 10 to 15 times longer than other existing systems. Methods One volunteer and one patient known for a thymic lesion underwent a chest MRI under ventilation percussion technique (VP-MR). Routinely used sequences were performed with and without the device during three sets of apnoea on inspiration. Results VP-MR was well tolerated in both cases. The mean duration of the thoracic stabilization was 10.5 min (range 8.5-12) and 5.8 min (range 5-6.2) for Volunteer 1 and Patient 1, respectively. An overall increased image quality was seen under VP-MR with a better delineation of the mediastinal lesion for Patient 1. Nodules discovered in Volunteer 1 were confirmed with low dose CT. Conclusion VP-MR was feasible and increased spatial resolution of chest MRI by allowing acquisition at full inspiration during thoracic stabilization approaching prolonged apnoea. This new technique could be of benefit to numerous thoracic disorders.	[Beigelman-Aubry, Catherine; Stuber, Matthias; Delacoste, Jean; Berchier, Gregoire; Rohner, Chantal; Bonanno, Gabriele; Coppo, Simone; Qanadli, Salah; Meuli, Reto] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Beigelman-Aubry, Catherine; Peguret, Nicolas; Stuber, Matthias; Delacoste, Jean; Belmondo, Bastien; Lovis, Alban; Simons, Julien; Long, Olivier; Grant, Kathleen; Berchier, Gregoire; Rohner, Chantal; Bonanno, Gabriele; Coppo, Simone; Schwitter, Juerg; Ozsahin, Mahmut; Qanadli, Salah; Meuli, Reto; Bourhis, Jean] Univ Lausanne, Lausanne, Switzerland; [Peguret, Nicolas; Ozsahin, Mahmut; Bourhis, Jean] CHU Vaudois, Dept Radiat Oncol, Lausanne, Switzerland; [Stuber, Matthias; Bonanno, Gabriele; Coppo, Simone] Ctr Biomed Imaging CIBM, Lausanne, Switzerland; [Belmondo, Bastien; Simons, Julien; Long, Olivier; Grant, Kathleen] CHU Vaudois, Dept Physiotherapy, Lausanne, Switzerland; [Lovis, Alban] CHU Vaudois, Dept Pneumol, Lausanne, Switzerland; [Schwitter, Juerg] CHU Vaudois, Div Cardiol, Lausanne, Switzerland; [Schwitter, Juerg] CHU Vaudois, Cardiac MR Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Beigelman-Aubry, C (corresponding author), CHU Vaudois, Dept Radiol, Lausanne, Switzerland.; Beigelman-Aubry, C (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Catherine.beigelman-aubry@chuv.ch	; Beigelman-Aubry, Catherine/F-4305-2017	Delacoste, Jean/0000-0002-9936-2698; Bourhis, Jean/0000-0001-5162-1171; Beigelman-Aubry, Catherine/0000-0001-7092-6448; QANADLI, Salah Dine/0000-0003-1330-660X				Allan PF, 2010, RESP CARE, V55, P734; Biederer J, 2002, EUR RADIOL, V12, P378, DOI 10.1007/s00330-001-1147-7; De la Roque ED, 2011, PEDIATR PULM, V46, P218, DOI 10.1002/ppul.21354; Heye T, 2014, J MAGN RESON IMAGING; Kauczor HU, 2010, J THORAC IMAG, V25, P34, DOI 10.1097/RTI.0b013e3181cc4cd7; Kaza E, 2015, PHYS MED BIOL, V60, P1681, DOI 10.1088/0031-9155/60/4/1681; Lederlin M, 2014, J MAGN RESON IMAGING, V40, P839, DOI 10.1002/jmri.24429; Lucangelo U, 2003, Minerva Anestesiol, V69, P841; Peguret N, 2015, APNEA LIKE SUPPRESSI; Piccini D, 2012, MAGN RESON MED, V68, P571, DOI 10.1002/mrm.23247; Puderbach M, 2007, EUR J RADIOL, V64, P345, DOI 10.1016/j.ejrad.2007.08.009; Razek AAKA, 2014, RADIOLOGY, V273, P268, DOI 10.1148/radiol.14131643; Seki S, 2014, EUR J RADIOL, V83, P835, DOI 10.1016/j.ejrad.2014.01.005; Short K, 2010, RESP CARE, V55, P1762; Tibiletti M, 2016, MAGN RESON MED, V75, P1324, DOI 10.1002/mrm.25673; Vargas F, 2005, CRIT CARE, V9, pR382, DOI 10.1186/cc3724; Wild JM, 2012, INSIGHTS IMAGING, V3, P345, DOI 10.1007/s13244-012-0176-x	17	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178807	10.1371/journal.pone.0178807	http://dx.doi.org/10.1371/journal.pone.0178807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604833	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400018
J	Kukielka, EA; Martinez-Lopez, B; Beltran-Alcrudo, D				Kukielka, Esther Andrea; Martinez-Lopez, Beatriz; Beltran-Alcrudo, Daniel			Modeling the live-pig trade network in Georgia: Implications for disease prevention and control	PLOS ONE			English	Article							AFRICAN-SWINE-FEVER; PRODUCTION SYSTEMS; BIOSECURITY; MOVEMENT; PATTERNS; BEHAVIOR; FARMERS; VIRUS	Live pig trade patterns, drivers and characteristics, particularly in backyard predominant systems, remain largely unexplored despite their important contribution to the spread of infectious diseases in the swine industry. A better understanding of the pig trade dynamics can inform the implementation of risk-based and more cost-effective prevention and control programs for swine diseases. In this study, a semi-structured questionnaire elaborated by FAO and implemented to 487 farmers was used to collect data regarding basic characteristics about pig demographics and live-pig trade among villages in the country of Georgia, where very scarce information is available. Social network analysis and exponential random graph models were used to better understand the structure, contact patterns and main drivers for pig trade in the country. Results indicate relatively infrequent (a total of 599 shipments in one year) and geographically localized (median Euclidean distance between shipments = 6.08 km; IQR = 0-13.88 km) pig movements in the studied regions. The main factors contributing to live-pig trade movements among villages were being from the same region (i.e., local trade), usage of a middleman or a live animal market to trade live pigs by at least one farmer in the village, and having a large number of pig farmers in the village. The identified villages' characteristics and structural network properties could be used to inform the design of more cost-effective surveillance systems in a country which pig industry was recently devastated by African swine fever epidemics and where backyard production systems are predominant.	[Kukielka, Esther Andrea; Martinez-Lopez, Beatriz] Univ Calif Davis, CADMS, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Beltran-Alcrudo, Daniel] FAO, FAO Budapest, Budapest, Hungary	Food & Agriculture Organization of the United Nations (FAO)	Kukielka, EA (corresponding author), Univ Calif Davis, CADMS, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	ekukielka@ucdavis.edu	Lopez, Beatriz Martinez/AAE-6692-2021; Beltran-Alcrudo, Daniel/AAL-7358-2021	Beltran-Alcrudo, Daniel/0000-0002-8646-357X; Kukielka, Esther/0000-0002-8655-3778	Food and Agriculture Organization of the United Nations; discretionary funds at the Center for Animal Disease Modeling and Surveillance; Loreto Godoy Memorial Fellowship	Food and Agriculture Organization of the United Nations; discretionary funds at the Center for Animal Disease Modeling and Surveillance; Loreto Godoy Memorial Fellowship	Funding for the field implementation of the questionnaires was provided by the Food and Agriculture Organization of the United Nations (DBA). Additional funding to conduct this study was provided by discretionary funds at the Center for Animal Disease Modeling and Surveillance (BML) and the Loreto Godoy Memorial Fellowship (EK), granted by the University of California Davis, California.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Beltran-Alcrudo D, 2008, AFRICAN SWINE FEVER; Costard S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17074; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dietze K, 2012, AFRICAN SWINE FEVER; Gogin A, 2013, VIRUS RES, V173, P198, DOI 10.1016/j.virusres.2012.12.007; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; Handcock M.S., 2016, STATNET SOFTWARE TOO; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Handcock MS, 2003, DYNAMIC SOCIAL NETWORK MODELING AND ANALYSIS, P229; Hardstaff JL, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0354-4; Harris J.K., 2014, INTRO EXPONENTIAL RA; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Lee K, 2017, PREV VET MED, V138, P113, DOI 10.1016/j.prevetmed.2017.02.001; Lentz HHK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155196; Leslie EEC, 2015, PREV VET MED, V118, P319, DOI 10.1016/j.prevetmed.2014.12.006; Luke D. A., 2015, USERS GUIDE NETWORK; Lusher D., 2012, EXPONENTIAL RANDOM G; Marquetoux N, 2016, PREV VET MED, V126, P94, DOI 10.1016/j.prevetmed.2016.01.022; Martinez-Lopez B, 2009, TRANSBOUND EMERG DIS, V56, P109, DOI 10.1111/j.1865-1682.2009.01073.x; Martinez-Lopez B, 2014, GEOSPATIAL HEALTH, V8, P489, DOI 10.4081/gh.2014.38; Morris Martina, 2008, J Stat Softw, V24, P1548; Nantima N, 2016, TROP ANIM HEALTH PRO, V48, P727, DOI 10.1007/s11250-016-1015-8; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Ortiz-Pelaez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030710; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R Core Team, 2021, R LANGUAGE ENV STAT; Relun A, 2017, FRONTIERS VET SCI, V4; Relun A, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00004; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Te Grotenhuis M, 2011, INT J EPIDEMIOL, V40, P1123, DOI 10.1093/ije/dyr081; van Buuren S, 2011, J STAT SOFTW, V45, P1; Yatabe T, 2015, PREV VET MED, V122, P195, DOI 10.1016/j.prevetmed.2015.09.005; Zhou XY, 2015, J INFECTION, V71, P470, DOI 10.1016/j.jinf.2015.06.012	37	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178904	10.1371/journal.pone.0178904	http://dx.doi.org/10.1371/journal.pone.0178904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX1NV	28599000	gold, Green Published, Green Submitted			2022-12-26	WOS:000402992000014
J	Xue, Y; Schmollinger, S; Attar, N; Campos, OA; Vogelauer, M; Carey, MF; Merchant, SS; Kurdistani, SK				Xue, Yong; Schmollinger, Stefan; Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Carey, Michael F.; Merchant, Sabeeha S.; Kurdistani, Siavash K.			Endoplasmic reticulum-mitochondria junction is required for iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OUTER-MEMBRANE; MESSENGER-RNA; CELLULAR-METABOLISM; CONTACT SITES; SMP DOMAINS; YEAST; PROTEIN; GENE; DEFICIENCY	The endoplasmic reticulum (ER)-mitochondria encounter structure (ERMES) is a protein complex that physically tethers the two organelles to each other and creates the physical basis for communication between them. ERMES functions in lipid exchange between the ER and mitochondria, protein import into mitochondria, and maintenance of mitochondrial morphology and genome. Here, we report that ERMES is also required for iron homeostasis. Loss of ERMES components activates an Aft1-dependent iron deficiency response even in iron-replete conditions, leading to accumulation of excess iron inside the cell. This function is independent of known ERMES roles in calcium regulation, phospholipid biosynthesis, or effects on mitochondrial morphology. A mutation in the vacuolar protein sorting 13 (VPS13) gene that rescues the glycolytic phenotype of ERMES mutants suppresses the iron deficiency response and iron accumulation. Our findings reveal that proper communication between the ER and mitochondria is required for appropriate maintenance of cellular iron levels.	[Xue, Yong; Attar, Narsis; Campos, Oscar A.; Vogelauer, Maria; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Attar, Narsis; Campos, Oscar A.; Carey, Michael F.; Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Kurdistani, Siavash K.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Schmollinger, Stefan; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Xue, Yong] Huaihai Inst Technol, Jiangsu Key Lab Marine Pharmaceut Compound Screen, Lianyungang 222005, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Jiangsu Ocean University	Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA.; Kurdistani, SK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.	skurdistani@mednet.ucla.edu		Carey, Michael/0000-0003-3899-6280; xue, yong/0000-0002-7229-7232; Schmollinger, Stefan/0000-0002-7487-8014	National Institutes of Health [CA178415, GM074701]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy [DE-FD02-04ER15529]; NATIONAL CANCER INSTITUTE [R01CA178415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA178415 (to S. K. K.) and GM074701 (to M. F. C.) and Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, United States Department of Energy Grant DE-FD02-04ER15529 (to S. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The aligned and raw data have been deposited in the Gene Expression Omnibus under GEO Series accession number GSE99499.	AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; BITTER GA, 1984, GENE, V32, P263, DOI 10.1016/0378-1119(84)90002-7; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Cankorur-Cetinkaya A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2771-6; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Ellenrieder L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13021; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Gozzelino R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010130; Gregg C., 2009, J VIS EXP, P1417; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Kolehmainen J, 2003, AM J HUM GENET, V72, P1359, DOI 10.1086/375454; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2011, P NATL ACAD SCI USA, V108, P14151, DOI 10.1073/pnas.1111314108; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Lang AB, 2015, J CELL BIOL, V210, P883, DOI 10.1083/jcb.201502105; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Lin SJ, 1997, J BIOL CHEM, V272, P9215; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Park JS, 2016, MOL BIOL CELL, V27, P2435, DOI 10.1091/mbc.E16-02-0112; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; Stroud DA, 2011, J MOL BIOL, V413, P743, DOI 10.1016/j.jmb.2011.09.012; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tan T, 2013, J CELL SCI, V126, P3563, DOI 10.1242/jcs.121244; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Velayos-Baeza A, 2004, GENOMICS, V84, P536, DOI 10.1016/j.ygeno.2004.04.012; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Youngman MJ, 2004, J CELL BIOL, V164, P677, DOI 10.1083/jcb.200308012	47	32	33	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13197	13204		10.1074/jbc.M117.784249	http://dx.doi.org/10.1074/jbc.M117.784249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637866	hybrid, Green Published			2022-12-26	WOS:000407465300011
J	Bocanegra-Ibarias, P; Garza-Gonzalez, E; Morfin-Otero, R; Barrios, H; Villarreal-Trevino, L; Rodriguez-Noriega, E; Garza-Ramos, U; Petersen-Morfin, S; Silva-Sanchez, J				Bocanegra-Ibarias, Paola; Garza-Gonzalez, Elvira; Morfin-Otero, Rayo; Barrios, Humberto; Villarreal-Trevino, Licet; Rodriguez-Noriega, Eduardo; Garza-Ramos, Ulises; Petersen-Morfin, Santiago; Silva-Sanchez, Jesus			Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; PROVIDENCIA-RETTGERI; ESCHERICHIA-COLI; RESISTANCE; BACTERIA; PLASMID; GENES; PCR; IDENTIFICATION; SURVEILLANCE	Objectives To characterize the microbiological, molecular and epidemiological data of an outbreak of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital in Mexico. Methods From September 2014 to July 2015, all CRE clinical isolates recovered during an outbreak in the Hospital Civil " Fray Antonio Alcalde" in Jalisco, Mexico were screened for antimicrobial susceptibility, carbapenemase production, carbapenemase-encoding genes, and plasmid profiles. Horizontal transfer of imipenem resistance; and clonal diversity by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST); as well as biofilm production and the presence of 14 virulence genes were analyzed in selected isolates. Results Fifty-two carbapenem-resistant isolates corresponding to 5 species were detected, i. e., Klebsiella pneumoniae (n = 46), Enterobacter cloacae (n = 3), Escherichia coli (n = 1), Providencia rettgeri (n = 1) and Citrobacter freundii (n = 1) with carbapenemase encoding genes blaNDM-1 (n = 48), blaVIM (n = 3), blaIMP (n = 1) and blaKPC (n = 1) detected in these isolates. The blaNDM-1 gene was detected in plasmids from 130-to 170-kb in K. pneumoniae (n = 46); E. cloacae (n = 3), E. coli (n = 1) and P. rettgeri (n = 1). The transfer of plasmids harboring the blaNDM-1 gene was obtained in eight transconjugants. One plasmid restriction pattern was detected, with the blaNDM-1 identified in different restriction fragments. Predominant clone A of K. pneumoniae isolates archived 28/ 46 (60%) isolates and belongs to ST392. Besides, ST307, ST309, ST846, ST2399, and ST2400 were detected for K. pneumoniae; as well as E. cloacae ST182 and E. coli ST10. The fimA and uge genes were more likely to be identified in K. pneumoniae carbapenem-susceptible isolates (p = < 0.001) and biofilm production was more liable to be observed in carbapenem-resistant isolates (p = < 0.05). Conclusions Four Enterobacteriaceae species harboring the bla(NDM-1) gene were detected in a nosocomial outbreak in Mexico; horizontal transfer and strain transmission were demonstrated for the bla(NDM-1) gene. Given the variation in the size of the plasmid harboring bla(NDM-1), complex rearrangements must also be occurring.	[Bocanegra-Ibarias, Paola; Villarreal-Trevino, Licet] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico; [Morfin-Otero, Rayo; Rodriguez-Noriega, Eduardo; Petersen-Morfin, Santiago] Univ Guadalajara, Hosp Civil Guadalajara Fray Antonio Alcalde, Ctr Univ Ciencias Salud, Inst Patol Infecciosa & Expt, Guadalajara, Jalisco, Mexico; [Barrios, Humberto; Garza-Ramos, Ulises; Silva-Sanchez, Jesus] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico	Universidad Autonoma de Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad de Guadalajara; Instituto Nacional de Salud Publica	Silva-Sanchez, J (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	jsilva@insp.mx	Morfín-Otero, Rayo/AAR-8027-2021	Morfín-Otero, Rayo/0000-0001-9576-1950; Garza Ramos, Ulises/0000-0002-5013-3050; Bocanegra-Ibarias, Paola/0000-0003-4602-3817; Rodriguez-Noriega, Eduardo/0000-0002-1386-4815	Mexican Council for Science and Technology [136339, 130224]	Mexican Council for Science and Technology	This work was supported by grants 136339 and 130224 from Mexican Council for Science and Technology (http://conacyt.gob.mx/) to JSS.	[Anonymous], 2016, M100S CLSI; Aschbacher R, 2008, J ANTIMICROB CHEMOTH, V61, P515, DOI 10.1093/jac/dkm508; Bado I, 2016, J GLOB ANTIMICROB RE, V6, P5, DOI 10.1016/j.jgar.2016.02.001; Bandeira M, 2014, PATHOGENS, V3, P720, DOI 10.3390/pathogens3030720; Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010; Barrios H, 2014, PEDIATR INFECT DIS J, V33, P335, DOI 10.1097/INF.0000000000000173; Barrios H, 2013, J ANTIMICROB CHEMOTH, V68, P1934, DOI 10.1093/jac/dkt124; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bontron S, 2016, J ANTIMICROB CHEMOTH, V71, P2318, DOI 10.1093/jac/dkw139; Burmolle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041259; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chang FY, 2001, ANTIMICROB AGENTS CH, V45, P2407, DOI 10.1128/AAC.45.9.2407-2413.2001; Carvalho-Assef APD, 2013, J ANTIMICROB CHEMOTH, V68, P2956, DOI 10.1093/jac/dkt298; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Fuursted K, 2012, MICROBES INFECT, V14, P155, DOI 10.1016/j.micinf.2011.08.015; Garza-Ramos U, 2016, MICROB DRUG RESIST, V22, P179, DOI 10.1089/mdr.2015.0181; Garza-Ramos U, 2014, DIAGN MICR INFEC DIS, V79, P483, DOI 10.1016/j.diagmicrobio.2014.05.010; Hamprecht A, 2013, J ANTIMICROB CHEMOTH, V68, P558, DOI 10.1093/jac/dks447; Jamal WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152638; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Kaufmann Mary Elizabeth, 1998, V15, P33; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Levesque S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144878; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Miller J.H, 1972, EXPT MOL GENETICS, pxvi; Miyoshi-Akiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066358; Nishio H, 2004, J CLIN MICROBIOL, V42, P5256, DOI 10.1128/JCM.42.11.5256-5263.2004; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Rojas LJ, 2016, ANTIMICROB AGENTS CH, V60, P4346, DOI 10.1128/AAC.03072-15; Rozales FP, 2014, INT J INFECT DIS, V25, P79, DOI 10.1016/j.ijid.2014.01.005; Sader HS, 2016, INT J ANTIMICROB AG, V48, P144, DOI 10.1016/j.ijantimicag.2016.04.021; Shiroto K, 2005, J MED MICROBIOL, V54, P1065, DOI 10.1099/jmm.0.46194-0; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2016, CLIN BREAKP BACT V 6; Torres-Gonzalez P, 2015, ANTIMICROB AGENTS CH, V59, P7080, DOI 10.1128/AAC.00055-15; Wang Q, 2016, EUR J CLIN MICROBIOL; Wei WJ, 2015, CHINESE MED J-PEKING, V128, P1969, DOI 10.4103/0366-6999.160566; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Xie LY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00133; Zhu J, 2016, EUR J CLIN MICROBIOL, V35, P611, DOI 10.1007/s10096-016-2578-z	47	55	59	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179651	10.1371/journal.pone.0179651	http://dx.doi.org/10.1371/journal.pone.0179651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636666	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000404118300046
J	Miyazawa, K; Masujin, K; Okada, H; Ushiki-Kaku, Y; Matsuura, Y; Yokoyama, T				Miyazawa, Kohtaro; Masujin, Kentaro; Okada, Hiroyuki; Ushiki-Kaku, Yuko; Matsuura, Yuichi; Yokoyama, Takashi			Selective propagation of mouse-passaged scrapie prions with long incubation period from a mixed prion population using GT1-7 cells	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; STRAIN VARIATION; MURINE BIOASSAY; SHEEP; TRANSMISSION; INACTIVATION; ANTIBODIES; COFACTOR; AGENT	In our previous study, we demonstrated the propagation of mouse-passaged scrapie isolates with long incubation periods (L-type) derived from natural Japanese sheep scrapie cases in murine hypothalamic GT1-7 cells, along with disease-associated prion protein (PrPSc) accumulation. We here analyzed the susceptibility of GT1-7 cells to scrapie prions by exposure to infected mouse brains at different passages, following interspecies transmission. Wild-type mice challenged with a natural sheep scrapie case (Kanagawa) exhibited heterogeneity of transmitted scrapie prions in early passages, and this mixed population converged upon one with a short incubation period (S-type) following subsequent passages. However, when GT1-7 cells were challenged with these heterologous samples, L-type prions became dominant. This study demonstrated that the susceptibility of GT1-7 cells to L-type prions was at least 10(5) times higher than that to S-type prions and that L-type prion-specific biological characteristics remained unchanged after serial passages in GT1-7 cells. This suggests that a GT1-7 cell culture model would be more useful for the economical and stable amplification of L-type prions at the laboratory level. Furthermore, this cell culture model might be used to selectively propagate L-type scrapie prions from a mixed prion population.	[Miyazawa, Kohtaro; Masujin, Kentaro; Okada, Hiroyuki; Matsuura, Yuichi] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Prion Dis Unit, Tsukuba, Ibaraki, Japan; [Ushiki-Kaku, Yuko] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Yokoyama, Takashi] NARO, Natl Inst Anim Hlth, Dept Planning & Gen Adm, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Miyazawa, K (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Div Transboundary Anim Dis, Prion Dis Unit, Tsukuba, Ibaraki, Japan.	miyazawak@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021; Miyazawa, Kohtaro/ABB-1464-2021	Matsuura, Yuichi/0000-0003-3383-7918; 	Ministry of Health, Labor, and Welfare of Japan; National Agriculture and Food Research Organization (NARO)	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Agriculture and Food Research Organization (NARO)	K. Miyazawa received the Grants-in-Aid from the Ministry of Health, Labor, and Welfare of Japan. K. Miyazawa, K. Masujin, HO, YM and TY received the basic research fund of National Agriculture and Food Research Organization (NARO).	Beck KE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-77; Beck KE, 2012, BRAIN PATHOL, V22, P265, DOI 10.1111/j.1750-3639.2011.00526.x; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; CARP RI, 1991, J GEN VIROL, V72, P293, DOI 10.1099/0022-1317-72-2-293; Cassard H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6821; Comoy EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11573; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Hirogari Y, 2003, MICROBIOL IMMUNOL, V47, P871, DOI 10.1111/j.1348-0421.2003.tb03453.x; Horiuchi M, 2002, J CLIN MICROBIOL, V40, P3421, DOI 10.1128/JCM.40.9.3421-3426.2002; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Masujin K, 2009, ARCH VIROL, V154, P1929, DOI 10.1007/s00705-009-0534-2; Matsuura Y, 2013, BIOCHEM BIOPH RES CO, V432, P86, DOI 10.1016/j.bbrc.2013.01.081; Miyazawa K, 2014, PRION, V8, P306, DOI 10.4161/pri.32232; Oelschlegel AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117154; Okada H, 2011, J COMP PATHOL, V144, P251, DOI 10.1016/j.jcpa.2010.10.001; Ryou C, 2007, J MICROBIOL BIOTECHN, V17, P1059; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Supattapone S, 2014, J BIOL CHEM, V289, P19850, DOI 10.1074/jbc.R113.511329; Takatsuki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126930; Thackray AM, 2011, J GEN VIROL, V92, P1482, DOI 10.1099/vir.0.028886-0; Ushiki-Kaku Y, 2014, J VET MED SCI, V76, P285, DOI 10.1292/jvms.13-0409; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yokoyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015450; Yoshioka M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-134; Zurawel AA, 2014, BIOCHEMISTRY-US, V53, P68, DOI 10.1021/bi4014825	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179317	10.1371/journal.pone.0179317	http://dx.doi.org/10.1371/journal.pone.0179317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636656	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300032
J	van Amsterdam, MA; van Assen, S; Sprenger, HG; Wilting, KR; Stienstra, Y; Bierman, WFW				van Amsterdam, Marleen A.; van Assen, Sander; Sprenger, Herman G.; Wilting, Kasper R.; Stienstra, Ymkje; Bierman, Wouter F. W.			Yield of yearly routine physical examination in HIV-1 infected patients is limited: A retrospective cohort study in the Netherlands	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; INVASIVE ANAL CANCER; MEN; MALIGNANCIES; SEX	Background Routine physical examinations might be of value in HIV-infected patients, but the yield is unknown. We determined the diagnoses that would have been missed without performing annual routine physical examinations in HIV-infected patients with stable disease. Methods Data were collected from the medical records of 299 HIV-1-infected patients with CD4 count >350 cells/mm(3) if not using combination antiretroviral therapy (cART), or CD4 count >100 cells/mm3 and undetectable viral load if using cART. We defined the diagnoses that would have been missed without performing routine physical examinations on annual check-ups in 2010. Exclusion criteria were hepatitis B/C co-infection, start/switch of cART <24 weeks, pregnancy, and transgenderism. Results 215 patients (72%) had positive findings: lipodystrophy (30%), lymphadenopathy (16%) and hypertension (8.4%) were the most common. Two-thirds of all findings were not new or were based on complaints indicating a physical examination even if not routinely scheduled. For 24 patients (8.0%) the routine physical examination led to the finding of a new diagnosis: six-all men who have sex with men (MSM)-had a concurrent sexually transmitted infection, eight had hypertension, and ten others had a large variety of diagnoses. A total atrioventricular block with bradycardia was the most clinically relevant finding. Conclusions Annual physical examinations of HIV-infected patients with stable disease brought few new diagnoses that would have been missed without performing a routine examination. Our results suggest that standard assessments could be restricted to six-monthly measuring blood pressure in all patients and annually performing anogenital and digital rectal examination on MSM.	[van Amsterdam, Marleen A.; Sprenger, Herman G.; Stienstra, Ymkje; Bierman, Wouter F. W.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Infect Dis Serv, Groningen, Netherlands; [van Assen, Sander] Treant Zorggroep, Dept Internal Med, Emmen, Netherlands; [Wilting, Kasper R.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol & Infect Control, Groningen, Netherlands	University of Groningen; University of Groningen	Bierman, WFW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Infect Dis Serv, Groningen, Netherlands.	w.f.w.bierman@umcg.nl						Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Anuurad E, 2009, METAB SYNDR RELAT D, V7, P401, DOI 10.1089/met.2008.0096; Barber T, 2011, HIV MED, V12, P73; Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Boulware LE, 2007, ANN INTERN MED, V146, P289, DOI 10.7326/0003-4819-146-4-200702200-00008; Boyd, MONITORING REPORT 20; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Crum-Cianflone N, 2009, ARCH INTERN MED, V169, P1130, DOI 10.1001/archinternmed.2009.104; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; European AIDS Clinical Society, 2016, EACS GUID VERS 8 1; European AIDS Clinical Society, 2014, EACS GUID VERS 7 1; GAINES H, 1988, BRIT MED J, V297, P1363, DOI 10.1136/bmj.297.6660.1363; Heiligenberg M, 2012, AIDS, V26, P646, DOI 10.1097/QAD.0b013e3283504bbf; Heiligenberg M, 2012, SEX TRANSM DIS, V39, P8, DOI 10.1097/OLQ.0b013e3182354e81; Helfand M, 2001, AM J PREV MED, V20, P47, DOI 10.1016/S0749-3797(01)00258-6; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Nag D, 2016, J CYTOL, V33, P66, DOI 10.4103/0970-9371.182518; Ong JJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-557; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Piketty C, 2008, AIDS, V22, P1203, DOI 10.1097/QAD.0b013e3283023f78; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Tuddenham S, 2013, SEX TRANSM DIS, V40, P886, DOI 10.1097/OLQ.0000000000000041; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Wang CCJ, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0406-0; Wolff T, 2009, ANN INTERN MED, V150, P194, DOI 10.7326/0003-4819-150-3-200902030-00009; Zetola NM, 2007, CLIN INFECT DIS, V44, P1222, DOI 10.1086/513427	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179539	10.1371/journal.pone.0179539	http://dx.doi.org/10.1371/journal.pone.0179539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636651	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300040
J	Basu, K; Lajoie, D; Aumentado-Armstrong, T; Chen, J; Koning, RI; Bossy, B; Bostina, M; Sik, A; Bossy-Wetzel, E; Rouiller, I				Basu, Kaustuv; Lajoie, Driss; Aumentado-Armstrong, Tristan; Chen, Jin; Koning, Roman I.; Bossy, Blaise; Bostina, Mihnea; Sik, Attila; Bossy-Wetzel, Ella; Rouiller, Isabelle			Molecular mechanism of DRP1 assembly studied in vitro by cryo-electron microscopy	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; MITOCHONDRIAL FISSION MACHINERY; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; ELECTRON-MICROSCOPY; MEMBRANE FISSION; CONFORMATIONAL-CHANGES; NEURONAL MITOCHONDRIA	Mitochondria are dynamic organelles that continually adapt their morphology by fusion and fission events. An imbalance between fusion and fission has been linked to major neurodegenerative diseases, including Huntington's, Alzheimer's, and Parkinson's diseases. A member of the Dynamin superfamily, dynamin-related protein 1 (DRP1), a dynamin-related GTPase, is required for mitochondrial membrane fission. Self-assembly of DRP1 into oligomers in a GTP-dependent manner likely drives the division process. We show here that DRP1 self-assembles in two ways: i) in the presence of the non-hydrolysable GTP analog GMP-PNP into spiral-like structures of similar to 36 nm diameter; and ii) in the presence of GTP into rings composed of 13-18 monomers. The most abundant rings were composed of 16 monomers and had an outer and inner ring diameter of similar to 30 nm and similar to 20 nm, respectively. Three dimensional analysis was performed with rings containing 16 monomers. The single-particle cryo-electron microscopy map of the 16 monomer DRP1 rings suggests a side-by-side assembly of the monomer with the membrane in a parallel fashion. The inner ring diameter of 20 nm is insufficient to allow four membranes to exist as separate entities. Furthermore, we observed that mitochondria were tubulated upon incubation with DRP1 protein in vitro. The tubes had a diameter of similar to 30nm and were decorated with protein densities. These findings suggest DRP1 tubulates mitochondria, and that additional steps may be required for final mitochondrial fission.	[Basu, Kaustuv; Lajoie, Driss; Aumentado-Armstrong, Tristan; Sik, Attila; Rouiller, Isabelle] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Basu, Kaustuv] McGill Univ, Facil Elect Microscopy Res, Montreal, PQ, Canada; [Chen, Jin; Bossy, Blaise; Bossy-Wetzel, Ella] Univ Cent Florida, Dept Biomed Sci, Orlando, FL 32816 USA; [Koning, Roman I.] Leiden Univ, Sect Elect Microscopy, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands; [Bostina, Mihnea] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Sik, Attila] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Neuronal Networks Grp, Birmingham, W Midlands, England	McGill University; McGill University; State University System of Florida; University of Central Florida; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Otago; University of Birmingham	Basu, K (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.; Basu, K (corresponding author), McGill Univ, Facil Elect Microscopy Res, Montreal, PQ, Canada.	kaustuv.basu@mcgill.ca; isabelle.rouiller@mcgill.ca	rouiller, isabelle/K-7679-2012; Chen, Jin/M-1837-2019; Rouiller, Isabelle/AAE-9637-2019; Aumentado-Armstrong, Tristan/AAX-5245-2020	rouiller, isabelle/0000-0002-1288-8575; Chen, Jin/0000-0001-7617-1664; Aumentado-Armstrong, Tristan/0000-0003-4876-7246; Bostina, Mihnea/0000-0003-3621-3772	Canadian Institutes of Health Research [86693MOP, 81105MOP]; NIH [R01 NS055193]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055193] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Canadian Institutes of Health Research (86693MOP and 81105MOP) and NIH grant R01 NS055193.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bossy B, 2010, J ALZHEIMERS DIS, V20, pS513, DOI 10.3233/JAD-2010-100552; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Clinton RW, 2016, J BIOL CHEM, V291, P478, DOI 10.1074/jbc.M115.680025; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fleischer S, 1979, Methods Enzymol, V55, P32; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Francy CA, 2015, J BIOL CHEM, V290, P11692, DOI 10.1074/jbc.M114.610881; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Kim YW, 2001, PLANT PHYSIOL, V127, P1243, DOI 10.1104/pp.010450; Kislin M, 2017, J NEUROSCI, V37, P333, DOI [10.1523/JNEUROSCI.1510-16.2016, 10.1523/JNEUROSCI.1510-16.2017]; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Loson OC, 2015, PROTEIN SCI, V24, P386, DOI 10.1002/pro.2629; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Macdonald PJ, 2016, J BIOL CHEM, V291, P493, DOI 10.1074/jbc.M115.680181; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Manczak M, 2012, HUM MOL GENET, V21, P2538, DOI 10.1093/hmg/dds072; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McBride HM, 2016, NATURE, V540, P43, DOI 10.1038/nature20482; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morozov YM, 2017, NEUROBIOL AGING, V51, P9, DOI 10.1016/j.neurobiolaging.2016.12.001; Mountassif D, 2006, COMP BIOCHEM PHYS B, V143, P285, DOI 10.1016/j.cbpb.2005.11.019; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Otera H., 2012, INT J CELL BIOL, DOI DOI 10.1155/2012/821676; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Rosenbloom AB, 2014, P NATL ACAD SCI USA, V111, P13093, DOI 10.1073/pnas.1320044111; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Stepanyants N, 2015, MOL BIOL CELL, V26, P3104, DOI 10.1091/mbc.E15-06-0330; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yan LM, 2011, J MOL CELL BIOL, V3, P378, DOI 10.1093/jmcb/mjr032; Zhang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18725; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	78	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179397	10.1371/journal.pone.0179397	http://dx.doi.org/10.1371/journal.pone.0179397			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632757	Green Published, gold			2022-12-26	WOS:000404046100027
J	Custodio, AH; de Lima, MC; Vaccari, B; Boer, PA; Gontijo, JAR				Custodio, Augusto H.; de Lima, Marcelo C.; Vaccari, Barbara; Boer, Patricia A.; Gontijo, Jose A. R.			Renal sodium handling and blood pressure changes in gestational protein-restricted offspring: Role of renal nerves and ganglia neurokinin expression	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; GENE-RELATED PEPTIDE; INHIBITORY RENORENAL REFLEXES; RENIN-ANGIOTENSIN SYSTEM; SUBSTANCE-P RECEPTOR; AFFERENT NEURONS; NITRIC-OXIDE; DENERVATION ABOLISHES; SENSORY RECEPTORS; KIDNEY	Background Considering long-term changes in renal sodium handling and blood pressure in maternal protein-restricted (LP) offspring, we assumed that the development of LP hypertension results from abnormal dorsal root ganglia (DRG) neurokinin expression associated with impaired responsiveness of renal sensory receptors, promoting a reduced urinary excretion of sodium. The present study investigates whether increased blood pressure in protein-restricted offspring would be associated with changes in the DRG cells and in renal pelvic wall expression of NK1R, SP and CGRP when compared to NP offspring. In addition, we assessed the tubular sodium handling, estimated by creatinine and lithium clearances before and after bilateral renal denervation in conscious LP offspring relative to age-matched NP counterparts. Methods Dams received a normal (NP) or low-protein diet (LP) during their entire pregnancy period. Male NP or LP offspring underwent bilateral surgical renal denervation before the 8-week renal functional test and blood pressure measurements. Immunofluorescence staining in DRG cells was assessed in optical sections by confocal laser scanning microscope. Results The current data demonstrated a sustained rise in blood pressure associated with a decrease in fractional excretion of sodium (FENa) by reducing post-proximal tubule sodium rejection in 16-wk old LP rats relative to age-matched NP counterparts. According to this study, bilateral renal denervation attenuated blood pressure and increased FENa in LP offspring. Furthermore, an immunohistochemical analysis showed a reduced expression of SP and CGRP in DRGs of LP when compared with NP rats. Renal pelvis of LP rats did not show a strong CGRP expression related to NP rats, whereas there was no change in SP immunostaining. Conclusions These observations raise the possibility that impaired DRG and pelvic neurokinin expression associated with responsiveness of renal sensory receptors in 16-wk old LP offspring are conducive to excess renal reabsorption of sodium and development of hypertension in this programmed model.	[Custodio, Augusto H.; de Lima, Marcelo C.; Vaccari, Barbara; Boer, Patricia A.; Gontijo, Jose A. R.] Univ Estadual Campinas, Dept Internal Med, Fac Med Sci, Campinas, SP, Brazil	Universidade Estadual de Campinas	Gontijo, JAR (corresponding author), Univ Estadual Campinas, Dept Internal Med, Fac Med Sci, Campinas, SP, Brazil.	gontijo@fcm.unicamp.br	Gontijo, José/AAW-2644-2021; Boer, Patricia Aline/E-2551-2013; Boer, Patrícia A/P-4435-2014	Boer, Patricia Aline/0000-0002-1196-2606; Gontijo, Jose/0000-0002-4658-385X; Vaccari Cardoso, Barbara/0000-0002-7376-0727	CNPq [500868/91-3]; CAPES; FAPESP [2013/12486-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Grants from CNPq (no. 500868/91-3), CAPES and FAPESP (2013/12486-5) supported this work.	Alexander BT, 2005, HYPERTENSION, V45, P754, DOI 10.1161/01.HYP.0000153319.20340.2a; ALVAREZ FJ, 1991, J NEUROCYTOL, V20, P716, DOI 10.1007/BF01187846; Alwasel SH, 2009, CLIN SCI, V117, P75, DOI 10.1042/CS20080294; ANTON AH, 1962, J PHARMACOL EXP THER, V138, P360; Ashton N, 2000, BRAZ J MED BIOL RES, V33, P731, DOI 10.1590/S0100-879X2000000700002; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Baum M, 2010, AM J PHYSIOL-RENAL, V298, pF235, DOI 10.1152/ajprenal.00288.2009; Boer PA, 2005, MOL BRAIN RES, V138, P35, DOI 10.1016/j.molbrainres.2005.03.015; Boer PA, 2005, LIFE SCI, V76, P1805, DOI 10.1016/j.lfs.2004.09.029; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; COLLIS MG, 1980, HYPERTENSION, V2, P45, DOI 10.1161/01.HYP.2.1.45; Dasinger JH, 2016, HYPERTENSION, V68, P826, DOI 10.1161/HYPERTENSIONAHA.116.06603; DE KONINCK Y, 1991, P NATL ACAD SCI USA, V88, P11344, DOI 10.1073/pnas.88.24.11344; Di Marco GS, 2003, J CELL BIOCHEM, V89, P144, DOI 10.1002/jcb.10485; DiBona GF, 2000, AM J PHYSIOL-REG I, V279, pR1517, DOI 10.1152/ajpregu.2000.279.5.R1517; DiBona GF, 2000, HYPERTENSION, V36, P1083, DOI 10.1161/01.HYP.36.6.1083; DIBONA GF, 1992, HYPERTENSION, V19, pI28, DOI 10.1161/01.HYP.19.1_Suppl.I28; FERGUSON M, 1988, J COMP NEUROL, V274, P9, DOI 10.1002/cne.902740103; GERARD NP, 1991, BIOCHEMISTRY-US, V30, P10640, DOI 10.1021/bi00108a006; Gontijo JAR, 1999, ACTA PHYSIOL SCAND, V166, P159; Gontijo JR, 1999, HYPERTENSION, V33, P493, DOI 10.1161/01.HYP.33.1.493; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; Huang A, 1996, J HYPERTENS, V14, P887, DOI 10.1097/00004872-199607000-00012; Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645; KLINE RL, 1987, CAN J PHYSIOL PHARM, V65, P1540, DOI 10.1139/y87-243; KOPP UC, 1984, AM J PHYSIOL, V246, pF67, DOI 10.1152/ajprenal.1984.246.1.F67; KOPP UC, 1991, AM J PHYSIOL, V261, pR1513, DOI 10.1152/ajpregu.1991.261.6.R1513; KOPP UC, 1987, HYPERTENSION, V9, P69, DOI 10.1161/01.HYP.9.1.69; KOPP UC, 1991, AM J PHYSIOL, V260, pR232, DOI 10.1152/ajpregu.1991.260.1.R232; LIU L, 1993, ANAT EMBRYOL, V188, P345; Lutaif NA, 2015, J PHYSIOL SCI, V65, P265, DOI 10.1007/s12576-015-0364-9; Manning J, 2002, AM J PHYSIOL-RENAL, V283, pF202, DOI 10.1152/ajprenal.00358.2001; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Mesquita FF, 2010, NEPHROL DIAL TRANSPL, V25, P380, DOI 10.1093/ndt/gfp505; Mizuno M, 2013, HYPERTENSION, V61, P180, DOI 10.1161/HYPERTENSIONAHA.112.199356; MOSS NG, 1989, MINER ELECTROL METAB, V15, P59; Murray JM, 2007, J MICROSC-OXFORD, V228, P390, DOI 10.1111/j.1365-2818.2007.01861.x; NIIJIMA A, 1975, J PHYSIOL-LONDON, V245, P81, DOI 10.1113/jphysiol.1975.sp010836; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; OPARIL S, 1987, CAN J PHYSIOL PHARM, V65, P1548, DOI 10.1139/y87-244; PATEL KP, 1981, HYPERTENSION, V3, P682, DOI 10.1161/01.HYP.3.6.682; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; Quyyumi AA, 1997, CIRCULATION, V95, P104, DOI 10.1161/01.CIR.95.1.104; RUDD MA, 1986, AM J PHYSIOL, V251, pF655, DOI 10.1152/ajprenal.1986.251.4.F655; Schobel HP, 1996, PAIN, V66, P117, DOI 10.1016/0304-3959(96)03079-5; Sene LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071310; Seybold VS, 2003, J NEUROSCI, V23, P1816; SITSEN JMA, 1983, HYPERTENSION, V5, P185, DOI 10.1161/01.HYP.5.2.185; SU HC, 1986, NEUROSCIENCE, V18, P727, DOI 10.1016/0306-4522(86)90066-7; Vaccari B, 2015, J RENIN-ANGIO-ALDO S, V16, P33, DOI 10.1177/1470320313481081; VIRUS RM, 1981, EUR J PHARMACOL, V72, P209, DOI 10.1016/0014-2999(81)90275-2; Waters JC, 2007, METHOD CELL BIOL, V81, P115, DOI 10.1016/S0091-679X(06)81007-1; Xavier F, 2000, BRAZ J MED BIOL RES, V33, P347, DOI 10.1590/S0100-879X2000000300014; Zheng F, 1997, NEUROSCIENCE, V76, P1245, DOI 10.1016/S0306-4522(96)00441-1	54	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179499	10.1371/journal.pone.0179499	http://dx.doi.org/10.1371/journal.pone.0179499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632750	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100030
J	Hervas, D; Fornes-Ferrer, V; Gomez-Escribano, AP; Sequedo, MD; Peiro, C; Millan, JM; Vazquez-Manrique, RP				Hervas, David; Fornes-Ferrer, Victoria; Pilar Gomez-Escribano, Ana; Dolores Sequedo, Maria; Peiro, Carmen; Maria Millan, Jose; Vazquez-Manrique, Rafael P.			Metformin intake associates with better cognitive function in patients with Huntington's disease	PLOS ONE			English	Article							WEIGHT-LOSS; INSULIN; THERAPY; CELLS; OLD	Huntington's disease (HD) is an inherited, dominant neurodegenerative disorder caused by an abnormal expansion of CAG triplets in the huntingtin gene (htt). Despite extensive efforts to modify the progression of HD thus far only symptomatic treatment is available. Recent work suggests that treating invertebrate and mice HD models with metformin, a well-known AMPK activator which is used worldwide to treat type 2-diabetes, reduces mutant huntingtin from cells and alleviates many of the phenotypes associated to HD. Herein we report statistical analyses of a sample population of participants in the Enroll-HD database, a world-wide observational study on HD, to assess the effect of metformin intake in HD patients respect to cognitive status using linear models. This cross-sectional study shows for the first time that the use of metformin associates with better cognitive function in HD patients.	[Hervas, David; Fornes-Ferrer, Victoria] Hosp Univ & Politecn La Fe, Hlth Res Inst La Fe, Dept Biostat, Valencia, Spain; [Pilar Gomez-Escribano, Ana; Dolores Sequedo, Maria; Maria Millan, Jose; Vazquez-Manrique, Rafael P.] Hosp Univ & Politecn La Fe, Hlth Res Inst La Fe, Res Grp Mol Cellular & Genom Biomed, Valencia, Spain; [Dolores Sequedo, Maria; Maria Millan, Jose; Vazquez-Manrique, Rafael P.] CIBER Enfermedades Raras CIBERER, Madrid, Spain; [Peiro, Carmen] Hosp Univ & Politecn La Fe, Dept Neurol, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitari i Politecnic La Fe	Vazquez-Manrique, RP (corresponding author), Hosp Univ & Politecn La Fe, Hlth Res Inst La Fe, Res Grp Mol Cellular & Genom Biomed, Valencia, Spain.; Vazquez-Manrique, RP (corresponding author), CIBER Enfermedades Raras CIBERER, Madrid, Spain.	rafael_vazquez@iislafe.es	Hervas, David/L-1322-2016; Vázquez-Manrique, Rafael/K-7882-2014	Hervas, David/0000-0003-0635-4961; Vázquez-Manrique, Rafael/0000-0002-1594-0033; Fornes, Victoria/0000-0001-9648-3059; GOMEZ ESCRIBANO, ANA PILAR/0000-0003-4391-5932	Institute de Salud Carlos III (ISCIII, Madrid, Spain) [CP11/00090]; ISCIII [PI14/00949]; Fundacio Telemarato de la TV3 [559]; European Regional Development Fund; CHDI Foundation	Institute de Salud Carlos III (ISCIII, Madrid, Spain)(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); Fundacio Telemarato de la TV3; European Regional Development Fund(European Commission); CHDI Foundation	RVM holds a "Miguel Servet" fellowship (Ref: CP11/00090) funded by the Institute de Salud Carlos III (ISCIII, Madrid, Spain), a grant from the ISCIII (PI14/00949) and Fundacio Telemarato de la TV3 (ref: 559). The funds from the ISCIII are partially supported by the European Regional Development Fund. RVM is also a Marie Curie fellow (CIG322034, EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Enroll-HD Study team, its collaborators (see haps://www.enroll-hd,org/for-researchers/technical-support/ for Site Principle Investigators and Study Coordinators) and study participants. Enroll-HD is a longitudinal observational study for Huntington's disease families intended to accelerate progress towards therapeutics; it is sponsored by CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to developing therapeutics for HD. Enroll-HD would not be possible without the vital contribution of the research participants and their families.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Hatters DA, 2008, IUBMB LIFE, V60, P724, DOI 10.1002/iub.111; Ju TC, 2014, BBA-MOL BASIS DIS, V1842, P1668, DOI 10.1016/j.bbadis.2014.06.012; Ju TC, 2011, J CELL BIOL, V194, P209, DOI 10.1083/jcb.201105010; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Lee SK, 2011, J CELL BIOCHEM, V112, P1259, DOI 10.1002/jcb.23000; Lexis CPH, 2015, BMJ OPEN DIAB RES CA, V3, DOI [10.1136/bmjdrc-2015-000090, 10.1136/bmjdrc-2015000090]; Li DH, 2011, J DIABETES, V3, P320, DOI 10.1111/j.1753-0407.2011.00119.x; Lu M, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw047; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Martinez-Horta S, 2016, PARKINSONISM RELAT D; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2001, NEUROLOGY, V57, P658, DOI 10.1212/WNL.57.4.658; Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497; SARABIA V, 1992, J CLIN INVEST, V90, P1386, DOI 10.1172/JCI116005; Schulte Joost, 2011, Curr Trends Neurol, V5, P65; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; van der Burg JMM, 2011, NEUROBIOL DIS, V44, P1, DOI 10.1016/j.nbd.2011.05.006; Vazquez-Manrique RP, 2015, HUM MOL GENET; VELAZQUEZ EM, 1994, METABOLISM, V43, P647, DOI 10.1016/0026-0495(94)90209-7; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Zilliox LA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0775-x	30	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179283	10.1371/journal.pone.0179283	http://dx.doi.org/10.1371/journal.pone.0179283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632780	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100016
J	Goodenough, AE; Little, N; Carpenter, WS; Hart, AG				Goodenough, Anne E.; Little, Natasha; Carpenter, William S.; Hart, Adam G.			Birds of a feather flock together: Insights into starling murmuration behaviour revealed using citizen science	PLOS ONE			English	Article							SCALE-FREE CORRELATIONS; STURNUS-VULGARIS; SELFISH HERD; PREDATION RISK; GROUP-SIZE; EVOLUTION; FISH; AGGREGATIONS; WAVES	Pre-roost murmuration displays by European starlings Sturnus vulgaris are a spectacular example of collective animal behaviour. To date, empirical research has focussed largely on flock movement and biomechanics whereas research on possible causal mechanisms that affect flock size and murmuration duration has been limited and restricted to a small number of sites. Possible explanations for this behaviour include reducing predation through the dilution, detection or predator confusion effects (the "safer together" hypotheses) or recruiting more birds to create larger (warmer) roosts (the "warmer together" hypothesis). We collected data on size, duration, habitat, temperature and predators from >3,000 murmurations using citizen science. Sightings were submitted from 23 countries but UK records predominated. Murmurations occurred across a range of habitats but there was no association between habitat and size/duration. Size increased significantly from October to early February, followed by a decrease until the end of the season in March (overall mean 30,082 birds; maximum 750,000 birds). Mean duration was 26 minutes (+/- 44 seconds SEM). Displays were longest at the start/end of the season, probably due to a significant positive relationship with day length. Birds of prey were recorded at 29.6% of murmurations. The presence of predators including harrier Circus, peregrine Falco peregrinus, and sparrowhawk Accipiter nisus was positively correlated with murmuration size (R-2 = 0.401) and duration (R-2 =0.258), especially when these species were flying near to, or actively engaging with, starlings. Temperature was negatively correlated with duration but the effect was much weaker than that of day length. When predators were present, murmurations were statistically more likely to end with all birds going down en masse to roost rather than dispersing from the site. Our findings suggest that starling murmurations are primarily an anti-predator adaptation rather than being undertaken to attract larger numbers of individuals to increase roost warmth.	[Goodenough, Anne E.; Carpenter, William S.; Hart, Adam G.] Univ Gloucestershire, Sch Nat & Social Sci, Francis Close Hall, Cheltenham, Glos, England; [Little, Natasha] Royal Soc Biol, Charles Darwin House, London, England	University of Gloucestershire	Goodenough, AE (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Francis Close Hall, Cheltenham, Glos, England.	aegoodenough@glos.ac.uk		Goodenough, Anne/0000-0002-7662-6670				Armstrong E. A, 1955, THE WREN; Attanasi A, 2014, NAT PHYS, V10, P692, DOI [10.1038/nphys3035, 10.1038/NPHYS3035]; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camazine S., 2003, SELF ORG BIOL SYSTEM; Carere C, 2009, ANIM BEHAV, V77, P101, DOI 10.1016/j.anbehav.2008.08.034; Cavagna A, 2010, MATH MOD METH APPL S, V20, P1491, DOI 10.1142/S0218202510004660; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Crawley MJ, 2005, STAT INTRO USING R; DAVIS GJ, 1970, ANIM BEHAV, V18, P362, DOI 10.1016/S0003-3472(70)80049-5; DEGROOT P, 1980, ANIM BEHAV, V28, P1249, DOI 10.1016/S0003-3472(80)80113-8; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Dias PAD, 2015, INT J PRIMATOL, V36, P311, DOI 10.1007/s10764-015-9827-3; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; ELGAR MA, 1986, BEHAV ECOL SOCIOBIOL, V19, P433, DOI 10.1007/BF00300546; EMLEN J. T., 1952, AUK, V69, P160; Erba S, 2015, ECOL INDIC, V48, P477, DOI 10.1016/j.ecolind.2014.09.010; Faraway J.J., 2002, PRACTICAL REGRESSION; Field A., 2000, DISCOVERING STAT USI; FOSTER WA, 1981, NATURE, V293, P466, DOI 10.1038/293466a0; Goodenough AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034338; Hamilton W. J., 1969, Ecology, V50, P886; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hart A, 2006, CURR BIOL, V16, P42; HART A, 2012, INT J ZOOL, V2012, DOI DOI 10.1155/2012/105345; Hemelrijk CK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126913; Hemelrijk CK, 2015, BEHAV ECOL SOCIOBIOL, V69, P755, DOI 10.1007/s00265-015-1891-3; Hemelrijk CK, 2015, J STAT PHYS, V158, P563, DOI 10.1007/s10955-014-1154-0; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Hemelrijk CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022479; Higby Louisa K., 2012, International Journal of Zoology, V2012, P1; Hogan BG, 2017, ROYAL SOC OPEN SCI, P4; King AJ, 2012, CURR BIOL, V22, pR112, DOI 10.1016/j.cub.2011.11.033; KRAUSE J, 1994, ETHOLOGY, V98, P128; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; LAZARUS J, 1979, ANIM BEHAV, V27, P855, DOI 10.1016/0003-3472(79)90023-X; MORRISON DW, 1985, AUK, V102, P793; Nicolis G, 1977, SELF ORG NONEQUILIBR; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; Olson RS, 2016, ARTIF LIFE, V22, P299, DOI 10.1162/ARTL_a_00206; Olson RS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0305; Orpwood JE, 2008, ANIM BEHAV, V76, P143, DOI 10.1016/j.anbehav.2008.01.016; Pearce DJG, 2014, P NATL ACAD SCI USA, V111, P10422, DOI 10.1073/pnas.1402202111; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Procaccini A, 2011, ANIM BEHAV, V82, P759, DOI 10.1016/j.anbehav.2011.07.006; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Quantum GIS Development Team, 2016, QUANT GIS GEOGR INF; SMITH SM, 1972, CONDOR, V74, P478, DOI 10.2307/1365903; Stafford R, 2012, PLOS ONE, V5; Sumpter DJ, 2010, ETHOL ECOL EVOL; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; The R Foundation, 2016, R PROJ STAT COMP VIE; Thirgood S, 2004, ANIM CONSERV, V7, P113, DOI 10.1017/S1367943004001404; TREISMAN M, 1975, ANIM BEHAV, V23, P779, DOI 10.1016/0003-3472(75)90106-2; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935; Watt PJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P179, DOI 10.1007/s002650050429; WHITEHEAD SC, 1995, J AVIAN BIOL, V26, P193, DOI 10.2307/3677319; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Worthington JP, 2012, METHODS ECOL EVOL, V3, P303, DOI 10.1111/j.2041-210X.2011.00164.x; Zoratto F, 2010, J AVIAN BIOL, V41, P427, DOI 10.1111/j.1600-048X.2010.04974.x	63	14	15	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179277	10.1371/journal.pone.0179277	http://dx.doi.org/10.1371/journal.pone.0179277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628640	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000404043100023
J	Amlot, R; Carter, H; Riddle, L; Larner, J; Chilcott, RP				Amlot, Richard; Carter, Holly; Riddle, Lorna; Larner, Joanne; Chilcott, Robert P.			Volunteer trials of a novel improvised dry decontamination protocol for use during mass casualty incidents as part of the UK'S Initial Operational Response (IOR)	PLOS ONE			English	Article							ACCEPTABILITY; MANAGEMENT	Previous studies have demonstrated that rapid evacuation, disrobing and emergency decontamination can enhance the ability of emergency services and acute hospitals to effectively manage chemically-contaminated casualties. The purpose of this human volunteer study was to further optimise such an "Initial Operational Response" by (1) identifying an appropriate method for performing improvised skin decontamination and (2) providing guidance for use by first responders and casualties. The study was performed using two readily available, absorbent materials (paper towels and incontinence pads). The decontamination effectiveness of the test materials was measured by quantifying the amount of a chemical warfare agent simulant (methyl salicylate) removed from each volunteer's forearm skin. Results from the first study demonstrated that simulant recovery was lower in all of the dry decontamination conditions when compared to matched controls, suggesting that dry decontamination serves to reduce chemical exposure. Blotting in combination with rubbing was the most effective form of decontamination. There was no difference in effectiveness between the two absorbent materials. In the following study, volunteers performed improvised dry decontamination, either with or without draft guidelines. Volunteers who received the guidance were able to carry out improvised dry decontamination more effectively, using more of the absorbent product (blue roll) to ensure that all areas of the body were decontaminated and avoiding cross-contamination of other body areas by working systematically from the head downwards. Collectively, these two studies suggest that absorbent products that are available on ambulances and in acute healthcare settings may have generic applicability for improvised dry decontamination. Wherever possible, emergency responders and healthcare workers should guide casualties through decontamination steps; in the absence of explicit guidance and instructions, improvised dry decontamination may not be performed correctly or safely.	[Amlot, Richard; Carter, Holly; Riddle, Lorna] Publ Hlth England, Emergency Response Dept Sci & Technol, Salisbury, Wilts, England; [Larner, Joanne; Chilcott, Robert P.] Univ Hertfordshire, Sch Pharm, Res Ctr Top Drug Delivery & Toxicol, Hatfield, Herts, England	Public Health England; University of Hertfordshire	Amlot, R (corresponding author), Publ Hlth England, Emergency Response Dept Sci & Technol, Salisbury, Wilts, England.	richard.amlot@phe.gov.uk		Chilcott, Robert/0000-0002-8845-9400	Department of Health Policy Research Programme (CBRN7: EDICTAS - Emergency Decontamination in Clinical Treatments at Scene) [047_0200]; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London; Health Protection Research Unit in Evaluation of Interventions at University of Bristol; Public Health England (PHE)	Department of Health Policy Research Programme (CBRN7: EDICTAS - Emergency Decontamination in Clinical Treatments at Scene); National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London; Health Protection Research Unit in Evaluation of Interventions at University of Bristol; Public Health England (PHE)	This paper describes independent research commissioned and funded by the Department of Health Policy Research Programme (CBRN7: EDICTAS - Emergency Decontamination in Clinical Treatments at Scene 047_0200). Holly Carter and Richard AmIot are part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London and Health Protection Research Unit in Evaluation of Interventions at University of Bristol, in partnership with Public Health England (PHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter H, 2015, J APPL SOC PSYCHOL, V45, P173, DOI 10.1111/jasp.12286; Carter H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089846; Carter H, 2013, BASIC APPL SOC PSYCH, V35, P575, DOI 10.1080/01973533.2013.840634; Carter H, 2013, DISASTER PREV MANAG, V22, P132, DOI 10.1108/09653561311325280; Carter H, 2012, BIOSECUR BIOTERROR, V10, P280, DOI 10.1089/bsp.2012.0013; Chilcott RP, 2014, ENVIRON INT, V72, P37, DOI 10.1016/j.envint.2014.02.006; Gemmill AW, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-211; Kassouf N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170966; Larner J., 2012, THESIS; Liang WC, 2003, BREAST CANCER RES TR, V79, P199, DOI 10.1023/A:1023914612152; Matar H, 2014, TOXICOL IN VITRO, V28, P492, DOI 10.1016/j.tiv.2014.01.001; Matar H, 2010, TOXICOLOGY, V278, P344, DOI 10.1016/j.tox.2010.08.088; Maynard RL, 2009, GEN APPL TOXICOLOGY; National Ambulance Resilience Unit (NARU), 2013, INIT OP RESP PROGR G; New Dimension Regional Team, 2003, NAT GUID DEC FIR SER; Newman SP, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13280; Okumura T, 1998, ACAD EMERG MED, V5, P618, DOI 10.1111/j.1553-2712.1998.tb02471.x; Pearce JM, 2013, DISASTER MED PUBLIC, V7, P65, DOI 10.1001/dmp.2012.56; Pimenta JM, 2003, SEX TRANSM INFECT, V79, P16, DOI 10.1136/sti.79.1.16	19	23	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179309	10.1371/journal.pone.0179309	http://dx.doi.org/10.1371/journal.pone.0179309			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622352	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300020
J	Lanzen, A; Lekang, K; Jonassen, I; Thompson, EM; Troedsson, C				Lanzen, Anders; Lekang, Katrine; Jonassen, Inge; Thompson, Eric M.; Troedsson, Christofer			DNA extraction replicates improve diversity and compositional dissimilarity in metabarcoding of eukaryotes in marine sediments	PLOS ONE			English	Article							RIBOSOMAL-RNA; SPECIES-DIVERSITY; DEEP; QUANTIFICATION; NUMBER; SIZE; BIAS; PCR	Human impact on marine benthic communities has traditionally been assessed using visible morphological traits and has focused on the macrobenthos, whereas the ecologically important organisms of the meio- and microbenthos have received less attention. DNA metabarcoding offers an alternative to this approach and enables a larger fraction of the biodiversity in marine sediments to be monitored in a cost-efficient manner. Although this methodology remains poorly standardised and challenged by biases inherent to rRNA copy number variation, DNA extraction, PCR, and limitations related to taxonomic identification, it has been shown to be semi-quantitative and useful for comparing taxon abundances between samples. Here, we evaluate the effect of replicating genomic DNA extraction in order to counteract small scale spatial heterogeneity and improve diversity and community structure estimates in metabarcoding-based monitoring. For this purpose, we used ten technical replicates from three different marine sediment samples. The effect of sequence depth was also assessed, and in silico pooling of DNA extraction replicates carried out in order to maintain the number of reads constant. Our analyses demonstrated that both sequencing depth and DNA extraction replicates could improve diversity estimates as well as the ability to separate samples with different characteristics. We could not identify a "sufficient" replicate number or sequence depth, where further improvements had a less significant effect. Based on these results, we consider replication an attractive alternative to directly increasing the amount of sample used for DNA extraction and strongly recommend it for future metabarcoding studies and routine assessments of sediment biodiversity.	[Lanzen, Anders] NEIKER Tecnalia, Dept Conservat Nat Resources, Derio, Spain; [Lekang, Katrine; Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway; [Jonassen, Inge] Univ Bergen, Dept Informat, Computat Biol Unit, Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Thompson, Eric M.; Troedsson, Christofer] Uni Res AS, Uni Res Environm, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen	Lanzen, A (corresponding author), NEIKER Tecnalia, Dept Conservat Nat Resources, Bizkaia Technol Pk, Derio, Spain.	alanzen@neiker.eus	Lanzén, Anders/F-3818-2016; Jonassen, Inge/AAC-7035-2020; Lanzén, Anders/AAG-5048-2019	Lanzén, Anders/0000-0002-7138-6364; Lanzén, Anders/0000-0002-7138-6364	Research Council of Norway (NFR) [190265/S40]; Statoil; Norwegian Deepwater Program (NDP); NFR	Research Council of Norway (NFR)(Research Council of Norway); Statoil; Norwegian Deepwater Program (NDP); NFR(Research Council of Norway)	This work was supported by the Research Council of Norway (NFR, http://www.forskningsradet.no/en, grant no.190265/S40), Statoil (http://www.statoil.com) and the Norwegian Deepwater Program (NDP; https://epim.no/ndp/). Statoil contributed to the financing of a PhD stipend related to the project funded by NFR, which was in no way contingent on, or linked to, specific research outcomes. Statoil or other funders had no involvement in or influence of study design, data collection and analysis, or preparation of the manuscript.	Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borja A, 2013, MAR POLLUT BULL, V68, P1, DOI 10.1016/j.marpolbul.2013.01.041; Bourlat SJ, 2013, MAR POLLUT BULL, V74, P19, DOI 10.1016/j.marpolbul.2013.05.042; Brannock PM, 2015, MAR GENOM, V23, P67, DOI 10.1016/j.margen.2015.05.007; Brown EA, 2015, ECOL EVOL, V5, P2234, DOI 10.1002/ece3.1485; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Chariton AA, 2014, ENVIRON TOXICOL CHEM, V33, P359, DOI 10.1002/etc.2450; Cowart DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117562; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; Danovaro R, 2014, TRENDS ECOL EVOL, V29, P465, DOI 10.1016/j.tree.2014.06.002; Danovaro R, 2013, DEEP-SEA RES PT II, V92, P97, DOI 10.1016/j.dsr2.2013.03.035; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Forster D, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw120; Giner CR, 2016, APPL ENVIRON MICROB, V82, P4757, DOI 10.1128/AEM.00560-16; Godhe A, 2008, APPL ENVIRON MICROB, V74, P7174, DOI 10.1128/AEM.01298-08; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Guardiola M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139633; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Handley LL, 2015, BIOL J LINN SOC, V115, P750, DOI 10.1111/bij.12516; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JUMARS PA, 1976, J MAR RES, V34, P217; Lanzen A, 2016, MOL ECOL, V25, P4392, DOI 10.1111/mec.13761; Lanzen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049334; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Lejzerowicz F, 2014, DEEP-SEA RES PT II, V108, P17, DOI 10.1016/j.dsr2.2014.07.018; Lekang K, 2015, AQUAT MICROB ECOL, V75, P15, DOI 10.3354/ame01741; Maechler M., 2016, CLUSTER CLUSTERANALY; Maurer D, 2000, MAR POLLUT BULL, V40, P98, DOI 10.1016/S0025-326X(99)00235-0; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Noland SA, 2011, REPORT NO 20011 0245; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Penton CR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00824; Pilloni G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040467; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Ranjard L, 2003, ENVIRON MICROBIOL, V5, P1111, DOI 10.1046/j.1462-2920.2003.00521.x; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thurber AR, 2014, BIOGEOSCIENCES, V11, P3941, DOI 10.5194/bg-11-3941-2014; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	53	39	40	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179443	10.1371/journal.pone.0179443	http://dx.doi.org/10.1371/journal.pone.0179443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622351	Green Submitted, Green Published, gold			2022-12-26	WOS:000403506300034
J	Kametani, Y; Katano, I; Miyamoto, A; Kikuchi, Y; Ito, R; Muguruma, Y; Tsuda, B; Habu, S; Tokuda, Y; Ando, K; Ito, M				Kametani, Yoshie; Katano, Ikumi; Miyamoto, Asuka; Kikuchi, Yusuke; Ito, Ryoji; Muguruma, Yukari; Tsuda, Banri; Habu, Sonoko; Tokuda, Yutaka; Ando, Kiyoshi; Ito, Mamoru			NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; PERIPHERAL-BLOOD; B-CELL; IMMUNE-RESPONSES; TGN1412 TRIAL; PLASMA-CELLS; MHC LIGANDS; NOG MICE; T-CELLS; IMMUNODEFICIENT	Immunodeficient mice transplanted with human peripheral blood mononuclear cells (PBMCs) are promising tools to evaluate human immune responses to vaccines. However, these mice usually develop severe graft-versus-host disease (GVHD), which makes estimation of antigen-specific IgG production after antigen immunization difficult. To evaluate anti-gen-specific IgG responses in PBMC-transplanted immunodeficient mice, we developed a novel NOD/Shi-scid-IL2r. null (NOG) mouse strain that systemically expresses the human IL-4 gene (NOG-hIL-4-Tg). After human PBMC transplantation, GVHD symptoms were significantly suppressed in NOG-hIL-4-Tg compared to conventional NOG mice. In kinetic analyses of human leukocytes, long-term engraftment of human T cells has been observed in peripheral blood of NOG-hIL-4-Tg, followed by dominant CD4+ T rather than CD8+ T cell proliferation. Furthermore, these CD4+ T cells shifted to type 2 helper (Th2) cells, resulting in long-term suppression of GVHD. Most of the human B cells detected in the transplanted mice had a plasmablast phenotype. Vaccination with HER2 multiple antigen peptide (CH401MAP) or keyhole limpet hemocyanin (KLH) successfully induced antigen-specific IgG production in PBMC-transplanted NOG-hIL-4-Tg. The HLA haplotype of donor PBMCs might not be relevant to the antibody secretion ability after immunization. These results suggest that the human PBMC-transplanted NOG-hIL-4-Tg mouse is an effective tool to evaluate the production of antigen-specific IgG antibodies.	[Kametani, Yoshie; Miyamoto, Asuka; Kikuchi, Yusuke] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci, Isehara, Kanagawa, Japan; [Kametani, Yoshie] Tokai Univ, Inst Adv Biosci, Hiratsuka, Kanagawa, Japan; [Katano, Ikumi; Ito, Ryoji; Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Miyamoto, Asuka; Tsuda, Banri; Tokuda, Yutaka] Tokai Univ, Sch Med, Dept Breast & Endocrine Surg, Isehara, Kanagawa, Japan; [Muguruma, Yukari; Ando, Kiyoshi] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa, Japan; [Habu, Sonoko] Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Juntendo University	Kametani, Y (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci, Isehara, Kanagawa, Japan.; Kametani, Y (corresponding author), Tokai Univ, Inst Adv Biosci, Hiratsuka, Kanagawa, Japan.	y-kametn@is.icc.u-tokai.ac.jp		Kametani, Yoshie/0000-0002-7417-1836	Japan Society for the Promotion of Science [22220007]; Tokai University; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokai University; MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science by a Grant-in-Aid for Scientific Research (ITO) (S) [grant number 22220007] to MI; a Tokai University Grant-in-aid Aid to YK (2013-2014); and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2012-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Castro CD, 2015, IMMUNOL REV, V267, P30, DOI 10.1111/imr.12327; CHEN FA, 1995, J IMMUNOL, V155, P2833; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Harada Y, 1996, BRIT J HAEMATOL, V92, P184, DOI 10.1046/j.1365-2141.1996.300835.x; Henden AS, 2015, J IMMUNOL, V194, P4604, DOI 10.4049/jimmunol.1500117; Hunig T, 2012, NAT REV IMMUNOL, V12, P317, DOI 10.1038/nri3192; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, CELL MOL IMMUNOL, V9, P208, DOI 10.1038/cmi.2012.2; Ito R, 2009, TRANSPLANTATION, V87, P1654, DOI 10.1097/TP.0b013e3181a5cb07; Jackson SM, 2009, BLOOD, V113, P3999, DOI 10.1182/blood-2008-03-145979; Jego G, 1999, BLOOD, V94, P701, DOI 10.1182/blood.V94.2.701.414k16_701_712; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Krenger W, 1996, IMMUNOL RES, V15, P50, DOI 10.1007/BF02918284; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Levesque MC, 2006, LEUKEMIA RES, V30, P24, DOI 10.1016/j.leukres.2005.05.022; Macallan DC, 2005, BLOOD, V105, P3633, DOI 10.1182/blood-2004-09-3740; Mehrishi JN, 2007, VACCINE, V25, P3517, DOI 10.1016/j.vaccine.2007.02.078; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Misiak J, 2015, METHODS MOL BIOL, V1291, P163, DOI 10.1007/978-1-4939-2498-1_14; Miyako H, 2011, ANTICANCER RES, V31, P3361; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Nagasawa T, 2015, FRONT IMMUNOL, V6, DOI [10.3389/fimmu.2015.00301, 10.3389/fimmu.2014.00445]; PARKER KC, 1994, J IMMUNOL, V152, P163; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Shultz LD, 2000, J IMMUNOL, V164, P2496, DOI 10.4049/jimmunol.164.5.2496; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Stern LJ, 2009, CURR PHARM DESIGN, V15, P3249, DOI 10.2174/138161209789105171; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; Theocharides APA, 2016, HAEMATOLOGICA, V101, P5, DOI 10.3324/haematol.2014.115212; van Rijn RS, 2003, BLOOD, V102, P2522, DOI 10.1182/blood-2002-10-3241; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Waritani T, 2017, METHODSX, V4, P153, DOI 10.1016/j.mex.2017.03.002; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149	40	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179239	10.1371/journal.pone.0179239	http://dx.doi.org/10.1371/journal.pone.0179239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617827	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600026
J	Prasadani, WC; Senanayake, CM; Jayathilaka, N; Ekanayake, S; Seneviratne, KN				Prasadani, W. Chaturi; Senanayake, Chaturi M.; Jayathilaka, Nimanthi; Ekanayake, Sagarika; Seneviratne, Kapila N.			Effect of three edible oils on the intestinal absorption of caffeic acid: An in vivo and in vitro study	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; CHAIN FATTY-ACIDS; ANTIOXIDANT CAPACITY; POLYPHENOLS; TRANSPORT; CACO-2; BIOAVAILABILITY; SODIUM; PLASMA; ASSAY	Polyphenolic antioxidants are mainly absorbed through passive paracellular permeation regulated by tight junctions. Some fatty acids are known to modulate tight junctions. Fatty acids resulting from the digestion of edible oils may improve the absorption of polyphenolic antioxidants. Therefore, we explored the effect of three edible oils on the intestinal absorption of caffeic acid. Rats were fed with soybean oil and caffeic acid dissolved in distilled water. Caffeic acid contents in the plasma collected up to 1 hr were quantified. The experiment was repeated with coconut oil and olive oil. Component fatty acids of the oils were individually tested in vitro for their effect on permeability of caffeic acid using Caco-2 cell monolayers. Highest absorption of caffeic acid was observed in animals fed with coconut oil. In vitro transport percentages of caffeic acid in 2.5 mmol/L solutions of fatty acids were 22.01 +/- 0.12 (lauric), 15.30 +/- 0.25 (myristic acid), 13.59 +/- 0.35 (linoleic acid), 3.70 +/- 0.09 (oleic acid) and 0.10 +/- 2.0 (all other fatty acids). Lauric acid and myristic acid are the two major fatty acids present in coconut oil. Therefore, these fatty acids may contribute to the higher absorption of caffeic acid in the presence of coconut oil.	[Prasadani, W. Chaturi; Senanayake, Chaturi M.; Jayathilaka, Nimanthi; Seneviratne, Kapila N.] Univ Kelaniya, Dept Chem, Fac Sci, Kelaniya, Sri Lanka; [Ekanayake, Sagarika] Univ Sri Jayawardenapura, Dept Biochem, Fac Med Sci, Nugegoda, Sri Lanka	University Kelaniya; University Sri Jayewardenepura	Seneviratne, KN (corresponding author), Univ Kelaniya, Dept Chem, Fac Sci, Kelaniya, Sri Lanka.	kapilas@kln.ac.lk	Ekanayake, Sagarika/D-7594-2015; Seneviratne, Kapila N/X-8535-2019; Ekanayake, Sagarika/GQA-4481-2022; Jayathilaka, Nimanthi/AAG-3697-2019	Ekanayake, Sagarika/0000-0002-0383-9923; Jayathilaka, Nimanthi/0000-0001-8741-3075	National Research Council Sri Lanka [12-012]; National Science Foundation, Sri Lanka [RG/2015/AG/03]	National Research Council Sri Lanka; National Science Foundation, Sri Lanka(National Science Foundation (NSF))	This work was supported by: 1) National Research Council Sri Lanka, Grant 12-012, http:// www.nrc.gov.lk/; 2) National Science Foundation, Sri Lanka, RG/2015/AG/03, http://www.nsf.ac.lk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2013, NUTR RES, V33, P180, DOI 10.1016/j.nutres.2012.12.010; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; BJARNASON I, 1995, GASTROENTEROLOGY, V108, P1566, DOI 10.1016/0016-5085(95)90708-4; Chattopadhyay R, 2014, J BIOL CHEM, V289, P3148, DOI 10.1074/jbc.M113.528190; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; D'Archivio M, 2010, INT J MOL SCI, V11, P1321, DOI 10.3390/ijms11041321; Duthie GG, 1998, EUR J CLIN NUTR, V52, P733, DOI 10.1038/sj.ejcn.1600635; HUGHES TE, 1987, J BIOL CHEM, V262, P3762; Jewell C, 2003, BRIT J NUTR, V89, P639, DOI 10.1079/BJN2003835; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kim JH, 2010, INVEST OPHTH VIS SCI, V51, P561, DOI 10.1167/iovs.09-3774; Konishi Y, 2003, J AGR FOOD CHEM, V51, P7296, DOI 10.1021/jf034894t; Lelfert WR, 2008, NUTR RES, V28, P842, DOI 10.1016/j.nutres.2008.09.001; Maher S, 2009, ADV DRUG DELIVER REV, V61, P1427, DOI 10.1016/j.addr.2009.09.006; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m; Pabla D, 2010, EUR J PHARM SCI, V40, P466, DOI 10.1016/j.ejps.2010.05.002; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Poquet L, 2008, DRUG METAB DISPOS, V36, P190, DOI 10.1124/dmd.107.017558; Porrini M, 2008, NUTR METAB CARDIOVAS, V18, P647, DOI 10.1016/j.numecd.2008.08.004; Rastogi H., 2013, J DRUG DELIVERY THER, V3, P20, DOI [10.22270/jddt.v3i3.506, DOI 10.22270/JDDT.V3I3.506]; Roche HM, 2001, GUT, V48, P797, DOI 10.1136/gut.48.6.797; Scalbert A, 2002, BIOMED PHARMACOTHER, V56, P276, DOI 10.1016/S0753-3322(02)00205-6; Seneviratne KN, 2009, FOOD SCI TECHNOL INT, V15, P419, DOI 10.1177/1082013209352718; Seneviratne KN, 2009, FOOD CHEM, V114, P1444, DOI 10.1016/j.foodchem.2008.11.038; Seneviratne KN, 2009, INT J FOOD SCI TECH, V44, P792, DOI 10.1111/j.1365-2621.2008.01900.x; Soderholm JD, 1998, DIGEST DIS SCI, V43, P1547, DOI 10.1023/A:1018823100761; Spencer JPE, 2003, J NUTR, V133, p3255S, DOI 10.1093/jn/133.10.3255S; TURNER JR, 1995, GASTROENTEROLOGY, V109, P1391, DOI 10.1016/0016-5085(95)90605-3; Vissers MN, 2002, J NUTR, V132, P409, DOI 10.1093/jn/132.3.409; Waraho T, 2012, FOOD RES INT, V48, P353, DOI 10.1016/j.foodres.2012.05.017; Waraho T, 2009, J AGR FOOD CHEM, V57, P7112, DOI 10.1021/jf901270m	33	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179292	10.1371/journal.pone.0179292	http://dx.doi.org/10.1371/journal.pone.0179292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617858	gold, Green Submitted, Green Published			2022-12-26	WOS:000403364600029
J	Zhang, WJ; Su, J; Xu, HD; Yu, SS; Liu, YN; Zhang, Y; Sun, LK; Yue, Y; Zhou, XL				Zhang, Wenjia; Su, Jing; Xu, Huadan; Yu, Shanshan; Liu, Yanan; Zhang, Yong; Sun, Liankun; Yue, Ying; Zhou, Xiaoli			Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; INDUCED APOPTOSIS; BREAST-CANCER; DICHLOROACETATE; METABOLISM; COUMARIN; AGENTS; ANTICANCER; CARCINOMA; GROWTH	Pyruvate dehydrogenase kinase 1 (PDK1) is overexpressed in ovarian cancer and thus is a promising anticancer therapeutic target. Our previous work suggests that coumarin compounds are potential inhibitors of PDKs. In this study, we used the ovarian cancer cell line SKOV3 as the model system and examined whether dicumarol (DIC), a coumarin compound, could inhibit ovarian cancer through targeting PDK1. We showed that DIC potently inhibited the kinase activity of PDK1, shifted the glucose metabolism from aerobic glycolysis to oxidative phosphorylation, generated a higher level of reactive oxygen species (ROS), attenuated the mitochondrial membrane potential (MMP), induced apoptosis, and reduced cell viability in vitro. The same phenotypes induced by DIC also were translated in vivo, leading to significant suppression of xenograft growth. This study not only identifies a novel inhibitor for PDK1, but it also reveals novel anticancer mechanisms of DIC and provides a promising anticancer therapy that targets the Warburg effect.	[Zhang, Wenjia; Yue, Ying] Jilin Univ, Hosp 1, Dept Gynecol Oncol, Changchun, Peoples R China; [Su, Jing; Xu, Huadan; Liu, Yanan; Zhang, Yong; Sun, Liankun; Zhou, Xiaoli] Jilin Univ, Coll Basic Med Sci, Changchun, Peoples R China; [Yu, Shanshan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai, Peoples R China	Jilin University; Jilin University; Shanghai Jiao Tong University	Yue, Y (corresponding author), Jilin Univ, Hosp 1, Dept Gynecol Oncol, Changchun, Peoples R China.; Zhou, XL (corresponding author), Jilin Univ, Coll Basic Med Sci, Changchun, Peoples R China.	yying119@126.com; zhouxl@jlu.edu.cn			National Natural Science Foundation of China [81472419, 81672948, 81272876, 31400681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (No. 81472419, 81672948, 81272876, and 31400681).	Amin KM, 2011, BIOORGAN MED CHEM, V19, P6087, DOI 10.1016/j.bmc.2011.08.037; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; Bansal Y, 2013, MED CHEM RES, V22, P3049, DOI 10.1007/s00044-012-0321-6; Basanagouda M, 2014, EUR J MED CHEM, V74, P225, DOI 10.1016/j.ejmech.2013.12.061; Bello RI, 2004, METHOD ENZYMOL, V382, P234; Bhattacharya S., 2011, RES J MED PLANT, V5, P116, DOI [DOI 10.3923/RJMP.2011.116.126, 10.3923/rjmp.2011.116.126]; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Buranrat B, 2010, WORLD J GASTROENTERO, V16, P2362, DOI 10.3748/wjg.v16.i19.2362; Calcutt NA, 2009, J NEUROPATH EXP NEUR, V68, P985, DOI 10.1097/NEN.0b013e3181b40217; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; Dong G., 2016, ONCOTARGET, DOI 10.18632/oncotarget.11906; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Fabian C, 2012, FEBS J, V279, P882, DOI 10.1111/j.1742-4658.2012.08479.x; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Fujiwara S, 2013, BRIT J CANCER, V108, P170, DOI 10.1038/bjc.2012.527; Handin RI, 2016, HIST ANTITHROMBOTIC; Ngo H, 2015, MOL BIOL REP, V42, P825, DOI 10.1007/s11033-014-3764-7; Haugrud AB, 2014, BREAST CANCER RES TR, V147, P539, DOI 10.1007/s10549-014-3128-y; He DX, 2016, CLIN SCI, V130, P2267, DOI 10.1042/CS20160536; Jain M, 2013, CHEM BIOL DRUG DES, V81, P499, DOI 10.1111/cbdd.12000; Jeoung NH, 2015, DIABETES METAB J, V39, P188, DOI 10.4093/dmj.2015.39.3.188; Matos MJ, 2012, MED CHEM, V8, P1140; Kankotia S, 2014, BBA-REV CANCER, V1846, P617, DOI 10.1016/j.bbcan.2014.08.005; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; KEYES SR, 1985, CANCER RES, V45, P213; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Kinnaird A, 2015, J MOL MED, V93, P127, DOI 10.1007/s00109-014-1250-2; Kirito K, 2009, CELL CYCLE, V8, P2844, DOI 10.4161/cc.8.17.9544; Kukimoto-Niino M, 2011, ACTA CRYSTALLOGR D, V67, P763, DOI 10.1107/S090744491102405X; Li YQ, 2016, AM J CANCER RES, V6, P2076; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu T, 2017, ONCOL REP, V37, P193, DOI 10.3892/or.2016.5253; Liu T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168859; Ma X., 1999, CHINESE J THROMBOSIS, V6, P127; Mandai M, 2015, ONCOTARGET, V6, P30704, DOI 10.18632/oncotarget.5228; Manjunatha M, 2011, J COORD CHEM, V64, P4264, DOI 10.1080/00958972.2011.621082; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Moore JD, 2014, ONCOTARGET, V5, P12862, DOI 10.18632/oncotarget.2656; Park EJ, 2014, EXP CELL RES, V323, P144, DOI 10.1016/j.yexcr.2014.01.009; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; SPRAGUE HB, 1948, MED CLIN N AM, P1309; STACPOOLE PW, 1992, DIABETES CARE, V15, P785, DOI 10.2337/diacare.15.6.785; Sun WY, 2015, CANCER RES, V75, P4923, DOI 10.1158/0008-5472.CAN-15-1023; Sutton KM, 2012, BIOCHEM BIOPH RES CO, V426, P421, DOI 10.1016/j.bbrc.2012.08.111; Thakur A, 2015, EUR J MED CHEM, V101, P476, DOI 10.1016/j.ejmech.2015.07.010; Tsoucalas G, 2016, CURR PHARM DESIGN, V22, P1857, DOI 10.2174/1381612822666160111124615; Watanabe J, 2006, ONCOGENE, V25, P2500, DOI 10.1038/sj.onc.1209162; Watzka M, 2011, J THROMB HAEMOST, V9, P109, DOI 10.1111/j.1538-7836.2010.04095.x; Weigt S, 2012, REPROD TOXICOL, V33, P133, DOI 10.1016/j.reprotox.2011.07.001; Xiang XY, 2016, INT J ONCOL, V49, P773, DOI 10.3892/ijo.2016.3552; Zhang SL, 2016, J MED CHEM, V59, P3562, DOI 10.1021/acs.jmedchem.5b01828; Zhang W, 2015, INT J BIOL SCI, V11, P1390, DOI 10.7150/ijbs.13325; Zhao XH, 2016, TUMOR BIOL, V37, P14989, DOI 10.1007/s13277-016-5415-1; Zhou XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030340; Zhu DX, 2016, SCI REP-UK, V6, DOI 10.1038/srep37478	58	15	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179672	10.1371/journal.pone.0179672	http://dx.doi.org/10.1371/journal.pone.0179672			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617852	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600054
J	Zhu, D; Wang, Y; Zheng, YF; Yang, DY; Guo, K; Yang, XR; Jing, XX; Wong, IY; You, QS; Tao, Y; Jonas, JB				Zhu, Dan; Wang, Yan; Zheng, Yan Fei; Yang, Da Yong; Guo, Kai; Yang, Xian Rong; Jing, Xin Xia; Wong, Ian Y.; You, Qi Sheng; Tao, Yong; Jonas, Jost B.			Choroidal thickness in school children: The Gobi Desert Children Eye Study	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURES; MACULAR DEGENERATION; VOLUME VARIATIONS; HEALTHY-SUBJECTS; AXIAL LENGTH; AGE; GROWTH; MYOPIA; INDIVIDUALS; ASSOCIATION	Purpose To investigate choroidal thickness (CT) and its associations in children in a school-based study. Methods The cross-sectional school-based Gobi Desert Children Eye Study included 1565 out of 1911 (81.9%) eligible children from all schools in the oasis region of Ejina in the Gobi Desert. A detailed ophthalmic examination was performed, including spectral-domain optical coherence tomography with enhanced depth imaging for CT measurement. Results CT measurements were available for 1463 (93.5%) students (mean age: 11.8 +/- 3.5 years; range: 7-21 years). Mean subfoveal choroidal thickness (SFCT) was 282 +/- 49 mu m. CT was thickest at 1000 mu m temporal to the fovea (286 +/- 49 mu m), followed by the subfoveal region (282 +/- 49 mu m; P< 0.001), the region at 2500 mu m temporal to the fovea (278 +/- 49 mu m), the region at 1000 mu m nasal to the fovea (254 +/- 49 mu m; P< 0.001), and the region at 2500 mu m nasal to the fovea (197 +/- 50 mu m; P< 0.001). In cross-sectional analysis, the mean SFCT increased with age from 288 mu m at 7 years of age to 304 mu m at 11 years, and then decreased to 258 mu m at 18 years. In multivariate analysis, thicker SFCT was associated (regression coefficient r:0.38) with higher hyperopic refractive error (P< 0.001; standardized regression coefficient beta:0.31; non-standardized regression coefficient B:7.61;95% confidence intervals (CI):6.29,8.93), younger age (P< 0.001; beta:-0.10;B:-1.39;95%CI:-2.14,-0.64),male gender (P = 0.03;beta:-0.05;B:-5.33;95% CI:-10.1,-0.53), higher corneal refractive power (P< 0.001; beta:0.12;B:3.68; 95%CI: 2.12,5.24), and non-Han Chinese ethnicity (P = 0.03; beta: 0.05;B:6.16; 95%CI:0.50,11.8). Ratio of CT(1000 mu m nasal to fovea)/SFCT (0.90 +/- 0.06; range: 0.66,1.23) and ratio of CT(2500 mu m nasal to fovea)/SFCT (0.70 +/- 0.13; range: 0.28,1.23) decreased with older age (P = 0.01; and P = 0.001, respectively), while ratio of CT(1000 mu m temporal to fovea)/SFCT (1.02 +/- 0.06; range: 0.56,1.37) and ratio of CT (2500 mu m temporal to fovea)/SFCT (0.99 +/- 0.11; range: 0.54,1.84) increased with older age (both P< 0.001). Time spent outdoors or indoors was not significantly associated with CTrelated parameter in multivariate analysis. Conclusions In contrast to SFCT in adults and despite elongating axial length, SFCT in children increased in cross- sectional analysis with older age (up to 11 years of age) and then started to decrease with further ageing. It suggests an increase in choroidal volume up to the age of 11 years. In children, the choroid was thickest at 1000 mu m temporal to the fovea, followed by the subfoveal region, and this difference significantly increased with older age. In contrast, CT nasal to the fovea in relationship to SFCT decreased with older age. CT was independent of lifestyle- associated parameters.	[Zhu, Dan; Wang, Yan; Zheng, Yan Fei; Yang, Da Yong; Guo, Kai; Yang, Xian Rong; Jing, Xin Xia] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Wong, Ian Y.] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China; [You, Qi Sheng; Jonas, Jost B.] Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China; [You, Qi Sheng] Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Tao, Yong] Capital Med Univ, Dept Ophthalmol, Beijing Chaoyang Hosp, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Inner Mongolia Medical University; University of Hong Kong; Capital Medical University; University of California System; University of California San Diego; Capital Medical University; Ruprecht Karls University Heidelberg	Zhu, D (corresponding author), Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China.; You, QS (corresponding author), Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing, Peoples R China.; You, QS (corresponding author), Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Ctr, La Jolla, CA 92093 USA.	zhudan1968@163.com; qishengbio@163.com	You, Qisheng/AAG-7153-2020	You, Qisheng/0000-0003-0743-7320; Tao, Yong/0000-0003-1443-2667	Program for National High Technology Research and Development Program of China [2015AA020949]; Beijing Nova Program [Z15111000030000]; Program for New Century Excellent Talents in University [NCET-12-0010]; Fok Ying-Tong Education Foundation [141038]; ICO-Retina Research Foundation Helmerich Fellowship, Beijing Talents Fund [2015000021223ZK22]; Chinese National Natural Science Foundation [81400422, GJZR15165]	Program for National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fok Ying-Tong Education Foundation(Fok Ying Tung Education Foundation); ICO-Retina Research Foundation Helmerich Fellowship, Beijing Talents Fund; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Program for National High Technology Research and Development Program of China (No. 2015AA020949), Beijing Nova Program (Z15111000030000), Program for New Century Excellent Talents in University (No: NCET-12-0010), the Fok Ying-Tong Education Foundation (No. 141038), ICO-Retina Research Foundation Helmerich Fellowship, Beijing Talents Fund (2015000021223ZK22) and the Chinese National Natural Science Foundation (No. 81400422, GJZR15165). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Bidaut-Garnier M, 2014, RETINA-J RET VIT DIS, V34, P768, DOI 10.1097/IAE.0b013e3182a487a4; Cao XS, 2014, RETINA-J RET VIT DIS, V34, P1554, DOI 10.1097/IAE.0000000000000122; Cao XS, 2014, OPHTHALMOLOGICA, V231, P221, DOI 10.1159/000357114; Chhablani JK, 2015, INDIAN J OPHTHALMOL, V63, P474, DOI 10.4103/0301-4738.162577; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Guo K, 2015, INVEST OPHTH VIS SCI, V56, P1769, DOI 10.1167/iovs.14-15737; Gupta P, 2015, AM J OPHTHALMOL, V159, P293, DOI 10.1016/j.ajo.2014.10.034; He L, 2014, VISION RES, V102, P52, DOI 10.1016/j.visres.2014.07.005; He L, 2014, EXP EYE RES, V123, P56, DOI 10.1016/j.exer.2014.04.005; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Herrera L, 2015, RETINA; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Jonas JB, 2016, GRAEFES ARC IN PRESS; Jonas JB, 2015, J GLAUCOMA, V24, P619, DOI 10.1097/IJG.0000000000000063; Jonas JB, 2014, RETINA-J RET VIT DIS, V34, P1149, DOI 10.1097/IAE.0000000000000035; Jonas JB, 2014, INVEST OPHTH VIS SCI, V55, P1292, DOI 10.1167/iovs.13-13351; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2016, OPHTHALMOLOGY, V123, P220, DOI 10.1016/j.ophtha.2015.06.020; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Kim YT, 2011, EYE, V25, P1635, DOI 10.1038/eye.2011.258; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Lee Jung Wook, 2016, Korean J Ophthalmol, V30, P32, DOI 10.3341/kjo.2016.30.1.32; Li XQ, 2014, INVEST OPHTH VIS SCI, V55, P550, DOI 10.1167/iovs.13-13476; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Mapelli C, 2013, INVEST OPHTH VIS SCI, V54, P6841, DOI 10.1167/iovs.13-12761; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Nagasawa T, 2013, INVEST OPHTH VIS SCI, V54, P7068, DOI 10.1167/iovs.13-12350; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Park KA, 2013, RETINA-J RET VIT DIS, V33, P1971, DOI 10.1097/IAE.0b013e3182923477; Read SA, 2015, INVEST OPHTH VIS SCI, V56, P3103, DOI 10.1167/iovs.15-16446; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P7578, DOI 10.1167/iovs.13-12772; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P3586, DOI 10.1167/iovs.13-11732; Ruiz-Moreno JM, 2013, INVEST OPHTH VIS SCI, V54, P353, DOI 10.1167/iovs.12-10863; Sanchez-Cano A, 2014, AM J OPHTHALMOL, V158, P574, DOI 10.1016/j.ajo.2014.05.035; Schuster AK, 2014, AM J OPHTHALMOL, V158, P1342, DOI 10.1016/j.ajo.2014.09.008; Shao L, 2014, AM J OPHTHALMOL, V158, P702, DOI 10.1016/j.ajo.2014.05.023; Shen L, 2016, RETINA; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Sullivan-Mee M, 2015, AM J OPHTHALMOL, V160, P637, DOI 10.1016/j.ajo.2015.06.024; Summers JA, 2013, EXP EYE RES, V114, P120, DOI 10.1016/j.exer.2013.03.008; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang YX, 2016, BR J OPHTHA IN PRESS; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yang DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109355; Zengin MO, 2014, EYE, V28, P1482, DOI 10.1038/eye.2014.227; Zhang JM, 2015, INVEST OPHTH VIS SCI, V56, P7646, DOI 10.1167/iovs.15-17137	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179579	10.1371/journal.pone.0179579	http://dx.doi.org/10.1371/journal.pone.0179579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617854	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600048
J	Urbani, L; Maghsoudlou, P; Milan, A; Menikou, M; Hagen, CK; Totonelli, G; Camilli, C; Eaton, S; Burns, A; Olivo, A; De Coppi, P				Urbani, Luca; Maghsoudlou, Panagiotis; Milan, Anna; Menikou, Maria; Hagen, Charlotte Klara; Totonelli, Giorgia; Camilli, Carlotta; Eaton, Simon; Burns, Alan; Olivo, Alessandro; De Coppi, Paolo			Long-term cryopreservation of decellularised oesophagi for tissue engineering clinical application	PLOS ONE			English	Article							DETERGENT ENZYMATIC TREATMENT; EXTRACELLULAR-MATRIX; TRACHEAL REPLACEMENT; ACELLULAR MATRIX; REGENERATION; PRESERVATION; SCAFFOLD; LUNG; STORAGE; KIDNEY	Oesophageal tissue engineering is a therapeutic alternative when oesophageal replacement is required. Decellularised scaffolds are ideal as they are derived from tissue-specific extracellular matrix and are non-immunogenic. However, appropriate preservation may significantly affect scaffold behaviour. Here we aim to prove that an effective method for shorta- and long-term preservation can be applied to tissue engineered products allowing their translation to clinical application. Rabbit oesophagi were decellularised using the detergent-enzymatic treatment (DET), a combination of deionised water, sodium deoxycholate and DNase-I. Samples were stored in phosphate-buffered saline solution at 4 degrees C (4 degrees C) or slow cooled in medium with 10% Me2SO at - 1 degrees C/min followed by storage in liquid nitrogen (SCM). Structural and functional analyses were performed prior to and after 2 and 4 weeks and 3 and 6 months of storage under each condition. Efficient decellularisation was achieved after 2 cycles of DET as determined with histology and DNA quantification, with preservation of the ECM. Only the SCM method, commonly used for cell storage, maintained the architecture and biomechanical properties of the scaffold up to 6 months. On the contrary, 4 degrees C method was effective for short-term storage but led to a progressive distortion and degradation of the tissue architecture at the following time points. Efficient storage allows a timely use of decellularised oesophagi, essential for clinical translation. Here we describe that slow cooling with cryoprotectant solution in liquid nitrogen vapour leads to reliable long-term storage of decellularised oesophageal scaffolds for tissue engineering purposes.	[Urbani, Luca; Maghsoudlou, Panagiotis; Milan, Anna; Menikou, Maria; Totonelli, Giorgia; Camilli, Carlotta; Eaton, Simon; Burns, Alan; De Coppi, Paolo] UCL, Great Ormond St Inst Child Hlth, London, England; [Hagen, Charlotte Klara; Olivo, Alessandro] UCL, Dept Med Phys & Biomed Engn, London, England; [Burns, Alan] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	University of London; University College London; University of London; University College London; Erasmus University Rotterdam; Erasmus MC	Urbani, L; De Coppi, P (corresponding author), UCL, Great Ormond St Inst Child Hlth, London, England.	l.urbani@ucl.ac.uk; p.decoppi@ucl.ac.uk	Totonelli, Giorgia/AAH-9253-2019; Burns, Alan J/C-4988-2008; Camilli, Carlotta/AAB-6827-2022; Burns, Alan/AAC-1266-2022; Eaton, Simon/C-4942-2008; Camilli, Carlotta/AAB-4888-2022	Camilli, Carlotta/0000-0002-4858-336X; Eaton, Simon/0000-0003-0892-9204; Camilli, Carlotta/0000-0002-4858-336X; Milan, Anna/0000-0003-3397-6563; Urbani, Luca/0000-0002-4988-552X; Maghsoudlou, Panagiotis/0000-0002-9945-3901; Burns, Alan/0000-0002-1725-1071; De Coppi, Paolo/0000-0002-1659-0207; Olivo, Alessandro/0000-0002-7150-2951	OAK Foundation [OCAY-14-191]; GOSHCC [V0615, V1282]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London [RP-2014-04-046]; EPSRC [EP/I021884/1, EP/L001381/1]; Engineering and Physical Sciences Research Council [EP/I021884/1, EP/L001381/1] Funding Source: researchfish; National Institute for Health Research [RP_2014-04-046] Funding Source: researchfish	OAK Foundation; GOSHCC; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the OAK Foundation (grant number OCAY-14-191) and the GOSHCC (grant ref. V0615 and V1282) and supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (RP-2014-04-046). AO and CKH are funded by the EPSRC (grants EP/I021884/1 and EP/L001381/1). The authors are grateful to the personnel of beamline ID17 at the European Synchrotron Radiation Facility for their help in setting up and running the synchrotron experiment.	Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Baiguera S, 2012, BIOMATERIALS, V33, P3662, DOI 10.1016/j.biomaterials.2012.01.064; Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005; Bakhach J, 2009, ORGANOGENESIS, V5, P119, DOI 10.4161/org.5.3.9583; Balestrini JL, 2016, TISSUE ENG PART C-ME, V22, P260, DOI [10.1089/ten.TEC.2015.0449, 10.1089/ten.tec.2015.0449]; Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033; Bonenfant NR, 2013, BIOMATERIALS, V34, P3231, DOI 10.1016/j.biomaterials.2013.01.031; Brockbank KGM, 2012, CELL TISSUE BANK, V13, P663, DOI 10.1007/s10561-011-9288-7; Brockbank KGM, 2011, ANN THORAC SURG, V91, P1829, DOI 10.1016/j.athoracsur.2011.02.043; Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110; Gallo M, 2016, HEART VESSELS, V31, P1862, DOI 10.1007/s00380-016-0839-5; Hagen CK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18156; Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318; Jungebluth P, 2009, J THORAC CARDIOV SUR, V138, P586, DOI 10.1016/j.jtcvs.2008.09.085; Luc G, 2014, EXPERT REV MED DEVIC, V11, P225, DOI 10.1586/17434440.2014.870470; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Maghsoudlou P, 2013, JOVE-J VIS EXP, V7, P80; Maghsoudlou P, 2013, BIOMATERIALS, V34, P6638, DOI 10.1016/j.biomaterials.2013.05.015; Mansbridge J, 2006, J ANAT, V209, P527, DOI 10.1111/j.1469-7580.2006.00631.x; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Piccoli M, 2016, BIOMATERIALS, V74, P245, DOI 10.1016/j.biomaterials.2015.10.005; POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0; Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9; Ross EA, 2012, ORGANOGENESIS, V8, P49, DOI 10.4161/org.20209; Schenke-Layland K, 2006, ANN THORAC SURG, V81, P918, DOI 10.1016/j.athoracsur.2005.09.016; Schenke-Layland K, 2007, ANN THORAC SURG, V83, P1641, DOI 10.1016/j.athoracsur.2006.12.005; Schuurman HJ, 2015, INT J SURG, V23, P312, DOI 10.1016/j.ijsu.2015.09.051; Shojaie S, 2015, STEM CELL REP, V4, P419, DOI 10.1016/j.stemcr.2015.01.004; Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546; Spitz L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-24; Totonelli G, 2013, PEDIATR SURG INT, V29, P87, DOI 10.1007/s00383-012-3194-3; Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012; Zani A, 2009, SEMIN PEDIATR SURG, V18, P57, DOI 10.1053/j.sempedsurg.2008.10.011	37	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179341	10.1371/journal.pone.0179341	http://dx.doi.org/10.1371/journal.pone.0179341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599006	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000033
J	Volk-Draper, LD; Hall, KL; Wilber, AC; Ran, S				Volk-Draper, Lisa D.; Hall, Kelly L.; Wilber, Andrew C.; Ran, Sophia			Lymphatic endothelial progenitors originate from plastic myeloid cells activated by toll-like receptor-4	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR-C; BONE-MARROW; STEM-CELLS; TUMOR LYMPHANGIOGENESIS; CYTOKINE PRODUCTION; NODE METASTASIS; PRECURSOR CELLS; BREAST-CANCER; CRUCIAL ROLE	Background Myeloid-derived lymphatic endothelial cells (M-LECP) are induced by inflammation and play an important role in adult lymphangiogenesis. However, the mechanisms driving M-LECP differentiation are currently unclear. We previously showed that activation of Toll-like receptor-4 (TLR4) induces myeloid-lymphatic transition (MLT) of immortalized mouse myeloid cells. Here the goals were to assess the potential of different TLR4 ligands to induce prolymphatic reprogramming in human and mouse primary myeloid cells and to identify transcriptional changes regulating this process. Methodology/Principal findings Human and mouse myeloid cells were reprogrammed to the lymphatic phenotype by TLR4 ligands including lipopolysaccharide (LPS), recombinant high mobility group box 1 protein (HMGB1), and paclitaxel. TLR4 induced similar MLT in cells from mice of different strains and immune status. Commonly induced genes were detected by transcriptional profiling in human and mouse myeloid cells from either immunocompetent or immunodeficient mice. Shared trends included: (1) novel expression of lymphatic-specific markers vascular endothelial growth factor receptor-3 (VEGFR-3), lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) and podoplanin (PDPN) largely absent prior to induction; (2) lack of notable changes in blood vessel-specific markers; (3) transient expression of VEGFR-3, but sustained increase of vascular endothelial growth factor-C (VEGF-C) and a variety of inflammatory cytokines; (4) dependency of VEGFR-3 upregulation and other LEC genes on NF-kappa B; and (5) novel expression of lymphatic-specific (e.g., PROX1) and stem/progenitor (e.g., E2F1) transcription factors known for their roles in adult and embryonic vascular formation. M-LECP generated by TLR4 ligands in vitro were functional in vivo as demonstrated by significantly increased lymphatic vessel density and lymphatic metastasis detected in orthotopic breast cancer models. Conclusions/Significance We established a novel TLR4-dependent protocol for in vitro production of functionally competent M-LECP from primary human or mouse myeloid cells and identified many potential regulators of this process. This information can be further exploited for research and therapeutic purposes.	[Volk-Draper, Lisa D.; Hall, Kelly L.; Wilber, Andrew C.; Ran, Sophia] Southern Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Carbondale, IL 62901 USA; [Wilber, Andrew C.; Ran, Sophia] Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62901 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University	Ran, S (corresponding author), Southern Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Carbondale, IL 62901 USA.; Ran, S (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62901 USA.	sran@siumed.edu	Wilber, Andrew/I-9259-2019	Wilber, Andrew/0000-0002-8457-599X; Ran, Sophia/0000-0003-3958-6099	National Institute of Health [5R01CA140732, 1R01CA199649-01A1]; Illinois William E. McElroy Charitable Foundation; Simmons Cancer Institute at Southern Illinois University School of Medicine, Illinois, USA; NATIONAL CANCER INSTITUTE [R01CA140732, R01CA199649] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois William E. McElroy Charitable Foundation; Simmons Cancer Institute at Southern Illinois University School of Medicine, Illinois, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants numbers 5R01CA140732, 1R01CA199649-01A1 from National Institute of Health and by awards from the Illinois William E. McElroy Charitable Foundation and the Simmons Cancer Institute at Southern Illinois University School of Medicine, Illinois, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2002, GROWTH FACTORS, V20, P99, DOI 10.1080/08977190290031969; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Alphonse RS, 2015, NAT PROTOC, V10, P1697, DOI 10.1038/nprot.2015.107; Alunno A, 2016, J CELL MOL MED, V20, P613, DOI 10.1111/jcmm.12793; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Bogos K, 2009, CLIN CANCER RES, V15, P1741, DOI 10.1158/1078-0432.CCR-08-1372; Bork PM, 1997, FEBS LETT, V402, P85, DOI 10.1016/S0014-5793(96)01502-5; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Changming W, 2011, LYMPHOLOGY, V44, P48; Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Ding MX, 2012, MOL MED REP, V6, P1023, DOI 10.3892/mmr.2012.1043; Finnin M, 1999, J LEUKOCYTE BIOL, V66, P953, DOI 10.1002/jlb.66.6.953; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Han LP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2641248; He YL, 2004, CANCER RES, V64, P3737, DOI 10.1158/0008-5472.CAN-04-0088; Hur J, 2014, MOL THER, V22, P1518, DOI 10.1038/mt.2014.61; Jang BC, 2006, INT J ONCOL, V29, P1509; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jiang SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003812; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Karpanen T, 2001, CANCER RES, V61, P1786; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kesler CT, 2013, WIRES SYST BIOL MED, V5, P111, DOI 10.1002/wsbm.1201; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lee JY, 2010, CIRCULATION, V122, P1413, DOI 10.1161/CIRCULATIONAHA.110.941468; Lee SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11019; Li Y, 2015, J INT MED RES, V43, P494, DOI 10.1177/0300060515581671; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Munoz C, 1996, BLOOD, V88, P3482, DOI 10.1182/blood.V88.9.3482.bloodjournal8893482; Nguyen VA, 2009, J CELL MOL MED, V13, P522, DOI 10.1111/j.1582-4934.2008.00340.x; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu HL, 2013, J OBSTET GYNAECOL RE, V39, P1268, DOI 10.1111/jog.12047; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Ran Sophia, 2012, Cancers (Basel), V4, P618, DOI 10.3390/cancers4030618; Ran Sophia, 2010, Pathophysiology, V17, P229, DOI 10.1016/j.pathophys.2009.11.003; Religa P, 2005, BLOOD, V106, P4184, DOI 10.1182/blood-2005-01-0226; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Stec M, 2012, ANTICANCER RES, V32, P4749; Suzuki H, 2005, BLOOD, V105, P2372, DOI 10.1182/blood-2004-07-2547; Tan YZ, 2014, J CELL MOL MED, V18, P422, DOI 10.1111/jcmm.12233; Tawada M, 2014, ONCOL REP, V32, P2359, DOI 10.3892/or.2014.3499; Tawada M, 2012, J GASTROENTEROL, V47, P1057, DOI 10.1007/s00535-012-0638-4; van't Hull EF, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29080; Volk LD, 2011, NEOPLASIA, V13, P327, DOI 10.1593/neo.101490; Volk-Draper L, 2014, CANCER RES, V74, P5421, DOI 10.1158/0008-5472.CAN-14-0067; Yang Y, 2015, CELL REPROGRAM, V17, P69, DOI 10.1089/cell.2014.0043; Zampell J, 2011, AM J PHYSIOL-CELL PH, V4, P709; Zumsteg A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006494; Zumsteg A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007067	60	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179257	10.1371/journal.pone.0179257	http://dx.doi.org/10.1371/journal.pone.0179257			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598999	gold, Green Submitted, Green Published			2022-12-26	WOS:000402992000032
J	Feng, SF; Shi, TY; Qiu, JX; Yang, HH; Wu, Y; Zhou, WX; Wang, W; Wu, HT				Feng, Shufang; Shi, Tianyao; Qiu, Jiangxia; Yang, Haihong; Wu, Yan; Zhou, Wenxia; Wang, Wei; Wu, Haitao			Notch1 deficiency in postnatal neural progenitor cells in the dentate gyrus leads to emotional and cognitive impairment	FASEB JOURNAL			English	Article						adult neurogenesis; anxiety; synaptic transmission; pCREB	ADULT HIPPOCAMPAL NEUROGENESIS; ELEMENT-BINDING PROTEIN; PATTERN SEPARATION; SYNAPTIC PLASTICITY; STEM-CELLS; FATE SPECIFICATION; NEURONS; CA3; MAINTENANCE; BRAIN	It is well known that Notch1 signaling plays a crucial role in embryonic neural development and adult neurogenesis. The latest evidence shows that Notch1 also plays a critical role in synaptic plasticity in mature hippocampal neurons. So far, deeper insights into the function of Notch1 signaling during the different steps of adult neurogenesis are still lacking, and the mechanisms by which Notch1 dysfunction is associated with brain disorders are also poorly understood. In the current study, we found that Notch1 was highly expressed in the adult-born immature neurons in the hippocampal dentate gyrus. Using a genetic approach to selectively ablate Notch1 signaling in late immature precursors in the postnatal hippocampus by cross-breeding doublecortin (DCX)(+) neuron-specific proopiomelanocortin (POMC)-alpha Cre mice with floxed Notch1 mice, we demonstrated a previously unreported pivotal role of Notch1 signaling in survival and function of adult newborn neurons in the dentate gyrus. Moreover, behavioral and functional studies demonstrated that POMC-Notch1(-/-) mutant mice showed anxiety and depressive-like behavior with impaired synaptic transmission properties in the dentate gyrus. Finally, our mechanistic study showed significantly compromised phosphorylation of cAMP response element-binding protein (CREB) in Notch1 mutants, suggesting that the dysfunction of Notch1 mutants is associated with the disrupted pCREB signaling in postnatally generated immature neurons in the dentate gyrus.-Feng, S., Shi, T., Qiu, J., Yang, H., Wu, Y., Zhou, W., Wang, W., Wu, H. Notch1 deficiency in postnatal neural progenitor cells in the dentate gyrus leads to emotional and cognitive impairment.	[Feng, Shufang; Qiu, Jiangxia; Yang, Haihong; Wu, Yan; Wu, Haitao] Beijing Inst Basic Med Sci, Dept Neurobiol, Taiping Rd 27, Beijing 100850, Peoples R China; [Shi, Tianyao; Zhou, Wenxia] Beijing Inst Pharmacol & Toxicol, Dept Tradit Chinese Med TCM & Neuroimmunopharmaco, Beijing, Peoples R China; [Wang, Wei] Jinzhou Med Univ, Affiliated Hosp 1, Dept Orthoped, Res Inst, Jinzhou, Peoples R China; [Wu, Haitao] Nantong Univ, Coinnovat Ctr Neuroregenerat, Key Lab Neuroregenerat, Nantong, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Jinzhou Medical University; Nantong University	Wu, HT (corresponding author), Beijing Inst Basic Med Sci, Dept Neurobiol, Taiping Rd 27, Beijing 100850, Peoples R China.	wuht@bmi.ac.cn	Wu, Haitao/AAK-4389-2020	Wu, Haitao/0000-0001-8437-3194; Zhou, Wenxia/0000-0002-6175-4821	Program 973, from State Key Development Program for Basic Research of China [2014CB542203]; National Natural Science Foundation of China [31371149, 31522029]; Beijing Municipal Science and Technology Commission [Z161100000216154]	Program 973, from State Key Development Program for Basic Research of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	The authors thank all of the members of the H.W. laboratory for their encouragement and discussions. This work was supported, in part, by Program 973, Grant 2014CB542203, from the State Key Development Program for Basic Research of China (to H.W.), National Natural Science Foundation of China Grants 31371149 and 31522029 (to H.W.), and Grant Z161100000216154 Beijing Municipal Science and Technology Commission (to H.W.) The authors declare no conflicts of interest.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Aguilar-Arredondo A, 2015, REV NEUROSCIENCE, V26, P269, DOI 10.1515/revneuro-2014-0071; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Aujla PK, 2013, DEVELOPMENT, V140, P3511, DOI 10.1242/dev.098681; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bazelot M, 2012, EUR J NEUROSCI, V35, P244, DOI 10.1111/j.1460-9568.2011.07962.x; Brandt MD, 2010, EUR J NEUROSCI, V32, P1256, DOI 10.1111/j.1460-9568.2010.07410.x; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Corbo JC, 2002, J NEUROSCI, V22, P7548; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Eisch AJ, 2008, J NEUROSCI, V28, P11785, DOI 10.1523/JNEUROSCI.3798-08.2008; Feng SF, 2012, BEHAV BRAIN RES, V232, P245, DOI 10.1016/j.bbr.2012.04.019; Ferrari-Toninelli G, 2009, DEV NEUROBIOL, V69, P378, DOI 10.1002/dneu.20710; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Germain J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074992; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Kappeler C, 2007, J COMP NEUROL, V500, P239, DOI 10.1002/cne.21170; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2007, LEARN MEMORY, V14, P745, DOI 10.1101/lm.703907; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; OKA C, 1995, DEVELOPMENT, V121, P3291; Ortega-Perez I, 2007, J MOL HISTOL, V38, P555, DOI 10.1007/s10735-007-9114-5; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Platel JC, 2010, BRAIN RES REV, V63, P60, DOI 10.1016/j.brainresrev.2010.02.004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Spampanato J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041029; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wu HT, 2012, NEURON, V75, P94, DOI 10.1016/j.neuron.2012.04.033; Zhang JB, 2013, J NEUROSCI, V33, P12825, DOI 10.1523/JNEUROSCI.0783-13.2013; Zhang K, 2014, NEUROBIOL DIS, V64, P66, DOI 10.1016/j.nbd.2013.12.010; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	64	9	9	3	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4347	4358		10.1096/fj.201700216RR	http://dx.doi.org/10.1096/fj.201700216RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28611114				2022-12-26	WOS:000413397400014
J	Jorge-Finnigan, A; Kleppe, R; Jung-KC, K; Ying, M; Marie, M; Rios-Mondragon, I; Salvatore, MF; Saraste, J; Martinez, A				Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Ying, Ming; Marie, Michael; Rios-Mondragon, Ivan; Salvatore, Michael F.; Saraste, Jaakko; Martinez, Aurora			Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; dopamine; Parkinson disease; phosphorylation; vesicles; axonal transport; tyrosine hydroxylase phosphorylated at Ser-31; tyrosine hydroxylase	VESICULAR MONOAMINE TRANSPORTER-2; SITE-SPECIFIC PHOSPHORYLATION; CHAPERONE HSC70 INTERACTS; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AXONAL-TRANSPORT; IN-SITU; CATECHOLAMINE BIOSYNTHESIS; GOLGI FRAGMENTATION; SYNAPTIC VESICLES	Tyrosine hydroxylase (TH) catalyzes the conversion of l-tyrosine into l-DOPA, which is the rate-limiting step in the synthesis of catecholamines, such as dopamine, in dopaminergergic neurons. Low dopamine levels and death of the dopaminergic neurons are hallmarks of Parkinson's disease (PD), where -synuclein is also a key player. TH is highly regulated, notably by phosphorylation of several Ser/Thr residues in the N-terminal tail. However, the functional role of TH phosphorylation at the Ser-31 site (THSer(P)-31) remains unclear. Here, we report that THSer(P)-31 co-distributes with the Golgi complex and synaptic-like vesicles in rat and human dopaminergic cells. We also found that the TH microsomal fraction content decreases after inhibition of cyclin-dependent kinase 5 (Cdk5) and ERK1/2. The cellular distribution of an overexpressed phospho-null mutant, TH1-S31A, was restricted to the soma of neuroblastoma cells, with decreased association with the microsomal fraction, whereas a phospho-mimic mutant, TH1-S31E, was distributed throughout the soma and neurites. TH1-S31E associated with vesicular monoamine transporter 2 (VMAT2) and -synuclein in neuroblastoma cells, and endogenous THSer(P)-31 was detected in VMAT2- and -synuclein-immunoprecipitated mouse brain samples. Microtubule disruption or co-transfection with -synuclein A53T, a PD-associated mutation, caused TH1-S31E accumulation in the cell soma. Our results indicate that Ser-31 phosphorylation may regulate TH subcellular localization by enabling its transport along microtubules, notably toward the projection terminals. These findings disclose a new mechanism of TH regulation by phosphorylation and reveal its interaction with key players in PD, opening up new research avenues for better understanding dopamine synthesis in physiological and pathological states.	[Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Ying, Ming; Rios-Mondragon, Ivan; Saraste, Jaakko; Martinez, Aurora] Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Jorge-Finnigan, Ana; Kleppe, Rune; Jung-KC, Kunwar; Martinez, Aurora] KG Jebsen Ctr Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway; [Marie, Michael] Univ Bergen, Dept Mol Biol, Thormohlensgaten 55, N-5020 Bergen, Norway; [Salvatore, Michael F.] Univ North Texas, Hlth Sci Ctr, Inst Hlth Aging, Ft Worth, TX 76107 USA	University of Bergen; University of Bergen; University of North Texas System; University of North Texas Denton	Jorge-Finnigan, A (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.; Jorge-Finnigan, A (corresponding author), KG Jebsen Ctr Neuropsychiat Disorders, Jonas Lies Vei 91, N-5009 Bergen, Norway.	ana.jorge-finnigan@uib.no	Martinez, Aurora/M-3088-2019; Salvatore, Michael/ABC-8926-2021	Martinez, Aurora/0000-0003-1643-6506; Kleppe, Rune/0000-0002-6086-755X; K C, Kunwar Jung/0000-0002-6745-7318	Research Council of Norway [FRIMEDBIO 214012]; K. G. Jebsen Foundation; Norwegian Research Council [Yggdrasil 210731]; Fundacion Ramon Areces; Helse Vest; European Union Marie Curie IF Program [PIEF-GA-2011-299972]	Research Council of Norway(Research Council of Norway); K. G. Jebsen Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Fundacion Ramon Areces; Helse Vest; European Union Marie Curie IF Program	This work was supported by Research Council of Norway Grant FRIMEDBIO 214012 and the K. G. Jebsen Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Norwegian Research Council (Yggdrasil 210731), Fundacion Ramon Areces, Helse Vest, and European Union Marie Curie IF Program Grant PIEF-GA-2011-299972. To whom correspondence should be addressed. E-mail: ana. jorge-finnigan@uib.no.	Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Alter SP, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0362-3; Alvarez D, 2003, BIOCHEMISTRY-US, V42, P7205, DOI 10.1021/bi027343p; Bellucci A, 2012, BRAIN RES, V1476, P183, DOI 10.1016/j.brainres.2012.04.014; BRIMIJOIN S, 1977, BRAIN RES, V121, P77, DOI 10.1016/0006-8993(77)90439-5; Buddhala C, 2009, NEUROCHEM INT, V55, P9, DOI 10.1016/j.neuint.2009.01.020; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Dobransky T, 2005, J NEUROCHEM, V95, P305, DOI 10.1111/j.1471-4159.2005.03367.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Encalada SE, 2014, ANNU REV BIOPHYS, V43, P141, DOI 10.1146/annurev-biophys-051013-022746; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Gervasi NM, 2016, RNA, V22, P883, DOI 10.1261/rna.053272.115; Gottle M, 2013, J NEUROCHEM, V127, P805, DOI 10.1111/jnc.12366; Gondre-Lewis MC, 2012, INT REV CEL MOL BIO, V299, P27, DOI 10.1016/B978-0-12-394310-1.00002-3; Gordon SL, 2009, BBA-MOL CELL RES, V1793, P1860, DOI 10.1016/j.bbamcr.2009.10.001; Groblewski PA, 2011, BEHAV BRAIN RES, V217, P399, DOI 10.1016/j.bbr.2010.11.018; Guo JT, 2008, CELL MOL NEUROBIOL, V28, P35, DOI 10.1007/s10571-007-9227-0; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Harada K, 1996, J NEUROCHEM, V67, P629; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Haycock JW, 2002, J NEUROCHEM, V81, P947, DOI 10.1046/j.1471-4159.2002.00881.x; HAYCOCK JW, 1992, P NATL ACAD SCI USA, V89, P2365, DOI 10.1073/pnas.89.6.2365; ICHIKAWA S, 1990, BIOCHEM BIOPH RES CO, V173, P1331, DOI 10.1016/S0006-291X(05)80933-7; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Koch JC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.169; KOIKE T, 1984, J NEUROCHEM, V42, P1472, DOI 10.1111/j.1471-4159.1984.tb02812.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korner G, 2015, BRAIN, V138, P2948, DOI 10.1093/brain/awv224; KUCZENSKI RT, 1972, J BIOL CHEM, V247, P3114; Kurian MA, 2011, LANCET NEUROL, V10, P721, DOI 10.1016/S1474-4422(11)70141-7; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Lohr KM, 2014, P NATL ACAD SCI USA, V111, P9977, DOI 10.1073/pnas.1402134111; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Miranda-Barrientos J, 2014, ASN NEURO, V6, DOI 10.1042/AN20140006; MITCHELL JP, 1990, J BIOL CHEM, V265, P22358; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Nakagomi S, 2008, NEUROBIOL DIS, V29, P221, DOI 10.1016/j.nbd.2007.08.015; Nakashima A, 2011, BIOCHEM BIOPH RES CO, V407, P343, DOI 10.1016/j.bbrc.2011.03.020; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Parra LA, 2016, J BIOL CHEM, V291, P17510, DOI 10.1074/jbc.M116.728782; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pifl C, 2014, J NEUROSCI, V34, P8210, DOI 10.1523/JNEUROSCI.5456-13.2014; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prado VF, 2013, BIOCHEM J, V450, P265, DOI 10.1042/BJ20121662; Requena DF, 2009, J NEUROCHEM, V110, P581, DOI 10.1111/j.1471-4159.2009.06135.x; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2014, J NEUROCHEM, V129, P548, DOI 10.1111/jnc.12652; Salvatore MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029867; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Sannerud Ragna, 2008, V457, P253, DOI 10.1007/978-1-59745-261-8_19; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Sun KH, 2008, MOL BIOL CELL, V19, P3052, DOI 10.1091/mbc.E07-11-1106; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; TERLAND O, 1980, BIOCHIM BIOPHYS ACTA, V597, P318, DOI 10.1016/0005-2736(80)90109-1; Trillo L, 2013, NEUROSCI BIOBEHAV R, V37, P1363, DOI 10.1016/j.neubiorev.2013.05.008; van Rijn RM, 2006, MOL PHARMACOL, V70, P604, DOI 10.1124/mol.105.020818; Wijemanne S, 2015, NAT REV NEUROL, V11, P414, DOI 10.1038/nrneurol.2015.86; Willemsen MA, 2010, BRAIN, V133, P1810, DOI 10.1093/brain/awq087; WOOTEN GF, 1973, J NEUROCHEM, V20, P1361, DOI 10.1111/j.1471-4159.1973.tb00248.x; Ying M, 2000, J CELL SCI, V113, P3623; Zatloukal B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096690	76	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14092	14107		10.1074/jbc.M116.762344	http://dx.doi.org/10.1074/jbc.M116.762344			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28637871	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000408439800016
J	Akerele, D; Ljolje, D; Talundzic, E; Udhayakumar, V; Lucchi, NW				Akerele, David; Ljolje, Dragan; Talundzic, Eldin; Udhayakumar, Venkatachalam; Lucchi, Naomi W.			Molecular diagnosis of Plasmodium ovale by photo-induced electron transfer fluorogenic primers: PET-PCR	PLOS ONE			English	Article							REAL-TIME PCR; WALLIKERI INFECTION; MALARIA; MICROSCOPY; FALCIPARUM; PARASITE; IDENTIFICATION; MALAYSIA; CURTISI; ASSAY	Accurate diagnosis of malaria infections continues to be challenging and elusive, especially in the detection of submicroscopic infections. Developing new malaria diagnostic tools that are sensitive enough to detect low-level infections, user friendly, cost effective and capable of performing large scale diagnosis, remains critical. We have designed novel self-quenching photo-induced electron transfer (PET) fluorogenic primers for the detection of P. ovale by real-time PCR. In our study, a total of 173 clinical samples, consisting of different malaria species, were utilized to test this novel PET-PCR primer. The sensitivity and specificity were calculated using nested-PCR as the reference test. The novel primer set demonstrated a sensitivity of 97.5% and a specificity of 99.2% (95% CI 85.2-99.8% and 95.2-99.9% respectively). Furthermore, the limit of detection for P. ovale was found to be 1 parasite/mu l. The PET-PCR assay is a new molecular diagnostic tool with comparable performance to other commonly used PCR methods. It is relatively easy to perform, and amiable to large scale malaria surveillance studies and malaria control and elimination programs. Further field validation of this novel primer will be helpful to ascertain the utility for large scale malaria screening programs.	[Akerele, David] Emory Med Ctr, Div Pediat Infect Dis, Atlanta, GA USA; [Ljolje, Dragan; Talundzic, Eldin] Atlanta Res & Educ Fdn, Decatur, GA USA; [Udhayakumar, Venkatachalam; Lucchi, Naomi W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Lucchi, NW (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA 30333 USA.	Nlucchi@cdc.gov		Lucchi, Naomi/0000-0001-8789-8041	Malaria Branch; CDC; Atlanta Research and Education Foundation (AREF)	Malaria Branch; CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Atlanta Research and Education Foundation (AREF)	We would like to thank the Malaria Branch, CDC, and the Atlanta Research and Education Foundation (AREF) for supporting this project and Dr. John W. Barnwell for proving critical samples used in this study. We would also like to thank Dr. Colin Sutherland and his lab team at London School of Hygiene and Tropical Medicine for providing us with our P. ovale curtisi and P. ovale wallikeri clinical samples.	Calderaro A, 2007, J CLIN MICROBIOL, V45, P1624, DOI 10.1128/JCM.02316-06; Calderaro A, 2008, DIAGN MICR INFEC DIS, V61, P434, DOI 10.1016/j.diagmicrobio.2008.03.016; Chaturvedi N, 2015, T ROY SOC TROP MED H, V109, P352, DOI 10.1093/trstmh/trv015; Chavatte JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0985-8; Cinquetti G, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-288; Cohen R, 2013, AM J TROP MED HYG, V89, P501, DOI 10.4269/ajtmh.12-0724; Collins WE, 2005, CLIN MICROBIOL REV, V18, P570, DOI 10.1128/CMR.18.3.570-581.2005; Diallo MA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1485-1; Erdman Laura K, 2008, Travel Med Infect Dis, V6, P82, DOI 10.1016/j.tmaid.2007.10.001; Fuehrer HP, 2012, J CLIN MICROBIOL, V50, P4100, DOI 10.1128/JCM.02180-12; Nguyen HV, 2012, AM J TROP MED HYG, V87, P989, DOI 10.4269/ajtmh.2012.12-0047; Houze S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-284; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Lau YL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-389; Lee EY, 1999, CLIN INFECT DIS, V29, P697, DOI 10.1086/598667; Liew JWK, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1070-z; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Luo W, 2005, J CLIN MICROBIOL, V43, P1851, DOI 10.1128/JCM.43.4.1851-1857.2005; LYSENKO AJ, 1969, B WORLD HEALTH ORGAN, V40, P383; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Miller RH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003469; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118; Oguike MC, 2011, INT J PARASITOL, V41, P677, DOI 10.1016/j.ijpara.2011.01.004; Rojo-Marcos G, 2014, EMERG INFECT DIS, V20, P409, DOI 10.3201/eid2003.130745; Snounou G, 1996, Methods Mol Biol, V50, P263; Talundzic E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-31; William T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002026; Win TT, 2004, EMERG INFECT DIS, V10, P1235, DOI 10.3201/eid1007.030411; Win TT, 2002, TROP MED INT HEALTH, V7, P231, DOI 10.1046/j.1365-3156.2002.00857.x; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, WORLD MAL REP 2015	32	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179178	10.1371/journal.pone.0179178	http://dx.doi.org/10.1371/journal.pone.0179178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640824	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800020
J	Chen, J; Guo, W; Dang, XQ; Huang, YK; Liu, FY; Meng, XZ; An, YY; Long, MX; Bao, JL; Zhou, ZY; Xiang, ZH; Pan, GQ				Chen, Jie; Guo, Wei; Dang, Xiaoqun; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing			Easy labeling of proliferative phase and sporogonic phase of microsporidia Nosema bombycis in host cells	PLOS ONE			English	Article							POLAR TUBE PROTEINS; SPORE WALL PROTEIN; EMERGENT PATHOGENS; IDENTIFICATION; LOCALIZATION; ADHERENCE; SAMPLES	Microsporidia are eukaryotic, unicellular parasites that have been studied for more than 150 years. These organisms are extraordinary in their ability to invade a wide range of hosts including vertebrates and invertebrates, such as human and commercially important animals. A lack of appropriate labeling methods has limited the research of the cell cycle and protein locations in intracellular stages. In this report, an easy fluorescent labeling method has been developed to mark the proliferative and sporogonic phases of microsporidia Nosema bombycis in host cells. Based on the presence of chitin, Calcofluor White M2R was used to label the sporogonic phase, while beta-tubulin antibody coupled with fluorescence secondary antibody were used to label the proliferative phase by immunofluorescence. This method is simple, efficient and can be used on both infected cells and tissue slices, providing a great potential application in microsporidia research.	[Chen, Jie; Guo, Wei; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Chen, Jie; Huang, Yukang; Liu, Fangyan; Meng, Xianzhi; An, Yaoyao; Long, Mengxian; Bao, Jialing; Zhou, Zeyang; Xiang, Zhonghuai; Pan, Guoqing] Minist Agr, Key Lab Sericultural Biol & Genet Breeding, Chongqing, Peoples R China; [Guo, Wei] Shandong Univ, State Key Lab Microbial Technol, Sch Life Sci, Jinan, Peoples R China; [Dang, Xiaoqun; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Shandong University; Chongqing Normal University	Pan, GQ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.; Pan, GQ (corresponding author), Minist Agr, Key Lab Sericultural Biol & Genet Breeding, Chongqing, Peoples R China.	gqpan@swu.edu.cn		Huang, Yukang/0000-0002-7108-8340	National Natural Science Foundation of China [31602012, 31470250, 31402138]; China Postdoctoral Science Foundation [2015M570763]; Fundamental Research Funds for the Central Universities [XDJK2015C004, XDJK2015A010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the grants from National Natural Science Foundation of China (No. 31602012, 31470250, 31402138); Project funded by China Postdoctoral Science Foundation (No. 2015M570763), and Fundamental Research Funds for the Central Universities (No. XDJK2015C004, XDJK2015A010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becnel JJ, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P521; Bouzahzah B, 2010, INFECT IMMUN, V78, P2745, DOI 10.1128/IAI.01205-09; Cali A, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P71; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chen J, 2013, PARASITOLOGY, V140, P1394, DOI 10.1017/S0031182013000875; Dang XQ, 2013, J INVERTEBR PATHOL, V112, P166, DOI 10.1016/j.jip.2012.10.009; Dubuffet A, 2013, APPL ENVIRON MICROB, V79, P385, DOI 10.1128/AEM.02699-12; Franzen C., 2008, OPEN PARASITOL J, V2, P1, DOI [10.2174/1874421400802010001, DOI 10.2174/1874421400802010001]; Graczyk TK, 2007, J CLIN MICROBIOL, V45, P1255, DOI 10.1128/JCM.01975-06; Green LC, 2000, J CLIN MICROBIOL, V38, P3811, DOI 10.1128/JCM.38.10.3811-3814.2000; Hazard EI, 1976, AGR TECHNICAL B, P104; Heinz E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004547; Kent ML, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P493; Lee SC, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P231; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108279; Li Z, 2012, EUKARYOT CELL, V11, P229, DOI 10.1128/EC.05127-11; Liu H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01459; Liu H, 2016, ACTA BIOCH BIOPH SIN, V48, P246, DOI 10.1093/abbs/gmv140; Liu R, 2012, HUBEI AGR SCI, V51, P1797; [刘仁华 LIU Renhua], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P53; LOM JII, 1963, ACTA PROTOZOOLOGICA, V1, P81; Luallen RJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005724; Moura H, 1997, ARCH PATHOL LAB MED, V121, P888; [潘国庆 Pan Guoqing], 2013, [蚕业科学, Acta Sericologica Sinica], V39, P310; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Peterson TS, 2011, DIS AQUAT ORGAN, V95, P175, DOI 10.3354/dao02346; Polonais V, 2013, FEMS MICROBIOL LETT, V346, P36, DOI 10.1111/1574-6968.12198; Qiu HaiHong, 2014, African Journal of Biotechnology, V13, P2459; Reinke AW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14023; Santiana M, 2016, J EUKARYOT MICROBIOL, V63, P318, DOI 10.1111/jeu.12281; Stentiford GD, 2016, TRENDS PARASITOL, V32, P336, DOI 10.1016/j.pt.2015.12.004; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; VANGOOL T, 1993, J CLIN PATHOL, V46, P694, DOI 10.1136/jcp.46.8.694; Vavra J, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P1; Wang Y, 2015, PARASITOLOGY, V142, P534, DOI 10.1017/S0031182014001565; Wu ZL, 2008, PROTEOMICS, V8, P2447, DOI 10.1002/pmic.200700584; Yang DL, 2015, INFECT IMMUN, V83, P1715, DOI 10.1128/IAI.03155-14; Yang DL, 2014, J PARASITOL, V100, P623, DOI 10.1645/13-286.1; Zhang X, 2009, AGR SCI TECHNOLOGY, V10, P164; Zhao WX, 2015, PARASITOLOGY, V142, P865, DOI 10.1017/S0031182015000190	42	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179618	10.1371/journal.pone.0179618	http://dx.doi.org/10.1371/journal.pone.0179618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640848	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800044
J	Wang, J; Wang, Q; Lu, DF; Zhou, FF; Wang, D; Feng, RL; Wang, K; Molday, R; Xie, J; Wen, TQ				Wang, Jiao; Wang, Qian; Lu, Dongfang; Zhou, Fangfang; Wang, Dong; Feng, Ruili; Wang, Kai; Molday, Robert; Xie, Jiang; Wen, Tieqiao			A biosystems approach to identify the molecular signaling mechanisms of TMEM30A during tumor migration	PLOS ONE			English	Article							CANCER-CELL INVASION; COLORECTAL-CANCER; DOWN-REGULATION; BREAST-CANCER; LUNG-CANCER; GTPASE AXIS; METASTASIS; ADHESION; NETWORK; CDC50A	Understanding the molecular mechanisms underlying cell migration, which plays an important role in tumor growth and progression, is critical for the development of novel tumor therapeutics. Overexpression of transmembrane protein 30A (TMEM30A) has been shown to initiate tumor cell migration, however, the molecular mechanisms through which this takes place have not yet been reported. Thus, we propose the integration of computational and experimental approaches by first predicting potential signaling networks regulated by TMEM30A using a) computational biology methods, b) our previous mass spectrometry results of the TMEM30A complex in mouse tissue, and c) a number of migration-related genes manually collected from the literature, and subsequently performing molecular biology experiments including the in vitro scratch assay and real-time quantitative polymerase chain reaction (qPCR) to validate the reliability of the predicted network. The results verify that the genes identified in the computational signaling network are indeed regulated by TMEM30A during cell migration, indicating the effectiveness of our proposed method and shedding light on the regulatory mechanisms underlying tumor migration, which facilitates the understanding of the molecular basis of tumor invasion.	[Wang, Jiao; Wang, Qian; Zhou, Fangfang; Wang, Dong; Feng, Ruili; Wen, Tieqiao] Shanghai Univ, Sch Life Sci, Lab Mol Neural Biol, Shanghai, Peoples R China; [Lu, Dongfang; Xie, Jiang] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China; [Wang, Kai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl, Shanghai, Peoples R China; [Molday, Robert] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Shanghai University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of British Columbia	Wen, TQ (corresponding author), Shanghai Univ, Sch Life Sci, Lab Mol Neural Biol, Shanghai, Peoples R China.; Xie, J (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.	jiangx@shu.edu.cn; wtq@shu.edu.cn		WANG, kai/0000-0002-6194-0480	National Natural Science Foundation of China [31500827]; Natural Science Foundation of Shanghai [14ZR1414400]; Young Eastern Scholar [QD2015033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Young Eastern Scholar	This work was sponsored by the National Natural Science Foundation of China (Grant Number 31500827), the Natural Science Foundation of Shanghai (Grant Number 14ZR1414400), and Young Eastern Scholar (Grant Number QD2015033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli G, 2017, BREAST, V31, P57, DOI 10.1016/j.breast.2016.10.004; Ahronian LG, 2016, ONCOGENE, V35, P4653, DOI 10.1038/onc.2016.2; Becker MS, 2016, ONCOTARGET, V7, P51908, DOI 10.18632/oncotarget.10188; Chikara S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-016-1512-3; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Devis L, 2017, J PATHOL, V241, P475, DOI 10.1002/path.4851; Fan JA, 2010, CANCER BIOTHER RADIO, V25, P521, DOI 10.1089/cbr.2010.0784; Folmer DE, 2012, J HISTOCHEM CYTOCHEM, V60, P205, DOI 10.1369/0022155411435705; Fujino Y, 2017, CANCER SCI, V108, P390, DOI 10.1111/cas.13152; He XQ, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0633-8; Indovina P, 2017, J CELL PHYSIOL, V232, P129, DOI 10.1002/jcp.25397; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Ji ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13291; Ji ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102798; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Khajah MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041847; Kikkawa Y, 2016, EXP CELL RES, V344, P76, DOI 10.1016/j.yexcr.2016.04.002; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Krakhmal NV, 2015, ACTA NATURAE, V7, P17, DOI 10.32607/20758251-2015-7-2-17-28; Li CL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2628-z; Li JJ, 2017, J BIOL CHEM, V292, P1112, DOI 10.1074/jbc.M116.750349; Li ZW, 2017, CELL DEATH DIFFER, V24, P59, DOI 10.1038/cdd.2016.95; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Miyoshi N, 2010, ONCOL REP, V23, P505, DOI 10.3892/or_00000662; Poulter NS, 2015, INT J BIOCHEM CELL B, V66, P69, DOI 10.1016/j.biocel.2015.07.008; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Schmid SL, 2010, MOL BIOL CELL, V21, P3818, DOI 10.1091/mbc.E10-05-0386; Schwickert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143993; Segal E, 2003, BIOINFORMATICS, V19, pi264, DOI 10.1093/bioinformatics/btg1037; Sun HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168907; te Boekhorst V, 2016, ADV CANCER RES, V132, P209, DOI 10.1016/bs.acr.2016.07.005; Tung KH, 2013, CANCER LETT, V331, P58, DOI 10.1016/j.canlet.2012.12.001; Vestergaard AL, 2015, FEBS LETT, V589, P3908, DOI 10.1016/j.febslet.2015.11.031; Wang J, 2013, J NEUROSCI RES, V91, P1394, DOI 10.1002/jnr.23261; Wang J, 2012, MOL BIOSYST, V8, P2916, DOI 10.1039/c2mb25147g; Wang K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-164; Wang KF, 2017, CANCER LETT, V394, P1, DOI 10.1016/j.canlet.2016.12.036; Wang WS, 2010, DIS ESOPHAGUS, V23, P512, DOI 10.1111/j.1442-2050.2009.01035.x; Zegers Mirjam M, 2014, Small GTPases, V5, pe28997, DOI 10.4161/sgtp.28997; Zhang DJ, 2017, INT J CANCER, V140, P2298, DOI 10.1002/ijc.30656; Zhang X, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0181-x; Zhao Xing-Ming, 2009, Journal of Bioinformatics and Computational Biology, V7, P309, DOI 10.1142/S0219720009004138; Zimmermann Miriam, 2013, Methods Mol Biol, V986, P227, DOI 10.1007/978-1-62703-311-4_15	43	1	1	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179900	10.1371/journal.pone.0179900	http://dx.doi.org/10.1371/journal.pone.0179900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640862	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800080
J	Fairhurst, MT; Scott, M; Deroy, O				Fairhurst, Merle T.; Scott, Minnie; Deroy, Ophelia			Voice over: Audio-visual congruency and content recall in the gallery setting	PLOS ONE			English	Article							TRIAL MULTISENSORY MEMORIES; SEMANTIC CONGRUENCY; SENSORY MODALITY; TERM-MEMORY; GENDER; FACES; INFORMATION; RECOGNITION; PERCEPTION; KNOWLEDGE	Experimental research has shown that pairs of stimuli which are congruent and assumed to 'go together' are recalled more effectively than an item presented in isolation. Will this multisensory memory benefit occur when stimuli are richer and longer, in an ecological setting? In the present study, we focused on an everyday situation of audio-visual learning and manipulated the relationship between audio guide tracks and viewed portraits in the galleries of the Tate Britain. By varying the gender and narrative style of the voice-over, we examined how the perceived congruency and assumed unity of the audio guide track with painted portraits affected subsequent recall. We show that tracks perceived as best matching the viewed portraits led to greater recall of both sensory and linguistic content. We provide the first evidence that manipulating crossmodal congruence and unity assumptions can effectively impact memory in a multisensory ecological setting, even in the absence of precise temporal alignment between sensory cues.	[Fairhurst, Merle T.; Deroy, Ophelia] Univ London, Sch Adv Study, Ctr Study Senses, London, England; [Fairhurst, Merle T.; Deroy, Ophelia] Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, Munich, Germany; [Scott, Minnie] Tate Leaning, London, England	University of London; University of London School of Advanced Study; University of Munich	Fairhurst, MT (corresponding author), Univ London, Sch Adv Study, Ctr Study Senses, London, England.; Fairhurst, MT (corresponding author), Ludwig Maximilians Univ Munchen, Munich Ctr Neurosci, Munich, Germany.	merle.fairhurst@gmail.com		Deroy, Ophelia/0000-0001-9431-3136	RTS-AHRC, within the Arts and Humanities Research Council 'Science in Culture' scheme [AH-L007053/1]; AHRC [AH/L007053/1] Funding Source: UKRI	RTS-AHRC, within the Arts and Humanities Research Council 'Science in Culture' scheme; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	MerleT. Fairhurst and Ophelia Derory are funded by the RTS-AHRC grant (AH-L007053/1), within the Arts and Humanities Research Council 'Science in Culture' scheme.	Altieri N, 2015, BRAIN TOPOGR, V28, P479, DOI 10.1007/s10548-013-0333-7; Blank H, 2011, J NEUROSCI, P31; Blank H, 2015, HUM BRAIN MAPP, V36, P324, DOI 10.1002/hbm.22631; Brieber D, 2015, ACTA PSYCHOL, V154, P36, DOI 10.1016/j.actpsy.2014.11.004; Bulthoff I, 2015, COGNITION, V137, P9, DOI 10.1016/j.cognition.2014.12.006; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Chan JS, 2013, MULTISENS RES BRILL, V26, P184; de Boisferon AH, 2015, INFANCY, V20, P661, DOI 10.1111/infa.12088; Deroy O., 2013, CONSCIOUS COGN, V22; Deroy O, 2016, MULTISENS RES, V29, P29, DOI 10.1163/22134808-00002488; Fernald GM, 1921, J EDUC RES, V4, P355, DOI 10.1080/00220671.1921.10879216; Flom R., 2013, INTEGRATING FACE AND, P71, DOI [https://doi.org/10.1007/978-1-4614-3585-3_4, DOI 10.1007/978-1-4614-3585-3_4]; Goolkasian P, 2005, AM J PSYCHOL, V118, P61; GREEN KP, 1991, PERCEPT PSYCHOPHYS, V50, P524, DOI 10.3758/BF03207536; Heikkila J, 2016, EXP BRAIN RES, V234, P1199, DOI 10.1007/s00221-015-4341-6; Hyde DC, 2011, DEV PSYCHOBIOL, V53, P359, DOI 10.1002/dev.20525; Imai M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116494; Joassin F, 2011, NEUROIMAGE, V54, P1654, DOI 10.1016/j.neuroimage.2010.08.073; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; Lachs L, 2004, ECOL PSYCHOL, V16, P159, DOI 10.1207/s15326969eco1603_1; Lee SG, 2016, IEEE T BIOMED ENG, V7486, P1, DOI DOI 10.1109/IEDM.2016.7838026; Lehmann S, 2005, COGNITIVE BRAIN RES, V24, P326, DOI 10.1016/j.cogbrainres.2005.02.005; Liu TT, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-4; Maria Montessori, 1912, MONTESSORI METHOD; Matusz PJ, 2015, EUR J NEUROSCI, V41, P699, DOI 10.1111/ejn.12804; Mavica LW, 2013, J EXP PSYCHOL HUMAN, V39, P307, DOI 10.1037/a0030945; McGettigan C, 2011, J COGNITIVE NEUROSCI, V23, P961, DOI 10.1162/jocn.2010.21491; Meyerhoff HS, 2016, MEM COGNITION, V44, P390, DOI 10.3758/s13421-015-0575-6; Moran ZD, 2013, MULTISENS RES, V26, P581, DOI 10.1163/22134808-00002436; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; Murray MM, 2005, NEUROIMAGE, V27, P473, DOI 10.1016/j.neuroimage.2005.04.016; Pa J, 2008, J COGNITIVE NEUROSCI, V20, P2198, DOI 10.1162/jocn.2008.20154; Papeo L, 2015, BRAIN LANG, V141, P135, DOI 10.1016/j.bandl.2014.11.011; Patterson ML, 2002, J EXP CHILD PSYCHOL, V81, P93, DOI 10.1006/jecp.2001.2644; Perrodin C, 2015, TRENDS COGN SCI, V19, P783, DOI 10.1016/j.tics.2015.09.002; POULINDUBOIS D, 1994, DEV PSYCHOL, V30, P436, DOI 10.1037/0012-1649.30.3.436; Quak M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00197; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; SPELKE ES, 1979, INFANT BEHAV DEV, V2, P13, DOI 10.1016/S0163-6383(79)80004-1; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Thelen A, 2015, COGNITION, V138, P148, DOI 10.1016/j.cognition.2015.02.003; Thelen A, 2013, MULTISENS RES, V26, P483, DOI 10.1163/22134808-00002426; THOMPSON VA, 1994, CAN J EXP PSYCHOL, V48, P380, DOI 10.1037/1196-1961.48.3.380; Vatakis A, 2007, PERCEPT PSYCHOPHYS, V69, P744, DOI 10.3758/BF03193776; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; WALKER S, 1995, PERCEPT PSYCHOPHYS, V57, P1124, DOI 10.3758/BF03208369; WALKER-ANDREWS A S, 1991, Ecological Psychology, V3, P55, DOI 10.1207/s15326969eco0302_1; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Yovel G, 2013, TRENDS COGN SCI, V17, P263, DOI 10.1016/j.tics.2013.04.004	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0177622	10.1371/journal.pone.0177622	http://dx.doi.org/10.1371/journal.pone.0177622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636667	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300004
J	Hadac, O; Muzika, F; Nevoral, V; Pribyl, M; Schreiber, I				Hadac, Otto; Muzika, Frantisek; Nevoral, Vladislav; Pribyl, Michal; Schreiber, Igor			Minimal oscillating subnetwork in the Huang-Ferrell model of the MAPK cascade	PLOS ONE			English	Article							COMPLEX ISOTHERMAL REACTORS; REACTION NETWORK STRUCTURE; PROTEIN-KINASE CASCADES; MULTISITE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; NEGATIVE FEEDBACK; DEFICIENCY-ONE; DYNAMICS; SYSTEMS; BISTABILITY	Prompted by the recent growing evidence of oscillatory behavior involving MAPK cascades we present a systematic approach of analyzing models and elucidating the nature of biochemical oscillations based on reaction network theory. In particular, we formulate a minimal biochemically consistent mass action subnetwork of the Huang-Ferrell model of the MAPK signalling that provides an oscillatory response when a parameter controlling the activation of the top-tier kinase is varied. Such dynamics are either intertwined with or separated from the earlier found bistable/hysteretic behavior in this model. Using the theory of stability of stoichiometric networks, we reduce the original MAPK model, convert kinetic to convex parameters and examine those properties of the minimal subnetwork that underlie the oscillatory dynamics. We also use the methods of classification of chemical oscillatory networks to explain the rhythmic behavior in physicochemical terms, i.e., we identify of the role of individual biochemical species in positive and negative feedback loops and describe their coordinated action leading to oscillations. Our approach provides an insight into dynamics without the necessity of knowing rate coefficients and thus is useful prior the statistical evaluation of parameters.	[Hadac, Otto; Muzika, Frantisek; Nevoral, Vladislav; Pribyl, Michal; Schreiber, Igor] Univ Chem & Technol, Dept Chem Engn, Prague, Czech Republic	University of Chemistry & Technology, Prague	Schreiber, I (corresponding author), Univ Chem & Technol, Dept Chem Engn, Prague, Czech Republic.	Igor.Schreiber@vscht.cz	Schreiber, Igor/A-3951-2012; Pribyl, Michal/AAR-2146-2020; Nevoral, Vladislav/AAA-6724-2021	Nevoral, Vladislav/0000-0002-8017-8524; Schreiber, Igor/0000-0001-6482-2722	Ministry of Education, Youth and Sports, Czech Republic [KONTAKT II LH14009]	Ministry of Education, Youth and Sports, Czech Republic(Ministry of Education, Youth & Sports - Czech RepublicCzech Republic Government)	This work was supported by Czech-US collaborative grant KONTAKT II LH14009 from the Ministry of Education, Youth and Sports, Czech Republic (URL : http ://www.msmt.cz/vyzkum-a-vyvoj/program-kontakt-ii-lh), funding received by IS. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Arcak M, 2008, MATH BIOSCI ENG, V5, P1, DOI 10.3934/mbe.2008.5.1; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; CLARKE BL, 1980, ADV CHEM PHYS, V43, P1; Conradi C, 2008, MATH BIOSCI, V211, P105, DOI 10.1016/j.mbs.2007.10.004; Conradi C, 2015, B MATH BIOL, V77, P126, DOI 10.1007/s11538-014-0054-4; Eiswirth M, 1996, J PHYS CHEM-US, V100, P19118, DOI 10.1021/jp961688y; Errami H, 2015, J COMPUT PHYS, V291, P279, DOI 10.1016/j.jcp.2015.02.050; FEINBERG M, 1988, CHEM ENG SCI, V43, P1, DOI 10.1016/0009-2509(88)87122-7; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; Freund A, 1991, ADV CHEM PHYS, V100, P127; Hadac O, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790126; Hadley G., 1962, LINEAR PROGRAMMING; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Hu H, 2013, CELL SIGNAL, V25, P26, DOI 10.1016/j.cellsig.2012.09.014; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; HUNG YF, 1995, J PHYS CHEM-US, V99, P1980, DOI 10.1021/j100007a031; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kholodenko BN, 2009, WIRES SYST BIOL MED, V1, P28, DOI 10.1002/wsbm.16; Kubicek M., 1983, COMPUTATIONAL METHOD; Li GP, 2003, CELL BIOCHEM BIOPHYS, V39, P45, DOI 10.1385/CBB:39:1:45; Mai ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054441; Marek M., 1991, CHAOTIC BEHAV DETERM; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; Nebyla M, 2012, BIOPHYS J, V102, P990, DOI 10.1016/j.bpj.2012.01.038; Nguyen LK, 2012, J R SOC INTERFACE, V9, P1998, DOI 10.1098/rsif.2012.0028; Nomura M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00068; Milian MP, 2015, MATH BIOSCI, V262, P125, DOI 10.1016/j.mbs.2014.12.010; Pismen LM., 2006, PATTERNS INTERFACES; Pribyl M, 2003, BIOPHYS J, V84, P3624, DOI 10.1016/S0006-3495(03)75093-0; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Ross J, 2005, DETERMINATION COMPLE; Rubinstein BY, 2016, MOL BIOL CELL, V27, P2331, DOI 10.1091/mbc.E16-03-0137; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Schuster S, 2002, J MATH BIOL, V45, P153, DOI 10.1007/s002850200143; Sepulchre JA, 2013, ACTA BIOTHEOR, V61, P59, DOI 10.1007/s10441-013-9177-5; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Ventura AC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000041; Vera J, 2010, MOL BIOSYST, V6, P2174, DOI 10.1039/c0mb00018c; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Yi M, 2011, BIOPHYS CHEM, V157, P33, DOI 10.1016/j.bpc.2011.04.007; Zhao Q, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055004; Zumsande M, 2010, J THEOR BIOL, V265, P481, DOI 10.1016/j.jtbi.2010.04.025	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178457	10.1371/journal.pone.0178457	http://dx.doi.org/10.1371/journal.pone.0178457			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636629	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300013
J	Kundu, AK; Iyer, SV; Chandra, S; Adhikari, AS; Iwakuma, T; Mandal, TK				Kundu, Anup K.; Iyer, Swathi V.; Chandra, Sruti; Adhikari, Amit S.; Iwakuma, Tomoo; Mandal, Tarun K.			Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma	PLOS ONE			English	Article							GENE-THERAPY; PANCREATIC-CANCER; IN-VITRO; DELIVERY; NANOPARTICLES; TUMORS; CELLS; EXPRESSION; ADENOVIRUS; MUTATIONS	Objectives The tumor suppressor p53 plays a crucial role in the development of osteosarcoma. The primary objective of this study is to develop and optimize lipid based nanoparticle formulations that can carry siRNA and effectively silence mutant p53 in 318-1, a murine osteosarcoma cell line. Methods The nanoparticles were composed of a mixture of two lipids (cholesterol and DOTAP) and either PLGA or PLGA-PEG and prepared by using an EmulsiFlex-B3 high pressure homogenizer. A series of studies that include using different nanoparticles, different amount of siRNAs, cell numbers, incubation time, transfection media volume, and storage temperature was performed to optimize the gene silencing efficiency. Key findings Replacement of lipids by PLGA or PLGA-PEG decreased the particle size and overall cytotoxicity. Among all lipid-polymer nanoformulations, nanoparticles with 10% PLGA showed highest mutant p53 knockdown efficiency while maintaining higher cell viability when a nanoparticle to siRNA ratio equal to 6.8: 0.66 and 75 nM siRNA was used. With long term storage the mutant p53 knockdown efficiency decreased to a greater extent. Conclusions This study warrants a future evaluation of this formulation for gene silencing efficiency of mutant p53 in tissue culture and animal models for the treatment of osteosarcoma.	[Kundu, Anup K.; Mandal, Tarun K.] Xavier Univ, Ctr Nanomed & Drug Delivery, Coll Pharm, New Orleans, LA 70125 USA; [Kundu, Anup K.; Chandra, Sruti] Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA; [Iyer, Swathi V.; Adhikari, Amit S.; Iwakuma, Tomoo] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Iyer, Swathi V.; Adhikari, Amit S.; Iwakuma, Tomoo] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA USA	Xavier University of Louisiana; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kundu, AK (corresponding author), Xavier Univ, Ctr Nanomed & Drug Delivery, Coll Pharm, New Orleans, LA 70125 USA.; Kundu, AK (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA 70125 USA.	akundu@xula.edu		Iyer, Swathi/0000-0001-5686-2978	Louisiana Cancer Research Consortium, NIMHD [TL4GM118968, 5G12MD007595]; NIGMS [8UL1GM118967, R25GM060926]; NIH [1R01CA127481, R21CA129776, 1G12RR02626001]; Loui siana Board of Regents RC/EEP; LEQSF [(2007-12)-ENH-PKSFI-PRS-02]; Xavier University of Louisiana and LBRN Pilot; NATIONAL CANCER INSTITUTE [R01CA174735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118967] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium, NIMHD; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loui siana Board of Regents RC/EEP; LEQSF; Xavier University of Louisiana and LBRN Pilot; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work is funded in part by the Louisiana Cancer Research Consortium, NIMHD grant number TL4GM118968 and 5G12MD007595, NIGMS grant number 8UL1GM118967 and R25GM060926, NIH grants1R01CA127481, R21CA129776, 1G12RR02626001, Loui siana Board of Regents RC/EEP (2007-11), and LEQSF (2007-12)-ENH-PKSFI-PRS-02, CUR from Xavier University of Louisiana and LBRN Pilot. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Apaolaza PS, 2016, BIOMATERIALS, V90, P40, DOI 10.1016/j.biomaterials.2016.03.004; Benjamin R, 2001, Hum Gene Ther, V12, P1591; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Chandra PK, 2012, MOL THER, V20, P1724, DOI 10.1038/mt.2012.107; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Denduluri Sahitya K, 2015, J Biomed Res, V30, DOI 10.7555/JBR.29.20150075; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Du J, 2012, INT J MOL SCI, V13, P516, DOI 10.3390/ijms13010516; Eastham JA, 2000, J UROLOGY, V164, P814, DOI 10.1016/S0022-5347(05)67320-X; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; Gopalakrishnan AM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01534; Grayson ACR, 2006, PHARM RES-DORDR, V23, P1868, DOI 10.1007/s11095-006-9009-2; Hattori Y, 2015, BIOL PHARM BULL, V38, P30, DOI 10.1248/bpb.b14-00526; Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111; Hecker JG, 2016, METHODS MOL BIOL, V1382, P307, DOI 10.1007/978-1-4939-3271-9_23; Iyer SV, 2016, ONCOTARGET, V7, P5401, DOI 10.18632/oncotarget.6634; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kafri T, 1998, P NATL ACAD SCI USA, V95, P11377, DOI 10.1073/pnas.95.19.11377; Khan A, 2004, J DRUG TARGET, V12, P393, DOI 10.1080/10611860400003858; Kundu AK, 2012, INT J PHARMACEUT, V423, P525, DOI 10.1016/j.ijpharm.2011.11.040; Kundu AK, 2012, EUR J PHARM BIOPHARM, V80, P257, DOI 10.1016/j.ejpb.2011.10.023; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LESOONWOOD LA, 1995, HUM GENE THER, V6, P395, DOI 10.1089/hum.1995.6.4-395; Lim YH, 2016, WILEY INTERDISCIP RE, V10, P1401; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mercade E, 2001, ANN ONCOL, V12, P379, DOI 10.1023/A:1011177223129; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Nemunaitis J, 2000, J CLIN ONCOL, V18, P609, DOI 10.1200/JCO.2000.18.3.609; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Overholtzer M, 2003, P NATL ACAD SCI USA, V100, P11547, DOI 10.1073/pnas.1934852100; Ren YA, 2016, CANCER RES, V76, P2206, DOI 10.1158/0008-5472.CAN-15-1046; Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takahashi Shunji, 2006, Breast Cancer, V13, P8, DOI 10.2325/jbcs.13.8; Thomas CE, 2001, MOL THER, V3, P36, DOI 10.1006/mthe.2000.0224; Wunder JS, 2005, J CLIN ONCOL, V23, P1483, DOI 10.1200/JCO.2005.04.074; Zhao X, 2015, BIOMATERIALS, V46, P13, DOI 10.1016/j.biomaterials.2014.12.028; Zhdanov RI, 2002, BIOELECTROCHEMISTRY, V58, P53, DOI 10.1016/S1567-5394(02)00132-9	41	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179168	10.1371/journal.pone.0179168	http://dx.doi.org/10.1371/journal.pone.0179168			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636657	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300027
J	Blasiak, R; Spijkers, J; Tokunaga, K; Pittman, J; Yagi, N; Osterblom, H				Blasiak, Robert; Spijkers, Jessica; Tokunaga, Kanae; Pittman, Jeremy; Yagi, Nobuyuki; Osterblom, Henrik			Climate change and marine fisheries: Least developed countries top global index of vulnerability	PLOS ONE			English	Article							IMPACTS; MANAGEMENT; CONFLICT; SHIFTS	Future impacts of climate change on marine fisheries have the potential to negatively influence a wide range of socio-economic factors, including food security, livelihoods and public health, and even to reshape development trajectories and spark transboundary conflict. Yet there is considerable variability in the vulnerability of countries around the world to these effects. We calculate a vulnerability index of 147 countries by drawing on the most recent data related to the impacts of climate change on marine fisheries. Building on the Intergovernmental Panel on Climate Change framework for vulnerability, we first construct aggregate indices for exposure, sensitivity and adaptive capacity using 12 primary variables. Seven out of the ten most vulnerable countries on the resulting index are Small Island Developing States, and the top quartile of the index includes countries located in Africa (17), Asia (7), North America and the Caribbean (4) and Oceania (8). More than 87% of least developed countries are found within the top half of the vulnerability index, while the bottom half includes all but one of the Organization for Economic Co-operation and Development member states. This is primarily due to the tremendous variation in countries' adaptive capacity, as no such trends are evident from the exposure or sensitivity indices. A negative correlation exists between vulnerability and per capita carbon emissions, and the clustering of states at different levels of development across the vulnerability index suggests growing barriers to meeting global commitments to reducing inequality, promoting human well-being and ensuring sustainable cities and communities. The index provides a useful tool for prioritizing the allocation of climate finance, as well as activities aimed at capacity building and the transfer of marine technology.	[Blasiak, Robert; Spijkers, Jessica; Osterblom, Henrik] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Blasiak, Robert; Yagi, Nobuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Blasiak, Robert] United Nations Univ Inst Adv Study Sustainabil, Shibuya Ku, Tokyo, Japan; [Spijkers, Jessica] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Tokunaga, Kanae] Univ Tokyo, Ocean Alliance, Bunkyo Ku, Tokyo, Japan; [Pittman, Jeremy] Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada	Stockholm University; University of Tokyo; United Nations University; James Cook University; University of Tokyo; University of Waterloo	Blasiak, R (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Blasiak, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan.; Blasiak, R (corresponding author), United Nations Univ Inst Adv Study Sustainabil, Shibuya Ku, Tokyo, Japan.	robert.blasiak@su.se		Spijkers, Jessica/0000-0002-2598-4507; Tokunaga, Kanae/0000-0002-6171-5187; Blasiak, Robert/0000-0002-0888-0159	Japan Society for the Promotion of Science KAKENHI [16K18743, 24121010]; Nippon Foundation University of British Columbia NEREUS Program; Nippon Foundation through the University of Tokyo Ocean Alliance; Liber Ero Fellowship Program; Baltic Ecosystem Adaptive Management Program (BEAM); Nippon Foundation; Guidance for Resilience in the Anthropocene: Investments for development (GRAID); Swedish International Development Agency (SIDA); Stockholm Resilience Centre	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nippon Foundation University of British Columbia NEREUS Program; Nippon Foundation through the University of Tokyo Ocean Alliance; Liber Ero Fellowship Program; Baltic Ecosystem Adaptive Management Program (BEAM); Nippon Foundation(Nippon Foundation); Guidance for Resilience in the Anthropocene: Investments for development (GRAID); Swedish International Development Agency (SIDA); Stockholm Resilience Centre	RB was funded by the Japan Society for the Promotion of Science KAKENHI grants 16K18743 and 24121010. JS and RB were funded by the Nippon Foundation University of British Columbia NEREUS Program. KT was funded by the Nippon Foundation through the University of Tokyo Ocean Alliance for the project titled "Science on Consensus Building Methods Related to Ocean Use." JP was funded by the Liber Ero Fellowship Program. NY was funded by Japan Society for the Promotion of Science KAKENHI grant 24121010. HO was funded by the Baltic Ecosystem Adaptive Management Program (BEAM), the Nippon Foundation, Guidance for Resilience in the Anthropocene: Investments for development (GRAID), Swedish International Development Agency (SIDA) and Mistra, through a core grant to Stockholm Resilience Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Aldy JE, 2006, ENVIRON RESOUR ECON, V33, P533, DOI 10.1007/s10640-005-6160-x; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Biggs R., 2015, PRINCIPLES BUILDING; Blasiak R, 2015, ENVIRON SCI POLICY, V54, P134, DOI 10.1016/j.envsci.2015.06.022; Blasiak R, 2015, MAR POLICY, V57, P18, DOI 10.1016/j.marpol.2015.03.013; Blasiak R, 2015, MAR POLICY, V52, P52, DOI 10.1016/j.marpol.2014.11.001; Central Intelligence Agency, 2016, WORLD FACTBOOK; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2015, ICES J MAR SCI; Christian JR, 2013, CLIMATE TRENDS PROJE; Claus S, 2017, MARINE REGIONS; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; FAO, 2019, FAO STAT DAT; FAO, 2016, CONTRIBUTING FOOD SE; Field C. B., 2014, IMPACTS ADAPTATION A; Food and Agriculture Organization (FAO), 2016, FISH COMM PROD TRAD; Food and Agriculture Organization (FAO), 2016, CAPT PROD 1950 2014; Food and Agriculture Organization (FAO), 1997, 929 FAO; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Heil MT, 2000, ENVIRON RESOUR ECON, V17, P163, DOI 10.1023/A:1008326515058; International Council for the Exploration of the Sea (ICES), 2014, ADV SEPT 2014 MACK N, P19; International Labour Organization (ILO), 2011, EC ACT POP EST PROJ; Islam MM, 2014, REG ENVIRON CHANGE, V14, P281, DOI 10.1007/s10113-013-0487-6; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kalikoski DC, 2010, MAR POLICY, V34, P742, DOI 10.1016/j.marpol.2010.02.003; Kaufmann D, 2015, WORLDWIDE GOVERNANCE; Kristiansen T., 2017, PLOT CMIP5 SST DATA; Kristiansen T., 2017, CREATE ENSEMBLE AVER; McClanahan T, 2015, FISH FISH, V16, P78, DOI 10.1111/faf.12045; Miller KA, 2000, SOC ADAPTATION CLIMA; Pauly D., 2015, SEA US CONCEPTS DESI; Payne MR, 2015, ICES J MAR SCI; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pomeroy R, 2007, MAR POLICY, V31, P645, DOI 10.1016/j.marpol.2007.03.012; Pomeroy R, 2016, MAR POLICY, V67, P94, DOI 10.1016/j.marpol.2016.01.005; PORTNER HO, 2014, OCEAN SYSTEMS CLIM A, P411; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Spijkers J, 2017, REG ENV CHANGE; Sumaila U. Rashid, 2010, Journal of Bioeconomics, V12, P201, DOI 10.1007/s10818-010-9091-8; Sumaila UR, 2013, IPBPECHIC2013146 EUR; Thilsted SH, 2016, FOOD POLICY, V61, P126, DOI 10.1016/j.foodpol.2016.02.005; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; United Nations, 2015, 2030 AG SUST DEV; United Nations Framework Convention on Climate Change (UNFCCC), 2014, UNFCC STAND COMM FIN; United Nations General Assembly (UNGA), 2014, A69177 UNGA; United Nations General Assembly (UNGA), 2012, ARES66288 UNGA; Wilson C, 2002, 86 U QUEENSL; World Bank, 2016, NET ENR RAT BOTH SEX; World Bank, 2016, GDP PER CAP CURR US; World Bank, 2016, CO2 EM METR TONS PER; World Bank, 2016, AD LIT RAT POP 15 YE; World Health Organization (WHO), 2016, DAT BY COUNTR	58	88	92	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179632	10.1371/journal.pone.0179632	http://dx.doi.org/10.1371/journal.pone.0179632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY5UN	28632781	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000404046100042
J	Leroy, A; Cevallos, C; Cebolla, AM; Caharel, S; Dan, B; Cheron, G				Leroy, Axelle; Cevallos, Carlos; Cebolla, Ana-Maria; Caharel, Stephanie; Dan, Bernard; Cheron, Guy			Short-term EEG dynamics and neural generators evoked by navigational images	PLOS ONE			English	Article							TOP-DOWN MODULATION; ALLOCENTRIC REFERENCE FRAMES; VISUAL-CORTEX; SPATIAL NAVIGATION; VIRTUAL-REALITY; HUMAN BRAIN; PREFRONTAL CORTEX; MOTION PERCEPTION; HUMAN CEREBELLUM; WORKING-MEMORY	The ecological environment offered by virtual reality is primarily supported by visual information. The different image contents and their rhythmic presentation imply specific bottom-up and top-down processing. Because these processes already occur during passive observation we studied the brain responses evoked by the presentation of specific 3D virtual tunnels with respect to 2D checkerboard. For this, we characterized electroencephalograhy dynamics (EEG), the evoked potentials and related neural generators involved in various visual paradigms. Time-frequency analysis showed modulation of alpha-beta oscillations indicating the presence of stronger prediction and after-effects of the 3D-tunnel with respect to the checkerboard. Whatever the presented image, the generators of the P100 were situated bilaterally in the occipital cortex (BA18, BA19) and in the right inferior temporal cortex (BA20). In checkerboard but not 3D-tunnel presentation, the left fusiform gyrus (BA37) was additionally recruited. P200 generators were situated in the temporal cortex (BA21) and the cerebellum (lobule VI/Crus I) specifically for the checkerboard while the right parahippocampal gyrus (BA36) and the cerebellum (lobule IV/V and IX/X) were involved only during the 3D-tunnel presentation. For both type of image, P300 generators were localized in BA37 but also in BA19, the right BA21 and the cerebellar lobule VI for only the checkerboard and the left BA20-BA21 for only the 3D-tunnel. Stronger P300 delta-theta oscillations recorded in this later situation point to a prevalence of the effect of changing direction over the proper visual content of the 3D-tunnel. The parahippocampal gyrus (BA36) implicated in navigation was also identified when the 3D-tunnel was compared to their scrambled versions, highlighting an action-oriented effect linked to navigational content.	[Leroy, Axelle; Cevallos, Carlos; Cebolla, Ana-Maria; Dan, Bernard; Cheron, Guy] Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Movement Biomech, Brussels, Belgium; [Leroy, Axelle] Haute Ecole Condorcet, Mons, Belgium; [Cevallos, Carlos] Escuela Politec Nacl, Fac Ingn Mecan, Dept Ingn Mecan, Quito, Ecuador; [Caharel, Stephanie] Univ Lorraine, Lab Psychol Interact & Relat Intersubject, InterPsy EA4432, Nancy, France; [Dan, Bernard] Inkendaal Rehabil Hosp, Vlezenbeek, Belgium; [Cheron, Guy] Univ Mons Hainaut, Lab Electrophysiol, Mons, Belgium	Universite Libre de Bruxelles; Escuela Politecnica Nacional Ecuador; Universite de Lorraine; University of Mons	Cheron, G (corresponding author), Univ Libre Bruxelles, ULB Neurosci Inst, Lab Neurophysiol & Movement Biomech, Brussels, Belgium.; Cheron, G (corresponding author), Univ Mons Hainaut, Lab Electrophysiol, Mons, Belgium.	gcheron@ulb.ac.be	B., Carlos Cevallos/T-4048-2019	B., Carlos Cevallos/0000-0002-4699-670X; Dan, Bernard/0000-0002-2051-9876	Belgian Federal Science Policy Office; European Space Agency [AO-2004, 118]; Belgian National Fund for Scientific Research (FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); FEDER (BIOFACT); MINDWALKER project - European Commission; Fonds G. Leibu; NeuroAtt BIOWIN - Walloon Country of Belgium	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); FEDER (BIOFACT); MINDWALKER project - European Commission(European Commission); Fonds G. Leibu; NeuroAtt BIOWIN - Walloon Country of Belgium	We would like to thank T. D'Angelo, C. de Scoville, M. Dufief, E. Toussaint, E. Hortmanns, and M. Petieau, for expert technical assistance, M. Vidal for the virtual 3D tunnel realization and J. Dufrane for correcting the English version of the manuscript. This work was funded by the Belgian Federal Science Policy Office, the European Space Agency (AO-2004, 118), the Belgian National Fund for Scientific Research (FNRS), the research funds of the Universite Libre de Bruxelles and of the Universite de Mons (Belgium), the FEDER support (BIOFACT), the MINDWALKER project ("FP7" 2007-2013) supported by the European Commission, the Fonds G. Leibu and the NeuroAtt BIOWIN project supported by Walloon Country of Belgium.; This work was funded by the Belgian Federal Science Policy Office, the European Space Agency (AO-2004, 118), the Belgian National Fund for Scientific Research (FNRS), the research funds of the Universite Libre de Bruxelles and of the Universite de Mons (Belgium), the FEDER support (BIOFACT), the MINDWALKER project ("FP7" 2007-2013) supported by the European Commission, the Fonds G. Leibu and the NeuroAtt BIOWIN project supported by Walloon Country of Belgium.	Ardila A, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/872487; Babiloni C, 2011, CLIN NEUROPHYSIOL, V122, P1348, DOI 10.1016/j.clinph.2010.12.001; Baier B, 2014, ANN NEUROL, V76, P754, DOI 10.1002/ana.24272; Balser N, 2014, HUM BRAIN MAPP, V35, P4016, DOI 10.1002/hbm.22455; Bardy C, 2009, NEUROSCIENCE, V158, P951, DOI 10.1016/j.neuroscience.2008.09.057; Baumann O, 2010, NEUROIMAGE, V49, P2816, DOI 10.1016/j.neuroimage.2009.10.021; Blatt GJ, 2003, J COMP NEUROL, V466, P161, DOI 10.1002/cne.10866; Bohbot VD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00431; Burgess N, 2005, HIPPOCAMPUS, V15, P825, DOI 10.1002/hipo.20111; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Caspers J, 2014, HUM BRAIN MAPP, V35, P2754, DOI 10.1002/hbm.22364; Cebolla AM, 2011, NEUROIMAGE, V54, P1297, DOI 10.1016/j.neuroimage.2010.08.060; Cheron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082371; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Collins DL, 1994, J COMPUTER ASSISTED; Cordones I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063751; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Denis D, 2017, NEUROIMAGE, V146, P1102, DOI 10.1016/j.neuroimage.2016.10.022; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Dion LA, 2013, INT J PSYCHOPHYSIOL, V88, P136, DOI 10.1016/j.ijpsycho.2013.03.001; Edelman GM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00063; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Farmer AD, 2015, J PHYSIOL-LONDON, V593, P1183, DOI 10.1113/jphysiol.2014.284240; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fenske MJ, 2006, PROG BRAIN RES, V155, P3, DOI 10.1016/S0079-6123(06)55001-0; Fischer J, 2011, J COGNITIVE NEUROSCI, V23, P119, DOI 10.1162/jocn.2010.21417; Frey SH, 2006, J NEUROSCI, V26, P13194, DOI 10.1523/JNEUROSCI.3914-06.2006; Gaunet F, 2001, COGNITIVE BRAIN RES, V11, P409, DOI 10.1016/S0926-6410(01)00013-1; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; GESELOWI.DB, 1967, BIOPHYS J, V7, P1, DOI 10.1016/S0006-3495(67)86571-8; Gould NF, 2007, AM J PSYCHIAT, V164, P516, DOI 10.1176/appi.ajp.164.3.516; Gramann K, 2010, J COGNITIVE NEUROSCI, V22, P2836, DOI 10.1162/jocn.2009.21369; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Gruber T, 2004, EUR J NEUROSCI, V19, P1073, DOI 10.1111/j.0953-816X.2004.03176.x; Handel B, 2009, J NEUROSCI, V29, P15126, DOI 10.1523/JNEUROSCI.3972-09.2009; Hamame CM, 2012, NEUROIMAGE, V59, P872, DOI 10.1016/j.neuroimage.2011.07.087; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; HOLM S, 1979, SCAND J STAT, V6, P65; Hulsdunker T, 2016, MED SCI SPORT EXER, V48, P2125, DOI 10.1249/MSS.0000000000001010; Iaria G, 2003, J NEUROSCI, V23, P5945; Iaria G, 2008, EUR J NEUROSCI, V27, P1017, DOI 10.1111/j.1460-9568.2008.06060.x; INTRILIGATOR J, 1994, BIOL PSYCHOL, V37, P207, DOI 10.1016/0301-0511(94)90003-5; Jandl NM, 2015, NEUROSCIENCE, V305, P257, DOI 10.1016/j.neuroscience.2015.07.089; Jenkinson N, 2010, CEREBELLUM, V9, P548, DOI 10.1007/s12311-010-0193-6; Kappenman Emily S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P110; Kellermann T, 2012, J NEUROSCI, V32, P11453, DOI 10.1523/JNEUROSCI.0678-12.2012; Kober SE, 2012, INT J PSYCHOPHYSIOL, V83, P365, DOI 10.1016/j.ijpsycho.2011.12.003; Kohler PJ, 2016, J NEUROSCI, V36, P714, DOI 10.1523/JNEUROSCI.2962-15.2016; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Nakatani C, 2014, J COGNITIVE NEUROSCI, V26, P1168, DOI 10.1162/jocn_a_00540; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oishi N, 2007, NEUROIMAGE, V36, P1301, DOI 10.1016/j.neuroimage.2007.04.030; Panouilleres M, 2012, HUM BRAIN MAPP, V33, P1512, DOI 10.1002/hbm.21301; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paulin MG, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S06; Pollen DA, 2011, CEREB CORTEX, V21, P1941, DOI 10.1093/cercor/bhq285; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Sato N, 2003, J NEUROPHYSIOL, V90, P876, DOI 10.1152/jn.01089.2002; SCHIFF SJ, 1994, ELECTROEN CLIN NEURO, V91, P442, DOI 10.1016/0013-4694(94)90165-1; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Slobounov SM, 2015, INT J PSYCHOPHYSIOL, V95, P254, DOI 10.1016/j.ijpsycho.2014.11.003; Sokolov AA, 1991, CEREB CORTEX N Y N, V24; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Utz S, 2015, PERCEPTION, V44, P1263, DOI 10.1177/0301006615596900; Vaidya CJ, 2002, NEUROPSYCHOLOGIA, V40, P2136, DOI 10.1016/S0028-3932(02)00053-2; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vidal JR, 2014, NEUROIMAGE, V95, P129, DOI 10.1016/j.neuroimage.2014.03.049; Vidal M, 2004, COGNITIVE BRAIN RES, V19, P244, DOI 10.1016/j.cogbrainres.2003.12.006; Vidal M, 2006, PERCEPT PSYCHOPHYS, V68, P1338, DOI 10.3758/BF03193732; Weiner KS, 2015, NEUROPSYCHOLOGIA; Whittingstall K, 2009, NEURON, V64, P281, DOI 10.1016/j.neuron.2009.08.016; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Yordanova J, 1998, NEUROREPORT, V9, P3159, DOI 10.1097/00001756-199810050-00007; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zheng JL, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5983671	90	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178817	10.1371/journal.pone.0178817	http://dx.doi.org/10.1371/journal.pone.0178817			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632774	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100010
J	Teka, WW; Hamade, KC; Barnett, WH; Kim, T; Markin, SN; Rybak, IA; Molkov, YI				Teka, Wondimu W.; Hamade, Khaldoun C.; Barnett, William H.; Kim, Taegyo; Markin, Sergey N.; Rybak, Ilya A.; Molkov, Yaroslav I.			From the motor cortex to the movement and back again	PLOS ONE			English	Article							PRIMATE CORTICOMOTONEURONAL CELLS; FREE ARM MOVEMENTS; FICTIVE LOCOMOTION; LIMB BIOMECHANICS; ISOMETRIC-FORCE; VISUAL TARGETS; SINGLE-NEURON; CORTICAL REPRESENTATION; PREPARATORY ACTIVITY; HUNTINGTONS-DISEASE	The motor cortex controls motor behaviors by generating movement-specific signals and transmitting them through spinal cord circuits and motoneurons to the muscles. Precise and well-coordinated muscle activation patterns are necessary for accurate movement execution. Therefore, the activity of cortical neurons should correlate with movement parameters. To investigate the specifics of such correlations among activities of the motor cortex, spinal cord network and muscles, we developed a model for neural control of goal-directed reaching movements that simulates the entire pathway from the motor cortex through spinal cord circuits to the muscles controlling arm movements. In this model, the arm consists of two joints (shoulder and elbow), whose movements are actuated by six muscles (4 single-joint and 2 double-joint flexors and extensors). The muscles provide afferent feedback to the spinal cord circuits. Cortical neurons are defined as cortical "controllers" that solve an inverse problem based on a proposed straight-line trajectory to a target position and a predefined bell-shaped velocity profile. Thus, the controller generates a motor program that produces a task-specific activation of low-level spinal circuits that in turn induce the muscle activation realizing the intended reaching movement. Using the model, we describe the mechanisms of correlation between cortical and motoneuronal activities and movement direction and other movement parameters. We show that the directional modulation of neuronal activity in the motor cortex and the spinal cord may result from direction-specific dynamics of muscle lengths. Our model suggests that directional modulation first emerges at the level of muscle forces, augments at the motoneuron level, and further increases at the level of the motor cortex due to the dependence of frictional forces in the joints, contractility of the muscles and afferent feedback on muscle lengths and/or velocities.	[Teka, Wondimu W.] Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA; [Hamade, Khaldoun C.; Kim, Taegyo; Markin, Sergey N.; Rybak, Ilya A.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Barnett, William H.; Molkov, Yaroslav I.] Georgia State Univ, Atlanta, GA 30303 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Drexel University; University System of Georgia; Georgia State University	Teka, WW (corresponding author), Indiana Univ Purdue Univ, Indianapolis, IN 46202 USA.	wondimuwub@gmail.com	Molkov, Yaroslav/C-6336-2012; , wondimu/N-3011-2017; Barnett, William/GWU-7996-2022	Molkov, Yaroslav/0000-0002-0862-1974; , wondimu/0000-0002-2196-9537; Rybak, Ilya/0000-0003-3461-349X	CHDI Foundation	CHDI Foundation	This work was supported by the CHDI Foundation.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Addou T, 2015, J NEUROPHYSIOL, V113, P487, DOI 10.1152/jn.00094.2014; Ajemian R, 2008, NEURON, V58, P414, DOI 10.1016/j.neuron.2008.02.033; ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; ASHE J, 1994, CEREB CORTEX, V4, P590, DOI 10.1093/cercor/4.6.590; Bennett KMB, 1996, J NEUROPHYSIOL, V75, P1826, DOI 10.1152/jn.1996.75.5.1826; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Bonfiglioli C, 1998, NEUROPSYCHOLOGIA, V36, P1203, DOI 10.1016/S0028-3932(97)00171-1; CAMINITI R, 1990, J NEUROSCI, V10, P2039; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Carpenter AF, 1999, SCIENCE, V283, P1752, DOI 10.1126/science.283.5408.1752; Chan SS, 2006, J NEURAL ENG, V3, P327, DOI 10.1088/1741-2560/3/4/010; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Cherian A, 2011, J NEUROPHYSIOL, V106, P564, DOI 10.1152/jn.00553.2010; Churchland MM, 2007, J NEUROPHYSIOL, V97, P4235, DOI 10.1152/jn.00095.2007; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; DOEMGES F, 1992, J PHYSIOL-LONDON, V447, P563, DOI 10.1113/jphysiol.1992.sp019018; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FLAMENT D, 1988, J NEUROPHYSIOL, V60, P1268, DOI 10.1152/jn.1988.60.4.1268; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Garner B A, 2001, Comput Methods Biomech Biomed Engin, V4, P93; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GISZTER SF, 1993, J NEUROSCI, V13, P467; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Griffin DM, 2015, SCIENCE, V350, P667, DOI 10.1126/science.aaa8035; Harischandra N, 2008, BIOL CYBERN, V99, P125, DOI 10.1007/s00422-008-0243-z; Hatsopoulos NG, 2005, J NEUROPHYSIOL, V94, P2261, DOI 10.1152/jn.00533.2005; Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; Holdefer RN, 2002, EXP BRAIN RES, V146, P233, DOI 10.1007/s00221-002-1166-x; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jones KE, 2001, J PHYSIOL-LONDON, V536, P635, DOI 10.1111/j.1469-7793.2001.0635c.xd; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kalaska J, 2009, INTENTION ACTION MOT, P139; KETTNER RE, 1988, J NEUROSCI, V8, P2938; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Kurtzer I, 2005, NAT NEUROSCI, V8, P498, DOI 10.1038/nn1420; Lebedev MA, 2017, PHYSIOL REV, V97, P767, DOI 10.1152/physrev.00027.2016; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; Lemay MA, 2001, IEEE T NEUR SYS REH, V9, P12, DOI 10.1109/7333.918272; LESTIENNE F, 1979, EXP BRAIN RES, V35, P407; Lillicrap TP, 2013, NEURON, V77, P168, DOI 10.1016/j.neuron.2012.10.041; Markin SN, 2016, SPR SER COMPUT NEURO, P21, DOI 10.1007/978-1-4939-3267-2_2; Maynard EM, 1999, J NEUROSCI, V19, P8083; MCCREA DA, 1980, J NEUROPHYSIOL, V44, P475, DOI 10.1152/jn.1980.44.3.475; Merchant H, 2008, J NEUROSCI, V28, P9164, DOI 10.1523/JNEUROSCI.1898-08.2008; Merchant H, 2012, PROG NEUROBIOL, V99, P163, DOI 10.1016/j.pneurobio.2012.08.005; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Morrow MM, 2007, J NEUROPHYSIOL, V97, P1786, DOI 10.1152/jn.00150.2006; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nichols T. Richard, 1999, P255; Porter R, 1993, CORTICOSPINAL FUNCTI; PRATT CA, 1987, J NEUROPHYSIOL, V57, P56, DOI 10.1152/jn.1987.57.1.56; Prochazka A, 1999, PROG BRAIN RES, V123, P133, DOI 10.1016/S0079-6123(08)62850-2; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reimer J, 2009, ADV EXP MED BIOL, V629, P243, DOI 10.1007/978-0-387-77064-2_12; Reinold MM, 2008, AM J SPORT MED, V36, P523, DOI 10.1177/0363546507308935; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Scott SH, 2000, NAT NEUROSCI, V3, P307, DOI 10.1038/73859; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; Sergio LE, 1998, J NEUROPHYSIOL, V80, P1577, DOI 10.1152/jn.1998.80.3.1577; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Stark E, 2006, J NEUROPHYSIOL, V95, P1966, DOI 10.1152/jn.00981.2005; Taira M, 1996, EXP BRAIN RES, V109, P367; Tanaka H, 2013, J NEUROPHYSIOL, V109, P1182, DOI 10.1152/jn.00279.2012; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Todorov E., 2002, PROG MOT CONTROL, V6, P125; Trainin E, 2007, J NEUROPHYSIOL, V97, P3736, DOI 10.1152/jn.01064.2006; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908; Trumbower RD, 2010, J NEUROPHYSIOL, V104, P3612, DOI 10.1152/jn.00804.2009; Veeger HEJ, 1997, J BIOMECH, V30, P647, DOI 10.1016/S0021-9290(97)00011-0; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9	84	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179288	10.1371/journal.pone.0179288	http://dx.doi.org/10.1371/journal.pone.0179288			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632736	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100018
J	Wallace, JM; Bhattacharya, S; Horgan, GW				Wallace, Jacqueline M.; Bhattacharya, Sohinee; Horgan, Graham W.			Weight change across the start of three consecutive pregnancies and the risk of maternal morbidity and SGA birth at the second and third pregnancy	PLOS ONE			English	Article							BODY-MASS INDEX; ADVERSE PREGNANCY; PLACENTAL WEIGHT; OBESE WOMEN; OUTCOMES; GAIN; ASSOCIATION; POPULATION; POSTPARTUM; STILLBIRTH	Background Weight-change across parities and/or current BMI may influence maternal and fetal morbidity and requires to be differentiated to better inform weight-management guidance. Methods Direction, pattern and magnitude of weight-change across three consecutive parities and thereby two inter-pregnancy periods was described in 5079 women. The association between inter-pregnancy weight-change versus current BMI and adverse maternal events, SGA-birth and preterm delivery at second and third pregnancy were investigated by logistic regression. Results More women gained weight across the defined childbearing period than lost it, with similar to 35% of normal and overweight women gaining sufficient weight to move up a BMI-category. Nine patterns of weight-change were defined across two inter-pregnancy periods and 50% of women remained weight-stable throughout (within 2BMI units/period). Women who were overweight/obese at first pregnancy had higher risk of substantial weight-gain and loss (>10kg) during each of two inter-pregnancy periods. Inter-pregnancy weight-gain (>2BMI units) between first and second pregnancy increased the risk of maternal morbidity (1 or more event of hypertensive disease, caesarean-section, thromboembolism) at second pregnancy, while weight-loss (> 2BMI units) increased the risk of SGA-birth. Similarly, increased risk of maternal morbidity at the third pregnancy was influenced by weight-gain during both inter-pregnancy periods but not by current BMI-category. Both weight-gain between first and second pregnancy, and being overweight/obese by third pregnancy protected the fetus against SGA-birth whereas weight-loss between second and third pregnancy doubled the SGA risk. Conclusion Half the women studied exhibited significant weight-fluctuations. This influenced their risk of maternal morbidity and SGA-birth at second and third pregnancy.	[Wallace, Jacqueline M.] Univ Aberdeen, Rowett Inst, Aberdeen, Scotland; [Bhattacharya, Sohinee] Aberdeen Matern Hosp, Dugald Baird Ctr Res Womens Hlth, Aberdeen, Scotland; [Horgan, Graham W.] Univ Aberdeen, Rowett Inst, Biomath & Stat Scotland, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; James Hutton Institute; University of Aberdeen	Wallace, JM (corresponding author), Univ Aberdeen, Rowett Inst, Aberdeen, Scotland.	Jacqueline.Wallace@abdn.ac.uk		Wallace, Jacqueline/0000-0003-3099-5902	Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS, Theme 7: Diet and Health)	Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS, Theme 7: Diet and Health)	This work was funded by the Scottish Government's Rural and Environmental Science and Analytical Services Division (RESAS, Theme 7: Diet and Health). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrams B, 2013, OBESITY, V21, P1514, DOI 10.1002/oby.20503; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; BILLEWIC.WZ, 1970, BRIT J PREV SOC MED, V24, P97; Bogaerts A, 2013, OBSTET GYNECOL, V122, P999, DOI 10.1097/AOG.0b013e3182a7f63e; Bonellie Sandra, 2008, BMC Pregnancy Childbirth, V8, P5, DOI 10.1186/1471-2393-8-5; CAMPBELL D, 1993, BRIT J OBSTET GYNAEC, V100, P436, DOI 10.1111/j.1471-0528.1993.tb15268.x; Cnattingius S, 2016, LANCET, V387, P558, DOI 10.1016/S0140-6736(15)00990-3; Cohen AK, 2014, INT J OBESITY, V38, P714, DOI 10.1038/ijo.2013.156; Elliott-Sale K J, 2014, Pregnancy Hypertens, V4, P234, DOI 10.1016/j.preghy.2014.03.015; Faucher MA, 2015, WOMEN BIRTH, V28, pE70, DOI 10.1016/j.wombi.2015.03.006; Gaudet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/640291; Getahun D, 2007, AM J OBSTET GYNECOL, V196, pe1; Getahun D, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.015; Gunderson EP, 2004, INT J OBESITY, V28, P525, DOI 10.1038/sj.ijo.0802551; Gunderson EP, 2008, AM J EPIDEMIOL, V167, P178, DOI 10.1093/aje/kwm298; Hutcheon JA, 2015, OBESITY, V23, P532, DOI 10.1002/oby.21011; Jain AP, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.018; Kapadia MZ, 2015, OBES REV, V16, P189, DOI 10.1111/obr.12238; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; McDonald Sarah D, 2010, BMJ, V341, pc3428, DOI 10.1136/bmj.c3428; Neville CE, 2014, INT J OBESITY, V38, P577, DOI 10.1038/ijo.2013.132; Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293; Siega-Riz AM, 2012, ADV NUTR, V3, P105, DOI 10.3945/an.111.001081; Slane JD, 2015, WOMEN HEALTH ISS, V25, P390, DOI 10.1016/j.whi.2015.03.005; Spradley FT, 2015, AM J PHYSIOL-REG I, V309, pR1326, DOI 10.1152/ajpregu.00178.2015; Temming L, 2014, J MATERN-FETAL NEO M, V27, P84, DOI 10.3109/14767058.2013.806473; Vasconcelos Cláudia Machado Coelho Souza de, 2014, Rev. Bras. Ginecol. Obstet., V36, P222, DOI 10.1590/S0100-7203201400050007; Villamor E, 2016, OBESITY; Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7; Wallace JM, 2012, PLACENTA, V33, P611, DOI 10.1016/j.placenta.2012.05.006; Wallace JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154812; Wallace JM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-40; Whiteman VE, 2011, GYNECOL OBSTET INVES, V72, P192, DOI 10.1159/000324375; Whiteman VE, 2011, ARCH GYNECOL OBSTET, V284, P235, DOI 10.1007/s00404-011-1917-7	34	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179589	10.1371/journal.pone.0179589	http://dx.doi.org/10.1371/journal.pone.0179589			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628636	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100039
J	Austin, L; Ewing, G; Grande, G				Austin, Lynn; Ewing, Gail; Grande, Gunn			Factors influencing practitioner adoption of carer-led assessment in palliative homecare: A qualitative study of the use of the Carer Support Needs Assessment Tool (CSNAT)	PLOS ONE			English	Article							OF-LIFE CARE; CAREGIVERS	Introduction Informal caregivers play a pivotal role in supporting patients approaching the end of life. The Carer Support Needs Assessment Tool (CSNAT) is designed to facilitate person-centred assessment and support through a process that is practitioner-facilitated, but carer-led. This study explored practitioners' experiences of implementing the CSNAT in palliative homecare. Methods We conducted qualitative interviews/focus groups with 20 practitioners in one UK hospice homecare service (18 nurses, two healthcare assistants) before and after the implementation of the CSNAT. Thematic analysis of the data was underpinned by framework analysis. Results Not all practitioners appreciated that using the CSNAT required a shift towards a more person-centred approach to assessment; consequently they tagged the tool onto their existing practitioner-led practice. Practitioners who did use the CSNAT as intended were able to act as role models and support their colleagues in making this transition. Practitioners' comments revealed a number of contradictions: 1) Most felt that they 'already do' identify carer support needs, but feared using the CSNAT could increase their workload; 2) some worried about introducing the CSNAT 'too soon', but recognised that it was 'too late' once patients were close to the end of life; 3) whilst practitioners stated 'they were there for the family as well as the patient', care provision was overtly centred around patients. Conclusion This study provides vital insights into barriers and facilitators to implementing the CSNAT as part of a person-centred approach to assessment. The findings identified the training and support required to help practitioners make this transition to this new way of working.	[Austin, Lynn] Univ Manchester, Fac Biol Med & Hlth Sci, Ctr Primary Care, Manchester, Lancs, England; [Ewing, Gail] Univ Cambridge, Ctr Family Res, Cambridge, England; [Grande, Gunn] Univ Manchester, Fac Biol Med & Hlth, Div Nursing Midwifery & Social Work, Manchester, Lancs, England	University of Manchester; University of Cambridge; University of Manchester	Austin, L (corresponding author), Univ Manchester, Fac Biol Med & Hlth Sci, Ctr Primary Care, Manchester, Lancs, England.	lynn.austin@manchester.ac.uk	Austin, Lynn/P-1255-2014	Austin, Lynn/0000-0003-4399-4554	Dimbleby Cancer Care	Dimbleby Cancer Care	This work was supported by the Dimbleby Cancer Care - grant number not allocated. Sole role was to fund the research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot M, 2014, INT J PALLIAT NURS, V20, P9, DOI 10.12968/ijpn.2014.20.1.9; Canadian HPCA, 2013, MOD GUID HOSP PALL C; Connolly M, 2010, PATIENT EDUC COUNS, V79, P87, DOI 10.1016/j.pec.2009.06.004; Deeken JF, 2003, J PAIN SYMPTOM MANAG, V26, P922, DOI 10.1016/S0885-3924(03)00327-0; DH, 2009, END LIF CAR STRAT QU; DH, 2014, TRANSF PRIM CAR SAF; Ewing G, 2016, PALLIATIVE MED, V30, P392, DOI 10.1177/0269216315596662; Ewing Gail, 2015, Br J Community Nurs, V20, P580, DOI 10.12968/bjcn.2015.20.12.580; Ewing G, 2013, J PAIN SYMPTOM MANAG, V46, P395, DOI 10.1016/j.jpainsymman.2012.09.008; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Fields A, 2013, INT J PALLIAT NURS, V19, P558, DOI 10.12968/ijpn.2013.19.11.558; Hileman J W, 1992, Oncol Nurs Forum, V19, P771; Hill HC, 2014, PALLIATIVE MED, V28, P256, DOI 10.1177/0269216313499960; HM Government, 2008, CAR HEART 21 CENT FA; HTH, 2009, ID CAR NEEDS PALL SE; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Levesque L, 2010, INT J NURS STUD, V47, P876, DOI 10.1016/j.ijnurstu.2009.12.006; Lewis J, 2003, QUALITATIVE RES PRAC; National Cancer Action Team, 2010, PROGRAM NATL END LIF; National Council for Palliative Care (NCPC), 2012, WHO CAR SUPP CAR PEO; National Institute for Health and Care Excellence (NICE), 2004, IMPR SUPP PALL CAR A; NCAT, 2011, HOL NEEDS ASS PEOPL; NHS England, 2014, NHS ENG COMM CAR; NHS Improving Quality, 2014, COMM CAR REP FIND OU; NHS Institute for Innovation and Improvement, 2009, SUST GUID; Osse BHP, 2006, CANCER NURS, V29, P378, DOI 10.1097/00002820-200609000-00005; Palliative Care Australia, 2005, STAND PROV QUAL PALL; Payne S., 2013, SUPPORTING FAMILY CA; Salmon Jennifer R, 2005, Am J Hosp Palliat Care, V22, P188, DOI 10.1177/104990910502200307; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042	31	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179287	10.1371/journal.pone.0179287	http://dx.doi.org/10.1371/journal.pone.0179287			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX8NF	28622348	Green Submitted, gold, Green Published			2022-12-26	WOS:000403506300019
J	Gluck, S; Buttafuoco, A; Meier, AF; Arnoldi, F; Vogt, B; Schraner, EM; Ackermann, M; Eichwald, C				Gluck, Selene; Buttafuoco, Antonino; Meier, Anita F.; Arnoldi, Francesca; Vogt, Bernd; Schraner, Elisabeth M.; Ackermann, Mathias; Eichwald, Catherine			Rotavirus replication is correlated with S/G2 interphase arrest of the host cell cycle	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSP5; MESSENGER-RNA; IN-VITRO; VIROPLASM FORMATION; BINDING-PROTEIN; PHOSPHORYLATION; LOCALIZATION; DYNAMICS; GENOME; EG5	In infected cells rotavirus (RV) replicates in viroplasms, cytosolic structures that require a stabilized microtubule (MT) network for their assembly, maintenance of the structure and perinuclear localization. Therefore, we hypothesized that RV could interfere with the MT breakdown that takes place in mitosis during cell division. Using synchronized RV-permissive cells, we show that RV infection arrests the cell cycle in S/G2 phase, thus favoring replication by improving viroplasms formation, viral protein translation, and viral assembly. The arrest in S/G2 phase is independent of the host or viral strain and relies on active RV replication. RV infection causes cyclin B1 down-regulation, consistent with blocking entry into mitosis. With the aid of chemical inhibitors, the cytoskeleton network was linked to specific signaling pathways of the RV-induced cell cycle arrest. We found that upon RV infection Eg5 kinesin was delocalized from the pericentriolar region to the viroplasms. We used a MA104-Fucci system to identify three RV proteins (NSP3, NSP5, and VP2) involved in cell cycle arrest in the S-phase. Our data indicate that there is a strong correlation between the cell cycle arrest and RV replication.	[Gluck, Selene; Buttafuoco, Antonino; Meier, Anita F.; Vogt, Bernd; Schraner, Elisabeth M.; Ackermann, Mathias; Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland; [Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Schraner, Elisabeth M.] Univ Zurich, Inst Anat, Vetsuisse, Zurich, Switzerland; [Gluck, Selene] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Iife Sci, Lausanne, Switzerland	University of Zurich; University of Trieste; University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Eichwald, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	ceichwald@vetvir.uzh.ch	Arnoldi, Francesca/AAQ-6859-2021; Meier, Anita/AAP-5484-2020; ARNOLDI, Francesca/K-5020-2016	Meier, Anita/0000-0002-7691-0735; Eichwald, Catherine/0000-0003-0001-4843; Gluck, Selene/0000-0002-8019-3783; ARNOLDI, Francesca/0000-0003-0651-5526	University of Zurich;  [F-52601-10-01]	University of Zurich; 	This work was supported by a private donation of the late Prof. Dr. Robert Wyler to M.A. (F-52601-10-01) as well as by general funds allocated to M.A. by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova I, 1996, J GEN VIROL, V77, P2059, DOI 10.1099/0022-1317-77-9-2059; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; ALTENBURG BC, 1980, J GEN VIROL, V46, P75, DOI 10.1099/0022-1317-46-1-75; Arias CF, 2015, J VIROL, V89, P890, DOI 10.1128/JVI.01787-14; Arnold Michelle, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c03s15; Arnold MM, 2009, VIRUSES-BASEL, V1, P1035, DOI 10.3390/v1031035; Ayala-Breton C, 2009, J VIROL, V83, P8819, DOI 10.1128/JVI.02308-08; Bagchi P, 2010, J VIROL, V84, P6834, DOI 10.1128/JVI.00225-10; Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10; Bartoli KM, 2011, MOL BIOL CELL, V22, P3420, DOI 10.1091/mbc.E11-03-0211; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Berois M, 2003, J VIROL, V77, P1757, DOI 10.1128/JVI.77.3.1757-1763.2003; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cahu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003936; Campagna M, 2005, J GEN VIROL, V86, P1481, DOI 10.1099/vir.0.80598-0; Campagna M, 2007, J GEN VIROL, V88, P2800, DOI 10.1099/vir.0.82922-0; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Carreno-Torres JJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-350; Cheung W, 2010, J VIROL, V84, P6782, DOI 10.1128/JVI.01757-09; Ciarlet M, 2000, J GEN VIROL, V81, P1237, DOI 10.1099/0022-1317-81-5-1237; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Contin R, 2010, J GEN VIROL, V91, P1782, DOI 10.1099/vir.0.019133-0; Cuadras MA, 2003, VIROLOGY, V313, P308, DOI 10.1016/S0042-6822(03)00326-X; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; De Lorenzo G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166719; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Dresch C, 2008, J IMMUNOL, V181, P4495, DOI 10.4049/jimmunol.181.7.4495; Eichwald C, 2004, P NATL ACAD SCI USA, V101, P16304, DOI 10.1073/pnas.0406691101; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Frias AH, 2012, INNATE IMMUN-LONDON, V18, P294, DOI 10.1177/1753425911401930; Gac M, 2010, VIROLOGY, V404, P293, DOI 10.1016/j.virol.2010.05.018; Gonzalez RA, 2000, ARCH VIROL, V145, P1963, DOI 10.1007/s007050070069; GROENE WS, 1992, J VIROL METHODS, V38, P93, DOI 10.1016/0166-0934(92)90172-A; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Guglielmi KM, 2010, J BIOL CHEM, V285, P18123, DOI 10.1074/jbc.R110.117671; Halasz P, 2010, J GEN VIROL, V91, P2007, DOI 10.1099/vir.0.018275-0; Harper Jane V., 2004, V296, P113; Harper Jane V., 2004, V296, P157; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Laimbacher AS, 2012, MOL THER; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lopez S, 2016, ANNU REV VIROL, V3, P591, DOI 10.1146/annurev-virology-110615-042152; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; McDonald SM, 2011, J VIROL, V85, P3095, DOI 10.1128/JVI.02360-10; Mendez E, 1999, VIROLOGY, V263, P450, DOI 10.1006/viro.1999.9976; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Patton JT, 2006, CURR TOP MICROBIOL, V309, P169; Petris G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096700; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Poncet D, 1997, J VIROL, V71, P34, DOI 10.1128/JVI.71.1.34-41.1997; Rowicka M, 2007, P NATL ACAD SCI USA, V104, P16892, DOI 10.1073/pnas.0706022104; Rubio RM, 2013, J VIROL, V87, P6336, DOI 10.1128/JVI.00361-13; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sanchez-Tacuba L, 2015, J VIROL, V89, P12145, DOI 10.1128/JVI.01874-15; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Sotelo PH, 2010, VIRUS RES, V149, P104, DOI 10.1016/j.virusres.2009.12.006; Sun M, 1997, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V19, P48; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Zeng CQY, 1996, J VIROL, V70, P2736, DOI 10.1128/JVI.70.5.2736-2742.1996	76	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179607	10.1371/journal.pone.0179607	http://dx.doi.org/10.1371/journal.pone.0179607			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622358	Green Published, gold, Green Accepted			2022-12-26	WOS:000403506300043
J	Muche, A; Arendt, T; Schliebs, R				Muche, Abebe; Arendt, Thomas; Schliebs, Reinhard			Oxidative stress affects processing of amyloid precursor protein in vascular endothelial cells	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; SECRETASE ACTIVITY; ALPHA-SECRETASE; TG2576 MICE; ACTIVATION; KINASE; EXPRESSION; CULTURES	Background Oxidative stress is thought to be a key player in the pathogenesis of neurodegenerative dementia, including Alzheimer's disease (AD). It has been assumed that oxidative stress contributes to the beta-amyloid deposition in cerebral blood vessels. Methods In order to prove this hypothesis, we examined the effect of oxidative stress on the processing of amyloid precursor protein (APP) in primary endothelial cells (EC) derived from cerebral cortical tissue of transgenic Tg2576 mice. Following exposure of EC by 1 mu M hydrogen peroxide for up to 48 hours, formation and secretion of APP cleavage products sAPP alpha and sAPP beta into the culture medium as well as the expression of endothelial APP were assessed. Results Oxidative stress resulted in enhanced secretion of sAPP beta into the culture medium as compared to controls (absence of hydrogen peroxide), which was accompanied by an increased APP expression, induction of VEGF synthesis, nitric oxide and oxygen free radicals productions, and differential changes of endothelial phospo-p42/44 MAPK expression. Conclusion The data suggest that oxidative stress may represent a major risk factor in causing A beta deposition in the brain vascular system by initiating the amyloidogenic route of endothelial APP processing. The enhanced beta-secretase activity following oxidative stress exposure, possibly promoted by phosphorylation of p42/44 MAPK.	[Muche, Abebe] Univ Gondar, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Arendt, Thomas; Schliebs, Reinhard] Univ Leipzig, Paul Flechsig Inst Brain Res, Fac Med, Leipzig, Germany	University of Gondar; Leipzig University	Muche, A (corresponding author), Univ Gondar, Dept Human Anat, Coll Med & Hlth Sci, Gondar, Ethiopia.	abemuche@yahoo.com	Arendt, Thomas/C-8747-2012	Muche, Abebe/0000-0003-0258-388X; Arendt, Thomas/0000-0003-4553-1625	Ministry of Research and Education of the State Saxonia; Medical Faculty of the University of Leipzig; Alzheimer Forschungsinitiative (AFI); Deutscher Akademischer Austauschdienst (DAAD)	Ministry of Research and Education of the State Saxonia; Medical Faculty of the University of Leipzig; Alzheimer Forschungsinitiative (AFI); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Funded by Ministry of Research and Education of the State Saxonia, the Medical Faculty of the University of Leipzig, the Alzheimer Forschungsinitiative (AFI), the Deutscher Akademischer Austauschdienst (DAAD).; The expert technical assistance of Mrs. Renate Jendrek is gratefully acknowledged. The authors like to express their gratitude to Dr. Karen Hsiao Ashe, Department of Neurology, University of Minnesota, USA, for kindly providing three Tg2576 founder mice. The study was supported by grants of the Ministry of Research and Education of the State Saxonia, the Medical Faculty of the University of Leipzig, and the Alzheimer Forschungsinitiative (AFI). A.M. gratefully acknowledges the receipt of a scholarship by the Deutscher Akademischer Austauschdienst (DAAD).	Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Burger S, 2010, INT J DEV NEUROSCI, V28, P597, DOI 10.1016/j.ijdevneu.2010.07.231; Burger S, 2009, INT J DEV NEUROSCI, V27, P517, DOI 10.1016/j.ijdevneu.2009.06.011; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Cole SL, 2009, NEUROBIOL AGING, V30, P1535, DOI 10.1016/j.neurobiolaging.2007.12.012; Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009; Desdouits-Magnen J, 1998, J NEUROCHEM, V70, P524; Enciu AM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/297512; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Gahr M, 2013, BRAIN RES, V1519, P19, DOI 10.1016/j.brainres.2013.04.052; GORDON EL, 1991, IN VITRO CELL DEV B, V27, P312; Grinberg LT, 2012, EXP GERONTOL, V47, P838, DOI 10.1016/j.exger.2012.08.005; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Halliwell B, 1997, NUTR REV, V55, pS44, DOI 10.1111/j.1753-4887.1997.tb06100.x; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ichikawa N, 1996, J PHARMACOL TOXICOL, V36, P45, DOI 10.1016/1056-8719(96)00072-X; Kwak YD, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-17; Li S, 2010, NEUROSCI LETT, V470, P106, DOI 10.1016/j.neulet.2009.12.064; Lichtenthaler SF, 2012, CURR ALZHEIMER RES, V9, P165; Lim HJ, 2013, J NUTR BIOCHEM, V24, P1302, DOI 10.1016/j.jnutbio.2012.10.005; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mills J, 1997, J NEUROSCI, V17, P9415; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Muche A, 2015, NUTR NEUROSCI, V18, P1, DOI 10.1179/1476830513Z.000000000112; Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583; Smith EE, 2009, STROKE, V40, P2601, DOI 10.1161/STROKEAHA.108.536839; Sultana R, 2009, ACTA NEUROPATHOL, V118, P131, DOI 10.1007/s00401-009-0517-0; Sun XL, 2012, J NEUROCHEM, V120, P62, DOI 10.1111/j.1471-4159.2011.07515.x; Tamagno E, 2005, J NEUROCHEM, V92, P628, DOI 10.1111/j.1471-4159.2004.02895.x; Vincent B, 2012, CURR ALZHEIMER RES, V9, P140, DOI 10.2174/156720512799361646; Yim SY, 2009, INT J MOL MED, V24, P91, DOI 10.3892/ijmm_00000211; Zhang H, 2011, NEUROCHEM RES, V36, P49, DOI 10.1007/s11064-010-0260-x; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	43	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178127	10.1371/journal.pone.0178127	http://dx.doi.org/10.1371/journal.pone.0178127			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617802	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600005
J	Feng, B; Guo, QS; Zheng, KD; Qin, YX; Du, YJ				Feng, Bo; Guo, Qianshuang; Zheng, Kaidi; Qin, Yuanxia; Du, Yongjun			Antennal transcriptome analysis of the piercing moth Oraesia emarginata (Lepidoptera: Noctuidae)	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEINS; SEX-PHEROMONE; ODORANT-BINDING; GYPSY-MOTH; OLFACTORY GENES; RECEPTORS; EXPRESSION; RESPONSES; FAMILY; IDENTIFICATION	The piercing fruit moth Oraesia emarginata is an economically significant pest; however, our understanding of its olfactory mechanisms in infestation is limited. The present study conducted antennal transcriptome analysis of olfactory genes using real-time quantitative reverse transcription PCR analysis (RT-qPCR). We identified a total of 104 candidate chemosensory genes from several gene families, including 35 olfactory receptors (ORs), 41 odorant-binding proteins, 20 chemosensory proteins, 6 ionotropic receptors, and 2 sensory neuron membrane proteins. Seven candidate pheromone receptors (PRs) and 3 candidate pheromone-binding proteins (PBPs) for sex pheromone recognition were found. OemaOR29 and OemaPBP1 had the highest fragments per kb per million fragments (FPKM) values in all ORs and OBPs, respectively. Eighteen olfactory genes were upregulated in females, including 5 candidate PRs, and 20 olfactory genes were upregulated in males, including 2 candidate PRs (OemaOR29 and 4) and 2 PBPs (OemaPBP1 and 3). These genes may have roles in mediating sex-specific behaviors. Most candidate olfactory genes of sex pheromone recognition (except OemaOR29 and OemaPBP3) in O. emarginata were not clustered with those of studied noctuid species (type I pheromone). In addition, OemaOR29 was belonged to cluster PRIII, which comprise proteins that recognize type II pheromones instead of type I pheromones. The structure and function of olfactory genes that encode sex pheromones in O. emarginata might thus differ from those of other studied noctuids. The findings of the present study may help explain the molecular mechanism underlying olfaction and the evolution of olfactory genes encoding sex pheromones in O. emarginata.	[Feng, Bo; Guo, Qianshuang; Zheng, Kaidi; Du, Yongjun] Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China; [Qin, Yuanxia] Newcon Inc, Dept Res & Dev, Ningbo, Zhejiang, Peoples R China; [Du, Yongjun] Zhejiang Univ, Inst Pesticide & Environm Toxicol, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Zhejiang University	Du, YJ (corresponding author), Wenzhou Med Univ, Inst Hlth & Environm Ecol, Wenzhou, Zhejiang, Peoples R China.; Du, YJ (corresponding author), Zhejiang Univ, Inst Pesticide & Environm Toxicol, Hangzhou, Zhejiang, Peoples R China.	yongjundu@zju.edu.cn			Agro-scientific Research in the Public Interest in China [201203036]; Ningbo Science and Technology Funds [2013C1025]	Agro-scientific Research in the Public Interest in China; Ningbo Science and Technology Funds	This work was supported financially by the Special Fund for Agro-scientific Research in the Public Interest in China (Grant No. 201203036) to YD and Ningbo Science and Technology Funds (Grant No. 2013C1025) to YQ.; We are grateful to Caroline Du (University of California Irvine) for final English correction and enhancement. The Special Fund for Agro-scientific Research in the Public Interest in China (Grant No. 201203036) to YD and Ningbo Science and Technology Funds (Grant No. 2013C1025) to YQ supported this study.	Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Ando T, 2008, J PESTIC SCI, V33, P17, DOI 10.1584/jpestics.R07-06; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Braks MAH, 2007, J CHEM ECOL, V33, P567, DOI 10.1007/s10886-006-9223-8; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Cao DP, 2014, INT J BIOL SCI, V10, P846, DOI 10.7150/ijbs.9297; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Delle-Vedove R, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.52; Ding BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4353; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; Feng Bo, 2015, BMC Genomics, V16; Feng Bo, 2013, Acta Entomologica Sinica, V56, P1440; Goyret J, 2008, P NATL ACAD SCI USA, V105, P4565, DOI 10.1073/pnas.0708629105; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Iatrou K, 2008, INSECT BIOCHEM MOLEC, V38, P268, DOI 10.1016/j.ibmb.2007.11.008; Izumi Y, 2015, APPL ENTOMOL ZOOL, V50, P231, DOI 10.1007/s13355-015-0330-2; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Liu NY, 2013, COMP BIOCHEM PHYS A, V165, P254, DOI 10.1016/j.cbpa.2013.03.016; Liu NY, 2012, COMP BIOCHEM PHYS B, V161, P295, DOI 10.1016/j.cbpb.2011.11.007; McKenzie SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-718; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nieberding CM, 2012, ECOL LETT, V15, P415, DOI 10.1111/j.1461-0248.2012.01748.x; Nieberding CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002751; OHMASA Y, 1991, APPL ENTOMOL ZOOL, V26, P55, DOI 10.1303/aez.26.55; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Reiter S, 2015, J NEUROSCI, V35, P12309, DOI 10.1523/JNEUROSCI.3802-14.2015; Renou M., 2014, NEUROBIOLOGY CHEM CO, V1, P23; Riffell JA, 2014, SCIENCE, V344, P1515, DOI 10.1126/science.1251041; Sanes JT, 2016, ARCH BIOCHEM BIOPHYS, V606, P53, DOI 10.1016/j.abb.2016.07.008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stelinski LL, 2009, NATURWISSENSCHAFTEN, V96, P585, DOI 10.1007/s00114-009-0507-z; Suckling DM, 2010, J CHEM ECOL, V36, P744, DOI 10.1007/s10886-010-9810-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian R, 2007, APPL ENTOMOL ZOOL, V42, P433, DOI 10.1303/aez.2007.433; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Vogt RG, 2015, INSECT BIOCHEM MOLEC, V62, P142, DOI 10.1016/j.ibmb.2015.03.003; Walker WB, 2016, SCI REP-UK, V6, DOI 10.1038/srep23518; Wang HL, 2010, J CHEM ECOL, V36, P535, DOI 10.1007/s10886-010-9777-3; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Watanabe H, 2009, BIOSCI BIOTECH BIOCH, V73, P1443, DOI 10.1271/bbb.90029; Watanabe Hayaki, 2007, Invertebrate Neuroscience, V7, P109, DOI 10.1007/s10158-007-0046-2; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Yang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121261; Yu Y, 2013, BIOORGAN MED CHEM, V21, P1811, DOI 10.1016/j.bmc.2013.01.043; Yu YX, 2012, INT J BIOL SCI, V8, P979, DOI 10.7150/ijbs.4557; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]; Zhang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep18576; ZHANG DD, 2015, FRONT ECOL EVOL, V3; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117054; Zhang LW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164729; Zhang SF, 2014, INSECT BIOCHEM MOLEC, V52, P69, DOI 10.1016/j.ibmb.2014.06.006; Zhang TT, 2012, J INSECT PHYSIOL, V58, P941, DOI 10.1016/j.jinsphys.2012.04.010; Zhang TT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128550; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhu GH, 2016, INSECT BIOCHEM MOLEC, V75, P1, DOI 10.1016/j.ibmb.2016.05.006	73	15	20	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179433	10.1371/journal.pone.0179433	http://dx.doi.org/10.1371/journal.pone.0179433			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614384	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900053
J	Graham, AM; Presnell, JS				Graham, Allie M.; Presnell, Jason S.			Hypoxia Inducible Factor (HIF) transcription factor family expansion, diversification, divergence and selection in eukaryotes	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; FACTOR-I-ALPHA; TRANSACTIVATION DOMAIN; FUNCTIONAL DIVERGENCE; NATURAL-SELECTION; PROTEIN; GENE; EVOLUTION; GENOME; PAS	Hypoxia inducible factor (HIF) transcription factors are crucial for regulating a variety of cellular activities in response to oxygen stress (hypoxia). In this study, we determine the evolutionary history of HIF genes and their associated transactivation domains, as well as perform selection and functional divergence analyses across their four characteristic domains. Here we show that the HIF genes are restricted to metazoans: At least one HIF-a homolog is found within the genomes of non-bilaterians and bilaterian invertebrates, while most vertebrate genomes contain between two and six HIF-alpha genes. We also find widespread purifying selection across all four characteristic domain types, bHLH, PAS, NTAD, CTAD, in HIF-alpha genes, and evidence for Type I functional divergence between HIF-1a, HIF-2a / EPAS, and invertebrate HIF genes. Overall, we describe the evolutionary histories of the HIF transcription factor gene family and its associated transactivation domains in eukaryotes. We show that the NTAD and CTAD domains appear de novo, without any appearance outside of the HIF-alpha subunits. Although they both appear in invertebrates as well as vertebrate HIF-alpha sequences, there seems to have been a substantial loss across invertebrates or were convergently acquired in these few lineages. We reaffirm that HIF-1 alpha is phylogenetically conserved among most metazoans, whereas HIF-2 alpha appeared later. Overall, our findings can be attributed to the substantial integration of this transcription factor family into the critical tasks associated with maintenance of oxygen homeostasis and vascularization, particularly in the vertebrate lineage.	[Graham, Allie M.; Presnell, Jason S.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	University of Miami	Graham, AM (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	graham.allie@gmail.com		Presnell, Jason/0000-0002-7225-6692; Graham, Allie/0000-0001-7404-168X				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carrero P, 2000, MOL CELL BIOL, V20, P402, DOI 10.1128/MCB.20.1.402-415.2000; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; de Mendoza A, 2013, P NATL ACAD SCI USA, V110, pE4858, DOI 10.1073/pnas.1311818110; De S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-275; Derelle R, 2012, MOL BIOL EVOL, V29, P1277, DOI 10.1093/molbev/msr295; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050566; Hoogewijs D, 2007, INTEGR COMP BIOL, V47, P552, DOI 10.1093/icb/icm072; Hopkins SR, 2001, COMMON THEMES ADAPTA, P153; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li Y, 2014, MOL BIOL EVOL, V31, P1200, DOI 10.1093/molbev/msu070; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Murrell B, 2013, MOL BIOL EVOLUTION; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2011, MOL BIOL EVOLUTION; Qu Y, 2013, NATURE COMMUNICATION; Rambaut A, 2009, FIGTREE V1 3 1 TREE; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Rytkonen KT, 2008, GENE, V420, P1, DOI 10.1016/j.gene.2008.04.018; Rytkonen KT, 2007, COMP BIOCHEM PHYS D, V2, P177, DOI 10.1016/j.cbd.2007.03.001; Rytkonen KT, 2014, GENE, V541, P60, DOI 10.1016/j.gene.2014.03.007; Rytkonen KT, 2013, EVOLUTION, V67, P873, DOI 10.1111/j.1558-5646.2012.01820.x; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Semenza GL., 2007, SCI STKE, V2007, pCM8, DOI [DOI 10.1126/STKE.4072007CM8, 10.1126/stke.4072007cm8]; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Soria PS, 2014, MOL BIOL EVOLUTION; Terova G, 2008, AQUACULTURE, V279, P150, DOI 10.1016/j.aquaculture.2008.03.041; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Guiyang, 2014, Oxid Med Cell Longev, V2014, P273692, DOI 10.1155/2014/273692; Wang GD, 2014, GENOME BIOL EVOL, V6, P2122, DOI 10.1093/gbe/evu162; Wang M-S, 2015, MOL BIOL EVOLUTION; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	75	40	40	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179545	10.1371/journal.pone.0179545	http://dx.doi.org/10.1371/journal.pone.0179545			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614393	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900061
J	Jegerlehner, S; Bulliard, JL; Aujesky, D; Rodondi, N; Germann, S; Konzelmann, I; Chiolero, A				Jegerlehner, Sabrina; Bulliard, Jean-Luc; Aujesky, Drahomir; Rodondi, Nicolas; Germann, Simon; Konzelmann, Isabelle; Chiolero, Arnaud		NICER Working Grp	Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study	PLOS ONE			English	Article							MORTALITY; SURVIVAL; EPIDEMIC; NODULES; SURGERY	Background The increase in incidence of thyroid cancer during the last decades without concomitant rise in mortality may reflect the growing detection of indolent forms of thyroid cancer, and may have fueled unnecessary thyroidectomies. Our aim was therefore, to compare recent secular trends in surgical intervention rate for thyroid cancer with the incidence and mortality of thyroid cancer to assess overdiagnosis and resulting overtreatment. Methods We conducted a population-based temporal trend study in Switzerland from 1998 to 2012. All cases of invasive thyroid cancer, deaths from thyroid cancer, and cancer-related thyroidectomies were analyzed. We calculated changes in age-standardized thyroid cancer incidence rates, stratified by histologic subtype and tumor stage, thyroid cancer-specific mortality, and thyroidectomy rates. Results Between 1998 and 2012, the age-standardized annual incidence of thyroid cancer increased from 5.9 to 11.7 cases/100,000 among women (annual mean absolute increase: + 0.43/100,000/year) and from 2.7 to 3.9 cases/100,000 among men (+ 0.11/100,000/year). The increase was limited to the papillary subtype, the most indolent form of thyroid cancer. The incidence of early stages increased sharply, the incidence of advanced stages increased marginally, and the mortality from thyroid cancer decreased slightly. There was a three-to four-fold increase in the age-standardized annual thyroidectomy rate in both sexes. Conclusions We observed a large increase in the incidence of thyroid cancer, limited to papillary and early stage tumors, with a three-to four-fold parallel increase in thyroidectomy. The mortality slightly decreased. These findings suggest that a substantial and growing part of the detected thyroid cancers are overdiagnosed and overtreated. Impact Targeted screening and diagnostic strategies are warranted to avoid overdetection and unnecessary treatment of thyroid cancers.	[Jegerlehner, Sabrina; Aujesky, Drahomir; Rodondi, Nicolas] Univ Bern, Bern Univ Hosp, Inselspital, Div Gen Internal Med, Bern, Switzerland; [Bulliard, Jean-Luc; Germann, Simon; Chiolero, Arnaud] Lausanne Univ Hosp, IUMSP, Div Chron Dis, Lausanne, Switzerland; [Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Germann, Simon; Konzelmann, Isabelle; Chiolero, Arnaud] OVS, Sion, Switzerland; [Chiolero, Arnaud] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada	University of Bern; University Hospital of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; McGill University	Jegerlehner, S (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Div Gen Internal Med, Bern, Switzerland.	sabrina.jegerlehner@insel.ch	Herrmann, Christian/J-1094-2019; Bulliard, Jean-Luc/AAA-7481-2021	Herrmann, Christian/0000-0001-9349-8917; Bulliard, Jean-Luc/0000-0001-9750-2709; Chiolero, Arnaud/0000-0002-5544-8510; Rodondi, Nicolas/0000-0001-9083-6896; Mousavi, Seyed Mohsen/0000-0003-3537-6799	Swiss Society of General Internal Medicine (SGIM) [SF2015/1]	Swiss Society of General Internal Medicine (SGIM)	This work was supported from the Swiss Society of General Internal Medicine (SGIM) [Grant number SF2015/1], (http://www.sgaim.ch/de/forschung/kontakt-sgim-foundation.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; AKSLEN LA, 1990, APMIS, V98, P549, DOI 10.1111/j.1699-0463.1990.tb01070.x; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1882, DOI 10.1001/jama.2017.4011; Bosetti C, 2013, ANN ONCOL, V24, P2657, DOI 10.1093/annonc/mdt301; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Bulliard JL, 2015, PUBLIC HEALTH REV, V36, DOI 10.1186/s40985-015-0012-1; Bundesamt fur Gesundheit (BAG), 2015, JAHRESBERICHT UMWELT; Bundesamt fur Gesundheit (BAG), 2011, 20 JAHR NACH TSCHERN; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chan DSY, 2014, SURG-J R COLL SURG E, V12, P195, DOI 10.1016/j.surge.2013.11.020; Cherenfant J, 2013, SURGERY, V154, P1016, DOI 10.1016/j.surg.2013.04.055; Chiolero A, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14060; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Fagin JA, 2016, NEW ENGL J MED, V375, P1054, DOI 10.1056/NEJMra1501993; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hall P, 1998, ACTA ONCOL, V37, P325, DOI 10.1080/028418698430539; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hedinger, 2012, HISTOLOGICAL TYPING; Ho AS, 2015, CANCER-AM CANCER SOC, V121, P1793, DOI 10.1002/cncr.29289; Husson O, 2013, ENDOCR-RELAT CANCER, V20, P263, DOI 10.1530/ERC-12-0336; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lim H, 2017, JAMA-J AM MED ASSOC, V317, P1338, DOI 10.1001/jama.2017.2719; Loyo M, 2013, LARYNGOSCOPE, V123, P2056, DOI 10.1002/lary.23923; Montanaro F, 2006, EUR J CANCER PREV, V15, P178, DOI 10.1097/01.cej.0000197450.94980.36; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Normile D, 2016, SCIENCE, V351, P1022, DOI 10.1126/science.351.6277.1022; Pettersson B, 1993, BRIT J CANCER, V67, P330; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Schweizerische Operationsklassifikation (CHOP), SCHWEIZ OP CHOP; SILVA ID, 1993, BRIT J CANCER, V67, P330, DOI 10.1038/bjc.1993.61; Sosa JA, 2013, SURGERY, V154, P1420, DOI 10.1016/j.surg.2013.07.006; Storm H, 2005, EUR J CANCER PREV, V14, P309; Takamura N, 2016, LANCET DIABETES ENDO, V4, P647, DOI 10.1016/S2213-8587(16)30112-7; Tufano RP, 2015, JAMA OTOLARYNGOL, V141, P566, DOI 10.1001/jamaoto.2015.0647; UN Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), UNSCEAR 2008 REP, VII; Van den Bruel A, 2013, J CLIN ENDOCR METAB, V98, P4063, DOI 10.1210/jc.2013-1705; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	42	88	89	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179387	10.1371/journal.pone.0179387	http://dx.doi.org/10.1371/journal.pone.0179387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614405	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900047
J	Zeller, KA; Vickers, TW; Ernest, HB; Boyce, WM				Zeller, Katherine A.; Vickers, T. Winston; Ernest, Holly B.; Boyce, Walter M.			Multi-level, multi-scale resource selection functions and resistance surfaces for conservation planning: Pumas as a case study	PLOS ONE			English	Article							HOME-RANGE SIZE; GENE FLOW; HABITAT; CONNECTIVITY; LANDSCAPE; MOVEMENTS; SCALE; PERFORMANCE; DISTANCE	The importance of examining multiple hierarchical levels when modeling resource use for wildlife has been acknowledged for decades. Multi-level resource selection functions have recently been promoted as a method to synthesize resource use across nested organizational levels into a single predictive surface. Analyzing multiple scales of selection within each hierarchical level further strengthens multi-level resource selection functions. We extend this multi-level, multi-scale framework to modeling resistance for wildlife by combining multi-scale resistance surfaces from two data types, genetic and movement. Resistance estimation has typically been conducted with one of these data types, or compared between the two. However, we contend it is not an either/or issue and that resistance may be better-modeled using a combination of resistance surfaces that represent processes at different hierarchical levels. Resistance surfaces estimated from genetic data characterize temporally broad-scale dispersal and successful breeding over generations, whereas resistance surfaces estimated from movement data represent fine-scale travel and contextualized movement decisions. We used telemetry and genetic data from a long-term study on pumas (Puma concolor) in a highly developed landscape in southern California to develop a multilevel, multi-scale resource selection function and a multi-level, multi-scale resistance surface. We used these multi-level, multi-scale surfaces to identify resource use patches and resistant kernel corridors. Across levels, we found puma avoided urban, agricultural areas, and roads and preferred riparian areas and more rugged terrain. For other landscape features, selection differed among levels, as did the scales of selection for each feature. With these results, we developed a conservation plan for one of the most isolated puma populations in the U.S. Our approach captured a wide spectrum of ecological relationships for a population, resulted in effective conservation planning, and can be readily applied to other wildlife species.	[Zeller, Katherine A.] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Vickers, T. Winston; Boyce, Walter M.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Davis, CA 95616 USA; [Ernest, Holly B.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA	University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Davis; University of Wyoming	Zeller, KA (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	kathyzeller@gmail.com	Ernest, Holly/D-5731-2012	Ernest, Holly/0000-0002-0205-8818	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation; Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies	California State Department of Parks and Recreation; California Department of Fish and Wildlife; Nature Conservancy; McBeth Foundation; Anza Borrego Foundation; Nature Reserve of Orange County; National Science Foundation(National Science Foundation (NSF)); Foothill/Eastern Transportation Corridor Agency; San Diego County Association of Governments Environmental Mitigation Program; San Diego Foundation; Felidae Conservation Fund; Mountain Lion Foundation; Santa Rosa Plateau Foundation; Institute for Wildlife Studies	This work was supported by the California State Department of Parks and Recreation (WMB; http//www.parks.ca.gov/), California Department of Fish and Wildlife (WMB; https://www.dfg.ca.gov/), The Nature Conservancy (WMB, TWV, SAM, HBE; http://www.nature.org/), The McBeth Foundation (WMB, TWV; http:// mcbethfoundation.com/), The Anza Borrego Foundation (WMB; http://theabf.org/), The Nature Reserve of Orange County (TWV, HBE, WMB; http://www.naturereserveoc.org/), The National Science Foundation (WMB; http://www.nsf.gov/), The Foothill/Eastern Transportation Corridor Agency (TWV, WMB, PRH; https://www. thetollroads.com/), San Diego County Association of Governments Environmental Mitigation Program (TWV, WMB; http://vww.sandag.org/index.asp? classid=17&projectid=263&fuseaction=projects.detail), The San Diego Foundation (TWV; http://www.sdfoundation.org/), Felidae Conservation Fund (WMB, TWV; http://www.felidaefund.org/), The Mountain Lion Foundation (TWV; Http://www. mountanlion.org/), the Santa Rosa Plateau Foundation (TWV; http://www.srpf.org/), the Institute for Wildlife Studies (TWV; http://www.iws.org), and private donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahms B, 2016, J APPL ECOL; ADDICOTT JF, 1987, OIKOS, V49, P340, DOI 10.2307/3565770; Barton K., MUMIN MULTIMODEL INF; Bauder J, MULTILEVEL MULTISCAL; Bauder JM, 2015, WILDLIFE RES, V42, P437, DOI 10.1071/WR14233; BEIER P, 1993, CONSERV BIOL, V7, P94, DOI 10.1046/j.1523-1739.1993.07010094.x; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Beier P., 2007, CONCEPTUAL STEPS DES; Benson JF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0957; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Coulon A, 2008, LANDSCAPE ECOL, V23, P603, DOI 10.1007/s10980-008-9220-0; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Cushman Samuel A., 2014, Diversity-Basel, V6, P844; Cushman SA, 2010, LANDSCAPE ECOL, V25, P1613, DOI 10.1007/s10980-010-9534-6; Cushman SA, 2010, SPATIAL COMPLEXITY, INFORMATICS, AND WILDLIFE CONSERVATION, P349, DOI 10.1007/978-4-431-87771-4_19; DeCesare NJ, 2006, J MAMMAL, V87, P531, DOI 10.1644/05-MAMM-A-259R1.1; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Duong T., R PACKAGE VERSION; Ernest HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107985; Estrada E.G., 2012, GPDTEST BOOTSTRAP GO; Fieberg J, 2007, ECOLOGY, V88, P1059, DOI 10.1890/06-0930; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gilleland E., 2013, TN502STR17 NCAR; Gonzalez--Borrajo N, 2017, MAMMAL REV, V47, P62, DOI 10.1111/mam.12081; Grigione MM, 2002, ANIM CONSERV, V5, P317, DOI 10.1017/S1367943002004079; Gustafson KD, SINGLE MIGRANT ENHAN; Hardin JW, 2012, GEN ESTIMATING EQUAT; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Jenness J., 2013, DEM SURFACE TOOLS; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; McGarigal K, 2016, LANDSCAPE ECOL, V31, P1161, DOI 10.1007/s10980-016-0374-x; Morrison SA, 2009, CONSERV BIOL, V23, P275, DOI 10.1111/j.1523-1739.2008.01079.x; NEI M, 1978, GENETICS, V89, P583; Nielsen C.K., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T18868A50663436.EN]; Nielson SE, 2002, URSUS, V13, P45; Pitman RT, 2017, J APPL ECOL; R Core Team, 2018, R LANGUAGE ENV STAT; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Shirk A, MOL ECOL RESOUR; Shirk AJ, 2014, ECOL APPL, V24, P1434, DOI 10.1890/13-1510.1; Storch I, 2003, LANDSCAPE ECOLOGY AND RESOURCE MANAGEMENT: LINKING THEORY WITH PRACTICE, P303; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; vansEtten J., 2015, GDISTANCE DISTANCES, P1; Vickers TW, 2015, PLOS ONE; Wasserman T., 2012, USDA FOREST SERVICE; Weaver JE, 2012, LANDSCAPE ECOL, V27, P1351, DOI 10.1007/s10980-012-9786-4; Wheatley M, 2009, ECOL COMPLEX, V6, P150, DOI 10.1016/j.ecocom.2008.10.011; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Zeller KA, 2016, LANDSCAPE ECOL, V31, P1319, DOI 10.1007/s10980-015-0301-6; Zeller KA, 2014, LANDSCAPE ECOL, V29, P541, DOI 10.1007/s10980-014-9991-4; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	65	59	59	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179570	10.1371/journal.pone.0179570	http://dx.doi.org/10.1371/journal.pone.0179570			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609466	Green Published, Green Submitted, gold			2022-12-26	WOS:000403274700043
J	De Groef, A; Van Kampen, M; Vervloesem, N; De Geyter, S; Dieltjens, E; Christiaens, MR; Neven, P; Geraerts, I; Devoogdt, N				De Groef, An; Van Kampen, Marijke; Vervloesem, Nele; De Geyter, Sophie; Dieltjens, Evi; Christiaens, Marie-Rose; Neven, Patrick; Geraerts, Inge; Devoogdt, Nele			An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability	PLOS ONE			English	Article							TRIGGER POINTS; PAIN; SURGERY	Purpose To develop a tool to evaluate myofascial adhesions objectively in patients with breast cancer and to investigate its interrater reliability. Methods 1) Development of the evaluation tool. Literature was searched, experts in the field of myofascial therapy were consulted and pilot testing was performed. 2) Thirty patients (63% had a mastectomy, 37% breast-conserving surgery and 97% radiotherapy) with myofascial adhesions were evaluated using the developed tool by 2 independent raters. The Weighted Kappa (WK) and the intra-class correlation coefficient (ICC) were calculated. Results 1) The evaluation tool for Myofascial Adhesions in Patients with Breast Cancer (MAP-BC evaluation tool) consisted of the assessment of myofascial adhesions at 7 locations: axillary and breast region scars, musculi pectorales region, axilla, frontal chest wall, lateral chest wall and the inframammary fold. At each location the degree of the myofascial adhesion was scored at three levels (skin, superficial and deep) on a 4-points scale (between no adhesions and very stiff adhesions). Additionally, a total score (0-9) was calculated, i.e. the sum of the different levels of each location. 2) Interrater agreement of the different levels separately was moderate for the axillary and mastectomy scar (WK 0.62-0.73) and good for the scar on the breast (WK > 0.75). Moderate agreement was reached for almost all levels of the non-scar locations. Interrater reliability of the total scores was the highest for the scars (ICC0.82-0.99). At non-scar locations good interrater reliability was reached, except for the inframammary fold (ICC = 0.71). Conclusions The total scores of all locations of the MAP-BC evaluation tool had good to excellent interrater reliability, except for the inframammary fold which only reached moderate reliability.	[De Groef, An; Van Kampen, Marijke; Vervloesem, Nele; De Geyter, Sophie; Dieltjens, Evi; Geraerts, Inge; Devoogdt, Nele] Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium; [De Groef, An; Van Kampen, Marijke; Vervloesem, Nele; De Geyter, Sophie; Dieltjens, Evi; Geraerts, Inge; Devoogdt, Nele] Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium; [Christiaens, Marie-Rose; Neven, Patrick] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Christiaens, Marie-Rose] Univ Leuven, KU Leuven, Dept Surg Oncol, Leuven, Belgium; [Neven, Patrick] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven	De Groef, A (corresponding author), Univ Leuven, KU Leuven, Dept Rehabil Sci, Leuven, Belgium.; De Groef, A (corresponding author), Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium.	an.degroef@kuleuven.be	De Groef, An/C-1724-2015; De Groef, An/AAA-9841-2021; Devoogdt, Nele/AAB-3933-2020	De Groef, An/0000-0001-6771-2836; De Groef, An/0000-0001-6771-2836; Devoogdt, Nele/0000-0002-8117-7080; Vervloesem, Nele/0000-0002-8900-7764; Geraerts, Inge/0000-0003-3617-6334	agency for Innovation by Science and Technology (Applied Biomedical Research) [IWT 110703]	agency for Innovation by Science and Technology (Applied Biomedical Research)	This study was funded by the agency for Innovation by Science and Technology (Applied Biomedical Research) (IWT 110703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the agency for Innovation by Science and Technology (Applied Biomedical Research) (IWT 110703). The authors have no further conflicts of interest.	Bergmann A, 2012, BREAST CANCER RES TR, V131, P987, DOI 10.1007/s10549-011-1805-7; Cheville AL, 2007, J SURG ONCOL, V95, P409, DOI 10.1002/jso.20782; Fernandez-Lao C, 2012, CLIN J PAIN, V28, P113, DOI 10.1097/AJP.0b013e318225dc02; Fernandez-Lao C, 2010, CLIN J PAIN, V26, P798, DOI 10.1097/AJP.0b013e3181f18c36; Fourie WJ, 2008, J BODYW MOV THER, V12, P349, DOI 10.1016/j.jbmt.2008.04.043; Gebruers N, 2015, ARCH PHYS MED REHAB, V96, P1131, DOI 10.1016/j.apmr.2015.01.014; Hidding JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096748; Karki A, 2005, J REHABIL MED, V37, P180, DOI 10.1080/16501970410024181; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Lewit K, 2004, J MANIP PHYSIOL THER, V27, P399, DOI 10.1016/j.jmpt.2004.05.004; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simons D., 1999, MYOFASCIAL PAIN DYSF; Stubblefield MD, 2014, PM&R, V6, P170, DOI 10.1016/j.pmrj.2013.08.605; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Lacomba MT, 2010, CLIN J PAIN, V26, P320, DOI 10.1097/AJP.0b013e3181c4904a; Wickstrom G, 2000, SCAND J WORK ENV HEA, V26, P363, DOI 10.5271/sjweh.555	18	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179116	10.1371/journal.pone.0179116	http://dx.doi.org/10.1371/journal.pone.0179116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598978	gold, Green Published, Green Submitted			2022-12-26	WOS:000402992000025
J	George, J; Mathur, R; Shah, AD; Pujades-Rodriguez, M; Denaxas, S; Smeeth, L; Timmis, A; Hemingway, H				George, Julie; Mathur, Rohini; Shah, Anoop Dinesh; Pujades-Rodriguez, Mar; Denaxas, Spiros; Smeeth, Liam; Timmis, Adam; Hemingway, Harry			Ethnicity and the first diagnosis of a wide range of cardiovascular diseases: Associations in a linked electronic health record cohort of 1 million patients	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; CORONARY-HEART-DISEASE; SOUTH ASIANS; SCOTTISH HEALTH; ATHEROSCLEROSIS RISK; LIFETIME RISKS; FOLLOW-UP; STROKE; FAILURE; LINKAGE	Background While the association of ethnic group with individual cardiovascular diseases has been studied, little is known about ethnic differences in the initial lifetime presentation of clinical cardiovascular disease in contemporary populations. Methods and results We studied 1,068,318 people, aged >= 30 years and free from diagnosed CVD at baseline (90.9% White, 3.6% South Asian and 2.9% Black), using English linked electronic health records covering primary care, hospital admissions, acute coronary syndrome registry and mortality registry (CALIBER platform). During 5.7 years median follow-up between 1997-2010, 95,224 people experienced an incident cardiovascular diagnosis. 69.9% (67.2%-72.4%) of initial presentation in South Asian < 60 yrs were coronary heart disease presentations compared to 47.8% (47.3%-48.3%) in White and 40.1% (36.3%-43.9%) in Black patients. Compared to White patients, Black patients had significantly lower age-sex adjusted hazard ratios (HRs) for initial lifetime presentation of all the coronary disease diagnoses (stable angina HR 0.80 (95% CI 0.68-0.93); unstable angina-0.75 (0.59-0.97); myocardial infarction 0.49 (0.40-0.62)) while South Asian patients had significantly higher HRs (stable angina-1.67 (1.52-1.84); unstable angina 1.82 (1.56-2.13); myocardial infarction-1.67 (1.49-1.87). We found no ethnic differences in initial presentation with heart failure (Black 0.97 (0.79-1.20); S Asian 1.04(0.87-1.26)). Compared to White patients, Black patients were more likely to present with ischaemic stroke (1.24 (0.97-1.58)) and intracerebral haemorrhage (1.44 (0.97-2.12)). Presentation with peripheral arterial disease was less likely for Black (0.63 (0.50-0.80)) and South Asian patients (0.70 ( 0.57-0.86)) compared with White patients. Discussion While we found the anticipated substantial predominance of coronary heart disease presentations in South Asian and predominance of stroke presentations in Black patients, we found no ethnic differences in presentation with heart failure. We consider the public health and research implications of our findings.	[George, Julie; Shah, Anoop Dinesh; Pujades-Rodriguez, Mar; Denaxas, Spiros; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, Biomed Res Ctr, London, England; [George, Julie; Shah, Anoop Dinesh; Pujades-Rodriguez, Mar; Denaxas, Spiros; Hemingway, Harry] UCL, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Mathur, Rohini; Smeeth, Liam] London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol, Elect Hlth Records Grp, London, England; [Pujades-Rodriguez, Mar] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Timmis, Adam] Barts Heart Ctr, NIHR Cardiovasc Biomed Res Unit, London, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Leeds	George, J (corresponding author), UCL, Farr Inst Hlth Informat Res, Biomed Res Ctr, London, England.; George, J (corresponding author), UCL, Natl Inst Hlth Res, Biomed Res Ctr, London, England.	j.george@ucl.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Pujades-Rodriguez, Mar/T-1129-2018; Hemingway, Harry/C-1219-2009; Smeeth, Liam/X-5862-2018	Shah, Anoop Dinesh/0000-0002-8907-5724; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Hemingway, Harry/0000-0003-2279-0624; Denaxas, Spiros/0000-0001-9612-7791; Smeeth, Liam/0000-0002-9168-6022	National Institute for Health Research [RP-PG-040710314]; Wellcome Trust [WT/086091/Z/08/Z]; Medical Research Council [MR/K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research (NIHR); Wellcome Trust; Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust [WT/201375/Z/16/Z]; Wellcome Trust Clinical Research Training Fellowship [WT/0938/30/Z/10/Z]; Wellcome Trust Senior Research Fellowship in Clinical Science [WT/098504/Z/12/Z]; NIHR; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (NIHR); Wellcome Trust(Wellcome Trust); Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust; Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the National Institute for Health Research (RP-PG-040710314) and the Wellcome Trust (WT/086091/Z/08/Z). The study was carried out as part of the CArdiovascular disease research using LInked Bespoke studies and Electronic health Records (CALIBER) programme. HH was supported by an award (grant MR/K006584/1) to establish the Farr Institute of Health Informatics Research London at UCLPartners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research (NIHR), and Wellcome Trust. HH is a NIHR Senior Investigator (NF-SI-0616-10066.). RM was supported by a Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust (WT/201375/Z/16/Z). ADS was supported by a Wellcome Trust Clinical Research Training Fellowship (WT/0938/30/Z/10/Z). LS was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (WT/098504/Z/12/Z). This article presents independent research funded in part by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FS, 2016, JACC-HEART FAIL, V4, P911, DOI 10.1016/j.jchf.2016.08.001; Bahrarni H, 2008, ARCH INTERN MED, V168, P2138, DOI 10.1001/archinte.168.19.2138; Bansal N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003415; Bates DW, 2014, HEALTH AFFAIR, V33, P1123, DOI 10.1377/hlthaff.2014.0041; Becares L, 2013, HEALTH PLACE, V22, P48, DOI 10.1016/j.healthplace.2013.03.005; Bell S, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j909; Bennett PC, 2009, QJM-INT J MED, V102, P3, DOI 10.1093/qjmed/hcn140; Bhopal RS, 2012, EUR J PREV CARDIOL, V19, P1503, DOI 10.1177/1741826711423217; Bhopal RS, 2012, HEART, V98, P468, DOI 10.1136/heartjnl-2011-301191; Bhopal RS, 2012, EUR J PREV CARDIOL, V19, P1250, DOI 10.1177/1741826711425775; Bhopal RS, 2002, BRIT MED J, V325, P903; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Daskalopoulou M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153838; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Feinstein M, 2012, CIRCULATION, V126, P50, DOI 10.1161/CIRCULATIONAHA.111.057232; Fischbacher CM, 2014, INT J EPIDEMIOL, V43, P129, DOI 10.1093/ije/dyt237; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Gallagher AM, 2011, PHARMACOEPIDEM DR S, pS1; General Practitioners Committee British Medical Association, 2003, INV GEN PRACT NEW GE; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Gill PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026710; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hamaad A, 2006, INT J CARDIOL, V107, P235, DOI 10.1016/j.ijcard.2005.03.020; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hull SA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572544; Ix JH, 2008, J AM COLL CARDIOL, V51, P2347, DOI 10.1016/j.jacc.2008.03.022; Kovesdy CP, 2015, CIRCULATION, V132, P1538, DOI 10.1161/CIRCULATIONAHA.114.015124; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; McLennan D., 2011, ENGLISH INDICES DEPR; National Institute for Health and Clinical Excellence, 2014, CARD DIS RISK ASS RE; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Noble M, 2007, ENGLISH INDICES DEPR; Office for National Statistics, 2016, DEATHS REG ENGL WAL; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Robson J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007578; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Safford MM, 2012, JAMA-J AM MED ASSOC, V308, P1768, DOI 10.1001/jama.2012.14306; Scarborough P, 2010, ETHNIC DIFFERENCES C; Sebastianski M, 2014, HEART, V100, P100, DOI 10.1136/heartjnl-2013-303605; Shah AS, 2010, HEART, V96, P27, DOI 10.1136/hrt.2009.170183; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Smith GD., 2000, CRITICAL PUBLIC HLTH, V10, P375, DOI DOI 10.1080/09581590010005331; Sundquist K, 2004, J EPIDEMIOL COMMUN H, V58, P71, DOI 10.1136/jech.58.1.71; Tillin T, 2014, HEART, V100, P60, DOI 10.1136/heartjnl-2013-304474; Tillin T, 2013, J AM COLL CARDIOL, V61, P1777, DOI 10.1016/j.jacc.2012.12.046; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Vascular Programme (Department of Health), 2008, PUTT PREV 1 VASC CHE; Wang YZ, 2013, STROKE, V44, P3298, DOI 10.1161/STROKEAHA.113.002604; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Zaman MJS, 2011, J PUBLIC HEALTH-UK, V33, P430, DOI 10.1093/pubmed/fdq093; Zaman MJS, 2013, HEART, V99, P729, DOI 10.1136/heartjnl-2012-302925	59	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178945	10.1371/journal.pone.0178945	http://dx.doi.org/10.1371/journal.pone.0178945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598987	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000402992000016
J	Wang, YZ; Cao, XM; Zhao, YQ; Fei, J; Hu, XX; Li, N				Wang, Yuzhe; Cao, Xuemin; Zhao, Yiqiang; Fei, Jing; Hu, Xiaoxiang; Li, Ning			Optimized double-digest genotyping by sequencing (ddGBS) method with high-density SNP markers and high genotyping accuracy for chickens	PLOS ONE			English	Article							REDUCED REPRESENTATION LIBRARIES; LINKAGE DISEQUILIBRIUM; HIGH-THROUGHPUT; GENOME; POPULATION; DISCOVERY; TRAITS; DIVERSITY; FUTURE; LINES	High-density single nucleotide polymorphism (SNP) markers are crucial to improve the resolution and accuracy of genome-wide association study (GWAS) and genomic selection (GS). Numerous approaches, including whole genome sequencing, genome sampling sequencing, and SNP chips are able to discover or genotype markers at different densities and costs. Achieving an optimal balance between sequencing resolution and budgets, especially in large-scale population genetics research, constitutes a major challenge. Here, we performed improved double-enzyme digestion genotyping by sequencing (ddGBS) on chicken. We evaluated eight double-enzyme digestion combinations, and EcoR I-Mse I was chosen as the optimal combination for the chicken genome. We firstly proposed that two parameters, optimal read-count point (ORP) and saturated read-count point (SRP), could be utilized to determine the optimal sequencing volume. A total of 291,772 high-density SNPs from 824 animals were identified. By validation using the SNP chip, we found that the consistency between ddGBS data and the SNP chip is over 99%. The approach that we developed in chickens, which is high-quality, high-density, cost-effective (300 K, $30/sample), and time-saving (within 48 h), will have broad applications in animal breeding programs.	[Wang, Yuzhe; Cao, Xuemin; Zhao, Yiqiang; Fei, Jing; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China; [Li, Ning] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China.	huxx@cau.edu.cn			948 Program of the Ministry of Agriculture of China [2012-G1[4]]; National High Technology Research and Development Program of China [2013AA102501]; National Natural Science Foundation of China (NSFC) [31272432]	948 Program of the Ministry of Agriculture of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was financially supported by grants from the 948 Program of the Ministry of Agriculture of China (2012-G1[4]), the National High Technology Research and Development Program of China (2013AA102501), and the National Natural Science Foundation of China (NSFC, 31272432).; This study was financially supported by grants from the National High Technology Research and Development Program of China (2013AA102501) the National Natural Science Foundation of China (NSFC, 31272432) and the 948 Program of the Ministry of Agriculture of China (2012-G1[4]). We thank Jiangli Ren and Yebo Peng for their assistance with library construction and sequencing data analysis. We also thank Zhaoliang Liu, Yujun Zhang, and Fei Gao for improving the manuscript.	Aerts J, 2007, CYTOGENET GENOME RES, V117, P338, DOI 10.1159/000103196; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Andreescu C, 2007, GENETICS, V177, P2161, DOI 10.1534/genetics.107.082206; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Andrews KR, 2014, MOL ECOL, V23, P1661, DOI 10.1111/mec.12686; Arends D, 2016, INT J OBESITY, V40, P1784, DOI 10.1038/ijo.2016.150; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Besnier F, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-3; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Byrne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057438; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cromie GA, 2013, G3-GENES GENOM GENET, V3, P2163, DOI 10.1534/g3.113.007492; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Gardner KM, 2014, G3-GENES GENOM GENET, V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jiang ZH, 2016, INT J BIOL SCI, V12, P100, DOI 10.7150/ijbs.13498; Kerstens HHD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-94; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liao RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137010; Malavera A, 2015, EXPERT REV MED DEVIC, V12, P679, DOI 10.1586/17434440.2015.1090308; Megens HJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-86; Myers G, 1999, J ACM, V46, P395, DOI 10.1145/316542.316550; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Parker CC, 2014, GENETICS, V198, P103, DOI 10.1534/genetics.114.167056; Parker CC, 2012, BEHAV GENET, V42, P437, DOI 10.1007/s10519-011-9524-8; Pertille F, 2016, SCI REP-UK, V6, DOI 10.1038/srep26929; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pettersson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002180; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Scheben A, 2016, PLANT BIOTECHNOL J; Sheng ZY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-151; Toonen RJ, 2013, PEERJ, V1, DOI 10.7717/peerj.203; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Wyatt AW, 2013, ASIAN J ANDROL, V15, P301, DOI 10.1038/aja.2013.13; Zhai ZX, 2015, ANIM GENET, V46, P216, DOI 10.1111/age.12250	48	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179073	10.1371/journal.pone.0179073	http://dx.doi.org/10.1371/journal.pone.0179073			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598985	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000021
J	Tian, R; Wang, J; Yan, H; Wu, J; Xu, Q; Zhan, X; Gui, Z; Ding, M; He, J				Tian, R.; Wang, J.; Yan, H.; Wu, J.; Xu, Q.; Zhan, X.; Gui, Z.; Ding, M.; He, J.			Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis	ONCOGENE			English	Article							MICRORNA-21 EXPRESSION; MIR-125B INHIBITOR; BRAIN-TUMORS; GLIOMA; INVASION; TEMOZOLOMIDE; METAANALYSIS; BIOMARKERS; APOPTOSIS; MIR-16-1	The function of miR16 in multiforme glioblastoma multiforme (GBM) and its stem cells (GSCs) remains elusive. To this end, we investigated the patterns of miR16 expression in these cells and their correlation with malignant behaviors and clinical outcomes. The levels of miR16 and its targeted genes in tumor tissue of GBM and GBM SGH44, U87, U251 cells as well as their stem cell counterparts were measured by qRT-PCR or western blot or immunohistochemistry. Luciferase reporter assay was used to confirm the binding of miR16 to 3'-UTR of its target genes. The effects of miR16 on malignant behaviors were investigated, including tumor cell viability, soft-agar colony formation, GSCs Matrigel colony forming and migration and invasion as well as nude mice xenograft model. Differentially expression patterns of miR16 in glioblastoma cells and GSCs cells were found in this study. Changes of miR16 targeted genes, Bcl2 (B cell lymphoma 2), CDK6 (Cyclin-dependent kinase 6), CCND1 (cyclin D1), CCNE1 (cyclin E1) and SOX5 were confirmed in glioblastoma cell lines and tissue specimens. In vitro and in vivo studies showed that tumor cell proliferation was inhibited by miR16 mimic, but enhanced by miR16 inhibitor. The expression level of miR16 positively correlates with GSCs differentiation, but negatively with the abilities of migration, motility, invasion and colony formation in glioblastoma cells. The inhibitory effects of miR16 on its target genes were also found in nude mice xenograft model. Our findings revealed that the miR16 functions as a tumor suppressor in GSCs and its association with prognosis in GBM.	Anhui Med Univ, Anhui Prov Hosp Affiliated, Dept Pathol, Hefei, Anhui, Peoples R China; [He, J.] Anhui Prov Canc Hosp, 107 Huan Hu Dong Rd, Hefei 230031, Anhui, Peoples R China	Anhui Medical University	He, J (corresponding author), Anhui Prov Canc Hosp, 107 Huan Hu Dong Rd, Hefei 230031, Anhui, Peoples R China.; He, J (corresponding author), Anhui Med Univ, Anhui Prov Hosp Affiliated, 107 Huan Hu Dong Rd, Hefei 230031, Anhui, Peoples R China.	hejie2005g@sina.com			National Natural Science of China [81272800, 81072057, 8152323]	National Natural Science of China(National Natural Science Foundation of China (NSFC))	This study was sponsored by National Natural Science of China (Grant Nos. 81272800, 81072057 and 8152323).	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Areeb Z, 2015, J NEURO-ONCOL, V125, P237, DOI 10.1007/s11060-015-1912-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blakaj A, 2008, J BIOL CHEM, V283, P9505, DOI 10.1074/jbc.R800002200; Boije M, 2012, CANCER RES S8, V72, P3343; Brower JV, 2014, NEUROCHEM INT, V77, P68, DOI 10.1016/j.neuint.2014.06.002; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen J, 2014, TUMOR BIOL, V35, P6293, DOI 10.1007/s13277-014-1821-4; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cuddapah VA, 2014, NAT REV NEUROSCI, V15, P455, DOI 10.1038/nrn3765; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; He XY, 2016, MOL NEUROBIOL, V53, P1856, DOI 10.1007/s12035-015-9140-3; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Li C, 2016, J NEURO-ONCOL, V130, P11, DOI 10.1007/s11060-016-2233-7; Li XD, 2013, ANAT REC, V296, P427, DOI 10.1002/ar.22626; Li XX, 2016, MOL NEUROBIOL, V53, P577, DOI 10.1007/s12035-014-9017-x; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu G, 2010, EXP NEUROL, V226, P200, DOI 10.1016/j.expneurol.2010.08.032; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Najbauer J, 2014, PATHOL ONCOL RES, V20, P789, DOI 10.1007/s12253-014-9837-z; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Ouyang Q, 2016, INT J NEUROSCI, V126, P1, DOI 10.3109/00207454.2015.1017881; Pavon LF, 2016, ONCOTARGET, V7, P40546, DOI 10.18632/oncotarget.9658; Rinkenbaugh AL, 2016, ONCOTARGET, V7, P69173, DOI 10.18632/oncotarget.12507; Santhi WS, 2013, ORAL ONCOL, V49, P567, DOI 10.1016/j.oraloncology.2013.01.001; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shan ZN, 2016, ONCOTARGET, V7, P78813, DOI 10.18632/oncotarget.12385; Shi L, 2014, BIODRUGS, V28, P41, DOI 10.1007/s40259-013-0053-2; Shi L, 2012, NEUROMOL MED, V14, P303, DOI 10.1007/s12017-012-8188-8; Shi L, 2012, INT J ONCOL, V40, P119, DOI 10.3892/ijo.2011.1179; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Tchougounova E, 2009, ONCOGENE, V28, P1537, DOI 10.1038/onc.2009.9; Wang Q, 2014, MOL MED REP, V10, P3310, DOI 10.3892/mmr.2014.2583; Wu N, 2012, FEBS LETT, V586, P3831, DOI 10.1016/j.febslet.2012.08.023; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	39	24	25	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5861	5873		10.1038/onc.2017.182	http://dx.doi.org/10.1038/onc.2017.182			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28628119	hybrid, Green Published			2022-12-26	WOS:000413292900008
J	Mu, P; Akashi, T; Lu, F; Kishida, S; Kadomatsu, K				Mu, P.; Akashi, T.; Lu, F.; Kishida, S.; Kadomatsu, K.			A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-kappa B degradation and cell growth suppression in neuroblastoma	ONCOGENE			English	Article							II-DEPENDENT TRANSCRIPTION; PANCREATIC-CANCER CELLS; WASH COMPLEX; PROMOTES NEUROBLASTOMA; DOWN-REGULATION; LAEVIS OOCYTES; GENE; EXPRESSION; UBIQUITINATION; IDENTIFICATION	Downregulated in renal cell carcinoma 1 (DRR1) has important roles in tumor cell growth, neuron survival and spine formation, and was recently shown to bind actin. However, the roles of nuclear DRR1 remain largely unexplored. Here, we identified an interaction between filamentous actin (F-actin) and DRR1 in the nucleus, and demonstrated that copper metabolism MURR1 domain-containing 1 (COMMD1) is another binding partner of DRR1. Accordingly, DRR1, F-actin and COMMD1 were shown to form a complex in the nucleus, and the stability of COMMD1 was enhanced in this complex. Increased nuclear COMMD1 in turn promoted the degradation of NF-kappa B. In addition, DRR1 and COMMD1 suppressed the cyclin D1 expression, G1/S transition and cell proliferation of neuroblastoma cells. The binding between DRR1 and F-actin in the nucleus was required for these events. Consistent with these facts, low expressions of DRR1 were associated with tumorigenesis of human neuroblastoma and its mouse model. This study has thus revealed a novel nuclear complex of F-actin, DRR1 and COMMD1 that is involved in NF-kappa B degradation and cell cycle suppression in neuroblastoma cells.	[Mu, P.; Lu, F.; Kishida, S.; Kadomatsu, K.] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi, Japan; [Akashi, T.] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Omics Anal, Nagoya, Aichi, Japan; [Lu, F.] Tianjin Univ Tradit Chinese Med, Sch Chinese Mat Med, Tianjin, Peoples R China; [Lu, F.] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Nagoya University; Nagoya University; Tianjin University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine	Kadomatsu, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology (JST CREST) [16010731701]; Japan Agency for Medical Research and Development (AMED) [16ck0106011h0503]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22890080]	Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology (JST CREST); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr Bernd Knoll for the Flag-NLS-WT-actin, Flag-NLS-S14C-actin and Flag-NLS-R62D-actin constructs. This work was supported in part by a Grants-in-Aid (16010731701) from Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology (JST CREST) to K. Kadomatsu, a Grants-in-Aid (16ck0106011h0503) from Japan Agency for Medical Research and Development (AMED) (Tailor-made Medical Treatment Program) to K. Kadomatsu, and a Grant-in-Aid (22890080) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) to P. Mu.	Almuzzaini B, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0147-z; Asano Y, 2010, BIOCHEM BIOPH RES CO, V394, P829, DOI 10.1016/j.bbrc.2010.03.085; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0; CLARK TG, 1979, CELL, V18, P1101, DOI 10.1016/0092-8674(79)90223-X; Deng ZH, 2015, J CELL SCI, V128, P373, DOI 10.1242/jcs.161513; Dudley A, 2014, ONCOGENE, V33, P4952, DOI 10.1038/onc.2013.436; Fedoseienko A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165385; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hansford LM, 2004, P NATL ACAD SCI USA, V101, P12664, DOI 10.1073/pnas.0401083101; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Huang J, 2012, HISTOCHEM CELL BIOL, V138, P41, DOI 10.1007/s00418-012-0932-5; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Huang Y, 2008, J BIOL CHEM, V283, P11453, DOI 10.1074/jbc.M708544200; Kishida S, 2013, CANCER RES, V73, P1318, DOI 10.1158/0008-5472.CAN-12-3070; Kokai E, 2014, HISTOCHEM CELL BIOL, V141, P123, DOI 10.1007/s00418-013-1151-4; Le PU, 2010, ONCOGENE, V29, P4636, DOI 10.1038/onc.2010.216; LE PU, 2010, ELIFE, V29, P4636, DOI DOI 10.1038/ONC.2010.216; Li HY, 2014, GASTROENTEROLOGY, V147, P184, DOI 10.1053/j.gastro.2014.04.007; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu Q, 2009, ONCOL REP, V22, P1069, DOI 10.3892/or_00000538; Lu FJ, 2016, ONCOL RES, V24, P171, DOI 10.3727/096504016X14634208142987; Lu FJ, 2015, CANCER SCI, V106, P390, DOI 10.1111/cas.12628; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Masana M, 2014, PSYCHONEUROENDOCRINO, V48, P98, DOI 10.1016/j.psyneuen.2014.06.009; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mu P, 2009, INT J CANCER, V125, P2978, DOI 10.1002/ijc.24382; Muller PAJ, 2009, TRAFFIC, V10, P514, DOI 10.1111/j.1600-0854.2009.00892.x; O'Hara A, 2014, J CELL SCI, V127, P3659, DOI 10.1242/jcs.149328; Obrdlik A, 2011, NUCLEUS-PHILA, V2, P72, DOI 10.4161/nucl.2.1.14508; Pastuszak-Lewandoska D, 2015, ADV EXP MED BIOL, V852, P39, DOI 10.1007/5584_2014_109; Phillips-Krawczak CA, 2015, MOL BIOL CELL, V26, P91, DOI 10.1091/mbc.E14-06-1073; Plessner M, 2015, J BIOL CHEM, V290, P11209, DOI 10.1074/jbc.M114.627166; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sato M, 2013, ONCOL RES, V21, P333, DOI 10.3727/096504014X14024160459249; Schmidt MV, 2011, P NATL ACAD SCI USA, V108, P17213, DOI 10.1073/pnas.1103318108; Takahashi Y, 2013, SCIENCE, V341, P860, DOI 10.1126/science.1230717; Udali S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0077-1; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; van den Boom J, 2006, INT J CANCER, V119, P2330, DOI 10.1002/ijc.22108; Vonk WIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029183; Wang L, 2000, GENE CHROMOSOME CANC, V27, P1, DOI 10.1002/(SICI)1098-2264(200001)27:1<1::AID-GCC1>3.0.CO;2-6; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Yamazaki S, 2016, HISTOCHEM CELL BIOL, V145, P389, DOI 10.1007/s00418-016-1416-9; Yeh DW, 2016, CELL DEATH DIFFER, V23, P841, DOI 10.1038/cdd.2015.147; Yoo YD, 2007, J BIOL CHEM, V282, P7616, DOI 10.1074/jbc.M607596200; Zhao XY, 2007, BIOCHEM BIOPH RES CO, V361, P74, DOI 10.1016/j.bbrc.2007.06.158	57	25	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5745	5756		10.1038/onc.2017.181	http://dx.doi.org/10.1038/onc.2017.181			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28604741				2022-12-26	WOS:000412843900008
J	Olivera-Perez, HM; Lam, L; Dang, J; Jiang, WL; Rodriguez, F; Rigali, E; Weitzman, S; Porter, V; Rubbi, L; Morselli, M; Pellegrini, M; Fiala, M				Olivera-Perez, Henry M.; Lam, Larry; Dang, Johnny; Jiang, Weilan; Rodriguez, Fabian; Rigali, Elizabeth; Weitzman, Sarah; Porter, Verna; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo; Fiala, Milan			Omega-3 fatty acids increase the unfolded protein response and improve amyloid-beta phagocytosis by macrophages of patients with mild cognitive impairment	FASEB JOURNAL			English	Article							ENDOPLASMIC-RETICULUM STRESS; ALZHEIMERS-DISEASE PATIENTS; ER STRESS; NEURODEGENERATIVE DISORDERS; OMEGA-3 SUPPLEMENTATION; ALLOSTERIC INHIBITION; RESOLVIN D1; A-BETA; INFLAMMATION; TRANSCRIPTION	Macrophages (M phi s) of patients with Alzheimer's disease and mild cognitive impairment (MCI) are defective in amyloid-beta(1-42) (A beta) phagocytosis and have low resistance to apoptosis by A beta. Omega-3 fatty acids (omega-3s) in vitro and in vivo and the omega-3 mediator, resolvin D1, in vitro increase A beta phagocytosis by M phi s of patients with MCI. We have investigated the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress by M phi s in a longitudinal study of fish-derived, omega-3-supplemented patients with MCI. Patients in the apolipoprotein E (ApoE)e3/e3 subgroup over time exhibited an increase of protein kinase RNA-like ER kinase (PERK) expression, A beta phagocytosis, intermediate M1-M2 M phi type, and a Mini-Mental State Examination (MMSE) rate of change of +1.8 points per year, whereas patients in the ApoEe3/e4 subgroup showed individually divergent results with an MMSE rate of change of -3.2 points per year. In vitro treatment of M phi s by fish-derived omega-3 emulsion increased A beta phagocytosis, PERK expression, and UPR RNA signature, and decreased ER stress signature. Augmented genes in the UPR signature included chaperones, lectins, foldases, and N-linked glycosylation enzymes. In summary, fish-derived omega-3s increase cytoprotective genes and decrease proapoptotic genes, improve immune clearance of A beta, and are associated with an improved MMSE rate of change in ApoEe3/e3 vs. ApoEe3/e4 patients.-Olivera-Perez, H. M., Lam, L., Dang, J., Jiang, W., Rodriguez, F., Rigali, E., Weitzman, S., Porter, V., Rubbi, L., Morselli, M., Pellegrini, M., Fiala, M. Omega-3 fatty acids increase the unfolded protein response and improve amyloid-beta phagocytosis by macrophages of patients with mild cognitive impairment.	[Olivera-Perez, Henry M.; Lam, Larry; Dang, Johnny; Jiang, Weilan; Rodriguez, Fabian; Rigali, Elizabeth; Weitzman, Sarah; Rubbi, Liudmilla; Morselli, Marco; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, Sch Med, Dept Cell Mol & Dev Biol, Life Sci, Los Angeles, CA 90095 USA; [Porter, Verna] Univ Calif Los Angeles, Dept Neurol, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fiala, M (corresponding author), Univ Calif Los Angeles, Sch Med, 100 UCLA Med Plaza,Suite 150, Los Angeles, CA 90095 USA.	mfiala@ucla.edu	Morselli, Marco/AAF-3182-2019	Morselli, Marco/0000-0003-3351-5791; Fiala, Milan/0000-0001-8023-6053; Pellegrini, Matteo/0000-0001-9355-9564	U.S. National Institutes of Health, National Institute of General Medical Sciences [5P01GM099134-03]; Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant 5P01GM099134-03 (to M.P.) and a donation from Smartfish AS (to M.F.). Smartfish AS supplied the drink to the patients who requested it. The authors thank Leonard Haller, Angela Kim, Janteshpreet Sandhu, Jessica Xu, Gigi Arnone, Sheila Hou, Peter Cho, and Yasmine Alhoch (all from University of California, Los Angeles, Los Angeles, CA, USA) for assistance with data collection. The authors thank R. Rao (the Buck Institute, Novato, CA, USA) for testing the APOE genotype of study patients. The authors are grateful to Fawaz George Haj and Bruce Hammock (both from University of California, Davis, Davis, CA, USA) for helpful discussions of lipid mediators and ER stress. Smartfish was not involved in the design, analysis, interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria from Smartfish.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Cai Y, 2016, AUTOPHAGY, V12, P225, DOI 10.1080/15548627.2015.1121360; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Chow CY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004924; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Duara R, 2011, AM J GERIAT PSYCHIAT, V19, P951, DOI 10.1097/JGP.0b013e3182107c69; Duran-Aniotz C, 2017, ACTA NEUROPATHOL, V134, P489, DOI 10.1007/s00401-017-1694-x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Famenini S, 2017, FASEB J, V31, P148, DOI 10.1096/fj.201600677RR; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2015, J ALZHEIMERS DIS, V48, P293, DOI 10.3233/JAD-150367; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hong Y, 2016, INT IMMUNOPHARMACOL, V33, P83, DOI 10.1016/j.intimp.2016.02.002; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Lam L, 2016, FASEB J, V30, P3461, DOI 10.1096/fj.201600259RR; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Liu Guanghao, 2012, Am J Neurodegener Dis, V1, P60; Maly DJ, 2014, NAT CHEM BIOL, V10, P892, DOI 10.1038/nchembio.1664; Meyerovich K, 2016, J MOL ENDOCRINOL, V57, pR1, DOI 10.1530/JME-15-0306; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Pereira DM, 2015, NAT PROD REP, V32, P705, DOI 10.1039/c4np00102h; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Walker AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081170; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yassine HN, 2017, JAMA NEUROL, V74, P337, DOI 10.1001/jamaneurol.2016.4899; Yassine HN, 2016, JAMA NEUROL, V73, P1208, DOI 10.1001/jamaneurol.2016.1924; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	38	13	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4359	4369		10.1096/fj.201700290R	http://dx.doi.org/10.1096/fj.201700290R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28634213	Green Published			2022-12-26	WOS:000413397400015
J	Wu, N; Meng, FY; Zhou, TH; Han, YY; Kennedy, L; Venter, J; Francis, H; DeMorrow, S; Onori, P; Invernizzi, P; Bernuzzi, F; Mancinelli, R; Gaudio, E; Franchitto, A; Glaser, S; Alpini, G				Wu, Nan; Meng, Fanyin; Zhou, Tianhao; Han, Yuyan; Kennedy, Lindsey; Venter, Julie; Francis, Heather; DeMorrow, Sharon; Onori, Paolo; Invernizzi, Pietro; Bernuzzi, Francesca; Mancinelli, Romina; Gaudio, Eugenio; Franchitto, Antonio; Glaser, Shannon; Alpini, Gianfranco			Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation	FASEB JOURNAL			English	Article						angiogenesis; biliary epithelium; cholangiopathy; cholestasis; miRNA	ENDOTHELIAL GROWTH-FACTOR; BILE-DUCT LIGATION; CHOLESTATIC RATS; UP-REGULATION; CANCER CELLS; MELATONIN; EXPRESSION; MICE; PROLIFERATION; CHOLANGIOCYTES	Melatonin therapy or prolonged exposure to complete darkness reduces biliary hyperplasia and liver fibrosis in bile-duct-ligated (BDL) rats; however, no information exists in primary sclerosing cholangitis (PSC). Thus, we aimed to determine the therapeutic effects of prolonged dark therapy or melatonin administration on hepatic fibrosis in the multidrug resistance gene 2-knockout (Mdr2(-/-)) mouse model of PSC. Melatonin levels, biliary mass, liver fibrosis, angiogenesis and miR-200b expression were evaluated in wild-type and Mdr2(-/-) mice exposed to darkness or melatonin treatment or in male patients with PSC and healthy controls. Mdr2(-/-) mice were also treated with miR-200b inhibitor or control before evaluating biliary mass, liver fibrosis, and angiogenesis. After overexpression of arylalkylamine N-acetyltransferase (AANAT; the enzyme regulating melatonin synthesis) or inhibition of miR-200b in cholangiocytes and hepatic stellate cells in vitro, we evaluated angiogenesis and fibrosis gene expression. After exposure to darkness or administration of melatonin, Mdr2(-/-) mice show elevated serum melatonin levels and inhibition of biliary mass, along with reduction of liver fibrosis and angiogenesis. MicroRNA PCR analysis demonstrated that miR-200b expression increased in Mdr2(-/-) mice and patients with PSC compared with controls and decreased in Mdr2(-/-) mice subjected to dark exposure or melatonin treatment. Inhibition of miR-200b in Mdr2(-/-) ablates biliary proliferation, liver fibrosis, and angiogenesis. In vitro, overexpression of AANAT or inhibition of miR-200b in cholangiocytes and hepatic stellate cells decreased the expression of miR-200b, angiogenesis, and fibrosis genes. Dark therapy or targeting melatonin/miR-200b axis may be important in the management of biliary damage and liver fibrosis in cholangiopathies including PSC.-Wu, N., Meng, F., Zhou, T., Han, Y., Kennedy, L., Venter, J., Francis, H., DeMorrow, S., Onori, P., Invernizzi, P., Bernuzzi, F., Mancinelli, R., Gaudio, E., Franchitto, A., Glaser, S., Alpini G. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.	[Wu, Nan; Meng, Fanyin; Zhou, Tianhao; Han, Yuyan; Kennedy, Lindsey; Venter, Julie; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Texas A&M Univ, Hlth Sci Ctr, Dept Med, Div Gastroenterol, Temple, TX USA; [Meng, Fanyin; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Baylor Scott & White, Digest Res Ctr, Temple, TX USA; [Meng, Fanyin; Francis, Heather; DeMorrow, Sharon; Glaser, Shannon; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA; [Onori, Paolo; Mancinelli, Romina; Gaudio, Eugenio] La Sapienza, Dept Anat Histol & Forens Med & Orthoped Sci, Rome, Italy; [Invernizzi, Pietro; Bernuzzi, Francesca] Humanitas Clin & Res Ctr, Ctr Autoimmune Liver Dis, Rozzano, Italy; [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Invernizzi, Pietro; Bernuzzi, Francesca] Bicocca Univ, Dept Med & Surg, Monza, Italy	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Baylor Health Care System; Sapienza University Rome; IRCCS Humanitas Research Hospital; University of Milano-Bicocca	Glaser, S; Alpini, G (corresponding author), Cent Texas Vet Univ Hlth Care Syst, Texas A&M Hlth Sci Ctr, Olin E Teague Med Ctr, 1901 South 1st St,Bldg 205,1R60, Temple, TX 76504 USA.	sglaser@medicine.tamhsc.edu; galpini@tamu.edu	Onori, Paolo/J-9394-2013; bernuzzi, francesca/AAQ-7073-2020; Zhou, Tianhao/AAO-3542-2021; Franchitto, Antonio/C-8095-2009; Invernizzi, Pietro/AAB-8367-2022; Mancinelli, Romina/Y-4540-2018	Onori, Paolo/0000-0002-7195-3760; Zhou, Tianhao/0000-0002-5722-6954; Invernizzi, Pietro/0000-0003-3262-1998; Mancinelli, Romina/0000-0003-2040-0581	Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN); Veterans Affairs (VA); VA [5I01BX000574, 5I01BX002192, 1I01BX001724, 1I01BX003031, 1IO1BX002638]; University of Rome "La Sapienza,"; Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma [2010-RBAP10Z7FS]; U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases [DK054811, DK076898, DK107310, DK110035, DK062975, DK108959, DK082435]; Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107310, R01DK082435, R01DK054811, R01DK062975, R01DK108959, R01DK115184, R01DK110035, R01DK076898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025997, R21AA025157] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000574, I01BX002638, I01BX003031, I01BX001724, I01BX002192] Funding Source: NIH RePORTER	Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN); Veterans Affairs (VA)(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); University of Rome "La Sapienza,"; Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma(Ministry of Education, Universities and Research (MIUR)); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Central Texas Veterans Health Care System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology (Baylor Scott & White), a Translational Genomics Research Institute (TGEN) seed grant, and a Veterans Affairs (VA) Research Career Scientist Award (to G.A.); and VA Merit Awards 5I01BX000574 (to G.A.) 5I01BX002192 (to S.G.), 1I01BX001724 (to F.M.), 1I01BX003031 (to H.F.), and 1IO1BX002638 (to S.D.); University of Rome "La Sapienza," and Fondo per gli Investimenti della Ricerca di Base (FIRB) Accordi di Programma 2010-RBAP10Z7FS (to E.G.); U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases Grants DK054811, DK076898, DK107310, DK110035, and DK062975 (to G.A., F.M., and S.G.), DK108959 (to H.F.), and DK082435 to (S.D., N.W., and F.M.). This publication is the result of work supported by resources at the Central Texas Veterans Health Care System. The content is the responsibility of the authors alone, and does not necessarily reflect the views or policies of the Department of Veterans Affairs or the U.S. Government. G.A., A.F., and S.G. share senior authorship. The authors declare no conflicts of interest.	Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; Aron JH, 2009, SEMIN IMMUNOPATHOL, V31, P383, DOI 10.1007/s00281-009-0154-7; Calderone V, 2016, GASTROENTEROLOGY, V150, P982, DOI 10.1053/j.gastro.2015.11.038; Chaparro M, 2007, ANN HEPATOL, V6, P208, DOI 10.1016/S1665-2681(19)31900-3; Delis S, 2009, DIGEST LIVER DIS, V41, P72, DOI 10.1016/j.dld.2007.11.016; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Fava G, 2005, CANCER RES, V65, P11437, DOI 10.1158/0008-5472.CAN-05-1470; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Franchitto Antonio, 2013, Hepatobiliary Surg Nutr, V2, P68, DOI 10.3978/j.issn.2304-3881.2012.10.11; Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034; Glaser S., 2014, GASTROENTEROLOGY, V146; Han YY, 2014, AM J PHYSIOL-GASTR L, V307, pG894, DOI 10.1152/ajpgi.00288.2014; Huang LT, 2009, PEDIATR RES, V65, P176, DOI 10.1203/PDR.0b013e31818d5bc7; Jardim-Perassi BV, 2016, ANTI-CANCER AGENT ME, V16, P347, DOI 10.2174/1871520615666150511094201; Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704; Kim SJ, 2015, BIOCHEM BIOPH RES CO, V458, P462, DOI 10.1016/j.bbrc.2015.01.117; Kim YD, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12386; Lewczuk B, 2000, NEUROENDOCRINOL LETT, V21, P293; Li L, 2014, HEPATOLOGY, V60, P896, DOI 10.1002/hep.27050; Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45; Lv D, 2012, CHINESE J CANCER RES, V24, P310, DOI [10.3978/j.issn.1000-9604.2012.09.03, 10.1007/s11670-012-0269-6]; Maroni L, 2015, CELL MOL GASTROENTER, V1, P368, DOI 10.1016/j.jcmgh.2015.05.005; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Montagnese S, 2013, LIVER INT, V33, P203, DOI 10.1111/liv.12026; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Padgett KA, 2009, J AUTOIMMUN, V32, P246, DOI 10.1016/j.jaut.2009.02.022; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Renzi A, 2013, HEPATOLOGY, V57, P1130, DOI 10.1002/hep.26105; Renzi A, 2011, AM J PHYSIOL-GASTR L, V301, pG634, DOI 10.1152/ajpgi.00206.2011; Sezer A, 2010, CURR THER RES CLIN E, V71, P118, DOI 10.1016/j.curtheres.2010.03.004; Sohn EJ, 2015, J CANCER, V6, P19, DOI 10.7150/jca.9591; Tahan G, 2010, CAN J SURG, V53, P313; Velissaris D, 2008, WORLD J GASTROENTERO, V14, P4190, DOI 10.3748/wjg.14.4190; Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Xiao YT, 2014, CELL SIGNAL, V26, P925, DOI 10.1016/j.cellsig.2014.01.003; Xiong MX, 2012, AM J PHYSIOL-RENAL, V302, pF369, DOI 10.1152/ajprenal.00268.2011; Zhang JJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040673; ZHOU P, 2014, SCI REP UK, V4	40	35	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4305	4324		10.1096/fj.201700097R	http://dx.doi.org/10.1096/fj.201700097R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28634212	Green Published			2022-12-26	WOS:000413397400011
J	Teran, GE; Ferrer, J; Benitez, M; Alonso, F; Aguilera, G; Mirande, JM				Enrique Teran, Guillermo; Ferrer, Juliano; Benitez, Mauricio; Alonso, Felipe; Aguilera, Gaston; Marcos Mirande, Juan			Living in the waterfalls: A new species of Trichomycterus (Siluriformes: Trichomycteridae) from Tabay stream, Misiones, Argentina	PLOS ONE			English	Article							SOUTHEASTERN BRAZIL; CATFISH; GENUS; BASIN; CORDILLERA; COLOMBIA	A new species assigned to the genus Trichomycterus from the area of the waterfalls of Tabay stream, Parana A River basin, Misiones, Argentina, is described. Trichomycterus ytororo sp. nov. is distinguished from all other species in the genus by the presence of 31-35 dorsal procurrent caudal-fin rays and the combination of some external characters such as: coloration, number of pectoral-fin rays and pores of the laterosensory canals. The new taxon belongs to a presumably monophyletic group of species composed of T. crassicaudatus, T. igobi, and T. stawiarski based on the presence of 24 or more thickly ossified and rigid procurrent caudal-fin rays with a slender distal tip extending along the tips of at least ten neural spines.	[Enrique Teran, Guillermo; Aguilera, Gaston; Marcos Mirande, Juan] UEL CONICET, Inst Vertebrados, Fdn Miguel Lillo, San Miguel De Tucuman, Argentina; [Ferrer, Juliano] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Dept Zool, Porto Alegre, RS, Brazil; [Benitez, Mauricio] UNaM CONICET, Inst Biol Subtrop, Lab Genet Evolut, Posadas, Argentina; [Alonso, Felipe] IBIGEO CONICET, Inst Bio & Geociencias NOA, Rosario De Lerma, Salta, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Universidade Federal do Rio Grande do Sul	Aguilera, G (corresponding author), UEL CONICET, Inst Vertebrados, Fdn Miguel Lillo, San Miguel De Tucuman, Argentina.	gaguilera@lillo.org.ar	Alonso, Felipe/AAA-5717-2020; Ferrer, Juliano/V-9887-2019	Alonso, Felipe/0000-0001-7227-2732; Ferrer, Juliano/0000-0001-6198-6289; Aguilera, Gaston/0000-0002-5486-2787; Mirande, Juan Marcos/0000-0003-4370-3526; Teran, Guillermo/0000-0002-3795-3345	Fondo para la Investigacion Cientifica y Tecnica [PICT-2011-0992]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP-11420110100301]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [152354/2016-6]; Mercedes Azpelicueta (CONICET)	Fondo para la Investigacion Cientifica y Tecnica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mercedes Azpelicueta (CONICET)	This work was supported by Fondo para la Investigacion Cientifica y Tecnica (PICT-2011-0992 to JMM), http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP-11420110100301 to JMM), http://www.conicet. gov.ar/; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Proc. 152354/2016-6 to JF), http://cnpq.br/web/guest/paging-inicial. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Pablo Pereyra (FML) for figure 3. We thank Celeste Kummer for assistance with the radiograph of the holotype and paratypes. Mercedes Azpelicueta (CONICET) for constant support. This work was possible due to the invaluable help of Diego Baldo and Juan Martin Ferro. We thank Pedro Sanchez for logistical assistance in the field. Ministerio de Ecologia, Misiones for collecting permits. We thank Carlos DoNascimiento (IAvH) and an anonymous reviewer for careful reviews in the manuscript. We are also thankful to Fundacion Miguel Lillo, CONICET (PIP-11420110100301 to JMM) and FONCyT (PICT-2011-0992 to JMM); CNPq (Proc. 152354/2016-6 to JF).	Arratia FG, 1978, STUD NEOTROP FAUNA E, V13, P157; ARRATIA G, 1984, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V111, P493; Arratia G., 1990, INT S VERT BIOG SYST, P395; Arratia Gloria, 1998, Ichthyological Exploration of Freshwaters, V9, P347; Barbosa M.A., 2008, INT J ICHTHYOLOGY, V14, P175; Barbosa Maria Anais, 2003, Ichthyological Exploration of Freshwaters, V14, P281; Barbosa MA, 2012, VERTEBR ZOOL, V62, P79; Barbosa MA, 2010, ICHTHYOL EXPLOR FRES, V21, P97; Baskin J. N, 1973, STRUCTURE RELATIONSH; Bockmann Flávio A., 2004, Neotrop. ichthyol., V2, P61, DOI 10.1590/S1679-62252004000200003; Costa W.J.E.M., 1992, REV FRANCAISE AQUARI, V18, P101; Costa Wilson J.E.M., 1993, Revue Francaise d'Aquariologie Herpetologie, V20, P43; Datovo A, 2012, ZOOTAXA, P33; Datovo A, 2010, NEOTROP ICHTHYOL, V8, P193, DOI 10.1590/S1679-62252010000200001; de Pinna Mario C.C., 1998, P279; de Pinna MCC, 2003, CHECK LIST FRESHWATE, P270; DEPINNA MCC, 1989, AM MUS NOVIT, P1; DoNascimiento C, 2015, COPEIA, V103, P933, DOI 10.1643/CI-14-132; DoNascimiento C, 2014, NEOTROP ICHTHYOL, V12, P717, DOI 10.1590/1982-0224-20140005; Dutra GM, 2012, NEOTROP ICHTHYOL, V10, P225, DOI 10.1590/S1679-62252012000200001; Eigenmann C. H., 1917, Philadelphia Proceedings of the American Philosophical Society, V56; Eigenmann CH., 1918, MEMOIRS CARNEGIE MUS, V7, P259, DOI DOI 10.5962/BHL.TITLE.43951; Eschmeyer WN, CATALOG FISHES GENER; Fernandez L, 2005, COPEIA, P68; Fernandez L, 2006, ENVIRON BIOL FISH, V75, P385, DOI 10.1007/s10641-005-5065-4; Fernandez L, 2009, COPEIA, P195, DOI 10.1643/CI-08-083; Ferrer J, 2013, NEOTROP ICHTHYOL, V11, P217, DOI 10.1590/S1679-62252013000200001; Garcia-Melo LJ, 2016, ZOOTAXA, V4117, P226, DOI 10.11646/zootaxa.4117.2.6; Lima Sergio M.Q., 2004, Zootaxa, V761, P1; Rizzato PP, 2017, J MORPHOL, V278, P4, DOI 10.1002/jmor.20616; Schaefer SA, 2009, COPEIA, P510, DOI 10.1643/CI-08-186; Schultze H.-P, 2013, MESOZOIC FISHES, P187; TAYLOR W R, 1985, Cybium, V9, P107; Wosiacki WB, 2005, ZOOTAXA, P49; Wosiacki Wolmar B., 2008, Neotropical Ichthyology, V6, P17; Wosiacki WB, 2008, COPEIA, P273, DOI 10.1643/CI-06-237	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179594	10.1371/journal.pone.0179594	http://dx.doi.org/10.1371/journal.pone.0179594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640842	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800042
J	Takahashi, M; Takahashi, M; Komine, K; Yamada, H; Kasahara, Y; Chikamatsu, S; Okita, A; Ito, S; Ouchi, K; Okada, Y; Imai, H; Saijo, K; Shirota, H; Takahashi, S; Mori, T; Shimodaira, H; Ishioka, C				Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi			The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; OLDER PATIENTS; SURVIVAL; ONCOLOGY; TOLERANCE; MORTALITY; CHEMOTHERAPY; ADULTS; RISK	Background Some elderly cancer patients, even with good Eastern Cooperative Oncology Group performance status (ECOG-PS), have poor survival outcomes and cannot tolerate standard therapy. Few studies have detailed the associations between the G8 screening tool, ECOG-PS, and overall survival (OS) in such patients. Methods Cancer patients, aged 70 years or older, were assessed for G8 and classified into three groups according to their G8 score: <11 as the low score group, 11-14 as the intermediate score group, and > 14 as the high score group. We retrospectively analyzed the association between G8 score and OS in all patients and for each ECOG-PS-categorized group. Results Out of 264 enrolled patients, most patients (87%) with solid tumor were categorized as TNM stage IV. ECOG-PS was 0 or 1 in 215 patients and >= 2 in 48; there was missing data for one patient. Among all patients, the low score group with a median OS of 7.7 months survived significantly less than both the high score group with a median OS of 25.6 months [ Hazard ratio (HR) 3.48; 95% confidence interval (CI), 1.96-6.63; p < 0.0001] and the intermediate score group with a median of 15.6 months (HR 1.83; 95% CI, 1.28-2.65; p < 0.001). In the multivariate analysis, TNM stage and G8 score were independent prognostic factors for OS. When patients with an ECOG-PS of 0 or 1 were analyzed, patients with a lower G8 score showed significantly shorter OS than patients with a higher score when any two groups were compared. Conclusion This novel classification of the G8 score contributes to prompt identification of patients with poor prognosis and improved the prognostic value of ECOG-PS. Using G8 with ECOG-PS may be helpful in deciding treatment for elderly patients with advanced cancer.	[Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Shirota, Hidekazu; Takahashi, Shin; Mori, Takahiro; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan; [Takahashi, Masahiro; Takahashi, Masanobu; Komine, Keigo; Yamada, Hideharu; Kasahara, Yuki; Chikamatsu, Sonoko; Okita, Akira; Ito, Shukuei; Ouchi, Kota; Okada, Yoshinari; Imai, Hiroo; Saijo, Ken; Takahashi, Shin; Shimodaira, Hideki; Ishioka, Chikashi] Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Ishioka, C (corresponding author), Tohoku Univ Hosp, Dept Med Oncol, Aoba Ku, Sendai, Miyagi, Japan.; Ishioka, C (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Clin Oncol, Aoba Ku, Sendai, Miyagi, Japan.	chikashi@tohoku.ac.jp		Ishioka, Chikashi/0000-0002-3023-1227; qi wu, xiao feng/0000-0003-2502-3666; Masahiro, Takahashi/0000-0001-6820-6011; Mori, Takahiro/0000-0001-7324-8574; Takahashi, Shin/0000-0001-6695-3099	JSPS KAKENHI [JP16K19304]; Ono Pharmaceutical Company; Taiho Pharma; Taiho; Chugai; Takeda; Byer; Pfeizer; Mochida; Asahikasei; Bristol-Myers Squibb; Daiichi-Sankyo; Merck Serono; Novartis; Yakult; Ono; Grants-in-Aid for Scientific Research [15K08962] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ono Pharmaceutical Company; Taiho Pharma; Taiho; Chugai; Takeda(Takeda Pharmaceutical Company Ltd); Byer; Pfeizer; Mochida; Asahikasei(Asahi Kasei Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Merck Serono(Merck & Company); Novartis(Novartis); Yakult; Ono; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K19304, Masahiro Takahashi. Masanobu Takahashi reports receiving research funding from Ono Pharmaceutical Company. K.S. reports receiving research funding from Taiho Pharma. Hideki S. reports receiving research funding from Taiho Pharma. C. I. reports receiving lecture fees from Taiho, Chugai, Takeda, Byer, Pfeizer, Mochida, Asahikasei, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, and Novartis, and research funding from Chugai, Taiho, Bristol-Myers Squibb, Daiichi-Sankyo, Merck Serono, Yakult, Ono, and Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2016, EUR J CANC, pii; Bellera CA, 2012, ANN ONCOL, V23, P2166, DOI 10.1093/annonc/mdr587; Bourdel-Marchasson I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148523; Braes T, 2009, AGE AGEING, V38, P600, DOI 10.1093/ageing/afp097; Bridgewater J, 2016, ANN ONCOL, V27, P134, DOI 10.1093/annonc/mdv483; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clough-Gorr KM, 2010, J CLIN ONCOL, V28, P380, DOI 10.1200/JCO.2009.23.5440; Decoster L, 2015, ANN ONCOL, V26, P288, DOI 10.1093/annonc/mdu210; Denewet N, 2016, ACTA CLIN BELG, V71, P206, DOI 10.1080/17843286.2016.1153816; Dubruille S, 2015, J GERIATR ONCOL, V6, P362, DOI 10.1016/j.jgo.2015.07.006; Freyer G, 2005, ANN ONCOL, V16, P1795, DOI 10.1093/annonc/mdi368; Hamaker ME, 2012, LANCET ONCOL, V13, pE437, DOI 10.1016/S1470-2045(12)70259-0; Hamaker ME, 2014, ANN HEMATOL, V93, P1031, DOI 10.1007/s00277-013-2001-0; Hamaker ME, 2012, ONCOLOGIST, V17, P1439, DOI 10.1634/theoncologist.2012-0186; Hori M, 2015, JPN J CLIN ONCOL, V45, P884, DOI 10.1093/jjco/hyv088; Iacovelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108940; Jonna S, 2016, SUPPORT CARE CANCER, V24, P4807, DOI 10.1007/s00520-016-3334-8; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; Kenis C, 2014, J CLIN ONCOL, V32, P19, DOI 10.1200/JCO.2013.51.1345; Kobayashi Y, 2011, J CANCER RES CLIN, V137, P1079, DOI 10.1007/s00432-010-0973-x; Kuzuya M, 2005, NUTRITION, V21, P498, DOI 10.1016/j.nut.2004.08.023; Liuu E, 2014, J GERIATR ONCOL, V5, P11, DOI 10.1016/j.jgo.2013.08.003; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285; Puts MTE, 2011, CRIT REV ONCOL HEMAT, V78, P138, DOI 10.1016/j.critrevonc.2010.04.003; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Sargent DJ, 2009, J CLIN ONCOL, V27, P1948, DOI 10.1200/JCO.2008.20.2879; Sattar S, 2014, ONCOLOGIST, V19, P1056, DOI 10.1634/theoncologist.2014-0180; Soubeyran P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115060; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Wedding U, 2007, J CANCER RES CLIN, V133, P945, DOI 10.1007/s00432-007-0233-x; Wildiers H, 2014, J CLIN ONCOL, V32, P2595, DOI 10.1200/JCO.2013.54.8347	32	42	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179694	10.1371/journal.pone.0179694	http://dx.doi.org/10.1371/journal.pone.0179694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640844	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800053
J	Das, A; Rahman, MI; Ferdous, AS; Al-Amin; Rahman, MM; Nahar, N; Uddin, MA; Islam, MR; Khan, H				Das, Avizit; Rahman, Mohammad Imtiazur; Ferdous, Ahlan Sabah; Al-Amin; Rahman, Mohammad Mahbubur; Nahar, Nilufar; Uddin, Md. Aftab; Islam, Mohammad Riazul; Khan, Haseena			An endophytic Basidiomycete, Grammothele lineata, isolated from Corchorus olitorius, produces paclitaxel that shows cytotoxicity	PLOS ONE			English	Article							TAXOL(R) PACLITAXEL; FUNGUS; LEAF	Grammothele lineata, an endophyte isolated in our laboratory from jute (Corchorus olitorius acc. 2015) was found to be a substantial paclitaxel producer. Taxol and its related compounds, produced by this endophyte were extracted by growing the fungus in simple nutrient media (potato dextrose broth, PDB). Taxol was identified and characterized by different analytical techniques (TLC, HPLC, FTIR, LC-ESI-MS/MS) following its extraction by ethyl acetate. In PDB media, this fungus was found to produce 382.2 mu gL(-1) of taxol which is about 7.6 x 10(3) fold higher than the first reported endophytic fungi, Taxomyces andreanae. The extracted taxol exhibited cytotoxic activity in an in vitro culture of HeLa cancer cell line. The fungal extract also exhibited antifungal and antibacterial activities against different pathogenic strains. This is the first report of a jute endophytic fungus harboring the capacity to produce taxol and also the first reported taxol producing species that belongs to the Basidiomycota phylum, so far unknown to be a taxol producer. These findings suggest that the fungal endophyte, Grammothele lineata can be an excellent source of taxol and can also serve as a potential species for chemical and genetic engineering to enhance further the production of taxol.	[Das, Avizit; Rahman, Mohammad Imtiazur; Ferdous, Ahlan Sabah; Al-Amin; Islam, Mohammad Riazul; Khan, Haseena] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Rahman, Mohammad Mahbubur] BCSIR, Dev Fiber & Polymer Sci Lab, Dhaka, Bangladesh; [Nahar, Nilufar] Univ Dhaka, Dept Chem, Dhaka, Bangladesh; [Uddin, Md. Aftab] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh	University of Dhaka; Bangladesh Council of Scientific & Industrial Research (BCSIR); University of Dhaka; University of Dhaka	Khan, H (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	haseena@du.ac.bd		Uddin, Md. Aftab/0000-0003-1665-2751; Amin, Al-/0000-0002-6641-4404; khan, haseena/0000-0003-4643-4106; Ferdous, Ahlan/0000-0002-3610-304X	Higher Education Quality Enhancement Project (HEQEP) [CP-3250]; Ministry of Education, Government of People's Republic of Bangladesh; The World Bank	Higher Education Quality Enhancement Project (HEQEP); Ministry of Education, Government of People's Republic of Bangladesh; The World Bank	This work was supported by Subproject: CP-3250, window2, academic innovation fund, Under the Higher Education Quality Enhancement Project (HEQEP), Funded by Ministry of Education, Government of People's Republic of Bangladesh with the assistance of The World Bank (funding received by HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedi Y.S., 1996, SUPPLEMENT CULTIVATI, P443; Bhanot A., 2011, INT J PHYTOMED, V3, P9; Chen L, 2016, CRIT REV MICROBIOL, V42, P454, DOI 10.3109/1040841X.2014.959892; Choi J, 2016, MYCOBIOLOGY, V44, P105, DOI 10.5941/MYCO.2016.44.2.105; Defoirdt N, 2010, COMPOS PART A-APPL S, V41, P588, DOI 10.1016/j.compositesa.2010.01.005; DIDIER E, 1994, TETRAHEDRON LETT, V35, P3063, DOI 10.1016/S0040-4039(00)76828-6; Erkel G, 2008, BIOTECHNOLOGY SET, P489; Gangadevi V., 2008, MYCOL BALC, V5, P1, DOI DOI 10.5281/zenodo.2548403; Goveas SW, 2011, EURASIA J BIOSCI, V5, P48, DOI DOI 10.5053/EJ0BI0S.2011.5.0.6; Gu Y, 2015, APPL BIOCHEM BIOTECH, V175, P155, DOI 10.1007/s12010-014-1254-y; Hao X., 2013, NATURAL PRODUCTS, P2797, DOI DOI 10.1007/978-3-642-22144-6_124; Heinig U, 2013, FUNGAL DIVERS, V60, P161, DOI 10.1007/s13225-013-0228-7; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; Hu YM, 2003, ACTA BOT SIN, V45, P373; Ilhan S., 2007, International Journal of Natural and Engineering Sciences, V1, P59; Kathiravan G, 2010, FITOTERAPIA, V81, P557, DOI 10.1016/j.fitote.2010.01.021; Kumaran RS, 2008, ENG LIFE SCI, V8, P438, DOI 10.1002/elsc.200800019; Kumaran RS, 2008, J BIOSCI BIOENG, V106, P103, DOI 10.1263/jbb.106.103; Kumaran RS, 2010, J BIOSCI BIOENG, V110, P541, DOI 10.1016/j.jbiosc.2010.06.007; Kumaran RS, 2009, BIOTECHNOL APPL BIOC, V54, P21, DOI 10.1042/BA20080110; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P304, DOI 10.1016/j.tibtech.2014.03.011; Lee S.B., 1988, FUNGAL GENET REP, V35, P23, DOI [10.4148/1941-4765.1531, DOI 10.4148/1941-4765.1531]; Li CJ, 2012, MOLECULES, V17, P9348, DOI 10.3390/molecules17089348; Merlin JN, 2012, J ACAD IND RES, V1, P281; Mirjalili MH, 2012, FEMS MICROBIOL LETT, V328, P122, DOI 10.1111/j.1574-6968.2011.02488.x; Najnin RA, 2015, ANN MICROBIOL, V65, P1615, DOI 10.1007/s13213-014-1001-1; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Noh MJ, 1999, BIOTECHNOL BIOENG, V64, P620, DOI 10.1002/(SICI)1097-0290(19990905)64:5&lt;620::AID-BIT13&gt;3.0.CO;2-W; Pinruan U, 2010, FUNGAL DIVERS, V41, P71, DOI 10.1007/s13225-010-0029-1; Quin MB, 2014, NAT PROD REP, V31, P1449, DOI 10.1039/c4np00075g; Reck MA, 2009, MYCOTAXON, V109, P361, DOI 10.5248/109.361; Schuffler A, 2009, MYCOTA, V15, P209; Somjaipeng S, 2016, ENZYME MICROB TECH, V90, P69, DOI 10.1016/j.enzmictec.2016.05.002; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; STULL DP, 1995, APPL BIOCHEM BIOTECH, V54, P133, DOI 10.1007/BF02787915; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang X., 2014, PROCEDIA ENV SCI, V16, P125; Wawrzyn GT, 2012, CHEM BIOL, V19, P772, DOI 10.1016/j.chembiol.2012.05.012; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Yuan JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-935; Zaidman BZ, 2005, APPL MICROBIOL BIOT, V67, P453, DOI 10.1007/s00253-004-1787-z; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang P, 2008, BIOTECHNOL LETT, V30, P2119, DOI 10.1007/s10529-008-9801-7; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhou X, 2007, APPL BIOCHEM MICRO+, V43, P439, DOI 10.1134/S000368380704014X; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y	48	24	26	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178612	10.1371/journal.pone.0178612	http://dx.doi.org/10.1371/journal.pone.0178612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636663	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300014
J	Ali, HH; Sunar, MS; Kolivand, H				Ali, Hatam H.; Sunar, Mohd Shahrizal; Kolivand, Hoshang			Soft bilateral filtering volumetric shadows using cube shadow maps	PLOS ONE			English	Article							ALGORITHM	Volumetric shadows often increase the realism of rendered scenes in computer graphics. Typical volumetric shadows techniques do not provide a smooth transition effect in real-time with conservation on crispness of boundaries. This research presents a new technique for generating high quality volumetric shadows by sampling and interpolation. Contrary to conventional ray marching method, which requires extensive time, this proposed technique adopts downsampling in calculating ray marching. Furthermore, light scattering is computed in High Dynamic Range buffer to generate tone mapping. The bilateral interpolation is used along a view rays to smooth transition of volumetric shadows with respect to preserving-edges. In addition, this technique applied a cube shadow map to create multiple shadows. The contribution of this technique isreducing the number of sample points in evaluating light scattering and then introducing bilateral interpolation to improve volumetric shadows. This contribution is done by removing the inherent deficiencies significantly in shadow maps. This technique allows obtaining soft marvelous volumetric shadows, having a good performance and high quality, which show its potential for interactive applications.	[Ali, Hatam H.; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, UTM IRDA Digital Media Ctr, Skudai, Johor, Malaysia; [Ali, Hatam H.; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, Game Innovat Ctr Excellence, Inst Human Ctr Engn, Skudai, Johor, Malaysia; [Ali, Hatam H.; Sunar, Mohd Shahrizal] Univ Teknol Malaysia, Fac Comp, Dept Software Engn, Skudai, Johor, Malaysia; [Kolivand, Hoshang] Liverpool John Moores Univ, Dept Comp Sci, Liverpool, Merseyside, England	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Liverpool John Moores University; University of Liverpool	Ali, HH; Sunar, MS (corresponding author), Univ Teknol Malaysia, UTM IRDA Digital Media Ctr, Skudai, Johor, Malaysia.; Ali, HH; Sunar, MS (corresponding author), Univ Teknol Malaysia, Game Innovat Ctr Excellence, Inst Human Ctr Engn, Skudai, Johor, Malaysia.; Ali, HH; Sunar, MS (corresponding author), Univ Teknol Malaysia, Fac Comp, Dept Software Engn, Skudai, Johor, Malaysia.	ali_hattam@yahoo.com; shahrizal@utm.my	Sunar, Mohd Shahrizal/AFQ-7366-2022; Kolivand, Hoshang/B-2501-2016	Sunar, Mohd Shahrizal/0000-0002-0244-1622; Ali, Hatem Salama/0000-0002-7306-3454; Kolivand, Hoshang/0000-0001-5460-5679	MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Media Centre Universiti Teknologi Malaysia Skudai Johor MALAYSIA; MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Me- dia Centre Universiti Teknologi Malaysia Skudai Johor MALAYSIA. [Q. J130000.2528.12H18 RUG]	MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Media Centre Universiti Teknologi Malaysia Skudai Johor MALAYSIA; MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Me- dia Centre Universiti Teknologi Malaysia Skudai Johor MALAYSIA.	This research was supported by MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Media Centre Universiti Teknologi Malaysia 81310 Skudai Johor MALAYSIA.; This research was supported by Vot. Q. J130000.2528.12H18 RUG at MaGIC-X (Media and Games Innovation Centre of Excellence) UTM-IRDA Digital Me- dia Centre Universiti Teknologi Malaysia 81310 Skudai Johor MALAYSIA.	Ali HH, 2016, MULTIMED TOOLS APPL, P1; Baran I, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866200; Chen J., 2011, S INT 3D GRAPH GAM, P7; Dobashi Yoshinori, 2002, P ACM SIGGRAPH EUROG, P99; Engelhardt T, 2010, P 2010 ACM SIGGRAPH, P119; GEORGIEV I., 2013, ACM T GRAPHIC, V32, P1; Guan T, 2015, ACM T INTEL SYST TEC, V7, DOI 10.1145/2795234; Hanika J., 2012, DIGIPRO 12, P7, DOI [10.1145/2370919.2370921, DOI 10.1145/2370919.2370921]; Hoshang Kolivand, 2012, REAL TIME OUTDOOR RE; Klehm O, 2015, P 41 GRAPH INT C, P115; KLEHM O., 2014, J COMPUTER GRAPHICS, V3, P7; Kolivand Hoshang, 2011, Journal of Computer Sciences, V7, P980, DOI 10.3844/jcssp.2011.980.985; Lili W, 2010, ED INF TECHN ICEIT 2, V1, pV1; Lin HY, 2013, IET IMAGE PROCESS, V7, P762, DOI 10.1049/iet-ipr.2013.0067; Max N. L., 1986, Computer Graphics, V20, P117, DOI 10.1145/15886.15899; Michelin D, 2006, J WSCG, V14, P65; Nathan Vos, 2014, GPU PRO 5 ADV RENDER, P127; Pan HL, 2016, NEUROCOMPUTING, V175, P644, DOI 10.1016/j.neucom.2015.10.104; Pegoraro V, P GRAPH INT 2009 200, P71; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Toth B, 2009, EUROGRAPHICS SHORT P, P14; Wang LL, 2014, COMPUT GRAPH FORUM, V33, P264, DOI 10.1111/cgf.12348; Wei BC, 2015, MULTIMEDIA SYST, V21, P381, DOI 10.1007/s00530-014-0364-2; Wyman C., 2013, P 5 HIGH PERF GRAPH, P45, DOI DOI 10.1145/2492045.2492050; Wyman C, 2008, RT08: IEEE/EG SYMPOSIUM ON INTERACTIVE RAY TRACING 2008, PROCEEDINGS, P87, DOI 10.1109/RT.2008.4634627; Wyman Chris, 2011, P ACM SIGGRAPH S HIG, P33; Zhang YD, 2008, SCI CHINA SER F, V51, P2115, DOI 10.1007/s11432-008-0124-z; Zhang YD, 2010, SCI CHINA INFORM SCI, V53, P1963, DOI 10.1007/s11432-010-4075-9	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178415	10.1371/journal.pone.0178415	http://dx.doi.org/10.1371/journal.pone.0178415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632740	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000404046100008
J	Tseng, YC; Tseng, YH; Kao, HL; Hsieh, CC; Chou, TY; Goan, YG; Hsu, WH; Hsu, HS				Tseng, Yen-Chiang; Tseng, Yen-Han; Kao, Hua-Lin; Hsieh, Chih-Cheng; Chou, Teh-Ying; Goan, Yih-Gang; Hsu, Wen-Hu; Hsu, Han-Shui			Long term oncological outcome of thymoma and thymic carcinoma - an analysis of 235 cases from a single institution	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; EPITHELIAL TUMORS; RETROSPECTIVE ANALYSIS; SURGICAL RESECTION; MALIGNANT THYMOMA; SURVIVAL; DATABASE; RECURRENCE; IMPACT; STAGE	Background and objectives Thymoma has a variable long-term oncological outcome after surgical resection. Survival and tumor recurrence were analyzed to determine the predisposing factors for tumor recurrence. Methods A total of 235 patients who underwent surgery for thymoma or thymic carcinoma from December 1997 to March 2013 were analyzed using Masaoka staging system and World Health Organization (WHO) histological classification. Surgical intervention included extended thymothymectomy via median sternotomy and thymomectomy via thoracotomy/video-assisted thoracoscopic surgery (VATS). Results The median duration of follow-up was 105 months (12-198 months). Among these 235 patients, recurrence was observed in 25 patients (10.7%). according to Masaoka stage I, IIA, IIB, III, IVA, IVB, recurrence rates were 1/65(1.5%), 8/106(7.5%), 1/32(3.1%), 6/20 (30.0%), 8/10(80.0%), 1/1(100.0%), respectively. Disease or treatment-related mortality was observed in 13 patients. Overall survival rate was 94.4%. After univariate analysis, predisposing factors for tumor recurrence included Masaoka stage, WHO histologic type, tumor size, adjuvant therapy and margin status. Conclusions Due to the indolent behavior of thymoma, tumor recurrence appears to be a better assessment of oncological outcome rather than survival. Factors associated with tumor recurrence include Masaoka stage, WHO histologic type, tumor size, adjuvant therapy and margin status.	[Tseng, Yen-Chiang; Goan, Yih-Gang] Kaohsiung Vet Gen Hosp, Dept Surg, Div Thorac Surg, Kaohsiung, Taiwan; [Tseng, Yen-Chiang; Hsieh, Chih-Cheng; Chou, Teh-Ying] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Tseng, Yen-Chiang; Hsieh, Chih-Cheng; Hsu, Wen-Hu; Hsu, Han-Shui] Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan; [Tseng, Yen-Han] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Kao, Hua-Lin; Chou, Teh-Ying] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Hsu, Han-Shui] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Hsu, HS (corresponding author), Taipei Vet Gen Hosp, Dept Surg, Div Thorac Surg, Taipei, Taiwan.; Hsu, HS (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.	hsuhs@vghtpe.gov.tw						Detterbeck FC, 2014, J THORAC ONCOL, V9; Detterbeck F, 2011, J THORAC ONCOL, V6, pS1698, DOI 10.1097/JTO.0b013e31821e7b12; Detterbeck FC, 2010, J THORAC ONCOL, V5, pS318, DOI 10.1097/JTO.0b013e3181f20dab; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; Forquer JA, 2010, INT J RADIAT ONCOL, V76, P440, DOI 10.1016/j.ijrobp.2009.02.016; Fu H, 2016, ANN SURG ONCOL, V23, P619, DOI 10.1245/s10434-015-4825-4; Fukui T, 2016, EUR J CARDIO-THORAC, V50, P1068, DOI 10.1093/ejcts/ezw178; Guerrera F, 2015, EUR J CARDIO-THORAC, V48, P48, DOI 10.1093/ejcts/ezu368; Huang J, 2010, J THORAC ONCOL, V5, P2017, DOI 10.1097/JTO.0b013e3181f13682; Hung YS, 2009, J INTERN MED TAIWAN, V20, P344; KOGA K, 1994, PATHOL INT, V44, P359; Lee GD, 2016, J THORAC DIS, V8, P901, DOI 10.21037/jtd.2016.03.53; Margaritora S, 2010, ANN THORAC SURG, V89, P245, DOI 10.1016/j.athoracsur.2009.08.074; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Nakagawa K, 2014, J SURG ONCOL, V109, P179, DOI 10.1002/jso.23499; Okumura M, 2002, CANCER-AM CANCER SOC, V94, P624, DOI 10.1002/cncr.10226; Patel S, 2012, INT J RADIAT ONCOL, V82, P1797, DOI 10.1016/j.ijrobp.2011.03.010; Rea F, 2004, EUR J CARDIO-THORAC, V26, P412, DOI 10.1016/j.ejcts.2004.04.041; Rosai J., 1999, WORLD HLTH ORG HISTO; Ruffini E, 2014, EUR J CARDIO-THORAC, V46, P361, DOI 10.1093/ejcts/ezt649; Strobel P, 2004, J CLIN ONCOL, V22, P1501, DOI 10.1200/JCO.2004.10.113; Tseng YC, 2013, J THORAC ONCOL, V8, P952, DOI 10.1097/JTO.0b013e31828cb3c2; Weis CA, 2015, J THORAC ONCOL, V10, P367, DOI 10.1097/JTO.0000000000000393; Wright CD, 2005, J THORAC CARDIOV SUR, V130, P1413, DOI 10.1016/j.jtcvs.2005.07.026	24	14	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179527	10.1371/journal.pone.0179527	http://dx.doi.org/10.1371/journal.pone.0179527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632791	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100035
J	Huang, LK; Wang, HH; Lai, YC; Chang, SC				Huang, Li-Kuo; Wang, Hsueh-Han; Lai, Yi-Chun; Chang, Shi-Chuan			The impact of glycemic status on radiological manifestations of pulmonary tuberculosis in diabetic patients	PLOS ONE			English	Article							MELLITUS; OUTCOMES; DISEASE; IMAGES; CT	Setting Diabetes mellitus (DM) may increase risk of pulmonary tuberculosis (PTB) and influence its radiological manifestations. Objective To evaluate the impact of glycemic status on radiological findings of PTB in diabetic patients. Methods Between January 2010 and December 2015, chest radiographs (CXRs) in consecutive 214 DM patients with culture-proved PTB and 123 available thoracic computed tomography (CT) scans were enrolled. An equal number of non-DM patients with similar demographics was included as the control group. Glycemic status was assessed by glycosylated hemoglobin (HbA1c), and a cutoff of 8% was used to further investigate radiological features of diabetic PTB. Two radiologists and one pulmonologist reviewed the chest images independently. Results Compared with non-DM patients, primary PTB pattern and extensive disease on CXRs as well as primary PTB pattern, large non-cavitary nodule, more than one cavity in a single lesion, unusual location, and all lobe involvement of lesions on thoracic CT scans were more common in DM patients. Furthermore, diabetics with HbA1c > 8% were more likely to exhibit unusual findings (P < 0.001), far advanced extensive lesions (P < 0.001) on CXRs, lymphadenopathy (P = 0.028), more than one cavity in a single lesion (P < 0.001) and all lobe involvement (P = 0.041) on thoracic CT scans. Conclusions Glycemic status influenced radiological manifestations of diabetic PTB. Given an increased risk of atypical radiological presentations of PTB in DM patients, physicians should be alert and pay more attention to those with poor glycemic control.	[Huang, Li-Kuo; Wang, Hsueh-Han] Natl Yang Ming Univ Hosp, Dept Radiol, Yi Lan, Taiwan; [Huang, Li-Kuo; Lai, Yi-Chun] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lai, Yi-Chun] Natl Yang Ming Univ Hosp, Div Chest Med, Dept Internal Med, Yi Lan, Taiwan; [Chang, Shi-Chuan] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chang, Shi-Chuan] Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, SC (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Chang, SC (corresponding author), Natl Yang Ming Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.	scchang@vghtpe.gov.tw						AGRAWAL AK, 1988, LUNG INDIA, V6, P177; Al-Tawfiq JA, 2009, INT J TUBERC LUNG D, V13, P367; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Andreu J, 2004, EUR J RADIOL, V51, P139, DOI 10.1016/j.ejrad.2004.03.009; Bacakoglu F, 2001, RESPIRATION, V68, P595, DOI 10.1159/000050578; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chiang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093397; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Falk A, 1969, CLASSIFICATION PULMO, P68; Feng JY, 2009, INT J TUBERC LUNG D, V13, P1387; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; IKEZOE J, 1992, AM J ROENTGENOL, V159, P1175, DOI 10.2214/ajr.159.6.1442377; Jeong YJ, 2008, AM J ROENTGENOL, V191, P834, DOI 10.2214/AJR.07.3896; Leung AN, 1999, RADIOLOGY, V210, P307, DOI 10.1148/radiology.210.2.r99ja34307; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Moreno G, 2013, J AM GERIATR SOC, V61, P2027, DOI 10.1111/jgs.12513; MORRIS JT, 1992, CHEST, V102, P539, DOI 10.1378/chest.102.2.539; Ottmani SE, 2010, INT J TUBERC LUNG D, V14, P1513; Perez-Guzman C, 2000, AM J RESP CRIT CARE, V162, P1738, DOI 10.1164/ajrccm.162.5.2001040; Perez-Guzman C, 2001, INT J TUBERC LUNG D, V5, P455; Perez-Guzman C, 2011, LUNG INDIA, V28, P191, DOI 10.4103/0970-2113.83976; Rizzi EB, 2003, CLIN RADIOL, V58, P469, DOI 10.1016/S0009-9260(03)00056-4; Sidibe EH, 2007, J FR STUD RES HLTH, V17, P29; Tsukaguchi K, 1992, Kekkaku, V67, P755; Uchida K, 1991, Ann Nucl Med, V5, P97; UMUT S, 1994, CHEST, V106, P326; Wang JY, 2005, INT J TUBERC LUNG D, V9, P777; Webb EA, 2009, INT J TUBERC LUNG D, V13, P868; WHO, 2011, COLLABORATIVE FRAMEW; Yabuuchi H, 2002, ACTA RADIOL, V43, P44	34	17	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179750	10.1371/journal.pone.0179750	http://dx.doi.org/10.1371/journal.pone.0179750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628646	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100047
J	Siebenkas, C; Chiappinelli, KB; Guzzetta, AA; Sharma, A; Jeschke, J; Vatapalli, R; Baylin, SB; Ahuja, N				Siebenkas, Cornelia; Chiappinelli, Katherine B.; Guzzetta, Angela A.; Sharma, Anup; Jeschke, Jana; Vatapalli, Rajita; Baylin, Stephen B.; Ahuja, Nita			Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells	PLOS ONE			English	Article							IMMUNOMODULATORY ACTION; IMMUNOTHERAPY; MECHANISMS; MOLECULES; THERAPY; SGI-110; GENES; CD2	Innovative therapies for solid tumors are urgently needed. Recently, therapies that harness the host immune system to fight cancer cells have successfully treated a subset of patients with solid tumors. These responses have been strong and durable but observed in subsets of patients. Work from our group and others has shown that epigenetic therapy, specifically inhibiting the silencing DNA methylation mark, activates immune signaling in tumor cells and can sensitize to immune therapy in murine models. Here we show that colon and ovarian cancer cell lines exhibit lower expression of transcripts involved in antigen processing and presentation to immune cells compared to normal tissues. In addition, treatment with clinically relevant low doses of DNMT inhibitors (that remove DNA methylation) increases expression of both antigen processing and presentation and Cancer Testis Antigens in these cell lines. We confirm that treatment with DNMT inhibitors upregulates expression of the antigen processing and presentation molecules B2M, CALR, CD58, PSMB8, PSMB9 at the RNA and protein level in a wider range of colon and ovarian cancer cell lines and treatment time points than had been described previously. In addition, we show that DNMTi treatment upregulates many Cancer Testis Antigens common to both colon and ovarian cancer. This increase of both antigens and antigen presentation by epigenetic therapy may be one mechanism to sensitize patients to immune therapies.	[Siebenkas, Cornelia; Guzzetta, Angela A.; Sharma, Anup; Jeschke, Jana; Vatapalli, Rajita; Ahuja, Nita] Johns Hopkins Univ, Sch Med, Dept Surg, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Chiappinelli, Katherine B.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Guzzetta, Angela A.] Univ Texas Southwestern Med Sch, Dept Surg, Dallas, TX USA; [Vatapalli, Rajita] Northwestern Univ, Dept Urol, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; George Washington University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Johns Hopkins University; Johns Hopkins Medicine	Ahuja, N (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	kchiapp1@gwu.edu; nahuja1@jhmi.edu	Vatapalli, Rajita/AAN-1397-2021	Jeschke, Jana/0000-0002-6047-2558	National Cancer Institute (NCI) [CA058184]; Stand Up To Cancer (SU2C) Epigenetic Dream Team; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [K23 CM 27141]; American College of Surgeons/ Society of University Surgeons; Department of Defense (DOD) Teal Award [BC031272]; NIH [F32CA183214]; NATIONAL CANCER INSTITUTE [R00CA204592] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer (SU2C) Epigenetic Dream Team; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American College of Surgeons/ Society of University Surgeons; Department of Defense (DOD) Teal Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NCI) CA058184, Stand Up To Cancer (SU2C) Epigenetic Dream Team, The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, K23 CM 27141 (NA), the American College of Surgeons/ Society of University Surgeons (NA), Department of Defense (DOD) Teal Award BC031272 (SBB), and NIH award F32CA183214 (KBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aptsiauri N, 2007, ADV EXP MED BIOL, V601, P123; Bangia N, 2006, IMMUNOL INVEST, V35, P485, DOI 10.1080/08820130600808246; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P803, DOI 10.1007/s00262-011-1147-7; Cabrera T, 2007, TISSUE ANTIGENS, V69, P264, DOI 10.1111/j.1399-0039.2006.00777.x; Chiappinelli KB, 2016, CANCER RES, V76, P1683, DOI 10.1158/0008-5472.CAN-15-2125; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; DAVIS S, 2012, METHYLUMI HANDLE ILL; Driscoll JJ, 2010, TARGET ONCOL, V5, P281, DOI 10.1007/s11523-010-0165-2; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Issa Jean-Pierre, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS24, DOI 10.1038/ncponc0355; James SR, 2006, ONCOGENE, V25, P6975, DOI 10.1038/sj.onc.1209678; Karpf AR, 2006, EPIGENETICS-US, V1, P116, DOI 10.4161/epi.1.3.2988; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Matei D, 2012, CANCER RES, V72, P2197, DOI 10.1158/0008-5472.CAN-11-3909; Odunsi K, 2014, CANCER IMMUNOL RES, V2, P37, DOI 10.1158/2326-6066.CIR-13-0126; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Shakya R, 2013, CANCER RES, V73, P885, DOI 10.1158/0008-5472.CAN-12-1880; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Srivastava P, 2015, EPIGENETICS-US, V10, P237, DOI 10.1080/15592294.2015.1017198; Srivastava P, 2014, LEUKEMIA RES, V38, P1332, DOI 10.1016/j.leukres.2014.09.001; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Taverna P, 2013, BLOOD, V122, P1442; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	37	57	61	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179501	10.1371/journal.pone.0179501	http://dx.doi.org/10.1371/journal.pone.0179501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622390	gold, Green Submitted, Green Published			2022-12-26	WOS:000403506300038
J	Hohlbaum, K; Bert, B; Dietze, S; Palme, R; Fink, H; Thone-Reineke, C				Hohlbaum, Katharina; Bert, Bettina; Dietze, Silke; Palme, Rupert; Fink, Heidrun; Thoene-Reineke, Christa			Severity classification of repeated isoflurane anesthesia in C57BL/6JRj mice-Assessing the degree of distress	PLOS ONE			English	Article							FECAL CORTICOSTERONE METABOLITES; LABORATORY RODENTS; STRESS-RESPONSE; MESSENGER-RNA; PAIN; BEHAVIOR; RATS; ANXIETY; HAIR; SEX	According to the EU Directive 2010/63, the severity of a procedure has to be classified as mild, moderate or severe. General anesthesia is thought to be mild, but the Directive does not differentiate between single and repeated anesthesia. Therefore, we investigated the impact of repeated administration of isoflurane, the most commonly used inhalation anesthetic, on the well-being of adult C57BL/6JRj mice, in comparison to single administrations and to untreated animals, when applied six times for 45 min at an interval of 3-4 days. For the animals anesthetized, excitations, phases of anesthesia, and vital parameters were monitored. Well-being after anesthesia was assessed using a behavioral test battery including luxury behavior like burrowing and nest building behavior, the Mouse Grimace Scale (MGS), the free exploratory paradigm for anxiety-related behavior, home cage activity and the rotarod test for activity, as well as food intake and body weight. Additionally, hair corticosterone and fecal corticosterone metabolites were measured. Our results show that nest building behavior, home cage activity, body weight, and corticosterone concentrations were not influenced by anesthesia, whereas changes in burrowing behavior, the MGS, food intake, and the free exploratory behavior indicated that the well-being of the mice was more affected by repeated than single isoflurane anesthesia. This effect depended on the sex of the animals, with female mice being more susceptible than male mice. However, repeated isoflurane anesthesia caused only short-term mild distress and impairment of well-being, mainly in the immediate postanesthetic period. Well-being stabilized at 8 days after the last anesthesia, at the latest. Therefore, we conclude that when using our anesthesia protocol, the severity of both single and repeated isoflurane anesthesia in C57BL/6JRj mice can be classified as mild. However, within the mild severity category, repeated isoflurane anesthesia ranks higher than single isoflurane anesthesia. Additionally, our results imply that male and female mice can differently perceive the severity of a procedure.	[Hohlbaum, Katharina; Thoene-Reineke, Christa] Free Univ Berlin, Inst Anim Welf Anim Behav & Lab Anim Sci, Dept Vet Med, Berlin, Germany; [Hohlbaum, Katharina; Bert, Bettina; Dietze, Silke; Fink, Heidrun] Free Univ Berlin, Inst Pharmacol & Toxicol, Dept Vet Med, Berlin, Germany; [Palme, Rupert] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, Vienna, Austria; [Bert, Bettina] BfR Fed Inst Risk Assessment, Berlin, Germany	Free University of Berlin; Free University of Berlin; University of Veterinary Medicine Vienna; Federal Institute for Risk Assessment	Hohlbaum, K (corresponding author), Free Univ Berlin, Inst Anim Welf Anim Behav & Lab Anim Sci, Dept Vet Med, Berlin, Germany.; Hohlbaum, K (corresponding author), Free Univ Berlin, Inst Pharmacol & Toxicol, Dept Vet Med, Berlin, Germany.	katharina.hohlbaum@fu-berlin.de	Palme, Rupert/A-3499-2008	Palme, Rupert/0000-0001-9466-3662; Bert, Bettina/0000-0002-8202-9290	German Federal Ministry of Education and Research [031A262A]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study is part of the Berlin Brandenburg research platform BB3R (www bb3r de) and was funded by the German Federal Ministry of Education and Research (grant number: 031A262A) (www.bmbf.de/en/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M., 2014, BMC VET RES, V10, P963; Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Altholtz LY, 2006, J AM ASSOC LAB ANIM, V45, P17; An XL, 2011, EXP ANIM TOKYO, V60, P111, DOI 10.1538/expanim.60.111; Atanasov NA, 2015, J AM ASSOC LAB ANIM, V54, P737; Bekhbat M, 2016, BEHAV BRAIN RES, V305, P122, DOI 10.1016/j.bbr.2016.03.003; Bert B, 2013, J PHARMACOL TOX MET, V68, P240, DOI 10.1016/j.vascn.2013.01.001; Bryant CD, 2008, J NEUROGENET, V22, P315, DOI 10.1080/01677060802357388; Cozzoli DK, 2014, ALCOHOL, V48, P741, DOI 10.1016/j.alcohol.2014.07.015; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Di S, 2003, J NEUROSCI, V23, P4850; Ding F, 2016, J ANESTH, V30, P684, DOI 10.1007/s00540-016-2189-y; Finlayson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166446; Flaishon R, 2003, ANESTH ANALG, V97, P1046, DOI 10.1213/01.ANE.0000080202.70592.A7; Flaishon R, 1999, BRAIN RES, V815, P287, DOI 10.1016/S0006-8993(98)01120-2; Flecknell P., 2016, LAB ANIMAL ANAESTHES; Flecknell PA, 1999, LAB ANIM-UK, V33, P41, DOI 10.1258/002367799780578516; Gao W, 2013, J CHROMATOGR B, V928, P1, DOI 10.1016/j.jchromb.2013.03.008; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; GRAD B, 1968, J GERONTOL, V23, P522, DOI 10.1093/geronj/23.4.522; Gunther L, 2011, NEUROPHARMACOLOGY, V61, P433, DOI 10.1016/j.neuropharm.2011.03.004; Harrison NL, 2003, ANESTH ANALG, V97, P616, DOI 10.1213/01.ANE.0000086120.30172.12; Hayase T, 2016, MED GAS RES, V6, P70, DOI 10.4103/2045-9912.184715; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Jacobsen KR, 2012, J AM ASSOC LAB ANIM, V51, P69; Jarcho MR, 2016, HORM BEHAV, V78, P135, DOI 10.1016/j.yhbeh.2015.11.004; Jirkof P, 2014, J NEUROSCI METH, V234, P139, DOI 10.1016/j.jneumeth.2014.02.001; Jirkof P, 2013, LAB ANIM-UK, V47, P153, DOI 10.1177/0023677213475603; Jirkof P, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00165; Kalueff AV, 2004, BRAIN RES PROTOC, V13, P151, DOI 10.1016/j.brainresprot.2004.04.002; Kikuchi T, 2013, NEUROSCIENCE, V237, P151, DOI 10.1016/j.neuroscience.2013.01.062; Kita M, 2013, ADV BIOMED ENG RES, V1, P24; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Li FX, 2015, ANESTHESIOLOGY, V122, P768, DOI 10.1097/ALN.0000000000000607; Long RP, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8524560; MARTIN DC, 1990, NEUROCHEM RES, V15, P969, DOI 10.1007/BF00965741; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; Miller A, 2015, APPL ANIM BEHAV SCI, V172, P58, DOI 10.1016/j.applanim.2015.08.038; Miller AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166652; Moody CM, 2014, APPL ANIM BEHAV SCI, V158, P95, DOI 10.1016/j.applanim.2014.04.011; Mukaida K, 2007, ANESTH ANALG, V104, P836, DOI 10.1213/01.ane.0000255200.42574.22; Neumaier JF, 2000, MOL BRAIN RES, V82, P65, DOI 10.1016/S0169-328X(00)00181-9; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Paylor R, 2006, PHYSIOL BEHAV, V87, P95, DOI 10.1016/j.physbeh.2005.09.002; Raap DK, 2002, NEUROENDOCRINOLOGY, V76, P348, DOI 10.1159/000067582; Rex A, 2005, EUR J NEUROSCI, V22, P1185, DOI 10.1111/j.1460-9568.2005.04251.x; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Russel W. M. S., 1959, PRINC HUM EXP TECH; Schuettler J, 2008, HDB EXPT PHARM; Scorrano F, 2015, FASEB J, V29, P859, DOI 10.1096/fj.14-254474; Solomonow J., 2015, TULANE UNDERGRADUATE, V2, P14; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; Stokes EL, 2009, LAB ANIM-UK, V43, P149, DOI 10.1258/la.2008.008020; TerRiet MF, 2000, BRIT J ANAESTH, V85, P305, DOI 10.1093/bja/85.2.305; Thomson S, 2010, EXP CLIN ENDOCR DIAB, V118, P133, DOI 10.1055/s-0029-1220771; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44; Tsuji M, 2000, PSYCHOPHARMACOLOGY, V152, P157, DOI 10.1007/s002130000514; Voigt CC, 2013, ANIM WELFARE, V22, P449, DOI 10.7120/09627286.22.4.449; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Whittington RA, 2006, ANESTH ANALG, V103, P92, DOI 10.1213/01.ane.0000221488.48352.61; WYRWICZ AM, 1987, BIOCHIM BIOPHYS ACTA, V927, P86, DOI 10.1016/0167-4889(87)90069-3; Yokoyama C, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw079; Yonezaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122118; Yu T, 2015, J CHROMATOGR B, V1002, P267, DOI 10.1016/j.jchromb.2015.08.035	69	81	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179588	10.1371/journal.pone.0179588	http://dx.doi.org/10.1371/journal.pone.0179588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617851	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600049
J	Akershoek, JJ; Brouwer, KM; Vlig, M; Boekema, BKHL; Beelen, RHJ; Middelkoop, E; Ulrich, MMW				Akershoek, Johanneke J.; Brouwer, Katrien M.; Vlig, Marcel; Boekema, Bouke K. H. L.; Beelen, Rob H. J.; Middelkoop, Esther; Ulrich, Magda M. W.			Differential effects of Losartan and Atorvastatin in partial and full thickness burn wounds	PLOS ONE			English	Article							SCAR ASSESSMENT SCALE; ANGIOTENSIN-II; KERATINOCYTE MIGRATION; RECEPTOR; FIBROSIS; STATINS; RAT; INFLAMMATION; ACTIVATION; SYSTEM	Healing of burn wounds is often associated with scar formation due to excessive inflammation and delayed wound closure. To date, no effective treatment is available to prevent the fibrotic process. The Renin Angiotensin System (RAS) was shown to be involved in fibrosis in various organs. Statins (e. g. Atorvastatin), Angiotensin receptor antagonists (e. g. Losartan) and the combination of these drugs are able to reduce the local RAS activation, and reduced fibrosis in other organs. We investigated whether inhibition of the RAS could improve healing of burn wounds by treatment with Atorvastatin, Losartan or the combination of both drugs. Therefore, full and partial thickness burn wounds were inflicted on both flanks of Yorkshire pigs. Oral administration of Atorvastatin, Losartan or the combination was started at post-burn day 1 and continued for 28 days. Full thickness wounds were excised and transplanted with an autologous meshed split-thickness skin graft at post-burn day 14. Partial thickness wounds received conservative treatment. Atorvastatin treatment resulted in enhanced graft take and wound closure of the full thickness wounds, faster resolution of neutrophils compared to all treatments and reduced alpha-smooth muscle actin positive cells compared to control treatment. Treatment with Losartan and to a lesser extent the combination therapy resulted in diminished graft take, increased wound contraction and poorer scar outcome. In contrast, Losartan treatment in partial thickness wounds decreased the alpha-smooth muscle actin + fibroblasts and contraction. In conclusion, we showed differential effects of Losartan and Atorvastatin in full and partial thickness wounds. The extensive graft loss seen in Losartan treated wounds is most likely responsible for the poor clinical outcome of these full thickness burn wounds. Therefore, Losartan treatment should not be started before transplantation in order to prevent graft loss. Atorvastatin seems to accelerate the healing process in full thickness wounds possibly by dampening the proinflammatory response.	[Akershoek, Johanneke J.; Brouwer, Katrien M.; Middelkoop, Esther] Vrije Univ Amsterdam, Med Ctr, Dept Plast Reconstruct & Hand Surg, Res Inst MOVE, Amsterdam, Netherlands; [Akershoek, Johanneke J.; Brouwer, Katrien M.; Vlig, Marcel; Boekema, Bouke K. H. L.; Middelkoop, Esther; Ulrich, Magda M. W.] Assoc Dutch Burn Ctr, Beverwijk, Netherlands; [Beelen, Rob H. J.; Ulrich, Magda M. W.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ulrich, MMW (corresponding author), Assoc Dutch Burn Ctr, Beverwijk, Netherlands.; Ulrich, MMW (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	mulrich@burns.nl	Middelkoop, Esther/M-3735-2014; Ulrich, Magda/H-7744-2019; Brouwer, Katrien M/K-6168-2012; Vlig, Marcel/ABB-4001-2020; Boekema, Bouke/H-5200-2019	Middelkoop, Esther/0000-0001-8843-1080; Ulrich, Magda/0000-0001-6369-2196; Brouwer, Katrien M/0000-0002-6768-3358; Vlig, Marcel/0000-0003-3280-5877; Boekema, Bouke/0000-0002-9085-6982	Dutch Burns Foundation, Beverwijk, The Netherlands [NBS WO 10.109]; European Commission [FP7-HEALTH-2011-1, 279024]	Dutch Burns Foundation, Beverwijk, The Netherlands(Netherlands Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Dutch Burns Foundation, Beverwijk, The Netherlands (project NBS WO 10.109), http://brandwondenstichting.nl/, MU; European Commission (FP7-HEALTH-2011-1, Grant Agreement no. 279024), project EuroSkinGraft, EM.	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Bagnato G, 2013, RHEUMATOLOGY, V52, P1377, DOI 10.1093/rheumatology/ket144; Bedi O, 2016, N-S ARCH PHARMACOL, V389, P695, DOI 10.1007/s00210-016-1252-4; Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155; Coleman CM, 2007, AM J PHYSIOL-RENAL, V293, pF262, DOI 10.1152/ajprenal.00071.2007; Dechend R, 2001, AM J HYPERTENS, V14, p55S, DOI 10.1016/S0895-7061(01)02070-2; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Draaijers LJ, 2004, PLAST RECONSTR SURG, V113, P1960, DOI 10.1097/01.PRS.0000122207.28773.56; Drapala A, 2014, J RENIN-ANGIO-ALDO S, V15, P250, DOI 10.1177/1470320314531058; El-Ashmawy N.E., 2015, CLIN EXP PHARM PHYSL; Elbaz M, 2012, ANN NEUROL, V71, P699, DOI 10.1002/ana.22694; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Hayden MR, 2011, CARDIORENAL MED, V1, P193, DOI 10.1159/000329926; Hop MJ, 2014, BURNS, V40, P1544, DOI 10.1016/j.burns.2014.04.014; Hop MJ, 2012, BURNS, V38, P617, DOI 10.1016/j.burns.2012.01.013; Jasinska M, 2007, PHARMACOL REP, V59, P483; Jiang ZL, 2016, J ASTHMA ALLERGY, V9, P101, DOI 10.2147/JAA.S104508; Kamber M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00170; Kim M, 2008, J GASTROENTEROL, V43, P889, DOI 10.1007/s00535-008-2239-9; Kim MY, 2012, LIVER INT, V32, P977, DOI 10.1111/j.1478-3231.2012.02774.x; Kobayashi T, 2013, J APPL PHYSIOL, V114, P262, DOI 10.1152/japplphysiol.00140.2011; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Li C, 2005, TRANSPLANTATION, V79, P1522, DOI 10.1097/01.TP.0000155305.49439.4C; Lim DS, 2001, CIRCULATION, V103, P789, DOI 10.1161/01.CIR.103.6.789; Lunder M, 2013, HEART VESSELS, V28, P246, DOI 10.1007/s00380-012-0259-0; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mezzano SA, 2001, HYPERTENSION, V38, P635, DOI 10.1161/hy09t1.094234; Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7; Murphy AM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0023-z; Nam HK, 2013, AM J NEPHROL, V37, P7, DOI 10.1159/000345990; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nehme A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10035; Nie Lianbo, 2004, Journal of UOEH, V26, P165; Palin NK, 2015, AM J NEPHROL, V41, P383, DOI 10.1159/000431338; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Reichert K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166845; Diez RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014145; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sakai H, 2015, MOL PHARMACOL, V87, P277, DOI 10.1124/mol.114.096461; Schierwagen R, 2017, AM J PHYSIOL-GASTR L, V312, pG407, DOI 10.1152/ajpgi.00441.2016; Steckelings UM, 2005, BRIT J DERMATOL, V153, P887, DOI 10.1111/j.1365-2133.2005.06806.x; Suh JW, 2010, J KOREAN MED SCI, V25, P16, DOI 10.3346/jkms.2010.25.1.16; Takeda H, 2004, AM J PATHOL, V165, P1653, DOI 10.1016/S0002-9440(10)63422-0; Tzanidis A, 2001, J MOL CELL CARDIOL, V33, P969, DOI 10.1006/jmcc.2001.1361; van de Goot F, 2009, J BURN CARE RES, V30, P274, DOI 10.1097/BCR.0b013e318198a252; van der Wal MBA, 2012, QUAL LIFE RES, V21, P13, DOI 10.1007/s11136-011-9924-5; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wilgus TA, 2013, ADV WOUND CARE, V2, P379, DOI 10.1089/wound.2012.0383; Yahata Y, 2006, J BIOL CHEM, V281, P13209, DOI 10.1074/jbc.M509771200; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006; Zhang O, 2015, INT IMMUNOPHARMACOL, V26, P58, DOI 10.1016/j.intimp.2015.03.005	51	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179350	10.1371/journal.pone.0179350	http://dx.doi.org/10.1371/journal.pone.0179350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614412	Green Submitted, Green Published, gold			2022-12-26	WOS:000403280900045
J	Liu, XN; Li, N; Wen, CY				Liu, Xiaona; Li, Na; Wen, Chaoyang			Effect of pathological heterogeneity on shear wave elasticity imaging in the staging of deep venous thrombosis	PLOS ONE			English	Article							VEIN THROMBOSIS; PULMONARY-EMBOLISM; BLOOD-CLOTS; ULTRASOUND; ELASTOGRAPHY; MODEL; CARTILAGE	Background We aimed to observe the relationship between the pathological components of a deep venous thrombus (DVT), which was divided into three parts, and the findings on quantitative ultrasonic shear wave elastography (SWE) to increase the accuracy of thrombus staging in a rabbit model. Methods A flow stenosis-induced vein thrombosis model was used, and the thrombus was divided into three parts (head, body and tail), which were associated with corresponding observation points. Elasticity was quantified in vivo using SWE over a 2-week period. A quantitative pathologic image analysis (QPIA) was performed to obtain the relative percentages of the components of the main clots. Results DVT maturity occurred at 2 weeks, and the elasticity of the whole thrombus and the three parts (head, body and tail) showed an increasing trend, with the Young's modulus values varying from 2.36 +/- 0.41 kPa to 13.24 +/- 1.71 kPa; 2.01 +/- 0.28 kPa to 13.29 +/- 1.48 kPa; 3.27 +/- 0.57 kPa to 15.91 +/- 2.05 kPa; and 1.79 +/- 0.36 kPa to 10.51 +/- 1.61 kPa, respectively. Significant increases occurred on different days for the different parts: the head showed significant increases on days 4 and 6; the body showed significant increases on days 4 and 7; and the tail showed significant increases on days 3 and 6. The QPIA showed that the thrombus composition changed dynamically as the thrombus matured, with the fibrin and calcium salt deposition gradually increasing and the red blood cells (RBCs) and platelet trabecula gradually decreasing. Significant changes were observed on days 4 and 7, which may represent the transition points for acute, sub-acute and chronic thrombi. Significant heterogeneity was observed between and within the thrombi. Conclusions Variations in the thrombus components were generally consistent between the SWE and QPIA. Days 4 and 7 after thrombus induction may represent the transition points for acute, sub-acute and chronic thrombi in rabbit models. A dynamic examination of the same part of the thrombus may be helpful for improving the sensitivity and reproducibility of SWE for DVT diagnosis and staging.	[Liu, Xiaona; Li, Na; Wen, Chaoyang] Chinese PLA Peoples Liberat Army Med Sch, Beijing, Peoples R China; [Liu, Xiaona] Binzhou Med Univ Hosp, Dept Ultrasound, Binzhou, Shandong, Peoples R China; [Li, Na] 463rd Hosp Shenyang Mil Reg, Dept Auxiliary Diag, Shenyang, Liaoning, Peoples R China; [Wen, Chaoyang] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ultrasound, Beijing, Peoples R China	Binzhou Medical University; Chinese People's Liberation Army General Hospital	Wen, CY (corresponding author), Chinese PLA Peoples Liberat Army Med Sch, Beijing, Peoples R China.; Wen, CY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ultrasound, Beijing, Peoples R China.	wency304@163.com			National Natural Sciences Foundation [81141019]; Hainan Province Science and Technology Plan Key Program [ZDXM2014062]; Hainan Province Natural Sciences Foundation [813227]; Hainan Province Medical Scientific Research Subject [Qiong2012PT-73]; Binzhou Medical College Scientific Plan and Research Foundation [BY2015KJ17]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Hainan Province Science and Technology Plan Key Program; Hainan Province Natural Sciences Foundation; Hainan Province Medical Scientific Research Subject; Binzhou Medical College Scientific Plan and Research Foundation	This project was supported by the National Natural Sciences Foundation [81141019] to CW; Hainan Province Science and Technology Plan Key Program [ZDXM2014062] to CW; Hainan Province Natural Sciences Foundation [813227] to CW; Hainan Province Medical Scientific Research Subject [Qiong2012PT-73] to CW; and Binzhou Medical College Scientific Plan and Research Foundation [BY2015KJ17] to XL.	Bansal PN, 2010, OSTEOARTHR CARTILAGE, V18, P184, DOI 10.1016/j.joca.2009.09.003; Bernal M, 2013, ULTRASOUND MED BIOL, V39, P2123, DOI 10.1016/j.ultrasmedbio.2013.05.014; Bernal M, 2012, ULTRASOUND MED BIOL, V38, P2218, DOI 10.1016/j.ultrasmedbio.2012.08.007; Dharmarajah B, 2015, PHLEBOLOGY, V30, P77, DOI 10.1177/0268355514528691; Emelianov SY, 2002, ULTRASOUND MED BIOL, V28, P757, DOI 10.1016/S0301-5629(02)00516-1; Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008; Gent M, 1996, CIRCULATION, V93, P80, DOI 10.1161/01.CIR.93.1.80; Hirsh J, 1996, CIRCULATION, V93, P2212, DOI 10.1161/01.CIR.93.12.2212; Hyers TM, 1998, CHEST, V114, p561S, DOI 10.1378/chest.114.5_Supplement.561S; Martin I, 1999, ANN BIOMED ENG, V27, P656, DOI 10.1114/1.205; Mfoumou E, 2014, THROMB RES, V133, P265, DOI 10.1016/j.thromres.2013.11.001; Orbell JH, 2008, BRIT J SURG, V95, P137, DOI 10.1002/bjs.6077; Raskob GE, 2010, AM J PREV MED, V38, pS502, DOI 10.1016/j.amepre.2010.01.010; Rubin JM, 2006, J ULTRAS MED, V25, P1179, DOI 10.7863/jum.2006.25.9.1179; Schmitt C, 2011, J BIOMECH, V44, P622, DOI 10.1016/j.jbiomech.2010.11.015; Taber KH, 1996, JMRI-J MAGN RESON IM, V6, P878, DOI 10.1002/jmri.1880060607; Thanaporn P, 2003, SURGERY, V134, P365, DOI 10.1067/msy.2003.249; Viola F, 2010, CLIN CHIM ACTA, V411, P106, DOI 10.1016/j.cca.2009.10.017; WAKEFIELD TW, 1995, ARTERIOSCL THROM VAS, V15, P258, DOI 10.1161/01.ATV.15.2.258; Wakefield TW, 1999, J VASC SURG, V30, P885, DOI 10.1016/S0741-5214(99)70013-3; Wang C, 2014, CLIN APPL THROMB-HEM, V20, P311, DOI 10.1177/1076029612461066; Xie H, 2005, ULTRASOUND MED BIOL, V31, P1351, DOI 10.1016/j.ultrasmedbio.2005.06.005; Xie H, 2004, ULTRASOUND MED BIOL, V30, P1385, DOI 10.1016/j.ultrasmedbio.2004.08.015; Xie L, 2010, OSTEOARTHR CARTILAGE, V18, P65, DOI 10.1016/j.joca.2009.07.014	24	13	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179103	10.1371/journal.pone.0179103	http://dx.doi.org/10.1371/journal.pone.0179103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614362	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900033
J	Danielsson, T; Carlsson, J; Schreyer, H; Ahnesjo, J; Ten Siethoff, L; Ragnarsson, T; Tugetam, S; Bergman, P				Danielsson, Tom; Carlsson, Jorg; Schreyer, Hendrik; Ahnesjo, Jonas; Ten Siethoff, Lasse; Ragnarsson, Thony; Tugetam, Sa; Bergman, Patrick			Blood biomarkers in male and female participants after an Ironman-distance triathlon	PLOS ONE			English	Article							CARDIAC TROPONIN-T; OXIDATIVE STRESS; EXERCISE INTENSITY; ENDURANCE EXERCISE; DAMAGE; RESPONSES; ELEVATION; DURATION; RUNNERS; MARKERS	Background While overall physical activity is clearly associated with a better short-term and long-term health, prolonged strenuous physical activity may result in a rise in acute levels of blood-biomarkers used in clinical practice for diagnosis of various conditions or diseases. In this study, we explored the acute effects of a full Ironman-distance triathlon on biomarkers related to heart-, liver-, kidney-and skeletal muscle damage immediately post-race and after one week's rest. We also examined if sex, age, finishing time and body composition influenced the post-race values of the biomarkers. Methods A sample of 30 subjects was recruited (50% women) to the study. The subjects were evaluated for body composition and blood samples were taken at three occasions, before the race (T1), immediately after (T2) and one week after the race (T3). Linear regression models were fitted to analyse the independent contribution of sex and finishing time controlled for weight, body fat percentage and age, on the biomarkers at the termination of the race (T2). Linear mixed models were fitted to examine if the biomarkers differed between the sexes over time (T1-T3). Results Being male was a significant predictor of higher post-race (T2) levels of myoglobin, CK, and creatinine levels and body weight was negatively associated with myoglobin. In general, the models were unable to explain the variation of the dependent variables. In the linear mixed models, an interaction between time (T1-T3) and sex was seen for myoglobin and creatinine, in which women had a less pronounced response to the race. Conclusion Overall women appear to tolerate the effects of prolonged strenuous physical activity better than men as illustrated by their lower values of the biomarkers both post- race as well as during recovery.	[Danielsson, Tom; Ahnesjo, Jonas; Ten Siethoff, Lasse; Ragnarsson, Thony; Tugetam, Sa; Bergman, Patrick] Linneaus Univ, Dept Sport Sci, Kalmar, Sweden; [Carlsson, Jorg] Linneaus Univ, Dept Biosci, Kalmar, Sweden; [Carlsson, Jorg; Schreyer, Hendrik] Kalmar Hosp, Dept Cardiol, Kalmar, Sweden; [Tugetam, Sa] Linneaus Univ, Dept Pedag, Kalmar, Sweden	Linnaeus University; Linnaeus University; Linnaeus University	Bergman, P (corresponding author), Linneaus Univ, Dept Sport Sci, Kalmar, Sweden.	patrick.bergman@lnu.se	Bergman, Patrick/B-5906-2012	Bergman, Patrick/0000-0003-4934-8684; ten Siethoff, Lasse/0000-0001-6878-3142	Kalmar County Council	Kalmar County Council	Part of this study was funded by Kalmar County Council (http://www.ltkalmar.se/) via funds to JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2010, GLOB REC PHYS ACT HL; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Britt R, 2012, AVERAGE IRONMAN FINI; Buerger-Mendonca M, 2008, ANN HEPATOL, V7, P245, DOI 10.1016/S1665-2681(19)31855-1; Carlsson J, 2016, LAKARTIDNINGEN; Dannecker EA, 2012, J PAIN, V13, P1242, DOI 10.1016/j.jpain.2012.09.014; de Milander L, 2009, APPL PHYSIOL NUTR ME, V34, P858, DOI 10.1139/H09-083; Duttaroy S, 2012, SCAND CARDIOVASC J, V46, P2, DOI 10.3109/14017431.2011.622783; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; Fu F, 2009, INT J SPORTS MED, V30, P168, DOI 10.1055/s-0028-1104586; Furman J, 2015, JAAPA-J AM ACAD PHYS, V28, P38, DOI 10.1097/01.JAA.0000458861.78559.3b; Gomez-Merino D, 2006, EUR CYTOKINE NETW, V17, P117; Hoffman MD, 2012, WILD ENVIRON MED, V23, P56, DOI 10.1016/j.wem.2011.11.001; Knechtle B, 2014, OPEN ACCESS J SPORTS, V5, P159, DOI 10.2147/OAJSM.S65977; Leischik R, 2014, INT J ENV RES PUB HE, V11, P9082, DOI 10.3390/ijerph110909082; Meili D, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-25; Mohanty S, 2016, J CARDIOVASCULAR ELE; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Neubauer O, 2008, MED SCI SPORT EXER, V40, P2119, DOI 10.1249/MSS.0b013e3181824dab; Neumayr G, 2005, INT J SPORTS MED, V26, P2, DOI 10.1055/s-2004-815717; NILSSON J, 1989, ACTA PHYSIOL SCAND, V136, P217, DOI 10.1111/j.1748-1716.1989.tb08655.x; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; Pinho RA, 2010, CLIN J SPORT MED, V20, P306, DOI 10.1097/JSM.0b013e3181e413df; Pouliot-Laforte A, 2014, J MUSCULOSKEL NEURON, V14, P155; Puggina EF, 2014, AN ACAD BRAS CIENC, V86, P429, DOI 10.1590/0001-37652014112912; Reichhold S, 2009, FREE RADICAL RES, V43, P753, DOI 10.1080/10715760903040628; Rifai N, 1999, AM J CARDIOL, V83, P1085, DOI 10.1016/S0002-9149(99)00020-X; Ruiz JR, 2013, J PHYSIOL-LONDON, V591, P4943, DOI 10.1113/jphysiol.2013.257147; Shave R, 2010, J AM COLL CARDIOL, V56, P169, DOI 10.1016/j.jacc.2010.03.037; Stewart GM, 2016, J PHYSIOL-LONDON, V594, P3031, DOI 10.1113/JP271889; Sugama K, 2015, EXERC IMMUNOL REV, V21, P130; Tulloh L, 2006, BRIT J SPORT MED, V40, P605, DOI 10.1136/bjsm.2005.022319; Verbalis JG, 2007, SPORTS MED, P37; Waskiewicz Z, 2012, EUR J APPL PHYSIOL, V112, P1679, DOI 10.1007/s00421-011-2135-5; Wedin JO, 2015, SCAND J MED SCI SPOR, V25, P495, DOI 10.1111/sms.12304	35	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179324	10.1371/journal.pone.0179324	http://dx.doi.org/10.1371/journal.pone.0179324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609447	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700028
J	Khin, NC; Lowe, JL; Jensen, LM; Burgio, G				Khin, Nay Chi; Lowe, Jenna L.; Jensen, Lora M.; Burgio, Gaetan			No evidence for genome editing in mouse zygotes and HEK293T human cell line using the DNA-guided Natronobacterium gregoryi Argonaute (NgAgo)	PLOS ONE			English	Article								A recently published research article reported that the extreme halophile archaebacterium Natronobacterium gregoryi Argonaute enzyme (NgAgo) could cleave the cellular DNA under physiological temperature conditions in cell line and be implemented as an alternative to CRISPR/Cas9 genome editing technology. We assessed this claim in mouse zygotes for four loci (Sptb, Tet-1, Tet-2 and Tet-3) and in the human HEK293T cell line for the EMX1 locus. Over 100 zygotes were microinjected with nls-NgAgo-GK plasmid provided from Addgene and various concentrations of 5'-phosphorylated guide DNA (gDNA) from 2.5 ng/mu l to 50 ng/mu l and cultured to blastocyst stage of development. The presence of indels was verified using T7 endonuclease 1 assay (T7E1) and Sanger sequencing. We reported no evidence of successful editing of the mouse genome. We then assessed the lack of editing efficiency in HEK293T cell line for the EMX1 endogenous locus by monitoring the NgAgo protein expression level and the editing efficiency by T7E1 assay and Sanger sequencing. We reported that the NgAgo protein was expressed from 8 hours to a maximum expression at 48 hours post-transfection, confirming the efficient delivery of the plasmid and the gDNA but no evidence of successful editing of EMX1 target in all transfected samples. Together our findings indicate that we failed to edit using NgAgo.	[Khin, Nay Chi; Lowe, Jenna L.; Jensen, Lora M.; Burgio, Gaetan] Australian Natl Univ, Dept Immunol & Infect Dis, John Curtin Sch Med Res, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research	Burgio, G (corresponding author), Australian Natl Univ, Dept Immunol & Infect Dis, John Curtin Sch Med Res, Canberra, ACT, Australia.	Gaetan.burgio@anu.edu.au	Burgio, Gaetan/B-6722-2015	Burgio, Gaetan/0000-0002-7434-926X	National Collaborative Research Infrastructure (NCRIS) through Australian Phenomics Network in Australia	National Collaborative Research Infrastructure (NCRIS) through Australian Phenomics Network in Australia	This work was supported from the National Collaborative Research Infrastructure (NCRIS) through the Australian Phenomics Network in Australia. The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Burgess S, 2016, PROTEIN CELL, V7, P913, DOI 10.1007/s13238-016-0343-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Gao F, 2016, NAT BIOTECHNOL, V34, P768, DOI 10.1038/nbt.3547; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Lee SH, 2017, NAT BIOTECHNOL, V35, P17, DOI 10.1038/nbt.3753; Martinez-Galvez G, 2016, HUM GENE THER, V27, P419, DOI 10.1089/hum.2016.071; Qi JL, 2016, CELL RES, V26, P1349, DOI 10.1038/cr.2016.134; Richardson Lorna, 2014, Methods Mol Biol, V1092, P61, DOI 10.1007/978-1-60327-292-6_5; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	9	15	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178768	10.1371/journal.pone.0178768	http://dx.doi.org/10.1371/journal.pone.0178768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609472	Green Submitted, Green Published, gold			2022-12-26	WOS:000403274700012
J	Burridge, AK; Hornlein, C; Janssen, AW; Hughes, M; Bush, SL; Marletaz, F; Gasca, R; Pierrot-Bults, AC; Michel, E; Todd, JA; Young, JR; Osborn, KJ; Menken, SBJ; Peijnenburg, KTCA				Burridge, Alice K.; Hornlein, Christine; Janssen, Arie W.; Hughes, Martin; Bush, Stephanie L.; Marletaz, Ferdinand; Gasca, Rebeca; Pierrot-Bults, Annelies C.; Michel, Ellinor; Todd, Jonathan A.; Young, Jeremy R.; Osborn, Karen J.; Menken, Steph B. J.; Peijnenburg, Katja T. C. A.			Time-calibrated molecular phylogeny of pteropods	PLOS ONE			English	Article							EOCENE THERMAL MAXIMUM; OPISTHOBRANCHIA MOLLUSCA; HOLOPLANKTONIC MOLLUSCA; EUTHYNEURAN GASTROPODS; OCEAN ACIDIFICATION; EVOLUTION; THECOSOMATA; SYSTEMATICS; MORPHOLOGY; CARBONATE	Pteropods are a widespread group of holoplanktonic gastropod molluscs and are uniquely suitable for study of long-term evolutionary processes in the open ocean because they are the only living metazoan plankton with a good fossil record. Pteropods have been proposed as bioindicators to monitor the impacts of ocean acidification and in consequence have attracted considerable research interest, however, a robust evolutionary framework for the group is still lacking. Here we reconstruct their phylogenetic relationships and examine the evolutionary history of pteropods based on combined analyses of Cytochrome Oxidase I, 28S, and 18S ribosomal rRNA sequences and a molecular clock calibrated using fossils and the estimated timing of the formation of the Isthmus of Panama. Euthecosomes with uncoiled shells were monophyletic with Creseis as the earliest diverging lineage, estimated at 41-38 million years ago (mya). The coiled euthecosomes (Limacina, Heliconoides, Thielea) were not monophyletic contrary to the accepted morphology-based taxonomy; however, due to their high rate heterogeneity no firm conclusions can be drawn. We found strong support for monophyly of most euthecosome genera, but Clio appeared as a polyphyletic group, and Diacavolinia grouped within Cavolinia, making the latter genus paraphyletic. The highest evolutionary rates were observed in Heliconoides inflatus and Limacina bulimoides for both 28S and 18S partitions. Using a fossil-calibrated phylogeny that sets the first occurrence of coiled euthecosomes at 79-66 mya, we estimate that uncoiled euthecosomes evolved 51-42 mya and that most extant uncoiled genera originated 40-15 mya. These findings are congruent with a molecular clock analysis using the Isthmus of Panama formation as an independent calibration. Although not all phylogenetic relationships could be resolved based on three molecular markers, this study provides a useful resource to study pteropod diversity and provides general insight into the processes that generate and maintain their diversity in the open ocean.	[Burridge, Alice K.; Janssen, Arie W.; Pierrot-Bults, Annelies C.; Peijnenburg, Katja T. C. A.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Burridge, Alice K.; Hornlein, Christine; Hughes, Martin; Pierrot-Bults, Annelies C.; Menken, Steph B. J.; Peijnenburg, Katja T. C. A.] Univ Amsterdam, IBED, Amsterdam, Netherlands; [Hornlein, Christine] Koninklijk Nederlands Inst Onderzoek Zee NIOZ, Yerseke, Netherlands; [Hughes, Martin; Michel, Ellinor; Todd, Jonathan A.] Nat Hist Museum, Cromwell Rd, London, England; [Bush, Stephanie L.; Osborn, Karen J.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Bush, Stephanie L.; Osborn, Karen J.] Monterey Bay Aquarium Res Inst, Moss Landing, CA USA; [Marletaz, Ferdinand] Okinawa Inst Sci & Technol, Mol Genet Unit, Onna Son, Japan; [Gasca, Rebeca] El Colegio Frontera ECOSUR, Unidad Chetumal, Quintana Roo, Chetumal, Mexico; [Young, Jeremy R.] UCL, Dept Earth Sci, London, England	Naturalis Biodiversity Center; University of Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Natural History Museum London; Smithsonian Institution; Smithsonian National Museum of Natural History; Monterey Bay Aquarium Research Institute; Okinawa Institute of Science & Technology Graduate University; El Colegio de la Frontera Sur (ECOSUR); University of London; University College London	Peijnenburg, KTCA (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.; Peijnenburg, KTCA (corresponding author), Univ Amsterdam, IBED, Amsterdam, Netherlands.	K.T.C.A.Peijnenburg@uva.nl	Todd, Jonathan/M-7064-2019; Marlétaz, Ferdinand/H-3018-2019; Gasca, Rebeca/Q-7720-2016	Todd, Jonathan/0000-0002-0433-1611; Marlétaz, Ferdinand/0000-0001-8124-4266; Gasca, Rebeca/0000-0002-9716-1964; Bush, Stephanie/0000-0001-5169-7686; Hughes, Martin/0000-0002-2003-8917; Young, Jeremy/0000-0001-9320-9804; Osborn, Karen/0000-0002-4226-9257	Netherlands Organisation for Scientific Research (NWO) [863.08.024, 016.161351]; Natural History Museum of London / Imperial College Biosystematics Mres programme; John Templeton Foundation [43915]; Smithsonian Women's Committee; Smithsonian research funds; Monterey Bay Aquarium; David and Lucile Packard Foundation; National Science Foundation (USA) [OCE-1230900, OCE-1029478, OCE-1338959]; National Ocean and Atmospheric Administration's Northeast Fisheries Science Center; UK Natural Environmental Research Council; National Oceanography Centre, Southampton; NOM; Atlantic Meridional Transect Programme [308]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Natural History Museum of London / Imperial College Biosystematics Mres programme; John Templeton Foundation; Smithsonian Women's Committee; Smithsonian research funds; Monterey Bay Aquarium; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation (USA)(National Science Foundation (NSF)); National Ocean and Atmospheric Administration's Northeast Fisheries Science Center; UK Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Oceanography Centre, Southampton; NOM; Atlantic Meridional Transect Programme	This work was supported by a Netherlands Organisation for Scientific Research (NWO) cruise participation grant, Veni and Vidi grants 863.08.024 and 016.161351 (http://www.nwo.nl), respectively, to K.T.C.A. Peijnenburg. M. Hughes was supported by the Natural History Museum of London / Imperial College Biosystematics Mres programme and John Templeton Foundation grant 43915 (https://www.templeton.org). S.L. Bush was funded by the Smithsonian Women's Committee grants and Smithsonian research funds to K.J. Osborn, and the Monterey Bay Aquarium. The David and Lucile Packard Foundation provided funding for numerous cruises to the Monterey Bay Aquarium Research Institute in which K.J. Osborn and S.L. Bush participated. Plankton collections for this study were (partially) supported by National Science Foundation (USA) grants OCE-1230900 to the UNOLS Training Program and OCE-1029478 and OCE-1338959 (https://www.nsf.gov) to E. Goetze, National Ocean and Atmospheric Administration's Northeast Fisheries Science Center to NOAA/National Marine Fisheries Service and M. Vecchione, and the UK Natural Environmental Research Council National Capability funding to Plymouth Marine Laboratory and the National Oceanography Centre, Southampton. Funding for SEAMAP surveys was provided by NOM. This is contribution number 308 of the Atlantic Meridional Transect Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Be AWH, 1977, OCEANIC MICROPALEONT, V1, P733; Bednarsek N, 2012, EARTH SYST SCI DATA, V4, P167, DOI 10.5194/essd-4-167-2012; Bednarsek N, 2016, PROG OCEANOGR, V145, P1, DOI 10.1016/j.pocean.2016.04.002; Bernasconi MP, 1982, B SOC PALEONTOL ITAL, V21, P2; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bowen BW, 2016, P NATL ACAD SCI USA, V113, P7962, DOI 10.1073/pnas.1602404113; Bralower TJ, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000662; Burridge AK, ASSESSING SPEC UNPUB; Burridge AK, 2016, PROG OCEANO IN PRESS; Burridge AK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177325; Burridge AK, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.619.10043; Burridge AK, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0310-8; Cahuzac Bruno, 2010, Scripta Geologica, V141, P1; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Checchia-Rispoli G., 1921, B REALE COMITATO GEO, V48, P1; Comeau S, 2012, P ROY SOC B-BIOL SCI, V279, P732, DOI 10.1098/rspb.2011.0910; Corse E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059439; Cowman PF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1541; Curry D., 1965, Proceedings of the Malacological Society of London, V36, P357; CURRY D, 1979, MALACOLOGIA, V18, P23; Curry D., 1982, CAHIERS MICROPALEONT, V4, P35; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2001, MOL PHYLOGENET EVOL, V19, P225, DOI 10.1006/mpev.2001.0926; DeBlainville HMD, 1824, DICT SCI NATURELLES, V7, P105; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gasca R, 2014, J MOLLUS STUD, V80, P35, DOI 10.1093/mollus/eyt038; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Gibbs SJ, 2006, GEOLOGY, V34, P233, DOI 10.1130/G22381.1; GILMER RW, 1986, MAR BIOL, V91, P47, DOI 10.1007/BF00397570; Harzhauser M, 2002, PALAEOGEOGR PALAEOCL, V183, P103, DOI 10.1016/S0031-0182(01)00464-3; Harzhauser M, 2007, ZOOL ANZ, V246, P241, DOI 10.1016/j.jcz.2007.05.001; HODGKINSON KA, 1992, B AM PALEONTOL, V103, P62; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Janssen AB, 2016, PSYCHOL MED, V46, P2999, DOI 10.1017/S0033291716001598; JANSSEN A. W., 1990, SCRIPTA GEOLOGICA, V91, P1; JANSSEN A. W., 2003, CAINOZOIC RES, V2, P163; Janssen Arie W., 2007, Scripta Geologica (Leiden), V135, P29; Janssen Arie W., 2005, Basteria, V69, P25; Janssen Arie W., 2016, Basteria, V80, P59; Janssen AW, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P341, DOI 10.1007/978-94-007-6704-1_19; Janssen Arie W., 2010, Museo Regionale di Scienze Naturali Bollettino (Turin), V28, P197; Janssen Arie W., 2012, Bollettino Malacologico, V48, P1; Janssen AW, NOTES SYSTEMAT UNPUB, V25; Jennings RM, 2010, DEEP-SEA RES PT II, V57, P2199, DOI 10.1016/j.dsr2.2010.09.022; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Kelly DC, 1996, GEOLOGY, V24, P423; Klussmann-Kolb A, 2006, J ZOOL SYST EVOL RES, V44, P118, DOI 10.1111/j.1439-0469.2006.00351.x; LALLI C M, 1976, Veliger, V18, P237; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Maas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053889; Marshall P., 1918, Transactions and Proceedings of the New Zealand Institute Wellington, V50; Meisenheimer J, 1906, WISSENSCHAFTLICHE ER; Meyer O., 1887, VORTAGE ABANDLUNGEN, V2, P3; Moya A, 2016, GLOBAL CHANGE BIOL, V22, P3888, DOI 10.1111/gcb.13350; Muller RD, 2016, ANNU REV EARTH PL SC, V44, P107, DOI 10.1146/annurev-earth-060115-012211; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; PAFORTVANIERSEL T, 1979, BIJDR DIERKD, V48, P111, DOI 10.1163/26660644-04802002; RAMPAL J, 1973, CR ACAD SCI D NAT, V277, P1345; Rampal J., 2011, REV I PECHES MARITIM, V37, P369; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Scarsella F., 1934, B SOC GEOL ITAL, V53, P177; Schneider LJ, 2013, PALEOBIOLOGY, V39, P628, DOI 10.1666/12050; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuecker MF, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041436; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Troschel FH, 1854, ARCH NATURGESCH, V20, P196; van der Spoel S., 1987, Bulletin Zoologisch Museum Universiteit van Amsterdam, V11, P77; van der Spoel S., 1982, Bulletin Zoologisch Museum Universiteit van Amsterdam, V9, P1; Van der Spoel S., 1967, THESIS; van der Spoel Siebrecht, 1999, P649; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; WENNECK T. L., 2008, DEEP SEA RES 2, V55, P6; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004; Zapata F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1739; Zeebe RE, 2012, ANNU REV EARTH PL SC, V40, P141, DOI 10.1146/annurev-earth-042711-105521	87	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0177325	10.1371/journal.pone.0177325	http://dx.doi.org/10.1371/journal.pone.0177325			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604805	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400006
J	D'ippolito, S; Di Simone, N; Orteschi, D; Pomponi, MG; Genuardi, M; Sisti, LG; Castellani, R; Rossi, ED; Scambia, G; Zollino, M				D'ippolito, Silvia; Di Simone, Nicoletta; Orteschi, Daniela; Pomponi, Maria Grazia; Genuardi, Maurizio; Sisti, Leuconoe Grazia; Castellani, Roberta; Rossi, Esther Diana; Scambia, Giovanni; Zollino, Marcella			The chromosome analysis of the miscarriage tissue. Miscarried embryo/fetal crown rump length (CRL) measurement: A practical use	PLOS ONE			English	Article							RECURRENT PREGNANCY LOSS; MATERNAL CELL CONTAMINATION; MICROSATELLITE ANALYSIS; GENETIC ABNORMALITIES; SPONTANEOUS-ABORTIONS; MICROARRAY-ANALYSIS; CONCEPTION; KARYOTYPE; PRODUCTS; STILLBIRTH	Objective To investigate whether miscarried embryo/fetal crown rump length (CRL) measurement may yield a practical application for predicting a conclusive result at the cytogenetic analysis of miscarriage tissue. Our study might help in improving the cytogenetic method, the results of which may be affected by maternal cell contamination (MCC). In particular, we aimed at establishing whether the miscarried embryo/fetal CRL measurement shows accuracy in predicting the possibility of MCC and the scan cut-off value useful to this purpose and, as a result, suggest a multi-step procedure for the genetic ascertainment. Methods Women experiencing at least two miscarriages of less than 20 weeks size at the Pregnancy Loss Unit at Fondazione Policlinico A. Gemelli underwent a scan before surgery. The CRL value was recorded. After the dilatation and courettage (D&C) procedure, miscarriage tissue was processed through the proposed multi-step procedure before performing oligo-nucleotide-based and SNP (single nucleotide polymorphisms)-based comparative genomic hybridization (CGH+SNP) microarray analysis. Results 63 women and 63 miscarriages met the criteria. By using the Receiving Operator Characteristic (ROC) curves, CRL showed an AUC of 0.816 (95% CI: 0.703-0.928, p<0.001). A CRL >= 24.5 mm cut-off value showed a higher positive likelihood ratio (5.27) but, conversely, a higher negative likelihood ratio (0.64) in predicting the possibility of MCC. Microarray analysis was successful in the totality of cases in which the embryo/fetal origin of miscarriage tissues was proven. Conclusions The 24.5 mm CRL value emerges as the most suitable cut-off enabling the identification of cases in which the embryo-fetal component can be isolated in the absence of MCC and the chromosomal array provide informative results.	[D'ippolito, Silvia; Di Simone, Nicoletta; Castellani, Roberta; Scambia, Giovanni] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Dept Obstet & Gynecol, Rome, Italy; [Orteschi, Daniela; Pomponi, Maria Grazia; Genuardi, Maurizio; Zollino, Marcella] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Inst Genom Med, Rome, Italy; [Sisti, Leuconoe Grazia] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Rome, Italy; [Rossi, Esther Diana] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Div Anat Pathol & Histol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Di Simone, N (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Dept Obstet & Gynecol, Rome, Italy.	nicoletta.disimone@policlinicogemelli.it	Rossi, esther/R-8601-2017; pomponi, maria grazia/K-4267-2018; Genuardi, Maurizio/K-3049-2018; Zollino, Marcella/AAC-3891-2022; D'IPPOLITO, SILVIA/L-1879-2019	pomponi, maria grazia/0000-0002-0417-9939; Genuardi, Maurizio/0000-0002-7410-8351; Zollino, Marcella/0000-0003-4871-9519; D'IPPOLITO, SILVIA/0000-0002-6160-0558; Rossi, Esther/0000-0003-3819-4229; DI SIMONE, NICOLETTA/0000-0003-1273-3335; sisti, leuconoe grazia/0000-0002-5443-0001				Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Bardos J, 2015, OBSTET GYNECOL, V125, P1313, DOI 10.1097/AOG.0000000000000859; Bell KA, 1999, FERTIL STERIL, V71, P334, DOI 10.1016/S0015-0282(98)00445-2; Bernardi LA, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.03.038; Bossano C, 2009, FERTIL STERIL, V92, pS92; Branch DW, 2010, NEW ENGL J MED, V363, P1740, DOI 10.1056/NEJMcp1005330; Campos-Galindo I, 2015, J ASSIST REPROD GEN, V32, P839, DOI 10.1007/s10815-015-0460-z; Carp H, 2001, FERTIL STERIL, V75, P678, DOI 10.1016/S0015-0282(00)01801-X; Christiansen OB, 2005, FERTIL STERIL, V83, P821, DOI 10.1016/j.fertnstert.2004.12.018; Foyouzi N, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.007; Gardner R, 2012, CHROMOSOME ABNORMALI, V4th; Jarrett KL, 2001, AM J OBSTET GYNECOL, V185, P198, DOI 10.1067/mob.2001.114692; Jaslow CR, 2010, FERTIL STERIL, V93, P1234, DOI 10.1016/j.fertnstert.2009.01.166; Kutteh WH, 2015, SEMIN REPROD MED, V33, P161, DOI 10.1055/s-0035-1552586; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Lathi RB, 2002, J ASSIST REPROD GEN, V19, P536, DOI 10.1023/A:1020916003666; Lathi RB, 2014, FERTIL STERIL, V101, P178, DOI 10.1016/j.fertnstert.2013.09.031; Levy B, 2014, OBSTET GYNECOL, V124, P202, DOI 10.1097/AOG.0000000000000325; Lo JO, 2014, OBSTET GYNECOL SURV, V69, P613, DOI 10.1097/OGX.0000000000000119; MacDorman MF, 2012, NATL VITAL STAT REP, V60, P1; Mathur N, 2014, FERTIL STERIL, V101, P1349, DOI 10.1016/j.fertnstert.2014.02.004; Menasha J, 2005, GENET MED, V7, P251, DOI 10.1097/01.GIM.0000160075.96707.04; Murugappan G, 2014, FERTIL STERIL, V102, pE9, DOI 10.1016/j.fertnstert.2014.07.006; Nagan N, 2011, J MOL DIAGN, V13, P7, DOI 10.1016/j.jmoldx.2010.11.013; Napolitano R, 2014, BJOG-INT J OBSTET GY, V121, P556, DOI 10.1111/1471-0528.12478; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; OHNO M, 1991, OBSTET GYNECOL, V77, P394; Preisler J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4579; Reddy UM, 2012, NEW ENGL J MED, V367, P2185, DOI 10.1056/NEJMoa1201569; Romero ST, 2015, ULTRASOUND OBST GYN, V45, P89, DOI 10.1002/uog.14713; Rosenfeld JA, 2015, ULTRASOUND OBST GYN, V46, P478, DOI 10.1002/uog.14866; Sahoo T, 2016, GENET MED; Stephenson MD, 2006, HUM REPROD, V21, P1076, DOI 10.1093/humrep/dei417; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Sugiura-Ogasawara M, 2004, FERTIL STERIL, V81, P367, DOI 10.1016/j.fertnstert.2003.07.014; Wapner RJ, 2010, CLIN OBSTET GYNECOL, V53, P628, DOI 10.1097/GRF.0b013e3181ee2793; WOLF GC, 1995, AM J OBSTET GYNECOL, V173, P1364, DOI 10.1016/0002-9378(95)90616-9	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178113	10.1371/journal.pone.0178113	http://dx.doi.org/10.1371/journal.pone.0178113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604823	Green Submitted, gold, Green Published			2022-12-26	WOS:000403088400011
J	Smith, OM; Chant, C; Burns, KEA; Kaur, M; Ashraf, S; DosSantos, CC; Hwang, SW; Friedrich, JO				Smith, Orla M.; Chant, Clarence; Burns, Karen E. A.; Kaur, Maninder; Ashraf, Said; DosSantos, Claudia C.; Hwang, Stephen W.; Friedrich, Jan O.			Characteristics, clinical course, and outcomes of homeless and non-homeless patients admitted to ICU: A retrospective cohort study	PLOS ONE			English	Article							NEIGHBORHOOD POVERTY RATE; ADULTS; HOSPITALIZATION; POPULATION; HEALTH; COSTS	Background Little is known about homeless patients in intensive care units (ICUs). Objectives To compare clinical characteristics, treatments, and outcomes of homeless to non-homeless patients admitted to four ICUs in a large inner-city academic hospital. Methods 63 randomly-selected homeless compared to 63 age-, sex-, and admitting-ICU-matched non-homeless patients. Results Compared to matched non-homeless, homeless patients (average age 48 +/- 12 years, 90% male, 87% admitted by ambulance, 56% mechanically ventilated, average APACHE II 17) had similar comorbidities and illness severity except for increased alcohol (70% vs 17%, p<0.001) and illicit drug(46% vs 8%, p<0.001) use and less documented hypertension (16% vs 40%, p = 0.005) or prescription medications (48% vs 67%, p<0.05). Intensity of ICU interventions was similar except for higher thiamine (71% vs 21%, p<0.0001) and nicotine (38% vs 14%, p = 0.004) prescriptions. Homeless patients exhibited significantly lower Glasgow Coma Scores and significantly more bacterial respiratory cultures. Longer durations of antibiotics, vasopressors/ inotropes, ventilation, ICU and hospital lengths of stay were not statistically different, but homeless patients had higher hospital mortality (29% vs 8%, p = 0.005). Review of all deaths disclosed that withdrawal of life-sustaining therapy occurred in similar clinical circumstances and proportions in both groups, regardless of family involvement. Using multivariable logistic regression, homelessness did not appear to be an independent predictor of hospital mortality. Conclusions Homeless patients, admitted to ICU matched to non-homeless patients by age and sex (characteristics most commonly used by clinicians), have higher hospital mortality despite similar comorbidities and illness severity. Trends to longer durations of life supports may have contributed to the higher mortality. Additional research is required to validate this higher mortality and develop strategies to improve outcomes in this vulnerable population.	[Smith, Orla M.; Burns, Karen E. A.; Kaur, Maninder; Ashraf, Said; DosSantos, Claudia C.; Friedrich, Jan O.] St Michaels Hosp, Crit Care Dept, Toronto, ON, Canada; [Smith, Orla M.; Chant, Clarence; Burns, Karen E. A.; DosSantos, Claudia C.; Friedrich, Jan O.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Smith, Orla M.] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada; [Chant, Clarence] St Michaels Hosp, Pharm Dept, Toronto, ON, Canada; [Burns, Karen E. A.; DosSantos, Claudia C.; Hwang, Stephen W.; Friedrich, Jan O.] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Burns, Karen E. A.; DosSantos, Claudia C.; Hwang, Stephen W.; Friedrich, Jan O.] Univ Toronto, Toronto, ON, Canada; [Burns, Karen E. A.; DosSantos, Claudia C.; Friedrich, Jan O.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Hwang, Stephen W.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Kaur, Maninder] Univ Hosp Conway, Family Med Dept, Monroe, LA USA; [Ashraf, Said] Wayne State Univ, Dept Internal Med, Detroit Med Ctr, Detroit, MI 48202 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Detroit Medical Center; Wayne State University	Friedrich, JO (corresponding author), St Michaels Hosp, Crit Care Dept, Toronto, ON, Canada.; Friedrich, JO (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.; Friedrich, JO (corresponding author), St Michaels Hosp, Dept Med, Toronto, ON, Canada.; Friedrich, JO (corresponding author), Univ Toronto, Toronto, ON, Canada.; Friedrich, JO (corresponding author), Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada.	friedrichj@smh.ca	Hwang, Stephen W./GVR-7773-2022; Hwang, Stephen/D-2297-2011	Friedrich, Jan/0000-0001-7248-2350; Hwang, Stephen/0000-0002-1276-1101	Clinician Scientist Award from Canadian Institutes of Health Research (CIHR); Ministry of Research and Innovation; CIHR Clinician Scientist Award	Clinician Scientist Award from Canadian Institutes of Health Research (CIHR); Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); CIHR Clinician Scientist Award(Canadian Institutes of Health Research (CIHR))	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Dr. Burns is supported by a Clinician Scientist Award from the Canadian Institutes of Health Research (CIHR) and an Early Researcher Award from the Ministry of Research and Innovation. Dr. Friedrich is supported by a CIHR Clinician Scientist Award. None of the funding agencies had any direct involvement in the design and conduct of this study.	Bein T, 2012, INTENS CARE MED, V38, P612, DOI 10.1007/s00134-012-2463-x; Bige N, 2015, CRIT CARE MED, V43, P1246, DOI 10.1097/CCM.0000000000000944; Chant C, 2014, INTENS CARE MED, V40, P123, DOI 10.1007/s00134-013-3124-4; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Human Resources and Skills Development Canada, HOM SHELT BEDS HOUS; Hwang SW, 2011, MED CARE, V49, P350, DOI 10.1097/MLR.0b013e318206c50d; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Isaacs SL, 2004, NEW ENGL J MED, V351, P1137, DOI 10.1056/NEJMsb040329; MARTELL JV, 1992, ANN INTERN MED, V116, P299, DOI 10.7326/0003-4819-116-4-299; Mendu ML, 2012, CRIT CARE MED, V40, P1427, DOI 10.1097/CCM.0b013e318241e51e; Plevneshi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007255; Salit SA, 1998, NEW ENGL J MED, V338, P1734, DOI 10.1056/NEJM199806113382406; US Department of Housing and Urban Development, 2012 ANN HOM ASS REP; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594	15	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179207	10.1371/journal.pone.0179207	http://dx.doi.org/10.1371/journal.pone.0179207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604792	gold, Green Published, Green Submitted			2022-12-26	WOS:000403088400035
J	Wu, XK; Yan, LH; Liu, YX; Xian, WF; Wang, LY; Ding, XM				Wu, Xiangkun; Yan, Lihua; Liu, Yongxi; Xian, Wenfeng; Wang, Liuyu; Ding, Xunmeng			MicroRNA-448 suppresses osteosarcoma cell proliferation and invasion through targeting EPHA7	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; LUNG ADENOCARCINOMA; COLORECTAL-CANCER; GASTRIC-CANCER; IN-VITRO; EXPRESSION; METASTASIS; PROMOTES; CARCINOMA	Osteosarcoma is the most common type of malignant bone tumor, often affecting adolescents and children. MicroRNAs (miRNAs) are a group of small, non-protein coding, endogenous RNAs that play critical roles in osteosarcoma tumorigenesis. In our study, we demonstrated that miR-448 expression was downregulated in osteosarcoma tissues and cell lines. Overexpression of miR-448 suppressed osteosarcoma cell proliferation, colony formation and migration. Moreover, we found that EPHA7 was a direct target gene of miR-448 in osteosarcoma cells. We further demonstrated that the EPHA7 expression level was upregulated in osteosarcoma tissues. Interestingly, the expression level of EPHA7 was inversely correlated with the expression level of miR-448 in osteosarcoma tissues. In addition, elevated expression of miR-448 suppressed osteosarcoma cell proliferation and invasion through targeting EPHA7. Taken together, these findings suggest that miR-448 functioned as a tumor suppressor gene in the development of osteosarcoma through targeting EPHA7.	[Wu, Xiangkun; Liu, Yongxi; Xian, Wenfeng; Wang, Liuyu; Ding, Xunmeng] Nanyang Second Peoples Hosp, Dept Orthopaed Surg, Nanyang, Henan, Peoples R China; [Yan, Lihua] Nanyang Second Peoples Hosp, Dept Med Oncol, Nanyang, Henan, Peoples R China		Yan, LH (corresponding author), Nanyang Second Peoples Hosp, Dept Med Oncol, Nanyang, Henan, Peoples R China.	yanlihua@163.com	, 吴向坤 南阳二院 骨科/AGY-0707-2022					Ahmad A, 2014, AM J TRANSL RES, V6, P384; Cai CK, 2012, ONCOL REP, V28, P1764, DOI 10.3892/or.2012.1995; Chen L, 2013, FEBS LETT, V587, P1366, DOI 10.1016/j.febslet.2013.03.007; Delebinski CI, 2015, CELL PROLIFERAT, V48, P600, DOI 10.1111/cpr.12208; Denoyelle C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.389; Fan L, 2012, ACTA BIOCH BIOPH SIN, V44, P407, DOI 10.1093/abbs/gms019; Fujiwara T, 2014, STEM CELLS, V32, P959, DOI 10.1002/stem.1618; Gao XC, 2014, CANCER LETT, V353, P25, DOI 10.1016/j.canlet.2014.07.011; Gao YS, 2015, AM J TRANSL RES, V7, P2519; Hong XH, 2016, ONCOTARGET, V7, P22092, DOI 10.18632/oncotarget.8020; Hu SX, 2016, CELL PROLIFERAT, V49, P395, DOI 10.1111/cpr.12263; Huang K, 2014, AM J TRANSL RES, V6, P841; Huang X, 2015, CELL PROLIFERAT, V48, P593, DOI 10.1111/cpr.12207; Ji F, 2013, BONE, V56, P220, DOI 10.1016/j.bone.2013.05.020; Jiang JX, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0095-7; Kang M, 2015, AM J TRANSL RES, V7, P2212; Li B, 2016, AM J TRANSL RES, V8, P3013; Li P, 2015, AM J TRANSL RES, V7, P2053; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Liu DC, 2013, DIAGN CYTOPATHOL, V41, P199, DOI 10.1002/dc.21821; Liu MX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101493; Lopez-Nieva P, 2012, CARCINOGENESIS, V33, P452, DOI 10.1093/carcin/bgr271; Lv Y, 2015, CLIN TRANSL ONCOL, V17, P903, DOI 10.1007/s12094-015-1325-8; Novello C, 2013, INT J ONCOL, V42, P667, DOI 10.3892/ijo.2012.1717; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Shan TD, 2016, CELL PROLIFERAT, V49, P102, DOI 10.1111/cpr.12230; Shen L, 2014, TUMOR BIOL, V35, P2069, DOI 10.1007/s13277-013-1274-1; Shen LH, 2016, EXP THER MED, V12, P2747, DOI 10.3892/etm.2016.3659; Song XF, 2015, AM J TRANSL RES, V7, P2254; Sun YC, 2016, CELL PROLIFERAT, V49, P636, DOI 10.1111/cpr.12288; Tang J, 2014, CELL PROLIFERAT, V47, P427, DOI 10.1111/cpr.12129; Tsai HC, 2014, ONCOTARGET, V5, P3800, DOI 10.18632/oncotarget.1998; Tsuboi M, 2010, INT J ONCOL, V36, P635, DOI 10.3892/ijo_00000539; Wang JD, 2007, HUM PATHOL, V38, P1649, DOI 10.1016/j.humpath.2007.01.030; Wang LF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-79; Wu DG, 2016, CELL PROLIFERAT, V49, P476, DOI 10.1111/cpr.12264; Wu XS, 2016, TUMOR BIOL, V37, P10545, DOI 10.1007/s13277-016-4942-0; Xiang C, 2015, CELL PHYSIOL BIOCHEM, V36, P435, DOI 10.1159/000430110; Xu JL, 2013, BIOMED PHARMACOTHER, V67, P381, DOI 10.1016/j.biopha.2013.03.013; Yin Z, 2016, CELL PROLIFERATION; Zhu HQ, 2015, CELL PHYSIOL BIOCHEM, V36, P487, DOI 10.1159/000430114	41	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0175553	10.1371/journal.pone.0175553	http://dx.doi.org/10.1371/journal.pone.0175553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604772	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400002
J	Sousa, FAB; Vasque, RE; Gobatto, CA				Barros Sousa, Filipe Antonio; Vasque, Rubens Eduardo; Gobatto, Claudio Alexandre			Anaerobic metabolism during short all-out efforts in tethered running: Comparison of energy expenditure and mechanical parameters between different sprint durations for testing	PLOS ONE			English	Article							HUMAN-MUSCLE METABOLISM; WINGATE TEST; POWER OUTPUT; 30-S; CAPACITY; RELIABILITY; PERFORMANCE; RESPONSES; TREADMILL; RECOVERY	This study's aims to verify the energy expenditure, metabolic distress and usefulness to evaluate the anaerobic constructs for different all-out durations in running efforts. Twelve active male underwent four testing sessions, one for familiarization and three performing one all-out (AO) tethered running sprint lasting 30s, 20s or 10s. Oxygen consumption, excess post exercise oxygen consumption, and lactate production were retained to analyse metabolic function, together with mechanical power and work as performance parameters. Paired results were compared via one-way ANOVA for repeated measures (Tukey-HSD post-hoc), effect sizes and ICC for absolute agreement. Statistical significance was accepted at p <= 0.05. Despite total and energy expenditure from oxidative pathway being significantly higher for longer durations (p < 0.001; ES > 0.7), glycolytic energy expenditure presented an agreement between AO30s and AO20s (ICC-A = 0.63*), while the paired comparisons to AO10s have presented significant differences (p < 0.01; ES > 1.0). Phosphagen energy expenditure were similar between all-out durations (p = 0.12; ICC-A = 0.62*; ES < 0.5). Maximum mechanical power was higher in AO10s than in AO30s (p = 0.03; ES = 0.6), not being different between AO10s and AO20s (p = 0.67; ICC-A = 0.88*; ES = 0.2) and between AO20s and AO30s (p = 0.18; ICC-A = 0.56*; ES = 0.4). In addition, agreement between work in the first ten seconds was confirmed via ICC only between AO10s and AO20s (p = 0.50; ICC-A = 0.86*; ES = 0.3), but not for the other paired comparisons (p < 0.1; ICC < 0.45; ES > 0.5). AO20s is a better alternative to estimate anaerobic power and capacity in one single test, with similar oxidative demand than AO30s.	[Barros Sousa, Filipe Antonio; Vasque, Rubens Eduardo; Gobatto, Claudio Alexandre] Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil; [Barros Sousa, Filipe Antonio] Einstein Integrated Fac Limeira, Limeira, Brazil	Universidade Estadual de Campinas	Gobatto, CA (corresponding author), Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil.	claudio.gobatto@fca.unicamp.br	Gobatto, Claudio A/E-7388-2014; Sousa, Filipe A B/H-2444-2017; Gobatto, Claudio/O-7257-2015	Gobatto, Claudio/0000-0002-1441-7582; Sousa, Filipe Antonio/0000-0001-8252-725X	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO [2009/08535-5, 2013/16710-7, 2015/19241-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [461559/2014-5]	FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the FUNDACAO DE AM PARO A PESQUISA DO ESTADO DE SAO PAULO (Protocol number: 2009/08535-5 to CAB; 2013/16710-7 and 2015/19241-3) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Protocol number: 461559/2014-5 to CAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Bertuzzi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145733; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; Bogdanis GC, 1998, ACTA PHYSIOL SCAND, V163, P261, DOI 10.1046/j.1365-201x.1998.00378.x; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Calbet JAL, 2003, J APPL PHYSIOL, V94, P668, DOI 10.1152/japplphysiol.00128.2002; Calbet JAL, 1997, EUR J APPL PHYSIOL O, V76, P308, DOI 10.1007/s004210050253; Chamari K, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0012-1; Cheetham M E, 1985, Br J Sports Med, V19, P81; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; Cohen J.E., 1988, STAT POWER ANAL BEHA; Del Coso J, 2006, APPL PHYSIOL NUTR ME, V31, P186, DOI 10.1139/H05-026; Driss T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/589361; ENGEL PC, 1978, ANAL BIOCHEM, V88, P475, DOI 10.1016/0003-2697(78)90447-5; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gama MC, 2016, INT J SPORT MED; GREENHAFF PL, 1994, J PHYSIOL-LONDON, V478, P149, DOI 10.1113/jphysiol.1994.sp020238; Hachana Y, 2012, J STRENGTH COND RES, V26, P1324, DOI 10.1519/JSC.0b013e3182305485; LAKOMY HKA, 1987, ERGONOMICS, V30, P627, DOI 10.1080/00140138708969756; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; Milioni F, 2017, INT J SPORTS MED, V38, P226, DOI 10.1055/s-0042-117722; Minahan C, 2007, INT J SPORTS MED, V28, P836, DOI 10.1055/s-2007-964976; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; Pereira VH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10489; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Stickley CD, 2008, J STRENGTH COND RES, V22, P958, DOI 10.1519/JSC.0b013e31816a906e; VANDEWALLE H, 1989, EUR J APPL PHYSIOL O, V58, P375, DOI 10.1007/BF00643512; Vincent S, 2004, EUR J APPL PHYSIOL, V91, P15, DOI 10.1007/s00421-003-0957-5; Zagatto A, 2011, SCAND J MED SCI SPOR, V21, pE222, DOI 10.1111/j.1600-0838.2010.01258.x; Zagatto AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172032; Zajac A, 1999, J STRENGTH COND RES, V13, P16, DOI 10.1519/00124278-199902000-00003	34	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179378	10.1371/journal.pone.0179378	http://dx.doi.org/10.1371/journal.pone.0179378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599009	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000036
J	Kim, HM; Kim, YM; Huh, JH; Lee, ES; Kwon, MH; Lee, BR; Ko, HJ; Chung, CH				Kim, Hong Min; Kim, You Mi; Huh, Ji Hye; Lee, Eun Soo; Kwon, Mi Hye; Lee, Bo Ra; Ko, Hyun-Jeong; Chung, Choon Hee			alpha-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATION; OBESITY; MACROPHAGE; ACCUMULATION; ANTIOXIDANT; XANTHONES; CYTOKINE	Obesity induces various metabolic diseases such as dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes. Fat expansion in adipose tissue induces adipose tissue dysfunction and inflammation, insulin resistance, and other metabolic syndromes. alpha-Mangostin (alpha-MG) has been previously studied for its anti-cancer, anti-inflammatory, and antioxidant activities. In this study, we investigated the effects of alpha-MG on adipose tissue inflammation and hepatic steatosis. We categorized study animals into four groups: regular diet control mice, RD mice treated with alpha-MG, high fat diet-induced obese mice, and HFD mice treated with alpha-MG. alpha-MG treatment significantly reduced not only the body, liver, and fat weights, but also plasma glucose, insulin, and triglyceride levels in HFD mice. Additionally, adiponectin levels of alpha-MG-treated mice were significantly higher than those of control HFD mice. Immunohistochemistry of liver and adipose tissue showed that CD11c expression was reduced in alpha-MG fed obese mice. alpha-MG treatment of HFD mice down-regulated the adipose-associated inflammatory cytokines and CCR2 in both liver and adipose tissue. Moreover, glucose tolerance and insulin sensitivity were significantly improved in alpha-MG fed obese mice. alpha-Mangostin ameliorates adipose inflammation and hepatic steatosis in HFDinduced obese mice.	[Kim, Hong Min; Kim, You Mi; Huh, Ji Hye; Lee, Eun Soo; Kwon, Mi Hye; Chung, Choon Hee] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Lee, Bo Ra; Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, South Korea	Yonsei University; Kangwon National University	Chung, CH (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea.	cchung@yonsei.ac.kr		Chung, Choon/0000-0003-1144-7206; Ko, Hyun-Jeong/0000-0002-3844-928X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2016R1A6A3A11932829]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1A6A3A11932829).	Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Akao Y, 2008, INT J MOL SCI, V9, P355, DOI 10.3390/ijms9030355; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Bloomgarden ZT, 2003, DIABETES CARE, V26, P1922, DOI 10.2337/diacare.26.6.1922; Bolus WR, 2015, J LEUKOCYTE BIOL, V98, P467, DOI 10.1189/jlb.3HI0115-018R; Chen LG, 2008, FOOD CHEM TOXICOL, V46, P688, DOI 10.1016/j.fct.2007.09.096; Devalaraja S, 2011, FOOD RES INT, V44, P1856, DOI 10.1016/j.foodres.2011.04.008; Fjeldborg K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/309548; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Jung HA, 2006, J AGR FOOD CHEM, V54, P2077, DOI 10.1021/jf052649z; Kim HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120711; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Michaud A, 2012, METABOLISM, V61, P689, DOI 10.1016/j.metabol.2011.10.004; Ngawhirunpat T, 2010, PHARM BIOL, V48, P55, DOI 10.3109/13880200903046138; Park SK, 2015, IEEE INT MEM WORKSH, P1; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Pradhan A, 2007, NUTR REV, V65, pS152, DOI [10.1111/j.1753-4887.2007.tb00354.x, 10.1301/nr.2007.dec.S152-S156]; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Quan XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033376; Sakagami Y, 2005, PHYTOMEDICINE, V12, P203, DOI 10.1016/j.phymed.2003.09.012; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Watanapokasin R, 2011, WORLD J GASTROENTERO, V17, P2086, DOI 10.3748/wjg.v17.i16.2086; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405; Zeyda M, 2010, INT J OBESITY, V34, P1684, DOI 10.1038/ijo.2010.103	28	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179204	10.1371/journal.pone.0179204	http://dx.doi.org/10.1371/journal.pone.0179204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598982	Green Submitted, gold, Green Published			2022-12-26	WOS:000402992000030
J	Li, Y; Watanabe, K; Fujioka, M; Ogawa, K				Li, Yang; Watanabe, Kotaro; Fujioka, Masato; Ogawa, Kaoru			Characterization of slow-cycling cells in the mouse cochlear lateral wall	PLOS ONE			English	Article							SPIRAL LIGAMENT PATHOLOGY; HEMATOPOIETIC STEM-CELLS; IDENTIFICATION; DEGENERATION; LOCATION; MODEL; AGE	Cochlear spiral ligament fibrocytes (SLFs) play essential roles in the physiology of hearing including ion recycling and the generation of endocochlear potential. In adult animals, SLFs can repopulate after damages, yet little is known about the characteristics of proliferating cells that support SLFs' self-renewal. Here we report in detail about the characteristics of cycling cells in the spiral ligament (SL). Fifteen P6 mice and six noise-exposed P28 mice were injected with 5-bromo-20-deoxyuridine (BrdU) for 7 days and we chased BrdU retaining cells for as long as 60 days. Immunohistochemistry revealed that the BrdU positive IB4 (an endotherial marker) negative cells expressed an early SLF marker Pou3f4 but negative for cleaved-Caspase 3. Marker studies revealed that type 3 SLFs displayed significantly higher percentage of BrdU(+) cells compared to other subtypes. Notably, the cells retained BrdU until P72, demonstrating they were dividing slowly. In the noise-damaged mice, in contrast to the loss of the other types, the number of type 3 SLFs did not altered and the BrdU incorporating-phosphorylated Histone H3 positive type 3 cells were increased from day 1 to 14 after noise exposure. Furthermore, the cells repopulating type 1 area, where the cells diminished profoundly after damage, were positive for the type 3 SLF markers. Collectively, in the latral wall of the cochlea, type 3 SLFs have the stem cell capacity and may contribute to the endogenous regeneration of lateral wall spiral ligament. Manipulating type 3 cells may be employed for potential regenerative therapies.	[Li, Yang; Watanabe, Kotaro; Fujioka, Masato; Ogawa, Kaoru] Keio Univ, Dept Otorhinolaryngol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan; [Li, Yang] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Xian, Peoples R China	Keio University; Xi'an Jiaotong University	Fujioka, M (corresponding author), Keio Univ, Dept Otorhinolaryngol, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	masato@2002.jukuin.keio.ac.jp	li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022	Fujioka, Masato/0000-0002-5317-0885	Takeda Science Foundation; MEXT [15H04991]; Xi'an Jiaotong University basic scientific research operation expenses [1191320078]	Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Xi'an Jiaotong University basic scientific research operation expenses	This work was supported by the Takeda Science Foundation and by MEXT (to MF), Grant-in-Aid for Scientific Research (B) (15H04991) to MF and Xi'an Jiaotong University basic scientific research operation expenses (no. 1191320078) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Ayano Mitsui for technical assistance and Makoto Hosoya for helpful comments and discussions. This work was supported by the Takeda Science Foundation and by MEXT, Grant-in-Aid for Scientific Research (B) (15H04991) to M.F. and Xi'an Jiaotong University basic scientific research operation expenses (No.1191320078) to Y.L.	Alison MR, 2009, J PATHOL, V217, P144, DOI 10.1002/path.2498; Capuco AV, 2007, EXP BIOL MED, V232, P1381, DOI 10.3181/0703-RM-58; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Delprat B, 2005, MOL CELL BIOL, V25, P847, DOI 10.1128/MCB.25.2.847-853.2005; Forge A, 2003, J COMP NEUROL, V467, P207, DOI 10.1002/cne.10916; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Jarvinen Elina, 2010, Int J Stem Cells, V3, P46; Kawai Y, 2016, LARYNGOSCOPE, V126, pE164, DOI 10.1002/lary.25558; Kelly JJ, 2011, NEUROSCIENCE, V180, P360, DOI 10.1016/j.neuroscience.2011.02.011; Lang H, 2003, JARO-J ASSOC RES OTO, V4, P164, DOI 10.1007/s10162-002-2056-4; Li FS, 2010, J GASTROENTEROL, V45, P113, DOI 10.1007/s00535-009-0139-2; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mizutari K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00198; Mizutari K, 2011, BRAIN RES, V1419, P1, DOI 10.1016/j.brainres.2011.08.062; Mutai H, 2009, NEUROSCIENCE, V163, P1255, DOI 10.1016/j.neuroscience.2009.07.059; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; ROBERSON DW, 1994, AM J OTOL, V15, P28; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; Sun GW, 2012, J NEUROSCI RES, V90, P1713, DOI 10.1002/jnr.23067; Taniguchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048544; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamashita H, 1999, ACTA OTO-LARYNGOL, V119, P322, DOI 10.1080/00016489950181323	31	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179293	10.1371/journal.pone.0179293	http://dx.doi.org/10.1371/journal.pone.0179293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632772	gold, Green Submitted, Green Published			2022-12-26	WOS:000404046100019
J	van Waateringe, RP; Mook-Kanamori, MJ; Slagter, SN; van der Klauw, MM; van Vliet-Ostaptchouk, JV; Graaff, R; Lutgers, HL; Suhre, K; Selim, MME; Mook-Kanamori, DO; Wolffenbuttel, BHR				van Waateringe, Robert P.; Mook-Kanamori, Marjonneke J.; Slagter, Sandra N.; van der Klauw, Melanie M.; van Vliet-Ostaptchouk, Jana V.; Graaff, Reindert; Lutgers, Helen L.; Suhre, Karsten; Selim, Mohammed M. El-Din; Mook-Kanamori, Dennis O.; Wolffenbuttel, Bruce H. R.			The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; RANDOMIZED CLINICAL-TRIAL; PERIPHERAL ARTERY-DISEASE; MIDDLE-AGED MEN; SECONDHAND SMOKE; INSULIN SENSITIVITY; MAILLARD REACTION; SERUM COTININE; EXPOSURE; CESSATION	Background Skin autofluorescence, a biomarker for advanced glycation end products (AGEs) accumulation, has been shown to predict diabetes-related cardiovascular complications and is associated with several environmental and lifestyle factors. In the present study, we examined the association between various smoking behaviors and skin autofluorescence, as well as the association between several cotinine biomarkers and skin autofluorescence, using both epidemiological and metabolomics data. Methods In a cross-sectional study, we evaluated participants from the LifeLines Cohort Study and the Qatar Metabolomics Study on Diabetes (QMDiab). In the LifeLines Cohort Study smoking behavior and secondhand smoking were assessed in 8,905 individuals including 309 individuals (3.5%) with type 2 diabetes. In QMDiab, cotinine biomarkers were measured in saliva, plasma and urine in 364 individuals of whom 188 (51%) had type 2 diabetes. Skin autofluorescence was measured non-invasively in all participants using the AGE Reader. Results Skin autofluorescence levels increased with a higher number of hours being exposed to secondhand smoking. Skin autofluorescence levels of former smokers approached levels of never smokers after around 15 years of smoking cessation. Urinary cotinine N-oxide, a biomarker of nicotine exposure, was found to be positively associated with skin autofluorescence in the QMDiab study (p = 0.03). Conclusions In the present study, we have demonstrated that secondhand smoking is associated with higher skin autofluorescence levels whereas smoking cessation has a beneficial effect on skin autofluorescence. Finally, urinary cotinine N-oxide might be used as an alternative way for questionnaires to examine the effect of (environmental) tobacco smoking on skin autofluorescence.	[van Waateringe, Robert P.; Slagter, Sandra N.; van der Klauw, Melanie M.; van Vliet-Ostaptchouk, Jana V.; Graaff, Reindert; Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Mook-Kanamori, Marjonneke J.; Mook-Kanamori, Dennis O.] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Dept Biostat Epidemiol & Sci Comp, Riyadh, Saudi Arabia; [Mook-Kanamori, Marjonneke J.] Weill Cornell Med Coll, Dept Physiol & Biophys, Doha, Qatar; [Lutgers, Helen L.] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands; [Suhre, Karsten] Weill Cornell Med Coll, Bioinformat Core, Doha, Qatar; [Suhre, Karsten] Helmholtz Zentrum Munchen, Res Ctr Environm Hlth, Neuherberg, Germany; [Selim, Mohammed M. El-Din] Hamad Med Corp, Dept Dermatol, Doha, Qatar; [Mook-Kanamori, Dennis O.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands	University of Groningen; King Faisal Specialist Hospital & Research Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Medical Center Leeuwarden; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hamad Medical Corporation; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Waateringe, RP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.	r.p.van.waateringe@umcg.nl	Suhre, Karsten/AAF-1778-2020; van der Klauw, Melanie/A-2138-2014	Suhre, Karsten/0000-0001-9638-3912; van der Klauw, Melanie/0000-0001-7178-009X; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153	'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar; Qatar Foundation; Weill Cornell Medical College in Qatar (WCMC-Q) - Qatar Foundation; Dutch Science Organization [916.14.023]; Netherlands Consortium for Healthy Ageing (NCHA); Bio-SHaRE-EU; Biobank Standardisation and Harmonisation for research excellence in the European Union	'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Weill Cornell Medical College in Qatar (WCMC-Q) - Qatar Foundation(Qatar Foundation (QF)); Dutch Science Organization; Netherlands Consortium for Healthy Ageing (NCHA); Bio-SHaRE-EU; Biobank Standardisation and Harmonisation for research excellence in the European Union	The manuscript is based on data from the LifeLines cohort study. LifeLines adheres to standards for open data availability. The data catalogue of LifeLines is publicly accessible on www.lifelines.net. All international researchers can apply for data at the LifeLines research office (LLscience@umcg.nl). The LifeLines system allows access for reproducibility of the study results. The QMDiab study was supported by 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation. Support for some of the experiments was provided by the Weill Cornell Medical College in Qatar (WCMC-Q) bioinformatics and virtual metabolomics core which is funded by the Qatar Foundation. Dennis Mook-Kanamori is supported by Dutch Science Organization (ZonMW-VENI Grant 916.14.023). This work was supported by Netherlands Consortium for Healthy Ageing (NCHA), Bio-SHaRE-EU, Biobank Standardisation and Harmonisation for research excellence in the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Netherlands Consortium for Healthy Ageing (NCHA), BioSHaRE-EU, Biobank Standardisation and Harmonisation for research excellence in the European Union. Bioresource research impact factor BRIF4568.	Avila-Tang E, 2013, TOB CONTROL, V22, P164, DOI 10.1136/tobaccocontrol-2011-050298; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Basta G, 2002, CIRCULATION, V105, P816, DOI 10.1161/hc0702.104183; Baynes JW, 2000, FREE RADICAL BIO MED, V28, P1708, DOI 10.1016/S0891-5849(00)00228-8; Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Benowitz NL, 1999, ENVIRON HEALTH PERSP, V107, P349, DOI 10.2307/3434427; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; BROWNLEE M, 1994, DIABETES, V43, P836, DOI 10.2337/diab.43.6.836; Cai WJ, 2012, P NATL ACAD SCI USA, V109, P15888, DOI 10.1073/pnas.1205847109; Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915; Chowdhury P, 1998, P SOC EXP BIOL MED, V218, P168; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; de Vos LC, 2015, ARTERIOSCL THROM VAS, V35, P1532, DOI 10.1161/ATVBAHA.115.305407; de Vos LC, 2013, ARTERIOSCL THROM VAS, V33, P131, DOI 10.1161/ATVBAHA.112.300016; den Dekker MAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083084; DUNN JA, 1991, BIOCHEMISTRY-US, V30, P1205, DOI 10.1021/bi00219a007; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Eliasson B, 1997, EUR J CLIN INVEST, V27, P450, DOI 10.1046/j.1365-2362.1997.1330680.x; Eny KM, 2014, DIABETOLOGIA, V57, P1623, DOI 10.1007/s00125-014-3286-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Hoonhorst SJM, 2014, METABOLISM, V63, P1149, DOI 10.1016/j.metabol.2014.06.006; Howard DJ, 1998, CANCER EPIDEM BIOMAR, V7, P981; Iversen B, 2013, EUR J EPIDEMIOL, V28, P659, DOI 10.1007/s10654-013-9785-z; Jha P, 2013, NEW ENGL J MED, V368, P341, DOI 10.1056/NEJMsa1211128; Johnson HM, 2010, J AM COLL CARDIOL, V55, P1988, DOI 10.1016/j.jacc.2010.03.002; Koetsier M, 2010, DIABETES TECHNOL THE, V12, P399, DOI 10.1089/dia.2009.0113; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Meerwaldt R, 2009, AM J KIDNEY DIS, V53, P138, DOI 10.1053/j.ajkd.2008.08.031; MONNIER VM, 1990, J GERONTOL, V45, pB105, DOI 10.1093/geronj/45.4.B105; Mook-Kanamori DO, 2014, J CLIN ENDOCR METAB, V99, pE479, DOI 10.1210/jc.2013-3596; Mook-Kanamori MJ, 2013, DERM-ENDOCRINOL, V5, P325, DOI 10.4161/derm.26046; Mulder DJ, 2008, ATHEROSCLEROSIS, V197, P217, DOI 10.1016/j.atherosclerosis.2007.03.027; Nicholl ID, 1998, MOL MED, V4, P594, DOI 10.1007/BF03401759; Ohkuma T, 2015, PLOS ONE, V10, DOI [10, 10.1371/journal.pone.0122023]; Pirkle JL, 1996, JAMA-J AM MED ASSOC, V275, P1233, DOI 10.1001/jama.275.16.1233; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Seccareccia F, 2003, EUR J EPIDEMIOL, V18, P487, DOI 10.1023/A:1024672522802; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; TAYLOR AE, 1992, CIRCULATION, V86, P699, DOI 10.1161/01.CIR.86.2.699; Unoki H, 2007, DIABETES RES CLIN PR, V76, P236, DOI 10.1016/j.diabres.2006.09.016; van Waateringe RP, 2016, EUR J CLIN INVEST, V46, P481, DOI 10.1111/eci.12627; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069915; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	55	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179330	10.1371/journal.pone.0179330	http://dx.doi.org/10.1371/journal.pone.0179330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632785	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100021
J	Kempny, A; Dimopoulos, K; Uebing, A; Diller, GP; Rosendahl, U; Belitsis, G; Gatzoulis, MA; Wort, SJ				Kempny, Aleksander; Dimopoulos, Konstantinos; Uebing, Anselm; Diller, Gerhard-Paul; Rosendahl, Ulrich; Belitsis, George; Gatzoulis, Michael A.; Wort, Stephen J.			Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015	PLOS ONE			English	Article							CENTILE CURVES; RISK; PREVALENCE; SURVIVAL; ADULT	Background The number of patients with congenital heart disease (CHD) is increasing worldwide and most of them will require cardiac surgery, once or more, during their lifetime. The total volume of cardiac surgery in CHD patients at a national level and the associated mortality and predictors of death associated with surgery are not known. We aimed to investigate the surgical volume and associated mortality in CHD patients in England. Methods Using a national hospital episode statistics database, we identified all CHD patients undergoing cardiac surgery in England between 1997 and 2015. Results We evaluated 57,293 patients (median age 11.9years, 46.7% being adult, 56.7% female). There was a linear increase in the number of operations performed per year from 1,717 in 1997 to 5,299 performed in 2014. The most common intervention at the last surgical event was an aortic valve procedure (9,276; 16.2%), followed by repair of atrial septal defect (9,154; 16.0%), ventricular septal defect (7,746; 13.5%), tetralogy of Fallot (3,523; 6.1%) and atrioventricular septal defect (3,330; 5.8%) repair. Associated mortality remained raised up to six months following cardiac surgery. Several parameters were predictive of post-operative mortality, including age, complexity of surgery, need for emergency surgery and socioeconomic status. The relationship of age with mortality was "U"-shaped, and mortality was highest amongst youngest children and adults above 60 years of age. Conclusions The number of cardiac operations performed in CHD patients in England has been increasing, particularly in adults. Mortality remains raised up to 6-months after surgery and was highest amongst young children and seniors.	[Kempny, Aleksander; Dimopoulos, Konstantinos; Uebing, Anselm; Diller, Gerhard-Paul; Gatzoulis, Michael A.; Wort, Stephen J.] Imperial Coll London, Royal Brompton Hosp, Adult Congenital Heart Ctr, London, England; [Kempny, Aleksander; Dimopoulos, Konstantinos; Uebing, Anselm; Diller, Gerhard-Paul; Gatzoulis, Michael A.; Wort, Stephen J.] Imperial Coll London, Royal Brompton Hosp, Natl Ctr Pulm Hypertens, London, England; [Diller, Gerhard-Paul] Univ Hosp Muenster, Dept Cardiol & Angiol, Adult Congenital & Valvular Heart Dis Ctr, Munster, Germany; [Rosendahl, Ulrich; Belitsis, George] Imperial Coll London, Royal Brompton Hosp, Dept Cardiac Surg, London, England; [Belitsis, George] Great Ormond St Hosp Sick Children, Dept Cardiac Surg, London, England	Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton Hospital; University of Munster; Imperial College London; Royal Brompton Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Kempny, A (corresponding author), Imperial Coll London, Royal Brompton Hosp, Adult Congenital Heart Ctr, London, England.; Kempny, A (corresponding author), Imperial Coll London, Royal Brompton Hosp, Natl Ctr Pulm Hypertens, London, England.	kempny@gmail.com	Uebing, Anselm Sebastian/AAY-2554-2020; Dimopoulos, Konstantinos/AAD-5229-2019; Uebing, Anselm/A-8350-2010	Uebing, Anselm Sebastian/0000-0001-8504-0228; Dimopoulos, Konstantinos/0000-0003-1300-0504; Uebing, Anselm/0000-0001-8504-0228; Belitsis, Georgios/0000-0001-7296-8633	NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust and Imperial College London	This project was supported by the NIHR Cardiovascular Biomedical Research Unit of Royal Brompton and Harefield NHS Foundation Trust and Imperial College London. This report is independent research by the National Institute for Health Research Biomedical Research Unit Funding Scheme. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.	Aranson NJ, 2015, CIRCULATION, V131, P1291, DOI 10.1161/CIRCULATIONAHA.114.006512; Aylin P, 2007, EUR J VASC ENDOVASC, V33, P461, DOI 10.1016/j.ejvs.2006.10.033; Best KE, 2015, HEART, V101, P1807, DOI 10.1136/heartjnl-2015-307826; Bhatt AB, 2015, CIRCULATION, V131, P1884, DOI 10.1161/CIR.0000000000000204; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Dadvand P, 2009, PAEDIATR PERINAT EP, V23, P58, DOI 10.1111/j.1365-3016.2008.00987.x; Diller GP, 2015, CIRCULATION, V132, P2118, DOI 10.1161/CIRCULATIONAHA.115.017202; Finkelstein DM, 2003, J NATL CANCER I, V95, P1434, DOI 10.1093/jnci/djg052; Geva T, 2014, LANCET, V383, P1921, DOI 10.1016/S0140-6736(13)62145-5; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; Jacobs ML, 2013, J THORAC CARDIOV SUR, V145, P1046, DOI 10.1016/j.jtcvs.2012.06.029; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kogon B, 2014, J THORAC CARDIOV SUR, V147, P666, DOI 10.1016/j.jtcvs.2013.09.053; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; O'Leary JM, 2013, JAMA-J AM MED ASSOC, V309, P984, DOI 10.1001/jama.2013.564; Pagel C, 2013, HEART, V99, P1445, DOI 10.1136/heartjnl-2013-303671; R Core Team, 2021, R LANGUAGE ENV STAT; Reinohl J, 2015, NEW ENGL J MED, V373, P2438, DOI 10.1056/NEJMoa1500893; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rigby RA, 2004, STAT MED, V23, P3053, DOI 10.1002/sim.1861; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Siregar S, 2013, EUR J CARDIO-THORAC, V44, P875, DOI 10.1093/ejcts/ezt119; Statistics OfN, 2016, OFF NAT STAT; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025	31	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178963	10.1371/journal.pone.0178963	http://dx.doi.org/10.1371/journal.pone.0178963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628610	Green Published, gold			2022-12-26	WOS:000404043100012
J	Febbraro, F; Svenningsen, K; Tran, TP; Wiborg, O				Febbraro, Fabia; Svenningsen, Katrine; Thao Phuong Tran; Wiborg, Ove			Neuronal substrates underlying stress resilience and susceptibility in rats	PLOS ONE			English	Article							CHRONIC MILD STRESS; FOS-LIKE IMMUNOREACTIVITY; ANXIETY-RELATED-BEHAVIOR; C-FOS; GENE-EXPRESSION; MAJOR DEPRESSION; NERVOUS-SYSTEM; ANIMAL-MODEL; LEARNED HELPLESSNESS; HABENULAR NUCLEUS	Background Stress and stressful life events have repeatedly been shown as causally related to depression. The Chronic Mild Stress rat model is a valid model of stress-induced depression. Like humans, rats display great heterogeneity in their response to stress and adversity. Hence some individuals are stress-sensitive and prone to develop depression-like behaviour in response to modest stressors, while others are stress-resilient and remain essentially symptom free. Objectives Compared to the large body of research, which describes stress-induced maladaptive neurobiological changes, relatively little attention has been devoted to understand resiliency to stress. The aim of the present study was to identify changes in neuronal activity, associated with stress-resilient and stress-susceptible chronic mild stress endophenotypes, by examining c-Fos expression in 13 different brain areas. Changes in c-Fos expression have been reported as associated to stressful conditions. Methods Stress-induced modulation of neuronal activation patterns in response to the chronic mild stress paradigm was mapped using the immediate early gene expression c-Fos as a marker. Quantification of the c-Fos-like immunoreactivity responses was done by semi automated profile counting procedures and design-based stereology. Results Exposure to chronic mild stress significantly altered c-Fos expression in a total of 6 out of 13 investigated areas. Chronic mild stress was found to suppress the c-Fos response within the magnocellular ventral lateral geniculate nucleus of both stress subgroups. In the the lateral and ventral orbital cortices of stress-resilient rats, the c-Fos like immunoreactivity response was also repressed by stress exposure. On the contrary the c-Fos response within the amygdala, medial habenula, and infralimbic cortex was increased selectively for the stress-susceptible rats. Conclusions The study was initiated to characterize neuronal substrates associated with stress-coping mechanisms. Six areas, all of which represents limbic structures, were found to be sensitive to stress exposure. The effects within these areas associate to the hedonic status of the rats. Hence, these areas might be associated to stress-coping mechanisms underlying the chronic mild stress induced segregation into stress-susceptible and stress-resilient endophenotypes.	[Febbraro, Fabia] Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Aarhus C, Denmark; [Svenningsen, Katrine] Hosp Southern Jutland, Focused Res Unit Mol Diagnost, Focused Res Unit Mol Diagnost & Clin Res, IRS Ctr Sonderjylland, Abenra, Denmark; [Thao Phuong Tran] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark; [Wiborg, Ove] Aarhus Univ, Hlth, Dept Clin Med, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Wiborg, O (corresponding author), Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Aarhus C, Denmark.	fabia.febbraro@dandrite.au.dk; ove.wiborg@cfin.au.dk	Febbraro, Fabia/AAO-9454-2020; Febbraro, Fabia/G-9097-2016	Febbraro, Fabia/0000-0001-8336-2776				Anand A, 2003, ANN NY ACAD SCI, V985, P370; Antonijevic I, 2008, STRESS, V11, P15, DOI 10.1080/10253890701378967; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; CHASTRETTE N, 1991, BRAIN RES, V563, P339, DOI 10.1016/0006-8993(91)91559-J; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; Christensen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080666; Christiansen S, 2012, STRESS, V15, P647, DOI 10.3109/10253890.2011.654370; Cirulli F, 1998, BRAIN BEHAV IMMUN, V12, P123, DOI 10.1006/brbi.1998.0505; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; de Medeiros MA, 2005, NEUROPSYCHOPHARMACOL, V30, P1246, DOI 10.1038/sj.npp.1300694; Duncan GE, 1996, J PHARMACOL EXP THER, V277, P1076; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; GRAEFF FG, 1994, BRAZ J MED BIOL RES, V27, P811; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Henningsen K, 2012, BEHAV PHARMACOL, V23, P735, DOI 10.1097/FBP.0b013e32835a5184; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Huguet G, 2016, CEREBELLUM; Isingrini E, 2016, NAT NEUROSCI, V19, P560, DOI 10.1038/nn.4245; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Kanarik M, 2011, EUR NEUROPSYCHOPHARM, V21, P92, DOI 10.1016/j.euroneuro.2010.06.015; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P265, DOI 10.1016/0149-7634(81)90008-7; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Langel J, 2014, J BIOL RHYTHM, V29, P192, DOI 10.1177/0748730414533289; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; MIYATA S, 1994, NEUROSCI LETT, V175, P63, DOI 10.1016/0304-3940(94)91078-2; Miyata S, 2001, MOL BRAIN RES, V90, P39, DOI 10.1016/S0169-328X(01)00072-9; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; NAGAO M, 1993, NEUROSCI LETT, V151, P37, DOI 10.1016/0304-3940(93)90039-N; Ostrander MM, 2009, STRESS, V12, P469, DOI 10.3109/10253890802641966; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pariante Carmine M, 2006, J Psychopharmacol, V20, P79, DOI 10.1177/1359786806066063; Paxinos G., 1998, RAT BRAIN STEREOTAXI, Vfourth; Pfau ML, 2015, NEUROBIOL STRESS, V1, P66, DOI 10.1016/j.ynstr.2014.09.004; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Puglisi-Allegra S, 2015, BEHAV BRAIN RES, V277, P58, DOI 10.1016/j.bbr.2014.07.052; Salchner P, 2006, NEUROPHARMACOLOGY, V50, P1048, DOI 10.1016/j.neuropharm.2006.02.008; Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021; Shuboni DD, 2015, PHYSIOL BEHAV, V138, P75, DOI 10.1016/j.physbeh.2014.09.006; Singewald N, 2007, NEUROSCI BIOBEHAV R, V31, P18, DOI 10.1016/j.neubiorev.2006.02.003; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wiborg O, 2013, CELL TISSUE RES, V354, P155, DOI 10.1007/s00441-013-1664-0; Wiegrebe L, 2008, BIOL CYBERN, V98, P587, DOI 10.1007/s00422-008-0216-2; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Zangenehpour S, 2002, MOL BRAIN RES, V109, P221, DOI 10.1016/S0169-328X(02)00556-9; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012; Zozulya AA, 2008, J IMMUNOTOXICOL, V5, P221, DOI 10.1080/15476910802131444; Zurawek D, 2016, MOL NEUROBIOLOGY	69	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179434	10.1371/journal.pone.0179434	http://dx.doi.org/10.1371/journal.pone.0179434			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622391	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300032
J	Bor, J; Ahmed, S; Fox, MP; Rosen, S; Meyer-Rath, G; Katz, IT; Tanser, F; Pillay, D; Barnighausen, T				Bor, Jacob; Ahmed, Shahira; Fox, Matthew P.; Rosen, Sydney; Meyer-Rath, Gesine; Katz, Ingrid T.; Tanser, Frank; Pillay, Deenan; Baernighausen, Till			Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study	PLOS ONE			English	Article							REGRESSION DISCONTINUITY DESIGNS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; CAUSAL-INFERENCE; CARE; RETENTION; INFECTION; PROGRAM; COHORT	Background The World Health Organization recommends initiating antiretroviral therapy (ART) regardless of CD4 count. We assessed the effect of ART eligibility on treatment uptake and simulated the impact of WHO's recommendations in South Africa. Methods We conducted an empirical analysis of cohort data using a regression discontinuity design, and then used this model for policy simulation. We enrolled all patients (n = 19,279) diagnosed with HIV between August 2011 and December 2013 in the Hlabisa HIV Treatment and Care Programme in rural South Africa. Patients were ART-eligible with CD4<350 cells/mm(3) or Stage III/IV illness. We estimated: (1) distribution of first CD4 counts in 2013; (2) probability of initiating ART <= 6 months of HIV diagnosis under existing criteria at each CD4 count; (3) probability of initiating ART by CD4 count if thresholds were eliminated; and (4) number of expected new initiators if South Africa eliminates thresholds. Findings In 2013, 38.9% of patients diagnosed had a CD4 count 500. 8.0% of these patients initiated even without eligible CD4 counts. If CD4 criteria were eliminated, we project that an additional 19.2% of patients with CD4 >= 500 would initiate ART; 72.8% would not initiate ART despite being eligible. Eliminating CD4 criteria would increase the number starting ART by 26.7%. If these numbers hold nationally, this would represent an additional 164,000 initiators per year, a 5.2% increase in patients receiving ART and 5.3% increase in programme costs. Conclusions Removing CD4 criteria alone will modestly increase timely uptake of ART. However, our results suggest the majority of newly-eligible patients will not initiate. Improved testing, linkage, and initiation procedures are needed to achieve 90-90-90 targets.	[Bor, Jacob; Ahmed, Shahira; Fox, Matthew P.; Rosen, Sydney; Meyer-Rath, Gesine] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA; [Bor, Jacob; Tanser, Frank; Pillay, Deenan; Baernighausen, Till] Africa Hlth Res Inst, Somkhele, South Africa; [Bor, Jacob; Tanser, Frank; Pillay, Deenan; Baernighausen, Till] Africa Hlth Res Inst, Durban, South Africa; [Bor, Jacob; Ahmed, Shahira; Fox, Matthew P.; Rosen, Sydney; Meyer-Rath, Gesine] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Bor, Jacob; Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Katz, Ingrid T.] Brigham & Womens Hosp, Div Womens Hlth, 75 Francis St, Boston, MA 02115 USA; [Katz, Ingrid T.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA USA; [Katz, Ingrid T.] Harvard Med Sch, Boston, MA USA; [Pillay, Deenan] UCL, Dept Virol, London, England; [Baernighausen, Till] Heidelberg Univ, Heidelberg Inst Publ Hlth, Heidelberg, Germany; [Baernighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Boston University; Africa Health Research Institute; Africa Health Research Institute; University of Witwatersrand; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of London; University College London; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health	Bor, J (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02215 USA.; Bor, J (corresponding author), Africa Hlth Res Inst, Somkhele, South Africa.; Bor, J (corresponding author), Africa Hlth Res Inst, Durban, South Africa.; Bor, J (corresponding author), Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.; Bor, J (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.	jbor@bu.edu	Tanser, Frank/ABE-8326-2021; Fox, Matthew/K-2004-2019; Bärnighausen, Till/Y-2388-2019	Katz, Ingrid/0000-0002-3014-238X; Tanser, Frank/0000-0001-9797-0000; Rosen, Sydney/0000-0002-6560-2964	US National Institute of Mental Health award [1K01MH105320]; US National Institute of Child Health and Development award [1R01HD084233]; US Agency for International Development (USAID) [AID 674-a-12-00029]; Wellcome Trust [082384/Z/07/Z]; United States Presidents Emergency Plan for AIDS Relief [674-A-00-08-0001-00]; Peter T. Paul Career Development Professorship; Alexander von Humboldt Foundation through the Alexander von Humboldt professor award - Federal Ministry of Education and Research; Wellcome Trust; European Commission; Clinton Health Access Initiative; NIA of NIH [P01-AG041710]; NIAID of NIH [R01-AI124389, R01-AI112339]; FIC of NIH [D43-TW009775]; Academy of Medical Sciences (AMS) [AMS-NAF2-Tanser] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH097667, K01MH105320] Funding Source: NIH RePORTER	US National Institute of Mental Health award; US National Institute of Child Health and Development award; US Agency for International Development (USAID)(United States Agency for International Development (USAID)); Wellcome Trust(Wellcome TrustEuropean Commission); United States Presidents Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)); Peter T. Paul Career Development Professorship; Alexander von Humboldt Foundation through the Alexander von Humboldt professor award - Federal Ministry of Education and Research(Alexander von Humboldt Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Clinton Health Access Initiative; NIA of NIH; NIAID of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC of NIH; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by US National Institute of Mental Health award 1K01MH105320 (JB), US National Institute of Child Health and Development award 1R01HD084233 (TB, FT), and US Agency for International Development (USAID) cooperative agreement AID 674-a-12-00029 (JB, MF, SR). The Africa Health Research Institute receives core funding from the Wellcome Trust (082384/Z/07/Z); and the Hlabisa Cohort was funded by the United States Presidents Emergency Plan for AIDS Relief (award no. 674-A-00-08-0001-00). Dr. Bor received support from the Peter T. Paul Career Development Professorship. Dr. Barnighausen received support from the Alexander von Humboldt Foundation through the Alexander von Humboldt professor award, funded by the Federal Ministry of Education and Research; the Wellcome Trust; the European Commission; the Clinton Health Access Initiative; and from NIA of NIH (P01-AG041710), NIAID of NIH (R01-AI124389 and R01-AI112339) as well as FIC of NIH (D43-TW009775). All funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of any of the funders or the US government.	[Anonymous], 2013, S AFR ANT TREATM GUI; Bor J, 2015, POP ASS AM ANN M SAN; Bor J, 2016, REAL WORLD IMPACT CD; Bor J, 2015, EPIDEMIOLOGY, V26, pE28, DOI 10.1097/EDE.0000000000000256; Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Carmona S, 2016, 21 INT AIDS C JUL 18, P782; Chiu C, 2016, INT AIDS C DURB S AF; Clouse K, 2014, TROP MED INT HEALTH, V19, P1411, DOI 10.1111/tmi.12387; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; Hahn JY, 2001, ECONOMETRICA, V69, P201, DOI 10.1111/1468-0262.00183; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Imbens G, 2012, REV ECON STUD, V79, P933, DOI 10.1093/restud/rdr043; Imbens GW, 2008, J ECONOMETRICS, V142, P615, DOI 10.1016/j.jeconom.2007.05.001; Katz IT, 2015, AIDS BEHAV, V19, P704, DOI 10.1007/s10461-014-0920-y; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Meyer-Rath G, 2010, INT AIDS C VIENN AUS; Meyer-Rath G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001247; Moscoe E, 2015, J CLIN EPIDEMIOL, V68, P132, DOI 10.1016/j.jclinepi.2014.06.021; Motsoaledi A., 2016, HLTH DEP BUDGET VOTE; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Mutevedzi PC, 2013, TROP MED INT HEALTH, V18, P934, DOI 10.1111/tmi.12135; O'Keeffe AG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5293; Pillay Y., 2013, IAS 2013 7 INT AIDS; Plazy M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1207-2; Plazy M, 2014, TROP MED INT HEALTH, V19, P680, DOI 10.1111/tmi.12301; Rosen S, 2016, INITIATING ART PATIE; Rosen S, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002015, 10.1371/journal.pmed.1002106]; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Rubin D.B., 1977, J EDUC STAT, V2, P1, DOI [10.3102/10769986002001001, DOI 10.3102/10769986002001001]; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; South African National Ministry of Health, 2010, S AFR ANT TREATM GUI; Venkataramani AS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1216; World Health Organization, 2015, GUID START ANT THER	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178249	10.1371/journal.pone.0178249	http://dx.doi.org/10.1371/journal.pone.0178249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617805	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600008
J	Danish, HH; Aronov, D; Fee, MS				Danish, Husain H.; Aronov, Dmitriy; Fee, Michale S.			Rhythmic syllable-related activity in a songbird motor thalamic nucleus necessary for learned vocalizations	PLOS ONE			English	Article							ZEBRA FINCH SONG; INSPIRATORY PREMOTOR NEURONS; BRAIN-STEM TELLS; CONTROL-SYSTEM; VOCAL CONTROL; FUNCTIONAL-ORGANIZATION; COROLLARY DISCHARGE; SEQUENCE GENERATION; SUPERIOR COLLICULUS; FOREBRAIN CIRCUIT	Birdsong is a complex behavior that exhibits hierarchical organization. While the representation of singing behavior and its hierarchical organization has been studied in some detail in avian cortical premotor circuits, our understanding of the role of the thalamus in adult bird-song is incomplete. Using a combination of behavioral and electrophysiological studies, we seek to expand on earlier work showing that the thalamic nucleus Uvaeformis (Uva) is necessary for the production of stereotyped, adult song in zebra finch (Taeniopygia guttata). We confirm that complete bilateral lesions of Uva abolish singing in the 'directed' social context, but find that in the 'undirected' social context, such lesions result in highly variable vocalizations similar to early babbling song in juvenile birds. Recordings of neural activity in Uva reveal strong syllable-related modulation, maximally active prior to syllable onsets and minimally active prior to syllable offsets. Furthermore, both song and Uva activity exhibit a pronounced coherent modulation at 10Hz-a pattern observed in downstream premotor areas in adult and, even more prominently, in juvenile birds. These findings are broadly consistent with the idea that Uva is critical in the sequential activation of behavioral modules in HVC.	[Danish, Husain H.; Aronov, Dmitriy; Fee, Michale S.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Fee, MS (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, E25-618, Cambridge, MA 02139 USA.	fee@mit.edu			NIH [R01DC009183]; Hertz Foundation; Howard Hughes Medical Research Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hertz Foundation; Howard Hughes Medical Research Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by: Funding to M.S.F. provided by the NIH (grant no. R01DC009183); Funding to D.A. from the Hertz Foundation Silvio Micali Fellowship (http://www.hertzfoundation.org/); Funding to H.H.D. by the Howard Hughes Medical Research Fellows Program (http://www.hhmi.org/programs/medical-research-fellows-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding to M.S.F. was provided by the NIH (grant no. R01DC009183), to D.A. from the Hertz Foundation Silvio Micali Fellowship and to H.H.D. by the Howard Hughes Medical Research Fellows Program. We thank Galen Lynch, Michael Stetner, and Emily Mackevicius for comments on the manuscript.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Akutagawa E, 2010, J COMP NEUROL, V518, P3086, DOI 10.1002/cne.22383; Alonso RG, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00041; Amador A, 2013, NATURE, V495, P59, DOI 10.1038/nature11967; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; Andalman AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025461; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Ashmore RC, 2005, J NEUROSCI, V25, P8543, DOI 10.1523/JNEUROSCI.1668-05.2005; Ashmore RC, 2008, J NEUROSCI, V28, P2613, DOI 10.1523/JNEUROSCI.4547-07.2008; Ashmore RC, 2008, J NEUROPHYSIOL, V99, P373, DOI 10.1152/jn.00830.2007; Boari S, 2015, J NEUROPHYSIOL, V114, P2912, DOI 10.1152/jn.00385.2015; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Coleman MJ, 2005, J NEUROBIOL, V63, P70, DOI 10.1002/neu.20122; CYNX J, 1990, J COMP PSYCHOL, V104, P3, DOI 10.1037/0735-7036.104.1.3; Dubbeldam JL, 2002, BRAIN RES BULL, V57, P349, DOI 10.1016/S0361-9230(01)00689-X; Fee MS, 2013, BIRDSONG, SPEECH, AND LANGUAGE: EXPLORING THE EVOLUTION OF MIND AND BRAIN, P353; Fee MS, 2004, ANN NY ACAD SCI, V1016, P153, DOI 10.1196/annals.1298.022; Fee MS, 2001, J NEUROSCI METH, V112, P83, DOI 10.1016/S0165-0270(01)00426-5; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Gibb L, 2009, J NEUROPHYSIOL, V102, P1763, DOI 10.1152/jn.91154.2008; Glaze CM, 2007, J NEUROSCI, V27, P7631, DOI 10.1523/JNEUROSCI.1065-07.2007; Glaze CM, 2006, J NEUROSCI, V26, P991, DOI 10.1523/JNEUROSCI.3387-05.2006; Goldin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067814; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hamaguchi K, 2016, NEURON, V91, P680, DOI 10.1016/j.neuron.2016.06.019; Hanuschkin A, 2011, J COMPUT NEUROSCI, V31, P509, DOI 10.1007/s10827-011-0318-z; HOPKINS CD, 1976, J COMP PHYSIOL, V111, P171, DOI 10.1007/BF00605531; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jarvis ED, 2007, J ORNITHOL, V148, pS35, DOI 10.1007/s10336-007-0243-0; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; KARTEN HJ, 1991, BRAIN BEHAV EVOLUT, V38, P264, DOI 10.1159/000114393; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubke MF, 2005, J NEUROPHYSIOL, V94, P2379, DOI 10.1152/jn.00257.2005; Lashley KS., 1951, PROBLEM SERIAL ORDER, V21; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Leonardo A, 2004, P NATL ACAD SCI USA, V101, P16935, DOI 10.1073/pnas.0407870101; Li MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011918; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; Liu WC, 2004, P NATL ACAD SCI USA, V101, P18177, DOI 10.1073/pnas.0408065101; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Lynch GF, 2016, NEURON, V90, P877, DOI 10.1016/j.neuron.2016.04.021; MARLER P, 1981, TRENDS NEUROSCI, V4, P88, DOI 10.1016/0166-2236(81)90029-1; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mitra P., 2007, OBSERVED BRAIN DYNAM; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Okubo TS, 2015, NATURE, V528, P352, DOI 10.1038/nature15741; Okubo Tatsuo S, 2014, Cold Spring Harb Protoc, V2014, P1273, DOI 10.1101/pdb.prot084624; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Otchy TM, 2015, NATURE, V528, P358, DOI 10.1038/nature16442; Picardo MA, 2016, NEURON, V90, P866, DOI 10.1016/j.neuron.2016.02.016; Reiner A, 2004, ANN NY ACAD SCI, V1016, P77, DOI 10.1196/annals.1298.013; Reinke H, 1998, J COMP NEUROL, V391, P147; Reinke H, 1997, J COMP NEUROL, V379, P347; Saar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001461; Perl YS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051909; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Striedter GF, 1998, J NEUROBIOL, V34, P27, DOI 10.1002/(SICI)1097-4695(199801)34:1<27::AID-NEU3>3.0.CO;2-E; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Veit L, 2011, J NEUROPHYSIOL, V106, P1747, DOI 10.1152/jn.00247.2011; VICARIO DS, 1988, J COMP NEUROL, V271, P346, DOI 10.1002/cne.902710305; VICARIO DS, 1991, J COMP NEUROL, V309, P486, DOI 10.1002/cne.903090405; VU ET, 1994, J NEUROSCI, V14, P6924; WILLIAMS H, 1993, J NEUROBIOL, V24, P903, DOI 10.1002/neu.480240704; Wurtz RH, 2005, PROG BRAIN RES, V149, P207, DOI 10.1016/S0079-6123(05)49015-9; WURTZ RH, 1980, J NEUROPHYSIOL, V43, P1168, DOI 10.1152/jn.1980.43.4.1168; Zann RA., 1996, ZEBRA FINCH SYNTHESI	77	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0169568	10.1371/journal.pone.0169568	http://dx.doi.org/10.1371/journal.pone.0169568			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617829	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600001
J	Leisner, CP; Kamileen, MO; Conway, ME; O'Connor, SE; Buell, CR				Leisner, Courtney P.; Kamileen, Mohamed O.; Conway, Megan E.; O'Connor, Sarah E.; Buell, C. Robin			Differential iridoid production as revealed by a diversity panel of 84 cultivated and wild blueberry species	PLOS ONE			English	Article							MORINDA-CITRIFOLIA; HIGHBUSH BLUEBERRY; ANTIOXIDANT; VACCINIUM; ANTHOCYANINS; GLYCOSIDES; AMERICAN; EXTRACT; DAMAGE; CELLS	Cultivated blueberry (Vaccinium corymbosum, Vaccinium angustifolium, Vaccinium darrowii, and Vaccinium virgatum) is an economically important fruit crop native to North America and a member of the Ericaceae family. Several species in the Ericaceae family including cranberry, lignonberry, bilberry, and neotropical blueberry species have been shown to produce iridoids, a class of pharmacologically important compounds present in over 15 plant families demonstrated to have a wide range of biological activities in humans including anticancer, anti-bacterial, and anti-inflammatory. While the antioxidant capacity of cultivated blueberry has been well studied, surveys of iridoid production in blueberry have been restricted to fruit of a very limited number of accessions of V. corymbosum, V. angustifolium and V. virgatum; none of these analyses have detected iridoids. To provide a broader survey of iridoid biosynthesis in cultivated blueberry, we constructed a panel of 84 accessions representing a wide range of cultivated market classes, as well as wild blueberry species, and surveyed these for the presence of iridoids. We identified the iridoid glycoside monotropein in fruits and leaves of all 13 wild Vaccinium species, yet only five of the 71 cultivars. Monotropein positive cultivars all had recent introgressions from wild species, suggesting that iridoid production can be targeted through breeding efforts that incorporate wild germplasm. A series of diverse developmental tissues was also surveyed in the diversity panel, demonstrating a wide range in iridoid content across tissues. Taken together, this data provides the foundation to dissect the molecular and genetic basis of iridoid production in blueberry.	[Leisner, Courtney P.; Conway, Megan E.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Kamileen, Mohamed O.; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England	Michigan State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Leisner, CP (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.	cleisner@msu.edu	O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	Kamileen, Mohamed Omar/0000-0002-1346-1055; O'Connor, Sarah/0000-0003-0356-6213; Buell, C Robin/0000-0002-6727-4677; Leisner, Courtney/0000-0002-8285-686X	National Institute of Health National Research Service [1F32AT008761-01]; Michigan State University Foundation; Michigan State University Foundation (CRB), Biotechnology and Biological Sciences Research Council [BB/J004561/1]; BBSRC [BBS/E/J/000CA512, BB/N007905/1, BBS/E/J/000PR9790] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9790, BBS/E/J/000CA512, BB/N007905/1] Funding Source: researchfish	National Institute of Health National Research Service; Michigan State University Foundation; Michigan State University Foundation (CRB), Biotechnology and Biological Sciences Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Institute of Health National Research Service Award Postdoctoral Fellowship Award 1F32AT008761-01 (CPL), Michigan State University Foundation (CRB), Biotechnology and Biological Sciences Research Council Award BB/J004561/1 (supports SEO, MOK, award to SEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brevis PA, 2008, J AM SOC HORTIC SCI, V133, P427, DOI 10.21273/JASHS.133.3.427; Bunea A, 2013, PHYTOCHEMISTRY, V95, P436, DOI 10.1016/j.phytochem.2013.06.018; Clark JR, 1996, HORTSCIENCE, V31, P1043, DOI 10.21273/HORTSCI.31.6.1043; Deng SX, 2011, PHYTOCHEM ANALYSIS, V22, P26, DOI 10.1002/pca.1246; Dinda B, 2011, CHEM PHARM BULL, V59, P803, DOI 10.1248/cpb.59.803; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Ehlenfeldt MK, 2005, HORTSCIENCE, V40, P1556, DOI 10.21273/HORTSCI.40.5.1556; Guerra MC, 2005, BRIT J NUTR, V94, P211, DOI 10.1079/BJN20051425; Hancock J. F., 2008, P115, DOI 10.1007/978-1-4020-6907-9_4; Heffels P., 2016, FOOD RES INT; Jensen HD, 2002, J AGR FOOD CHEM, V50, P6871, DOI 10.1021/jf0205110; Kim DH, 2000, TOXICOL LETT, V114, P181, DOI 10.1016/S0378-4274(99)00295-7; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Lin S, 2009, J NAT PROD, V72, P650, DOI 10.1021/np800716f; Liu J, 2010, J FOOD SCI, V75, pH103, DOI 10.1111/j.1750-3841.2010.01546.x; Liu W, 2013, INT J MOL SCI, V14, P21447, DOI 10.3390/ijms141121447; Ma CH, 2013, J AGR FOOD CHEM, V61, P3548, DOI 10.1021/jf400515g; Manganaris GA, 2014, J SCI FOOD AGR, V94, P825, DOI 10.1002/jsfa.6432; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Modaressi M, 2009, PHYTOTHER RES, V23, P99, DOI 10.1002/ptr.2568; Moyer RA, 2002, J AGR FOOD CHEM, V50, P519, DOI 10.1021/jf011062r; Papandreou MA, 2009, BEHAV BRAIN RES, V198, P352, DOI 10.1016/j.bbr.2008.11.013; Pentzold S, 2014, BIOL REV, V89, P531, DOI 10.1111/brv.12066; Potterat O, 2007, PLANTA MED, V73, P191, DOI 10.1055/s-2007-967115; Shaughnessy KS, 2009, NUTR RES, V29, P130, DOI 10.1016/j.nutres.2009.01.001; Swiatek L, 1972, HERBA POL, V2, P168; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; Viljoen A, 2012, CURR MED CHEM, V19, P2104; Wang HL, 2017, FOOD CHEM, V217, P773, DOI 10.1016/j.foodchem.2016.09.002; Yi WG, 2005, J AGR FOOD CHEM, V53, P7320, DOI 10.1021/jf051333o	30	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179417	10.1371/journal.pone.0179417	http://dx.doi.org/10.1371/journal.pone.0179417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609455	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700037
J	Auensen, A; Hussain, AI; Falk, RS; Walle-Hansen, MM; Bye, J; Pettersen, KI; Aukrust, P; Ueland, T; Gullestad, LL				Auensen, Andreas; Hussain, Amjad Iqbal; Falk, Ragnhild Sorum; Walle-Hansen, Marte Meyer; Bye, Jorun; Pettersen, Kjell Ingar; Aukrust, Pal; Ueland, Thor; Gullestad, Lars Lysgaard			Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis	PLOS ONE			English	Article							CLINICAL FACTORS; RISK; DISEASE	Objectives Among patients with severe aortic stenosis (AS), we investigated the associations of N-terminal pro-natriuretic peptide (NT-proBNP), high-sensitive troponin T (hsTnT), and high-sensitive C-reactive protein (hs-CRP) with 3-year mortality and major adverse cardiovascular events (MACE) during 1 year. Methods This observational cohort study prospectively enrolled 442 patients with severe AS who were referred for evaluation of possible valve replacement. Clinical data was recorded before the decision of whether to operate was made. We studied the prognostic value of assessing biomarkers by serum levels, and tested associations of NT-proBNP, hsTnT, and hs-CRP with clinical outcomes (3-year all-cause mortality and risk of MACE in the year following study inclusion) using adjusted multivariable analysis. Results Elevated serum levels of these biomarkers at baseline evaluation were associated with increased all-cause 3-year mortality regardless of treatment assignment. Adjusted analysis showed that none of the studied biomarkers (NT-proBNP, hsTnT or hs-CRP) or any other covariates were associated with 3-year all-cause mortality following surgical aortic valve replacement (SAVR). However, adjusted analyses showed that hsTnT (HR, 1.51; 95% CI, 1.11-2.05; P = 0.008) and left ventricular ejection fraction (HR 0.97; 95% CI 0.94-0.97, P = 0.043) was associated with MACE for operated patients. Conclusions Whereas NT-proBNP, hsTnT and hs-CRP had no independently prognostic value in relation to all-cause mortality following SAVR, hsTnT was independently associated with MACE following operation. The use of these clinically available biomarkers, in particular hsTnT, should be clarified in larger studies.	[Auensen, Andreas; Hussain, Amjad Iqbal; Pettersen, Kjell Ingar; Gullestad, Lars Lysgaard] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Auensen, Andreas; Hussain, Amjad Iqbal; Gullestad, Lars Lysgaard] Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway; [Auensen, Andreas; Hussain, Amjad Iqbal; Walle-Hansen, Marte Meyer; Bye, Jorun; Pettersen, Kjell Ingar; Aukrust, Pal; Ueland, Thor; Gullestad, Lars Lysgaard] Univ Oslo, Fac Med, Oslo, Norway; [Falk, Ragnhild Sorum] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Aukrust, Pal; Ueland, Thor] Oslo Univ Hosp, Rikshosp, Res Inst Internal Med, Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Ueland, Thor] Univ Tromso, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso	Auensen, A (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway.; Auensen, A (corresponding author), Univ Oslo, Fac Med, Ctr Heart Failure Res, Oslo, Norway.; Auensen, A (corresponding author), Univ Oslo, Fac Med, Oslo, Norway.	andreas.auensen@medisin.uio.no	Falk, Ragnhild Sørum/H-5613-2019	Falk, Ragnhild Sørum/0000-0001-8398-3492; Auensen, Andreas/0000-0001-7991-382X	University of Oslo	University of Oslo	University of Oslo funded this study.	Barra S, 2011, REV PORT CARDIOL, V30, P655, DOI 10.1016/S0870-2551(11)70004-X; Bergler-Klein J, 2014, CAN J CARDIOL, V30, P1027, DOI 10.1016/j.cjca.2014.07.014; Capoulade R, 2014, HEART, V100, P1606, DOI 10.1136/heartjnl-2014-305729; Carabello BA, 2009, LANCET, V373, P956, DOI 10.1016/S0140-6736(09)60211-7; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; Clavel MA, 2014, J AM COLL CARDIOL, V63, P2016, DOI 10.1016/j.jacc.2014.02.581; Galante A, 2001, J AM COLL CARDIOL, V38, P1078, DOI 10.1016/S0735-1097(01)01484-X; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Henri C, 2016, CAN J CARDIOL, V32, P183, DOI 10.1016/j.cjca.2015.06.007; Kodali SK, 2012, NEW ENGL J MED, V366, P1686, DOI 10.1056/NEJMoa1200384; Kupari M, 2005, J INTERN MED, V258, P231, DOI 10.1111/j.1365-2796.2005.01529.x; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; Nunes JPL, 2003, INT J CARDIOL, V89, P281, DOI 10.1016/S0167-5273(02)00502-8; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Parikh V, 2016, CIRCULATION, V8, P373; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; Ross J Jr, 1968, Circulation, V38, P61; Solberg OG, 2012, SCAND CARDIOVASC J, V46, P278, DOI 10.3109/14017431.2012.687836; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179304	10.1371/journal.pone.0179304	http://dx.doi.org/10.1371/journal.pone.0179304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604834	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400045
J	Tsai, YF; Tseng, LM; Hsu, CY; Yang, MH; Chiu, JH; Shyr, YM				Tsai, Yi-Fang; Tseng, Ling-Ming; Hsu, Chih-Yi; Yang, Muh-Hwa; Chiu, Jen-Hwey; Shyr, Yi-Ming			Brain-derived neurotrophic factor (BDNF) - TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer	PLOS ONE			English	Article							LUNG-CANCER; TUMOR MICROENVIRONMENT; FACTOR EXPRESSION; GROWTH-FACTOR; METASTASIS; PROMOTES; SURVIVAL; NEUROBLASTOMA; ANGIOGENESIS; INVASION	Aims There is good evidence that the tumor microenvironment plays an important role in cancer metastasis and progression. Our previous studies have shown that brain-derived neurotrophic factor (BDNF) participates in the process of metastasis and in the migration of cancer cells. The aim of this study was to investigate the role of BDNF on the tumor cell microenvironment, namely, the cancer cell-endothelial cell interaction of TNBC cells. Methods We conducted oligoneucleotide microarray analysis of potential biomarkers that are able to differentiate recurrent TNBC from non-recurrent TNBC. The MDA-MB-231 and human endothelial HUVEC lines were used for this study and our approaches included functional studies, such as migration assay, as well as Western blot and real-time PCR analysis of migration and angiogenic signaling. In addition, we analyzed the survival outcome of TNBC breast cancer patients according to their expression level of BDNF using clinical samples. Results The results demonstrated that BDNF was able to bring about autocrinal (MDA-MB-231) and paracrinal (HUVECs) regulation of BDNF-TrkB gene expression and this affected cell migratory activity. The BDNF-induced migratory activity was blocked by inhibitors of ERK, PI3K and TrkB when MDA-MB-231 cells were examined, but only an inhibitor of ERK blocked this activity when HUVEC cells were used. Furthermore, decreased migratory activity was found for Delta BDNF and Delta TrkB cell lines. Ingenuity pathway analysis (IPA) of MDA-MB-231 cells showed that BDNF is a key factor that is able to regulate a network made up of metalloproteases and calmodulin. Protein expression levels in a tissue array of tumor slices were found to be correlated with patient prognosis and the results showed that there was significant correlation of TrkB expression, but not of BDNF. expressionwith patient DFS and OS. Conclusion Our study demonstrates that up-regulation of the BDNF signaling pathway seems tobe involved in the mechanism associated with early recurrence in triple negative breast cancer cell. In addition, BDNF can function in either an autocrine or a paracrine manner to increase the migration ability of both MDA-MB-231 cells and HUVEC cells. Finally, overexpression of TrkB, but not of BDNF, is significantly associated with a poor survival outcome for TNBC patients.	[Tsai, Yi-Fang; Tseng, Ling-Ming; Chiu, Jen-Hwey; Shyr, Yi-Ming] Taipei Vet Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan; [Tsai, Yi-Fang; Tseng, Ling-Ming; Chiu, Jen-Hwey; Shyr, Yi-Ming] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Tsai, Yi-Fang; Yang, Muh-Hwa] Natl Yang Ming Univ, Inst Clin Med, Inst Tradit Med, Sch Med, Taipei, Taiwan; [Tseng, Ling-Ming; Shyr, Yi-Ming] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan; [Hsu, Chih-Yi] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Hsu, Chih-Yi] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Yang, Muh-Hwa] Taipei Vet Gen Hosp, Div Med Oncol, Dept Med, Taipei, Taiwan; [Yang, Muh-Hwa] Taipei Vet Gen Hosp, Genom Med Res Ctr, Taipei, Taiwan; [Chiu, Jen-Hwey] Cheng Hsin Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chiu, Jen-Hwey] Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University	Chiu, JH (corresponding author), Taipei Vet Gen Hosp, Comprehens Breast Hlth Ctr, Taipei, Taiwan.; Chiu, JH (corresponding author), Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Chiu, JH (corresponding author), Cheng Hsin Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.; Chiu, JH (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, Sch Med, Taipei, Taiwan.	chiujh@ym.edu.tw	Yang, Muh-Hwa/AAE-4691-2020	Chiu, Jen-Hwey/0000-0003-3046-6250				ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burks H, 2016, MOL CELLULAR ENDOCRI; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30404; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Coughlin T, 2016, CURRENT DRUG TARGETS; Deindl E, 2014, ACTA PHYSIOL, V211, P268, DOI 10.1111/apha.12299; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Ernfors P, 1995, INT J DEV BIOL, V39, P799; Gao B., 2016, J GENE MED; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Hua ZY, 2016, TUMOR BIOL, V37, P16227, DOI 10.1007/s13277-016-5433-z; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huth L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102558; Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005; Lai PC, 2010, ONCOL REP, V24, P1265, DOI 10.3892/or_00000981; Lawn S, 2015, J BIOL CHEM, V290, P3814, DOI 10.1074/jbc.M114.599373; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lin CY, 2014, BIOCHEM PHARMACOL, V91, P522, DOI 10.1016/j.bcp.2014.08.008; Liu ZL, 2014, MOL MED REP, V10, P2459, DOI 10.3892/mmr.2014.2525; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Martinenaite E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1238541; Nitsche U, 2016, ONCOL LETT, V12, P3804, DOI 10.3892/ol.2016.5132; Ouyang LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep39541; Patani N, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-23; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Romero-Lopez M, 2017, BIOMATERIALS, V116, P118, DOI 10.1016/j.biomaterials.2016.11.034; Salvatore V, 2016, ONCOTARGET; Singh R, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e11076; Tajbakhsh A, 2017, JOURNAL OF CELLULAR; Tsai CH, 2015, MOL MED REP, V12, P7326, DOI 10.3892/mmr.2015.4360; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Xia H, 2016, INT J ONCOL, V49, P1325, DOI 10.3892/ijo.2016.3628; Zhang L, 2014, CURR MOL MED, V14, P762; Zhu GQ, 2016, ONCOL LETT, V12, P3478, DOI 10.3892/ol.2016.5047	42	35	36	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178173	10.1371/journal.pone.0178173	http://dx.doi.org/10.1371/journal.pone.0178173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604807	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400012
J	Wilson, CL; Rhodes, KM; Payne, RA				Wilson, Carol L.; Rhodes, Kirsty M.; Payne, Rupert A.			Financial incentives improve recognition but not treatment of cardiovascular risk factors in severe mental illness	PLOS ONE			English	Article							PRIMARY-CARE; SCHIZOPHRENIA; PEOPLE	Objectives Severe mental illness (SMI) is associated with premature cardiovascular disease, prompting the UK primary care payment-for-performance system (Quality and Outcomes Framework, QOF) to incentivise annual physical health reviews. This study aimed to assess the QOF's impact on detection and treatment of cardiovascular risk factors in people with SMI. Methods A retrospective open cohort study of UK general practice was conducted between 1996 and 2014, using segmented logistic regression with 2004 and 2011 as break points, reflecting the introduction of relevant QOF incentives in these years. 67239 SMI cases and 359951 randomly-selected unmatched controls were extracted from the Clinical Practice Research Datalink (CPRD). Results There was strong evidence (p <= 0.015) the 2004 QOF indicator (general health) resulted in an immediate increase in recording of elevated cholesterol (odds ratio 1.37 (95% confidence interval 1.24 to 1.51)); obesity (OR 1.21 (1.06 to 1.38)); and hypertension (OR 1.19 (1.04 to 1.38)) in the SMI group compared with the control group, which was sustained in subsequent years. Similar findings were found for diabetes, although the evidence was weaker (p = 0.059; OR 1.21 (0.99 to 1.49)). There was evidence (p<0.001) of a further, but unsustained, increase in recording of elevated cholesterol and obesity in the SMI group following the 2011 QOF indicator (cardiovascular specific). There was no clear evidence that the QOF indicators affected the prescribing of lipid modifying medications or anti-diabetic medications. Conclusion Incentivising general physical health review for SMI improves identification of cardiovascular risk factors, although the additional value of specifically incentivising cardiovascular risk factor assessment is unclear. However, incentives do not affect pharmacological management of these risks.	[Wilson, Carol L.; Payne, Rupert A.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Rhodes, Kirsty M.] MRC Biostat Unit, Cambridge, England; [Payne, Rupert A.] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol, Avon, England	University of Cambridge; MRC Biostatistics Unit; University of Bristol	Payne, RA (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.; Payne, RA (corresponding author), Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol, Avon, England.	r.payne@bristol.ac.uk		Rhodes, Kirsty/0000-0002-8568-4979	MRC [MC_UU_00002/5] Funding Source: UKRI; Medical Research Council [MC_UU_00002/5] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2021, LANG ENV STAT COMP; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Crawford MJ, 2014, BRIT J PSYCHIAT, V205, P473, DOI 10.1192/bjp.bp.113.142521; De Hert M, 2009, EUR PSYCHIAT, V24, P412, DOI 10.1016/j.eurpsy.2009.01.005; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Jandoc R, 2015, J CLIN EPIDEMIOL, V68, P950, DOI 10.1016/j.jclinepi.2014.12.018; Kisely S, 2009, BRIT J PSYCHIAT, V195, P545, DOI 10.1192/bjp.bp.109.067082; Kontopantelis E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008650; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Lutterman T, 2003, DHHS PUBLICATION DHHS PUBLICATION; NHS Digital, 2017, QUAL OUTC FRAM; NICE, 2009, SCHIZ COR INT TREATM; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Reilly S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009010; Roberts L, 2007, FAM PRACT, V24, P34, DOI 10.1093/fampra/cml054; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; StataCorp, 2013, STATA STAT SOFTW REL; Wood D, 1998, HEART, V80, pS1	22	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179392	10.1371/journal.pone.0179392	http://dx.doi.org/10.1371/journal.pone.0179392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX1NV	28598998	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000037
J	Spolverini, A; Fuchs, G; Bublik, DR; Oren, M				Spolverini, A.; Fuchs, G.; Bublik, D. R.; Oren, M.			let-7b and let-7c microRNAs promote histone H2B ubiquitylation and inhibit cell migration by targeting multiple components of the H2B deubiquitylation machinery	ONCOGENE			English	Article							BREAST-CANCER; TUMOR-SUPPRESSOR; LUNG-CANCER; CHROMATIN MODIFICATIONS; MESENCHYMAL TRANSITION; DOWN-REGULATION; POOR-PROGNOSIS; SELF-RENEWAL; MONOUBIQUITINATION; EXPRESSION	Monoubiquitylation of histone H2B (H2Bub1) is catalyzed mainly by the RNF20/RNF40 complex and erased by multiple deubiquitylating enzymes (DUBs). H2Bub1 influences many aspects of chromatin function, including transcription regulation and DNA repair. Cancer cells often display reduced levels of H2Bub1, and this reduction may contribute to cancer progression. The let-7 family of microRNAs (miRNAs) comprises multiple members with reported tumor-suppressive features, whose expression is frequently downregulated in cancer. We now report that let-7b and let-7c can positively regulate cellular H2Bub1 levels. Overexpression of let-7b and let-7c in a variety of non-transformed and cancer-derived cell lines results in H2Bub1 elevation. The positive effect of let-7b and let-7c on H2Bub1 levels is achieved through targeting of multiple mRNAs, coding for distinct components of the H2B deubiquitylation machinery. Specifically, let-7b and let-7c bind directly and inhibit the mRNAs encoding the DUBs USP42 and USP44, and also the mRNA encoding the adapter protein ATXN7L3, which is part of the DUB module of the SAGA complex. RNF20 knockdown (KD) strongly reduces H2Bub1 levels and increases the migration of non-transformed mammary epithelial cells and breast cancer-derived cells. Remarkably, overexpression of let-7b, which partly counteracts the effect of RNF20 KD on H2Bub1 levels, also reverses the pro-migratory effect of RNF20 KD. Likewise, ATXN7L3 KD also increases H2Bub1 levels and reduces cell migration, and this anti-migratory effect is abolished by simultaneous KD of RNF20. Together, our findings uncover a novel function of let-7 miRNAs as regulators of H2B ubiquitylation, suggesting an additional mechanism whereby these miRNAs can exert their tumor-suppressive effects.	[Spolverini, A.; Fuchs, G.; Bublik, D. R.; Oren, M.] Weizmann Inst Sci, Dept Mol Cell Biol, POB 26,234 Herzl St, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, POB 26,234 Herzl St, IL-7610001 Rehovot, Israel.	moshe.oren@weizmann.ac.il		Oren, Moshe/0000-0003-4311-7172	Dr Miriam and Sheldon G. Adelson Medical Research Foundation; European Research Council [293438]; Center of Excellence grant from the Israel Science Foundation; Robert Bosch Foundation [11.5.8000.0094]; Moross Integrated Cancer Center	Dr Miriam and Sheldon G. Adelson Medical Research Foundation; European Research Council(European Research Council (ERC)European Commission); Center of Excellence grant from the Israel Science Foundation; Robert Bosch Foundation; Moross Integrated Cancer Center	We thank Ofra Golani from the Bioinformatics Unit of the Weizmann Institute for expert help with image analysis; Yonit Hoffman and Gali Brand for help with data analysis; and Sharath Chandra Arandkar and Ohad Tarcic for valuable discussions. This study was supported in part by the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, grant 293438 (RUBICAN) from the European Research Council, a Center of Excellence grant from the Israel Science Foundation, the Robert Bosch Foundation (project 11.5.8000.0094) and the Moross Integrated Cancer Center. MO is incumbent of the Andre Lwoff chair in molecular biology.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Atanassov BS, 2016, MOL CELL, V62, P558, DOI 10.1016/j.molcel.2016.03.030; Atanassov BS, 2011, FEBS LETT, V585, P2016, DOI 10.1016/j.febslet.2010.10.042; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chen DL, 2015, ONCOTARGET, V6, P10868, DOI 10.18632/oncotarget.3451; Chernikova SB, 2012, CANCER RES, V72, P2111, DOI 10.1158/0008-5472.CAN-11-2209; Chiu SC, 2014, CELL TRANSPLANT, V23, P459, DOI 10.3727/096368914X678418; Cole AJ, 2015, ENDOCR-RELAT CANCER, V22, pT19, DOI 10.1530/ERC-14-0185; Cui SY, 2013, MOL CANCER RES, V11, P699, DOI 10.1158/1541-7786.MCR-13-0019-T; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dawson SJ, 2013, EMBO J, V32, P617, DOI 10.1038/emboj.2013.19; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Gambari R, 2016, INT J ONCOL, V49, P5, DOI 10.3892/ijo.2016.3503; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Haakensen VD, 2016, INT J CANCER, V139, P1117, DOI 10.1002/ijc.30142; Han X, 2015, CANCER GENE THER, V22, P122, DOI 10.1038/cgt.2014.75; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hock AK, 2014, J BIOL CHEM, V289, P34862, DOI 10.1074/jbc.M114.589267; Hu J, 2015, LUNG CANCER, V88, P239, DOI 10.1016/j.lungcan.2015.02.019; Hu XW, 2013, MOL CANCER RES, V11, P240, DOI 10.1158/1541-7786.MCR-12-0432; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jansen MPHM, 2012, BREAST CANCER RES TR, V133, P937, DOI 10.1007/s10549-011-1877-4; Johnsen SA, 2012, FEBS LETT, V586, P1592, DOI 10.1016/j.febslet.2012.04.002; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kari V, 2011, CELL CYCLE, V10, P3495, DOI 10.4161/cc.10.20.17769; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lal A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002363; Lan XJ, 2016, CELL REP, V17, P2382, DOI 10.1016/j.celrep.2016.10.076; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ma L, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0773-7; Majid S, 2013, CLIN CANCER RES, V19, P73, DOI 10.1158/1078-0432.CCR-12-2952; Melling N, 2016, PATHOL ONCOL RES, V22, P95, DOI 10.1007/s12253-015-9977-9; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakamura K, 2011, MOL CELL, V41, P515, DOI 10.1016/j.molcel.2011.02.002; Olive V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005813; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Prenzel T, 2011, CANCER RES, V71, P5739, DOI 10.1158/0008-5472.CAN-11-1896; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Song QC, 2014, ONCOL REP, V31, P1263, DOI 10.3892/or.2014.2989; Stahlhut C, 2015, CELL CYCLE, V14, P2171, DOI 10.1080/15384101.2014.1003008; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Sun X, 2016, CANCER GENE THER, V23, P83, DOI 10.1038/cgt.2016.3; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang B, 2015, ONCOTARGET, V6, P12654, DOI 10.18632/oncotarget.3705; Tarcic O, 2017, CELL DEATH DIFFER, V24, P694, DOI 10.1038/cdd.2016.126; Tarcic O, 2016, CELL REP, V14, P1462, DOI 10.1016/j.celrep.2016.01.020; Tommasi S, 2016, ONCOTARGET, V7, P80363, DOI 10.18632/oncotarget.10345; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Urasaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036775; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang E, 2013, P NATL ACAD SCI USA, V110, P3901, DOI 10.1073/pnas.1301045110; Wang PY, 2013, FEBS LETT, V587, P2675, DOI 10.1016/j.febslet.2013.07.004; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wang ZJ, 2013, WORLD J GASTROENTERO, V19, P8099, DOI 10.3748/wjg.v19.i44.8099; Wang ZJ, 2015, HUM PATHOL, V46, P1006, DOI 10.1016/j.humpath.2015.04.001; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang F, 2011, MOL CELL, V41, P384, DOI 10.1016/j.molcel.2011.01.024; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023389; Zhang YX, 2011, J CANCER RES CLIN, V137, P1245, DOI 10.1007/s00432-011-0998-9; Zhang ZP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-124; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2; Zhao YM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a025064; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	99	21	22	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5819	5828		10.1038/onc.2017.187	http://dx.doi.org/10.1038/onc.2017.187			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28604753	Green Accepted			2022-12-26	WOS:000413292900004
J	Royce, SG; Rele, S; Broughton, BRS; Kelly, K; Samuel, CS				Royce, Simon G.; Rele, Siddharth; Broughton, Brad R. S.; Kelly, Kilian; Samuel, Chrishan S.			Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease	FASEB JOURNAL			English	Article						asthma; airway remodeling; therapies; pulmonary delivery	STROMAL CELLS; COMBINATION THERAPY; EXPERIMENTAL-MODEL; EPITHELIAL-CELLS; MOUSE MODEL; ASTHMA; INFLAMMATION; SERELAXIN; MICE; PROLIFERATION	Structural changes known as airway remodeling (AWR) characterize chronic/severe asthma and contribute to lung dysfunction. Thus, we assessed the in vivo efficacy of induced pluripotent stem cell and mesenchymoangioblast-derived mesenchymal stem cells (MCA-MSCs) on AWR in a murine model of chronic allergic airways disease (AAD)/asthma. Female Balb/c mice were subjected to a 9-wk model of ovalbumin (Ova)induced chronic AAD and treated intravenously or intranasally with MCA-MSCs from weeks 9 to 11. Changes in airway inflammation (AI), AWR, and airway hyperresponsiveness (AHR) were assessed. Ova-injured mice presented with AI, goblet cell metaplasia, epithelial thickening, increased airway TGF-beta 1 levels, subepithelial myofibroblast and collagen accumulation, total lung collagen concentration, and AHR (all P < 0.001 vs. uninjured control group). Apart from epithelial thickness, all other parameters measured were significantly, although not totally, decreased by intravenous delivery of MCA-MSCs to Ova-injured mice. In comparison, intranasal delivery of MCA-MSCs to Ova-injured mice significantly decreased all parameters measured (all P < 0.05 vs. Ova group) and, most notably, normalized aberrant airway TGF-b1 levels, airway/lung fibrosis, and AHR to values measured in uninjured animals. MCA-MSCs also increased collagen-degrading gelatinase levels. Hence, direct delivery of MCA-MSCs offers great therapeutic benefit for the AWR and AHR associated with chronic AAD.	[Royce, Simon G.; Rele, Siddharth; Samuel, Chrishan S.] Monash Univ, Fibrosis Lab, Clayton, Vic, Australia; [Broughton, Brad R. S.] Monash Univ, Cardiovasc & Pulm Pharmacol Grp, Cardiovasc Dis Program, Biomed Discovery Inst, Clayton, Vic, Australia; Monash Univ, Dept Pharmacol, Clayton, Vic, Australia; [Royce, Simon G.] Monash Univ, Dept Med, Cent Clin Sch, Prahran, Vic, Australia; [Kelly, Kilian] Cynata Therapeut, Armadale, Vic, Australia	Monash University; Monash University; Monash University; Monash University	Royce, SG; Samuel, CS (corresponding author), Monash Univ, Fibrosis Lab, Dept Pharmacol, Clayton, Vic 3800, Australia.	simon.royce@monash.edu; chrishan.samuel@monash.edu		/0000-0001-8844-974X; Rele, Siddharth/0000-0003-2778-2893	National Health and Medical Research Council (NHMRC) of Australia [GNT1041766]; Cynata Therapeutics	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cynata Therapeutics	The authors acknowledge the facilities and technical assistance of Monash Histology Platform (Department of Anatomy and Developmental Biology, Monash University). This work was supported by a National Health and Medical Research Council (NHMRC) of Australia Senior Research Fellowship (GNT1041766) to C.S.S., and by Cynata Therapeutics funding to C.S.S. and S.G.R. S.G.R., S.R., B.R.S.B., and C.S.S. are with the Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University. S.G.R. is also affiliated with the Central Clinical School, Monash University. K.K. is an employee and shareholder of Cynata Therapeutics Ltd., but was not involved with performing the experiments or analysis of data.	Abreu SC, 2013, RESP PHYSIOL NEUROBI, V185, P615, DOI 10.1016/j.resp.2012.11.005; Adams N. P., 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD3534.PUB3; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Broide DH, 2008, J ALLERGY CLIN IMMUN, V121, P560, DOI 10.1016/j.jaci.2008.01.031; Carsin A, 2016, EUR RESPIR REV, V25, P158, DOI 10.1183/16000617.0101-2015; Cates CJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006922.pub3; Cates CJ, 2013, COCHRANE DB SYST REV, V6; Cho KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165661; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; GAO F, 2016, CELL DEATH DIS, V7; Goodwin M, 2011, STEM CELLS, V29, P1137, DOI 10.1002/stem.656; Hastie AT, 2002, AM J RESP CRIT CARE, V165, P266, DOI 10.1164/ajrccm.165.2.2101069; Holgate ST, 2000, CLIN EXP ALLERGY, V30, P37; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Huuskes BM, 2015, FASEB J, V29, P540, DOI 10.1096/fj.14-254789; Inamdar AC, 2013, EXP LUNG RES, V39, P315, DOI 10.3109/01902148.2013.816803; Kapoor S, 2012, J ALLERGY CLIN IMMUN, V129, P1094, DOI 10.1016/j.jaci.2011.10.048; Knight Darryl A, 2010, Expert Rev Respir Med, V4, P747, DOI 10.1586/ers.10.72; Koch JM, 2016, CYTOTHERAPY, V18, P219, DOI 10.1016/j.jcyt.2015.10.013; Lim R, 2013, RESPIRATION, V85, P332, DOI 10.1159/000343078; Mancheno-Corvo P, 2015, STEM CELLS DEV, V24, P2158, DOI 10.1089/scd.2014.0508; Martinez-Gonzalez I, 2014, STEM CELLS DEV, V23, P2352, DOI 10.1089/scd.2013.0616; Mathias LJ, 2013, J IMMUNOL, V191, P5914, DOI 10.4049/jimmunol.1300667; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Ogulur I, 2014, INT IMMUNOPHARMACOL, V20, P101, DOI 10.1016/j.intimp.2014.02.028; Ou-Yang HF, 2011, EXP BIOL MED, V236, P1461, DOI 10.1258/ebm.2011.011221; Patel KP, 2016, BRIT J PHARMACOL, V173, P2016, DOI 10.1111/bph.13494; Pitchford S, 2003, BRIT J PHARMACOL, V138, P1181, DOI 10.1038/sj.bjp.0705136; Reddel HK, 2000, EUR RESPIR J, V16, P226, DOI 10.1034/j.1399-3003.2000.16b08.x; Rolfe K J, 2012, ISRN Dermatol, V2012, P698034, DOI 10.5402/2012/698034; Royce SG, 2016, CLIN SCI, V130, P2151, DOI 10.1042/CS20160328; Royce SG, 2015, STEM CELL RES, V15, P495, DOI 10.1016/j.scr.2015.09.007; Royce SG, 2014, PHARMACOL THERAPEUT, V141, P250, DOI 10.1016/j.pharmthera.2013.10.008; Royce SG, 2013, AM J RESP CELL MOL, V48, P135, DOI 10.1165/rcmb.2011-0320OC; Royce SG, 2013, CLIN SCI, V124, P41, DOI 10.1042/CS20120024; Samuel CS, 2016, TRENDS PHARMACOL SCI, V37, P485, DOI 10.1016/j.tips.2016.02.007; Shifren Adrian, 2012, J Allergy (Cairo), V2012, P316049, DOI 10.1155/2012/316049; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Sun YQ, 2012, STEM CELLS, V30, P2692, DOI 10.1002/stem.1241; Urbanek K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158746; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Weiss DJ, 2014, STEM CELLS, V32, P16, DOI 10.1002/stem.1506; Wener RRL, 2013, EUR RESPIR REV, V22, P227, DOI 10.1183/09059180.00001913; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Zeng SL, 2015, MOL MED REP, V12, P2511, DOI 10.3892/mmr.2015.3706	52	19	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4168	4178		10.1096/fj.201700178R	http://dx.doi.org/10.1096/fj.201700178R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	28626025				2022-12-26	WOS:000408713300038
J	Xu, ML; Bi, CWC; Liu, EYL; Dong, TTX; Tsim, KWK				Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.			Wnt3a induces the expression of acetylcholinesterase during osteoblast differentiation via the Runx2 transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase (AChE); differentiation; DNA methylation; osteoblast; Wnt signaling; Runx2	MEMBRANE-ANCHOR PRIMA; MYOGENIC DIFFERENTIATION; CULTURED OSTEOBLASTS; BONE-DEVELOPMENT; MATRIX PROTEINS; GENE-EXPRESSION; CPG METHYLATION; MESSENGER-RNA; CELLS; GLYCOSYLATION	Acetylcholinesterase (AChE) hydrolyzes acetylcholine to terminate cholinergic transmission in neurons. Apart from this AChE activity, emerging evidence suggests that AChE could also function in other, non-neuronal cells. For instance, in bone, AChE exists as a proline-rich membrane anchor (PRiMA)-linked globular form in osteoblasts, in which it is proposed to play a noncholinergic role in differentiation. However, this hypothesis is untested. Here, we found that in cultured rat osteoblasts, AChE expression was increased in parallel with osteoblastic differentiation. Because several lines of evidence indicate that AChE activity in osteoblast could be triggered by Wnt/-catenin signaling, we added recombinant human Wnt3a to cultured osteoblasts and found that this addition induced expression of the ACHE gene and protein product. This Wnt3a-induced AChE expression was blocked by the Wnt-signaling inhibitor Dickkopf protein-1 (DKK-1). We hypothesized that the Runt-related transcription factor 2 (Runx2), a downstream transcription factor in Wnt/-catenin signaling, is involved in AChE regulation in osteoblasts, confirmed by the identification of a Runx2-binding site in the ACHE gene promoter, further corroborated by ChIP. Of note, Runx2 overexpression in osteoblasts induced AChE expression and activity of the ACHE promoter tagged with the luciferase gene. Moreover, deletion of the Runx2-binding site in the ACHE promoter reduced its activity during osteoblastic differentiation, and addition of 5-azacytidine and trichostatin A to differentiating osteoblasts affected AChE expression, suggesting epigenetic regulation of the ACHE gene. We conclude that AChE plays a role in osteoblastic differentiation and is regulated by both Wnt3a and Runx2.	[Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China; [Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China; [Xu, Miranda L.; Bi, Cathy W. C.; Liu, Etta Y. L.; Dong, Tina T. X.; Tsim, Karl W. K.] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen 518000, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	botsim@ust.hk		XU, Miranda/0000-0001-7660-0051	Hong Kong Research Council Theme-based Research Scheme Grant [T13-607/12R]; TUYF Charitable Trust [TUYF15SC01]; Science and Technology Plan of Shenzhen [JCYJ20160229205726699, JCYJ20160229205812004];  [663012];  [662713];  [M-HKUST604/13]	Hong Kong Research Council Theme-based Research Scheme Grant; TUYF Charitable Trust; Science and Technology Plan of Shenzhen; ; ; 	This work was supported by Hong Kong Research Council Theme-based Research Scheme Grant T13-607/12R, General Research Fund Grants 663012, 662713, M-HKUST604/13, the TUYF Charitable Trust grant TUYF15SC01, and Science and Technology Plan of Shenzhen Grants JCYJ20160229205726699 (to K.T.) and JCYJ20160229205812004 (to T.D.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Angus LM, 2001, J BIOL CHEM, V276, P17603, DOI 10.1074/jbc.M100916200; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen VP, 2011, J BIOL CHEM, V286, P32948, DOI 10.1074/jbc.M111.261248; Choi R. C., 2010, J MOL NEUROSCI, V40, P1; Choi RCY, 2003, J NEUROSCI, V23, P4445; Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397; Dokmanovic M, 2007, MOL CANCER THER, V6, P2525, DOI 10.1158/1535-7163.MCT-07-0251; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FROST HM, 1990, ANAT RECORD, V226, P433, DOI 10.1002/ar.1092260405; Genever PG, 1999, BONE, V24, P297, DOI 10.1016/S8756-3282(98)00187-2; Grisaru D, 1999, MOL CELL BIOL, V19, P788; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Guo AJY, 2011, J BIOL CHEM, V286, P27882, DOI 10.1074/jbc.M111.236281; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Inkson CA, 2004, BONE, V35, P819, DOI 10.1016/j.bone.2004.05.026; Kang MI, 2007, J CELL BIOCHEM, V102, P224, DOI 10.1002/jcb.21291; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354; Kuhlwilm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083218; LAPIDOTLIFSON Y, 1989, P NATL ACAD SCI USA, V86, P4715, DOI 10.1073/pnas.86.12.4715; Lau KM, 2016, BRAIN RES, V1642, P114, DOI 10.1016/j.brainres.2016.03.013; Layer P G, 1990, Acta Histochem Suppl, V38, P145; Leung KW, 2009, FEBS J, V276, P3031, DOI 10.1111/j.1742-4658.2009.07022.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luk WKW, 2012, FEBS J, V279, P3229, DOI 10.1111/j.1742-4658.2012.08708.x; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Ofek K, 2013, CHEM-BIOL INTERACT, V203, P113, DOI 10.1016/j.cbi.2012.07.007; Perry C, 2002, ONCOGENE, V21, P8428, DOI 10.1038/sj.onc.1205945; Sato M, 1998, J BONE MINER RES, V13, P1221, DOI 10.1359/jbmr.1998.13.8.1221; Siow NL, 2002, J BIOL CHEM, V277, P36129, DOI 10.1074/jbc.M206498200; Spieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161675; Stains JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-222; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; UMEZU Y, 1993, ARCH HISTOL CYTOL, V56, P217, DOI 10.1679/aohc.56.217; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P1, DOI 10.1007/s00223-004-0258-y; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Xu ML, 2016, CHEM-BIOL INTERACT, V259, P295, DOI 10.1016/j.cbi.2016.03.025; Xu ML, 2015, J MOL NEUROSCI, V57, P486, DOI 10.1007/s12031-015-0629-z; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	45	26	27	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12667	12678		10.1074/jbc.M117.777581	http://dx.doi.org/10.1074/jbc.M117.777581			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28607150	hybrid, Green Published			2022-12-26	WOS:000406636900030
J	Li, YY; Chen, QZ; Nan, HY; Li, XM; Lu, SJ; Zhao, XH; Liu, BH; Guo, CH; Kong, FJ; Cao, D				Li, Yuanyuan; Chen, Quanzhen; Nan, Haiyang; Li, Xiaoming; Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Guo, Changhong; Kong, Fanjiang; Cao, Dong			Overexpression of GmFDL19 enhances tolerance to drought and salt stresses in soybean	PLOS ONE			English	Article							BZIP TRANSCRIPTION FACTOR; REACTIVE OXYGEN; SALINITY; GENE; IDENTIFICATION; RESISTANCE; ACID	The basic leucine zipper (bZIP) family of transcription factors plays an important role in the growth and developmental process as well as responds to various abiotic stresses, such as drought and high salinity. Our previous work identified GmFDL19, a bZIP transcription factor, as a flowering promoter in soybean, and the overexpression of GmFDL19 caused early flowering in transgenic soybean plants. Here, we report that GmFDL19 also enhances tolerance to drought and salt stress in soybean. GmFDL19 was determined to be a group A member, and its transcription expression was highly induced by abscisic acid (ABA), polyethylene glycol (PEG 6000) and high salt stresses. Overexpression of GmFDL19 in soybean enhanced drought and salt tolerance at the seedling stage. The relative plant height (RPH) and relative shoot dry weight (RSDW) of transgenic plants were significantly higher than those of the WT after PEG and salt treatments. In addition, the germination rate and plant height of the transgenic soybean were also significantly higher than that of WT plants after various salt treatments. Furthermore, we also found that GmFDL19 could reduce the accumulation of Na+ ion content and up-regulate the expression of several ABA/stressresponsive genes in transgenic soybean. We also found that GmFDL19 overexpression increased the activities of several antioxidative enzyme and chlorophyll content but reduced malondialdehyde content. These results suggested that GmFDL19 is involved in soybean abiotic stress responses and has potential utilization to improve multiple stress tolerance in transgenic soybean.	[Li, Yuanyuan; Guo, Changhong] Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin, Peoples R China; [Li, Yuanyuan; Chen, Quanzhen; Nan, Haiyang; Li, Xiaoming; Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Kong, Fanjiang; Cao, Dong] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Li, Xiaoming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lu, Sijia; Zhao, Xiaohui; Liu, Baohui; Kong, Fanjiang] Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Harbin Normal University; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou University	Guo, CH (corresponding author), Harbin Normal Univ, Coll Life Sci & Technol, Key Lab Mol Cytogenet & Genet Breeding Heilongjia, Harbin, Peoples R China.; Kong, FJ; Cao, D (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.; Kong, FJ (corresponding author), Guangzhou Univ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	kaku3008@163.com; kongfj@iga.ac.cn; caodong@iga.ac.cn	Kong, Fanjiang/AGQ-2334-2022; li, yuanyuan/GZA-4435-2022	Kong, Fanjiang/0000-0001-7138-1478	National Natural Science Foundation of China [31430065, 31371643, 31571686]; Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences [XDA08030108]; Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]; Research and Development of Applied Technology Project, Harbin [2014RFQY055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences; Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences; Heilongjiang Natural Science Foundation of China(Natural Science Foundation of Heilongjiang Province); Research and Development of Applied Technology Project, Harbin	This work was supported in part by the National Natural Science Foundation of China (grants 31430065, 31371643, and 31571686), the Open Foundation of the Key Laboratory of Soybean Molecular Design Breeding, Chinese Academy of Sciences, the Strategic Action Plan for Science and Technology Innovation of the Chinese Academy of Sciences (XDA08030108) to B. Liu and F. Kong; the Heilongjiang Natural Science Foundation of China [ZD201001, JC201313]; the Research and Development of Applied Technology Project, Harbin [2014RFQY055].	Cao D, 2011, PLANT CELL TISS ORG, V107, P541, DOI 10.1007/s11240-011-0005-9; Chen HT, 2014, PLANT GROWTH REGUL, V73, P299, DOI 10.1007/s10725-014-9890-3; Deshmukh R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00244; Do TD, 2016, SCI REP-UK, P6, DOI DOI 10.1038/S41598-016-0015-2; Dong LD, 2015, J EXP BOT, V66, P2635, DOI 10.1093/jxb/erv078; Fath A, 2001, NEW PHYTOL, V151, P99, DOI 10.1046/j.1469-8137.2001.00153.x; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Gong X, 2015, PLANT CELL REP, V34, P1963, DOI 10.1007/s00299-015-1843-4; Guan RX, 2014, PLANT J, V80, P937, DOI 10.1111/tpj.12695; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Khan MS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00792; Ko KP, 2013, J EPIDEMIOL, V23, P337, DOI 10.2188/jea.JE20120232; Li WYF, 2008, NEW PHYTOL, V178, P80, DOI 10.1111/j.1469-8137.2007.02356.x; Li YuanYuan, 2017, Soybean Science, V36, P351; Liao H, 2003, GENE, V318, P103, DOI 10.1016/S0378-1119(03)00764-9; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liao Y, 2008, J INTEGR PLANT BIOL, V50, P221, DOI 10.1111/j.1744-7909.2007.00593.x; Liu CT, 2014, PLANT MOL BIOL, V84, P19, DOI 10.1007/s11103-013-0115-3; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nie WX, 2015, PROTOPLASMA, V252, P127, DOI 10.1007/s00709-014-0663-7; Phang TH, 2008, J INTEGR PLANT BIOL, V50, P1196, DOI 10.1111/j.1744-7909.2008.00760.x; Qi DH, 2014, J TAIWAN INST CHEM E, V45, P504, DOI 10.1016/j.jtice.2013.06.021; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Ruan CJ, 2011, CRIT REV BIOTECHNOL, V31, P153, DOI 10.3109/07388551.2010.505908; Sulieman S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/687213; Sun YX, 2006, CHINESE SCI BULL, V51, P1306, DOI 10.1007/s11434-006-1306-y; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tuyen DD, 2010, THEOR APPL GENET, V121, P229, DOI 10.1007/s00122-010-1304-y; Wang F, 2015, PLANT J, V83, P224, DOI 10.1111/tpj.12879; Wang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00067; Xu ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20366; Yan JH, 2014, PLANT CELL PHYSIOL, V55, P74, DOI 10.1093/pcp/pct159; Ying S, 2012, PLANTA, V235, P253, DOI 10.1007/s00425-011-1496-7; Zhang LN, 2015, PHYSIOL PLANTARUM, V153, P538, DOI 10.1111/ppl.12261; Zhang X, 2011, PLANT MOL BIOL, V75, P365, DOI 10.1007/s11103-011-9732-x; Zhou GA, 2010, PLANT MOL BIOL, V72, P357, DOI 10.1007/s11103-009-9575-x; Zhou L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-181	45	43	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179554	10.1371/journal.pone.0179554	http://dx.doi.org/10.1371/journal.pone.0179554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640834	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800037
J	Breedt, E; Lacerda, L; Essop, MF				Breedt, Emilene; Lacerda, Lydia; Essop, M. Faadiel			Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE PREVENTION; CARDIAC ENERGY-METABOLISM; EVIDENCE-BASED GUIDELINES; FATTY-ACID OXIDATION; SUB-SAHARAN AFRICA; SEX-DIFFERENCES; CLINICAL CHARACTERISTICS; CARBOHYDRATE-METABOLISM; VENTRICULAR-FUNCTION; GLUCOSE-OXIDATION	Acute heart failure (AHF) is the most common primary diagnosis for hospitalized heart diseases in Africa. As increased fatty acid beta-oxidation (FAO) during heart failure triggers detrimental effects on the myocardium, we hypothesized that trimetazidine (TMZ) (partial FAO inhibitor) offers cardioprotection under normal and obese-related diabetic conditions. Hearts were isolated from 12-14-week-old obese male and female diabetic (db/db) mice versus lean non-diabetic littermates (db/+) controls. The Langendorff retrograde isolated heart perfusion system was employed to establish an ex vivo AHF model: a) Stabilization phase-Krebs Henseleit buffer (10 mM glucose) at 100 mmHg (25 min); b) Critical Acute Heart Failure (CAHF) phase-(1.2 mM palmitic acid, 2.5 mM glucose) at 20 mmHg (25 min); and c) Recovery Acute Heart Failure phase (RAHF)-(1.2 mM palmitic acid, 10 mM glucose) at 100 mmHg (25 min). Treated groups received 5 mu M TMZ in the perfusate during either the CAHF or RAHF stage for the full duration of each respective phase. Both lean and obese males benefited from TMZ treatment administered during the RAHF phase. Sex differences were observed only in lean groups where the phases of the estrous cycle influenced therapy; only the lean follicular female group responded to TMZ treatment during the CAHF phase. Lean luteal females rather displayed an inherent cardioprotection (without treatments) that was lost with obesity. However, TMZ treatment initiated during RAHF was beneficial for obese luteal females. TMZ treatment triggered significant recovery for male and obese female hearts when administered during RAHF. There were no differences between lean and obese male hearts, while lean females displayed a functional recovery advantage over lean males. Thus TMZ emerges as a worthy therapeutic target to consider for AHF treatment in normal and obese-diabetic individuals (for both sexes), but only when administered during the recovery phase and not during the very acute stages.	[Breedt, Emilene; Lacerda, Lydia; Essop, M. Faadiel] Stellenbosch Univ, Dept Physiol Sci, Cardiometab Res Grp, Stellenbosch, South Africa	Stellenbosch University	Essop, MF (corresponding author), Stellenbosch Univ, Dept Physiol Sci, Cardiometab Res Grp, Stellenbosch, South Africa.	mfessop@sun.ac.za		Essop, Faadiel/0000-0002-8434-4294	National Research Foundation (ZA) [96300]; Stellenbosch University	National Research Foundation (ZA); Stellenbosch University	This study was supported by the National Research Foundation (ZA) 96300 and Stellenbosch University.	Aasum E, 1997, CARDIOVASC RES, V33, P370, DOI 10.1016/S0008-6363(96)00203-9; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Atella V, 2009, ATHEROSCLEROSIS SUPP, V10, P3, DOI 10.1016/S1567-5688(09)70003-0; Barbagallo M, 2001, HYPERTENSION, V37, P142, DOI 10.1161/01.HYP.37.1.142; Barre J, 2003, BIOPHARM DRUG DISPOS, V24, P159, DOI 10.1002/bdd.350; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bigos KL, 2009, GENDER MED, V6, P522, DOI 10.1016/j.genm.2009.12.004; Bucci M, 2012, CARDIOVASC THER, V30, P333, DOI 10.1111/j.1755-5922.2011.00275.x; Bueno H, 1993, JAMA-J AM MED ASSOC, V303, P2141, DOI DOI 10.1001/JAMA.2010.748; Caligioni Claudia S, 2009, Curr Protoc Neurosci, VAppendix 4, p4I, DOI 10.1002/0471142301.nsa04is48; Campbell SE, 2001, AM J PHYSIOL-ENDOC M, V281, pE803, DOI 10.1152/ajpendo.2001.281.4.E803; Cano Climaco, 2003, Am J Ther, V10, P444, DOI 10.1097/00045391-200311000-00011; Damasceno A, 2007, J AM COLL CARDIOL, V50, P1688, DOI 10.1016/j.jacc.2007.07.030; Daniels LB, 2006, AM HEART J, V151, P999, DOI 10.1016/j.ahj.2005.10.011; Deshpande G, 2014, CARDIOVASC RES, V103, DOI 10.1093/cvr/cvu098.179; Deshpande GP, 2010, CARDIOVASC DRUG THER, V24, P459, DOI 10.1007/s10557-010-6258-4; Dubey RK, 1998, HYPERTENSION, V31, P522, DOI 10.1161/01.HYP.31.1.522; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9; Felker GM, 2010, CIRC-HEART FAIL, V3, P314, DOI 10.1161/CIRCHEARTFAILURE.109.893222; Filippatos G, 2007, HEART FAIL REV, V12, P87, DOI 10.1007/s10741-007-9008-3; Folmes Clifford D L, 2005, Curr Atheroscler Rep, V7, P63, DOI 10.1007/s11883-005-0077-2; Fragasso G, 2006, EUR HEART J, V27, P942, DOI 10.1093/eurheartj/ehi816; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Gao DF, 2011, HEART, V97, P278, DOI 10.1136/hrt.2010.208751; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hummel A, 2015, DTSCH ARZTEBL INT, V112, P298, DOI 10.3238/arztebl.2015.0298; Ikizler M, 2006, ARCH MED RES, V37, P700, DOI 10.1016/j.arcmed.2006.01.008; Iozzo P, 2010, NUTR METAB CARDIOVAS, V20, P147, DOI 10.1016/j.numecd.2009.08.011; Jackson PJ, 1996, XENOBIOTICA, V26, P221, DOI 10.3109/00498259609046702; JOHNSON LM, 1979, BIOL REPROD, V20, P552, DOI 10.1095/biolreprod20.3.552; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Konhilas JP, 2007, CIRCULATION, V116, P2747, DOI 10.1161/CIRCULATIONAHA.106.672006; Konhilas John P, 2010, J Biomed Biotechnol, V2010, P562051, DOI 10.1155/2010/562051; Laribi S, 2012, MED EMERG, V10, P25; Li YJ, 2010, ACTA PHARMACOL SIN, V31, P560, DOI 10.1038/aps.2010.31; Liu ZL, 2016, METABOLISM, V65, P122, DOI 10.1016/j.metabol.2015.10.022; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lopaschuk GD, 1997, MOL CELL BIOCHEM, V172, P137, DOI 10.1023/A:1006875823561; Lopaschuk GD, 2003, CIRC RES, V93, pE33, DOI 10.1161/01.RES.0000086964.07404.A5; Lopaschuk GD, 2001, CORONARY ARTERY DIS, V12, pS8; Lopatin YM, 2016, INT J CARDIOL, V203, P909, DOI 10.1016/j.ijcard.2015.11.060; MacDonald JK, 2014, AM J PHYSIOL-HEART C, V306, pH938, DOI 10.1152/ajpheart.00730.2013; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Mather KJ, 2000, J CLIN ENDOCR METAB, V85, P4644, DOI 10.1210/jc.85.12.4644; Mebazaa A, 2015, EUR J HEART FAIL, V17, P544, DOI 10.1002/ejhf.289; Metra M, 2010, INT J CARDIOL, V144, P175, DOI 10.1016/j.ijcard.2010.04.003; Moldovanova I, 2008, HYPERTENSION, V51, P1203, DOI 10.1161/HYPERTENSIONAHA.107.107433; Monti LD, 2006, AM J PHYSIOL-ENDOC M, V290, pE54, DOI 10.1152/ajpendo.00083.2005; Mosca L, 2004, ARTERIOSCL THROM VAS, V24, pE29, DOI 10.1161/01.ATV.0000114834.85476.81; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Nieminen MS, 2008, EUR J HEART FAIL, V10, P140, DOI 10.1016/j.ejheart.2007.12.012; Nieminen MS, 2006, EUR HEART J, V27, P2725, DOI 10.1093/eurheartj/ehl193; Nilsson SE, 2009, GENDER MED, V6, P433, DOI 10.1016/j.genm.2009.09.011; OCHS HR, 1981, PHARMACOLOGY, V23, P24, DOI 10.1159/000137524; Odening KE, 2012, HEART RHYTHM, V9, P823, DOI 10.1016/j.hrthm.2012.01.009; Ogah OS, 2015, CLIN RES CARDIOL, V104, P481, DOI 10.1007/s00392-015-0810-y; Opie Lionel H., 2010, Transactions of the Royal Society of South Africa, V65, P185, DOI 10.1080/0035919X.2010.537886; Pang YF, 2015, AM J PHYSIOL-ENDOC M, V308, pE899, DOI 10.1152/ajpendo.00527.2014; Parissis J, 2015, INT J CARDIOL, V180, P46, DOI 10.1016/j.ijcard.2014.11.123; Parks RJ, 2013, PFLUG ARCH EUR J PHY, V465, P747, DOI 10.1007/s00424-013-1233-0; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Prior J. C., 2014, J RESTORATIVE MED, V3, P85; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Robertson S, 2010, DIABETES, V59, P782, DOI 10.2337/db09-1556; Sabbah HM, 2005, HEART FAIL REV, V10, P281, DOI 10.1007/s10741-005-7541-5; Salerno A, 2015, ACTA DIABETOL, V52, P753, DOI 10.1007/s00592-014-0695-7; Simon N, 1997, BRIT J CLIN PHARMACO, V44, P591, DOI 10.1046/j.1365-2125.1997.t01-1-00628.x; Simoncini T, 2004, ENDOCRINOLOGY, V145, P5745, DOI 10.1210/en.2004-0510; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Sliwa K, 2013, HEART, V99, P1317, DOI 10.1136/heartjnl-2013-303592; Soldin OP, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/187103; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Tsuchihashi-Makaya M, 2011, INT J CARDIOL, V150, P338, DOI 10.1016/j.ijcard.2011.03.042; Tuunanen H, 2006, CIRCULATION, V114, P2130, DOI 10.1161/CIRCULATIONAHA.106.645184; Ussher JR, 2014, CAN J CARDIOL, V30, P940, DOI 10.1016/j.cjca.2014.04.023; Voors AA, 2012, EUR J HEART FAIL, V14, P955, DOI 10.1093/eurjhf/hfs122; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; Wittnich C, 2013, PFLUG ARCH EUR J PHY, V465, P719, DOI 10.1007/s00424-013-1232-1; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302	82	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179509	10.1371/journal.pone.0179509	http://dx.doi.org/10.1371/journal.pone.0179509			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632748	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100031
J	Choi, SH; Ji, SK; Lee, SA; Park, MJ; Chang, MJ				Choi, Sang-Hee; Ji, Suk Kyeong; Lee, Seung Ah; Park, Min Jong; Chang, Moon Jong			Magnetic resonance imaging of posterolateral plica of the elbow joint: Asymptomatic vs. symptomatic subjects	PLOS ONE			English	Article							SYNOVIAL FOLD; PAIN	Background Magnetic resonance imaging (MRI) may be useful to diagnose a posterolateral plica syndrome of the elbow joint because this syndrome has less clear clinical features. The purposes of this study were to document mediolateral and sagittal dimensions of a posterolateral synovial fold and to determine the proportion of subjects with the posterolateral plica in asymptomatic elbows. We also aimed to determine whether the dimensions of the posterolateral synovial fold and the prevalence of the plica differ between symptomatic and asymptomatic subjects. Materials and methods This retrospective review of prospectively collected data included 50 asymptomatic elbows (asymptomatic group) and 14 elbows with arthroscopically confirmed posterolateral plicae (plica group). The mediolateral and sagittal dimensions of the posterolateral synovial fold were measured. In addition, the criteria for the prevalence of posterolateral plica was determined with conventional MRI as synovial fold dimension >= 3 mm and coverage of radial head by synovial fold >= 30%. Results The plica group showed larger posterolateral synovial fold dimensions compared to the asymptomatic group. The median mediolateral and sagittal dimensions of the synovial fold in the asymptomatic group were 3.8 mm and 4.7 mm, respectively. Dimensions in the plica group were 7.0 mm and 7.4 mm, respectively. When the presence of posterolateral plica was determined using the dimension criteria, there was no difference in the prevalence of the plica between the asymptomatic and the plica group. However, using the coverage criteria, the prevalence of posterolateral elbow plica was significantly greater in the plica group than the asymptomatic group (64% vs. 18%; p < 0.001). Conclusions The patients who underwent arthroscopic surgery for posterolateral plica syndrome had larger dimensions of the posterolateral synovial fold and higher prevalence of the posterolateral plica on conventional MRI compared to the asymptomatic subjects.	[Choi, Sang-Hee; Ji, Suk Kyeong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Lee, Seung Ah] Kyung Hee Univ, Dept Phys Med & Rehabil, Coll Med, Seoul, South Korea; [Park, Min Jong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Chang, Moon Jong] Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Kyung Hee University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Chang, MJ (corresponding author), Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthoped Surg, Seoul, South Korea.	moonjongchang@gmail.com		Chang, Moon Jong/0000-0002-2352-7599				Antuna SA, 2001, ARTHROSCOPY, V17, P491, DOI 10.1053/jars.2001.20096; Awaya H, 2001, AM J ROENTGENOL, V177, P1377, DOI 10.2214/ajr.177.6.1771377; de Luzuriaga BCR, 2013, SKELETAL RADIOL, V42, P675, DOI 10.1007/s00256-012-1523-1; Duparc F, 2002, SURG RADIOL ANAT, V24, P302, DOI 10.1007/s00276-002-0055-0; Husarik DB, 2010, RADIOLOGY, V257, P185, DOI 10.1148/radiol.10092163; Kim DH, 2006, AM J SPORT MED, V34, P438, DOI 10.1177/0363546505281917; Kotnis NA, 2012, SKELETAL RADIOL, V41, P369, DOI 10.1007/s00256-011-1343-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ruch DS, 2006, J SHOULDER ELB SURG, V15, P367, DOI 10.1016/j.jse.2005.08.013; Steinert AF, 2010, ARCH ORTHOP TRAUM SU, V130, P347, DOI 10.1007/s00402-008-0798-0	10	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0174320	10.1371/journal.pone.0174320	http://dx.doi.org/10.1371/journal.pone.0174320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622337	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300001
J	Shen, ZW; Wang, HF; Xi, WW; Deng, XG; Chen, J; Zhang, Y				Shen, Zhengwen; Wang, Huafeng; Xi, Weiwen; Deng, Xiaogang; Chen, Jin; Zhang, Yu			Multi-phase simultaneous segmentation of tumor in lung 4D-CT data with context information	PLOS ONE			English	Article							ENERGY MINIMIZATION; SHAPE PRIOR; CT; IMAGES; PET; MOTION; MRI	Lung 4D computed tomography (4D-CT) plays an important role in high-precision radiotherapy because it characterizes respiratory motion, which is crucial for accurate target definition. However, the manual segmentation of a lung tumor is a heavy workload for doctors because of the large number of lung 4D-CT data slices. Meanwhile, tumor segmentation is still a notoriously challenging problem in computer-aided diagnosis. In this paper, we propose a new method based on an improved graph cut algorithm with context information constraint to find a convenient and robust approach of lung 4D-CT tumor segmentation. We combine all phases of the lung 4D-CT into a global graph, and construct a global energy function accordingly. The sub-graph is first constructed for each phase. A context cost term is enforced to achieve segmentation results in every phase by adding a context constraint between neighboring phases. A global energy function is finally constructed by combining all cost terms. The optimization is achieved by solving a max-flow/min-cut problem, which leads to simultaneous and robust segmentation of the tumor in all the lung 4D-CT phases. The effectiveness of our approach is validated through experiments on 10 different lung 4D-CT cases. The comparison with the graph cut without context constraint, the level set method and the graph cut with star shape prior demonstrates that the proposed method obtains more accurate and robust segmentation results.	[Shen, Zhengwen; Wang, Huafeng; Xi, Weiwen; Chen, Jin; Zhang, Yu] Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Shen, Zhengwen; Wang, Huafeng; Xi, Weiwen; Chen, Jin; Zhang, Yu] Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Guangzhou, Guangdong, Peoples R China; [Deng, Xiaogang] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, Y (corresponding author), Southern Med Univ, Sch Biomed Engn, Guangzhou, Guangdong, Peoples R China.; Zhang, Y (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Med Image Proc, Guangzhou, Guangdong, Peoples R China.	yuzhang@smu.edu.cn			National Natural Science Foundation of China [31271067, 61671230]; Natural Science Foundation of Guangdong Province [S2013010014049]; Guangdong Provincial Key Laboratory of Medical Image Processing [2014B030301042]; Science and Technology Program of Guangzhou [201607010097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Key Laboratory of Medical Image Processing; Science and Technology Program of Guangzhou	This work was supported by the National Natural Science Foundation of China under Grant No. 31271067 and No. 61671230, the Natural Science Foundation of Guangdong Province under Grant No. S2013010014049, the Guangdong Provincial Key Laboratory of Medical Image Processing under Grant No. 2014B030301042, and the Science and Technology Program of Guangzhou under Grant No. 201607010097.	Awad J, 2011, P SPIE INT SOC OPTIC, V7963, P345; Bagci U, 2013, MED IMAGE ANAL, V17, P929, DOI 10.1016/j.media.2013.05.004; Ballangan C, 2013, COMPUT METH PROG BIO, V109, P260, DOI 10.1016/j.cmpb.2012.10.009; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2000, LECT NOTES COMPUT SC, V1935, P276; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Castillo R, 2009, PHYS MED BIOL, V54, P1849, DOI 10.1088/0031-9155/54/7/001; Cui H, 2013, IEEE ENG MED BIO, P6071, DOI 10.1109/EMBC.2013.6610937; Das P, 2009, IMAGE VISION COMPUT, V27, P206, DOI 10.1016/j.imavis.2008.02.006; El-Baz A, 2013, INT J BIOMED IMAGING, V2013, DOI [10.1155/2013/517632, 10.1155/2013/942353]; Georg Manfred, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563024; Ginneken B, 2007, MED IMAGE COMPUTING, V39, P93; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Guo FM, 2015, MED IMAGE ANAL, V23, P43, DOI 10.1016/j.media.2015.04.001; Han DF, 2011, LECT NOTES COMPUT SC, V6801, P245, DOI 10.1007/978-3-642-22092-0_21; Ju W, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2488902; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Kolmogorov V, 2002, LECT NOTES COMPUT SC, V2352, P65; Li CM, 2011, IEEE T IMAGE PROCESS, V20, P2007, DOI 10.1109/TIP.2011.2146190; Li RJ, 2009, PHYS MED BIOL, V54, P4821, DOI 10.1088/0031-9155/54/15/012; Malcolm J, 2007, IEEE IMAGE PROC, P2061; Montgomery DWG, 2007, MED PHYS, V34, P722, DOI 10.1118/1.2432404; Plajer I, 2010, INF TECHN APPL BIOM, P1; Rietzel E, 2005, INT J RADIAT ONCOL, V61, P1535, DOI 10.1016/j.ijrobp.2004.11.037; Vandemeulebroucke J, 2011, MED PHYS, V38, P166, DOI 10.1118/1.3523619; Veksler O, 2008, LECT NOTES COMPUT SC, V5304, P454, DOI 10.1007/978-3-540-88690-7_34; Vivanti R, 2015, INT J COMPUT ASS RAD, V10, P1505, DOI 10.1007/s11548-015-1150-0; Wang H, 2013, PATTERN RECOGN, V46, P1409, DOI 10.1016/j.patcog.2012.11.002	31	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178411	10.1371/journal.pone.0178411	http://dx.doi.org/10.1371/journal.pone.0178411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622338	gold, Green Submitted, Green Published			2022-12-26	WOS:000403506300002
J	Zou, LJ; Wang, XC; Jiang, LP; Wang, SP; Xiong, X; Yang, HS; Gao, W; Gong, M; Hu, CAA; Yin, YL				Zou, Lijun; Wang, Xiaocheng; Jiang, Liping; Wang, Shengping; Xiong, Xia; Yang, Huansheng; Gao, Wei; Gong, Min; Hu, Chien-An A.; Yin, Yulong			Molecular cloning, characterization and expression analysis of Frizzled 6 in the small intestine of pigs (Sus scrofa)	PLOS ONE			English	Article							SIGNALING COMPONENTS; CELL MATURATION; CRYPT-VILLUS; WNT; RECEPTORS; POLARITY; FAMILY; MECHANISMS; SUPPLEMENTATION; ACTIVATION	Frizzled 6 (FZD6) encodes an integral membrane protein that functions in multiple signal transduction pathways, for example, as a receptor in Wnt/planar cell polarity (PCP) signaling pathway for polarized cell migration and organ morphogenesis. Mutations in FZD6 have been identified in a variety of tumors. In this study, the full-length cDNA of Sus scrofa FZD6 (Sfz6) was cloned and characterized. Nucleotide sequence analysis demonstrates that the Sfz6 gene encodes the 712 amino-acid (aa) protein with seven transmembrane domain. Tissue distribution analysis showed that Sfz6 mRNA is ubiquitously expressed in various tissues, being highest in kidney, moderate in jejunum, ileum, colon, liver, and spleen. However, FZD6 protein is highly expressed in the heart and there was no significant difference in other tissues. The relative abundance and localization of FZD6 protein in jejunum along the crypt-villus axis was determined by Western blot and immunohistochemical localization. The results show that in the jejunum, FZD6 protein is highly expressed in the villus and less in the crypt cells. Cellular proliferation and viability assays indicate that knockdown of FZD6 with small interfering RNAs (siRNA) significantly reduced the cell viability of the intestinal porcine enterocyte cells (IPEC-J2). Furthermore, qPCR and Western blot analysis revealed that expressions of ras-related C3 botulinum toxin substrate 1 (Rac1); ras homolog gene family member A (RhoA) and c-Jun N-terminal kinase 1 (JNK1), some components of PCP signaling pathway were upregulated (P < 0.05) by knockdown of FZD6 in IPEC-J2 cells. In conclusion, these results showed that FZD6 abundance in the villus was higher than that in crypt cells and knockdown of FZD6 induces PCP signal pathway components expression in IPEC-J2 cells. Our findings provide the foundation for further investigation into porcine FZD6 gene.	[Zou, Lijun; Wang, Xiaocheng; Wang, Shengping; Xiong, Xia; Gao, Wei; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China; [Zou, Lijun; Yang, Huansheng; Hu, Chien-An A.; Yin, Yulong] Hunan Normal Univ, Coll Life Sci, Lab Anim Nutr & Human Hlth, Changsha, Hunan, Peoples R China; [Zou, Lijun] Hunan First Normal Coll, Lab Basic Biol, Changsha, Hunan, Peoples R China; [Jiang, Liping] Cent S Univ, Sch Basic Med Sci, Changsha, Hunan, Peoples R China; [Gong, Min] Jiangxi Sci & Technol Normal Univ, Nanchang, Jiangxi, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Normal University; Hunan First Normal University; Central South University; Jiangxi Science & Technology Normal University	Xiong, X; Yin, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop Reg, Changsha, Hunan, Peoples R China.; Yin, YL (corresponding author), Hunan Normal Univ, Coll Life Sci, Lab Anim Nutr & Human Hlth, Changsha, Hunan, Peoples R China.	xx@isa.ac.cn; yinyulong@isa.ac.cn	Yang, Huansheng/AAA-1380-2020	Zou, Lijun/0000-0002-5469-068X	National Program on Key Basic Research Project [2016YFD0500504]; National Nature Science Foundation of China [31330075, 31572420, 31402089]; Hunan Provincial Innovation Foundation for Postgraduate [CX20166172]	National Program on Key Basic Research Project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Innovation Foundation for Postgraduate	This work was jointly supported by the National Program on Key Basic Research Project (2016YFD0500504), National Nature Science Foundation of China (31330075; 31572420; 31402089) and Hunan Provincial Innovation Foundation for Postgraduate (CX20166172).	Cetin S, 2007, AM J PHYSIOL-GASTR L, V292, pG1347, DOI 10.1152/ajpgi.00375.2006; Chang H, 2013, P NATL ACAD SCI USA, V110, pE908, DOI 10.1073/pnas.1301430110; Chang J, 2008, J PROTEOMICS, V71, P530, DOI 10.1016/j.jprot.2008.08.003; Fan MZ, 2001, J ANIM SCI, V79, P371; Feng ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026399; Gao XF, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/730678; Geng MM, 2011, AMINO ACIDS, V40, P1513, DOI 10.1007/s00726-010-0761-6; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hughes KR, 2011, INFLAMM BOWEL DIS, V17, P213, DOI 10.1002/ibd.21353; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kilander MBC, 2014, CELL SIGNAL, V26, P1943, DOI 10.1016/j.cellsig.2014.05.012; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Piga R, 2014, TOXICOLOGY, V320, P67, DOI 10.1016/j.tox.2014.03.002; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Suzuki T, 2009, BBA-GEN SUBJECTS, V1790, P1624, DOI 10.1016/j.bbagen.2009.08.004; Tokuhara M, 1998, BIOCHEM BIOPH RES CO, V243, P622, DOI 10.1006/bbrc.1998.8143; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang W, 2009, AMINO ACIDS, V37, P593, DOI 10.1007/s00726-008-0178-7; Wang YS, 1996, J BIOL CHEM, V271, P4468; Wu J, 2013, NAT CELL BIOL, V15, P1045, DOI 10.1038/ncb2806; Xiong X, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-41; Yang HS, 2013, J ANIM SCI, V91, P2740, DOI 10.2527/jas.2012-5795; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	37	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179421	10.1371/journal.pone.0179421	http://dx.doi.org/10.1371/journal.pone.0179421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614361	Green Submitted, Green Published, gold			2022-12-26	WOS:000403280900050
J	Korshoej, AR; Hansen, FL; Thielscher, A; von Oettingen, GB; Sorensen, JCH				Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; Thielscher, Axel; von Oettingen, Gorm Burckhardt; Sorensen, Jens Christian Hedemann			Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study	PLOS ONE			English	Article							RANDOMIZED PHASE-III; ELECTRIC-FIELD; ADJUVANT TEMOZOLOMIDE; DIELECTRIC-PROPERTIES; GLIOBLASTOMA; STANDARD; THERAPY; CARE; RADIOTHERAPY; NOVOTTF-100A	Background Tumor treating fields (TTFields) are increasingly used in the treatment of glioblastoma. TTFields inhibit cancer growth through induction of alternating electrical fields. To optimize TTFields efficacy, it is necessary to understand the factors determining the strength and distribution of TTFields. In this study, we provide simple guiding principles for clinicians to assess the distribution and the local efficacy of TTFields in various clinical scenarios. Methods We calculated the TTFields distribution using finite element methods applied to a realistic head model. Dielectric property estimates were taken from the literature. Twentyfour tumors were virtually introduced at locations systematically varied relative to the applied field. In addition, we investigated the impact of central tumor necrosis on the induced field. Results Local field "hot spots" occurred at the sulcal fundi and in deep tumors embedded in white matter. The field strength was not higher for tumors close to the active electrode. Left/right field directions were generally superior to anterior/posterior directions. Central necrosis focally enhanced the field near tumor boundaries perpendicular to the applied field and introduced significant field non-uniformity within the tumor. Conclusions The TTFields distribution is largely determined by local conductivity differences. The well conducting tumor tissue creates a preferred pathway for current flow, which increases the field intensity in the tumor boundaries and surrounding regions perpendicular to the applied field. The cerebrospinal fluid plays a significant role in shaping the current pathways and funnels currents through the ventricles and sulci towards deeper regions, which thereby experience higher fields. Clinicians may apply these principles to better understand how TTFields will affect individual patients and possibly predict where local recurrence may occur. Accurate predictions should, however, be based on patient specific models. Future work is needed to assess the robustness of the presented results towards variations in conductivity.	[Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; von Oettingen, Gorm Burckhardt; Sorensen, Jens Christian Hedemann] Aarhus Univ Hosp, Dept Neurosurg, Norrebrogade 44, Aarhus C, Denmark; [Korshoej, Anders Rosendal; Hansen, Frederik Lundgaard; von Oettingen, Gorm Burckhardt; Sorensen, Jens Christian Hedemann] Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd 100, Aarhus N, Denmark; [Thielscher, Axel] Univ Copenhagen, Danish Res Ctr Magnet Resonance, Hosp Hvidovre, Kettegaards Alle 30, Hvidovre, Denmark; [Thielscher, Axel] Tech Univ Denmark, Biomed Engn, DTU Electro, Bldg 349, Lyngby, Denmark; [Thielscher, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany	Aarhus University; Aarhus University; University of Copenhagen; Technical University of Denmark; Max Planck Society	Korshoej, AR (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, Norrebrogade 44, Aarhus C, Denmark.; Korshoej, AR (corresponding author), Aarhus Univ, Dept Clin Med, Palle Juul Jensens Blvd 100, Aarhus N, Denmark.	andekors@rm.dk		Korshoej, Anders/0000-0003-4285-8171; Thielscher, Axel/0000-0002-4752-5854	Eva og Henry Fraenkels Mindefond; Danish Council for Independent Research; Medical Sciences; Lundbeckfonden [R118-A11308, R59 A5399]; Interdisciplinary Synergy Grant "Basics" - NovoNordisk fonden [11413]; Lundbeck Foundation [R118-2012-11308] Funding Source: researchfish	Eva og Henry Fraenkels Mindefond; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Medical Sciences; Lundbeckfonden(Lundbeckfonden); Interdisciplinary Synergy Grant "Basics" - NovoNordisk fonden; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Eva og Henry Fraenkels Mindefond (RI: Anders R. Korshoej), The Danish Council for Independent Research, Medical Sciences, Lundbeckfonden (RI: Axel Thielscher; Grant Nr. R118-A11308 and RI: Hartwig Siebner; Grant Nr. R59 A5399, Grant of Excellence "ContAct"), an Interdisciplinary Synergy Grant "Basics" sponsored by NovoNordisk fonden (recipients: Hartwig Siebner, Axel Thielscher & Lars K. Hansen, Grant Nr. 11413). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SEMINARS ONCOLOGY; [Anonymous], [No title captured]; [Anonymous], 2015, ASCO ANN M P; [Anonymous], 1990, PROCEEDINGS OF THE T; [Anonymous], 2013, SEMINARS ONCOLOGY; Becker KP, 2012, CANCER J, V18, P12, DOI 10.1097/PPO.0b013e318244d7eb; Davies AM, 2013, ANN NY ACAD SCI, V1291, P86, DOI 10.1111/nyas.12112; Engineering in Medicine and Biology Society (EMBC), 2016, 2016 IEEE 38 ANN INT; Fonkem E, 2012, NOVOTTF 100A NEW TRE; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; GEDDES LA, 1987, NEUROSURGERY, V20, P94; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; Gera N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125269; Giladi M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18046; Hottinger AF, 2014, CHIN J CANCER, V33, P32, DOI 10.5732/cjc.013.10207; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Korshoej AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164051; Latikka J, 2001, PHYS MED BIOL, V46, P1611, DOI 10.1088/0031-9155/46/6/302; Lok E, 2015, COMPUTED MODELING AL; Lok E, 2015, EXPERT REV MED DEVIC, V12, P717, DOI 10.1586/17434440.2015.1086641; LU Y, 1992, INT J HYPERTHER, V8, P755, DOI 10.3109/02656739209005023; Mehta M, 2017, CRIT REV ONCOL HEMAT, V111, P60, DOI 10.1016/j.critrevonc.2017.01.005; Miranda PC, 2014, PHYS MED BIOL, V59, P4137, DOI 10.1088/0031-9155/59/15/4137; Mrugala MM, 2013, DISCOV MED, V15, P221; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; Pohl H. A, 1978, CAMBRIDGE MONOGRAPHS; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Rulseh AM, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-220; Saturnino GB, 2015, NEUROIMAGE, V120, P25, DOI 10.1016/j.neuroimage.2015.06.067; Smart T, 2010, J R STAT SOC A STAT, V173, P272, DOI 10.1111/j.1467-985X.2009.00624_6.x; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou265.40; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taillibert S, 2015, CURR OPIN NEUROL, V28, P659, DOI 10.1097/WCO.0000000000000250; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wenger C, 2015, INT J RAD ONCOLOGY B; Wenger C, 2015, PHYS MED BIOL, V60, P7339, DOI 10.1088/0031-9155/60/18/7339; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479	44	20	20	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179214	10.1371/journal.pone.0179214	http://dx.doi.org/10.1371/journal.pone.0179214			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604803	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400038
J	Thomas, AW; Watts, R; Filippi, CG; Nickerson, JP; Andrews, T; Lieberman, G; Naylor, MR; Eppstein, MJ; Freeman, K				Thomas, Alexander W.; Watts, Richard; Filippi, Christopher G.; Nickerson, Joshua P.; Andrews, Trevor; Lieberman, Gregory; Naylor, Magdalena R.; Eppstein, Margaret J.; Freeman, Kalev			Dynamic changes in diffusion measures improve sensitivity in identifying patients with mild traumatic brain injury	PLOS ONE			English	Article							AXONAL INJURY; WHITE-MATTER; FRACTIONAL ANISOTROPY; BIDIRECTIONAL CHANGES; TENSOR; CONCUSSION; MODEL; MR; REPRODUCIBILITY; ABNORMALITIES	The goal of this study was to investigate patterns of axonal injury in the first week after mild traumatic brain injury (mTBI). We performed a prospective cohort study of 20 patients presenting to the emergency department with mTBI, using 3.0T diffusion tensor MRI immediately after injury and again at 1 week post-injury. Corresponding data were acquired from 16 controls over a similar time interval. Fractional anisotropy (FA) and other diffusion measures were calculated from 11 a priori selected axon tracts at each time-point, and the change across time in each region was quantified for each subject. Clinical outcomes were determined by standardized neurocognitive assessment. We found that mTBI subjects were significantly more likely to have changes in FA in those 11 regions of interest across the one week time period, compared to control subjects whose FA measurements were stable across time. Longitudinal imaging was more sensitive to these subtle changes in white matter integrity than cross-sectional assessments at either of two time points, alone. Analyzing the sources of variance in our control population, we show that this increased sensitivity is likely due to the smaller within-subject variability obtained by longitudinal analysis with each subject as their own control. This is in contrast to the larger between-subject variability obtained by cross-sectional analysis of each individual subject to normalized data from a control group. We also demonstrated that inclusion of all a priori ROIs in an analytic model as opposed to measuring individual ROIs improves detection of white matter changes by overcoming issues of injury heterogeneity. Finally, we employed genetic programming (a bio-inspired computational method for model estimation) to demonstrate that longitudinal changes in FA have utility in predicting the symptomatology of patients with mTBI. We conclude concussive brain injury caused acute, measurable changes in the FA of white matter tracts consistent with evolving axonal injury and/or edema, which may contribute to post-concussive symptoms.	[Thomas, Alexander W.; Freeman, Kalev] Univ Vermont, Dept Surg, Burlington, VT 05405 USA; [Watts, Richard; Nickerson, Joshua P.; Andrews, Trevor] Univ Vermont, Dept Radiol, Burlington, VT USA; [Filippi, Christopher G.] Univ Vermont, Dept Neurol, Burlington, VT USA; [Filippi, Christopher G.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Andrews, Trevor] Philips HealthTech, Cleveland, OH USA; [Lieberman, Gregory; Naylor, Magdalena R.] Univ Vermont, Dept Psychiat, Burlington, VT USA; [Lieberman, Gregory] US Army, Res Lab, Human Res & Engn Directorate, Aberdeen, MD USA; [Eppstein, Margaret J.] Univ Vermont, Dept Comp Sci, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont; Hofstra University; Northwell Health; Philips; Philips Healthcare; University of Vermont; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Vermont	Freeman, K (corresponding author), Univ Vermont, Dept Surg, Burlington, VT 05405 USA.	Kalev.Freeman@med.uvm.edu	Watts, Richard/AEU-2679-2022; Filippi, Christopher G/AAA-5493-2021	Andrews, Trevor/0000-0003-0331-1798; Eppstein, Margaret/0000-0002-7775-1430	National institute of health [1K08GM098795]	National institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National institute of health: 1K08GM098795 for author KF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors, TA, has a commercial affiliation with Philips HealthTech, but this did not play any role in the study. The commercial sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier N, 2015, NONLINEAR FUNCTIONAL; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Herrera J.J., 2016, J NEUROTRAUMA; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Nickerson JP, 2009, CLIN NEURORADIOL, V19, P129, DOI 10.1007/s00062-009-8040-1; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schmidt M., 2013, EUREQA VERSION 0 98; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Setsompop K, 2012, NEUROIMAGE, V63, P569, DOI 10.1016/j.neuroimage.2012.06.033; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014	46	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178360	10.1371/journal.pone.0178360	http://dx.doi.org/10.1371/journal.pone.0178360			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604837	gold, Green Published, Green Submitted			2022-12-26	WOS:000403088400014
J	Lam, CS; Li, JJ; Tipoe, GL; Youdim, MBH; Fung, ML				Lam, Chun-Sing; Li, Jing-Jie; Tipoe, George Lim; Youdim, Moussa B. H.; Fung, Man-Lung			Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; RECEPTOR ACTIVATION; DENDRITIC SPINES; SLEEP DISORDERS; AMYLOID-BETA; BRAIN; STRESS; MAO; RATS; INHIBITORS	Co-morbid depression is prevalent in patients with obstructive sleep apnea. Here we report that monoamine oxidase A (MAO-A) plays pathogenic roles in the comorbidity. We found that chronic intermittent hypoxia significantly increased the MAO-A expression in the rat hippocampus and markedly decreased the dendritic length and spine density in the pyramidal neurons with less pre- and post-synaptic proteins. The MAO-A upregulation resulted in increased 5-hydroxyindoleacetic acid/serotonin ratio, oxidative stress, leading to NF-kappa B activation, inflammation and apoptosis. Also, the expression of cytokine-responsive indoleamine 2,3-dioxygenase-1 (IDO-1) was significantly augmented in hypoxia, resulting in increased kynurenine/tryptophan ratio and lowered serotonin level in the hippocampus. Moreover, depressive-like behaviors were observed in the hypoxic rat. Administration of M30, a brain-selective MAO-A inhibitor with iron-chelating properties, prior to hypoxic treatment prevented the aberrant changes in the hippocampus and depressive behavior. In human SH-SY5Y cells expressing MAO-A but not MAO-B, hypoxia significantly increased the MAO-A expression, which was blocked by M30 or clorgyline. Collectively, the MAO-A upregulation induced by chronic intermittent hypoxia plays significant pathogenic role in oxidative stress, inflammation and IDO-1 activation resulting in serotonin depletion and neurodegeneration.	[Lam, Chun-Sing; Li, Jing-Jie; Tipoe, George Lim; Fung, Man-Lung] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Tipoe, George Lim; Fung, Man-Lung] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Youdim, Moussa B. H.] Technion Israel Inst Technol, Fac Med, Eve Topf Ctr Neurodegenerat Dis Res, Haifa, Israel	University of Hong Kong; University of Hong Kong; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Fung, ML (corresponding author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.; Fung, ML (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	fungml@hku.hk		George, Tipoe/0000-0002-2603-0625	University of Hong Kong [104004440]; General Research Fund of Research Grants Council, Hong Kong [17102316]	University of Hong Kong(University of Hong Kong); General Research Fund of Research Grants Council, Hong Kong	This work was supported by internal funding (104004440) granted by The University of Hong Kong and the General Research Fund (17102316) of Research Grants Council, Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the technical support of Mr. Y.M. Lo. The authors declare no competing financial interests. This work was supported by internal funding (104004440) granted by The University of Hong Kong and the General Research Fund (17102316) of Research Grants Council, Hong Kong.	Andres AL, 2013, J NEUROSCI, V 33, P16945, DOI 10.1523/JNEUROSCI.1445-13.2013; Bar-Am O, 2015, NEUROBIOL AGING, V36, P1529, DOI 10.1016/j.neurobiolaging.2014.10.026; Corona AW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-93; Dayyat EA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-77; Dhingra D, 2014, PHARMACOL REP, V66, P1, DOI 10.1016/j.pharep.2013.06.001; Du LS, 2002, NEUROREPORT, V13, P1195, DOI 10.1097/00001756-200207020-00025; Du LS, 2004, NEUROREPORT, V15, P2097, DOI 10.1097/00001756-200409150-00020; Duncan JW, 2016, NEUROPHARMACOLOGY, V105, P329, DOI 10.1016/j.neuropharm.2016.01.024; Eldahdouh SS, 2014, EGYPT J CHEST DIS TU, V63, P389, DOI 10.1016/j.ejcdt.2013.11.009; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gal S, 2005, J NEUROCHEM, V95, P79, DOI 10.1111/j.1471-4159.2005.03341.x; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hung MW, 2008, J PINEAL RES, V44, P214, DOI 10.1111/j.1600-079X.2007.00514.x; Huo XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094278; Jeon H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03483; Johnson S, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00180; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kawahara S, 2005, INTERNAL MED, V44, P422, DOI 10.2169/internalmedicine.44.422; Kim H, 2012, J CLIN INVEST, V122, P2940, DOI 10.1172/JCI61884; Kratsovnik E, 2005, J MOL NEUROSCI, V26, P27, DOI 10.1385/JMN:26:1:027; Lam CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117990; Liao JC, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-299; Liu JP, 2010, J ALZHEIMERS DIS, V22, P541, DOI 10.3233/JAD-2010-100948; Liu YN, 2015, EUR CYTOKINE NETW, V26, P15, DOI 10.1684/ecn.2015.0362; Lotufo-Neto F, 1999, NEUROPSYCHOPHARMACOL, V20, P226, DOI 10.1016/S0893-133X(98)00075-X; Lugo-Huitron R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/104024; McCall WV, 2006, J CLIN SLEEP MED, V2, P424; Meyer JH, 2006, ARCH GEN PSYCHIAT, V63, P1209, DOI 10.1001/archpsyc.63.11.1209; Morais M, 2014, J PSYCHOPHARMACOL, V28, P1178, DOI 10.1177/0269881114553646; Nair D, 2013, J NEUROCHEM, V127, P531, DOI 10.1111/jnc.12360; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; Pimentel LS, 2015, J ALZHEIMERS DIS, V47, P373, DOI 10.3233/JAD-143126; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; SCHURR A, 1991, BRAIN RES, V568, P199, DOI 10.1016/0006-8993(91)91398-K; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shepertycky MR, 2005, SLEEP, V28, P309; Vandeputte M, 2003, SLEEP MED, V4, P343, DOI 10.1016/S1389-9457(03)00059-5; Wahner-Roedler DL, 2007, GENDER MED, V4, P329, DOI 10.1016/S1550-8579(07)80062-3; Weinreb O, 2016, BRIT J PHARMACOL, V173, P2080, DOI 10.1111/bph.13318; Wichers MC, 2004, J PSYCHIATR NEUROSCI, V29, P11; Wuwongse S, 2013, BBA-MOL BASIS DIS, V1832, P2245, DOI 10.1016/j.bbadis.2013.07.022; Xie W, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-41; Yau SY, 2014, CELL TRANSPLANT, V23, P481, DOI 10.3727/096368914X678490; Youdim MBH, 2005, TRENDS PHARMACOL SCI, V26, P27, DOI 10.1016/j.tips.2004.11.007; Youdim MBH, 2004, NEUROLOGY, V63, pS32, DOI 10.1212/WNL.63.7_suppl_2.S32; Youdim Moussa B H, 2013, Exp Neurobiol, V22, P1, DOI 10.5607/en.2013.22.1.1	50	16	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0177940	10.1371/journal.pone.0177940	http://dx.doi.org/10.1371/journal.pone.0177940			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599322	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000005
J	Huang, GC; Kaufman, AJ; Xu, K; Manova, K; Singh, B				Huang, Guochang; Kaufman, Andrew J.; Xu, Ke; Manova, Katia; Singh, Bhuvanesh			Squamous cell carcinoma-related oncogene (SCCRO) neddylates Cul3 protein to selectively promote midbody localization and activity of Cul3(KLHL21) protein complex during abscission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B; CULLIN NEDDYLATION; UBIQUITIN LIGASES; NEDD8-ACTIVATING ENZYME; S PHASE; NEDD8; CYTOKINESIS; CANCER; CONJUGATION; ACTIVATION	Squamous cell carcinoma-related oncogene (SCCRO)/DCUN1D1, a component of the neddylation E3 complex, regulates the activity of the cullin-RING-ligase type of ubiquitination E3s by promoting neddylation of cullin family members. Studies have shown that SCCRO regulates proliferation in vitro and in vivo. Here we show that inactivation of SCCRO results in prolonged mitotic time because of delayed and/or failed abscission. The effects of SCCRO on abscission involve its role in neddylation and localization of Cul3 to the midbody. The Cul3 adaptor KLHL21 mediates the effects of SCCRO on abscission, as it fails to localize to the midbody in SCCRO-deficient cells during abscission, and its inactivation resulted in phenotypic changes identical to SCCRO inactivation. Ubiquitination-promoted turnover of Aurora B at the midbody was deficient in SCCRO-and KLHL21-deficient cells, suggesting that it is the target of Cul3KLHL21 at the midbody. Correction of abscission delays in SCCRO-deficient cells with addition of an Aurora B inhibitor at the midbody stage suggests that Aurora B is the target of SCCRO-promoted Cul3KLHL21 activity. The activity of other Cul3-anchored complexes, including Cul3KLHL9/KLHL13, was intact in SCCRO-deficient cells, suggesting that SCCRO selectively, rather than collectively, neddylates cullins in vivo. Combined, these findings support a model in which the SCCRO, substrate, and substrate adaptors cooperatively provide tight control of neddylation and cullin-RING-ligase activity in vivo.	[Huang, Guochang; Kaufman, Andrew J.; Singh, Bhuvanesh] Mem Sloan Kettering Canc Ctr, Dept Surg, Lab Epithelial Canc Biol, New York, NY 10065 USA; [Xu, Ke; Manova, Katia] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10065 USA; [Kaufman, Andrew J.] Mt Sinai Med Ctr, Dept Cardiothorac Surg, New York, NY 10029 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Singh, B (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	singhb@mskcc.org		Xu, Ke/0000-0003-2628-2061	NCI, National Institutes of Health Cancer Center Support Grant [P30 CA008748]; Hackers for Hope; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI, National Institutes of Health Cancer Center Support Grant; Hackers for Hope; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NCI, National Institutes of Health Cancer Center Support Grant P30 CA008748 and by a research grant from the Hackers for Hope. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bommelje CC, 2014, CLIN CANCER RES, V20, P372, DOI 10.1158/1078-0432.CCR-13-1252; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Chew EH, 2007, J BIOL CHEM, V282, P17032, DOI 10.1074/jbc.M701153200; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Fu WM, 2016, J BIOL CHEM, V291, P6200, DOI 10.1074/jbc.M115.692756; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Glotzer NI., 2005, SCIENCE, V307, P1735; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Han K, 2016, ONCOTARGET, V7, P23812, DOI 10.18632/oncotarget.8068; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Heir P, 2013, MOL CELL BIOL, V33, P1621, DOI 10.1128/MCB.01342-12; Huang GC, 2014, J BIOL CHEM, V289, P34728, DOI 10.1074/jbc.M114.585505; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Jackman J., 2001, CURR PROTOC CELL BIO; Kawakami I., 2011, EMBO J, V20, P4003; Keuss MJ, 2016, J CELL SCI, V129, P1441, DOI 10.1242/jcs.181784; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Leck YC, 2010, BIOCHEM BIOPH RES CO, V398, P588, DOI 10.1016/j.bbrc.2010.06.128; Li LH, 2013, BIOCHEM BIOPH RES CO, V432, P494, DOI 10.1016/j.bbrc.2013.02.028; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Mathieu J, 2013, DEV CELL, V26, P250, DOI 10.1016/j.devcel.2013.07.005; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2017, NAT CHEM BIOL, V13, P850, DOI 10.1038/nchembio.2386; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zhang Y, 2016, ONCOTARGET, V7, P45263, DOI 10.18632/oncotarget.9481; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	48	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15254	15265		10.1074/jbc.M117.778530	http://dx.doi.org/10.1074/jbc.M117.778530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28620047	Green Published, hybrid			2022-12-26	WOS:000410809800008
J	Rose, BA; Yokota, T; Chintalgattu, V; Ren, SX; Iruela-Arispe, L; Khakoo, AY; Minamisawa, S; Wang, YB				Rose, Beth A.; Yokota, Tomohiro; Chintalgattu, Vishnu; Ren, Shuxun; Iruela-Arispe, Luisa; Khakoo, Aarif Y.; Minamisawa, Susumu; Wang, Yibin			Cardiac myocyte p38 kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; cardiac hypertrophy; cardiomyocyte; p38 MAPK; vascular endothelial growth factor (VEGF); cross-talk	ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR EXPRESSION; INDUCIBLE FACTOR-I; MAP KINASES; PRESSURE-OVERLOAD; VEGF EXPRESSION; HYPOXIA; PATHWAY; HYPERTROPHY	Stress-induced p38 mitogen-activated protein kinase (MAPK) activity is implicated in pathological remodeling in the heart. For example, constitutive p38 MAPK activation in cardiomyocytes induces pathological features, including myocyte hypertrophy, apoptosis, contractile dysfunction, and fetal gene expression. However, the physiological function of cardiomyocyte p38 MAPK activity in beneficial compensatory vascular remodeling is unclear. This report investigated the functional role and the underlying mechanisms of cardiomyocyte p38 MAPK activity in cardiac remodeling induced by chronic stress. Using both in vitro and in vivo model systems, we found that p38 MAPK activity is required for hypoxia-induced pro-angiogenic activity from cardiomyocytes and that p38 MAPK activation in cardiomyocyte is sufficient to promote paracrine signaling-mediated, pro-angiogenic activity. We further demonstrate that VEGF is a paracrine factor responsible for the p38 MAPK-mediated pro-angiogenic activity from cardiomyocytes and that p38 MAPK pathway activation is sufficient for inducing VEGF secretion from cardiomyocytes in an Sp1-dependent manner. More significantly, cardiomyocyte-specific inactivation of p38 in mouse heart impaired compensatory angiogenesis after pressure overload and promoted early onset of heart failure. In summary, p38MAPK has a critical role in the cross-talk between cardiomyocytes and vasculature by regulating stress-induced VEGF expression and secretion in cardiomyocytes. We conclude that as part of a stress-induced signaling pathway, p38 MAPK activity significantly contributes to both pathological and compensatory remodeling in the heart.	[Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Physiol, Los Angeles, CA 90095 USA; [Rose, Beth A.; Yokota, Tomohiro; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Dept Med, Los Angeles, CA 90095 USA; [Yokota, Tomohiro; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan; [Chintalgattu, Vishnu; Khakoo, Aarif Y.] Amgen Inc, Metab Disorders, San Francisco, CA 94080 USA; [Iruela-Arispe, Luisa] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Inst Mol Biol, Sch Life Sci, Los Angeles, CA 90095 USA; [Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Minato Ku, 25-8 Nishi Shimbashi, Tokyo 1058461, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Waseda University; Amgen; University of California System; University of California Los Angeles; Jikei University	Wang, YB (corresponding author), CHS, Rm BH 569,650 Charles E Young Dr,Box 957115, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yokota, Tomohiro/0000-0003-2540-3810; Minamisawa, Susumu/0000-0003-4728-2116; Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL070079, HL103205, HL098954]; UCLA Cardiovascular Research Laboratories; National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship; NHLBI-UCLA Vascular Biology Training Fellowship; Construction of Lab-exchange Type Health and Biomedical Science Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070079, R01HL098954, R01HL103205] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H01529] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Cardiovascular Research Laboratories; National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI-UCLA Vascular Biology Training Fellowship; Construction of Lab-exchange Type Health and Biomedical Science Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grants HL070079, HL103205, and HL098954. This work was also supported by the UCLA Cardiovascular Research Laboratories. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Institutes of Health Molecular, Cellular, and Integrated Physiology Predoctoral Fellowship and an NHLBI-UCLA Vascular Biology Training Fellowship.; Supported by Construction of Lab-exchange Type Health and Biomedical Science Research Consortium.	Angelis E, 2008, CIRC RES, V102, P1222, DOI 10.1161/CIRCRESAHA.107.163550; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Caretti A, 2007, EXP BIOL MED, V232, P887; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chintalgattu V, 2010, J CLIN INVEST, V120, P472, DOI 10.1172/JCI39434; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Isowa S, 2010, ANTICANCER RES, V30, P2755; Jung Young D., 2001, Angiogenesis, V4, P155, DOI 10.1023/A:1012291524723; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Khurana R, 2005, CIRCULATION, V112, P1813, DOI 10.1161/CIRCULATIONAHA.105.535294; Koodie L, 2010, AM J PATHOL, V177, P984, DOI 10.2353/ajpath.2010.090621; KUBALAK SW, 1994, J BIOL CHEM, V269, P16961; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Oak MH, 2003, ARTERIOSCL THROM VAS, V23, P1001, DOI 10.1161/01.ATV.0000070101.70534.38; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; Singh S, 2015, J BIOL CHEM, V290, P950, DOI 10.1074/jbc.M114.589325; Sodhi A, 2000, CANCER RES, V60, P4873; Tanaka T, 2000, J MOL CELL CARDIOL, V32, P1955, DOI 10.1006/jmcc.2000.1228; Veeranki S, 2014, AM J PHYSIOL-HEART C, V306, pH1116, DOI 10.1152/ajpheart.00003.2014; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, BIOCHEM BIOPH RES CO, V216, P669, DOI 10.1006/bbrc.1995.2674; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Westerhof N, 2006, PHYSIOL REV, V86, P1263, DOI 10.1152/physrev.00029.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Yamamoto T, 2002, ARCH BIOCHEM BIOPHYS, V398, P1, DOI 10.1006/abbi.2001.2632; Yamamoto T, 2001, J CELL BIOCHEM, V82, P591, DOI 10.1002/jcb.1179; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115; Zhang JC, 2014, MOL MED REP, V10, P1231, DOI 10.3892/mmr.2014.2341	47	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12787	12800		10.1074/jbc.M117.784553	http://dx.doi.org/10.1074/jbc.M117.784553			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28637870	Green Published, hybrid			2022-12-26	WOS:000407220100011
J	Huang, WC; Lee, CY; Hsieh, TS				Huang, Wan-Chen; Lee, Chun-Ying; Hsieh, Tao-shih			Single-molecule Forster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; DNA topoisomerase; enzyme kinetics; protein dynamic; protein-DNA interaction; single-molecule biophysics; DNA gate dynamics; single-molecule Forster Resonance Energy Transfer	STEADY-STATE ANALYSIS; STRUCTURAL BASIS; ATPASE ACTIVITY; PROTEIN CLAMP; GATE-DNA; MECHANISM; CLEAVAGE; INHIBITION; HYDROLYSIS; TRANSPORT	Topoisomerases play crucial roles in DNA replication, transcription, and recombination. For instance, topoisomerase II (Top2) is critically important for resolving DNA tangles during cell division, and as such, it is a broad anticancer drug target. Top2 regulates DNA topology by transiently breaking one double-stranded DNA molecule (cleavage), allowing a second double strand to pass through the opened DNA gate (opening), and then closing the gate by rejoining the broken ends. Drugs that modulate Top2 catalysis may therefore affect enzymatic activity at several different steps. Previous studies have focused on examining DNA cleavage and ligation; however, the dynamic opening and closing of the DNA gate has been less explored. Here, we used the single-molecule Forster resonance energy transfer (smFRET) method to observe the open and closed state of the DNA gate and to measure dwell times in each state. Our results show that Top2 binds and bends DNA to increase the energy transfer efficiency (E-FRET), and ATP treatment further induces the fluctuation of E-FRET, representing the gate opening and closing. Additionally, our results demonstrate that both types of Top2-targeting anticancer drugs, the catalytic inhibitor dexrazoxane (ICRF187) and mechanistic poison teniposide (VM26), can interfere with DNA gate dynamics and shorten the dwell time in the closed state. Moreover, Top2 bound to the nonhydrolyzable ATP analog 5-adenylyl-,-imidodiphosphate exhibits altered DNA gate dynamics, but the DNA gate appears to open and close even after N-gate closure. In summary, we have utilized single-molecule detection to unravel Top2 DNA gate dynamics and reveal previously unknown effects of Top2 drugs on these dynamics.	[Huang, Wan-Chen; Lee, Chun-Ying; Hsieh, Tao-shih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lee, Chun-Ying; Hsieh, Tao-shih] Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan; [Hsieh, Tao-shih] Duke Univ, Dept Biochem, Med Ctr, Durham, NC 27710 USA	Academia Sinica - Taiwan; National Taiwan University; Duke University	Huang, WC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	wchuang1@gate.sinica.edu.tw	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373	Ministry of Science and Technology Taiwan MOST Grant [105-2321-B-001-006]; Academia Sinica intramural funding Grant [AS-105-TP-B04]	Ministry of Science and Technology Taiwan MOST Grant; Academia Sinica intramural funding Grant	This work was supported by Ministry of Science and Technology Taiwan MOST Grant 105-2321-B-001-006 and Academia Sinica intramural funding Grant AS-105-TP-B04 (to T. S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; Collins TRL, 2009, NUCLEIC ACIDS RES, V37, P712, DOI 10.1093/nar/gkn1059; Deweese JE, 2010, METALLOMICS, V2, P450, DOI 10.1039/c003759a; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Hardin AH, 2011, NUCLEIC ACIDS RES, V39, P5729, DOI 10.1093/nar/gkr109; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Huang KC, 2001, J BIOL CHEM, V276, P44488, DOI 10.1074/jbc.M104383200; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Lee S, 2012, P NATL ACAD SCI USA, V109, P2925, DOI 10.1073/pnas.1115704109; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Morris SK, 1999, J BIOL CHEM, V274, P30690, DOI 10.1074/jbc.274.43.30690; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Olland S, 1999, J BIOL CHEM, V274, P21688, DOI 10.1074/jbc.274.31.21688; OSHEROFF N, 1991, BIOESSAYS, V13, P269, DOI 10.1002/bies.950130603; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; ROBINSON MJ, 1991, BIOCHEMISTRY-US, V30, P1807, DOI 10.1021/bi00221a012; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang L, 2002, ENVIRON MOL MUTAGEN, V39, P348, DOI 10.1002/em.10072; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117	37	3	4	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12589	12598		10.1074/jbc.M117.792861	http://dx.doi.org/10.1074/jbc.M117.792861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28630044	hybrid, Green Published			2022-12-26	WOS:000406636900023
J	Kosmidis, P; Bonzheim, I; Dufke, C; Colak, S; Hentrich, T; Schroeder, C; Bauer, P; Adam, P; Fend, F				Kosmidis, Perikles; Bonzheim, Irina; Dufke, Claudia; Colak, Sema; Hentrich, Thomas; Schroeder, Christopher; Bauer, Peter; Adam, Patrick; Fend, Falko			Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia	PLOS ONE			English	Article							HEAVY-CHAIN GENE; B-CELL LYMPHOMA; VARIABLE-REGION; HEALTHY-INDIVIDUALS; SOMATIC MUTATIONS; GERMINAL-CENTERS; IMMUNOGLOBULIN; TRANSLOCATION; PROGRESSION; EVOLUTION	Follicular lymphoma (FL) is characterized genetically by a significant intraclonal diversity of rearranged immunoglobulin heavy chain (IGH) genes and a substantial cell migration activity (follicular trafficking). Recently, in situ follicular neoplasia (ISFN), characterized by accumulations of immunohistochemically strongly BCL2-positive, t(14;18)+ clonal B cells confined to germinal centers in reactive lymph nodes, has been identified as a precursor lesion of FL with low risk of progression to manifest FL. The extent of ongoing somatic hypermutation of rearranged IGH genes and interfollicular trafficking in ISFN is not known. In this study we performed an in depth analysis of clonal evolution and cell migration patterns in a case of pure ISFN involving multiple lymph nodes. Using laser microdissection and next generation sequencing (NGS) we documented significant intraclonal diversity of the rearranged IGH gene and extensive interfollicular migration between germinal centers of the same lymph node as well as between different lymph nodes. Furthermore, we identified N-glycosylation motifs characteristic for FL in the CDR3 region.	[Kosmidis, Perikles; Bonzheim, Irina; Colak, Sema; Adam, Patrick; Fend, Falko] Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany; [Kosmidis, Perikles; Bonzheim, Irina; Colak, Sema; Adam, Patrick; Fend, Falko] Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany; [Dufke, Claudia; Hentrich, Thomas; Schroeder, Christopher; Bauer, Peter] Univ Hosp Tubingen, Inst Med Genet & Appl Genom, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bonzheim, I (corresponding author), Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany.; Bonzheim, I (corresponding author), Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany.	irina.bonzheim@med.uni-tuebingen.de	Hentrich, Thomas/N-9336-2019	Hentrich, Thomas/0000-0002-1488-9096	IZKF fortune program, University of Tubingen [F14.63209]; Karl-Thiemig-Stiftung	IZKF fortune program, University of Tubingen; Karl-Thiemig-Stiftung	This work was supported by the IZKF fortune program (F14.63209), University of Tubingen (PA, https:www.medizin.uni-tuebingen.de/Forschung/Forschungsf%C3%B6rderung/Interne+Forschungsf%C31%B6rderung/Junior+Academy/fort%C3%BCne.html. PK and PA were in part supported by the Karl-Thiemig-Stiftung.	Aarts WM, 2000, BLOOD, V95, P2922, DOI 10.1182/blood.V95.9.2922.009k38_2922_2929; Adam P, 2007, CYTOGENET GENOME RES, V118, P328, DOI 10.1159/000108317; Adam P, 2005, AM J SURG PATHOL, V29, P1661, DOI 10.1097/01.pas.0000173233.29741.38; Adam P, 2013, HUM PATHOL; Anastasov N, 2010, HAEMATOL-HEMATOL J, V95, P760, DOI 10.3324/haematol.2009.014050; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Bonzheim I, 2011, BLOOD, V118, P3442, DOI 10.1182/blood-2011-07-368944; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Chang B, 1995, ANN NY ACAD SCI, V764, P170; Cheung MC, 2009, LEUKEMIA, V23, P1176, DOI 10.1038/leu.2009.9; CLEARY ML, 1986, CELL, V44, P97, DOI 10.1016/0092-8674(86)90488-5; Coelho V, 2010, P NATL ACAD SCI USA, V107, P18587, DOI 10.1073/pnas.1009388107; Cong PJ, 2002, BLOOD, V99, P3376, DOI 10.1182/blood.V99.9.3376; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Henopp T, 2011, HISTOPATHOLOGY, V59, P139, DOI 10.1111/j.1365-2559.2011.03897.x; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jegalian AG, 2011, BLOOD, V118, P2976, DOI 10.1182/blood-2011-05-355255; Koch I, 2006, DIAGN MOL PATHOL, V15, P149, DOI 10.1097/01.pdm.0000213450.99655.54; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Mamessier E, 2015, HAEMATOLOGICA, V100, pE155, DOI 10.3324/haematol.2014.115782; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P658, DOI 10.1111/j.1365-2559.2010.03529.x; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292; Roulland S, 2014, J CLIN ONCOL, V32, P1347, DOI 10.1200/JCO.2013.52.8190; Roulland S, 2011, ADV IMMUNOL, V111, P1, DOI 10.1016/B978-0-12-385991-4.00001-5; Schmidt J, 2014, LEUKEMIA, V28, P1103, DOI 10.1038/leu.2013.307; Schneider D, 2015, BLOOD, V125, P3287, DOI 10.1182/blood-2014-11-609404; Schuler F, 2003, SEMIN CANCER BIOL, V13, P203, DOI 10.1016/S1044-579X(03)00016-6; Sotlar K, 2003, AM J PATHOL, V162, P737, DOI 10.1016/S0002-9440(10)63870-9; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Stevenson FK, 2012, BLOOD, V119, P3659, DOI 10.1182/blood-2011-11-367730; Sungalee S, 2014, J CLIN INVEST, V124, P5337, DOI 10.1172/JCI72415; Swerdlow SH, 2008, WHO CLASSIFICATION T; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Wartenberg M, 2013, HAEMATOLOGICA, V98, P1433, DOI 10.3324/haematol.2012.074252; Zhu DL, 2002, BLOOD, V99, P2562, DOI 10.1182/blood.V99.7.2562; Zuckerman NS, 2010, INT IMMUNOL, V22, P875, DOI 10.1093/intimm/dxq441	37	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178503	10.1371/journal.pone.0178503	http://dx.doi.org/10.1371/journal.pone.0178503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640838	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800006
J	Martinez-Garcia, M; Martinez, LM; Malo, J				Martinez-Garcia, Marina; Martinez, Luis M.; Malo, Jesus			Topographic Independent Component Analysis reveals random scrambling of orientation in visual space	PLOS ONE			English	Article							CELL RECEPTIVE-FIELDS; FUNCTIONAL ARCHITECTURE; STRIATE CORTEX; RETINOTOPIC ORGANIZATION; SPATIAL STRUCTURE; NATURAL IMAGES; GAIN-CONTROL; MAPS; MODEL; COLUMNS	Neurons at primary visual cortex (V1) in humans and other species are edge filters organized in orientation maps. In these maps, neurons with similar orientation preference are clustered together in iso-orientation domains. These maps have two fundamental properties: (1) retinotopy, i.e. correspondence between displacements at the image space and displacements at the cortical surface, and (2) a trade-off between good coverage of the visual field with all orientations and continuity of iso-orientation domains in the cortical space. There is an active debate on the origin of these locally continuous maps. While most of the existing descriptions take purely geometric/mechanistic approaches which disregard the network function, a clear exception to this trend in the literature is the original approach of Hyvarinen and Hoyer based on infomax and Topographic Independent Component Analysis (TICA). Although TICA successfully addresses a number of other properties of V1 simple and complex cells, in this work we question the validity of the orientation maps obtained from TICA. We argue that the maps predicted by TICA can be analyzed in the retinal space, and when doing so, it is apparent that they lack the required continuity and retinotopy. Here we show that in the orientation maps reported in the TICA literature it is easy to find examples of violation of the continuity between similarly tuned mechanisms in the retinal space, which suggest a random scrambling incompatible with the maps in primates. The new experiments in the retinal space presented here confirm this guess: TICA basis vectors actually follow a random salt-and-pepper organization back in the image space. Therefore, the interesting clusters found in the TICA topology cannot be interpreted as the actual cortical orientation maps found in cats, primates or humans. In conclusion, Topographic ICA does not reproduce cortical orientation maps.	[Martinez-Garcia, Marina; Martinez, Luis M.] CSIC, Inst Neurociencias, Alicante, Spain; [Martinez-Garcia, Marina; Malo, Jesus] Univ Valencia, Image Proc Lab, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Valencia	Malo, J (corresponding author), Univ Valencia, Image Proc Lab, Valencia, Spain.	jesus.malo@uv.es	Malo, Jesus/K-9235-2017	Malo, Jesus/0000-0002-5684-8591; Martinez Garcia, marina/0000-0002-2228-4396	Spanish Ministry of Economy and Competitiveness (MINECO) - European Regional Development Fund (ERDF) [TIN2015-71130-REDT, BFU2014-58776-R, TIN2013-50520-EXP]; Severo Ochoa Program for Centers of Excellence in R+D (SEV)	Spanish Ministry of Economy and Competitiveness (MINECO) - European Regional Development Fund (ERDF); Severo Ochoa Program for Centers of Excellence in R+D (SEV)	The authors acknowledge the financial support received from the Spanish Ministry of Economy and Competitiveness (MINECO) under the grants TIN2015-71130-REDT, BFU2014-58776-R, TIN2013-50520-EXP, co-financed by the European Regional Development Fund (ERDF), and the Severo Ochoa Program for Centers of Excellence in R+D (SEV-2013-0317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Bednar JA, 2012, J PHYSIOL-PARIS, V106, P194, DOI 10.1016/j.jphysparis.2011.12.001; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bosking WH, 2002, NAT NEUROSCI, V5, P874, DOI 10.1038/nn908; Buccigrossi RW, 1999, IEEE T IMAGE PROCESS, V8, P1688, DOI 10.1109/83.806616; Buzas P, 2003, EUR J NEUROSCI, V18, P957, DOI 10.1046/j.1460-9568.2003.02808.x; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cardoso JF, 2004, J MACH LEARN RES, V4, P1177, DOI 10.1162/jmlr.2003.4.7-8.1177; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Cover TM, 2006, ELEMENTS OF INFORMAT; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Frazor RA, 2007, LECT NOTES COMPUT SC, V4729, P30; Fregnac Y, 2015, NEURON, V88, P110, DOI 10.1016/j.neuron.2015.09.041; Gilbert CD, 2012, NEURON, V75, P250, DOI 10.1016/j.neuron.2012.06.030; Hore VRA, 2012, VISUAL NEUROSCI, V29, P283, DOI 10.1017/S0952523812000338; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hyvarinen A, 2001, NEUROCOMPUTING, V38, P1307, DOI 10.1016/S0925-2312(01)00490-8; Hyvarinen A, 2001, NEURAL COMPUT, V13, P1527, DOI 10.1162/089976601750264992; Hyvarinen A, 2001, VISION RES, V41, P2413, DOI 10.1016/S0042-6989(01)00114-6; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Hyvarinen A, 2001, IMAGEICA MATLAB TOOL; Kaschube M, 2014, CURR OPIN NEUROBIOL, V24, P95, DOI 10.1016/j.conb.2013.08.017; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kavukcuoglu K, 2009, PROC CVPR IEEE, P1605, DOI 10.1109/CVPRW.2009.5206545; Keil W, 2012, SCIENCE, V336, DOI 10.1126/science.1206416; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Laparra V, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00557; Laparra V, 2010, J MACH LEARN RES, V11, P873; LINSKER R, 1986, P NATL ACAD SCI USA, V83, P8779, DOI 10.1073/pnas.83.22.8779; Liu J, 2001, IEEE T IMAGE PROCESS, V10, P1647, DOI 10.1109/83.967393; Ma LB, 2008, NEUROCOMPUTING, V71, P2217, DOI 10.1016/j.neucom.2007.06.013; Malo J, 2006, IEEE T IMAGE PROCESS, V15, P68, DOI 10.1109/TIP.2005.860325; Malo J, 2006, NETWORK-COMP NEURAL, V17, P85, DOI 10.1080/09548980500439602; Malo J, 2010, NEURAL COMPUT, V22, P3179, DOI 10.1162/NECO_a_00046; Martinez-Garcia M, 2016, P MODVIS; Meng YC, 2012, SCIENCE, V336, DOI 10.1126/science.1205737; OBERMAYER K, 1992, PHYS REV A, V45, P7568, DOI 10.1103/PhysRevA.45.7568; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Paik SB, 2011, NAT NEUROSCI, V14, P919, DOI 10.1038/nn.2824; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Schottdorf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086139; Schuett S, 2002, J NEUROSCI, V22, P6549; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Watson AB, 1997, J OPT SOC AM A, V14, P2379, DOI 10.1364/JOSAA.14.002379; Wilson SP, DEV NEUROBIOLOGY, V75, P667	59	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178345	10.1371/journal.pone.0178345	http://dx.doi.org/10.1371/journal.pone.0178345			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640816	gold, Green Published			2022-12-26	WOS:000404135800005
J	Cemin, HS; Vieira, SL; Stefanello, C; Kipper, M; Kindlein, L; Helmbrecht, A				Cemin, Henrique Scher; Vieira, Sergio Luiz; Stefanello, Catarina; Kipper, Marcos; Kindlein, Liris; Helmbrecht, Ariane			Digestible lysine requirements of male broilers from 1 to 42 days of age reassessed	PLOS ONE			English	Article							AMINO-ACID-REQUIREMENTS; FEMALE BROILERS; ACCURATE PREDICTION; PROTEIN-TURNOVER; CRUDE PROTEIN; CHICKS; PERFORMANCE; DIETS; DEFICIENCY; THREONINE	Three experiments were conducted separately to estimate the digestible Lys (dig. Lys) requirements of Cobb x Cobb 500 male broilers using different statistical models. For each experiment, 1,200 chicks were housed in 48 floor pens in a completely randomized design with 6 treatments and 8 replicates. Broilers were fed diets with increasing dig. Lys levels from 1 to 12 d (Exp. 1), from 12 to 28 d (Exp. 2), and 28 to 42 d (Exp. 3). Increasing dig. Lys levels were equally spaced from 0.97 to 1.37% in Exp. 1, 0.77 to 1.17% in Exp. 2, and 0.68 to 1.07% in Exp. 3. The lowest dig. Lys diets were not supplemented with L-Lysine and all other essential AA met or exceeded recommendations. In Exp. 3, six birds per pen were randomly selected from each replication to evaluate carcass and breast yields. Digestible Lys requirements were estimated by quadratic polynomial (QP), linear broken-line (LBL), quadratic broken-line (QBL), and exponential asymptotic (EA) models. Overall, dig. Lys requirements varied among response variables and statistical models. Increasing dietary dig. Lys had a positive effect on BW, carcass and breast yields. Levels of dig. Lys that optimized performance using QP, LBL, QBL, and EA models were 1.207, 1.036, 1.113, and 1.204% for BWG and 1.190, 1.027, 1.100, and 1.172% for FCR in Exp. 1; 1.019, 0.853, 0.944; 1.025% for BWG and 1.050, 0.879, 1.032, and 1.167% for FCR in Exp. 2; and 0.960, 0.835, 0.933, and 1.077% for BWG, 0.981, 0.857, 0.963, and 1.146% for FCR in Exp. 3. The QP, LBL, QBL, and EA also estimated dig. Lys requirements as 0.941, 0.846, 0.925, and 1.070% for breast meat yield in Exp. 3. In conclusion, Lys requirements vary greatly according to the statistical analysis utilized; therefore, the origin of requirement estimation must be taken into account in order to allow adequate comparisons between references.	[Cemin, Henrique Scher; Vieira, Sergio Luiz; Stefanello, Catarina; Kipper, Marcos] Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil; [Kindlein, Liris] Univ Fed Rio Grande do Sul, Dept Prevent Vet Med, Porto Alegre, RS, Brazil; [Helmbrecht, Ariane] Evonik Nutr & Care GmbH, Hanau, Germany	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Vieira, SL (corresponding author), Univ Fed Rio Grande do Sul, Dept Anim Sci, Porto Alegre, RS, Brazil.	slvieira@ufrgs.br	, sergio/AAH-5952-2020; Stefanello, Catarina/AAR-4441-2020; Stefanello, Catarina/AAS-8577-2020	Stefanello, Catarina/0000-0002-5940-6692; vieira, sergio/0000-0001-6206-9183; Kindlein, Liris/0000-0002-3925-1128	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS); Evonik Nutrition Care GmbH	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Evonik Nutrition Care GmbH	The authors wish to thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) and Evonik Nutrition & Care GmbH for their support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Baker DH, 2002, POULTRY SCI, V81, P485, DOI 10.1093/ps/81.4.485; BAKER DH, 1997, BIOKYOWA TECHNICAL R, V9, P1; Dozier WA, 2008, POULTRY SCI, V87, P1385, DOI 10.3382/ps.2007-00529; Dozier WA, 2012, J APPL POULTRY RES, V21, P348, DOI 10.3382/japr.2011-00418; Dozier WA, 2010, POULTRY SCI, V89, P2173, DOI 10.3382/ps.2010-00710; Dozier WA, 2009, J APPL POULTRY RES, V18, P690, DOI 10.3382/japr.2009-00016; Dozier WA, 2009, POULTRY SCI, V88, P1676, DOI 10.3382/ps.2008-00539; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Evonik, 2010, AMI NODAT 4 0; Fontaine J, 2001, J AGR FOOD CHEM, V49, P57, DOI 10.1021/jf000946s; Fontaine J, 2002, J AGR FOOD CHEM, V50, P3902, DOI 10.1021/jf011637k; Garcia A, 2005, POULTRY SCI, V84, P1350, DOI 10.1093/ps/84.9.1350; Garcia AR, 2006, POULTRY SCI, V85, P498, DOI 10.1093/ps/85.3.498; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; HOLSHEIMER JP, 1992, POULTRY SCI, V71, P872, DOI 10.3382/ps.0710872; Labadan MC, 2001, POULTRY SCI, V80, P599, DOI 10.1093/ps/80.5.599; Leclercq B, 1998, POULTRY SCI, V77, P118, DOI 10.1093/ps/77.1.118; LOWRY SR, 1992, J ANIM SCI, V70, P1971, DOI 10.2527/1992.7061971x; MORAN ET, 1990, POULTRY SCI, V69, P702, DOI 10.3382/ps.0690702; MUNKS B, 1945, POULTRY SCI, V24, P459, DOI 10.3382/ps.0240459; National Research Council, 1994, NUTR REQ POULTR; Pavan E, 2006, J ANIM SCI, V84, P171; Pesti GM, 2009, BRIT POULTRY SCI, V50, P16, DOI 10.1080/00071660802530639; Rodehutscord M, 1999, ARCH ANIM NUTR, V52, P223, DOI 10.1080/17450399909386164; Rostagno H.S., 2011, COMPOSICAO ALIMENTOS, V2, P186; SAS , 2009, SAS US GUID STAT VER; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; SCHUTTE JB, 1995, BRIT POULTRY SCI, V36, P747, DOI 10.1080/00071669508417819; Sklan D, 2003, BRIT POULTRY SCI, V44, P266, DOI 10.1080/0007166031000124586; Sterling KG, 2006, POULTRY SCI, V85, P1045, DOI 10.1093/ps/85.6.1045; Tesseraud S, 2001, J ANIM SCI, V79, P927; Tesseraud S, 1996, BRIT POULTRY SCI, V37, P641, DOI 10.1080/00071669608417893; Vedenov D, 2008, J ANIM SCI, V86, P500, DOI 10.2527/jas.2007-0536	33	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179665	10.1371/journal.pone.0179665	http://dx.doi.org/10.1371/journal.pone.0179665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636626	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300047
J	Chan, YC; Hwang, JH				Chan, Yin-Ching; Hwang, Juen-Haur			Effects of Spirulina on the functions and redox status of auditory system in senescence-accelerated prone-8 mice	PLOS ONE			English	Article							BRAIN-STEM RESPONSE; SENSORINEURAL HEARING-LOSS; OXIDATIVE STRESS; MOUSE COCHLEA; ABR LATENCY; AGE; IMPAIRMENT; DAMAGE; SEX; INFLAMMATION	To our knowledge, the effects of Spirulina platensis water extract (SP) on hearing function have not yet been reported. This study investigated the effects of SP on the function and redox status of the auditory system. Auditory brainstem responses and redox status were compared between two groups of 3-month-old senescence-accelerated prone-8 (SAMP8) mice: the control group was fed a normal diet, and the experimental group was fed a normal diet with oral supplementation of SP for 6 weeks. Compared with the control group, the experimental group had significantly lower hearing thresholds according to auditory brainstem responses measured using click sounds and 8-kHz tone burst sound stimulation at the end of this study. The experimental group had a shorter I-III interval of auditory brainstem responses with 16-kHz tone burst stimulation than the control group that was of borderline significance. Additionally, the experimental group had significantly higher mRNA expression of the superoxide dismutase and catalase genes in the cochlea and brainstem and significantly higher mRNA expression of the glutathione peroxidase gene in the cochlea. Further, the experimental group had significantly lower malondialdehyde levels in the cochlea and brainstem than the control group. However, tumor necrosis factor-alpha mRNA expression was not significantly different between the control and experimental groups. SP could decrease hearing degeneration in senescence-accelerated prone-8 mice possibly by increasing superoxide dismutase, catalase, and glutathione peroxidase gene expression and decreasing damage from oxidative stress in the cochlea and brainstem.	[Chan, Yin-Ching] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Providence University - Taiwan; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan.; Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	g120796@tzuchi.com.tw		Chan, Yin Ching/0000-0001-9602-0775	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation [DTCRD-102]	Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation	The work presented in this manuscript was supported by a grant (DTCRD-102) from the Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation	Caruso S, 2000, MENOPAUSE, V7, P178, DOI 10.1097/00042192-200007030-00008; COLLET L, 1992, INT J NEUROSCI, V67, P187, DOI 10.3109/00207459208994784; de Rivera C, 2006, NEUROBIOL AGING, V27, P1035, DOI 10.1016/j.neurobiolaging.2005.05.003; Enrietto JA, 1999, AM J OTOLARYNG, V20, P371, DOI 10.1016/S0196-0709(99)90076-5; Hong BN, 2009, BIOL PHARM BULL, V32, P597, DOI 10.1248/bpb.32.597; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Hwang JH, 2008, AUDIOL NEURO-OTOL, V13, P29, DOI 10.1159/000107468; Hwang JH, 2007, AUDIOL NEURO-OTOL, V12, P285, DOI 10.1159/000103209; Hwang JH, 2015, AUDIOL NEURO-OTOL, V20, P322, DOI 10.1159/000381934; Hwang JH, 2015, METAB BRAIN DIS, V30, P191, DOI 10.1007/s11011-014-9597-1; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060730; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058215; Hwang JH, 2012, INT J AUDIOL, V51, P920, DOI 10.3109/14992027.2012.721933; Hwang JH, 2012, NEUROBIOL AGING, V33, P1920, DOI 10.1016/j.neurobiolaging.2011.10.012; Hwang JH, 2011, CLIN ENDOCRINOL, V75, P614, DOI 10.1111/j.1365-2265.2011.04090.x; Hwang JH, 2011, J NUTR SCI VITAMINOL, V57, P186, DOI 10.3177/jnsv.57.186; Hwang JH, 2011, OTOLARYNG HEAD NECK, V144, P114, DOI 10.1177/0194599810390859; JERGER J, 1988, EAR HEARING, V9, P168, DOI 10.1097/00003446-198808000-00002; LIGHTFOOT GR, 1993, BRIT J AUDIOL, V27, P211, DOI 10.3109/03005369309076695; McCarty MF, 2010, MED HYPOTHESES, V74; Menardo J, 2012, ANTIOXID REDOX SIGN, V16, P263, DOI 10.1089/ars.2011.4037; Oku T, 1997, ORL-J OTO-RHIN-LARYN, V59, P141, DOI 10.1159/000276927; Proctor TB, 1998, AM J OTOL, V19, P226; Revuelta M, 2016, BRAIN PATHOL, V26, P186, DOI 10.1111/bpa.12272; Romay C, 1999, J PHARM PHARMACOL, V51, P641, DOI 10.1211/0022357991772646; SAITOH Y, 1994, HEARING RES, V75, P27, DOI 10.1016/0378-5955(94)90052-3; Seidman MD, 2002, OTOLARYNG HEAD NECK, V127, P138, DOI 10.1067/mhn.2002.127627; Seidman MD, 2002, AGEING RES REV, V1, P331, DOI 10.1016/S1568-1637(02)00004-1; Simsek G, 2013, EUR ARCH OTO-RHINO-L, V270, P1789, DOI 10.1007/s00405-012-2183-4; Sininger YS, 1998, HEARING RES, V126, P58, DOI 10.1016/S0378-5955(98)00152-X; Snell KB, 2000, J ACOUST SOC AM, V107, P1615, DOI 10.1121/1.428446; Tadros SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090279; Tokgoz SA, 2012, J LARYNGOL OTOL, V126, P464, DOI 10.1017/S0022215112000382; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Watson DR, 1996, AUDIOLOGY, V35, P246; Wu CC, 2015, NEUROBIOL AGING, V36, P2085, DOI 10.1016/j.neurobiolaging.2015.02.030	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178916	10.1371/journal.pone.0178916	http://dx.doi.org/10.1371/journal.pone.0178916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636628	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300022
J	Sinn, DH; Min, YW; Son, HJ; Rhee, PL; Paik, SW; Hong, SN; Gwak, GY				Sinn, Dong Hyun; Min, Yang Won; Son, Hee Jung; Rhee, Poong-Lyul; Paik, Seung Woon; Hong, Sung Noh; Gwak, Geum-Youn			Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma	PLOS ONE			English	Article							BODY-MASS INDEX; VISCERAL FAT ACCUMULATION; CARDIOVASCULAR-DISEASE; PLASMA ADIPONECTIN; INCREASED RISK; CANCER; INSULIN; IMPACT; CARCINOGENESIS; DISPARITIES	Background The risk of colorectal adenoma (CRA), an important precursor of colorectal cancer, is largely unknown among obese individuals without obesity-related metabolic abnormalities, a condition described as metabolically-healthy obese (MHO). The aim of this study was to examine the association among metabolic status, the different categories of body mass index (BMI), and CRA in a large cohort of adults. Methods We analyzed the association among metabolic status, BMI categories and CRA in asymptomatic adults who underwent a first-time colonoscopy as part of the comprehensive health check-up program at the Health Promotion Center of Samsung Medical Center, from January 2005 to December 2012. Being metabolically healthy was defined as lacking any metabolic syndrome components and having a homeostasis model assessment of insulin resistance <2.5. Results The prevalence of "any," "multiple," and "high-risk" CRA was 25.6%, 8.3%, and 4.4% among 9,182 metabolically-healthy participants, and 35.9%, 12.5%, and 7.0% among 17,407 metabolically-unhealthy participants, respectively. Increased BMI showed a significant dosedependent relationship with the prevalence of "any," "multiple," and "high-risk" CRA, in both metabolically-healthy and unhealthy participants. In multivariable-adjusted models that accounted for potential confounders including age, sex, smoking, alcohol, first-degree family history of colorectal cancer, and aspirin use, the odds ratio (OR) for any CRA comparing MHO with metabolically-healthy normal-weight (MHNW) participants was 1.25 (95% confidence interval (CI), 1.09-1.43). Further adjustment for metabolic components associated with obesity did not significantly change the association. Similarly, the ORs for multiple CRAs and high risk CRA were higher in MHO participants than MHNW participants [ORs (95% CI), 1.63 (1.31-2.04) and 1.53 (1.14-2.04), respectively]. Conclusions The MHO phenotype was closely associated with higher prevalence of CRA, including high-risk adenoma. This finding supports the conclusion that MHO increases the risk of colorectal cancer.	[Sinn, Dong Hyun; Min, Yang Won; Son, Hee Jung; Rhee, Poong-Lyul; Paik, Seung Woon; Hong, Sung Noh; Gwak, Geum-Youn] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Son, Hee Jung] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Hong, SN; Gwak, GY (corresponding author), Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	sungnoh.hong@samsung.com; gy.gwak@samsung.com	Gwak, Geum Youn/F-4605-2014; Sinn, Dong Hyun/L-3701-2019; Sinn, Dong Hyun/O-5941-2014	Sinn, Dong Hyun/0000-0002-7126-5554; Rhee, Poong-Lyul/0000-0003-0495-5296; Gwak, Geum-Youn/0000-0002-6453-3450				Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055; Borg BB, 2009, CLIN GASTROENTEROL H, V7, P670, DOI 10.1016/j.cgh.2009.02.014; Bosman F. T., 2010, WHO classification of tumours of the digestive system; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cha JM, 2015, GASTROINTEST ENDOSC, V82, P1080, DOI 10.1016/j.gie.2015.04.018; Chang Y, 2012, INT J OBESITY, V36, P1187, DOI 10.1038/ijo.2011.247; Chang Y, 2016, ANN INTERN MED, V165, P744, DOI 10.7326/L16-0405; Chang Y, 2016, OBESITY, V24, P1996, DOI 10.1002/oby.21580; Chang Y, 2016, AM J GASTROENTEROL, V111, P1133, DOI 10.1038/ajg.2016.178; Eckel RH, 2006, CIRCULATION, V113, P2943, DOI 10.1161/CIRCULATIONAHA.106.176583; Endo H, 2011, GUT, V60, P1363, DOI 10.1136/gut.2010.235754; Erarslan E, 2009, DIGEST DIS SCI, V54, P862, DOI 10.1007/s10620-008-0440-6; Fruhbeck G, 2014, OBESITY FACTS, V7, P408, DOI 10.1159/000370038; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Ma YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053916; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Murphy N, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001988; Mutoh M, 2011, GASTROENTEROLOGY, V140, P2000, DOI 10.1053/j.gastro.2011.02.019; Okabayashi K, 2012, AM J GASTROENTEROL, V107, P1175, DOI 10.1038/ajg.2012.180; Otake S, 2005, CLIN CANCER RES, V11, P3642, DOI 10.1158/1078-0432.CCR-04-1868; Otake S, 2010, WORLD J GASTROENTERO, V16, P1252, DOI 10.3748/wjg.v16.i10.1252; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Puri R, 2014, J AM COLL CARDIOL, V63, P2687, DOI 10.1016/j.jacc.2014.03.043; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Riondino S, 2014, WORLD J GASTROENTERO, V20, P5177, DOI 10.3748/wjg.v20.i18.5177; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Soriguer F, 2013, J CLIN ENDOCR METAB, V98, P2318, DOI 10.1210/jc.2012-4253; St-Pierre AC, 2005, CAN MED ASSOC J, V172, P1301, DOI 10.1503/cmaj.1040834; Stefan N, 2016, LANCET DIABETES ENDO, V4, P457, DOI 10.1016/S2213-8587(15)00474-X; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yamaji T, 2012, INT J OBESITY, V36, P440, DOI 10.1038/ijo.2011.114; Yun KE, 2013, CANCER RES, V73, P4020, DOI 10.1158/0008-5472.CAN-12-3477	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179480	10.1371/journal.pone.0179480	http://dx.doi.org/10.1371/journal.pone.0179480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636624	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300037
J	Ahmad, M; Kaszubski, PA; Cobbs, L; Reynolds, H; Smith, RT				Ahmad, Meleha; Kaszubski, Patrick A.; Cobbs, Lucy; Reynolds, Harmony; Smith, Roland Theodore			Choroidal thickness in patients with coronary artery disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RETICULAR MACULAR DISEASE; AGE-RELATED MACULOPATHY; BLUE MOUNTAINS EYE; HEALTHY-SUBJECTS; MICROVASCULAR DYSFUNCTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; AXIAL LENGTH; DEGENERATION	Purpose To evaluate choroidal thickness (CTh) in patients with coronary artery disease (CAD) compared to healthy controls. Design Cross-sectional. Methods Setting: Ambulatory clinic of a large city hospital. Patient population: Thirty-four patients had documented CAD, defined as history of >50% obstruction in at least one coronary artery on cardiac catheterization, positive stress test, ST elevation myocardial infarction, or revascularization procedure. Twenty-eight age-matched controls had no self-reported history of CAD or diabetes. Patients with high myopia, dense cataracts, and retinal disease were excluded. Observation procedures: Enhanced depth imaging optical coherence tomography and questionnaire regarding medical and ocular history. Main outcome measures: Subfoveal CTh and CTh 2000 mu m superior, inferior, nasal, and temporal to the fovea in the left eye, measured by 2 readers. Results CTh was significantly lower in patients with CAD compared to controls at the subfoveal location (252 vs. 303 mu m, P = 0.002) and at all 4 cardinal macular locations. The mean difference in CTh between the 2 groups ranged from 46 to 75 mu m and was greatest in the inferior location. Within the CAD group, CTh was significantly lower temporally (P = 0.007) and nasally (P<0.001) than subfoveally, consistent with the pattern observed in controls. On multivariate analysis, CAD was negatively associated with subfoveal CTh (P = 0.006) after controlling for diabetes, hypertension, and hypercholesterolemia. Conclusions and relevance Patients with CAD have a thinner macular choroid than controls, with preservation of the normal spatial CTh pattern. Decreased CTh might predispose patients with CAD to high-risk phenotypes of age-related macular degeneration such as reticular pseudodrusen and could serve as a potential biomarker of disease in CAD.	[Ahmad, Meleha; Kaszubski, Patrick A.; Cobbs, Lucy; Smith, Roland Theodore] NYU, Sch Med, Dept Ophthalmol, New York, NY 10003 USA; [Reynolds, Harmony] NYU, Sch Med, Leon H Charney Div Cardiol, Cardiovasc Clin Res Ctr,Dept Med, New York, NY USA	New York University; New York University	Smith, RT (corresponding author), NYU, Sch Med, Dept Ophthalmol, New York, NY 10003 USA.	roland.smith@nyumc.org	Reynolds, Harmony/AAU-3154-2021	Reynolds, Harmony/0000-0003-0284-0655; smith, theodore/0000-0002-1693-943X	Foundation Fighting Blindness unrestricted funds from Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [R01EY015520] Funding Source: NIH RePORTER	Foundation Fighting Blindness unrestricted funds from Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an Individual Investigator Award from Foundation Fighting Blindness unrestricted funds from Research to Prevent Blindness (New York, NY) to the Department of Ophthalmology, New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladioglu K, 2015, J CLIN ULTRASOUND, V43, P567, DOI 10.1002/jcu.22269; Ahn SJ, 2014, INVEST OPHTH VIS SCI, V55, P7775, DOI 10.1167/iovs.14-14915; Akay F, 2016, EUR J OPHTHALMOL, V26, P152, DOI 10.5301/ejo.5000675; Alexander SL, 2007, OPHTHALMOLOGY, V114, P2174, DOI 10.1016/j.ophtha.2007.09.017; Altinkaynak H, 2014, CURR EYE RES, V39, P1123, DOI 10.3109/02713683.2014.898310; American Heart Association, BRINDG GAP CVD HLTH; Barteselli G, 2012, OPHTHALMOLOGY, V119, P2572, DOI 10.1016/j.ophtha.2012.06.065; Bittencourt M, 2014, J OPHTHAMIC INFLAMM, V25, P258; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; COLEMAN DJ, 1979, AM J OPHTHALMOL, V88, P369; Cymerman RM, 2016, CURR EYE RES, V41, P1482, DOI 10.3109/02713683.2015.1128552; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Esmaeelpour M, 2011, INVEST OPHTH VIS SCI, V52, P5311, DOI 10.1167/iovs.10-6875; Ferrara D, 2016, PROG RETIN EYE RES, V52, P130, DOI 10.1016/j.preteyeres.2015.10.002; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Gok M, 2015, INDIAN J OPHTHALMOL, V63, P239, DOI 10.4103/0301-4738.156928; GUYER DR, 1992, OPHTHALMOLOGY, V99, P287; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; Hogan MJ, 1971, HISTOLOGY HUMAN EYE; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Karapetyan A, 2016, RETINA-J RET VIT DIS, V36, P82, DOI 10.1097/IAE.0000000000000654; KIM DY, 2015, J OPHTHALMOL, V2015, DOI DOI 10.1155/2015/620372; KOSEKI T, 1992, Nippon Ganka Gakkai Zasshi, V96, P757; LINSENMEIER RA, 1992, J GEN PHYSIOL, V99, P177, DOI 10.1085/jgp.99.2.177; McClintic BR, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.05.030; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Nguyen-Khoa BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1280, DOI 10.1001/archopht.126.9.1280; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Novais EA, 2015, OSLI RETINA, V46, P920, DOI 10.3928/23258160-20151008-04; Rastogi N, 2016, SURV OPHTHALMOL, V61, P422, DOI 10.1016/j.survophthal.2015.10.003; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Sanchez-Cano A, 2014, AM J OPHTHALMOL, V158, P574, DOI 10.1016/j.ajo.2014.05.035; Sayin N, 2015, OSLI RETINA, V46, P180, DOI 10.3928/23258160-20150213-20; Sigler EJ, 2014, EYE, V28, P838, DOI 10.1038/eye.2014.100; Sizmaz S, 2013, BRIT J OPHTHALMOL, V97, P601, DOI 10.1136/bjophthalmol-2012-302393; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Tan JSL, 2007, OPHTHALMOLOGY, V114, P1143, DOI 10.1016/j.ophtha.2006.09.033; Tan KA, 2016, SURV OPHTHALMOL, V61, P566, DOI 10.1016/j.survophthal.2016.02.007; Toyokawa N, 2012, OPHTHAL SURG LAS IM, V43, P109, DOI 10.3928/15428877-20120102-06; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; VINGERLING JR, 1995, AM J EPIDEMIOL, V142, P404, DOI 10.1093/oxfordjournals.aje.a117648; Wong IY, 2013, RETINA-J RET VIT DIS, V33, P423, DOI 10.1097/IAE.0b013e3182753b5a; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009	48	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0175691	10.1371/journal.pone.0175691	http://dx.doi.org/10.1371/journal.pone.0175691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632734	Green Submitted, gold, Green Published			2022-12-26	WOS:000404046100002
J	Kellner, KF; Swihart, RK				Kellner, Kenneth F.; Swihart, Robert K.			Simulation of oak early life history and interactions with disturbance via an individual-based model, SOEL	PLOS ONE			English	Article							NORTHERN-HEMISPHERE TREES; WHITE-TAILED DEER; RED OAK; SEED PRODUCTION; SENSITIVITY-ANALYSIS; COMPETITIVE SUCCESS; PREDATOR SATIATION; SHELTERWOOD METHOD; WOODY VEGETATION; ACORN PRODUCTION	Early tree life history and demography are driven by interactions with the environment such as seed predation, herbivory, light availability, and drought. For oak (Quercus) in the eastern United States, these interactions may contribute to oak regeneration failure. Numerous studies have examined the impact of individual factors (like seed predation) on the oak regeneration process, but less information is available on the relative and combined impacts of multiple intrinsic and extrinsic factors on early oak life history. We developed an individual- based, spatially explicit model to Simulate Oak Early Life history (SOEL). The model connects acorn survival, acorn dispersal, germination, seedling growth, and seedling survival submodels based on empirical data with an existing gap model (JABOWA). Using SOEL, we assessed the sensitivity of several metrics of oak regeneration to different parameters associated with early oak life history. We also applied the model in three individual case studies to assess: (1) how variable acorn production interacts with timing of timber harvest; (2) the effect of shelterwood harvest-induced differences on seed predation; and (3) the consequences of interactions between drought, seedling growth and survival, and timber harvest. We found that oak regeneration metrics including percent emergence, seedling density, and sapling density were most sensitive to the amount of acorn production, acorn caching probability by scatterhoarders, and seedling growth rates. In the case studies, we found that timing harvest to follow large acorn crops can increase the density of oak regeneration in the short term following harvest, at least under some conditions. Following midstory removal, lower weevil infestation probability and lower post-dispersal acorn survival resulted in a modest decline in seedling density, but the decline did not persist to the sapling life stage class. Drought frequency had a powerful negative impact on both growth and survival for individual seedlings, which resulted in large reductions in both seedling and sapling density. The case studies presented here represent only a few examples of what could be accomplished within the SOEL modeling framework. Further studies could focus on different early life history parameters, or connect the parameter values to different predictor variables based on field data.	[Kellner, Kenneth F.; Swihart, Robert K.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kellner, KF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	kkellner@purdue.edu			Indiana Division of Forestry, the Department of Forestry and Natural Resources at Purdue University; Purdue University Graduate School; McIntire-Stennis Forestry Program	Indiana Division of Forestry, the Department of Forestry and Natural Resources at Purdue University; Purdue University Graduate School; McIntire-Stennis Forestry Program	Funding for the project was provided by the Indiana Division of Forestry, the Department of Forestry and Natural Resources at Purdue University, the Purdue University Graduate School, and the McIntire-Stennis Forestry Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2012, J TORREY BOT SOC, V139, P167, DOI 10.3159/TORREY-D-11-00075.1; Andruk CM, 2014, FOREST ECOL MANAG, V334, P193, DOI 10.1016/j.foreco.2014.08.037; [Anonymous], 2013, US FOR SERV GEN TECH; [Anonymous], 2009, ECOLOGY SILVICULTURE; Auguie B, 2017, GRIDEXTRA MISCELLANE; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; Bellocq MI, 2005, FOREST ECOL MANAG, V205, P311, DOI 10.1016/j.foreco.2004.10.013; Bigger David S., 1998, Integrative Biology, V1, P60, DOI 10.1002/(SICI)1520-6602(1998)1:2<60::AID-INBI4>3.0.CO;2-Z; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Brose P., 2011, P 17 CENTR HARDW FOR; Buckley DS, 1998, ECOLOGY, V79, P65, DOI 10.1890/0012-9658(1998)079[0065:RONROP]2.0.CO;2; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; BUNDY PP, 1991, NORTH J APPL FOR, V8, P173, DOI DOI 10.1093/NJAF/8.4.173; Caughlin TT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2095; CHRISTISEN DONALD M., 1955, JOUR FOREST, V53, P439; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; Crimmins S. M., 2010, International Journal of Forestry Research, V2010, P592034, DOI 10.1155/2010/592034; Dey DC, 2008, FOREST SCI, V54, P77; Dey DC, 2014, FOREST SCI, V60, P926, DOI 10.5849/forsci.13-114; Dey DC, 1991, COMPREHENSIVE OZARK; Greenberg CH, 2001, OAK FOREST ECOSYSTEMS, P149; Guariguata MR, 1998, FOREST ECOL MANAG, V112, P87, DOI 10.1016/S0378-1127(98)00318-1; Gustafson EJ, 2013, ECOSYSTEMS, V16, P60, DOI 10.1007/s10021-012-9596-1; Haas JP, 2005, J MAMMAL, V86, P1015, DOI 10.1644/1545-1542(2005)86[1015:ESOTEO]2.0.CO;2; Hanley Mick E., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P191, DOI 10.1078/1433-8319-00058; Haulton S., 2009, INDIANA DIVISION FOR; Healy WM, 1999, FOREST ECOL MANAG, V116, P1, DOI 10.1016/S0378-1127(98)00460-5; Holm JA, 2013, ECOSPHERE, V4, DOI [10.1890/ES13-00223, 10.1890/ES13-00223.1]; Horsley SB, 2003, ECOL APPL, V13, P98, DOI 10.1890/1051-0761(2003)013[0098:WTDIOT]2.0.CO;2; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; Jenkins MA, 1998, FOREST ECOL MANAG, V109, P57, DOI 10.1016/S0378-1127(98)00256-4; Kellner KF, 2016, FOREST ECOL MANAG, V375, P182, DOI 10.1016/j.foreco.2016.05.042; Kellner KF, 2017, PLANT ECOL, V218, P213, DOI 10.1007/s11258-016-0678-6; Kellner KF, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1473; Kellner KF, 2014, NEW FOREST, V45, P265, DOI 10.1007/s11056-014-9409-9; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; KIRKLAND GL, 1990, OIKOS, V59, P313, DOI 10.2307/3545141; Kittredge David B., 1995, Northern Journal of Applied Forestry, V12, P115; Koenig WD, 2000, AM NAT, V155, P59, DOI 10.1086/303302; Koenig WD, 2001, OAK FOREST ECOSYSTEMS, P129; Larsen DR, 1998, FOREST ECOL MANAG, V106, P1, DOI 10.1016/S0378-1127(97)00233-8; Lhotka JM, 2003, NORTH J APPL FOR, V20, P85, DOI 10.1093/njaf/20.2.85; Liang JJ, 2013, FOREST SCI, V59, P359, DOI 10.5849/forsci.11-123; LOFTIS DL, 1990, FOREST SCI, V36, P917; Lombardo JA, 2008, FOREST ECOL MANAG, V255, P2566, DOI 10.1016/j.foreco.2008.01.017; Lombardo JA, 2009, CAN J FOREST RES, V39, P1600, DOI 10.1139/X09-079; Lusk JJ, 2007, FOREST ECOL MANAG, V242, P656, DOI 10.1016/j.foreco.2007.01.084; Maeto K, 2003, OECOLOGIA, V137, P392, DOI 10.1007/s00442-003-1381-6; Marquis D., 1976, ACORN WEEVILS RODENT; MARTIN U, 1987, PHYSIOL PLANTARUM, V69, P182, DOI 10.1111/j.1399-3054.1987.tb01964.x; McShea WJ, 2007, J WILDLIFE MANAGE, V71, P1717, DOI 10.2193/2006-169; Megrey BA, 2001, ICES J MAR SCI, V58, P1015, DOI 10.1006/jmsc.2001.1104; Meiners SJ, 2002, AM MIDL NAT, V147, P247, DOI 10.1674/0003-0031(2002)147[0247:SOAHDT]2.0.CO;2; Miller BF, 2009, FOREST ECOL MANAG, V258, P1067, DOI 10.1016/j.foreco.2009.05.025; Mishra V, 2010, J HYDROMETEOROL, V11, P46, DOI 10.1175/2009JHM1156.1; Morrissey RC, 2008, CAN J FOREST RES, V38, P1419, DOI 10.1139/X08-018; National Climatic Data Center, 2014, MONTHL CLIM SUMM 201; National Drought Mitigation Center, 2015, TAB DAT ARCH MORG MO; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Oliver C.D., 1996, FOREST STAND DYNAMIC; Olson M. G., 2015, OPEN J FOR, V05, P568, DOI DOI 10.4236/OJF.2015.55051; PALLARDY SG, 1993, CAN J FOREST RES, V23, P1766, DOI 10.1139/x93-223; Plummer M., 2003, P 3 INT WORKSH DISTR; Quero JL, 2006, NEW PHYTOL, V170, P819, DOI 10.1111/j.1469-8137.2006.01713.x; Rathfon RA, 2008, P 16 CENTR HARDW FOR, P59; Rogers R, 1998, FOREST ECOL MANAG, V106, P45, DOI 10.1016/S0378-1127(97)00238-7; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Rose AK, 2012, J WILDLIFE MANAGE, V76, P750, DOI 10.1002/jwmg.291; Schnurr JL, 2002, OIKOS, V96, P402, DOI 10.1034/j.1600-0706.2002.960302.x; SORK VL, 1993, ECOLOGY, V74, P528, DOI 10.2307/1939313; SORK VL, 1993, ANN FOREST SCI, V50, P128; Steiner K. C., 1995, General Technical Report - Northeastern Forest Experiment Station, USDA Forest Service, P489; Sundaram M, 2016, J MAMMAL; Sundaram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130942; Thiele JC, 2014, RNETLOGO PROVIDES IN; vanHees AFM, 1997, ANN SCI FOREST, V54, P9, DOI 10.1051/forest:19970102; Weigel DR, 2002, CAN J FOREST RES, V32, P703, DOI [10.1139/x02-042, 10.1139/X02-042]; Wilensky U., 1999, NETLOGO INTERNET; Xu CG, 2008, RELIAB ENG SYST SAFE, V93, P1563, DOI 10.1016/j.ress.2007.06.003; Zamora R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107385; Zuidema PA, 2010, J ECOL, V98, P345, DOI 10.1111/j.1365-2745.2009.01626.x; [No title captured]	82	8	8	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179643	10.1371/journal.pone.0179643	http://dx.doi.org/10.1371/journal.pone.0179643			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632773	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100043
J	Rivera, M; Ramos, Y; Rodriguez-Valentin, M; Lopez-Acevedo, S; Cubano, LA; Zou, J; Zhang, Q; Wang, GD; Boukli, NM				Rivera, Mariela; Ramos, Yanilda; Rodriguez-Valentin, Madeline; Lopez-Acevedo, Sheila; Cubano, Luis A.; Zou, Jin; Zhang, Qiang; Wang, Guangdi; Boukli, Nawal M.			Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; OXIDATIVE STRESS; AUTOPHAGY; PROTEIN; INHIBITION; CASPASE-12; CYCLE; ROS	Curcumin, an extract from the turmeric rhizome (Curcuma longa), is known to exhibit anti-inflammatory, antioxidant, chemopreventive and antitumoral activities against aggressive and recurrent cancers. Accumulative data indicate that curcumin may induce cancer cell death. However, the detailed mechanism underlying its pro-apoptotic and anti-cancer effects remains to be elucidated. In the present study, we examined the signaling pathways triggered by curcumin, specifically, the exact molecular mechanisms of curcumin-induced apoptosis in highly metastatic human prostate cancer cells. The effect of curcumin was evaluated using for the first time in prostate cancer, a gel-free shotgun quantitative proteomic analysis coupled with Tandem Mass Tag isobaric labeling-based-signaling networks. Results were confirmed at the gene expression level by qRT-PCR and at the protein expression level by western blot and flow cytometry. Our findings revealed that curcumin induced an Endoplasmic Reticulum stress-mediated apoptosis in PC3. The mechanisms by which curcumin promoted cell death in these cells were associated with cell cycle arrest, increased reactive oxygen species, autophagy and the Unfolded Protein Response. Furthermore, the upregulation of ER stress was measured using key indicators of ER stress: Glucose-Regulated Protein 78, Inositol-Requiring Enzyme 1 alpha, Protein Disulfide isomerase and Calreticulin. Chronic ER stress induction was concomitant with the upregulation of pro-apoptotic markers (caspases 3,9,12) and Poly (ADP-ribose) polymerase. The downregulated proteins include anti-apoptotic and anti-tumor markers, supporting their curcumin-induced pro-apoptotic role in prostate cancer cells. Taken together, these data suggest that curcumin may serve as a promising anticancer agent by inducing a chronic ER stress mediated cell death and activation of cell cycle arrest, UPR, autophagy and oxidative stress responses.	[Rivera, Mariela; Ramos, Yanilda; Rodriguez-Valentin, Madeline; Lopez-Acevedo, Sheila; Cubano, Luis A.; Boukli, Nawal M.] Univ Cent Caribe, Sch Med, Biomed Prote Facil, Dept Microbiol & Immunol, Bayamon, PR 00960 USA; [Zou, Jin] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Zhang, Qiang; Wang, Guangdi] Xavier Univ Louisiana, RCMI Canc Res Ctr, Dept Chem, New Orleans, LA USA	Clark Atlanta University; Xavier University of Louisiana	Boukli, NM (corresponding author), Univ Cent Caribe, Sch Med, Biomed Prote Facil, Dept Microbiol & Immunol, Bayamon, PR 00960 USA.	nawal.boukli@uccaribe.edu		Rodriguez-Valentin, Madeline/0000-0003-1920-7522; Lopez Acevedo, Sheila/0000-0003-2778-4696; Rivera, Mariela/0000-0003-3085-5619	NIH [G12MD007583]; Xavier University of Louisiana [5G12MD007595]; Clark Atlanta University from the National Institute on Minority Health and Health Disparities (NIMHD) RCMI Program [8G12MD007590]; Universidad Central del Caribe Biomedical Proteomics Facility [G12MD007583]; National Institute on Minority Health and Health Disparities [G12MD007590, G12MD007583, G12MD007595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xavier University of Louisiana; Clark Atlanta University from the National Institute on Minority Health and Health Disparities (NIMHD) RCMI Program; Universidad Central del Caribe Biomedical Proteomics Facility; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by NIH grants to the Universidad Central del Caribe Biomedical Proteomics Facility (G12MD007583) (NMB), Xavier University of Louisiana (GW) (5G12MD007595) and Clark Atlanta University (8G12MD007590) from the National Institute on Minority Health and Health Disparities (NIMHD) RCMI Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was made possible by grants to the Universidad Central del Caribe Biomedical Proteomics Facility (G12MD007583) to NMB, Xavier University of Louisiana to GW (5G12MD007595) and Clark Atlanta University (8G12MD007590) from the National Institute on Minority Health and Health Disparities (NIMHD) RCMI Program. The authors wish to thank Dr. Maricarmen Colon and Dr. Henrique Martins for their scientific input and support.	Ao X, 2014, CELL DEATH DIFFER, V21, P348, DOI 10.1038/cdd.2013.187; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bakhshi J, 2008, APOPTOSIS, V13, P904, DOI 10.1007/s10495-008-0221-x; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Burton LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164115; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Chen SH, 2015, FEBS OPEN BIO, V5, P91, DOI 10.1016/j.fob.2015.01.004; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Eskelinen EL, 2011, CURR OPIN PHARMACOL, V11, P294, DOI 10.1016/j.coph.2011.03.009; Gomes AV, 2013, SCI CAIRO, V2013, DOI DOI 10.1155/2013/637629; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Kaldis MKD, 2012, CYCLIN DEPENDENT KIN, DOI [10.1073/pnas.1115201109, DOI 10.1073/PNAS.1115201109]; Kawate T, 2013, BREAST CANCER RES TR, V139, P51, DOI 10.1007/s10549-013-2523-0; Kim DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162831; Kurapati Kesava Rao V, 2012, J Basic Clin Physiol Pharmacol, V23, P139, DOI 10.1515/jbcpp-2012-0021; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin HY, 2012, DIABETOLOGIA, V55, P2703, DOI 10.1007/s00125-012-2643-9; Sambrooks CL, 2012, J BIOL CHEM, V287, P22043, DOI 10.1074/jbc.M111.338335; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; PLENDERLEITH IH, 1990, CAN FAM PHYSICIAN, V36, P1827; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Rao KVK, 2011, OPEN PROTEOMICS J, V4, P1; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Ryan D, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0948-z; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Senft C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-491; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sundram V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035368; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; Wang GH, 2010, AM J TRANSL RES, V2, P65; Whitaker HC, 2013, BRIT J CANCER, V109, P983, DOI 10.1038/bjc.2013.396; Wu SH, 2010, ANTICANCER RES, V30, P2125; Yan MM, 2015, ONCOL LETT, V10, P1959, DOI 10.3892/ol.2015.3508; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zheng RZ, 2017, MED SCI MONITOR, V23, P163, DOI 10.12659/MSM.902711	46	47	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179587	10.1371/journal.pone.0179587	http://dx.doi.org/10.1371/journal.pone.0179587			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628644	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100038
J	Verbanck, M; Canouil, M; Leloire, A; Dhennin, V; Coumoul, X; Yengo, L; Froguel, P; Poulain-Godefroy, O				Verbanck, Marie; Canouil, Mickael; Leloire, Audrey; Dhennin, Veronique; Coumoul, Xavier; Yengo, Loic; Froguel, Philippe; Poulain-Godefroy, Odile			Low-dose exposure to bisphenols A, F and S of human primary adipocyte impacts coding and non-coding RNA profiles	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; ENDOCRINE DISRUPTORS; IN-VITRO; EXPRESSION; URINARY; DIFFERENTIATION; IDENTIFICATION; ADIPOGENESIS; MECHANISMS; MICRORNAS	Bisphenol A (BPA) exposure has been suspected to be associated with deleterious effects on health including obesity and metabolically-linked diseases. Although bisphenols F (BPF) and S (BPS) are BPA structural analogs commonly used in many marketed products as a replacement for BPA, only sparse toxicological data are available yet. Our objective was to comprehensively characterize bisphenols gene targets in a human primary adipocyte model, in order to determine whether they may induce cellular dysfunction, using chronic exposure at two concentrations: a "low-dose" similar to the dose usually encountered in human biological fluids and a higher dose. Therefore, BPA, BPF and BPS have been added at 10 nM or 10 mu M during the differentiation of human primary adipocytes from subcutaneous fat of three non-diabetic Caucasian female patients. Gene expression (mRNA/lncRNA) arrays and microRNA arrays, have been used to assess coding and non-coding RNA changes. We detected significantly deregulated mRNA/lncRNA and miRNA at low and high doses. Enrichment in "cancer" and "organismal injury and abnormalities" related pathways was found in response to the three products. Some long intergenic non-coding RNAs and small nucleolar RNAs were differentially expressed suggesting that bisphenols may also activate multiple cellular processes and epigenetic modifications. The analysis of upstream regulators of deregulated genes highlighted hormones or hormone-like chemicals suggesting that BPS and BPF can be suspected to interfere, just like BPA, with hormonal regulation and have to be considered as endocrine disruptors. All these results suggest that as BPA, its substitutes BPS and BPF should be used with the same restrictions.	[Verbanck, Marie; Canouil, Mickael; Leloire, Audrey; Dhennin, Veronique; Yengo, Loic; Froguel, Philippe; Poulain-Godefroy, Odile] Univ Lille, Inst Pasteur Lille, CHU Lille, CNRS,UMR 8199,EGID, Lille, France; [Coumoul, Xavier] INSERM, UMR S 1124, Toxicol Pharmacol & Signalisat Cellulaire, Paris, France; [Coumoul, Xavier] Univ Paris 05, ComUE Sorbonne Paris Cite, Paris, France; [Froguel, Philippe] Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London, England; [Verbanck, Marie] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Yengo, Loic] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Poulain-Godefroy, Odile] Univ Lille, Inst Pasteur Lille, CHU Lille, CNRS,INSERM,U1019,UMR8204,CIIL, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Icahn School of Medicine at Mount Sinai; University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Froguel, P; Poulain-Godefroy, O (corresponding author), Univ Lille, Inst Pasteur Lille, CHU Lille, CNRS,UMR 8199,EGID, Lille, France.; Froguel, P (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Genom Common Dis, London, England.; Poulain-Godefroy, O (corresponding author), Univ Lille, Inst Pasteur Lille, CHU Lille, CNRS,INSERM,U1019,UMR8204,CIIL, Lille, France.	philippe.froguel@cnrs.fr; odile.poulain@pasteur-lille.fr	COUMOUL, Xavier/AAR-3649-2020; FROGUEL, Philippe/O-6799-2017; Canouil, Mickaël/L-6657-2018; Poulain-Godefroy, Odile/AAF-5474-2021	COUMOUL, Xavier/0000-0003-2928-9648; FROGUEL, Philippe/0000-0003-2972-0784; Canouil, Mickaël/0000-0002-3396-4549; POULAIN-GODEFROY, Odile/0000-0001-8805-9450; Verbanck, Marie/0000-0002-1669-572X	Centre National de la Recherche Scientifique; Ministere de l'Ecologie, du Developpement Durable et de l'Energie" (MEDDE); European Research Council [ERC-2011-ADG]; ANR Equipex session [ANR-10-EQPX-07-01]; FEDER; Region Nord-Pas-de-Calais-Picardie	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Ecologie, du Developpement Durable et de l'Energie" (MEDDE); European Research Council(European Research Council (ERC)European Commission); ANR Equipex session(French National Research Agency (ANR)); FEDER(European Commission); Region Nord-Pas-de-Calais-Picardie(Region Hauts-de-France)	This study was funded by the Centre National de la Recherche Scientifique (www.cnrs. fr), the Ministere de l'Ecologie, du Developpement Durable et de l'Energie" (MEDDE) according to the "Programme National de Recherche sur les Perturbateurs Endocriniens" (13-MRES-PNRPE-2CVS-044; http://www.developpement-durable.gouv.fr), and the European Research Council (ERC-2011-ADG; https://erc.europa.eu). The authors thank the UMR 8199 LIGAN-PM Genomics platform (Lille, France) which belongs to the 'Federation de Recherche' 3508 Labex EGID (European Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the ANR Equipex 2010 session (ANR-10-EQPX-07-01; 'LIGAN-PM') for support in global data processing and qPCR. The LIGAN-PM Genomics platform (Lille, France) is also supported by the FEDER and the Region Nord-Pas-de-Calais-Picardie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank David Hot and the Transcriptomics and Applied Genomics Group (Inserm U 1019, CNRS UMR 8204, Institut Pasteur de Lille, University of Lille) for microarrays processing. The authors thank the UMR 8199 LIGAN-PM Genomics platform (Lille, France) which belongs to the 'Federation de Recherche' 3508 Labex EGID (European Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the ANR Equipex 2010 session (ANR-10-EQPX-07-01; 'LIGAN-PM') for support in global data processing and qPCR. The LIGAN-PM Genomics platform (Lille, France) is also supported by the FEDER and the Region Nord-Pas-de-Calais-Picardie.	Ahmed S, 2016, INT J OBES; Ali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106245; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2012, MOL CELL ENDOCRINOL, V355, P201, DOI 10.1016/j.mce.2011.12.012; Ariemma F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150762; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhan A, 2014, J STEROID BIOCHEM, V141, P160, DOI 10.1016/j.jsbmb.2014.02.002; Boucher JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163318; Boucher JG, 2016, ENDOCRINOLOGY, V157, P1397, DOI 10.1210/en.2015-1872; Boucher JG, 2014, OBESITY, V22, P2333, DOI 10.1002/oby.20848; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Chevalier N, 2015, REV ENDOCR METAB DIS, V16, P299, DOI 10.1007/s11154-016-9333-8; Dietrich DR, 2016, ARCH TOXICOL, V90, P489, DOI 10.1007/s00204-016-1671-5; Dupuis-Sandoval F, 2015, WIRES RNA, V6, P381, DOI 10.1002/wrna.1284; Ho SM, 2015, ENDOCRINOLOGY, V156, P3984, DOI 10.1210/en.2015-1067; Hutchinson TH, 2000, ENVIRON HEALTH PERSP, V108, P1007, DOI 10.2307/3434950; Karbiener M, 2014, STEM CELLS, V32, P1578, DOI 10.1002/stem.1603; Karbiener M, 2011, RNA BIOL, V8, P850, DOI 10.4161/rna.8.5.16153; Khan D, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00091; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Koncarevic A, 2012, ENDOCRINOLOGY, V153, P3133, DOI 10.1210/en.2012-1016; Lagarde F, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-13; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Maedler K, 2012, PLOS ONE, V7; Magliano DJ, 2014, DIABETES METAB, V40, P1, DOI 10.1016/j.diabet.2013.09.006; Magnusson B, 2010, BIOCHEM BIOPH RES CO, V395, P373, DOI 10.1016/j.bbrc.2010.04.022; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mileva G, 2014, INT J ENV RES PUB HE, V11, P7537, DOI 10.3390/ijerph110707537; Montes-Grajales D, 2013, TOXICOL LETT, V222, P312, DOI 10.1016/j.toxlet.2013.08.010; Myers GM, 2009, FERTIL STERIL, V92, P1920, DOI 10.1016/j.fertnstert.2008.09.033; Nadal A., 2017, J STEROID BIOCH MOL; Ohlstein JF, 2014, J MOL ENDOCRINOL, V53, P345, DOI 10.1530/JME-14-0052; Ranciere F, 2015, ENV HLTH, V14, P14; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Saal FSV, 2012, MOL CELL ENDOCRINOL, V354, P74, DOI 10.1016/j.mce.2012.01.001; Shankar A., 2012, INT SCH RES NOT, V2012, P965243, DOI DOI 10.5402/2012/965243; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Sjoholm K, 2006, BIOCHEM BIOPH RES CO, V344, P1308, DOI 10.1016/j.bbrc.2006.04.030; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Villeneuve DL, 2012, ENVIRON SCI TECHNOL, V46, P51, DOI 10.1021/es201150a; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wijayarathna R, 2016, HUM REPROD UPDATE, V22, P342, DOI 10.1093/humupd/dmv058; Zhang Z, 2012, OSTEOARTHR CARTILAGE, V20, P1638, DOI 10.1016/j.joca.2012.08.024; Zhou XL, 2014, J CHROMATOGR B, V944, P152, DOI 10.1016/j.jchromb.2013.11.009	49	43	45	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179583	10.1371/journal.pone.0179583	http://dx.doi.org/10.1371/journal.pone.0179583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628672	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100037
J	Xiong, B; Gu, XJ; Qiu, X; Dong, ZX; Ye, S; Sun, GC; Huang, SJ; Liu, XY; Xi, LJ; Wang, ZH				Xiong, Bo; Gu, Xianjie; Qiu, Xia; Dong, Zhixiang; Ye, Shuang; Sun, Guochao; Huang, Shengjia; Liu, Xinya; Xi, Lijuan; Wang, Zhihui			Variability in CitXET expression and XET activity in Citrus cultivar Huangguogan seedlings with differed degrees of etiolation	PLOS ONE			English	Article							CELL-WALL MODIFICATION; XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASES; ENDOXYLOGLUCAN TRANSFERASE; PHYSIOLOGICAL ROLES; ELONGATION ZONE; GENE FAMILY; ENZYMES; EVOLUTION; XTH; ENDOTRANSGLYCOSYLASES	Considering the known effects of xyloglucan endotransglycosylase (XET) on plant growth and development, we aimed to determine whether XETs help to regulate the growth and elongation of Huangguogan shoots and roots. We confirmed a possible role for XET during seedling etiolation. Our results revealed that the roots of etiolated seedlings (H-E) were longer than those of green seedlings (H-G). However, shoot length exhibited the opposite pattern. We also observed positive and negative effects on the xyloglucan-degrading activity of XET in the root sub-apical region and shoots of etiolated Huangguogan seedling, respectively. There was a significant down-regulation in CitXET expression in the etiolated shoots at 15 days after seed germination. On the contrary, it was significantly increased in the root sub-apical region of etiolated and multicolored seedlings at 15 days after seed germination. The XET coding sequence (i.e., CitXET) was cloned from Huangguogan seedlings using gene-specific primers. The encoded amino acid sequence was predicted by using bioinformatics-based methods. The 990-bp CitXET gene was highly homologous to other XET genes. The CitXET protein was predicted to contain 319 amino acids, with a molecular mass of 37.45 kDa and an isoelectric point of 9.05. The predicted molecular formula was C1724H2548N448O466S14, and the resulting protein included only one transmembrane structure. The CitXET secondary structure consisted of four main structures (i.e., 21% alpha-helix, 30.72% extended strand, 9.09% beta-turn, and 39.18% random coil). Analyses involving the NCBI Conserved Domains Database (NCBI-CDD), InterPro, and ScanProsite revealed that CitXET was a member of the glycosyl hydrolase family 16 (GH16), and included the DEIDFEFLG motif. Our results indicate that the differed degrees of etiolation influenced the CitXET expression pattern and XET activity in Huangguogan seedlings. The differential changes in XET activity and CitXET expression levels in Huangguogan seedlings may influence the regulation of root and shoot development, and may be important for seedling etiolation.	[Xiong, Bo; Qiu, Xia; Dong, Zhixiang; Ye, Shuang; Huang, Shengjia; Liu, Xinya; Xi, Lijuan; Wang, Zhihui] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China; [Gu, Xianjie] Mianyang Acad Agr Sci, Mianyang, Sichuan, Peoples R China; [Sun, Guochao; Wang, Zhihui] Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Wang, ZH (corresponding author), Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China.; Wang, ZH (corresponding author), Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China.	wangzhihui318@126.com						Albert M, 2004, PLANT BIOLOGY, V6, P402, DOI 10.1055/s-2004-817959; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Deng X. W, 2014, P NATL ACAD SCI USA, V9, DOI [10.1073/pnas.1402491111, DOI 10.1073/PNAS.1402491111]; Dogra V, 2016, PLANTA, V244, P505, DOI 10.1007/s00425-016-2520-8; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Frankova L, 2013, J EXP BOT, V64, P3519, DOI 10.1093/jxb/ert201; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Garmash EV, 2015, J PLANT PHYSIOL, V174, P75, DOI 10.1016/j.jplph.2014.09.016; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Hara Y, 2014, ANN BOT-LONDON, V114, P1309, DOI 10.1093/aob/mct292; Hedtke B, 2012, PLANT MOL BIOL, V78, P77, DOI 10.1007/s11103-011-9846-1; Henrissat B, 2001, PLANT MOL BIOL, V47, P55, DOI 10.1023/A:1010667012056; Iurlaro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01686; Katinakis P, 2015, BIOTECH HISTOCHEM, V10, DOI [10.3109/10520295.2015.1020875, DOI 10.3109/10520295.2015.1020875(2015).]; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Keuskamp DH, 2012, PLANT SIGNAL BEHAV, V7, P514, DOI 10.4161/psb.19340; Kitade Y, 2008, J PHYCOL, V44, P113, DOI 10.1111/j.1529-8817.2007.00456.x; Matsui A, 2005, PLANT J, V42, P525, DOI 10.1111/j.1365-313X.2005.02395.x; Nishitani K, 1997, INT REV CYTOL, V173, P157; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Osato Y, 2006, J PLANT RES, V119, P153, DOI 10.1007/s10265-006-0262-6; Quan S, 2013, PLANT PHYSIOL, V163, P1518, DOI 10.1104/pp.113.223453; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saladie M, 2006, PLANT J, V47, P282, DOI 10.1111/j.1365-313X.2006.02784.x; Sasidharan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090587; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi YZ, 2015, PHYTOCHEMISTRY, V112, P160, DOI 10.1016/j.phytochem.2014.09.020; Strohmeier M, 2004, PROTEIN SCI, V13, P3200, DOI 10.1110/ps.04828404; Suda Cecilia N. K., 2003, Braz. J. Plant Physiol., V15, P135, DOI 10.1590/S1677-04202003000300002; Tao NengGuo, 2004, Plant Molecular Biology Reporter, V22, P305, DOI 10.1007/BF02773142; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Thompson JE, 1997, BIOCHEM J, V327, P699; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; Van Sandt VST, 2007, ANN BOT-LONDON, V100, P1467, DOI 10.1093/aob/mcm248; Van Sandt VST, 2007, ANN BOT-LONDON, V99, P39, DOI 10.1093/aob/mcl232; Vissenberg K, 2000, PLANT CELL, V12, P1229, DOI 10.1105/tpc.12.7.1229; Vissenberg K, 2005, PLANT CELL PHYSIOL, V46, P192, DOI 10.1093/pcp/pci013; Vissenberg K, 2003, J EXP BOT, V54, P335, DOI 10.1093/jxb/erg024; Xiong B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46245; Xu C, 2012, J INTEGR PLANT BIOL, V54, P434, DOI 10.1111/j.1744-7909.2012.01130.x; Yokoyama R, 2001, PLANT CELL PHYSIOL, V42, P1025, DOI 10.1093/pcp/pce154; Yokoyama R, 2004, PLANT PHYSIOL, V134, P1088, DOI 10.1104/pp.103.035261; Zhu XF, 2012, PLANT CELL, V24, P4731, DOI 10.1105/tpc.112.106039	48	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178973	10.1371/journal.pone.0178973	http://dx.doi.org/10.1371/journal.pone.0178973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617857	Green Submitted, Green Published, gold			2022-12-26	WOS:000403364600018
J	Bergdolt, S; Kovtun, A; Hagele, Y; Liedert, A; Schinke, T; Amling, M; Huber-Lang, M; Ignatius, A				Bergdolt, Stephanie; Kovtun, Anna; Haegele, Yvonne; Liedert, Astrid; Schinke, Thorsten; Amling, Michael; Huber-Lang, Markus; Ignatius, Anita			Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing	PLOS ONE			English	Article							MICRO-COMPUTED TOMOGRAPHY; BLUNT CHEST TRAUMA; SYSTEMIC INFLAMMATION; CELL-DEATH; BONE; INTERLEUKIN-6; CALLUS; INJURY; C3A; PHOSPHORYLATION	The anaphylatoxin receptor C5aR1 plays an important role not only in innate immune responses, but also in bone metabolism and fracture healing, being highly expressed on immune and bone cells, including osteoblasts and osteoclasts. C5aR1 induces osteoblast migration, cytokine generation and osteoclastogenesis, however, the exact role of C5aR1-mediated signaling in osteoblasts is not entirely known. Therefore, we hypothesized that osteoblasts are essential target cells for C5a and that fracture healing should be disturbed in mice with an osteoblast-specific C5aR1 overexpression (Col1a1-C5aR1). Osteoblast activity in vitro, bone phenotype and fracture healing after isolated osteotomy and after combined osteotomy with additional thoracic trauma were analyzed. The systemic and local inflammatory reactions were analyzed by determining C5a and IL-6 concentrations in blood, bronchoalveolar lavage fluid and fracture callus and the recruitment of immune cells. In vitro, osteoblast proliferation and differentiation were similar to wildtype cells, and phosphorylation of p38 and expression of IL-6 and RANKL were increased in osteoblasts derived from Col1a1-C5aR1 mice. Bone phenotype and the inflammatory reaction were unaffected in Col1a1-C5aR1 mice. Fracture healing was significantly impaired as demonstrated by significantly reduced bone content, bone mineral density and flexural rigidity, possibly due to significantly increased osteoclast numbers. C5aR1 signaling in osteoblasts might possibly affect RANKL/OPG balance, leading to increased bone resorption. Additional trauma significantly impaired fracture healing, particularly in Col1a1-C5aR1 mice. In conclusion, the data indicate that C5aR1 signaling in osteoblasts plays a detrimental role in bone regeneration after fracture.	[Bergdolt, Stephanie; Kovtun, Anna; Haegele, Yvonne; Liedert, Astrid; Ignatius, Anita] Univ Ulm, Inst Orthoped Res & Biomech, Ulm, Germany; [Schinke, Thorsten; Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Huber-Lang, Markus] Univ Ulm, Inst Clin & Expt Traumaimmunol, Ulm, Germany	Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University	Ignatius, A (corresponding author), Univ Ulm, Inst Orthoped Res & Biomech, Ulm, Germany.	anita.ignatius@uni-ulm.de	Vikman, Anna/F-1115-2017; Huber-Lang, Markus/AAJ-2209-2020; Ignatius, Anita/M-6012-2013	Ignatius, Anita/0000-0002-4782-1979; Vikman, Anna/0000-0001-8531-9712	German Research Foundation (DFG) [KF0200 (IG18/14-2)]; Collaborative Research Center [CRC1149 (INST 40/491-1)]	German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Center	The study was funded by the German Research Foundation (DFG) in the framework of the Clinical Research Group KF0200 (IG18/14-2) and the Collaborative Research Center CRC1149 (INST 40/491-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Andrades JA, 1996, EXP CELL RES, V227, P208, DOI 10.1006/excr.1996.0269; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; Dong Q, 2015, SPINAL CORD, V53, P581, DOI 10.1038/sc.2015.65; Ehrnthaller C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081341; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GERARD NP, 1989, J BIOL CHEM, V264, P1760; Guo RF, 2004, FASEB J, V18, pA560; Huber-Lang M, 2016, SEMIN IMMUNOL, V28, P278, DOI 10.1016/j.smim.2016.04.005; Ignatius A, 2011, J TRAUMA, V71, P952, DOI 10.1097/TA.0b013e3181f8aa2d; Ignatius A, 2011, J CELL BIOCHEM, V112, P2594, DOI 10.1002/jcb.23186; Kanse SM, 2012, J IMMUNOL, V188, P2858, DOI 10.4049/jimmunol.1103029; Kemmler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131194; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kovtun A, 2016, EUR CELLS MATER, V32, P152, DOI 10.22203/eCM.v032a10; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Liang SA, 2011, J IMMUNOL, V186, P869, DOI 10.4049/jimmunol.1003252; Manthey HD, 2009, INT J BIOCHEM CELL B, V41, P2114, DOI 10.1016/j.biocel.2009.04.005; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pobanz JM, 2000, J PERIODONTAL RES, V35, P137, DOI 10.1034/j.1600-0765.2000.035003137.x; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Schoengraf P, 2013, IMMUNOBIOLOGY, V218, P1, DOI 10.1016/j.imbio.2012.01.020; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Tu Z, 2010, BLOOD, V116, P4456, DOI 10.1182/blood-2010-01-263590; Tuyt LML, 1999, J IMMUNOL, V162, P4893; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	40	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179512	10.1371/journal.pone.0179512	http://dx.doi.org/10.1371/journal.pone.0179512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614388	gold, Green Submitted, Green Published			2022-12-26	WOS:000403280900059
J	Buonocore, A; Fracasso, A; Melcher, D				Buonocore, Antimo; Fracasso, Alessio; Melcher, David			Pre-saccadic perception: Separate time courses for enhancement and spatial pooling at the saccade target	PLOS ONE			English	Article							VISUAL SPACE; OBJECT RECOGNITION; RECEPTIVE-FIELDS; ATTENTION; INTEGRATION; CORTEX; COMPRESSION; MECHANISMS; WORLD; AREA	We interact with complex scenes using eye movements to select targets of interest. Studies have shown that the future target of a saccadic eye movement is processed differently by the visual system. A number of effects have been reported, including a benefit for perceptual performance at the target ('enhancement'), reduced influences of backward masking ( 'unmasking '), reduced crowding ('un-crowding') and spatial compression towards the saccade target. We investigated the time course of these effects by measuring orientation discrimination for targets that were spatially crowded or temporally masked. In four experiments, we varied the target-flanker distance, the presence of forward/backward masks, the orientation of the flankers and whether participants made a saccade. Masking and randomizing flanker orientation reduced performance in both fixation and saccade trials. We found a small improvement in performance on saccade trials, compared to fixation trials, with a time course that was consistent with a general enhancement at the saccade target. In addition, a decrement in performance ( reporting the average flanker orientation, rather than the target) was found in the time bins nearest saccade onset when random oriented flankers were used, consistent with spatial pooling around the saccade target. We did not find strong evidence for un-crowding. Overall, our pattern of results was consistent with both an early, general enhancement at the saccade target and a later, peri-saccadic compression/ pooling towards the saccade target.	[Buonocore, Antimo] Tubingen Univ, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Buonocore, Antimo] Tubingen Univ, Hertie Inst Clin Brain Res, Tubingen, Germany; [Fracasso, Alessio] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [Fracasso, Alessio] Univ Med Ctr Utrecht, Radiol, Imaging Div, Utrecht, Netherlands; [Melcher, David] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW); Utrecht University; Utrecht University Medical Center; University of Trento	Buonocore, A (corresponding author), Tubingen Univ, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.	antimo.buonocore@cin.uni-tuebingen.de	Buonocore, Antimo/N-4794-2019; Buonocore, Antimo/D-2736-2013; Fracasso, Alessio/AAC-4830-2022; Melcher, David/D-1775-2010	Buonocore, Antimo/0000-0003-3917-510X; Buonocore, Antimo/0000-0003-3917-510X; Fracasso, Alessio/0000-0002-4542-112X; Melcher, David/0000-0003-0926-585X	European Research Council (ERC) [313658]; Autonomous Province of Trento through the call "Grandi Progetti", project "Characterizing and improving brain mechanisms of attention - ATTEND"	European Research Council (ERC)(European Research Council (ERC)European Commission); Autonomous Province of Trento through the call "Grandi Progetti", project "Characterizing and improving brain mechanisms of attention - ATTEND"	The research was supported by a European Research Council (ERC) grant (grant agreement no. 313658) awarded to DM. AB was funded by a research fellowship from the Autonomous Province of Trento through the call "Grandi Progetti 2012", project "Characterizing and improving brain mechanisms of attention - ATTEND". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu MN, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160559; Agaoglu MN, 2016, VISION RES, V127, P152, DOI 10.1016/j.visres.2016.08.003; Bartlett AM, 2011, J NEUROSCI, V31, P18423, DOI 10.1523/JNEUROSCI.4102-11.2011; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Bridgeman B, 1996, BEHAV BRAIN SCI, V19, P553, DOI 10.1017/S0140525X00082169; Bridgeman B, 2010, I-PERCEPTION, V1, P69, DOI 10.1068/i0387; Buonocore A, 2015, J VISION, V15, DOI 10.1167/15.15.3; Burr DC, 2010, TRENDS COGN SCI, V14, P528, DOI 10.1016/j.tics.2010.09.005; Corbett JE, 2014, ATTEN PERCEPT PSYCHO, V76, P746, DOI 10.3758/s13414-013-0595-x; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; CROSBIE RE, 1993, EUROSIM 92 - SIMULATION CONGRESS, P1; Dakin SC, 2009, J VISION, V9, DOI [10.1167/9.4.2, 10.1167/9.11.28]; De Pisapia N, 2010, CURR BIOL, V20, P613, DOI 10.1016/j.cub.2010.01.056; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Deubel H, 2008, PSYCHOL RES-PSYCH FO, V72, P630, DOI 10.1007/s00426-008-0165-3; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Fabius JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34488; Fracasso A, 2016, FRONT SYST NEUROSCI, V10, DOI [10.33139/fnsys.2015.00058, 10.3389/fnsys.2016.00058]; Fracasso A, 2015, J VISION, V15, DOI 10.1167/15.3.4; Ganmor E, 2015, J VISION, V15, DOI 10.1167/15.16.8; Hamker FH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040031; Harrison WJ, 2013, CURR BIOL, V23, P793, DOI 10.1016/j.cub.2013.03.050; Hartmann TS, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00013; Herwig A, 2015, J VISION, V15, DOI 10.1167/15.16.7; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; HONDA H, 1989, PERCEPT PSYCHOPHYS, V45, P162, DOI 10.3758/BF03208051; Honda H, 2006, VISION RES, V46, P3483, DOI 10.1016/j.visres.2006.05.013; Jutras MJ, 2013, P NATL ACAD SCI USA, V110, P13144, DOI 10.1073/pnas.1302351110; Khan AZ, 2015, EUR J NEUROSCI, V41, P1624, DOI 10.1111/ejn.12923; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kusunoki M, 2003, J NEUROPHYSIOL, V89, P1519, DOI 10.1152/jn.00519.2002; Lappe M, 2000, NATURE, V403, P892, DOI 10.1038/35002588; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2009, CURR BIOL, V19, P1988, DOI 10.1016/j.cub.2009.09.056; Li HH, 2016, CURR BIOL, V26, P1564, DOI 10.1016/j.cub.2016.04.028; Lin H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087368, 10.1371/journal.pone.0093112]; Livne T, 2007, J VISION, V7, DOI 10.1167/7.2.4; Livne T, 2010, J VISION, V10, DOI 10.1167/10.3.1; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Matin L., 1972, HDB SENSORY PHYSIOLO, P331, DOI [DOI 10.1007/978-3-642-88658-4_13, 10.1007/978-3-642-88658-4_13]; Melcher D, 2007, NAT NEUROSCI, V10, P903, DOI 10.1038/nn1917; Melcher D, 2015, VISUAL NEUROSCI, V32, DOI 10.1017/S095252381500019X; Melcher D, 2011, PHILOS T R SOC B, V366, P468, DOI 10.1098/rstb.2010.0277; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Morrone MC, 1997, J NEUROSCI, V17, P7941; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Nandy AS, 2012, NAT NEUROSCI, V15, P463, DOI 10.1038/nn.3021; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Neupane S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10402; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; Parkes L, 2001, NATURE; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Poder E, 2006, J VISION, V6, P163, DOI 10.1167/6.2.7; Prime SL, 2011, PHILOS T R SOC B, V366, P540, DOI 10.1098/rstb.2010.0184; R Core Team, 2021, R LANGUAGE ENV STAT; Rolfs M, 2012, J NEUROSCI, V32, P13744, DOI 10.1523/JNEUROSCI.2676-12.2012; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Saarela TP, 2010, J VISION, V10, DOI 10.1167/10.10.17; Saarela TP, 2009, J VISION, V9, DOI 10.1167/9.2.5; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; Super H, 2004, P NATL ACAD SCI USA, V101, P3230, DOI 10.1073/pnas.0400433101; Tas AC, 2012, J VISION, V12, DOI 10.1167/12.11.18; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; van Koningsbruggen MG, 2013, J NEUROSCI, V33, P11327, DOI 10.1523/JNEUROSCI.1567-13.2013; Vickery TJ, 2009, J VISION, V9, DOI 10.1167/9.2.12; Wolf C, 2015, J VISION, V15, DOI 10.1167/15.16.1; Wolfe BA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00103; Wurtz RH, 2011, PHILOS T R SOC B, V366, P492, DOI 10.1098/rstb.2010.0186; Wutz A, 2016, CURR BIOL, V26, P1659, DOI 10.1016/j.cub.2016.04.070; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Zirnsak M, 2014, TRENDS COGN SCI, V18, P621, DOI 10.1016/j.tics.2014.10.002; Zirnsak M, 2014, NATURE, V507, P504, DOI 10.1038/nature13149; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	76	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178902	10.1371/journal.pone.0178902	http://dx.doi.org/10.1371/journal.pone.0178902			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614367	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000403280900024
J	Liu, CC; Dou, Y; Guan, XL; Fu, Q; Zhang, Z; Hu, ZH; Zheng, J; Lu, YZ; Li, W				Liu, Congcong; Dou, Ying; Guan, Xuelian; Fu, Qiang; Zhang, Ze; Hu, Zenghui; Zheng, Jian; Lu, Yizeng; Li, Wei			De novo transcriptomic analysis and development of EST-SSRs for Sorbus pohuashanensis (Hance) Hedl	PLOS ONE			English	Article							RNA-SEQ; GENETIC DIVERSITY; MARKERS; IDENTIFICATION; DATABASE; L.; TRANSFERABILITY; SEQUENCES; TOOL	Sorbus pohuashanensis is a native tree species of northern China that is used for a variety of ecological purposes. The species is often grown as an ornamental landscape tree because of its beautiful form, silver flowers in early summer, attractive pinnate leaves in summer, and red leaves and fruits in autumn. However, development and further utilization of the species are hindered by the lack of comprehensive genetic information, which impedes research into its genetics and molecular biology. Recent advances in de novo transcriptome sequencing (RNA-seq) technology have provided an effective means to obtain genomic information from non-model species. Here, we applied RNA-seq for sequencing S. pohuashanensis leaves and obtained a total of 137,506 clean reads. After assembly, 96,213 unigenes with an average length of 770 bp were obtained. We found that 64.5% of the unigenes could be annotated using bioinformatics tools to analyze gene function and alignment with the NCBI database. Overall, 59,089 unigenes were annotated using the Nr database(non-redundant protein database), 35,225 unigenes were annotated using the GO (Gene Ontology categories) database, and 33,168 unigenes were annotated using COG (Cluster of Orthologous Groups). Analysis of the unigenes using the KEGG (Kyoto Encyclopedia of Genes and Genomes) database indicated that 13,953 unigenes were involved in 322 metabolic pathways. Finally, simple sequence repeat (SSR) site detection identified 6,604 unigenes that included EST-SSRs and a total of 7,473 EST-SSRs in the unigene sequences. Fifteen polymorphic SSRs were screened and found to be of use for future genetic research. These unigene sequences will provide important genetic resources for genetic improvement and investigation of biochemical processes in S. pohuashanensis.	[Liu, Congcong; Dou, Ying; Guan, Xuelian; Fu, Qiang; Zhang, Ze; Hu, Zenghui; Zheng, Jian] Beijing Univ Agr, Coll Landscape Architecture, Beijing, Peoples R China; [Zheng, Jian] Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China; [Zheng, Jian] Beijing Engn Res Ctr Rural Landscape Planning & D, Beijing, Peoples R China; [Lu, Yizeng] Shandong Prov Ctr Forest Tree Germplasm Resources, Jinan, Shandong, Peoples R China; [Li, Wei] Qingdao Agr Univ, Coll Landscape Architecture & Forestry, Qingdao, Peoples R China	Beijing University of Agriculture; Qingdao Agricultural University	Zheng, J (corresponding author), Beijing Univ Agr, Coll Landscape Architecture, Beijing, Peoples R China.; Zheng, J (corresponding author), Beijing Collaborat Innovat Ctr Ecoenvironm Improv, Beijing, Peoples R China.; Zheng, J (corresponding author), Beijing Engn Res Ctr Rural Landscape Planning & D, Beijing, Peoples R China.	buazhengjian708@126.com		Lu, Yizeng/0000-0002-5198-0155	Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [CITTCD20154043]; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment [PXM2015-014207-000014]; Beijing Municipal Education Commission [CEFF-PXM2016_014207_000038]	Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions; Building Project of Beijing Laboratory of Urban and Rural Ecological Environment; Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This study was supported by the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (CIT&TCD20154043), the Building Project of Beijing Laboratory of Urban and Rural Ecological Environment (PXM2015-014207-000014), and Beijing Municipal Education Commission (CEFF-PXM2016_014207_000038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Cheng YL, 2015, PLANT MOL BIOL REP, V33, P1804, DOI 10.1007/s11105-015-0875-9; Fan HongHong, 2009, Genomics and Applied Biology, V28, P869; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Huang HaiYan, 2013, Scientia Silvae Sinicae, V49, P176; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Labuda R, 2005, INT J FOOD MICROBIOL, V99, P215, DOI 10.1016/j.ijfoodmicro.2004.09.002; Li CY, 2016, MOLECULES, V21, DOI 10.3390/molecules21010067; Liu DF, 2013, PLOS ONE, V9; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marconi Thiago G, 2011, BMC Res Notes, V4, P264, DOI 10.1186/1756-0500-4-264; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Najafzadeh R, 2016, RUSS J GENET+, V52, P64, DOI 10.1134/S1022795415110113; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ramu P, 2009, THEOR APPL GENET, V119, P1193, DOI 10.1007/s00122-009-1120-4; Shen HaiLong, 2006, Scientia Silvae Sinicae, V42, P133; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang XiCheng, 2010, Scientia Agricultura Sinica, V43, P5079; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; [文亚峰 Wen Yafeng], 2015, [林业科学, Scientia Silvae Sinicae], V51, P40; Xu M, 2010, NEW FOREST, V40, P361, DOI 10.1007/s11056-010-9205-0; Yadav HK, 2011, TREE GENET GENOMES, V7, P207, DOI 10.1007/s11295-010-0326-6; Yang Hua, 2011, Journal of Anhui Agricultural University, V38, P882; Yao LH, 2010, GENET RESOUR CROP EV, V57, P841, DOI 10.1007/s10722-009-9524-1; [张振 Zhang Zhen], 2015, [林业科学, Scientia Silvae Sinicae], V51, P114; Zhao Y, 2009, HEREDITAS, V31, P311; Zheng Jian, 2007, Scientia Silvae Sinicae, V43, P86; Zheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142542; Zheng Jian, 2012, Journal of Plant Resources and Environment, V21, P50; Zheng Jian, 2009, Scientia Silvae Sinicae, V45, P44; Zheng Jian, 2008, Shengwu Duoyangxing, V16, P562, DOI 10.3724/SP.J.1003.2008.08201; Zheng Jian, 2009, Forest Research, V22, P91; Zheng JW., 2013, RESEARCH ON TRANSCRI; Zheng W, 1985, SYLVASINICA; Zhou T, 2016, MOLECULES, V21, DOI 10.3390/molecules21030166; Zhu Yan, 2009, Journal of Fruit Science, V26, P394	49	13	20	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179219	10.1371/journal.pone.0179219	http://dx.doi.org/10.1371/journal.pone.0179219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614366	gold, Green Published			2022-12-26	WOS:000403280900037
J	O'Donnell, KJ; Glover, V; Lahti, J; Lahti, M; Edgar, RD; Raikkonen, K; O'Connor, TG				O'Donnell, Kieran J.; Glover, Vivette; Lahti, Jari; Lahti, Marius; Edgar, Rachel D.; Raikkonen, Katri; O'Connor, Thomas G.			Maternal prenatal anxiety and child COMT genotype predict working memory and symptoms of ADHD	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; POSTNATAL DEPRESSION SCALE; CRISP EXPERIENTIAL INDEX; DIFFICULTIES QUESTIONNAIRE; VAL(158)MET GENOTYPE; STRESS; PREGNANCY; VALIDATION; ASSOCIATIONS; RELIABILITY	Maternal prenatal anxiety is an important risk factor for altered child neurodevelopment but there is uncertainty concerning the biological mechanisms involved and sources of individual differences in children's responses. We sought to determine the role of functional genetic variation in COMT, which encodes catechol-O-methyltransferase, in the association between maternal prenatal anxiety and child symptoms of ADHD and working memory. We used the prospectively-designed ALSPAC cohort (n = 6,969) for our primary data analyses followed by replication analyses in the PREDO cohort (n = 425). Maternal prenatal anxiety was based on self-report measures; child symptoms of ADHD were collected from 4-15 years of age; working memory was assessed from in-person testing at age 8 years; and genetic variation in COMT at rs4680 was determined in both mothers and children. The association between maternal prenatal anxiety and child attention/hyperactivity symptoms and working memory was moderated by the child's rs4680 genotype, with stronger effects obtained for the val/val (G: G) genotype relative to val/met (A:G) (all p < 0.01) and met/met (A: A) groups (all p < 0.05). Similar findings were observed in the PREDO cohort where maternal prenatal anxiety interacted with child rs4680 to predict symptoms of ADHD at 3.5 years of age. The findings, from two cohorts, show a robust gene-environment interaction, which may contribute to inter-individual differences in the effects of maternal prenatal anxiety on developmental outcomes from childhood to mid-adolescence.	[O'Donnell, Kieran J.] McGill Univ, Dept Psychiat, Ludmer Ctr Neuroinformat & Mental Hlth, Douglas Hosp Res Ctr, Montreal, PQ, Canada; [O'Donnell, Kieran J.] Canadian Inst Adv Res, Child & Brain Dev Program, Toronto, ON, Canada; [Glover, Vivette] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Lahti, Jari; Lahti, Marius; Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Fac Med, Helsinki, Finland; [Lahti, Jari] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [Lahti, Marius; Raikkonen, Katri] Univ Edinburgh, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Edgar, Rachel D.] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [O'Connor, Thomas G.] Univ Rochester, Med Ctr, Dept Psychiat, Wynne Ctr Family Res, Rochester, NY 14642 USA	McGill University; Canadian Institute for Advanced Research (CIFAR); Imperial College London; University of Helsinki; University of Helsinki; University of Edinburgh; University of British Columbia; University of Rochester	O'Connor, TG (corresponding author), McGill Univ, Dept Psychiat, Ludmer Ctr Neuroinformat & Mental Hlth, Douglas Hosp Res Ctr, Montreal, PQ, Canada.	kieran.odonnell@mcgill.ca; Tom_OConnor@URMC.Rochester.edu	O'Donnell, Kieran/ABC-5593-2020; Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018; O'Connor, Tom/AAG-1598-2020; Glover, Vivette/M-2711-2016; Lahti-Pulkkinen, Marius/Q-2472-2017	Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; O'Connor, Tom/0000-0002-8590-5057; Glover, Vivette/0000-0001-6543-1651; O'Donnell, Kieran/0000-0002-3935-1014; Lahti-Pulkkinen, Marius/0000-0002-5244-5525; Raikkonen, Katri/0000-0003-3124-3470; Edgar, Rachel/0000-0001-5507-6078	NIH [R01 MH073842]; Academy of Finland, Hope& Optimism Initiative; Signe and Ane Gylleberg Foundation; Emil Aaltonen Foundation; EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; EraNet Neuron; Sir Jules Thorn Charitable Trust; University of Helsinki; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland, Hope& Optimism Initiative(Academy of Finland); Signe and Ane Gylleberg Foundation; Emil Aaltonen Foundation; EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); EraNet Neuron; Sir Jules Thorn Charitable Trust; University of Helsinki; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr O'Donnell is a Canadian Institute For Advanced Research (CIFAR) Azrieli Global Scholar (Child and Brain Development). The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This particular project was funded in part by NIH grant R01 MH073842 (TO'C). The study sponsor had no role in the design, collection, analysis, or interpretation of data reported in this study.; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This particular project was funded in part by NIH grant R01 MH073842.; The PREDO study was funded by the Academy of Finland, Hope& Optimism Initiative, Signe and Ane Gylleberg Foundation, Emil Aaltonen Foundation, EVO (special state subsidy for health science research), Finnish Medical Foundation, Jane and Aatos Erkko Foundation, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, Sigrid Juselius Foundation, EraNet Neuron, Sir Jules Thorn Charitable Trust and University of Helsinki. The authors thank Jarkko Volanen for his assistance in data gathering.	ALDERMAN KJ, 1983, BRIT J MED PSYCHOL, V56, P329, DOI 10.1111/j.2044-8341.1983.tb01565.x; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Almli LM, 2014, JAMA PSYCHIAT, V71, P1392, DOI 10.1001/jamapsychiatry.2014.1339; Barnett JH, 2009, AM J PSYCHIAT, V166, P909, DOI 10.1176/appi.ajp.2009.08081251; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Betts KS, 2015, DEPRESS ANXIETY, V32, P82, DOI 10.1002/da.22272; BIRTCHNELL J, 1988, BRIT J MED PSYCHOL, V61, P255, DOI 10.1111/j.2044-8341.1988.tb02787.x; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Buss C, 2011, STRESS, V14, P665, DOI 10.3109/10253890.2011.623250; Buss C, 2009, PSYCHONEUROENDOCRINO; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Girchenko P, 2016, INTERNATIONAL JOURNA; Glover V, 2004, EARLY HUM DEV, V79, P107, DOI 10.1016/j.earlhumdev.2004.04.012; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Groen-Blokhuis MM, 2014, J AM ACAD CHILD PSY, V53, P1123, DOI 10.1016/j.jaac.2014.06.014; Huizink AC, 2002, J AM ACAD CHILD PSY, V41, P1078, DOI 10.1097/00004583-200209000-00008; Jabbi M, 2007, MOL PSYCHIATR, V12, P483, DOI 10.1038/sj.mp.4001975; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Jones RW, 2000, EUR J HUM GENET, V8, P653, DOI 10.1038/sj.ejhg.5200502; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Knickmeyer RC, 2014, CEREB CORTEX, V24, P1230, DOI 10.1093/cercor/bhs401; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Maccari S, 2003, NEUROSCI BIOBEHAV R, V27, P119, DOI 10.1016/S0149-7634(03)00014-9; Meyer BM, 2014, BRAIN STRUCTURE FUNC; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P1255, DOI 10.1017/S095457941400100X; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; O'Donnell KJ, 2016, FETAL ORIGINS MENTAL; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Qiu AQ, 2015, AM J PSYCHIAT, V172, P163, DOI 10.1176/appi.ajp.2014.14030313; Sarkar S, 2014, WORLD J BIOL PSYCHIA, V15, P346, DOI 10.3109/15622975.2014.903336; Spielberger C. D., 1970, STAI MANUAL FOR THE; Sun HJ, 2014, MOL NEUROBIOL, V49, P251, DOI 10.1007/s12035-013-8516-5; Thompson JMD, 2012, DEV MED CHILD NEUROL, V54, P148, DOI 10.1111/j.1469-8749.2011.04129.x; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Van den Bergh BRH, 2009, PSYCHONEUROENDOCRINO, V34, P791, DOI 10.1016/j.psyneuen.2008.12.008; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010; Weschler D, 1992, WISC 3 UK WESCHLER I; Yang BR, 2011, PSYCHOL MED, V41, P2593, DOI 10.1017/S0033291711000869	52	32	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0177506	10.1371/journal.pone.0177506	http://dx.doi.org/10.1371/journal.pone.0177506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614354	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900004
J	Soumagne, T; Chardon, ML; Dournes, G; Laurent, L; Degano, B; Laurent, F; Dalphin, JC				Soumagne, Thibaud; Chardon, Marie-Laure; Dournes, Gael; Laurent, Lucie; Degano, Bruno; Laurent, Francois; Dalphin, Jean Charles			Emphysema in active farmer's lung disease	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; ANTIGENS; ALVEOLITIS	Background Farmer's lung (FL) is a common type of hypersensitivity pneumonitis. It is often considered that fibrosis is the most frequent finding in chronic FL. Nevertheless, three cohort studies have suggested that some patients with chronic FL may develop emphysema. We aimed to evaluate the current prevalence of emphysema in active FL, to describe the radiological and functional features of emphysema in active FL, and to identify risk factors associated with emphysema in this population. Methods Patients aged over 18 years with active FL were prospectively recruited through the SOPHIA study (CPP Est; P-2009-521), between 2007 and 2015. Each patient had complete medical history screening, clinical examination, high resolution computed tomodensitometry, bronchoalveolar lavage, pulmonary function tests and serum precipitins. Results Among 33 patients with active FL, the prevalence of emphysema in this series of incident active FL cases was higher (48.5%) than that of fibrosis (12%) and was not dependent on smoking habits. Most patients with emphysema did not have lung hyperinflation. The possible risk factors for emphysema in active FL were a longer duration of exposure to organic dusts, and at a higher level. Conclusion Emphysema is found in half of patients with active FL and may be influenced by exposure patterns.	[Soumagne, Thibaud; Chardon, Marie-Laure; Laurent, Lucie; Dalphin, Jean Charles] CHU Besancon, Serv Pneumol, Besancon, France; [Soumagne, Thibaud; Laurent, Lucie; Degano, Bruno] CHU Besancon, Serv Physiol Explorat Fonct, Besancon, France; [Chardon, Marie-Laure] CHI Vesoul, Serv Pneumol, Vesoul, France; [Dournes, Gael; Laurent, Francois] CHU Bordeaux, Serv Imagerie Thorac & Cardiovasc, Pessac, France; [Dournes, Gael; Laurent, Francois] Univ Bordeaux, U1045, Ctr Rech Cardiothorac, Bordeaux, France; [Degano, Bruno] Univ Franche Comte, EA 3920, Besancon, France; [Dalphin, Jean Charles] Univ Franche Comte, UMR Chronoenvironm 6249, Besancon, France	Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite de Franche-Comte; Universite de Franche-Comte	Soumagne, T (corresponding author), CHU Besancon, Serv Pneumol, Besancon, France.; Soumagne, T (corresponding author), CHU Besancon, Serv Physiol Explorat Fonct, Besancon, France.	thibaud_soumagne@live.fr		Soumagne, Thibaud/0000-0002-9251-066X; Degano, Bruno/0000-0003-1644-7264				Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Bellanger AP, 2016, J IMMUNOL METHODS, V434, P61, DOI 10.1016/j.jim.2016.04.008; Bourke SJ, 2001, EUR RESPIR J, V18, p81S; Cormier Y, 2000, EUR RESPIR J, V16, P56, DOI 10.1034/j.1399-3003.2000.16a10.x; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Dalphin J-C, 2015, ORPHAN LUNG DIS CLIN, P457; DALPHIN JC, 1991, THORAX, V46, P619, DOI 10.1136/thx.46.9.619; Degano B, 2010, CHEST, V137, P1297, DOI 10.1378/chest.09-2060; Dournes G, 2015, AM J RESP CRIT CARE, V191, P63, DOI 10.1164/rccm.201408-1423OC; Erkinjuntti-Pekkanen R, 1998, AM J RESP CRIT CARE, V158, P662, DOI 10.1164/ajrccm.158.2.9710012; Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007; Fenoglio CM, 2007, EUR RESPIR J, V29, P706, DOI 10.1183/09031936.00001006; FOURNIER E, 1985, CHEST, V88, P563, DOI 10.1378/chest.88.4.563; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hoppin JA, 2014, OCCUP ENVIRON MED, V71, P484, DOI 10.1136/oemed-2013-101983; KURUP VP, 1987, MYCOPATHOLOGIA, V98, P91, DOI 10.1007/BF00437294; Lacasse Y, 2003, AM J RESP CRIT CARE, V168, P952, DOI 10.1164/rccm.200301-137OC; LALANCETTE M, 1993, AM REV RESPIR DIS, V148, P216, DOI 10.1164/ajrccm/148.1.216; LEBLANC P, 1986, ARCH INTERN MED, V146, P153, DOI 10.1001/archinte.146.1.153; Matsuoka S, 2010, RADIOGRAPHICS, V30, P55, DOI 10.1148/rg.301095110; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Ministere de l'agriculture, 2014, ENQ ANN LAIT; Mooney JJ, 2013, CHEST, V144, P586, DOI 10.1378/chest.12-2623; PEPYS J, 1963, LANCET, V2, P607; Quirce S, 2016, ALLERGY, V71, P765, DOI 10.1111/all.12866; Reboux G, 2001, AM J RESP CRIT CARE, V163, P1534, DOI 10.1164/ajrccm.163.7.2006077; Rival G, 2016, SARCOIDOSIS VASC DIF, V33, P117; Rossi A, 2015, RESP MED, V109, P785, DOI 10.1016/j.rmed.2015.03.010; Schenker MB, 1998, AM J RESP CRIT CARE, V158, pS1; Soumagne T, 2015, REV MAL RESPIR, V32, P275, DOI 10.1016/j.rmr.2014.04.104; Soumagne Thibaud, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2015-211560; Soumagne T, 2016, THORAX, V71, P804, DOI 10.1136/thoraxjnl-2015-207953; Walsh SLF, 2012, EUR RADIOL, V22, P1672, DOI 10.1007/s00330-012-2427-0; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285	35	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178263	10.1371/journal.pone.0178263	http://dx.doi.org/10.1371/journal.pone.0178263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614400	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900014
J	Thurfjell, H; Ciuti, S; Boyce, MS				Thurfjell, Henrik; Ciuti, Simone; Boyce, Mark S.			Learning from the mistakes of others: How female elk (Cervus elaphus) adjust behaviour with age to avoid hunters	PLOS ONE			English	Article							CONSISTENT INDIVIDUAL-DIFFERENCES; RESOURCE SELECTION; PREDATOR; MOVEMENT; EVOLUTION; RISK; PERSONALITY; LANDSCAPE; RESPONSES; ECOLOGY	In animal behaviour, there is a dichotomy between innate behaviours (e. g., temperament or personality traits) versus those behaviours shaped by learning. Innate personality traits are supposedly less evident in animals when confounded by learning acquired with experience through time. Learning might play a key role in the development and adoption of successful anti-predator strategies, and the related adaptation has the potential to make animals that are more experienced less vulnerable to predation. We carried out a study in a system involving a large herbivorous mammal, female elk, Cervus elaphus, and their primary predator, i. e., human hunters. Using fine-scale satellite telemetry relocations, we tested whether differences in behaviour depending on age were due solely to selection pressure imposed by human hunters, meaning that females that were more cautious were more likely to survive and become older. Or whether learning also was involved, meaning that females adjusted their behaviour as they aged. Our results indicated that both human selection and learning contributed to the adoption of more cautious behavioural strategies in older females. Whereas human selection of behavioural traits has been shown in our previous research, we here provide evidence of additive learning processes being responsible for shaping the behaviour of individuals in this population. Female elk are indeed almost invulnerable to human hunters when older than 9 +/- 10 y. o., confirming that experience contributes to their survival. Female elk monitored in our study showed individually changing behaviours and clear adaptation as they aged, such as reduced movement rates (decreased likelihood of encountering human hunters), and increased use of secure areas (forest and steeper terrain), especially when close to roads. We also found that elk adjusted behaviours depending on the type of threat (bow and arrow vs. rifle hunters). This fine-tuning by elk to avoid hunters, rather than just becoming more cautious during the hunting season, highlights the behavioural plasticity of this species. Selection on behavioural traits and/or behavioural shifts via learning are an important but often-ignored consequence of human exploitation of wild animals. Such information is a critical component of the effects of human exploitation of wildlife populations with implications for improving their management and conservation.	[Thurfjell, Henrik; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Thurfjell, Henrik] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Ciuti, Simone] Univ Freiburg, Dept Biometry & Environm Syst Anal, Freiburg, Germany	University of Alberta; Swedish University of Agricultural Sciences; University of Freiburg	Thurfjell, H (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.; Thurfjell, H (corresponding author), Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden.	henrik.thurfjell@slu.se	Ciuti, Simone/D-7283-2013; Boyce, Mark S/A-2620-2014	Ciuti, Simone/0000-0003-1052-9509; Boyce, Mark S/0000-0001-5811-325X; Thurfjell, Henrik/0000-0001-9261-7654	Natural Sciences and Engineering Research Council of Canada (NSERC) [364323-07]; Alberta Conservation Association [RES0008502]; Shell Canada Limited [364323]; Carl Tryggers Foundation for Scientific Research [CTS 12:499, CTS 13:477]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association; Shell Canada Limited; Carl Tryggers Foundation for Scientific Research	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, Grant number 364323-07) http:// www.nserc-crsng.gc.ca/index_eng.asp received by MSB; Alberta Conservation Association (Grant number RES0008502) http://www.abconservation .com/ received by MSB; Shell Canada Limited (Grant number 364323) http://www.shell ca./ received by MSB, and the Carl Tryggers Foundation for Scientific Research (Grant numbers CTS 12:499, CTS 13:477) http://www. carltryggersstrftelse.se/ received by HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Archard GA, 2010, J ZOOL, V281, P149, DOI 10.1111/j.1469-7998.2010.00714.x; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benz RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162989; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bleicher SS, 2016, ISR J ECOL EVOL, V62, P178, DOI 10.1080/15659801.2016.1176614; Blumstein DT, 1999, ANIM BEHAV, V58, P351, DOI 10.1006/anbe.1999.1156; Bonnot N, 2015, BEHAV ECOL, V26, P105, DOI 10.1093/beheco/aru169; Boyce MS, 2010, PHILOS T R SOC B, V365, P2213, DOI 10.1098/rstb.2010.0080; BROWN JS, 1992, EVOLUTION, V46, P1269, DOI 10.1111/j.1558-5646.1992.tb01123.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Carthey AJR, 2016, OIKOS, V125, P918, DOI 10.1111/oik.02723; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Cleveland SM, 2012, WILDLIFE SOC B, V36, P658, DOI 10.1002/wsb.182; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dawson EH, 2013, CURR BIOL, V23, P727, DOI 10.1016/j.cub.2013.03.035; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Ensing EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106997; ESRI, 2011, ARCGIS DESKT REL 10; Fey K, 2010, WILDLIFE RES, V37, P273, DOI 10.1071/WR08031; Found R, 2016, ANIM BEHAV, V115, P35, DOI 10.1016/j.anbehav.2016.02.007; Frair JL, 2008, J APPL ECOL, V45, P1504, DOI 10.1111/j.1365-2664.2008.01526.x; Frair JL, 2005, LANDSCAPE ECOL, V20, P273, DOI 10.1007/s10980-005-2075-8; Griffin AS, 2009, ANIM BEHAV, V78, P79, DOI 10.1016/j.anbehav.2009.03.012; Hansen BB, 2015, POLAR BIOL, V38, P145, DOI 10.1007/s00300-014-1572-0; Hellstrom G, 2011, BEHAV ECOL SOCIOBIOL, V65, P1917, DOI 10.1007/s00265-011-1201-7; Kareklas K, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0154-0; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Knight Richard L., 1995, P81; Knight Richard L., 1995, P51; KRANTZ GS, 1968, CURR ANTHROPOL, V9, P450, DOI 10.1086/200927; Krebs J.R., 1996, BEHAV ECOLOGY EVOLUT; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Manassa RP, 2014, BEHAV ECOL SOCIOBIOL, V68, P1237, DOI 10.1007/s00265-014-1734-7; Manassa RP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0720; Manassa RP, 2013, OECOLOGIA, V171, P845, DOI 10.1007/s00442-012-2458-x; Manassa RP, 2012, ANIM COGN, V15, P559, DOI 10.1007/s10071-012-0484-z; Millspaugh JJ, 2000, J WILDLIFE MANAGE, V64, P994, DOI 10.2307/3803209; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Muhly TB, 2010, INDIRECT PREDATOR ME; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Proffitt KM, 2013, J WILDLIFE MANAGE, V77, P514, DOI 10.1002/jwmg.491; Proffitt KM, 2010, J WILDLIFE MANAGE, V74, P210, DOI 10.2193/2008-593; R Core Team, 2021, R LANGUAGE ENV STAT; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Rivrud IM, 2016, ECOLOGY, V97, P1058, DOI 10.1890/15-1191.1; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Sommer-Trembo C, 2016, J ETHOL, V34, P155, DOI 10.1007/s10164-016-0460-1; Spiegel O, 2017, ECOL LETT, V20, P3, DOI 10.1111/ele.12708; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Swift KN, 2015, ANIM BEHAV, V109, P187, DOI 10.1016/j.anbehav.2015.08.021; Tortosa FS, 2015, BEHAV ECOL SOCIOBIOL, V69, P1649, DOI 10.1007/s00265-015-1976-z; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Webb SL, 2011, POPUL ECOL, V53, P483, DOI 10.1007/s10144-010-0258-x; Weckerly FW, 2005, WILDLIFE SOC B, V33, P1303, DOI 10.2193/0091-7648(2005)33[1303:HRAHTO]2.0.CO;2; Wolf M, 2007, NATURE, V450, pE5, DOI 10.1038/nature06327; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Wolf M, 2012, AM NAT, V179, P679, DOI 10.1086/665656; Wright GJ, 2006, J WILDLIFE MANAGE, V70, P1070, DOI 10.2193/0022-541X(2006)70[1070:SONYEB]2.0.CO;2; Zedrosser A, 2011, BIOL CONSERV, V144, P2163, DOI 10.1016/j.biocon.2011.05.005; Zuur Alain F., 2009, P1	72	40	40	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178082	10.1371/journal.pone.0178082	http://dx.doi.org/10.1371/journal.pone.0178082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614406	gold, Green Submitted, Green Published			2022-12-26	WOS:000403280900012
J	Lim, M; Ales, JM; Cottereau, BR; Hastie, T; Norcia, AM				Lim, Michael; Ales, Justin M.; Cottereau, Benoit R.; Hastie, Trevor; Norcia, Anthony M.			Sparse EEG/MEG source estimation via a group lasso	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; CONSTRAINED SOURCE ESTIMATION; M/EEG INVERSE PROBLEM; SOURCE RECONSTRUCTION; CORTICAL SURFACE; HUMAN BRAIN; EEG; MODEL; REGRESSION; RETINOTOPY	Non-invasive recordings of human brain activity through electroencephalography (EEG) or magnetoencelphalography (MEG) are of value for both basic science and clinical applications in sensory, cognitive, and affective neuroscience. Here we introduce a new approach to estimating the intra-cranial sources of EEG/MEG activity measured from extra-cranial sensors. The approach is based on the group lasso, a sparse-prior inverse that has been adapted to take advantage of functionally-defined regions of interest for the definition of physiologically meaningful groups within a functionally-based common space. Detailed simulations using realistic source-geometries and data from a human Visual Evoked Potential experiment demonstrate that the group-lasso method has improved performance over traditional l(2) minimum-norm methods. In addition, we show that pooling source estimates across subjects over functionally defined regions of interest results in improvements in the accuracy of source estimates for both the group-lasso and minimum-norm approaches.	[Lim, Michael] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ales, Justin M.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Cottereau, Benoit R.] Univ Toulouse, Ctr Rech Cerveau & Cognit, Toulouse, France; [Cottereau, Benoit R.] CNRS, Toulouse, France; [Hastie, Trevor] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Norcia, Anthony M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; University of St Andrews; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Stanford University; Stanford University	Norcia, AM (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	amnorcia@stanford.edu		Hastie, Trevor/0000-0002-0164-3142; Ales, Justin/0000-0002-2089-1563; Norcia, Anthony/0000-0001-5471-3821	National Institutes of Health [EY018875, EY015790, R01-EB001988-15]; National Science Foundation [DMS-1007719]; NATIONAL EYE INSTITUTE [R01EY018875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by EY018875, National Institutes of Health; EY015790, National Institutes of Health; DMS-1007719, National Science Foundation; and R01-EB001988-15, National Institutes of Health.	Ales J, 2010, NEUROIMAGE, V49, P2494, DOI 10.1016/j.neuroimage.2009.09.022; Ales JM, 2013, NEUROIMAGE, V67, P77, DOI 10.1016/j.neuroimage.2012.10.044; Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Benson N, 2015, J VIS, V15, P584; Bolstad A, 2009, NEUROIMAGE, V46, P1066, DOI 10.1016/j.neuroimage.2009.01.056; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Brewer AA, 2005, NAT NEUROSCI, V8, P1102, DOI 10.1038/nn1507; Chang WT, 2013, HUM BRAIN MAPP, V34, P2190, DOI 10.1002/hbm.22057; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Cottereau B, 2007, NEUROIMAGE, V38, P439, DOI 10.1016/j.neuroimage.2007.07.046; Cottereau BR, 2015, J NEUROSCI METH, V250, P64, DOI 10.1016/j.jneumeth.2014.07.015; Cottereau BR, 2014, NEUROIMAGE, V92, P193, DOI 10.1016/j.neuroimage.2014.01.055; Cottereau BR, 2012, HUM BRAIN MAPP, V33, P2694, DOI 10.1002/hbm.21394; Ding L, 2008, HUM BRAIN MAPP, V29, P1053, DOI 10.1002/hbm.20448; Ding L, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036008; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; GORODNITSKY IF, 1995, ELECTROEN CLIN NEURO, V95, P231, DOI 10.1016/0013-4694(95)00107-A; Gramfort A, 2012, PHYS MED BIOL, V57, P1937, DOI 10.1088/0031-9155/57/7/1937; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Hagler DJ, 2014, HUM BRAIN MAPP, V35, P1815, DOI 10.1002/hbm.22293; Hagler DJ, 2013, HUM BRAIN MAPP, V34, P665, DOI 10.1002/hbm.21461; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Helfrich RF, 2013, BRAIN TOPOGR, V26, P247, DOI 10.1007/s10548-012-0226-1; Henson RN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00076; Huk AC, 2002, J NEUROSCI, V22, P7195; Huk AC, 2002, NAT NEUROSCI, V5, P72, DOI 10.1038/nn774; Knosche TR, 2013, PRIOR KNOWLEDGE CORT, P7; Koyama S, 2005, CURR BIOL, V15, P2027, DOI 10.1016/j.cub.2005.10.069; Limpiti T, 2006, IEEE T BIO-MED ENG, V53, P1740, DOI 10.1109/TBME.2006.873743; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; Martinez-Montes E, 2008, J BIOL PHYS, V34, P315, DOI 10.1007/s10867-008-9077-0; MATSUURA K, 1995, IEEE T BIO-MED ENG, V42, P608, DOI 10.1109/10.387200; Mattout Jeremie, 2007, Comput Intell Neurosci, P67613, DOI 10.1155/2007/67613; Menendez RGD, 1998, P ANN INT IEEE EMBS, V20, P2143, DOI 10.1109/IEMBS.1998.747033; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Nagarajan SS, 2006, NEUROIMAGE, V30, P400, DOI 10.1016/j.neuroimage.2005.09.055; Norcia AM, 2015, J VISION, V15, DOI 10.1167/15.6.4; Ou W, 2008, LECT NOTES COMPUT SC, V5241, P26, DOI 10.1007/978-3-540-85988-8_4; Ou WM, 2009, NEUROIMAGE, V44, P932, DOI 10.1016/j.neuroimage.2008.05.063; Owen JP, 2012, NEUROIMAGE, V60, P305, DOI 10.1016/j.neuroimage.2011.12.027; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Phillips C, 2005, NEUROIMAGE, V24, P997, DOI 10.1016/j.neuroimage.2004.10.030; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Roe AW, 2012, NEURON, V74, P12, DOI 10.1016/j.neuron.2012.03.011; RUSH S, 1969, IEEE T BIO-MED ENG, VBM16, P15, DOI 10.1109/TBME.1969.4502598; Shmuel A, 2005, J NEUROSCI, V25, P2117, DOI 10.1523/JNEUROSCI.4137-04.2005; Simon N, 2013, J COMPUT GRAPH STAT, V22, P231, DOI 10.1080/10618600.2012.681250; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Tarantola A, 2005, INVERSE PROBLEM THEO; Thomas OM, 2002, NAT NEUROSCI, V5, P472, DOI 10.1038/nn837; Tian TS, 2011, STAT INTERFACE, V4, P521; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; VAUGHAN HG, 1970, ELECTROEN CLIN NEURO, V28, P360, DOI 10.1016/0013-4694(70)90228-2; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; WANG JZ, 1992, IEEE T BIO-MED ENG, V39, P665, DOI 10.1109/10.142641; Wang L, 2015, CEREB CORTEX, V25, P3911, DOI 10.1093/cercor/bhu277; Wipf D, 2009, NEUROIMAGE, V44, P947, DOI 10.1016/j.neuroimage.2008.02.059; Wipf DP, 2010, NEUROIMAGE, V49, P641, DOI 10.1016/j.neuroimage.2009.06.083; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	71	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0176835	10.1371/journal.pone.0176835	http://dx.doi.org/10.1371/journal.pone.0176835			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604790	Green Submitted, gold, Green Published			2022-12-26	WOS:000403088400004
J	Zhang, XH; Yuan, D; Sun, Q; Xu, L; Lee, E; Lewis, AJ; Zuckerbraun, BS; Rosengart, MR				Zhang, Xianghong; Yuan, Du; Sun, Qian; Xu, Li; Lee, Emma; Lewis, Anthony J.; Zuckerbraun, Brian S.; Rosengart, Matthew R.			Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis	FASEB JOURNAL			English	Article						mitochondria; macrophage; autophagy; mitochondrial membrane potential	ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL-FUNCTION; PARKINSONS-DISEASE; OXIDATIVE-PHOSPHORYLATION; AUTOPHAGY PROTECTS; ORGAN FAILURE; CALCIUM; MECHANISMS; ACTIVATION; PINK1	During sepsis and shock states, mitochondrial dysfunction occurs. Consequently, adaptive mechanisms, such as fission, fusion, and mitophagy, are induced to eliminate damaged portions or entire dysfunctional mitochondria. The regulatory PINK1/Parkin and DJ-1 pathways are strongly induced by mitochondrial depolarization, although a direct link between loss of mitochondrial membrane potential (Delta(Psi)) and mitophagy has not been identified. Mitochondria also buffer Ca2+, and their buffering capacity is dependent on Delta(Psi). Here, we characterize a role for calcium/calmodulin-dependent protein kinase (CaMK) I in the regulation of these mechanisms. Loss of Delta(Psi) with either pharmacologic depolarization or LPS leads to Ca2+-dependent mitochondrial recruitment and activation of CaMKI that precedes the colocalization of PINK1/Parkin and DJ-1. CaMKI is required and serves as both a PINK1 and Parkin kinase. The mechanisms operate in both immune and nonimmune cells and are induced in in vivo models of endotoxemia, sepsis, and hemorrhagic shock. These data support the idea that CaMKI links mitochondrial stress with the PINK1/Parkin and DJ-1 mechanisms of mitophagy.-Zhang, X., Yuan, D., Sun, Q., Xu, L., Lee, E., Lewis, A. J., Zuckerbraun, B. S., Rosengart, M. R. Calcium/calmodulin-dependent protein kinase regulates the PINK1/Parkin and DJ-1 pathways of mitophagy during sepsis.	[Zhang, Xianghong; Yuan, Du; Sun, Qian; Xu, Li; Lee, Emma; Lewis, Anthony J.; Zuckerbraun, Brian S.; Rosengart, Matthew R.] Univ Pittsburgh, Dept Surg, 200 Lothrop St,Suite F1266-1, Pittsburgh, PA 15213 USA; [Yuan, Du] Cent S Univ, Dept Med, Third Xiangya Hosp, Changsha, Hunan, Peoples R China; [Xu, Li] Huazhong Univ Sci & Technol, Union Hosp, Dept Emergency Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Huazhong University of Science & Technology	Rosengart, MR (corresponding author), Univ Pittsburgh, Dept Surg, 200 Lothrop St,Suite F1266-1, Pittsburgh, PA 15213 USA.	rosengartmr@upmc.edu		Lewis, Anthony/0000-0002-7986-0956	U.S. National Institutes of Health, National Institute of General Medical Sciences [R01-GM082852]; Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082852, T32GM008516] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Surgical Infection Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Kevin P. Mollen and John E. Griepentrog (both from the University of Pittsburgh) for their assistance in interpreting the final collective data and reviewing the final manuscript. This work was supported by the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01-GM082852 (to M.R.R.), and the Surgical Infection Society Junior Faculty Fellowship Award (to X.Z.). The authors declare no conflicts of interest.	Aerts L, 2015, J BIOL CHEM, V290, P2798, DOI 10.1074/jbc.M114.620906; Bauerfeld CP, 2012, J IMMUNOL, V188, P2847, DOI 10.4049/jimmunol.1102157; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Carchman EH, 2013, FASEB J, V27, P4703, DOI 10.1096/fj.13-229476; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Collage RD, 2013, CRIT CARE MED, V41, pE352, DOI 10.1097/CCM.0b013e31828cf436; Crouser ED, 2004, MITOCHONDRION, V4, P729, DOI 10.1016/j.mito.2004.07.023; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Eid N, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00100; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Evankovich J, 2012, AM J PHYSIOL-GASTR L, V303, pG189, DOI 10.1152/ajpgi.00051.2012; Gomez H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135032; Guo LP, 2013, J IMMUNOL, V190, P3620, DOI 10.4049/jimmunol.1102975; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Howe CJ, 2002, J BIOL CHEM, V277, P30469, DOI 10.1074/jbc.M205036200; Howe CJ, 2004, J BIOL CHEM, V279, P44573, DOI 10.1074/jbc.M404175200; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Loughran PA, 2013, NITRIC OXIDE-BIOL CH, V31, P9, DOI 10.1016/j.niox.2013.02.084; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; McCoy MK, 2012, ANTIOXID REDOX SIGN, V16, P869, DOI [10.1089/ars.2011.4019, 10.1089/ars.2011.4074]; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Nace GW, 2013, HEPATOLOGY, V58, P374, DOI 10.1002/hep.26346; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Puleston Daniel, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot086298; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimizu Y, 2016, J MOL CELL CARDIOL, V97, P56, DOI 10.1016/j.yjmcc.2016.04.008; Singer M, 2005, CRIT CARE MED, V33, pS539, DOI 10.1097/01.CCM.0000186080.13402.96; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Stedman DR, 2004, FEBS LETT, V566, P275, DOI 10.1016/j.febslet.2004.04.042; Takahashi-Niki K, 2016, BIOCHEM BIOPH RES CO, V474, P131, DOI 10.1016/j.bbrc.2016.04.084; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Whelan SP, 2014, J SURG RES, V186, P297, DOI 10.1016/j.jss.2013.08.007; Williams JA, 2015, AM J PHYSIOL-GASTR L, V309, pG324, DOI 10.1152/ajpgi.00108.2015; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; YOKOKURA H, 1995, J BIOL CHEM, V270, P23851, DOI 10.1074/jbc.270.40.23851; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015; Zhang XH, 2014, J IMMUNOL, V193, P2405, DOI 10.4049/jimmunol.1302798; Zhang XH, 2011, J LEUKOCYTE BIOL, V90, P249, DOI 10.1189/jlb.0510286	79	25	26	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4382	4395		10.1096/fj.201601096RRR	http://dx.doi.org/10.1096/fj.201601096RRR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28615325	Green Published			2022-12-26	WOS:000413397400017
J	Pradhan, S; Khatlani, T; Nairn, AC; Vijayan, KV				Pradhan, Subhashree; Khatlani, Tanvir; Nairn, Angus C.; Vijayan, K. Vinod			The heterotrimeric G protein G beta(1) interacts with the catalytic subunit of protein phosphatase 1 and modulates G protein-coupled receptor signaling in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ACTIVATION; PHOSPHORYLATION; INTEGRIN; DEPHOSPHORYLATION; G-ALPHA(12); INHIBITION; PI3K-GAMMA; DEFECTS; 1-BETA	Thrombosis is caused by the activation of platelets at the site of ruptured atherosclerotic plaques. This activation involves engagement of G protein-coupled receptors (GPCR) on platelets that promote their aggregation. Although it is known that protein kinases and phosphatases modulate GPCR signaling, how serine/threonine phosphatases integrate with G protein signaling pathways is less understood. Because the subcellular localization and substrate specificity of the catalytic subunit of protein phosphatase 1 (PP1c) is dictated by PP1c-interacting proteins, here we sought to identify new PP1c interactors. GPCRs signal via the canonical heterotrimeric G alpha and G beta gamma subunits. Using a yeast two-hybrid screen, we discovered an interaction between PP1c alpha and the heterotrimeric G protein G beta(1) subunit. Co-immunoprecipitation studies with epitope-tagged PP1c and G beta(1) revealed that G beta(1) interacts with the PP1c alpha, beta, and gamma 1 isoforms. Purified PP1c bound to recombinant G beta(1)-GST protein, and PP1c co-immunoprecipitated with G beta(1) in unstimulated platelets. Thrombin stimulation of platelets induced the dissociation of the PP1c-G beta(1) complex, which correlated with an association of PP1c with phospholipase C beta(3) (PLC beta 3), along with a concomitant dephosphorylation of the inhibitory Ser(1105) residue in PLC beta 3. siRNA-mediated depletion of GNB1 (encoding G beta(1)) in murine megakaryocytes reduced protease-activated receptor 4, activating peptide-induced soluble fibrinogen binding. Thrombin-induced aggregation was decreased in PP1c alpha(-/-) murine platelets and in human platelets treated with a small-molecule inhibitor of G beta gamma. Finally, disruption of PP1c-G beta(1) complexes with myristoylated G beta(1) peptides containing the PP1c binding site moderately decreased throm-bin-induced human platelet aggregation. These findings suggest that G beta(1) protein enlists PP1c to modulate GPCR signaling in platelets.	[Pradhan, Subhashree; Khatlani, Tanvir; Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Pradhan, Subhashree; Khatlani, Tanvir] MEDVAMC, CTRID, Houston, TX 77030 USA; [Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Khatlani, Tanvir] KAIMRC, Minist Natl Guard Hlth Affairs, Riyadh 11426, Saudi Arabia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Yale University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs	Vijayan, KV (corresponding author), Baylor Coll Med, Cardiovasc Res Sect, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.; Vijayan, KV (corresponding author), MEDVAMC, Rm 146,Bldg 109,2002 Holcombe Blvd, Houston, TX 77030 USA.	vvijayan@bcm.edu		Nairn, Angus/0000-0002-7075-0195	National Institutes of Health [HL081613, GM112806]; Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary R. Gibson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL081613 and GM112806. K. V. V. is supported by the Mary R. Gibson Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the United States government, or the National Institutes of Health.	Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chatterjee J, 2012, ANGEW CHEM INT EDIT, V51, P10054, DOI 10.1002/anie.201204308; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cohen PTW, 2002, J CELL SCI, V115, P241; Croci C, 2003, J BIOL CHEM, V278, P50682, DOI 10.1074/jbc.M305764200; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gegenbauer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080251; Gehret AU, 2013, ACS CHEM BIOL, V8, P588, DOI 10.1021/cb3004513; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Gushiken FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008304; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Lee SB, 1996, BLOOD, V88, P1684; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; Liu RJ, 2015, J MOL CELL CARDIOL, V87, P204, DOI 10.1016/j.yjmcc.2015.08.018; Ma PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119496; Ma PS, 2012, BLOOD, V119, P1935, DOI 10.1182/blood-2011-10-387910; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Poll F, 2011, J BIOL CHEM, V286, P32931, DOI 10.1074/jbc.M111.224899; RAO AK, 1989, BLOOD, V74, P664; Shankar H, 2006, CURR DRUG TARGETS, V7, P1253, DOI 10.2174/138945006778559166; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; Yamaguchi Y, 2002, CURR BIOL, V12, P1353, DOI 10.1016/S0960-9822(02)01034-5; Yang X, 1996, BLOOD, V88, P1676; You DJ, 2010, MOL CELLS, V30, P527, DOI 10.1007/s10059-010-0155-3; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Yue CP, 2000, J BIOL CHEM, V275, P30220, DOI 10.1074/jbc.M004276200; Yue CP, 1998, J BIOL CHEM, V273, P18023, DOI 10.1074/jbc.273.29.18023; Zhu DG, 2004, J BIOL CHEM, V279, P54983, DOI 10.1074/jbc.C400508200	35	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13133	13142		10.1074/jbc.M117.796656	http://dx.doi.org/10.1074/jbc.M117.796656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28615442	Green Published, hybrid			2022-12-26	WOS:000407465300005
J	Orth, C; Niemann, N; Hennig, L; Essen, LO; Batschauer, A				Orth, Christian; Niemann, Nils; Hennig, Lars; Essen, Lars-Oliver; Batschauer, Alfred			Hyperactivity of the Arabidopsis cryptochrome (cry1) L407F mutant is caused by a structural alteration close to the cry1 ATP-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; cryptochrome; nucleotide; photobiology; plant biochemistry; nucleotide binding	BLUE-LIGHT PHOTORECEPTORS; ELECTRON-TRANSFER; SIGNALING STATE; DNA PHOTOLYASE; DOMAIN; PROTEIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION; RECOGNITION; MECHANISMS	Plant cryptochromes (cry) act as UV-A/blue light receptors. The prototype, Arabidopsis thaliana cry1, regulates several light responses during the life cycle, including de-etiolation, and is also involved in regulating flowering time. The cry1 photocycle is initiated by light absorption by its FAD chromophore, which is most likely fully oxidized (FAD(ox)) in the dark state and photoreduced to the neutral flavin semiquinone (FADH degrees) in its lit state. Cryptochromes lack the DNA-repair activity of the closely related DNA photolyases, but they retain the ability to bind nucleotides such as ATP. The previously characterized L407F mutant allele of Arabidopsis cry1 is biologically hyperactive and seems to mimic the ATP-bound state of cry1, but the reason for this phenotypic change is unclear. Here, we show that cry1L407F can still bind ATP, has less pronounced photoreduction and formation of FADH degrees than wild-type cry1, and has a dark reversion rate 1.7 times lower than that of the wild type. The hyperactivity of cry1L407F is not related to a higher FADH degrees occupancy of the photoreceptor but is caused by a structural alteration close to the ATP-binding site. Moreover, we show that ATP binds to cry1 in both the dark and the lit states. This binding was not affected by cry1's C-terminal extension, which is important for signal transduction. Finally, we show that a recently discovered chemical inhibitor of cry1, 3-bromo-7-nitroindazole, competes for ATP binding and thereby diminishes FADH degrees formation, which demonstrates that both processes are important for cry1 function.	[Orth, Christian; Niemann, Nils; Batschauer, Alfred] Philipps Univ, Fac Biol, Dept Plant Physiol & Photobiol, D-35032 Marburg, Germany; [Essen, Lars-Oliver] Philipps Univ, Fac Chem, Dept Biochem, D-35032 Marburg, Germany; [Hennig, Lars] Swedish Univ Agr Sci, Dept Plant Biol, SE-75007 Uppsala, Sweden; [Hennig, Lars] Linnean Ctr Plant Biol, SE-75007 Uppsala, Sweden	Philipps University Marburg; Philipps University Marburg; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Batschauer, A (corresponding author), Philipps Univ, Fac Biol, Dept Plant Physiol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	batschau@staff.uni-marburg.de	Essen, Lars-Oliver/L-3862-2016; Hennig, Lars/G-2081-2011	Essen, Lars-Oliver/0000-0003-4272-4026; Hennig, Lars/0000-0002-6645-1862	Deutsche Forschungsgemeinschaft (DFG) within Priority Program "Flowering time control: from natural variation to crop improvement" [BA985/14-1]; Deutsche Forschungsgemeinschaft (DFG) within Collaborative Research Center 987	Deutsche Forschungsgemeinschaft (DFG) within Priority Program "Flowering time control: from natural variation to crop improvement"(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG) within Collaborative Research Center 987(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant BA985/14-1 (to A. B.) within Priority Program "Flowering time control: from natural variation to crop improvement," and grants within Collaborative Research Center 987 (to A. B. and L.-O. E.). The authors declare that they have no conflicts of interest with the contents of this article.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; BLATT MR, 1987, J MEMBRANE BIOL, V98, P257, DOI 10.1007/BF01871188; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Cailliez F, 2014, J AM CHEM SOC, V136, P12974, DOI 10.1021/ja506084f; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; El-Esawi M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1063758; Engelhard C, 2014, PLANT CELL, V26, P4519, DOI 10.1105/tpc.114.129809; Exner V, 2010, PLANT PHYSIOL, V154, P1633, DOI 10.1104/pp.110.160895; Forneris F, 2009, FEBS J, V276, P2833, DOI 10.1111/j.1742-4658.2009.07006.x; Gao J, 2015, P NATL ACAD SCI USA, V112, P9135, DOI 10.1073/pnas.1504404112; Gas E, 2009, PLANT CELL, V21, P18, DOI 10.1105/tpc.108.065243; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; He SB, 2015, MOL PLANT, V8, P822, DOI 10.1016/j.molp.2015.02.008; Hense A, 2015, J BIOL CHEM, V290, P1743, DOI 10.1074/jbc.M114.606327; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Komori H, 2001, P NATL ACAD SCI USA, V98, P13560, DOI 10.1073/pnas.241371398; Kondoh M, 2011, J MOL BIOL, V413, P128, DOI 10.1016/j.jmb.2011.08.031; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Liu BB, 2016, J PLANT RES, V129, P137, DOI 10.1007/s10265-015-0782-z; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mei QM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135940; Moore PK, 1996, METHOD ENZYMOL, V268, P393; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Muller P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05175; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; Nsa IY, 2015, GENETICS, V199, P233, DOI 10.1534/genetics.114.169441; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P352, DOI 10.1016/j.fgb.2009.11.004; Ong WD, 2017, PLANT CELL PHYSIOL, V58, P95, DOI 10.1093/pcp/pcw181; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Pedmale UV, 2016, CELL, V164, P233, DOI 10.1016/j.cell.2015.12.018; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; Pokorny R, 2005, ACTA CRYSTALLOGR F, V61, P935, DOI 10.1107/S1744309105028897; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Procopio M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00888; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shalitin D, 2003, PLANT CELL, V15, P2421, DOI 10.1105/tpc.013011; Shalitin D, 2002, NATURE, V417, P763, DOI 10.1038/nature00815; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tan ST, 2013, PLANT CELL, V25, P2618, DOI 10.1105/tpc.113.114322; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Wang Q, 2015, MOL PLANT, V8, P631, DOI 10.1016/j.molp.2015.03.005; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 2017, PHOTOCHEM PHOTOBIOL, V93, P112, DOI 10.1111/php.12663; Zhang M, 2016, SCIENCE, V354, P209, DOI 10.1126/science.aah6071	62	4	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12906	12920		10.1074/jbc.M117.788869	http://dx.doi.org/10.1074/jbc.M117.788869			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28634231	hybrid, Green Published			2022-12-26	WOS:000407220100020
J	Gu, X; Yan, Y; Novick, SJ; Kovach, A; Goswami, D; Ke, JY; Tan, MHE; Wang, LL; Li, XD; de Waal, PW; Webb, MR; Griffin, PR; Xu, HE; Melcher, K				Gu, Xin; Yan, Yan; Novick, Scott J.; Kovach, Amanda; Goswami, Devrishi; Ke, Jiyuan; Tan, M. H. Eileen; Wang, Lili; Li, Xiaodan; de Waal, Parker W.; Webb, Martin R.; Griffin, Patrick R.; Xu, H. Eric; Melcher, Karsten			Deconvoluting AMP-activated protein kinase (AMPK) adenine nucleotide binding and sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; AMP-activated kinase (AMPK); ATP; energy metabolism; protein kinase; CBS; HDX-MS; NADPH	PARKINSON-WHITE-SYNDROME; GAMMA-SUBUNIT ISOFORMS; ACETYL-COA CARBOXYLASE; STRUCTURAL BASIS; METABOLIC DISEASES; EXERCISE MIMETICS; GLYCOGEN-STORAGE; R225W MUTATION; ENERGY-CHARGE; LIFE-SPAN	AMP-activated protein kinase (AMPK) is a central cellular energy sensor that adapts metabolism and growth to the energy state of the cell. AMPK senses the ratio of adenine nucleotides (adenylate energy charge) by competitive binding of AMP, ADP, and ATP to three sites (CBS1, CBS3, and CBS4) in its -subunit. Because these three binding sites are functionally interconnected, it remains unclear how nucleotides bind to individual sites, which nucleotides occupy each site under physiological conditions, and how binding to one site affects binding to the other sites. Here, we comprehensively analyze nucleotide binding to wild-type and mutant AMPK protein complexes by quantitative competition assays and by hydrogen-deuterium exchange MS. We also demonstrate that NADPH, in addition to the known AMPK ligand NADH, directly and competitively binds AMPK at the AMP-sensing CBS3 site. Our findings reveal how AMP binding to one site affects the conformation and adenine nucleotide binding at the other two sites and establish CBS3, and not CBS1, as the high affinity exchangeable AMP/ADP/ATP-binding site. We further show that AMP binding at CBS4 increases AMP binding at CBS3 by 2 orders of magnitude and reverses the AMP/ATP preference of CBS3. Together, these results illustrate how the three CBS sites collaborate to enable highly sensitive detection of cellular energy states to maintain the tight ATP homeostastis required for cellular metabolism.	[Gu, Xin; Yan, Yan; Kovach, Amanda; Ke, Jiyuan; Tan, M. H. Eileen; Wang, Lili; Li, Xiaodan; de Waal, Parker W.; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Ctr Canc & Cell Biol, Labs Struct Sci & Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA; [Yan, Yan; Xu, H. Eric] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, VARI SIMM Ctr,Ctr Struct & Funct Drug Targets, Shanghai 201203, Peoples R China; [Novick, Scott J.; Goswami, Devrishi; Griffin, Patrick R.] Scripps Res Inst, Translat Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Tan, M. H. Eileen; Webb, Martin R.] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England	Van Andel Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute; Francis Crick Institute	Melcher, K (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Labs Struct Sci & Struct Biol & Biochem, 333 Bostwick Ave Northeast, Grand Rapids, MI 49503 USA.	karsten.melcher@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; de Waal, Parker/M-1138-2017	Melcher, Karsten/0000-0002-9125-4027; de Waal, Parker/0000-0001-6922-9768; Webb, Martin/0000-0002-0134-9621; Xu, H. Eric/0000-0002-6829-8144	Francis Crick Institute; Cancer Research UK [FC001211]; United Kingdom Medical Research Council [FC001211]; Wellcome Trust [FC001211]; Van Andel Research Institute; Ministry of Science and Technology (China) [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; National Science Foundation [91217311]; National Institute of Health [DK071662, GM102545, GM104212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104212, R01GM102545] Funding Source: NIH RePORTER; The Francis Crick Institute [10211] Funding Source: researchfish	Francis Crick Institute; Cancer Research UK(Cancer Research UK); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Van Andel Research Institute; Ministry of Science and Technology (China)(Ministry of Science and Technology, China); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); The Francis Crick Institute	This work was supported by the Francis Crick Institute with funding from Cancer Research UK Grant FC001211, United Kingdom Medical Research Council Grant FC001211, Wellcome Trust Grant FC001211 (to M.R.W.), grants from the Van Andel Research Institute (to H.E.X. and K.M.), Ministry of Science and Technology (China) Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001, National Science Foundation Grant 91217311 (to H.E.X.), and National Institute of Health Grants DK071662 (to H.E.X.) and GM102545 and GM104212 (to K.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bullon P, 2016, EXPERIENTIA SUPPL, V107, P129, DOI 10.1007/978-3-319-43589-3_6; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Chalmers Michael J, 2007, J Biomol Tech, V18, P194; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen L, 2013, NATURE, V498, pE8, DOI 10.1038/nature12189; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Cheng J, 2016, BBA-REV CANCER, V1866, P232, DOI 10.1016/j.bbcan.2016.09.006; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Costford SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000903; Crawford SA, 2010, DIABETOLOGIA, V53, P1986, DOI 10.1007/s00125-010-1788-7; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Daskalopoulos EP, 2016, EXPERIENTIA SUPPL, V107, P179, DOI 10.1007/978-3-319-43589-3_8; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DiCarlo SE, 2001, ADV PHYSIOL EDUC, V25, P71; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Goswami D, 2013, J AM SOC MASS SPECTR, V24, P1584, DOI 10.1007/s13361-013-0669-y; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Granlund A, 2010, EXP PHYSIOL, V95, P541, DOI 10.1113/expphysiol.2009.051326; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hinson JT, 2016, CELL REP, V17, P3292, DOI 10.1016/j.celrep.2016.11.066; Kim M, 2014, CIRC RES, V114, P966, DOI 10.1161/CIRCRESAHA.114.302364; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Ross FA, 2016, BIOCHEM J, V473, P189, DOI 10.1042/BJ20150910; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Wall CE, 2016, J MOL ENDOCRINOL, V57, pR49, DOI 10.1530/JME-16-0073; Wang ZY, 2016, EXPERIENTIA SUPPL, V107, P203, DOI 10.1007/978-3-319-43589-3_9; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Weikel KA, 2016, METABOLISM, V65, P634, DOI 10.1016/j.metabol.2016.01.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yang XD, 2016, J BIOL CHEM, V291, P23428, DOI 10.1074/jbc.M116.738591; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005	49	31	34	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12653	12666		10.1074/jbc.M117.793018	http://dx.doi.org/10.1074/jbc.M117.793018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28615457	Green Published, hybrid			2022-12-26	WOS:000406636900029
J	Munoz-Almaraz, FJ; Zamora-Martinez, F; Botella-Rocamora, P; Pardo, J				Javier Munoz-Almaraz, Francisco; Zamora-Martinez, Francisco; Botella-Rocamora, Paloma; Pardo, Juan			Supervised filters for EEG signal in naturally occurring epilepsy forecasting	PLOS ONE			English	Article							CANINE EPILEPSY; CLASSIFICATION	Nearly 1% of the global population has Epilepsy. Forecasting epileptic seizures with an acceptable confidence level, could improve the disease treatment and thus the lifestyle of the people who suffer it. To do that the electroencephalogram (EEG) signal is usually studied through spectral power band filtering, but this paper proposes an alternative novel method of preprocessing the EEG signal based on supervised filters. Such filters have been employed in a machine learning algorithm, such as the K-Nearest Neighbor (KNN), to improve the prediction of seizures. The proposed solution extends with this novel approach an algorithm that was submitted to win the third prize of an international Data Science challenge promoted by Kaggle contest platform and the American Epilepsy Society, the Epilepsy Foundation, National Institutes of Health (NIH) and Mayo Clinic. A formal description of these preprocessing methods is presented and a detailed analysis in terms of Receiver Operating Characteristics (ROC) curve and Area Under ROC curve is performed. The obtained results show statistical significant improvements when compared with the spectral power band filtering (PBF) typical baseline. A trend between performance and the dataset size is observed, suggesting that the supervised filters bring better information, compared to the conventional PBF filters, as the dataset grows in terms of monitored variables ( sensors) and time length. The paper demonstrates a better accuracy in forecasting when new filters are employed and its main contribution is in the field of machine learning algorithms to develop more accurate predictive systems.	[Javier Munoz-Almaraz, Francisco; Zamora-Martinez, Francisco; Botella-Rocamora, Paloma; Pardo, Juan] Univ CEU Cardenal Herrera, Dept Phys Sci Math & Comp, ESAI Embedded Syst & Artificial Intelligence Grp, Valencia, Spain; [Javier Munoz-Almaraz, Francisco] Univ CEU Cardenal Herrera, Escuela Super Ensenanzas Tecn, C San Bartolome 55, Valencia 46115, Spain	Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera	Munoz-Almaraz, FJ (corresponding author), Univ CEU Cardenal Herrera, Dept Phys Sci Math & Comp, ESAI Embedded Syst & Artificial Intelligence Grp, Valencia, Spain.; Munoz-Almaraz, FJ (corresponding author), Univ CEU Cardenal Herrera, Escuela Super Ensenanzas Tecn, C San Bartolome 55, Valencia 46115, Spain.	malmaraz@uchceu.es	Albiach, Juan Pardo/Z-3405-2019; Muñoz Almaraz, Francisco Javier/M-2265-2017; Castro-Bleda, M. J./H-2372-2011; Pardo, Juan/E-3839-2017	Albiach, Juan Pardo/0000-0003-4184-9855; Muñoz Almaraz, Francisco Javier/0000-0002-2372-5712; Pardo, Juan/0000-0003-4184-9855; Botella Rocamora, Paloma/0000-0003-1907-6091	Vicerrectorado de Investigacion of the Universidad CEU Cardenal Herrera	Vicerrectorado de Investigacion of the Universidad CEU Cardenal Herrera	This work has been supported by the grant Consolidacion de Indicadores CEU-UCH 2015-16 provided by Vicerrectorado de Investigacion of the Universidad CEU Cardenal Herrera.	Brinkmann BH, 2016, BRAIN, V139, P1713, DOI 10.1093/brain/aww045; Brinkmann BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133900; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Denison T, 2015, IEEE SPECTRUM, V52, P32, DOI 10.1109/MSPEC.2015.7024509; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Goldberger J., 2005, ADV NEURAL INFORM PR, V17, P513, DOI DOI 10.1109/TCSVT.2013.2242640; Howbert JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081920; Kaggle Inc, 2015, AM EP SOC SEIZ PREDI; Kodipaka S, 2007, MED IMAGE ANAL, V11, P79, DOI 10.1016/j.media.2006.10.002; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Korshunova I., 2015, EPILEPTIC SEIZURE PR; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Murray CJ, GLOBAL COMP ASSESSME; Park Y, 2011, EPILEPSIA, V52, P1761, DOI 10.1111/j.1528-1167.2011.03138.x; Parlett BN., 1998, SYMMETRIC EIGENVALUE; Patterson EE, 2014, ILAR J, V55, P182, DOI 10.1093/ilar/ilu021; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Qi FF, 2015, IEEE T NEUR NET LEAR, V26, P3070, DOI 10.1109/TNNLS.2015.2402694; World Health Organization, 2015, 999 WHO; Zamora-Martinez F, 2014, PATTERN RECOGNIZER L; Zamora-Martinez F, 2015, SEIZURE PREDICTION S	22	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178808	10.1371/journal.pone.0178808	http://dx.doi.org/10.1371/journal.pone.0178808			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632737	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100009
J	Kinoti, WM; Constable, FE; Nancarrow, N; Plummer, KM; Rodoni, B				Kinoti, Wycliff M.; Constable, Fiona E.; Nancarrow, Narelle; Plummer, Kim M.; Rodoni, Brendan			Analysis of intra-host genetic diversity of Prunus necrotic ringspot virus (PNRSV) using amplicon next generation sequencing	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; SPECIES LEVEL; RECOMBINATION; ILARVIRUSES; MOVEMENT; GENOME; IDENTIFICATION; TECHNOLOGIES; REASSORTMENT; VARIABILITY	PCR amplicon next generation sequencing (NGS) analysis offers a broadly applicable and targeted approach to detect populations of both high-or low-frequency virus variants in one or more plant samples. In this study, amplicon NGS was used to explore the diversity of the tripartite genome virus, Prunus necrotic ringspot virus (PNRSV) from 53 PNRSV-infected trees using amplicons from conserved gene regions of each of PNRSV RNA1, RNA2 and RNA3. Sequencing of the amplicons from 53 PNRSV-infected trees revealed differing levels of polymorphism across the three different components of the PNRSV genome with a total number of 5040, 2083 and 5486 sequence variants observed for RNA1, RNA2 and RNA3 respectively. The RNA2 had the lowest diversity of sequences compared to RNA1 and RNA3, reflecting the lack of flexibility tolerated by the replicase gene that is encoded by this RNA component. Distinct PNRSV phylo-groups, consisting of closely related clusters of sequence variants, were observed in each of PNRSV RNA1, RNA2 and RNA3. Most plant samples had a single phylo-group for each RNA component. Haplotype network analysis showed that smaller clusters of PNRSV sequence variants were genetically connected to the largest sequence variant cluster within a phylo-group of each RNA component. Some plant samples had sequence variants occurring in multiple PNRSV phylo-groups in at least one of each RNA and these phylo-groups formed distinct clades that represent PNRSV genetic strains. Variants within the same phylo-group of each Prunus plant sample had >= 97% similarity and phylo-groups within a Prunus plant sample and between samples had less <= 97% similarity. Based on the analysis of diversity, a definition of a PNRSV genetic strain was proposed. The proposed definition was applied to determine the number of PNRSV genetic strains in each of the plant samples and the complexity in defining genetic strains in multipartite genome viruses was explored.	[Kinoti, Wycliff M.; Constable, Fiona E.; Nancarrow, Narelle; Rodoni, Brendan] La Trobe Univ, Agr Victoria, AgriBio, Melbourne, Vic, Australia; [Kinoti, Wycliff M.; Rodoni, Brendan] La Trobe Univ, AgriBio, Sch Appl Syst Biol, Melbourne, Vic, Australia; [Plummer, Kim M.] La Trobe Univ, AgriBio, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia	La Trobe University; La Trobe University; La Trobe University	Kinoti, WM (corresponding author), La Trobe Univ, Agr Victoria, AgriBio, Melbourne, Vic, Australia.; Kinoti, WM (corresponding author), La Trobe Univ, AgriBio, Sch Appl Syst Biol, Melbourne, Vic, Australia.	wkinoti@students.latrobe.edu.au	Constable, Fiona/AAF-5520-2020; Plummer, Kim/B-4911-2016	Plummer, Kim/0000-0001-6846-642X	La Trobe University Research Scholarship; Almond Board Australia; Horticulture Innovation Australia	La Trobe University Research Scholarship; Almond Board Australia; Horticulture Innovation Australia(Horticulture Australia Limited)	This research was funded by the La Trobe University Research Scholarship (http://WWW.latrobe.edu.au/),the Almond Board Australia (http://WWW.australianalmonds.com.au) and Horticulture Innovation Australia (http://horticulture.com.au/). It was undertaken using the facilities Agriculture Victoria, Australia. This study forms part of a PhD project by the first author at the La Trobe University, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrew R., 2009, FIGTREE; Aparicio E, 1999, PHYTOPATHOLOGY, V89, P991, DOI 10.1094/PHYTO.1999.89.11.991; Aparicio F, 2002, VIRUS GENES, V25, P75, DOI 10.1023/A:1020126309692; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barzon L, 2013, J CLIN VIROL, V58, P346, DOI 10.1016/j.jcv.2013.03.003; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; Bergua M, 2014, PHYTOPATHOLOGY, V104, P1241, DOI 10.1094/PHYTO-11-13-0309-R; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; Chen LF, 2009, MOL PLANT PATHOL, V10, P415, DOI [10.1111/J.1364-3703.2009.00541.X, 10.1111/j.1364-3703.2009.00541.x]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Cui HG, 2015, CROP PROT, V74, P30, DOI 10.1016/j.cropro.2015.04.001; Di Terlizzi B, 2001, ARCH VIROL, V146, P825, DOI 10.1007/s007050170151; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Domingo E, 1998, CLIN DIAGN VIROL, V10, P97, DOI 10.1016/S0928-0197(98)00032-4; Dunham JP, 2014, VIRUS RES, V191, P172, DOI 10.1016/j.virusres.2014.07.030; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Fabre F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002654; Fauquet CM, 2005, ARCH VIROL, V150, P2151, DOI 10.1007/s00705-005-0583-0; Fiore N, 2008, ARCH VIROL, V153, P909, DOI 10.1007/s00705-008-0066-1; Garcia-Arenal F, 2003, INT MICROBIOL, V6, P225, DOI 10.1007/s10123-003-0142-z; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; GUO D, 1995, J GEN VIROL, V76, P1073, DOI 10.1099/0022-1317-76-5-1073; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hammond RW, 1998, J GEN VIROL, V79, P1815, DOI 10.1099/0022-1317-79-7-1815; Hull R., 2013, PLANT VIROLOGY; Illumina, PREP LIB SEQ MIS 201; Ince WL, 2013, J VIROL, V87, P4330, DOI 10.1128/JVI.02749-12; Iranzo J, 2012, P ROY SOC B-BIOL SCI, V279, P3812, DOI 10.1098/rspb.2012.1086; Jridi C, 2006, J VIROL, V80, P2349, DOI 10.1128/JVI.80.5.2349-2357.2006; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Krueger F., 2012, TRIM GALORE; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez F, 2012, MOL BIOL EVOL, V29, P3297, DOI 10.1093/molbev/mss135; Fajardo TVM, 2015, CIENC RURAL, V45, P2197, DOI 10.1590/0103-8478cr20141810; McElroy Kerensa, 2014, Microb Inform Exp, V4, P1, DOI 10.1186/2042-5783-4-1; MINK GI, 1987, PLANT DIS, V71, P91, DOI 10.1094/PD-71-0091; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Orton Richard J, 2015, BMC Genomics, V16, P229, DOI 10.1186/s12864-015-1456-x; Pallas V, 2012, PHYTOPATHOLOGY, V102, P1108, DOI 10.1094/PHYTO-02-12-0023-RVW; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655; Prabha K, 2013, INDIAN J VIROL, V24, P157, DOI 10.1007/s13337-013-0133-4; Prabhakaran S, 2010, MACH LEARN COMP BIOL; PRINGLE CR, 1991, ARCH VIROL, V119, P303, DOI 10.1007/BF01310680; Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Radford AD, 2012, J GEN VIROL, V93, P1853, DOI 10.1099/vir.0.043182-0; Randles J, 1997, PLANT PATHOGENS PLAN, P104; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roossinck MJ, 2002, J VIROL, V76, P3382, DOI 10.1128/JVI.76.7.3382-3387.2002; Sanchez-Navarro JA, 2013, J VIROL, V87, P10805, DOI 10.1128/JVI.01402-13; SanchezNavarro JA, 1997, ARCH VIROL, V142, P749, DOI 10.1007/s007050050116; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Scott SW, 1998, EUR J PLANT PATHOL, V104, P155, DOI 10.1023/A:1008668129926; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Van Regenmortel MHV, 2007, INFECT GENET EVOL, V7, P133, DOI 10.1016/j.meegid.2006.04.002; Van Regenmortel MHV, 2003, ARCH VIROL, V148, P2481, DOI 10.1007/s00705-003-0246-y; VANVLOTENDOTING L, 1985, PLANT MOL BIOL, V4, P323, DOI 10.1007/BF02418253; Vlot AC, 2002, J VIROL, V76, P11321, DOI 10.1128/JVI.76.22.11321-11328.2002; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Westbrooks K, 2008, LECT N BIOINFORMAT, V4983, P159, DOI 10.1007/978-3-540-79450-9_15; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Wu QF, 2015, ANNU REV PHYTOPATHOL, V53, P425, DOI 10.1146/annurev-phyto-080614-120030; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	81	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179284	10.1371/journal.pone.0179284	http://dx.doi.org/10.1371/journal.pone.0179284			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632759	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100017
J	Le, VT; Klebanoff, MA; Talavera, MM; Slaughter, JL				Le, Vi T.; Klebanoff, Mark A.; Talavera, Maria M.; Slaughter, Jonathan L.			Transient effects of transfusion and feeding advances (volumetric and caloric) on necrotizing enterocolitis development: A case-crossover study	PLOS ONE			English	Article							BLOOD-CELL TRANSFUSIONS; ASSOCIATION; ANEMIA; RISK	Objective To evaluate the short-term effects of feed fortification, feed volume increase, and PRBC transfusion on the odds of developing NEC. Study design Case-crossover study of neonatal intensive care infants born at <= 32 weeks' gestation who were admitted to 5 central Ohio intensive care units from January 2012-July 2016 and developed NEC Bell Stage >= 2. Each patient served as their own control, with exposure during the 48-hour period just prior to NEC onset (hazard period) being compared to a preceding 48-hour control period, thus eliminating confounding by patient factors fixed between both intervals. NEC onset was determined by chart review as the earliest occurrence of one of the following within 24 hours of confirmatory x-ray: (1) antibiotic initiation, (2) enteral feeding cessation, (3) physician first notified of abdominal concerns, or (4) abdominal x-ray ordered. Conditional logistic regression compared exposures to feed volume increase, fortification, and PRBC transfusion during the 48-hour period prior to NEC onset to those during a preceding 48-hour control period. Analyses were stratified by gestational age and anemia (defined: hemoglobin <= 9.3 g/dL within 7 days of NEC onset). Results We included 63 infants with confirmed NEC. Acute exposure to fortification (odds ratio [OR]: 1.67, 95% confidence interval [CI]: 0.61, 4.59), feed volume increase (OR: 0.63, 95% CI: 0.28, 1.38), and PRBC transfusion (OR: 1.80, 95% CI: 0.60, 5.37) was not associated with the onset of NEC. Gestational age and anemia did not significantly modify the associations. Sensitivity testing substituting 24- and 72-hour hazard and control periods produced similar results. Conclusion Using a case-crossover design, we did not detect an association between NEC development and feed fortification, feed volume increase, or PRBC transfusion within 48-hours prior to NEC-onset. Replication in a larger set of cases is needed.	[Le, Vi T.; Klebanoff, Mark A.; Talavera, Maria M.; Slaughter, Jonathan L.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA; [Klebanoff, Mark A.; Talavera, Maria M.; Slaughter, Jonathan L.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Slaughter, JL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH 43205 USA.; Slaughter, JL (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	jonathan.slaughter@nationwidechildrens.org	Slaughter, Jonathan L/E-4102-2011	Slaughter, Jonathan L/0000-0001-6831-7520	National Institutes of Health - National Heart, Lung, and Blood Institute [K08HL121182]; The Research Institute at Nationwide Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121182] Funding Source: NIH RePORTER	National Institutes of Health - National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); The Research Institute at Nationwide Children's Hospital(Ohio State University); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health - National Heart, Lung, and Blood Institute - K08HL121182 (Slaughter): (https://researchtraining.nih.gov/programs/career-development/K08) and the Institutional funds from The Research Institute at Nationwide Children's Hospital (Le): (http://www.nationwidechildrens.org/research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 2013, ARCH DIS CHILD-FETAL, V98, pF470, DOI 10.1136/archdischild-2012-303260; Bernstein D, 2003, PEDIAT MED STUDENTS; Berseth CL, 2003, PEDIATRICS, V111, P529, DOI 10.1542/peds.111.3.529; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Christensen RD, J PEDIAT, V158, P349; DeRienzo C, 2014, EARLY HUM DEV, V90, P237, DOI 10.1016/j.earlhumdev.2014.02.003; Dutta S, 2015, NUTRIENTS, V7, P423, DOI 10.3390/nu7010423; Guillen U, 2012, SEMIN PERINATOL, V36, P244, DOI 10.1053/j.semperi.2012.04.004; Hay S, 2016, SEMIN PERINATOL; Henderson G, 2009, ARCH DIS CHILD-FETAL, V94, pF120, DOI 10.1136/adc.2007.119560; Ho TTB, 2015, J PERINATOL, V35, P837, DOI 10.1038/jp.2015.73; Kirpalani H, 2012, SEMIN PERINATOL, V36, P269, DOI 10.1053/j.semperi.2012.04.007; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maheshwari A, 2015, CLIN PERINATOL, V42, P567, DOI 10.1016/j.clp.2015.04.014; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; Mohamed A, 2012, PEDIATRICS, V129, P529, DOI 10.1542/peds.2011-2872; Morgan J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001241.pub6; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Patel RM, 2016, JAMA-J AM MED ASSOC, V315, P889, DOI 10.1001/jama.2016.1204; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Sharma R, 2006, J PERINATOL, V26, P342, DOI 10.1038/sj.jp.7211510; Singh R, 2011, J PERINATOL, V31, P176, DOI 10.1038/jp.2010.145; Talavera MM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1119	24	13	13	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179724	10.1371/journal.pone.0179724	http://dx.doi.org/10.1371/journal.pone.0179724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632783	gold, Green Submitted, Green Published			2022-12-26	WOS:000404046100046
J	Chang, NH; Manion, KP; Loh, C; Pau, E; Baglaenko, Y; Wither, JE				Chang, Nan-Hua; Manion, Kieran P.; Loh, Christina; Pau, Evelyn; Baglaenko, Yuriy; Wither, Joan E.			Multiple tolerance defects contribute to the breach of B cell tolerance in New Zealand Black chromosome 1 congenic mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL; FUNCTIONAL DISSECTION; SUSCEPTIBILITY GENE; SELF-TOLERANCE; MURINE LUPUS; LYMPHOCYTES; ACTIVATION; LY108; RECEPTOR	Lupus is characterized by a loss of B cell tolerance leading to autoantibody production. In this study, we explored the mechanisms underlying this loss of tolerance using B6 congenic mice with an interval from New Zealand Black chromosome 1 (denoted c1(96-100)) sufficient for anti-nuclear antibody production. Transgenes for soluble hen egg white lysozyme (sHEL) and anti-HEL immunoglobulin were crossed onto this background and various tolerance mechanisms examined. We found that c1(96-100) mice produced increased levels of IgM and IgG anti-HEL antibodies compared to B6 mice and had higher proportions of germinal center B cells and long-lived plasma cells, suggesting a germinal center-dependent breach of B cell anergy. Consistent with impaired anergy induction, c1(96-100) double transgenic B cells showed enhanced survival and CD86 upregulation. Hematopoietic chimeric sHEL mice with a mixture of B6 and c1(96-100) HEL transgenic B cells recapitulated these results, suggesting the presence of a B cell autonomous defect. Surprisingly, however, there was equivalent recruitment of B6 and c1(96-100) B cells into germinal centers and differentiation to splenic plasmablasts in these mice. In contrast, there were increased proportions of c1(96-100) T follicular helper cells and long-lived plasma cells as compared to their B6 counterparts, suggesting that both B and T cell defects are required to breach germinal center tolerance in this model. This possibility was further supported by experiments showing an enhanced breach of anergy in double transgenic mice with a longer chromosome 1 interval with additional T cell defects.	[Chang, Nan-Hua; Manion, Kieran P.; Loh, Christina; Pau, Evelyn; Baglaenko, Yuriy; Wither, Joan E.] Krembil Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada; [Manion, Kieran P.; Loh, Christina; Pau, Evelyn; Baglaenko, Yuriy; Wither, Joan E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Wither, Joan E.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wither, Joan E.] Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wither, JE (corresponding author), Krembil Res Inst, Div Genet & Dev, Arthrit Ctr Excellence, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Wither, JE (corresponding author), Univ Hlth Network, Div Rheumatol, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca	Loh, Charles Yuen Yung/AAA-3762-2020	Loh, Charles Yuen Yung/0000-0003-2646-0358; Wither, Joan/0000-0001-5961-9228; Manion, Kieran/0000-0001-8945-9384; Baglaenko, Yuriy/0000-0002-9020-6824	Canadian Institutes of Health Research [MOP-37886]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JW received funding from the Canadian Institutes of Health Research, grant number MOP-37886, http://www.cihr-isrc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browne CD, 2009, IMMUNITY, V31, P749, DOI 10.1016/j.immuni.2009.08.026; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Chang NH, 2004, J IMMUNOL, V172, P1553, DOI 10.4049/jimmunol.172.3.1553; Chen YF, 2005, J IMMUNOL, V174, P7692, DOI 10.4049/jimmunol.174.12.7692; Cheung YH, 2011, GENES IMMUN, V12, P251, DOI 10.1038/gene.2010.71; Cheung YH, 2005, J IMMUNOL, V175, P8154, DOI 10.4049/jimmunol.175.12.8154; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; COHEN PL, 1977, J IMMUNOL, V119, P1534; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Guerra SG, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3844; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Healy JI, 1998, ANNU REV IMMUNOL, V16, P645, DOI 10.1146/annurev.immunol.16.1.645; IZUI S, 1978, J IMMUNOL, V121, P2213; Jennings P, 2008, J AUTOIMMUN, V31, P345, DOI 10.1016/j.jaut.2008.08.002; Keszei M, 2011, J EXP MED, V208, P811, DOI 10.1084/jem.20101653; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Morel L, 1997, J IMMUNOL, V158, P6019; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; NORVELL A, 1995, J IMMUNOL, V154, P4404; Pau E, 2011, CLIN IMMUNOL, V139, P215, DOI 10.1016/j.clim.2011.02.005; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; Roy V, 2005, J IMMUNOL, V175, P7363, DOI 10.4049/jimmunol.175.11.7363; Sobel ES, 1999, J IMMUNOL, V162, P2415; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; Talaei N, 2015, J IMMUNOL, V195, P4623, DOI 10.4049/jimmunol.1500552; Talaei N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075166; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Vaughn SE, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00450; Vuyyuru R, 2009, J IMMUNOL, V183, P5716, DOI 10.4049/jimmunol.0804215; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Weisel F, 2007, EUR J IMMUNOL, V37, P3330, DOI 10.1002/eji.200737971; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Wither JE, 2003, J IMMUNOL, V171, P1697, DOI 10.4049/jimmunol.171.4.1697; Wong EB, 2012, J IMMUNOL, V189, P5667, DOI 10.4049/jimmunol.1201661; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xie C, 2007, INT IMMUNOL, V19, P509, DOI 10.1093/intimm/dxm017; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhong MC, 2008, J BIOL CHEM, V283, P19255, DOI 10.1074/jbc.M800209200	48	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179506	10.1371/journal.pone.0179506	http://dx.doi.org/10.1371/journal.pone.0179506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628673	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100034
J	Tang, XL; Lin, JT; Wang, GH; Lu, JL				Tang, Xiaolin; Lin, Jiantao; Wang, Guanhai; Lu, Jianlin			MicroRNA-433-3p promotes osteoblast differentiation through targeting DKK1 expression	PLOS ONE			English	Article							CIRCULATING MIRNAS; BONE LOSS; COMMUNICATION; MICROVESICLES; MECHANISM; DIAGNOSIS; EXOSOMES	Dickkopf-1 (DKK1) is a powerful antagonist of canonical WNT signaling pathway, and is regarded as a biomarker for osteoporosis. Its expression is highly correlated with bone mass and osteoblasts maturation. In this study, mouse primary bone marrow cells and osteoblast cell lines were used. Luciferase reporter assay and western blotting methods were employed to validate if miRNA-433-3p epigenetically regulated DKK1 translation. Rat bone marrow derived osteoblasts were infected with lentivirus vector in which miR-433-3p was constructed. The authors constructed lentivirus mediated miRNA-433-3p stable expression and examined the alkaline phosphatase (ALP) activity and mineral deposition level in vitro. In situ hybridization method was used to observe miR-433-3p in primary osteoblasts. We built up an OVX rat model to mimic postmenopausal osteoporosis, and found aberrant circulating miR-433-3p and miR-106b, which were not reported previously. Results showed that miR-433-3p potentially regulated DKK1 mRNA, Furthermore, the correlation of serum DKK1 with circulating miR-433-3p level was significant (r = 0.7520, p = 0.046). In the luciferase reporter assay, we found that miR-433-3p siRNA decreased luminescence signal, indicating direct regulation of miR-433-3p on DKK1 mRNA. When the miR-433-3p binding site in DKK1 3'UTR was mutant, such reduction was prohibited. Western blotting result validated that miR-433-3p inhibited over 90% of DKK1 protein expression. Similarly, the change of protein expression was not observed in mutant group. The stable expression of lentivirus mediated miR-433-3p increased ALP activity and mineralization both in human and rat derived immortalized cells. We found that primary osteoblasts had higher miR-433-3p level compared with immortal cells through real-time PCR, as well as in situ hybridization experiment. Conclusively, our findings further emphasized the vital role of miR-433-3p in DKK1/WNT/beta-catenin pathway through decreasing DKK1 expression and inducing osteoblasts differentiation.	[Tang, Xiaolin; Lu, Jianlin] Shunde Polytech, Dept Med Sci, Foshan, Peoples R China; [Lin, Jiantao; Wang, Guanhai] Guangdong Med Univ, Tradit Chinese Med & New Drug Res Inst, Dongguan, Peoples R China	Shunde Polytechnic; Guangdong Medical University	Tang, XL (corresponding author), Shunde Polytech, Dept Med Sci, Foshan, Peoples R China.	celinetangphd@163.com						Ahmed SF, 2009, ENDOCR DEV, V16, P170, DOI 10.1159/000223695; Ahmed SF, 2013, J OSTEOPOROS, V2013, DOI 10.1155/2013/460210; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng P, 2013, J BONE MINER RES, V28, P1180, DOI 10.1002/jbmr.1845; Cheon YH, 2016, J BONE MINER RES, V31, P403, DOI 10.1002/jbmr.2612; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Deng LL, 2015, BONE, V79, P37, DOI 10.1016/j.bone.2015.05.022; Florio M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11505; Guo AJY, 2011, J BIOL CHEM, V286, P27882, DOI 10.1074/jbc.M111.236281; Gupta A, 2016, CELL SIGNAL, V28, P1048, DOI 10.1016/j.cellsig.2016.04.014; Heiland GR, 2010, ANN RHEUM DIS, V69, P2152, DOI 10.1136/ard.2010.132852; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Lane NE, 2006, NAT CLIN PRACT RHEUM, V2, P562, DOI 10.1038/ncprheum0298; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Lin S, 2016, EUR J PHARMACOL, V791, P331, DOI 10.1016/j.ejphar.2016.09.018; Lu MX, 2017, ONCOTARGET, V8, P8775, DOI 10.18632/oncotarget.14452; Ma WH, 2013, NEUROPEPTIDES, V47, P179, DOI 10.1016/j.npep.2012.12.002; Morhayim J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32034; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Prasad Prathibha, 2013, Indian J Dent Res, V24, P302, DOI 10.4103/0970-9290.117991; Ruiz MA, 2013, CAN J DIABETES, V37, P339, DOI 10.1016/j.jcjd.2013.07.003; Shao J, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/967673; Sims Natalie A, 2014, Bonekey Rep, V3, P481, DOI 10.1038/bonekey.2013.215; Soung DY, 2014, MOL ENDOCRINOL, V28, P546, DOI 10.1210/me.2013-1305; Sun WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.15; Surve VV, 2001, ACTA ORTHOP SCAND, V72, P525, DOI 10.1080/000164701753532880; THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Weilner S, 2015, BONE, V79, P43, DOI 10.1016/j.bone.2015.05.027; Weilner S, 2013, EXP GERONTOL, V48, P626, DOI 10.1016/j.exger.2012.11.017; Zerbini CAF, 2017, OSTEOPOROSIS INT, V28, P429, DOI 10.1007/s00198-016-3769-2; Zhang W, 2012, CURR OSTEOPOROS REP, V10, P93, DOI 10.1007/s11914-011-0086-8; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138; Zou YC, 2016, CONNECT TISSUE RES, V57, P200, DOI 10.3109/03008207.2015.1127916	42	45	52	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179860	10.1371/journal.pone.0179860	http://dx.doi.org/10.1371/journal.pone.0179860			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628652	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100048
J	Lin, HC; Xirasagar, S; Lee, HC; Huang, CC; Chen, CH				Lin, Herng-Ching; Xirasagar, Sudha; Lee, Hsin-Chien; Huang, Chung-Chien; Chen, Chao-Hung			Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; PSYCHIATRIC-DISORDERS; MENTAL-DISORDERS; MEDICAL-CARE; VIRUS; RISK; DEMENTIA; INFECTION; PREVALENCE; BRAIN	Associations of hepatitis C virus infection with Alzheimer's disease have not been studied among higher risk, bipolar disorder patients. This population-based case-control study investigated the risks of hepatitis C virus infection among Alzheimer's disease patients with bipolar disorder in the years preceding their Alzheimer's disease diagnosis. We used 20002013 data from the Longitudinal Health Insurance Database in Taiwan. Among patients with bipolar disorder, 73 were diagnosed with Alzheimer's disease (cases), who were compared with 365 individuals with bipolar disorder but without Alzheimer's disease (randomly selected controls matched on sex, age, and index year with cases). Prior claims (before the diagnosis year/index year for controls) were screened for a diagnosis of hepatitis C virus infection. Conditional logistic regression models were used for analysis. We found that 23 (31.51%) and 60 (16.44%) patients with bipolar disease were identified with a hepatitis C diagnosis among those with and without Alzheimer's disease, respectively. Compared to controls, patients with Alzheimer's disease showed 2.31-fold (95% confidence interval = 1.28-4.16) increased risk of hepatitis C infections adjusted for demographics and socio-economic status. Findings suggest an association of Alzheimer's disease with a preceding diagnosis of hepatitis C infection among patients with bipolar disorder. Findings may suggest a need for increased awareness of and appropriate surveillance for Alzheimer's disease in patients with bipolar disorder diagnosed with hepatitis C infection.	[Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Xirasagar, Sudha] Univ South Carolina, Dept Hlth Serv Policy & Management, Arnold Sch Publ Hlth, Columbia, SC USA; [Lee, Hsin-Chien] Taipei Med Univ, Dept Psychiat, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Sch Med, Dept Psychiat, Coll Med, Taipei, Taiwan; [Chen, Chao-Hung] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan; [Chen, Chao-Hung] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; University of South Carolina System; University of South Carolina Columbia; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Taipei Medical University	Chen, CH (corresponding author), Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.; Chen, CH (corresponding author), Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan.; Chen, CH (corresponding author), MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan.; Chen, CH (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.	s448@eip.mkc.edu.tw	Xirasagar, Sudha/AAA-2350-2022; Huang, CC/AAX-5872-2021	Huang, CC/0000-0003-0818-7175; lee, hsin-chien/0000-0002-7557-8259				Albert MS, 2011, NEUROBIOL AGING, V32, pS58, DOI 10.1016/j.neurobiolaging.2011.09.010; Almeida OP, 2016, BRIT J PSYCHIAT, V209, P121, DOI 10.1192/bjp.bp.115.180059; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Aprahamian I, 2014, ARQ NEURO-PSIQUIAT, V72, P913, DOI 10.1590/0004-282X20140153; Campos Lorenza Nogueira, 2008, Cad. Saúde Pública, V24, ps607; Carey MP, 1997, CLIN PSYCHOL REV, V17, P271, DOI 10.1016/S0272-7358(97)00019-6; Carmo RA, 2013, GEN HOSP PSYCHIAT, V35, P129, DOI 10.1016/j.genhosppsych.2012.11.005; Chen MH, 2015, J AM MED DIR ASSOC, V16, P504, DOI 10.1016/j.jamda.2015.01.084; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; CHIU WC, 2014, LIVER TRANSPLANT, V21, P1068, DOI DOI 10.1111/ENE.12317; Clemente AS, 2015, REV BRAS PSIQUIATR, V37, P155, DOI 10.1590/1516-4446-2012-1693; Diniz BS, 2017, AM J GERIAT PSYCHIAT, V25, P357, DOI 10.1016/j.jagp.2016.11.014; Dinwiddie SH, 2003, AM J PSYCHIAT, V160, P172, DOI 10.1176/appi.ajp.160.1.172; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Druss BG, 1998, AM J PSYCHIAT, V155, P1775, DOI 10.1176/ajp.155.12.1775; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688; Heeren M, 2011, J CEREBR BLOOD F MET, V31, P2199, DOI 10.1038/jcbfm.2011.82; Hilsabeck RC, 2002, HEPATOLOGY, V35, P440, DOI 10.1053/jhep.2002.31257; Himelhoch S, 2009, PSYCHOSOMATICS, V50, P30, DOI 10.1176/appi.psy.50.1.30; Hunt GE, 2016, J AFFECT DISORDERS, V206, P321, DOI 10.1016/j.jad.2016.06.051; Kessing LV, 2003, J AFFECT DISORDERS, V73, P261, DOI 10.1016/S0165-0327(02)00004-6; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Lee MH, 2014, INT J CANCER, V135, P1119, DOI 10.1002/ijc.28753; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Mojtabai R, 2014, PSYCHIAT SERV, V65, P818, DOI 10.1176/appi.ps.201300348; Monaco S, 2015, WORLD J GASTROENTERO, V21, P11974, DOI 10.3748/wjg.v21.i42.11974; Mora E, 2013, PSYCHOL MED, V43, P1187, DOI 10.1017/S0033291712001948; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Perry W, 2008, DIGEST DIS SCI, V53, P307, DOI 10.1007/s10620-007-9896-z; Pirl WF, 2005, PSYCHIAT SERV, V56, P1614, DOI 10.1176/appi.ps.56.12.1614; Preuss UW, 2010, AM J GERIAT PSYCHIAT, V18, P821, DOI 10.1097/JGP.0b013e3181ca3a13; Rifai Muhamad Aly, 2006, Prim Care Companion J Clin Psychiatry, V8, P361; Rise IV, 2016, NEUROPSYCH DIS TREAT, V12, P1203, DOI 10.2147/NDT.S100843; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Wang CS, 2007, AM J EPIDEMIOL, V166, P196, DOI 10.1093/aje/kwm061; Weissenborn K, 2006, GUT, V55, P1624, DOI 10.1136/gut.2005.080267; Weissenborn K, 2004, J HEPATOL, V41, P845, DOI 10.1016/j.jhep.2004.07.022; Zilkens RR, 2014, CURR ALZHEIMER RES, V11, P681, DOI 10.2174/1567205011666140812115004	42	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179312	10.1371/journal.pone.0179312	http://dx.doi.org/10.1371/journal.pone.0179312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX8NF	28622343	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300021
J	Bailie, C; Kilner, J; Maxwell, AP; McKnight, AJ				Bailie, Caitlin; Kilner, Jill; Maxwell, Alexander P.; McKnight, Amy Jayne			Development of next generation sequencing panel for UMOD and association with kidney disease	PLOS ONE			English	Article							UROMODULIN LEVELS; GENE; LOCI; IDENTIFICATION; HYPERTENSION; VARIANTS; SUSCEPTIBILITY; INDIVIDUALS; PREVALENCE; MUTATIONS	Chronic kidney disease (CKD) has a prevalence of approximately 10% in adult populations. CKD can progress to end-stage renal disease (ESRD) and this is usually fatal unless some form of renal replacement therapy (chronic dialysis or renal transplantation) is provided. There is an inherited predisposition to CKD with several genetic risk markers now identified. The UMOD gene has been associated with CKD of varying aetiologies. An AmpliSeq next generation sequencing panel was developed to facilitate comprehensive sequencing of the UMOD gene, covering exonic and regulatory regions. SNPs and CpG sites in the genomic region encompassing UMOD were evaluated for association with CKD in two studies; the UK Wellcome Trust Case-Control 3 Renal Transplant Dysfunction Study (n = 1088) and UK-ROI GENIE GWAS (n = 1726). A technological comparison of two Ion Torrent machines revealed 100% allele call concordance between S5 XLTM and PGM(TM) machines. One SNP (rs183962941), located in a non-coding region of UMOD, was nominally associated with ESRD (p = 0.008). No association was identified between UMOD variants and estimated glomerular filtration rate. Analysis of methylation data for over 480,000 CpG sites revealed differential methylation patterns within UMOD, the most significant of these was cg03140788 p = 3.7 x 10-(10)	[Bailie, Caitlin; Kilner, Jill; Maxwell, Alexander P.; McKnight, Amy Jayne] Queens Univ Belfast, Nephrol Res, Ctr Publ Hlth, Belfast City Hosp, Belfast, Antrim, North Ireland	Belfast City Hospital; Queens University Belfast	McKnight, AJ (corresponding author), Queens Univ Belfast, Nephrol Res, Ctr Publ Hlth, Belfast City Hosp, Belfast, Antrim, North Ireland.	a.j.mcknight@qub.ac.uk	McKnight, Amy Jayne/ABF-4492-2020	McKnight, Amy Jayne/0000-0002-7482-709X; Kilner, Jill/0000-0002-6020-4617; Maxwell, Alexander P./0000-0002-6110-7253	Diabetes UK; JDRF; US Ireland R&D partnership award - Science Foundation Ireland [SFI/08/US/B1517]; Northern Ireland Research Development Office; NIH NIDDK [R01 DK081923]; SFI_DfE Investigators Programme [15/IA/3152]; Department of Employment and Learning; Medical Research Council [MC_PC_15025] Funding Source: researchfish; Public Health Agency [STL/3714/07, STL/4760/13] Funding Source: researchfish; MRC [MC_PC_15025] Funding Source: UKRI	Diabetes UK(Diabetes UK); JDRF(Juvenile Diabetes Research Foundation); US Ireland R&D partnership award - Science Foundation Ireland(Science Foundation Ireland); Northern Ireland Research Development Office; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); SFI_DfE Investigators Programme(Science Foundation Ireland); Department of Employment and Learning; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Public Health Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Warren 3/UK GoKinD Study Group (UK-ROI collection) was jointly funded by Diabetes UK and the JDRF. Genome-wide genotyping from the GENIE consortium was supported by a US Ireland R&D partnership award funded by the Science Foundation Ireland under Grant No. SFI/08/US/B1517, the Northern Ireland Research Development Office, and NIH NIDDK R01 DK081923. This work was also supported by the SFI_DfE Investigators Programme (15/IA/3152) to AJM and a PhD studentship from the Department of Employment and Learning to CB. The funders had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahluwalia TS, 2011, J HYPERTENS, V29, P1731, DOI 10.1097/HJH.0b013e328349de25; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bleyer AJ, 1993, GENERE VIEWS; Boger CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002292; Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS71, DOI 10.1053/j.ajkd.2008.07.057; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Eckardt KU, 2012, NEPHROL DIAL TRANSPL, V27, P1454, DOI 10.1093/ndt/gfr456; Ekart R, 2013, THER APHER DIAL, V17, P363, DOI 10.1111/1744-9987.12079; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fogarty DG, 2011, BRENNER RECTORS KIDN, P2205; Gorski M, 2015, KIDNEY INT, V87, P1017, DOI 10.1038/ki.2014.361; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kottgen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038311; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Levey AS, 2010, KIDNEY INT, V78, P19, DOI 10.1038/ki.2010.115; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Liu CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002264; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; McKnight AJ, 2014, ADV CHRONIC KIDNEY D, V21, P287, DOI 10.1053/j.ackd.2014.03.010; Middleton RJ, 2006, NEPHROL DIAL TRANSPL, V21, P88, DOI 10.1093/ndt/gfi163; Mo L, 2004, AM J PHYSIOL-RENAL, V286, pF795, DOI 10.1152/ajprenal.00357.2003; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pattaro C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002584; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Reznichenko A, 2012, BMC MED GENET, P13; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Scolari F, 2014, NEPHROL DIAL TRANSPL, V30, P1; Shaw C, 2013, NEPHRON CLIN PRACT, V125, P29, DOI 10.1159/000360021; Shibuya K, 2004, BIOCHEM BIOPH RES CO, V319, P1181, DOI 10.1016/j.bbrc.2004.05.094; Smyth LJ, 2014, EPIGENETICS-US, V9, P366, DOI 10.4161/epi.27161; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Wing MR, 2014, NEPHROL DIAL TRANSPL, V29, P864, DOI 10.1093/ndt/gft537; Yamada Y, 2013, J MED GENET, V50, P410, DOI 10.1136/jmedgenet-2013-101518	51	3	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178321	10.1371/journal.pone.0178321	http://dx.doi.org/10.1371/journal.pone.0178321			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609449	Green Submitted, Green Published, gold			2022-12-26	WOS:000403274700005
J	Zhang, EJ; Xu, ZF; Duan, WY; Huang, SH; Lu, L				Zhang, Enjiao; Xu, Zhongfei; Duan, Weiyi; Huang, Shaohui; Lu, Li			Association between polymorphisms in pre-miRNA genes and risk of oral squamous cell cancer in a Chinese population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CARCINOMA; MICRORNAS; EXPRESSION; HEAD	Background MicroRNAs play important roles in the development of human cancers. This case-control study is to evaluate the roles of the polymorphisms in pre-miRNAs on risk of oral cancer in a Chinese population. Methods The genotypes of three polymorphisms were determined in 340 patients with oral squamous cell cancer and 340 healthy controls who were frequency matched for age and sex. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to assess the association. All analyses were performed using the SPSS software. 3.154() 0.001. Results For miR-499 rs3746444, individuals carrying homozygous CC genotype had increased risks of oral cancer compared with the homozygous wild TT genotype (adjusted OR was 3.154, 95% CI was 1.555-6.397, P value was 0.001). The C allele of miR-499 rs3746444 was associated with a higher risk of oral cancer with significant odds ratio of 1.453. In the stratified analyses by sex, the associations between miR-499 rs3746444 and miR-146a rs2910164 polymorphisms with the susceptibility of oral squamous cell cancer were significant in males. However, with 1/4 as many subjects there were no significant associations between the three polymorphisms and oral cancer risks in females. The joint effects of miRNA polymorphisms and smoking on the risk of OSCC were analyzed and the results suggested that the association between microRNA genetic variants and OSCC risk was modified by smoking. Conclusions These findings suggest that miR-499 rs3746444 and miR-146a rs2910164 polymorphisms may contribute to genetic susceptibility to oral squamous cell cancer.	[Zhang, Enjiao; Xu, Zhongfei; Duan, Weiyi; Huang, Shaohui; Lu, Li] China Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang, Peoples R China; [Zhang, Enjiao; Xu, Zhongfei; Duan, Weiyi; Huang, Shaohui; Lu, Li] China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Shenyang, Peoples R China	China Medical University; China Medical University	Lu, L (corresponding author), China Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Shenyang, Peoples R China.; Lu, L (corresponding author), China Med Univ, Sch Stomatol, Dept Oromaxillofacial Head & Neck Surg, Shenyang, Peoples R China.	luli@mail.cmu.edu.cn	lu, lu/HII-7530-2022		Natural Science Foundation of Liaoning Province, China [201501010]; Foundation of Liaoning Educational Committee [L2015597]; Scientific Start-up Fund for Youth of School of Stomatology [K10159-15-01]	Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province); Foundation of Liaoning Educational Committee; Scientific Start-up Fund for Youth of School of Stomatology	This study was supported by The PhD Start-up Fund of Natural Science Foundation of Liaoning Province, China (201501010), Foundation of Liaoning Educational Committee (L2015597), and The Scientific Start-up Fund for Youth of School of Stomatology (K10159-15-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2012, ONCOL REP, V27, P1097, DOI 10.3892/or.2011.1571; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Liu ZS, 2010, CANCER-AM CANCER SOC, V116, P4753, DOI 10.1002/cncr.25323; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Rivera C, 2014, ONCOL LETT, V8, P7, DOI 10.3892/ol.2014.2103; Saman DM, 2012, HEAD NECK ONCOL, V4, DOI 10.1186/1758-3284-4-1; Sherry ST, 1999, GENOME RES, V9, P677; Song XC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056622; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	22	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0176044	10.1371/journal.pone.0176044	http://dx.doi.org/10.1371/journal.pone.0176044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609461	Green Published, Green Submitted, gold			2022-12-26	WOS:000403274700001
J	Hayete, B; Wuest, D; Laramie, J; McDonagh, P; Church, B; Eberly, S; Lang, A; Marek, K; Runge, K; Shoulson, I; Singleton, A; Tanner, C; Khalil, I; Verma, A; Ravina, B				Hayete, Boris; Wuest, Diane; Laramie, Jason; McDonagh, Paul; Church, Bruce; Eberly, Shirley; Lang, Anthony; Marek, Kenneth; Runge, Karl; Shoulson, Ira; Singleton, Andrew; Tanner, Caroline; Khalil, Iya; Verma, Ajay; Ravina, Bernard			A Bayesian mathematical model of motor and cognitive outcomes in Parkinson's disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOPAMINE TRANSPORTERS; POPULATION; SCALE; LOCI; PROGRESSION; IMPUTATION; DEMENTIA; CAMPAIGN; SEQUENCE	Background There are few established predictors of the clinical course of PD. Prognostic markers would be useful for clinical care and research. Objective To identify predictors of long-term motor and cognitive outcomes and rate of progression in PD. Methods Newly diagnosed PD participants were followed for 7 years in a prospective study, conducted at 55 centers in the United States and Canada. Analyses were conducted in 244 participants with complete demographic, clinical, genetic, and dopamine transporter imaging data. Machine learning dynamic Bayesian graphical models were used to identify and simulate predictors and outcomes. The outcomes rate of cognition changes are assessed by the Montreal Cognitive Assessment scores, and rate of motor changes are assessed by UPDRS part-III. Results The most robust and consistent longitudinal predictors of cognitive function included older age, baseline Unified Parkinson's Disease Rating Scale (UPDRS) parts I and II, Schwab and England activities of daily living scale, striatal dopamine transporter binding, and SNP rs11724635 in the gene BST1. The most consistent predictor of UPDRS part III was baseline level of activities of daily living (part II). Key findings were replicated using longterm data from an independent cohort study. Conclusions Baseline function near the time of Parkinson's disease diagnosis, as measured by activities of daily living, is a consistent predictor of long-term motor and cognitive outcomes. Additional predictors identified may further characterize the expected course of Parkinson's disease and suggest mechanisms underlying disease progression. The prognostic model developed in this study can be used to simulate the effects of the prognostic variables on motor and cognitive outcomes, and can be replicated and refined with data from independent longitudinal studies.	[Hayete, Boris; Wuest, Diane; Church, Bruce; Runge, Karl; Khalil, Iya] GNS Healthcare, Cambridge, MA USA; [Laramie, Jason] Novartis, Cambridge, MA USA; [McDonagh, Paul] Alex Pharmaceut, Cambridge, MA USA; [Eberly, Shirley] Univ Rochester, Rochester, NY USA; [Lang, Anthony] Toronto Western Hosp, Morton & Gloria Movement Disorders Clin, Toronto, ON, Canada; [Lang, Anthony] Toronto Western Hosp, Edmond J Safra Program Parkinsons Dis, Toronto, ON, Canada; [Lang, Anthony] Univ Toronto, Toronto, ON, Canada; [Marek, Kenneth] Inst Neurodegenerat Disorders, New Haven, CT USA; [Shoulson, Ira] Georgetown Univ, Washington, DC USA; [Singleton, Andrew] NIA, NIH, Bethesda, MD 20892 USA; [Tanner, Caroline] Univ San Francisco, San Francisco, CA 94117 USA; [Tanner, Caroline] San Francisco VA Med Ctr, San Francisco, CA USA; [Verma, Ajay] Biogen Idec Inc, Cambridge, MA USA; [Ravina, Bernard] Voyager Therapeut, Cambridge, MA 02139 USA	Novartis; University of Rochester; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Biogen	Ravina, B (corresponding author), Voyager Therapeut, Cambridge, MA 02139 USA.	bravina@vygr.com	Lang, Anthony/ABF-8114-2021; Hayete, Boris/ABD-4515-2020; Singleton, Andrew B/C-3010-2009	Hayete, Boris/0000-0002-2521-1889; Verma, Ajay/0000-0001-7715-0443; Marek, Kenneth/0000-0002-4197-5627; Lang, Anthony/0000-0003-1229-3667	National Institute of Neurological Disorders and Stroke [5U01NS050095]; U.S. Department of Defense (DOD) Neurotoxin Exposure Treatment Parkinson's Research Program [W23RRYX7022N606]; Michael J. Fox Foundation for Parkinson's Research; Parkinson's Disease Foundation; Biogen Idec, Inc, Cambridge, MA; Biogen; NATIONAL INSTITUTE ON AGING [ZIAAG000949] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Department of Defense (DOD) Neurotoxin Exposure Treatment Parkinson's Research Program; Michael J. Fox Foundation for Parkinson's Research; Parkinson's Disease Foundation; Biogen Idec, Inc, Cambridge, MA; Biogen(Biogen); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Neurological Disorders and Stroke (5U01NS050095); U.S. Department of Defense (DOD) Neurotoxin Exposure Treatment Parkinson's Research Program (W23RRYX7022N606); Michael J. Fox Foundation for Parkinson's Research; Parkinson's Disease Foundation; The analysis was funded by Biogen Idec, Inc, Cambridge, MA. The funder provided support in the form of salaries for Bernard Ravina (at Biogen at the time) and Ajay Verma, and, indirectly via a commercial agreement with GNS Healthcare to provide analytical services, for Boris Hayete, Bruce Church, Paul McDonagh (at GNS at the time), Karl Runge, Iya Khalil, Jason Laramie (at GNS at the time), and Diane Wuest. Biogen Idec did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors with other affiliations were supported by their respective institutions and grants. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, J PARK DIS, P1; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Chen ML, 2014, PARKINSONISM RELAT D, V20, P280, DOI 10.1016/j.parkreldis.2013.11.009; Dahiru T, 2008, ANN IB POSTGRAD MED, V6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gendelman R, 2017, CANCER RES, V77, P1575, DOI 10.1158/0008-5472.CAN-16-0512; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jennings DL, 2004, ARCH NEUROL-CHICAGO, V61, P1224, DOI 10.1001/archneur.61.8.1224; Kieburtz K, 2015, JAMA-J AM MED ASSOC, V313, P584, DOI 10.1001/jama.2015.120; Levy G, 2007, ARCH NEUROL-CHICAGO, V64, P1242, DOI 10.1001/archneur.64.9.1242; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin Z, 2004, AM J HUM GENET, V75, P850, DOI 10.1086/425587; Morley JF, 2012, MOVEMENT DISORD, V27, P512, DOI 10.1002/mds.24946; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pinero J, 2017, NLME LINEAR NONLINEA; Ravina B, 2007, NEUROLOGY, V69, P342, DOI 10.1212/01.wnl.0000268695.63392.10; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Ravina B, 2009, MOVEMENT DISORD, V24, P2081, DOI 10.1002/mds.22690; Ritz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036199; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Schwab J, 1969, P 3 S PARK DIS, P152; Seibyl JP, 1997, J NUCL MED, V38, P1453; SEIBYL JP, 1995, ANN NEUROL, V38, P589, DOI 10.1002/ana.410380407; Seibyl JP, 1998, J NUCL MED, V39, P1500; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Uc EY, 2011, NEUROLOGY, V76, P1894, DOI 10.1212/WNL.0b013e31821d74fa; Venables W. N., MODERN APPL STAT S, V4th Fourth; Welsh M, 2003, MOVEMENT DISORD, V18, P637, DOI 10.1002/mds.10424; Williams-Gray CH, 2013, J NEUROL NEUROSUR PS, V84, P1258, DOI 10.1136/jnnp-2013-305277; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Xing H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001105; 2011, PROG NEUROBIOL, V95, P629, DOI DOI 10.1016/J.PNEUROBIO.2011.09.005	39	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178982	10.1371/journal.pone.0178982	http://dx.doi.org/10.1371/journal.pone.0178982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604798	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400022
J	Marunaka, K; Furukawa, C; Fujii, N; Kimura, T; Furuta, T; Matsunaga, T; Endo, S; Hasegawa, H; Anzai, N; Yamazaki, Y; Yamaguchi, M; Ikari, A				Marunaka, Kana; Furukawa, Chisa; Fujii, Naoko; Kimura, Toru; Furuta, Takumi; Matsunaga, Toshiyuki; Endo, Satoshi; Hasegawa, Hajime; Anzai, Naohiko; Yamazaki, Yasuhiro; Yamaguchi, Masahiko; Ikari, Akira			The RING finger- and PDZ domain-containing protein PDZRN3 controls localization of the Mg2+ regulator claudin-16 in renal tube epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; kidney; magnesium; protein phosphorylation; tight junction	CLATHRIN-DEPENDENT ENDOCYTOSIS; THICK ASCENDING LIMB; E3 UBIQUITIN LIGASE; TIGHT-JUNCTION; KINASE-A; HYPERTENSIVE-RATS; FAMILY PROTEINS; HENLES LOOP; PHOSPHORYLATION; PARACELLIN-1	Ion exchange in the renal tubules is fundamental to the maintenance of physiological ion levels. Claudin-16 (CLDN16) regulates the paracellular reabsorption of Mg2+ in the thick ascending limb of Henle's loop in the kidney, with dephosphorylation of CLDN16 increasing its intracellular distribution and decreasing paracellular Mg2+ permeability. CLDN16 is located in the tight junctions, but the mechanism regulating its localization is unclear. Using yeast two-hybrid systems, we found that CLDN16 binds to PDZRN3, a protein containing both RING-finger and PDZ domains. We also observed that the carboxyl terminus of the cytoplasmic CLDN16 region was required for PDZRN3 binding. PZDRN3 was mainly distributed in the cytosol of rat kidney cells and upon cell treatment with the protein kinase A inhibitor H-89, colocalized with CLDN16. H-89 also increased mono-ubiquitination and the association of CLDN16 with PDZRN3. Mono-ubiquitination levels of a K275A mutant were lower, and its association with PDZRN3 was reduced compared with wild-type (WT) CLDN16 and a K261A mutant, indicating that Lys-275 is the major ubiquitination site. An S217A mutant, a dephosphorylated form of CLDN16, localized to the cytosol along with PDZRN3 and the endosomal marker Rab7. PDZRN3 siRNA increased cell-surface localization of WT CLDN16 in H-89-treated cells or containing the S217A mutant and also suppressed CLDN16 endocytosis. Of note, H-89 decreased paracellular Mg2+ flux in WT CLDN16 cells, and PDZRN3 siRNA increased Mg2+ flux in the H-89-treated WT CLDN16 and S217A mutant cells. These results suggest that PDZRN3 mediates endocytosis of dephosphorylated CLDN16 and represents an important component of the CLDN16-trafficking machinery in the kidney.	[Marunaka, Kana; Furukawa, Chisa; Fujii, Naoko; Matsunaga, Toshiyuki; Endo, Satoshi; Ikari, Akira] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan; [Kimura, Toru] Kyorin Univ, Dept Pharmacol & Toxicol, Sch Med, Tokyo 1818611, Japan; [Furuta, Takumi] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Hasegawa, Hajime] Saitama Med Univ, Saitama Med Ctr, Saitama 3508550, Japan; [Anzai, Naohiko] Chiba Univ, Dept Pharmacol, Grad Sch Med, Chiba 3210293, Japan; [Yamazaki, Yasuhiro; Yamaguchi, Masahiko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Gifu Pharmaceutical University; Kyorin University; Kyoto University; Saitama Medical University; Chiba University; University of Shizuoka	Ikari, A (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Biochem Lab, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	ikari@gifu-pu.ac.jp	Endo, Satoshi/F-8059-2011; ANZAI, NAOHIKO/K-9492-2017	Endo, Satoshi/0000-0003-0578-9672; ANZAI, NAOHIKO/0000-0003-0605-0458	JSPS KAKENHI [15H04657]; Salt Science Research Foundation [1627]; Mishima Kaiun Memorial Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Salt Science Research Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	This work was supported in part by JSPS KAKENHI Grant 15H04657 (to A. I.) and grants from the Salt Science Research Foundation (1627) and the Mishima Kaiun Memorial Foundation (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Aono S, 2008, EXP CELL RES, V314, P3326, DOI 10.1016/j.yexcr.2008.08.012; Bender J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136768; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Fujii N, 2016, J BIOL CHEM, V291, P24787, DOI 10.1074/jbc.M116.728196; Gong YF, 2015, MOL BIOL CELL, V26, P4333, DOI 10.1091/mbc.E15-06-0422; Gong YF, 2015, P NATL ACAD SCI USA, V112, P4340, DOI 10.1073/pnas.1421441112; Gonzalez-Mariscal L, 2000, KIDNEY INT, V57, P2386, DOI 10.1046/j.1523-1755.2000.00098.x; Gunzel D, 2009, ANN NY ACAD SCI, V1165, P152, DOI 10.1111/j.1749-6632.2009.04051.x; Honda T, 2013, AM J PHYSIOL-CELL PH, V304, pC1091, DOI 10.1152/ajpcell.00343.2012; Honda T, 2010, MOL BIOL CELL, V21, P3269, DOI 10.1091/mbc.E10-02-0117; Hou JH, 2005, J CELL SCI, V118, P5109, DOI 10.1242/jcs.02631; Hou JH, 2007, J BIOL CHEM, V282, P17114, DOI 10.1074/jbc.M700632200; Ikari A, 2006, J CELL SCI, V119, P1781, DOI 10.1242/jcs.02901; Ikari A, 2004, J BIOL CHEM, V279, P54826, DOI 10.1074/jbc.M406331200; Ikari A, 2001, BIOCHEM BIOPH RES CO, V287, P671, DOI 10.1006/bbrc.2001.5644; Ikari A, 2008, J CELL PHYSIOL, V214, P221, DOI 10.1002/jcp.21178; Ikari A, 2006, J PHYSIOL SCI, V56, P379, DOI 10.2170/physiolsci.SC008906; Ikari A, 2014, BBA-MOL CELL RES, V1843, P2079, DOI 10.1016/j.bbamcr.2014.05.017; Ikari A, 2014, J BIOL CHEM, V289, P13112, DOI 10.1074/jbc.M113.541193; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jian YK, 2015, BIOCHEM BIOPH RES CO, V466, P356, DOI 10.1016/j.bbrc.2015.09.028; Kansaku A, 2006, ONCOGENE, V25, P5071, DOI 10.1038/sj.onc.1209468; Katoh M, 2004, INT J MOL MED, V13, P607; Kausalya PJ, 2006, J CLIN INVEST, V116, P878, DOI 10.1172/JCI26323; Ko JA, 2006, J CELL SCI, V119, P5106, DOI 10.1242/jcs.03290; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Konrad M, 2008, J AM SOC NEPHROL, V19, P171, DOI 10.1681/ASN.2007060709; Konrad M, 2006, AM J HUM GENET, V79, P949, DOI 10.1086/508617; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li J, 2015, INT J CLIN EXP PATHO, V8, P12225; Marracci S, 2016, INT J DEV BIOL, V60, P57, DOI 10.1387/ijdb.150381ld; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Muller D, 2006, J CLIN ENDOCR METAB, V91, P3076, DOI 10.1210/jc.2006-0200; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Ohta H, 2006, J VET MED SCI, V68, P453, DOI 10.1292/jvms.68.453; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Rice DS, 2001, MOL CELL NEUROSCI, V18, P525, DOI 10.1006/mcne.2001.1024; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Simon DB, 1999, SCIENCE, V285, P103, DOI 10.1126/science.285.5424.103; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Sulka B, 2009, J BIOL CHEM, V284, P10659, DOI 10.1074/jbc.M807643200; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; UMEMURA S, 1986, J HYPERTENS, V4, P19, DOI 10.1097/00004872-198602000-00004; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; von Nandelstadh P, 2009, MOL CELL BIOL, V29, P822, DOI 10.1128/MCB.01454-08; WU XY, 1995, CLIN EXP HYPERTENS, V17, P989, DOI 10.3109/10641969509033647; Zhang P, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.21	55	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13034	13044		10.1074/jbc.M117.779405	http://dx.doi.org/10.1074/jbc.M117.779405			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623232	Green Published, hybrid			2022-12-26	WOS:000407220100030
J	Aubry, KB; Raley, CM; McKelvey, KS				Aubry, Keith B.; Raley, Catherine M.; McKelvey, Kevin S.			The importance of data quality for generating reliable distribution models for rare, elusive, and cryptic species	PLOS ONE			English	Article							ANECDOTAL OCCURRENCE DATA; FISHER MARTES-PENNANTI; MAXIMUM-ENTROPY; GEOGRAPHIC DISTRIBUTIONS; ROCKY-MOUNTAINS; PACIFIC STATES; SAMPLE-SIZE; HABITAT; PERFORMANCE; SELECTION	The availability of spatially referenced environmental data and species occurrence records in online databases enable practitioners to easily generate species distribution models (SDMs) for a broad array of taxa. Such databases often include occurrence records of unknown reliability, yet little information is available on the influence of data quality on SDMs generated for rare, elusive, and cryptic species that are prone to misidentification in the field. We investigated this question for the fisher (Pekania pennanti), a forest carnivore of conservation concern in the Pacific States that is often confused with the more common Pacific marten (Martes caurina). Fisher occurrence records supported by physical evidence (verifiable records) were available from a limited area, whereas occurrence records of unknown quality (unscreened records) were available from throughout the fisher's historical range. We reserved 20% of the verifiable records to use as a test sample for both models and generated SDMs with each dataset using Maxent. The verifiable model performed substantially better than the unscreened model based on multiple metrics including AUC(test) values (0.78 and 0.62, respectively), evaluation of training and test gains, and statistical tests of how well each model predicted test localities. In addition, the verifiable model was consistent with our knowledge of the fisher's habitat relations and potential distribution, whereas the unscreened model indicated a much broader area of high-quality habitat (indices > 0.5) that included large expanses of high-elevation habitat that fishers do not occupy. Because Pacific martens remain relatively common in upper elevation habitats in the Cascade Range and Sierra Nevada, the SDM based on unscreened records likely reflects primarily a conflation of marten and fisher habitat. Consequently, accurate identifications are far more important than the spatial extent of occurrence records for generating reliable SDMs for the fisher in this region. We strongly recommend that practitioners avoid using anecdotal occurrence records to build SDMs but, if such data are used, the validity of resulting models should be tested with verifiable occurrence records.	[Aubry, Keith B.; Raley, Catherine M.] US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98512 USA; [McKelvey, Kevin S.] US Forest Serv, USDA, Rocky Mt Res Stn, Missoula, MT USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Aubry, KB (corresponding author), US Forest Serv, USDA, Pacific Northwest Res Stn, Olympia, WA 98512 USA.	kaubry@fs.fed.us						Aubry KB, 2003, BIOL CONSERV, V114, P79, DOI 10.1016/S0006-3207(03)00003-X; Aubry KB, 2004, MARTES CARNIVORE COM, P159; Aubry KB, 2013, J WILDLIFE MANAGE, V77, P965, DOI 10.1002/jwmg.563; Aubry Keith B., 1993, Northwestern Naturalist, V73, P69, DOI 10.2307/3536711; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Beck J, 2014, ECOL INFORM, V19, P10, DOI 10.1016/j.ecoinf.2013.11.002; Blackard JA, 2008, MAPPING US FOREST BI; Braunisch V, 2010, ECOGRAPHY, V33, P826, DOI 10.1111/j.1600-0587.2009.05891.x; Buskirk Steven W., 1994, P283; Carroll C, 2001, ECOL APPL, V11, P961, DOI 10.1890/1051-0761(2001)011[0961:CAFSFC]2.0.CO;2; Centre for Forest Conservation Genetics (CFCG), 2014, CLIMATEWNA V4 84; Corsi F, 2000, METH C CONS, P389; Costa H, 2015, ISPRS INT J GEO-INF, V4, P2496, DOI 10.3390/ijgi4042496; Davis FW, 2007, ECOL APPL, V17, P2195, DOI 10.1890/06-1484.1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ensing DJ, 2013, BOTANY, V91, P137, DOI 10.1139/cjb-2012-0205; Frey Jennifer K., 2013, Animals, V3, P327, DOI 10.3390/ani3020327; Gould GI, 1987, W65R4 CAL DEP FISH G; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Jenness J., 2013, LAND FACET CORRIDOR; JOHNSON RE, 1997, WASHINGTON STATE GAP, V3; Krohn W, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P115; Krohn William B., 1997, P211; Landscape Ecology Modeling Mapping and Analysis (LEMMA), 2012, GNN STRUCT SPEC SIZ; Lewis J.C., 1998, WASHINGTON STATE STA; Lewis JC, 2004, FEASIBILITY ASSESSME; Lofroth E.C., 2010, CONSERVATION FISHERS, VI; Lozier JD, 2009, J BIOGEOGR, V36, P1623, DOI 10.1111/j.1365-2699.2009.02152.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Olson LE, 2014, BIOL CONSERV, V169, P89, DOI 10.1016/j.biocon.2013.10.022; Osborne PE, 2009, DIVERS DISTRIB, V15, P671, DOI 10.1111/j.1472-4642.2009.00572.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Powell R.A., 2012, BIOL CONSERVATION MA, P93, DOI DOI 10.7591/9780801466076-009; RAINE RM, 1983, CAN J ZOOL, V61, P25, DOI 10.1139/z83-002; Raley CM., 2012, BIOL CONSERVATION MA, P231; Schempf PF, 1977, CALIFORNIA REGION; Schwartz MK, 2013, FOREST ECOL MANAG, V305, P103, DOI 10.1016/j.foreco.2013.05.014; Spencer W, 2011, BIOL CONSERV, V144, P788, DOI 10.1016/j.biocon.2010.10.027; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; U. S. Fish and Wildlife Service, 2014, FED REGISTER, V79, P60419; U.S. Fish and Wildlife Service, 2016, FINAL SPECIES REPORT; U.S. Geological Survey, 2015, 30M DEM US GEOL SURV; Wiken E., 2011, N AM TERRESTRIAL ECO; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Zielinski WJ, 1995, CALIF FISH GAME, V81, P104; Zielinski WJ, 2001, J MAMMAL, V82, P478, DOI 10.1644/1545-1542(2001)082&lt;0478:SOAMIC&gt;2.0.CO;2	53	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179152	10.1371/journal.pone.0179152	http://dx.doi.org/10.1371/journal.pone.0179152			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640819	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800018
J	Fischer, D; Lombardi, DA; Marucci-Wellman, H; Roenneberg, T				Fischer, Dorothee; Lombardi, David A.; Marucci-Wellman, Helen; Roenneberg, Till			Chronotypes in the US - Influence of age and sex	PLOS ONE			English	Article							SLEEP DURATION; MORNINGNESS-EVENINGNESS; INDIVIDUAL-DIFFERENCES; SOCIAL JETLAG; UNITED-STATES; MELATONIN; WORK; RISK; PHASE; EPIDEMIOLOGY	An individual's chronotype reflects how the circadian system embeds itself into the 24-h day with rhythms in physiology, cognition and behavior occurring accordingly earlier or later. In view of an increasing number of people working at unusual times and linked health and safety risks, the wide range in human chronotypes may provide opportunities to allow people to work (and sleep) at times that are in synch with their circadian physiology. We aimed at estimating the distribution of chronotypes in the US population by age and sex. Twelve years (2003-2014) of pooled diary data from the American Time Use Survey were used to calculate chronotype based on mid-point of sleep on weekends (MSFWe, n = 53,689). We observed a near-normal distribution overall and within each age group. The distribution's mean value is systematically different with age, shifting later during adolescence, showing a peak in 'lateness' at similar to 19 years, and shifting earlier thereafter. Men are typically later chronotypes than women before 40, but earlier types after 40. The greatest differences are observed between 15 and 25 for both sexes, equaling more than 50% of the total chronotype difference across all age groups. The variability in chronotype decreases with age, but is generally higher in males than females. This is the first study to estimate the distribution and prevalence of individual chronotypes in the US population based on a large-scale, nationally representative sample. Our finding that adolescents are on average the latest chronotypes supports delaying school start times to benefit their sleep and circadian alignment. The generally wide range in chronotypes may provide opportunities for tailored work schedules by matching external and internal time, potentially decreasing long- and short-term health and safety risks.	[Fischer, Dorothee; Lombardi, David A.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Fischer, Dorothee; Lombardi, David A.; Marucci-Wellman, Helen] Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA 01748 USA; [Roenneberg, Till] Ludwig Maximilians Univ Munchen, Ctr Chronobiol, Inst Med Psychol, Munich, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Liberty Mutual Research Institute for Safety; University of Munich	Fischer, D (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.; Fischer, D (corresponding author), Liberty Mutual Res Inst Safety, Ctr Injury Epidemiol, Hopkinton, MA 01748 USA.	dfischer@hsph.harvard.edu		Roenneberg, Till/0000-0003-2939-0332; Lombardi, David/0000-0001-6151-2024; Fischer, Dorothee/0000-0002-2122-3938				Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Boivin DB, 2016, P NATL ACAD SCI USA, V113, P10980, DOI 10.1073/pnas.1524484113; Borisenkov M. F., 2010, Human Physiology, V36, P348, DOI 10.1134/S0362119710030151; Broms U, 2014, CHRONOBIOL INT, V31, P182, DOI 10.3109/07420528.2013.836534; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Burgess HJ, 2005, J SLEEP RES, V14, P229, DOI 10.1111/j.1365-2869.2005.00470.x; Cain SW, 2010, J BIOL RHYTHM, V25, P288, DOI 10.1177/0748730410374943; Chang AM, 2015, P NATL ACAD SCI USA, V112, P1232, DOI 10.1073/pnas.1418490112; Crowley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112199; Crowley SJ, 2010, CHRONOBIOL INT, V27, P1469, DOI 10.3109/07420528.2010.503293; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Duarte LL, 2014, BRAZ J MED BIOL RES, V47, P316, DOI 10.1590/1414-431X20143001; Eastman CI, 2016, SCI REP-UK, V6, DOI 10.1038/srep36716; Fischer D, 2016, CHRONOBIOL INT, V33, P98, DOI 10.3109/07420528.2015.1113986; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Gamble AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111700; Gan Y, 2015, OCCUP ENVIRON MED, V72, P72, DOI 10.1136/oemed-2014-102150; Horne J. A., 1975, INT J CHRONOBIOL, V4, P97; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Kantermann T, 2015, J BIOL RHYTHM, V30, P449, DOI 10.1177/0748730415597520; KERKHOF GA, 1985, BIOL PSYCHOL, V20, P83, DOI 10.1016/0301-0511(85)90019-5; Kinne S, 2004, AM J PUBLIC HEALTH, V94, P443, DOI 10.2105/AJPH.94.3.443; Kitamura S, 2014, CHRONOBIOL INT, V31, P845, DOI 10.3109/07420528.2014.914035; Krueger PM, 2009, AM J EPIDEMIOL, V169, P1052, DOI 10.1093/aje/kwp023; Lowry R, 2012, J OBES, V2012, DOI 10.1155/2012/476914; Malone SK, 2016, CHRONOBIOL INT, V33, P10, DOI 10.3109/07420528.2015.1107729; Martin SK, 2002, CHRONOBIOL INT, V19, P695, DOI 10.1081/CBI-120006080; Marucci-Wellman HR, 2016, CHRONOBIOL INT, P1; McKenzie B, 2011, COMMUNICATING US 200; McKnight-Eily LR, 2011, PREV MED, V53, P271, DOI 10.1016/j.ypmed.2011.06.020; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; Merikanto I, 2015, J AFFECT DISORDERS, V188, P143, DOI 10.1016/j.jad.2015.08.061; Morgenthaler TI, 2016, J CLIN SLEEP MED JCS; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Perez-Lloret S, 2013, J CLIN SLEEP MED, V9, P466, DOI 10.5664/jcsm.2668; R Development Core Team, 2016, R LANG ENV STAT COMP; Randler C, 2011, J GENET PSYCHOL, V172, P302, DOI 10.1080/00221325.2010.535225; Roenneberg T, 2004, CURR BIOL, V14, pR1038, DOI 10.1016/j.cub.2004.11.039; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; Roenneberg T, 2003, J BIOL RHYTHM, V18, P80, DOI 10.1177/0748730402239679; Roenneberg T, 2002, J BIOL RHYTHM, V17, P495, DOI 10.1177/0748730402238231; Roenneberg T., 2015, J BIOL RHYTHM; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Santhi N, 2016, P NATL ACAD SCI USA, V113, pE2730, DOI 10.1073/pnas.1521637113; Tonetti L, 2008, CHRONOBIOL INT, V25, P745, DOI 10.1080/07420520802394191; Van Reen E, 2013, J BIOL RHYTHM, V28, P425, DOI 10.1177/0748730413511771; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Vetter C, 2015, DIABETES CARE, V38, P1707, DOI 10.2337/dc15-0302; Vetter C, 2015, CURR BIOL, V25, P907, DOI 10.1016/j.cub.2015.01.064; Wheaton AG., 2016, MMWR MORB MORTAL WKL, V65; Wheaton AG, 2015, MMWR-MORBID MORTAL W, V64, P809, DOI 10.15585/mmwr.mm6430a1; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	56	181	188	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178782	10.1371/journal.pone.0178782	http://dx.doi.org/10.1371/journal.pone.0178782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636610	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300017
J	Tamura, A; Akasaka, K; Otsudo, T; Shiozawa, J; Toda, Y; Yamada, K				Tamura, Akihiro; Akasaka, Kiyokazu; Otsudo, Takahiro; Shiozawa, Jyunya; Toda, Yuka; Yamada, Kaori			Dynamic knee valgus alignment influences impact attenuation in the lower extremity during the deceleration phase of a single-leg landing	PLOS ONE			English	Article							CRUCIATE LIGAMENT INJURY; DROP-LANDINGS; NEUROMUSCULAR CONTROL; ENERGY-ABSORPTION; VIDEO ANALYSIS; LOWER-LIMB; MECHANISMS; KINEMATICS; KINETICS; FEMALE	Dynamic knee valgus during landings is associated with an increased risk of non-contact anterior cruciate ligament (ACL) injury. In addition, the impact on the body during landings must be attenuated in the lower extremity joints. The purpose of this study was to investigate landing biomechanics during landing with dynamic knee valgus by measuring the vertical ground reaction force (vGRF) and angular impulses in the lower extremity during a single-leg landing. The study included 34 female college students, who performed the single-leg drop vertical jump. Lower extremity kinetic and kinematic data were obtained from a 3D motion analysis system. Participants were divided into valgus (N = 19) and varus (N = 15) groups according to the knee angular displacement during landings. The vGRF and angular impulses of the hip, knee, and ankle were calculated by integrating the vGRF-time curve and each joint's moment-time curve. vGRF impulses did not differ between two groups. Hip angular impulse in the valgus group was significantly smaller than that in the varus group (0.019 +/- 0.033 vs. 0.067 +/- 0.029 Nms/kgm, p < 0.01), whereas knee angular impulse was significantly greater (0.093 +/- 0.032 vs. 0.045 +/- 0.040 Nms/kgm, p < 0.01). There was no difference in ankle angular impulse between the groups. Our results indicate that dynamic knee valgus increases the impact the knee joint needs to attenuate during landing; conversely, the knee varus participants were able to absorb more of the landing impact with the hip joint.	[Tamura, Akihiro; Akasaka, Kiyokazu; Otsudo, Takahiro] Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan; [Akasaka, Kiyokazu; Otsudo, Takahiro] Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan; [Shiozawa, Jyunya] Zenshukai Hosp, Dept Rehabil, Maebashi, Gunma, Japan; [Toda, Yuka] Yokohama Asahi Ctr Gen Hosp, Dept Rehabil, Yokohama, Kanagawa, Japan; [Yamada, Kaori] Kanetsu Hosp, Dept Rehabil, Tsurugashima, Saitama, Japan	Saitama Medical University; Saitama Medical University	Akasaka, K (corresponding author), Saitama Med Univ, Grad Sch Med, Moroyama, Saitama, Japan.; Akasaka, K (corresponding author), Saitama Med Univ, Sch Phys Therapy, Moroyama, Saitama, Japan.	akasaka-smc@umin.ac.jp	Akasaka, Kiyokazu/ABI-0104-2022; Tamura, Akihiro/ABF-1688-2021	Tamura, Akihiro/0000-0003-2972-5745; Akasaka, Kiyokazu/0000-0003-2110-205X				Alentorn-Geli E, 2009, KNEE SURG SPORT TR A, V17, P705, DOI 10.1007/s00167-009-0813-1; Barr AE, 2001, BASIC BIOMECHANICS M; Brown TN, 2016, APPL ERGON, V52, P54, DOI 10.1016/j.apergo.2015.06.004; Chappell JD, 2005, AM J SPORT MED, V33, P1022, DOI 10.1177/0363546504273047; Decker MJ, 2003, CLIN BIOMECH, V18, P662, DOI 10.1016/S0268-0033(03)00090-1; Derrick TR, 2004, MED SCI SPORT EXER, V36, P832, DOI 10.1249/01.MSS.0000126779.65353.CB; DEVITA P, 1992, MED SCI SPORT EXER, V24, P108; Ford KR, 2003, MED SCI SPORT EXER, V35, P1745, DOI 10.1249/01.MSS.0000089346.85744.D9; Griffin LY, 2001, J AM ACAD ORTHOP SUR, V8, P141; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Kobayashi H, 2010, J SPORT SCI MED, V9, P669; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Kulas A, 2008, J BIOMECH, V41, P180, DOI 10.1016/j.jbiomech.2007.06.027; Lin CF, 2009, J BIOMECH, V42, P418, DOI 10.1016/j.jbiomech.2008.12.005; Madigan ML, 2003, J ELECTROMYOGR KINES, V13, P491, DOI 10.1016/S1050-6411(03)00037-3; MCNITTGRAY JL, 1993, J BIOMECH, V26, P1037, DOI 10.1016/S0021-9290(05)80003-X; Myer GD, 2004, J ATHL TRAINING, V39, P352; Olsen OE, 2004, AM J SPORT MED, V32, P1002, DOI 10.1177/0363546503261724; Urabe Y, 2005, KNEE, V12, P129, DOI 10.1016/j.knee.2004.05.002; Wernli K, 2016, J ORTHOP SPORT PHYS, V46, P194, DOI 10.2519/jospt.2016.6041; Wikstrom EA, 2008, SCAND J MED SCI SPOR, V18, P55, DOI 10.1111/j.1600-0838.2006.00629.x; Zhang SN, 2000, MED SCI SPORT EXER, V32, P812, DOI 10.1097/00005768-200004000-00014	22	12	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179810	10.1371/journal.pone.0179810	http://dx.doi.org/10.1371/journal.pone.0179810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632776	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100050
J	Khan, MS; Hutchison, C; Coker, RJ				Khan, Mishal S.; Hutchison, Coll; Coker, Richard J.			Risk factors that may be driving the emergence of drug resistance in tuberculosis patients treated in Yangon, Myanmar	PLOS ONE			English	Article							PRIVATE; CARE; PRACTITIONERS; HEALTH	Background The majority of new tuberculosis cases emerging every year occur in low and middleincome countries where public health systems are often characterised by weak infrastructure and inadequate resources. This study investigates healthcare seeking behaviour, knowledge and treatment of tuberculosis patients in Myanmar D which is facing an acute drug-resistant tuberculosis epidemic D and identifies factors that may increase the risk of emergence of drug-resistant tuberculosis. Methods We randomly selected adult smear-positive pulmonary tuberculosis patients diagnosed between September 2014 and March 2015 at ten public township health centres in Yangon, the largest city in Myanmar. Data on patients' healthcare seeking behaviour, treatment at the township health centres, co-morbidities and knowledge was collected through patient interviews and extraction from hospital records. A retrospective descriptive cross-sectional analysis was conducted. Results Of 404 TB patients selected to participate in the study, 11 had died since diagnosis, resulting in 393 patients being included in the final analysis. Results indicate that a high proportion of patients (16%; 95% CI = 13 +/- 20) did not have a treatment supporter assigned to improve adherence to medication, with men being more likely to have no treatment supporter assigned. Use of private healthcare providers was very common; 59% (54 +/- 64) and 30.3% (25.9 +/- 35.0) of patients reported first seeking care at private clinics and pharmacies respectively. We found that 8% (6 +/- 11) of tuberculosis patients had confirmed diabetes. Most patients had some knowledge about tuberculosis transmission and the consequences of missing treatment. However, 5% (3 +/- 8) stated that they miss taking tuberculosis medicines at least weekly, and patients with no knowledge of consequences of missing treatment were more likely to miss doses. Conclusions This study analysed healthcare seeking behaviour and treatment related practices of tuberculosis patients being managed under operational conditions in a fragile health system. Findings indicate that ensuring that treatment adherence support is arranged for all patients, monitoring of response to treatment among the high proportion of tuberculosis patients with diabetes and engagement with private healthcare providers could be strategies addressed to reduce the risk of emergence of drug-resistant tuberculosis.	[Khan, Mishal S.; Hutchison, Coll; Coker, Richard J.] London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, London, England; [Khan, Mishal S.; Coker, Richard J.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Coker, Richard J.] Mahidol Univ, Fac Publ Hlth, Bangkok, Thailand	University of London; London School of Hygiene & Tropical Medicine; National University of Singapore; Mahidol University	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, London, England.; Khan, MS (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.	mishal.khan@lshtm.ac.uk			United States Agency for International Development's Control and Prevention-Tuberculosis Project; FHI 360	United States Agency for International Development's Control and Prevention-Tuberculosis Project(United States Agency for International Development (USAID)); FHI 360	This study was a component of a larger programme of research funded through a grant from the United States Agency for International Development's Control and Prevention-Tuberculosis Project. We gratefully acknowledge the support of FHI 360, the participating health facilities in Yangon and the Myanmar National TB Control Programme for facilitating the study data collection.	Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chuc NTK, 1999, EUR J CLIN PHARMACOL, V55, P325, DOI 10.1007/s002280050636; Hazarika I, 2011, J GLOB INFECT DIS, V3, P19, DOI 10.4103/0974-777X.77291; Karumbi J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003343.pub4; Khan MS, 2014, LANCET, V384, P646, DOI 10.1016/S0140-6736(14)61175-2; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Saw Saw, 2002, Myanmar Health Sciences Research Journal, V14, P12; Saw Saw, 2009, Myanmar Health Sciences Research Journal, V21, P186; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2012, MULT RES TUB MYANM P; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; Zwi AB, 2001, BRIT MED J, V323, P463, DOI 10.1136/bmj.323.7311.463	18	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0177999	10.1371/journal.pone.0177999	http://dx.doi.org/10.1371/journal.pone.0177999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614357	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000403280900011
J	Lee, SR; Berlow, EL; Ostoja, SM; Brooks, ML; Genin, A; Matchett, JR; Hart, SC				Lee, Steven R.; Berlow, Eric L.; Ostoja, Steven M.; Brooks, Matthew L.; Genin, Alexandre; Matchett, John R.; Hart, Stephen C.			A multi-scale evaluation of pack stock effects on subalpine meadow plant communities in the Sierra Nevada	PLOS ONE			English	Article							RIPARIAN ECOSYSTEMS; VEGETATION; GRASSLAND; CALIFORNIA; MULTIVARIATE; RANGELANDS; PATTERNS; DROUGHT; STREAM	We evaluated the influence of pack stock (i.e., horse and mule) use on meadow plant communities in Sequoia and Yosemite National Parks in the Sierra Nevada of California. Meadows were sampled to account for inherent variability across multiple scales by: 1) controlling for among-meadow variability by using remotely sensed hydro-climatic and geospatial data to pair stock use meadows with similar non-stock (reference) sites, 2) accounting for within-meadow variation in the local hydrology using in-situ soil moisture readings, and 3) incorporating variation in stock use intensity by sampling across the entire available gradient of pack stock use. Increased cover of bare ground was detected only within "dry" meadow areas at the two most heavily used pack stock meadows (maximum animals per night per hectare). There was no difference in plant community composition for any level of soil moisture or pack stock use. Increased local-scale spatial variability in plant community composition (species dispersion) was detected in "wet" meadow areas at the two most heavily used meadows. These results suggest that at the meadow scale, plant communities are generally resistant to the contemporary levels of recreational pack stock use. However, finer-scale within-meadow responses such as increased bare ground or spatial variability in the plant community can be a function of local-scale hydrological conditions. Wilderness managers can improve monitoring of disturbance in Sierra Nevada meadows by adopting multiple plant community indices while simultaneously considering local moisture regimes.	[Lee, Steven R.; Brooks, Matthew L.; Matchett, John R.] US Geol Survey, Western Ecol Res Ctr, Yosemite Field Stn, Oakhurst, CA USA; [Berlow, Eric L.] Vibrant Data Labs, San Francisco, CA USA; [Ostoja, Steven M.] Univ Calif Davis, USDA Calif Climate Hub, ARS, John Muir Inst Environm, Davis, CA 95616 USA; [Genin, Alexandre] Univ Montpellier 2, Inst Sci Evolut, CNRS, Montpellier, France; [Hart, Stephen C.] Univ Calif Merced, Life & Environm Sci & Sierra Nevada Res Inst, Merced, CA USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of California System; University of California Merced	Lee, SR (corresponding author), US Geol Survey, Western Ecol Res Ctr, Yosemite Field Stn, Oakhurst, CA USA.	srlee@usgs.gov		Lee, Steven/0000-0002-4581-3684; Genin, Alexandre/0000-0002-3333-1338	U.S. Geological Survey Natural Resources Preservation Program; Vibrant Data Inc.	U.S. Geological Survey Natural Resources Preservation Program; Vibrant Data Inc.	Financial support was provided by the U.S. Geological Survey Natural Resources Preservation Program. One of our coauthors Eric Berlow works for a commercial company, Vibrant Data Inc. For the majority of the project his affiliation was with the University of California, Merced. But that changed during the writing phase of this manuscript. The funder, Vibrant Data Inc., provided support in the form of salaries for EB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this coauthor are articulated in the author contributions section.; This research was funded with support from the U.S. Geological Survey, Natural Resource Preservation Project Research fund. We thank UC Merced's Sierra Nevada Research Institute and the UC Natural Reserve System Yosemite Field Station for logistical support with housing field staff. We thank: Sylvia Haultain, Liz Ballinger and Mark Fincher for their assistance with NPS pack stock use records; Lucas Joppa for guidance on statistical methods for meadow selections; and the numerous field staff and volunteers for all their hard work and dedication. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Ager AA, 2004, CHARCTERIZATING MEAD; ALLENDIAZ BH, 1991, AM MIDL NAT, V126, P30, DOI 10.2307/2426147; ANDERSON GL, 1993, REMOTE SENS ENVIRON, V45, P165, DOI 10.1016/0034-4257(93)90040-5; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Baccei JS, 2017, REVIEW; Beever EA, 2000, WEST N AM NATURALIST, V60, P236; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Berlow EL, 2003, ECOL APPL, V13, P1375, DOI 10.1890/02-5099; Berlow EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072200; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; CLUZEAU D, 1992, SOIL BIOL BIOCHEM, V24, P1661, DOI 10.1016/0038-0717(92)90166-U; Cole DN, 2004, J RANGE MANAGE, V57, P153, DOI 10.2307/4003913; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; CRIST EP, 1984, IEEE T GEOSCI REMOTE, V22, P256, DOI 10.1109/TGRS.1984.350619; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DELMORAL R, 1983, AM J BOT, V70, P232, DOI 10.2307/2443269; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Dozier J, 2009, PHILOS T R SOC A, V367, P1021, DOI 10.1098/rsta.2008.0187; Fites-Kaufman JA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P456; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Graber D, 1996, SIERRA NEVADA ECOSYS, VII; GRAUMLICH LJ, 1993, QUATERNARY RES, V39, P249, DOI 10.1006/qres.1993.1029; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Hammersmark CT, 2008, RIVER RES APPL, V24, P735, DOI 10.1002/rra.1077; Han JJ, 2014, J ARID ENVIRON, V107, P1, DOI 10.1016/j.jaridenv.2014.03.007; Holmquist JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054109; Hopkinson P, NPSSEKINRR201366513; KAUFFMAN JB, 1984, J RANGE MANAGE, V37, P430, DOI 10.2307/3899631; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; LAYCOCK WA, 1975, J RANGE MANAGE, V28, P458, DOI 10.2307/3897222; Loheide SP, 2011, GEOMORPHOLOGY, V126, P364, DOI 10.1016/j.geomorph.2010.04.016; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007561; McClaran M. P., 1993, PACKSTOCK WILDERNESS; MCCLARAN MP, 1989, RANGELANDS, V11, P3; Nadian H, 1997, NEW PHYTOL, V135, P303, DOI 10.1046/j.1469-8137.1997.00653.x; National Park Service Integrated Resource Management Applications, GEOSP DAT 10M DIG EL; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Ostoja SM, 2014, RANGELAND J, V36, P411, DOI 10.1071/RJ14050; Ratliff R.D., 1985, PSW84; Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Sekhon JS, 2011, J STAT SOFTW, V42, P1; STERLING A, 1984, OIKOS, V42, P334, DOI 10.2307/3544402; Stringham TK, 2003, J RANGE MANAGE, V56, P106, DOI 10.2307/4003893; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Team RC, 2012, R LANG ENV STAT COMP; Thornton P.E., 2014, DAYMET DAILY SURFACE, DOI DOI 10.3334/ORNLDAAC/1219; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Van Wagtendonk Jan W., 1996, P281; Weixelman D, 2011, R5TP034; Weixelman DA, 1997, J RANGE MANAGE, V50, P315, DOI 10.2307/4003735; Wood S. H., 1975, THESIS	52	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178536	10.1371/journal.pone.0178536	http://dx.doi.org/10.1371/journal.pone.0178536			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609464	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700008
J	Murata, Y; Sugi, T; Weiss, LM; Kato, K				Murata, Yuho; Sugi, Tatsuki; Weiss, Louis M.; Kato, Kentaro			Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites	PLOS ONE			English	Article							INFECTION; DIFFERENTIATION; TRANSCRIPTION; PARASITE; KINASE; GENES	Drug treatment for toxoplasmosis is problematic, because current drugs cannot eradicate latent infection with Toxoplasma gondii and can cause bone marrow toxicity. Because latent infection remains after treatment, relapse of infection is a problem in both infections in immunocompromised patients and in congenitally infected patients. To identify lead compounds for novel drugs against Toxoplasma gondii, we screened a chemical compound library for anti-Toxoplasma activity, host cell cytotoxicity, and effect on bradyzoites. Of 878 compounds screened, 83 demonstrated > 90% parasite growth inhibition. After excluding compounds that affected host cell viability, we further characterized two compounds, tanshinone IIA and hydroxyzine, which had IC50 values for parasite growth of 2.5 mu M and 1.0 mu M, respectively, and had no effect on host cell viability at 25 mu M. Both tanshinone IIA and hydroxyzine inhibited parasite replication after invasion and both reduced the number of in vitro-induced bradyzoites, whereas, pyrimethamine, the current therapy, had no effect on bradyzoites. Both tanshinone IIA and hydroxyzine are potent lead compounds for further medicinal chemistry. The method presented for evaluating compounds for bradyzoite efficacy represents a new approach to the development of anti-Toxoplasma drugs to eliminate latency and treat acute infection.	[Murata, Yuho; Kato, Kentaro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido, Japan; [Sugi, Tatsuki; Weiss, Louis M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Obihiro University of Agriculture & Veterinary Medicine; Yeshiva University; Albert Einstein College of Medicine	Kato, K (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido, Japan.	kkato@obihiro.ac.jp	Sugi, Tatsuki/A-9110-2012		Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan [3407]; Japan Science and Technology Agency (JST); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI123495, R01AI095094] Funding Source: NIH RePORTER	Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants-in-aid for Young Scientists, Scientific Research on Innovative Areas (3407) from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan; by the Program to Disseminate Tenure Tracking System and the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST).	Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994; Cai YE, 2016, INT J NANOMED, V11, P121, DOI 10.2147/IJN.S84035; Dittmar AJ, 2016, DRUG REPURPOSING SCR, V1, P1; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Doggett JS, 2014, ANTIMICROB AGENTS CH, V58, P3547, DOI 10.1128/AAC.01823-13; Doggett JS, 2012, P NATL ACAD SCI USA, V109, P15936, DOI 10.1073/pnas.1208069109; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Dzierszinski F, 2004, EUKARYOT CELL, V3, P992, DOI 10.1128/EC.3.4.992-1003.2004; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P179, DOI 10.1007/s00406-013-0413-4; Fox BA, 2011, EUKARYOT CELL, V10, P1193, DOI 10.1128/EC.00297-10; Gillard M, 2002, MOL PHARMACOL, V61, P391, DOI 10.1124/mol.61.2.391; Goodwin DG, 2011, J PARASITOL, V97, P148, DOI 10.1645/GE-2536.1; Ishiwa A, 2013, PARASITOL RES, V112, P4169, DOI 10.1007/s00436-013-3608-8; Khan N, 2012, ANTIOXID REDOX SIGN, V16, P1195, DOI 10.1089/ars.2011.4162; Martins-Duarte ED, 2008, FEMS MICROBIOL LETT, V282, P290, DOI 10.1111/j.1574-6968.2008.01130.x; McLeod R, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P99, DOI 10.1016/B978-0-12-396481-6.00004-0; Miraglia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33274; Nare B, 2002, ANTIMICROB AGENTS CH, V46, P300, DOI 10.1128/AAC.46.2.300-307.2002; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Radke JR, 2006, PLOS PATHOG, V2, P964, DOI 10.1371/journal.ppat.0020105; Slusarczyk S, 2011, PLANTA MED, V77, P1594, DOI 10.1055/s-0030-1270933; Sugi T, 2014, ANAL BIOCHEM, V464, P9, DOI 10.1016/j.ab.2014.06.018; Watts E, 2015, MBIO, V6, DOI 10.1128/mBio.01155-15; WERNER H, 1976, ARZNEIMITTEL-FORSCH, V26, P53; Xie J, 2015, ACTA PHARMACOL SIN B, V5, P554, DOI 10.1016/j.apsb.2015.07.008; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	29	29	30	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178203	10.1371/journal.pone.0178203	http://dx.doi.org/10.1371/journal.pone.0178203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609444	Green Submitted, Green Published, gold			2022-12-26	WOS:000403274700004
J	Hu, JY; Lei, L; de Meaux, J				Hu, Jinyong; Lei, Li; de Meaux, Juliette			Temporal fitness fluctuations in experimental Arabidopsis thaliana populations	PLOS ONE			English	Article							LOCAL ADAPTATION; GENETIC-BASIS; NATURAL VARIATION; SEED DORMANCY; SELECTION; CLIMATE; GERMINATION; DIVERGENCE; ALLELES; DROUGHT	Understanding the genetics of lifetime fitness is crucial to understand a species' ecological preferences and ultimately predict its ability to cope with novel environmental conditions. Yet, there is a dearth of information regarding the impact of the ecological variance experienced by natural populations on expressed phenotypic and fitness differences. Here, we follow the natural dynamics of experimental A. thaliana populations over 5 successive plantings whose timing was determined by the natural progression of the plant's life cycle and disentangle the environmental and genetic factors that drive plant ecological performance at a given locality. We show that, at the temperate latitude where the experiment was conducted, a given genotype can experience winter-, spring-or summer-annual life cycles across successive seasons. Lifetime fitness across these seasons varied strongly, with a fall planting yielding 36-fold higher fitness compared to a spring planting. In addition, the actual life-stage at which plant overwinter oscillated across years, depending on the timing of the end of the summer season. We observed a rare but severe fitness differential coinciding with inadequate early flowering in one of the five planting. Substrate variation played a comparatively minor role, but also contributed to modulate the magnitude of fitness differentials between genotypes. Finally, reciprocal introgressions on chromosome 4 demonstrated that the fitness effect of a specific chromosomal region is strongly contingent on micro-geographic and seasonal fluctuations. Our study contributes to emphasize the extent to which the fitness impact of phenotypic traits and the genes that encode them in the genome can fluctuate. Experiments aiming at dissecting the molecular basis of local adaptation must apprehend the complexity introduced by temporal fluctuations because they massively affect the expression of phenotype and fitness differences.	[Hu, Jinyong] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan Province, Peoples R China; [Lei, Li] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [de Meaux, Juliette] Univ Cologne, Inst Bot, Bioctr, Zulpicherstr 47B, Cologne, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Minnesota System; University of Minnesota Twin Cities; University of Cologne	Hu, JY (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan Province, Peoples R China.; de Meaux, J (corresponding author), Univ Cologne, Inst Bot, Bioctr, Zulpicherstr 47B, Cologne, Germany.	hujinyong@mail.kib.ac.cn; jdemeaux@uni-koeln.de	Lei, Li/J-6122-2019	Lei, Li/0000-0001-5708-0118; de Meaux, Juliette/0000-0002-2942-4750	Deutsche Forschung Gesellschaft (DFG) [SFB680]; European Research Council [648617]	Deutsche Forschung Gesellschaft (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This research was supported by the Deutsche Forschung Gesellschaft (DFG) in the realm of SFB680, and by the European Research Council with Grant 648617 "AdaptoSCOPE". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2013, P NATL ACAD SCI USA, V110, P21077, DOI 10.1073/pnas.1316773110; Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Anderson JT, 2016, NEW PHYTOL, V210, P81, DOI 10.1111/nph.13693; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Brachi B, 2013, MOL ECOL, V22, P4222, DOI 10.1111/mec.12396; Burghardt LT, 2015, AM NAT, V185, P212, DOI 10.1086/679439; Burghardt LT, 2015, AM NAT; Campitelli BE, 2016, ECOL LETT, V19, P424, DOI 10.1111/ele.12575; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chiang GCK, 2013, EVOLUTION, V67, P883, DOI 10.1111/j.1558-5646.2012.01828.x; Crawley MJ, 2005, STAT INTRO USING R; de Meaux J, 2008, P NATL ACAD SCI USA, V105, P8994, DOI 10.1073/pnas.0803218105; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Donohue K, 2005, EVOLUTION, V59, P740, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Fournier-Level A., 2016, P NATL ACAD SCI USA, V113, pE2812, DOI DOI 10.1073/pnas.1517456113; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hendrick MF, 2016, MOL ECOL, V25, P5647, DOI 10.1111/mec.13753; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Joly-Lopez Z, 2016, CURR OPIN PLANT BIOL, V30, P101, DOI 10.1016/j.pbi.2016.02.008; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Le Corre V, 2002, MOL BIOL EVOL, V19, P1261, DOI 10.1093/oxfordjournals.molbev.a004187; Legris M, 2016, SCIENCE, V354, P897, DOI 10.1126/science.aaf5656; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Luo Y, 2015, HEREDITY, V114, P220, DOI 10.1038/hdy.2014.89; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Mitchell-Olds T, 2006, NATURE, V441, P947, DOI 10.1038/nature04878; Montesinos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007213; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Postma FM, 2015, MOL ECOL, V24, P785, DOI 10.1111/mec.13061; Roux F, 2016, CURR TOP DEV BIOL, V119, P111, DOI 10.1016/bs.ctdb.2016.03.001; Savolainen O, 2013, NAT REV GENET, V14, P807, DOI 10.1038/nrg3522; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; The 1001 Genomes Consortium, 2016, CELL; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Torjek O, 2008, J HERED, V99, P396, DOI 10.1093/jhered/esn014; Wilczek AM, 2014, P NATL ACAD SCI USA, V111, P7906, DOI 10.1073/pnas.1406314111; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Wolfe MD, 2014, NEW PHYTOL, V201, P323, DOI 10.1111/nph.12485; Wood CW, 2016, ECOL LETT, V19, P1189, DOI 10.1111/ele.12662	45	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178990	10.1371/journal.pone.0178990	http://dx.doi.org/10.1371/journal.pone.0178990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604796	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400023
J	Walsh, AD; Hesketh, KD; van der Pligt, P; Cameron, AJ; Crawford, D; Campbell, KJ				Walsh, Adam D.; Hesketh, Kylie D.; van der Pligt, Paige; Cameron, Adrian J.; Crawford, David; Campbell, Karen J.			Fathers' perspectives on the diets and physical activity behaviours of their young children	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; PARENTING PRACTICES; EATING BEHAVIORS; PEER MODELS; FOOD; DETERMINANTS; ADOLESCENTS; QUALITY; ASSOCIATIONS; ENVIRONMENT	Background Children's learning about food and physical activity is considerable during their formative years, with parental influence pivotal. Research has focused predominantly on maternal influences with little known about the relationships between fathers' and young children's dietary and physical activity behaviours. A greater understanding of paternal beliefs regarding young children's dietary and physical activity behaviours is important to inform the design and delivery of child-focussed health promotion interventions. This study aimed to describe fathers' perceived roles in their children's eating and physical activity behaviours. It also sought to document fathers' views regarding how they could be best supported to promote healthy eating and physical activity behaviours in their young children. Methods In depth, semi-structured interviews were conducted with twenty fathers living in socio-economically diverse areas of metropolitan Melbourne, Australia who had at least one child aged five years or less. All interviews were audio recorded, transcribed verbatim and thematically analysed. Results Thematic analysis of the transcripts revealed eight broad themes about fathers' beliefs, perceptions and attitudes towards the dietary and physical activity behaviours of their young children: (i) shared responsibility and consultation; (ii) family meal environment; (iii) parental role modelling; (iv) parental concerns around food; (v) food rewards; (vi) health education; (vii) limiting screen time; and (viii) parental knowledge. Analysis of themes according to paternal education/employment revealed no substantial differences in the views of fathers. Conclusions This exploratory study presents the views of a socio-economically diverse group of fathers regarding the dietary and physical activity behaviours of their young children and the insights into the underlying perceptions informing these views. The findings suggest that fathers believe healthy eating behaviours and being physically active are important for their young children. Fathers believe these behaviours can be promoted and supported in different ways including through the provision of appropriate meal and physical activity environments and parental role modelling of desired dietary and physical activity behaviours.	[Walsh, Adam D.; Hesketh, Kylie D.; van der Pligt, Paige; Crawford, David; Campbell, Karen J.] Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Cameron, Adrian J.] Deakin Univ, Sch Hlth & Social Dev, Geelong, Vic, Australia; [Cameron, Adrian J.] Deakin Univ, Global Obes Ctr, Geelong, Vic, Australia	Deakin University; Deakin University; Deakin University	Walsh, AD (corresponding author), Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	adam.walsh@deakin.edu.au	Crawford, David A/K-6301-2015; Hesketh, Kylie/B-7031-2013; Cameron, Adrian/AAF-2277-2020	Crawford, David A/0000-0002-2467-7556; Hesketh, Kylie/0000-0002-2702-7110; Cameron, Adrian/0000-0002-0568-5497	Australian Research Council Future Fellowship [FT130100637]; Honorary National Heart Foundation of Australia Future Leader Fellowship [100370]; Australian Research Council [DE160100141]; National Health and Medical Research Council Centre for Research Excellence in Obesity Policy and Food Systems [1041020]	Australian Research Council Future Fellowship(Australian Research Council); Honorary National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); Australian Research Council(Australian Research Council); National Health and Medical Research Council Centre for Research Excellence in Obesity Policy and Food Systems(National Health and Medical Research Council (NHMRC) of Australia)	KDH is supported by an Australian Research Council Future Fellowship (FT130100637; http://www.arc.gov.au/future-fellowships) and an Honorary National Heart Foundation of Australia Future Leader Fellowship (100370; https://www.heartfoundation.org.au/research/apply-for-funding/future-leader-fellowships). AJC is supported by an Australian Research Council fellowship (DE160100141; http://www.arc.gov.au/future-fellowships) and is a researcher within a National Health and Medical Research Council Centre for Research Excellence in Obesity Policy and Food Systems (1041020; https://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KJC, DC, PvdP and ADW have no financial relationships relevant to this article to disclose.	Australian Bureau of Statistics, 2011, CENSUS OF POPULATION; Berge JM, 2010, J AM DIET ASSOC, V110, P1036, DOI 10.1016/j.jada.2010.04.011; Bianchi SM, 2000, DEMOGRAPHY, V37, P401, DOI 10.1353/dem.2000.0001; BIRCH LL, 1980, CHILD DEV, V51, P489, DOI 10.2307/1129283; Birch LL, 1998, PEDIATRICS, V101, P539; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burgi F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-733; Campbell K., 2001, Australian Journal of Nutrition and Dietetics, V58, P19; Campbell KJ, 2007, HEALTH PROMOT INT, V22, P11, DOI 10.1093/heapro/dal035; Cleland V, 2011, AM J HEALTH PROMOT, V25, P159, DOI 10.4278/ajhp.090303-QUAN-93; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Crawford DA, 2012, BRIT J NUTR, V107, P1028, DOI 10.1017/S0007114511003801; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Grbich C., 1998, QUALITATIVE RES; Gustafson SL, 2006, SPORTS MED, V36, P79, DOI 10.2165/00007256-200636010-00006; Harris JL, 2010, PUBLIC HEALTH NUTR, V13, P409, DOI 10.1017/S1368980009991339; Hendy HM, 2002, APPETITE, V39, P217, DOI 10.1006/appe.2002.0510; Hinkley T, 2008, AM J PREV MED, V34, P435, DOI 10.1016/j.amepre.2008.02.001; Hinkley T, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-66; Horodynski MA, 2005, APPL NURS RES, V18, P106, DOI 10.1016/j.apnr.2004.05.002; Kelly LA, 2006, ARCH DIS CHILD, V91, P35, DOI 10.1136/adc.2005.080275; Khandpur N, 2016, CHILD OBES, V12, P455, DOI 10.1089/chi.2016.0118; Khandpur N, 2016, APPETITE, V101, P134, DOI 10.1016/j.appet.2016.02.161; Kourlaba G, 2009, PUBLIC HEALTH, V123, P738, DOI 10.1016/j.puhe.2009.10.005; Lamb ME, 2013, THE FATHERS ROLE CRO; Liamputtong P, 1999, QUALITATIVE RES; Lloyd AB, 2014, APPETITE, V79, P149, DOI 10.1016/j.appet.2014.04.010; Mallan KM, 2014, CHILD CARE HLTH DEV, V40, P715, DOI 10.1111/cch.12088; Mallan KM, 2014, APPETITE, V73, P40, DOI 10.1016/j.appet.2013.10.006; MIKULA G, 1989, EUR J SOC PSYCHOL, V19, P225, DOI 10.1002/ejsp.2420190304; Montgomery KC, 2009, J ADOLESCENT HEALTH, V45, pS18, DOI 10.1016/j.jadohealth.2009.04.006; Panter-Brick C, 2014, J CHILD PSYCHOL PSYC, V55, P1187, DOI 10.1111/jcpp.12280; Patton M. Q., 1990, QUALITATIVE EVALUATI; Peters J, 2012, EARLY CHILD DEV CARE, V182, P837, DOI 10.1080/03004430.2011.586698; Powell LM, 2007, PEDIATRICS, V120, P576, DOI 10.1542/peds.2006-3595; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Sherry B, 2004, J AM DIET ASSOC, V104, P215, DOI 10.1016/j.jada.2003.11.012; Sonntag D, 2015, NUTRIENTS, V7, P8565, DOI 10.3390/nu7105414; Sotos-Prieto M, 2015, PUBLIC HEALTH NUTR, V18, P275, DOI 10.1017/S1368980014000330; Spurrier NJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-31; Stombar Z, 2005, MONITOR PSYCHOL, V36, P11; Tanner C, 2014, WOMEN STUD INT FORUM, V44, P209, DOI 10.1016/j.wsif.2013.01.017; Vereecken C, 2009, AM J HEALTH PROMOT, V23, P233, DOI 10.4278/ajhp.07061355; Vollmer RL, 2015, J CHILD FAM STUD, V24, P3734, DOI 10.1007/s10826-015-0181-z; Vollmer RL, 2015, J ACAD NUTR DIET, V115, P919, DOI 10.1016/j.jand.2014.12.003; Vollmer RL, 2015, APPETITE, V89, P274, DOI 10.1016/j.appet.2015.02.021; Wake M, 2007, PEDIATRICS, V120, pE1520, DOI 10.1542/peds.2006-3707; Walsh AD, 2015, BRIT J NUTR, V114, P988, DOI 10.1017/S0007114515002755; Xiaolin Yang, 1996, International Review for the Sociology of Sport, V31, P273	50	29	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179210	10.1371/journal.pone.0179210	http://dx.doi.org/10.1371/journal.pone.0179210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX2VR	28604810	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400037
J	Wang, Q; Tang, YM; Xu, Y; Xu, SL; Jiang, Y; Dong, QP; Zhou, YS; Ge, WS				Wang, Qian; Tang, Yiman; Xu, Yue; Xu, Shilei; Jiang, Yong; Dong, Qiuping; Zhou, Yongsheng; Ge, Wenshu			The X-linked deubiquitinase USP9X is an integral component of centrosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; deubiquitylation (deubiquitination); protein stability; protein-protein interaction; proteomics	NEURONAL MIGRATION; HUMAN-DISEASE; PROTEIN; EXPRESSION; MIDBODY; CEP55; BRAIN; GENE; MONOUBIQUITINATION; STABILIZATION	The X-linked deubiquitinase USP9X has been implicated in multiple pathological disorders including malignancies and X-linked intellectual disability. However, its biological function and substrate repertoire remain to be investigated. In this study, we utilized the tandem mass tag labeling assay to identify USP9X-regulated proteins and revealed that the expression of multiple genes is altered in USP9X-deficient cells. Interestingly, we showed that USP9X promotes stabilization of centrosome proteins PCM1 and CEP55 through its catalytic activity. Remarkably, we demonstrated that USP9X is physically associated and spatially co-localized with PCM1 and CEP55 in the centrosome, and we revealed that either PCM1 or CEP55 loss resulted in impairment of USP9X centrosome localization. Moreover, we showed that USP9X is required for centrosome duplication, and this effect is dependent on its catalytic activity and its N-terminal module, which is responsible for physical association of USP9X with PCM1 and CEP55. Collectively, our experiments identified USP9X as an integral component of the centrosome where it functions to stabilize PCM1 and CEP55 and promote centrosome biogenesis.	[Jiang, Yong; Ge, Wenshu] Peking Univ Sch & Hosp Stomatol, Dept Gen Dent 2, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Tang, Yiman; Zhou, Yongsheng] Peking Univ Sch & Hosp Stomatol, Dept Prosthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Wang, Qian; Xu, Yue; Xu, Shilei; Dong, Qiuping] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China; [Zhou, Yongsheng] Beijing Key Lab Digital Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing 100081, Peoples R China	Peking University; Peking University; Tianjin Medical University	Ge, WS (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Gen Dent 2, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.; Zhou, YS (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Prosthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.	kqzhouysh@hsc.pku.edu.cn; esther1234@hsc.pku.edu.cn			National Natural Science Foundation of China [81200763, 81670963]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81200763 and 81670963 (to W. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Baumann K, 2012, NAT REV MOL CELL BIO, V13, DOI [10.1038/nrm3418, 10.1038/nrm3422]; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Conduit PT, 2015, NAT REV MOL CELL BIO, V16, P611, DOI 10.1038/nrm4062; David R, 2011, NAT REV MOL CELL BIO, V12, P466, DOI 10.1038/nrm3158; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Gomez-Ferreria MA, 2012, CELL CYCLE, V11, P3555, DOI 10.4161/cc.21574; Grasso D, 2011, J BIOL CHEM, V286, P8308, DOI 10.1074/jbc.M110.197301; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Gurling HMD, 2006, ARCH GEN PSYCHIAT, V63, P844, DOI 10.1001/archpsyc.63.8.844; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Homan CC, 2014, AM J HUM GENET, V94, P470, DOI 10.1016/j.ajhg.2014.02.004; Hori A, 2017, CELL MOL LIFE SCI, V74, P213, DOI 10.1007/s00018-016-2315-x; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Jeffery J, 2016, ONCOGENE, V35, P683, DOI 10.1038/onc.2015.128; Jolly LA, 2009, MOL BIOL CELL, V20, P2015, DOI 10.1091/mbc.E08-06-0596; Jung JK, 2016, CELL CYCLE, V15, P584, DOI 10.1080/15384101.2016.1138185; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Li J, 2013, NATURE, V495, P255, DOI 10.1038/nature11941; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694; Luders J, 2012, NAT CELL BIOL, V14, P1126, DOI 10.1038/ncb2617; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Naik E, 2014, J EXP MED, V211, P1947, DOI 10.1084/jem.20140860; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Paemka L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005022; Park Y, 2013, P NATL ACAD SCI USA, V110, P9433, DOI 10.1073/pnas.1221925110; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Stowe TR, 2012, MOL BIOL CELL, V23, P3322, DOI 10.1091/mbc.E12-02-0134; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Swaminathan S, 2004, NAT CELL BIOL, V6, P383, DOI 10.1038/ncb0504-383; Takayanagi H, 2015, ACTA CRYSTALLOGR F, V71, P175, DOI 10.1107/S2053230X14028143; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Urbe S, 2012, MOL BIOL CELL, V23, P1095, DOI 10.1091/mbc.E11-08-0668; van der Horst A, 2009, CELL CYCLE, V8, P3742, DOI 10.4161/cc.8.22.10047; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Wang S, 2014, P NATL ACAD SCI USA, V111, P4251, DOI 10.1073/pnas.1322198111; Wilkinson CJ, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-17; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Xu J, 2005, EUR J NEUROSCI, V21, P3017, DOI 10.1111/j.1460-9568.2005.04134.x; Xu J, 2005, J NEUROSCI RES, V80, P47, DOI 10.1002/jnr.20429; Zarrizi R, 2014, CANCER RES, V74, P6499, DOI 10.1158/0008-5472.CAN-14-0221; Zhang Y, 2012, J CLIN INVEST, V122, P4362, DOI 10.1172/JCI63084; Zhou W, 2013, CANCER CELL, V23, P48, DOI 10.1016/j.ccr.2012.12.001	59	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12874	12884		10.1074/jbc.M116.769943	http://dx.doi.org/10.1074/jbc.M116.769943			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28620049	Green Published, hybrid			2022-12-26	WOS:000407220100017
J	Hanke, CA; Gohlke, H				Hanke, Christian A.; Gohlke, Holger			Ligand-mediated and tertiary interactions cooperatively stabilize the P1 region in the guanine-sensing riboswitch	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CROSS-CORRELATION ANALYSIS; PROTEIN FLEXIBILITY; PURINE RIBOSWITCH; APTAMER DOMAIN; RIGIDITY PERCOLATION; FOLDING KINETICS; GENE-EXPRESSION; FORCE-FIELDS; INDUCED FIT	Riboswitches are genetic regulatory elements that control gene expression depending on ligand binding. The guanine-sensing riboswitch (Gsw) binds ligands at a three-way junction formed by paired regions P1, P2, and P3. Loops L2 and L3 cap the P2 and P3 helices and form tertiary interactions. Part of P1 belongs to the switching sequence dictating the fate of the mRNA. Previous studies revealed an intricate relationship between ligand binding and presence of the tertiary interactions, and between ligand binding and influence on the P1 region. However, no information is available on the interplay among these three main regions in Gsw. Here we show that stabilization of the L2-L3 region by tertiary interactions, and the ligand binding site by ligand binding, cooperatively influences the structural stability of terminal base pairs in the P1 region in the presence of Mg2+ ions. The results are based on molecular dynamics simulations with an aggregate simulation time of similar to 10 mu s across multiple systems of the unbound state of the Gsw aptamer and a G37A/C61U mutant, and rigidity analyses. The results could explain why the three-way junction is a central structural element also in other riboswitches and how the cooperative effect could become contextual with respect to intracellular Mg2+ concentration. The results suggest that the transmission of allosteric information to P1 can be entropy-dominated.	[Hanke, Christian A.; Gohlke, Holger] Heinrich Heine Univ Dusseldorf, Inst Pharmazeut & Med Chem, Math Nat Wissensch Fak, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Gohlke, H (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Pharmazeut & Med Chem, Math Nat Wissensch Fak, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de		Hanke, Christian A./0000-0002-4826-4908	Heinrich Heine University Dusseldorf; supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC) [4722, HDD08]	Heinrich Heine University Dusseldorf; supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC)	This work was supported by institutional funds of Heinrich Heine University Dusseldorf. We gratefully acknowledge the computing time granted by the John von Neumann Institute for Computing (NIC) and provided on the supercomputer JUROPA at julich Supercomputing Center (JSC) (NIC project 4722, HDD08). Additional computational support was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich-Heine-University of Dusseldorf (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the computing time granted by the John von Neumann Institute for Computing (NIC) and provided on the supercomputer JUROPA at Julich Supercomputing Center (JSC) (NIC project 4722, HDD08). Additional computational support was provided by the "Center for Information and Media Technology" (ZIM) at the Heinrich-Heine-University of Dusseldorf (Germany).	Abseher R, 1998, J MOL BIOL, V279, P911, DOI 10.1006/jmbi.1998.1807; Allner O, 2013, RNA, V19, P916, DOI 10.1261/rna.037549.112; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; AQVIST J, 1992, J MOL STRUC-THEOCHEM, V88, P135, DOI 10.1016/0166-1280(92)87163-T; Auffinger P., 2012, RNA 3D STRUCTURE ANA, P299; Baird NJ, 2010, RNA, V16, P598, DOI 10.1261/rna.1852310; Banas P, 2012, J PHYS CHEM B, V116, P12721, DOI 10.1021/jp309230v; Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104; Buck J, 2011, NUCLEIC ACIDS RES, V39, P9768, DOI 10.1093/nar/gkr664; Buck J, 2010, NUCLEIC ACIDS RES, V38, P4143, DOI 10.1093/nar/gkq138; Case D. A., 2012, AMBER 13; Case D.A., 2022, AMBER 2020; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2013, BIOPOLYMERS, V99, P969, DOI 10.1002/bip.22331; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de la Pena M, 2009, RNA, V15, P1949, DOI 10.1261/rna.1889509; Di Palma F, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S9-S6; Di Palma F, 2013, RNA, V19, P1517, DOI 10.1261/rna.040493.113; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Furtig B, 2015, CURR OPIN STRUC BIOL, V30, P112, DOI 10.1016/j.sbi.2015.02.007; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Fulle S, 2010, J CHEM INF MODEL, V50, P1489, DOI 10.1021/ci100101w; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Fulle S, 2009, J MOL BIOL, V387, P502, DOI 10.1016/j.jmb.2009.01.037; Galindo-Murillo R, 2015, BBA-GEN SUBJECTS, V1850, P1041, DOI 10.1016/j.bbagen.2014.09.007; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gohlke H, 2017, J CHEM THEORY COMPUT, V13, P1495, DOI 10.1021/acs.jctc.7b00014; Hanke CA, 2015, METHOD ENZYMOL, V553, P163, DOI 10.1016/bs.mie.2014.10.056; HARNED HS, 1951, J AM CHEM SOC, V73, P5880, DOI 10.1021/ja01156a523; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 1996, J MOL BIOL, V263, P120, DOI 10.1006/jmbi.1996.0562; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Liberman JA, 2012, WIRES RNA, V3, P369, DOI 10.1002/wrna.114; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mills R., 1989, SELF DIFFUSION ELECT; Mlynsky V, 2010, J PHYS CHEM B, V114, P6642, DOI 10.1021/jp1001258; Nguyen PH, 2009, J PHYS CHEM B, V113, P9340, DOI 10.1021/jp902013s; Noeske J, 2009, LIGAND BINDING CONFO; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P572, DOI 10.1093/nar/gkl1094; Nozinovic S, 2014, RNA BIOL, V11, P655, DOI 10.4161/rna.29439; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Ottink OM, 2010, BIOMOL NMR ASSIGN, V4, P89, DOI 10.1007/s12104-010-9215-z; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Porter EB, 2014, BBA-GENE REGUL MECH, V1839, P919, DOI 10.1016/j.bbagrm.2014.02.014; Prychyna O, 2009, BIOPOLYMERS, V91, P953, DOI 10.1002/bip.21283; Quarta G, 2012, PLOS COMPUTATIONAL B; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Reblova K, 2003, BIOPHYS J, V84, P3564, DOI 10.1016/S0006-3495(03)75089-9; Reblova K, 2006, BIOPOLYMERS, V82, P504, DOI 10.1002/bip.20503; Reining A, 2013, NATURE, V499, P355, DOI 10.1038/nature12378; Robinson H, 2000, NUCLEIC ACIDS RES, V28, P1760, DOI 10.1093/nar/28.8.1760; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sanbonmatsu KY, 2014, BBA-GENE REGUL MECH, V1839, P1046, DOI 10.1016/j.bbagrm.2014.06.010; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Sharma M, 2009, RNA, V15, P1673, DOI 10.1261/rna.1675809; Sklenovsky P, 2011, J CHEM THEORY COMPUT, V7, P2963, DOI 10.1021/ct200204t; Sponer J, 2014, J PHYS CHEM LETT, V5, P1771, DOI 10.1021/jz500557y; Sponer J, 2012, METHODS, V57, P25, DOI 10.1016/j.ymeth.2012.04.005; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Villa A, 2009, NUCLEIC ACIDS RES, V37, P4774, DOI 10.1093/nar/gkp486; Wakeman CA, 2014, J BACTERIOL, V196, P1206, DOI 10.1128/JB.01238-13; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang YM, 2004, J STRUCT BIOL, V147, P302, DOI 10.1016/j.jsb.2004.01.005; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x	98	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179271	10.1371/journal.pone.0179271	http://dx.doi.org/10.1371/journal.pone.0179271			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640851	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800027
J	Yuan, B; Liang, S; Jin, YX; Zhang, MJ; Zhang, JB; Kim, NH				Yuan, Bao; Liang, Shuang; Jin, Yong-Xun; Zhang, Ming-Jun; Zhang, Jia-Bao; Kim, Nam-Hyung			Toxic effects of atrazine on porcine oocytes and possible mechanisms of action	PLOS ONE			English	Article							IN-VITRO; DNA-DAMAGE; AROMATASE EXPRESSION; EXPOSURE; STEROIDOGENESIS; MATURATION; PESTICIDE; PHOSPHODIESTERASE; DIFFERENTIATION; PROLIFERATION	Because atrazine is a widely used herbicide, its adverse effects on the reproductive system have been extensively researched. In this study, we investigated the effects of atrazine exposure on porcine oocyte maturation and the possible mechanisms. Our results showed that the rates of oocyte maturation significantly decreased after treatment with 200 mu M atrazine in vitro. Atrazine treatment resulted in abnormal spindle morphology but did not affect actin distribution. Atrazine exposure not only triggered a DNA damage response but also decreased MPF levels in porcine oocytes. Our results also revealed that atrazine worsened porcine oocyte quality by causing excessive accumulation of superoxide radicals, increasing cathepsin B activity, and decreasing the GSH level and mitochondrial membrane potential. Furthermore, atrazine decreased developmental competence of porcine oocytes up to the blastocyst stage and changed some properties: cell numbers, apoptosis, and related gene expression levels. Collectively, our results indicate that porcine oocyte maturation is defective after atrazine treatment at least through disruption of spindle morphology, MPF activity, and mitochondrial function and via induction of DNA damage, which probably reduces developmental competence.	[Yuan, Bao; Liang, Shuang; Jin, Yong-Xun; Zhang, Ming-Jun; Zhang, Jia-Bao; Kim, Nam-Hyung] Jilin Univ, Dept Lab Anim, Coll Anim Sci, Changchun, Jilin, Peoples R China; [Yuan, Bao; Liang, Shuang; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea	Jilin University; Chungbuk National University	Zhang, JB; Kim, NH (corresponding author), Jilin Univ, Dept Lab Anim, Coll Anim Sci, Changchun, Jilin, Peoples R China.; Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea.	zjb515@126.com; nhkim@chungbuk.ac.kr			BioGreen 21 Program [PJ011126]; National Natural Science Foundation of China [31572400, 31501954]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the BioGreen 21 Program (No. PJ011126) and the National Natural Science Foundation of China (31572400, 31501954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2013, TOXICOL IN VITRO, V27, P700, DOI 10.1016/j.tiv.2012.11.005; Abarikwu SO, 2011, FREE RADICAL RES, V45, P1061, DOI 10.3109/10715762.2011.593177; Alleva R, 2016, MOL NUTR FOOD RES, V60, P2243, DOI 10.1002/mnfr.201600005; Basso E, 2016, MUTAT RES-GEN TOX EN, V806, P40, DOI 10.1016/j.mrgentox.2016.07.005; Belzunces B, 2017, J COMPUT CHEM, V38, P133, DOI 10.1002/jcc.24530; Casas E, 2010, TOXICOL IN VITRO, V24, P224, DOI 10.1016/j.tiv.2009.09.004; Chen JY, 2015, FOOD CHEM TOXICOL, V76, P61, DOI 10.1016/j.fct.2014.11.026; Chen XP, 2015, ENVIRON TOXICOL CHEM, V34, P1770, DOI 10.1002/etc.2980; Chromcova L, 2013, NEUROENDOCRINOL LETT, V34, P95; Dhali A, 2009, THERIOGENOLOGY, V71, P1408, DOI 10.1016/j.theriogenology.2009.01.011; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; Fan W, 2007, BIOCHEM BIOPH RES CO, V355, P1012, DOI 10.1016/j.bbrc.2007.02.062; Friedmann AS, 2002, REPROD TOXICOL, V16, P275, DOI 10.1016/S0890-6238(02)00019-9; Ghodageri MG, 2013, DRUG CHEM TOXICOL, V36, P217, DOI 10.3109/01480545.2012.710623; Hayes TB, 2010, P NATL ACAD SCI USA, V107, P4612, DOI 10.1073/pnas.0909519107; Hu KB, 2016, INT J ONCOL, V48, P2166, DOI 10.3892/ijo.2016.3433; Hyun SY, 2015, ONCOTARGET, V6, P4804, DOI 10.18632/oncotarget.3103; Jacquet P, 2015, MUTAT RES-GEN TOX EN, V792, P26, DOI 10.1016/j.mrgentox.2015.09.001; Ji QC, 2016, TOXICOL IN VITRO, V32, P63, DOI 10.1016/j.tiv.2015.12.006; Jin YX, 2013, GEN COMP ENDOCR, V184, P120, DOI 10.1016/j.ygcen.2013.01.010; Kaith S, 2015, REPROD DOMEST ANIM, V50, P214, DOI 10.1111/rda.12472; Karami-Mohajeri S, 2014, HUM EXP TOXICOL, V33, P251, DOI 10.1177/0960327113493300; Karmaus AL, 2015, TOXICOL SCI, V148, P544, DOI 10.1093/toxsci/kfv204; Kloas W, 2009, ANN NY ACAD SCI, V1163, P437, DOI 10.1111/j.1749-6632.2009.04456.x; Kucka M, 2012, TOXICOL APPL PHARM, V265, P19, DOI 10.1016/j.taap.2012.09.019; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Li XX, 2013, THERIOGENOLOGY, V79, P291, DOI 10.1016/j.theriogenology.2012.08.019; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mukherjee I, 2009, B ENVIRON CONTAM TOX, V83, P832, DOI 10.1007/s00128-009-9849-7; Murphy MB, 2006, AQUAT TOXICOL, V76, P230, DOI 10.1016/j.aquatox.2005.09.010; Omran NE, 2016, TOXICOL IND HEALTH, V32, P656, DOI 10.1177/0748233713506959; Papoulias DM, 2014, AQUAT TOXICOL, V154, P230, DOI 10.1016/j.aquatox.2014.05.022; Pogrmic-Majkic K, 2016, TOXICOLOGY, V368, P37, DOI 10.1016/j.tox.2016.08.016; Pogrmic-Majkic K, 2012, ENVIRON TOXICOL PHAR, V34, P495, DOI 10.1016/j.etap.2012.06.004; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; Rein ID, 2015, CELL CYCLE, V14, P3248, DOI 10.1080/15384101.2015.1085137; Riffle BW, 2014, REPROD TOXICOL, V47, P59, DOI 10.1016/j.reprotox.2014.05.008; Roberge M, 2004, TOXICOL LETT, V154, P61, DOI 10.1016/j.toxlet.2004.07.005; Roberge MT, 2006, FOOD CHEM TOXICOL, V44, P885, DOI 10.1016/j.fct.2005.11.014; Sass JB, 2006, INT J OCCUP ENV HEAL, V12, P260; Sharma A, 2012, J HAZARD MATER, V221, P275, DOI 10.1016/j.jhazmat.2012.04.045; Solomon KR, 2013, ENVIRON TOXICOL CHEM, V32, P10, DOI 10.1002/etc.2050; Thueson LE, 2015, TOXICOL SCI, V143, P418, DOI 10.1093/toxsci/kfu242; Traba HM, 2017, J ENV SCI HLTH B, P1; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; Wu BJ, 2017, CELL CYCLE, V16, P82, DOI 10.1080/15384101.2016.1252884; Yuan B, 2016, PEERJ, V4, DOI 10.7717/peerj.2454; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	49	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179861	10.1371/journal.pone.0179861	http://dx.doi.org/10.1371/journal.pone.0179861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640859	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800075
J	Riva, A; Borgesen, M; Guldmann-Christensen, M; Kyneb, MH; Voogd, K; Andersen, C; Epistolio, S; Merlo, E; Wolff, TY; Hamilton-Dutoit, S; Lorenzen, J; Christensen, UB; Frattini, M				Riva, Alice; Borgesen, Michael; Guldmann-Christensen, Mariann; Kyneb, Majbritt Hauge; Voogd, Kirsten; Andersen, Christina; Epistolio, Samantha; Merlo, Elisabetta; Wolff, Tine Yding; Hamilton-Dutoit, Stephen; Lorenzen, Jan; Christensen, Ulf Bech; Frattini, Milo			SensiScreen (R) KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; INTERCALATING NUCLEIC-ACIDS; ANTI-EGFR THERAPY; K-RAS MUTATIONS; ENRICHED PCR; RESISTANCE; PREDICTION; FAMILY; GENES	Activating mutations in codon 12 and codon 13 of the KRAS (Kirsten rat sarcoma viral oncogene homolog) gene are implicated in the development of several human cancer types and influence their clinical evaluation, treatment and prognosis. Numerous different methods for KRAS genotyping are currently available displaying a wide range of sensitivities, time to answer and requirements for laboratory equipment and user skills. Here we present Sen-siScreen (R) KRAS exon 2 simplex and multiplex CE vertical bar VDassays, that use a novel real-time PCR-based method for KRAS mutation detection based on PentaBase's proprietary DNA analogue technology and designed to work on standard real-time PCR instruments. By means of the included BaseBlocker (TM) technology, we show that SensiScreen (R) specifically amplifies the mutated alleles of interest with no or highly subdued amplification of the wild type allele. Furthermore, serial dilutions of mutant DNA in a wild type background demonstrate that all SensiScreen (R) assays display a limit of detection that falls within the range of 0.25-1%. Finally, in three different colorectal cancer patient populations, SensiScreen (R) assays confirmed the KRAS genotype previously determined by commonly used methods for KRAS mutation testing, and notably, in two of the populations, SensiScreen (R) identified additional mutant positive cases not detected by common methods.	[Riva, Alice; Epistolio, Samantha; Merlo, Elisabetta; Frattini, Milo] Inst Pathol, Lab Mol Pathol, Locarno, Switzerland; [Borgesen, Michael; Andersen, Christina; Christensen, Ulf Bech] PentaBase Aps, Odense, Denmark; [Guldmann-Christensen, Mariann; Voogd, Kirsten; Hamilton-Dutoit, Stephen] Aarhus Univ Hosp, Lab Res & Dev, Dept Pathol, Aarhus, Denmark; [Kyneb, Majbritt Hauge; Wolff, Tine Yding; Lorenzen, Jan] Danish Technol Inst, Life Sci Div, Aarhus, Denmark; [Voogd, Kirsten] Univ Southern Denmark, Odense, Denmark; [Wolff, Tine Yding] Aarhus Sch Engn, Aarhus, Denmark	Aarhus University; University of Southern Denmark; Aarhus University	Frattini, M (corresponding author), Inst Pathol, Lab Mol Pathol, Locarno, Switzerland.; Christensen, UB (corresponding author), PentaBase Aps, Odense, Denmark.	ubc@PentaBase.com; milo.frattini@ti.ch		Epistolio, Samantha/0000-0003-1236-2722; Hamilton-Dutoit, Stephen/0000-0003-2158-3885	Danish Agency for Science Technology and Innovation [E!7034]; Fondazione Ticinese per la Ricerca controil Cancro; Institute of Pathology, Locarno, Switzerland; Aarhus University Hospital, Aarhus, Denmark	Danish Agency for Science Technology and Innovation; Fondazione Ticinese per la Ricerca controil Cancro; Institute of Pathology, Locarno, Switzerland; Aarhus University Hospital, Aarhus, Denmark	Eurostars provided support in the form of salaries fo rauthors MB, CA, UBC, MF, AR, MHK & JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. PentaBase ApS provided salaries for UBC, CA and MB and took part in the designing of the SensiScreen products, but not the testing and analysis of patient material nor in the conclusions of the performance of SensiScreen against competing technologies. The specific roles of these authors are articulated in the' author contributions' section. The funders had no additional role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript. Support for this study was also provided by Danish Agency for Science Technology and Innovation [E!7034 ONSET diagnostics] and Fondazione Ticinese per la Ricerca controil Cancro. The Institute of Pathology, Locarno, Switzerland, and Aarhus University Hospital, Aarhus, Denmark performed\some analyses using their own funding	Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bearzatto A, 2002, CLIN CANCER RES, V8, P3782; Chang YY, 2016, AM J SURG, V212, P537, DOI 10.1016/j.amjsurg.2016.02.013; CHEN J, 1991, ANAL BIOCHEM, V195, P51, DOI 10.1016/0003-2697(91)90293-3; Christensen UB, 2004, NUCLEOS NUCLEOT NUCL, V23, P207, DOI 10.1081/NCN-120027829; Christensen UB, 2002, NUCLEIC ACIDS RES, V30, P4918, DOI 10.1093/nar/gkf624; Davidson CJ, 2012, BIOTECHNIQUES, V53, P182, DOI 10.2144/000113913; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dienstmann R, 2016, CANCER J, V22, P149, DOI 10.1097/PPO.0000000000000191; Edkins S, 2009, CANC BIOL THR, V5, P928; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Gao J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009532; Graham DM, 2016, CURR COLORECT CANC R, V12, P141, DOI 10.1007/s11888-016-0312-y; Gulbake A, 2016, WORLD J GASTROENTERO, V22, P582, DOI 10.3748/wjg.v22.i2.582; Jancik S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-79; KAHN SM, 1991, ONCOGENE, V6, P1079; Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046; Kudryavtseva AV, 2016, ONCOTARGET, V7, P53959, DOI 10.18632/oncotarget.9796; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Lee S., 2015, J MOL BIOMARK, V6; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Nollau P, 1996, INT J CANCER, V66, P332, DOI 10.1002/(SICI)1097-0215(19960503)66:3<332::AID-IJC11>3.0.CO;2-D; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Samowitz WS, 2007, MOL CANCER RES, V5, P165, DOI 10.1158/1541-7786.MCR-06-0398; Simen BB, 2015, ARCH PATHOL LAB MED, V139, P508, DOI 10.5858/arpa.2013-0710-OA; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Winder T, 2009, ONCOL REP, V21, P1283, DOI 10.3892/or_00000352; Xu WD, 2016, FRONT BIOSCI-LANDMRK, V21, P410, DOI 10.2741/4397	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178027	10.1371/journal.pone.0178027	http://dx.doi.org/10.1371/journal.pone.0178027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636636	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300007
J	Vancraenenbroeck, R; Kunzelmann, S; Webb, MR				Vancraenenbroeck, Renee; Kunzelmann, Simone; Webb, Martin R.			Development of a range of fluorescent reagentless biosensors for ATP, based on malonyl-coenzyme A synthetase	PLOS ONE			English	Article							INORGANIC-PHOSPHATE; DIMER FORMATION; LESS BIOSENSOR; PROTEIN; DYES	The range of ATP concentrations that can be measured with a fluorescent reagentless biosensor for ATP has been increased by modulating its affinity for this analyte. The ATP biosensor is an adduct of two tetramethylrhodamines with MatB from Rhodopseudomonas palustris. Mutations were introduced into the binding site to modify ATP binding affinity, while aiming to maintain the concomitant fluorescence signal. Using this signal, the effect of mutations in different parts of the binding site was measured. This mutational analysis revealed three variants in particular, each with a single mutation in the phosphate-binding loop, which had potentially beneficial changes in ATP binding properties but preserving a fluorescence change of similar to 3-fold on ATP binding. Two variants (T167A and T303A) weakened the binding, changing the dissociation constant from the parent's 6 mu M to 123 mu M and 42 mu M, respectively. Kinetic measurements showed that the effect of these mutations on affinity was by an increase in dissociation rate constants. These variants widen the range of ATP concentration that can be measured readily by this biosensor to > 100 mu M. In contrast, a third variant, S170A, decreased the dissociation constant of ATP to 3.8 mu M and has a fluorescence change of 4.2 on binding ATP. This variant has increased selectivity for ATP over ADP of > 200-fold. This had advantages over the parent by increasing sensitivity as well as increasing selectivity during ATP measurements in which ADP is present.	[Vancraenenbroeck, Renee; Webb, Martin R.] Francis Crick Inst, London, England; [Kunzelmann, Simone] Francis Crick Inst, Struct Biol Sci Technol Platform, London, England; [Vancraenenbroeck, Renee] Weizmann Inst Sci, Dept Struct Biol, Rehovot, Israel	Francis Crick Institute; Francis Crick Institute; Weizmann Institute of Science	Webb, MR (corresponding author), Francis Crick Inst, London, England.	martin.webb@crick.ac.uk		Vancraenenbroeck, Renee/0000-0003-2685-2749; Webb, Martin/0000-0002-0134-9621	Francis Crick Institute which receives its core - Cancer Research UK [FC001211]; UK Medical Research Council [FC001211]; Wellcome Trust [FC001211]; The Francis Crick Institute [10211, 10015] Funding Source: researchfish	Francis Crick Institute which receives its core - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001211), the UK Medical Research Council (FC001211), and the Wellcome Trust (FC001211).	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Brun MA, 2011, J AM CHEM SOC, V133, P16235, DOI 10.1021/ja206915m; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; CHAMBERS RW, 1974, J PHYS CHEM-US, V78, P380, DOI 10.1021/j100597a012; CORRIE JET, 1994, J CHEM SOC PERK T 1, P2967, DOI 10.1039/p19940002967; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; FORSTER T, 1957, Z ELEKTROCHEM, V61, P344; Gu H, 2006, FEBS LETT, V580, P5885, DOI 10.1016/j.febslet.2006.09.048; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hamman BD, 1996, J BIOL CHEM, V271, P7568, DOI 10.1074/jbc.271.13.7568; He ZH, 1997, J PHYSIOL-LONDON, V501, P125, DOI 10.1111/j.1469-7793.1997.125bo.x; KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kunzelmann S., 2014, FLUORESCENT METHODS, V105, P25, DOI DOI 10.1007/978-3-0348-0856-9_; Kunzelmann S, 2010, ACS CHEM BIOL, V5, P415, DOI 10.1021/cb9003173; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Okoh MP, 2006, BIOCHEMISTRY-US, V45, P14764, DOI 10.1021/bi060960j; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rawls H.R., 1965, PURE APPL CHEM, V11, P371, DOI [10.1351/pac196511030371, 10.1002/anie.201002307]; SCHOLES GD, 1994, J PHYS CHEM-US, V98, P4580, DOI 10.1021/j100068a017; SELWYN JE, 1972, J PHYS CHEM-US, V76, P762, DOI 10.1021/j100649a026; Solscheid C, 2015, BIOCHEMISTRY-US, V54, P5054, DOI 10.1021/acs.biochem.5b00449; Vancraenenbroeck R, 2015, ACS CHEM BIOL, V10, P2650, DOI 10.1021/acschembio.5b00346; Wang RE, 2011, CURR MED CHEM, V18, P4175; Wilkins MR, 1999, METH MOL B, V112, P531	26	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179547	10.1371/journal.pone.0179547	http://dx.doi.org/10.1371/journal.pone.0179547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636641	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300041
J	Alvarez-Simon, D; Munoz, X; Gomez-Olles, S; de Homdedeu, M; Untoria, MD; Cruz, MJ				Alvarez-Simon, Daniel; Munoz, Xavier; Gomez-Olles, Susana; de Homdedeu, Miquel; Untoria, Maria-Dolores; Cruz, Maria-Jesus			Effects of diesel exhaust particle exposure on a murine model of asthma due to soybean	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; COLONY-STIMULATING FACTOR; EPIDEMIC ASTHMA; ANIMAL-MODELS; MOUSE MODELS; POLLUTION; BARCELONA; IL-17	Background Exposure to soybean allergens has been linked to asthma outbreaks. Exposure to diesel exhaust particles (DEP) has been associated with an increase in the risk of asthma and asthma exacerbation; however, in both cases the underlying mechanisms remain poorly understood, as does the possible interaction between the two entities. Objective To investigate how the combination of soybean allergens and DEP can affect the induction or exacerbation of asthma in a murine model. Methods BALB/c mice received intranasal instillations of saline, 3 or 5 mg protein/ml soybean hull extract (SHE), or a combination of one of these three solutions with DEP. Airway hyperresponsiveness (AHR), pulmonary inflammation in bronchoalveolar lavage, total serum immunoglobulin E and histological studies were assessed. Results A 5 mg protein/ml SHE solution was able by itself to enhance AHR (p = 0.0033), increase eosinophilic inflammation (p = 0.0003), increase levels of IL-4, IL-5, IL-13, IL-17A, IL-17F and CCL20,and reduce levels of IFN-gamma. The combination of 5 mg protein/ml SHE with DEP also produced an increase in AHR and eosinophilic inflammation, but presented a slightly different cytokine profile with higher levels of Th17-related cytokines. However, while the 3 mg protein/ml SHE solution did not induce asthma, co-exposure with DEP resulted in a markedly enhanced AHR (p = 0.002) and eosinophilic inflammation (p = 0.004), with increased levels of IL-5, IL-17F and CCL20 and decreased levels of IFN-gamma. Conclusions & clinical relevance The combination of soybean allergens and DEP is capable of triggering an asthmatic response through a Th17-related mechanism when the soybean allergen concentration is too low to promote a response by itself. DEP monitoring may be a useful addition to allergen monitoring in order to prevent new asthma outbreaks.	[Alvarez-Simon, Daniel; Munoz, Xavier; Gomez-Olles, Susana; de Homdedeu, Miquel; Untoria, Maria-Dolores; Cruz, Maria-Jesus] Hosp Univ Vall dHebron, Pulmonol Serv, Barcelona, Spain; [Alvarez-Simon, Daniel; Munoz, Xavier] Univ Autonoma Barcelona, Med Dept, Barcelona, Spain; [Munoz, Xavier; Gomez-Olles, Susana; Untoria, Maria-Dolores; Cruz, Maria-Jesus] CIBER Enfermedades Resp Ciberes, Barcelona, Spain; [Munoz, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona	Munoz, X (corresponding author), Hosp Univ Vall dHebron, Pulmonol Serv, Barcelona, Spain.; Munoz, X (corresponding author), Univ Autonoma Barcelona, Med Dept, Barcelona, Spain.; Munoz, X (corresponding author), CIBER Enfermedades Resp Ciberes, Barcelona, Spain.; Munoz, X (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Barcelona, Spain.	xmunoz@vhebron.net	Alvarez-Simón, Daniel/AAD-3351-2021; Cruz, Maria Jesus/I-9073-2014	Alvarez-Simón, Daniel/0000-0002-3464-0909; Munoz, Xavier/0000-0002-8693-022X; Cruz, Maria Jesus/0000-0001-9759-5466; de Homdedeu, Miquel/0000-0002-2865-1740	Miguel Servet program run by the Institute de Salud Carlos III [CP12/03101]; Fundacio Catalana de Pneumologia (FUCAP); Institute de Salud Carlos III [CP12/03101]; European Regional Development Fund (FEDER)	Miguel Servet program run by the Institute de Salud Carlos III; Fundacio Catalana de Pneumologia (FUCAP); Institute de Salud Carlos III(Instituto de Salud Carlos III); European Regional Development Fund (FEDER)(European Commission)	MJC is a researcher supported by the Miguel Servet program run by the Institute de Salud Carlos III (CP12/03101). This project was supported by the Fundacio Catalana de Pneumologia (FUCAP), Institute de Salud Carlos III (CP12/03101) and European Regional Development Fund (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acciani TH, 2013, CLIN EXP ALLERGY, V43, P1406, DOI 10.1111/cea.12200; Alexis NE, 2014, INT IMMUNOPHARMACOL, V23, P347, DOI 10.1016/j.intimp.2014.08.009; ANTO JM, 1989, NEW ENGL J MED, V320, P1097, DOI 10.1056/NEJM198904273201701; Ballester F, AM J EPIDEMIOL, V199; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Brandt EB, 2014, J ALLERGY CLIN IMMUN, V132, P1; Brandt EB, 2015, J ALLERGY CLIN IMMUN, V136, P295, DOI 10.1016/j.jaci.2014.11.043; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Choy DF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3142; Codina RM, 1997, CHEST, V111, P75, DOI 10.1378/chest.111.1.75; Dias PM, 2013, J AUTOIMMUN, P40; Gomez-Olles S, 2006, CLIN EXP ALLERGY, V36, P1176, DOI 10.1111/j.1365-2222.2006.02542.x; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; Huang SK, 2015, J THORAC DIS, V7, P23, DOI 10.3978/j.issn.2072-1439.2014.12.13; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kawaguchi M, 2004, J ALLERGY CLIN IMMUN, V114, P444, DOI 10.1016/j.jaci.2004.03.047; Keely S, 2015, IMMUNITY, V43, P7, DOI 10.1016/j.immuni.2015.07.010; Kim BG, 2016, ALLERGY ASTHMA IMMUN, V8, P246, DOI 10.4168/aair.2016.8.3.246; Kim J, 2011, AM J PATHOL, V179, P2730, DOI 10.1016/j.ajpath.2011.08.008; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Lukacs NW, 2001, J EXP MED, V194, P551, DOI 10.1084/jem.194.4.551; Maes T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-7; Manni ML, 2014, EXPERT REV RESP MED, V8, P25, DOI 10.1586/17476348.2014.854167; Miyabara Y, 1998, EUR RESPIR J, V11, P291, DOI 10.1183/09031936.98.11020291; MURANAKA M, 1986, J ALLERGY CLIN IMMUN, V77, P616, DOI 10.1016/0091-6749(86)90355-6; Newcomb DC, 2013, CURR OPIN IMMUNOL, V25, P755, DOI 10.1016/j.coi.2013.08.002; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Nozato K, 2011, J ALLERGY, V2011, P1; Ota K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/602846; Provoost S, 2010, J IMMUNOL, V184, P426, DOI 10.4049/jimmunol.0902564; Rodrigo MJ, 2004, INT ARCH ALLERGY IMM, V134, P158, DOI 10.1159/000078649; Sagar S, 2015, EUR J PHARMACOL, V759, P272, DOI 10.1016/j.ejphar.2015.03.037; Stiegel MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152458; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Takano H, 1998, IMMUNOPHARM IMMUNOT, V20, P329, DOI 10.3109/08923979809038548; van Voorhis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082545; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Villalbi JR, 2004, J EPIDEMIOL COMMUN H, V58, P461, DOI 10.1136/jech.2003.009001; White MC, 1997, AM J EPIDEMIOL, V145, P432, DOI 10.1093/oxfordjournals.aje.a009125; Xia MC, 2015, J ALLERGY CLIN IMMUN, V136, P441, DOI 10.1016/j.jaci.2015.02.014	42	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179569	10.1371/journal.pone.0179569	http://dx.doi.org/10.1371/journal.pone.0179569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628664	Green Submitted, gold, Green Published			2022-12-26	WOS:000404043100036
J	Manko, A; Motta, JP; Cotton, JA; Feener, T; Oyeyemi, A; Vallance, BA; Wallace, JL; Buret, AG				Manko, Anna; Motta, Jean-Paul; Cotton, James A.; Feener, Troy; Oyeyemi, Ayodele; Vallance, Bruce A.; Wallace, John L.; Buret, Andre G.			Giardia co-infection promotes the secretion of antimicrobial peptides beta-defensin 2 and trefoil factor 3 and attenuates attaching and effacing bacteria-induced intestinal disease	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; CITROBACTER-RODENTIUM INFECTION; HYPOXIA-INDUCIBLE FACTOR; HUMAN BETA-DEFENSIN-2; LAMBLIA INFECTION; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; ENTERIC PATHOGENS; ACUTE DIARRHEA; HOST IMMUNITY	Our understanding of polymicrobial gastrointestinal infections and their effects on host biology remains incompletely understood. Giardia duodenalis is an ubiquitous intestinal protozoan parasite infecting animals and humans. Concomitant infections with Giardia and other gastrointestinal pathogens commonly occur. In countries with poor sanitation, Giardia infection has been associated with decreased incidence of diarrheal disease and fever, and reduced serum inflammatory markers release, via mechanisms that remain obscure. This study analyzed Giardia spp. co-infections with attaching and effacing (A/E) pathogens, and assessed whether and how the presence of Giardia modulates host responses to A/E enter-opathogens, and alters intestinal disease outcome. In mice infected with the A/E pathogen Citrobacter rodentium, co-infection with Giardia muris significantly attenuated weight loss, macro-and microscopic signs of colitis, bacterial colonization and translocation, while concurrently enhancing the production and secretion of antimicrobial peptides (AMPs) mouse beta-defensin 3 and trefoil factor 3 (TFF3). Co-infection of human intestinal epithelial cells (Caco-2) monolayers with G. duodenalis trophozoites and enteropathogenic Escherichia coli (EPEC) enhanced the production of the AMPs human beta-defensin 2 (HBD-2) and TFF3; this effect was inhibited with treatment of G. duodenalis with cysteine protease inhibitors. Collectively, these results suggest that Giardia infections are capable of reducing enteropathogen-induced colitis while increasing production of host AMPs. Additional studies also demonstrated that Giardia was able to directly inhibit the growth of pathogenic bacteria. These results reveal novel mechanisms whereby Giardia may protect against gastrointestinal disease induced by a co-infecting A/E enteropathogen. Our findings shed new light on how microbial-microbial interactions in the gut may protect a host during concomitant infections.	[Manko, Anna; Motta, Jean-Paul; Cotton, James A.; Feener, Troy; Oyeyemi, Ayodele; Buret, Andre G.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Manko, Anna; Motta, Jean-Paul; Feener, Troy; Oyeyemi, Ayodele; Wallace, John L.; Buret, Andre G.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [Manko, Anna; Motta, Jean-Paul; Cotton, James A.; Oyeyemi, Ayodele; Buret, Andre G.] Univ Calgary, Host Parasite Interact, Calgary, AB, Canada; [Vallance, Bruce A.] Child & Family Res Inst, Div Gastroenterol, Dept Pediat, Vancouver, BC, Canada; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Child & Family Research Institute; University of Calgary	Buret, AG (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.; Buret, AG (corresponding author), Univ Calgary, Inflammat Res Network, Calgary, AB, Canada.; Buret, AG (corresponding author), Univ Calgary, Host Parasite Interact, Calgary, AB, Canada.	aburet@ucalgary.ca	Motta, Jean-Paul/A-8844-2014; Wallace, John/AAL-3763-2021	Motta, Jean-Paul/0000-0002-9464-0695; Vallance, Bruce/0000-0003-1345-6747	Natural Sciences and Engineering Research Council of Canada (NSERC), Discovery Grant [183681-2011]; Natural Sciences and Engineering Research Council of Canada Collaborative Research and Training Experience Program (NSERC CREATE) [413888-2012]; Canadian Institutes of Health Research (CIHR) [12033]; Crohn's Colitis Canada (CCC) grant [20142017]; Alberta Innovates [201400488] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada (NSERC), Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada Collaborative Research and Training Experience Program (NSERC CREATE); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Crohn's Colitis Canada (CCC) grant; Alberta Innovates	Funded by Natural Sciences and Engineering Research Council of Canada (NSERC), Discovery Grant #183681-2011, www.nserc-crsng.gc.ca, Natural Sciences and Engineering Research Council of Canada Collaborative Research and Training Experience Program (NSERC CREATE), #413888-2012, www.nserc-crsng.gc.ca, Canadian Institutes of Health Research (CIHR) # 12033, www.cihr.gc.ca/e/193.html, Crohn's Colitis Canada (CCC) grant in aid of research, #20142017.	Acosta AM, 2014, CLIN INFECT DIS, V59, pS193, DOI 10.1093/cid/ciu653; Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; Amat C., 2015, FASEB J, V507, P1; Ankarklev J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001780; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; ARNDT H, 1992, INFLAMMATION, V16, P549, DOI 10.1007/BF00918979; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD526, DOI 10.1093/nar/gkn631; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bals R, 1999, INFECT IMMUN, V67, P3542, DOI 10.1128/IAI.67.7.3542-3547.1999; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Beatty JK, 2017, INT J PARASITOL; Beck PL, 2010, AM J PHYSIOL-GASTR L, V299, pG43, DOI 10.1152/ajpgi.00228.2009; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P1156, DOI 10.1097/INF.0000000000000427; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005108; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Bhargava A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136102; Bhavnani D, 2012, AM J EPIDEMIOL, V176, P387, DOI 10.1093/aje/kws220; Bilenko N, 2004, EUR J EPIDEMIOL, V19, P877, DOI 10.1023/B:EJEP.0000040533.75646.9c; Burd RS, 2002, SHOCK, V18, P461, DOI 10.1097/00024382-200211000-00013; Buret A. G., 2002, P109, DOI 10.1079/9780851996127.0109; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Chong KT, 2008, VIROLOGY, V380, P136, DOI 10.1016/j.virol.2008.07.024; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Cotton JA, 2015, PATHOGENS, V4, P764, DOI 10.3390/pathogens4040764; Cotton JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109087; Cotton JA, 2014, INFECT IMMUN, V82, P2772, DOI 10.1128/IAI.01771-14; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Dann SM, 2015, EXP PARASITOL, V156, P68, DOI 10.1016/j.exppara.2015.06.003; Devine DA, 2003, MOL IMMUNOL, V40, P431, DOI 10.1016/S0161-5890(03)00162-7; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Donowitz JR, 2016, CLIN INFECT DIS, V63, P792, DOI 10.1093/cid/ciw391; DuBois KN, 2008, J BIOL CHEM, V283, P18024, DOI 10.1074/jbc.M802133200; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Escobedo AA, 2014, EXPERT REV ANTI-INFE, V12, P1143, DOI 10.1586/14787210.2014.942283; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Griffiths EC, 2011, J INFECTION, V63, P200, DOI 10.1016/j.jinf.2011.06.005; Hagel I, 2011, ACTA TROP, V117, P189, DOI 10.1016/j.actatropica.2010.12.001; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Haque R, 2007, J HEALTH POPUL NUTR, V25, P387; Hawrelak Jason, 2003, Altern Med Rev, V8, P129; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hernandez C, 2009, BRIT J PHARMACOL, V156, P262, DOI 10.1111/j.1476-5381.2008.00044.x; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Huang YG, 2013, J CANCER RES THER, V9, P376, DOI 10.4103/0973-1482.119308; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Keselman A, 2016, INFECT IMMUN, V84, P2853, DOI 10.1128/IAI.00348-16; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; KINDON H, 1995, GASTROENTEROLOGY, V109, P516, DOI 10.1016/0016-5085(95)90340-2; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kutta H, 2006, J ANAT, V208, P609, DOI 10.1111/j.1469-7580.2006.00567.x; Lewis SB, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00068; LI Z, 1993, GASTROENTEROLOGY, V104, P467, DOI 10.1016/0016-5085(93)90415-9; Ma'ayeh SY, 2012, INT J PARASITOL, V42, P501, DOI 10.1016/j.ijpara.2012.04.004; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Mortimer L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004887; Motta JP, 2015, INFLAMM BOWEL DIS, V21, P1006, DOI 10.1097/MIB.0000000000000345; Motta JP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004212; Muhsen K, 2014, J TROP PEDIATRICS, V60, P99, DOI 10.1093/tropej/fmt085; Mukherjee AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786480; Muniz LR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00310; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Oberhelman RA, 2001, PEDIATR INFECT DIS J, V20, P792, DOI 10.1097/00006454-200108000-00014; Oberhuber G, 1997, SCAND J GASTROENTERO, V32, P48, DOI 10.3109/00365529709025062; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Podolsky DK, 2009, GASTROENTEROLOGY, V137, P209, DOI 10.1053/j.gastro.2009.03.007; Rall G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005858; Reti KL, 2015, INFECT IMMUN, V83, P4571, DOI 10.1128/IAI.00970-15; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Schubert AM, 2015, MBIO, V6, DOI 10.1128/mBio.00974-15; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Solaymani-Mohammadi S, 2011, J IMMUNOL, V187, P3769, DOI 10.4049/jimmunol.1100606; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Tako EA, 2013, MBIO, V4, DOI 10.1128/mBio.00660-13; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Troeger H, 2007, GUT, V56, P328, DOI 10.1136/gut.2006.100198; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Varoga D, 2008, J ANAT, V213, P749, DOI 10.1111/j.1469-7580.2008.00992.x; Veenemans J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001158; von Allmen N, 2006, PARASITOLOGY, V133, P139, DOI 10.1017/S0031182006000230; Walker CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084553; Wan LYM, 2016, CRIT REV FOOD SCI, V56, P2628, DOI 10.1080/10408398.2014.905450; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002437; Wang YH, 2011, AM J PATHOL, V179, P2866, DOI 10.1016/j.ajpath.2011.08.039; Wehkamp J, 2007, CURR OPIN GASTROEN, V23, P32, DOI 10.1097/MOG.0b013e32801182c2; Willing BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026988; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wilson M, 2002, BACTERIAL DIS MECH I, P246; Wlodarska M, 2015, SCI REP-UK, P5; Zarepour M, 2013, INFECT IMMUN, V81, P3672, DOI 10.1128/IAI.00854-13; Zhang SX, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0157-2; Zhao Z, 2016, CHINESE MED J-PEKING, V129, P696, DOI 10.4103/0366-6999.178011	104	43	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178647	10.1371/journal.pone.0178647	http://dx.doi.org/10.1371/journal.pone.0178647			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622393	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300004
J	Xue, ML; Liu, Y; Lyu, R; Ge, N; Liu, M; Ma, Y; Liang, H				Xue, Meilan; Liu, Ying; Lyu, Rui; Ge, Na; Liu, Man; Ma, Yan; Liang, Hui			Protective effect of aplysin on liver tissue and the gut microbiota in alcohol-fed rats	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; DISEASE; BARRIER; ETHANOL; INJURY; ENDOTOXEMIA; MECHANISM; STRAINS; CELLS; FLORA	Background This study investigated the protective effect of aplysin on the liver and its influence on inflammation and the gut microbiota in rats with ethanol-induced liver injury. Methods Male Sprague-Dawley rats were randomly assigned to an alcohol-containing liquid diet, control liquid diet or treatment with aplysin for 8 weeks. Hepatic and intestinal histopathological analysis was performed, and cytokine levels and the intestinal mucosal barrier were assessed. Enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) and 16S rDNA high-throughput sequencing were performed to provide an overview of the gut microbiota composition. Results Chronic alcohol exposure caused liver damage in rats. Serum aspartate aminotransferase (AST), aminotransferase (ALT), alkaline phosphatase (ALP) and triglyceride (TG) activities in liver tissue were higher than in the control group. Alcohol administration elevated the levels of serum transforming growth factor-beta (TGF-beta) and tumor necrosis factor-a (TNF-alpha) and reduced interleukin-10 (IL-10) levels compared with those of control rats. In addition, the levels of plasma endotoxin, diamine oxidase (DAO), and fatty acid-binding protein 2 (FABP2) in the alcohol group were higher than in the control group. The results of ERIC-PCR indicated that aplysin treatment shifted the overall structure of the ethanol-disrupted gut microbiota toward that of the control group. One hundred twenty to 190 genera of bacteria were detected by high throughput sequencing. Alcohol-induced changes in the gut microbial composition were detected at the genus level. These alcohol-induced effects could be reversed with aplysin treatment. Conclusions These results suggest that aplysin exerts a protective effect on ethanol-induced hepatic injury in rats by normalizing fecal microbiota composition and repairing intestinal barrier function.	[Xue, Meilan; Liu, Ying; Lyu, Rui; Liu, Man; Ma, Yan; Liang, Hui] Qingdao Univ Med, Qingdao, Peoples R China; [Ge, Na] Inner Mongolia Univ Sci & Technol, Baotou Med Coll, Baotou, Peoples R China	Qingdao University; Baotou Medical College; Inner Mongolia University of Science & Technology	Liang, H (corresponding author), Qingdao Univ Med, Qingdao, Peoples R China.	lianghuiyxb@163.com			National Natural Science Foundation of China [81573137, 81502298]; Nutrition Research and Education Fund of Danone Nutrition Dietary Center [DIC2014-03]; Shandong Provincial Natural Science Foundation [ZR2014JL056]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nutrition Research and Education Fund of Danone Nutrition Dietary Center(Danone Nutricia); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This work was carried out with the support of the National Natural Science Foundation of China (No. 81573137, No. 81502298) and Nutrition Research and Education Fund of Danone Nutrition Dietary Center (No. DIC2014-03). H L received the funding of the National Natural Science Foundation of China (No. 81573137) and Nutrition Research and Education Fund of Danone Nutrition Dietary Center (No. DIC2014-03). M X received the funding of the National Natural Science Foundation of China (No. 81502298) and Shandong Provincial Natural Science Foundation (No. ZR2014JL056). The roles of the funders included data collection and analysis.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; D'Argenio G, 2013, LIVER INT, V33, P687, DOI 10.1111/liv.12117; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; Feng SS, 2016, MOL MED REP, V13, P3459, DOI 10.3892/mmr.2016.4978; Frazier Thomas H, 2011, Therap Adv Gastroenterol, V4, P63, DOI 10.1177/1756283X10378925; Gang SG, 2012, ARCH PLAST SURG-APS, V39, P669, DOI 10.5999/aps.2012.39.6.669; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gao M, 2015, J SURG RES, V195, P550, DOI 10.1016/j.jss.2015.02.007; Gao ZM, 2011, J BACTERIOL, V193, P5572, DOI 10.1128/JB.05719-11; Ge N, 2013, FOOD CHEM TOXICOL, V62, P361, DOI 10.1016/j.fct.2013.08.071; Gong AJ, 2015, EXP BIOL MED, V240, P639, DOI 10.1177/1535370214555664; Hartmann P, 2013, HEPATOLOGY, V58, P108, DOI 10.1002/hep.26321; He J., 2009, CHIN J PUBLIC HLTH, V25, P1122; Hou YQ, 2011, AMINO ACIDS, V41, pS57, DOI 10.1007/s00726-011-1191-9; Kasztelan-Szczerbinska B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128347; Khosravi AD, 2016, ACTA CIR BRAS, V31, P206, DOI 10.1590/S0102-865020160030000009; Kikuchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086416; Kirpich IA, 2013, ALCOHOL, V47, P257, DOI 10.1016/j.alcohol.2013.01.005; Kishikawa H, 2005, ALCOHOL CLIN EXP RES, V29, P2116, DOI 10.1097/01.alc.0000192299.63463.50; Liang H, 2007, ASIA PAC J CLIN NUTR, V16, P164; Liu J, 2014, MAR DRUGS, V12, P5072, DOI 10.3390/md12095072; Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585; Louis H, 2003, ACTA GASTRO-ENT BELG, V66, P7; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Nagy LE, 2015, ALCOHOL RES-CURR REV, V37, P237; Patel S, 2015, BIOMOLECULES, V5, P2573, DOI 10.3390/biom5042573; Qin XF, 2015, TOXICOL LETT, V232, P356, DOI 10.1016/j.toxlet.2014.11.027; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharma R, 2010, PEDIATR SURG INT, V26, P11, DOI 10.1007/s00383-009-2536-2; Suk KT, 2014, WORLD J GASTROENTERO, V20, P12934, DOI 10.3748/wjg.v20.i36.12934; Sun J, 2005, J NAT PROD, V68, P915, DOI 10.1021/np050096g; Sun Q, 2016, AM J PHYSIOL-GASTR L, V310, pG205, DOI 10.1152/ajpgi.00270.2015; Swanson GR, 2015, AM J PHYSIOL-GASTR L, V308, pG1004, DOI 10.1152/ajpgi.00002.2015; TAMURA M, 1992, INFECT IMMUN, V60, P4932, DOI 10.1128/IAI.60.11.4932-4937.1992; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Xu R, 2016, EXP THER MED, V11, P943, DOI 10.3892/etm.2016.3015; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yin M, 1998, J PHARMACOL EXP THER, V286, P1014; Zhang L, 2015, AM J EMERG MED, V33, P867, DOI 10.1016/j.ajem.2015.01.047; Zhang QP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27572; Zhang W, 2010, EUR J GASTROEN HEPAT, V22, P1481, DOI 10.1097/MEG.0b013e32833eb8b0	48	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178684	10.1371/journal.pone.0178684	http://dx.doi.org/10.1371/journal.pone.0178684			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622357	gold, Green Submitted, Green Published			2022-12-26	WOS:000403506300005
J	Bray, N; Noyes, J; Harris, N; Edwards, RT				Bray, Nathan; Noyes, Jane; Harris, Nigel; Edwards, Rhiannon Tudor			Defining health-related quality of life for young wheelchair users: A qualitative health economics study	PLOS ONE			English	Article							CHILDREN; ADOLESCENTS; DISABILITY; PROVISION; MOBILITY; PATIENT; UTILITY; PEOPLE; CARE	Background Wheelchairs for children with impaired mobility provide health, developmental and psychosocial benefits, however there is limited understanding of how mobility aids affect the health-related quality of life of children with impaired mobility. Preference-based health-related quality of life outcome measures are used to calculate quality-adjusted life years; an important concept in health economics. The aim of this research was to understand how young wheelchair users and their parents define health-related quality of life in relation to mobility impairment and wheelchair use. Methods The sampling frame was children with impaired mobility (<= 18 years) who use a wheelchair and their parents. Data were collected through semi-structured face-to-face interviews conducted in participants' homes. Qualitative framework analysis was used to analyse the interview transcripts. An a priori thematic coding framework was developed. Emerging codes were grouped into categories, and refined into analytical themes. The data were used to build an understanding of how children with impaired mobility define health-related quality of life in relation to mobility impairment, and to assess the applicability of two standard measures of health-related quality of life. Results Eleven children with impaired mobility and 24 parents were interviewed across 27 interviews. Participants defined mobility-related quality of life through three distinct but interrelated concepts: 1) participation and positive experiences; 2) self-worth and feeling fulfilled; 3) health and functioning. A good degree of consensus was found between child and parent responses, although there was some evidence to suggest a shift in perception of mobility-related quality of life with child age. Conclusions Young wheelchair users define health-related quality of life in a distinct way as a result of their mobility impairment and adaptation use. Generic, preference-based measures of health-related quality of life lack sensitivity in this population. Development of a mobility-related quality of life outcome measure for children is recommended.	[Bray, Nathan; Edwards, Rhiannon Tudor] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales; [Noyes, Jane] Bangor Univ, Sch Social Sci, Bangor, Gwynedd, Wales; [Harris, Nigel] Bath Inst Med Engn, DesignAbil, Bath, Somerset, England	Bangor University; Bangor University; University of Bath	Bray, N (corresponding author), Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales.	n.bray@bangor.ac.uk		Bray, Nathan/0000-0001-7646-5435	National Institute for Social Care and Health Research (NISCHR; now called Health and Care Research Wales) as part of a PhD studentship award	National Institute for Social Care and Health Research (NISCHR; now called Health and Care Research Wales) as part of a PhD studentship award	The study was funded by the National Institute for Social Care and Health Research (NISCHR; now called Health and Care Research Wales) as part of a PhD studentship award. The funding organisation had no role in the design, conduct, analysis or interpretation of this research.	[Anonymous], 2011, IMP WHIZZ KIDZ SUPP; Bartonek A, 2012, ACTA PAEDIATR, V101, P953, DOI 10.1111/j.1651-2227.2012.02742.x; Bottos M, 2001, DEV MED CHILD NEUROL, V43, P769, DOI 10.1017/S0012162201001402; Bray Nathan, 2016, Pilot Feasibility Stud, V2, P32; Bray N, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-309; Brazier J., 1999, HEALTH TECHNOL ASSES, V4, P174, DOI [10.1177/135581969900400310, DOI 10.1177/135581969900400310, DOI 10.3310/hta3090]; Brazier JE, 2011, 11 NICE DSU; Burstrom K, 2014, ACTA PAEDIATR, V103, P426, DOI 10.1111/apa.12557; Contact a Family, 2011, ANN REV I MAD DIFF 2; Davies A, 2003, DISABIL REHABIL, V25, P286, DOI 10.1080/0963828021000043734; Davis L., 2012, CHILDREN EQUALITY EQ; Day H., 1996, CAN J REHABIL, V9, P159; Department of Health, 2004, STAND 8 CHILDR NAT S; Dobhal M, 2014, INDIAN PEDIATR, V51, P385, DOI 10.1007/s13312-014-0414-z; Dolan P, 2008, ECON J, V118, P215, DOI 10.1111/j.1468-0297.2007.02110.x; Evans S., 2007, DISABILITY SKILLS WO; Furumasu J, 2008, INT SEAT S 24 ANN M; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Hagberg L, 2017, DISABIL REHABIL-ASSI, V12, P115, DOI 10.3109/17483107.2014.1002540; Hannes K., 2011, SUPPLEMENTARY GUIDAN, DOI DOI 10.1016/J.JCLINEPI.2017.11.029; Hellbom G, 2003, ASSIST TECHNOL, P931; Home A., 2003, INT J THER REHABIL, V10, P511, DOI DOI 10.12968/BJTR.2003.10.11.13462; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Janssen MF, 2013, QUAL LIFE RES, V22, P1717, DOI 10.1007/s11136-012-0322-4; Jones MA, 2003, PHYS THER, V83, P253, DOI 10.1093/ptj/83.3.253; Lacey A., 2007, QUALITATIVE DATA ANA; Lawlor K, 2006, Pediatr Rehabil, V9, P219, DOI 10.1080/13638490500235649; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Misajon RA, 2005, INVEST OPHTH VIS SCI, V46, P4007, DOI 10.1167/iovs.04-1389; Morris C, 2014, HLTH SERVICES DELIVE, V2; Mulhern B, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17050; Mulhern B, 2012, EPILEPSY BEHAV, V24, P36, DOI 10.1016/j.yebeh.2012.02.025; Muscular Dystrophy Campaign, 2011, WHEELCH PROV CHILDR; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2008, SOC VAL JUDG PRINC D; Neilson A, 2000, J APPL RES INTELLECT, V13, P216, DOI 10.1046/j.1360-2322.2000.00023.x; NHS Improving Quality, 2014, RIGHT CHAIR RIGHT TI; Office for Disability Issues, 2014, OFF STAT DIS FACTS F; Oliver M, 1998, BRIT MED J, V317, P1446, DOI 10.1136/bmj.317.7170.1446; Pettersson I, 2007, ASSIST TECHNOL, V19, P143, DOI 10.1080/10400435.2007.10131871; Phillips E., 2017, PLOUGHSHARES; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427; Scalone L, 2010, P 27 SCI PLEN M EURO; Sen A, PHILOS EC ANTHOLOGY, P270; Stevens KJ, 2010, QUAL HEALTH RES, V20, P340, DOI 10.1177/1049732309358328; Tefft D, 2011, PHYS OCCUP THER PEDI, V31, P4, DOI 10.3109/01942638.2010.529005; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Ubel PA, 2003, QUAL LIFE RES, V12, P599, DOI 10.1023/A:1025119931010; United Nations, 1989, CONV RIGHTS CHILD; Vargus-Adams J, 2005, ARCH PHYS MED REHAB, V86, P940, DOI 10.1016/j.apmr.2004.10.036; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; Versteegh MM, 2016, SOC SCI MED, V165, P66, DOI 10.1016/j.socscimed.2016.07.043; Whizz-Kidz, 2011, ALL PART PARL GROUP; Wiart Lesley, 2004, Physical & Occupational Therapy in Pediatrics, V24, P3; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2008, The global burden of disease: 2004 update	59	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179269	10.1371/journal.pone.0179269	http://dx.doi.org/10.1371/journal.pone.0179269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX6PQ	28617820	Green Submitted, Green Published, gold			2022-12-26	WOS:000403364600028
J	Dziedzic, M; Powrozek, T; Orlowska, E; Koch, W; Kukula-Koch, W; Gawel, K; Bednarek-Skublewska, A; Malecka-Massalska, T; Milanowski, J; Petkowicz, B; Solski, J				Dziedzic, Marcin; Powrozek, Tomasz; Orlowska, Ewelina; Koch, Wojciech; Kukula-Koch, Wirginia; Gawel, Kinga; Bednarek-Skublewska, Anna; Malecka-Massalska, Teresa; Milanowski, Janusz; Petkowicz, Beata; Solski, Janusz			Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CARDIAC-FUNCTION; KIDNEY-FUNCTION; HYPERTENSION; BIOMARKERS; MEDIATORS; DISEASE; GENE; IMMUNITY; MIR-146	Background microRNA (miRNA) belongs to the non-coding RNAs family responsible for the regulation of gene expression. Renalase is a protein composed of 342 amino acids, secreted by the kidneys and possibly plays an important role in the regulation of sympathetic tone and blood pressure. The aim of the present study was to investigate plasma renalase concentration, and explore the relationship between miRNA-146a-5p expression and plasma renalase levels in hemodialyzed patients. Methods The study population comprised 55 subjects who succumbed to various cardiac events, 27 women and 28 men, aged 65-70 years. The total RNA including miRNA fraction was isolated using QiagenmiRNEasy Serum/Plasma kit according to the manufacturer's protocol. The isolated miRNAs were analyzed using a quantitative polymerase chain reaction (qRT-PCR) technique. The plasma renalase levels were measured using a commercial ELISA kit. Results In the group of patients with high levels of renalase, higher miRNA-146a expression was found, compared with those with low concentration of renalase. Patients with simultaneous low miRNA-146a expression and high level of renalase were confirmed to deliver a significantly longer survival time compared with other patients. Conclusions miRNA-146a and plasma renalase levels were estimated as independent prognostic factors of hemodialyzed patients' survival time. Patients with low miRNA-146a expression demonstrated a significantly longer survival time in contrast to the patients with a high expression level of miRNA-146a. Moreover, a significantly longer survival time was found in patients with high renalase activity compared with patients with low activity of the enzyme.	[Dziedzic, Marcin; Solski, Janusz] Med Univ Lublin, Dept Lab Diagnost, Lublin, Poland; [Powrozek, Tomasz; Malecka-Massalska, Teresa] Med Univ Lublin, Dept Human Physiol, Lublin, Poland; [Orlowska, Ewelina; Bednarek-Skublewska, Anna] Med Univ Lublin, Dept Nephrol, Lublin, Poland; [Koch, Wojciech] Med Univ Lublin, Chair & Dept Bromatol, Lublin, Poland; [Kukula-Koch, Wirginia] Med Univ Lublin, Chair & Dept Pharmacognosy, Med Plants Unit, Lublin, Poland; [Gawel, Kinga] Med Univ Lublin, Dept Expt & Clin Pharmacol, Lublin, Poland; [Milanowski, Janusz] Med Univ Lublin, Dept Pneumonol Oncol & Allergol, Lublin, Poland; [Petkowicz, Beata] Med Univ Lublin, Dept Oral Med, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Dziedzic, M (corresponding author), Med Univ Lublin, Dept Lab Diagnost, Lublin, Poland.	marcindziedzic@live.com	Koch, Wojciech/AAF-8967-2019; Kukula-Koch, Wirginia/I-5468-2019	Koch, Wojciech/0000-0001-8749-9657; Kukula-Koch, Wirginia/0000-0001-7076-600X; Malecka-Massalska, Teresa/0000-0003-3384-0324				Agarwal R, 2003, AM J MED, V115, P291, DOI 10.1016/S0002-9343(03)00366-8; Beaupre BA, 2015, ARCH BIOCHEM BIOPHYS, V579, P62, DOI 10.1016/j.abb.2015.05.016; Beaupre BA, 2013, J AM CHEM SOC, V135, P13980, DOI 10.1021/ja407384h; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Buraczynska M, 2011, NEUROMOL MED, V13, P321, DOI 10.1007/s12017-011-8158-6; Catalucci D, 2009, CIRC-CARDIOVASC GENE, V2, P402, DOI 10.1161/CIRCGENETICS.109.857425; Charlson ME, 1987, J CHRON DIS, V40; Chen NX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064558; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Desir GV, 2014, NEPHROL DIAL TRANSPL, V29, P22, DOI 10.1093/ndt/gft083; Desir GV, 2007, J AM SOC HYPERTENS, V1, P99, DOI 10.1016/j.jash.2006.12.001; Dziedzic M, 2014, ANN AGR ENV MED, V21, P132; Eikelis N, 2011, KIDNEY INT, V79, P1380, DOI 10.1038/ki.2011.90; Emilian C, 2012, CLIN J AM SOC NEPHRO, V7, P619, DOI 10.2215/CJN.10471011; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hao Yi, 2016, J Clin Exp Ophthalmol, V7; Kalyani A, 2015, J MOL BIOL, V427, P2629, DOI 10.1016/j.jmb.2015.07.003; Kopple JD, 2001, AM J KIDNEY DIS, V38, pS68, DOI 10.1053/ajkd.2001.27578; Kutty RK, 2013, MOL VIS, V19, P737; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Malyszko J, 2015, CURR VASC PHARMACOL, V13, P134, DOI 10.2174/1570161113666141217141805; Malyszko J, 2012, J HYPERTENS, V30, P457, DOI 10.1097/HJH.0b013e32834f0bb7; Martino F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038269; METZINGERLEMEUT.V, 2012, CURRENT BASIC PATHOL, V17, P183; Moran GR, 2016, BBA-PROTEINS PROTEOM, V1864, P177, DOI 10.1016/j.bbapap.2015.04.010; National Kidney Foundation, 2004, AM J KIDNEY DIS S, V43, pS1, DOI [DOI 10.1053/J.AJKD.2004.03.003, 10.1053/j.ajkd.2004.03.003]; Neal CS, 2011, NEPHROL DIAL TRANSPL, V26, P3794, DOI 10.1093/ndt/gfr485; Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Quelhas-Santos J, 2015, AM J PHYSIOL-RENAL, V308, pF84, DOI 10.1152/ajprenal.00274.2014; Quinn SR, 2011, INT IMMUNOL, V23, P421, DOI 10.1093/intimm/dxr034; Rutkowski B, 2009, REPORT RENAL REPLACE, P1; Sarnak MJ, 2000, J THROMB THROMBOLYS, V10, P169, DOI 10.1023/A:1018718727634; Scharer K, 1999, PEDIATR NEPHROL, V13, P951, DOI 10.1007/s004670050737; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Stec A, 2016, INT UROL NEPHROL, V48, P871, DOI 10.1007/s11255-016-1270-7; Szeto CC, 2012, DIS MARKERS, V33, P137, DOI 10.1155/2012/842764; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang F, 2015, J CELL MOL MED, V19, P1400, DOI 10.1111/jcmm.12527; Wang F, 2015, CLIN EXP NEPHROL, V19, P92, DOI 10.1007/s10157-014-0951-8; Wang HL, 2012, BRAZ J MED BIOL RES, V45, P1308, DOI 10.1590/S0100-879X2012007500165; Wang J, 2008, MOL BIOL REP, V35, P613, DOI 10.1007/s11033-007-9131-1; Wilflingseder J, 2015, NEPHROL DIAL TRANSPL, V30, P910, DOI 10.1093/ndt/gfu280; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zbroch E, 2012, KIDNEY BLOOD PRESS R, V35, P395, DOI 10.1159/000338178; Zbroch E, 2012, POL ARCH MED WEWN, V122, P40, DOI 10.20452/pamw.1132	54	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179218	10.1371/journal.pone.0179218	http://dx.doi.org/10.1371/journal.pone.0179218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614373	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900036
J	Hari, P; Aakala, T; Aalto, J; Back, J; Hollmen, J; Jogiste, K; Koupaei, KK; Kahkonen, MA; Korpela, M; Kulmala, L; Nikinmaa, E; Pumpanen, J; Salkinoja-Salonen, M; Schiestl-Aalto, P; Simojoki, A; Havimo, M				Hari, Pertti; Aakala, Tuomas; Aalto, Juho; Back, Jaana; Hollmen, Jaakko; Jogiste, Kalev; Koupaei, Kourosh Kabiri; Kahkonen, Mika A.; Korpela, Mikko; Kulmala, Liisa; Nikinmaa, Eero; Pumpanen, Jukka; Salkinoja-Salonen, Mirja; Schiestl-Aalto, Pauliina; Simojoki, Asko; Havimo, Mikko			Newtonian boreal forest ecology: The Scots pine ecosystem as an example	PLOS ONE			English	Article							NITROGEN DEPOSITION; THINNING INTENSITY; CELLULASE ACTIVITY; GROWTH; CARBON; SOIL; MODEL; PHOTOSYNTHESIS; TEMPERATURE; ENZYMES	Isaac Newton's approach to developing theories in his book Principia Mathematica proceeds in four steps. First, he defines various concepts, second, he formulates axioms utilising the concepts, third, he mathematically analyses the behaviour of the system defined by the concepts and axioms obtaining predictions and fourth, he tests the predictions with measurements. In this study, we formulated our theory of boreal forest ecosystems, called NewtonForest, following the four steps introduced by Newton. The forest ecosystem is a complicated entity and hence we needed altogether 27 concepts to describe the material and energy flows in the metabolism of trees, ground vegetation and microbes in the soil, and to describe the regularities in tree structure. Thirtyfour axioms described the most important features in the behaviour of the forest ecosystem. We utilised numerical simulations in the analysis of the behaviour of the system resulting in clear predictions that could be tested with field data. We collected retrospective time series of diameters and heights for test material from 6 stands in southern Finland and five stands in Estonia. The numerical simulations succeeded to predict the measured diameters and heights, providing clear corroboration with our theory.	[Hari, Pertti; Aakala, Tuomas; Aalto, Juho; Back, Jaana; Koupaei, Kourosh Kabiri; Kulmala, Liisa; Nikinmaa, Eero; Schiestl-Aalto, Pauliina; Havimo, Mikko] FI Univ Helsinki, Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Aalto, Juho; Schiestl-Aalto, Pauliina] Hyytiala Forestry Field Stn, Hyytialantie 124, Korkeakoski, Finland; [Hollmen, Jaakko; Korpela, Mikko] Aalto Univ, Dept Informat & Comp Sci, Sch Sci, Fi Aalto, Finland; [Jogiste, Kalev] Estonian Univ Life Sci, Dept Forest Biol, Friedrich Reinhold Kreutzwaldi 1, Tartu, Estonia; [Kahkonen, Mika A.; Salkinoja-Salonen, Mirja; Simojoki, Asko] FI Univ Helsinki, Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Pumpanen, Jukka] Univ Eastern Finland, Dept Environm & Biol Sci, Fi Kuopio, Finland	University of Helsinki; Aalto University; Estonian University of Life Sciences; University of Helsinki; University of Eastern Finland	Hari, P (corresponding author), FI Univ Helsinki, Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	pertti.hari@helsinki.fi	Kulmala, Liisa/GVS-9237-2022; Bäck, Jaana K/A-7405-2010; Aakala, Tuomas/AAA-2574-2020; Simojoki, Asko/Y-8194-2019; Pumpanen, Jukka/B-1254-2012	Kulmala, Liisa/0000-0003-1775-8240; Bäck, Jaana K/0000-0002-6107-667X; Aakala, Tuomas/0000-0003-0160-6410; Simojoki, Asko/0000-0003-2397-3553; Pumpanen, Jukka/0000-0003-4879-3663; Jogiste, Kalev/0000-0002-2484-8802; Salkinoja-Salonen, Mirja/0000-0003-1853-5268	Academy of Finland [1118615, 272041]; Estonian Ministry of Education and Research; Academy of Finland Centre of Excellence Program [1118615, 272041]; Estonian Ministry of Education and Research [IUT21-4]	Academy of Finland(Academy of Finland); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Academy of Finland Centre of Excellence Program(Academy of Finland); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was funded by Academy of Finland through grants no 1118615 and 272041, website http://www.aka.fi/, and by Estonian Ministry of Education and Research, website https://www.hm.ee/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Academy of Finland Centre of Excellence Program (grants no 1118615 and 272041) for financial support. Kalev Jogiste acknowledges grant IUT21-4 of the Estonian Ministry of Education and Research.	Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Criquet S, 2002, J MICROBIOL METH, V50, P165, DOI 10.1016/S0167-7012(02)00028-3; Eivazi F, 1996, CAN J FOREST RES, V26, P1799, DOI 10.1139/x26-204; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fahlvik N, 2014, SILVA FENN, V48, DOI 10.14214/sf.1013; HARI P, 1980, FLORA, V170, P28; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; HARI P, 1974, FLORA, V163, P357; HARI P, 1973, PHYSIOL PLANTARUM, V29, P45, DOI 10.1111/j.1399-3054.1973.tb04808.x; Hari P, 2008, BOREAL FORESTS CLIMA; Hari P., 2013, PHYS PHYSL FOREST EC, P349; Hari P., 2013, PHYS PHYSL FOREST EC; Hari P, 2008, BOREAL FORESTS CLIMA, P416; Hari P, 2013, PHYS PHYSL FOREST EC, P75; Hari P, 1982, ACTA FOR FENN, V177, P1; Hari P, 2014, BOREAL ENVIRON RES, V19, P142; Kolari P, 2007, TELLUS B, V59, P542, DOI 10.1111/j.1600-0889.2007.00262.x; Kulmala L, 2011, CAN J FOREST RES, V41, P2020, DOI [10.1139/X11-121, 10.1139/x11-121]; Linden A, 2014, PLANT SOIL, V377, P145, DOI 10.1007/s11104-013-1987-3; LINKINS AE, 1990, SOIL BIOL BIOCHEM, V22, P423, DOI 10.1016/0038-0717(90)90123-H; Liski J, 1998, EUR J SOIL SCI, V49, P407, DOI 10.1046/j.1365-2389.1998.4930407.x; MAKELA A, 1986, ECOL MODEL, V33, P205, DOI 10.1016/0304-3800(86)90041-4; Makela A, 1997, FOREST SCI, V43, P7; MAKELA A, 1992, J THEOR BIOL, V159, P443, DOI 10.1016/S0022-5193(05)80690-3; Makinen H, 2004, FOREST ECOL MANAG, V203, P21, DOI 10.1016/j.foreco.2004.07.028; Makinen H, 2004, FOREST ECOL MANAG, V201, P311, DOI 10.1016/j.foreco.2004.07.016; Nardi S, 2005, SOIL SCI SOC AM J, V69, P2012, DOI 10.2136/sssaj2004.0401; Nardi S, 2000, CHEMOSPHERE, V41, P653, DOI 10.1016/S0045-6535(99)00488-9; Nikinmaa Eero, 1992, Acta Forestalia Fennica, V235, P1; Nissinen A, 1998, ENVIRON POLLUT, V102, P61, DOI 10.1016/S0269-7491(98)80016-X; Pavel R, 2004, SOIL BIOL BIOCHEM, V36, P549, DOI 10.1016/j.soilbio.2003.10.024; PENNINGDEVRIES FW, 1974, J THEOR BIOL, V45, P339; Pensa M, 2005, TREE PHYSIOL, V25, P1265, DOI 10.1093/treephys/25.10.1265; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; PIETARINEN I, 1982, FOREST SCI, V28, P573; Pumpanen J, 2008, SOIL SCI SOC AM J, V72, P1187, DOI 10.2136/sssaj2007.0199; Saito T, 2003, ENZYME MICROB TECH, V33, P520, DOI 10.1016/S0141-0229(03)00158-3; Taiz L., 2002, PLANT PHYSIOL; Thornley I., 1990, PLANT CROP MODELING; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Waldrop MP, 2004, SOIL BIOL BIOCHEM, V36, P1443, DOI 10.1016/j.soilbio.2004.04.023; WIT C. T. DE, 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P47; Wittmann C, 2004, SOIL BIOL BIOCHEM, V36, P425, DOI 10.1016/j.soilbio.2003.10.019	43	3	3	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0177927	10.1371/journal.pone.0177927	http://dx.doi.org/10.1371/journal.pone.0177927			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614351	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900009
J	Lee, JW; Kim, W; Kwon, EK; Kim, Y; Shin, HM; Kim, DH; Min, CK; Choi, JY; Lee, WW; Choi, MS; Kim, BG; Cho, NH				Lee, Jae-Won; Kim, Won; Kwon, Eun-Kyung; Kim, Yuri; Shin, Hyun Mu; Kim, Dong-Hyun; Min, Chan-Ki; Choi, Ji-Yeob; Lee, Won-Woo; Choi, Myung-Sik; Kim, Byeong Gwan; Cho, Nam-Hyuk			Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C	PLOS ONE			English	Article							PREDICTS VIRAL RESPONSE; VIRUS-INFECTION; PEGYLATED INTERFERON; DENDRITIC CELLS; PLUS RIBAVIRIN; ALPHA-BETA; T-CELLS; TH17; INFLAMMATION; POLYMORPHISMS	Type I interferons (IFNs) play an important role in antiviral immunity as well as immunopathogenesis of diverse chronic viral infections. However, the precise mechanisms regulating the multifaceted effects of type I IFNs on the immune system and pathological inflammation still remain unclear. In order to assess the immunological dynamics associated with rapid viral clearance in chronic hepatitis C patients during the acute phase of type I IFN therapy, we analyzed multiple parameters of virological and immunological responses in a cohort of 59 Korean hepatitis C patients who received pegylated IFN-alpha and ribavirin (IFN/RBV). Most of the Korean patients had favorable alleles in the IFN-lambda loci for responsiveness to IFN/RBV (i.e., C/C in rs12979860, T/T in rs8099917, and TT/TT in rs368234815). Rapid virological response (RVR) was determined mainly by the hepatitis C virus genotype. Among the cytokines analyzed, higher plasma levels of IL-17A and FGF were observed in non-RVR patients infected with viral genotype 1 and IP-10 was consistently elevated in RVR group infected with genotype 2 during the early phase of antiviral therapy. In addition, these three cytokines were correlated each other, suggesting a functional linkage of the cytokines in antiviral responses during IFN/RBV therapy. A low baseline frequencies of regulatory T cells and.d T cells, but high level of group 2 innate lymphoid cells, in peripheral bloods were also significantly associated with the RVR group, implicating a potential role of the cellular immunity during the early phase of IFN/RBV therapy. Therefore, the immunological programs established by chronic hepatitis C and rapid disruption of the delicate balance by exogenous type I IFN might be associated with the subsequent virological outcomes in chronic hepatitis C patients.	[Lee, Jae-Won; Kwon, Eun-Kyung; Kim, Yuri; Kim, Dong-Hyun; Min, Chan-Ki; Lee, Won-Woo; Choi, Myung-Sik; Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; [Lee, Jae-Won; Kwon, Eun-Kyung; Kim, Yuri; Shin, Hyun Mu; Kim, Dong-Hyun; Min, Chan-Ki; Choi, Ji-Yeob; Lee, Won-Woo; Cho, Nam-Hyuk] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Won; Kim, Byeong Gwan] Seoul Natl Univ, Coll Med, Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Choi, Ji-Yeob; Lee, Won-Woo] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Choi, Myung-Sik; Cho, Nam-Hyuk] Seoul Natl Univ, Med Res Ctr, Inst Endem Dis, Seoul, South Korea; [Choi, Myung-Sik; Cho, Nam-Hyuk] Bundang Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Cho, NH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.; Cho, NH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, W (corresponding author), Seoul Natl Univ, Coll Med, Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.; Cho, NH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Endem Dis, Seoul, South Korea.; Cho, NH (corresponding author), Bundang Hosp, Seoul, South Korea.	drwon1@snu.ac.kr; chonh@snu.ac.kr	Kim, Won/H-6940-2019; Lee, Jae-Won/AAY-1647-2020	Kim, Won/0000-0002-2926-1007; Lee, Jae-Won/0000-0003-2267-6717; Lee, Won-Woo/0000-0002-5347-9591	SNUH Research Fund [800-20140047, 800-20140048]; National Research Foundation of Korea (NRF) - Korean government (MEST) [2013R1A2A2A01007299]	SNUH Research Fund; National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This study was supported by grants from the SNUH Research Fund (800-20140047, 800-20140048) and the National Research Foundation of Korea (NRF) funded by the Korean government (MEST; 2013R1A2A2A01007299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Jimenez-Sousa MA, 2010, EUR CYTOKINE NETW, V21, P84, DOI 10.1684/ecn.2010.0191; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Chang Q, 2012, J GASTROEN HEPATOL, V27, P273, DOI 10.1111/j.1440-1746.2011.06782.x; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864; Dogan UB, 2013, WORLD J GASTROENTERO, V19, P8678, DOI 10.3748/wjg.v19.i46.8678; Enomoto H, 2015, WORLD J HEPATOL, V7, P2681, DOI 10.4254/wjh.v7.i26.2681; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Griffiths SJ, 2015, J INNATE IMMUN, V7, P231, DOI 10.1159/000369902; Hao CQ, 2014, IMMUNOLOGY, V143, P531, DOI 10.1111/imm.12330; Heo NY, 2014, CLIN MOL HEPATOL, V20, P177, DOI 10.3350/cmh.2014.20.2.177; Hsu YC, 2013, HEPATOLOGY, V58, P150, DOI 10.1002/hep.26300; Hwang Y, 2015, KOREAN J INTERN MED, V30, P792, DOI 10.3904/kjim.2015.30.6.792; Imran M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-299; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jie ZL, 2014, J IMMUNOL, V192, P3289, DOI 10.4049/jimmunol.1303281; Joo SK, 2015, J CLIN GASTROENTEROL, V49, P697, DOI 10.1097/MCG.0000000000000215; Jung YK, 2013, J CLIN GASTROENTEROL, V47, P644, DOI 10.1097/MCG.0b013e3182896abf; Jung YK, 2013, CLIN MOL HEPATOL, V19, P26, DOI 10.3350/cmh.2013.19.1.26; Kang W, 2011, YONSEI MED J, V52, P871, DOI 10.3349/ymj.2011.52.6.871; Kim BS, 2016, ARCH PHARM RES, V39, P1537, DOI 10.1007/s12272-016-0823-8; Kim CH, 2008, J GASTROEN HEPATOL, V23, pA42; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lee HC, 2013, HEPATOLOGY, V57, P1314, DOI 10.1002/hep.26128; Loftis Jennifer M, 2010, Open Infect Dis J, V4, P132; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meng  P., 2016, INT J MOL SCI, V17; Murira A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00609; Nguyen KB, 2002, J IMMUNOL, V169, P4279, DOI 10.4049/jimmunol.169.8.4279; Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004; Paquette RL, 1998, J LEUKOCYTE BIOL, V64, P358, DOI 10.1002/jlb.64.3.358; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rajoriya N, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00400; Reda R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/846348; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sandhu DS, 2014, HEPATOLOGY, V59, P1166, DOI 10.1002/hep.26679; Shin EC, 2016, NAT REV IMMUNOL, V16, P509, DOI 10.1038/nri.2016.69; Shin Hyun Mu, 2015, Journal of Bacteriology and Virology, V45, P389, DOI 10.4167/jbv.2015.45.4.389; Sousa GM, 2012, CYTOKINE, V60, P138, DOI 10.1016/j.cyto.2012.06.003; Spadaro F, 2012, BLOOD, V119, P1407, DOI 10.1182/blood-2011-06-363564; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488	48	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179094	10.1371/journal.pone.0179094	http://dx.doi.org/10.1371/journal.pone.0179094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614389	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900032
J	Ndow, G; Gore, ML; Shimakawa, Y; Suso, P; Jatta, A; Tamba, S; Sow, A; Toure-Kane, C; Sadiq, F; Sabally, S; Njie, R; Thursz, MR; Lemoine, M				Ndow, Gibril; Gore, Mindy L.; Shimakawa, Yusuke; Suso, Penda; Jatta, Abdoulie; Tamba, Saydiba; Sow, Amina; Toure-Kane, Coumba; Sadiq, Fouzia; Sabally, Saihou; Njie, Ramou; Thursz, Mark R.; Lemoine, Maud			Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes	PLOS ONE			English	Article							PLATELET RATIO INDEX; LIVER FIBROSIS; VIRUS COINFECTION; TRANSIENT ELASTOGRAPHY; INFECTED ADULTS; HIGH PREVALENCE; CANCER; FEASIBILITY; TENOFOVIR; RESOURCE	Background Compliance with WHO guidelines on HBV screening and treatment in HIV-coinfected patients is often challenging in resource limited countries and has been poorly assessed in sub-Saharan Africa. Methods Between 2015 and 2016, we assessed physician's compliance with WHO guidelines on HIV-HBV coinfection in the largest HIV clinic in The Gambia, and the hepatic outcomes in HIV-HBV coinfected patients as compared to randomly selected HIV-monoinfected controls. Results 870 HIV-infected patients regularly seen in this clinic agreed to participate in our study. Only 187 (21.5%, 95% CI 18.8-24.3) had previously been screened for HBsAg, 23 (12.3%, 95% CI 8.0-17.9) were positive of whom none had liver assessment and only 6 (26.1%) had received Tenofovir. Our HBV testing intervention was accepted by all participants and found 94/870 (10.8%, 95% CI 8.8-13.1) positive, 78 of whom underwent full liver assessment along with 40 HBsAg-negative controls. At the time of liver assessment, 61/78 (78.2%) HIVHBV coinfected patients received ART with 7 (11.5%) on Tenofovir and 54 (88.5%) on Lamivudine alone. HIV-HBV coinfected patients had higher APRI score compared to controls (0.58 vs 0.42, p = 0.002). HBV DNA was detectable in 52/53 (98.1%) coinfected patients with 14/53 (26.4%) having HBV DNA > 20,000 IU/L. 10/12 (83.3%) had at least one detectable 3TC-associated HBV resistance, which tended to be associated with increase in liver fibrosis after adjusting for age and sex (p = 0.05). Conclusions Compliance with HBV testing and treatment guidelines is poor in this Gambian HIV programme putting coinfected patients at risk of liver complications. However, the excellent uptake of HBV screening and linkage to care in our study suggests feasible improvements.	[Ndow, Gibril; Sadiq, Fouzia; Thursz, Mark R.; Lemoine, Maud] Imperial Coll London, Div Digest Dis, Dept Surg & Canc, St Marys Hosp Campus, London, England; [Ndow, Gibril; Suso, Penda; Jatta, Abdoulie; Tamba, Saydiba; Njie, Ramou] MRC Unit Gambia, Hepatitis Unit, Dis Control & Eliminat, Fajara, Gambia; [Gore, Mindy L.] Imperial Coll London, Virol Sect, Dept Med, London, England; [Shimakawa, Yusuke] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Sow, Amina; Toure-Kane, Coumba] Univ Cheikh Anta DIOP, CHU Aristide Le Dantec, Lab Bacteriol Virol, Dakar, Senegal; [Sabally, Saihou] Brikama Hlth Ctr, Hands Care HIV Clin, Brikama, Gambia; [Njie, Ramou] WHO, IARC, Lyon, France	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University Cheikh Anta Diop Dakar; World Health Organization; International Agency for Research on Cancer (IARC)	Ndow, G (corresponding author), Imperial Coll London, Div Digest Dis, Dept Surg & Canc, St Marys Hosp Campus, London, England.; Ndow, G (corresponding author), MRC Unit Gambia, Hepatitis Unit, Dis Control & Eliminat, Fajara, Gambia.	g.ndow@imperial.ac.uk	Sadiq, Fouzia/V-2131-2018	Sadiq, Fouzia/0000-0001-9399-6078; Ndow, Gibril/0000-0001-5837-5110; Sow, Amina/0000-0001-6081-4506; Gore, Mindy/0000-0002-1458-1438; Thursz, Mark/0000-0002-8218-192X	Wellcome Trust-Imperial College Institutional Strategic Support Fund (ISSF); Wellcome Trust-Imperial College Centre for Global Health Research; NIHR Imperial Biomedical Research Centre; EU 7th Framework Programme (FP7-AFRICA, Collaborative Project PROLIFICA) [265994]; Wellcome Trust grant [104771/Z/14/Z]; Medical Research Council [MC_UP_A900_1120] Funding Source: researchfish; Wellcome Trust [104771/Z/14/Z] Funding Source: researchfish	Wellcome Trust-Imperial College Institutional Strategic Support Fund (ISSF); Wellcome Trust-Imperial College Centre for Global Health Research; NIHR Imperial Biomedical Research Centre; EU 7th Framework Programme (FP7-AFRICA, Collaborative Project PROLIFICA); Wellcome Trust grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust-Imperial College Institutional Strategic Support Fund (ISSF) fellowship awarded to GN. Additional funding was provided by the Wellcome Trust-Imperial College Centre for Global Health Research (GN), the NIHR Imperial Biomedical Research Centre (MRT), and the EU 7th Framework Programme (FP7-AFRICA-2010, Collaborative Project PROLIFICA, Grant Nr. 265994). MLG is supported by a Wellcome Trust grant (award number 104771/Z/14/Z awarded to Dr Marcus Dorner). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript.; We thank the Medical Research Council Unit The Gambia, the Hands on Care HIV clinic and the Wellcome Trust-Imperial College Centre for Global Health Research for supporting this study. We are grateful to Professor Simon Taylor-Robinson for his continuous support all through the project, and Dr Marcus Dorner and his team for their advice and help with the molecular virology work. We thank all study participants, the PROLIFICA Gambia team, and the MRC data management unit. Lastly, we are grateful for the administrative and logistical support from Dr Peter Norsworthy, Dawn Campbell, Kimberley Trim, Susan Farrell, Mavis Foster-Nyarko and Amie Ceesay.	Bota S, 2011, HEPAT MON, V11, P548; Boyd A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21426; Boyd A, 2015, ANTIVIR THER, V20, P643, DOI 10.3851/IMP2959; Diop S A, 2013, Bull Soc Pathol Exot, V106, P22, DOI 10.1007/s13149-012-0272-7; Garson JA, 2005, J VIROL METHODS, V126, P207, DOI 10.1016/j.jviromet.2005.03.001; Ghosh S, 2016, J VIRAL HEPATITIS, V23, P897, DOI 10.1111/jvh.12561; Gitau SN, 2016, J CLIN IMAG SCI, V6, DOI 10.4103/2156-7514.183582; Hawkins C, 2013, CLIN INFECT DIS, V57, pE189, DOI 10.1093/cid/cit564; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Japhet MM, 2016, C RETR OPP INF CROI; Johannessen A, 2015, LIVER INT, V35, P2059, DOI 10.1111/liv.12793; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kouarne MG, 2016, 21 INT AIDS C 18 22; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Ministry of Health & Social Welfare Republic of The Gambia, 2015, GUID ANT THER PREV T; ONU, 2015, TRANSF OUR WORLD 203; Organization WH, 2015, GUID PREV CAR TREATM; Ramirez-Mena A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw162; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shimakawa Y, 2013, INT J CANCER, V132, P658, DOI 10.1002/ijc.27646; Stabinski L, 2015, JAIDS-J ACQ IMM DEF, V68, pS274, DOI 10.1097/QAI.0000000000000496; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Stewart Balint, 2011, BMC Res Notes, V4, P561, DOI 10.1186/1756-0500-4-561; Stockdale AJ, 2015, CLIN INFECT DIS, V61, P883, DOI 10.1093/cid/civ421; United Nations, SUST DEV GOAL 3 ENS; Vinikoor MJ, 2016, TROP MED INT HEALTH, V21, P1435, DOI 10.1111/tmi.12764; Vinikoor MJ, 2015, LIVER INT, V35, P1886, DOI 10.1111/liv.12780; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2016, COMB HEP B C REACH E; World Health Organization, 2015, GLOB HLTH SECT STRAT; World Health Organization, 2014, STRENGTH PALL CAR CO	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179025	10.1371/journal.pone.0179025	http://dx.doi.org/10.1371/journal.pone.0179025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614401	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900030
J	Tasaki, E; Sakurai, H; Nitao, M; Matsuura, K; Iuchi, Y				Tasaki, Eisuke; Sakurai, Hiroki; Nitao, Masaru; Matsuura, Kenji; Iuchi, Yoshihito			Uric acid, an important antioxidant contributing to survival in termites	PLOS ONE			English	Article							SOCIAL INSECTS; LIFE-SPAN; OVEREXPRESSION; EXTENSION; SILKWORM; CATALASE; STRESS; MODEL; SKIN	Reactive oxygen species (ROS) are generated spontaneously in all organisms and cause oxidative damage to biomolecules when present in excess. Accumulated oxidative damage accelerates aging; enhanced antioxidant capacity may be a positive factor for longevity. Recently, numerous studies of aging and longevity have been performed using short-lived animals, however, longevity mechanisms remain unknown. Here we show that a termite Reticulitermes speratus that is thought to be long-lived eusocial insect than other solitary insects uses large quantities of uric acid as an antioxidant against ROS. We demonstrated that the accumulation of uric acid considerably increases the free radical-scavenging activity and resistance against ultraviolet-induced oxidative stress in laboratory-maintained termites. In addition, we found that externally administered uric acid aided termite survival under highly oxidative conditions. The present data demonstrates that in addition to nutritional and metabolic roles, uric acid is an essential antioxidant for survival and contributes significantly to longevity. Uric acid also plays important roles in primates but causes gout when present in excess in humans. Further longevity studies of long-lived organisms may provide important breakthroughs with human health applications.	[Tasaki, Eisuke; Iuchi, Yoshihito] Tottori Univ, United Grad Sch Agr, Dept Appl Bioresources Chem, 4-101 Koyamacho Minami, Tottori, Japan; [Tasaki, Eisuke; Sakurai, Hiroki; Nitao, Masaru; Iuchi, Yoshihito] Yamaguchi Univ, Fac Agr, Dept Biol Chem, 1677-1 Yoshida, Yamaguchi, Japan; [Matsuura, Kenji] Kyoto Univ, Grad Sch Agr, Dept Appl Biosci, Kitashirakawa Oiwakecho, Kyoto, Japan; [Iuchi, Yoshihito] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, 1677-1 Yoshida, Yamaguchi, Japan	Tottori University; Yamaguchi University; Kyoto University; Yamaguchi University	Iuchi, Y (corresponding author), Tottori Univ, United Grad Sch Agr, Dept Appl Bioresources Chem, 4-101 Koyamacho Minami, Tottori, Japan.; Iuchi, Y (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, 1677-1 Yoshida, Yamaguchi, Japan.; Iuchi, Y (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, 1677-1 Yoshida, Yamaguchi, Japan.	yiuchi@yamaguchi-u.ac.jp	Tasaki, Eisuke/G-7241-2019	Tasaki, Eisuke/0000-0002-6514-5134	Japan Society for the Promotion of Science [26660113, 25221206]; Grants-in-Aid for Scientific Research [17K19909] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html, No. 26660113 to YI and No. 25221206 to KM).	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Azpurua Jorge, 2013, Frontiers in Genetics, V3, P319, DOI 10.3389/fgene.2012.00319; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; HOLM S, 1979, SCAND J STAT, V6, P65; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; Kim KM, 2009, J CHROMATOGR B, V877, P2032, DOI 10.1016/j.jchromb.2009.05.037; Kolovou GD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/808307; Komoto N, 2002, INSECT BIOCHEM MOLEC, V32, P591, DOI 10.1016/S0965-1748(01)00134-5; Matsuo T, 1999, APPL ENTOMOL ZOOL, V34, P481, DOI 10.1303/aez.34.481; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Page RE, 2001, EXP GERONTOL, V36, P695, DOI 10.1016/S0531-5565(00)00236-9; POTRIKUS CJ, 1980, INSECT BIOCHEM, V10, P19, DOI 10.1016/0020-1790(80)90034-7; POTRIKUS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P4601, DOI 10.1073/pnas.78.7.4601; Sadowska-Bartosz I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/404680; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Tasaki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167412; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Thong-On A, 2012, MICROBES ENVIRON, V27, P186, DOI 10.1264/jsme2.ME11325	24	30	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179426	10.1371/journal.pone.0179426	http://dx.doi.org/10.1371/journal.pone.0179426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609463	gold, Green Submitted, Green Published			2022-12-26	WOS:000403274700038
J	Gonzalez-Lopez, L; Carballar-Lejarazu, R; Boni, GA; Cortes-Martinez, L; Cazares-Raga, FE; Trujillo-Ocampo, A; Rodriguez, MH; James, AA; Hernandez-Hernandez, FD				Gonzalez-Lopez, Lorena; Carballar-Lejarazu, Rebeca; Arrevillaga Boni, Gerardo; Cortes-Martinez, Leticia; Elena Cazares-Raga, Febe; Trujillo-Ocampo, Abel; Rodriguez, Mario H.; James, Anthony A.; de la Cruz Hernandez-Hernandez, Fidel			Lys48 ubiquitination during the intraerythrocytic cycle of the rodent malaria parasite, Plasmodium chabaudi	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; PROTEASOME INHIBITORS; FALCIPARUM; PROTEINS; ACTIN; DEGRADATION; SYSTEM; IDENTIFICATION; EXPRESSION; RESPONSES	Ubiquitination tags proteins for different functions within the cell. One of the most abundant and studied ubiquitin modification is the Lys48 polyubiquitin chain that modifies proteins for their destruction by proteasome. In Plasmodium is proposed that post-translational regulation is fundamental for parasite development during its complex life-cycle; thus, the objective of this work was to analyze the ubiquitination during Plasmodium chabaudi intraerythrocytic stages. Ubiquitinated proteins were detected during intraerythrocytic stages of Plasmodium chabaudi by immunofluorescent microscopy, bidimensional electrophoresis (2-DE) combined with immunoblotting and mass spectrometry. All the studied stages presented protein ubiquitination and Lys48 polyubiquitination with more abundance during the schizont stage. Three ubiquitinated proteins were identified for rings, five for trophozoites and twenty for schizonts. Only proteins detected with a specific anti-Lys48 polyubiquitin antibody were selected for Mass Spectrometry analysis and two of these identified proteins were selected in order to detect the specific amino acid residues where ubiquitin is placed. Ubiquitinated proteins during the ring and trophozoite stages were related with the invasion process and in schizont proteins were related with nucleic acid metabolism, glycolysis and protein biosynthesis. Most of the ubiquitin detection was during the schizont stage and the Lys48 polyubiquitination during this stage was related to proteins that are expected to be abundant during the trophozoite stage. The evidence that these Lys48 polyubiquitinated proteins are tagged for destruction by the proteasome complex suggests that this type of post-translational modification is important in the regulation of protein abundance during the life-cycle and may also contribute to the parasite cell-cycle progression.	[Gonzalez-Lopez, Lorena; Carballar-Lejarazu, Rebeca; Cortes-Martinez, Leticia; Elena Cazares-Raga, Febe; Trujillo-Ocampo, Abel; de la Cruz Hernandez-Hernandez, Fidel] IPN, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico; [Carballar-Lejarazu, Rebeca; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Carballar-Lejarazu, Rebeca; James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Arrevillaga Boni, Gerardo] IPN, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Rodriguez, Mario H.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of California System; University of California Irvine; University of California System; University of California Irvine; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Salud Publica	Hernandez-Hernandez, FD (corresponding author), IPN, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Infect & Patogenesis Mol, Mexico City, DF, Mexico.	cruzcruz@cinvestav.mx	Hernandez-Hernandez, Fidel/I-5193-2012; Gonzalez, Lorena/C-4676-2017	Hernandez-Hernandez, Fidel/0000-0002-7276-7513; Gonzalez, Lorena/0000-0002-1392-1533; James, Anthony/0000-0001-5577-3308; Carballar Lejarazu, Rebeca/0000-0002-9338-8774	CONACYT Mexico [180514]; UC-MEXUS CONACYT [CN-10-479]; CONACyT, Mexico [CVU 38745];  [225016]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UC-MEXUS CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	CONACYT Mexico #180514 and UC-MEXUS CONACYT #CN-10-479. URL: http://www.conacyt.gob.mx/. LGL received a Ph.D. scholarship 225016 and RCL (CVU 38745) received a postdoctoral fellowship from CONACyT, Mexico.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Aminake MN, 2012, INT J PARASITOL-DRUG, V2, P1, DOI 10.1016/j.ijpddr.2011.12.001; Andreadaki M, 2014, CELL MICROBIOL, V16, P751, DOI 10.1111/cmi.12274; Bianchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065932; Bozaykut P, 2014, FREE RADICAL BIO MED, V77, P195, DOI 10.1016/j.freeradbiomed.2014.08.012; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Buey RM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9923; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Chaikuad A, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-42; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; de Monerri NCS, 2015, CELL HOST MICROBE, V18, P621, DOI 10.1016/j.chom.2015.10.014; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gonzalez-Calixto C, 2014, J PROTEOMICS, V119C, P45; Hamilton MJ, 2014, MOL BIOSYST, V10, P715, DOI 10.1039/c3mb70506d; Hliscs M, 2015, CELL MICROBIOL, V17, P207, DOI 10.1111/cmi.12359; Horrocks P, 2000, MOL BIOCHEM PARASIT, V105, P115, DOI 10.1016/S0166-6851(99)00174-7; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; Keough DT, 2015, J MED CHEM, V58, P827, DOI 10.1021/jm501416t; Koiwai K, 2008, GENES CELLS, V13, P593, DOI 10.1111/j.1365-2443.2008.01191.x; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Mata-Cantero L, 2016, J PROTEOMICS, V139, P45, DOI 10.1016/j.jprot.2016.03.004; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Mayor T, 2016, AM J PHYSIOL-CELL PH; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nino CA, 2013, MICROBIOLOGYOPEN, V2, P525, DOI 10.1002/mbo3.88; Otto TD, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0086-0; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Ponts N, 2011, J BIOL CHEM, V286, P40320, DOI 10.1074/jbc.M111.238790; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Preuss J, 2012, IUBMB LIFE, V64, P603, DOI 10.1002/iub.1047; Price SR, 2003, INT J BIOCHEM CELL B, V35, P617, DOI 10.1016/S1357-2725(02)00385-0; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Radici L., 2013, ADV BIOSCI BIOTECHNO, V04, P1057, DOI [DOI 10.4236/ABB.2013.412141, 10.4236/abb.2013.412141]; Reynolds Jennifer M, 2007, BMC Clin Pharmacol, V7, P13, DOI 10.1186/1472-6904-7-13; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Soss SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128240; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Tachikui H, 2003, J MOL EVOL, V57, P737, DOI 10.1007/s00239-003-2532-4; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Trempe JF, 2011, CURR OPIN STRUC BIOL, V21, P792, DOI 10.1016/j.sbi.2011.09.009; Vahokoski J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004091; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; Wang LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17818; WHO, 2012, WORLD MAL REP 2012, V978; Wirth DF, 2002, NATURE, V419, P495, DOI 10.1038/419495a; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	68	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0176533	10.1371/journal.pone.0176533	http://dx.doi.org/10.1371/journal.pone.0176533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604779	gold, Green Published			2022-12-26	WOS:000403088400003
J	Kranczioch, C				Kranczioch, Cornelia			Individual differences in dual-target RSVP task performance relate to entrainment but not to individual alpha frequency	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; ATTENTIONAL BLINK; TEMPORAL ATTENTION; RESOURCE-ALLOCATION; DYNAMICS; IDENTIFICATION; OSCILLATIONS	The attentional blink (AB) paradigm is widely used to study visual temporal attention. An important feature of the standard AB paradigm is repetitive visual stimulation, more precisely the rapid serial visual presentation (RSVP) of numerous distracters interspersed with two targets. The RSVP stream is likely to result in entrainment of visual cortex, which has been suggested to negatively affect target identification in the AB paradigm. The present EEG study tested this idea with an inter-individual differences approach. AB task performance and measures of entrainment were derived from 51 participants. Other than predicted, moderate positive correlations were observed for inter-trial coherence and performance, but only for targets not immediately preceded by other targets. A positive correlation with power was evident for targets presented in the critical AB time window. In a second step, it was tested whether the distance between individual alpha frequency and RSVP frequency mediated correlations with inter-trial coherence, as entrainment of the visual cortex through repetitive visual stimulation is particularly effective when the frequency of the stimulation matches the individual alpha frequency. However, no evidence was found supporting such link. While compatible with a number of findings related to the AB and to visual entrainment, the findings of the present study do not provide evidence for the notion that entrainment to the RSVP stream creates a neural environment unfavourable for detecting targets an RSVP stream.	[Kranczioch, Cornelia] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Dept Psychol, Neuropsychol Lab, Oldenburg, Germany; [Kranczioch, Cornelia] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Kranczioch, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Dept Psychol, Neuropsychol Lab, Oldenburg, Germany.; Kranczioch, C (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany.	cornelia.kranczioch@uni-oldenburg.de			German Research Foundation [KR 3433/2-1]	German Research Foundation(German Research Foundation (DFG))	This research was funded by the German Research Foundation (www.dfg.de), grant KR 3433/2-1 (CK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga A, 2008, PSYCHOL RES-PSYCH FO, V72, P192, DOI 10.1007/s00426-006-0100-4; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P1, DOI 10.1007/s00426-008-0200-4; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; de Sa AMFLM, 2005, MED ENG PHYS, V27, P167, DOI 10.1016/j.medengphy.2004.09.011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Janson J, 2013, NEUROREPORT; Janson J, 2014, J COGNITIVE NEUROSCI, V26, P1454, DOI 10.1162/jocn_a_00551; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kranczioch C, 2007, NEUROIMAGE, V37, P947, DOI 10.1016/j.neuroimage.2007.05.044; Kranczioch C, 2013, BRAIN COGNITION, V81, P313, DOI 10.1016/j.bandc.2013.01.001; Kranczioch C, 2011, NEUROREPORT, V22, P161, DOI 10.1097/WNR.0b013e3283438b76; MacLean MH, 2012, ATTEN PERCEPT PSYCHO, V74, P1080, DOI 10.3758/s13414-012-0338-4; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martin EW, 2011, PSYCHON B REV, V18, P295, DOI 10.3758/s13423-011-0056-2; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Notbohm A, 2016, MODIFICATION BRAIN O, V10; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Regan D., 1989, HUMAN BRAIN ELECTROP; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Schwab K, 2006, NEUROREPORT, V17, P1829, DOI 10.1097/01.wnr.0000246326.89308.ec; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Shapiro KL, 2017, PSYCHON B REV; Troche SJ, 2013, ATTENTIONAL BLINK IM, P273; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Ward R, 1997, PERCEPT PSYCHOPHYS, V59, P593, DOI 10.3758/BF03211867; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Willems C, 2016, PSYCHON B REV, V23, P1289, DOI 10.3758/s13423-015-0977-2; Zauner A, 2012, NEUROIMAGE, V63, P674, DOI 10.1016/j.neuroimage.2012.06.075	33	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178934	10.1371/journal.pone.0178934	http://dx.doi.org/10.1371/journal.pone.0178934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX2VR	28604795	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000403088400020
J	Nam, H; Baek, J				Nam, Haewon; Baek, Jongduk			A metal artifact reduction algorithm in CT using multiple prior images by recursive active contour segmentation	PLOS ONE			English	Article							CONE-BEAM CT; COMPUTED-TOMOGRAPHY; PROJECTION DATA; DENTAL CT; RECONSTRUCTION; SUPPRESSION	We propose a novel metal artifact reduction (MAR) algorithm for CT images that completes a corrupted sinogram along the metal trace region. When metal implants are located inside a field of view, they create a barrier to the transmitted X-ray beam due to the high attenuation of metals, which significantly degrades the image quality. To fill in the metal trace region efficiently, the proposed algorithm uses multiple prior images with residual error compensation in sinogram space. Multiple prior images are generated by applying a recursive active contour (RAC) segmentation algorithm to the pre-corrected image acquired by MAR with linear interpolation, where the number of prior image is controlled by RAC depending on the object complexity. A sinogram basis is then acquired by forward projection of the prior images. The metal trace region of the original sinogram is replaced by the linearly combined sinogram of the prior images. Then, the additional correction in the metal trace region is performed to compensate the residual errors occurred by non-ideal data acquisition condition. The performance of the proposed MAR algorithm is compared with MAR with linear interpolation and the normalized MAR algorithm using simulated and experimental data. The results show that the proposed algorithm outperforms other MAR algorithms, especially when the object is complex with multiple bone objects.	[Nam, Haewon] Hongik Univ, Dept Liberal Arts & Sci, Sejong, South Korea; [Baek, Jongduk] Yonsei Univ, Yonsei Inst Convergence Technol, 162-1 Songdo Dong, Incheon, South Korea; [Baek, Jongduk] Yonsei Univ, Sch Integrated Technol, 162-1 Songdo Dong, Incheon, South Korea	Hongik University; Yonsei University; Yonsei University	Baek, J (corresponding author), Yonsei Univ, Yonsei Inst Convergence Technol, 162-1 Songdo Dong, Incheon, South Korea.; Baek, J (corresponding author), Yonsei Univ, Sch Integrated Technol, 162-1 Songdo Dong, Incheon, South Korea.	jongdukbaek@yonsei.ac.kr			MSIP (Ministry of Science, ICT and Future Planning), Korea under "IT Consilience Creative Program" [IITP-2015-R0346-15-1008]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A2A01054731, 2015R1C1A101052268, 2017M2A2A6A01019663]	MSIP (Ministry of Science, ICT and Future Planning), Korea under "IT Consilience Creative Program"; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the "IT Consilience Creative Program" (IITP-2015-R0346-15-1008) supervised by the IITP (Institute for Information & Communications Technology Promotion) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A2A01054731, 2015R1C1A101052268, 2017M2A2A6A01019663).	Abdoli M, 2012, MED PHYS, V39, P3343, DOI 10.1118/1.4709599; Boone JM, SIMULATION OF X RAY; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Choi J, 2011, J X-RAY SCI TECHNOL, V19, P457, DOI 10.3233/XST-2011-0307; GLOVER GH, 1981, MED PHYS, V8, P799, DOI 10.1118/1.595032; Handsfield LL, 2012, J APPL CLIN MED PHYS, V13, P181, DOI 10.1120/jacmp.v13i5.3976; Hubbell J. H., 2004, TECH REP; KALENDER WA, 1987, RADIOLOGY, V164, P576, DOI 10.1148/radiology.164.2.3602406; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lai KF, 1993, AS C COMP VIS, V10, P542; Lemmens C, 2009, IEEE T MED IMAGING, V28, P250, DOI 10.1109/TMI.2008.929103; Liu PT, 2013, PHYS MED BIOL, V58, P8401; Mahnken AH, 2003, INVEST RADIOL, V38, P769, DOI 10.1097/01.rli.0000086495.96457.54; Mehranian A, 2013, IEEE T MED IMAGING, V32, P1707, DOI 10.1109/TMI.2013.2265136; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Nasirudin RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124831; Prell D, 2009, PHYS MED BIOL, V54, P6575, DOI 10.1088/0031-9155/54/21/009; Robertson DD, 1997, J COMPUT ASSIST TOMO, V21, P293, DOI 10.1097/00004728-199703000-00024; Tohnak S, 2011, DENTOMAXILLOFAC RAD, V40, P184, DOI 10.1259/dmfr/25260548; Veldkamp WJH, 2010, MED PHYS, V37, P620, DOI 10.1118/1.3276777; Watzke O, 2004, EUR RADIOL, V14, P849, DOI 10.1007/s00330-004-2263-y; Williamson JF, 2002, MED PHYS, V29, P2404, DOI 10.1118/1.1509443; Yazdia M, 2005, INT J RADIAT ONCOL, V62, P1224, DOI 10.1016/j.ijrobp.2005.02.052; Yu HY, 2007, ACAD RADIOL, V14, P495, DOI 10.1016/j.acra.2006.12.015; Zhang XM, 2011, MED PHYS, V38, P701, DOI 10.1118/1.3533711; Zhang Y, 2006, MED PHYS, V33, P2288, DOI 10.1118/1.2241937; Zhang YB, 2013, MED PHYS, V40, DOI 10.1118/1.4794474; Zhang YB, 2007, INT J RADIAT ONCOL, V67, P924, DOI 10.1016/j.ijrobp.2006.09.045; Zhao SY, 2000, IEEE T MED IMAGING, V19, P1238, DOI 10.1109/42.897816	31	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179022	10.1371/journal.pone.0179022	http://dx.doi.org/10.1371/journal.pone.0179022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604794	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400026
J	Roberts, FR; Hupple, C; Norowski, E; Walsh, NC; Przewozniak, N; Aryee, KE; Van Dessel, FM; Jurczyk, A; Harlan, DM; Greiner, DL; Bortell, R; Yang, CX				Roberts, Frederick R.; Hupple, Clinton; Norowski, Elaine; Walsh, Nicole C.; Przewozniak, Natalia; Aryee, Ken-Edwin; Van Dessel, Filia M.; Jurczyk, Agata; Harlan, David M.; Greiner, Dale L.; Bortell, Rita; Yang, Chaoxing			Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model	PLOS ONE			English	Article							INNATE IMMUNITY; RECENT-ONSET; BETA-CELLS; PATHOGENESIS; EXPRESSION; CHILDREN; SERUM; SIGNATURE; RESISTANT; INFECTION	Background/Aims Studies of human cadaveric pancreas specimens indicate that pancreas inflammation plays an important role in type 1 diabetes pathogenesis. Due to the inaccessibility of pancreas in living patients, imaging technology to visualize pancreas inflammation is much in need. In this study, we investigated the feasibility of utilizing ultrasound imaging to assess pancreas inflammation longitudinally in living rats during the progression leading to type 1 diabetes onset. Methods The virus-inducible BBDR type 1 diabetes rat model was used to systematically investigate pancreas changes that occur prior to and during development of autoimmunity. The nearly 100% diabetes incidence upon virus induction and the highly consistent time course of this rat model make longitudinal imaging examination possible. A combination of histology, immunoblotting, flow cytometry, and ultrasound imaging technology was used to identify stage-specific pancreas changes. Results Our histology data indicated that exocrine pancreas tissue of the diabetes-induced rats underwent dramatic changes, including blood vessel dilation and increased CD8+ cell infiltration, at a very early stage of disease initiation. Ultrasound imaging data revealed significant acute and persistent pancreas inflammation in the diabetes-induced rats. The pancreas micro-vasculature was significantly dilated one day after diabetes induction, and large blood vessel (superior mesenteric artery in this study) dilation and inflammation occurred several days later, but still prior to any observable autoimmune cell infiltration of the pancreatic islets. Conclusions Our data demonstrate that ultrasound imaging technology can detect pancreas inflammation in living rats during the development of type 1 diabetes. Due to ultrasound's established use as a non-invasive diagnostic tool, it may prove useful in a clinical setting for type 1 diabetes risk prediction prior to autoimmunity and to assess the effectiveness of potential therapeutics.	[Roberts, Frederick R.; Hupple, Clinton] FuJiFilm VisualSon, Toronto, ON, Canada; [Norowski, Elaine; Walsh, Nicole C.; Przewozniak, Natalia; Aryee, Ken-Edwin; Van Dessel, Filia M.; Jurczyk, Agata; Greiner, Dale L.; Bortell, Rita; Yang, Chaoxing] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01655 USA; [Harlan, David M.] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA USA	Fujifilm Corporation; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Yang, CX (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01655 USA.	Chaoxing.yang@umassmed.edu			National Institute of Diabetes and Digestive and Kidney Diseases [R01DK105837]; NIH [UC4DK104218]; Leona M. and Harry B. Helmsley Charitable Trust [2012PG- T1D018]; FuJi Film VisualSonics Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105837, UC4DK104218] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; FuJi Film VisualSonics Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institute of Diabetes and Digestive and Kidney Diseases R01DK105837, NIH UC4DK104218, and The Leona M. and Harry B. Helmsley Charitable Trust (2012PG- T1D018). FuJi Film VisualSonics Inc. provided support in the form of salaries for authors F.R.R. and C.H., but did not have any additional role in the study design and decision to publish. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Atkinson MA, 2014, DIABETOLOGIA, V57, P656, DOI 10.1007/s00125-013-3159-7; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bortell Rita, 2012, Methods Mol Biol, V933, P31, DOI 10.1007/978-1-62703-068-7_3; Burch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135663; Campbell-Thompson M, 2012, JAMA-J AM MED ASSOC, V308, P2337, DOI 10.1001/jama.2012.15008; Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; Chopra P, 2009, IN VIVO, V23, P195; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.0404307101; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Ferreira RC, 2014, DIABETES, V63, P2538, DOI 10.2337/db13-1777; Gaglia JL, 2015, P NATL ACAD SCI USA, V112, P2139, DOI 10.1073/pnas.1424993112; GOTTLIEB PA, 1990, DIABETES, V39, P643, DOI 10.2337/diabetes.39.5.643; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Jurczyk A, 2013, DIABETES METAB SYNDR, V6, P493, DOI 10.2147/DMSO.S53154; Kallionpaa H, 2014, DIABETES, V63, P2402, DOI 10.2337/db13-1775; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Krogvold L, 2014, DIABETOLOGIA, V57, P841, DOI 10.1007/s00125-013-3155-y; Kruger AJ, 2010, EXP BIOL MED, V235, P1328, DOI 10.1258/ebm.2010.010150; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Panicot L, 1999, DIABETES, V48, P2316, DOI 10.2337/diabetes.48.12.2316; Planas R, 2010, IMMUNOL LETT, V133, P55, DOI 10.1016/j.imlet.2010.08.001; Pugliese A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0530-0; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Rowe P, 2013, DIABETES CARE, V36, P3815, DOI 10.2337/dc13-0203; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Wang XJ, 2008, J IMMUNOL, V180, P1929, DOI 10.4049/jimmunol.180.3.1929; Wen L, 2004, J IMMUNOL, V172, P3173, DOI 10.4049/jimmunol.172.5.3173; Yang CX, 2013, DIABETOLOGIA, V56, P2638, DOI 10.1007/s00125-013-3044-4; Yang CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078050; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264; Zhang QB, 2013, J EXP MED, V210, P191, DOI 10.1084/jem.20111843; Zipris D, 2003, J IMMUNOL, V170, P3592, DOI 10.4049/jimmunol.170.7.3592; Zipris D., 2009, CLIN IMMUNOL; Zipris D, 2011, DIABETES-METAB RES, V27, P824, DOI 10.1002/dmrr.1256	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178641	10.1371/journal.pone.0178641	http://dx.doi.org/10.1371/journal.pone.0178641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28605395	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400015
J	Puentes, AD; Goyanes, RM; Tonato, AMC; Torres-Espinola, FJ; Garcia, MA; de Almeida, L; Aguirre, MB; Guerendiain, M; Bargallo, AIC; Moreno, MS; Garcia-Valdes, L; Campoy, C; Lopez-Sabater, MC				de la Garza Puentes, Andrea; Montes Goyanes, Rosa; Chisaguano Tonato, Aida Maribel; Jose Torres-Espinola, Francisco; Arias Garcia, Miriam; de Almeida, Leonor; Bonilla Aguirre, Maria; Guerendiain, Marcela; Castellote Bargallo, Ana Isabel; Segura Moreno, Maite; Garcia-Valdes, Luz; Campoy, Cristina; Carmen Lopez-Sabater, M.		PREOBE Team	Association of maternal weight with FADS and ELOVL genetic variants and fatty acid levels-The PREOBE follow-up	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SERUM N-3; POLYMORPHISMS; PREGNANCY; RISK; PUFA; PHOSPHOLIPIDS; HOMEOSTASIS; INFANTS; CLUSTER	Single nucleotide polymorphisms (SNPs) in the genes encoding the fatty acid desaturase (FADS) and elongase (ELOVL) enzymes affect long-chain polyunsaturated fatty acid (LC-PUFA) production. We aimed to determine if these SNPs are associated with body mass index (BMI) or affect fatty acids (FAs) in pregnant women. Participants (n = 180) from the PREOBE cohort were grouped according to pre-pregnancy BMI: normal-weight (BMI = 18.5-24.9, n = 88) and overweight/obese (BMI >= 25, n = 92). Plasma samples were analyzed at 24 weeks of gestation to measure FA levels in the phospholipid fraction. Selected SNPs were genotyped (7 in FADS1, 5 in FADS2, 3 in ELOVL2 and 2 in ELOVL5). Minor allele carriers of rs174545, rs174546, rs174548 and rs174553 (FADS1), and rs1535 and rs174583 (FADS2) were nominally associated with an increased risk of having a BMI >= 25. Only for the normal-weight group, minor allele carriers of rs174537, rs174545, rs174546, and rs174553 (FADS1) were negatively associated with AA: DGLA index. Normal-weight women who were minor allele carriers of FADS SNPs had lower levels of AA, AA: DGLA and AA: LA indexes, and higher levels of DGLA, compared to major homozygotes. Among minor allele carriers of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher DHA: EPA index than the normal-weight group; however, they did not present higher DHA concentrations than the normal-weight women. In conclusion, minor allele carriers of FADS SNPs have an increased risk of obesity. Maternal weight changes the effect of genotype on FA levels. Only in the normal-weight group, minor allele carriers of FADS SNPs displayed reduced enzymatic activity and FA levels. This suggests that women with a BMI >= 25 are less affected by FADS genetic variants in this regard. In the presence of FADS2 and ELOVL2 SNPs, overweight/obese women showed higher n-3 LC-PUFA production indexes than women with normal weight, but this was not enough to obtain a higher n-3 LC-PUFA concentration.	[de la Garza Puentes, Andrea; de Almeida, Leonor; Bonilla Aguirre, Maria; Castellote Bargallo, Ana Isabel; Carmen Lopez-Sabater, M.] Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Barcelona, Spain; [Montes Goyanes, Rosa] Univ Santiago de Compostela, Food Res & Anal Inst, Santiago De Compostela, Spain; [Montes Goyanes, Rosa; Castellote Bargallo, Ana Isabel; Carmen Lopez-Sabater, M.] Inst Hlth Carlos III, CIBER Physiopathol Obes & Nutr CIBERobn, Madrid, Spain; [Chisaguano Tonato, Aida Maribel] Univ San Francisco Quito, Fac Hlth Sci, Publ Hlth Sch, Nutr, Quito, Ecuador; [Jose Torres-Espinola, Francisco; Arias Garcia, Miriam; Segura Moreno, Maite; Garcia-Valdes, Luz; Campoy, Cristina] Univ Granada, Ctr Excellence Paediat Res EURISTIKOS, Granada, Spain; [Jose Torres-Espinola, Francisco; Arias Garcia, Miriam; Segura Moreno, Maite; Garcia-Valdes, Luz; Campoy, Cristina] Univ Granada, Dept Paediat, Granada, Spain; [Guerendiain, Marcela] Univ Chimborazo, Sch Med, Riobamba, Ecuador; [Campoy, Cristina] Inst Hlth Carlos III, CIBER Epidemiol & Publ Hlth CIBEResp, Madrid, Spain	University of Barcelona; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lopez-Sabater, MC (corresponding author), Univ Barcelona, Fac Pharm & Food Sci, Dept Nutr Food Sci & Gastron, Barcelona, Spain.; Lopez-Sabater, MC (corresponding author), Inst Hlth Carlos III, CIBER Physiopathol Obes & Nutr CIBERobn, Madrid, Spain.	mclopez@ub.edu	Campoy, Cristina/F-4946-2017; Montes, Rosa/AAW-2021-2020	Campoy, Cristina/0000-0002-9860-6785; Montes, Rosa/0000-0002-4154-3541; de la Garza Puentes, Andrea/0000-0002-5471-9585; Guerendiain, Marcela/0000-0001-8990-7976; Segura, Maria Teresa/0000-0003-4269-7662	Spanish Ministry of Economy and Competitiveness [BFU2012-40254-C03-02]; CIBER-Obn; Mexican government; National Council on Science and Technology (CONACYT)	Spanish Ministry of Economy and Competitiveness(Spanish Government); CIBER-Obn; Mexican government; National Council on Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Authors thank the Spanish Ministry of Economy and Competitiveness (project BFU2012-40254-C03-02) and the CIBER-Obn for the financial support for this study. ADLGP thanks the Mexican government and National Council on Science and Technology (CONACYT) for her PhD grant. The funders had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Al-Hilal M, 2013, J LIPID RES, V54, P542, DOI 10.1194/jlr.P032276; Barman M, 2015, NUTRIENTS, V7, P10100, DOI 10.3390/nu7125521; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Harslof LBS, 2013, AM J CLIN NUTR, V97, P1403, DOI 10.3945/ajcn.113.058685; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Huang T, 2014, NUTRITION, V30, P897, DOI 10.1016/j.nut.2014.01.006; Inoue K, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-25; Itariu BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054634; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kelsey MM, 2014, GERONTOLOGY, V60, P222, DOI 10.1159/000356023; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Lattka E, 2013, BRIT J NUTR, V109, P1196, DOI 10.1017/S0007114512003108; Lattka E, 2012, ANN NUTR METAB, V60, P8, DOI 10.1159/000337308; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Li S, 2013, ADV DIFFER EQU, V2013, P1, DOI DOI 10.1371/J0URNAL; Liu FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121255; Lv XF, 2012, CIRC J, V76, P1987, DOI 10.1253/circj.CJ-12-0156; Chisaguano AM, 2013, ANAL METHODS-UK, V5, P1264, DOI 10.1039/c2ay26236c; Markhus MW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136409; Martino J, 2016, J CLIN ENDOCR METAB, V101, P58, DOI 10.1210/jc.2015-2590; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017181; Nagahara Y, 2015, J AM COLL CARDIOL, V65, pA1255, DOI 10.1016/S0735-1097(15)61255-4; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Nishizaki Y, 2014, AM J CARDIOL, V113, P441, DOI 10.1016/j.amjcard.2013.10.011; Nozue T, 2013, AM J CARDIOL, V111, P6, DOI 10.1016/j.amjcard.2012.08.038; Pauter AM, 2014, J LIPID RES, V55, P718, DOI 10.1194/jlr.M046151; Sibbons CM, 2014, PROSTAG LEUKOTR ESS, V90, P47, DOI 10.1016/j.plefa.2013.12.006; Steer CD, 2013, AM J CLIN NUTR, V98, P1575, DOI 10.3945/ajcn.112.051524; Steer CD, 2012, HUM MOL GENET, V21, P1504, DOI 10.1093/hmg/ddr588; Tarantal AF, 2014, NUTRIENTS, V6, P1725, DOI 10.3390/nu6041725; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yeates AJ, 2015, PROSTAG LEUKOTR ESS, V102, P13, DOI 10.1016/j.plefa.2015.08.004	35	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179135	10.1371/journal.pone.0179135	http://dx.doi.org/10.1371/journal.pone.0179135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598979	gold, Green Published, Green Submitted			2022-12-26	WOS:000402992000027
J	Trombetta, AC; Smith, V; Gotelli, E; Ghio, M; Paolino, S; Pizzorni, C; Vanhaecke, A; Ruaro, B; Sulli, A; Cutolo, M				Trombetta, Amelia Chiara; Smith, Vanessa; Gotelli, Emanuele; Ghio, Massimo; Paolino, Sabrina; Pizzorni, Carmen; Vanhaecke, Amber; Ruaro, Barbara; Sulli, Alberto; Cutolo, Maurizio			Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SERUM 25-HYDROXYVITAMIN D; CROHNS-DISEASE; MICROVASCULAR CHANGES; CLASSIFICATION; INSUFFICIENCY; CRITERIA; ADULTS	Objective Assessment of serum 25-hydroxyvitamin D (25(OH) D) correlations with clinical parameters and evaluation of the efficacy of standard oral supplementation in systemic sclerosis (SSc) patients. Methods 154 SSc patients were recruited, in all seasons. Serum 25(OH) D concentrations were evaluated using LIAISON 25-OH (Diasorin, Italy). Medsger disease severity scale (DSS), nailfold videocapillaroscopy (NVC) and all instrumental exam contemplated by international guidelines were performed. Drug assumption, including oral colecalciferol, was evaluated. Nonparametric tests were used for statistical analysis. Results Average 25(OH) D serum concentration was 18.7 +/- 9 ng/ml (<20 classified as deficiency). A significant correlation was found with presence/absence of lung bi-basal fibrotic changes (16.1 +/- 8 ng/ml and 20 +/- 10 ng/ml, respectively; p = 0.04). Peripheral vascular (p = 0.03), kidney (p = 0.02), gastrointestinal (p = 0.05) Medsger's DSS parameters were found to correlate with 25(OH) D serum concentrations. No significant correlations were observed with digital ulcers incidence, strictly correlated to patterns of microangiopathy, defined at NVC analysis (p<0.0001). Interestingly, no effects of treatment with oral colecalciferol (Dibase 1,000 IU daily for at least 6 months) were found on 25(OH) D serum concentrations in treated (18.8 +/- 10 ng/ml) or untreated (18.7 +/- 9 ng/ml) SSc patients (p = 0.81). A significant difference was observed among seasonal 25(OH) D serum concentrations (winter: 14.6 +/- 7.8 ng/ml, spring: 17.2 +/- 7.9 ng/ml, summer: 21.43 +/- 10 ng/ml, autumn: 20.2 +/- 10 ng/ml; p = 0.032) in all patients. Conclusion Serum 25(OH) D deficiency was found to correlate with lung involvement, peripheral vascular, kidney and gastrointestinal Medsger's DSS parameters and with seasonality In SSc patients. Supplementation with oral colecalciferol was found not effective in increasing 25 (OH) D serum concentrations. Therefore, for successful replacement, supra-physiological vitamin D3 doses or programmed UVB light exposure should be tested.	[Trombetta, Amelia Chiara; Gotelli, Emanuele; Ghio, Massimo; Paolino, Sabrina; Pizzorni, Carmen; Ruaro, Barbara; Sulli, Alberto; Cutolo, Maurizio] Univ Genoa, Res Lab, Genoa, Italy; [Smith, Vanessa; Vanhaecke, Amber] Univ Ghent, Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium	University of Genoa; Ghent University; Ghent University Hospital	Cutolo, M (corresponding author), Univ Genoa, Res Lab, Genoa, Italy.	Mcutolo@Unige.It	Trombetta, Amelia Chiara/AAL-1841-2021; Sulli, Alberto/AAD-1257-2022; Ruaro, Barbara/AAA-4408-2019	Ruaro, Barbara/0000-0001-8990-859X; Vanhaecke, Amber/0000-0002-1989-7060				Abreu MT, 2004, GUT, V53, P1129, DOI 10.1136/gut.2003.036657; Arnson Y, 2011, AUTOIMMUN REV, V10, P490, DOI 10.1016/j.autrev.2011.02.002; Belloli L, 2011, CLIN RHEUMATOL, V30, P145, DOI 10.1007/s10067-010-1564-6; BJELAKOVIC G, 2014, COCHRANE DB SYST REV, P7469, DOI [10.1002/14651858.cd007470.pub3, DOI 10.1002/14651858.CD007470.PUB3]; Bogh MKB, 2012, BRIT J DERMATOL, V167, P625, DOI 10.1111/j.1365-2133.2012.11069.x; Carmel NN, 2015, ISR MED ASSOC J, V17, P80; CLEMENS TL, 1982, LANCET, V1, P74; Cutolo M, 2000, J RHEUMATOL, V27, P155; Cutolo M, 2007, AUTOIMMUN REV, V7, P59, DOI 10.1016/j.autrev.2007.07.001; Cutolo M, 2011, VITAM HORM, V86, P327, DOI 10.1016/B978-0-12-386960-9.00014-9; Cutolo M, 2010, NAT REV RHEUMATOL, V6, P578, DOI 10.1038/nrrheum.2010.104; Cutolo M, 2008, BEST PRACT RES CL RH, V22, P1093, DOI 10.1016/j.berh.2008.09.001; Fu YTN, 2012, DIGEST DIS SCI, V57, P2144, DOI 10.1007/s10620-012-2130-7; Gambichler T, 2011, J RHEUMATOL, V38, P2492, DOI 10.3899/jrheum.110695; Garg M, 2013, INFLAMM BOWEL DIS, V19, P2634, DOI 10.1097/01.MIB.0000436957.77533.b2; Gosfield E, 2000, AM J PHYS MED REHAB, V79, P283, DOI 10.1097/00002060-200005000-00011; Groseanu L, 2016, EUR J RHEUMATOL, V3, P50, DOI 10.5152/eurjrheum.2015.0065; HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492; Hall WB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/218691; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Hollis BW, 2005, NEW ENGL J MED, V352, P515; Koutkia P, 2001, GASTROENTEROLOGY, V121, P1485, DOI 10.1053/gast.2001.29686; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Linker-Israeli M, 2001, CLIN IMMUNOL, V99, P82, DOI 10.1006/clim.2000.4998; Livshits G, 1999, ANN HUM GENET, V63, P429, DOI 10.1046/j.1469-1809.1999.6350429.x; Logan VF, 2013, BRIT J NUTR, V109, P1082, DOI 10.1017/S0007114512002851; Margulies SL, 2015, J DIGEST DIS, V16, P617, DOI 10.1111/1751-2980.12283; Marie I, 2015, AUTOIMMUN REV, V14, P547, DOI 10.1016/j.autrev.2015.01.018; McCarthy D, 2005, ALIMENT PHARM THER, V21, P1073, DOI 10.1111/j.1365-2036.2005.02446.x; Medsger TA, 1999, J RHEUMATOL, V26, P2159; Monticielo OA, 2012, LUPUS, V21, P43, DOI 10.1177/0961203311421798; Nishikawa J, 2013, CLIN GASTROENTEROL H, V11, pA21, DOI 10.1016/j.cgh.2012.08.036; Pappa HM, 2012, J CLIN ENDOCR METAB, V97, P2134, DOI 10.1210/jc.2011-3182; Pope JE, 1996, J RHEUMATOL, V23, P1912; Ritterhouse LL, 2011, ANN RHEUM DIS, V70, P1569, DOI 10.1136/ard.2010.148494; Robberecht E, 2011, EUR J CLIN NUTR, V65, P574, DOI 10.1038/ejcn.2010.280; Sampaio-Barros MM, 2016, REV BRAS REUMATOL, V56, P337, DOI [10.1016/j.rbre.2016.05.006, 10.1016/j.rbr.2016.03.004]; Seriolo B, 2011, CLIN RHEUMATOL, V30, P445, DOI 10.1007/s10067-011-1684-7; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Suibhne TN, 2012, J CROHNS COLITIS, V6, P182, DOI 10.1016/j.crohns.2011.08.002; Sulli A, 2008, ANN RHEUM DIS, V67, P885, DOI 10.1136/ard.2007.079756; Tangpricha V, 2012, J CLIN ENDOCR METAB, V97, P1082, DOI 10.1210/jc.2011-3050; Tavakkoli A, 2013, J CLIN GASTROENTEROL, V47, P515, DOI 10.1097/MCG.0b013e318266f81b; Vacca A, 2009, J RHEUMATOL, V36, P1924, DOI 10.3899/jrheum.081287; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Villaggio B, 2012, CLIN EXP RHEUMATOL, V30, P934; Wolfenden LL, 2008, CLIN ENDOCRINOL, V69, P374, DOI 10.1111/j.1365-2265.2008.03216.x	50	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179062	10.1371/journal.pone.0179062	http://dx.doi.org/10.1371/journal.pone.0179062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598975	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000020
J	Vu, LT; Long, NT; Brito, B; Stenfeldt, C; Phuong, NT; Hoang, BH; Pauszek, SJ; Hartwig, EJ; Smoliga, GR; Vu, PP; Quang, LTV; Hung, VV; Tho, ND; Dong, PV; Minh, PQ; Bertram, M; Fish, IH; Rodriguez, LL; Dung, DH; Arzt, J				Vu, Le T.; Long, Ngo T.; Brito, Barbara; Stenfeldt, Carolina; Phuong, Nguyen T.; Hoang, Bui H.; Pauszek, Steven J.; Hartwig, Ethan J.; Smoliga, George R.; Vu, Pham P.; Quang, Le T. V.; Hung, Vo V.; Tho, Nguyen D.; Dong, Pham V.; Minh, Phan Q.; Bertram, Miranda; Fish, Ian H.; Rodriguez, Luis L.; Dung, Do H.; Arzt, Jonathan			First detection of foot-and-mouth disease virus O/Ind-2001d in Vietnam	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SEROTYPE-O; PANDEMIC STRAIN; VIRAL PATHWAYS; PATHOGENESIS; DIAGNOSIS; WORLDWIDE; PATTERNS; AFRICA; SWINE	In recent years, foot-and-mouth disease virus (FMDV) serotype O, topotype Middle East-South Asia (ME-SA), lineage Ind-2001d has spread from the Indian subcontinent to the Middle East, North Africa, and Southeast Asia. In the current report, we describe the first detection of this lineage in Vietnam in May, 2015 in Dak Nong province. Three subsequent outbreaks caused by genetically related viruses occurred between May-October, 2015 after which the virus was not detected in clinical outbreaks for at least 15 subsequent months. The observed outbreaks affected (in chronological order): cattle in Dak Nong province, pigs in Dak Lak province and Dak Nong province, and cattle in Ninh Thuan province. The clinical syndromes associated with these outbreaks were consistent with typical FMD in the affected species. Overall attack rate on affected premises was 0.85 in pigs and 0.93 in cattle over the course of the outbreak. Amongst 378 pigs at risk on affected premises, 85 pigs died during the outbreaks; there were no deaths among cattle. The manner in which FMDV/O/ME-SA/Ind-2001d was introduced into Vietnam remains undetermined; however, movement of live cattle is the suspected route. This incursion has substantial implications for epidemiology and control of FMD in Southeast Asia.	[Vu, Le T.; Long, Ngo T.; Phuong, Nguyen T.; Hoang, Bui H.; Vu, Pham P.; Quang, Le T. V.; Hung, Vo V.] Minist Agr & Rural Dev, Reg Anim Hlth Off 6, Dept Anim Hlth, Ho Chi Minh City, Vietnam; [Brito, Barbara; Stenfeldt, Carolina; Pauszek, Steven J.; Hartwig, Ethan J.; Smoliga, George R.; Bertram, Miranda; Fish, Ian H.; Rodriguez, Luis L.; Arzt, Jonathan] USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient Point, NY USA; [Brito, Barbara; Stenfeldt, Carolina; Bertram, Miranda; Fish, Ian H.] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA; [Tho, Nguyen D.; Dong, Pham V.; Minh, Phan Q.; Dung, Do H.] Minist Agr & Rural Dev, Dept Anim Hlth, Hanoi, Vietnam	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Arzt, J (corresponding author), USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Orient Point, NY USA.; Dung, DH (corresponding author), Minist Agr & Rural Dev, Dept Anim Hlth, Hanoi, Vietnam.	dung.dah@gmail.com; Jonathan.Arzt@ars.usda.gov	Bertram, Miranda/X-7466-2019; Stenfeldt, Carolina/AAG-7940-2021	Bertram, Miranda/0000-0003-3321-960X; Arzt, Jonathan/0000-0002-7517-7893; Brito, Nayara/0000-0002-2711-6519; Stenfeldt, Carolina/0000-0002-2074-3886	Science and Technology Directorate of the U.S. Department of Agriculture, Agricultural Research Service CRIS [1940-32000-061-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-12-X-0060]; U.S. Department of State, Biosecurity Engagement Program through USDA; U.S. Department of State, Biosecurity Engagement Program through ARS Office of International Research; U.S. Department of Defense, Defense Threat Reduction Agency; Plum Island Animal Disease Center Research Participation Program fellowship	Science and Technology Directorate of the U.S. Department of Agriculture, Agricultural Research Service CRIS; Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of State, Biosecurity Engagement Program through USDA; U.S. Department of State, Biosecurity Engagement Program through ARS Office of International Research; U.S. Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Plum Island Animal Disease Center Research Participation Program fellowship	This research was funded in part by U.S. Department of Agriculture, Agricultural Research Service CRIS Project 1940-32000-061-00D and through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-12-X-0060. Additional funding was provided by the U.S. Department of State, Biosecurity Engagement Program through the USDA, ARS Office of International Research Programs and the Cooperative Biological Engagement Program of the U.S. Department of Defense, Defense Threat Reduction Agency. Barbara Brito, Carolina Stenfeldt, Ian Fish, and Miranda Bertram are the recipients of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the USDOE and USDA. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Brito BP, 2015, TRANSBOUND EMERG DIS; Cocks P, 2009, FAO ADB OIE SEAFMD S; de Carvalho Ferreira HC, 2015, TRANSBOUND EMERG DIS; Di Nardo A, 2011, REV SCI TECH OIE, V30, P63; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; FERRIS NP, 1988, VET MICROBIOL, V16, P201, DOI 10.1016/0378-1135(88)90024-7; Hemadri D, 2002, VIRUS GENES, V25, P23, DOI 10.1023/A:1020165923805; Jamal SM, 2011, INFECT GENET EVOL, V11, P1229, DOI 10.1016/j.meegid.2011.03.006; Kitching RP, 2002, REV SCI TECH OIE, V21, P505, DOI 10.20506/rst.21.3.1342; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Knowles NJ, 2005, EMERG INFECT DIS, V11, P1887; Knowles NJ, 2014, TRANSBOUND EMERG DIS; Mahapatra M, 2015, VACCINE, V33, P693, DOI 10.1016/j.vaccine.2014.11.058; Molecular Epidemiology/Genotyping Reports, 2016, MOL EP GEN REP; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Rambault A., 2006, FIG TREE TREE FIGURE; Rambaut A, 2007, TRACER VERSION 1 4 C; Ranjan R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167163; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P57, DOI 10.1111/j.1865-1682.2007.01013.x; Rweyemamu M, 2008, TRANSBOUND EMERG DIS, V55, P73, DOI 10.1111/j.1865-1682.2007.01016.x; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Subramaniam S, 2015, VET MICROBIOL, V178, P181, DOI 10.1016/j.vetmic.2015.05.015; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; Le VP, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0896-0; World Organisation for Animal Health, 2009, FOOT MOUTH DIS TECHN; WRLFMD, ANN OIE FAO WORLD RE; WRLFMD, 2016, Q REPORT; WRLFMD, 2015, Q OIE FAO FMD REF LA; WRLFMD, 2016, MOL EP GEN REP; WRLFMD, REF LAB REP 2015; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	34	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0177361	10.1371/journal.pone.0177361	http://dx.doi.org/10.1371/journal.pone.0177361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599321	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000003
J	Ivanov, AA; Gonzalez-Pecchi, V; Khuri, LF; Niu, Q; Wang, Y; Xu, Y; Bai, Y; Mo, X; Prochownik, EV; Johns, MA; Du, Y; Khuri, FR; Fu, H				Ivanov, A. A.; Gonzalez-Pecchi, V.; Khuri, L. F.; Niu, Q.; Wang, Y.; Xu, Y.; Bai, Y.; Mo, X.; Prochownik, E. V.; Johns, M. A.; Du, Y.; Khuri, F. R.; Fu, H.			OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc	ONCOGENE			English	Article							GENE-EXPRESSION; TUMOR-CELLS; CANCER; MAX; PHOSPHORYLATION; TRANSFORMATION; INTERACTORS; PATHWAYS; NETWORK; COMPLEX	Mitogen-activated protein kinase kinase 3 (MKK3) is a dual threonine/ tyrosine protein kinase that regulates inflammation, proliferation and apoptosis through specific phosphorylation and activation of the p38 mitogen-activated protein kinase. However, the role of MKK3 beyond p38-signaling remains elusive. Recently, we reported a protein-protein interaction (PPI) network of cancer-associated genes, termed OncoPPi, as a resource for the scientific community to generate new biological models. Analysis of the OncoPPi connectivity identified MKK3 as one of the major hub proteins in the network. Here, we show that MKK3 interacts with a large number of proteins critical for cell growth and metabolism, including the major oncogenic driver MYC. Multiple complementary approaches were used to demonstrate the direct interaction of MKK3 with MYC in vitro and in vivo. Computational modeling and experimental studies mapped the interaction interface to the MYC helix-loop-helix domain and a novel 15-residue MYC-binding motif in MKK3 (MBM). The MBM in MKK3 is distinct from the known binding sites for p38 or upstream kinases. Functionally, MKK3 stabilized MYC protein, enhanced its transcriptional activity and increased expression of MYC-regulated genes. The defined MBM peptide mimicked the MKK3 effect in promoting MYC activity. Together, the exploration of OncoPPi led to a new biological model in which MKK3 operates by two distinct mechanisms in cellular regulation through its phosphorylation of p38 and its activation of MYC through PPI.	[Ivanov, A. A.; Gonzalez-Pecchi, V.; Khuri, L. F.; Niu, Q.; Wang, Y.; Xu, Y.; Bai, Y.; Mo, X.; Johns, M. A.; Du, Y.; Khuri, F. R.; Fu, H.] Emory Univ, Dept Pharmacol, Atlanta, GA USA; [Ivanov, A. A.; Gonzalez-Pecchi, V.; Khuri, L. F.; Niu, Q.; Wang, Y.; Xu, Y.; Bai, Y.; Mo, X.; Johns, M. A.; Du, Y.; Khuri, F. R.; Fu, H.] Emory Univ, Emory Chem Biol Discovery Ctr, Atlanta, GA USA; [Prochownik, E. V.] UPMC, Childrens Hosp Pittsburgh, Sect Hematol Oncol, Pittsburgh, PA USA; [Prochownik, E. V.] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Du, Y.; Khuri, F. R.; Fu, H.] Emory Univ, Winship Canc Inst, Atlanta, GA USA	Emory University; Emory University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Ivanov, AA; Fu, H (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	andrey.ivanov@emory.edu; hfu@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Gonzalez, Valentina/0000-0002-9163-4118; Ivanov, Andrei A/0000-0001-7476-1329	NIH [U01CA168449]; Winship Cancer Institute [NIH 5P30CA138292]; Emory University Research Committee award; NATIONAL CANCER INSTITUTE [R01CA174713, U01CA168449, P30CA138292, U54CA199092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winship Cancer Institute; Emory University Research Committee award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Min Qui for technical assistance. We thank Lauren Rusnak for editing the manuscript. This research was supported in part by NIH U01CA168449 (HF) and Winship Cancer Institute (NIH 5P30CA138292) and by Emory University Research Committee 2015 award (AAI). The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Babur O, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0612-6; Baldari S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.591; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chymkowitch P, 2012, P NATL ACAD SCI USA, V109, P10450, DOI 10.1073/pnas.1200067109; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kragelj J, 2015, P NATL ACAD SCI USA, V112, P3409, DOI 10.1073/pnas.1419528112; Li S, 2015, CELL DEATH DIFFER, V22, P1000, DOI 10.1038/cdd.2014.188; Li ZG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14356; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Parajuli P, 2015, CELL PROLIFERAT, V48, P421, DOI 10.1111/cpr.12196; Ponzielli R, 2013, METHODS MOL BIOL, V1012, P51, DOI 10.1007/978-1-62703-429-6_4; Ruzinova MB, 2010, AM J SURG PATHOL, V34, P882, DOI 10.1097/PAS.0b013e3181db83af; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Sultana A, 2015, CURR PROTOC PROTEIN, V79, DOI DOI 10.1002/0471140864.ps1925s79; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tu WB, 2015, BBA-GENE REGUL MECH, V1849, P469, DOI 10.1016/j.bbagrm.2014.06.002; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	36	16	16	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5852	5860		10.1038/onc.2017.180	http://dx.doi.org/10.1038/onc.2017.180			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28628118	Green Accepted			2022-12-26	WOS:000413292900007
J	Angessa, TT; Zhang, XQ; Zhou, GF; Broughton, S; Zhang, WY; Li, CD				Angessa, Tefera Tolera; Zhang, Xiao-Qi; Zhou, Gaofeng; Broughton, Sue; Zhang, Wenying; Li, Chengdao			Early growth stages salinity stress tolerance in CM72 x Gairdner doubled haploid barley population	PLOS ONE			English	Article							HORDEUM-VULGARE L.; QUANTITATIVE TRAIT LOCI; SALT TOLERANCE; GERMINATION STAGE; CULTIVARS; SODIUM; GENES; WHEAT; QTLS	A doubled haploid (DH) population of barley (Hordeum vulgare L.) generated from salinity tolerant genotype CM72 and salinity sensitive variety Gairdner was studied for salinity stress tolerance at germination, seedling emergence and first leaf full expansion growth stages. Germination study was conducted with deionized water, 150 mM and 300 mM NaCl treatments. Seedling stage salinity tolerance was conducted with three treatments: control, 150 mM NaCl added at seedling emergence and first leaf full expansion growth stages. Results from this study revealed transgressive phenotypic segregations for germination percentage and biomass at seedling stage. Twelve QTL were identified on chromosomes 2H-6H each explaining 10-25% of the phenotypic variations. A QTL located at 176.5 cM on chromosome 3H was linked with fresh weight per plant and dry weight per plant in salinity stress induced at first leaf full expansion growth stage, and dry weight per plant in salinity stress induced at seedling emergence. A stable QTL for germination at both 150 and 300 mM salinity stress was mapped on chromosome 2H but distantly located from a QTL linked with seedling stage salinity stress tolerance. QTL, associated markers and genotypes identified in this study play important roles in developing salinity stress tolerant barley varieties.	[Angessa, Tefera Tolera; Zhang, Xiao-Qi; Zhou, Gaofeng; Li, Chengdao] Murdoch Univ, Sch Vet & Life Sci VLS, Western Barley Genet Alliance, Murdoch, WA, Australia; [Broughton, Sue; Li, Chengdao] Dept Agr & Food WA, Grains Ind, S Perth, WA, Australia; [Zhang, Wenying] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Coll Agr, Jingzhou, Hubei, Peoples R China	Murdoch University; Government of Western Australia; Department of Agriculture & Food - Western Australia; Yangtze University	Li, CD (corresponding author), Murdoch Univ, Sch Vet & Life Sci VLS, Western Barley Genet Alliance, Murdoch, WA, Australia.; Li, CD (corresponding author), Dept Agr & Food WA, Grains Ind, S Perth, WA, Australia.; Zhang, WY (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Coll Agr, Jingzhou, Hubei, Peoples R China.	wyzhang2006@gmail.com; C.Li@Murdoch.edu.au	Angessa, Tefera/GLU-7090-2022; Zhang, Wenying/P-2509-2018	Zhang, Wenying/0000-0002-9926-4115; Angessa, Tefera Tolera/0000-0002-2400-1732	Australian Grains Research and Development Corporation (GRDC) [UMU00046]	Australian Grains Research and Development Corporation (GRDC)(Grains R&D Corp)	We thank the Australian Grains Research and Development Corporation (GRDC) for funding the project UMU00046 within which this paper is published. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Australian Grains Research and Development Corporation (GRDC) for funding the project UMU00046 within which this paper is published.	Ahmed IM, 2013, PLANT PHYSIOL BIOCH, V63, P49, DOI 10.1016/j.plaphy.2012.11.004; Boyd WJR, 2003, AUST J AGR RES, V54, P1277, DOI 10.1071/AR03014; Campoli C, 2014, ADV BOT RES, V72, P131, DOI 10.1016/B978-0-12-417162-6.00005-5; Colmer TD, 2005, AUST J EXP AGR, V45, P1425, DOI 10.1071/EA04162; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Flowers TJ, 2001, PLANT SOIL, V231, P1, DOI 10.1023/A:1010372213938; Fricke W, 2006, J EXP BOT, V57, P1079, DOI 10.1093/jxb/erj095; Gong X, 2014, EUPHYTICA, V197, P355, DOI 10.1007/s10681-014-1072-x; GORHAM J, 1994, J EXP BOT, V45, P895, DOI 10.1093/jxb/45.7.895; IBM Corp, 2013, IBM SPSS STAT WINDOW; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Liu XH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3380-0; Mano Y, 1997, BREEDING SCI, V47, P353; Mano Y, 1997, EUPHYTICA, V94, P263, DOI 10.1023/A:1002968207362; Mano Y, 1996, BREEDING SCI, V46, P227; MARTINEZCOB A, 1987, PLANT SOIL, V104, P53, DOI 10.1007/BF02370624; MUNNS R, 1995, AUST J PLANT PHYSIOL, V22, P561, DOI 10.1071/PP9950561; Ooijen V., 2004, MAPQTL5 0 SOFTWARE M; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Sbei H, 2014, BREEDING SCI, V64, P378, DOI 10.1270/jsbbs.64.378; Shavrukov Y, 2010, FUNCT INTEGR GENOMIC, V10, P277, DOI 10.1007/s10142-009-0153-8; TAL M, 1994, IN VITRO CELL DEV-PL, V30P, P175; Utz HF, 1997, PLABSTAT A COMPUTER; Xu RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043079; Xu YH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0964-4; Xue DW, 2009, EUPHYTICA, V169, P187, DOI 10.1007/s10681-009-9919-2; Zhang HX, 2010, ANN BOT-LONDON, V106, P1027, DOI 10.1093/aob/mcq204; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9	29	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179715	10.1371/journal.pone.0179715	http://dx.doi.org/10.1371/journal.pone.0179715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640858	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800055
J	Arora, V; Ghosh, MK; Pal, S; Gangopadhyay, G				Arora, Vivek; Ghosh, M. K.; Pal, Soumili; Gangopadhyay, Gaurab			Allele specific CAPS marker development and characterization of chalcone synthase gene in Indian mulberry (Morus spp., family Moraceae)	PLOS ONE			English	Article							BIOSYNTHETIC GENES; EXPRESSION; ACCUMULATION; FLAVONOIDS; ACID	Chalcone synthase (CHS) is an essential enzyme in the phenylpropanoid pathway that catalyzes the first step in flavonoid biosynthesis in plants under diverse environmental stress. We have used CHS as a candidate gene in mulberry and developed Single Nucleotide Polymorphism (SNP) based co-dominant Cleaved Amplified Polymorphic Sequence (CAPS) marker associated with the CHS locus. The segregation pattern of the marker was studied in an F-1 population derived from a hybridization program between two mulberry genotypes showing polymorphism for the CHS locus. Differential CHS activity of the recombinants has been correlated with the segregation pattern of the marker. Homology modelling and docking studies are performed for both the identified CHS alleles and correlated with respective CHS activity. Phenotyping of Powdery Mildew infected F-1 population indicated a probable association with the CAPS marker.	[Arora, Vivek; Pal, Soumili; Gangopadhyay, Gaurab] Bose Inst, Div Plant Biol, Main Campus, Kolkata, India; [Ghosh, M. K.] Cent Sericultural Res & Training Inst, Berhampur, India	Department of Science & Technology (India); Bose Institute	Gangopadhyay, G (corresponding author), Bose Inst, Div Plant Biol, Main Campus, Kolkata, India.	gaurab@jcbose.ac.in		arora, vivek/0000-0001-6202-0689	Bose Institute, Department of Science and Technology, Government of India; University Grants Commission of India for research fellowship	Bose Institute, Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission of India for research fellowship	GG is funded by Bose Institute, Department of Science and Technology, Government of India. VA is funded by University Grants Commission of India for research fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora V., 2014, International Research Journal of Biological Sciences, V3, P40; Arora V., 2014, INT J GENET ENG BIOT, V52, P191; Bargsten JW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0330-3; Bhan N, 2015, PROTEIN SCI, V24, P167, DOI 10.1002/pro.2600; Cardoso DC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-66; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Das M, 2011, TRANSGENIC RES, V20, P231, DOI 10.1007/s11248-010-9405-6; Deng N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00174; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; MOUSTAFA E, 1967, PHYTOCHEMISTRY, V6, P625, DOI 10.1016/S0031-9422(00)86001-X; Obinata N., 2003, Plant Biotechnology, V20, P105, DOI 10.5511/plantbiotechnology.20.105; Pasold S, 2010, MOL PLANT PATHOL, V11, P545, DOI [10.1111/J.1364-3703.2010.00628.X, 10.1111/j.1364-3703.2010.00628.x]; Qi XW, 2014, MOL GENET GENOMICS, V289, P783, DOI 10.1007/s00438-014-0851-3; Rao A.A., 2002, EXPERT CONSULTATION, P21; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Vijayan K., 2007, INT J IND ENTOMOL, V15, P1; Wang CH, 2016, PLOS ONE, P1; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Xin Mingming, 2012, Genomics Proteomics & Bioinformatics, V10, P94, DOI 10.1016/j.gpb.2012.05.002; Zhao S, 2015, J AGR FOOD CHEM, V63, P8622, DOI 10.1021/acs.jafc.5b03221	29	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179189	10.1371/journal.pone.0179189	http://dx.doi.org/10.1371/journal.pone.0179189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640826	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800021
J	Proto, JD; Lu, A; Dorronsoro, A; Scibetta, A; Robbins, PD; Niedernhofer, LJ; Huard, J				Proto, Jonathan D.; Lu, Aiping; Dorronsoro, Akaitz; Scibetta, Alex; Robbins, Paul D.; Niedernhofer, Laura J.; Huard, Johnny			Inhibition of NF-kappa B improves the stress resistance and myogenic differentiation of MDSPCs isolated from naturally aged mice	PLOS ONE			English	Article							MUSCLE STEM-CELLS; SKELETAL-MUSCLE; LIFE-SPAN; REGENERATIVE CAPACITY; HEMATOPOIETIC STEM; PROGENITOR CELLS; CANCER-THERAPY; CYCLIN D1; SENESCENCE; ACTIVATION	A decline in the regenerative capacity of adult stem cells with aging is well documented. As a result of this decline, the efficacy of autologous stem cell therapies is likely to decline with increasing donor age. In these cases, strategies to restore the function of aged stem cells would have clinical utility. Globally, the transcription factor NF-kappa B is up-regulated in aged tissues. Given the negative role that NF-kappa B plays in myogenesis, we investigated whether the age-related decline in the function of muscle-derived stem/progenitor cells (MDSPCs) could be improved by inhibition of NF-kappa B. Herein, we demonstrate that pharmacologic or genetic inhibition of NF-kappa B activation increases myogenic differentiation and improves resistance to oxidative stress. Our results suggest that MDSPC "aging" may be reversible, and that pharmacologic targeting of pathways such as NF-kappa B may enhance the efficacy of cell-based therapies.	[Proto, Jonathan D.] Columbia Univ, Div Mol Med, Dept Med, New York, NY USA; [Lu, Aiping; Scibetta, Alex; Huard, Johnny] Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA; [Lu, Aiping; Huard, Johnny] Steadman Philippon Res Inst, Ctr Regenerat Sports Med, Vail, CO 81657 USA; [Dorronsoro, Akaitz; Robbins, Paul D.; Niedernhofer, Laura J.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL USA; [Proto, Jonathan D.] Sanofi Genzyme, Framingham, MA USA	Columbia University; University of Texas System; University of Texas Health Science Center Houston; Steadman Philippon Research Institute; Scripps Research Institute; Sanofi-Aventis; Genzyme Corporation	Huard, J (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Orthopaed Surg, Inst Mol Med, McGovern Med Sch, Houston, TX 77030 USA.; Huard, J (corresponding author), Steadman Philippon Res Inst, Ctr Regenerat Sports Med, Vail, CO 81657 USA.	johnny.huard@uth.tmc.edu	Dorronsoro, Akaitz/O-8905-2017	Dorronsoro, Akaitz/0000-0001-6141-8484; Niedernhofer, Laura/0000-0002-1074-1385; Robbins, Paul/0000-0003-1068-7099	National Institutes of Health [AG043376]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant AG043376 (Project 2 and Core A: PDR, Project 1 and Core B: LJN, Project 3: JH).	Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carlson ME, 2007, AGING CELL, V6, P371, DOI 10.1111/j.1474-9726.2007.00286.x; Castorina A, 2015, NEURAL REGEN RES, V10, P850, DOI 10.4103/1673-5374.158352; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dahlman JM, 2009, J CELL BIOCHEM, V106, P42, DOI 10.1002/jcb.21976; Deasy BM, 2003, STEM CELLS, V21, P536, DOI 10.1634/stemcells.21-5-536; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gosselin K, 2003, EXP GERONTOL, V38, P1271, DOI 10.1016/j.exger.2003.09.007; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hu ZL, 2008, CELL BIOL INT, V32, P761, DOI 10.1016/j.cellbi.2008.03.004; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim D, 2015, STEM CELL TRANSL MED, V4, P1144, DOI 10.5966/sctm.2015-0011; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Lu AP, 2012, MOL THER, V20, P661, DOI 10.1038/mt.2011.261; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Luo Y, 2014, TRANSPLANTATION, V97, P20, DOI 10.1097/TP.0b013e3182a7fcf8; Maier AB, 2007, ANN NY ACAD SCI, V1100, P323, DOI 10.1196/annals.1395.035; Nerlich AG, 2007, ANN NY ACAD SCI, V1096, P239, DOI 10.1196/annals.1397.090; Oh J, 2016, AGING-US, V8, P2871, DOI 10.18632/aging.101098; Okada M, 2012, MOL THER, V20, P138, DOI 10.1038/mt.2011.229; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Proto JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.66; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Radhakrishnan SK, 2006, BBA-REV CANCER, V1766, P53, DOI 10.1016/j.bbcan.2006.02.001; Salminen A, 2009, J CLIN IMMUNOL, V29, P397, DOI 10.1007/s10875-009-9296-6; Si YL, 2010, AGEING RES REV; Song MJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt183; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Takayama K, 2016, J ORTHOPAEDIC RES OF; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Warner HR, 2015, AGE, V37, DOI 10.1007/s11357-015-9761-5; Wright VJ, 2002, MOL THER, V6, P169, DOI 10.1006/mthe.2002.0654	46	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179270	10.1371/journal.pone.0179270	http://dx.doi.org/10.1371/journal.pone.0179270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640861	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800026
J	Mohan, P; Sinu, PA				Mohan, Prabitha; Sinu, Palatty Allesh			Parasitoid wasp usurps its host to guard its pupa against hyperparasitoids and induces rapid behavioral changes in the parasitized host	PLOS ONE			English	Article							TOBACCO HORNWORM; MANDUCA-SEXTA; BODYGUARD; INCREASES	Some parasites have an ability to fabricate the behavior of their host and impel the host to guard parasites' offspring, which is popularly called as bodyguard manipulation. Psalis pennatula larva parasitized by a braconid parasitoid wasp Microplitis pennatula exhibits some behavioral changes including the guarding of the parasitoid pupa from its natural enemies. We hypothesized that these behavioral change exhibited by the parasitized host larva are induced by the parasitoid and can be considered as an example of bodyguard manipulation. Even though hyperparasitoids are the more specialized natural enemy of parasitoids than predators, very few studies tested the success of guarding parasitoid pupa against hyperparasitoids. This study analyzed the success of guarding behavior of the parasitized host against hyperparasitoids. The onsets of parasite-induced phenotypic alterations (PIPAs) in the parasitized host were inspected to analyze whether these behavioral changes in the host larva manifests gradually or abruptly. The study concludes that parasitized host larva defends the parasitoid pupa from hyperparasitoids and the PIPAs in the parasitized host develops abruptly only after the egression of parasitoid prepupa.	[Mohan, Prabitha; Sinu, Palatty Allesh] Cent Univ Kerala, Dept Anim Sci, Kasargod, Kerala, India; [Sinu, Palatty Allesh] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA	Central University of Kerala; University of Arizona	Mohan, P (corresponding author), Cent Univ Kerala, Dept Anim Sci, Kasargod, Kerala, India.	prabitha87@gmail.com	Mohan, Prabitha/I-2738-2016; Sinu, Palatty Allesh/ABE-2620-2021	Mohan, Prabitha/0000-0002-3045-7621; Sinu, Palatty Allesh/0000-0001-7391-7133	CSIR New Delhi; Central University of Kerala	CSIR New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Central University of Kerala	The authors received no specific funding for this work, but Prabitha Mohan thanks CSIR New Delhi for a Junior and Senior Research Fellowship and the Central University of Kerala for facilities and support.	Adamo SA, 2005, ARCH INSECT BIOCHEM, V60, P185, DOI 10.1002/arch.20068; Adamo SA, 1997, J EXP BIOL, V200, P117; Ann L, 2013, BIOL CONTROL, V67, P39; [Anonymous], 2014, R LANG ENV STAT COMP; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; BRODEUR J, 1990, J INSECT BEHAV, V3, P751, DOI 10.1007/BF01065963; Dawkins R., 1982, pi; Dheilly NM, 2015, INFECT GENET EVOL, V34, P251, DOI 10.1016/j.meegid.2015.05.027; Dheilly NM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2773; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Harvey JA, 2008, PHYSIOL ENTOMOL, V33, P217, DOI 10.1111/j.1365-3032.2008.00623.x; Harvey JA, 2013, ENTOMOL EXP APPL, V149, P219, DOI 10.1111/eea.12127; Harvey JA, 2011, ANIM BEHAV, V81, P1281, DOI 10.1016/j.anbehav.2011.03.019; Koella JC, 1998, P ROY SOC B-BIOL SCI, V265, P763, DOI 10.1098/rspb.1998.0358; Maure F, 2011, BIOL LETTERS, V7, P843, DOI 10.1098/rsbl.2011.0415; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2010, OIKOS, V119, P1217, DOI 10.1111/j.1600-0706.2009.18077.x	19	8	9	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178108	10.1371/journal.pone.0178108	http://dx.doi.org/10.1371/journal.pone.0178108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636632	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300009
J	Newman, M; Halter, L; Lim, A; Lardelli, M				Newman, Morgan; Halter, Lena; Lim, Anne; Lardelli, Michael			Mitochondrion to endoplasmic reticulum apposition length in zebrafish embryo spinal progenitors is unchanged in response to perturbations associated with Alzheimer's disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; DEFICIENT HIPPOCAMPAL-NEURONS; GAMMA-SECRETASE; PRESENILIN GENE; OXIDASE; MUTATIONS; MEMBRANE; CLEAVAGE; STRESS; MODEL	Mutations in the human genes PRESENILIN1 (PSEN1), PRESENILIN2 (PSEN2) and AMYLOID BETA A4 PRECURSOR PROTEIN (APP) have been identified in familial Alzheimer's disease (AD). The length of mitochondrion-endoplasmic reticulum (M-ER) appositions is increased in Psen1(-/-)/PsenZ(-/-) double knockout murine embryonic fibroblasts and in fibroblasts from AD-affected individuals. Development of an easily accessible, genetically manipulable, in vivo system for studying M-ER appositions would be valuable so we attempted to manipulate M-ER apposition length in zebrafish (Danio rerio) embryos. We injected fertilized zebrafish eggs with antisense morpholino oligonucleotides (MOs) that inhibit expression of zebrafish familial AD gene orthologues psen1 and psen2. Furthermore, we treated zebrafish embryos with DAPT (a highly specific y-secretase inhibitor) or with sodium azide (to mimic partially hypoxic conditions). We then analyzed M-ER apposition in an identified, presumably proliferative neural cell type using electron microscopy. Our analysis showed no significant differences in M-ER apposition lengths at 48 hours post fertilization (hpf) between psen1 & psen2 MO co-injected embryos, embryos treated with DAPT, or sodium azide, and control embryos. Instead, the distribution of M-ER apposition lengths into different length classes was close to identical. However, this indicates that it is feasible to reproducibly measure M-ER size distributions in zebrafish embryos. While our observations differ from those of murine and human studies, this may be due to differences in cellular differentiation and metabolic state, cell age, or species-specific responses. In particular, by focusing on a presumably proliferative embryonic cell type, we may have selected a cell heavily already reliant on anaerobic glycolysis and less responsive to factors affecting M-ER apposition. Future examination of more differentiated, more secretory cell types may reveal measurable responses of M-ER apposition to environmental and genetic manipulation.	[Newman, Morgan; Halter, Lena; Lim, Anne; Lardelli, Michael] Univ Adelaide, Sch Biol Sci, Ctr Mol Pathol, Alzheimers Dis Genet Lab, Adelaide, SA, Australia	University of Adelaide	Newman, M; Lardelli, M (corresponding author), Univ Adelaide, Sch Biol Sci, Ctr Mol Pathol, Alzheimers Dis Genet Lab, Adelaide, SA, Australia.	morgan.newman@adelaide.edu.au; michael.lardelli@adelaide.edu.au	, Morgan/Y-5204-2019	Newman, Morgan/0000-0002-4930-4529	Adelaide Graduate Scholarship from the University of Adelaide; NHMRC [GNT1061006]; School of Biological Sciences of the University of Adelaide	Adelaide Graduate Scholarship from the University of Adelaide; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); School of Biological Sciences of the University of Adelaide	AL was supported by an Adelaide Graduate Scholarship from the University of Adelaide. MN was supported by NHMRC GNT1061006. Funding was provided by postgraduate student support funds from the School of Biological Sciences of the University of Adelaide.	Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Bernales S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00005; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cottrell DA, 2001, NEUROLOGY, V57, P260, DOI 10.1212/WNL.57.2.260; Cottrell DA, 2002, NEUROPATH APPL NEURO, V28, P390, DOI 10.1046/j.1365-2990.2002.00414.x; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Filadi R, 2016, CELL REP, V15, P2226, DOI 10.1016/j.celrep.2016.05.013; Gao J, 2007, NEUROCHEM INT, V50, P379, DOI 10.1016/j.neuint.2006.09.007; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Giorgi C, 2015, ANTIOXID REDOX SIGN, V22, P995, DOI 10.1089/ars.2014.6223; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Groth C, 2002, DEV GENES EVOL, V212, P486, DOI 10.1007/s00427-002-0269-5; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4; Kelleher RJ, 2017, P NATL ACAD SCI USA, V114, P629, DOI 10.1073/pnas.1619574114; Kimura N, 2001, BRAIN RES, V922, P30, DOI 10.1016/S0006-8993(01)03146-8; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leimer U, 1999, BIOCHEMISTRY-US, V38, P13602, DOI 10.1021/bi991453n; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Li JL, 2015, MECH DEVELOP, V137, P33, DOI 10.1016/j.mod.2015.04.001; Love S, 2016, ACTA NEUROPATHOL, V131, P645, DOI 10.1007/s00401-015-1522-0; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Moussavi Nik SH, 2015, HUM MOL GENET; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Musa A, 2001, DEV GENES EVOL, V211, P563, DOI 10.1007/s00427-001-0189-9; Newman M, 2014, HUM MOL GENET, V23, P602, DOI 10.1093/hmg/ddt448; Newman M, 2009, J ALZHEIMERS DIS, V16, P133, DOI 10.3233/JAD-2009-0945; Nik SHM, 2011, EXP CELL RES, V317, P1503, DOI 10.1016/j.yexcr.2011.04.004; Nornes S, 2008, HUM MOL GENET, V17, P402, DOI 10.1093/hmg/ddm317; Nornes S, 2009, EXP CELL RES, V315, P2791, DOI 10.1016/j.yexcr.2009.06.023; Panza F, 2010, CNS NEUROSCI THER, V16, P272, DOI 10.1111/j.1755-5949.2010.00164.x; PARKER WD, 1994, NEUROLOGY, V44, P1086, DOI 10.1212/WNL.44.6.1086; Parks AL, 2007, TRENDS GENET, V23, P140, DOI 10.1016/j.tig.2007.01.008; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Raturi A, 2013, BBA-MOL CELL RES, V1833, P213, DOI 10.1016/j.bbamcr.2012.04.013; Schon EA, 2012, MOL CELL NEUROSCI; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Sun LF, 2017, P NATL ACAD SCI USA, V114, pE476, DOI 10.1073/pnas.1618657114; Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; UITENBROEK D. G, 1997, SISA BINOMIAL; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vance JE., 2013, BIOCH BIOPHYS ACTA; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Voisin T, 2009, DRUG AGING, V26, P135, DOI 10.2165/0002512-200926020-00005; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yang T, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-15	65	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179859	10.1371/journal.pone.0179859	http://dx.doi.org/10.1371/journal.pone.0179859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636676	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300060
J	Chan, MN; Beaudreau, AH; Loring, PA				Chan, Maggie N.; Beaudreau, Anne H.; Loring, Philip A.			Evaluating patterns and drivers of spatial change in the recreational guided fishing sector in Alaska	PLOS ONE			English	Article							IDEAL FREE DISTRIBUTION; FISHERIES MANAGEMENT; RESPONSE DIVERSITY; LOCAL KNOWLEDGE; RESILIENCE; ALLOCATION; MOVEMENT; DYNAMICS; BEHAVIOR; SYSTEMS	Understanding the impacts of recreational fishing on habitats and species, as well as the social and ecological importance of place to anglers, requires information on the spatial distribution of fishing activities. This study documented long-term changes in core fishing areas of a major recreational fishery in Alaska and identified biological, regulatory, social, and economic drivers of spatial fishing patterns by charter operators. Using participatory mapping and in-person interviews, we characterized the spatial footprint of 46 charter operators in the communities of Sitka and Homer since the 1990s. The spatial footprint differed between Homer and Sitka respondents, with Homer operators consistently using larger areas for Pacific halibut than Sitka operators. Homer and Sitka showed opposite trends in core fishing location area over time, with an overall decrease in Homer and an overall increase in Sitka. For both Sitka and Homer respondents, the range of areas fished was greater for Pacific halibut than for rockfish/ lingcod or Pacific salmon. Spatial patterns were qualitatively different between businesses specializing in single species trips and those that operated multispecies trips and between businesses with one vessel and those with multiple vessels. In Homer, the most frequently cited reasons for changes in the location and/ or extent of fishing were changes in trip type and the price of fuel, while in Sitka, the most frequently cited reasons for spatial shifts were changes to Pacific halibut regulations and gaining experience or exploring new locations. The diversity of charter fishing strategies in Alaska may allow individual charter operators to respond differently to perturbations and thus maintain resilience of the industry as a whole to social, environmental, and regulatory change. This research also highlights the importance of understanding fishers' diverse portfolio of activities to effective ecosystem-based management.	[Chan, Maggie N.; Beaudreau, Anne H.] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA; [Loring, Philip A.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada	University of Alaska System; University of Alaska Fairbanks; University of Saskatchewan	Chan, MN (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Juneau, AK 99775 USA.	nlchan@alaska.edu	Loring, Philip A/I-1716-2019	Loring, Philip A/0000-0001-6039-2331	National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT [DGE0801720]; NOAA Saltonstall Kennedy Grant [NA14NMF4270059]; University of Alaska Fairbanks; University of Saskatchewan	National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT; NOAA Saltonstall Kennedy Grant; University of Alaska Fairbanks; University of Saskatchewan	This project was supported by the National Science Foundation Marine Ecosystem Sustainability in the Arctic and Subarctic (MESAS) IGERT (https://www.sfos.uaf.edu/mesas/; Award DGE0801720; MNC), NOAA Saltonstall Kennedy Grant (http://www.fisheries.noaa.gov/mb/financial_services/skhome.htm; #NA14NMF4270059; AHB), University of Alaska Fairbanks (AHB, MNC), and the University of Saskatchewan (PAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Acheson JM, 1987, QUESTION COMMONS, P1; Acheson JM, 1996, AM ANTHROPOL, P579; Alaska Department of Fish and Game, 2017, UNPUB; [Anonymous], 2015, NAT SALTW RECR FISH; Beaudreau AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152190; Bernard H. R., 2017, RES METHODS ANTHR; Brinson AA, 2013, NMFSFSPO135 NOAA US, V1; Close CH, 2006, J ENVIRON MANAGE, V78, P341, DOI 10.1016/j.jenvman.2005.04.027; Criddle K. R., 2003, Marine Resource Economics, V18, P291; Dean MR, 1998, ALASKA DEP FISH GAME, V99-1; Ditton RB, 1978, 1319 NMFS US DEP COM; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; GILLIS DM, 1993, CAN J FISH AQUAT SCI, V50, P323, DOI 10.1139/f93-038; Gillis DM, 2003, CAN J ZOOL, V81, P177, DOI 10.1139/Z02-240; Gilroy H, 1993, 55 INT PAC HAL COMM; Gilroy H., 2015, INT PAC HAL COMM 92; Hall GB, 2007, FISH RES, V83, P11, DOI 10.1016/j.fishres.2006.08.015; Hamel C, 2002, ANN REGIONAL SCI, V36, P247, DOI 10.1007/s001680200085; Herrmann M, 2001, ALASKA FISHERY RES B, V8; Howe AL, 1995, ALASKA DEP FISH GAME; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; JOHNSON BM, 1994, ECOL APPL, V4, P808, DOI 10.2307/1942010; Leslie P, 2013, CURR ANTHROPOL, V54, P114, DOI 10.1086/669563; Lew DK, 2010, N AM J FISH MANAGE, V30, P538, DOI 10.1577/M09-191.1; Lichtkoppler FR, 2008, FISHERIES, V33, P485, DOI 10.1577/1548-8446-33.10.485; Loring PA, 2013, J AGRIC FOOD SYST CO, V3, P13, DOI 10.5304/jafscd.2013.033.006; Matthias BG, 2014, FISHERIES, V39, P261, DOI 10.1080/03632415.2014.903836; MCCAY BJ, 1981, AM ETHNOL, V8, P356, DOI 10.1525/ae.1981.8.2.02a00080; Moreno-Baez M, 2012, OCEAN COAST MANAGE, V55, P111, DOI 10.1016/j.ocecoaman.2011.10.001; Naranjo-Madrigal H, 2015, MAR POLICY, V62, P102, DOI 10.1016/j.marpol.2015.09.003; Powers B, 2016, ALASKA DEP FISH GAME; Stewart IJ, INT PAC HAL COMM 92; Stewart IJ, 2016, INT PAC HAL COMM 92; Sutton SG, 2005, N AM J FISH MANAGE, V25, P536, DOI 10.1577/M04-059.1; Turner RA, 2013, SOC NATUR RESOUR, V26, P491, DOI 10.1080/08941920.2012.709313	36	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179584	10.1371/journal.pone.0179584	http://dx.doi.org/10.1371/journal.pone.0179584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY5UN	28632745	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100040
J	Pereira, AS; de Almeida, AAF; Branco, MCDS; Costa, MGC; Ahnert, D				Pereira, Allan Silva; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; Cardoso Costa, Marcio Gilberto; Ahnert, Dario			Combining ability, heritability and genotypic relations of different physiological traits in cacao hybrids	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE PARAMETERS; VAPOR-PRESSURE DEFICIT; GAS-EXCHANGE; SALT STRESS; PHOTOSYNTHESIS; EFFICIENCY; LEAF; RESISTANCE; LEAVES; DISEASE	Selecting parents and evaluating progenies is a very important step in breeding programs and involves approaches such as understanding the initial stages of growth and characterizing the variability among genotypes for different parameters, such as physiological, growth, biomass partitioning and nutrient translocation to the aerial part. In these cases, facilitating tools can be used to understand the involved gene dynamics, such as diallel crosses and genetic and phenotypic correlations. Our main hypothesis is that the contrasting phenotypes of these parental genotypes of cocoa used are due to genetic factors, and progenies derived from crosses of these parental genotypes are useful for breeding programs related to plant architecture, physiological parameters and translocation of mineral nutrients. We aimed to evaluate the combining abilities in progenies of cacao (Theobroma cacao L) originating from contrasting parents for canopy vigor. Emphasis was given to the evaluation of morphological and physiological parameters and the phenotypic and genotypic correlations to understand the dynamics of the action of the genes involved, as well as in expression profile from genes of gibberellins biosynthesis pathway in the parents. Fifteen F1 progenies were obtained from crosses of six clones (IMC 67, P4B, PUCALA, SCA 6, SCA 24 and SJ 02) that were evaluated in a randomized complete block design with four replicates of 12 plants per progeny, in a balanced half table diallel scheme. It is possible to identify and select plants and progenies of low, medium and high height, as there is expressive genetic variability for the evaluated parameters, some of these on higher additive effects, others on larger nonadditive effects and others under a balance of these effects. Most physiological parameters evaluated show that for selection of plants with the desired performance, no complex breeding methods would be necessary due to the high and medium heritability observed. Strong genetic components were observed from many of the correlations, which indicate the possibility to formulate selection indices for multi-traits, such as dwarfism or semidwarfism, tolerance to increase of leaf sodium concentrations and maintenance of the photosynthetic apparatus integrity under these conditions. Additionally, plants with higher carbon fixation, better water use, higher carboxylation efficiency and greater magnesium accumulation in leaves can be selected.	[Pereira, Allan Silva; de Almeida, Alex-Alan Furtado; da Silva Branco, Marcia Christina; Cardoso Costa, Marcio Gilberto; Ahnert, Dario] Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, Ilheus, BA, Brazil; [Ahnert, Dario] Comissao Execut Plano Lavoura Cacaueira CEPEC CEP, Ctr Pesquisas Cacau, Rod Jorge Amado, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, Ilheus, BA, Brazil.	alexalan@uesc.br	Pereira, Allan S/N-4407-2015; Costa, Marcio/AAG-3285-2020	Costa, Marcio/0000-0002-4358-5489; da Silva Branco, Marcia Christina/0000-0001-9998-713X	UESC; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); CAPES (Brazil); FAPESB (Brazil); UESC (Brazil)	UESC; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESB (Brazil)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); UESC (Brazil)	The authors confirm receipt of financial support from UESC, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to ASP, and Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to PhDs Raul Rene Melendez Valle (RRV) and Carlos Priminho Pirovani (CPP) for contributions to the execution logistics of this work and also to the institutions UESC, CAPES and FAPESB (Brazil) because the logistical and financial supports provided.	Alban M'Bo Kacou Antoine, 2016, Indian Journal of Plant Physiology, V21, P23, DOI 10.1007/s40502-015-0195-y; Almeida AAF, 2014, PHOTOSYNTHETICA, V52, P16, DOI 10.1007/s11099-013-0048-8; Arshad FM, 2015, ECOL MODEL, V309, P22, DOI 10.1016/j.ecolmodel.2015.03.020; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Balasimha D., 2011, UNDERSTANDING PHYSL, V39, P1; Balasimha D, 2013, GENOTYPIC VARIATIONS, V41, P40; Baligar VC, 2008, PHOTOSYNTHETICA, V46, P216, DOI 10.1007/s11099-008-0035-7; Barreto MA, 2015, EUPHYTICA, V206, P677, DOI 10.1007/s10681-015-1490-4; BEKELE FL, 1994, EUPHYTICA, V75, P231, DOI 10.1007/BF00025608; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cai Q, 2014, CORRELATION COMBININ, P2; Cervantes-Martinez C, 2006, J AM SOC HORTIC SCI, V131, P231, DOI 10.21273/JASHS.131.2.231; Chukwu S.C., 2016, AGR BIOL J N AM, V7, P95; CRUZ C. D., 2006, MODELOS BIOMETRICOS, V2; Cuzzuol Geraldo Rogerio Faustini, 2016, CAESALPINIA ECHINATA, V43, P151; DALEY PF, 1989, PLANT PHYSIOL, V90, P1233, DOI 10.1104/pp.90.4.1233; Daymond AJ, 2011, BIOL PLANTARUM, V55, P99, DOI 10.1007/s10535-011-0013-y; Daymond AJ, 2004, ANN APPL BIOL, V145, P257, DOI 10.1111/j.1744-7348.2004.tb00381.x; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P425, DOI 10.1590/S1677-04202007000400011; de Lucena CC, 2012, REV BRAS FRUTIC, V34, P1245, DOI 10.1590/S0100-29452012000400034; dos Santos EA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160647; dos Santos IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115746; EDWARDS CE, 2011, GENETICS, V375, P390, DOI DOI 10.1534/GENETCS.110.125112; Efron Y, 2003, INT WORKSH COC BREED, P79; Embrapa-Empresa Brasileira de Pesquisa Agropecuaria,, 1999, MANUAL ANALISES QUIM, P370; Engels JMM, 1994, P INT WORKSH COC BRE, P174; Fageria N.K., 2009, USE NUTR CROP PLANTS; Fanwoua J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00338; FAOSTAT, 2016, CROPS PROD MOD; FRANCISCO NETO E., 2008, GENETIC PARAMETERS G; Konrad Maria Luiza Freitas, 2005, Bragantia, V64, P339, DOI 10.1590/S0006-87052005000300004; Fritsche-Neto R, 2010, PESQUI AGROPECU BRAS, V45, P465, DOI 10.1590/S0100-204X2010000500005; Fumuro M., 1996, CHARACTERISTICS DRY; GARDNER CO, 1966, BIOMETRICS, V22, P439, DOI 10.2307/2528181; Gattward JN, 2012, PHYSIOL PLANTARUM, V146, P350, DOI 10.1111/j.1399-3054.2012.01621.x; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Gyau A, 2014, AGROFOREST SYST, V88, P1035, DOI 10.1007/s10457-014-9677-6; Hadley P., 1994, INT WORKSH COC BREED, P97; HANSCHE PE, 1979, CALIF AGR, V33, P4; Hermans C, 2003, J PLANT PHYSIOL, V160, P81, DOI 10.1078/0176-1617-00917; Hollender CA, 2016, NEW PHYTOL, V210, P227, DOI 10.1111/nph.13772; Jackson M.L., 1958, SOIL CHEM ANAL ENGLE, P183; Kalaji H.M., 2008, PHOTOCHEMISTRY RES P, P439; Kalaji HM, 2011, ENVIRON EXP BOT, V73, P64, DOI 10.1016/j.envexpbot.2010.10.009; KEGG, 2016, KYOTO ENCY GENES GEN; KIRKBY EA, 2007, INF AGRONOMICAS, V118, P1; Klich MG, 2000, ENVIRON EXP BOT, V44, P171, DOI 10.1016/S0098-8472(00)00056-3; Kotoda N, 2016, HORTIC J PREVIEW, V4, P1; Li G, 2010, IND CROP PROD, V31, P13, DOI 10.1016/j.indcrop.2009.07.015; Li Y.-M., 2015, INT J PLANT SOIL SCI, V7, P80, DOI 10.9734/IJPSS/2015/17368; Lichtenthaler HK, 2005, PHOTOSYNTHETICA, V43, P379, DOI 10.1007/s11099-005-0062-6; LICHTENTHALER HK, 1987, J PLANT PHYSIOL, V131, P101, DOI 10.1016/S0176-1617(87)80271-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long SP, 2006, PLANT CELL ENVIRON, V29, P315, DOI 10.1111/j.1365-3040.2005.01493.x; Lv AZ, 2012, J INTEGR AGR, V11, P43, DOI 10.1016/S1671-2927(12)60781-0; Massonnet C, 2007, ANN BOT-LONDON, V100, P1347, DOI 10.1093/aob/mcm222; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Memon S, 2015, EUPHYTICA, V204, P199, DOI 10.1007/s10681-015-1368-5; Mielke MS, 2005, BRAZ ARCH BIOL TECHN, V48, P815, DOI 10.1590/S1516-89132005000600018; Mukaka MM, 2012, MALAWI MED J, V24, P69; MURATA S, 1992, PLANT CELL PHYSIOL, V33, P1247; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Padi FK, 2013, CROP PROT, V51, P24, DOI 10.1016/j.cropro.2013.04.007; Padi FK, 2013, PLANT BREEDING, V132, P229, DOI 10.1111/pbr.12039; Panthee DR, 2015, DIALLEL ANAL LYCOPEN, P1483; Pilon-Smits EAH, 2009, CURR OPIN PLANT BIOL, V12, P267, DOI 10.1016/j.pbi.2009.04.009; Pinheiro TT, 2011, GENET MOL RES, V10, P3291, DOI 10.4238/2011.November.17.4; Rasheed F, 2015, PLANT CELL ENVIRON, V38, P670, DOI 10.1111/pce.12423; Rengel Z, 2008, PHYSIOL PLANTARUM, V133, P624, DOI 10.1111/j.1399-3054.2008.01079.x; Rodrigues Fabricio, 2009, Bragantia, V68, P75, DOI 10.1590/S0006-87052009000100009; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Santos ESL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145276; Schulze ED, 1982, PHYSL PLANT ECOLOGY, P181, DOI DOI 10.1007/978-3-642-68150-9_; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SOUMELIDOU K, 1994, ANN BOT-LONDON, V74, P605, DOI 10.1006/anbo.1994.1161; Souza Junior JO de, 2009, REV BRAS CIENC DO SO, V32, P2367; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; Tezara W, 2016, BOT SCI, V94, P1; TOWNSEND T, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0061989; Silva SDVM, 2010, PESQUI AGROPECU BRAS, V45, P680, DOI 10.1590/S0100-204X2010000700007; Vliet JA van, 2015, MINERAL NUTR COCOA R, P57; Waitt DE, 1998, HEREDITY, V80, P310, DOI 10.1046/j.1365-2540.1998.00298.x; Webster AD, 2004, ACTA HORTIC, P29, DOI 10.17660/ActaHortic.2004.658.1; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; Willits DH, 2001, J AM SOC HORTIC SCI, V126, P188, DOI 10.21273/JASHS.126.2.188; Winson D, 1969, HEREDITY, V24, P633; Xue JM, 2013, J PLANT NUTR SOIL SC, V176, P724, DOI 10.1002/jpln.201200272; Zanandrea I., 2006, Revista Brasileira de Agrociencia, V12, P157; Zare Bavani Mohammad Reza, 2015, Agriculturae Conspectus Scientificus, V80, P153; Zeng LH, 2015, FIELD CROP RES, V171, P176, DOI 10.1016/j.fcr.2014.10.004; Zhang XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126828; Zhou YC, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0909-3	93	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178790	10.1371/journal.pone.0178790	http://dx.doi.org/10.1371/journal.pone.0178790			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628670	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100011
J	Chang, M; Iizuka, H; Kashioka, H; Naruse, Y; Furukawa, M; Ando, H; Maeda, T				Chang, Ming; Iizuka, Hiroyuki; Kashioka, Hideki; Naruse, Yasushi; Furukawa, Masahiro; Ando, Hideyuki; Maeda, Taro			Unconscious improvement in foreign language learning using mismatch negativity neurofeedback: A preliminary study	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; EVENT-RELATED POTENTIALS; R-VERTICAL-BAR; PHONEME REPRESENTATIONS; BRAIN RESPONSES; ENGLISH; SPEECH; SOUND; PERCEPTION; ATTENTION	When people learn foreign languages, they find it difficult to perceive speech sounds that are nonexistent in their native language, and extensive training is consequently necessary. Our previous studies have shown that by using neurofeedback based on the mismatch negativity event-related brain potential, participants could unconsciously achieve learning in the auditory discrimination of pure tones that could not be consciously discriminated without the neurofeedback. Here, we examined whether mismatch negativity neurofeedback is effective for helping someone to perceive new speech sounds in foreign language learning. We developed a task for training native Japanese speakers to discriminate between 'l' and 'r' sounds in English, as they usually cannot discriminate between these two sounds. Without participants attending to auditory stimuli or being aware of the nature of the experiment, neurofeedback training helped them to achieve significant improvement in unconscious auditory discrimination and recognition of the target words 'light' and 'right'. There was also improvement in the recognition of other words containing 'l' and 'r' (e.g., 'blight' and 'bright'), even though these words had not been presented during training. This method could be used to facilitate foreign language learning and can be extended to other fields of auditory and clinical research and even other senses.	[Chang, Ming; Kashioka, Hideki; Naruse, Yasushi; Furukawa, Masahiro; Ando, Hideyuki; Maeda, Taro] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Nishi Ku, Iwaoka Cho, Kobe, Hyougo, Japan; [Chang, Ming; Kashioka, Hideki; Naruse, Yasushi; Furukawa, Masahiro; Ando, Hideyuki; Maeda, Taro] Osaka Univ, Iwaoka Cho, Kobe, Hyougo, Japan; [Chang, Ming; Furukawa, Masahiro; Ando, Hideyuki; Maeda, Taro] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan; [Iizuka, Hiroyuki] Hokkaido Univ, Grad Sch Informat Sci & Technol, Kita Ku, Sapporo, Hokkaido, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Osaka University; Hokkaido University	Chang, M (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks CiNet, Nishi Ku, Iwaoka Cho, Kobe, Hyougo, Japan.; Chang, M (corresponding author), Osaka Univ, Iwaoka Cho, Kobe, Hyougo, Japan.; Chang, M (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka, Japan.	chang.ming@nict.go.jp		Furukawa, Masahiro/0000-0003-0421-8106; ANDO, HIDEYUKI/0000-0002-8405-3120	Center of Innovation Program from Japan Science and Technology Agency, JST	Center of Innovation Program from Japan Science and Technology Agency, JST	This research is partially supported by the Center of Innovation Program from Japan Science and Technology Agency, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is partially supported by the Center of Innovation Program from Japan Science and Technology Agency, JST.	ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Bertoli S, 2002, CLIN NEUROPHYSIOL, V113, P396, DOI 10.1016/S1388-2457(02)00013-5; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Chang M, 2014, AH; Chang M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06729; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Koyama S, 2000, NEUROREPORT, V11, P3765, DOI 10.1097/00001756-200011270-00034; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; KUHL PK, 1994, CURR OPIN NEUROBIOL, V4, P812, DOI 10.1016/0959-4388(94)90128-7; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1993, NEUROREPORT, V4, P503; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; NAATANEN R, 1995, EAR HEARING, V16, P6; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pettigrew CM, 2004, EAR HEARING, V25, P284, DOI 10.1097/01.AUD.0000130800.88987.03; Phillips C., 1995, MIT WORKING PAPERS L, V26, P125; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; Sams M, 1990, J Cogn Neurosci, V2, P344, DOI 10.1162/jocn.1990.2.4.344; Sams M., 1985, CLIN NEUROPHYSIOL, V62, P437, DOI [10.1016/0168-5597(85)90054-1, DOI 10.1016/0168-5597(85)90054-1]; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Sonnadara RR, 2006, BRAIN RES, V1076, P187, DOI 10.1016/j.brainres.2005.12.093; STRANGE W, 1984, PERCEPT PSYCHOPHYS, V36, P131, DOI 10.3758/BF03202673; Sussman E, 2003, PSYCHOPHYSIOLOGY, V40, P430, DOI 10.1111/1469-8986.00045; TERVANIEMI M, 1994, BIOL PSYCHOL, V38, P157, DOI 10.1016/0301-0511(94)90036-1; Tervaniemi M, 1997, NEUROREPORT, V8, P2571, DOI 10.1097/00001756-199707280-00030; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Wang Y, 1999, J ACOUST SOC AM, V106, P3649, DOI 10.1121/1.428217; Winkler I, 1999, PSYCHOPHYSIOLOGY, V36, P638, DOI 10.1111/1469-8986.3650638; YAMADA RA, 1992, PERCEPT PSYCHOPHYS, V52, P376, DOI 10.3758/BF03206698	36	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178694	10.1371/journal.pone.0178694	http://dx.doi.org/10.1371/journal.pone.0178694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX6PQ	28617861	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600012
J	Pinsonneault, JK; Frater, JT; Kompa, B; Mascarenhas, R; Wang, DX; Sadee, W				Pinsonneault, Julia K.; Frater, John T.; Kompa, Benjamin; Mascarenhas, Roshan; Wang, Danxin; Sadee, Wolfgang			Intronic SNP in ESR1 encoding human estrogen receptor alpha is associated with brain ESR1 mRNA isoform expression and behavioral traits	PLOS ONE			English	Article							GENE POLYMORPHISMS; BIPOLAR DISORDER; CANDIDATE GENES; VARIANTS; RISK; DEPRESSION; IDENTIFICATION; IMBALANCE; SYMPTOMS; REVEALS	Genetic variants of ESR1 have been implicated in multiple diseases, including behavioral disorders, but causative variants remain uncertain. We have searched for regulatory variants affecting ESR1 expression in human brain, measuring allelic ESR1 mRNA expression in human brain tissues with marker SNPs in exon4 representing ESR1-008 (or ESR alpha-36), and in the 3'UTR of ESR1-203, two main ESR1 isoforms in brain. In prefrontal cortex from subjects with bipolar disorder, schizophrenia, and controls (n = 35 each; Stanley Foundation brain bank), allelic ESR1 mRNA ratios deviated from unity up to tenfold at the exon4 marker SNP, with large allelic ratios observed primarily in bipolar and schizophrenic subjects. SNP scanning and targeted sequencing identified rs2144025, associated with large allelic mRNA ratios (p = 1.6E10(-6)). Moreover, rs2144025 was significantly associated with ESR1 mRNA levels in the Brain eQTL Almanac and in brain regions in the Genotype-Tissue Expression project. In four GWAS cohorts, rs2104425 was significantly associated with behavioral traits, including: hypomanic episodes in female bipolar disorder subjects (GAIN bipolar disorder study; p = 0.0004), comorbid psychological symptoms in both males and females with attention deficit hyperactivity disorder (GAIN ADHD, p = 0.00002), psychological diagnoses in female children (eMERGE study of childhood health, subject age >= 9, p = 0.0009), and traits in schizophrenia (e.g., grandiose delusions, GAIN schizophrenia, p = 0.0004). The first common ESR1 variant (MAF 12-33% across races) linked to regulatory functions, rs2144025 appears conditionally to affect ESR1 mRNA expression in the brain and modulate traits in behavioral disorders.	[Pinsonneault, Julia K.; Frater, John T.; Kompa, Benjamin; Mascarenhas, Roshan; Wang, Danxin; Sadee, Wolfgang] Ohio State Univ, Coll Med & Publ Hlth, Dept Canc Biol & Genet, Ctr Pharmacogen, Columbus, OH 43210 USA; [Mascarenhas, Roshan] Newcastle Univ Med Malaysia, 1 JalanSarjana 1, Nusajaya, Johor, Malaysia	University System of Ohio; Ohio State University	Sadee, W (corresponding author), Ohio State Univ, Coll Med & Publ Hlth, Dept Canc Biol & Genet, Ctr Pharmacogen, Columbus, OH 43210 USA.	wolfgang.sadee@osumc.edu	Wang, Danxin/I-5810-2019	Wang, Danxin/0000-0002-7134-3065	National Institutes of Health [U01 GM092655]; National Center for Research Resources [UL1RR025755]; CCTS Biostatistics Study Design Core [UL1TR001070]; Ohio Supercomputer Center, Columbus Ohio; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); CCTS Biostatistics Study Design Core; Ohio Supercomputer Center, Columbus Ohio; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health U01 GM092655 (WS), and in part by the National Center for Research Resources UL1RR025755 (Col WS), the CCTS Biostatistics Study Design Core in grant UL1TR001070, and the Ohio Supercomputer Center, Columbus Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful to Audrey Papp for assistance with PGM sequencing. This study was supported by the National Institutes of Health U01 GM092655 (WS), and in part by the National Center for Research Resources UL1RR025755 (CoI WS), the CCTS BiostatisticsStudy Design Core in grant UL1TR001070, and the Ohio Supercomputer Center, Columbus Ohio. Details of funding sources are provided at the end of Supplementary Information for: Genetic Association Information Network (GAIN) Whole Genome Association of Bipolar Disorder version 3 (Accession: phs000017.v3.p1);Genetic Association Information Network (GAIN) Genome-Wide Association Study of Schizophrenia version 3 (Accession: phs000021.v3.p2);International Multi-Center ADHD Genetics Project (Accession: phs000016.v2.p2),part of Genetic Association Information Network (GAIN); The Gene Partnership (TGP) eMERGE Data Distribution Set 1(Accession:phs000495.vl.p1); The GTEx RNA-Seq and Whole Exome Sequencing data used for analysis in this manuscript were from dbGaP accession number phs000424.v5.pl.	Azad AK, 2013, GENES IMMUN, V14, P99, DOI 10.1038/gene.2012.61; Boada M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.016; Chimento A, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00001; Dahlgren A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001807; Dahlman I, 2008, PHARMACOGENET GENOM, V18, P967, DOI 10.1097/FPC.0b013e32831101ef; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; Forstmeier W, 2010, P ROY SOC B-BIOL SCI, V277, P3353, DOI 10.1098/rspb.2010.1007; Gade-Andavolu R, 2009, NEUROSCI LETT, V467, P155, DOI 10.1016/j.neulet.2009.10.028; Giegling I, 2009, AM J MED GENET B, V150B, P434, DOI 10.1002/ajmg.b.30834; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Goumidi L, 2011, J ALZHEIMERS DIS, V26, P431, DOI 10.3233/JAD-2011-110362; Hattori Y, 2016, MOL CELL ENDOCRINOL, V425, P111, DOI 10.1016/j.mce.2016.01.026; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Horton BM, 2014, P NATL ACAD SCI USA, V111, P1443, DOI 10.1073/pnas.1317165111; Huo L, 2007, BIOL PSYCHIAT, V62, P925, DOI 10.1016/j.biopsych.2006.12.019; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaalund SS, 2013, MOL PSYCHIAT; Karlsson S, 2016, SOC COGN AFFECT NEUR, V11, P877, DOI 10.1093/scan/nsw010; Keene KL, 2008, HUM GENET, V123, P333, DOI 10.1007/s00439-008-0482-z; Keyes K, 2015, SOC PSYCH PSYCH EPID, V50, P1893, DOI 10.1007/s00127-015-1087-1; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Ma SL, 2014, AM J GERIAT PSYCHIAT, V22, P489, DOI 10.1016/j.jagp.2012.08.006; Maruyama H, 2000, ARCH NEUROL-CHICAGO, V57, P236, DOI 10.1001/archneur.57.2.236; Mavaddat N, 2009, CANCER EPIDEM BIOMAR, V18, P255, DOI 10.1158/1055-9965.EPI-08-0704; Mill J, 2008, AM J MED GENET B, V147B, P1323, DOI 10.1002/ajmg.b.30751; Miller A, 2010, J PSYCHIATR RES, V44, P788, DOI 10.1016/j.jpsychires.2010.01.013; Nurnberger JI, 2014, JAMA PSYCHIAT, V71, P657, DOI 10.1001/jamapsychiatry.2014.176; Pinsonneault J, 2004, J PHARMACOL EXP THER, V311, P1088, DOI 10.1124/jpet.104.073098; Pinsonneault JK, 2006, HUM MOL GENET, V15, P2636, DOI 10.1093/hmg/ddl192; Pinsonneault JK, 2013, ARCH WOMEN MENT HLTH, V16, P499, DOI 10.1007/s00737-013-0373-8; Roberts KE, 2009, AM J RESP CRIT CARE, V179, P835, DOI 10.1164/rccm.200809-1472OC; Ryan J, 2012, DRUGS, V72, P1725, DOI 10.2165/11635960-000000000-00000; Ryan J, 2011, PSYCHONEUROENDOCRINO, V36, P1582, DOI 10.1016/j.psyneuen.2011.04.011; Savitz JB, 2014, NEUROSCI BIOBEHAV R, V42, P132, DOI 10.1016/j.neubiorev.2014.02.008; Sundermann EE, 2010, MENOPAUSE, V17, P874, DOI 10.1097/gme.0b013e3181df4a19; Thomas C, 2015, TRENDS ENDOCRINOL ME; Tobias JH, 2007, J CLIN ENDOCR METAB, V92, P2286, DOI 10.1210/jc.2006-2447; van Erp TGM, 2016, MOL PSYCHIATR, V21, P585, DOI 10.1038/mp.2015.118; Velasco J, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-16; Vermeersch H, 2013, HORM BEHAV, V63, P447, DOI 10.1016/j.yhbeh.2012.11.017; Wang DX, 2014, HUM MOL GENET, V23, P268, DOI 10.1093/hmg/ddt417; Wang DX, 2011, PHARMACOGENET GENOM, V21, P652, DOI 10.1097/FPC.0b013e3283498ee9; Wang S, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-12; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Xiong DH, 2005, OSTEOPOROSIS INT, V16, P2113, DOI 10.1007/s00198-005-2011-4; Yaffe K, 2009, NEUROBIOL AGING, V30, P607, DOI 10.1016/j.neurobiolaging.2007.08.003; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhao LJ, 2004, BONE, V35, P395, DOI 10.1016/j.bone.2004.04.013; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179020	10.1371/journal.pone.0179020	http://dx.doi.org/10.1371/journal.pone.0179020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617822	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600019
J	Rahmadhani, R; Zaharan, NL; Mohamed, Z; Moy, FM; Jalaludin, MY				Rahmadhani, Rayinda; Zaharan, Nur Lisa; Mohamed, Zahurin; Moy, Foong Ming; Jalaludin, Muhammad Yazid			The associations between VDR BsmI polymorphisms and risk of vitamin D deficiency, obesity and insulin resistance in adolescents residing in a tropical country	PLOS ONE			English	Article							D-RECEPTOR GENE; DESCRIBING METABOLIC SYNDROME; TYPE-2 DIABETES-MELLITUS; 1,25-DIHYDROXYVITAMIN D-3; KUALA-LUMPUR; CHILDREN; METAANALYSIS; DETERMINANTS; PARAMETERS; MALAYSIA	Background The vitamin D receptor (VDR) gene is expressed abundantly in different tissues; including adipocytes and pancreatic beta cells. The rs1544410 or BsmI single nucleotide polymorphism (SNP) in the intronic region of the VDR gene has been previously associated with vitamin D levels, obesity and insulin resistance. Aims This study was aimed to examine the association between BsmI polymorphism and risk of vitamin D deficiency, obesity and insulin resistance in adolescents living in a tropical country. Methods Thirteen-year-old adolescents were recruited via multistage sampling from twenty-three randomly selected schools across the city of Kuala Lumpur, Malaysia (n = 941). Anthropometric measurements were obtained. Obesity was defined as body mass index higher than the 95 th percentile of the WHO chart. Levels of fasting serum vitamin D (25-hydroxyvitamin D (25(OH) D)), glucose and insulin were measured. HOMA-IR was calculated as an indicator for insulin resistance. Genotyping was performed using the Sequenom MassARRAY platform (n = 807). The associations between BsmI and vitamin D, anthropometric parameters and HOMA-IR were examined using analysis of covariance and logistic regression. Result Those with AA genotype of BsmI had significantly lower levels of 25(OH) D (p = 0.001) compared to other genotypes. No significant differences was found across genotypes for obesity parameters. The AA genotype was associated with higher risk of vitamin D deficiency (p = 0.03) and insulin resistance (p = 0.03) compared to GG. The A allele was significantly associated with increased risk of vitamin D deficiency compared to G allele (adjusted odds ratio (OR) = 1.63 (95% Confidence Interval (CI) 1.03-2.59, p = 0.04). In those with concurrent vitamin D deficiency, having an A allele significantly increased their risk of having insulin resistance compared to G allele (adjusted OR = 2.66 (95% CI 1.36-5.19, p = 0.004). Conclusion VDR BsmI polymorphism was significantly associated with vitamin D deficiency and insulin resistance, but not with obesity in this population.	[Rahmadhani, Rayinda; Zaharan, Nur Lisa; Mohamed, Zahurin] Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia; [Moy, Foong Ming] Univ Malaya, Dept Social & Prevent Med, Julius Ctr, Fac Med, Kuala Lumpur, Malaysia; [Jalaludin, Muhammad Yazid] Univ Malaya, Dept Paediat, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Zaharan, NL (corresponding author), Univ Malaya, Dept Pharmacol, Fac Med, Kuala Lumpur, Malaysia.	nurlisazaharan@um.edu.my	Jalaludin, Muhammad Yazid/B-9172-2010; Moy, Foong Ming/B-7899-2010; Mohamed, Zahurin/C-1112-2010; Zaharan, Nur Lisa/F-8835-2012	Jalaludin, Muhammad Yazid/0000-0003-4513-8444; Moy, Foong Ming/0000-0002-0306-4419; Mohamed, Zahurin/0000-0002-4396-0517; Zaharan, Nur Lisa/0000-0002-8150-0642	High Impact Research, Ministry of Higher Education Grant, Malaysia [HIR H00021-00-E000082]; University Malaya Research Grant [RG310-11HTM]	High Impact Research, Ministry of Higher Education Grant, Malaysia; University Malaya Research Grant	This study is funded under the High Impact Research, Ministry of Higher Education Grant, Malaysia (HIR H00021-00-E000082) and the University Malaya Research Grant (RG310-11HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the High Impact Research, Ministry of Higher Education Grant, Malaysia (HIR H00021-00-E000082) and the University Malaya Research Grant (RG310-11HTM). The authors acknowledge the contributions of other co-investigators, postgraduate students and research assistants involved in this community based study including Associate Professor Dr Mohd Nahar Azmi Mohamed, Associate Professor Dr Ivy Chung, Mrs Fatin Fauzi, Mr Amir Hakim, Miss Debbie Ann Loh, Dr Jerri Ling, Dr Sandeep Singh, Miss Siti Aliwiyah Wan Jusoh and Mrs Nor Fazida Rasidi, The authors are grateful to all the students and their parents or guardians for their participation in making this study a success. We would also like to extend our gratitude to all the school teachers and colleagues for their support and assistance in this study. This manuscript has been proofread by the Research Management Centre, Faculty of Medicine, University of Malaya.	Al-Daghri NM, 2014, GENE, V542, P129, DOI 10.1016/j.gene.2014.03.044; Al-Sadat N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010689; Andiran N, 2012, J CLIN RES PEDIATR E, V4, P25, DOI 10.4274/jcrpe.574; Beydoun MA, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.19; Burton GR, 2002, GENE, V293, P21, DOI 10.1016/S0378-1119(02)00726-6; Christakos S, 1996, BIOCHEM J, V316, P361, DOI 10.1042/bj3160361; Cobayashi F, 2015, INT J MOL SCI, V16, P12531, DOI 10.3390/ijms160612531; Djennane M, 2014, OSTEOPOROSIS INT, V25, P1493, DOI 10.1007/s00198-014-2623-7; Erol M, 2015, J CLIN RES PEDIATR E, V7, P134, DOI 10.4274/jcrpe.1888; Fadzlina AA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S7; Ferrarezi DAF, 2012, METABOLISM, V61, P1413, DOI 10.1016/j.metabol.2012.03.018; Filus A, 2008, AGING MALE, V11, P134, DOI 10.1080/13685530802273426; Flores M, 2013, NUTRITION, V29, P802, DOI 10.1016/j.nut.2012.12.024; Fuleihan GE, 2015, J BONE MINER RES, V30, P1119, DOI 10.1002/jbmr.2536; Grundberg E, 2004, EUR J ENDOCRINOL, V150, P323, DOI 10.1530/eje.0.1500323; Hazreen MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Ingles SA, 1997, CANCER EPIDEM BIOMAR, V6, P93; Jain R, 2012, METABOLISM, V61, P293, DOI 10.1016/j.metabol.2011.06.018; Jia F, 2013, GENET TEST MOL BIOMA, V17, P30, DOI 10.1089/gtmb.2012.0267; Karohl C, 2010, AM J CLIN NUTR, V92, P1393, DOI 10.3945/ajcn.2010.30176; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Kiel DP, 1997, J BONE MINER RES, V12, P1049, DOI 10.1359/jbmr.1997.12.7.1049; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Kong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE916, DOI 10.1152/ajpendo.00410.2005; Kuhn T, 2014, EUR J NUTR, V53, P731, DOI 10.1007/s00394-013-0577-8; LEE S, 1994, ENDOCRINOLOGY, V134, P1602, DOI 10.1210/en.134.4.1602; Li L, 2013, ARCH MED RES, V44, P235, DOI 10.1016/j.arcmed.2013.02.002; Mackawy AMH, 2014, META GENE, V2, P540, DOI 10.1016/j.mgene.2014.07.002; Madsen KH, 2014, BRIT J NUTR, V112, P776, DOI 10.1017/S0007114514001263; Mangin M, 2014, INFLAMM RES, V63, P803, DOI 10.1007/s00011-014-0755-z; MisraM PD, 2008, PEDIATRICS, V122, P398; MORRISON NA, 1992, P NATL ACAD SCI USA, V89, P6665, DOI 10.1073/pnas.89.15.6665; Mutt SJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00228; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ochs-Balcom HM, 2011, AM J CLIN NUTR, V93, P5, DOI 10.3945/ajcn.2010.29986; Ogunkolade BW, 2002, DIABETES, V51, P2294, DOI 10.2337/diabetes.51.7.2294; Oh JY, 2002, METABOLISM, V51, P356, DOI 10.1053/meta.2002.29969; Pike JW, 2016, VITAM HORM, V100, P21, DOI 10.1016/bs.vh.2015.10.011; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Pulkki L, 2003, PREV MED, V36, P55, DOI 10.1006/pmed.2002.1125; Sanders T, 2015, INT J OBESITY, V39, P1224, DOI 10.1038/ijo.2015.69; Santoro D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/145828; Santos BR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-62; Schuch NJ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-96; Shafinaz IS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2924-1; Shieh A, 2017, ENDOCRIN METAB CLIN, V46, P135, DOI 10.1016/j.ecl.2016.09.006; Speer G, 2001, EUR J ENDOCRINOL, V144, P385, DOI 10.1530/eje.0.1440385; Sun Y, 2012, ACTA PAEDIATR, V101, pE163, DOI 10.1111/j.1651-2227.2011.02568.x; Tizaoui K, 2014, J STEROID BIOCHEM, V143, P240, DOI 10.1016/j.jsbmb.2014.03.011; Tworowska-Bardzinska U, 2008, GYNECOL ENDOCRINOL, V24, P514, DOI 10.1080/09513590802302985; Valtuena J, 2013, J NUTR SCI VITAMINOL, V59, P161; Vierucci F, 2013, EUR J PEDIATR, V172, P1607, DOI 10.1007/s00431-013-2119-z; Wise LA, 2014, FERTIL STERIL, V102; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, 2020, GROWTH REF 5 19 YEAR; Xu XJ, 2015, MED SCI MONITOR, V21, P1960, DOI 10.12659/MSM.894793; Ye WZ, 2001, EUR J ENDOCRINOL, V145, P181, DOI 10.1530/eje.0.1450181; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; Yu F, 2016, ASIA PAC J CLIN NUTR, V25, P614, DOI 10.6133/apjcn.092015.12; Zhao Y, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-129	61	33	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178695	10.1371/journal.pone.0178695	http://dx.doi.org/10.1371/journal.pone.0178695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617856	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600013
J	Xiao, KC; Yamauchi, T				Xiao, Kunchen; Yamauchi, Takashi			The role of attention in subliminal semantic processing: A mouse tracking study	PLOS ONE			English	Article							SPREADING ACTIVATION THEORY; CONSCIOUSNESS; PERCEPTION; ABSENCE; MOVEMENTS; COGNITION; DYNAMICS; DEPENDS; ACCESS; HAND	Recent evidence suggests that top-down attention facilitates unconscious semantic processing. To clarify the role of attention in unconscious semantic processing, we traced trajectories of the computer mouse in a semantic priming task and scrutinized the extent to which top-down attention enhances unconscious semantic processing in four different stimulus-onset asynchrony (SOA: 50, 200, 500, or 1000ms) conditions. Participants judged whether a target digit (e.g., "6") was larger or smaller than five, preceded by a masked priming digit (e.g., "9"). The pre-prime duration changed randomly from trial to trial to disrupt participants' top-down attention in an uncued condition (in a cued condition, a green square cue was presented to facilitate participants' top-down attention). The results show that top-down attention modifies the time course of subliminal semantic processing, and the temporal attention window lasts more than 1000ms; attention facilitated by the cue may amplify semantic priming to some extent, yet the amplification effect of attention is relatively minor.	[Xiao, Kunchen; Yamauchi, Takashi] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Yamauchi, T (corresponding author), Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA.	takashi-yamauchi@tamu.edu	Yamauchi, Takashi/GXM-8197-2022	Yamauchi, Takashi/0000-0002-6372-1118	Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered in part by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; ANDERSON JR, 1983, J VERB LEARN VERB BE, V22, P261, DOI 10.1016/S0022-5371(83)90201-3; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Chou WL, 2011, CONSCIOUS COGN, V20, P1265, DOI 10.1016/j.concog.2011.03.007; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; Cohen MA, 2011, PSYCHOL SCI, V22, P1165, DOI 10.1177/0956797611419168; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Faulkenberry TJ, 2014, CAN J EXP PSYCHOL, V68, P147, DOI 10.1037/cep0000021; Faulkenberry TJ, 2014, FRONT PSYCHOL, V5, P1; Finkbeiner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017095; Fisk GD, 2011, CONSCIOUS COGN, V20, P1221, DOI 10.1016/j.concog.2011.03.016; FOWLER CA, 1981, J EXP PSYCHOL GEN, V110, P341, DOI 10.1037/0096-3445.110.3.341; Freeman JB, 2011, JOURNAL OF EXPERIMEN, V46, P179; Freeman JB, 2011, PSYCHOL REV, V118, P247, DOI 10.1037/a0022327; Freeman JB, 2010, PERS SOC PSYCHOL B, V36, P1318, DOI 10.1177/0146167210378755; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Friedman J, 2009, P 9 C AUSTR SOC COGN, p98 ; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Heinemann A, 2009, CONSCIOUS COGN, V18, P966, DOI 10.1016/j.concog.2009.08.009; KIHLSTROM JF, 1993, CONSCIOUS COGN, V2, P334, DOI 10.1006/ccog.1993.1028; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Macmillan NA, 1996, PSYCHON B REV, V3, P164, DOI 10.3758/BF03212415; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Posner M.I., 2008, TOPICS INTEGRATIVE N, P31, DOI DOI 10.1017/CBO9780511541681.005; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rahnev D, 2012, ATTEN PERCEPT PSYCHO, V74, P521, DOI 10.3758/s13414-011-0246-z; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Santens S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025429, 10.1371/journal.pone.0025383]; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Spruyt A, 2012, COGNITION, V122, P91, DOI 10.1016/j.cognition.2011.08.017; Spruyt A, 2009, J MEM LANG, V61, P37, DOI 10.1016/j.jml.2009.03.004; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Van Opstal F, 2010, CONSCIOUS COGN, V19, P999, DOI 10.1016/j.concog.2010.05.002; Xiao K, 2015, P 37 ANN C COGN SCI, P2691; Xiao KC, 2015, CONSCIOUS COGN, V38, P88, DOI 10.1016/j.concog.2015.09.013; Xiao K, 2014, CONSCIOUS COGN, V27, P42, DOI 10.1016/j.concog.2014.04.004; Yamauchi T., 2015, P 37 ANN C COGN SCI, P2721; Yamauchi T, 2007, MEM COGNITION, V35, P852, DOI 10.3758/BF03193460; Yamauchi T, 2015, INT J HUM-COMPUT INT, V31, P911, DOI 10.1080/10447318.2015.1072787; Yamauchi T, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P221, DOI 10.1109/ICDMW.2014.131; Yamauchi T, 2013, INT CONF AFFECT, P399, DOI 10.1109/ACII.2013.72	54	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178740	10.1371/journal.pone.0178740	http://dx.doi.org/10.1371/journal.pone.0178740			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5IQ	28609460	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700011
J	Brinkrolf, P; Bohn, A; Lukas, RP; Heyse, M; Dierschke, T; Van Aken, HK; Hahnenkamp, K				Brinkrolf, Peter; Bohn, Andreas; Lukas, Roman-Patrik; Heyse, Marko; Dierschke, Thomas; Van Aken, Hugo Karel; Hahnenkamp, Klaus			Senior citizens as rescuers: Is reduced knowledge the reason for omitted lay-resuscitation-attempts? Results from a representative survey with 2004 interviews	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; SURVIVAL; ASSOCIATION; RATES; CPR	Objective Resuscitation (CPR) provided by a bystander prior to the arrival of the emergency services is a beneficial factor for surviving a cardiac arrest (CA). Our registry-based data show, that older patients receive bystander-CPR less frequently. Little is known on possible reasons for this finding. We sought to investigate the hypothesis that awareness of CPR measures is lower in older laypersons being a possible reason for less CPR-attempts in senior citizens. Methods 1206 datasets on bystander resuscitations actually carried out were analyzed for age-dependent differences. Subsequently, we investigated whether the knowledge required carrying out bystander-CPR and the self-confidence to do so differ between younger and older citizens using computer-assisted telephone interviewing. 2004 interviews were performed and statistically analyzed. Results A lower level of knowledge to carry out bystander-CPR was seen in older individuals. For example, 82.4% of interviewees under 65 years of age, knew the correct emergency number. In this group, 66.6% named CPR as the relevant procedure in CA. Among older individuals these responses were only given by 75.1% and 49.5% (V = 0.082; P < 0.001 and V = 0.0157; P < 0.001). Additionally, a difference concerning participants' confidence in their own abilities was detectable. 58.0% of the persons younger than 65 years were confident that they would detect a CA in comparison to 44.6% of the participants older than 65 years (V = 0.120; P < 0.001). Similarly, 62.7% of the interviewees younger than 65 were certain to know what to do during CPR compared to 51.3% of the other group (V = 0.103; P < 0.001). Conclusions Lower levels of older bystanders' knowledge and self-confidence might provide an explanation for why older patients receive bystander-CPR less frequently. Further investigation is necessary to identify causal connections and optimum ways to empower bystander resuscitation.	[Brinkrolf, Peter; Hahnenkamp, Klaus] Greifswald Univ Hosp, Dept Anaesthesiol, Greifswald, Germany; [Bohn, Andreas] City Munster Fire Serv, Emergency Serv, Munster, Germany; [Lukas, Roman-Patrik; Van Aken, Hugo Karel] Munster Univ Hosp, Dept Anaesthesiol Intens Care & Pain Therapy, Munster, Germany; [Heyse, Marko; Dierschke, Thomas] Univ Munster, Inst Sociol, Munster, Germany	University of Munster; University of Munster	Brinkrolf, P (corresponding author), Greifswald Univ Hosp, Dept Anaesthesiol, Greifswald, Germany.	peter.brinkrolf@uni-greifswald.de						[Anonymous], 2013, MUNST SPIEG ZAHL; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Boyce LW, 2015, NETH HEART J, V23, P20, DOI 10.1007/s12471-014-0617-x; Breckwoldt J, 2009, RESUSCITATION, V80, P1108, DOI 10.1016/j.resuscitation.2009.06.028; Casper Karen, 2003, Prehosp Emerg Care, V7, P299, DOI 10.1080/10903120390936455; Grasner JT, 2011, EUR HEART J, V32, P1649, DOI 10.1093/eurheartj/ehr107; Hader S, 2006, STICHPROBENQUALITAT, P11; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Herlitz J, 2005, RESUSCITATION, V66, P291, DOI 10.1016/j.resuscitation.2005.04.003; Herlitz J, 2005, AM HEART J, V149, P61, DOI 10.1016/j.ahj.2004.07.014; Hofmann O., 2012, QUALITATSSICHERUNG U, P139; Idris AH, 2015, CRIT CARE MED, V43, P840, DOI 10.1097/CCM.0000000000000824; Iwami T, 2006, RESUSCITATION, V69, P221, DOI 10.1016/j.resuscitation.2005.08.018; Jackson RE, 1997, ACAD EMERG MED, V4, P540, DOI 10.1111/j.1553-2712.1997.tb03574.x; Kitamura T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006462; Moriwaki Yoshihiro, 2014, J Emerg Trauma Shock, V7, P285, DOI 10.4103/0974-2700.142763; Nakahara S, 2015, JAMA-J AM MED ASSOC, V314, P247, DOI 10.1001/jama.2015.8068; Orimo Hajime, 2006, Nihon Ronen Igakkai Zasshi, V43, P27; Papalexopoulou K, 2014, HEART LUNG, V43, P66, DOI 10.1016/j.hrtlng.2013.09.008; Safdar B, 2014, ACAD EMERG MED, V21, P1503, DOI 10.1111/acem.12540; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Smith K, 2015, CIRCULATION, V131, P174, DOI 10.1161/CIRCULATIONAHA.114.011200; Statistisches Bundesamt, 2013, BEV ERW STERB 2009 1; Swor R, 2006, ACAD EMERG MED, V13, P596, DOI 10.1197/j.aem.2005.12.021; Tanaka Y, 2015, RESUSCITATION, V86, P74, DOI 10.1016/j.resuscitation.2014.11.004; Wong MKY, 2014, CIRCULATION, V130, P1883, DOI 10.1161/CIRCULATIONAHA.114.010633	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178938	10.1371/journal.pone.0178938	http://dx.doi.org/10.1371/journal.pone.0178938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604793	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400021
J	Buceta, J; Johnson, K				Buceta, Javier; Johnson, Kaylynn			Modeling the Ebola zoonotic dynamics: Interplay between enviroclimatic factors and bat ecology	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; VIRUS DISEASE; BRUCELLOSIS MODEL; WEST-AFRICA; PREDICTION; OUTBREAK	Understanding Ebola necessarily requires the characterization of the ecology of its main enzootic reservoir, i.e. bats, and its interplay with seasonal and enviroclimatic factors. Here we present a SIR compartmental model where we implement a bidirectional coupling between the available resources and the dynamics of the bat population in order to understand their migration patterns. Our compartmental modeling approach and simulations include transport terms to account for bats mobility and spatiotemporal climate variability. We hypothesize that environmental pressure is the main driving force for bats' migration and our results reveal the appearance of sustained migratory waves of Ebola virus infected bats coupled to resources availability. Ultimately, our study can be relevant to predict hot spots of Ebola outbreaks in space and time and suggest conservation policies to mitigate the risk of spillovers.	[Buceta, Javier; Johnson, Kaylynn] Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA; [Buceta, Javier] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Buceta, J (corresponding author), Lehigh Univ, Dept Chem & Biomol Engn, Bethlehem, PA 18015 USA.; Buceta, J (corresponding author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.	jab614@lehigh.edu	Buceta, Javier/ABB-1696-2021; Buceta, Javier/E-3705-2010	Buceta, Javier/0000-0003-1791-0011; Buceta, Javier/0000-0003-1791-0011	Lehigh University, CORE	Lehigh University, CORE	JB acknowledges support from Lehigh University, CORE 2015.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; [Anonymous], 2016, EB EP W AFR P WORKSH; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bank TW, 2014, EC IMPACT 2014 EBOLA; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Camacho A, 2014, EPIDEMICS-NETH, V9, P70, DOI 10.1016/j.epidem.2014.09.003; Center for Disease Control and Prevention, 2014, CCD REP; Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Drake JM, 2015, EMERG INFECT DIS, V21, P1447, DOI 10.3201/eid2108.141613; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Gelfand A, 2016, GOING VIRAL MODELING, pE53; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Hayman DTS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011978; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hoenen T, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0080-6; House T, 2014, ELIFE, V3, DOI 10.7554/eLife.03908; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Maganga GD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100172; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Murray J, 2006, MATH BIOL; Muyembe-Tamfum J.J., 2012, Onderstepoort j. vet. res., V79, P06; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Olival KJ, 2014, VIRUSES-BASEL, V6, P1759, DOI 10.3390/v6041759; Olivero J., 2016, MAMMAL REV, V46; Pinzon JE, 2004, AM J TROP MED HYG, V71, P664, DOI 10.4269/ajtmh.2004.71.664; Piot P, 2014, LANCET INFECT DIS, V14, P1034, DOI 10.1016/S1473-3099(14)70956-9; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Puechmaille Sebastien J., 2009, Endangered Species Research, V8, P15, DOI 10.3354/esr00157; Richter HV, 2008, J ZOOL, V275, P172, DOI 10.1111/j.1469-7998.2008.00425.x; Richter HV, 2006, J ZOOL, V268, P35, DOI 10.1111/j.1469-7998.2005.00020.x; Rizkalla C, 2007, ECOHEALTH, V4, P151, DOI 10.1007/s10393-007-0096-2; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Shen MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15818; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Walsh MG, 2015, PEERJ, V3, DOI 10.7717/peerj.735; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857	52	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179559	10.1371/journal.pone.0179559	http://dx.doi.org/10.1371/journal.pone.0179559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604813	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400054
J	Rees, EMA; Edmonds-Brown, VR; Alam, MF; Wright, RM; Britton, JR; Davies, GD; Cowx, IG				Rees, E. M. Ann; Edmonds-Brown, V. Ronni; Alam, M. Fasihul; Wright, Ros M.; Britton, J. Robert; Davies, Gareth D.; Cowx, Ian G.			Socio-economic drivers of specialist anglers targeting the non-native European catfish (Silurus glanis) in the UK	PLOS ONE			English	Article							INLAND FISHERIES MANAGEMENT; ENGLAND; PARTICIPATION; CONSERVATION; GROWTH; DIET; FISH; L.	Information about the socioeconomic drivers of Silurus glanis anglers in the UK were collected using questionnaires from a cross section of mixed cyprinid fisheries to elucidate human dimensions in angling and non-native fisheries management. Respondents were predominantly male (95%), 30-40 years of age with <10 yr angling experience for S. glanis; most had received college rather than university education. The majority (34%) were employed with low-moderate income status (<30k pound per annum), which may restrict time and expenditure spent on angling. Highest angling expenditure was on equipment and bait with most from southern England (54%) spending >500 pound per annum. The proportion of time spent angling for S. glanis was significantly related to angler motivations; fish size, challenge in catch, tranquil natural surroundings, escape from daily stress and to be alone were considered important drivers of increased time spent angling. Overall, poor awareness of: the risks and adverse ecological impacts associated with introduced S. glanis, non-native fisheries legislation, problems in use of unlimited ground bait and high fish stocking rates in angling lakes were evident, possibly related to inadequate training and information provided by angling organisations to anglers, as many stated that they were insufficiently informed.	[Rees, E. M. Ann; Edmonds-Brown, V. Ronni] Hertfordshire Univ, Dept Life Sci, Hatfield, Herts, England; [Alam, M. Fasihul] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Wright, Ros M.] Environm Agcy, Fisheries Tech Serv, Kelvedon, Essex, England; [Britton, J. Robert] Bournemouth Univ, Dept Life & Environm Sci, Poole, Dorset, England; [Davies, Gareth D.] Environm Agcy, Natl Fisheries Serv, Brampton, Cambs, England; [Cowx, Ian G.] Hull Univ, Hull Int Fisheries Inst, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England	University of Hertfordshire; Swansea University; Bournemouth University; University of Hull	Rees, EMA (corresponding author), Hertfordshire Univ, Dept Life Sci, Hatfield, Herts, England.	annrees2006@hotmail.co.uk	Britton, Robert/B-5040-2009; Alam, M Fasihul/AAD-7268-2020; Cowx, Ian G/A-5540-2009	Britton, Robert/0000-0003-1853-3086; Alam, M Fasihul/0000-0003-2590-851X				Aprahamian MW, 2010, FISHERIES MANAG ECOL, V17, P93, DOI 10.1111/j.1365-2400.2009.00667.x; Arlinghaus R., 2006, Human Dimensions of Wildlife, V11, P229, DOI 10.1080/10871200600802889; Arlinghaus R, 2003, FISH RES, V61, P19, DOI 10.1016/S0165-7836(02)00243-6; Arlinghaus R, 2015, FISHERIES MANAG ECOL, V22, P45, DOI 10.1111/fme.12075; Arlinghaus R, 2002, FISH FISH, V3, P261, DOI 10.1046/j.1467-2979.2002.00102.x; Arlinghaus R, 2012, FISHERIES, V37, P165, DOI 10.1080/03632415.2012.666473; Beardmore B, 2011, N AM J FISH MANAGE, V31, P861, DOI 10.1080/02755947.2011.629855; Benejam Lluis, 2007, Limnetica, V26, P169; Bevacqua D, 2011, HYDROBIOLOGIA, V671, P259, DOI 10.1007/s10750-011-0725-1; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Britton JR, 2007, FISHERIES MANAG ECOL, V14, P263, DOI 10.1111/j.1365-2400.2007.00554.x; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Britton JR, 2011, FISH FISH, V12, P256, DOI 10.1111/j.1467-2979.2010.00390.x; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Carol J, 2009, FUND APPL LIMNOL, V174, P317, DOI 10.1127/1863-9135/2009/0174-0317; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Copp Gordon H., 2007, Aquatic Invasions, V2, P113; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; Czarnecki Maciej, 2003, Archiwum Rybactwa Polskiego, V11, P141; Dorow M, 2011, AM FISH S S, V75, P319; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Gozlan RE, 2010, AQUAT INVASIONS, V5, P231, DOI 10.3391/ai.2010.5.3.02; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Hauser P, 1969, MONOGRAPH AM ACAD PO, V9, P100; Haworth J. T., 1983, Leisure Sciences, V5, P181, DOI 10.1080/01490408309513002; Hickley P, 2004, FISHERIES MANAG ECOL, V11, P203, DOI 10.1111/j.1365-2400.2004.00395.x; Hughes S, 2000, FISHERIES MANAG ECOL, V7, P75, DOI 10.1046/j.1365-2400.2000.00180.x; Johnston FD, 2013, FISH FISH, V14, P554, DOI 10.1111/j.1467-2979.2012.00487.x; Lever C, 1996, NATURALIZED FISHES W; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Martino A, 2011, AQUAT CONSERV, V21, P276, DOI 10.1002/aqc.1177; North R., 2002, Management and ecology of lake and reservoir fisheries. Proceedings of the symposium and workshop on Management and Ecology of Lake and Reservoir Fisheries, Hull, UK, April 2000, P284; Oystein A, 1991, SOCIAL SCI FRESHWATE, P44; Paulrud A, 2001, ARBETSRAPPORT I SKOG, V300, P29; Peirson G, 2001, FISHERIES MANAG ECOL, V8, P415, DOI 10.1046/j.1365-2400.2001.00263.x; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Rees EMA, 2014, J APPL ICHTHYOL, V30, P127, DOI 10.1111/jai.12254; Rees EMA, 2010, RIVER HAMPSHIR UNPUB, P1; Schroeder S. A., 2006, Human Dimensions of Wildlife, V11, P301, DOI 10.1080/10871200600894928; SERNS SL, 1981, T AM FISH SOC, V110, P216, DOI 10.1577/1548-8659(1981)110<216:ROAETT>2.0.CO;2; Syvaranta J, 2009, NATURWISSENSCHAFTEN, V96, P631, DOI 10.1007/s00114-009-0511-3; Williams AE, 2001, AQUAT CONSERV, V11, P357, DOI 10.1002/aqc.466; Zwirn Michael, 2005, Journal of Ecotourism, V4, P16, DOI 10.1080/14724040508668435	44	11	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178805	10.1371/journal.pone.0178805	http://dx.doi.org/10.1371/journal.pone.0178805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604839	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000403088400017
J	Ishii, T; Kawakami, E; Endo, K; Misawa, H; Watabe, K				Ishii, Tomohiro; Kawakami, Emiko; Endo, Kentaro; Misawa, Hidemi; Watabe, Kazuhiko			Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; UBIQUITIN-PROTEASOME SYSTEM; NEURODEGENERATIVE DISEASES; IN-VITRO; PROTEIN; NUCLEAR; EXPRESSION; CLEARANCE; AUTOPHAGY	TAR DNA-binding protein 43 (TDP-43) is a main constituent of cytoplasmic aggregates in neuronal and glial cells in cases of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. We have previously demonstrated that adenovirus-transduced artificial TDP-43 cytoplasmic aggregates formation is enhanced by proteasome inhibition in vitro and in vivo. However, the relationship between cytoplasmic aggregate formation and cell death remains unclear. In the present study, rat neural stem cell lines stably transfected with EGFP- or Sirius-expression vectors under the control of tubulin beta III, glial fibrillary acidic protein, or 2',3'-cyclic nucleotide 3'-phosphodiesterase promoter were differentiated into neurons, astrocytes, and oligodendrocytes, respectively, in the presence of retinoic acid. The differentiated cells were then transduced with adenoviruses expressing DsRed-tagged human wild type and C-terminal fragment TDP-43 under the condition of proteasome inhibition. Time-lapse imaging analyses revealed growing cytoplasmic aggregates in the transduced neuronal and glial cells, followed by collapse of the cell. The aggregates remained insoluble in culture media, consisted of sarkosyl-insoluble granular materials, and contained phosphorylated TDP-43. Moreover, the released aggregates were incorporated into neighboring neuronal cells, suggesting cell-to-cell spreading. The present study provides a novel tool for analyzing the detailed molecular mechanisms of TDP-43 proteinopathy in vitro.	[Ishii, Tomohiro; Kawakami, Emiko; Watabe, Kazuhiko] Tokyo Metropolitan Inst Med Sci, Lab Neurodegenerat Pathol, Tokyo, Japan; [Ishii, Tomohiro; Misawa, Hidemi] Keio Univ, Fac Pharm, Div Pharmacol, Tokyo, Japan; [Endo, Kentaro] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Tokyo, Japan; [Watabe, Kazuhiko] Kyorin Univ, Fac Hlth Sci, Dept Med Technol Neuropathol, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Keio University; Tokyo Metropolitan Institute of Medical Science; Kyorin University	Watabe, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Neurodegenerat Pathol, Tokyo, Japan.; Misawa, H (corresponding author), Keio Univ, Fac Pharm, Div Pharmacol, Tokyo, Japan.; Watabe, K (corresponding author), Kyorin Univ, Fac Hlth Sci, Dept Med Technol Neuropathol, Tokyo, Japan.	misawa-hd@pha.keio.ac.jp; watabe@ks.kyorin-u.ac.jp		Ishii, Tomohiro/0000-0003-3092-1401; Watabe, Kazuhiko/0000-0002-0245-3834	Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (JSPS KAKENHI) [24500428, 15K06763]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities [S1411004]	Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (JSPS KAKENHI); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (JSPS KAKENHI; https://www.isps.go.jp/english/e-grants/index.html) #24500428, #15K06763 (to K.W.) and MEXT-Supported Program for the Strategic Research Foundation (http://www.mext.go.jp/en/) at Private Universities 2014-2016 (#S1411004 to H.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6; Bourdenx M., 2015, PROG NEUROBIOL; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cowan CM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00114; Dennis K, 2002, GENE, V294, P269, DOI 10.1016/S0378-1119(02)00801-6; Feiler MS, 2015, J CELL BIOL, V211, P897, DOI 10.1083/jcb.201504057; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Gravel M, 2000, J NEUROCHEM, V75, P1940, DOI 10.1046/j.1471-4159.2000.0751940.x; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hornburg D, 2014, MOL CELL PROTEOMICS, V13, P3410, DOI 10.1074/mcp.M113.037291; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Krantic S, 2005, TRENDS NEUROSCI, V28, P670, DOI 10.1016/j.tins.2005.09.011; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; Lim J, 2015, DEV CELL, V32, P491, DOI 10.1016/j.devcel.2015.02.002; Mihevc SP, 2017, BRAIN, V140, P13, DOI 10.1093/brain/aww197; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nishimura AL, 2010, BRAIN, V133, P1763, DOI 10.1093/brain/awq111; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Nonaka T, 2009, FEBS LETT, V583, P394, DOI 10.1016/j.febslet.2008.12.031; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Ruegsegger C, 2016, BRAIN RES, V1648, P571, DOI 10.1016/j.brainres.2016.03.032; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Watabe K, 2014, NEUROPATHOLOGY, V34, P83, DOI 10.1111/neup.12058; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xiao SX, 2015, ACTA NEUROPATHOL, V130, P49, DOI 10.1007/s00401-015-1412-5; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	52	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179375	10.1371/journal.pone.0179375	http://dx.doi.org/10.1371/journal.pone.0179375			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599005	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000035
J	Meyer, C; Felblinger, J; Vuissoz, PA; Bonnemains, L				Meyer, Christophe; Felblinger, Jacques; Vuissoz, Pierre-Andre; Bonnemains, Laurent			Accuracy of subject-specific prediction of end-systolic time in MRI across a range of RR intervals	PLOS ONE			English	Article							SHRINKAGE THRESHOLDING ALGORITHM; TEMPORAL-RESOLUTION; PHASE-CONTRAST; VELOCITY; QUANTIFICATION; CHILDREN; DURATION; DOPPLER; IMPROVE	Background Prediction of End-Systole time is of utmost importance for cardiac MRI to correctly associate acquired k-space lines during reconstruction of cine acquisitions. This prediction is usually based on the patient's heart rate using Weissler's formula, which was calibrated by linear regression within a population and cannot account for individual variability. Objective We propose an automatic method to build a personalized model that better predicts end-systole. Methods A phase contrast sequence was modified to acquire only central k-space line with 6.6ms temporal resolution, in a slice passing through the aorta during 128 heartbeats in 35 subjects. Segmentation of aorta and detection of end of systolic ejection was automatic. Duration of electromechanical systole duration as function of heart rate was determined for each subject separately. Results In comparison with the global models, the adapted cardiac model predicted significantly better both echocardiographic end-systolic reference (bias = 0ms vs 17ms, p<0.001) and MRI measurements (bias = 6.8ms vs 17ms). Favorable impact was shown on the cine reconstruction of the 5 subjects with the higher cardiac variability (p = 0.02). Conclusions Personalization of cardiac model to the subject is feasible in MRI and reduces the error of prediction of systole.	[Meyer, Christophe; Felblinger, Jacques; Vuissoz, Pierre-Andre; Bonnemains, Laurent] INSERM, U947, Nancy, France; [Meyer, Christophe; Felblinger, Jacques; Vuissoz, Pierre-Andre] Univ Loraine, IADI, Nancy, France; [Felblinger, Jacques] CHU Nancy, Clin Invest Ctr CIC IT 1433, Nancy, France; [Bonnemains, Laurent] CHU Strasbourg, Dept Cardiac Surg, Strasbourg, France; [Bonnemains, Laurent] Univ Strasbourg, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine; CHU de Nancy; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bonnemains, L (corresponding author), INSERM, U947, Nancy, France.; Bonnemains, L (corresponding author), CHU Strasbourg, Dept Cardiac Surg, Strasbourg, France.; Bonnemains, L (corresponding author), Univ Strasbourg, Strasbourg, France.	laurent.bonnemains@inserm.fr	Felblinger, Jacques/ABG-2033-2021; Vuissoz, Pierre-André/Y-8259-2019; bonnemains, laurent/A-3394-2013	Felblinger, Jacques/0000-0002-9245-6595; Vuissoz, Pierre-André/0000-0003-3519-1743; bonnemains, laurent/0000-0002-5194-1762				BOCK M, 1995, MAGN RESON IMAGING, V13, P21, DOI 10.1016/0730-725X(94)00077-G; Bonnemains L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143744; BOUDOULAS H, 1979, CIRCULATION, V60, P164, DOI 10.1161/01.CIR.60.1.164; Feinstein JA, 1997, JMRI-J MAGN RESON IM, V7, P794, DOI 10.1002/jmri.1880070505; FLESSAS AP, 1970, AM HEART J, V80, P522, DOI 10.1016/0002-8703(70)90201-2; GOLDE D, 1970, CIRCULATION, V42, P1029, DOI 10.1161/01.CIR.42.6.1029; HARRIS LC, 1964, AM J CARDIOL, V14, P448, DOI 10.1016/0002-9149(64)90028-1; Jung B, 2006, J MAGN RESON IMAGING, V24, P1033, DOI 10.1002/jmri.20703; Langham MC, 2011, MAGN RESON MED, V65, P750, DOI 10.1002/mrm.22651; Lin HY, 2012, MAGN RESON MED, V68, P703, DOI 10.1002/mrm.23273; Meyer C, 2012, J CARDIOVASCULAR MAG, V14, pW53; Meyer C, 2012, MAGNETIC RESONANCE M, V25, P339; Meyer C, 2014, MAGN RESON MATER PHY, V27, P211, DOI 10.1007/s10334-013-0405-4; Moller HE, 1996, J MAGN RESON IMAGING, V6, P503, DOI 10.1002/jmri.1880060314; Odille F, 2005, P 22 ANN M ESMRMB BA; Odille F, 2007, IEEE T BIO-MED ENG, V54, P630, DOI 10.1109/TBME.2006.889174; Oster J, 2010, IEEE T BIO-MED ENG, V57, P1628, DOI 10.1109/TBME.2010.2046324; R Core Team, 2020, R LANG ENV STAT COMP; Sengupta PP, 2007, J AM COLL CARDIOL, V49, P899, DOI 10.1016/j.jacc.2006.07.075; Siest G, 1998, CLIN CHEM LAB MED, V36; SLODKI SJ, 1969, J AM GERIATR SOC, V17, P673, DOI 10.1111/j.1532-5415.1969.tb02321.x; WEISSLER AM, 1965, AM J CARDIOL, V15, P153, DOI 10.1016/0002-9149(65)90449-2; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149; WILLEMS JL, 1970, CIRCULATION, V42, P37, DOI 10.1161/01.CIR.42.1.37; Zhang Y, 2011, J ELECTROMAGNET WAVE, V25, P1081, DOI 10.1163/156939311795762024; Zhang YD, 2015, INFORM SCIENCES, V322, P115, DOI 10.1016/j.ins.2015.06.017; Zhang YD, 2015, IEEJ T ELECTR ELECTR, V10, P116, DOI 10.1002/tee.22059; Zhang YD, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/546814; Zhou K, 2009, MAGN RESON MED, V62, P1085, DOI 10.1002/mrm.22074	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179011	10.1371/journal.pone.0179011	http://dx.doi.org/10.1371/journal.pone.0179011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598980	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000019
J	Noyma, NP; de Magalhaes, L; Miranda, M; Mucci, M; van Oosterhout, F; Huszar, VLM; Marinho, MM; Lima, ERA; Lurling, M				Noyma, Natalia P.; de Magalhaes, Leonardo; Miranda, Marcela; Mucci, Maira; van Oosterhout, Frank; Huszar, Vera L. M.; Marinho, Marcelo M.; Lima, Eduardo R. A.; Lurling, Miquel			Coagulant plus ballast technique provides a rapid mitigation of cyanobacterial nuisance	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; MICROCYSTIS-AERUGINOSA; HYDROGEN-PEROXIDE; CLAY FLOCCULATION; WATER-TREATMENT; LOCAL SOILS; FRESH-WATER; REMOVAL; CHITOSAN; EUTROPHICATION	Cyanobacteria blooms are a risk to environmental health and public safety due to the potent toxins certain cyanobacteria can produce. These nuisance organisms can be removed from water bodies by biomass flocculation and sedimentation. Here, we studied the efficacy of combinations of a low dose coagulant (poly-aluminium chloride-PAC-or chitosan) with different ballast compounds (red soil, bauxite, gravel, aluminium modified zeolite and lanthanum modified bentonite) to remove cyanobacterial biomass from water collected in Funil Reservoir (Brazil). We tested the effect of different cyanobacterial biomass concentrations on removal efficiency. We also examined if zeta potential was altered by treatments. Addition of low doses of PAC and chitosan (1-8 mg Al L-1) to the cyanobacterial suspensions caused flock formation, but did not settle the cyanobacteria. When those low dose coagulants were combined with ballast, effective settling in a dose-dependent way up to 99.7% removal of the flocks could be achieved without any effect on the zeta potential and thus without potential membrane damage. Removal efficacy was influenced by the cyanobacterial biomass and at higher biomass more ballast was needed to achieve good removal. The combined coagulant-ballast technique provides a promising alternative to algaecides in lakes, ponds and reservoirs.	[Noyma, Natalia P.; de Magalhaes, Leonardo; Miranda, Marcela; Marinho, Marcelo M.] Univ Estado Rio De Janeiro, Dept Plant Biol, Lab Ecol & Physiol Phytoplankton, Rio De Janeiro, Brazil; [Mucci, Maira; van Oosterhout, Frank; Lurling, Miquel] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, Wageningen, Netherlands; [Huszar, Vera L. M.] Univ Fed Rio de Janeiro, Museu Nacl, Rio De Janeiro, Brazil; [Lima, Eduardo R. A.] Univ Estado Rio De Janeiro, Chem Inst, Rio De Janeiro, RJ, Brazil; [Lurling, Miquel] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	Universidade do Estado do Rio de Janeiro; Wageningen University & Research; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Noyma, NP (corresponding author), Univ Estado Rio De Janeiro, Dept Plant Biol, Lab Ecol & Physiol Phytoplankton, Rio De Janeiro, Brazil.	np.noyma@gmail.com	Miranda, Marcela A.C.N/G-7811-2017; Huszar, Vera L M/J-7126-2012; Noyma, Natália P/V-4708-2018; Miranda, Marcela/AAY-3456-2020; Marinho, Marcelo Manzi/C-1515-2013; KNAW, NIOO-KNAW/A-4320-2012	Miranda, Marcela A.C.N/0000-0001-6994-8690; Huszar, Vera L M/0000-0002-8096-1404; Noyma, Natália P/0000-0001-5301-9408; Miranda, Marcela/0000-0001-6994-8690; Marinho, Marcelo Manzi/0000-0001-5661-4528; Mucci, Maira/0000-0002-3896-2294; de Magalhaes, Leonardo/0000-0003-0167-0690; Rocha de Almeida Lima, Eduardo/0000-0003-4767-1672; KNAW, NIOO-KNAW/0000-0002-3835-159X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [400408/2014-7]; Fudacao de Apoio a Pesquisa do Estado do Rio de Janeiro [FAPERJ-111.267/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fudacao de Apoio a Pesquisa do Estado do Rio de Janeiro	This study was sponsored by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a Science without Borders Grant (400408/2014-7) and by Fudacao de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ-111.267/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrington DJ, 2013, ECOL ENG, V50, P86, DOI 10.1016/j.ecoleng.2012.04.024; Carpenter SR, 2005, P NATL ACAD SCI USA, V102, P10002, DOI 10.1073/pnas.0503959102; Chen W, 2008, WATER RES, V42, P763, DOI 10.1016/j.watres.2007.08.007; Cheng PX, 2015, WATER SCI TECH-W SUP, V15, P339, DOI 10.2166/ws.2014.119; Codd GA, 2005, TOXICOL APPL PHARM, V203, P264, DOI 10.1016/j.taap.2004.02.016; Cooke G.D., 2005, RESTORATION MANAGEME, Vthird, DOI DOI 10.1002/RRR.3450090207; de MagalhAes L, 2016, ESTUAR COAST, P1; Dittmann E, 2006, MOL NUTR FOOD RES, V50, P7, DOI 10.1002/mnfr.200500162; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Douglas GB, 2002, GOOGLE PATENTS; Funari E, 2008, CRIT REV TOXICOL, V38, P97, DOI 10.1080/10408440701749454; Greenfield DI, 2014, ENVIRON MANAGE, V54, P1110, DOI 10.1007/s00267-014-0339-2; Grutzmacher G, 2010, ENVIRON SCI TECHNOL, V44, P657, DOI 10.1021/es9016816; Hagstrom JA, 2005, HARMFUL ALGAE, V4, P249, DOI 10.1016/j.hal.2004.03.004; Hamilton DP, 2016, AQUAT ECOL, V50, P351, DOI 10.1007/s10452-016-9594-z; Han J, 2013, ECOTOX ENVIRON SAFE, V96, P17, DOI 10.1016/j.ecoenv.2013.06.008; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Henderson RK, 2008, SEPAR SCI TECHNOL, V43, P1653, DOI 10.1080/01496390801973771; Holst T, 2003, WATER RES, V37, P4748, DOI 10.1016/S0043-1354(03)00413-5; Huang CP, 1996, J CHEM TECHNOL BIOT, V66, P227, DOI 10.1002/(SICI)1097-4660(199607)66:3<227::AID-JCTB499>3.0.CO;2-M; Jancula D, 2011, CHEMOSPHERE, V85, P1415, DOI 10.1016/j.chemosphere.2011.08.036; JONES GJ, 1994, WATER RES, V28, P871, DOI 10.1016/0043-1354(94)90093-0; Li H, 2015, ENVIRON SCI TECHNOL, V49, P6249, DOI 10.1021/acs.est.5b00840; Li J, 2013, INT J BIOL MACROMOL, V62, P4, DOI 10.1016/j.ijbiomac.2013.08.009; Li L, 2015, J ENVIRON SCI, V28, P47, DOI 10.1016/j.jes.2014.04.017; Li L, 2013, ENVIRON SCI TECHNOL, V47, P4555, DOI 10.1021/es305234d; Li ZH, 2015, INT J BIOL MACROMOL, V75, P378, DOI 10.1016/j.ijbiomac.2015.01.056; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Lurling M, 2014, TOXINS, V6, P3260, DOI 10.3390/toxins6123260; Lurling M, 2013, WATER RES, V47, P6527, DOI 10.1016/j.watres.2013.08.019; Lurling M, 2013, HYDROBIOLOGIA, V710, P253, DOI 10.1007/s10750-012-1141-x; Matthijs HCP, 2012, WATER RES, V46, P1460, DOI 10.1016/j.watres.2011.11.016; Miao CG, 2014, ENVIRON TECHNOL, V35, P340, DOI 10.1080/09593330.2013.828091; Noyma NP, 2016, WATER RES, V97, P26, DOI 10.1016/j.watres.2015.11.057; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2014, ESTUAR COAST, V37, P243, DOI 10.1007/s12237-014-9773-x; Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047; Pan G, 2012, ENVIRON SCI TECHNOL, V46, P5077, DOI 10.1021/es3000307; Pan G, 2011, HARMFUL ALGAE, V10, P381, DOI 10.1016/j.hal.2011.01.003; Pan G, 2011, ECOL ENG, V37, P302, DOI 10.1016/j.ecoleng.2010.11.019; Park TG, 2013, HARMFUL ALGAE, V30, pS131, DOI 10.1016/j.hal.2013.10.012; Pierce RH, 2004, HARMFUL ALGAE, V3, P141, DOI 10.1016/j.hal.2003.09.003; Rangel LM, 2012, HYDROBIOLOGIA, V693, P13, DOI 10.1007/s10750-012-1083-3; Sarpola A, 2004, J MASS SPECTROM, V39, P1209, DOI 10.1002/jms.722; Sengco MR, 2001, MAR ECOL PROG SER, V210, P41, DOI 10.3354/meps210041; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Soares MCS, 2009, AQUAT MICROB ECOL, V57, P137, DOI 10.3354/ame01336; Spears BM, 2013, SCI TOTAL ENVIRON, V442, P103, DOI 10.1016/j.scitotenv.2012.09.066; Sun F, 2013, SEP PURIF TECHNOL, V115, P123, DOI 10.1016/j.seppur.2013.05.004; van Loosdrecht MCM, 2014, SCIENCE, V344, P1452, DOI 10.1126/science.1255183; Van Oosterhout F, 2011, J PLANKTON RES, V33, P255, DOI 10.1093/plankt/fbq092; Waajen G, 2016, WATER RES, V97, P83, DOI 10.1016/j.watres.2015.11.034; Watson SB, 1997, LIMNOL OCEANOGR, V42, P487, DOI 10.4319/lo.1997.42.3.0487; White S, 2011, BIORESOURCE TECHNOL, V102, P1675, DOI 10.1016/j.biortech.2010.09.097; Wu CD, 2011, WATER SCI TECH-W SUP, V11, P159, DOI 10.2166/ws.2011.030; Wulff A, 2007, HARMFUL ALGAE, V6, P388, DOI 10.1016/j.hal.2006.11.003; Yang R, 2016, WATER RES, V95, P59, DOI 10.1016/j.watres.2016.02.068; Yu X, 1996, J COLLOID INTERF SCI, V177, P283, DOI 10.1006/jcis.1996.0033; Zou H, 2006, ENVIRON POLLUT, V141, P201, DOI 10.1016/j.envpol.2005.08.042	60	17	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178976	10.1371/journal.pone.0178976	http://dx.doi.org/10.1371/journal.pone.0178976			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598977	Green Published, gold			2022-12-26	WOS:000402992000018
J	Rouviere, O; Dagonneau, T; Cros, F; Bratan, F; Roche, L; Mege-Lechevallier, F; Ruffion, A; Crouzet, S; Colombel, M; Rabilloud, M				Rouviere, Olivier; Dagonneau, Tristan; Cros, Fanny; Bratan, Flavie; Roche, Laurent; Mege-Lechevallier, Florence; Ruffion, Alain; Crouzet, Sebastien; Colombel, Marc; Rabilloud, Muriel			Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS; CONTRAST-ENHANCED MRI; DATA SYSTEM; PERIPHERAL ZONE; 3 T; LOCALIZATION; DIFFUSION; GUIDELINES; SUSPICION; ACCURACY	Purpose To assess the diagnostic weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers (csPCa). Materials and methods We used a prospective database of 262 patients who underwent T2-weighted, diffusion-weighted, and dynamic contrast-enhanced (DCE) imaging before prostatectomy. For each lesion, two independent readers (R1, R2) prospectively defined nine features: shape, volume (V_Max), signal abnormality on each pulse sequence, number of pulse sequences with a marked (S_Max) and non-visible (S_Min) abnormality, likelihood of extracapsular extension (ECE) and PSA density (dPSA). Overall likelihood of malignancy was assessed using a 5-level Likert score. Features were evaluated using the area under the receiver operating characteristic curve (AUC). csPCa was defined as Gleason >= 7 cancer (csPCa-A), Gleason >= 7(4+3) cancer (csPCa-B) or Gleason >= 7 cancer with histological extraprostatic extension (csPCa-C), Results For csPCa-A, the Signal1 model (S_Max+S_Min) provided the best combination of signal-related variables, for both readers. The performance was improved by adding V_Max, ECE and/or dPSA, but not shape. All models performed better with DCE findings than without. When moving from csPCa-A to csPCa-B and csPCa-C definitions, the added value of V_Max, dPSA and ECE increased as compared to signal-related variables, and the added value of DCE decreased. For R1, the best models were Signal1+ECE+dPSA (AUC = 0,805 [95% CI: 0,757-0,866]), Signal1+V_Max+dPSA (AUC = 0.823 [95% CI: 0.760-0.893]) and Signal1+ECE+dPSA [AUC = 0.840 (95% CI: 0.774-0.907)] for csPCa-A, csPCA-B and csPCA-C respectively. The AUCs of the corresponding Likert scores were 0.844 [95% CI: 0.806-0.877, p = 0.11], 0.841 [95% CI: 0.799-0.876, p = 0.52]) and 0.849 [95% CI: 0.811-0.884, p = 0.49], respectively. For R2, the best models were Signal1+ V_Max+dPSA (AUC = 0,790 [95% CI: 0,731-0,857]), Signal1+ V_Max (AUC = 0.813 [95% CI: 0.746-0.882]) and Signal1+ECE+V_Max (AUC = 0.843 [95% CI: 0.781-0.907]) for csPCa-A, csPCA-B and csPCA-C respectively. The AUCs of the corresponding Likert scores were 0.829 [95% CI: 0.791-0.868, p = 0.13], 0.790 [95% CI: 0.742-0.841, p = 0.12]) and 0.808 [95% CI: 0.764-0.845, p = 0.006]), respectively. Conclusion Combination of simple variables can match the Likert score's results. The optimal combination depends on the definition of csPCa.	[Rouviere, Olivier; Cros, Fanny; Bratan, Flavie] Hosp Civils Lyon, Dept Urinary & Vasc Imaging, Hop Edouard Herriot, Lyon, France; [Rouviere, Olivier; Crouzet, Sebastien; Colombel, Marc; Rabilloud, Muriel] Univ Lyon, Lyon, France; [Rouviere, Olivier; Crouzet, Sebastien; Colombel, Marc; Rabilloud, Muriel] Univ Lyon 1, Fac Med Lyon Est, Lyon, France; [Rouviere, Olivier; Crouzet, Sebastien] INSERM, U1032, LabTau, Lyon, France; [Dagonneau, Tristan; Roche, Laurent; Rabilloud, Muriel] Hosp Civils Lyon, Serv Biostat & Bioinformat, Lyon, France; [Dagonneau, Tristan; Roche, Laurent; Rabilloud, Muriel] CNRS, UMR5558, Lab Biometrie & Biol Evolut, Equipe Biotat Sante, Villeurbanne, France; [Mege-Lechevallier, Florence] Hosp Civils Lyon, Hop Edouard Herriot, Dept Pathol, Lyon, France; [Ruffion, Alain] Hosp Civils Lyon, Dept Urol, Ctr Hosp Lyon Sud, Pierre Benite, France; [Crouzet, Sebastien; Colombel, Marc] Hosp Civils Lyon, Dept Urol, Hop Edouard Herriot, Lyon, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CHU Lyon; CHU Lyon; CHU Lyon	Rouviere, O (corresponding author), Hosp Civils Lyon, Dept Urinary & Vasc Imaging, Hop Edouard Herriot, Lyon, France.; Rouviere, O (corresponding author), Univ Lyon, Lyon, France.; Rouviere, O (corresponding author), Univ Lyon 1, Fac Med Lyon Est, Lyon, France.; Rouviere, O (corresponding author), INSERM, U1032, LabTau, Lyon, France.	olivier.rouviere@netcourrier.com	; Rouviere, Olivier/O-8150-2017	Roche, Laurent/0000-0001-8946-4917; Rouviere, Olivier/0000-0002-0030-478X				Dinh AH, 2016, RADIOLOGY, V280, P117, DOI 10.1148/radiol.2016151406; Barentsz JO, 2016, EUR UROL, V69, P41, DOI 10.1016/j.eururo.2015.08.038; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Bratan F, 2015, RADIOLOGY, V275, P144, DOI 10.1148/radiol.14140524; Bratan F, 2013, EUR RADIOL, V23, P2019, DOI 10.1007/s00330-013-2795-0; Chesnais AL, 2013, CLIN RADIOL, V68, pE323, DOI 10.1016/j.crad.2013.01.018; Costa DN, 2016, J UROLOGY, V195, P80, DOI 10.1016/j.juro.2015.07.080; de Cobelli O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139696; Delongchamps NB, 2011, BJU INT, V107, P1411, DOI 10.1111/j.1464-410X.2010.09808.x; Dhingsa R, 2004, RADIOLOGY, V230, P215, DOI 10.1148/radiol.2301021562; Dickinson L, 2011, EUR UROL, V59, P477, DOI 10.1016/j.eururo.2010.12.009; Dinh AH, 2015, DIAGN INTERV IMAG, V96, P365, DOI 10.1016/j.diii.2014.11.016; Eggener SE, 2015, J UROLOGY, V194, P626, DOI 10.1016/j.juro.2015.01.126; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Girouin N, 2007, EUR RADIOL, V17, P1498, DOI 10.1007/s00330-006-0478-9; Habchi H, 2014, CLIN RADIOL, V69, pE120, DOI 10.1016/j.crad.2013.10.018; Hambrock T, 2013, RADIOLOGY, V266, P521, DOI 10.1148/radiol.12111634; Hamoen EHJ, 2015, EUR UROL, V67, P1112, DOI 10.1016/j.eururo.2014.10.033; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hoeks CMA, 2013, RADIOLOGY, V266, P207, DOI 10.1148/radiol.12120281; Hom JJ, 2006, RADIOLOGY, V238, P192, DOI 10.1148/radiol.2381041675; Isebaert S, 2013, J MAGN RESON IMAGING, V37, P1392, DOI 10.1002/jmri.23938; Kim JY, 2014, RADIOLOGY, V271, P435, DOI 10.1148/radiol.13130801; Langer DL, 2009, J MAGN RESON IMAGING, V30, P327, DOI 10.1002/jmri.21824; Mertan FV, 2016, J UROLOGY, V196, P690, DOI 10.1016/j.juro.2016.04.057; Moldovan PC, 2017, EUR UROL; Mozer P, 2015, BJU INT, V115, P50, DOI 10.1111/bju.12690; Muller BG, 2015, RADIOLOGY, V277, P741, DOI 10.1148/radiol.2015142818; Niaf E, 2014, RADIOLOGY, V271, P761, DOI 10.1148/radiol.14130448; Park SY, 2016, RADIOLOGY, V280, P108, DOI 10.1148/radiol.16151133; Perdona S, 2013, UROL ONCOL-SEMIN ORI, V31, P761, DOI 10.1016/j.urolonc.2011.07.010; Puech P, 2013, Diagn Interv Imaging, V94, P1299, DOI 10.1016/j.diii.2013.09.010; Puech P, 2013, RADIOLOGY, V268, P461, DOI 10.1148/radiol.13121501; Rais-Bahrami S, 2013, J UROLOGY, V190, P1721, DOI 10.1016/j.juro.2013.05.052; Rastinehad AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143404; Renard-Penna R, 2015, RADIOLOGY, V275, P458, DOI 10.1148/radiol.14140184; Riches SF, 2015, EUR RADIOL, V25, P1247, DOI 10.1007/s00330-014-3479-0; Rosenkrantz AB, 2016, RADIOLOGY, DOI DOI 10.1148/RADIOL.2016152542; Rosenkrantz AB, 2016, AM J ROENTGENOL, P1; Rosenkrantz AB, 2016, AM J ROENTGENOL, V206, P1040, DOI 10.2214/AJR.15.15768; Rosenkrantz Andrew B, 2013, Radiology, V269, P482, DOI 10.1148/radiol.13122233; Rouviere O, 2012, EUR RADIOL, V22, P1149, DOI 10.1007/s00330-011-2343-8; Samaratunga H, 2011, MODERN PATHOL, V24, P6, DOI 10.1038/modpathol.2010.178; Schoots IG, 2015, EUR UROL, V68, P438, DOI 10.1016/j.eururo.2014.11.037; Tan CH, 2015, AM J ROENTGENOL, V204, pW439, DOI 10.2214/AJR.14.13373; Turkbey B, 2013, RADIOLOGY, V268, P144, DOI 10.1148/radiol.13121325; Turkbey B, 2010, RADIOLOGY, V255, P89, DOI 10.1148/radiol.09090475; Vache T, 2014, RADIOLOGY, V272, P446, DOI 10.1148/radiol.14131584; Valerio M, 2015, EUR UROL, V68, P8, DOI 10.1016/j.eururo.2014.10.026; Vargas HA, 2015, EUR RADIOL; Vargas HA, 2012, RADIOLOGY, V265, P478, DOI 10.1148/radiol.12120041; Vilanova JC, 2011, AM J ROENTGENOL, V196, pW715, DOI 10.2214/AJR.10.5700; Vos EK, 2015, INVEST RADIOL, V50, P490, DOI 10.1097/RLI.0000000000000157; Washino S, 2017, BJU INT, V119, P225, DOI 10.1111/bju.13465; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052	56	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178901	10.1371/journal.pone.0178901	http://dx.doi.org/10.1371/journal.pone.0178901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599001	Green Published, gold, Green Submitted			2022-12-26	WOS:000402992000013
J	Zhang, K; Myllymaki, SM; Gao, P; Devarajan, R; Kytola, V; Nykter, M; Wei, GH; Manninen, A				Zhang, K.; Myllymaki, S-M; Gao, P.; Devarajan, R.; Kytola, V.; Nykter, M.; Wei, G-H; Manninen, A.			Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with alpha V-Class integrins to promote EMT	ONCOGENE			English	Article							BREAST-CANCER CELLS; PROSTATE-CANCER; SIGNALING PATHWAYS; EPITHELIAL-CELLS; SRC; GROWTH; ALPHA-V-BETA-6; INHIBITION; POLARITY; PLATFORM	In many cancer types, integrin-mediated signaling regulates proliferation, survival and invasion of tumorigenic cells. However, it is still unclear how integrins crosstalk with oncogenes to regulate tumorigenesis and metastasis. Here we show that oncogenic K-Ras(V12) upregulates alpha 6-integrin expression in Madin-Darby canine kidney (MDCK) cells via activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK)/Fos-related antigen 1-signaling cascade. Activated alpha 6-integrins promoted metastatic capacity and anoikis resistance, and led to perturbed growth of MDCK cysts. Transcriptomic analysis of K-Ras(V12)-transformed MDCK cells also revealed robust downregulation of alpha V-class integrins. Re-expression of alpha V-integrin in K-Ras(V12)-transformed MDCK cells synergistically upregulated the expression of Zinc finger E-box-binding homeobox 1 and Twist-related protein 1 and triggered epithelial-mesenchymal transition leading to induced cell motility and invasion. These results delineate the signaling cascades connecting oncogenic K-Ras(V12) with alpha 6- and alpha V-integrin functions to modulate cancer cell survival and tumorigenesis, and reveal new possible strategies to target highly oncogenic K-Ras(V12) mutants.	[Zhang, K.; Myllymaki, S-M; Gao, P.; Devarajan, R.; Wei, G-H; Manninen, A.] Univ Oulu, Fac Biochem & Mol Med, Ctr Excellence Cell Extracellular Matrix Res, Bioctr Oulu, Aapistie 5, SF-90220 Oulu, Finland; [Kytola, V.; Nykter, M.] Univ Tampere, Inst Biomed Technol & BioMediTech, Prostate Canc Res Ctr, Tampere, Finland; [Kytola, V.; Nykter, M.] Tampere Univ Hosp, Tampere, Finland; [Myllymaki, S-M] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Helsinki, Finland	University of Oulu; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Manninen, A (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Ctr Excellence Cell Extracellular Matrix Res, Bioctr Oulu, Aapistie 5, SF-90220 Oulu, Finland.	aki.manninen@oulu.fi	Devarajan, Raman/GOH-0098-2022; Zhang, Kai/M-9831-2017; Manninen, Aki/AAC-8067-2019	Zhang, Kai/0000-0003-2962-3976; Manninen, Aki/0000-0002-6263-8101; Nykter, Matti/0000-0001-6956-2843; Wei, Gong-Hong/0000-0001-6546-9334; Devarajan, Raman/0000-0002-8728-0476; gao, ping/0000-0003-1383-3290; Myllymaki, Satu-Marja/0000-0003-0521-5062	Academy of Finland [251314, 135560, 263770, 140974/AM, 284618, 279760/GHW]	Academy of Finland(Academy of Finland)	We thank Dr Ritva Heljasvaara and Dr Heli Ruotsalainen for their help related to mouse work. Riitta Jokela is acknowledged for overall expert technical assistance, Jaana Traskelin for expert technical assistance at Biocenter Oulu Virus Core Laboratory and Veli-Pekka Ronkainen for expert assistance in microscopy at Biocenter Oulu Tissue Imaging Center. This work was funded by Academy of Finland (251314, 135560, 263770, 140974/AM, 284618 and 279760/GHW).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aoudjit F., 2012, CHEMOTHER RES PRACT, V2012, P1; Arai T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027782; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Boggiano JC, 2012, DEV CELL, V22, P695, DOI 10.1016/j.devcel.2012.03.013; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bunda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9859; Bunda S, 2014, P NATL ACAD SCI USA, V111, pE3785, DOI 10.1073/pnas.1406559111; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Cheng PF, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14183; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dhillon AS, 2015, ONCOGENE, V34, P4421, DOI 10.1038/onc.2014.374; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; Evellin S, 2013, MOL CELL BIOL, V33, P1198, DOI 10.1128/MCB.01054-12; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Halaoui R, 2015, ONCOGENE, V34, P939, DOI 10.1038/onc.2014.59; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jiang WG, 2015, SEMIN CANCER BIOL, V35, pS244, DOI 10.1016/j.semcancer.2015.03.008; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Lee JL, 2014, J CELL SCI, V127, P3217, DOI 10.1242/jcs.146142; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Manninen A, 2015, EXP CELL RES, V334, P337, DOI 10.1016/j.yexcr.2015.01.003; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Partanen JI, 2007, P NATL ACAD SCI USA, V104, P14694, DOI 10.1073/pnas.0704677104; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuck S, 2004, P NATL ACAD SCI USA, V101, P4912, DOI 10.1073/pnas.0401285101; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimizu H, 2003, ONCOGENE, V22, P831, DOI 10.1038/sj.onc.1206203; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Slattum GM, 2014, NAT REV CANCER, V14, P495, DOI 10.1038/nrc3767; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Zhang K, 2016, ONCOTARGET, V7, P84178, DOI 10.18632/oncotarget.12390	69	39	42	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5681	5694		10.1038/onc.2017.177	http://dx.doi.org/10.1038/onc.2017.177			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28604746	Green Published, hybrid			2022-12-26	WOS:000412843900003
J	Peterson, RG; Van Jackson, C; Zimmerman, KM; Alsina-Fernandez, J; Michael, MD; Emmerson, PJ; Coskun, T				Peterson, Richard G.; Van Jackson, Charles; Zimmerman, Karen M.; Alsina-Fernandez, Jorge; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer			Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse	PLOS ONE			English	Article							DIET-INDUCED OBESITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; LEPTIN RESISTANCE; C57BL/6J MICE; GLP-1 ANALOG; WEIGHT-LOSS; HIGH-FAT; METFORMIN; EXPRESSION	The FATZO/Pco mouse is the result of a cross of the C57BL/6J and AKR/J strains. The crossing of these two strains and the selective inbreeding for obesity, insulin resistance and hyperglycemia has resulted in an inbred strain exhibiting obesity in the presumed presence of an intact leptin pathway. Routinely used rodent models for obesity and diabetes research have a monogenic defect in leptin signaling that initiates obesity. Given that obesity and its sequelae in humans are polygenic in nature and not associated with leptin signaling defects, the FATZO mouse may represent a more translatable rodent model for study of obesity and its associated metabolic disturbances. The FATZO mouse develops obesity spontaneously when fed a normal chow diet. Glucose intolerance with increased insulin levels are apparent in FATZO mice as young as 6 weeks of age. These progress to hyperglycemia/pre-diabetes and frank diabetes with decreasing insulin levels as they age. The disease in these mice is multi-faceted, similar to the metabolic syndrome apparent in obese individuals, and thus provides a long pre-diabetic state for determining the preventive value of new interventions. We have assessed the utility of this new model for the pre-clinical screening of agents to stop or slow progression of the metabolic syndrome to severe diabetes. Our assessment included: 1) characterization of the spontaneous development of disease, 2) comparison of metabolic disturbances of FATZO mice to control mice and 3) validation of the model with regard to the effectiveness of current and emerging anti-diabetic agents; rosiglitazone, metformin and semaglutide. Conclusion: Male FATZO mice spontaneously develop significant metabolic disease when compared to normal controls while maintaining hyperglycemia in the presence of high leptin levels and hyperinsulinemia. The disease condition responds to commonly used antidiabetic agents.	[Peterson, Richard G.; Van Jackson, Charles; Zimmerman, Karen M.] Crown Biosci Indiana, Indianapolis, IN 46268 USA; [Alsina-Fernandez, Jorge; Michael, M. Dodson; Emmerson, Paul J.; Coskun, Tamer] Eli Lilly & Co, Indianapolis, IN 46285 USA	Eli Lilly	Peterson, RG (corresponding author), Crown Biosci Indiana, Indianapolis, IN 46268 USA.	rpeterson@crownbio.com	Coskun, Tamer/AAR-8422-2021	Michael, Mervyn/0000-0002-0224-1065	SBIR grant from NIH [2R44DK082065]; Eli Lilly and Company; Crown Bioscience Indiana; SBIR	SBIR grant from NIH; Eli Lilly and Company(Eli Lilly); Crown Bioscience Indiana; SBIR	This project was partially funded by an SBIR grant from NIH (2R44DK082065) to PreClinOmics. Additional funding was supplied by Eli Lilly and Company in the form of salaries for authors MDM, PJE, JAF and TC but it did not have any additional role in the study design, data collection and analysis. There was also a contract from Eli Lilly and Company to do the semaglutide experiment. Funding was also supplied by PreClinOmics (now Crown Bioscience Indiana) for authors CVJ, KMZ, and RGP in the form of salaries and other compensation. RGP was one of the owners and CSO for PreClinOmics and was the principal investigator on the SBIR grants and as such was responsible for the animal model development before, during and after the tenure of the SBIR funding and as such, was involved in study design, data collection, data analysis and manuscript production. CVJ is the general manager and CSO of Crown Bioscience Indiana and as such, since March 2016, was partially responsible for the continued support of the project in the form of material, salaries study design, data collection, data analysis and manuscript production. The other specific roles of these authors are articulated in the author contributions section.	Al-Barazanji K, 2015, J PHARMACOL EXP THER, V353, P496, DOI 10.1124/jpet.115.222828; Alexander J, 2006, INT J OBESITY, V30, P50, DOI 10.1038/sj.ijo.0803110; Anderson J, 2016, POSTGRAD MED; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Anthony J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077946; Bolen S, 2016, DIABETES MEDICATIONS; Bowles L, 2001, J CLIN PATHOL, V54, P1, DOI 10.1136/jcp.54.1.1; Brietzke SA, 2015, MED CLIN N AM, V99, P87, DOI 10.1016/j.mcna.2014.08.012; Brown ML, 2011, OBESITY, V19, P1940, DOI 10.1038/oby.2011.97; Buckingham RE, 2008, DIABETES OBES METAB, V10, P312, DOI 10.1111/j.1463-1326.2006.00700.x; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; Coelho MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154310; Cottrell EC, 2012, HDB EXP PHARM, V3-21; Diamant M, 2003, DRUGS, V63, P1373, DOI 10.2165/00003495-200363130-00004; Diaz MB, 2006, PHYSIOL BEHAV, V88, P191, DOI 10.1016/j.physbeh.2006.03.028; DIXON FJ, 1953, P SOC EXP BIOL MED, V83, P287; DIXON FJ, 1952, J EXP MED, V96, P313, DOI 10.1084/jem.96.4.313; Droz BA, 2017, CORRELATION DIS SEVE; Eliasson B, 2014, ADIPOCYTE, V3, P314, DOI 10.4161/adip.34425; Ervin RB., 2009, NATL HLTH STAT REPOR, V13; Eschwege E, 2000, ARCH MAL COEUR VAISS, V93, P13; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Filippatos TD, 2013, ARCH MED SCI, V9, P788, DOI 10.5114/aoms.2013.38671; Firouzjaei A, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.16; FRIEDMAN JM, 1991, MAMM GENOME, V1, P130, DOI 10.1007/BF00351059; Fu YL, 2015, NEPHRON, V129, P68, DOI 10.1159/000370254; Funcke Jan-Bernd, 2014, Mol Cell Pediatr, V1, P3, DOI 10.1186/s40348-014-0003-1; Gentilella R, 2009, DIABETES OBES METAB, V11, P544, DOI 10.1111/j.1463-1326.2008.01018.x; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Grundy SM, 2016, TRENDS CARDIOVAS MED, V26, P364, DOI 10.1016/j.tcm.2015.10.004; Hadjadj S, 2016, DIABETES CARE, V39, P1718, DOI 10.2337/dc16-0522; Hannema SE, 2016, HORM RES PAEDIAT, V85, P412, DOI 10.1159/000444055; Harris KB, 2016, PHARMACOTHERAPY; Harzallah A, 2016, ARCH PHYSIOL BIOCHEM, V122, P75, DOI 10.3109/13813455.2016.1148053; Henderson SJ, 2016, DIABETES OBES METAB; Hostalek U, 2015, DRUGS, V75, P1071, DOI 10.1007/s40265-015-0416-8; Huang TTK, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0767-x; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Joost HG, 2014, MAMM GENOME, V25, P401, DOI 10.1007/s00335-014-9514-2; Kay JP, 2001, METABOLISM, V50, P1457, DOI 10.1053/meta.2001.28078; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030; Kim GW, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.18; Kim HJ, 2013, PHYSIOL BEHAV, V110, P213, DOI 10.1016/j.physbeh.2013.01.011; Kong APS, 2016, BEST PRACT RES CL EN, V30, P345, DOI 10.1016/j.beem.2016.06.003; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Ktorza A, 1997, DIABETES METAB, V23, P38; Lau J, 2015, J MED CHEM, V58, P7370, DOI 10.1021/acs.jmedchem.5b00726; Lawson HA, 2010, EMIDDTABS23; Leiter EH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/165327; Leow MK, 2015, NEW ENGL J MED, V372, P1266, DOI 10.1056/NEJMc1501146; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mearns ES, 2015, DIABETIC MED, V32, P1530, DOI 10.1111/dme.12837; Mithieux G, 1996, REPROD NUTR DEV, V36, P357, DOI 10.1051/rnd:19960402; Mota Maria, 2004, Rom J Intern Med, V42, P247; Nauck MA, 2016, DIABETES CARE, V39, P231, DOI 10.2337/dc15-0165; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; O'Harte FP, 2016, DIABETES OBES METAB; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Oh H, 2015, EUR J PHARMACOL, V768, P139, DOI 10.1016/j.ejphar.2015.10.042; Peterson RG, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/487816; Prpic V, 2003, ENDOCRINOLOGY, V144, P1155, DOI 10.1210/en.2002-220835; Reaven Gerald M, 2003, Curr Atheroscler Rep, V5, P364, DOI 10.1007/s11883-003-0007-0; Reaven GM, 2009, CAN MED ASSOC J, V180, P601, DOI 10.1503/cmaj.090092; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Reuter T.Y., 2007, DRUG DISCOV, V4, P3, DOI [10.1016/j.ddmod.2007.09.004, DOI 10.1016/J.DDMOD.2007.09.004]; Rhee MK, 2010, DIABETES CARE, V33, P49, DOI 10.2337/dc09-0341; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Rotella CM, 2005, J ENDOCRINOL INVEST, V28, P746, DOI 10.1007/BF03347560; Roth JD, 2008, INT J OBESITY, V32, P1201, DOI 10.1038/ijo.2008.91; Rynders CA, 2014, J CLIN ENDOCR METAB, V99, P220, DOI 10.1210/jc.2013-2687; Seifarth C, 2013, EXP CLIN ENDOCR DIAB, V121, P27, DOI 10.1055/s-0032-1327734; Shang Wen-Bin, 2013, Zhongguo Zhong Yao Za Zhi, V38, P4119; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Sun L, 2016, BIOCHEM PHARMACOL, p[110, 80]; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; van den Hoek AM, 2008, J NEUROENDOCRINOL, V20, P120, DOI 10.1111/j.1365-2826.2007.01626.x; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wabitsch M, 2015, J CLIN ENDOCR METAB, V100, P3227, DOI 10.1210/jc.2015-2263; Wabitsch M, 2015, NEW ENGL J MED, V372, P48, DOI 10.1056/NEJMoa1406653; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wu J, 2013, ENDOCRINE, V44, P87, DOI 10.1007/s12020-012-9826-5; Xin ZL, 2006, J MED CHEM, V49, P4459, DOI 10.1021/jm060461g; Zhang J, 2015, JAMA-J AM MED ASSOC, V315, P2292; Zhang J, 2016, CHEM BIOL DRUG DES	90	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179856	10.1371/journal.pone.0179856	http://dx.doi.org/10.1371/journal.pone.0179856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640857	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800074
J	Feygenzon, V; Loewenstein, S; Lubezky, N; Pasmanic-Chor, M; Sher, O; Klausner, JM; Lahat, G				Feygenzon, Valerya; Loewenstein, Shelly; Lubezky, Nir; Pasmanic-Chor, Metsada; Sher, Osnat; Klausner, Joseph M.; Lahat, Guy			Unique cellular interactions between pancreatic cancer cells and the omentum	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; GENE-EXPRESSION; MESOTHELIN; ADIPOSE; PROGRESSION; RESISTANCE; GROWTH; CHEMORESISTANCE; QUANTIFICATION; CHEMOTHERAPY	Pancreatic cancer is a common cause of cancer-related mortality. Omental spread is frequent and usually represents an ominous event, leading to patient death. Omental metastasis has been studied in ovarian cancer, but data on its role in pancreatic cancer are relatively scarce and the molecular biology of this process has yet to be explored. We prepared tissue explants from human omental fat, and used conditioned medium from the explants for various in vitro and in vivo experiments designed to evaluate pancreatic cancer development, growth, and survival. Mass spectrometry identified the fat secretome, and mRNA array identified specific fat-induced molecular alternations in tumor cells. Omental fat increased pancreatic cancer cellular growth, migration, invasion, and chemoresistance. We identified diverse potential molecules secreted by the omentum, which are associated with various pro-tumorigenic biological processes. Our mRNA array identified specific omenta-linduced molecular alternations that are associated with cancer progression and metastasis. Omental fat increased the expression of transcription factors, mRNA of extracellular matrix proteins, and adhesion molecules. In support with our in vitro data, in vivo experiments demonstrated an increased pancreatic cancer tumor growth rate of PANC-1 cells co-cultured for 24 hours with human omental fat conditioned medium. Our results provide novel data on the role of omental tissue in omental metastases of pancreatic cancer. They imply that omental fat secreted factors induce cellular reprogramming of pancreatic cancer cells, resulting in increased tumor aggressiveness. Understanding the mechanisms of omental metastases may enable us to discover new potential targets for therapy.	[Feygenzon, Valerya; Lubezky, Nir; Sher, Osnat; Klausner, Joseph M.; Lahat, Guy] Tel Aviv Univ, Nicholas & Elizabeth Cathedra Expt Surg, Sackler Sch Med, Tel Aviv, Israel; [Loewenstein, Shelly; Lubezky, Nir; Klausner, Joseph M.; Lahat, Guy] Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel; [Pasmanic-Chor, Metsada] Tel Aviv Univ, Bioinformat Unit, Tel Aviv, Israel; [Sher, Osnat] Tel Aviv Sourasky Med Ctr, Dept Pathol, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Loewenstein, S (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel.	shellyl@tlvmc.gov.il			Israeli Cancer Association [20140123]	Israeli Cancer Association	This work was supported by the Israeli Cancer Association, Grant number: 20140123 (www.cancer.org.il) to GL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi N, 2013, CARCINOGENESIS, V34, P2361, DOI 10.1093/carcin/bgt227; Behan JW, 2009, CANCER RES, V69, P7867, DOI 10.1158/0008-5472.CAN-09-0800; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P163, DOI 10.1007/s12079-009-0069-z; Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chang MC, 2009, BIOCHEM J, V424, P449, DOI 10.1042/BJ20082196; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Cheng WF, 2009, BRIT J CANCER, V100, P1144, DOI 10.1038/sj.bjc.6604964; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Chudek Jerzy, 2006, Pharmacol Rep, V58 Suppl, P81; Clark R, 2013, AM J PATHOL, V183, P576, DOI 10.1016/j.ajpath.2013.04.023; Delitto D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1820-x; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Fain JN, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hasegawa S, 2016, INT J ONCOL, V48, P145, DOI 10.3892/ijo.2015.3258; Hoggard N, 2012, OBESITY, V20, P1158, DOI 10.1038/oby.2012.14; Humbert M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009430; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji SQ, 2013, BRAZ J MED BIOL RES, V46, P758, DOI 10.1590/1414-431X20132907; Jung Young Suk, 2012, PLoS One, V7, pe38773, DOI 10.1371/journal.pone.0038773; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kaneda A, 2002, INT J CANCER, V100, P57, DOI 10.1002/ijc.10464; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kolb A, 2005, CANCER BIOL THER, V4, P740, DOI 10.4161/cbt.4.7.1821; Kong B, 2010, ONCOGENE, V29, P5146, DOI 10.1038/onc.2010.258; Ksiazek K, 2010, INT J CANCER, V127, P293, DOI 10.1002/ijc.25036; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Le O, 2013, WORLD J RADIOL, V5, P106, DOI 10.4329/wjr.v5.i3.106; Levin Y, 2011, PROTEOMICS, V11, P3273, DOI 10.1002/pmic.201000661; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Mikula-Pietrasik J, 2017, INT J BIOCHEM CELL B, V86, P26, DOI 10.1016/j.biocel.2017.03.013; Mikula-Pietrasik J, 2015, ONCOTARGET, V6, P29178, DOI 10.18632/oncotarget.4932; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Peixoto RD, 2015, CANCER MED-US, V4, P1171, DOI 10.1002/cam4.459; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Qian Xiaohua, 2001, Pathology and Oncology Research, V7, P251; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rabenau KE, 2004, ONCOGENE, V23, P5056, DOI 10.1038/sj.onc.1207681; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Ricciardelli C, 2016, ENDOCR-RELAT CANCER, V23, pT155, DOI 10.1530/ERC-16-0320; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Schneider D, 2002, BBA-MOL BASIS DIS, V1588, P1, DOI 10.1016/S0925-4439(02)00052-2; Seux M, 2011, ONCOGENE, V30, P3049, DOI 10.1038/onc.2011.25; Shore S, 2003, ALIMENT PHARM THER, V18, P1049, DOI 10.1111/j.1365-2036.2003.01781.x; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Streppel MM, 2012, HUM PATHOL, V43, P1755, DOI 10.1016/j.humpath.2012.01.005; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tsai Ming-Ju, 2014, ISRN Biochem, V2014, P351959, DOI 10.1155/2014/351959; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Urbich C, 2009, BLOOD, V113, P5669, DOI 10.1182/blood-2009-01-196485; Vervoort SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053238; Wang KJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002809; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Weber CK, 2001, GASTROENTEROLOGY, V121, P657, DOI 10.1053/gast.2001.27222; White PB, 2010, J GASTROINTEST SURG, V14, P1888, DOI 10.1007/s11605-010-1349-x; Yang K, 2008, ADIPOSE TISSUE PROTO; Yin FQ, 2013, ONCOL REP, V30, P3, DOI 10.3892/or.2013.2446; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zhang YQ, 2013, CANCER RES, V73, P6359, DOI 10.1158/0008-5472.CAN-13-1558-T; Zhivkova-Galunska M, 2010, CANCER BIOL THER, V10, P54, DOI 10.4161/cbt.10.1.12161	73	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179862	10.1371/journal.pone.0179862	http://dx.doi.org/10.1371/journal.pone.0179862			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632775	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100053
J	Saglimbene, V; Natale, P; Palmer, S; Scardapane, M; Craig, JC; Ruospo, M; Gargano, L; Lucisano, G; Torok, M; Celia, E; Gelfman, R; Bednarek-Skublewska, A; Dulawa, J; Stroumza, P; Leal, M; Del Castillo, D; Murgo, AM; Schon, S; Wollheim, C; Hegbrant, J; Strippoli, GFM				Saglimbene, Valeria; Natale, Patrizia; Palmer, Suetonia; Scardapane, Marco; Craig, Jonathan C.; Ruospo, Marinella; Gargano, Letizia; Lucisano, Giuseppe; Torok, Marietta; Celia, Eduardo; Gelfman, Ruben; Bednarek-Skublewska, Anna; Dulawa, Jan; Stroumza, Paul; Leal, Miguel; Del Castillo, Domingo; Murgo, Angelo Marco; Schon, Staffan; Wollheim, Charlotta; Hegbrant, Jorgen; Strippoli, Giovanni F. M.			The prevalence and correlates of low sexual functioning in women on hemodialysis: A multinational, cross-sectional study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; HEMOGLOBIN LEVEL VARIABILITY; MAINTENANCE HEMODIALYSIS; INDEX FSFI; DYSFUNCTION; DIALYSIS; ASSOCIATIONS; METAANALYSIS; REPLACEMENT	Sexual dysfunction may affect 80% of women in hemodialysis. However the specific patterns and clinical correlates of sexual functioning remain poorly described. The aim of this study was to assess prevalence and correlates of the individual domains of sexual functioning in women treated with hemodialysis. We recruited, into this multinational crosssectional study, women treated with long-term hemodialysis (Collaborative Working Group on Depression and Sexual dysfunction in Hemodialysis study). Self-reported domains of sexual functioning were assessed by the Female Sexual Function Index, which is routinely administered within the network of dialysis patients followed by the working group. Lower scores represented lower sexual functioning. Socio-demographic and clinical correlates of each domain of sexual functioning were identified by stepwise multi-variable linear regression. Sensitivity analyses were restricted to women who reported being sexually active. We found that of 1309 enrolled women, 659 (50.3%) provided complete responses to FSFI survey questions and 232 (35%) reported being sexually active. Overall, most respondents reported either no sexual activity or low sexual functioning in all measured domains (orgasm 75.1%; arousal 64.0%; lubrication 63.3%; pain 60.7%; satisfaction 60.1%; sexual desire 58.0%). Respondents who were waitlisted for a kidney transplant reported scores with higher sexual functioning, while older respondents reported scores with lower functioning. The presence of depression was associated with worse lubrication and pain scores [ mean difference for depressed versus non-depressed women (95% CI) -0.42 (-0.73 to -0.11), -0.53 (-0.89 to -0.16), respectively] while women who had experienced a previous cardiovascular event reported higher pain scores [-0.77 (-1.40- to -0.13)]. In conclusion, women in hemodialysis reported scores consistent with marked low sexual functioning across a range of domains; the low functioning appeared to be associated with comorbidity.	[Saglimbene, Valeria; Natale, Patrizia; Ruospo, Marinella; Gargano, Letizia; Torok, Marietta; Celia, Eduardo; Gelfman, Ruben; Bednarek-Skublewska, Anna; Dulawa, Jan; Stroumza, Paul; Leal, Miguel; Del Castillo, Domingo; Murgo, Angelo Marco; Schon, Staffan; Wollheim, Charlotta; Hegbrant, Jorgen; Strippoli, Giovanni F. M.] Diaverum, Med Sci Off, Lund, Sweden; [Saglimbene, Valeria; Craig, Jonathan C.; Strippoli, Giovanni F. M.] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Palmer, Suetonia] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Scardapane, Marco; Lucisano, Giuseppe] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Ruospo, Marinella] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Nephrol & Transplantat, Novara, Italy; [Bednarek-Skublewska, Anna] Med Univ Lublin, Lublin, Poland; [Dulawa, Jan] Med Univ Silesia, SHS, Katowice, Poland; [Hegbrant, Jorgen; Strippoli, Giovanni F. M.] Diaverum Acad, Bari, Italy; [Strippoli, Giovanni F. M.] Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy	Diaverum; University of Sydney; University of Otago; University of Eastern Piedmont Amedeo Avogadro; Medical University of Lublin; Medical University Silesia; Diaverum; Universita degli Studi di Bari Aldo Moro	Strippoli, GFM (corresponding author), Diaverum, Med Sci Off, Lund, Sweden.; Strippoli, GFM (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.; Strippoli, GFM (corresponding author), Diaverum Acad, Bari, Italy.; Strippoli, GFM (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.	gfmstrippoli@gmail.com	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Bednarek-Skublewska, Anna/0000-0002-1973-2135				Basok EK, 2009, INT UROL NEPHROL, V41, P473, DOI 10.1007/s11255-008-9475-z; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; Cornellana MJ, 2017, CLIMACTERIC, V20, P164, DOI 10.1080/13697137.2017.1282453; Davison SN, 2006, KIDNEY INT, V69, P1621, DOI 10.1038/sj.ki.5000184; Diemont WL, 2000, AM J KIDNEY DIS, V35, P845, DOI 10.1016/S0272-6386(00)70254-X; Ebben JP, 2006, CLIN J AM SOC NEPHRO, V1, P1205, DOI 10.2215/CJN.01110306; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Finkelstein FO, 2007, NAT CLIN PRACT NEPHR, V3, P200, DOI 10.1038/ncpneph0438; Finkelstein FO, 2014, CLIN J AM SOC NEPHRO, V9, P6, DOI 10.2215/CJN.11831113; Gilbertson DT, 2008, CLIN J AM SOC NEPHRO, V3, P133, DOI 10.2215/CJN.01610407; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Kim JH, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-4; Makhlouf A, 2007, UROL CLIN N AM, V34, P565, DOI 10.1016/j.ucl.2007.08.009; Manns B, 2014, CLIN J AM SOC NEPHRO, V9, P1813, DOI 10.2215/CJN.01610214; MASTROGIACOMO I, 1984, NEPHRON, V37, P195, DOI 10.1159/000183243; McCabe MP, 2016, J SEX MED, V13, P153, DOI 10.1016/j.jsxm.2015.12.015; Mitchell KR, 2017, BJOG; Navaneethan SD, 2010, AM J KIDNEY DIS, V56, P670, DOI 10.1053/j.ajkd.2010.06.016; Nazarpour S, 2016, TAIWAN J OBSTET GYNE, V55, P480, DOI 10.1016/j.tjog.2016.06.001; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Peng YS, 2005, KIDNEY INT, V68, P760, DOI 10.1111/j.1523-1755.2005.00454.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Seidman SN, 2006, J SEX MARITAL THER, V32, P267, DOI 10.1080/00926230600575355; Shiften JL, 2008, OBSTET GYNECOL, V112, P970, DOI 10.1097/AOG.0b013e3181898cdb; Sogni F, 2008, CLIN NEPHROL, V70, P48; Song YS, 2008, UROLOGY, V71, P243, DOI 10.1016/j.urology.2007.10.020; STEPANSKI E, 1995, J AM SOC NEPHROL, V6, P192; Strippoli GFM, 2012, CLIN J AM SOC NEPHRO, V7, P974, DOI 10.2215/CJN.12601211; Tong A, 2015, AM J KIDNEY DIS; Toorians AWFT, 1997, NEPHROL DIAL TRANSPL, V12, P2654, DOI 10.1093/ndt/12.12.2654; Unruh ML, 2008, AM J KIDNEY DIS, V52, P305, DOI 10.1053/j.ajkd.2008.04.019; von Elm E, 2014, INT J SURG	35	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179511	10.1371/journal.pone.0179511	http://dx.doi.org/10.1371/journal.pone.0179511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY5UN	28632793	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100032
J	Zedan, AH; Blavnsfeldt, SG; Hansen, TF; Nielsen, BS; Marcussen, N; Pleckaitis, M; Osther, PJS; Sorensen, FB				Zedan, Ahmed Hussein; Blavnsfeldt, Soren Garm; Hansen, Torben Frostrup; Nielsen, Boye Schnack; Marcussen, Niels; Pleckaitis, Mindaugas; Osther, Palle Jorn Sloth; Sorensen, Flemming Brandt			Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations	PLOS ONE			English	Article							DIGITAL RECTAL EXAMINATION; DISEASE-FREE SURVIVAL; MICRORNA EXPRESSION; RADICAL PROSTATECTOMY; GLEASON SCORES; SMOOTH-MUSCLE; PROGRESSION; CARCINOMA; TARGETS; ANTIGEN	Introduction In the last decade microRNAs (miRNAs) have been widely investigated in prostate cancer (PCa) and have shown to be promising biomarkers in diagnostic, prognostic and predictive settings. However, tumor heterogeneity may influence miRNA expression. The aims of this study were to assess the impact of tumor heterogeneity, as demonstrated by a panel of selected miRNAs in PCa, and to correlate miRNA expression with risk profile and patient outcome. Material and methods Prostatectomy specimens and matched, preoperative needle biopsies from a retrospective cohort of 49 patients, who underwent curatively intended surgery for localized PCa, were investigated with a panel of 6 miRNAs (miRNA-21, miRNA-34a, miRNA-125b, miRNA-126, miRNA-143, and miRNA-145) using tissue micro-array (TMA) and in situ hybridization (ISH). Inter-and intra-patient variation was assessed using intra-class correlation (ICC). Results Four miRNAs (miRNA-21, miRNA-34a, miRNA-125, and miRNA-126) were significantly upregulated in PCa compared to benign prostatic hyperplasia (BPH), and except for miRNA-21 these miRNAs documented a positive correlation between the expression level in PCa cores and their matched BPH cores, (r > 0.72). The ICC varied from 0.451 to 0.764, with miRNA-34a showing an intra-tumoral heterogeneity accounting for less than 50% of the total variation. Regarding clinicopathological outcomes, only miRNA-143 showed potential as a prognostic marker with a higher expression correlating with longer relapse-free survival (p = 0.016). Conclusion The present study documents significant upregulation of the expression of miRNA-21, miRNA-34a, miRNA-125, and miRNA-126 in PCa compared to BPH and suggests a possible prognostic value associated with the expression of miRNA-143. The results, however, document intra-tumoral heterogeneity in the expression of various miRNAs calling for caution when using these tumor tissue biomarkers in prognostic and predictive settings.	[Zedan, Ahmed Hussein; Blavnsfeldt, Soren Garm; Osther, Palle Jorn Sloth] Vejle Hosp, Dept Urol, Urol Res Ctr, Vejle, Denmark; [Zedan, Ahmed Hussein; Hansen, Torben Frostrup] Vejle Hosp, Dept Oncol, Vejle, Denmark; [Zedan, Ahmed Hussein; Osther, Palle Jorn Sloth; Sorensen, Flemming Brandt] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Nielsen, Boye Schnack] Bioneer AS, Horsholm, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Pleckaitis, Mindaugas; Sorensen, Flemming Brandt] Vejle Hosp, Dept Clin Pathol, Vejle, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Bioneer A/S; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Lillebaelt Hospital	Zedan, AH (corresponding author), Vejle Hosp, Dept Urol, Urol Res Ctr, Vejle, Denmark.; Zedan, AH (corresponding author), Vejle Hosp, Dept Oncol, Vejle, Denmark.; Zedan, AH (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark.	ahmed.hussein.riad.zedan@rsyd.dk	Hansen, Torben Frøstrup/K-5583-2019; Zedan, Ahmed Hussein/K-1845-2017	Hansen, Torben Frøstrup/0000-0001-7476-671X; Sorensen, Flemming Brandt/0000-0002-5446-1035; Zedan, Ahmed Hussein/0000-0002-8895-6394	Research Council of Lillebaelt Hospital; Danish Agency of Research and Innovation	Research Council of Lillebaelt Hospital; Danish Agency of Research and Innovation	This study was funded by the Research Council of Lillebaelt Hospital (AHZ) and The Danish Agency of Research and Innovation (BSN). The funder provided support in the form of costs of ISH analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Avgeris M, 2013, BRIT J CANCER, V108, P2573, DOI 10.1038/bjc.2013.250; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Boorjian SA, 2009, J UROLOGY, V181, P95, DOI 10.1016/j.juro.2008.09.016; Cannistraci A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/146170; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Cohen MS, 2008, EUR UROL, V54, P371, DOI 10.1016/j.eururo.2008.03.049; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; DANESHGARI F, 1995, UROLOGY, V45, P604, DOI 10.1016/S0090-4295(99)80051-X; Danneman D, 2016, BJU INT, P1; DeVere White RW, UROL ONCOL, V27, P307; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Hart M, 2014, MOL CANCER RES, V12, P250, DOI 10.1158/1541-7786.MCR-13-0230; Heneghan HM, 2010, CURR OPIN PHARMACOL, V10, P543, DOI 10.1016/j.coph.2010.05.010; Hoogendam A, 1999, FAM PRACT, V16, P621, DOI 10.1093/fampra/16.6.621; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kang SG, 2012, ASIAN J ANDROL, V14, P752, DOI 10.1038/aja.2012.68; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Lakhkar A, 2016, AM J PHYSIOL-HEART C, V310, pH1107, DOI 10.1152/ajpheart.00961.2015; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Melia J, 2006, HISTOPATHOLOGY, V48, P644, DOI 10.1111/j.1365-2559.2006.02393.x; Mian BM, 2006, UROLOGY, V67, P379, DOI 10.1016/j.urology.2005.08.018; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; Moul JW, 2000, J UROLOGY, V163, P1632, DOI 10.1016/S0022-5347(05)67511-8; Mouritzen P, 2003, EXPERT REV MOL DIAGN, V3, P27, DOI 10.1586/14737159.3.1.27; Nielsen B. S., 2012, METHOD MOL BIOL, P67, DOI [10.1007/978-1-61779-427-8_5, DOI 10.1007/978-1-61779-427-8_5]; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Partin AW, 1997, JAMA-J AM MED ASSOC, V277, P1445, DOI 10.1001/jama.277.18.1445; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ren QH, 2014, AM J TRANSL RES, V6, P329; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shi XB, 2011, PROSTATE, V71, P538, DOI 10.1002/pros.21270; Sobin LH, 2009, UICC INTERNA TIONAL; Sundhedsdatastyrelsen, 2016, NYE KRAEFTT DANM, V52; Sundhedsstyrelsen, 2016, TAL AN TAL AN; Thorlacius-Ussing G, 2017, INFLAMM BOWEL DIS, V23, P739, DOI 10.1097/MIB.0000000000001086; VILLERS A, 1992, CANCER, V70, P2313, DOI 10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Wilt Timothy J, 2008, COCHRANE DB SYST REV, P1; Wolters T, 2012, PROSTATE, V72, P108, DOI 10.1002/pros.21415; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yamamura S, 2012, PLOS ONE, V7	61	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179113	10.1371/journal.pone.0179113	http://dx.doi.org/10.1371/journal.pone.0179113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628624	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100015
J	Curtis, JW				Curtis, Jacqueline W.			Spatial distribution of child pedestrian injuries along census tract boundaries: Implications for identifying area-based correlates	PLOS ONE			English	Article							SOUTHERN CALIFORNIA COUNTY; SOCIOECONOMIC-STATUS; NEIGHBORHOOD; PREVENTION; ASSOCIATION; INFORMATION; COLLISIONS; FAMILY; INCOME; RISK	Census tracts are often used to investigate area-based correlates of a variety of health outcomes. This approach has been shown to be valuable in understanding the ways that health is shaped by place and to design appropriate interventions that account for community-level processes. Following this line of inquiry, it is common in the study of pedestrian injuries to aggregate the point level locations of these injuries to the census tracts in which they occur. Such aggregation enables investigation of the relationships between a range of socioeconomic variables and areas of notably high or low incidence. This study reports on the spatial distribution of child pedestrian injuries in a mid-sized U. S. city over a three-year period. Utilizing a combination of geospatial approaches, Near Analysis, Kernel Density Estimation, and Local Moran's I, enables identification, visualization, and quantification of close proximity between incidents and tract boundaries. Specifically, results reveal that nearly half of the 100 incidents occur within roads that are also census tract boundaries. Results also uncover incidents that occur on tract boundaries, not merely near them. This geographic pattern raises the question of the utility of associating area-based census data from any one tract to the injuries occurring in these border zones. Furthermore, using a standard spatial join technique in a Geographic Information System (GIS), these points located on the border are counted as falling into census tracts on both sides of the boundary, which introduces uncertainty in any subsequent analysis. Therefore, two additional approaches of aggregating points to polygons were tested in this study. Results differ with each approach, but without any alert of such differences to the GIS user. This finding raises a fundamental concern about techniques through which points are aggregated to polygons in any study using point level incidents and their surrounding census tract socioeconomic data to understand health and place. This study concludes with a suggested protocol to test for this source of uncertainty in analysis and an approach that may remove it.	[Curtis, Jacqueline W.] Kent State Univ, Dept Geog, GIS Hlth & Hazards Lab, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Curtis, JW (corresponding author), Kent State Univ, Dept Geog, GIS Hlth & Hazards Lab, Kent, OH 44242 USA.	jmills30@kent.edu	Curtis, Jacqueline/V-1162-2019	Curtis, Jacqueline/0000-0001-6046-6476				ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Bell N, 2010, INT J ENV RES PUB HE, V7, P1002, DOI 10.3390/ijerph7031002; Bell NJ, 2009, BURNS, V35, P1133, DOI 10.1016/j.burns.2009.04.028; BRADDOCK M, 1994, AM J PUBLIC HEALTH, V84, P1158, DOI 10.2105/AJPH.84.7.1158; BRADDOCK M, 1991, PEDIATRICS, V88, P1242; Chakravarthy B, 2012, TRAFFIC INJ PREV, V13, P193, DOI 10.1080/15389588.2011.642034; Chakravarthy B, 2010, TRAFFIC INJ PREV, V11, P508, DOI 10.1080/15389588.2010.497546; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cusimano MD, 2007, INJURY PREV, V13, P51, DOI 10.1136/ip.2006.012468; Cusimano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008669; DURKIN MS, 1994, AM J PUBLIC HEALTH, V84, P587, DOI 10.2105/AJPH.84.4.587; Edelman LS, 2007, J NURS SCHOLARSHIP, V39, P306, DOI 10.1111/j.1547-5069.2007.00185.x; ESRI, 2015, ARCMAP 10 4; Haas B, 2015, J TRAUMA ACUTE CARE, V78, P860, DOI 10.1097/TA.0000000000000595; Haynes R, 2003, SOC SCI MED, V57, P625, DOI 10.1016/S0277-9536(02)00446-X; Kim MH, 2007, J EPIDEMIOL COMMUN H, V61, P135, DOI 10.1136/jech.2006.047738; Krieger N, 2006, J URBAN HEALTH, V83, P355, DOI 10.1007/s11524-006-9040-y; LaScala EA, 2000, ACCIDENT ANAL PREV, V32, P651, DOI 10.1016/S0001-4575(99)00100-1; Lightstone A S, 2001, Inj Prev, V7, P155, DOI 10.1136/ip.7.2.155; MALEK M, 1990, ACCIDENT ANAL PREV, V22, P301, DOI 10.1016/0001-4575(90)90046-N; Potter BK, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-132; Reading R, 1999, SOC SCI MED, V48, P321, DOI 10.1016/S0277-9536(98)00311-6; Reading R, 2005, CHILD YOUTH ENV, V15, P165; RIVARA FP, 1985, PEDIATRICS, V76, P375; Silverman JD, 2013, CAN J PUBLIC HEALTH, V104, pE405, DOI 10.17269/cjph.104.4053; Soubhi H, 2004, AM J HEALTH BEHAV, V28, P397; Statter M, 2011, J TRAUMA, V71, pS511, DOI 10.1097/TA.0b013e31823a4b70; US. Census, 2010, GEOGR TERMS CONC CEN	28	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179331	10.1371/journal.pone.0179331	http://dx.doi.org/10.1371/journal.pone.0179331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614377	gold, Green Submitted, Green Published			2022-12-26	WOS:000403280900043
J	Gherasim, A; Martinez-Baz, I; Castilla, J; Pozo, F; Larrauri, A				Gherasim, Alin; Martinez-Baz, Ivan; Castilla, Jesus; Pozo, Francisco; Larrauri, Amparo		cycEVA Working Grp	Effect of previous and current vaccination against influenza A(H1N1) pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; SEASON; VACCINES; CIRCULATION; PROTECTION; EFFICACY	Background Recent studies suggest that the protective effect of the current influenza vaccine could be influenced by vaccination in previous seasons. We estimated the combined effect of the previous and current influenza vaccines from the 2010-2011 season to the 2015-2016 season in Spain. Methods We performed a test-negative case-control study in patients >= 9 years old. We estimated the influenza vaccine effectiveness (IVE) against influenza A(H1N1) pdm09, A(H3N2), and B virus. Results We included 1206 influenza A(H1N1) pdm09 cases, 1358 A(H3N2) cases and 1079 B cases. IVE against A(H1N1) pdm09 virus in the pooled-season analysis was 53% (95% Confidence Interval (CI): 21% to 72%) for those vaccinated only in the current season and 50% (95% CI: 23% to 68%) for those vaccinated in the both current and previous seasons. Against the influenza A(H3N2) virus, IVE was 17% (95% CI: -43% to 52%) for those vaccinated only in the current season and 3% (95% CI: -33% to 28%) for those vaccinated in both seasons. Regarding influenza B, we obtained similar IVEs for those vaccinated only in the current and those vaccinated in both seasons: 57% (95% CI: 12% to 79%) and 56% (95% CI: 36% to 70%), respectively. Conclusion Our results suggested no interference between the previous and current influenza vaccines against A(H1N1) pdm09 and B viruses, but a possible negative interference against A (H3N2) virus.	[Gherasim, Alin; Larrauri, Amparo] Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain; [Martinez-Baz, Ivan; Castilla, Jesus] IdiSNA Navarra Inst Hlth Res, Inst Salud Publ & Laboral Navarra, Pamplona, Spain; [Martinez-Baz, Ivan; Castilla, Jesus; Larrauri, Amparo] Inst Hlth Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Pozo, Francisco] Carlos III Hlth Inst, WHO Natl Influenza Ctr, Natl Influenza Reference Lab, Natl Ctr Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Larrauri, A (corresponding author), Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain.; Larrauri, A (corresponding author), Inst Hlth Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	alarrauri@isciii.es	Jimenez-Jorge, Silvia/AAC-1708-2022; Cenoz, Manuel García/B-5647-2013; Pozo, Francisco/F-4426-2012; Larrauri, Amparo/Q-9613-2017; Castilla, Jesus/B-9048-2008; Martínez-Baz, Iván/H-4954-2017; Casas, Inmaculada/X-7579-2019	Jimenez-Jorge, Silvia/0000-0003-2944-6711; Cenoz, Manuel García/0000-0001-7316-9104; Pozo, Francisco/0000-0003-1828-733X; Larrauri, Amparo/0000-0002-1704-2245; Castilla, Jesus/0000-0002-6396-7265; Martínez-Baz, Iván/0000-0002-3405-2277; Casas, Inmaculada/0000-0003-1840-1198; Delgado Sanz, Maria Concepcion/0000-0002-2603-3471	Horizon program of the European Commission (I-MOVE-plus, EU) [634446]; European Centre for Disease Prevention and Control (I-MOVE, ECDC) [0J/16/07/2014-Proc/2014/024]	Horizon program of the European Commission (I-MOVE-plus, EU); European Centre for Disease Prevention and Control (I-MOVE, ECDC)	This study was funded by the Horizon 2020 program of the European Commission (I-MOVE-plus, EU 634446) and by the European Centre for Disease Prevention and Control (I-MOVE, ECDC tender 0J/16/07/2014-Proc/2014/024).	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182; Bragstad K, 2013, EURO SURVEILL, V18; Broberg E, 2016, EURO SURVEILL, V21; de los Reyes JAD, 2012, EUROSURVEILLANCE, V17, P1; Delgado-Sanz C., 2012, INFLUENZA SURVEILLAN, V720, P153; European Medicines Agency, 2009, POSS MOD RISK BAS CO, P1; Gherasim A, 2016, VACCINE, V34, P2371, DOI 10.1016/j.vaccine.2016.03.035; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jimenez-Jorge S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.28.21187; Jimenez-Jorge S, 2012, VACCINE, V30, P3595, DOI 10.1016/j.vaccine.2012.03.048; Jimenez-Jorge S, 2014, EURO SURVEILL, V19; Jimenez-Jorge S, 2015, VACCINE, V33, P3276, DOI 10.1016/j.vaccine.2015.03.051; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Kelly HA, 2012, INFLUENZA OTHER RESP, P1; Kissling E, 2013, EURO SURVEILL, V18; Larrauri Camara Amparo, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P2, DOI 10.1016/S0213-005X(12)70098-8; Martinez-Baz I., 2017, J INFECT DIS; Martinez-Baz I, 2015, HUM VACC IMMUNOTHER, V11, P1626, DOI 10.1080/21645515.2015.1038002; McLean HQ, 2014, J INFECT DIS; McLean HQ, 2014, CLIN INFECT DIS; Ohmit SE, 2013, CLIN INFECT DIS; Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650; Pebody R, 2011, EUROSURVEILLANCE, V16, P1; Savulescu C, 2011, EUROSURVEILLANCE, V16, P5; Savulescu C, 2014, VACCINE, V32, P4404, DOI 10.1016/j.vaccine.2014.06.063; Savulescu C, 2010, VACCINE, V28, P2903, DOI 10.1016/j.vaccine.2010.01.054; Scorza FB, 2016, VACCINE, V34, P2926, DOI 10.1016/j.vaccine.2016.03.085; SKOWRONSKI DM, 2015, EURO SURVEILL, V20; Skowronski DM, 2014, J INFECT DIS; Skowronski DM, 2017, J INFECT DIS; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Spanish Ministry of Health SSaE, 2016, REC INFL VACC SEAS 2; Sullivan SG, 2014, EXPERT REV VACCINES, V13, P1571, DOI 10.1586/14760584.2014.966695; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010; World Health Organization, 2012, 47 WHO	39	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179160	10.1371/journal.pone.0179160	http://dx.doi.org/10.1371/journal.pone.0179160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614376	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900034
J	Allareddy, V; Rampa, S; Rotta, AT; Allareddy, V				Allareddy, Veerajalandhar; Rampa, Sankeerth; Rotta, Alexandre T.; Allareddy, Veerasathpurush			The impact of septicemia occurring during hospitalization for renal transplantation procedures on outcomes in adults in United States	PLOS ONE			English	Article							KIDNEY-TRANSPLANTATION; CADAVERIC TRANSPLANTATION; SURGICAL COMPLICATIONS; RISK-FACTORS; MORTALITY; DIALYSIS; EPIDEMIOLOGY; COMORBIDITY; INFECTIONS; SURVIVAL	Introduction Immediate success rates of renal transplantation (RT) procedures are generally very high. National estimates of the impact of post-operative complications, specifically, septicemia occurring during hospitalization for RT's on outcomes is unclear. We sought, to examine the prevalence of septicemia in patients having renal transplantation procedures and to quantify the impact of septicemia on in-hospital mortality (IHM), length of stay (LOS), and hospital charges (HC). Materials and methods We performed a retrospective analysis of the Nationwide Inpatient Sample (NIS) for the years 2004 to 2010. All patients aged >= 18 years who underwent RT were selected. Association between occurrence of septicemia and outcomes (IHM, HC and LOS) was examined by multivariable linear and logistic regression models with adjustments for patient and hospital level confounders. Results During the study period, 113,058 patients underwent RT, and, of these, 2459 (2.2%) developed septicemia. Characteristics included mean age (50 years), gender (males, 60%) and race (whites, 54%). Majority of RT's were performed in teaching (96%) and large institutes (85.5%). Outcomes for patients with septicemia and without septicemia, included: IHM (12.9% vs. 0.4%), discharge routinely (42.4% vs. 82.6%), mean HC ($ 528,980 vs. $ 182,165), mean LOS in days (35.2 vs 7.3), respectively, Those who developed septicemia were associated with significantly higher HC (estimate: 0.8357, 95% CI: {0.7636-0.9077}, increase of $ 247,081 from mean, p<0.0001), longer LOS (1.2116{1.1015-1.3216}, increase of 18.7 days form mean, p<0.0001) and higher IHM (Odds ratio = 31.33; {20.25-48.48}, p<0.0001) compared to their counterparts. Increasing age (OR = 1.02 {1.01-1.02}, p<0.0001) and increase in co-morbid burden (OR = 1.57 {1.42-1.74}, p<0.0001) were associated with higher risk for developing septicemia. Conclusions Despite advances in medical/surgical care, septicemia is not an uncommon complication in patients having renal transplantation procedures and is associated with poor outcomes. Increasing age and co-morbid burden are independent predictors of occurrence of septicemia.	[Allareddy, Veerajalandhar] Univ Iowa, Div Pediat Crit Care, Stead Family Childrens Hosp, Iowa City, IA 52242 USA; [Rampa, Sankeerth] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Hlth Serv & Res, Omaha, NE USA; [Rotta, Alexandre T.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Div Pediat Crit Care, Cleveland, OH 44106 USA; [Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Iowa City, IA 52242 USA	University of Iowa; University of Nebraska System; University of Nebraska Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Iowa	Allareddy, V (corresponding author), Univ Iowa, Div Pediat Crit Care, Stead Family Childrens Hosp, Iowa City, IA 52242 USA.	veerajalandhar-allareddy@uiowa.edu		Rotta, Alexandre/0000-0002-4406-2276				Abbott KC, 2001, AM J NEPHROL, V21, P120, DOI 10.1159/000046234; Abecassis M, 2008, CLIN J AM SOC NEPHRO, V3, P471, DOI 10.2215/CJN.05021107; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BLS-Bureau of Labor Statistics, CONS PRIC IND INFL R; Briggs JD, 2001, NEPHROL DIAL TRANSPL, V16, P1545, DOI 10.1093/ndt/16.8.1545; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Centers for Disease Control and Prevention, NATL HEALTHC SAF NET; Centers of Disease Control and Prevention/National Center for Health Statistics, CLASS DIS FUNCT DIS; Dantas SRPE, 2006, J HOSP INFECT, V63, P117, DOI 10.1016/j.jhin.2005.10.018; Eaton S, 2002, AM J RESP CRIT CARE, V165, pA471; EGGERS P, 1992, SEMIN NEPHROL, V12, P284; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Esper AM, 2006, CRIT CARE MED, V34, P2576, DOI 10.1097/01.CCM.0000239114.50519.0E; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; Healthcare Cost and Utilization Project (HCUP), NAT INP SAMP NIS 200; Hernandez D, 2006, NEPHROL DIAL TRANSPL, V21, P2908, DOI 10.1093/ndt/gfl338; Hosmer David W, 2013, APPL LOGISTIC REGRES; Humar A, 2005, SEMIN DIALYSIS, V18, P505, DOI 10.1111/j.1525-139X.2005.00097.x; KARLBERG I, 1995, INT J TECHNOL ASSESS, V11, P611, DOI 10.1017/S026646230000876X; Kaye KS, 2005, J INFECT DIS, V191, P1056, DOI 10.1086/428626; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Machnicki G, 2006, TRANSPLANT REV-ORLAN, V20, P61, DOI DOI 10.1016/J.TRRE.2006.05.001; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Malone DL, 2002, J SURG RES, V103, P89, DOI 10.1006/jsre.2001.6343; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; OJO AO, 1994, AM J KIDNEY DIS, V24, P59, DOI 10.1016/S0272-6386(12)80160-0; Ollendorf DA, 2002, VALUE HEALTH, V5, P79, DOI 10.1046/j.1524-4733.2002.52013.x; Organ Procurement and Transplantation Network, CONC KIDN ALL; Pessaux P, 2003, ARCH SURG-CHICAGO, V138, P314, DOI 10.1001/archsurg.138.3.314; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Ravva P, 2014, STAT MED, V33, P1460, DOI 10.1002/sim.6045; Raymond DP, 2001, AM SURGEON, V67, P827; Schnuelle P, 1998, J AM SOC NEPHROL, V9, P2135; Scott JD, 2001, INFECT CONT HOSP EP, V22, P347, DOI 10.1086/501911; SUTHANTHIRAN M, 1994, NEW ENGL J MED, V331, P365, DOI 10.1056/NEJM199408113310606; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wong G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029591; Wu C, 2005, J AM SOC NEPHROL, V16, P3437, DOI 10.1681/ASN.2005040439; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179466	10.1371/journal.pone.0179466	http://dx.doi.org/10.1371/journal.pone.0179466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609479	Green Published, gold			2022-12-26	WOS:000403274700041
J	Zhang, ZC; Lai, S; Wang, YG; Li, L; Yin, HD; Wang, Y; Zhao, XL; Li, DY; Yang, MY; Zhu, Q				Zhang, Zhichao; Lai, Shuang; Wang, Yagang; Li, Liang; Yin, Huadong; Wang, Yan; Zhao, Xiaoling; Li, Diyan; Yang, Mingyao; Zhu, Qing			Rhythmic expression of circadian clock genes in the preovulatory ovarian follicles of the laying hen	PLOS ONE			English	Article							LUTEINIZING-HORMONE; GRANULOSA-CELLS; STIMULATING-HORMONE; CHICKEN OVARY; METABOLISM; MECHANISMS; OVULATION; TISSUES; PINEAL; BMAL1	The circadian clock is reported to play a role in the ovaries in a variety of vertebrate species, including the domestic hen. However, the ovary is an organ that changes daily, and the laying hen maintains a strict follicular hierarchy. The aim of this study was to examine the spatial- temporal expression of several known canonical clock genes in the granulosa and theca layers of six hierarchy follicles. We demonstrated that the granulosa cells (GCs) of the F1-F3 follicles harbored intrinsic oscillatory mechanisms in vivo. In addition, cultured granulosa cells (GCs) from F1 follicles exposed to luteinizing hormone (LH) synchronization displayed Per2 mRNA oscillations, whereas, the less mature GCs (F5 plus F6) displayed no circadian change in Per2 mRNA levels. Cultures containing follicle-stimulating hormone (FSH) combined with LH expressed levels of Per2 mRNA that were 2.5-fold higher than those in cultures with LH or FSH alone. These results show that there is spatial specificity in the localization of clock cells in hen preovulatory follicles. In addition, our results support the hypothesis that gonadotropins provide a cue for the development of the functional cellular clock in immature GCs.	[Zhang, Zhichao; Lai, Shuang; Wang, Yagang; Li, Liang; Yin, Huadong; Wang, Yan; Li, Diyan; Yang, Mingyao; Zhu, Qing] Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China; [Zhao, Xiaoling] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Zhu, Q (corresponding author), Sichuan Agr Univ, Inst Anim Genet & Breeding, Chengdu, Sichuan, Peoples R China.	zhuqingsicau@163.com	Li, Liang/AAG-7614-2020	Li, Liang/0000-0001-9139-5025	China Agriculture Research System [CARS-41]; Twelfth Five Year Plan for Breeding Program in Sichuan [2011NZ0099-7]; thirteenth Five Year Plan for Breeding Program in Sichuan [16ZC2838]	China Agriculture Research System; Twelfth Five Year Plan for Breeding Program in Sichuan; thirteenth Five Year Plan for Breeding Program in Sichuan	This work was financially supported by the China Agriculture Research System (CARS-41) (http://cyjstx.sdny.gov.cn/); The Twelfth Five Year Plan for Breeding Program in Sichuan (2011NZ0099-7) (http://www.sc.gov.cn/) and the thirteenth Five Year Plan for Breeding Program in Sichuan (16ZC2838) (http://www.sc.gov.cn) to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball GF, 2007, ENDOCRINOLOGY, V148, P3029, DOI 10.1210/en.2007-0570; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bosler O, 2015, FRONT NEUROENDOCRIN, V38, P50, DOI 10.1016/j.yfrne.2015.02.001; Chen HT, 2013, AM J PHYSIOL-CELL PH, V304, pC1131, DOI 10.1152/ajpcell.00008.2013; Chen HT, 2013, AM J PHYSIOL-ENDOC M, V304, pE566, DOI 10.1152/ajpendo.00432.2012; Chu GY, 2012, AM J PHYSIOL-ENDOC M, V302, pE645, DOI 10.1152/ajpendo.00470.2011; Fahrenkrug J, 2006, ENDOCRINOLOGY, V147, P3769, DOI 10.1210/en.2006-0305; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; Gras S, 2012, CELL TISSUE RES, V350, P539, DOI 10.1007/s00441-012-1489-2; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Johnson AL, 1996, BIOL REPROD, V55, P304, DOI 10.1095/biolreprod55.2.304; Johnson ML, 2002, ENDOCRINE, V18, P261, DOI 10.1385/ENDO:18:3:261; Karaganis SP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-206; Karman BN, 2006, BIOL REPROD, V75, P624, DOI 10.1095/biolreprod.106.050732; Kirsch I, 2011, PHILOS T R SOC B, V366, P1781, DOI 10.1098/rstb.2010.0410; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Nakao N, 2007, ENDOCRINOLOGY, V148, P3031, DOI 10.1210/en.2007-0044; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; SARKAR DK, 1976, NATURE, V264, P461, DOI 10.1038/264461a0; Schmierer B, 2003, BIOL REPROD, V68, P620, DOI 10.1095/biolreprod.102.008714; Sellix MT, 2015, J BIOL RHYTHM, V30, P7, DOI 10.1177/0748730414554222; Sellix MT, 2010, CURR BIOL, V20, pR266, DOI 10.1016/j.cub.2010.01.045; SHARP PJ, 1984, J EXP ZOOL, V232, P475, DOI 10.1002/jez.1402320314; SILVER R, 1986, POULTRY SCI, V65, P2355, DOI 10.3382/ps.0652355; Tischkau SA, 2011, CHRONOBIOL INT, V28, P10, DOI 10.3109/07420528.2010.530363; Underwood H, 2001, MICROSC RES TECHNIQ, V53, P48, DOI 10.1002/jemt.1068; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yoshikawa T, 2009, ENDOCRINOLOGY, V150, P4338, DOI 10.1210/en.2008-1280; Zhang CQ, 1997, GEN COMP ENDOCR, V105, P402, DOI 10.1006/gcen.1996.6843; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zhang ZC, 2016, POULTRY SCI, V95, P1653, DOI 10.3382/ps/pew051	35	9	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179019	10.1371/journal.pone.0179019	http://dx.doi.org/10.1371/journal.pone.0179019			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604799	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400025
J	Lam, KYC; Yao, P; Wang, HY; Duan, R; Dong, TTX; Tsim, KWK				Lam, Kelly Y. C.; Yao, Ping; Wang, Huaiyou; Duan, Ran; Dong, Tina T. X.; Tsim, Karl W. K.			Asarone from Acori Tatarinowii Rhizome prevents oxidative stress-induced cell injury in cultured astrocytes: A signaling triggered by Akt activation	PLOS ONE			English	Article							ALPHA-ASARONE; GENE-EXPRESSION; ANTIOXIDANT; INDUCTION; REGIONS; CALAMUS	Acori Tatarinowii Rhizome (ATR; the dried rhizome of Acori tatarinowii Schott) is a well-known herb being used for mental disorder in China and Asia. Volatile oil is considered as the active ingredient of ATR, and asarones account for more than 90% of total volatile oil. Here, the protective effects of ATR oil and asarones, both alpha-asarone and beta-asarone, were probed in cultured rat astrocytes. The cyto-protective effect of ATR oil and asarones against tBHP-induced astrocyte injury was revealed, and additionally ATR oil and asarones reduced the tBHP-induced intracellular reactive oxygen species (ROS) accumulation. In parallel, the activity of anti-oxidant response element (ARE) promoter construct (pARE-Luc), being transfected in cultured astrocytes, was markedly induced by application of ATR oil and asarones. The mRNAs encoding anti-oxidant enzymes, e.g. glutathione S-transferase (GST), glutamate-cysteine ligase modulatory subunit (GCLM), glutamate-cysteine ligase catalytic subunit (GCLC) and NAD(P) H quinone oxidoreductase (NQO1) were induced by ATR oil and asarones in a dose-dependent manner. The ATR oil/asarone-induced gene expression could be mediated by Akt phosphorylation; because the applied LY294002, a phosphoinositide 3-kinase inhibitor, fully abolished the induction. These results demonstrated that a-asarone and beta-asarone could account, at least partly, the function of ATR being a Chinese medicinal herb.	[Lam, Kelly Y. C.; Yao, Ping; Wang, Huaiyou; Duan, Ran; Dong, Tina T. X.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Huaiyou; Duan, Ran; Dong, Tina T. X.; Tsim, Karl W. K.] HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Ctr Chinese Med, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.; Tsim, KWK (corresponding author), HKUST Shenzhen Res Inst, Hitech Pk, Shenzhen, Guangdong, Peoples R China.	botsim@ust.hk		Tsim, Karl/0000-0003-4808-1674; Wang, Huai-You/0000-0003-1407-9912	Hong Kong Research Grants Council [T13-607/12R, 663012, 662713, M-HKUST604/13, TUYF15SC01]; Hong Kong Jockey Club Charities Trust [HKJCCT12SC01]; Foundation of The Awareness of Nature [TAON12SC01, JCYJ20160229205726699, JCYJ20160229205812004]; Lee's Pharmaceutical Co. Ltd.	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Jockey Club Charities Trust; Foundation of The Awareness of Nature; Lee's Pharmaceutical Co. Ltd.	This research was supported by Hong Kong Research Grants Council Theme-based Research Scheme (T13-607/12R), GRF (663012, 662713, M-HKUST604/13), TUYF15SC01, The Hong Kong Jockey Club Charities Trust (HKJCCT12SC01) and Foundation of The Awareness of Nature (TAON12SC01) to Karl TSIM, JCYJ20160229205726699 to Prof. Tsim, JCYJ20160229205812004 to Dr. Dong and JCYJ20160229210027564 to Dr. Wang. Kelly Y.C. LAM received a Kanya Lee Scholarship from Lee's Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Jee-Yin, 2014, Exp Neurobiol, V23, P200, DOI 10.5607/en.2014.23.3.200; Chen JP, 2014, PHYTOTHER RES, V28, P1727, DOI 10.1002/ptr.5202; Chen JP, 2013, J AGR FOOD CHEM, V61, P7315, DOI 10.1021/jf402379u; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Limon ID, 2009, NEUROSCI LETT, V453, P98, DOI 10.1016/j.neulet.2009.02.011; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dowell JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070163; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal Y, 2015, PLANTA MED, V81, P333, DOI 10.1055/s-0035-1545694; Keenoy BMY, 2001, LIFE SCI, V68, P2037, DOI 10.1016/S0024-3205(01)01001-3; Kovacic P, 2012, CURR NEUROPHARMACOL, V10, P289, DOI 10.2174/157015912804143487; Kumar H, 2012, BIOSCI BIOTECH BIOCH, V76, P1518, DOI 10.1271/bbb.120247; Lam KYC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163337; Lam KYC, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-016-0113-x; Liang L, 2013, J AGR FOOD CHEM, V61, P2755, DOI 10.1021/jf304768p; Maiwulanjiang M, 2014, J ETHNOPHARMACOL, V153, P491, DOI 10.1016/j.jep.2014.03.010; Maiwulanjiang M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/687958; Manikandan S, 2005, BIOL PHARM BULL, V28, P2327, DOI 10.1248/bpb.28.2327; Manikandan S, 2005, PHARMACOL RES, V52, P467, DOI 10.1016/j.phrs.2005.07.007; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Pages N, 2010, NEUROSCI RES, V68, P337, DOI 10.1016/j.neures.2010.08.011; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Yang YX, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-236; Zhang L, 2010, BRAIN RES, V1357, P157, DOI 10.1016/j.brainres.2010.08.007; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z; ZHU KY, 2013, EVID-BASED COMPL ALT, V2013, P31385	29	26	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179077	10.1371/journal.pone.0179077	http://dx.doi.org/10.1371/journal.pone.0179077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598994	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000022
J	Ney, G; Schul, J				Ney, Gideon; Schul, Johannes			Population structure within the one-dimensional range of a coastal plain katydid	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; COMPARATIVE PHYLOGEOGRAPHY; DISPERSAL; INFERENCE; GENETICS; DISTANCE; MODEL; SIMULATION; GENOTYPE; PROGRAMS	Biogeography plays a significant role in species' dispersal, and in turn population structure, across the landscape. The North American katydid Neoconocephalus melanorhinus belongs to a genus with high mobility. Unlike other members of the genus, N. melanorhinus is a salt marsh specialist restricted to a narrow corridor along the Atlantic and Gulf coasts. In addition, their range crosses at least one known biogeographic barrier and possesses biogeographic characteristics of the stepping-stone as well as the hierarchical island model of dispersal. Using AFLP markers we searched for areas that conform to the predictions of isolation by distance and for areas of non-uniform increases in genetic variance, indicative of isolation by barrier. We found significant genetic differentiation between all twelve sampled sites. Isolation by distance was the predominant pattern of variation across their range. In addition, we saw possible evidence of two biogeographic barriers to gene flow, one at the Atlantic-Gulf divide and the other along the Gulf coast. We also observed a change in body size across the range. Body size, as measured by male hind femur length, correlated closely with latitude, a possible indication of differential selection across the species range.	[Ney, Gideon; Schul, Johannes] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Ney, G (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	gdnwb3@mail.missouri.edu			National Science Foundation [IOS 1146878]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (www.nstgov) received by JS (IOS 1146878). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1989, SCIENCE, V243, P646, DOI 10.1126/science.243.4891.646; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; COCKERHAM CC, 1973, GENETICS, V74, P679; Cockerham CC, 1969, EVOLUTION, P72; Coyne J.A., 2004, SPECIATION; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; DINGLE H, 1990, OECOLOGIA, V84, P199, DOI 10.1007/BF00318272; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frederick K. E., 2013, THESIS; Greenfield M.D., 1990, P71; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Holland BR, 2008, SYST BIOL, V57, P347, DOI 10.1080/10635150802044037; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; KIMURA M, 1964, GENETICS, V49, P561; LAMB T, 1992, J HERED, V83, P262, DOI 10.1093/oxfordjournals.jhered.a111211; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; Masaki S., 1983, GEO J, V7, P483, DOI DOI 10.1007/BF00218520; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL, V20, P3144, DOI 10.1111/j.1365-294X.2011.05164.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; MOUSSEAU TA, 1989, EVOLUTION, V43, P1483, DOI 10.1111/j.1558-5646.1989.tb02598.x; Orr MR, 1996, EVOLUTION, V50, P704, DOI 10.1111/j.1558-5646.1996.tb03880.x; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; PARK O, 1949, PHYSIOL ZOOL, V22, P359, DOI 10.1086/physzool.22.4.30152061; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Rambaut A., 2010, TRACER V 1 5 PROGRAM; Rehn JA, 1915, T AM ENTOMOL SOC, V40, P377; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAUNDERS NC, 1986, GENETICS, V112, P613; SLATKIN M, 1991, GENETICS, V127, P627; Snyder RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007203; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stoner KJL, 2004, ECOL APPL, V14, P1306, DOI 10.1890/03-5112; Vekemans X, 2002, SOFTWARE ESTIMATING, P1; Walker T. J., 2017, SINGING INSECTS N AM; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; Wright S, 1943, GENETICS, V28, P114; Zhang H, 2012, HEREDITY, V108, P616, DOI 10.1038/hdy.2011.132; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	51	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179361	10.1371/journal.pone.0179361	http://dx.doi.org/10.1371/journal.pone.0179361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599010	gold, Green Published, Green Submitted			2022-12-26	WOS:000402992000034
J	Nakayama, M; Sakai, E; Echizen, K; Yamada, Y; Oshima, H; Han, TS; Ohki, R; Fujii, S; Ochiai, A; Robine, S; Voon, DC; Tanaka, T; Taketo, MM; Oshima, M				Nakayama, M.; Sakai, E.; Echizen, K.; Yamada, Y.; Oshima, H.; Han, T-S; Ohki, R.; Fujii, S.; Ochiai, A.; Robine, S.; Voon, D. C.; Tanaka, T.; Taketo, M. M.; Oshima, M.			Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation	ONCOGENE			English	Article							LI-FRAUMENI-SYNDROME; STEM-CELLS; COLORECTAL-CANCER; COLON-CANCER; PANCREATIC-CANCER; MOUSE MODEL; GAIN; EXPRESSION; GROWTH; MICROENVIRONMENT	Tumor suppressor TP53 is frequently mutated in colorectal cancer (CRC), and most mutations are missense type. Although gain-offunctions by mutant p53 have been demonstrated experimentally, the precise mechanism for malignant progression in in vivo tumors remains unsolved. We generated Apc(Delta 716) Trp53(LSL_R270H) villin-CreER compound mice, in which mutant p53(R270H) was expressed in the intestinal epithelia upon tamoxifen treatment, and examined the intestinal tumor phenotypes and tumor-derived organoids. Mutant Trp53(R270H), but not Trp53-null mutation accelerated submucosal invasion with generation of desmoplastic microenvironment. The nuclear accumulation of p53 was evident in Apc(Delta 716) Trp53(R270H/R270H) homozygous tumors like human CRC. Although p53 was distributed to the cytoplasm in Apc(Delta 716) Trp53(+/R270H) heterozygous tumors, it accumulated in the nuclei at the invasion front, suggesting a regulation mechanism for p53 localization by the microenvironment. Importantly, mutant p53 induced drastic morphological changes in the tumor organoids to complex glandular structures, which was associated with the acquisition of invasiveness. Consistently, the branching scores of human CRC that carry TP53 mutations at codon 273 significantly increased in comparison with those of TP53 wild-type tumors. Moreover, allografted Apc(Delta 716) Trp53(R270H/R270H) organoid tumors showed a malignant histology with an increased number of myofibroblasts in the stroma. These results indicate that nuclear-accumulated mutant p53(R270H) induces malignant progression of intestinal tumors through complex tumor gland formation and acquisition of invasiveness. Furthermore, RNA sequencing analyses revealed global gene upregulation by mutant p53(R270H), which was associated with the activation of inflammatory and innate immune pathways. Accordingly, it is possible that mutant p53(R270H) induces CRC progression, not only by a cell intrinsic mechanism, but also by the generation or activation of the microenvironment, which may synergistically contribute to the acceleration of submucosal invasion. Therefore, the present study indicates that nuclearaccumulated mutant p53(R270H) is a potential therapeutic target for the treatment of advanced CRCs.	[Nakayama, M.; Sakai, E.; Echizen, K.; Oshima, H.; Han, T-S; Voon, D. C.; Oshima, M.] Kanazawa Univ, Div Genet, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan; [Echizen, K.; Han, T-S; Tanaka, T.; Oshima, M.] Japan Agcy Med Res & Dev, AMED, AMED CREST, Tokyo, Japan; [Yamada, Y.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa, Japan; [Ohki, R.] Natl Canc Ctr, Div Rare Canc Res, Tokyo, Japan; [Fujii, S.] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Pathol, Chiba, Japan; [Ochiai, A.] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Chiba, Japan; [Robine, S.] Inst Curie, Equipe Morphogenese & Signalisat Cellulaires, Paris, France; [Voon, D. C.] Kanazawa Univ, Inst Frontier Sci Initiat, Canc Res Core, Kanazawa, Ishikawa, Japan; [Tanaka, T.] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Taketo, M. M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Taketo, M. M.] Kanazawa Univ, Canc Res Inst, Div Expt Therapeut, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Kanazawa University; Chiba University; Kyoto University; Kanazawa University	Oshima, M (corresponding author), Kanazawa Univ, Div Genet, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan.	oshimam@staff.kanazawa-u.ac.jp	Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Oshima, Hiroko/0000-0001-6855-4008; Tanaka, Tomoaki/0000-0002-9761-1750; yamada, yoichi/0000-0001-6103-0658; Voon, Dominic Chih-Cheng/0000-0002-2963-9305	AMED-CREST, AMED, Japan Agency for Medical Research and Development, Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [15H02362, 26430110]	AMED-CREST, AMED, Japan Agency for Medical Research and Development, Japan(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Yoshie Jomen, Ayako Tsuda and Manami Watanabe for technical assistance. Computations were partially performed on the NIG supercomputer at ROIS National Institute of Genetics. This work was supported by AMED-CREST, AMED, Japan Agency for Medical Research and Development, Japan, Grants-in-Aid for Scientific Research (A) (#15H02362) tand (C) (26430110) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Amoyel M, 2015, EMBO J, V34, P1287, DOI 10.15252/embj.201591541; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Doyle B, 2010, J PATHOL, V222, P129, DOI 10.1002/path.2748; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fujii S, 2015, ONCOGENE, V34, P4834, DOI 10.1038/onc.2014.402; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Liebig B, 2005, CANCER LETT, V223, P159, DOI 10.1016/j.canlet.2004.10.013; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Muller PAJ, 2013, ONCOGENE, V32, P1252, DOI 10.1038/onc.2012.148; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oshima H, 2015, CANCER RES, V75, P766, DOI 10.1158/0008-5472.CAN-14-2036; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pfister NT, 2015, GENE DEV, V29, P1298, DOI 10.1101/gad.263202.115; Salahudeen AA, 2015, NAT MED, V21, P215, DOI 10.1038/nm.3818; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066; Zhu JJ, 2015, NATURE, V525, P206, DOI 10.1038/nature15251	42	35	36	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5885	5896		10.1038/onc.2017.194	http://dx.doi.org/10.1038/onc.2017.194			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28628120	hybrid, Green Published			2022-12-26	WOS:000413292900010
J	Mhashal, AR; Vardi-Kilshtain, A; Kohen, A; Major, DT				Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Kohen, Amnon; Major, Dan Thomas			The role of the Met(20) loop in the hydride transfer in Escherichia coli dihydrofolate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; molecular dynamics; protein dynamic; quantum chemistry; reductase; dihydrofolate reductase	MECHANICAL/MOLECULAR-MECHANICAL CHARACTERIZATION; MOLECULAR-DYNAMICS SIMULATIONS; ACTIVE-SITE; FREE-ENERGY; CATALYTIC MECHANISM; CRYSTAL-STRUCTURES; TRANSITION-STATE; COMBINED QUANTUM; FUNCTIONAL-ROLE; CONFORMATIONAL-CHANGES	A key question concerning the catalytic cycle of Escherichia coli dihydrofolate reductase (ecDHFR) is whether the Met(20) loop is dynamically coupled to the chemical step during catalysis. A more basic, yet unanswered question is whether the Met(20) loop adopts a closed conformation during the chemical hydride transfer step. To examine the most likely conformation of the Met(20) loop during the chemical step, we studied the hydride transfer in wild type (WT) ecDHFR using hybrid quantum mechanics-molecular mechanics free energy simulations with the Met(20) loop in a closed and disordered conformation. Additionally, we investigated three mutant forms (I14X; X = Val, Ala, Gly) of the enzyme that have increased active site flexibility and donor-acceptor distance dynamics in closed and disordered Met(20) loop states. We found that the conformation of the Met(20) loop has a dramatic effect on the ordering of active site hydration, although the Met(20) loop conformation only has a moderate effect on the hydride transfer rate and donor-acceptor distance dynamics. Finally, we evaluated the pK(a) of the substrate N5 position in closed and disordered Met(20) loop states and found a strong correlation between N5 basicity and the conformation of the Met(20) loop.	[Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Major, Dan Thomas] Bar Ilan Univ, Dept Chem, IL-5290002 Ramat Gan, Israel; [Mhashal, Anil R.; Vardi-Kilshtain, Alexandra; Major, Dan Thomas] Bar Ilan Univ, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-5290002 Ramat Gan, Israel; [Kohen, Amnon] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA	Bar Ilan University; Bar Ilan University; University of Iowa	Major, DT (corresponding author), Bar Ilan Univ, Lise Meitner Minerva Ctr Computat Quantum Chem, IL-5290002 Ramat Gan, Israel.	majort@biu.ac.il	Mhashal, Anil/ABA-7245-2021; Major, Dan T/J-8761-2014	Major, Dan T/0000-0002-9231-0676; Mhashal, Anil/0000-0002-8232-8135	Israel Science Foundation [2146/15]; United States-Israel Binational Science Foundation [2012340]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Israel Science Foundation Grant 2146/15 and United States-Israel Binational Science Foundation Grant 2012340. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal PK, 2002, J PHYS CHEM B, V106, P3283, DOI 10.1021/jp020190v; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Arora K, 2013, TOP CURR CHEM, V337, P165, DOI 10.1007/128_2012_408; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Best RB, 2012, BIOPHYS J, V103, P1045, DOI 10.1016/j.bpj.2012.07.042; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Boekelheide N, 2011, P NATL ACAD SCI USA, V108, P16159, DOI 10.1073/pnas.1106397108; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWN KA, 1992, FARADAY DISCUSS, V93, P217, DOI 10.1039/fd9929300217; BYSTROFF C, 1990, BIOCHEMISTRY-US, V29, P3263, DOI 10.1021/bi00465a018; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; Castillo R, 1999, J AM CHEM SOC, V121, P12140, DOI 10.1021/ja9843019; Cummins PL, 1996, J COMPUT CHEM, V17, P1598, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1598::AID-JCC2>3.0.CO;2-G; DEWAR MJS, 1985, J PHYS CHEM-US, V89, P2145, DOI 10.1021/j100257a004; Doron D, 2015, J PHYS CHEM B, V119, P906, DOI 10.1021/jp5059963; Doron D, 2012, J CHEM THEORY COMPUT, V8, P2484, DOI 10.1021/ct300235k; Doron D, 2011, J CHEM THEORY COMPUT, V7, P3420, DOI 10.1021/ct2004808; Fan Y, 2013, BIOCHEMISTRY-US, V52, P2036, DOI 10.1021/bi301559q; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Ferrer S, 2003, J PHYS CHEM B, V107, P14036, DOI 10.1021/jp0354898; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Francis K., 2016, CURR BIOTECHNOL, V4, P77; GAO JL, 1992, J PHYS CHEM-US, V96, P537, DOI 10.1021/j100181a009; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Garcia-Viloca M, 2003, J MOL BIOL, V327, P549, DOI 10.1016/S0022-2836(03)00123-2; Hockney R. W., 1970, Methods in computational physics. IX. Plasma physics, P135; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ruiz-Pernia JJ, 2013, J AM CHEM SOC, V135, P18689, DOI 10.1021/ja410519h; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khavrutskii IV, 2007, PROTEIN SCI, V16, P1087, DOI 10.1110/ps.062724307; Kohen A, 2015, ACCOUNTS CHEM RES, V48, P466, DOI 10.1021/ar500322s; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee H, 1996, BIOCHEMISTRY-US, V35, P7012, DOI 10.1021/bi960028g; Li GH, 2003, J PHYS CHEM B, V107, P14521, DOI 10.1021/jp0356158; LI LY, 1992, BIOCHEMISTRY-US, V31, P7826, DOI 10.1021/bi00149a012; Liu CT, 2014, P NATL ACAD SCI USA, V111, P18231, DOI 10.1073/pnas.1415940111; Loveridge EJ, 2012, NAT CHEM, V4, P292, DOI 10.1038/nchem.1296; Loveridge EJ, 2011, CHEMBIOCHEM, V12, P1258, DOI 10.1002/cbic.201000794; Luk LYP, 2013, P NATL ACAD SCI USA, V110, P16344, DOI 10.1073/pnas.1312437110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MAHARAJ G, 1990, BIOCHEMISTRY-US, V29, P4554, DOI 10.1021/bi00471a008; Major DT, 2017, RSC THEOR COMPUT CHE, V9, P340; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 1998, CHEM BIOL, V5, pR105, DOI 10.1016/S1074-5521(98)90616-0; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Miller GP, 1998, BIOCHEMISTRY-US, V37, P6336, DOI 10.1021/bi973065w; Nam K, 2005, J CHEM THEORY COMPUT, V1, P2, DOI 10.1021/ct049941i; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Radkiewicz JL, 2000, J AM CHEM SOC, V122, P225, DOI 10.1021/ja9913838; Rajagopalan PTR, 2002, BIOCHEMISTRY-US, V41, P12618, DOI 10.1021/bi026369d; REYES VM, 1995, BIOCHEMISTRY-US, V34, P2710, DOI 10.1021/bi00008a039; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; ROSSI I, 1995, CHEM PHYS LETT, V233, P231, DOI 10.1016/0009-2614(94)01450-A; Roston D, 2014, J COMPUT CHEM, V35, P1411, DOI 10.1002/jcc.23629; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, BIOCHEMISTRY-US, V43, P374, DOI 10.1021/bi035464z; Stojkovic V, 2012, J AM CHEM SOC, V134, P1738, DOI 10.1021/ja209425w; Stojkovic V, 2010, CHEM COMMUN, V46, P8974, DOI 10.1039/c0cc02988b; Thorpe IF, 2005, J AM CHEM SOC, V127, P12997, DOI 10.1021/ja053558l; Thorpe IF, 2003, J PHYS CHEM B, V107, P14042, DOI 10.1021/jp035734n; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Wan Q, 2014, P NATL ACAD SCI USA, V111, P18225, DOI 10.1073/pnas.1415856111; WARREN MS, 1991, BIOCHEMISTRY-US, V30, P11092, DOI 10.1021/bi00110a011; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; WARSHEL A, 1986, BIOCHEMISTRY-US, V25, P8368, DOI 10.1021/bi00374a006; Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u	73	19	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	2017	292	34					14229	14239		10.1074/jbc.M117.777136	http://dx.doi.org/10.1074/jbc.M117.777136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE8FA	28620051	Green Published, hybrid			2022-12-26	WOS:000408439800026
J	O'Donnell, BM; Mackie, TD; Subramanya, AR; Brodsky, JL				O'Donnell, Brighid M.; Mackie, Timothy D.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			Endoplasmic reticulum-associated degradation of the renal potassium channel, ROMK, leads to type II Bartter syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (Hsp70); endoplasmic reticulum-associated protein degradation (ERAD); ER quality control; proteasome; Saccharomyces cerevisiae; yeast; Cdc48	TRANSMEMBRANE CONDUCTANCE REGULATOR; ALPHA-SYNUCLEIN TOXICITY; K+ CHANNEL; PROTEIN-DEGRADATION; AAA-ATPASE; MOLECULAR CHAPERONES; SURFACE EXPRESSION; IN-VITRO; SACCHAROMYCES-CEREVISIAE; APOLIPOPROTEIN-B	Type II Bartter syndrome is caused by mutations in the renal outer medullary potassium (ROMK) channel, but the molecular mechanisms underlying this disease are poorly defined. To rapidly screen for ROMK function, we developed a yeast expression system and discovered that yeast cells lacking endogenous potassium channels could be rescued by WT ROMK but not by ROMK proteins containing any one of four Bartter mutations. We also found that the mutant proteins were significantly less stable than WT ROMK. However, their degradation was slowed in the presence of a proteasome inhibitor or when yeast cells contained mutations in the CDC48 or SSA1 gene, which is required for endoplasmic reticulum (ER)-associated degradation (ERAD). Consistent with these data, sucrose gradient centrifugation and indirect immunofluorescence microscopy indicated that most ROMK protein was ER-localized. To translate these findings to a more relevant cell type, we measured the stabilities of WT ROMK and the ROMK Bartter mutants in HEK293 cells. As in yeast, the Bartter mutant proteins were less stable than the WT protein, and their degradation was slowed in the presence of a proteasome inhibitor. Finally, we discovered that low-temperature incubation increased the steady-state levels of a Bartter mutant, suggesting that the disease-causing mutation traps the protein in a folding-deficient conformation. These findings indicate that the underlying pathology for at least a subset of patients with type II Bartter syndrome is linked to the ERAD pathway and that future therapeutic strategies should focus on correcting deficiencies in ROMK folding.	[O'Donnell, Brighid M.; Mackie, Timothy D.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA; [O'Donnell, Brighid M.; Subramanya, Arohan R.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643	National Institutes of Health [GM75061, DK79307, DK098145, 5T32 DK71492-10, 4K12HD052892-10]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD052892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098145, P30DK079307, T32DK071492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM75061 and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J. L. B.), DK098145 (to A. R. S.), and 5T32 DK71492-10 and 4K12HD052892-10 (to B. M. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Brandvold KR, 2015, J MOL BIOL, V427, P2931, DOI 10.1016/j.jmb.2015.05.010; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choe H, 1997, AM J PHYSIOL-RENAL, V273, pF516, DOI 10.1152/ajprenal.1997.273.4.F516; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Fallen K, 2009, CHANNELS, V3, P57, DOI 10.4161/chan.3.1.7817; Fang LA, 2010, AM J PHYSIOL-RENAL, V299, pF1359, DOI 10.1152/ajprenal.00257.2010; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Fremont OT, 2012, WORLD J PEDIATR, V8, P25, DOI 10.1007/s12519-012-0333-9; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Grove DE, 2011, MOL BIOL CELL, V22, P301, DOI 10.1091/mbc.E10-09-0760; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; HEBERT SC, 1984, AM J PHYSIOL, V246, pF745, DOI 10.1152/ajprenal.1984.246.6.F745; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; IMAI T, 1995, J BIOTECHNOL, V38, P165, DOI 10.1016/0168-1656(94)00130-5; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Kolb AR, 2011, AM J PHYSIOL-RENAL, V301, pF1, DOI 10.1152/ajprenal.00141.2011; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Li K, 2017, MOL CELL, V65, P52, DOI 10.1016/j.molcel.2016.10.027; Lin DH, 2002, AM J PHYSIOL-RENAL, V283, pF671, DOI 10.1152/ajprenal.00160.2002; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; McNicholas CM, 1996, AM J PHYSIOL-RENAL, V271, pF275, DOI 10.1152/ajprenal.1996.271.2.F275; MCNICHOLAS CM, 1994, P NATL ACAD SCI USA, V91, P8077, DOI 10.1073/pnas.91.17.8077; McNicholas CM, 1998, AM J PHYSIOL-RENAL, V275, pF972, DOI 10.1152/ajprenal.1998.275.6.F972; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Molinari M, 2015, SEMIN CELL DEV BIOL, V41, P70, DOI 10.1016/j.semcdb.2015.05.009; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nakatsukasa K, 2010, METHODS MOL BIOL, V619, P365, DOI 10.1007/978-1-60327-412-8_21; Narayan P, 2014, NAT CHEM BIOL, V10, P911, DOI [10.1038/NCHEMBIO.1663, 10.1038/nchembio.1663]; Needham PG, 2015, J MOL BIOL, V427, P2948, DOI 10.1016/j.jmb.2015.04.010; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Perri ER, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00080; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Rieg T, 2007, KIDNEY INT, V72, P566, DOI 10.1038/sj.ki.5002369; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sackin H, 2006, BIOPHYS J, V90, P3582, DOI 10.1529/biophysj.105.076653; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Seyberth HW, 2011, PEDIATR NEPHROL, V26, P1789, DOI 10.1007/s00467-011-1871-4; Shuck ME, 1997, J BIOL CHEM, V272, P586; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Srivastava S, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.160; Starremans PGJF, 2002, PFLUG ARCH EUR J PHY, V443, P466, DOI 10.1007/s004240100708; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; VALLEJO AN, 1994, PCR METH APPL, V4, pS123; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vendruscolo M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a010454; Wang J, 2016, CELL SIGNAL, V28, P1099, DOI 10.1016/j.cellsig.2016.05.007; Wang WH, 2004, CURR OPIN NEPHROL HY, V13, P549, DOI 10.1097/00041552-200409000-00011; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Welling P., 2016, ION CHANNELS TRANSPO, P643; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xiao XJ, 2017, J BIOL CHEM, V292, P7744, DOI 10.1074/jbc.A116.734384; Xu ZC, 1996, J BIOL CHEM, V271, P9313, DOI 10.1074/jbc.271.16.9313; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zaks-Makhina E, 2009, J BIOL CHEM, V284, P15432, DOI 10.1074/jbc.M901586200; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	113	21	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12813	12827		10.1074/jbc.M117.786376	http://dx.doi.org/10.1074/jbc.M117.786376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28630040	hybrid, Green Published			2022-12-26	WOS:000407220100013
J	Jiang, YF; AkhavanAghdam, Z; Tsimring, LS; Hao, N				Jiang, Yanfei; AkhavanAghdam, Zohreh; Tsimring, Lev S.; Hao, Nan			Coupled feedback loops control the stimulus-dependent dynamics of the yeast transcription factor Msn2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); cell signaling; computer modeling; protein kinase A (PKA); systems biology; feedback regulation; signaling circuits; single-cell imaging analysis	SNF1 PROTEIN-KINASE; GENE-EXPRESSION PROGRAMS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; NUCLEOCYTOPLASMIC OSCILLATIONS; FACTOR TRANSLOCATION; SIGNALING DYNAMICS; GLUCOSE STARVATION; NETWORK MOTIFS; ACTIVATION	Information about environmental stimuli often can be encoded by the dynamics of signaling molecules or transcription factors. In the yeast Saccharomyces cerevisiae, different types of stresses induce distinct nuclear translocation dynamics of the general stress-responsive transcription factor Msn2, but the underlying mechanisms remain unclear. Using deterministic and stochastic modeling, we reproduced in silico the different dynamic responses of Msn2 to glucose limitation and osmotic stress observed in vivo and found that a positive feedback loop on protein kinase A mediated by the AMP-activated protein kinase Snf1 is coupled with a negative feedback loop to generate the characteristic pulsatile dynamics of Msn2. The model predicted that the stimulus-specific positive feedback loop could be responsible for the difference between Msn2 dynamics induced by glucose limitation and osmotic stress. This prediction was further verified experimentally by time-lapse microscopic examinations of the snf1 strain. In this mutant lacking the Snf1-mediated positive feedback loop, Msn2 responds similarly to glucose limitation and osmotic stress, and its pulsatile translocation is largely abrogated. Our combined computational and experimental analysis reveals a regulatory mechanism by which cells can encode information about environmental cues into distinct signaling dynamics through stimulus-specific network architectures.	[Jiang, Yanfei; AkhavanAghdam, Zohreh; Hao, Nan] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Tsimring, Lev S.; Hao, Nan] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hao, N (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	nhao@ucsd.edu	; Hao, Nan/O-3462-2016	Tsimring, Lev/0000-0003-0709-3548; Hao, Nan/0000-0003-2857-4789; AkhavanAghdam, Zohreh/0000-0003-3307-7541	National Institutes of Health [R01 GM111458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240, R01GM111458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111458. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AkhavanAghdam Z, 2016, ELIFE, V5, DOI 10.7554/eLife.18458; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Batchelor E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.20; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Besozzi D, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-10; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gonze D, 2008, J R SOC INTERFACE, V5, pS95, DOI 10.1098/rsif.2008.0141.focus; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hansen AS, 2016, CURR BIOL, V26, pR269, DOI 10.1016/j.cub.2016.02.058; Hansen AS, 2015, CELL REP, V12, P1226, DOI 10.1016/j.celrep.2015.07.035; Hansen AS, 2015, NAT PROTOC, V10, P1181, DOI 10.1038/nprot.2015.079; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicastro R, 2015, J BIOL CHEM, V290, P24715, DOI 10.1074/jbc.M115.658005; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Petrenko N, 2013, MOL BIOL CELL, V24, P2045, DOI 10.1091/mbc.E12-12-0870; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Shashkova S, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov026; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	40	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12366	12372		10.1074/jbc.C117.800896	http://dx.doi.org/10.1074/jbc.C117.800896			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28637875	Green Published, hybrid			2022-12-26	WOS:000406636900001
J	Galvin, M; Ryan, P; Maguire, S; Heverin, M; Madden, C; Vajda, A; Normand, C; Hardiman, O				Galvin, Miriam; Ryan, Padhraig; Maguire, Sinead; Heverin, Mark; Madden, Caoifa; Vajda, Alice; Normand, Charles; Hardiman, Orla			The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population-based study of consultations, interventions and costs	PLOS ONE			English	Article							ALS; MANAGEMENT; TIMELINES; SURVIVAL; SYSTEM	Background Amyotrophic Lateral Sclerosis (ALS) is a devastating neurological condition that requires coordinated, multidisciplinary clinical management. ALS is prone to misdiagnosis as its signs and symptoms may be non-specific, which may prolong patients' journey to multidisciplinary ALS care. Methods Using chart review and national register data, we have detailed the journey of a national cohort of ALS patients (n = 155) from the time of first symptom to presentation at a multidisciplinary clinic (MDC). Key milestones were analysed, including frequency of consultations, clinical interventions, and associated economic cost. Results A majority of patients was male (60%), 65 years of age and over (54%), and had spinal onset ALS (72%). Time from onset of first symptoms to ALS diagnosis was a mean of 15.1 months (median, 11). There was a mean interval of 17.4 months (median 12.5) from first symptoms to arrival at the MDC, and a mean of 4.09 (median, 4) consultations with health care professionals. Electromyography and nerve conduction studies were among the most common interventions. Direct referral by a general practitioner (GP) to a neurologist was associated with reduced cost, but not reduced diagnostic delay. Bulbar ALS was associated with shorter time from symptom onset to diagnosis. Neurologist consultation in the first three consultations was associated with lower costs prior to the ALS clinic attendance but not a shorter time from first symptom to final diagnosis. Mean cost prior to attending the MDC was (sic)3,486 per patient. Conclusions Expedited referral to the multidisciplinary ALS clinic would have reduced costs by an estimated (sic)2,072 per patient. Development of a standardised pathway with early referral to neurology of patients with suspected symptoms of ALS could limit unnecessary interventions and reduce cost of care.	[Galvin, Miriam; Heverin, Mark; Madden, Caoifa; Vajda, Alice; Hardiman, Orla] Trinity Coll Dublin, Acad Unit Neurol, Trinity Biomed Sci Inst, Dublin, Ireland; [Ryan, Padhraig; Normand, Charles] Trinity Coll Dublin, Dept Hlth Policy & Management, Dublin, Ireland; [Maguire, Sinead; Hardiman, Orla] Beaumont Hosp, Natl ALS Clin, Dept Neurol, Natl Neurosci Ctr, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Galvin, M (corresponding author), Trinity Coll Dublin, Acad Unit Neurol, Trinity Biomed Sci Inst, Dublin, Ireland.	GALVINMI@tcd.ie	Hardiman, Orla/Y-3441-2019	Hardiman, Orla/0000-0003-2610-1291; Normand, Charles/0000-0002-0885-5754; Galvin, Miriam/0000-0002-8232-8020; Ryan, Padhraig/0000-0001-7852-5606; Vajda, Alice/0000-0001-9105-6680	Irish Health Research Board Dublin, as part of the HRB Interdisciplinary Capacity Enhancement Awards [ICE/2012/]	Irish Health Research Board Dublin, as part of the HRB Interdisciplinary Capacity Enhancement Awards	This research was supported by funding from the Irish Health Research Board Dublin (http://www.hrb.ie), as part of the HRB Interdisciplinary Capacity Enhancement Awards (ICE/2012/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Cellura E, 2012, CLIN NEUROL NEUROSUR, V114, P550, DOI 10.1016/j.clineuro.2011.11.026; Chio A, 2006, NEUROLOGY, V67, P902, DOI 10.1212/01.wnl.0000233840.41688.df; Cristini Jacqueline, 2006, JAAPA, V19, P29; Department of Health Ireland, 2016, DHA39 PRINC PROC AG; Elamin M, 2013, NEUROLOGY, V80, P1590, DOI 10.1212/WNL.0b013e31828f18ac; Galvin M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1229-x; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hobson E, 2015, CLIN REV MOTOR NEURO; Miller RG, 2009, NEUROLOGY, V73, P1227, DOI 10.1212/WNL.0b013e3181bc01a4; Mitchell JD, 2010, AMYOTROPH LATERAL SC, V11, P537, DOI 10.3109/17482968.2010.495158; Motor Neurone Disease Association and Royal College of General Practitioners, 2014, PROGR WEAKN COULD BE; O'Brien MR, 2011, AMYOTROPH LATERAL SC, V12, P97, DOI 10.3109/17482968.2010.546414; Paganoni S, 2015, NEUROREHABILITATION, V37, P53, DOI 10.3233/NRE-151240; Paganoni S, 2014, AMYOTROPH LAT SCL FR, V15, P453, DOI 10.3109/21678421.2014.903974; Roche JC, 2012, BRAIN, V135, P847, DOI 10.1093/brain/awr351; Rooney J, 2015, J NEUROL NEUROSUR PS, V86, P496, DOI 10.1136/jnnp-2014-309601; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Srinivasan J, 2006, MUSCLE NERVE, V34, P359, DOI 10.1002/mus.20555; Stephens HE, 2015, AMYOTROPH LAT SCL FR, V16, P196, DOI 10.3109/21678421.2014.994530; Tramacere I, 2015, J NEUROL NEUROSUR PS, V86, P1180, DOI 10.1136/jnnp-2014-310176; Van Der Steen I, 2009, AMYOTROPH LATERAL SC, V10, P27, DOI 10.1080/17482960802103131	22	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179796	10.1371/journal.pone.0179796	http://dx.doi.org/10.1371/journal.pone.0179796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640860	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800067
J	Lee, ES; Lee, MY; Kwon, MH; Kim, HM; Kang, JS; Kim, YM; Lee, EY; Chung, CH				Lee, Eun Soo; Lee, Mi Young; Kwon, Mi-Hye; Kim, Hong Min; Kang, Jeong Suk; Kim, You Mi; Lee, Eun Young; Chung, Choon Hee			Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice	PLOS ONE			English	Article							INCREASES CIRCULATING ADIPONECTIN; ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; RECEPTOR ANTAGONIST; HUMAN MONOCYTES; SEROTONIN; OBESITY; SERUM; SIRT1; CELL	The aim of this study was to evaluate the effects of sarpogrelate hydrochloride (SH), a selective serotonin 2A receptor antagonist, on diabetic nephropathy in a type 2 diabetes mouse model. We treated db/m and db/db mice with SH (30 mg/kg/day) for 12 weeks. Rat renal proximal tubule cells (NRK-52E) and mouse macrophages (Raw 264.7) were stimulated by high glucose (30 mM glucose) or LPS (100 ng/ml) with or without SH (20 mu M). We found that SH treatment increased serum adiponectin level and decreased urinary albumin, macrophage infiltration to glomeruli, and renal inflammatory and fibrosis signals, which were highly expressed in diabetic mice. Proximal tubule cells treated with high glucose (30 mM) also showed increased inflammatory and fibrosis signals. However, SH (20 mu M) treatment reduced these changes. Moreover, SH treatment inhibited LPS-stimulated macrophage migration and activation. These findings suggest that SH ameliorates diabetic nephropathy not only by suppressing macrophage infiltration, but also by anti-inflammatory and antifibrotic effects.	[Lee, Eun Soo; Lee, Mi Young; Kwon, Mi-Hye; Kim, Hong Min; Kim, You Mi; Chung, Choon Hee] Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea; [Kang, Jeong Suk; Lee, Eun Young] Soonchunhyang Univ, Dept Internal Med, Cheonan Hosp, Cheonan, South Korea	Yonsei University; Soonchunhyang University	Chung, CH (corresponding author), Yonsei Univ, Dept Internal Med, Wonju Coll Med, Wonju, South Korea.	cchung@yonsei.ac.kr	Lee, Eun Young/Q-6592-2019	Lee, Eun Young/0000-0002-4513-9888; Chung, Choon/0000-0003-1144-7206	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A02060785, 2015R1A6A1A03032522]; Yonsei University Wonju College of Medicine [YUWCM-2009-23]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Yonsei University Wonju College of Medicine	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02060785, 2015R1A6A1A03032522) to EYL, and the research grant from Yonsei University Wonju College of Medicine (YUWCM-2009-23) to MYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02060785, 2015R1A6A1A03032522) and the research grant from Yonsei University Wonju College of Medicine (YUWCM-2009-23).	Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Cai XL, 2015, INT J DISTRIB SENS N, DOI 10.1155/2015/976127; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Goyal RK, 2011, J CARDIOVASC PHARM T, V16, P380, DOI 10.1177/1074248410384708; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Ka SO, 2015, J ENDOCRINOL, V224, P109, DOI 10.1530/JOE-14-0527; Kasho M, 1998, KIDNEY INT, V54, P1083, DOI 10.1046/j.1523-1755.1998.00114.x; Kim DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153965; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; King GL, 2008, J PERIODONTOL, V79, P1527, DOI 10.1902/jop.2008.080246; Kobayashi S, 2008, CLIN EXP NEPHROL, V12, P119, DOI 10.1007/s10157-007-0011-8; LANE PH, 1992, KIDNEY INT, V41, P1085, DOI 10.1038/ki.1992.165; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Lee YJ, 2010, AM J PHYSIOL-RENAL, V298, pF1263, DOI 10.1152/ajprenal.00475.2009; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Malyszko J, 1995, Pol Arch Med Wewn, V94, P26; MALYSZKO J, 1994, THROMB RES, V75, P569, DOI 10.1016/0049-3848(94)90231-3; MONTERO A, 1995, FUNDAM CLIN PHARM, V9, P175, DOI 10.1111/j.1472-8206.1995.tb00278.x; NEBIGIL CG, 1995, AM J PHYSIOL-RENAL, V268, pF122, DOI 10.1152/ajprenal.1995.268.1.F122; Ni W, 2006, CLIN EXP PHARMACOL P, V33, P575, DOI 10.1111/j.1440-1681.2006.04410.x; Nomura S, 2005, BLOOD COAGUL FIBRIN, V16, P423, DOI 10.1097/01.mbc.0000176197.48134.08; Nymark M, 2009, DIABETES CARE, V32, P1689, DOI 10.2337/dc09-0467; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; RAPPORT MM, 1948, J BIOL CHEM, V176, P1243; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Sakai N, 2015, KIDNEY INT, V87, P11, DOI 10.1038/ki.2014.322; SAXENA PR, 1990, J CARDIOVASC PHARM, V15, pS17, DOI 10.1097/00005344-199001001-00004; Seok SJ, 2013, NEPHROL DIAL TRANSPL, V28, P1700, DOI 10.1093/ndt/gfs555; Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Szabo A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00358; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Takahashi T, 2002, DIABETES RES CLIN PR, V58, P123, DOI 10.1016/S0168-8227(02)00105-5; TAKAHASHI T, 1992, J CARDIOVASC PHARM, V20, P779, DOI 10.1097/00005344-199211000-00014; Takishita E, 2004, J CARDIOVASC PHARM, V43, P266, DOI 10.1097/00005344-200402000-00015; Tsuchiya R, 2008, J VET MED SCI, V70, P181, DOI 10.1292/jvms.70.181; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Xiao JH, 2016, INT J MOL MED, V37, P659, DOI 10.3892/ijmm.2016.2486; Yamakawa J, 2003, DIABETES CARE, V26, P2477, DOI 10.2337/diacare.26.8.2477; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Zhao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113398	54	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179221	10.1371/journal.pone.0179221	http://dx.doi.org/10.1371/journal.pone.0179221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640832	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800022
J	Liao, KH; Chang, SJ; Chang, HC; Chien, CL; Huang, TS; Feng, TC; Lin, WW; Shih, CC; Yang, MH; Yang, SH; Lin, CH; Hwang, WL; Lee, OK				Liao, Ko-Hsun; Chang, Shing-Jyh; Chang, Hsin-Chuan; Chien, Chen-Li; Huang, Tse-Shun; Feng, Te-Chia; Lin, Wen-Wei; Shih, Chuan-Chi; Yang, Muh-Hwa; Yang, Shung-Haur; Lin, Chi-Hung; Hwang, Wei-Lun; Lee, Oscar K.			Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-beta 2 expression	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROGENITOR-CELL; GROWTH-FACTOR; BONE-MARROW; FAMILY PROTEINS; MECHANISMS; DIFFERENTIATION; PROLIFERATION; ETO; VASCULOGENESIS	Tissue angiogenesis is intimately regulated during embryogenesis and postnatal development. Defected angiogenesis contributes to aberrant development and is the main complication associated with ischemia-related diseases. We previously identified the increased expression of RUNX1T1 in umbilical cord blood-derived endothelial colony-forming cells (ECFCs) by gene expression microarray. However, the biological relevance of RUNX1T1 in endothelial lineage is not defined clearly. Here, we demonstrate RUNX1T1 regulates the survival, motility and tube forming capability of ECFCs and EA. hy926 endothelial cells by loss-and gain-of function assays, respectively. Second, embryonic vasculatures and quantity of bone marrow-derived angiogenic progenitors are found to be reduced in the established Runx1t1 heterozygous knockout mice. Finally, a central RUNX1T1-regulated signature is uncovered and VEGFA, BMP4 as well as TGF-beta 2 are demonstrated to mediate RUNX1T1-orchested angiogenic activities. Taken together, our results reveal that RUNX1T1 serves as a common angiogenic driver for vaculogenesis and functionality of endothelial lineage cells. Therefore, the discovery and application of pharmaceutical activators for RUNX1T1 will improve therapeutic efficacy toward ischemia by promoting neovascularization.	[Liao, Ko-Hsun; Chang, Hsin-Chuan; Chien, Chen-Li; Huang, Tse-Shun; Lin, Wen-Wei; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Chang, Shing-Jyh; Shih, Chuan-Chi] Hsinchu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Feng, Te-Chia; Hwang, Wei-Lun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Yang, Muh-Hwa; Lee, Oscar K.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Immun & Inflammat Res Ctr, Taipei, Taiwan; [Yang, Muh-Hwa] Natl Yang Ming Univ, Canc Res Ctr, Taipei, Taiwan; [Yang, Muh-Hwa] Taipei Vet Gen Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan; [Yang, Muh-Hwa] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Yang, Shung-Haur] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Yang, Shung-Haur] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Lee, Oscar K.] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lee, Oscar K.] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taipei Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital	Hwang, WL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.; Lee, OK (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Lee, OK (corresponding author), Natl Yang Ming Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Lee, OK (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan.; Lee, OK (corresponding author), Taipei City Hosp, Taipei, Taiwan.	wlhwang930@tmu.edu.tw; DAV47@tpech.gov.tw	Yang, Muh-Hwa/AAE-4691-2020		Ministry of Science and Technology (MOST) [104-2321-B-101-027, 103-2314-B-010-053-MY3, 104-0210-01-09-02, 103-2633-H-010-001, 105-2320-B-038-009-MY2]; Yuan's General Hospital [106YGH-TMU-02]; Hsinchu Mackay Memorial Hospital [MMH-HB-10614]; Taipei Medical University [TMU104-AE1-B11]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Yuan's General Hospital; Hsinchu Mackay Memorial Hospital; Taipei Medical University	This work is supported by Ministry of Science and Technology (MOST; 104-2321-B-101-027 to S.H.Y; 103-2314-B-010-053-MY3 to O.K.L; 104-0210-01-09-02, and 103-2633-H-010-001 to M.H.Y and 105-2320-B-038-009-MY2 to W.L.H), Yuan's General Hospital (106YGH-TMU-02 to W.L. H), Hsinchu Mackay Memorial Hospital (MMH-HB-10614 to C.C.S) and Taipei Medical University (TMU104-AE1-B11 to W.L.H).r The authors dedicate this work to the memory of Professor Hsei-Wei Wang (Apr. 1969-Sep. 2015). Dr. Hsei-Wei Wang focused on bioinformatics and molecular biology research; without his long-term devotion to EPC research this paper could not have been completed. The authors would like to thank Dr. Tzong-Shyuan Lee and Dr. Po-Hsun Huang for their advice and helpful comments. The authors also acknowledge the technical services provided by the Microarray & Gene Expression Analysis Core Facility and Instrument Resource Center of the National Yang-Ming University. The Runxl tl knock-out mice were generated under the supervision of the Transgenic Mouse Model Core Facility of the National Core Facility Program for Biotechnology, National Science Council (NSC) and the Gene Knockout Mouse Core Laboratory of National Taiwan University Center of Genomic Medicine. The authors also acknowledge the technical supports provided by Flow cytometry Core Facility of National Yang Ming University and Imaging Core Facility of Nanotechnology of the UST-YMU. This work is supported by Ministry of Science and Technology (MOST; 104-2321-B-101-027 to S. H.Y; 103-2314-B-010-053-MY3 to O.K.L; 104-0210-01-09-02, and 103-2633-H-010-001 to M. H.Y; and 105-2320-B-038-009-MY2 to W.L.H), Yuan's General Hospital (106YGH-TMU-02 to W.L.H), Hsinchu Mackay Memorial Hospital (MMH-HB-10614 to C.C.S) and Taipei Medical University (TMU104-AE1-B11 to W.L.H).	Aaker JD, 2010, NEUROSCI LETT, V474, P46, DOI 10.1016/j.neulet.2010.03.004; Alfayez M, 2016, ANTICANCER RES, V36, P5257, DOI 10.21873/anticanres.11096; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Ardila DC, 2015, BIOMATERIALS, V37, P164, DOI 10.1016/j.biomaterials.2014.10.021; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baby N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089326; Bauer SM, 2006, J VASC SURG, V43, P134, DOI 10.1016/j.jvs.2005.08.038; Benitez CM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004645; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Boyd NL, 2007, EXP BIOL MED, V232, P833; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; Cao Y, 2002, MECH DEVELOP, V119, P35, DOI 10.1016/S0925-4773(02)00285-X; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cheng CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-182; Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166; Dai L, 2012, INT J CANCER, V131, P834, DOI 10.1002/ijc.26428; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Erickson PF, 1996, BLOOD, V88, P1813; Ferguson JE, 2005, ARTERIOSCL THROM VAS, V25, P2246, DOI 10.1161/01.ATV.0000183609.55154.44; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Gendron RL, 1996, DEV BIOL, V177, P332, DOI 10.1006/dbio.1996.0167; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Junge A, 2017, GENE, V615, P35, DOI 10.1016/j.gene.2017.03.015; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kota Sunil K, 2012, Indian J Endocrinol Metab, V16, P918, DOI 10.4103/2230-8210.102992; Koyano-Nakagawa N, 2005, DEV BIOL, V278, P22, DOI 10.1016/j.ydbio.2004.10.010; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lee Poay Sian Sabrina, 2014, World J Stem Cells, V6, P355, DOI 10.4252/wjsc.v6.i3.355; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107127; Lutter S, 2012, J CELL BIOL, V197, P837, DOI 10.1083/jcb.201110132; Marcelo KL, 2013, CIRC RES, V112, P1272, DOI 10.1161/CIRCRESAHA.113.300506; Melnick AM, 2000, MOL CELL BIOL, V20, P2075, DOI 10.1128/MCB.20.6.2075-2086.2000; Merkestein M, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/521381; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Moreno-Miralles I, 2009, CURR OPIN HEMATOL, V16, P195, DOI 10.1097/MOH.0b013e32832a07d6; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nelson J, 2015, FASEB J, V29, P3085, DOI 10.1096/fj.14-267989; Okumura AJ, 2007, EXP HEMATOL, V35, P978, DOI 10.1016/j.exphem.2007.03.002; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Torry DS, 1997, AM J REPROD IMMUNOL, V37, P21; van de Locht LT, 1994, LEUKEMIA, V8; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wang S, 2015, J NANOSCI NANOTECHNO, V15, P4239, DOI 10.1166/jnn.2015.9785; Wildonger J, 2005, DEV BIOL, V286, P507, DOI 10.1016/j.ydbio.2005.08.026; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wolford JK, 1998, GENE, V212, P103, DOI 10.1016/S0378-1119(98)00141-3; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Yoder MC, 2013, J MOL MED, V91, P285, DOI 10.1007/s00109-013-1002-8; Yu J, 2013, TOXICOL LETT, V218, P224, DOI 10.1016/j.toxlet.2013.01.028; Zhao TQ, 2010, MICROVASC RES, V80, P188, DOI 10.1016/j.mvr.2010.03.014	64	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179758	10.1371/journal.pone.0179758	http://dx.doi.org/10.1371/journal.pone.0179758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640846	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800061
J	Himori, K; Tatebayashi, D; Kanzaki, K; Wada, M; Westerblad, H; Lanner, JT; Yamada, T				Himori, Koichi; Tatebayashi, Daisuke; Kanzaki, Keita; Wada, Masanobu; Westerblad, Hakan; Lanner, Johanna T.; Yamada, Takashi			Neuromuscular electrical stimulation prevents skeletal muscle dysfunction in adjuvant-induced arthritis rat	PLOS ONE			English	Article							DESMIN-RELATED CARDIOMYOPATHY; RHEUMATOID-ARTHRITIS; SOLEUS MUSCLE; FATIGUE; DISEASE; PEROXYNITRITE; IMPAIRMENT; PREVALENCE; MECHANISMS; EXPRESSION	Skeletal muscle weakness is a prominent feature in patients with rheumatoid arthritis (RA). In this study, we investigated whether neuromuscular electrical stimulation (NMES) training protects against skeletal muscle dysfunction in rats with adjuvant-induced arthritis (AIA). AIA was produced by intraarticular injection of complete Freund's adjuvant into the knees of Wistar rats. For NMES training, dorsiflexor muscles were stimulated via a surface electrode (0.5 ms pulse, 50 Hz, 2 s on/4 s off). NMES training was performed every other day for three weeks and consisted of three sets produced at three min intervals. In each set, the electrical current was set to achieve 60% of the initial maximum isometric torque and the current was progressively increased to maintain this torque; stimulation was stopped when the 60% torque could no longer be maintained. After the intervention period, extensor digitorum longus (EDL) muscles were excised and used for physiological and biochemical analyses. There was a reduction in specific force production (i.e. force per cross-sectional area) in AIA EDL muscles, which was accompanied by aggregation of the myofibrillar proteins actin and desmin. Moreover, the protein expressions of the pro-oxidative enzymes NADPH oxidase, neuronal nitric oxide synthase, p62, and the ratio of the autophagosome marker LC3bII/LC3bI were increased in AIA EDL muscles. NMES training prevented all these AIA-induced alterations. The present data suggest that NMES training prevents AIA-induced skeletal muscle weakness presumably by counteracting the formation of actin and desmin aggregates. Thus, NMES training can be an effective treatment for muscle dysfunction in patients with RA.	[Himori, Koichi; Tatebayashi, Daisuke; Yamada, Takashi] Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Kanzaki, Keita] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Soja, Okayama, Japan; [Wada, Masanobu] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Japan; [Westerblad, Hakan; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Sapporo Medical University; Okayama Prefectural University; Hiroshima University; Karolinska Institutet	Yamada, T (corresponding author), Sapporo Med Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan.	takashi.yamada1976@sapmed.ac.jp	Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Westerblad, Hakan/0000-0002-8180-3029	Japan Society for the Promotion of Science [26702021]; Ake Wiberg Foundation [M14-0210]; KI Rheumatology fund [2014reum42670]; Reumatikerforbundet [R-481591]; Swedish Research Council [521-2012-1645]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ake Wiberg Foundation; KI Rheumatology fund; Reumatikerforbundet; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Japan Society for the Promotion of Science: 26702021, https://www.isps.go.ip/english/; Ake Wiberg Foundation: M14-0210, http://akeddiberdse/; KI Rheumatology fund: 2014reum42670, http:// fonder.ki.se/; Reumatikerforbundet: R-481591, https://www.reumatikerforbundet.org/; and Swedish Research Council: 521-2012-1645, https://www.vr.se.	Adams GR, 2004, J APPL PHYSIOL, V96, P1613, DOI 10.1152/japplphysiol.01162.2003; ALLEN DG, 1995, EXP PHYSIOL, V80, P497, DOI 10.1113/expphysiol.1995.sp003864; Bhuiyan MS, 2013, J CLIN INVEST, V123, P5284, DOI 10.1172/JCI70877; Biol AJ, 2007, J NEUROPATH EXP NEUR, V66, P711, DOI 10.1097/nen.0b013e3181256b4c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carnio S, 2014, CELL REP, V8, P1509, DOI 10.1016/j.celrep.2014.07.061; Pimenta AD, 2007, EUR J APPL PHYSIOL, V102, P119, DOI 10.1007/s00421-007-0542-4; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1075, DOI 10.1016/S0891-5849(01)00690-6; Fedorova M, 2009, BBA-MOL BASIS DIS, V1792, P1185, DOI 10.1016/j.bbadis.2009.09.011; Gondin J, 2005, MED SCI SPORT EXER, V37, P1291, DOI 10.1249/01.mss.0000175090.49048.41; Gondin J, 2011, EUR J APPL PHYSIOL, V111, P2473, DOI 10.1007/s00421-011-2101-2; Gondin J, 2010, MUSCLE NERVE, V41, P667, DOI 10.1002/mus.21572; Gregory CM, 2005, PHYS THER, V85, P358, DOI 10.1093/ptj/85.4.358; Hakkinen A, 2001, ARTHRITIS RHEUM-US, V44, P515; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Maffiuletti NA, 2010, EUR J APPL PHYSIOL, V110, P223, DOI 10.1007/s00421-010-1502-y; Maloyan A, 2007, P NATL ACAD SCI USA, V104, P5995, DOI 10.1073/pnas.0609202104; McLendon PM, 2011, AM J PHYSIOL-HEART C, V301, pH1220, DOI 10.1152/ajpheart.00601.2011; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munneke M, 2005, ARTHRIT RHEUM-ARTHR, V53, P410, DOI 10.1002/art.21165; Munro R, 1997, ANN RHEUM DIS, V56, P326, DOI 10.1136/ard.56.5.326; Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x; OLDHAM JA, 1989, J HAND SURG-BRIT EUR, V14B, P294, DOI 10.1016/0266-7681(89)90085-5; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Pigna E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26991; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Segard BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076361; Supinski G, 1999, J APPL PHYSIOL, V87, P776, DOI 10.1152/jappl.1999.87.2.776; Tiago T, 2006, BIOCHEM BIOPH RES CO, V342, P44, DOI 10.1016/j.bbrc.2006.01.112; Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; Westerblad H, 2000, EUR J APPL PHYSIOL, V83, P166, DOI 10.1007/s004210000275; Yamada T, 2015, ANN RHEUM DIS, V74, P1907, DOI 10.1136/annrheumdis-2013-205007; Yamada T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0045-7; Yamada T, 2009, ARTHRITIS RHEUM-US, V60, P3280, DOI 10.1002/art.24907	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179925	10.1371/journal.pone.0179925	http://dx.doi.org/10.1371/journal.pone.0179925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636643	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300063
J	Sanderson, WC; Scherbov, S; Gerland, P				Sanderson, Warren C.; Scherbov, Sergei; Gerland, Patrick			Probabilistic population aging	PLOS ONE			English	Article							COUNTRIES; FORECASTS	We merge two methodologies, prospective measures of population aging and probabilistic population forecasts. We compare the speed of change and variability in forecasts of the old age dependency ratio and the prospective old age dependency ratio as well as the same comparison for the median age and the prospective median age. While conventional measures of population aging are computed on the basis of the number of years people have already lived, prospective measures are computed also taking account of the expected number of years they have left to live. Those remaining life expectancies change over time and differ from place to place. We compare the probabilistic distributions of the conventional and prospective measures using examples from China, Germany, Iran, and the United States. The changes over time and the variability of the prospective indicators are smaller than those that are observed in the conventional ones. A wide variety of new results emerge from the combination of methodologies. For example, for Germany, Iran, and the United States the likelihood that the prospective median age of the population in 2098 will be lower than it is today is close to 100 percent.	[Sanderson, Warren C.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren C.; Scherbov, Sergei] WU, VID OAW, IIASA, World Populat Program,Wittgenstein Ctr Demog & Gl, Schlosspl 1, Laxenburg, Austria; [Scherbov, Sergei] Austrian Acad Sci, Vienna Inst Demog, Vienna, Austria; [Scherbov, Sergei] Russian Presidential Acad Natl Econ & Publ Adm RA, Moscow, Russia; [Gerland, Patrick] United Nations Org, DESA, Populat Div, Two UN Plaza,Room DC2-1934, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA); Austrian Academy of Sciences; Russian Presidential Academy of National Economy & Public Administration	Sanderson, WC (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.; Sanderson, WC (corresponding author), WU, VID OAW, IIASA, World Populat Program,Wittgenstein Ctr Demog & Gl, Schlosspl 1, Laxenburg, Austria.	warren.sanderson@stonybrook.edu	Sanderson, Warren/R-3398-2019; Scherbov, Sergey/F-3158-2019; Gerland, Patrick/F-7390-2013	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Gerland, Patrick/0000-0002-2082-3122; Sanderson, Warren/0000-0002-2205-948X	European Research Council under the European Union's Seventh Frame work Programme / ERC [ERC2012-AdG323947-Re-Ageing]	European Research Council under the European Union's Seventh Frame work Programme / ERC(European Research Council (ERC))	We thank the Population Division of the United Nations for providing access to asubset of trajectories of probabilistic population projections and associated abridged life tables based on the World Population Prospects: The 2015 Revision. There search leading to these results has received funding from the European Research Council under the European Union's Seventh Frame work Programme (FP7/2007-2013) / ERC grant agreement no ERC2012-AdG323947-Re-Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed in this paper are those of the authors and do not necessarily represent those of the United Nations.	AbbasiShavazi MJ, 2009, FERTILITY TRANSITION IN IRAN: REVOLUTION AND REPRODUCTION, P1; Bordone V, 2015, INTELLIGENCE, V52, P90, DOI 10.1016/j.intell.2015.07.005; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; He W, 2016, P95161; International Labour Organization (ILO), 2011, EC ACT POP EST PROJ; Keilman N, 2004, INT STAT REV, V72, P5; Keilman N., 2002, DEMOGR RES, V6, P409, DOI [10.4054/DemRes.2002.6.15, DOI 10.4054/DEMRES.2002.6.15]; Keilman N, 2008, POPUL DEV REV, V34, P137, DOI 10.1111/j.1728-4457.2008.00209.x; KEYFITZ N, 1981, POPUL DEV REV, V7, P579, DOI 10.2307/1972799; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Lee RD, 2014, POP AG GEN EC GLOB P; Lee RD., 1999, FRONTIERS POPULATI S, V24, P156; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W, 2004, INT STAT REV, V72, P1, DOI 10.1111/j.1751-5823.2004.tb00219.x; Lutz W, 1997, NATURE, V387, P803, DOI 10.1038/42935; Lutz W, 1999, FRONTIERS POPULATION, V24, P139; OECD, 2014, OECD PENS OUTL 2014; OECD, 2013, PENS GLANC 2013 RET; Raftery AE, 2012, P NATL ACAD SCI USA, V109, P13915, DOI 10.1073/pnas.1211452109; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; Sanderson WC, 2004, POPUL ENVIRON, V26, P173, DOI 10.1007/s11111-004-0839-8; Scherbov S., 2014, WORLD POPULATION HUM, P563; Sevcikova H, 2015, ARXIV150305215; United Nations, 2015, ESAPWP241 UN; United Nations, 2015, STESASERA390; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; WHO US National Institute of Aging, 2011, US NATL I AG GLOB HL	30	19	19	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179171	10.1371/journal.pone.0179171	http://dx.doi.org/10.1371/journal.pone.0179171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636675	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000404118300028
J	Kruse, A; Fattah-Hosseini, S; Saha, S; Johnson, R; Warwick, E; Sturgeon, K; Mueller, L; MacCoss, MJ; Shatters, RG; Heck, MC				Kruse, Angela; Fattah-Hosseini, Somayeh; Saha, Surya; Johnson, Richard; Warwick, EricaRose; Sturgeon, Kasie; Mueller, Lukas; MacCoss, Michael J.; Shatters, Robert G., Jr.; Heck, Michelle Cilia			Combining 'omics and microscopy to visualize interactions between the Asian citrus psyllid vector and the Huanglongbing pathogen Candidatus Liberibacter asiaticus in the insect gut	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; DIAPHORINA-CITRI; GENE-EXPRESSION; WOLBACHIA INFECTION; MOLECULAR-MECHANISMS; HEMIPTERA PSYLLIDAE; VIRUS TRANSMISSION; AEDES-AEGYPTI; APOPTOSIS; DISEASE	Huanglongbing, or citrus greening disease, is an economically devastating bacterial disease of citrus. It is associated with infection by the gram-negative bacterium Candidatus Liberibacter asiaticus (CLas). CLas is transmitted by Diaphorina citri, the Asian citrus psyllid (ACP). For insect transmission to occur, CLas must be ingested during feeding on infected phloem sap and cross the gut barrier to gain entry into the insect vector. To investigate the effects of CLas exposure at the gut-pathogen interface, we performed RNAseq and mass spectrometry-based proteomics to analyze the transcriptome and proteome, respectively, of ACP gut tissue. CLas exposure resulted in changes in pathways involving the TCA cycle, iron metabolism, insecticide resistance and the insect's immune system. We identified 83 long non-coding RNAs that are responsive to CLas, two of which appear to be specific to the ACP. Proteomics analysis also enabled us to determine that Wolbachia, a symbiont of the ACP, undergoes proteome regulation when CLas is present. Fluorescent in situ hybridization (FISH) confirmed that Wolbachia and CLas inhabit the same ACP gut cells, but do not co-localize within those cells. Wolbachia cells are prevalent throughout the gut epithelial cell cytoplasm, and Wolbachia titer is more variable in the guts of CLas exposed insects. CLas is detected on the luminal membrane, in puncta within the gut epithelial cell cytoplasm, along actin filaments in the gut visceral muscles, and rarely, in association with gut cell nuclei. Our study provides a snapshot of how the psyllid gut copes with CLas exposure and provides information on pathways and proteins for targeted disruption of CLas-vector interactions at the gut interface.	[Kruse, Angela; Heck, Michelle Cilia] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA; [Kruse, Angela; Fattah-Hosseini, Somayeh; Saha, Surya; Mueller, Lukas; Heck, Michelle Cilia] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Johnson, Richard; MacCoss, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Warwick, EricaRose; Sturgeon, Kasie; Shatters, Robert G., Jr.] USDA ARS, Subtrop Insects & Hort Res Unit, US Hort Res Lab, Ft Pierce, FL USA; [Warwick, EricaRose; Sturgeon, Kasie] Univ Florida, Plant Pathol, Citrus Res & Educ Ctr, Lake Alfred, FL USA; [Heck, Michelle Cilia] USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr, Ithaca, NY 14853 USA	Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Heck, MC (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.; Heck, MC (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Heck, MC (corresponding author), USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr, Ithaca, NY 14853 USA.	mlc68@cornell.edu	Saha, Surya/S-9548-2018	Saha, Surya/0000-0002-1160-1413; Heck, Michelle/0000-0003-0921-4489; Kruse, Angela/0000-0001-8776-2769; Shatters, Robert/0000-0002-3903-772X; Fattah-Hosseini, Somayeh/0000-0002-4969-1573	United States Department of Agriculture; National Institute of Food and Agriculture [2015-20016-2328]; California Citrus Research Board [5300-155, 5300-163]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); California Citrus Research Board; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was funded by United States Department of Agriculture, National Institute of Food and Agriculture (https://nifa.usda.gov/) grant 2015-20016-2328 to MH, MM and LM and California Citrus Research Board (http://citrusresearch.org/) grants 5300-155 to MH and 5300-163 to MH and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2005, INSECT BIOCHEM MOLEC, V35, P709, DOI 10.1016/j.ibmb.2005.02.019; Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bolger AM, 2014, TRIMMOMATIC FLEXIBLE; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Chu CC, 2016, MICROB ECOL, V71, P999, DOI 10.1007/s00248-016-0733-9; Cilia M, 2009, J Biomol Tech, V20, P201; Ferrara TFD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145132; de-Morais GS, 2005, BIOCHEM BIOPH RES CO, V328, P106, DOI DOI 10.1016/J.BBRC.2004.12.135; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dolan MF, 2004, EUR J PROTISTOL, V40, P257, DOI 10.1016/j.ejop.2004.01.005; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Dutt M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137134; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Etebari K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14642; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Fallon AM, 2009, IN VITRO CELL DEV-AN, V45, P460, DOI 10.1007/s11626-009-9193-6; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Ghanim M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33418; Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gray S, 2014, ADV VIRUS RES, V89, P141, DOI 10.1016/B978-0-12-800172-1.00004-5; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajeri S, 2014, J BIOTECHNOL, V176, P42, DOI 10.1016/j.jbiotec.2014.02.010; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann M, 2014, ENVIRON ENTOMOL, V43, P1215, DOI 10.1603/EN14193; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Huang HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11413; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kikuta S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00290; Kliot A, 2014, JOVE-J VIS EXP, DOI 10.3791/51030; Kolora LD, 2015, CURR MICROBIOL, V70, P710, DOI 10.1007/s00284-015-0774-1; Korayem AM, 2004, INSECT BIOCHEM MOLEC, V34, P1297, DOI 10.1016/j.ibmb.2004.09.001; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JA, 2015, P NATL ACAD SCI USA, V112, P7605, DOI 10.1073/pnas.1508253112; Leng N, 2017, AG DATA COMMONS; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mar T, 2014, J PROTEOMICS, V102, P83, DOI 10.1016/j.jprot.2014.03.004; Martini X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129373; McKenzie CL, 2009, PLANT DIS, V93, P1074, DOI 10.1094/PDIS-93-10-1074A; McKenzie CL, 2004, J ECON ENTOMOL, V97, P970, DOI 10.1603/0022-0493(2004)097[0970:EOSOOS]2.0.CO;2; Medeiros RB, 2004, J VIROL, V78, P4976, DOI 10.1128/JVI.78.10.4976-4982.2004; Morgan JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062444; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; Nwugo CC, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0942-x; Nwugo CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067442; Nwugo CC, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-59; Paul REL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-30; Pelz-Stelinski KS, 2016, ANN ENTOMOL SOC AM, V109, P371, DOI 10.1093/aesa/saw007; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Ramsey JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140826; Ramsey JS C J, ROYAL SOC OPEN SCI; Reese Justin, 2014, J Genomics, V2, P54; Ren SL, 2016, J APPL MICROBIOLOGY; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha S, 2017, BIORXIV; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Tiwari S, 2011, ANN ENTOMOL SOC AM, V104, P297, DOI 10.1603/AN10128; Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y; Valenzuela-Miranda D, 2016, FISH SHELLFISH IMMUN, V59, P427, DOI 10.1016/j.fsi.2016.11.001; Vo M, 2010, J MED ENTOMOL, V47, P215, DOI 10.1603/ME09041; Vontas J, 2005, INSECT MOL BIOL, V14, P509, DOI 10.1111/j.1365-2583.2005.00582.x; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0	93	65	67	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179531	10.1371/journal.pone.0179531	http://dx.doi.org/10.1371/journal.pone.0179531			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632769	Green Submitted, Green Published, gold			2022-12-26	WOS:000404046100036
J	Liu, JC; Zacksenhouse, M; Eisen, A; Nofech-Mozes, S; Zacksenhaus, E				Liu, Jeffrey C.; Zacksenhouse, Miriam; Eisen, Andrea; Nofech-Mozes, Sharon; Zacksenhaus, Eldad			Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2(+): ER alpha(-) breast cancer	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; GENE SIGNATURE; GROWTH-FACTOR; MAMMARY EPITHELIUM; TRASTUZUMAB; EXPRESSION; DISULFIRAM; PERTUZUMAB; DOCETAXEL; EFFICACY	Background Multi-gene prognostic signatures derived from primary tumor biopsies can guide clinicians in designing an appropriate course of treatment. Identifying genes and pathways most essential to a signature performance may facilitate clinical application, provide insights into cancer progression, and uncover potentially new therapeutic targets. We previously developed a 17-gene prognostic signature (HTICS) for HER2(+): ER alpha(-) breast cancer patients, using genes that are differentially expressed in tumor initiating cells (TICs) versus non-TICs from MMTV-Her2/neu mammary tumors. Here we probed the pathways and genes that underlie the prognostic power of HTICS. Methods We used Leave-One Out, Data Combination Test, Gene Set Enrichment Analysis (GSEA), Correlation and Substitution analyses together with Receiver Operating Characteristic (ROC) and Kaplan-Meier survival analysis to identify critical biological pathways within HTICS. Publically available cohorts with gene expression and clinical outcome were used to assess prognosis. NanoString technology was used to detect gene expression in formalin-fixed paraffin embedded (FFPE) tissues. Results We show that three major biological pathways: cell proliferation, immune response, and cell migration, drive the prognostic power of HTICS, which is further tuned by Homeostatic and Glycan metabolic signalling. A 6-gene minimal Core that retained a significant prognostic power, albeit less than HTICS, also comprised the proliferation/immune/migration pathways. Finally, we developed NanoString probes that could detect expression of HTICS genes and their substitutions in FFPE samples. Conclusion Our results demonstrate that the prognostic power of a signature is driven by the biological processes it monitors, identify cell proliferation, immune response and cell migration as critical pathways for HER2(+): ER alpha(-) cancer progression, and defines substitutes and Core genes that should facilitate clinical application of HTICS.	[Liu, Jeffrey C.; Zacksenhaus, Eldad] Univ Hlth Network, Toronto Gen Res Inst, Div Adv Diagnost, Toronto, ON, Canada; [Zacksenhouse, Miriam] Technion Israel Inst Technol Haifa, Fac Mech Engn, Brain Comp Interfaces Rehabil Lab, Haifa, Israel; [Eisen, Andrea; Nofech-Mozes, Sharon] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Zacksenhaus, Eldad] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Technion Israel Institute of Technology; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Liu, JC; Zacksenhaus, E (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Adv Diagnost, Toronto, ON, Canada.; Zacksenhaus, E (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	jeff.liu@utoronto.ca; eldad.zacksenhaus@utoronto.ca	Zacksenhaus, Eldad/AAD-3584-2020; Nofech-Mozes, Sharon/AAP-9855-2021	Zacksenhouse, Miriam/0000-0003-3022-5449	Canadian Breast Cancer Foundation (CBCF), Ontario, Canada	Canadian Breast Cancer Foundation (CBCF), Ontario, Canada	This study was conducted with support from the Canadian Breast Cancer Foundation (CBCF), Ontario, Canada to AE, SNM, and EZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson V, 2011, CLIN CANCER RES, V17, P952, DOI 10.1158/1078-0432.CCR-09-1947; Allensworth JL, 2015, MOL ONCOL, V9, P1155, DOI 10.1016/j.molonc.2015.02.007; Bachelder RE, 2001, CANCER RES, V61, P5736; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bianchini G, 2014, LANCET ONCOL, V15, pE58, DOI 10.1016/S1470-2045(13)70477-7; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Deng T, 2014, CANCER RES, V74, P2119, DOI 10.1158/0008-5472.CAN-13-2138; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Eswaran J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00264; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goss PE, 2004, CLIN CANCER RES, V10, p372S, DOI 10.1158/1078-0432.CCR-031210; Gray J, 2012, NATURE, V486, P328, DOI 10.1038/486328a; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Liu JC, 2014, EMBO MOL MED, V6, P1542, DOI 10.15252/emmm.201404402; Liu JC, 2013, ONCOTARGET, V4, P1317, DOI 10.18632/oncotarget.1170; Liu JC, 2012, P NATL ACAD SCI USA, V109, P5832, DOI 10.1073/pnas.1201105109; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mouttet D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146474; O'Sullivan CC, 2015, J CLIN ONCOL, V33, P2600, DOI 10.1200/JCO.2015.60.8620; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Robinson TJW, 2013, CELL CYCLE, V12, P3013, DOI 10.4161/cc.26063; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sosa MS, 2014, NAT REV CANCER, V14, P611, DOI 10.1038/nrc3793; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Tofigh A, 2014, CELL REP, V9, P129, DOI 10.1016/j.celrep.2014.08.073; Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802	41	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179223	10.1371/journal.pone.0179223	http://dx.doi.org/10.1371/journal.pone.0179223			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632792	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100013
J	Wismer, AJ; Bohil, CJ				Wismer, Andrew J.; Bohil, Corey J.			Base-rate sensitivity through implicit learning	PLOS ONE			English	Article							CLASSIFIERS INDEPENDENCE ASSUMPTION; PERCEPTUAL CATEGORIZATION; DELAYED FEEDBACK; MULTIPLE SYSTEMS; RATE FALLACY; RULE; MEMORY; MODEL; EXPERIENCE; NETWORK	Two experiments assessed the contributions of implicit and explicit learning to base-rate sensitivity. Using a factorial design that included both implicit and explicit learning disruptions, we tested the hypothesis that implicit learning underlies base-rate sensitivity from experience (and that explicit learning contributes comparatively little). Participants learned to classify two categories of simple stimuli (bar graph heights) presented in a 3:1 base-rate ratio. Participants learned either from "observational" training to disrupt implicit learning or "response" training which supports implicit learning. Category label feedback on each trial was followed either immediately or after a 2.5 second delay by onset of a working memory task intended to disrupt explicit reasoning about category membership feedback. Decision criterion values were significantly larger following response training, suggesting that implicit learning underlies base-rate sensitivity. Disrupting explicit processing had no effect on base-rate learning as long as implicit learning was supported. These results suggest base-rate sensitivity develops from experience primarily through implicit learning, consistent with separate learning systems accounts of categorization.	[Wismer, Andrew J.; Bohil, Corey J.] Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Wismer, AJ (corresponding author), Univ Cent Florida, Dept Psychol, Orlando, FL 32816 USA.	andrew.wismer@knights.ucf.edu		Bohil, Corey/0000-0003-1727-9418; Wismer, Andrew/0000-0002-7600-8610	National Institute on Aging [R15 AG045821-01A1]; Office of Naval Research [N00014-15-1-2243]; US Army Medical Research Acquisition Activity [W81XWH-11-2-0038]; NATIONAL INSTITUTE ON AGING [R15AG045821] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office of Naval Research(Office of Naval Research); US Army Medical Research Acquisition Activity; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging (Grant R15 AG045821-01A1, https://www.nia.nih.gov), Office of Naval Research (Grant N00014-15-1-2243, http.//www.onr.navy.. mil/), and US Army Medical Research Acquisition Activity (Grant W81XWH-11-2-0038, http.//www.usamraa.army.mil/) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann JF, 2015, ATTEN PERCEPT PSYCHO, V77, P638, DOI 10.3758/s13414-014-0779-z; [Anonymous], 2017, COMP PROGR JASP VERS; Ashby F.G., 2011, COVIS FORMAL APPROAC, P65, DOI [10.1017/CBO9780511921322.004, DOI 10.1017/CBO9780511921322.004]; Ashby FG, 2011, ANN NY ACAD SCI, V1224, P147, DOI 10.1111/j.1749-6632.2010.05874.x; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 2002, MEM COGNITION, V30, P666, DOI 10.3758/BF03196423; Barbey AK, 2007, BEHAV BRAIN SCI, V30, P241, DOI 10.1017/S0140525X07001653; Bohil CJ, 2003, PERCEPT PSYCHOPHYS, V65, P478, DOI 10.3758/BF03194577; Bohil CJ, 2003, MEM COGNITION, V31, P181, DOI 10.3758/BF03194378; Bohil CJ, 2001, PERCEPT PSYCHOPHYS, V63, P361, DOI 10.3758/BF03194476; Bohil CJ, 2015, PSYCHON B REV, V22, P586, DOI 10.3758/s13423-014-0694-2; CHRISTENSENSZALANSKI JJJ, 1982, ORGAN BEHAV HUM PERF, V29, P270, DOI 10.1016/0030-5073(82)90260-4; Cincotta CM, 2007, J COGNITIVE NEUROSCI, V19, P249, DOI 10.1162/jocn.2007.19.2.249; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Ell SW, 2009, ATTEN PERCEPT PSYCHO, V71, P1263, DOI 10.3758/APP.71.6.1263; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; ESTES WK, 1989, J EXP PSYCHOL LEARN, V15, P556, DOI 10.1037/0278-7393.15.4.556; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Filoteo JV, 2010, PSYCHOL SCI, V21, P415, DOI 10.1177/0956797610362646; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Helie S, 2015, BRAIN COGNITION, V95, P19, DOI 10.1016/j.bandc.2015.01.009; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; HOLYOAK KJ, 1993, ANNU REV PSYCHOL, V44, P265, DOI 10.1146/annurev.ps.44.020193.001405; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Koehler JJ, 1996, BEHAV BRAIN SCI, V19, P1, DOI 10.1017/S0140525X00041157; KUBOVY M, 1977, J EXP PSYCHOL GEN, V106, P427, DOI 10.1037/0096-3445.106.4.427; KUBOVY M, 1980, COGNITIVE PROCESS, P239; Maddox WT, 2005, MEM COGNITION, V33, P303, DOI 10.3758/BF03195319; Maddox WT, 2003, J EXP PSYCHOL LEARN, V29, P650, DOI 10.1037/0278-7393.29.4.650; Maddox WT, 2004, MEM COGNITION, V32, P582, DOI 10.3758/BF03195849; Maddox WT, 2004, PERCEPT PSYCHOPHYS, V66, P104, DOI 10.3758/BF03194865; Maddox WT, 2003, J EXP PSYCHOL LEARN, V29, P1174, DOI 10.1037/0278-7393.29.6.1174; Maddox WT, 2003, J EXP PSYCHOL LEARN, V29, P307, DOI 10.1037/0278-7393.29.2.307; Maddox WT, 2002, J EXP ANAL BEHAV, V78, P567, DOI 10.1901/jeab.2002.78-567; Markman AB, 2006, PSYCHOL SCI, V17, P944, DOI 10.1111/j.1467-9280.2006.01809.x; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; Poldrack RA, 2008, NEUROSCI BIOBEHAV R, V32, P197, DOI 10.1016/j.neubiorev.2007.07.007; Smith EE, 2008, NEUROSCI BIOBEHAV R, V32, P249, DOI 10.1016/j.neubiorev.2007.07.009; Spellman BA, 1996, BEHAV BRAIN SCI, V19, P38, DOI 10.1017/S0140525X00041406; STERNBERG S, 1969, AM SCI, V57, P421; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wagenmakers EJ, 2017, PSYCHONOMIC IN PRESS; Wagenmakers EJ, 2016, PSYCHONOMIC B REV; Zeithamova D, 2007, MEM COGNITION, V35, P1380, DOI 10.3758/BF03193609; Zeithamova D, 2006, MEM COGNITION, V34, P387, DOI 10.3758/BF03193416	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179256	10.1371/journal.pone.0179256	http://dx.doi.org/10.1371/journal.pone.0179256			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY5UN	28632779	Green Submitted, gold, Green Published			2022-12-26	WOS:000404046100015
J	Bernatchez, E; Langlois, A; Brassard, J; Flamand, N; Marsolais, D; Blanchet, MR				Bernatchez, Emilie; Langlois, Anick; Brassard, Julyanne; Flamand, Nicolas; Marsolais, David; Blanchet, Marie-Renee			Hypersensitivity pneumonitis onset and severity is regulated by CD103 dendritic cell expression	PLOS ONE			English	Article							T-CELLS; AIRWAY INFLAMMATION; INTERFERON-GAMMA; IN-VIVO; LUNG; BRONCHOALVEOLAR; MODULATION; TOLERANCE; FIBROSIS; ANTIGENS	Background Pulmonary dendritic cells drive lung responses to foreign antigens, including Saccharopolyspora rectivirgula, a causative agent of hypersensitivity pneumonitis. While the airway inflammatory mechanisms involved in hypersensitivity pneumonitis are well described, the mechanisms leading to the break in homeostasis and hypersensitivity pneumonitis onset are not well-described, and could involve CD103(+) dendritic cells, which are found at baseline and during inflammatory responses in the lung. However, recent demonstration of the ability of CD103(+) dendritic cells to induce inflammatory responses starkly contrasts with their classically described role as regulatory cells. These discrepancies may be attributable to the lack of current information on the importance of CD103 expression and modulation on these cells during inflammatory episodes. Methods To verify the importance of CD103 expression in the regulation of hypersensitivity pneumonitis, wild-type and Cd103(-/-) mice were exposed intranasally to S. rectivirgula and airway inflammation was quantified. Surface expression of CD103 in response to S. rectivirgula exposure was studied and cell transfers were used to determine the relative importance of CD103 expression on dendritic cells and T cells in regulating the inflammation in hypersensitivity pneumonitis. Results Cd103(-/-) mice developed an exacerbated inflammatory response as early as 18h following S. rectivirgula exposure. CD103 expression on dendritic cells was downregulated quickly following S. rectivirgula exposure, and cell transfers demonstrated that CD103 expression on dendritic cells specifically (and not T cells) regulates the onset and severity of this response. Conclusion All in all, we demonstrate that CD103 expression by dendritic cells, but not T cells, is crucial for homeostasis maintenance and the regulation of the TH17 airway inflammatory response in hypersensitivity pneumonitis.	[Bernatchez, Emilie; Langlois, Anick; Brassard, Julyanne; Flamand, Nicolas; Marsolais, David; Blanchet, Marie-Renee] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Blanchet, MR (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	marie-renee.blanchet@criucpq.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200; Brassard, Julyanne/0000-0001-9093-674X	Canadian Institutes of Health Research [272245]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant #272245) (http://www.chir-irsc.gc.ca/e/193.html). EB, DM and M-RB are Fonds de Recherche du Quebec en Sante scholars (http://www.frqs.gouv.qc.ca.); JB is a Canadian Institutes of Health Research scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Bernatchez E, 2015, AM J PHYSL LUNG CELL; Bhan U, 2013, J IMMUNOL, V190, P349, DOI 10.4049/jimmunol.1202225; Bhan U, 2011, AM J PATHOL, V179, P2779, DOI 10.1016/j.ajpath.2011.08.019; Blanchet MR, 2011, AM J RESP CRIT CARE, V184, P687, DOI 10.1164/rccm.201011-1764OC; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; CORMIER Y, 1993, J LAB CLIN MED, V121, P683; COSTABEL U, 1985, AM REV RESPIR DIS, V131, P337; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Desch AN, 2011, J EXP MED, V208, P1789, DOI 10.1084/jem.20110538; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fear V.S., 2016, PHYSL REP, V4; Fong DJ, 2010, IMMUNOLOGY, V130, P125, DOI 10.1111/j.1365-2567.2009.03219.x; Furuhashi Kazuki, 2012, Am J Respir Cell Mol Biol, V46, P165, DOI 10.1165/rcmb.2011-0070OC; Girard M, 2009, EUR RESPIR J, V34, P749, DOI 10.1183/09031936.00140908; Gudmundsson G, 1997, J CLIN INVEST, V99, P2386, DOI 10.1172/JCI119420; Gudmundsson G, 1998, J IMMUNOL, V161, P991; Hasan SA, 2013, J ALLERGY CLIN IMMUN, V131, P1663, DOI 10.1016/j.jaci.2013.01.015; Heldal KK, 2015, ANN AGR ENV MED, V22, P253, DOI 10.5604/12321966.1152076; Jimenez-Alvarez L, 2011, EXP MOL PATHOL, V91, P718, DOI 10.1016/j.yexmp.2011.09.010; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Lappin MB, 1999, IMMUNOLOGY, V98, P181; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Liu P, 2010, PARASITE IMMUNOL, V32, P57, DOI 10.1111/j.1365-3024.2009.01161.x; Mach N, 2000, CANCER RES, V60, P3239; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nous S, 2010, AM J RESP CRIT CARE, V181, P1318, DOI 10.1164/rccm.200909-1396OC; Park Y, 2009, J LEUKOCYTE BIOL, V86, P1427, DOI 10.1189/jlb.0908542; Pepys J, 1990, Allergy Proc, V11, P101, DOI 10.2500/108854190778993263; Pepys J, 1963, ALLERGY PROC, V11, P101; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Schafer J, 2013, ANN OCCUP HYG, V57, P875, DOI 10.1093/annhyg/met010; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; SCHUYLER M, 1982, INT ARCH ALLER A IMM, V68, P108, DOI 10.1159/000233077; Selman M, 2012, SEMIN RESP CRIT CARE, V33, P543, DOI 10.1055/s-0032-1325163; Sergio CA, 2015, IMMUNOLOGY, V144, P574, DOI 10.1111/imm.12411; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; van Kampen V, 2012, J TOXICOL ENV HEAL A, V75, P492, DOI 10.1080/15287394.2012.674918; Yamasaki H, 1999, J IMMUNOL, V163, P3516; Yi EHS, 2002, CRIT REV CL LAB SCI, V39, P581, DOI 10.1080/10408360290795583; Zelante T, 2015, CELL REP, V12, P1789, DOI 10.1016/j.celrep.2015.08.030	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179678	10.1371/journal.pone.0179678	http://dx.doi.org/10.1371/journal.pone.0179678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628641	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100045
J	Li, YC; Chen, J; Liu, YT; Zhang, WG; He, WH; Xu, HY; Liu, LQ; Ma, EL				Li, Yanchun; Chen, Jv; Liu, Yutong; Zhang, Weige; He, Wenhui; Xu, Hanying; Liu, Lianqing; Ma, Enlong			Nanoscale quantification of the biophysical characterization of combretastatin A-4-treated tumor cells using atomic force microscopy	PLOS ONE			English	Article							AUTOPHAGY; APOPTOSIS; MECHANICS; TUBULIN; ARREST; AGENT; A-4	As an inhibitor of microtubule assembly, combretastatin A-4 (CA-4)-induced biological responses in tumor cells have been well known, but the corresponding changes in nano-biophysical properties were not investigated given the lack of an ideal tool. Using AFM technique, we investigated the alteration of nano-biophysical properties when CA-4-treated tumor cells underwent the different biological processes, including cell cycle arrest, apoptosis and autophagy. We found that CA-4-resistant cells were rougher with the presence of characteristic "ridges", indicating that the development of "ridge" structure may be a determinant of the sensitivity of cells to CA-4 compounds. CA-4 induced G2/M arrest and apoptosis in sensitive cells but triggered anti-apoptotic autophagy in resistant cells. CA-4 treatment caused an increase in stiffness in both sensitive and resistant cells. However, these cells exhibited different changes in cell surface roughness. CA-4 decreased Ra and Rq values in sensitive cells but increased these values in resistant cells. The reorganization of F-actin might contribute to the different changes of nano-biophysical properties in CA-4-sensitive and-resistant cells. Our results suggest that cellular nano-biophysical properties, such as "ridges", roughness and stiffness, could be applied as potential biomarkers for evaluating CA-4 compounds, and knowledge regarding how biological alterations cause changes in cellular nano-biophysical properties is helpful to develop a new high-resolution screening tool for anti-tumor agents.	[Li, Yanchun; Chen, Jv; Liu, Yutong; He, Wenhui; Xu, Hanying; Ma, Enlong] Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China; [Li, Yanchun; Liu, Lianqing] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang, Peoples R China; [Zhang, Weige] Shenyang Pharmaceut Univ, Dept Med Chem, Shenyang, Peoples R China	Shenyang Pharmaceutical University; Chinese Academy of Sciences; Shenyang Institute of Automation, CAS; Shenyang Pharmaceutical University	Ma, EL (corresponding author), Shenyang Pharmaceut Univ, Dept Pharmacol, Shenyang, Peoples R China.	maenlong@hotmail.com		Zhang, Weige/0000-0002-4492-3072; Liu, Lianqing/0000-0002-2271-5870	State Key Laboratory of Robotics, Shenyang Institute of Automation, China Academy of Sciences; National Natural Science Foundation of China [81470135]; Excellent Scholar Projects from the Educational Department of Liaoning Province [LJQ2013108]; Natural Science Foundation of Liaoning Province [2015020722]; SPU Excellent Scholar Fund	State Key Laboratory of Robotics, Shenyang Institute of Automation, China Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Scholar Projects from the Educational Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); SPU Excellent Scholar Fund	The authors are very grateful for the support provided by State Key Laboratory of Robotics, Shenyang Institute of Automation, China Academy of Sciences. The research was funded by National Natural Science Foundation of China (81470135), Excellent Scholar Projects from the Educational Department of Liaoning Province (LJQ2013108), Natural Science Foundation of Liaoning Province (2015020722) and SPU Excellent Scholar Fund.	Bohle AS, 2000, INT J CANCER, V87, P838, DOI 10.1002/1097-0215(20000915)87:6<838::AID-IJC13>3.0.CO;2-7; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Cirla A, 2003, NAT PROD REP, V20, P558, DOI 10.1039/b306797c; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Francis LW, 2009, BIOL CELL, V101, P481, DOI 10.1042/BC20080189; Gostek J, 2015, EUR BIOPHYS J BIOPHY, V44, P49, DOI 10.1007/s00249-014-1000-y; Grady ME, 2016, J MECH BEHAV BIOMED, V61, P197, DOI 10.1016/j.jmbbm.2016.01.022; Greene LM, 2012, BIOCHEM PHARMACOL, V84, P612, DOI 10.1016/j.bcp.2012.06.005; HAMEL E, 1983, BIOCHEM PHARMACOL, V32, P3864, DOI 10.1016/0006-2952(83)90163-6; Horber JKH, 2003, SCIENCE, V302, P1002, DOI 10.1126/science.1067410; Liu M, 2015, BIOCHEM BIOPH RES CO, V468, P214, DOI 10.1016/j.bbrc.2015.10.127; Ma EL, 2009, TOXICOL IN VITRO, V23, P874, DOI 10.1016/j.tiv.2009.05.001; Magalhaes HIF, 2013, TOXICOL APPL PHARM, V272, P117, DOI 10.1016/j.taap.2013.06.001; Marrelli M, 2011, CURR MED CHEM, V18, P3035, DOI 10.2174/092986711796391642; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Pillet F, 2014, BBA-GEN SUBJECTS, V1840, P1028, DOI 10.1016/j.bbagen.2013.11.019; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Siemann DW, 2009, CELL TISSUE RES, V335, P241, DOI 10.1007/s00441-008-0646-0; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zhou DX, 2008, CELL MOL NEUROBIOL, V28, P895, DOI 10.1007/s10571-008-9267-0	20	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179115	10.1371/journal.pone.0179115	http://dx.doi.org/10.1371/journal.pone.0179115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628642	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100016
J	Wang, LZ; Wang, ZX; Zhu, R; Bi, JP; Feng, XY; Liu, WM; Wu, JX; Zhang, HH; Wu, H; Kong, W; Yu, B; Yu, XH				Wang, Lizheng; Wang, Zixuan; Zhu, Rui; Bi, Jinpeng; Feng, Xinyao; Liu, Wenmo; Wu, Jiaxin; Zhang, Haihong; Wu, Hui; Kong, Wei; Yu, Bin; Yu, Xianghui			Therapeutic efficacy of AAV8-mediated intrastriatal delivery of human cerebral dopamine neurotrophic factor in 6-OHDA-induced parkinsonian rat models with different disease progression	PLOS ONE			English	Article							PHASE-I TRIAL; GENE-THERAPY; OPEN-LABEL; TYROSINE-HYDROXYLASE; CDNF PREVENTS; ANIMAL-MODELS; DOUBLE-BLIND; GDNF; OVEREXPRESSION; STRIATUM	Parkinson's disease (PD) is a progressive and age-associated neurodegenerative disorder. Patients at different stages of the disease course have distinguished features, mainly in the number of dopaminergic neurons. Cerebral dopamine neurotrophic factor (CDNF) is a recently discovered neurotrophic factor, being deemed as a hopeful candidate for PD treatment. Here, we evaluated the efficacy of CDNF in protecting dopaminergic function using the 6-OHDA-induced PD rat model suffering from different levels of neuronal loss and the recombinant adeno-associated virus 8 (AAV8) as a carrier for the CDNFgene. The results showed that AAV8-CDNF administration significantly improved the motor function and increased the tyrosine hydroxylase (TH) levels in PD rats with mild lesions (2 weeks post lesion), but it had limited therapeutic effects in rats with severe lesions (5 weeks post lesion). To better improve the recovery of motor function in severely lesioned PD rats, we employed a strategy using the CDNF gene along with the aromatic amino acid decarboxylase (AADC) gene. This combination therapeutic strategy indeed showed an enhanced benefit in restoring the motor function of severely lesioned PD rats by providing the neuroprotective effect of CDNF and dopamine enhancing effect of AADC as expected. This study may provide a basis for future clinical application of CDNF in PD patients at different stages and offer a new alternative strategy of joint use of CDNF and AADC for advanced PD patients in clinical trials.	[Wang, Lizheng; Wang, Zixuan; Zhu, Rui; Bi, Jinpeng; Feng, Xinyao; Liu, Wenmo; Wu, Jiaxin; Zhang, Haihong; Wu, Hui; Kong, Wei; Yu, Bin; Yu, Xianghui] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin Province, Peoples R China; [Kong, Wei; Yu, Xianghui] Jilin Univ, Sch Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University	Yu, XH (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin Province, Peoples R China.	yubin@jlu.edu.cn; xianghui@jlu.edu.cn	Wu, Jiaxin/GVT-3486-2022		National Natural Science Foundation of China [81472816, 31300756]; Science & Technology Development Plan of Jilin Province [20160101240JC]; Graduate Innovation Fund of Jilin University [2016151]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Development Plan of Jilin Province; Graduate Innovation Fund of Jilin University(Jilin University)	This study was supported by the following funders: 1) National Natural Science Foundation of China (No. 81472816, X.Y.; 31300756, B.Y.), http://www.nsfc.gov.cn/publish/portal1/; 2) Science & Technology Development Plan of Jilin Province (No. 20160101240JC), http://www.jlkjxm.com/; and 3) Graduate Innovation Fund of Jilin University (No. 2016151), http://gil.jlu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Airavaara Mikko, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS143, DOI 10.1016/S1353-8020(11)70045-1; Aoi M, 2000, RESTOR NEUROL NEUROS, V17, P31; Berry AL, 2011, J NEUROL, V258, P179, DOI 10.1007/s00415-010-5796-9; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Brizard M, 2006, NEUROBIOL DIS, V21, P90, DOI 10.1016/j.nbd.2005.06.015; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Cordero-Llana O, 2015, MOL THER, V23, P244, DOI 10.1038/mt.2014.206; Domanskyi A, 2015, HUM GENE THER, V26, P550, DOI 10.1089/hum.2015.065; Eberling JL, 2008, NEUROLOGY, V70, P1980, DOI 10.1212/01.wnl.0000312381.29287.ff; Garea-Rodriguez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149776; Georgievska B, 2002, EXP NEUROL, V177, P461, DOI 10.1006/exnr.2002.8006; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Herzog CD, 2013, NEUROBIOL DIS, V58, P38, DOI 10.1016/j.nbd.2013.04.011; Hirsch L, 2016, NEUROEPIDEMIOLOGY, V46, P292, DOI 10.1159/000445751; Hoffer BJ, 2011, EXP NEUROL, V230, P162, DOI 10.1016/j.expneurol.2011.04.015; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Klein RL, 2006, MOL THER, V13, P517, DOI 10.1016/j.ymthe.2005.10.008; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Le WD, 2014, NEUROTHERAPEUTICS, V11, P92, DOI 10.1007/s13311-013-0234-1; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Matlik K, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0128-16.2017; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Oiwa Y, 2002, BRAIN RES, V947, P271, DOI 10.1016/S0006-8993(02)02934-7; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Politis M, 2014, J CLIN INVEST, V124, P1340, DOI 10.1172/JCI71640; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Rosenblad C, 2003, EUR J NEUROSCI, V17, P260, DOI 10.1046/j.1460-9568.2003.02456.x; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Sajadi A, 2005, J NEUROCHEM, V93, P1482, DOI 10.1111/j.1471-4159.2005.03139.x; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Wang L, 2016, THERANOSTICS, V6, P1145, DOI 10.7150/thno.15257	38	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179476	10.1371/journal.pone.0179476	http://dx.doi.org/10.1371/journal.pone.0179476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622392	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300037
J	Hiroshige, Y; Hara, M; Nagai, A; Hikitsuchi, T; Umeda, M; Kawajiri, Y; Nakayama, K; Suzuki, K; Takada, A; Ishii, A; Yamamoto, T				Hiroshige, Yuuji; Hara, Masaaki; Nagai, Atsushi; Hikitsuchi, Tomoyuki; Umeda, Mitsuo; Kawajiri, Yumi; Nakayama, Koji; Suzuki, Koichi; Takada, Aya; Ishii, Akira; Yamamoto, Toshimichi			A human genotyping trial to estimate the post-feeding time from mosquito blood meals	PLOS ONE			English	Article							DIGESTION; SUCCESS; DNA	Mosquitoes occur almost worldwide, and females of some species feed on blood from humans and other animals to support ovum maturation. In warm and hot seasons, such as the summer in Japan, fed mosquitoes are often observed at crime scenes. The current study attempted to estimate the time that elapsed since feeding from the degree of human DNA digestion in mosquito blood meals and also to identify the individual human sources of the DNA using genotyping in two species of mosquito: Culex pipiens pallens and Aedes albopictus. After stereomicroscopic observation, the extracted DNA samples were quantified using a human DNA quantification and quality control kit and were genotyped for 15 short tandem repeats using a commercial multiplexing kit. It took about 3 days for the complete digestion of a blood meal, and genotyping was possible until 2 days post-feeding. The relative peak heights of the 15 STRs and DNA concentrations were useful for estimating the post-feeding time to approximately half a day between 0 and 2 days. Furthermore, the quantitative ratios derived from STR peak heights and the quality control kit (Q129/Q41, Q305/Q41, and Q305/Q129) were reasonably effective for estimating the approximate post-feeding time after 2-3 days. We suggest that this study may be very useful for estimating the time since a mosquito fed from blood meal DNA, although further refinements are necessary to estimate the times more accurately.	[Hiroshige, Yuuji; Ishii, Akira; Yamamoto, Toshimichi] Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan; [Hara, Masaaki; Takada, Aya] Saitama Med Univ, Dept Forens Med, 38 Morohongo, Moroyama, Saitama, Japan; [Nagai, Atsushi] Gifu Univ, Grad Sch Med, Dept Legal Med, Gifu, Japan; [Hikitsuchi, Tomoyuki; Umeda, Mitsuo; Kawajiri, Yumi; Nakayama, Koji] Dainihon Jochugiku Co Ltd, Res & Dev Lab, 1 Chome,Daikoku Cho, Toyonaka, Osaka, Japan; [Suzuki, Koichi] Osaka Med Coll, Dept Legal Med, 2-7 Daigaku, Takatsuki, Osaka, Japan	Nagoya University; Saitama Medical University; Gifu University; Osaka Medical College	Yamamoto, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Legal Med & Bioeth, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan.	yamachan@med.nagoya-u.ac.jp			Japan Society for the Promotion of Science [26460885]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (No. 26460885). The funder did not provide support in the form of salaries for authors [TH, MU, YK, KN] and did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are elucidated in the "Author contributions" section.	Applied Biosystems, 2010, APPL BIOSYSTEMS STEP; Applied Biosystems, 2015, AMPFTSTR ID PLUS PCR; Arai M., 2012, MODERN MEDIA, V58, P199; Chow-Shaffer E, 2000, J MED ENTOMOL, V37, P492, DOI 10.1603/0022-2585-37.4.492; Curic G, 2014, FORENSIC SCI INT-GEN, V8, P109, DOI 10.1016/j.fsigen.2013.07.011; Detinova TS, 1962, WHO MONOGR SER, V47, P54; EDMAN JD, 1969, MOSQ NEWS, V29, P386; Gower A. K. O., 1955, AUSTR J BIOL SCI, V9, P125, DOI 10.1071/BI9560125; Greenberg JA, 2012, J VECTOR ECOL, V37, P83, DOI 10.1111/j.1948-7134.2012.00203.x; Harbach RE, 2015, ZOOLOGICA SCRIPTA, V45, P34; Kamimura K., 2004, MOSQUITOES CONTROL M, V26, P25; Kapa Biosystems, 2017, KAPA HUM GEN DNA QUA; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Martinez-de la Puente J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0571-0; Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109; Mukabana WR, 2002, B ENTOMOL RES, V92, P233, DOI 10.1079/BER2002164; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Oshaghi MA, 2006, EXP PARASITOL, V114, P259, DOI 10.1016/j.exppara.2006.04.001; Sasa M, 1976, SCI MOSQUITO; Tuten HC, 2012, MED VET ENTOMOL, V26, P407, DOI 10.1111/j.1365-2915.2012.01012.x; Umetsu K, 1980, REPORTS NATL RES I P, V33, P206; Umetsu K, 1979, REPORTS NATL RES I P, V32, P27; Watanabe G., 2004, JPN J FORENSIC SCI T, V9, P49	23	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179319	10.1371/journal.pone.0179319	http://dx.doi.org/10.1371/journal.pone.0179319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617865	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600031
J	Pantophlet, AJ; Roelofsen, H; de Vries, MP; Gerrits, WJJ; van den Borne, JJGC; Vonk, RJ				Pantophlet, Andre J.; Roelofsen, Han; de Vries, Marcel P.; Gerrits, Walter J. J.; van den Borne, Joost J. G. C.; Vonk, Roel J.			The use of metabolic profiling to identify insulin resistance in veal calves	PLOS ONE			English	Article							MILK-FED CALVES; SENSITIVITY; REPLACER; LACTOSE; METABOANALYST; HYPERGLYCEMIA; GLUCOSURIA; SERVER; MUSCLE; SERUM	Heavy veal calves (4-6 months old) are at risk of developing insulin resistance and disturbed glucose homeostasis. Prolonged insulin resistance could lead to metabolic disorders and impaired growth performance. Recently, we discovered that heavy Holstein-Friesian calves raised on a high-lactose or high-fat diet did not differ in insulin sensitivity, that insulin sensitivity was low and 50% of the calves could be considered insulin resistant. Understanding the patho-physiological mechanisms underlying insulin resistance and discovering bio-markers for early diagnosis would be useful for developing prevention strategies. Therefore, we explored plasma metabolic profiling techniques to build models and discover potential biomarkers and pathways that can distinguish between insulin resistant and moderately insulin sensitive veal calves. The calves (n = 14) were classified as insulin resistant (IR) or moderately insulin sensitive (MIS) based on results from a euglycemic-hyperinsulinemic clamp, using a cut-off value (M/I-value <4.4) to identify insulin resistance. Metabolic profiles of fasting plasma samples were analyzed using reversed phase (RP) and hydrophilic interaction (HILIC) liquid chromatography-mass spectrometry (LC-MS). Orthogonal partial least square discriminant analysis was performed to compare metabolic profiles. Insulin sensitivity was on average 2.3x higher (P <0.001) in MIS than IR group. For both RP-LC-MS and HILIC-LC-MS satisfactory models were build ((RY)-Y-2 >90% and Q(2)Y >66%), which allowed discrimination between MIS and IR calves. A total of 7 and 20 metabolic features (for RPLC-MS and HILIC-LC-MS respectively) were most responsible for group separation. Of these, 7 metabolites could putatively be identified that differed (P <0.05) between groups (potential biomarkers). Pathway analysis indicated disturbances in glycerophospholipid and sphingolipid metabolism, the glycine, serine and threonine metabolism, and primary bile acid biosynthesis. These results demonstrate that plasma metabolic profiling can be used to identify insulin resistance in veal calves and can lead to underlying mechanisms.	[Pantophlet, Andre J.; de Vries, Marcel P.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Pantophlet, Andre J.; de Vries, Marcel P.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Groningen, Netherlands; [Roelofsen, Han; de Vries, Marcel P.; Vonk, Roel J.] Univ Groningen, Univ Med Ctr Groningen, Med Biom, Groningen, Netherlands; [Gerrits, Walter J. J.; van den Borne, Joost J. G. C.] Wageningen Univ, Anim Nutr Grp, Wageningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Wageningen University & Research	Pantophlet, AJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.; Pantophlet, AJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.	a.j.pantophlet@umcg.nl			Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Product Board Animal Feed (The Hague, The Netherlands)	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Product Board Animal Feed (The Hague, The Netherlands)(Netherlands Government)	The study was founded by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs, and the Product Board Animal Feed (The Hague, The Netherlands) for financially supporting this research to J.J.G.C. van den Borne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger RD, 2013, METABOLITES, V3, P552; Bergman BC, 2015, AM J PHYSIOL-ENDOC M, V309, pE398, DOI 10.1152/ajpendo.00134.2015; Bowen BP, 2010, J AM SOC MASS SPECTR, V21, P1471, DOI 10.1016/j.jasms.2010.04.003; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gowda GAN, 2008, EXPERT REV MOL DIAGN, V8, P617, DOI 10.1586/14737159.8.5.617; Graham SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119452; HOSTETTLERALLEN RL, 1994, J ANIM SCI, V72, P160, DOI 10.2527/1994.721160x; Hugi D, 1997, J ANIM SCI, V75, P469; Humer E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158633; Kavishwar A, 2013, J HISTOCHEM CYTOCHEM, V61, P910, DOI 10.1369/0022155413502792; Larsen PJ, 2014, MOL METAB, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Lucio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013317; Lynn KS, 2015, ANAL CHEM, V87, P2143, DOI 10.1021/ac503325c; Meikle PJ, 2016, NAT REV ENDOCRINOL; Motley ED, 2002, HYPERTENSION, V39, P508, DOI 10.1161/hy02t2.102907; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Pantophlet AJ, 2016, J DAIRY SCI, V99, P10022, DOI 10.3168/jds.2016-11524; Pantophlet AJ, 2016, J DAIRY SCI, V99, P7602, DOI 10.3168/jds.2016-11084; Pantophlet AJ, 2016, J DAIRY SCI, V99, P3072, DOI 10.3168/jds.2015-10277; Pantophlet AJ, 2016, J NUTR; Rauschert S, 2016, J CLIN ENDOCR METAB, V101, P871, DOI 10.1210/jc.2015-3525; Stanley CC, 2002, J DAIRY SCI, V85, P2335, DOI 10.3168/jds.S0022-0302(02)74313-0; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Zhang XL, 2013, BBA-MOL BASIS DIS, V1832, P1207, DOI 10.1016/j.bbadis.2013.03.009; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	30	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179612	10.1371/journal.pone.0179612	http://dx.doi.org/10.1371/journal.pone.0179612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617863	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600050
J	Wilson, MB; Held, BW; Freiborg, AH; Blanchette, RA; Salomon, CE				Wilson, Michael B.; Held, Benjamin W.; Freiborg, Amanda H.; Blanchette, Robert A.; Salomon, Christine E.			Resource capture and competitive ability of non-pathogenic Pseudogymnoascus spp. and P. destructans, the cause of white-nose syndrome in bats	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; PATHOGEN; FUNGI; HIBERNACULA; EVOLUTION; SUPPORTS; GROWTH	White-nose syndrome (WNS) is a devastating fungal disease that has been causing the mass mortality of hibernating bats in North America since 2006 and is caused by the psychrophilic dermatophyte Pseudogymnoascus destructans. Infected bats shed conidia into hibernaculum sediments and surfaces, but it is unknown if P. destructans can form stable, reproductive populations outside its bat hosts. Previous studies have found non-pathogenic Pseudogymnoascus in bat hibernacula, and these fungi may provide insight into the natural history of P. destructans. We compared the relatedness, resource capture, and competitive ability of non-pathogenic Pseudogymnoascus isolates with P. destructans to determine if they have similar adaptations for survival in hibernacula sediment. All non-pathogenic Pseudogymnoascus isolates grew faster, utilized a broader range of substrates with higher efficiency, and were generally more resistant to antifungals compared to P. destructans. All isolates also showed the ability to displace P. destructans in co-culture assays, but only some produced extractible antifungal metabolites. These results suggest that P. destructans would perform poorly in the same environmental niche as non-pathogenic Pseudogymnoascus, and must have an alternative saprophytic survival strategy if it establishes active populations in hibernaculum sediment and non-host surfaces.	[Wilson, Michael B.; Freiborg, Amanda H.; Salomon, Christine E.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Held, Benjamin W.; Blanchette, Robert A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Salomon, CE (corresponding author), Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA.	csalomon@umn.edu		Blanchette, Robert A./0000-0003-2819-6511; Salomon, Christine/0000-0003-4976-598X	Minnesota Environment and Natural Resources Trust Fund	Minnesota Environment and Natural Resources Trust Fund	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund, M.L. 2013, Chp. 52, Sec. 2, Subd. 03 (http://www.Iccmr.Ieg.mn/index.html) to CES and RAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette RA, 2016, FUNGAL ECOL, V23, P58, DOI 10.1016/j.funeco.2016.06.001; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Chaturvedi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017032; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Firn RD, 2000, MOL MICROBIOL, V37, P989, DOI 10.1046/j.1365-2958.2000.02098.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Hassan N, 2016, REV ENVIRON SCI BIO, V15, P147, DOI 10.1007/s11157-016-9395-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khankhet J, 2014, PLOS ONE, P9; Leopardi S, ELSEVIER, V25, pR217; Lindner DL, 2011, MYCOLOGIA, V103, P241, DOI 10.3852/10-262; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Lorch JM, 2013, MYCOLOGIA, V105, P237, DOI 10.3852/12-207; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Muller LK, 2013, MYCOLOGIA, V105, P253, DOI 10.3852/12-242; POINDEXTER JS, 1981, ADV MICROB ECOL, V5, P63; Puechmaille SJ, 2011, PLOS ONE, P6; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Reynolds HT, 2016, FUNGAL ECOL, V23, P20, DOI 10.1016/j.funeco.2016.04.010; Reynolds HT, 2015, J WILDLIFE DIS, V51, P318, DOI 10.7589/2014-06-157; Reynolds HT, 2014, PLOS ONE, P16; Schlatter DC, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0470-6; SHEARER CA, 1995, CAN J BOT, V73, pS1259, DOI 10.1139/b95-386; Turner Gregory G., 2011, Bat Research News, V52, P13; U. S. Fish and Wildlife Service. White-Nose Syndrome, 2016, FACT SHEET; Vanderwolf KJ, 2013, INT J SPELEOL, V42, P77, DOI 10.5038/1827-806X.42.1.9; Vanderwolf KJ, 2013, NORTHEAST NAT, V20, P115, DOI 10.1656/045.020.0109; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Weinstein RN, 2000, MYCOLOGIA, V92, P222, DOI 10.2307/3761554; Zhang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141316	45	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178968	10.1371/journal.pone.0178968	http://dx.doi.org/10.1371/journal.pone.0178968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617823	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600017
J	Cato, K; Sylven, SM; Lindback, J; Skalkidou, A; Rubertsson, C				Cato, Karin; Sylven, Sara M.; Lindback, Johan; Skalkidou, Alkistis; Rubertsson, Christine			Risk factors for exclusive breastfeeding lasting less than two months-Identifying women in need of targeted breastfeeding support	PLOS ONE			English	Article							ASSOCIATION; DEPRESSION; ANALGESIA; DURATION; LIFE	Background Breastfeeding rates in Sweden are declining, and it is important to identify women at risk for early cessation of exclusive breastfeeding. Objective The aim of this study was to investigate factors associated with exclusive breastfeeding lasting less than two months postpartum. Methods A population-based longitudinal study was conducted at Uppsala University Hospital, Sweden. Six hundred and seventy-nine women were included in this sub-study. Questionnaires were sent at five days, six weeks and six months postpartum, including questions on breastfeeding initiation and duration as well as several other background variables. The main outcome measure was exclusive breastfeeding lasting less than two months postpartum. Multivariable logistic regression analysis was used in order to calculate adjusted Odds Ratios (AOR) and 95% Confidence Intervals (95% CI). Results Seventy-seven percent of the women reported exclusive breastfeeding at two months postpartum. The following variables in the multivariate regression analysis were independently associated with exclusive breastfeeding lasting less than two months postpartum: being a first time mother (AOR 2.15, 95% CI 1.32 +/- 3.49), reporting emotional distress during pregnancy (AOR 2.21, 95% CI 1.35 +/- 3.62) and giving birth by cesarean section (AOR 2.63, 95% CI 1.34 +/- 5.17). Conclusions Factors associated with shorter exclusive breastfeeding duration were determined. Identification of women experiencing emotional distress during pregnancy, as well as scrutiny of caregiving routines on cesarean section need to be addressed, in order to give individual targeted breastfeeding support and promote longer breastfeeding duration.	[Cato, Karin; Skalkidou, Alkistis; Rubertsson, Christine] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Sylven, Sara M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lindback, Johan] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Cato, K (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	karin.cato@kbh.uu.se	Lindbäck, Johan/R-2900-2017; Skalkidou, Alkistis/C-1521-2015	Lindbäck, Johan/0000-0002-6473-8798; Skalkidou, Alkistis/0000-0002-4935-7532; Sylven, Sara M/0000-0002-3142-5111	Swedish Research Council [523-2014-2342]; Marianne and Marcus Wallenberg Foundation [MMW2011.0115]; Soderstrom-Konigska Foundation [2007-20716]; Swedish Society of Medicine [2007-19575]; Ake Wiberg Foundation [302298937]; Allmanna BBs Minnesfond; Gillbergska Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Soderstrom-Konigska Foundation; Swedish Society of Medicine; Ake Wiberg Foundation; Allmanna BBs Minnesfond; Gillbergska Foundation	This work was supported by: Swedish Research Council, 523-2014-2342, www.vr.se, AS; Marianne and Marcus Wallenberg Foundation, MMW2011.0115, www.wallenberg.com/mmw, AS; Soderstrom-Konigska Foundation, 2007-20716, www.sls.se, AS; Swedish Society of Medicine, 2007-19575, www.sls.se, AS; Ake Wiberg Foundation, 302298937, ake-wiberg.se, AS; Allmanna BBs Minnesfond, 2007 Skalkidou, www.allmannabb.se, AS; Gillbergska Foundation, 2008 Skalkidou, www.gillberg.ska.se, AS; Gillbergska Foundation, 2014 Cato, www.gillbergska.se, KC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-80; Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; [Anonymous], 2009, 622009 SFOG ARG; Brimdyr K, 2015, BIRTH-ISS PERINAT C, V42, P319, DOI 10.1111/birt.12186; Cato K, 2014, BREASTFEED MED, V9, P294, DOI 10.1089/bfm.2014.0005; DiGirolamo AM, 2008, PEDIATRICS, V122, pS43, DOI 10.1542/peds.2008-1315e; Ekstrom Anette, 2003, J Hum Lact, V19, P172, DOI 10.1177/0890334403252537; Figueiredo B, 2013, J PEDIAT-BRAZIL, V89, P332, DOI 10.1016/j.jped.2012.12.002; Fontein-Kuipers Y, WOMEN BIRTH; Gubler T, 2013, J PERINAT MED, V41, P331, DOI 10.1515/jpm-2012-0102; Hackman NM, 2015, BREASTFEED MED, V10, P156, DOI 10.1089/bfm.2014.0119; Harrell FE, 2001, REGRESSION MODELING; Henderson JJ, 2003, AUST NZ J OBSTET GYN, V43, P372, DOI 10.1046/j.0004-8666.2003.t01-1-00117.x; Karlstrom A, 2013, BJOG-INT J OBSTET GY, V120, P479, DOI 10.1111/1471-0528.12129; Karlstrom A, 2007, JOGNN-J OBST GYN NEO, V36, P430, DOI 10.1111/J.1552-6909.2007.00160.x; Kronborg H, 2015, SCAND J PUBLIC HEALT, V43, P138, DOI 10.1177/1403494814567171; Lindau JF, 2015, EUR J PEDIATR, V174, P533, DOI 10.1007/s00431-014-2428-x; Murray EK, 2007, BIRTH-ISS PERINAT C, V34, P202, DOI 10.1111/j.1523-536X.2007.00172.x; National Food Agency Sweden, SPADB; Ransjo-Arvidson AB, 2001, BIRTH-ISS PERINAT C, V28, P5, DOI 10.1046/j.1523-536x.2001.00005.x; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; ROSENGREN A, 1993, BRIT MED J, V307, P1102, DOI 10.1136/bmj.307.6912.1102; SIMKIN P, 1992, BIRTH-ISS PERINAT C, V19, P64, DOI 10.1111/j.1523-536X.1992.tb00382.x; Socialstyrelsen, 2014, AMN FOR ROKV BARN FO; Socialstyrelsen, 2014, AMN FOR ROKV BARN FO; Velandia M, 2012, ACTA PAEDIAT OSLO NO, V1992, P101; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, IMPL BAB FRIENDL HOS; WHO, BREASTFEEDING; Ystrom E, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-36	30	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179402	10.1371/journal.pone.0179402	http://dx.doi.org/10.1371/journal.pone.0179402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5KN	28614419	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900048
J	Minol, JP; Reinsch, I; Luik, M; Leferink, A; Barth, M; Assmann, A; Lichtenberg, A; Akhyari, P				Minol, Jan-Philipp; Reinsch, Isabella; Luik, Maximilian; Leferink, Anne; Barth, Mareike; Assmann, Alexander; Lichtenberg, Artur; Akhyari, Payam			Focal induction of ROS-release to trigger local vascular degeneration	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; OXIDATIVE STRESS; THROMBOSIS; OXYGEN; INJURY; CELLS; CALCIFICATION; ACTIVATION; MODELS; BENGAL	Reactive oxygen species (ROS) play an important role in the process of cardiovascular degeneration. We evaluated the potential of a controlled, local induction of ROS-release by application of rose bengal (RB) and photo energy to induce atherosclerosis-like focal vascular degeneration in vivo. After injection of RB, rats fed with a pro-degenerative diet underwent focal irradiation of the abdominal aorta by a green laser (ROS group), while the controls received irradiation without RB. Aortic tissue was analyzed by histology and immunohistochemistry at 0, 2, 4, 8, 28 and 56 days (n = 5). The intimal surface topography was analyzed by scanning electron microscopy. In the ROS group, an initial thrombus formation had disappeared by day 8. Similarly, ROS-derived products displayed the highest concentrations at day 0. Relative matrix metalloproteinase (MMP) activity achieved a maximum after 8 days (ROS group vs. control group: 1.60 +/- 0.11 vs. 0.98 +/- 0.01; p < 0.001). After 28 days, no significant differences in any aspect were found between the ROS group and the controls. However, after 56 days, the aortic tissue of ROS animals exhibited relative mediapronounced thickening (ROS vs. control: 2.15 +/- 0.19 vs. 0.87 +/- 0.10; p < 0.001) with focal calcification and reduced expression of alpha smooth muscle actin (aSMA). The ROSreleasing application of RB and photo energy allowed for the induction of vascular degeneration in a rodent model. This protocol may be used for the focal induction of vascular disease without systemic side effects and can thereby elucidate the role of ROS in the multifactorial processes of vessel degeneration and atherogenesis.	[Minol, Jan-Philipp; Reinsch, Isabella; Luik, Maximilian; Barth, Mareike; Assmann, Alexander; Lichtenberg, Artur; Akhyari, Payam] Univ Hosp, Dept Cardiovasc Surg, Dusseldorf, Germany; [Leferink, Anne] Univ Twente, MIRA Inst, Dept Tissue Regenerat, Enschede, Netherlands	University of Twente	Minol, JP (corresponding author), Univ Hosp, Dept Cardiovasc Surg, Dusseldorf, Germany.	phil.minol@gmx.de	Barth, Mareike/AAB-2975-2020; Leferink, Ir. A. M./G-5024-2012; Akhyari, Payam/AAK-8866-2020	Barth, Mareike/0000-0002-6118-6799; Leferink, Ir. A. M./0000-0002-3765-8450; Akhyari, Payam/0000-0002-6452-8678	Department of Cardiovascular Surgery, Heinrich Heine University Duesseldorf, Medical Faculty; Susanne Bunnenberg Foundation at Duesseldorf Cardiovascular Center	Department of Cardiovascular Surgery, Heinrich Heine University Duesseldorf, Medical Faculty; Susanne Bunnenberg Foundation at Duesseldorf Cardiovascular Center	This work was supported by institutional funds of the Department of Cardiovascular Surgery, Heinrich Heine University Duesseldorf, Medical Faculty. The authors are thankful for further support granted by Susanne Bunnenberg Foundation at Duesseldorf Cardiovascular Center. http://www.gffu.hhu.de/stiftungen/susanne-bunnenberg-stiffung-am-nniversitaetsklinikum-duesseldorf.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann A, 2013, BIOMATERIALS, V34, P6015, DOI 10.1016/j.biomaterials.2013.04.037; Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200; Cho KS, 1999, INVEST OPHTH VIS SCI, V40, P911; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Gielis JF, 2011, FREE RADICAL BIO MED, V50, P765, DOI 10.1016/j.freeradbiomed.2010.12.018; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hajjar DP, 2013, AM J PATHOL, V182, P1474, DOI 10.1016/j.ajpath.2013.01.010; HIRATA Y, 1994, ATHEROSCLEROSIS, V107, P117, DOI 10.1016/0021-9150(94)90147-3; Inamo J, 1996, THROMB RES, V83, P229, DOI 10.1016/0049-3848(96)00131-4; JERNIGAN HM, 1993, EXP EYE RES, V56, P25, DOI 10.1006/exer.1993.1005; Kikuchi S, 1998, ARTERIOSCL THROM VAS, V18, P1069, DOI 10.1161/01.ATV.18.7.1069; Lambert CR, 1996, J AM CHEM SOC, V118, P3297, DOI 10.1021/ja9600800; Leopold JA, 2009, FREE RADICAL BIO MED, V47, P1673, DOI 10.1016/j.freeradbiomed.2009.09.009; Li AE, 1999, CIRC RES, V85, P304, DOI 10.1161/01.RES.85.4.304; Nomura J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04554; Perez P, 2014, EXP THER MED, V8, P64, DOI 10.3892/etm.2014.1677; Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076; Spinale FG, 2014, BIOCHEM PHARMACOL, V90, P7, DOI 10.1016/j.bcp.2014.04.011; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tie GD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000241; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047; VANDEPLASSCHE G, 1990, J MOL CELL CARDIOL, V22, P287, DOI 10.1016/0022-2828(90)91462-G; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810; WILSON CA, 1991, INVEST OPHTH VIS SCI, V32, P2357	26	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179342	10.1371/journal.pone.0179342	http://dx.doi.org/10.1371/journal.pone.0179342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614411	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900044
J	Bjersand, K; Seidal, T; Sundstrom-Poromaa, I; Akerud, H; Skirnisdottir, I				Bjersand, Kathrine; Seidal, Tomas; Sundstrom-Poromaa, Inger; Akerud, Helena; Skirnisdottir, Ingiridur			The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer	PLOS ONE			English	Article							I-II; SURFACE EXPRESSION; P53 STATUS; CARCINOMA; IMPACT; CELLS; TRANSPORTERS; PROTEIN; CHEMOTHERAPY; METASTASIS	Objectives To evaluate the prognostic effect of the Heterogeneous nuclear ribonucleoprotein type M (HNRPM) and Solute carrier 1A5 (SLC1A5) in FIGO-stages I-II epithelial ovarian cancer. Methods A retrospective cohort study was designed to investigate the prognostic effect of HNRPM and SLC1A5, and the association with clinical-pathologic characteristics in 131 patients with FIGO-stages I-II epithelial ovarian cancer. Tissue microarrays were constructed and protein levels were assessed by immunohistochemistry (IHC). Results Positive HRNPM status was associated with positive staining for PUMA (P = 0.04), concomitant PUMA and p21 staining (P = 0.005), and VEGF-R2 (P = 0.003). Positive SLC1A5 staining was associated with positive staining of p27 (P = 0.030), PUMA (P = 0.039), concomitant PUMA and p27 staining, and VEGF-R2 (P = 0.039). In non-serous tumors (n = 72), the SLC1A5 positivity was associated with recurrent disease (P = 0.01). In a multivariable logistic regression analysis FIGO-stage (OR = 12.4), tumor grade (OR = 5.1) and SLC1A5 positivity (OR = 0.1) were independent predictive factors for recurrent disease. Disease-free survival (DFS) in women with SLC1A5-positive non-serous tumors was 92% compared with of 66% in patients with SLC1A5-negative non-serous tumors (Log-rank = 15.343; P = 0.008). In Cox analysis with DFS as endpoint, FIGO-stage (HR = 4.5) and SLC1A5 status (HR = 0.3) were prognostic factors. Conclusions As the proteins HRNPM and SLC1A5 are associated with the cell cycle regulators p21 or p27, the apoptosis regulators PTEN and PUMA, and the VEGF-R2 it is concluded that both proteins have role in the pathogenesis of ovarian cancer. In patients with non-serous ovarian cancer SLC1A5 protects from recurrent disease, presumably by means of biological mechanisms that are unrelated to cytotoxic drug sensitivity.	[Bjersand, Kathrine; Sundstrom-Poromaa, Inger; Skirnisdottir, Ingiridur] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Seidal, Tomas] Halmstad Med Ctr Hosp, Dept Pathol, Halmstad, Sweden; [Akerud, Helena] Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University	Skirnisdottir, I (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	ingiridur.skirnisdottir@kbh.uu.se		Skirnisdottir, Ingiridur/0000-0001-9840-2240	Uppsala-Orebro Regional Research Council; Foundation for Gynecological Oncology, Orebro University hospital	Uppsala-Orebro Regional Research Council; Foundation for Gynecological Oncology, Orebro University hospital	This work was supported by the Uppsala-Orebro Regional Research Council and the Foundation for Gynecological Oncology, Orebro University hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenova O, 2003, EXP CELL RES, V291, P228, DOI 10.1016/S0014-4827(03)00373-2; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen SJ, 2014, AM J PHYSIOL-GASTR L, V306, pG394, DOI 10.1152/ajpgi.00328.2013; El-Gebali S, 2013, MOL ASPECTS MED, V34, P719, DOI 10.1016/j.mam.2012.12.007; Gullick WJ, 1995, OVARIAN CANC, P63; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P240, DOI 10.1016/j.biopha.2012.11.011; Klasa-Mazurkiewicz D, 2011, POL J PATHOL, V62, P31; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Laguinge L, 2005, ANTICANCER RES, V25, P23; Lee YH, 2011, INT J GYNECOL PATHOL, V30, P205, DOI 10.1097/PGP.0b013e3182063e71; Nagano K, 2004, ONCOGENE, V23, P1693, DOI 10.1038/sj.onc.1207297; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Seidal T, 2001, AM J SURG PATHOL, V25, P1204, DOI 10.1097/00000478-200109000-00013; Skirnisdotir I, 2016, INT J ONCOL, V48, P998, DOI 10.3892/ijo.2016.3333; Skirnisdottir I, 2001, INT J GYNECOL CANCER, V11, P119, DOI 10.1046/j.1525-1438.2001.00086.x; Skirnisdottir I, 2004, INT J GYNECOL CANCER, V14, P259, DOI 10.1111/j.1048-891X.2004.014209.x; Skirnisdottir I, 2012, ONCOL REP, V27, P741, DOI 10.3892/or.2011.1578; Skirnisdottir I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-524; Skirnisdottir I, 2013, CANCER GENOM PROTEOM, V10, P27; Skirnisdottir I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-407; Skirnisdottir I, 2011, INT J GYNECOL CANCER, V21, P1024, DOI 10.1097/IGC.0b013e31821dc906; Skirnisdottir IA, 2011, INT J GYNECOL CANCER, V21, P236, DOI 10.1097/IGC.0b013e31820986e5; Thomas P, 2011, CLIN EXP METASTAS, V28, P923, DOI 10.1007/s10585-011-9419-3; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P113, DOI 10.1093/jnci/95.2.113; Vargas TR, 2014, ONCOGENE, V33, P2866, DOI 10.1038/onc.2013.252; Weber GF, 2008, CANCER LETT, V270, P181, DOI 10.1016/j.canlet.2008.04.030; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	31	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179363	10.1371/journal.pone.0179363	http://dx.doi.org/10.1371/journal.pone.0179363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609484	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700031
J	Gomez-Garzon, C; Hernandez-Santana, A; Dussan, J				Gomez-Garzon, Camilo; Hernandez-Santana, Alejandra; Dussan, Jenny			A genome-scale metabolic reconstruction of Lysinibacillus sphaericus unveils unexploited biotechnological potentials	PLOS ONE			English	Article							BACILLUS-SPHAERICUS; OXIDATIVE STRESS; IRON-METABOLISM; GEOBACILLUS SP; LAYER PROTEIN; BACTERIUM; DNA; STRAIN; HEME; CLASSIFICATION	The toxic lineage (TL) of Lysinibacillus sphaericus has been extensively studied because of its potential biotechnological applications in biocontrol of mosquitoes and bioremediation of toxic metals. We previously proposed that L. sphaericus TL should be considered as a novel species based on a comparative genomic analysis. In the current work, we constructed the first manually curated metabolic reconstruction for this species on the basis of the available genomes. We elucidated the central metabolism of the proposed species and, beyond confirming the reported experimental evidence with genomic a support, we found insights to propose novel applications and traits to be considered in further studies. The strains belonging to this lineage exhibit a broad repertory of genes encoding insecticidal factors, some of them remain uncharacterized. These strains exhibit other unexploited biotechnological important traits, such as lactonases (quorum quenching), toxic metal resistance, and potential for aromatic compound degradation. In summary, this study provides a guideline for further research aimed to implement this organism in biocontrol and bioremediation. Similarly, we highlighted the unanswered questions to be responded in order to gain a deeper understanding of the L. sphaericus TL biology.	[Gomez-Garzon, Camilo; Hernandez-Santana, Alejandra; Dussan, Jenny] Univ Los Andes, Ctr Invest Microbiol CIMIC, Bogota, Colombia	Universidad de los Andes (Colombia)	Dussan, J (corresponding author), Univ Los Andes, Ctr Invest Microbiol CIMIC, Bogota, Colombia.	jdussan@uniandes.edu.co		Hernandez-Santana, Alejandra/0000-0002-9191-3838; Gomez Garzon, Camilo Andres/0000-0003-4971-8999	Faculty of Sciences of Universidad de los Andes	Faculty of Sciences of Universidad de los Andes	This project was supported by Faculty of Sciences of Universidad de los Andes. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREEV J, 1994, FEBS LETT, V349, P411, DOI 10.1016/0014-5793(94)00715-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bahuguna A, 2011, J ENVIRON SCI-CHINA, V23, P975, DOI 10.1016/S1001-0742(10)60504-9; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; Beier S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00149; Berry C, 2017, J INVERTEBR PATHOL, V142, P16, DOI 10.1016/j.jip.2016.07.015; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Allievi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111114; Cowles KN, 2005, CELL MICROBIOL, V7, P209, DOI 10.1111/j.1462-5822.2004.00448.x; Pena-Montenegro TD, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-2; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dementiev A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0295-9; Devi P, 2017, MAR DRUGS, V15, DOI 10.3390/md15020030; Diaz E, 2013, CURR OPIN BIOTECH, V24, P431, DOI 10.1016/j.copbio.2012.10.010; Dubois T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002629; Durot M, 2009, FEMS MICROBIOL REV, V33, P164, DOI 10.1111/j.1574-6976.2008.00146.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Francke C, 2005, TRENDS MICROBIOL, V13, P550, DOI 10.1016/j.tim.2005.09.001; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Fukushima T, 2013, P NATL ACAD SCI USA, V110, P13821, DOI 10.1073/pnas.1304235110; Fukushima T, 2012, P NATL ACAD SCI USA, V109, P16829, DOI 10.1073/pnas.1210131109; Gomez-Garzon C, 2017, CAN J MICROBIOL, V63, P74, DOI 10.1139/cjm-2016-0323; Gomez-Garzon C, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3056-9; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; Hernandez-Santana A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00545-16; Hu GP, 2014, RES MICROBIOL, V165, P110, DOI 10.1016/j.resmic.2013.11.003; Hu XM, 2008, J BACTERIOL, V190, P2892, DOI 10.1128/JB.01652-07; Karp PD, 2016, BRIEF BIOINFORM, V17, P877, DOI 10.1093/bib/bbv079; Kumar P, 2013, BIOTECHNOL ADV, V31, P1543, DOI 10.1016/j.biotechadv.2013.08.007; Lopez D, 2010, FEMS MICROBIOL REV, V34, P134, DOI 10.1111/j.1574-6976.2009.00199.x; Lozano LC, 2017, CURR MICROBIOL, V74, P371, DOI 10.1007/s00284-016-1185-7; Lozano LC, 2013, WORLD J MICROB BIOT, V29, P1383, DOI 10.1007/s11274-013-1301-9; Manchola L, 2014, REMEDIATION, V25, P85, DOI 10.1002/rem.21416; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Meneghini R, 1997, FREE RADICAL BIO MED, V23, P783, DOI 10.1016/S0891-5849(97)00016-6; Misal SA, 2014, BIOTECHNOL LETT, V36, P127, DOI 10.1007/s10529-013-1338-8; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; MYERS P, 1978, INFECT IMMUN, V19, P1047, DOI 10.1128/IAI.19.3.1047-1053.1978; Nishiwaki H, 2007, APPL ENVIRON MICROB, V73, P3404, DOI 10.1128/AEM.00021-07; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pollmann K, 2005, MICROBIOL-SGM, V151, P2961, DOI 10.1099/mic.0.28201-0; R Core Team, 2021, R LANGUAGE ENV STAT; Rahman A, 2015, DATA BRIEF, V5, P579, DOI 10.1016/j.dib.2015.09.040; Rahman A, 2014, J ENVIRON SCI HEAL A, V49, P1349, DOI 10.1080/10934529.2014.928247; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Schmidt RM, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw076; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Urzua LS, 2013, ARCH MICROBIOL, V195, P431, DOI 10.1007/s00203-013-0890-x; Stauff DL, 2007, J BIOL CHEM, V282, P26111, DOI 10.1074/jbc.M703797200; Suhr M, 2016, JOVE-J VIS EXP, DOI 10.3791/53572; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Velasquez L, 2009, J HAZARD MATER, V167, P713, DOI 10.1016/j.jhazmat.2009.01.044; Wang LH, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P379; Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005; Xu K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1359-x; Zuo GH, 2015, GENOM PROTEOM BIOINF, V13, P321, DOI 10.1016/j.gpb.2015.08.004	71	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179666	10.1371/journal.pone.0179666	http://dx.doi.org/10.1371/journal.pone.0179666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604819	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400055
J	Richards, MD; Goltz, HC; Wong, AMF				Richards, Michael D.; Goltz, Herbert C.; Wong, Agnes M. F.			Alterations in audiovisual simultaneity perception in amblyopia	PLOS ONE			English	Article							MULTISENSORY TEMPORAL INTEGRATION; POSTNATAL VISUAL DEPRIVATION; STRABISMIC AMBLYOPIA; SPEECH-PERCEPTION; ANISOMETROPIC AMBLYOPIA; CONTRAST SENSITIVITY; MOTION PERCEPTION; GLOBAL MOTION; PRIOR ENTRY; FELLOW EYE	Amblyopia is a developmental visual impairment that is increasingly recognized to affect higher-level perceptual and multisensory processes. To further investigate the audiovisual (AV) perceptual impairments associated with this condition, we characterized the temporal interval in which asynchronous auditory and visual stimuli are perceived as simultaneous 50% of the time (i.e., the AV simultaneity window). Adults with unilateral amblyopia (n = 17) and visually normal controls (n = 17) judged the simultaneity of a flash and a click presented with both eyes viewing. The signal onset asynchrony (SOA) varied from 0 ms to 450 ms for auditory-lead and visual-lead conditions. A subset of participants with amblyopia (n = 6) was tested monocularly. Compared to the control group, the auditory-lead side of the AV simultaneity window was widened by 48 ms (36%; p = 0.002), whereas that of the visual-lead side was widened by 86 ms (37%; p = 0.02). The overall mean window width was 500 ms, compared to 366 ms among controls (37% wider; p = 0.002). Among participants with amblyopia, the simultaneity window parameters were unchanged by viewing condition, but subgroup analysis revealed differential effects on the parameters by amblyopia severity, etiology, and foveal suppression status. Possible mechanisms to explain these findings include visual temporal uncertainty, interocular perceptual latency asymmetry, and disruption of normal developmental tuning of sensitivity to audiovisual asynchrony.	[Richards, Michael D.] Univ Toronto, Fac Med, Inst Med Sci, Toronto, ON, Canada; [Richards, Michael D.; Goltz, Herbert C.; Wong, Agnes M. F.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Richards, Michael D.; Wong, Agnes M. F.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Goltz, Herbert C.; Wong, Agnes M. F.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Goltz, HC; Wong, AMF (corresponding author), Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.; Wong, AMF (corresponding author), Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada.; Goltz, HC; Wong, AMF (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON, Canada.	herb.goltz@sickkids.ca; agnes.wong@sickkids.ca			Canadian Institutes of Health Research (CIHR) [MOP 106663]; Canada Foundation for Innovation (CFI); John and Melinda Thompson Endowment Fund in Vision Neurosciences; Department of Ophthalmology and Vision Sciences at The Hospital for Sick Children; Vision Science Research Program at the University of Toronto	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); John and Melinda Thompson Endowment Fund in Vision Neurosciences; Department of Ophthalmology and Vision Sciences at The Hospital for Sick Children; Vision Science Research Program at the University of Toronto	This work was supported by grant MOP 106663 from the Canadian Institutes of Health Research (CIHR), Leaders Opportunity Fund from the Canada Foundation for Innovation (CFI), the John and Melinda Thompson Endowment Fund in Vision Neurosciences, the Department of Ophthalmology and Vision Sciences at The Hospital for Sick Children, and the Vision Science Research Program at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2008, VISION RES, V48, P1965, DOI 10.1016/j.visres.2008.06.012; ABRAHAMSSON M, 1988, BRIT J OPHTHALMOL, V72, P44, DOI 10.1136/bjo.72.1.44; American Academy of Ophthalmology Pediatric Ophtalmology/Strabismus Panel, 2012, PREF PRACT PATT GUID; ANDREASSI JL, 1975, PHYSIOL PSYCHOL, V3, P189, DOI 10.3758/BF03337503; Attebo K, 1998, OPHTHALMOLOGY, V105, P154, DOI 10.1016/S0161-6420(98)91862-0; Birch EE, 2016, INVEST OPHTH VIS SCI, V57, P5649, DOI 10.1167/iovs.16-19986; Birch EE, 2013, PROG RETIN EYE RES, V33, P67, DOI 10.1016/j.preteyeres.2012.11.001; Brown S A, 2000, Ophthalmic Epidemiol, V7, P249, DOI 10.1076/0928-6586(200012)7:4;1-Y;FT249; Buch H, 2001, ACTA OPHTHALMOL SCAN, V79, P441, DOI 10.1034/j.1600-0420.2001.790503.x; Burgmeier R, 2015, JAMA OPHTHALMOL, V133, P11, DOI 10.1001/jamaophthalmol.2014.3307; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Chen YC, 2017, CURR BIOL, V27, P583, DOI 10.1016/j.cub.2017.01.009; Chen YC, 2016, J EXP CHILD PSYCHOL, V146, P17, DOI 10.1016/j.jecp.2016.01.010; Collignon O, 2015, CURR BIOL, V25, P2379, DOI 10.1016/j.cub.2015.07.036; de Heering A, 2016, CURR BIOL, V26, P3101, DOI 10.1016/j.cub.2016.10.014; Donohue SE, 2010, ATTEN PERCEPT PSYCHO, V72, P1120, DOI 10.3758/APP.72.4.1120; Driver J., 1996, ENHANCEMENT SELECTIV; ENGEL GR, 1971, NATURE, V234, P308, DOI 10.1038/234308a0; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Foucher JR, 2007, SCHIZOPHR RES, V97, P118, DOI 10.1016/j.schres.2007.08.013; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GIASCHI DE, 1992, INVEST OPHTH VIS SCI, V33, P2483; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Grant KW, 2000, J ACOUST SOC AM, V108, P1197, DOI 10.1121/1.1288668; Hairston WD, 2005, EXP BRAIN RES, V166, P474, DOI 10.1007/s00221-005-2387-6; HARRAD RA, 1992, VISION RES, V32, P2135, DOI 10.1016/0042-6989(92)90075-T; Hess RF, 1999, VISION RES, V39, P901, DOI 10.1016/S0042-6989(98)00157-6; HESS RF, 1977, VISION RES, V17, P1049, DOI 10.1016/0042-6989(77)90009-8; Hillock AR, 2011, NEUROPSYCHOLOGIA, V49, P461, DOI 10.1016/j.neuropsychologia.2010.11.041; Hillock-Dunn A, 2012, DEVELOPMENTAL SCI, V15, P688, DOI 10.1111/j.1467-7687.2012.01171.x; Ho CS, 2005, VISION RES, V45, P1615, DOI 10.1016/j.visres.2004.12.009; Huang PC, 2012, INVEST OPHTH VIS SCI, V53, P8325, DOI 10.1167/iovs.12-10835; Keetels M, 2005, EXP BRAIN RES, V167, P635, DOI 10.1007/s00221-005-0067-1; Kovacs I, 2000, VISION RES, V40, P1775, DOI 10.1016/S0042-6989(00)00008-0; Krueger D. E., 1984, REPORT NATL EYE I VI; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; LEVI DM, 1977, INVEST OPHTH VIS SCI, V16, P90; LEVI DM, 1994, VISION RES, V34, P3315, DOI 10.1016/0042-6989(94)90067-1; Lewis T, 2016, J VISION, V16, P1121; Lewkowicz DJ, 2014, CHILD DEV, V85, P685, DOI 10.1111/cdev.12142; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Martin B, 2013, NEUROPSYCHOLOGIA, V51, P358, DOI 10.1016/j.neuropsychologia.2012.07.002; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Mirabella G, 2011, ARCH OPHTHALMOL-CHIC, V129, P176, DOI 10.1001/archophthalmol.2010.354; Moro S., 2015, J VIS, V15, P721, DOI DOI 10.1167/15.12.721; MORRELL LK, 1968, J EXP PSYCHOL, V77, P14, DOI 10.1037/h0021289; Narinesingh C, 2015, INVEST OPHTH VIS SCI, V56, P2107, DOI 10.1167/iovs.14-15898; Narinesingh C, 2014, INVEST OPHTH VIS SCI, V55, P3158, DOI 10.1167/iovs.14-14140; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Petrini K, 2009, COGNITION, V110, P432, DOI 10.1016/j.cognition.2008.11.015; Powers AR, 2009, J NEUROSCI, V29, P12265, DOI 10.1523/JNEUROSCI.3501-09.2009; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; Putzar L, 2007, NAT NEUROSCI, V10, P1243, DOI 10.1038/nn1978; Putzar L, 2010, RESTOR NEUROL NEUROS, V28, P251, DOI 10.3233/RNN-2010-0526; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Roseboom W, 2009, J VISION, V9, DOI 10.1167/9.12.4; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; SOKOL S, 1983, BRIT J OPHTHALMOL, V67, P310, DOI 10.1136/bjo.67.5.310; Spang K, 2009, INVEST OPHTH VIS SCI, V50, P5207, DOI 10.1167/iovs.07-1604; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; St John R, 1998, BEHAV BRAIN RES, V90, P167, DOI 10.1016/S0166-4328(97)00096-X; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Stevenson RA, 2013, EXP BRAIN RES, V225, P479, DOI 10.1007/s00221-012-3387-y; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stevenson RA, 2011, NEUROIMAGE, V55, P1339, DOI 10.1016/j.neuroimage.2010.12.063; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Student Support Services Team, 2008, SCH HEAR SCREEN GUID; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; THOMPSON JR, 1991, PUBLIC HEALTH, V105, P455, DOI 10.1016/S0033-3506(05)80616-X; TREDICI TD, 1984, AM J OPHTHALMOL, V98, P499, DOI 10.1016/0002-9394(84)90139-9; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vinding T, 2009, ACTA OPHTHALMOL, V69, P796; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wallace MT, 2007, J NEUROPHYSIOL, V97, P921, DOI 10.1152/jn.00497.2006; Wallace MT, 2004, J NEUROSCI, V24, P9580, DOI 10.1523/JNEUROSCI.2535-04.2004; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zhang W, 2005, DOC OPHTHALMOL, V110, P173, DOI 10.1007/s10633-005-4312-5	92	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179516	10.1371/journal.pone.0179516	http://dx.doi.org/10.1371/journal.pone.0179516			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX1NV	28598996	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000040
J	Overstreet, JM; Wang, YQ; Wang, X; Niu, AL; Gewin, LS; Yao, B; Harris, RC; Zhang, MZ				Overstreet, Jessica M.; Wang, Yinqiu; Wang, Xin; Niu, Aolei; Gewin, Leslie S.; Yao, Bing; Harris, Raymond C.; Zhang, Ming-Zhi			Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis	FASEB JOURNAL			English	Article						EGFR; HB-EGF; EMT; tubular dysfunction; epithelial dedifferentiation	CHRONIC KIDNEY-DISEASE; ANGIOTENSIN-II; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; URETERAL OBSTRUCTION; INJURY; EGF; PROGRESSION; PATHOPHYSIOLOGY; EXPRESSION	Epidermal growth factor receptor (EGFR) has been implicated in the pathogenesis of diabetic nephropathy and renal fibrosis; however, the causative role of sustained EGFR activation is unclear. Here, we generated a novel kidney fibrotic mouse model of persistent EGFR activation by selectively expressing the EGFR ligand, human heparin-binding EGF-like growth factor (hHB-EGF), in renal proximal tubule epithelium. hHB-EGF expression increased tyrosine kinase phosphorylation of EGFR and the subsequent activation of downstream signaling pathways, including ERK and AKT, as well as the profibrotic TGF-beta 1/SMAD pathway. Epithelial-specific activation of EGFR was sufficient to promote spontaneous and progressive renal tubulointerstitial fibrosis, as characterized by increased collagen deposition, immune cell infiltration, and alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts. Tubule-specific EGFR activation promoted epithelial dedifferentiation and cell-cycle arrest. Furthermore, EGFR activation in epithelial cells promoted the proliferation of alpha-SMA(+) myofibroblasts in a paracrine manner. Genetic or pharmacologic inhibition of EGFR tyrosine kinase activity or downstream MEK activity attenuated the fibrotic phenotype. This study provides definitive evidence that sustained activation of EGFR in proximal epithelia is sufficient to cause spontaneous, progressive renal tubulointerstitial fibrosis, evident by epithelial dedifferentiation, increased myofibroblasts, immune cell infiltration, and increased matrix deposition.-Overstreet, J. M., Wang, Y., Wang, X., Niu, A., Gewin, L. S., Yao, B., Harris, R. C., Zhang, M.-Z. Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis.	[Overstreet, Jessica M.; Wang, Yinqiu; Wang, Xin; Niu, Aolei; Gewin, Leslie S.; Yao, Bing; Harris, Raymond C.; Zhang, Ming-Zhi] Vanderbilt Univ, Div Nephrol, Sch Med, 1161 21st Ave South,C3121 MCN, Nashville, TN 37232 USA; [Harris, Raymond C.; Zhang, Ming-Zhi] Vanderbilt Univ, Vanderbilt Ctr Kidney Dis, Sch Med, Nashville, TN 37232 USA; [Gewin, Leslie S.; Harris, Raymond C.] Nashville Vet Affairs Hosp, Dept Nephrol, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Harris, RC (corresponding author), Vanderbilt Univ, Div Nephrol, Sch Med, 1161 21st Ave South,C3121 MCN, Nashville, TN 37232 USA.	ray.harris@vanderbilt.edu			U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK51265, DK95785, DK103067, T32DK07569]; Veterans Affairs Merit Award [00507969]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051265, T32DK007569, R01DK095785, R01DK108968, R24DK103067] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK51265, DK95785, and DK103067 (to R.C.H. and M.-Z.Z.) and T32DK07569 (to J.M.O.); Veterans Affairs Merit Award 00507969 (to R.C.H.). The authors declare no conflicts of interest.	Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Cao Q, 2014, KIDNEY INT SUPPL, V4, P16, DOI 10.1038/kisup.2014.4; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Endo T, 2015, J PATHOL, V236, P251, DOI 10.1002/path.4514; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kefaloyianni E, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87023; Kim MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143961; Kok HM, 2014, NAT REV NEPHROL, V10, P700, DOI 10.1038/nrneph.2014.184; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Liu N, 2012, J AM SOC NEPHROL, V23, P854, DOI 10.1681/ASN.2011050493; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Meng XM, 2014, NAT REV NEPHROL, V10, P493, DOI 10.1038/nrneph.2014.114; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Miyazawa T, 2013, KIDNEY INT, V84, P1176, DOI 10.1038/ki.2013.214; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Rayego-Mateos S, 2013, J PATHOL, V231, P480, DOI 10.1002/path.4250; Rayego-Mateos S, 2013, J MOL CELL BIOL, V5, P323, DOI 10.1093/jmcb/mjt030; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zeng FH, 2016, AM J PHYSIOL-RENAL, V311, pF695, DOI 10.1152/ajprenal.00377.2015; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zhang MZ, 2014, DIABETES, V63, P2063, DOI 10.2337/db13-1279; Zhang MZ, 2012, J CLIN INVEST, V122, P4519, DOI 10.1172/JCI60363; Zhuang S, 2008, AM J PHYSIOL-RENAL, V294, pF459, DOI 10.1152/ajprenal.00473.2007	44	36	39	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4407	4421		10.1096/fj.201601359RR	http://dx.doi.org/10.1096/fj.201601359RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626027	Green Published			2022-12-26	WOS:000413397400019
J	Hernandez-Vasquez, MN; Adame-Garcia, SR; Hamoud, N; Chidiac, R; Reyes-Cruz, G; Gratton, JP; Cote, JF; Vazquez-Prado, J				Nohemi Hernandez-Vasquez, Magda; Rafael Adame-Garcia, Sendi; Hamoud, Noumeira; Chidiac, Rony; Reyes-Cruz, Guadalupe; Gratton, Jean Philippe; Cote, Jean-Francois; Vazquez-Prado, Jose			Cell adhesion controlled by adhesion G protein-coupled receptor GPR124/ADGRA2 is mediated by a protein complex comprising intersectins and Elmo-Dock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; NUCLEOTIDE EXCHANGE FACTOR; ENDOTHELIAL-CELLS; SCAFFOLD PROTEINS; CNS ANGIOGENESIS; EPS15 HOMOLOGY; RAC ACTIVATION; RHO-GTPASES; GPR124; MIGRATION	Developmental angiogenesis and the maintenance of the blood-brain barrier involve endothelial cell adhesion, which is linked to cytoskeletal dynamics. GPR124 (also known as TEM5/ADGRA2) is an adhesion G protein-coupled receptor family member that plays a pivotal role in brain angiogenesis and in ensuring a tight blood-brain barrier. However, the signaling properties of GPR124 remain poorly defined. Here, we show that ectopic expression of GPR124 promotes cell adhesion, additive to extracellular matrix-dependent effect, coupled with filopodia and lamellipodia formation and an enrichment of a pool of the G protein-coupled receptor at actin-rich cellular protrusions containing VASP, a filopodial marker. Accordingly, GPR124-expressing cells also displayed increased activation of both Rac and Cdc42 GTPases. Mechanistically, we uncover novel direct interactions between endogenous GPR124 and the Rho guanine nucleotide exchange factors Elmo/Dock and intersectin (ITSN). Small fragments of either Elmo or ITSN1 that bind GPR124 blocked GPR124-induced cell adhesion. In addition, G beta gamma interacts with the C-terminal tail of GPR124 and promotes the formation of a GPR124-Elmo complex. Furthermore, GPR124 also promotes the activation of the Elmo-Dock complex, as measured by Elmo phosphorylation on a conserved C-terminal tyrosine residue. Interestingly, Elmo and ITSN1 also interact with each other independently of their GPR124-recognition regions. Moreover, endogenous phospho-Elmo and ITSN1 co-localize with GPR124 at lamellipodia of adhering endothelial cells, where GPR124 expression contributes to polarity acquisition during wound healing. Collectively, our results indicate that GPR124 promotes cell adhesion via Elmo-Dock and ITSN. This constitutes a previously unrecognized complex formed of atypical and conventional Rho guanine nucleotide exchange factors for Rac and Cdc42 that is putatively involved in GPR124-dependent angiogenic responses.	[Nohemi Hernandez-Vasquez, Magda; Vazquez-Prado, Jose] Natl Polytech Inst CINVESTAV IPN, Ctr Res & Adv Studies, Dept Pharmacol, Mexico City 14740, DF, Mexico; [Rafael Adame-Garcia, Sendi; Reyes-Cruz, Guadalupe] Natl Polytech Inst CINVESTAV IPN, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City 14740, DF, Mexico; [Hamoud, Noumeira; Cote, Jean-Francois] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Montreal, PQ H3T 1J4, Canada; [Chidiac, Rony; Gratton, Jean Philippe] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3T 1J4, Canada	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal	Vazquez-Prado, J (corresponding author), CINVESTAV IPN, Dept Pharmacol, Ave Inst Politecn Nacl 2508, Mexico City, DF 14740, Mexico.	jvazquez@cinvestav.mx	VAZQUEZ-PRADO, JOSE/C-1630-2017	VAZQUEZ-PRADO, JOSE/0000-0001-5797-6643; Gratton, Jean-Philippe/0000-0001-9877-8520; Hernandez Vasquez, Magda Nohemi/0000-0002-5449-3598	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) [152434, 240119]; Canadian Institutes of Health Research; PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"); FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; CONACyT fellowship	CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"); FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; CONACyT fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico) Grants 152434 (to J. V.-P.) and 240119 (to G. R.-C.), a Canadian Institutes of Health Research grant (to J. F. C.), and PNPC (en el marco del "Programa de Fortalecimiento Academico del Posgrado de Alta Calidad"). The authors declare that they have no conflicts of interest with the contents of this article.; Graduate student supported by a CONACyT fellowship.; Supported by ITABEC (Instituto Tamaulipeco de Becas, Estimulos y Creditos Educativos) of the Tamaulipas State Government.; Recipient of an FRQS (Fonds de recherche du Quebec - Sante) Senior Career Award; holder of the Transat Chair in Breast Cancer Research.	Abu-Thuraia A, 2015, MOL CELL BIOL, V35, P76, DOI 10.1128/MCB.00764-14; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Anderson KD, 2011, P NATL ACAD SCI USA, V108, P2807, DOI 10.1073/pnas.1019761108; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Bardita C, 2013, JOVE-J VIS EXP, DOI 10.3791/50316; Barzik M, 2014, MOL BIOL CELL, V25, P2604, DOI 10.1091/mbc.E14-02-0712; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bianco A, 2007, NATURE, V448, P362, DOI 10.1038/nature05965; Carretero-Ortega J, 2010, MOL PHARMACOL, V77, P435, DOI 10.1124/mol.109.060400; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gryaznova T, 2015, CELL SIGNAL, V27, P1499, DOI 10.1016/j.cellsig.2015.03.006; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Hernandez-Garcia R, 2015, VASC PHARMACOL, V74, P60, DOI 10.1016/j.vph.2015.10.003; Herrero-Garcia E, 2017, BBA-MOL CELL RES, V1864, P23, DOI 10.1016/j.bbamcr.2016.10.005; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Monk KR, 2015, MOL PHARMACOL, V88, P617, DOI 10.1124/mol.115.098749; Mu L, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/181536; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Pucharcos C, 2000, FEBS LETT, V478, P43, DOI 10.1016/S0014-5793(00)01793-2; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Savdie C, 2006, CELL TISSUE RES, V324, P69, DOI 10.1007/s00441-005-0102-3; St Croix B, 2000, SCIENCE, V289, P1197; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Summers L, 2013, MOL CELL NEUROSCI, V57, P93, DOI 10.1016/j.mcn.2013.10.007; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Tong XK, 2000, EMBO J, V19, P1263, DOI 10.1093/emboj/19.6.1263; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Vazquez-Prado J, 2016, MOL PHARMACOL, V90, P573, DOI 10.1124/mol.116.105338; Wang Y, 2014, CURR MOL MED, V14, P543, DOI 10.2174/1566524014666140414205943; Wang YH, 2016, J CANCER, V7, P973, DOI 10.7150/jca.15118; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018	59	15	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12178	12191		10.1074/jbc.M117.780304	http://dx.doi.org/10.1074/jbc.M117.780304			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28600358	Green Published, hybrid			2022-12-26	WOS:000406053300016
J	Peng, YZ; Yuan, JJ; Zhang, ZC; Chang, X				Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing			Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; B-CELL; ALTERNATIVE CLEAVAGE; ELONGATION-FACTOR; DIFFERENTIATION; POLYADENYLATION; RIBONUCLEOPROTEIN; TRANSLATION; TRANSCRIPTION; REPRESSION	Increasing evidence indicates that alternative processing of mRNA, including alternative splicing, 3 ' alternative polyadenylation, and regulation of mRNA stability/translation, represents a major mechanism contributing to protein diversification. For example, in alternative polyadenylation, the 3 ' end of the immunoglobulin heavy chain mRNA is processed during B cell differentiation, and this processing involves RNA-binding proteins. hnRNPLL (heterogeneous nuclear ribonucleoprotein L-like protein) is an RNA-binding protein expressed in terminally differentiated lymphocytes, such as memory T cells and plasma cells. hnRNPLL regulates various processes of RNA metabolism, including alternative pre-mRNA splicing and RNA stability. In plasma cells, hnRNPLL also regulates the transition from the membrane isoform of the immunoglobulin heavy-chain (mIgH) to the secreted isoform (sIgH), but the precise mechanism remains to be identified. In this study, we report that hnRNPLL specifically associates with cytoplasmic PABPC1 (poly(A)-binding protein 1) in both T cells and plasma cells. We found that although PABPC1 is not required for the alternative splicing of CD45, a primary target of hnRNPLL in lymphocytes, PABPC1 does promote the binding of hnRNPLL to the immunoglobulin mRNA and regulates switching from mIgH to sIgH in plasma cells. Given the recently identified role of PABPC1 in mRNA alternative polyadenylation, our findings suggest that PABPC1 recruits hnRNPLL to the 3 ' -end of RNA and regulates the transition from membrane Ig to secreted Ig through mRNA alternative polyadenylation. In conclusion, our study has revealed a mechanism that regulates immunoglobulin secretion in B cells via cooperation between a plasma cell-specific RBP (hnRNPLL) and a universally expressed RBP (PABPC1).	[Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing] Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China; [Peng, Yuanzheng; Yuan, Juanjuan; Zhang, Zhenchao; Chang, Xing] Univ Chinese Acad Sci, Chinese Acad Sci, Sch Med, Shanghai Jiao Tong Univ, Shanghai 200031, Peoples R China; [Peng, Yuanzheng; Yuan, Juanjuan; Chang, Xing] Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chang, X (corresponding author), Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200031, Peoples R China.; Chang, X (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Sch Med, Shanghai Jiao Tong Univ, Shanghai 200031, Peoples R China.; Chang, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Collaborat Innovat Ctr Syst Biomed, Shanghai 200031, Peoples R China.	changxing@sibs.ac.cn		Chang, Xing/0000-0002-5072-9225	National Science Foundation of China [31370858, 81671552]; Ministry of Science and Technology, China [2014CB943600]; Science and Technology Commission of Shanghai Municipality [13PJ1409300, 17ZR449700]; National Thousand Talents Program for Distinguished Young Scholars (China)	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Thousand Talents Program for Distinguished Young Scholars (China)	This work was supported by Grants 31370858 and 81671552 from the National Science Foundation of China, 2014CB943600 from Ministry of Science and Technology, China, 13PJ1409300 and 17ZR449700 from Science and Technology Commission of Shanghai Municipality, and National Thousand Talents Program for Distinguished Young Scholars (China).	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Benson MJ, 2012, P NATL ACAD SCI USA, V109, P16252, DOI 10.1073/pnas.1214414109; Bruce SR, 2003, RNA, V9, P1264, DOI 10.1261/rna.5820103; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chang X, 2016, WIRES RNA, V7, P295, DOI 10.1002/wrna.1335; Chang X, 2015, P NATL ACAD SCI USA, V112, pE1888, DOI 10.1073/pnas.1422490112; Cho V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r26; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Jenal M, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.022; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kini HK, 2016, RNA, V22, P61, DOI 10.1261/rna.053447.115; Kumar GR, 2010, MOL CELL BIOL, V30, P4996, DOI 10.1128/MCB.00600-10; Li WC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005166; Ma JL, 2006, RNA, V12, P122, DOI 10.1261/rna.2159506; Martincic K, 2009, NAT IMMUNOL, V10, P1102, DOI 10.1038/ni.1786; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Pascale A, 2005, P NATL ACAD SCI USA, V102, P12065, DOI 10.1073/pnas.0504702102; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; Peterson Martha L., 1992, Gene Expression, V2, P319; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; Shankarling G, 2013, BIOCHEM J, V453, P271, DOI 10.1042/BJ20130432; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Wang HH, 2016, CHIN CONT DECIS CONF, P1, DOI 10.1109/CCDC.2016.7530945; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wu Z, 2008, IMMUNITY, V29, P863, DOI 10.1016/j.immuni.2008.11.004; Yabas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026440; Ye J, 2014, CELL STEM CELL, V15, P271, DOI 10.1016/j.stem.2014.08.010	37	16	16	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	2017	292	29					12285	12295		10.1074/jbc.M117.794834	http://dx.doi.org/10.1074/jbc.M117.794834			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FB3OX	28611064	Green Published, hybrid			2022-12-26	WOS:000406053300024
J	Mascia, C; Vita, S; Zuccal, P; Marocco, R; Tieghi, T; Savinelli, S; Rossi, R; Iannetta, M; Pozzetto, I; Furlan, C; Mengoni, F; Mastroianni, CM; Vullo, V; Lichtner, M				Mascia, Claudia; Vita, Serena; Zuccal, Paola; Marocco, Raffaella; Tieghi, Tiziana; Savinelli, Stefano; Rossi, Raffaella; Iannetta, Marco; Pozzetto, Irene; Furlan, Caterina; Mengoni, Fabio; Mastroianni, Claudio Maria; Vullo, Vincenzo; Lichtner, Miriam			Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; MACROPHAGE ACTIVATION MARKER; INNATE IMMUNE-RESPONSE; VIRUS-INFECTION; SOLUBLE CD163; LIVER FIBROSIS; INDUCIBLE PROTEIN-10; FREE THERAPY; EXPRESSION; GAMMA	Background and aims Increased levels of chemokine interferon-gamma (IFN-gamma)-inducible protein-10 (CXCL10), soluble CD163 (sCD163) and soluble CD14 (sCD14) have been reported in HCV infection. The aim of this study was to compare, sCD163 and sCD14 levels in HCV-infected patients undergoing direct acting antiviral (DAA)-containing regimens with or without interferon (IFN). Methods sCD163, sCD14 and CXCL10 were longitudinally measured by ELISA in 159 plasma samples from 25 HCV-infected patients undergoing IFN-based treatment plus telaprevir or boceprevir and 28 HCV infected subjects treated with DAA IFN-free regimens. Twenty-five healthy donors (HD) were included as controls. Results At baseline CXCL10, sCD163 and sCD14 levels were higher in HCV-infected patients than in HD. CXCL10 and sCD163 levels were significantly decreased in responder (R) patients who achieved sustained virological response (SVR), with both IFN-based and IFN-free regimens, while they were persistently elevated in non-responders (NR) patients who stopped IFN-based treatments because of failure or adverse events. Conversely, sCD14 levels were apparently unchanged during therapy, but at the end of treatment the levels reached normal ranges. Comparing the two regimens, the extent of CXCL10 reduction was more pronounced in patients undergoing DAA IFN-free therapies, whereas sCD163 and sCD14 reduction was similar in the two groups. Interestingly, only in IFN-based regimens baseline sCD163 levels were significantly higher in NR than in R patients, while in the IFN-free treatment group also patients with high sCD163 plasma levels obtained SVR. At the end of therapy, even if the biomarkers were largely decreased, their levels remained significantly higher compared to HD. Only in the early fibrosis stages, sCD163 values tended to normalize. Conclusions These results indicate that IFN-free regimens including newer DAA induce an early and marked decrease in circulating inflammatory biomarkers. However, the full normalization of biomarkers was not obtained, especially in patients with advanced fibrosis, thus underlying the need for a treatment in the early stages of HCV infection.	[Mascia, Claudia; Vita, Serena; Zuccal, Paola; Marocco, Raffaella; Tieghi, Tiziana; Savinelli, Stefano; Rossi, Raffaella; Iannetta, Marco; Pozzetto, Irene; Furlan, Caterina; Mengoni, Fabio; Mastroianni, Claudio Maria; Vullo, Vincenzo; Lichtner, Miriam] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Marocco, Raffaella; Tieghi, Tiziana; Pozzetto, Irene; Mastroianni, Claudio Maria; Lichtner, Miriam] Sapienza Univ, SM Goretti Hosp, Infect Dis Unit, Latina, Italy	Sapienza University Rome; Sapienza University Rome	Mascia, C (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.	claumascia@tiscali.it	Iannetta, Marco/M-4619-2019; Vita, Serena/AAC-3345-2022; Iannetta, Marco/B-5596-2017; MASTROIANNI, Claudio Maria/O-9741-2019	Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; MASTROIANNI, Claudio Maria/0000-0002-1286-467X				Ahlenstiel G, 2010, GASTROENTEROLOGY, V138, P325, DOI 10.1053/j.gastro.2009.08.066; Andersen ES, 2014, EUR J CLIN MICROBIOL, V33, P117, DOI 10.1007/s10096-013-1936-3; Aristoteli LP, 2006, ATHEROSCLEROSIS, V184, P342, DOI 10.1016/j.atherosclerosis.2005.05.004; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bility MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep39520; Brownell J, 2013, J HEPATOL, V59, P701, DOI 10.1016/j.jhep.2013.06.001; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Dultz G, 2016, J VIRAL HEPATITIS, V23, P267, DOI 10.1111/jvh.12488; Freiberg MS, 2011, CIRC-CARDIOVASC QUAL, V4, P425, DOI 10.1161/CIRCOUTCOMES.110.957415; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Jirillo E, 1998, IMMUNOPHARM IMMUNOT, V20, P1, DOI 10.3109/08923979809034805; Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129; Kostadinova L, 2016, J INFECT DIS, V214, P1438, DOI 10.1093/infdis/jiw372; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Larrea E, 1996, HEPATOLOGY, V23, P210, DOI 10.1002/hep.510230203; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin JC, 2014, J INFECT DIS, V210, P1881, DOI 10.1093/infdis/jiu325; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Malone DFG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105665; Mihm S, 2003, J MED VIROL, V70, P562, DOI 10.1002/jmv.10431; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Mochizuki K, 1997, HEPATOLOGY, V25, P713, DOI 10.1002/hep.510250337; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moreno JA, 2012, EUR HEART J, V33, P252, DOI 10.1093/eurheartj/ehr123; Narumi S, 1997, J IMMUNOL, V158, P5536; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065211; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Sacchi P, 2015, DIGEST LIVER DIS, V47, P218, DOI 10.1016/j.dld.2014.11.012; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Shaked I, 2014, ARTERIOSCL THROM VAS, V34, P1085, DOI 10.1161/ATVBAHA.113.303153; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Werner CR, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0261-0; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424	41	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179400	10.1371/journal.pone.0179400	http://dx.doi.org/10.1371/journal.pone.0179400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636655	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300034
J	Bowles, EJA; Walker, RL; Anderson, ML; Dublin, S; Crane, PK; Larson, EB				Bowles, Erin J. Aiello; Walker, Rod L.; Anderson, Melissa L.; Dublin, Sascha; Crane, Paul K.; Larson, Eric B.			Risk of Alzheimer's disease or dementia following a cancer diagnosis	PLOS ONE			English	Article								Objective We evaluated dementia and Alzheimer's disease (AD) risks after a cancer diagnosis in a population-based prospective cohort, the Adult Changes in Thought (ACT) study. Methods We followed community-dwelling people aged >= 65 years without dementia at study entry for incident dementia and AD from 1994-2015. We linked study data with cancer registry data and categorized cancer diagnoses as prevalent (diagnosed before ACT study enrollment) or incident (diagnosed during follow-up). We used Cox regression to estimate causespecific hazard ratios (HRs) with 95% confidence intervals (CIs) for dementia or AD risk comparing people with a cancer diagnosis to people without cancer. We conducted sensitivity analyses restricted to people surviving beyond age 80, and stratified by cancer stage, type, and whether the cancer was smoking-related. Results Among 4,357 people, 756 (17.4%) had prevalent cancer; 583 (13.4%) developed incident cancer, 1,091 (25.0%) developed dementia, and 877 (20.1%) developed AD over a median 6.4 years (34,482 total person-years) of follow-up. Among complete cases (no missing covariates)with at least one follow-up assessment, adjusted HRs for dementia following prevalent and incident cancer diagnoses were 0.92 (95% CI: 0.76, 1.11) and 0.87 (95% CI: 0.64, 1.04), compared to no cancer history. HRs for AD were 0.95 (95% CI: 0.77, 1.17) for prevalent cancer and 0.73 (95% CI: 0.55, 0.96) for incident cancer. In sensitivity analyses, prevalent late-stage cancers were associated with reduced risks of dementia (HR = 0.51, 95% CI: 0.30, 0.89) and AD (HR = 0.50, 95% CI: 0.27, 0.94). When limited to people who survived beyond age 80, incident cancers were still associated with reduced AD risk (HR = 0.69, 95% CI: 0.51, 0.92). Conclusions Our results do not support an inverse association between prevalent cancer diagnoses, which were primarily early-stage, less aggressive cancers, and risk of dementia or AD. A reduced risk of AD following an incident cancer diagnosis is biologically plausible but may reflect selective mortality.	[Bowles, Erin J. Aiello; Walker, Rod L.; Anderson, Melissa L.; Dublin, Sascha; Larson, Eric B.] Kaiser Permanente Washington, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 20002 USA; [Dublin, Sascha] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Crane, Paul K.; Larson, Eric B.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA	Kaiser Permanente; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bowles, EJA (corresponding author), Kaiser Permanente Washington, Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 20002 USA.	bowles.e@ghc.org		Walker, Rod/0000-0002-8464-9805	National Institute on Aging at the National Institutes of Health [U01AG006781]; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging at the National Institutes of Health (grant U01AG006781 to ELB and PKC, multiple Pls). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Boudreau DM, 2014, BREAST CANCER RES TR, V144, P405, DOI 10.1007/s10549-014-2870-5; Crane PK, 2016, ALZHEIMERS DEMENT, V12, P419, DOI 10.1016/j.jalz.2015.10.007; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Demetrius LA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0006; Driver JA, 2015, BBA-GEN SUBJECTS, V1850, P2069, DOI 10.1016/j.bbagen.2014.12.025; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Freedman DM, 2016, CANC MED; Ganguli M, 2015, ALZ DIS ASSOC DIS, V29, P177, DOI 10.1097/WAD.0000000000000086; Geiger AM, 2008, CANCER-AM CANCER SOC, V112, P2617, DOI 10.1002/cncr.23447; Hornbrook MC, 2005, J NATL CANC I MONOGR, V35, P12, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI033; Ibanez K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004173; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lanni C, 2012, FREE RADICAL BIO MED, V52, P1727, DOI 10.1016/j.freeradbiomed.2012.02.034; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Migliore L, 2002, MUTAT RES-REV MUTAT, V512, P135, DOI 10.1016/S1383-5742(02)00046-7; Musicco M, 2013, NEUROLOGY, V81, P322, DOI 10.1212/WNL.0b013e31829c5ec1; Realmuto S, 2012, J ALZHEIMERS DIS, V31, P177, DOI 10.3233/JAD-2012-120184; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Roe CM, 2005, NEUROLOGY, V64, P895, DOI 10.1212/01.WNL.0000152889.94785.51; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Zhang QH, 2015, NEUROL SCI, V36, P1987, DOI 10.1007/s10072-015-2282-2	24	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179857	10.1371/journal.pone.0179857	http://dx.doi.org/10.1371/journal.pone.0179857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632787	gold, Green Submitted, Green Published			2022-12-26	WOS:000404046100052
J	Hametner, B; Parragh, S; Weber, T; Wassertheurer, S				Hametner, Bernhard; Parragh, Stephanie; Weber, Thomas; Wassertheurer, Siegfried			Wave intensity of aortic root pressure as diagnostic marker of left ventricular systolic dysfunction	PLOS ONE			English	Article							HEART-FAILURE; PULSE PRESSURE; REFLECTION QUANTIFICATION; GENERAL-POPULATION; EJECTION FRACTION; EUROPEAN-SOCIETY; ASSOCIATION; VELOCITY; PREVALENCE; GUIDELINES	Background Systolic left ventricular function strongly influences the blood pressure waveform. Therefore, pressure-derived parameters might potentially be used as non-invasive, diagnostic markers of left ventricular impairment. The aim of this study was to investigate the performance of pressure-based parameters in combination with electrocardiography (ECG) for the detection of left ventricular systolic dysfunction defined as severely reduced ejection fraction (EF). Methods and results Two populations, each comprising patients with reduced EF and pressure-matched controls, were included for the main analysis (51/102 patients) and model testing (44/88 patients). Central pressure was derived from radial readings and used to compute blood flow. Subsequently, pulse wave analysis and wave intensity analysis were performed and the ratio of the two peaks of forward intensity (SDR) was calculated as a novel index of ventricular function. SDR was significantly decreased in the reduced EF group (2.5 vs. 4.4, P<0.001), as was central pulse pressure, augmentation index and ejection duration (ED), while the QRS-duration was prolonged. SDR and ED were independent predictors of ventricular impairment and when combined with QRS in a simple decision tree, a reduced EF could be detected with a sensitivity of 92% and a specificity of 80%. The independent power of ED, SDR and QRS to predict reduced EF was furthermore confirmed in the test population. Conclusion The detection or indication of reduced ejection fraction from pressure-derived parameters seems feasible. These parameters could help to improve the quality of cardiovascular risk stratification or might be used in screening strategies in the general population.	[Hametner, Bernhard; Parragh, Stephanie; Wassertheurer, Siegfried] AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Biomed Syst, Vienna, Austria; [Parragh, Stephanie] Vienna Univ Technol, Inst Anal & Sci Comp, Vienna, Austria; [Weber, Thomas] Klinikum Wels Grieskirchen, Cardiol Dept, Wels, Austria	Austrian Institute of Technology (AIT); Technische Universitat Wien	Hametner, B (corresponding author), AIT Austrian Inst Technol GmbH, Ctr Hlth & Bioresources, Biomed Syst, Vienna, Austria.	bernhard.hametner@ait.ac.at; thomas.weber3@liwest.at		Hametner, Bernhard/0000-0003-2048-1019	Talente; Austrian Ministry for Transport, Innovation and Technology BMVIT (FEMCOR Project) [849808]	Talente; Austrian Ministry for Transport, Innovation and Technology BMVIT (FEMCOR Project)	This work was supported by the program "Talente" by the Austrian Ministry for Transport, Innovation and Technology BMVIT (FEMCOR Project, FFG No. 849808). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cincin A, 2012, EXP CLIN CARDIOL, V17, P210; Curtis SL, 2007, AM J PHYSIOL-HEART C, V293, pH557, DOI 10.1152/ajpheart.01095.2006; Denardo SJ, 2010, CIRC-HEART FAIL, V3, P149, DOI 10.1161/CIRCHEARTFAILURE.109.862383; Fischer M, 2003, Z KARDIOL, V92, P294, DOI 10.1007/s00392-003-0899-2; Fok H, 2014, HYPERTENSION, V63, P1050, DOI 10.1161/HYPERTENSIONAHA.113.02955; Gu HT, 2017, HYPERTENSION, V69, P633, DOI 10.1161/HYPERTENSIONAHA.116.08545; Haiden A, 2014, AM J HYPERTENS, V27, P702, DOI 10.1093/ajh/hpt185; Hametner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141656; Hametner B, 2013, COMPUT METH PROG BIO, V109, P250, DOI 10.1016/j.cmpb.2012.10.005; Hobbs FDR, 2000, EUR HEART J, V21, P1877, DOI 10.1053/euhj.2000.2170; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Khan NK, 2007, EUR J HEART FAIL, V9, P491, DOI 10.1016/j.ejheart.2006.11.003; Khir AW, 2001, J BIOMECH, V34, P1145, DOI 10.1016/S0021-9290(01)00076-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laskey WK, 2016, JACC-HEART FAIL, V4, P42, DOI 10.1016/j.jchf.2015.09.012; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murkofsky RL, 1998, J AM COLL CARDIOL, V32, P476, DOI 10.1016/S0735-1097(98)00242-3; Ntsinjana HN, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00065; PARKER KH, 1990, J BIOMECH ENG-T ASME, V112, P322, DOI 10.1115/1.2891191; Parragh S, 2015, INT J CARDIOL, V190, P308, DOI 10.1016/j.ijcard.2015.04.183; Parragh S, 2015, PHYSIOL MEAS, V36, P179, DOI 10.1088/0967-3334/36/2/179; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Regnault V, 2014, HYPERTENSION, V63, P105, DOI 10.1161/HYPERTENSIONAHA.113.02046; Sharman JE, 2009, HYPERTENSION, V54, P1099, DOI 10.1161/HYPERTENSIONAHA.109.133066; Sugawara M, 2009, MED BIOL ENG COMPUT, V47, P197, DOI 10.1007/s11517-008-0388-x; Tartiere JM, 2006, J HUM HYPERTENS, V20, P213, DOI 10.1038/sj.jhh.1001965; Weber T, 2007, J CARD FAIL, V13, P353, DOI 10.1016/j.cardfail.2007.02.008; Weber T, 2015, J HYPERTENS, V33, P1023, DOI 10.1097/HJH.0000000000000518; Weber T, 2013, J AM COLL CARDIOL, V61, P1874, DOI 10.1016/j.jacc.2013.02.013; Weber T, 2011, HYPERTENSION, V58, P825, DOI 10.1161/HYPERTENSIONAHA.111.176313; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002; Wilkinson IB, 2002, AM J HYPERTENS, V15, P24, DOI 10.1016/S0895-7061(01)02252-X; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	36	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179938	10.1371/journal.pone.0179938	http://dx.doi.org/10.1371/journal.pone.0179938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628659	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100051
J	Heraclides, A; Bashiardes, E; Fernandez-Dominguez, E; Bertoncini, S; Chimonas, M; Christofi, V; King, J; Budowle, B; Manoli, P; Cariolou, MA				Heraclides, Alexandros; Bashiardes, Evy; Fernandez-Dominguez, Eva; Bertoncini, Stefania; Chimonas, Marios; Christofi, Vasilis; King, Jonathan; Budowle, Bruce; Manoli, Panayiotis; Cariolou, Marios A.			Y-chromosomal analysis of Greek Cypriots reveals a primarily common pre-Ottoman paternal ancestry with Turkish Cypriots	PLOS ONE			English	Article							EARLY FARMERS; POPULATION; DIVERSITY; MIGRATIONS; LINEAGES; EUROPE; ORIGIN; DNA	Genetics can provide invaluable information on the ancestry of the current inhabitants of Cyprus. A Y-chromosome analysis was performed to (i) determine paternal ancestry among the Greek Cypriot (GCy) community in the context of the Central and Eastern Mediterranean and the Near East; and (ii) identify genetic similarities and differences between Greek Cypriots (GCy) and Turkish Cypriots (TCy). Our haplotype-based analysis has revealed that GCy and TCy patrilineages derive primarily from a single gene pool and show very close genetic affinity (low genetic differentiation) to Calabrian Italian and Lebanese patrilineages. In terms of more recent (past millennium) ancestry, as indicated by Y-haplotype sharing, GCy and TCy share much more haplotypes between them than with any surrounding population (7-8% of total haplotypes shared), while TCy also share around 3% of haplotypes with mainland Turks, and to a lesser extent with North Africans. In terms of Y-haplogroup frequencies, again GCy and TCy show very similar distributions, with the predominant haplogroups in both being J2a-M410, E-M78, and G2-P287. Overall, GCy also have a similar Yhaplogroup distribution to non-Turkic Anatolian and Southwest Caucasian populations, as well as Cretan Greeks. TCy show a slight shift towards Turkish populations, due to the presence of Eastern Eurasian (some of which of possible Ottoman origin) Y-haplogroups. Overall, the Y-chromosome analysis performed, using both Y-STR haplotype and binary Y-haplogroup data puts Cypriot in the middle of a genetic continuum stretching from the Levant to Southeast Europe and reveals that despite some differences in haplotype sharing and haplogroup structure, Greek Cypriots and Turkish Cypriots share primarily a common pre-Ottoman paternal ancestry.	[Heraclides, Alexandros; Bashiardes, Evy; Chimonas, Marios; Christofi, Vasilis; Manoli, Panayiotis; Cariolou, Marios A.] Cyprus Inst Neurol & Genet, Dept Cardiovasc Genet, Nicosia, Cyprus; [Heraclides, Alexandros; Bashiardes, Evy; Chimonas, Marios; Christofi, Vasilis; Manoli, Panayiotis; Cariolou, Marios A.] Cyprus Inst Neurol & Genet, Lab Forens Genet, Nicosia, Cyprus; [Heraclides, Alexandros] Univ Nicosia, Dept Primary Care & Populat Hlth, Med Sch, Nicosia, Cyprus; [Bashiardes, Evy; Cariolou, Marios A.] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus; [Fernandez-Dominguez, Eva] Univ Durham, Dept Archaeol, Durham, England; [Bertoncini, Stefania] Univ Pisa, Dept Biol, Pisa, Italy; [King, Jonathan; Budowle, Bruce] Univ North Texas, Ctr Human Identificat, Hlth Sci Ctr, Ft Worth, TX USA; [Budowle, Bruce] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah, Saudi Arabia	University of Nicosia; Durham University; University of Pisa; University of North Texas System; University of North Texas Denton; King Abdulaziz University	Cariolou, MA (corresponding author), Cyprus Inst Neurol & Genet, Dept Cardiovasc Genet, Nicosia, Cyprus.; Cariolou, MA (corresponding author), Cyprus Inst Neurol & Genet, Lab Forens Genet, Nicosia, Cyprus.; Cariolou, MA (corresponding author), Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus.	cariolou@cing.ac.cy	Fernandez-Dominguez, Eva/ABF-9039-2021; Heraclides, Alexandros/AFN-4638-2022	Budowle, Bruce/0000-0003-4116-2930; King, Jonathan/0000-0003-4541-1789; Heraclides, Alexandros/0000-0002-1304-3275; Fernandez-Dominguez, Eva/0000-0002-9447-907X	Cyprus Institute of Neurology Genetics	Cyprus Institute of Neurology Genetics	The study was supported by internal funds provided to the Department of Cardiovascular Genetics and the Laboratory of Forensic Genetics by its parent organization, The Cyprus Institute of Neurology & Genetics.	Ahmet D, 2004, ORIGINS TURKISH CYPR; Alakoc YD, 2010, FORENSIC SCI INT-GEN, V4, pE135, DOI 10.1016/j.fsigen.2010.01.016; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Arbel B, 2000, CYPRUS FRANKS VENICE; Athey TW., 2006, J GENET GENEAL, V2, P34; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; BAYSAL E, 1992, BRIT J HAEMATOL, V81, P607, DOI 10.1111/j.1365-2141.1992.tb03000.x; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Bintliff J, 2003, ETHNOARCHAEOLOGY PAS; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Brisighelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050794; Bryer A. A. M., 1988, PEOPLES SETTLEMENT A; Burgarella C, 2011, EUR J HUM GENET, V19, P70, DOI 10.1038/ejhg.2010.154; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Cohen R, 2008, GLOB DIASPORA, P1; Contu D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001430; Cowper B, 1861, SYRIAC MISCELLANIES; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cullen J, 2008, WORLD HAPLOGROUP HAP; Daniel JF, 1940, EXPEDITION MAGAZINE, V8; Demetriou A, 2001, PHOENICIANS CYPRUS T, VIV; Di Gaetano C, 2009, EUR J HUM GENET, V17, P91, DOI 10.1038/ejhg.2008.120; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Erdem Y.H., 1996, SLAVERY OTTOMAN EMPI; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; George H, 1952, HIST CYPRUS OTTOMAN; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Gurkan C, 2017, ANN HUM BIOL, V44, P164, DOI 10.1080/03014460.2016.1207805; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; HADJILYRA Alexander-Michael, 2009, ARMENIANS CYPRUS; Herrera KJ, 2012, EUR J HUM GENET, V20, P313, DOI 10.1038/ejhg.2011.192; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hollard C, 2014, FORENSIC SCI INT-GEN, V12, P199, DOI 10.1016/j.fsigen.2014.05.012; Iacovou M, 2008, CYPRUS MIGRATION HEL; Jennings R., 1992, CHRISTIANS MUSLIMS O; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Kharkov VN, 2007, RUSS J GENET+, V43, P551, DOI 10.1134/S1022795407050110; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Koukoudis Asterios I., 2003, STUDIES VLACHS, V2; Lazaridis I, 2016, NATURE; Lazaridis I, 2016, GENETIC STRUC TURE W; Mallinson W, 1992, JENNINGS RONALD CHRI, P1571; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Mathieson I., 2017, BIORXIV; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Michell RLN, 1908, 19 CENTURY J, P751; Nesim, 2013, EUROPEAN J TURKISH S, V16; Olalde I., 2017, BIORXIV; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Papadopoulos T, 1980, PROXENIKA EGGRAPHA T; Petrejcikova E, 2014, ANTHROPOL ANZ, V71, P275, DOI 10.1127/0003-5548/2014/0368; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Ramos-Luis E, 2014, FORENSIC SCI INT-GEN, V9, P162, DOI 10.1016/j.fsigen.2013.12.008; Robino C, 2004, FORENSIC SCI INT, V145, P61, DOI 10.1016/j.forsciint.2004.02.026; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Sarno S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096074; Smith R. Payne, 1860, 3 PART ECCLESIASTICA; Tofanelli S, 2016, EUR J HUM GENET, V24, P429, DOI 10.1038/ejhg.2015.124; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Voskarides K, 2016, INVESTIG GENET, V7, DOI 10.1186/s13323-016-0032-8; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020	69	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179474	10.1371/journal.pone.0179474	http://dx.doi.org/10.1371/journal.pone.0179474			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622394	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000403506300036
J	Park, JJ; Dempewolf, E; Zhang, WZ; Wang, ZY				Park, Jong-Jin; Dempewolf, Emma; Zhang, Wenzheng; Wang, Zeng-Yu			RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis	PLOS ONE			English	Article							GENOME; SYSTEM; COMPLEX; ENDONUCLEASE; IMMUNITY; LEAF	Clustered regularly interspaced short palindromic repeats (CRISPR) and the CRISPR associated protein 9 (Cas9) system allows effective gene modification through RNA-guided DNA targeting. The Cas9 has undergone a series of functional alterations from the original active endonuclease to partially or completely deactivated Cas9. The catalytically deactivated Cas9 (dCas9) offers a platform to regulate transcriptional expression with the addition of activator or repressor domains. We redesigned a CRISPR/Cas9 activation system by adding the p65 transactivating subunit of NF-kappa B and a heat-shock factor 1 (HSF) activation domain to dCas9 bound with the VP64 (tetramer of VP16) activation domain for application in plants. The redesigned CRISPR/Cas9 activation system was tested in Arabidopsis to increase endogenous transcriptional levels of production of anthocyanin pigment 1 (PAP1) and Arabidopsis thaliana vacuolar H+-pyrophosphatase (AVP1). The expression of PAP1 was increased two- to three-fold and the activated plants exhibited purple leaves similar to that of PAP1 overexpressors. The AVP1 gene expression was increased two- to five-fold in transgenic plants. In comparison to the wild type, AVP1 activated plants had increased leaf numbers, larger single-leaf areas and improved tolerance to drought stress. The AVP1 activated plants showed similar phenotypes to AVP1 overexpressors. Therefore, the redesigned CRISPR/Cas9 activation system containing modified p65-HSF provides a simple approach for producing activated plants by upregulating endogenous transcriptional levels.	[Park, Jong-Jin; Dempewolf, Emma; Zhang, Wenzheng; Wang, Zeng-Yu] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA; [Park, Jong-Jin; Wang, Zeng-Yu] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37830 USA	Noble Research Institute; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Wang, ZY (corresponding author), Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA.	zywang@noble.org		Park, Jongjin/0000-0001-6262-8889	BioEnergy Science Center; Samuel Roberts Noble Foundation	BioEnergy Science Center; Samuel Roberts Noble Foundation	This work was supported by BioEnergy Science Center and The Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Demirci Y., 2017, J CELL PHYSL; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Piatek A, 2015, PLANT BIOTECHNOL J, V13, P578, DOI 10.1111/pbi.12284; Rowan DD, 2009, NEW PHYTOL, V182, P102, DOI 10.1111/j.1469-8137.2008.02737.x; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	23	30	30	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179410	10.1371/journal.pone.0179410	http://dx.doi.org/10.1371/journal.pone.0179410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622347	Green Submitted, Green Published, gold			2022-12-26	WOS:000403506300029
J	Secor, PR; Sass, G; Nazik, H; Stevens, DA				Secor, Patrick R.; Sass, Gabriele; Nazik, Hasan; Stevens, David A.			Effect of acute predation with bacteriophage on intermicrobial aggression by Pseudomonas aeruginosa	PLOS ONE			English	Article							NS FAMILY-MEMBERS; ASPERGILLUS-FUMIGATUS; ANTIMICROBIAL SUSCEPTIBILITY; PREVALENCE; REGULATORS; EVOLUTION; VIRULENCE; BIOFILMS	In persons with structural lung disease, particularly those with cystic fibrosis (CF), chronic airway infections cause progressive loss of lung function. CF airways can be colonized by a variety of microorganisms; the most frequently encountered bacterial and fungal pathogens are Pseudomonas aeruginosa and Aspergillus fumigatus, respectively. Co-infection with P. aeruginosa and A. fumigatus often results in a more rapid loss of lung function, indicating that interactions between these pathogens affect infection pathogenesis. There has been renewed interest in the use of viruses (bacteriophage, mycoviruses) as alternatives to antibiotics to treat these infections. In previous work, we found that filamentous Pf bacteriophage produced by P. aeruginosa directly inhibited the metabolic activity of A. fumigatus by binding to and sequestering iron. In the current study, we further examined how filamentous Pf bacteriophage affected interactions between P. aeruginosa and A. fumigatus. Here, we report that the antifungal properties of supernatants collected from P. aeruginosa cultures infected with Pf bacteriophage were substantially less inhibitory towards A. fumigatus biofilms. In particular, we found that acute infection of P. aeruginosa by Pf bacteriophage inhibited the production of the virulence factor pyoverdine. Our results raise the possibility that the reduced production of antimicrobials by P. aeruginosa infected by Pf bacteriophage may promote conditions in CF airways that allow co-infection with A. fumigatus to occur, exacerbating disease severity. Our results also highlight the importance of considering how the use of bacteriophage as therapeutic agents could affect the behavior and composition of polymicrobial communities colonizing sites of chronic infection.	[Secor, Patrick R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Sass, Gabriele; Nazik, Hasan; Stevens, David A.] Calif Inst Med Res, San Jose, CA 95128 USA; [Nazik, Hasan; Stevens, David A.] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Nazik, Hasan] Istanbul Univ, Dept Med Microbiol, Fac Med, Istanbul, Turkey; [Secor, Patrick R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Washington; University of Washington Seattle; Stanford University; Istanbul University; University of Montana System; University of Montana	Secor, PR (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Secor, PR (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	psecor@uw.edu			Cystic Fibrosis Foundation [SECOR15F0]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	DAS was funded in part by a gift from Mr. John Flatley to the California Institute for Medical Research. PRS was supported by a Postdoctoral Fellowship (SECOR15F0) from the Cystic Fibrosis Foundation (https://www.cff.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakare N, 2003, MYCOSES, V46, P19, DOI 10.1046/j.1439-0507.2003.00830.x; Beauvais A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MB-0017-2015; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Castang S, 2012, J BACTERIOL, V194, P5101, DOI 10.1128/JB.00932-12; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Clemons KV, 2009, MED MYCOL, V47, pS132, DOI 10.1080/13693780802213340; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DENNING DW, 1991, ANTIMICROB AGENTS CH, V35, P1329, DOI 10.1128/AAC.35.7.1329; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Ferreira JAG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134692; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Hosseinidoust Z, 2013, APPL ENVIRON MICROB, V79, P6110, DOI 10.1128/AEM.01421-13; Imperi F, 2009, P NATL ACAD SCI USA, V106, P20440, DOI 10.1073/pnas.0908760106; Knezevic P, 2015, VIROLOGY, V483, P64, DOI 10.1016/j.virol.2015.04.008; Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53; Manos J, 2008, J MED MICROBIOL, V57, P1454, DOI 10.1099/jmm.0.2008/005009-0; McElroy KE, 2014, P NATL ACAD SCI USA, V111, pE1419, DOI 10.1073/pnas.1314340111; Mcvay CS, 2007, ANTIMICROB AGENTS CH, V51, P1934, DOI 10.1128/AAC.01028-06; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Morio F, 2012, J ANTIMICROB CHEMOTH, V67, P1870, DOI 10.1093/jac/dks160; Moss BJ, 2008, BIOTECHNOL PROGR, V24, P780, DOI 10.1021/bp070334t; Nazik H, 2016, 7 ADV ASP C MANCH UK; Nazik H, 2015, ANTIMICROB AGENTS CH, V59, P6514, DOI 10.1128/AAC.01684-15; OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Penner JC, 2016, MICROBIOL-SGM, V162, P1583, DOI 10.1099/mic.0.000344; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; RUSSEL M, 1989, J VIROL, V63, P3284, DOI 10.1128/JVI.63.8.3284-3295.1989; Secor PR, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00648-16; Secor PR, 2015, CELL HOST MICROBE, V18, P549, DOI 10.1016/j.chom.2015.10.013; Shirazi F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150155; Smith K, 2015, MED MYCOL, V53, P645, DOI 10.1093/mmy/myv048; Stintzi A, 1998, FEMS MICROBIOL LETT, V166, P341, DOI 10.1111/j.1574-6968.1998.tb13910.x; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Valenza G, 2008, J CYST FIBROS, V7, P123, DOI 10.1016/j.jcf.2007.06.006; van de Sande WWJ, 2010, EUR J CLIN MICROBIOL, V29, P755, DOI 10.1007/s10096-010-0946-7; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09	42	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179659	10.1371/journal.pone.0179659	http://dx.doi.org/10.1371/journal.pone.0179659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622385	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300048
J	Spigler, G; Wilson, SP				Spigler, Giacomo; Wilson, Stuart P.			Familiarization: A theory of repetition suppression predicts interference between overlapping cortical representations	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; HORIZONTAL CONNECTIONS; NEURONAL ADAPTATION; RECOGNITION MEMORY; NEURAL MECHANISMS; BRAIN; FMRI; MAPS; GRANDMOTHER; INHIBITION	Repetition suppression refers to a reduction in the cortical response to a novel stimulus that results from repeated presentation of the stimulus. We demonstrate repetition suppression in a well established computational model of cortical plasticity, according to which the relative strengths of lateral inhibitory interactions are modified by Hebbian learning. We present the model as an extension to the traditional account of repetition suppression offered by sharpening theory, which emphasises the contribution of afferent plasticity, by instead attributing the effect primarily to plasticity of intra-cortical circuitry. In support, repetition suppression is shown to emerge in simulations with plasticity enabled only in intra-cortical connections. We show in simulation how an extended 'inhibitory sharpening theory' can explain the disruption of repetition suppression reported in studies that include an intermediate phase of exposure to additional novel stimuli composed of features similar to those of the original stimulus. The model suggests a re-interpretation of repetition suppression as a manifestation of the process by which an initially distributed representation of a novel object becomes a more localist representation. Thus, inhibitory sharpening may constitute a more general process by which representation emerges from cortical re-organisation.	[Spigler, Giacomo; Wilson, Stuart P.] Univ Sheffield, Sheffield Robot, Sheffield, S Yorkshire, England; [Spigler, Giacomo; Wilson, Stuart P.] Univ Sheffield, Dept Psychol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Spigler, G (corresponding author), Univ Sheffield, Sheffield Robot, Sheffield, S Yorkshire, England.; Spigler, G (corresponding author), Univ Sheffield, Dept Psychol, Sheffield, S Yorkshire, England.	g.spigler@sheffield.ac.uk		Wilson, Stuart/0000-0001-8125-5133; Spigler, Giacomo/0000-0002-8274-2117	European Commission; Horizon 2020 Research and Innovation Programme; Human Brain Project [SGA1]; HBP SGA1 [720270]	European Commission(European CommissionEuropean Commission Joint Research Centre); Horizon 2020 Research and Innovation Programme; Human Brain Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HBP SGA1	This work was supported by the European Commission, Horizon 2020 Research and Innovation Programme, Human Brain Project SGA1, programme 720270 (HBP SGA1).	Auksztulewicz R, 2016, CORTEX, V80, P125, DOI 10.1016/j.cortex.2015.11.024; Bednar JA, 2000, NEURAL COMPUT, V12, P1721, DOI 10.1162/089976600300015321; Bednar JA, 2015, CORTICAL MAPS NEUROS, V1073858415597645; Bednar JA, 2012, J PHYSIOL-PARIS, V106, P194, DOI 10.1016/j.jphysparis.2011.12.001; Bednar James A, 2009, Front Neuroinform, V3, P8, DOI 10.3389/neuro.11.008.2009; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Carreira-Perpinan MA, 2004, J NEUROPHYSIOL, V92, P2947, DOI 10.1152/jn.00281.2004; Cohen MA, 2014, P NATL ACAD SCI USA, V111, P8955, DOI 10.1073/pnas.1317860111; Connor CE, 2005, NATURE, V435, P1036, DOI 10.1038/4351036a; DAYAN P, 1993, NEURAL COMPUT, V5, P392, DOI 10.1162/neco.1993.5.3.392; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Epstein RA, 2008, J NEUROPHYSIOL, V99, P2877, DOI 10.1152/jn.90376.2008; Ethier C, 2006, J NEUROSCI, V26, P5574, DOI 10.1523/JNEUROSCI.5332-05.2006; Fischer T, 2014, THESIS; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Gotts SJ, 2012, COGN NEUROSCI-UK, V3, P227, DOI 10.1080/17588928.2012.670617; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grotheer M, 2016, CORTEX, V80, P113, DOI 10.1016/j.cortex.2015.11.027; Helmstaedter M, 2009, CEREB CORTEX, V19, P951, DOI 10.1093/cercor/bhn130; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RN, 2015, CORTEX; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Henson RNA, 2002, CEREB CORTEX, V12, P178, DOI 10.1093/cercor/12.2.178; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; James TW, 2006, HUM BRAIN MAPP, V27, P37, DOI 10.1002/hbm.20165; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Keysers C, 2002, TRENDS COGN SCI, V6, P120, DOI 10.1016/S1364-6613(00)01852-0; Kriegeskorte N., 2009, FRONTIERS NEUROSCIEN, V3, P35; Kriegeskorte N, 2013, TRENDS COGN SCI, V17, P401, DOI 10.1016/j.tics.2013.06.007; Larsson J, 2012, CEREB CORTEX, V22, P567, DOI 10.1093/cercor/bhr119; Law JS, 2009, MODELING DEV ORG ORI; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Miikkulainen R, 2006, OMPUTATIONAL MAPS VI; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Muller NG, 2012, CEREB CORTEX; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Quiroga RQ, 2008, TRENDS COGN SCI, V12, P87, DOI 10.1016/j.tics.2007.12.003; Quiroga RQ, 2013, SCI AM, V308, P30, DOI 10.1038/scientificamerican0213-30; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ren M, 2007, SCIENCE, V316, P758, DOI 10.1126/science.1135468; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Spigler G, 2014, THESIS; Stevens JLR, 2013, J NEUROSCI, V33, P15747, DOI 10.1523/JNEUROSCI.1037-13.2013; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; von der Malsburg C, 1973, Kybernetik, V14, P85; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wilson SP, 2015, DEV NEUROBIOL, V75, P667, DOI 10.1002/dneu.22281; Wilson SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008778; Wimber M, 2015, NAT NEUROSCI, V18, P582, DOI 10.1038/nn.3973	60	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179306	10.1371/journal.pone.0179306	http://dx.doi.org/10.1371/journal.pone.0179306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604787	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000403088400046
J	Mukherjee, S; Dash, S; Lohitesh, K; Chowdhury, R				Mukherjee, Sudeshna; Dash, Subhra; Lohitesh, K.; Chowdhury, Rajdeep			The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells	PLOS ONE			English	Article							IN-VITRO; MULTIDRUG-RESISTANCE; INDUCED APOPTOSIS; CANCER; CHEMOTHERAPY; ACTIVATION; PATHWAYS; DEATH; LINES; JNK	Osteosarcoma (OS) is an aggressive bone malignancy commonly observed in children and adolescents. Sub-optimal therapy for years has irretrievably compromised the chances of OS patient survival; also, lack of extensive research on this rare disease has hindered therapeutic development. Cisplatin, a common anti-tumor drug, is currently an integral part of treatment regime for OS along with methotrexate and doxorubicin. However, toxicity issues associated with combination module impede OS therapy. Also, despite the proven benefits of cisplatin, acquisition of resistance remains a concern with cisplatin-based therapy. This prompted us to investigate the molecular effects of cisplatin exposure and changes associated with acquired resistance in OS cells. Cisplatin shock was found to activate MAPK signaling and autophagy in OS cells. An activation of JNK and autophagy acted as pro-survival strategy, while ERK1/2 triggered apoptotic signals upon cisplatin stress. A crosstalk between JNK and autophagy was observed. Maximal sensitivity to cisplatin was obtained with simultaneous inhibition of both autophagy and JNK pathway. Cisplatin resistant cells were further developed by repetitive drug exposure followed by clonal selection. The resistant cells showed an altered signaling circuitry upon cisplatin exposure. Our results provide valuable cues to possible molecular alterations that can be considered for development of improved therapeutic strategy against osteosarcoma.	[Mukherjee, Sudeshna; Dash, Subhra; Lohitesh, K.; Chowdhury, Rajdeep] Birla Inst Technol & Sci BITS, Dept Biol Sci, Pilani, Rajasthan, India	Birla Institute of Technology & Science Pilani (BITS Pilani)	Chowdhury, R (corresponding author), Birla Inst Technol & Sci BITS, Dept Biol Sci, Pilani, Rajasthan, India.	rajdeep.chowdhury@pilani.bits-pilani.ac.in			SERB, Science and Engineering Research Board [SB/FT/LS-233/2012]; DST-SERB [SB/FT/LS-233/2012]	SERB, Science and Engineering Research Board; DST-SERB	This work was supported by SERB, Science and Engineering Research Board, SB/FT/LS-233/2012 dated 02 May, 2013 for Dr Rajdeep Chowdhury. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank DST-SERB (SB/FT/LS-233/2012) for providing funding support for conducting the experiments. We acknowledge BITS-Pilani, Pilani Campus for providing us infrastructural support.	[Anonymous], ONCOTARGET; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Bacci G, 2001, CLIN ORTHOP RELAT R, P186; Bacci G, 2008, J SURG ONCOL, V98, P415, DOI 10.1002/jso.21140; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Bielack SS, 2008, CURR TREAT OPTION ON, V9, P67, DOI 10.1007/s11864-008-0057-1; Blay JY, 2007, ONKOLOGIE, V30, P226, DOI 10.1159/000101702; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Chowdhury R, 2012, CHEM RES TOXICOL, V25, P2194, DOI 10.1021/tx300274a; Chowdhury R, 2009, APOPTOSIS, V14, P108, DOI 10.1007/s10495-008-0284-8; Denton D, 2012, CELL DEATH DIFFER, V19, P87, DOI 10.1038/cdd.2011.146; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ferrari S, 2007, CURR OPIN ONCOL, V19, P341, DOI 10.1097/CCO.0b013e328122d73f; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; Hughes DPM, 2009, EXPERT OPIN DRUG DEL, V6, P1311, DOI 10.1517/17425240903280422; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Lou ZY, 2013, J INT MED RES, V41, P1505, DOI 10.1177/0300060513490618; Martelli L, 2007, BIOCHEM PHARMACOL, V74, P20, DOI 10.1016/j.bcp.2007.03.025; Martin G. Steven, 2003, Cancer Cell, V4, P167, DOI 10.1016/S1535-6108(03)00216-2; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; Mohseny AB, 2011, LAB INVEST, V91, P1195, DOI 10.1038/labinvest.2011.72; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; O'Farrill JS, 2014, ADV EXP MED BIOL, V804, P147, DOI 10.1007/978-3-319-04843-7_8; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Riganti C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00105; Romney N, 2015, ADV BIOL CHEM, V5, P286; Schuldes H, 1997, CANCER, V79, P1723; Sridharan S, CANCERS BASEL, V3, P2630; Sridharan Savitha, 2011, Cancers (Basel), V3, P2630, DOI 10.3390/cancers3022630; Sui XB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04694; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yan XD, 2007, ONCOL REP, V17, P1163; Yang X, 2014, BRIT J CANCER, V110, P2896, DOI 10.1038/bjc.2014.254; Zhang ZC, 2015, ONCOL LETT, V10, P2941, DOI 10.3892/ol.2015.3692; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	46	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179203	10.1371/journal.pone.0179203	http://dx.doi.org/10.1371/journal.pone.0179203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598976	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000029
J	Liu, L; He, J; Wei, X; Wan, G; Lao, Y; Xu, W; Li, Z; Hu, H; Hu, Z; Luo, X; Wu, J; Xie, W; Zhang, Y; Xu, N				Liu, L.; He, J.; Wei, X.; Wan, G.; Lao, Y.; Xu, W.; Li, Z.; Hu, H.; Hu, Z.; Luo, X.; Wu, J.; Xie, W.; Zhang, Y.; Xu, N.			MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability	ONCOGENE			English	Article							SET ENRICHMENT ANALYSIS; EXPRESSION PROFILES; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; CANCER; MICRORNAS; GENE; BECLIN-1; CLUSTER; DISEASE	Gene expression analysis of The Cancer Genome Atlas (TCGA) breast cancer data set show that miR-20a is upregulated in human breast cancer, especially in triple-negative subtype. Gene Set Enrichment Analysis suggests that miR-20a expression negatively correlates with the autophagy/ lysosome pathway. We report here that miR-20a inhibits the basal and nutrient starvation-induced autophagic flux and lysosomal proteolytic activity, increases intracellular reactive oxygen species levels and DNA damage response by targeting several key regulators of autophagy, including BECN1, ATG16L1 and SQSTM1. Re-introduction of exogenous BECN1, ATG16L1 or SQSTM1 reverses the inhibitory effect of miR-20a on autophagy and decreases DNA damage. A negative correlation between miR-20a and its target genes is observed in breast cancer tissues. Lower levels of BECN1, ATG16L1 and SQSTM1 are more common in triple-negative cancers than in other subtypes. High levels of miR-20a also associate with higher frequency of copynumber alterations and DNA mutations in breast cancer patients. Further studies in a xenograft mouse model show that miR-20a promotes tumor initiation and tumor growth. Collectively, these findings suggest that miR-20a-mediated autophagy defect might be a new mechanism underlying the oncogenic function of miRNA during breast tumorigenesis.	[Liu, L.; Wan, G.; Xu, W.; Wu, J.] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Liu, L.; He, J.; Wei, X.; Wan, G.; Xu, W.; Luo, X.; Wu, J.; Xie, W.; Zhang, Y.; Xu, N.] Tsinghua Univ, Div Life Sci, Key Lab Hlth Sci & Technol, Grad Sch Shenzhen, Shenzhen, Peoples R China; [Lao, Y.] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Li, Z.] Peking Univ, Grad Sch Shenzhen, Sch Chem Biol & Biotechnol, Shenzhen, Peoples R China; [Hu, H.] Peking Univ, Dept Breast Surg, Shenzhen Hosp, Shenzhen, Peoples R China; [Hu, Z.] Wuhan 1 Hosp, Dept Clin Oncol, Wuhan, Hubei, Peoples R China; [Xie, W.; Zhang, Y.; Xu, N.] Tsinghua Univ, Open FIESTA Ctr, Shenzhen, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Shanghai University of Traditional Chinese Medicine; Peking University; Peking University; Tsinghua University	Zhang, Y; Xu, N (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Hlth Sci & Technol, Bldg L,Tsinghua Campus, Shenzhen 518055, Peoples R China.	zhangyo@sz.tsinghua.edu.cn; xu.naihan@sz.tsinghua.edu.cn	Wu, Jiangbin/GWC-7165-2022; Xu, Naihan/C-2778-2018; , Yuanzhi/D-3936-2015	Wu, Jiangbin/0000-0003-3109-417X; Zhang, Yaou/0000-0002-2501-8093; He, Jie/0000-0002-5880-8112; , Yuanzhi/0000-0002-7803-4484	National Natural Science Foundation of China [31571418, 31371315]; Shenzhen Science and Technology Innovation Committee [JCYJ20160226185623304, JCYJ20140417115840281]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Innovation Committee	We thank the National Natural Science Foundation of China (No. 31571418 and 31371315) and the Shenzhen Science and Technology Innovation Committee (JCYJ20160226185623304, JCYJ20140417115840281) for financial support.	Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cai ZQ, 2015, J BIOL CHEM, V290, P19967, DOI 10.1074/jbc.M115.661504; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Conkrite K, 2011, GENE DEV, V25, P1734, DOI 10.1101/gad.17027411; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Ko A, 2014, CELL DEATH DIFFER, V21, P92, DOI 10.1038/cdd.2013.124; Kongara S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00171; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lao YZ, 2014, AUTOPHAGY, V10, P736, DOI 10.4161/auto.28034; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu EY, 2015, P NATL ACAD SCI USA, V112, P773, DOI 10.1073/pnas.1409563112; Liu EY, 2012, J CELL SCI, V125, P2349, DOI 10.1242/jcs.093708; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shi J, 2007, CURR BIOINFORM, V2, P133, DOI 10.2174/157489307780618231; Singh R, 2013, CANCER BIOL THER, V14, P201, DOI 10.4161/cbt.23296; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tang H, 2015, EBIOMEDICINE, V2, P255, DOI 10.1016/j.ebiom.2015.01.008; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Wu WKK, 2012, ONCOGENE, V31, P939, DOI 10.1038/onc.2011.295; Xu W, 2015, BIOCHEM BIOPH RES CO, V457, P300, DOI 10.1016/j.bbrc.2014.12.104; Yan HJ, 2010, HUM GENE THER, V21, P1723, DOI 10.1089/hum.2010.061; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	54	43	46	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5874	5884		10.1038/onc.2017.193	http://dx.doi.org/10.1038/onc.2017.193			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28628113	Green Published, hybrid			2022-12-26	WOS:000413292900009
J	Jang, H; Banerjee, A; Chavan, T; Gaponenko, V; Nussinov, R				Jang, Hyunbum; Banerjee, Avik; Chavan, Tanmay; Gaponenko, Vadim; Nussinov, Ruth			Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); fluorescence; GTPase Kras (KRAS); molecular dynamics; nuclear magnetic resonance (NMR); post-translational modification (PTM); KRAS-driven adenocarcinoma; PI3K; hypervariable region; prenylation	FREE-ENERGY CALCULATIONS; SMALL GTPASE K-RAS4B; MOLECULAR-DYNAMICS; RAS ISOFORMS; K-RAS; ONCOGENIC MUTATIONS; STRUCTURAL BASIS; CALCIUM SENSOR; H-RAS; BINDING	In calmodulin (CaM)-rich environments, oncogenic KRAS plays a critical role in adenocarcinomas by promoting PI3K/Akt signaling. We previously proposed that at elevated calcium levels in cancer, CaM recruits PI3K to the membrane and extracts K-Ras4B from the membrane, organizing a K-Ras4B-CaM-PI3K ternary complex. CaM can thereby replace a missing receptor-tyrosine kinase signal to fully activate PI3K. Recent experimental data show that CaM selectively promotes K-Ras signaling but not of N-Ras or H-Ras. How CaM specifically targets K-Ras and how it extracts it from the membrane in KRAS-driven cancer is unclear. Obtaining detailed structural information for a CaM-K-Ras complex is still challenging. Here, using molecular dynamics simulations and fluorescence experiments, we observed that CaM preferentially binds unfolded K-Ras4B hypervariable regions (HVRs) and not -helical HVRs. The interaction involved all three CaM domains including the central linker and both lobes. CaM specifically targeted the highly polybasic anchor region of the K-Ras4B HVR that stably wraps around CaM's acidic linker. The docking of the farnesyl group to the hydrophobic pockets located at both CaM lobes further enhanced CaM-HVR complex stability. Both CaM and K-Ras4B HVR are highly flexible molecules, suggesting that their interactions permit highly dynamic flexible-body motions. We, therefore, anticipate that the flexible-body interaction is required to extract K-Ras4B from the membrane, as conformational plasticity enables CaM to orient efficiently to the polybasic HVR anchor, which is partially diffused into the liquid-phase membrane. Our structural model of the CaM-K-Ras4B HVR association provides plausible clues to CaM's regulatory action in PI3K activation involving the ternary complex in cell proliferation signaling by oncogenic K-Ras.	[Jang, Hyunbum; Nussinov, Ruth] Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, NCI Frederick, Frederick, MD 21702 USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gaponenko, Vadim] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Chavan, Tanmay] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Stanford University; Tel Aviv University; Sackler Faculty of Medicine	Nussinov, R (corresponding author), Leidos Biomed Res Inc, Canc & Inflammat Program, Frederick Natl Lab Canc Res, NCI Frederick, Frederick, MD 21702 USA.; Gaponenko, V (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	vadimg@uic.edu; NussinoR@helix.nih.gov	Gaponenko, Vadim/K-9729-2019	Banerjee, Avik/0000-0002-0668-5480; Chavan, Tanmay/0000-0002-2702-6863; Jang, Hyunbum/0000-0001-9402-4051; Nussinov, Ruth/0000-0002-8115-6415; Gaponenko, Vadim/0000-0002-7891-9223	National Institutes of Health [HHSN261200800001E]; Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010441, R01CA188427, ZIABC010442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health under Contract HHSN261200800001E (Frederick National Laboratory for Cancer Research) and by the Intramural Research Program of National Institutes of Health, Frederick National Laboratory for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the United States government. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government.	Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Alvarez-Moya Blanca, 2011, Small GTPases, V2, P99; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakrabarti M, 2016, J PHYS CHEM B, V120, P667, DOI 10.1021/acs.jpcb.5b11110; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chavan TS, 2015, BIOPHYS J, V109, P2602, DOI 10.1016/j.bpj.2015.09.034; Chavan TS, 2013, MOLECULES, V18, P7103, DOI 10.3390/molecules18067103; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chung SI, 2016, ONCOTARGET, V7, P7354, DOI 10.18632/oncotarget.6931; Erwin N, 2016, PHYS CHEM CHEM PHYS, V18, P30020, DOI 10.1039/c6cp06553h; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Grayson P, 2003, BIOPHYS J, V85, P36, DOI 10.1016/S0006-3495(03)74452-X; Haiech J., 2000, TOPICS FLUORESCENCE, P175; Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Komeiji Y, 2002, FEBS LETT, V521, P133, DOI 10.1016/S0014-5793(02)02853-3; Li ZL, 2017, STRUCTURE, V25, P679, DOI 10.1016/j.str.2017.02.007; Liao JH, 2006, J BIOL CHEM, V281, P29730, DOI 10.1074/jbc.M600668200; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Lu SY, 2016, CHEM SOC REV, V45, P4929, DOI 10.1039/c5cs00911a; Lu SY, 2016, CHEM REV, V116, P6607, DOI 10.1021/acs.chemrev.5b00542; Lu SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21949; Lu SY, 2015, J BIOL CHEM, V290, P28887, DOI 10.1074/jbc.M115.664755; Mageean CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142674; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Muratcioglu S, 2017, J PHYS CHEM B, V121, P5917, DOI 10.1021/acs.jpcb.7b03035; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nussinov R, 2016, SEMIN CELL DEV BIOL, V58, P79, DOI 10.1016/j.semcdb.2016.04.001; Nussinov R, 2016, EXPERT OPIN THER TAR, V20, P831, DOI 10.1517/14728222.2016.1135131; Nussinov R, 2016, CANCER RES, V76, P18, DOI 10.1158/0008-5472.CAN-15-1536; Nussinov R, 2015, MOL CANCER RES, V13, P1265, DOI 10.1158/1541-7786.MCR-15-0165; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Sidhu RS, 2003, BIOCHEM BIOPH RES CO, V304, P655, DOI 10.1016/S0006-291X(03)00635-1; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang W, 2000, J MOL BIOL, V303, P567, DOI 10.1006/jmbi.2000.4057; Weise K, 2012, J AM CHEM SOC, V134, P11503, DOI 10.1021/ja305518h; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Zhang M, 2012, STRUCTURE, V20, P911, DOI 10.1016/j.str.2012.03.019; Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528	59	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12544	12559		10.1074/jbc.M117.785063	http://dx.doi.org/10.1074/jbc.M117.785063			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28623230	Green Published, hybrid			2022-12-26	WOS:000406636900020
J	Bwogi, J; Jere, KC; Karamagi, C; Byarugaba, DK; Namuwulya, P; Baliraine, FN; Desselberger, U; Iturriza-Gomara, M				Bwogi, Josephine; Jere, Khuzwayo C.; Karamagi, Charles; Byarugaba, Denis K.; Namuwulya, Prossy; Baliraine, Frederick N.; Desselberger, Ulrich; Iturriza-Gomara, Miren			Whole genome analysis of selected human and animal rotaviruses identified in Uganda from 2012 to 2014 reveals complex genome reassortment events between human, bovine, caprine and porcine strains	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; SEQUENCE-INDEPENDENT AMPLIFICATION; ACUTE DIARRHEA; MOLECULAR CHARACTERIZATION; ZOONOTIC TRANSMISSION; WA-LIKE; DIVERSITY; CHILDREN; EPIDEMIOLOGY; CLASSIFICATION	Rotaviruses of species A (RVA) are a common cause of diarrhoea in children and the young of various other mammals and birds worldwide. To investigate possible interspecies transmission of RVAs, whole genomes of 18 human and 6 domestic animal RVA strains identified in Uganda between 2012 and 2014 were sequenced using the Illumina HiSeq platform. The backbone of the human RVA strains had either a Wa - or a DS-1-like genetic constellation. One human strain was a Wa-like mono-reassortant containing a DS-1-like VP2 gene of possible animal origin. All eleven genes of one bovine RVA strain were closely related to those of human RVAs. One caprine strain had a mixed genotype backbone, suggesting that it emerged from multiple reassortment events involving different host species. The porcine RVA strains had mixed genotype backbones with possible multiple reassortant events with strains of human and bovine origin. Overall, whole genome characterisation of rotaviruses found in domestic animals in Uganda strongly suggested the presence of human-to animal RVA transmission, with concomitant circulation of multi-reassortant strains potentially derived from complex interspecies transmission events. However, whole genome data from the human RVA strains causing moderate and severe diarrhoea in under-fives in Uganda indicated that they were primarily transmitted from person-to-person.	[Bwogi, Josephine; Namuwulya, Prossy] Uganda Virus Res Inst, EPI Lab, Entebbe, Uganda; [Bwogi, Josephine; Karamagi, Charles] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Jere, Khuzwayo C.; Iturriza-Gomara, Miren] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Jere, Khuzwayo C.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Dept Med Lab Sci, Blantyre, Malawi; [Byarugaba, Denis K.] Makerere Univ, Dept Microbiol, Coll Vet Med & Biosecur, Kampala, Uganda; [Baliraine, Frederick N.] LeTourneau Univ, Dept Biol & Kinesiol, Longview, TX USA; [Desselberger, Ulrich] Univ Cambridge, Dept Med, Cambridge, England	Uganda Virus Research Institute; Makerere University; University of Liverpool; University of Malawi; Makerere University; University of Cambridge	Bwogi, J (corresponding author), Uganda Virus Res Inst, EPI Lab, Entebbe, Uganda.; Bwogi, J (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	josephinebwn@yahoo.co.uk	Bwogi, Josephine/AGJ-4829-2022; Gomara, Miren Iturriza/B-4351-2013; Baliraine, Frederick/AAU-8437-2021	Bwogi, Josephine/0000-0001-6975-7106; Gomara, Miren Iturriza/0000-0001-5816-6423; Byarugaba, Denis K./0000-0002-4175-5659; Jere, Khuzwayo/0000-0003-3376-8529	THRiVE; Wellcome Trust [087540]; Cambridge Alborado Research funds; WHO; Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan [105508]; Medical Research Council [MR/K002279/1, G0900753] Funding Source: researchfish; MRC [G0900753, MR/K002279/1] Funding Source: UKRI	THRiVE; Wellcome Trust(Wellcome Trust); Cambridge Alborado Research funds; WHO(World Health Organization); Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by THRiVE, Wellcome Trust grant no. 087540 and Cambridge Alborado Research funds to JB, WHO funds for laboratory twinning initiative between Health Protection Agency (now Public Health England), Uganda Virus Research Institute and Laboratory for Viral infections, Almaty, Kazakhstan (Project no 105508) and WHO funds for rotavirus surveillance in Uganda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimo JO, 2015, VET MICROBIOL, V175, P195, DOI 10.1016/j.vetmic.2014.11.027; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Dulgheroff ACB, 2016, BRAZ J MICROBIOL, V47, P731, DOI 10.1016/j.bjm.2016.04.012; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bwogi J, 2016, ARCH VIROL, V161, P999, DOI 10.1007/s00705-015-2742-2; Chakraborty P, 2016, EPIDEMIOL INFECT, V144, P2780, DOI 10.1017/S0950268816000807; De Grazia S, 2016, INFECT GENET EVOL, V44, P85, DOI 10.1016/j.meegid.2016.06.039; Delogu R, 2016, INFECT GENET EVOL, V44, P303, DOI 10.1016/j.meegid.2016.07.018; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Doan YH, 2013, J CLIN MICROBIOL, V51, P182, DOI 10.1128/JCM.02062-12; Dong HJ, 2013, INFECT GENET EVOL, V20, P155, DOI 10.1016/j.meegid.2013.08.024; Donker NC, 2011, INFECT GENET EVOL, V11, P1602, DOI 10.1016/j.meegid.2011.05.024; Doro R, 2015, EXPERT REV ANTI-INFE, V13, P1337, DOI 10.1586/14787210.2015.1089171; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esona MD, 2009, J MED VIROL, V81, P937, DOI 10.1002/jmv.21468; Estes MK, 2001, NOVART FDN SYMP, V238, P82; Ghosh S, 2007, ARCH VIROL, V152, P423, DOI 10.1007/s00705-006-0848-2; Ghosh S, 2012, INFECT GENET EVOL, V12, P471, DOI 10.1016/j.meegid.2011.12.012; Ghosh S, 2010, J GEN VIROL, V91, P2367, DOI 10.1099/vir.0.022244-0; Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heylen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100953; Ianiro G, 2014, INFECT GENET EVOL, V21, P129, DOI 10.1016/j.meegid.2013.10.029; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Jere KC, 2012, VET MICROBIOL, V159, P245, DOI 10.1016/j.vetmic.2012.03.040; Jere KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/jmv.22207; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Kobayashi N, 2007, COMMUNICATING CURREN, P847; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Uriarte ELL, 2014, VET MICROBIOL, V171, P189, DOI 10.1016/j.vetmic.2014.03.013; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Malik YS, 2014, INDIAN J ANIM SCI, V84, P1035; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez M, 2014, INFECT GENET EVOL, V27, P402, DOI 10.1016/j.meegid.2014.08.015; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2006, J CLIN MICROBIOL, V44, P1801, DOI 10.1128/JCM.44.5.1801-1809.2006; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2010, EMERG INFECT DIS, V16, P625, DOI 10.3201/eid1604.091591; Midgley SE, 2012, VET MICROBIOL, V156, P238, DOI 10.1016/j.vetmic.2011.10.027; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nakagomi T, 2011, MOL CHARACTERIZATION; Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009; Nyaga MM, 2015, INFECT GENET EVOL, V31, P321, DOI 10.1016/j.meegid.2015.02.011; Papp H, 2013, INFECT GENET EVOL, V19, P71, DOI 10.1016/j.meegid.2013.06.013; Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06; Rajendran P, 2014, VACCINE, V32, pA89, DOI 10.1016/j.vaccine.2014.03.026; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Steyer A, 2008, J GEN VIROL, V89, P1690, DOI 10.1099/vir.0.2008/001206-0; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tacharoenmuang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139381; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; van der Heide R, 2005, J CLIN MICROBIOL, V43, P669, DOI 10.1128/JCM.43.2.669-675.2005; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795	66	37	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178855	10.1371/journal.pone.0178855	http://dx.doi.org/10.1371/journal.pone.0178855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640820	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800011
J	Gertler, M; Czogiel, I; Stark, K; Wilking, H				Gertler, Maximilian; Czogiel, Irina; Stark, Klaus; Wilking, Hendrik			Assessment of recall error in self-reported food consumption histories among adults-Particularly delay of interviews decrease completeness of food histories-Germany, 2013	PLOS ONE			English	Article							ESCHERICHIA-COLI; OUTBREAK; CHALLENGES; INFECTIONS	Introduction Poor recall during investigations of foodborne outbreaks may lead to misclassifications in exposure ascertainment. We conducted a simulation study to assess the frequency and determinants of recall errors. Methods Lunch visitors in a cafeteria using exclusively cashless payment reported their consumption of 13 food servings available daily in the three preceding weeks using a self-administered paper-questionnaire. We validated this information using electronic payment information. We calculated associated factors on misclassification of recall according to time, age, sex, education level, dietary habits and type of servings. Results We included 145/226 (64%) respondents who reported 27,095 consumed food items. Sensitivity of recall was 73%, specificity 96%. In multivariable analysis, for each additional day of recall period, the adjusted chance for false-negative recall increased by 8% (OR: 1.1; 95%CI: 1.06, 1.1), for false-positive recall by 3% (OR: 1.03; 95%-CI: 1.02, 1.05), for indecisive recall by 12% (OR: 1.1; 95%-CI: 1.08, 1.15). Sex and education-level had minor effects. Discussion Forgetting to report consumed foods is more frequent than reporting food-items actually not consumed. Bad recall is strongly enhanced by delay of interviews and may make hypothesis generation and testing very challenging. Side dishes are more easily missed than main courses. If available, electronic payment data can improve food-history information.	[Gertler, Maximilian; Czogiel, Irina; Stark, Klaus; Wilking, Hendrik] RKI, Dept Infect Dis Epidemiol, Berlin, Germany; [Gertler, Maximilian; Czogiel, Irina] RKI, Postgrad Training Appl Epidemiol PAE, Berlin, Germany; [Gertler, Maximilian] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden	Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control	Gertler, M (corresponding author), RKI, Dept Infect Dis Epidemiol, Berlin, Germany.; Gertler, M (corresponding author), RKI, Postgrad Training Appl Epidemiol PAE, Berlin, Germany.; Gertler, M (corresponding author), ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden.	maximilian.gertler@charite.de		Wilking, Hendrik/0000-0002-8574-5831; Gertler, Maximilian/0000-0002-6384-9162	Robert Koch Institute, Berlin, Germany; European Centers for Disease Control	Robert Koch Institute, Berlin, Germany; European Centers for Disease Control	The funder of the study is the Robert Koch Institute, Berlin, Germany, as all authors of the manuscript and other contributors are employees of the institute and provided contributions during their normal working time. IC is partially contracted by the European Centers for Disease Control. No other institutions contributed funds or personnel to the project.	Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Centers for Disease Control and Prevention (CDC), 2008, INV OUTBR, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; DECKER MD, 1986, AM J EPIDEMIOL, V124, P859, DOI 10.1093/oxfordjournals.aje.a114464; Ethelberg S, 2009, CLIN INFECT DIS, V48, pE78, DOI 10.1086/597502; European Centre for Disease Prevention and Control (ECDC), 2008, TOOLK INV RESP FOOD, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; Frank C, 2011, EURO SURVEILL, V16; Fretz R, 2010, EUROSURVEILLANCE, V15, P2; MANN JM, 1981, AM J PUBLIC HEALTH, V71, P1362, DOI 10.2105/AJPH.71.12.1362; Robert Koch Institute (RKI), 2008, UNT LEB AUSBR, DOI [10.1007/s12082-008-0148-1, DOI 10.1007/S12082-008-0148-1]; Shah L, 2009, EMERG INFECT DIS, V15, P1286, DOI 10.3201/eid1508.081585; Taylor E, 2010, J PUBLIC HEALTH MAN, V16, P221, DOI 10.1097/PHH.0b013e3181b3a3e4; Werber D, 2013, AM J EPIDEMIOL, V178, P984, DOI 10.1093/aje/kwt069; Wilking H, 2012, EMERG INFECT DIS, V18, P169, DOI 10.3201/eid1801.111044	15	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179121	10.1371/journal.pone.0179121	http://dx.doi.org/10.1371/journal.pone.0179121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640839	Green Published, gold			2022-12-26	WOS:000404135800017
J	Kuracha, MR; Thomas, P; Loggie, BW; Govindarajan, V				Kuracha, Murali R.; Thomas, Peter; Loggie, Brian W.; Govindarajan, Venkatesh			Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies	PLOS ONE			English	Article							COLORECTAL-CANCER; PSEUDOMYXOMA-PERITONEI; TUMOR-GROWTH; IN-VITRO; INHIBITION; CARCINOMA; BRAF; PROGNOSIS; KINASE; MUC2	Mucinous colorectal adenocarcinomas (MCAs) are clinically and morphologically distinct from nonmucinous colorectal cancers (CRCs), show a distinct spectrum of genetic alterations (higher KRAS mutations, lower p53, high MUC2), exhibit more aggressive behavior (more prone to peritoneal dissemination and lymph node involvement) and are associated with poorer response to chemotherapy with limited treatment options. Here, we report the effectiveness of combinatorial targeting of two KRAS-mediated parallel pathways in reducing MUC2 production and mucinous tumor growth in vitro and in vivo. By knockdown of mutant KRAS we show that, mutant KRAS (a) is necessary for MUC2 production in vitro and (b) synergistically engages PI3K/AKT and MEK/ERK pathways to maintain MUC2 expression in MCA cells. These results define a novel and a previously undescribed role for oncogenic KRAS in mucinous cancers. MCA cells were sensitive to MEK inhibition suggesting cellular dependence ('addiction') of KRAS-mutant MCA cells on hyperactivation of the MEKdriven pathway. Interestingly, MCA cells, though initially sensitive, were later resistant to PI3K single agent inhibition. Our studies suggest that this resistance involves dynamic rewiring of signaling circuits mediated through relief of RTK inhibition and MEK-ERK rebound activation. This resistance however, could be overcome by co-targeting of PI3K and MEK. Our studies thus provide a rational basis for MEK-and PI3K-targeted combination therapy for not only KRAS mutant MCA but also for other related mucinous neoplasms that overproduce MUC2 and have a high rate of KRAS mutations such as pseudomyxoma peritonei.	[Kuracha, Murali R.; Thomas, Peter; Loggie, Brian W.] Creighton Univ, Dept Surg, Omaha, NE 68178 USA; [Govindarajan, Venkatesh] Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	Creighton University; Creighton University	Govindarajan, V (corresponding author), Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA.	g.v@creighton.edu			Nebraska's excise tax on cigarettes; National Organization of Rare Disorders (NORD); Cancer Development grant [LB595]; Creighton University [G20RR024001]; Creighton University	Nebraska's excise tax on cigarettes; National Organization of Rare Disorders (NORD); Cancer Development grant; Creighton University; Creighton University	These studies were supported by revenue from Nebraska's excise tax on cigarettes awarded to Creighton University through the Nebraska Department of Health & Human Services (DHHS). Its contents represent the views of the authors and do not necessarily represent the official views of the State of Nebraska or DHHS. This research was supported by National Organization of Rare Disorders (NORD) (VG), LB595 Cancer Development grant (VG), G20RR024001 (Creighton University) and Creighton University patient cancer research funds (BWL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Catalano V, 2009, BRIT J CANCER, V100, P881, DOI 10.1038/sj.bjc.6604955; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Choudry HA, 2012, J SURG ONCOL, V106, P911, DOI 10.1002/jso.23146; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Dilly AK, 2015, TRANSL RES, V166, P344, DOI 10.1016/j.trsl.2015.03.004; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Hanski C, 1997, J PATHOL, V182, P385, DOI 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Hugen N, 2014, ANN ONCOL, V25, P651, DOI 10.1093/annonc/mdt591; Hugen N, MOLECULAR BACKGROUND; Hyngstrom JR, 2012, ANN SURG ONCOL, V19, P2814, DOI 10.1245/s10434-012-2321-7; Josephs Debra H, 2015, Transl Oncogenomics, V7, P33, DOI 10.4137/TOG.S30529; Kopetz S, 2010, ASCO ANN M P; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Masoumi-Moghaddam S, 2016, CLIN TRANSL ONCOL; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mekenkamp LJM, 2012, EUR J CANCER, V48, P501, DOI 10.1016/j.ejca.2011.12.004; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Mizoshita T, 2007, HISTOL HISTOPATHOL, V22, P251, DOI 10.14670/HH-22.251; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; O'Connell JT, 2002, AM J PATHOL, V161, P551, DOI 10.1016/S0002-9440(10)64211-3; O'Connell JT, 2002, MODERN PATHOL, V15, P958, DOI 10.1097/01.MP.0000026617.52466.9F; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Shapiro G, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.3005; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Shetty S, 2013, J SURG RES, V180, P97, DOI 10.1016/j.jss.2012.10.053; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Tanaka H, 2006, INT J CANCER, V118, P2765, DOI 10.1002/ijc.21701; TIBBETTS LM, 1988, CANCER RES, V48, P3751; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179510	10.1371/journal.pone.0179510	http://dx.doi.org/10.1371/journal.pone.0179510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640835	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800035
J	Li, YM; Zhuge, RS; Zhang, ZT; Tian, YM; Ding, N				Li, Yong-Mei; Zhuge, Rui-Shen; Zhang, Zu-Tai; Tian, Yue-Ming; Ding, Ning			The effect of subpressure on the bond strength of resin to zirconia ceramic	PLOS ONE			English	Article							SURFACE-ROUGHNESS; SYSTEMS; CEMENT	Objective This study was conducted to investigate the effect of subpressure on the bond strength of resin to zirconia ceramic. The subpressure would create a pressure gradient which could clean out the bubbles in the adhesives or bonding interface. Methods Twenty-eight pre-sintered zirconia discs were fabricated. Half of them were polished (group P, n = 14), and the rest were sandblasted (group S, n = 14). After sintered, the surface roughness of the zirconia discs was measured. Then, they were randomly divided into two subgroups (n = 7). The groups were named as follows: PC: P + no additional treatments; PP: P + 0.04 MPa after application of adhesives; SC: S + no additional treatments; and SP: S + 0.04 MPa after application of adhesives. Resin columns were bonded to the zirconia specimens to determine shear bond strength (SBS). The bonding interfaces were observed and the fracture modes were evaluated. Statistical analysis was performed on all data. Results The surface roughness of group S was significantly higher than that of group P (P<0.05). The SBS values were PC = 13.48 +/- 0.7 MPa, PP = 15.22 +/- 0.8 MPa, SC = 17.23 +/- 0.7 MPa and SP = 21.68 +/- 1.4 MPa. There were significant differences among the groups (P<0.05). Scanning electron microscopy (SEM) results showed that the adhesives of group SP and PP were closer and denser to the zirconia ceramic than that of group PC and SC. The proportion of the mixed fracture mode significantly increased after adding subpressure (P<0.05). Conclusion Subpressure can improve the shear bond strength of resin to zirconia ceramics and increase micro-infiltration between the adhesives and the zirconia ceramics, especially on the rough surfaces.	[Li, Yong-Mei; Zhuge, Rui-Shen; Zhang, Zu-Tai; Tian, Yue-Ming; Ding, Ning] Capital Med Univ, Sch Stomatol, Beijing, Peoples R China	Capital Medical University	Zhang, ZT (corresponding author), Capital Med Univ, Sch Stomatol, Beijing, Peoples R China.	zutaizhang@ccmu.edu.cn	li, yong/HDN-3885-2022		National Natural Science Foundation of China [81371175, 81671027]; Beijing Natural Science Foundation [7152065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China [Grant No. 81371175, 81671027] and the Beijing Natural Science Foundation [Grant No. 7152065]. http://www.nsfc.gov.cn/.	Aboushelib MN, 2007, J PROSTHETIC DENT, V98; Ahmad I, 1999, Pract Periodontics Aesthet Dent, V11, P197; Akin GE, 2015, PHOTOMED LASER SURG, V33, P246, DOI 10.1089/pho.2014.3861; Blatz MB, 2007, QUINTESSENCE INT, V38, P745; Budhe S., 2015, APPL ADHES SCI, V3, P20, DOI [DOI 10.1186/s40563-015-0050-4, DOI 10.1186/S40563-015-0050-4]; Bulbul M, 2010, J PROSTHET DENT, V103, P303, DOI 10.1016/S0022-3913(10)60063-7; Cavalcanti AN, 2009, PHOTOMED LASER SURG, V27, P473, DOI 10.1089/pho.2008.2293; Derand P, 2000, INT J PROSTHODONT, V13, P131; Fischer J, 2010, J PROSTHET DENT, V103, P267, DOI 10.1016/S0022-3913(10)60056-X; Golafshan N, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa68ed; Goracci C, 2011, AUST DENT J, V56, P77, DOI 10.1111/j.1834-7819.2010.01298.x; Harding AB, 2012, J PROSTHODONT, V21, P346, DOI 10.1111/j.1532-849X.2012.00843.x; Hata U, 2008, PROSTHODONT RES PRAC, V7, P153; He M, 2014, DENT MAT J, V33; Hwang DS, 2010, SOFT MATTER, V6, P3232, DOI 10.1039/c002632h; Inokoshi M, 2014, J DENT RES, V93, P329, DOI 10.1177/0022034514524228; Kadir MRA, 2008, IFMBE PROC, V21, P457; Kasraei Shahin, 2014, Restor Dent Endod, V39, P296, DOI 10.5395/rde.2014.39.4.296; KEITH O, 1994, AM J ORTHOD DENTOFAC, V106, P605, DOI 10.1016/S0889-5406(94)70085-0; Kitayama S, 2010, DENT MATER, V26, P426, DOI 10.1016/j.dental.2009.11.159; Landsiedel R, 2012, ARCH TOXICOL, V86, P1021, DOI 10.1007/s00204-012-0858-7; Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008; Martin J, 2009, LANGMUIR ACS J SURFA, V25; Michida SM, 2015, J APPL BIOMATERIALS, V13; Moezzizadeh M, 2017, DENT MATER J, V36, P54, DOI 10.4012/dmj.2015-382; Montes AMJR, 2001, J DENT, V29, P435; Moon JE, 2011, DENT MATER, V27, P651, DOI 10.1016/j.dental.2011.03.005; Nobutaka A, 2016, DENT MATER J, V36, P19; Nordahl N, 2015, J ORAL SCI, V57, P255, DOI 10.2334/josnusd.57.255; Ozcan M, 2008, DENT MATER J, V27, P99; Paranhos MPG, 2011, QUINTESSENCE INT, V42, P79; Pozzobon JL, 2017, J ADHES SCI TECHNOL, V19, P7; Rashid Haroon, 2014, Eur J Dent, V8, P571, DOI 10.4103/1305-7456.143646; Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3; Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022; Vogt UF, 2010, J EUR CERAM SOC, V30, P3005, DOI 10.1016/j.jeurceramsoc.2010.06.003; von Steyern PV, 2006, J ORAL REHABIL, V33, P682, DOI 10.1111/j.1365-2842.2005.01604.x; Wei YH, 2013, DENT MATER J, V32, P564, DOI 10.4012/dmj.2013-007; Yang B, 2010, DENT MATER, V26, P44, DOI 10.1016/j.dental.2009.08.008; Yildirim M, 2000, INT J PERIODONT REST, V20, P81; Zhou W, 2016, SCI REP-UK, V6, DOI 10.1038/srep22269	41	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179668	10.1371/journal.pone.0179668	http://dx.doi.org/10.1371/journal.pone.0179668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640855	gold, Green Published, Green Submitted			2022-12-26	WOS:000404135800049
J	Zhao, JL; Duan, FQ; Pan, ZK; Wu, ZK; Li, JH; Deng, QQ; Li, XN; Zhou, MQ				Zhao, Junli; Duan, Fuqing; Pan, Zhenkuan; Wu, Zhongke; Li, Jinhua; Deng, Qingqiong; Li, Xiaona; Zhou, Mingquan			Craniofacial similarity analysis through sparse principal component analysis	PLOS ONE			English	Article							3D FACE RECOGNITION; RECONSTRUCTION; SELECTION; SKULL; MODEL; SHAPE	The computer-aided craniofacial reconstruction (CFR) technique has been widely used in the fields of criminal investigation, archaeology, anthropology and cosmetic surgery. The evaluation of craniofacial reconstruction results is important for improving the effect of craniofacial reconstruction. Here, we used the sparse principal component analysis (SPCA) method to evaluate the similarity between two sets of craniofacial data. Compared with principal component analysis (PCA), SPCA can effectively reduce the dimensionality and simultaneously produce sparse principal components with sparse loadings, thus making it easy to explain the results. The experimental results indicated that the evaluation results of PCA and SPCA are consistent to a large extent. To compare the inconsistent results, we performed a subjective test, which indicated that the result of SPCA is superior to that of PCA. Most importantly, SPCA can not only compare the similarity of two craniofacial datasets but also locate regions of high similarity, which is important for improving the craniofacial reconstruction effect. In addition, the areas or features that are important for craniofacial similarity measurements can be determined from a large amount of data. We conclude that the craniofacial contour is the most important factor in craniofacial similarity evaluation. This conclusion is consistent with the conclusions of psychological experiments on face recognition and our subjective test. The results may provide important guidance for three-or two-dimensional face similarity evaluation, analysis and face recognition.	[Zhao, Junli; Li, Jinhua; Li, Xiaona] Qingdao Univ, Sch Data Sci & Software Engn, Qingdao, Peoples R China; [Zhao, Junli] Qingdao Univ, Coll Automat & Elect Engn, Qingdao, Peoples R China; [Duan, Fuqing; Wu, Zhongke; Deng, Qingqiong; Zhou, Mingquan] Minist Educ, Engn Res Ctr Virtual Real & Applicat, Beijing, Peoples R China; [Duan, Fuqing; Wu, Zhongke; Deng, Qingqiong; Zhou, Mingquan] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China; [Pan, Zhenkuan] Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China	Qingdao University; Qingdao University; Beijing Normal University; Qingdao University	Duan, FQ (corresponding author), Minist Educ, Engn Res Ctr Virtual Real & Applicat, Beijing, Peoples R China.; Duan, FQ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing, Peoples R China.; Pan, ZK (corresponding author), Qingdao Univ, Coll Comp Sci & Technol, Qingdao, Peoples R China.	fqduan@bnu.edu.cn; zkpan@126.com		Zhao, Junli/0000-0002-2034-6426; Duan, Fuqing/0000-0002-3849-8532	National Natural Science Foundation of China [61572078]; Natural Science Foundation of Beijing Municipality [4152027, 4152028]; Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application [MEOBNUEVRA201601]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2013BAI01603]; National High-tech R&D Program (863 Program) of China [2015AA020506]; Program for New Century Excellent Talents in University [NCET-13-0051]; Xianyang Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National High-tech R&D Program (863 Program) of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Xianyang Hospital	This work was funded by the National Natural Science Foundation of China (no. 61572078), Natural Science Foundation of Beijing Municipality (CN) (no. 4152027 and no. 4152028), and the Open Research Fund of the Ministry of Education Engineering Research Center of Virtual Reality Application (MEOBNUEVRA201601). It was also partially supported by grants from Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (no. 2013BAI01603), National High-tech R&D Program (863 Program) of China (no. 2015AA020506) and the Program for New Century Excellent Talents in University (NCET-13-0051).; The authors gratefully appreciate the anonymous reviewers for all of their helpful comments. We also acknowledge the support of Xianyang Hospital for providing CT images.	Achermann B, 2000, INT C PATT RECOG, P809, DOI 10.1109/ICPR.2000.906199; Berretti S, 2010, P ACM WORKSH 3D OBJ, P81, DOI DOI 10.1145/1877808.1877825; Berretti S, 2010, IEEE T PATTERN ANAL, V32, P2162, DOI 10.1109/TPAMI.2010.43; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Chang KI, 2003, ACM WORKSH MULT US A, P25; Chin-Seng Chua, 2000, Proceedings Fourth IEEE International Conference on Automatic Face and Gesture Recognition (Cat. No. PR00580), P233, DOI 10.1109/AFGR.2000.840640; Claes P, 2006, FORENSIC SCI INT, V159, pS147, DOI 10.1016/j.forsciint.2006.02.035; Cook J, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P502, DOI 10.1109/TDPVT.2004.1335279; Deng QQ, 2011, FORENSIC SCI INT, V208, P95, DOI 10.1016/j.forsciint.2010.11.011; Duan FQ, 2014, IEEE T INF FOREN SEC, V9, P1322, DOI 10.1109/TIFS.2014.2332981; Feng J, 2008, IMAGE VISION COMPUT, V26, P761, DOI 10.1016/j.imavis.2007.08.018; GORDON GG, 1991, P SOC PHOTO-OPT INS, V1570, P234, DOI 10.1117/12.48428; HELMER RP, 1993, FORENSIC ANAL SKULL, P229; Hesher C, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P201, DOI 10.1109/ISSPA.2003.1224850; Hongyan Li, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P2114, DOI 10.1109/BMEI.2011.6098733; Hu YL, 2013, MULTIMED TOOLS APPL, V64, P345, DOI 10.1007/s11042-012-1005-4; Ip HHS, 2002, P 15 INT C VIS INT, P314; Jahanbin S, 2008, BIOM THEOR APPL SYST, P1; Kurtek S, 2015, COMPUT GRAPH-UK, V51, P52, DOI 10.1016/j.cag.2015.05.027; Lee JC, 1990, COMP VIS 1990 P 3 IN, P722; Lee WJ, 2016, FORENSIC SCI INT, V269, P21, DOI 10.1016/j.forsciint.2016.11.003; Lee Y, 2003, PROCEEDINGS EC-VIP-MC 2003, VOLS 1 AND 2, P429; Lee YH, 2004, IEEE IMAGE PROC, P1429; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Lu XG, 2006, IEEE T PATTERN ANAL, V28, P31, DOI 10.1109/TPAMI.2006.15; Medioni G., 2003, IEEE WORKSH AMFG; NAGAMINE T, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL I, P324, DOI 10.1109/ICPR.1992.201567; Pan G, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL III, PROCEEDINGS, P193; Papatheodorou T, 2005, LECT NOTES COMPUT SC, V3546, P997; Passalis G., 2005, P IEEE WORKSH FAC RE, P171, DOI DOI 10.1109/CVPR.2005.573; Russ T., 2006, P IEEE COMP SOC C CO, P1391, DOI [10.1109/CVPR.2006.13, DOI 10.1109/CVPR.2006.13]; Sjostrand K, 2006, MED IMAGING 2006 IMA, V6144, P1579; SNOW CC, 1970, AM J PHYS ANTHROPOL, V33, P221, DOI 10.1002/ajpa.1330330207; Stephan CN, 2001, J FORENSIC SCI, V46, P432; Tanaka H. T., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P638, DOI 10.1109/ICPR.1996.547024; ter Haar FB, 2008, IEEE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS 2008, PROCEEDINGS, P259, DOI 10.1109/SMI.2008.4547996; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; VaneZis M., 2008, FORENSIC FACIAL RECO; Wang G., 2011, HUMAN FACE PERCETION, P5; Wang YH, 2011, FACE RECOGNITION PRI, P16; Wong HS, 2004, PATTERN RECOGN, V37, P2307, DOI [10.1016/S0031-3203(04)00192-X, 10.1016/j.patcog.2004.05.004]; Yuan X, 2005, IEEE INT SYMP CIRC S, P3211; Zhao J, 2014, COMPUTATIONAL MATH M, V2014; Zhu Xin-yi, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics, P942, DOI 10.1109/BMEI.2011.6098426; Zhu Xin-yi, 2010, Application Research of Computers, V27, P3153, DOI 10.3969/j.issn.1001-3695.2010.08.093; [朱新懿 Zhu Xinyi], 2012, [中国图象图形学报, Journal of Image and Graphics], V17, P568; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	50	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179671	10.1371/journal.pone.0179671	http://dx.doi.org/10.1371/journal.pone.0179671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640836	gold, Green Submitted, Green Published			2022-12-26	WOS:000404135800050
J	Lee, MS; Kuo, LL; Tan, ECH; Lee, OK				Lee, Meng-Sheng; Kuo, Li-Lin; Tan, Elise Chia-Hui; Lee, Oscar K.			Is normal-tension glaucoma a risk factor for stroke?-A 10-year follow-up study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR BLOOD-FLOW; OPTIC-NERVE HEAD; VISUAL-FIELD DEFECTS; INTRAOCULAR-PRESSURE; PROPENSITY SCORE; HEALTHY-SUBJECTS; NITRIC-OXIDE; PROGRESSION; PREVALENCE	Objectives To investigate whether patients with normal-tension glaucoma (NTG) have a higher incidence of stroke. Design A population-based retrospective cohort study based on data from the Taiwan National Health Insurance Research Database (NHIRD) from January 1, 2001, to December 31, 2010. Methods Data were retrospectively collected from the NHIRD. A total of 245 (20.1%) patients with a history of stroke at the time of glaucoma diagnosis were excluded, and 1,218 patients with NTG who were 20 years of age and older were identified. Patients' age, gender and preexisting comorbidities, including hypertension, diabetes, congestive heart failure, ischemic heart disease, atrial fibrillation and disorders of lipid metabolism, were recorded. The propensity score method with a 1: 5 matching ratio was used to minimize selection bias. Cox regression with robust variance estimation was used to estimate the hazard ratio (HR) of developing stroke between the NTG and control groups. Results After adjusting for patient age, gender, and pre-existing comorbidities, the HR was 6.34, indicating that the incidence of stroke was significantly higher in patients with NTG than in controls. Furthermore, a higher risk of stroke was also found in most subgroups with the above-mentioned comorbidities. Conclusion NTG is a significant risk factor for subsequent stroke in most of the described comorbidity subgroups. Early interventions for stroke prevention should be provided to newly diagnosed patients with NTG.	[Lee, Meng-Sheng; Kuo, Li-Lin] Taipei City Hosp, Dept Ophthalmol, Taipei, Taiwan; [Kuo, Li-Lin] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Kuo, Li-Lin] Natl Yang Ming Univ, Inst Publ Hlth & Community Med, Res Ctr, Taipei, Taiwan; [Tan, Elise Chia-Hui] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei, Taiwan; [Tan, Elise Chia-Hui] Natl Res Inst Chinese Med, Minist Hlth & Welf, Taipei, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lee, Oscar K.] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Research Institute of Chinese Medicine; National Yang Ming Chiao Tung University; Taipei City Hospital	Kuo, LL (corresponding author), Taipei City Hosp, Dept Ophthalmol, Taipei, Taiwan.; Kuo, LL (corresponding author), Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan.; Kuo, LL (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth & Community Med, Res Ctr, Taipei, Taiwan.	DAC50@tpech.gov.tw		Tan, Elise (Chia-Hui)/0000-0002-8115-3011				Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Asrani S, 2011, CURR EYE RES, V36, P429, DOI 10.3109/02713683.2011.559563; Austin PC, 2013, STAT MED; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Buch H, 2001, OPHTHALMOLOGY, V108, P2347, DOI 10.1016/S0161-6420(01)00823-5; CAPRIOLI J, 1985, ARCH OPHTHALMOL-CHIC, V103, P1145; CARTWRIGHT MJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P898; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Doyle A, 2005, ACTA OPHTHALMOL SCAN, V83, P191, DOI 10.1111/j.1600-0420.2005.00436.x; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; DRANCE SM, 1988, AM J OPHTHALMOL, V105, P35, DOI 10.1016/0002-9394(88)90118-3; FAZIO P, 1990, ARCH OPHTHALMOL-CHIC, V108, P705, DOI 10.1001/archopht.1990.01070070091042; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; FELDMAN F, 1969, CAN J OPHTHALMOLOGY, V4, P358; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Garhofer G, 2004, J GLAUCOMA, V13, P340, DOI 10.1097/00061198-200408000-00013; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; GASSER P, 1991, AM J OPHTHALMOL, V111, P585, DOI 10.1016/S0002-9394(14)73703-1; Gherghel D, 2000, AM J OPHTHALMOL, V130, P597, DOI 10.1016/S0002-9394(00)00766-2; Gherghel D, 2007, OPHTHAL PHYSL OPT, V27, P336, DOI 10.1111/j.1475-1313.2007.00485.x; Gungor IU, 2011, MED PRIN PRACT, V20, P220, DOI 10.1159/000323596; Hayreh SS, 1999, SURV OPHTHALMOL, V43, pS27, DOI 10.1016/S0039-6257(99)00018-1; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HITCHINGS RA, 1983, BRIT J OPHTHALMOL, V67, P818, DOI 10.1136/bjo.67.12.818; Ho JD, 2009, STROKE, V40, P2685, DOI 10.1161/STROKEAHA.109.554642; Kim YD, 2010, EYE, V24, P567, DOI 10.1038/eye.2009.163; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Lamoureux EL, 2007, OPTOMETRY VISION SCI, V84, P789, DOI 10.1097/OPX.0b013e3181334b83; Landers J, 2002, CLIN EXP OPHTHALMOL, V30, P242, DOI 10.1046/j.1442-9071.2002.00528.x; Leung DYL, 2009, OPHTHALMOLOGY, V116, P1250, DOI 10.1016/j.ophtha.2009.02.003; Mroczkowska S, 2013, JAMA OPHTHALMOL, V131, P36, DOI 10.1001/2013.jamaophthalmol.1; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Oettli A, 2011, J GLAUCOMA, V20, P303, DOI 10.1097/IJG.0b013e3181e666a1; ONG K, 1995, OPHTHALMOLOGY, V102, P1632; Pemp B, 2009, BRIT J OPHTHALMOL, V93, P486, DOI 10.1136/bjo.2008.148676; PHELPS CD, 1984, AM J OPHTHALMOL, V98, P823, DOI 10.1016/0002-9394(84)90721-9; PHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rahmani B, 1996, OPHTHALMOLOGY, V103, P1721, DOI 10.1016/S0161-6420(96)30435-1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sacco RL, 1997, STROKE, V28, P1507, DOI 10.1161/01.STR.28.7.1507; SCHULZER M, 1990, BRIT J OPHTHALMOL, V74, P196, DOI 10.1136/bjo.74.4.196; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Shields MB, 2012, J GLAUCOMA, V21, P141, DOI 10.1097/IJG.0b013e31820719f6; SOMMER A, 1979, ARCH OPHTHALMOL-CHIC, V97, P1444, DOI 10.1001/archopht.1979.01020020106002; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Sommer A, 2011, ARCH OPHTHALMOL-CHIC, V129, P785, DOI 10.1001/archophthalmol.2011.117; Sowka Joseph, 2005, Optometry, V76, P600, DOI 10.1016/j.optm.2005.08.020; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Su WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Thonginnetra O, 2010, J GLAUCOMA, V19, P151, DOI 10.1097/IJG.0b013e318193c45c; Titchener AG, 2013, J HAND SURG-EUR VOL, V38E, P159, DOI 10.1177/1753193412442464; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Wollstein G, 1998, OPHTHALMOLOGY, V105, P1557, DOI 10.1016/S0161-6420(98)98047-2	65	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179307	10.1371/journal.pone.0179307	http://dx.doi.org/10.1371/journal.pone.0179307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628626	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100026
J	Pereira, AE; Souza, D; Zukoff, SN; Meinke, LJ; Siegfried, BD				Pereira, Adriano E.; Souza, Dariane; Zukoff, Sarah N.; Meinke, Lance J.; Siegfried, Blair D.			Cross-resistance and synergism bioassays suggest multiple mechanisms of pyrethroid resistance in western corn rootworm populations	PLOS ONE			English	Article							INSECT SODIUM-CHANNELS; PARATHION RESISTANCE; KNOCKDOWN RESISTANCE; SOIL INSECTICIDES; MOLECULAR-BIOLOGY; COLEOPTERA; CHRYSOMELIDAE; SUSCEPTIBILITY; METHYL; INDUCTION	Recently, resistance to the pyrethroid bifenthrin was detected and confirmed in field populations of western corn rootworm, Diabrotica virgifera virgifera LeConte from southwestern areas of Nebraska and Kansas. As a first step to understand potential mechanisms of resistance, the objectives of this study were i) to assess adult mortality at diagnostic concentration- LC99 to the pyrethroids bifenthrin and tefluthrin as well as DDT, ii) estimate adult and larval susceptibility to the same compounds as well as the organophosphate methyl-parathion, and iii) perform synergism experiments with piperonyl butoxide (PBO) (P450 inhibitor) and S, S, S-tributyl-phosphorotrithioate (DEF) (esterase inhibitor) in field populations. Most of the adult field populations exhibiting some level of bifenthrin resistance exhibited significantly lower mortality to both pyrethroids and DDT than susceptible control populations at the estimated LC99 of susceptible populations. Results of adult dose-mortality bioassays also revealed elevated LC50 values for bifenthrin resistant populations compared to the susceptible control population with resistance ratios ranging from 2.5 to 5.5-fold for bifenthrin, 28 to 54.8-fold for tefluthrin, and 16.3 to 33.0 for DDT. These bioassay results collectively suggest some level of cross-resistance between the pyrethroids and DDT. In addition, both PBO and DEF reduced the resistance ratios for resistant populations although there was a higher reduction in susceptibility of adults exposed to PBO versus DEF. Susceptibility in larvae varied among insecticides and did not correlate with adult susceptibility to tefluthrin and DDT, as most resistance ratios were <5-fold when compared to the susceptible population. These results suggest that both detoxifying enzymes and target site insensitivity might be involved as resistance mechanisms.	[Pereira, Adriano E.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Souza, Dariane; Meinke, Lance J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Zukoff, Sarah N.] Kansas State Univ, Southwest Res & Extens Ctr, Garden City, KS USA; [Siegfried, Blair D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; Kansas State University; State University System of Florida; University of Florida	Pereira, AE (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	aelias374@yahoo.com.br		Souza, Dariane/0000-0003-3681-9053; Zukoff, Sarah/0000-0002-4918-3667	Monsanto Corn Rootworm Knowledge Grant [69292]; Department of Entomology/Institute of Agriculture and Natural Resources/University of Nebraska-Lincoln	Monsanto Corn Rootworm Knowledge Grant; Department of Entomology/Institute of Agriculture and Natural Resources/University of Nebraska-Lincoln	This work was supported by: 1- Monsanto Corn Rootworm Knowledge Grant (No. 69292): The recipients were BDS and LJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2- Department of Entomology/Institute of Agriculture and Natural Resources/University of Nebraska-Lincoln: The recipient was AEP as an assistantship awarded for the PhD program.; The authors thank numerous growers who allowed beetle collections to be made on their land in western Nebraska and Kansas, and to consultant Larry Appel for keeping us informed about beetle populations in the fields of western Nebraska. Thanks to the valuable comments from anonymous reviewers. This project has been funded by Monsanto Corn Rootworm Knowledge Grant (No. 69292).	Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; ARNOLD JTA, 1975, ENTOMOL EXP APPL, V18, P180, DOI 10.1007/BF00299986; BALL HJ, 1962, J ECON ENTOMOL, V55, P439, DOI 10.1093/jee/55.4.439; BALL HJ, 1968, J ECON ENTOMOL, V61, P496, DOI 10.1093/jee/61.2.496; BALL HJ, 1973, J ECON ENTOMOL, V66, P1015, DOI 10.1093/jee/66.5.1015; BALL HJ, 1963, J ECON ENTOMOL, V56, P553, DOI 10.1093/jee/56.5.553; BIGGER JH, 1963, J ECON ENTOMOL, V56, P118, DOI 10.1093/jee/56.1.118; Boetel MA, 2003, J ECON ENTOMOL, V96, P714, DOI 10.1603/0022-0493-96.3.714; Bouvier JC, 2002, ARCH INSECT BIOCHEM, V51, P55, DOI 10.1002/arch.10052; CHIO H, 1978, J ECON ENTOMOL, V71, P389, DOI 10.1093/jee/71.3.389; Coates BS, 2016, INSECT MOL BIOL, V25, P1, DOI 10.1111/imb.12194; CULY MD, 1992, J ECON ENTOMOL, V85, P2440, DOI 10.1093/jee/85.6.2440; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Dun Z, 2010, J APPL ENTOMOL, V134, P409, DOI 10.1111/j.1439-0418.2009.01487.x; EPA. Environmental Protection Agency, 2012, BACKGR SUMM N METH C; EPA. Environmental Protection Agency, 2006, ORG CUM RISK ASS UPD; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Ffrench-Constant R.H., 1990, PESTICIDE RESISTANCE, P4, DOI [10.1007/978-1-4684-6429-0_2, DOI 10.1007/978-1-4684-6429-0_2]; FINNEY D J, 1971, P333; FISHER JR, 1989, J KANSAS ENTOMOL SOC, V62, P607; Foreword Metcalf R., 1986, METHODS STUDY PEST D, pvii; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; GRAY ME, 1992, J ECON ENTOMOL, V85, P544, DOI 10.1093/jee/85.2.544; HILL RE, 1948, J ECON ENTOMOL, V41, P392, DOI 10.1093/jee/41.3.392; Hollingworth RM, 2008, GLOBAL PESTICIDE RESISTANCE IN ARTHROPODS, P40, DOI 10.1079/9781845933531.0040; Larval Ball H., 1948, NEBRASKA AGR EXPT ST, V3, P20; LeOra, 1987, POLO PC US GUID PROB; LIU YB, 1995, J ECON ENTOMOL, V88, P788, DOI 10.1093/jee/88.4.788; Magalhaes LC, 2007, J APPL ENTOMOL, V131, P251, DOI 10.1111/j.1439-0418.2007.01153.x; Meinke L.J., 2015, ADULT CORN ROOTWORM; Meinke LJ, 2009, AGR FOREST ENTOMOL, V11, P29, DOI 10.1111/j.1461-9563.2008.00419.x; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Miota F, 1998, PESTIC BIOCHEM PHYS, V61, P39, DOI 10.1006/pest.1998.2348; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; Pereira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142299; Pridgeon JW, 2002, PESTIC BIOCHEM PHYS, V73, P149, DOI 10.1016/S0048-3575(02)00103-7; Rinkevich FD, 2012, PESTIC BIOCHEM PHYS, V104, P192, DOI 10.1016/j.pestbp.2012.08.001; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; ROUSH RT, 1986, J ECON ENTOMOL, V79, P1178, DOI 10.1093/jee/79.5.1178; Roush RT., 1990, PESTICIDE RESISTANCE, P97, DOI DOI 10.1007/978-1-4684-6429-0_5; Sappington Thomas W., 2006, American Entomologist, V52, P90; SAWICKI RM, 1978, NATURE, V275, P443, DOI 10.1038/275443a0; Scharf ME, 1999, J ECON ENTOMOL, V92, P33, DOI 10.1093/jee/92.1.33; Scharf ME, 2000, PESTIC BIOCHEM PHYS, V67, P137, DOI 10.1006/pest.2000.2481; Scharf ME, 2001, INSECT MOL BIOL, V10, P139, DOI 10.1046/j.1365-2583.2001.00248.x; Schleier JJ, 2012, J ECON ENTOMOL, V105, P85, DOI 10.1603/EC11267; Schleier JJ, 2011, RSC GREEN CHEM SER, V11, P94; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; SCOTT JG, 1986, J ECON ENTOMOL, V79, P571, DOI 10.1093/jee/79.3.571; SCOTT JG, 1983, PESTIC BIOCHEM PHYS, V19, P141, DOI 10.1016/0048-3575(83)90133-5; Siegfried BD, 1998, J AGR ENTOMOL, V15, P359; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Stroup WW, 2015, AGRON J, V107, P811, DOI 10.2134/agronj2013.0342; Tinsley NA, 2012, J APPL ENTOMOL, V135, P361, DOI 10.1111/j.1439-0418.2011.01656.x; Urias-Lopez MA, 2001, J ECON ENTOMOL, V94, P106, DOI 10.1603/0022-0493-94.1.106; Wangila DS, 2015, J ECON ENTOMOL, V108, P742, DOI 10.1093/jee/tou063; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Witmer JE, 2003, ENVIRON ENTOMOL, V32, P366, DOI 10.1603/0046-225X-32.2.366; Wright RJ, 2000, J ECON ENTOMOL, V93, P7, DOI 10.1603/0022-0493-93.1.7; Xi JH, 2015, PESTIC BIOCHEM PHYS, V119, P74, DOI 10.1016/j.pestbp.2015.02.002; Yu S. J., 2014, The toxicology and biochemistry of insecticides; Zhou XG, 2003, J ECON ENTOMOL, V96, P1855, DOI 10.1603/0022-0493-96.6.1855; Zhu KY, 2001, J ECON ENTOMOL, V94, P929, DOI 10.1603/0022-0493-94.4.929; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	65	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179311	10.1371/journal.pone.0179311	http://dx.doi.org/10.1371/journal.pone.0179311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628635	Green Published, gold			2022-12-26	WOS:000404043100027
J	Ekino, T; Yoshiga, T; Takeuchi-Kaneko, Y; Kanzaki, N				Ekino, Taisuke; Yoshiga, Toyoshi; Takeuchi-Kaneko, Yuko; Kanzaki, Natsumi			Transmission electron microscopic observation of body cuticle structures of phoretic and parasitic stages of Parasitaphelenchinae nematodes	PLOS ONE			English	Article							PINE-WOOD NEMATODE; N. SP NEMATODA; COLEOPTERA-CURCULIONIDAE SCOLYTINAE; MONOCHAMUS-ALTERNATUS COLEOPTERA; PSACOTHEA-HILARIS COLEOPTERA; ENTOMOPARASITIC ADULT FORM; SPOTTED LONGICORN BEETLE; BURSAPHELENCHUS-XYLOPHILUS; PHYLOGENETIC-RELATIONSHIPS; CAENORHABDITIS-ELEGANS	Using transmission electron microscopy, we examined the body cuticle ultrastructures of phoretic and parasitic stages of the parasitaphelenchid nematodes Bursaphelenchus xylophilus, B. conicaudatus, B. luxuriosae, B. rainulfi; an unidentified Bursaphelenchus species, and an unidentified Parasitaphelenchus species. Nematode body cuticles usually consist of three zones, a cortical zone, a median zone, and a basal zone. The phoretic stages of Bursaphelenchus spp., isolated from the tracheal systems of longhorn beetles or the elytra of bark beetles, have a thick and radially striated basal zone. In contrast, the parasitic stage of Parasitaphelenchus sp., isolated from bark beetle hemocoel, has no radial striations in the basal zone. This difference probably reflects the peculiar ecological characteristics of the phoretic stage. A well-developed basal radially striated zone, composed of very closely linked proteins, is the zone closest to the body wall muscle. Therefore, the striation is necessary for the phoretic species to be able to seek, enter, and depart from host/carrier insects, but is not essential for internal parasites in parasitaphelenchid nematodes. Phylogenetic relationships inferred from near-full-length small subunit ribosomal RNA sequences suggest that the cuticle structures of parasitic species have apomorphic characters, e.g., lack of striation in the basal zone, concurrent with the evolution of insect parasitism from a phoretic life history.	[Ekino, Taisuke; Yoshiga, Toyoshi] Saga Univ, Dept Appl Biol Sci, Lab Nematol, Fac Agr, Saga, Japan; [Ekino, Taisuke; Yoshiga, Toyoshi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan; [Takeuchi-Kaneko, Yuko] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan	Saga University; Kagoshima University; Kyoto University; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Kanzaki, N (corresponding author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan.; Kanzaki, N (corresponding author), Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi Ku, Kyoto, Japan.	nkanzaki@affrc.go.jp		Ekino, Taisuke/0000-0001-5028-2980	Japan Society for the Promotion of Science and Environment Research [15H04514, 26292178, 17H03831]	Japan Society for the Promotion of Science and Environment Research	This study was supported in part by the Grants-in-Aid for Scientific Research (B), Nos. 15H04514, 26292178 and 17H03831 from the Japan Society for the Promotion of Science and Environment Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa T, 2000, NEMATOLOGY, V2, P495, DOI 10.1163/156854100509402; Aikawa T., 2008, PINE WILT DIS, P123, DOI [10.1007/978-4-431-75655-2_13, DOI 10.1007/978-4-431-75655-2_13]; BIRD AF, 1981, INT J PARASITOL, V11, P431, DOI 10.1016/0020-7519(81)90061-8; BIRD AF, 1968, J PARASITOL, V54, P475, DOI 10.2307/3277069; BIRD AF, 1991, STRUCTURE NEMATODE; Braasch H, 2000, RUSS J NEMATOL, V8, P1; BRAASCH H, 2001, EPPO B, V31, P127, DOI DOI 10.5935/0103-5053.20160142; Burr A.H. Jay, 2004, P25, DOI 10.1079/9780851998183.0025; CHITWOOD B. G., 1936, PROC HELMINTH SOC WASHINGTON, V3, P39; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Decraemer W, 2003, BIOL REV, V78, P465, DOI 10.1017/S1464793102006115; EDGAR RS, 1982, J NEMATOL, V14, P248; Gems D, 1996, P NATL ACAD SCI USA, V93, P1665, DOI 10.1073/pnas.93.4.1665; Giblin RM, 1983, REV NEMATOL, V7, P177; Giblin RM, 1984, REV NEMATOL, V6, P39; Giblin-Davis RM, 2005, J NEMATOL, V37, P336; Giblin-Davis RM, 2006, J NEMATOL, V38, P150; GIBLINDAVIS RM, 1993, J NEMATOL, V25, P161; GRIFFITH R, 1987, PLANT DIS, V71, P193; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNT DJ, 1974, NEMATOLOGICA, V20, P174, DOI 10.1163/187529274X00140; Hunt DJ, 1993, APHELENCHIDA LONGIDO; JONES JT, 1993, FUND APPL NEMATOL, V16, P433; Kadoya Y, 2010, INTEGRATED IMAGING R; Kanzaki N, 2003, NEMATOLOGY, V5, P565, DOI 10.1163/156854103322683283; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2001, NEMATOLOGY, V3, P473, DOI 10.1163/156854101753250809; Kanzaki N, 2000, NEMATOLOGY, V2, P165, DOI 10.1163/156854100509051; Kanzaki N., 2012, PRACTICAL PLANT NEMA, P161; Kanzaki N, 2016, VECTOR MEDIATED TRAN, P87, DOI DOI 10.1094/9780890545355.007; Kanzaki N, 2014, NEMATOLOGY, V16, P683, DOI 10.1163/15685411-00002797; Kanzaki N, 2013, J PARASITOL, V99, P803, DOI 10.1645/GE-3253.1; Kanzaki N, 2012, NEMATOLOGY, V14, P223, DOI 10.1163/138855411X587121; Kanzaki N, 2009, J PARASITOL, V95, P113, DOI 10.1645/GE-1633.1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; KONDO E, 1989, APPL ENTOMOL ZOOL, V24, P103, DOI 10.1303/aez.24.103; KONDO E, 1978, APPL ENTOMOL ZOOL, V13, P1; KONDO E, 1986, APPL ENTOMOL ZOOL, V21, P340, DOI 10.1303/aez.21.340; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; LEE DL, 1966, PARASITOLOGY, V56, P127, DOI 10.1017/S0031182000071158; LINIT MJ, 1988, J NEMATOL, V20, P227; Mamiya Y., 1975, Japanese Journal of Nematology., V5, P16; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Manton SM, 1937, J EXP BIOL, V14, P470; Neuhaus B, 1996, J PARASITOL, V82, P820, DOI 10.2307/3283897; Poinar GO., 1975, ENTOMOGENOUS NEMATOD; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasband WS., 2014, IMAGE J; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; SAUNDERS JOSEPH L., 1961, ANN ENT SOC AMER, V54, P792, DOI 10.1093/aesa/54.6.792; Shimizu A, 2013, ENVIRON ENTOMOL, V42, P79, DOI 10.1603/EN12165; Tanaka R, 2012, APPL ENTOMOL ZOOL, V47, P291, DOI 10.1007/s13355-012-0115-9; Tanaka SE, 2014, NEMATOLOGY, V16, P259, DOI 10.1163/15685411-00002763; TANG L, 1994, INFECT IMMUN, V62, P961, DOI 10.1128/IAI.62.3.961-967.1994; Tomalak M, 2015, NEMATOLOGY, V17, P1165, DOI 10.1163/15685411-00002931; Tomalak M, 2013, NEMATOLOGY, V15, P907, DOI 10.1163/15685411-00002729; WEBER P, 1984, TROPENMED PARASITOL, V35, P221; Wharton D. A, 1986, FUNCTIONAL BIOL NEMA; WINGFIELD MJ, 1983, CAN J FOREST RES, V13, P1068, DOI 10.1139/x83-143; WINGFIELD MJ, 1983, PLANT DIS, V67, P35, DOI 10.1094/PD-67-35; WISSE E, 1968, J ULTRA MOL STRUCT R, V24, P210, DOI 10.1016/S0022-5320(68)90059-2; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; WRIGHT JC, 1989, TISSUE CELL, V21, P263, DOI 10.1016/0040-8166(89)90071-2; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; [No title captured]	68	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179465	10.1371/journal.pone.0179465	http://dx.doi.org/10.1371/journal.pone.0179465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622353	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300035
J	Habib, C; Yu, YY; Gozzi, K; Ching, C; Shemesh, M; Chai, YR				Habib, Cameron; Yu, Yiyang; Gozzi, Kevin; Ching, Carly; Shemesh, Moshe; Chai, Yunrong			Characterization of the regulation of a plant polysaccharide utilization operon and its role in biofilm formation in Bacillus subtilis	PLOS ONE			English	Article							BETA-GALACTOSIDASE; MASTER REGULATOR; GENE; BIOCONTROL; CCPA; DEGRADATION; PLASMIDS; GALACTAN; GLUCOSE; PROTEIN	The soil bacterium Bacillus subtilis is often found in association with plants in the rhizosphere. Previously, plant polysaccharides have been shown to stimulate formation of root-associated multicellular communities, or biofilms, in this bacterium, yet the underlying mechanism is not fully understood. A five-gene gan operon (ganSPQAB) in B. subtilis has recently been shown to be involved in utilization of the plant-derived polysaccharide galactan. Despite these findings, molecular details about the regulation of the operon and the role of the operon in biofilm formation remain elusive. In this study, we performed comprehensive genetic analyses on the regulation of the gan operon. We show that this operon is regulated both by a LacI-like transcription repressor (GanR), which directly binds to pairs of inverted DNA repeats in the promoter region of the operon, and by the catabolite control protein A ( CcpA). Derepression can be triggered by the presence of the inducer beta-1,4-galactobiose, a hydrolysis product of galactan, or in situ when B. subtilis cells are associated with plant roots. In addition to the transcriptional regulation, the encoded beta-galactosidase GanA (by ganA), which hydrolyzes beta-1,4-galactobiose into galactose, is inhibited at the enzymatic level by the catalytic product galactose. Thus, the galactan utilization pathway is under complex regulation involving both positive and negative feedback mechanisms in B. subtilis. We discuss about the biological significance of such complex regulation as well as a hypothesis of biofilm induction by galactan via multiple mechanisms.	[Habib, Cameron; Yu, Yiyang; Gozzi, Kevin; Ching, Carly; Chai, Yunrong] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Shemesh, Moshe] Agr Res Org, Volcani Ctr, Rishon Leziyyon, Israel; [Gozzi, Kevin] MIT, Dept Biol, Cambridge, MA USA	Northeastern University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Massachusetts Institute of Technology (MIT)	Chai, YR (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	y.chai@northeastern.edu	Shemesh, Moshe/AAR-7506-2020	Shemesh, Moshe/0000-0002-3854-6151; Gozzi, Kevin/0000-0002-1168-1425	Northeastern University; Provost Research Fund from Northeastern University	Northeastern University; Provost Research Fund from Northeastern University	This work was supported by a start-up grant from Northeastern University and in part by the National Science Foundation (CAREER_1651732) to YC.KG was supported by a Provost Research Fund from Northeastern University.	Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cairns LS, 2014, MOL MICROBIOL, V93, P587, DOI 10.1111/mmi.12697; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Chai YR, 2011, EMBO J, V30, P1402, DOI 10.1038/emboj.2011.36; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniel RA, 1997, J BACTERIOL, V179, P5636, DOI 10.1128/jb.179.17.5636-5638.1997; Duanis-Assaf D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01517; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; ERRINGTON J, 1990, J BACTERIOL, V172, P488, DOI 10.1128/JB.172.1.488-490.1990; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; GRYCZAN TJ, 1978, J BACTERIOL, V134, P318, DOI 10.1128/JB.134.1.318-329.1978; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobley L, 2013, P NATL ACAD SCI USA, V110, P13600, DOI 10.1073/pnas.1306390110; Huppert LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096267; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Krispin O, 1998, J BACTERIOL, V180, P2265, DOI 10.1128/JB.180.8.2265-2270.1998; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Marciniak BC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-401; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ochiai A, 2007, APPL ENVIRON MICROB, V73, P3803, DOI 10.1128/AEM.00147-07; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ryttersgaard C, 2004, J MOL BIOL, V341, P107, DOI 10.1016/j.jmb.2004.05.017; SAKAMOTO T, 1994, BIOSCI BIOTECH BIOCH, V58, P353, DOI 10.1271/bbb.58.353; Sambrook JD, 2001, LAB MANUAL; Schroeder JW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01085-13; Shaikh FA, 2007, FEBS LETT, V581, P2441, DOI 10.1016/j.febslet.2007.04.053; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Shipkowski S, 2006, APPL ENVIRON MICROB, V72, P7730, DOI 10.1128/AEM.01306-06; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Soldo B, 2003, GENE, V319, P65, DOI 10.1016/S0378-1119(03)00793-5; Solomon HV, 2013, ACTA CRYSTALLOGR F, V69, P1114, DOI 10.1107/S1744309113023609; Soriano M, 2006, MICROBIOL-SGM, V152, P617, DOI 10.1099/mic.0.28562-0; Subramaniam AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01501; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Tobisch S, 1999, J BACTERIOL, V181, P6996, DOI 10.1128/JB.181.22.6996-7004.1999; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Watzlawick H, 2016, J BACTERIOL, V198, P2887, DOI 10.1128/JB.00468-16; Yan F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01025; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zeriouh H, 2014, ENVIRON MICROBIOL, V16, P2196, DOI 10.1111/1462-2920.12271	58	9	9	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179761	10.1371/journal.pone.0179761	http://dx.doi.org/10.1371/journal.pone.0179761			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617843	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600058
J	Sakane, Y; Kanamoto, N; Yamauchi, I; Tagami, T; Morita, Y; Miura, M; Sone, M; Yasoda, A; Kimura, T; Nakao, K; Inagaki, N				Sakane, Yoriko; Kanamoto, Naotetsu; Yamauchi, Ichiro; Tagami, Tetsuya; Morita, Yusuke; Miura, Masako; Sone, Masakatsu; Yasoda, Akihiro; Kimura, Takeshi; Nakao, Kazuwa; Inagaki, Nobuya			Regulation of type 1 iodothyronine deiodinase by LXR alpha	PLOS ONE			English	Article							THYROID-HORMONE RECEPTORS; LIVER-X; RETINOIC-ACID; NUCLEAR RECEPTORS; RESPONSE ELEMENT; TRANSCRIPTIONAL REGULATION; DIRECT REPEATS; DNA-BINDING; GENE; T0901317	The iodothyronine deiodinases are selenoenzymes that regulate the activity of thyroid hormone via specific inner- or outer-ring deiodination. In humans, type 1 deiodinase (D1) is highly expressed in the liver, but the mechanism by which its gene expression is regulated remains to be elucidated. Liver X receptor a (LXR alpha), a transcription factor of the nuclear receptor superfamily, is highly expressed in the liver, where it functions as a sensor for excess intracellular oxysterols. LXR alpha interacts with other nuclear receptors on promoters of genes that contain a binding core sequence for nuclear receptors. In addition, it is reported that the promoter of the gene encoding human D1 (hDIO1) contains the core sequence for one of nuclear receptors, thyroid hormone receptor (TR). We investigated the involvement of LXR alpha in the regulation of hDIO1, in the liver. We performed hDIO1 promoter-reporter assays using a synthetic LXR agonist, T0901317, and compared promoter activity between a human liver carcinoma cell line, HepG2, and a clone of human embryonic kidney cells, TSA201. We defined the region between nucleotides -131 and -114, especially nucleotides -126 and -125, of the hDIO1 promoter as critical for basal and LXR alpha-mediated specific transcriptional activation in HepG2 cells. An increase in hDIO1 expression was observed in LXR alpha-stimulated cells, but absent in cycloheximide-treated cells, indicating that new protein synthesis is required for LXR alpha-mediated regulation of hDIO1. On the other hand, electrophoretic mobility shift assays revealed that LXR alpha and RXRa bound to the hDIO1 promoter. We also demonstrated that LXR alpha and TR alpha compete with each other on this specific region of the promoter. In conclusion, our results indicated that LXR alpha plays a specific and important role in activation of TH by regulating D1, and that LXR alpha binds to and regulates the hDIO1 promoter, competing with TRa on specific sequences within the promoter.	[Sakane, Yoriko; Kanamoto, Naotetsu; Yamauchi, Ichiro; Miura, Masako; Sone, Masakatsu; Yasoda, Akihiro; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Tagami, Tetsuya] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Div Endocrinol & Metab, Kyoto, Japan; [Morita, Yusuke; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Sakane, Yoriko] Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Kyoto, Japan; [Kanamoto, Naotetsu] Osaka City Gen Hosp, Dept Endocrinol, Osaka, Japan; [Miura, Masako] Rakuwakai Otowa Hosp, Dept Endocrinol, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Osaka City General Hospital	Kanamoto, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.; Kanamoto, N (corresponding author), Osaka City Gen Hosp, Dept Endocrinol, Osaka, Japan.	kyotetsu@kuhp.kyoto-u.ac.jp	Kanamoto, Naotetsu/ABE-5569-2021	Kanamoto, Naotetsu/0000-0002-4541-0981; Yamauchi, Ichiro/0000-0002-4236-502X	JSPS KAKENHI [16H06902]; MEXT KAKENHI [21229013, 20790659, 18790635, 19591075]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16H06902, 17K19654] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Number 16H06902), MEXT KAKENHI (Grant Numbers 21229013, 20790659, 18790635, and 19591075; https://www.jsps.go.jp/j-grantsinaid/), and Takeda Science Foundation (http://www.takeda-sci.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by JSPS KAKENHI (Grant Number 16H06902), MEXT KAKENHI (Grant Numbers 21229013, 20790659, 18790635, and 19591075), and the Takeda Science Foundation. We gratefully acknowledge the work of past and present members of our laboratory and our discussions with them, which have helped to shape many of the ideas presented here.	Ahmed AH, 2011, J CLIN ENDOCR METAB, V96, P2904, DOI 10.1210/jc.2011-0138; Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Ayers S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081186; Berkenstam A, 2004, MECH AGEING DEV, V125, P707, DOI 10.1016/j.mad.2004.05.005; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; Davies JS, 2008, ENDOCRINE, V33, P196, DOI 10.1007/s12020-008-9067-9; Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; Hashimoto K, 2006, J BIOL CHEM, V281, P295, DOI 10.1074/jbc.M507877200; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Houck KA, 2004, MOL GENET METAB, V83, P184, DOI 10.1016/j.ymgme.2004.07.007; Huuskonen J, 2004, BIOCHEMISTRY-US, V43, P1626, DOI 10.1021/bi0301643; Ishida E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054901; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kanamoto N, 2012, ENDOCRINOLOGY, V153, P492, DOI 10.1210/en.2011-1310; KATZ RW, 1994, J BIOL CHEM, V269, P18915; Koenig RJ, 2005, THYROID, V15, P835, DOI 10.1089/thy.2005.15.835; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; SCHRECK R, 1994, J CLIN ENDOCR METAB, V79, P791, DOI 10.1210/jc.79.3.791; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; Zhang YQ, 2001, J BIOL CHEM, V276, P974, DOI 10.1074/jbc.M005894200; Zhao LF, 2012, DIABETES, V61, P1062, DOI 10.2337/db11-1255	38	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179213	10.1371/journal.pone.0179213	http://dx.doi.org/10.1371/journal.pone.0179213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617824	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600025
J	Borin, TF; Shankar, A; Angara, K; Rashid, MH; Jain, M; Iskander, A; Ara, R; Lebedyeva, I; Korkaya, H; Achyut, BR; Arbab, AS				Borin, Thaiz F.; Shankar, Adarsh; Angara, Kartik; Rashid, Mohammad H.; Jain, Meenu; Iskander, Asm; Ara, Roxan; Lebedyeva, Iryna; Korkaya, Hasan; Achyut, Bhagelu R.; Arbab, Ali S.			HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SUPPRESSOR-CELLS; STEM-CELLS; DISTANT METASTASIS; ERK 1/2; RESISTANCE; EXPRESSION; GROWTH; PROTEINS; PATHWAY	Distant metastasis is the primary cause of death in the majority of the cancer types. Recently, much importance has been given to tumor microenvironment (TME) in the development of invasive malignant tumors, as well as the metastasis potential. The ability of tumor cells to modulate TME and to escape immune-mediated attack by releasing immunosuppressive cytokines has become a hallmark of breast cancer. Our study shows the effect of IV formulation of HET0016 (HPBCD-HET0016) a selective inhibitor of 20-HETE synthesis, administered intravenously in immune-competent in vivo mouse model of murine breast cancer. 4T1 luciferase positive cells were implanted to the mammary fat pad in Balb/c mice. Treatment started on day 15, and was administered for 5 days a week for 3 weeks. The development of metastasis was detected via optical imaging. Blood, spleen, lungs, bone marrow and tumor were collected for flow cytometry, to investigate changes in myeloid-derived suppressive cells (MDSCs) populations and endothelial phenotype. Tumor and lungs were collected for protein analysis. Our results show that HPBCD-HET0016: (1) decreased tumor volume and lung metastasis compared to the vehicle group; (2) reduced migration and invasion of tumor cells and levels of metalloproteinases in the lungs of animals treated with HPBCD-HET0016 via PI3K/AKT pathway; and (3) decreased expression of pro-inflammatory cytokines, growth factors and granulocytic MDSCs population in the lung microenvironment in treated animals. Thus, HPBCD-HET0016 showed potential in treating lung metastasis in a preclinical mouse model and needs further investigations on TME.	[Borin, Thaiz F.; Shankar, Adarsh; Angara, Kartik; Rashid, Mohammad H.; Jain, Meenu; Iskander, Asm; Ara, Roxan; Korkaya, Hasan; Achyut, Bhagelu R.; Arbab, Ali S.] Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA; [Lebedyeva, Iryna] Augusta Univ, Dept Chem & Phys, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Borin, TF; Arbab, AS (corresponding author), Augusta Univ, Georgia Canc Ctr, Augusta, GA 30912 USA.	tborin@augusta.edu; aarbab@augusta.edu	Korkaya, Hasan/ABD-6282-2020; Rashid, Mohammad Harun/E-3985-2019; Borin, Thaiz Ferraz/E-8013-2012; Korkaya, Hasan/GRY-1016-2022; Arbab, Ali/AAS-1933-2020	Korkaya, Hasan/0000-0002-0719-5862; Rashid, Mohammad Harun/0000-0003-1056-4910; Borin, Thaiz Ferraz/0000-0003-1464-9823; Angara, Kartik/0000-0002-6334-9301	National Institutes of Health (NIH) [R01CA160216, R01CA172048]; Georgia Cancer Center; NATIONAL CANCER INSTITUTE [R01CA160216, R01CA172048] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (NIH) grants R01CA160216 and R01CA172048, and from startup fund from Georgia Cancer Center.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bebenek M, 2013, WSPOLCZESNA ONKOL, V17, P120, DOI 10.5114/wo.2013.34612; Borin TF, 2016, J PINEAL RES, V60, P3, DOI 10.1111/jpi.12270; Borin TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116247; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Cochaud S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03456; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; Draghiciu O, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/21624011.2014.954829; Escobar P, 2015, ONCOTARGET, V6, P29034, DOI 10.18632/oncotarget.4732; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Jain M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41809; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Johnson Amanda L, 2015, Adv Pharmacol, V74, P223, DOI 10.1016/bs.apha.2015.05.002; Kimbung S, 2015, SEMIN CANCER BIOL, V35, P85, DOI 10.1016/j.semcancer.2015.08.009; Kryczek I, 2011, J IMMUNOL, V186, P4388, DOI 10.4049/jimmunol.1003251; Lim YC, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0748-6; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Monu NR, 2012, IMMUNOL INVEST, V41, P595, DOI 10.3109/08820139.2012.673191; Morita Yoshihiro, 2016, Mol Ther Nucleic Acids, V5, pe399, DOI 10.1038/mtna.2016.103; Narasimhan P, 2009, STROKE, V40, P1467, DOI 10.1161/STROKEAHA.108.534644; Olimon-Andalon V, 2015, TUMOR BIOL, V36, P3669, DOI 10.1007/s13277-014-3005-7; Pan PY, 2008, BLOOD, V111, P219, DOI 10.1182/blood-2007-04-086835; Semenza GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI 10.1016/j.bbamcr.2015.05.036; Shankar A, 2016, ONCOTARGETS THER, V9, P1205, DOI 10.2147/OTT.S93790; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Simonetti S, 2012, BREAST, V21, P165, DOI 10.1016/j.breast.2011.09.004; Tabaries S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0558-3; Taherian A, 2012, IRAN J BASIC MED SCI, V15, P669; Wang Z, 2016, INT J BIOL MARKERS; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Weidle UH, 2016, CANCER GENOM PROTEOM, V13, P129; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Yiicel B, 2014, AUSTIN J MED ONCOL, V1, P7; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Yu W, 2011, CANCER CHEMOTH PHARM, V68, P619, DOI 10.1007/s00280-010-1521-8; Zheng H, 2014, TOXICOL APPL PHARM, V280, P10, DOI 10.1016/j.taap.2014.07.018	41	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178830	10.1371/journal.pone.0178830	http://dx.doi.org/10.1371/journal.pone.0178830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609459	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700016
J	Nobrega, RLB; Guzha, AC; Torres, GN; Kovacs, K; Lamparter, G; Amorim, RSS; Couto, E; Gerold, G				Nobrega, Rodolfo L. B.; Guzha, Alphonce C.; Torres, Gilmar N.; Kovacs, Kristof; Lamparter, Gabriele; Amorim, Ricardo S. S.; Couto, Eduardo; Gerold, Gerhard			Effects of conversion of native cerrado vegetation to pasture on soil hydro-physical properties, evapotranspiration and streamflow on the Amazonian agricultural frontier	PLOS ONE			English	Article							LAND-USE CHANGE; BRAZILIAN CERRADO; ENERGY-BALANCE; HYDRAULIC-PROPERTIES; WATER; COVER; RUNOFF; RIVER; CONSERVATION; COMPACTION	Understanding the impacts of land-use change on landscape-hydrological dynamics is one of the main challenges in the Northern Brazilian Cerrado biome, where the Amazon agricultural frontier is located. Motivated by the gap in literature assessing these impacts, we characterized the soil hydro-physical properties and quantified surface water fluxes from catchments under contrasting land-use in this region. We used data from field measurements in two headwater micro-catchments with similar physical characteristics and different land use, i.e. cerrado sensu stricto vegetation and pasture for extensive cattle ranching. We determined hydraulic and physical properties of the soils, applied ground-based remote sensing techniques to estimate evapotranspiration, and monitored streamflow from October 2012 to September 2014. Our results show significant differences in soil hydro-physical properties between the catchments, with greater bulk density and smaller total porosity in the pasture catchment. We found that evapotranspiration is smaller in the pasture ( 639 +/- 31% mm yr(-1)) than in the cerrado catchment ( 1,004 +/- 24% mm yr(-1)), and that streamflow from the pasture catchment is greater with runoff coefficients of 0.40 for the pasture and 0.27 for the cerrado catchment. Overall, our results confirm that conversion of cerrado vegetation to pasture causes soil hydro-physical properties deterioration, reduction in evapotranspiration reduction, and increased streamflow.	[Nobrega, Rodolfo L. B.; Guzha, Alphonce C.; Kovacs, Kristof; Lamparter, Gabriele; Gerold, Gerhard] Univ Goettingen, Fac Geosci & Geog, Dept Phys Geog, Gottingen, Germany; [Torres, Gilmar N.; Amorim, Ricardo S. S.; Couto, Eduardo] Univ Fed Mato Grosso, Dept Soil & Agr Engn, Cuiaba, MT, Brazil; [Torres, Gilmar N.] CIFOR, World Agroforestry Ctr, USDA Forest Serv, Int Programs, Nairobi, Kenya	University of Gottingen; Universidade Federal de Mato Grosso; CGIAR; Center for International Forestry Research (CIFOR); World Agroforestry (ICRAF)	Nobrega, RLB (corresponding author), Univ Goettingen, Fac Geosci & Geog, Dept Phys Geog, Gottingen, Germany.	rodolfo.nobrega@geo.uni-gottingen.de	Nóbrega, Rodolfo/M-7800-2016; Torres, Gilmar/D-4633-2013; Couto, Eduardo Guimarães/AAF-5790-2019; Couto, Eduardo Guimarães/E-4240-2010; Torres, Gilmar/AAG-6583-2021; AMORIM, RICARDO S S/K-2587-2012; Torres, Gilmar Nunes/AAG-5147-2019	Nóbrega, Rodolfo/0000-0002-9858-8222; Torres, Gilmar/0000-0003-4307-415X; Couto, Eduardo Guimarães/0000-0002-5271-9709; Couto, Eduardo Guimarães/0000-0002-5271-9709; AMORIM, RICARDO S S/0000-0002-4570-1770; Torres, Gilmar Nunes/0000-0003-4307-415X	Bundesministerin fur Bildung und Forschung (CarBioCial project) [01LL0902A]; Fundacao de Amparo a Pesquisa do Estdo de Mato Grosso [335908/2012]; Brazilian National Council for Scientific and Technological Development [481990/2013-5]; German Research Foundation; Open Access Publication Funds of the Gottingen University; German Academic Exchange Service (DAAD); CAPES	Bundesministerin fur Bildung und Forschung (CarBioCial project)(Federal Ministry of Education & Research (BMBF)); Fundacao de Amparo a Pesquisa do Estdo de Mato Grosso; Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was feasible thanks to the support of the Bundesministerin fur Bildung und Forschung (www.bmbf.de) through its grant to GG (CarBioCial project, grant number: 01LL0902A). The authors also acknowledge the financial support of the Fundacao de Amparo a Pesquisa do Estdo de Mato Grosso (www.fapemat.mt.gov.br; grant number: 335908/2012) and the Brazilian National Council for Scientific and Technological Development (www.cnpq.br; grant number: 481990/2013-5) to RSSA, the German Research Foundation and the Open Access Publication Funds of the Gottingen University to RLBN, and the German Academic Exchange Service (DAAD) and CAPES for the financial support to RLBN and GNT, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar Danielle B. S. de, 2006, Eng. Agríc., V26, P103, DOI 10.1590/S0100-69162006000100012; Alho Cleber J. R, 2012, Estud. av., V26, P151, DOI 10.1590/S0103-40142012000100011; Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Allen R, 2011, HYDROL PROCESS, V25, P4011, DOI 10.1002/hyp.8408; Allen RG, 2007, J IRRIG DRAIN ENG, V133, P380, DOI 10.1061/(ASCE)0733-9437(2007)133:4(380); Andrade RG, 2014, PROC SPIE, V9239, DOI 10.1117/12.2067225; ASCE-EWRI, 2005, ASCE STANDARDIZED RE, P213; Ataide KRP, 2015, P 18 S BRAS SENS REM, P6381; Baker DB, 2004, J AM WATER RESOUR AS, V40, P503, DOI 10.1111/j.1752-1688.2004.tb01046.x; Ballester MVR, 2003, REMOTE SENS ENVIRON, V87, P429, DOI 10.1016/j.rse.2002.10.001; Bastiaanssen WGM, 1998, J HYDROL, V212, P213, DOI [10.1016/S0022-1694(98)00254-6, 10.1016/S0022-1694(98)00253-4]; Bastiaanssen WGM, 2000, J HYDROL, V229, P87, DOI 10.1016/S0022-1694(99)00202-4; Beuchle R, 2015, APPL GEOGR, V58, P116, DOI 10.1016/j.apgeog.2015.01.017; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; Bruijnzeel LA, 2004, AGR ECOSYST ENVIRON, V104, P185, DOI 10.1016/j.agee.2004.01.015; BRUIJNZEEL LA, 2005, INT HYDROL SER, P462; Burke W, 1986, SOIL STRUCTURE ASSES; Burt TP, 2015, WATER RESOUR RES, V51, P5919, DOI 10.1002/2014WR016839; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; CARTER MR, 1988, SOIL TILL RES, V12, P37, DOI 10.1016/0167-1987(88)90054-2; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Chaplot V, 2000, SOIL SCI, V165, P961, DOI 10.1097/00010694-200012000-00006; Chaves J, 2008, HYDROL PROCESS, V22, P1766, DOI 10.1002/hyp.6803; Coe MT, 2009, J HYDROL, V369, P165, DOI 10.1016/j.jhydrol.2009.02.043; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; da Rocha HR, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000640; da Silva BB, 2015, ECOHYDROLOGY, V8, P1272, DOI 10.1002/eco.1580; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; de Moraes JM, 2006, HYDROL PROCESS, V20, P2509, DOI 10.1002/hyp.6213; de Oliveira OC, 2004, AGR ECOSYST ENVIRON, V103, P289, DOI 10.1016/j.agee.2003.12.004; DIAB M, 1988, GEODERMA, V43, P143, DOI 10.1016/0016-7061(88)90040-7; Drewry JJ, 2008, AUST J SOIL RES, V46, P237, DOI 10.1071/SR07125; Eckhardt K, 2005, HYDROL PROCESS, V19, P507, DOI 10.1002/hyp.5675; EMBRAPA, 1997, MANUAL METODOS ANALI; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Farrick KK, 2013, HYDROL PROCESS, V27, P3254, DOI 10.1002/hyp.9935; Felfili J.M., 2001, CERRADO CARACTERIZAC, P195; FELFILI JM, 1992, NATURE AND DYNAMICS OF FOREST-SAVANNA BOUNDARIES, P393; Figueiredo RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001200; Furley PA, 1999, GLOBAL ECOL BIOGEOGR, V8, P223, DOI 10.1046/j.1466-822X.1999.00142.x; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Germer S, 2009, J HYDROL, V364, P349, DOI 10.1016/j.jhydrol.2008.11.013; Germer S, 2010, J HYDROL, V380, P473, DOI 10.1016/j.jhydrol.2009.11.022; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Giambelluca TW, 2009, AGR FOREST METEOROL, V149, P1365, DOI 10.1016/j.agrformet.2009.03.006; GOODLAND R, 1971, J ECOL, V59, P411, DOI 10.2307/2258321; GOODLAND R, 1973, J ECOL, V61, P219, DOI 10.2307/2258929; Greenwood KL, 2001, AUST J EXP AGR, V41, P1231, DOI 10.1071/EA00102; Guzha AC, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P1833; Guzha AC, 2015, HYDROL PROCESS, V29, P508, DOI 10.1002/hyp.10161; Guzha AC, 2013, IAHS-AISH P, V359, P346; Hamza MA, 2005, SOIL TILL RES, V82, P121, DOI 10.1016/j.still.2004.08.009; Hayhoe SJ, 2011, GLOBAL CHANGE BIOL, V17, P1821, DOI 10.1111/j.1365-2486.2011.02392.x; Herbst M, 2006, GEODERMA, V132, P206, DOI 10.1016/j.geoderma.2005.05.008; Herbst M, 2002, PHYS CHEM EARTH, V27, P701, DOI 10.1016/S1474-7065(02)00054-2; Hoffmann WA, 2005, OECOLOGIA, V145, P307, DOI 10.1007/s00442-005-0129-x; Hunke P., 2015, GEODERMA REG, V4, P31, DOI DOI 10.1016/J.GE0DRS.2014.12.001; Hunke P, 2015, ECOHYDROLOGY, V8, P1154, DOI 10.1002/eco.1573; IUSS Working Group WRB, 2014, WORLD REFERENCE BASE, DOI [10.1017/S0014479706394902, DOI 10.1017/S0014479706394902]; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jepson W, 2005, GEOGR J, V171, P99, DOI 10.1111/j.1475-4959.2005.00153.x; Jepson W, 2010, ANN ASSOC AM GEOGR, V100, P87, DOI 10.1080/00045600903378960; Juhasz CEP, 2007, SCI AGR, V64, P344, DOI 10.1590/S0103-90162007000400005; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Lapola DM, 2011, EARTH INTERACT, V15, DOI 10.1175/2010EI333.1; Lathuilliere MJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024024; Lim KJ, 2005, J AM WATER RESOUR AS, V41, P1407, DOI 10.1111/j.1752-1688.2005.tb03808.x; Lim KJ, 2010, COMPUT GEOSCI-UK, V36, P936, DOI 10.1016/j.cageo.2010.01.004; Lima JEFW, 2000, DETERMINACAO EVAPOTR; Lin HS, 1998, SOIL SCI, V163, P2, DOI 10.1097/00010694-199801000-00002; LOGSDON SD, 1990, SOIL SCI SOC AM J, V54, P1096, DOI 10.2136/sssaj1990.03615995005400040029x; Marcuzzo FFN., 2011, REV BRASILEIRA RECUR, V16, P157, DOI [10.21168/rbrh.v16n4.p157-167, DOI 10.21168/RBRH.V16N4.P157-167]; Marimon Beatriz Schwantes, 2010, Acta Amaz., V40, P107, DOI 10.1590/S0044-59672010000100014; Martinez LJ, 2004, SOIL TILL RES, V75, P3, DOI 10.1016/j.still.2003.12.001; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mkhwanazi M, 2015, REMOTE SENS-BASEL, V7, P15046, DOI 10.3390/rs71115046; Montanari R, 2012, PRECIS AGRIC, V13, P542, DOI 10.1007/s11119-012-9265-6; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Munoz-Villers LE, 2013, HYDROL EARTH SYST SC, V17, P3543, DOI 10.5194/hess-17-3543-2013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neill C, 2001, ECOL APPL, V11, P1817, DOI 10.1890/1051-0761(2001)011[1817:DFPANA]2.0.CO;2; Neill C, 2013, WATERSHED RESPONSES; Neill C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0425; Neill C, 2011, BIOGEOCHEMISTRY, V105, P7, DOI 10.1007/s10533-011-9597-8; Ogden FL, 2013, WATER RESOUR RES, V49, P8443, DOI 10.1002/2013WR013956; Oliveira PTS, 2015, HYDROL EARTH SYST SC, V19, P2899, DOI 10.5194/hess-19-2899-2015; Oliveira PTS, 2014, WATER RESOUR RES, V50, P7100, DOI 10.1002/2013WR015202; Oliveira RS, 2005, FUNCT ECOL, V19, P574, DOI 10.1111/j.1365-2435.2005.01003.x; Paco TA, 2014, J HYDROL, V519, P2067, DOI 10.1016/j.jhydrol.2014.09.075; Dias LCP, 2015, J HYDROL-REG STUD, V4, P108, DOI 10.1016/j.ejrh.2015.05.010; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Recha JW, 2012, EARTH INTERACT, V16, DOI 10.1175/2012EI000439.1; Richard L.A., 1949, AGR ENG, V28, P451; Richey JE, 2011, BIOGEOCHEMISTRY, V105, P1, DOI 10.1007/s10533-011-9622-y; Roa-Garcia MC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009582; Ruhoff AL, 2012, REMOTE SENS-BASEL, V4, P703, DOI 10.3390/rs4030703; Sanchez-Azofeifa GA, 2005, BIOTROPICA, V37, P477, DOI 10.1111/j.1744-7429.2005.00066.x; Sano EE, 2007, INT J REMOTE SENS, V28, P2739, DOI 10.1080/01431160600981517; Sano EE, 2008, PESQUI AGROPECU BRAS, V43, P153, DOI 10.1590/S0100-204X2008000100020; SANTOS H.G. dos, 2018, SISTEMA BRASILEIRO C, V5; Santos JC, 2011, TROP CONSERV SCI, V4, P276, DOI 10.1177/194008291100400306; Scheffler R, 2011, AGR ECOSYST ENVIRON, V144, P281, DOI 10.1016/j.agee.2011.08.016; Scherer-Warren M., 2012, REV BRAS GEOGR FISIC, P361; Scherer-Warren M, 2013, ESTIMATIVA EVAPOTRAN; Schneider R, 1963, GROUND WATER PROVINC; Silva C. L., 1999, Revista Brasileira de Ciencia do Solo, V23, P695, DOI 10.1590/S0100-06831999000300024; Smith J, 1998, ENVIRON MODEL ASSESS, V3, P31, DOI DOI 10.1023/A:1019094218552; Soil Survey Staff, 2014, ILL GUID SOIL TAX IG; Tomasella J, 2009, GEOPHYS MONOGR SER, V186, P505, DOI 10.1029/2008GM000727; Troch PA, 2015, WATER RESOUR RES, V51, P4903, DOI 10.1002/2015WR017032; Valpassos MAR, 2001, PESQUI AGROPECU BRAS, V36, P1539, DOI 10.1590/S0100-204X2001001200011; VOGEL RM, 1994, J WATER RES PL-ASCE, V120, P485, DOI 10.1061/(ASCE)0733-9496(1994)120:4(485); VOLTZ M, 1994, GEODERMA, V62, P109, DOI 10.1016/0016-7061(94)90031-0; Williams MR, 1997, BIOGEOCHEMISTRY, V38, P67, DOI 10.1023/A:1005774431820; Wohl E, 2012, NAT CLIM CHANGE, V2, P655, DOI [10.1038/NCLIMATE1556, 10.1038/nclimate1556]; Zimmermann B, 2006, FOREST ECOL MANAG, V222, P29, DOI 10.1016/j.foreco.2005.10.070	117	45	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179414	10.1371/journal.pone.0179414	http://dx.doi.org/10.1371/journal.pone.0179414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609462	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000403274700035
J	Liu, ZL; Dugan, B; Masiello, CA; Gonnermann, HM				Liu, Zuolin; Dugan, Brandon; Masiello, Caroline A.; Gonnermann, Helge M.			Biochar particle size, shape, and porosity act together to influence soil water properties	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; PHYSICAL-PROPERTIES; CHEMICAL-PROPERTIES; CHARCOAL; REPELLENCY; RETENTION; IMPROVE; IMPACT	Many studies report that, under some circumstances, amending soil with biochar can improve field capacity and plant-available water. However, little is known about the mechanisms that control these improvements, making it challenging to predict when biochar will improve soil water properties. To develop a conceptual model explaining biochar's effects on soil hydrologic processes, we conducted a series of well constrained laboratory experiments using a sand matrix to test the effects of biochar particle size and porosity on soil water retention curves. We showed that biochar particle size affects soil water storage through changing pore space between particles (interpores) and by adding pores that are part of the biochar (intrapores). We used these experimental results to better understand how biochar intrapores and biochar particle shape control the observed changes in water retention when capillary pressure is the main component of soil water potential. We propose that biochar's intrapores increase water content of biochar-sand mixtures when soils are drier. When biochar-sand mixtures are wetter, biochar particles' elongated shape disrupts the packing of grains in the sandy matrix, increasing the volume between grains (interpores) available for water storage. These results imply that biochars with a high intraporosity and irregular shapes will most effectively increase water storage in coarse soils.	[Liu, Zuolin; Masiello, Caroline A.; Gonnermann, Helge M.] Rice Univ, Dept Earth Sci, MS, Houston, TX 77005 USA; [Masiello, Caroline A.] Rice Univ, Dept Chem, MS, Houston, MS USA; [Masiello, Caroline A.] Rice Univ, Dept Biosci, MS, Houston, MS USA; [Dugan, Brandon] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA	Rice University; Rice University; Rice University; Colorado School of Mines	Liu, ZL (corresponding author), Rice Univ, Dept Earth Sci, MS, Houston, TX 77005 USA.	zl17@rice.edu	Gonnermann, Helge M/B-1054-2012; Masiello, Caroline/A-2653-2011	Masiello, Caroline/0000-0003-2102-6229	National Science Foundation(US) [NSF-EAR-0911685]	National Science Foundation(US)(National Science Foundation (NSF))	This work was supported by National Science Foundation(US), grant number: NSF-EAR-0911685, URL: https://www.nsf.gov/. Description of the role: The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; ASTM International, 2008, D6836 ASTM INT, V4.09; Brady N.C, 2000, NATURE PROPERTIES SO; Brewer CE, 2014, BIOMASS BIOENERG, V66, P176, DOI 10.1016/j.biombioe.2014.03.059; Briggs C, 2012, SOIL SCI, V177, P263, DOI 10.1097/SS.0b013e3182482784; Brockhoff SR, 2010, AGRON J, V102, P1627, DOI 10.2134/agronj2010.0188; Carcaillet C, 2001, HOLOCENE, V11, P231, DOI 10.1191/095968301674071040; Deng XL, 2013, GRANUL MATTER, V15, P401, DOI 10.1007/s10035-013-0413-0; DURNER W, 1994, WATER RESOUR RES, V30, P211, DOI 10.1029/93WR02676; Githinji L, 2014, ARCH AGRON SOIL SCI, V60, P457, DOI 10.1080/03650340.2013.821698; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; Hansen V, 2016, SOIL TILL RES, V161, P1, DOI 10.1016/j.still.2016.03.002; Hardie M, 2014, PLANT SOIL, V376, P347, DOI 10.1007/s11104-013-1980-x; Herath HMSK, 2013, GEODERMA, V209, P188, DOI 10.1016/j.geoderma.2013.06.016; Hillel D., 1998, ENV SOIL PHYS; Jeffery S, 2015, GEODERMA, V251, P47, DOI 10.1016/j.geoderma.2015.03.022; Kaiser K, 2000, ORG GEOCHEM, V31, P711, DOI 10.1016/S0146-6380(00)00046-2; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; LeCroy C, 2013, SOIL BIOL BIOCHEM, V58, P248, DOI 10.1016/j.soilbio.2012.11.023; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, FRONT ECOL ENVIRON, V5, P381, DOI 10.1890/1540-9295(2007)5[381:BITB]2.0.CO;2; Letey J, 2000, J HYDROL, V231, P61, DOI 10.1016/S0022-1694(00)00183-9; Liu ZL, 2016, J HYDROL, V533, P461, DOI 10.1016/j.jhydrol.2015.12.007; Ma NN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154091; Major J, 2009, BIOCHAR ENV MANAGEME, P271; Marshall T.J., 1996, SOIL PHYS, DOI [10.1017/CBO9781139170673, DOI 10.1017/CBO9781139170673]; Masiello C, BIOCHAR EFFECTS SOIL; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Ojeda G, 2015, GEODERMA, V249, P1, DOI 10.1016/j.geoderma.2015.02.014; Omondi MO, 2016, GEODERMA, V274, P28, DOI 10.1016/j.geoderma.2016.03.029; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Schindler U, 2010, J PLANT NUTR SOIL SC, V173, P563, DOI 10.1002/jpln.200900201; Scott H. L., 2014, CAB Reviews, V9, P1, DOI 10.1079/PAVSNNR20149019; Shang J, 2008, J COLLOID INTERF SCI, V328, P299, DOI 10.1016/j.jcis.2008.09.039; Smetanova A, 2013, Z GEOMORPHOL, V57, P111, DOI 10.1127/0372-8854/2012/S-00117; Sorrenti G, 2016, SCI TOTAL ENVIRON, V563, P237, DOI 10.1016/j.scitotenv.2016.03.245; Streubel JD, 2011, SOIL SCI SOC AM J, V75, P1402, DOI 10.2136/sssaj2010.0325; Sun FF, 2014, J PLANT NUTR SOIL SC, V177, P26, DOI 10.1002/jpln.201200639; Sun H, 2012, IND ENG CHEM RES, V51, P3587, DOI 10.1021/ie201309r; Thies J.E, 2009, BIOCHAR ENV MANAGEME, P85, DOI [DOI 10.4324/9781849770552, 10.4324/9781849770552]; Doan TT, 2015, SCI TOTAL ENVIRON, V514, P147, DOI 10.1016/j.scitotenv.2015.02.005; TRYON EH, 1948, ECOL MONOGR, V18, P81, DOI 10.2307/1948629; VILLAUME JF, 1985, GROUND WATER MONIT R, V5, P60, DOI 10.1111/j.1745-6592.1985.tb00925.x; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Wang Y, 2013, ENERG FUEL, V27, P5890, DOI 10.1021/ef400972z; Wang Z, 2000, J HYDROL, V231, P76, DOI 10.1016/S0022-1694(00)00185-2; Waqas M, 2015, ENVIRON SCI POLLUT R, V22, P12114, DOI 10.1007/s11356-015-4432-8	48	101	105	19	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179079	10.1371/journal.pone.0179079	http://dx.doi.org/10.1371/journal.pone.0179079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598988	gold, Green Published, Green Submitted			2022-12-26	WOS:000402992000023
J	Pathan, EK; Ghormade, V; Deshpande, MV				Pathan, Ejaj K.; Ghormade, Vandana; Deshpande, Mukund V.			Selection of reference genes for quantitative real-time RT-PCR assays in different morphological forms of dimorphic zygomycetous fungus Benjaminiella poitrasii	PLOS ONE			English	Article							GLUTAMATE-DEHYDROGENASE RATIO; YEAST-MYCELIUM TRANSITION; MUCOR-CIRCINELLOIDES; NORMALIZATION; EXPRESSION; QUANTIFICATION; PATHOGENESIS; DERIVATIVES; GERMINATION; MUTANTS	Benjaminiella poitrasii, a dimorphic non-pathogenic zygomycetous fungus, exhibits a morphological yeast (Y) to hypha (H) reversible transition in the vegetative phase, sporangiospores (S) in the asexual phase and zygospores (Z) in the sexual phase. To study the gene expression across these diverse morphological forms, suitable reference genes are required. In the present study, 13 genes viz. ACT, 18S rRNA, eEF1a, eEF-Tu, eIF-1A, Tuba, Tub-b, Ubc, GAPDH, Try, WS-21, NADGDH and NADPGDH were evaluated for their potential as a reference, particularly for studying gene expression during the Y-H reversible transition and also for other asexual and sexual life stages of B. poitrasii. Analysis of RT-qPCR data using geNorm, normFinder and BestKeeper software revealed that genes such as Ubc, 18S rRNA and WS-21 were expressed at constant levels in each given subset of RNA samples from all the morphological phases of B. poitrasii. Therefore, these reference genes can be used to elucidate the role of morpho-genes in B. poitrasii. Further, use of the two most stably expressed genes (Ubc and WS-21) to normalize the expression of the ornithine decarboxylase gene (Bpodc) in different morphological forms of B. poitrasii, generated more reliable results, indicating that our selection of reference genes was appropriate.	[Pathan, Ejaj K.; Deshpande, Mukund V.] CSIR, AcSIR, Natl Chem Lab, Biochem Sci Div, Pune, Maharashtra, India; [Ghormade, Vandana] Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Department of Science & Technology (India); Agharkar Research Institute (ARI)	Deshpande, MV (corresponding author), CSIR, AcSIR, Natl Chem Lab, Biochem Sci Div, Pune, Maharashtra, India.	mv.deshpande@ncl.res.in			Department of Science and Technology, New Delhi; University Grants Commission, India	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India)	Authors are thankful to Department of Science and Technology, New Delhi for funding the project. EP thanks University Grants Commission, India for research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from Department of Science and Technology, New Delhi is gratefully acknowledged. EKP thanks University Grants Commission, India for research fellowship.	Amin A, 2004, ANTON LEEUW INT J G, V85, P327, DOI 10.1023/B:ANTO.0000020384.26238.48; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bavikar SN, 2008, BIOORG MED CHEM LETT, V18, P5512, DOI 10.1016/j.bmcl.2008.09.013; Blasco JL, 2002, RES MICROBIOL, V153, P155, DOI 10.1016/S0923-2508(02)01301-3; Bohle K, 2007, J BIOTECHNOL, V132, P353, DOI 10.1016/j.jbiotec.2007.08.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhary PM, 2015, INDIAN J CHEM B, V54, P908; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Ghormade V, 2000, NATURWISSENSCHAFTEN, V87, P236, DOI 10.1007/s001140050711; Ghormade V, 2005, J MYCOL PL PATHOL, V35, P442; Jimenez-Bremont JF, 2008, MICROBIOL RES, V163, P717, DOI 10.1016/j.micres.2008.05.001; Joshi CV, 2013, ANTON LEEUW INT J G, V104, P25, DOI 10.1007/s10482-013-9921-5; KHALE A, 1992, J BACTERIOL, V174, P3723, DOI 10.1128/JB.174.11.3723-3728.1992; KHALE A, 1990, ANTON LEEUW INT J G, V57, P37, DOI 10.1007/BF00400334; KHALEKUMAR A, 1993, J BACTERIOL, V175, P6052, DOI 10.1128/JB.175.18.6052-6055.1993; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Li QQ, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-22; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; O'Donnell K, 2001, MYCOLOGIA, V93, P286, DOI 10.2307/3761650; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; Sambrook J., 2001, MOL CLONING LAB MANU; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Valle-Maldonado MI, 2015, MOL BIOL REP, V42, P705, DOI 10.1007/s11033-014-3818-x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voigt K, 2001, GENE, V270, P113, DOI 10.1016/S0378-1119(01)00464-4; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	30	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0179454	10.1371/journal.pone.0179454	http://dx.doi.org/10.1371/journal.pone.0179454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598997	gold, Green Submitted, Green Published			2022-12-26	WOS:000402992000039
J	Patel, KR; Bai, Y; Trieu, KG; Barrios, J; Ai, XB				Patel, Kruti R.; Bai, Yan; Trieu, Kenneth G.; Barrios, Juliana; Ai, Xingbin			Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma	FASEB JOURNAL			English	Article						allergen; neuroplasticity; beta 2AR agonist	SMOOTH-MUSCLE-CELLS; INHALED CORTICOSTEROIDS; MUSCARINIC RECEPTORS; UNCONTROLLED ASTHMA; CA2+ OSCILLATIONS; OZONE EXPOSURE; LUNG-FUNCTION; EARLY-LIFE; CONTRACTION; ALLERGEN	Asthma often progresses into adulthood from early-life episodes of adverse environmental exposures. However, how the injury to developing lungs contributes to the pathophysiology of persistent asthma remains poorly understood. In this study, we identified an age-related mechanism along the cholinergic nerve-airway smooth muscle (ASM) axis that underlies prolonged airway hyperreactivity (AHR) in mice. We showed that ASM continued to mature until similar to 3 wk after birth. Coinciding with postnatal ASM maturation, there was a critical time window for the development of ASM hypercontractility after cholinergic stimulation. We found that allergen exposure in neonatal mice, but not in adult mice, elevated the level and activity of cholinergic nerves (termed neuroplasticity). We demonstrated that cholinergic neuroplasticity is necessary for the induction of persistent AHR after neonatal exposure during rescue assays in mice deficient in neuroplasticity. In addition, early intervention with cholinergic receptor muscarinic (ChRM)-3 blocker reversed the progression of AHR in the neonatal exposure model, whereas beta 2-adrenoceptor agonists had no such effect. Together, our findings demonstrate a functional relationship between cholinergic neuroplasticity and ASM contractile phenotypes that operates uniquely in early life to induce persistent AHR after allergen exposure. Targeting ChRM3 may have disease-modifying benefits in childhood asthma.-Patel, K. R., Bai, Y., Trieu, K. G., Barrios, J., Ai, X. Targeting acetylcholine receptor M3 prevents the progression of airway hyperreactivity in a mouse model of childhood asthma.	[Patel, Kruti R.] Harvard Med Sch, Brigham & Womens Hosp, Div Neurol, Boston, MA 02115 USA; [Bai, Yan; Trieu, Kenneth G.; Ai, Xingbin] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis Ave, Boston, MA 02115 USA; [Barrios, Juliana] Boston Univ, Sch Med, Div Pulm, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Ai, XB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis Ave, Boston, MA 02115 USA.	xai@partners.org		Patel, Kruti/0000-0002-4303-8717; Trieu, Kenneth/0000-0002-4851-1876	American Asthma Foundation [12-0086]; U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute [1R01HL116163, 1R01HL132991]; F31 Training Grant [HL007035]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116163, K08HL135443, R01HL132991, T32HL007035] Funding Source: NIH RePORTER	American Asthma Foundation; U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); F31 Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by an American Asthma Foundation Award 12-0086, and U.S. National Institutes of Health (NIH) National Heart, Lung and Blood Institute Grants 1R01HL116163 and 1R01HL132991 (to X.A.) and F31 Training Grant HL007035 (to J.B.). The authors declare no conflicts of interest.	Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; BERGER J, 1978, J TOXICOL ENV HEALTH, V4, P587, DOI 10.1080/15287397809529682; Boterman M, 2005, EUR J PHARMACOL, V516, P85, DOI 10.1016/j.ejphar.2005.04.029; Bradley SJ, 2016, P NATL ACAD SCI USA, V113, P4524, DOI 10.1073/pnas.1521706113; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Buehring B, 2013, J ALLERGY CLIN IMMUN, V132, P1019, DOI 10.1016/j.jaci.2013.08.040; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Carey SA, 2011, AM J PHYSIOL-LUNG C, V300, pL242, DOI 10.1152/ajplung.00177.2010; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Hunter DD, 2010, AM J RESP CELL MOL, V43, P750, DOI 10.1165/rcmb.2009-0191OC; Kajekar R, 2007, RESP PHYSIOL NEUROBI, V155, P55, DOI 10.1016/j.resp.2006.03.002; Kerstjens HAM, 2015, LANCET RESP MED, V3, P367, DOI 10.1016/S2213-2600(15)00031-4; Kerstjens HAM, 2011, J ALLERGY CLIN IMMUN, V128, P308, DOI 10.1016/j.jaci.2011.04.039; Kistemaker LEM, 2015, TRENDS PHARMACOL SCI, V36, P164, DOI 10.1016/j.tips.2014.11.005; Kistemaker LEM, 2014, AM J RESP CELL MOL, V50, P690, DOI 10.1165/rcmb.2013-0220OC; Kistemaker LEM, 2013, EUR RESPIR J, V42, P1677, DOI 10.1183/09031936.00112412; LARSEN GL, 1994, AM J PHYSIOL, V266, pL263, DOI 10.1152/ajplung.1994.266.3.L263; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Oenema TA, 2012, AM J PHYSIOL-LUNG C, V303, pL589, DOI 10.1152/ajplung.00400.2011; Patel KR, 2016, MUCOSAL IMMUNOL, V9, P1466, DOI 10.1038/mi.2016.11; Pera T, 2014, CURR OPIN PHARMACOL, V16, P72, DOI 10.1016/j.coph.2014.03.005; Perez JF, 2005, J GEN PHYSIOL, V125, P535, DOI 10.1085/jgp.200409216; Perez JF, 2005, J GEN PHYSIOL, V125, P555, DOI 10.1085/jgp.200409217; Peters SP, 2010, NEW ENGL J MED, V363, P1715, DOI 10.1056/NEJMoa1008770; Ressmeyer AR, 2010, AM J RESP CELL MOL, V43, P179, DOI 10.1165/rcmb.2009-0222OC; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Schleputz M, 2011, J APPL PHYSIOL, V110, P545, DOI 10.1152/japplphysiol.00409.2010; Scott GD, 2012, CHEM IMMUNOL ALLERGY, V98, P48, DOI 10.1159/000336498; Stern DA, 2008, LANCET, V372, P1058, DOI DOI 10.1016/S0140-6736(08)61447-6; Szczepankiewicz A, 2012, EUR RESPIR J, V39, P1035, DOI 10.1183/09031936.00136611; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Townley RG, 2010, EXPERT OPIN BIOL TH, V10, P1595, DOI 10.1517/14712598.2010.526103; Vogelberg C, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0175-9; WANG ZW, 1995, AM J RESP CRIT CARE, V151, P830; Wu ZX, 2009, ENVIRON HEALTH PERSP, V117, P1434, DOI 10.1289/ehp.0800511; Yost BL, 1999, J APPL PHYSIOL, V87, P1272, DOI 10.1152/jappl.1999.87.4.1272; Yu M, 2008, J ALLERGY CLIN IMMUN, V122, P640, DOI 10.1016/j.jaci.2008.04.038; Zhang WW, 2015, CAN J PHYSIOL PHARM, V93, P129, DOI 10.1139/cjpp-2014-0388	45	14	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4335	4346		10.1096/fj.201700186R	http://dx.doi.org/10.1096/fj.201700186R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28619712	Green Published			2022-12-26	WOS:000413397400013
J	Yadav, V; Gao, XH; Willard, B; Hatzoglou, M; Banerjee, R; Kabil, O				Yadav, Vinita; Gao, Xing-Huang; Willard, Belinda; Hatzoglou, Maria; Banerjee, Ruma; Kabil, Omer			Hydrogen sulfide modulates eukaryotic translation initiation factor 2 alpha (eIF2 alpha) phosphorylation status in the integrated stress-response pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE BETA-SYNTHASE; TO-MESENCHYMAL TRANSITION; UNFOLDED PROTEIN RESPONSE; INDUCED HEART-FAILURE; CARDIAC DYSFUNCTION; IN-VITRO; H2S; CELLS	Hydrogen sulfide (H2S) regulates various physiological processes, including neuronal activity, vascular tone, inflammation, and energy metabolism. Moreover, H2S elicits cytoprotective effects against stressors in various cellular models of injury. However, the mechanism of the signaling pathways mediating the cytoprotective functions of H2S is not well understood. We previously uncovered a heme-dependent metabolic switch for transient induction of H2S production in the trans-sulfuration pathway. Here, we demonstrate that increased endogenous H2S production or its exogenous administration modulates major components of the integrated stress response promoting a metabolic state primed for stress response. We show that H2S transiently increases phosphorylation of eukaryotic translation initiation factor 2 (eIF2 alpha) resulting in inhibition of general protein synthesis. The H2S-induced increase in eIF2 alpha phosphorylation was mediated at least in part by inhibition of protein phosphatase-1 (PP1c) via persulfidation at Cys-127. Overexpression of a PP1c cysteine mutant (C127S-PP1c) abrogated the H2S effect on eIF2 alpha phosphorylation. Our data support a model in which H2S exerts its cytoprotective effect on ISR signaling by inducing a transient adaptive reprogramming of global mRNA translation. Although a transient increase in endogenous H2S production provides cytoprotection, its chronic increase such as in cystathionine beta-synthase deficiency may pose a problem.	[Yadav, Vinita; Banerjee, Ruma; Kabil, Omer] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Gao, Xing-Huang; Hatzoglou, Maria] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Willard, Belinda] Cleveland Clin, Lerner Res Inst, Prote & Metabol Lab, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Cleveland Clinic Foundation	Kabil, O (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA.	omerk@umich.edu	Yadav, Vinita/J-3605-2019; Kabil, Omer/AAJ-1435-2020	Yadav, Vinita/0000-0003-1026-5697; 	American Heart Association [13SDG17070096]; National Institutes of Health [DK53307, DK60596, HL58984, GM112455]; American Diabetes Association [1-17-PDF-129]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307, R01DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 13SDG17070096 (to O. K.), National Institutes of Health Grants DK53307 and DK60596 (to M. H.) and HL58984 and GM112455 (to R. B.), and American Diabetes Association Postdoctoral Fellowship 1-17-PDF-129 (to X. H. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 1996, J NEUROSCI, V16, P1066; Ali MY, 2006, BRIT J PHARMACOL, V149, P625, DOI 10.1038/sj.bjp.0706906; Ansari SB, 2016, CHEM-BIOL INTERACT, V252, P28, DOI 10.1016/j.cbi.2016.03.036; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Barr LA, 2015, NITRIC OXIDE-BIOL CH, V46, P145, DOI 10.1016/j.niox.2014.12.013; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Chen BF, 2013, ANALYST, V138, P946, DOI 10.1039/c2an36113b; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Cohen PTW, 2002, J CELL SCI, V115, P241; Dello Russo C, 2000, J NEUROENDOCRINOL, V12, P225; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Fawcett EM, 2015, AGING CELL, V14, P92, DOI 10.1111/acel.12301; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Garcia-Haro L, 2010, FASEB J, V24, P5080, DOI 10.1096/fj.10-166306; Geng B, 2004, BIOCHEM BIOPH RES CO, V313, P362, DOI 10.1016/j.bbrc.2003.11.130; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Gong QH, 2011, J ALZHEIMERS DIS, V24, P173, DOI 10.3233/JAD-2011-110128; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Horsman JW, 2016, J BIOL CHEM, V291, P5320, DOI 10.1074/jbc.M115.697102; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Jha S, 2008, AM J PHYSIOL-HEART C, V295, pH801, DOI 10.1152/ajpheart.00377.2008; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kabil O, 2016, J BIOL CHEM, V291, P16418, DOI 10.1074/jbc.C116.742213; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2006, ANTIOXID REDOX SIGN, V8, P661, DOI 10.1089/ars.2006.8.661; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kondo K, 2013, CIRCULATION, V127, P1116, DOI 10.1161/CIRCULATIONAHA.112.000855; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Krokowski D, 2015, J BIOL CHEM, V290, P17822, DOI 10.1074/jbc.M114.636217; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Li XH, 2016, INT J MOL MED, V38, P1152, DOI 10.3892/ijmm.2016.2701; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Majumder M, 2015, INT J BIOCHEM CELL B, V59, P135, DOI 10.1016/j.biocel.2014.12.004; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pereira SR, 2013, FEBS J, V280, P674, DOI 10.1111/j.1742-4658.2011.08454.x; Polhemus DJ, 2013, CIRC-HEART FAIL, V6, P1077, DOI 10.1161/CIRCHEARTFAILURE.113.000299; Shelkovnikova TA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.199; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Snyder S. H., 2009, SCI SIGNAL, V2; Tang XQ, 2008, CLIN EXP PHARMACOL P, V35, P180, DOI 10.1111/j.1440-1681.2007.04799.x; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vorobets VS, 2002, RUSS J APPL CHEM+, V75, P229, DOI 10.1023/A:1016152117662; Wei HL, 2010, ANTIOXID REDOX SIGN, V12, P1079, DOI 10.1089/ars.2009.2898; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Xie L, 2012, AM J PHYSIOL-CELL PH, V303, pC81, DOI 10.1152/ajpcell.00281.2011; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Ying R, 2016, LIFE SCI, V144, P208, DOI 10.1016/j.lfs.2015.11.025; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	68	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 11	2017	292	32					13143	13153		10.1074/jbc.M117.778654	http://dx.doi.org/10.1074/jbc.M117.778654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD3XI	28637872	Green Published, hybrid			2022-12-26	WOS:000407465300006
J	Vessichelli, M; Mariggio, S; Varone, A; Zizza, P; Di Santo, A; Amore, C; Dell'Elba, G; Cutignano, A; Fontana, A; Cacciapuoti, C; Di Costanzo, G; Zannini, M; de Cristofaro, T; Evangelista, V; Corda, D				Vessichelli, Mariangela; Mariggio, Stefania; Varone, Alessia; Zizza, Pasquale; Di Santo, Angelomaria; Amore, Concetta; Dell'Elba, Giuseppe; Cutignano, Adele; Fontana, Angelo; Cacciapuoti, Carmela; Di Costanzo, Gaetano; Zannini, Mariastella; de Cristofaro, Tiziana; Evangelista, Virgilio; Corda, Daniela			The natural phosphoinositide derivative glycerophosphoinositol inhibits the lipopolysaccharide-induced inflammatory and thrombotic responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lipid signaling; lipopolysaccharide (LPS); monocyte; NF-B (NF-KB); pharmacology; second messenger; sepsis; tissue factor; transcription regulation	NF-KAPPA-B; TANDEM MASS-SPECTROMETRY; GENE-EXPRESSION; TISSUE FACTOR; POSSIBLE MECHANISM; HUMAN MONOCYTES; IN-VITRO; ACTIVATION; RESOLUTION; BINDING	Inflammatory responses are elicited through lipid products of phospholipase A(2) activity that acts on the membrane phospholipids, including the phosphoinositides, to form the proinflammatory arachidonic acid and, in parallel, the glycerophosphoinositols. Here, we investigate the role of the glycerophosphoinositol in the inflammatory response. We show that it is part of a negative feedback loop that limits proinflammatory and prothrombotic responses in human monocytes stimulated with lipopolysaccharide. This inhibition is exerted both on the signaling cascade initiated by the lipopolysaccharide with the glycerophosphoinositol-dependent decrease in IB kinase /, p38, JNK, and Erk1/2 kinase phosphorylation and at the nuclear level with decreased NF-B translocation and binding to inflammatory gene promoters. In a model of endotoxemia in the mouse, treatment with glycerophosphoinositol reduced TNF- synthesis, which supports the concept that glycerophosphoinositol inhibits the de novo synthesis of proinflammatory and prothrombotic compounds and might thus have a role as an endogenous mediator in the resolution of inflammation. As indicated, this effect of glycerophosphoinositol can also be exploited in the treatment of manifestations of severe inflammation by exogenous administration of the compound.	[Vessichelli, Mariangela; Mariggio, Stefania; Varone, Alessia; Zizza, Pasquale; Corda, Daniela] CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy; [Di Santo, Angelomaria; Amore, Concetta; Dell'Elba, Giuseppe; Evangelista, Virgilio] Consorzio & Fdn Mario Negri Sud, Lab Vasc Biol & Pharmacol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy; [Cutignano, Adele; Fontana, Angelo] CNR, Inst Biomol Chem, Via Campi Flegrei 34, I-80078 Naples, Italy; [Cacciapuoti, Carmela; Di Costanzo, Gaetano] Ist Ricovero & Cura Carattere Sci, Transfus Serv, Dept Hematol Oncol, Natl Canc Inst,G Pascale Fdn, Via M Semmola 52, I-80131 Naples, Italy; [Cacciapuoti, Carmela; Di Costanzo, Gaetano] Ist Ricovero & Cura Carattere Sci, Stem Cell Transplantat Unit, Natl Canc Inst, G Pascale Fdn, Via M Semmola 52, I-80131 Naples, Italy; [Zannini, Mariastella; de Cristofaro, Tiziana] CNR, Inst Expt Endocrinol & Oncol, Via S Pansini 5, I-80131 Naples, Italy; [Zizza, Pasquale] Regina Elena Inst Canc Res, Oncogen & Epigenet Unit, Via E Chianesi 53, I-00144 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Corda, D (corresponding author), CNR, Inst Prot Biochem, Via P Castellino 111, I-80131 Naples, Italy.; Evangelista, V (corresponding author), Consorzio & Fdn Mario Negri Sud, Lab Vasc Biol & Pharmacol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	evangelista59gino@gmail.com; d.corda@ibp.cnr.it	Mariggio', Stefania/H-5467-2015; Zizza, Pasquale/K-3292-2018; Zannini, Mariastella/I-1735-2012; Fontana, Angelo/AAO-2741-2021; Fontana, Angelo/C-3354-2012; De+Cristofaro, Tiziana/AAX-4405-2020; Cutignano, Adele/C-3343-2012; CORDA, DANIELA/K-6385-2016	Mariggio', Stefania/0000-0002-6397-3016; Zizza, Pasquale/0000-0001-7281-6090; Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Cutignano, Adele/0000-0003-3035-9252; DECRISTOFARO, TIZIANA/0000-0003-0121-0002; ZANNINI, MARIASTELLA/0000-0002-5740-9769; CORDA, DANIELA/0000-0002-3614-751X	Italian Association for Cancer Research (Milan, Italy) [IG10341, IG14675]; Ministry for Education, Universities and Research Project "FaReBio di Qualita"; Programma Operativo Nazionale Project [01-00862]; Research Projects of National Interest Project [2012CK5RPF_05]; National Research Plan-National Research Council Aging Program; Progetto Bandiera "Epigen"; Programma Operativo Regionale Project OcKey; Italian Foundation for Cancer Research (Milan, Italy)	Italian Association for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Ministry for Education, Universities and Research Project "FaReBio di Qualita"; Programma Operativo Nazionale Project; Research Projects of National Interest Project; National Research Plan-National Research Council Aging Program; Progetto Bandiera "Epigen"; Programma Operativo Regionale Project OcKey; Italian Foundation for Cancer Research (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Italian Association for Cancer Research (Milan, Italy) Grants IG10341 and IG14675, the Ministry for Education, Universities and Research Project "FaReBio di Qualita," Programma Operativo Nazionale Project 01-00862, Research Projects of National Interest Project 2012CK5RPF_05, National Research Plan-National Research Council Aging Program 2012-2014, Progetto Bandiera "Epigen," and the Programma Operativo Regionale Project OcKey. D. Corda, P. Zizza, and S. Mariggio are authors of United States Patent 9351983, Use of Glycerophosphoinositols for the Treatment of Septic Shock.; Recipients of fellowships from the Italian Foundation for Cancer Research (Milan, Italy).	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Berrie CP, 2002, EUR J CANCER, V38, P2463, DOI 10.1016/S0959-8049(02)00485-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Colgan SP, 2015, SEMIN IMMUNOL, V27, P177, DOI 10.1016/j.smim.2015.03.007; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 1996, ANTICANCER RES, V16, P1341; Corda D, 2016, [No title captured], Patent No. [9351983 B2, 9351983]; Corda D, 2012, BIOCHEM SOC T, V40, P101, DOI 10.1042/BST20110679; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Cucullo L, 2004, BRAIN RES, V997, P147, DOI 10.1016/j.brainres.2003.09.079; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; di Santo A, 2011, J THROMB HAEMOST, V9, P1029, DOI 10.1111/j.1538-7836.2011.04236.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinarello CA, 2007, EUR J IMMUNOL, V37, pS34, DOI 10.1002/eji.200737772; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Faenza I, 2013, FEBS J, V280, P6311, DOI 10.1111/febs.12450; Falasca M, 1998, ONCOGENE, V16, P2357, DOI 10.1038/sj.onc.1201758; Filippi BM, 2008, BBA-MOL CELL RES, V1783, P2311, DOI 10.1016/j.bbamcr.2008.07.021; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grauso L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123198; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kim JH, 2008, CHEM-BIOL INTERACT, V171, P133, DOI 10.1016/j.cbi.2007.07.008; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levi M, 2014, INT J LAB HEMATOL, V36, P228, DOI 10.1111/ijlh.12221; Lewin SR, 1997, J VIROL, V71, P2114, DOI 10.1128/JVI.71.3.2114-2119.1997; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lowell CA, 1998, P NATL ACAD SCI USA, V95, P7580, DOI 10.1073/pnas.95.13.7580; Mancini R, 2003, MOL BIOL CELL, V14, P503, DOI 10.1091/mbc.E02-04-0179; Mariggio S, 2006, FEBS LETT, V580, P6789, DOI 10.1016/j.febslet.2006.11.039; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Natoli G., 2009, COLD SPRING HARB PER, V1; NEMERSON Y, 1988, BLOOD, V71, P1; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; OETH PA, 1994, MOL CELL BIOL, V14, P3772, DOI 10.1128/MCB.14.6.3772; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patrussi L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00213; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Suzuki T, 2000, BLOOD, V96, P2584; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Zizza P, 2012, J BIOL CHEM, V287, P16849, DOI 10.1074/jbc.M111.309419	56	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12828	12841		10.1074/jbc.M116.773861	http://dx.doi.org/10.1074/jbc.M116.773861			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28600357	Green Published, hybrid			2022-12-26	WOS:000407220100014
J	Hobaiter, C; Samuni, L; Mullins, C; Akankwasa, WJ; Zuberbuhler, K				Hobaiter, Catherine; Samuni, Liran; Mullins, Caroline; Akankwasa, Walter John; Zuberbuhler, Klaus			Variation in hunting behaviour in neighbouring chimpanzee communities in the Budongo forest, Uganda	PLOS ONE			English	Article							GOMBE-NATIONAL-PARK; WILD CHIMPANZEES; PAN-TROGLODYTES; MAHALE MOUNTAINS; PREDATION; FOOD; HARASSMENT; HABITUATION; RECIPROCITY; MAMMALS	Hunting and sharing of meat is seen across all chimpanzee sites, with variation in prey preferences, hunting techniques, frequencies, and success rates. Here, we compared hunting and meat-eating behaviour in two adjacent chimpanzee communities (Pan troglodytes schweinfurthii) of Budongo Forest, Uganda: the Waibira and Sonso communities. We observed consistent between-group differences in prey-species preferences and in post-hunting behaviour. Sonso chimpanzees show a strong prey preference for Guereza colobus monkeys (Colobus guereza occidentalis; 74.9% hunts), and hunt regularly (1-2 times a month) but with large year-to-year and month-to-month variation. Waibira chimpanzee prey preferences are distributed across primate and duiker species, and resemble those described in an early study of Sonso hunting. Waibira chimpanzees (which include ex-Sonso immigrants) have been observed to feed on red duiker (Cephalophus natalensis; 25%, 9/36 hunts), a species Sonso has never been recorded to feed on (18 years data, 27 years observations), despite no apparent differences in prey distribution; and show less rank-related harassment of meat possessors. We discuss the two most likely and probably interrelated explanations for the observed intergroup variation in chimpanzee hunting behaviour, that is, long-term disruption of complex group-level behaviour due to human presence and possible socially transmitted differences in prey preferences.	[Hobaiter, Catherine; Mullins, Caroline; Zuberbuhler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Mullins, Caroline; Zuberbuhler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland; [Hobaiter, Catherine; Samuni, Liran; Mullins, Caroline; Akankwasa, Walter John; Zuberbuhler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Samuni, Liran] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Akankwasa, Walter John] Makerere Univ, Sch Vet Med & Anim Resources, Kampala, Uganda; [Zuberbuhler, Klaus] Univ Neuchatel, Inst Biol, Dept Comparat Cognit, Neuchatel, Switzerland	University of St Andrews; University of St Andrews; Max Planck Society; Makerere University; University of Neuchatel	Hobaiter, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.; Hobaiter, C (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews, Fife, Scotland.; Hobaiter, C (corresponding author), Budongo Conservat Field Stn, Masindi, Uganda.	clh42@st-andrews.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Hobaiter, Cat/0000-0002-3893-0524	Leverhulme Trust Research Leadership [F/00268/AP]; British Academy [SG411998]	Leverhulme Trust Research Leadership; British Academy	This research was funded by the Leverhulme Trust Research Leadership Award F/00268/AP (http://www.leverhulme.ac.uk/) and the British Academy grant SG411998 (http://www.brit. ac.uk).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Babweteera F., 2012, ECOLOGICAL IMPACT LO, P31; Bertolani P, 2008, FOLIA PRIMATOL, V79, P162, DOI 10.1159/000111720; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Boesch C, 2002, HUM NATURE-INT BIOS, V13, P27, DOI 10.1007/s12110-002-1013-6; Boesch C., 2000, CHIMPANZEES TAR FORE; Brown GR, 2004, ADV STUD BEHAV, V34, P265, DOI 10.1016/S0065-3454(04)34007-6; Brown J.L., 1987, HELPING COMMUNAL BRE; Carter GG, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2573; De Kort SR, 2006, ANIM BEHAV, V72, P297, DOI 10.1016/j.anbehav.2005.10.016; Eggling WJ, 1969, J ECOL, V34, P20; Elbroch LM, 2017, CURR ZOOL, V63, P357, DOI 10.1093/cz/zow080; EVANS CS, 1994, ANIM BEHAV, V47, P1159, DOI 10.1006/anbe.1994.1154; FRAGASZY DM, 1992, AM J PRIMATOL, V26, P259, DOI 10.1002/ajp.1350260404; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Gilby IC, 2008, ANIM BEHAV, V75, P351, DOI 10.1016/j.anbehav.2007.06.008; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gruber T, 2012, J COMP PSYCHOL, V126, P446, DOI 10.1037/a0028702; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Hicks TC, 2013, FOLIA PRIMATOL, V84, P135, DOI 10.1159/000350650; Hobaiter C, 2017, WAIBIRA CHIMPANZEE D; HOELZEL AR, 1991, BEHAV ECOL SOCIOBIOL, V29, P197, DOI 10.1007/BF00166401; Hohmann G., 1996, FOOD STATUS QUEST, P47; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Hosaka K., 2016, MAHALE CHIMPANZEES 5, P275; Humle T, 2002, AM J PRIMATOL, V58, P133, DOI 10.1002/ajp.10055; Kaburu SSK, 2015, ANIM BEHAV, V99, P61, DOI 10.1016/j.anbehav.2014.10.018; Kalan AK, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0167-8; Kalan AK, 2015, ECOL INDIC, V54, P217, DOI 10.1016/j.ecolind.2015.02.023; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kuhl HS, PLOS ONE; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Laporte MNC, 2010, ANIM BEHAV, V80, P467, DOI 10.1016/j.anbehav.2010.06.005; Luncz LV, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0348; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; Newton-Fisher NE, 2002, FOLIA PRIMATOL, V73, P281, DOI 10.1159/000067454; Newton-Fisher NE., 2014, HDB PALAEOANTHROPOLO, V2, P1; NISHIDA T, 1979, Primates, V20, P1, DOI 10.1007/BF02373826; NISHIDA T, 1983, J HUM EVOL, V12, P467, DOI 10.1016/S0047-2484(83)80142-0; Nishida T., 2011, CHIMPANZEES LAKESHOR; Nishida Toshisada, 1992, P159; Peres Carlos A., 1999, Neotropical Primates, V7, P11; Plumptre AJ, 2000, J APPL ECOL, V37, P356, DOI 10.1046/j.1365-2664.2000.00499.x; Plumptre AJ, 2003, ALBERTINE RIFT TECHN, P105; Pruetz JD, R SOC OPEN SCI; Pruetz Jill D., 2006, P161; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Reynolds V., 2005, CHIMPANZEES BUDONGO; SAKALUK SK, 1984, SCIENCE, V223, P609, DOI 10.1126/science.223.4636.609; Samuni L, 2014, ANIM COGN, V17, P997, DOI 10.1007/s10071-014-0731-6; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Silk JB, 2013, ANIM BEHAV, V85, P941, DOI 10.1016/j.anbehav.2013.02.014; STANFORD CB, 1994, AM J PHYS ANTHROPOL, V94, P213, DOI 10.1002/ajpa.1330940206; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; TAKAHATA Y, 1984, INT J PRIMATOL, V5, P213, DOI 10.1007/BF02735758; Takahata Y., 1986, HUM EVOL, V1, P277; Tennie C, 2009, BEHAV ECOL SOCIOBIOL, V63, P421, DOI 10.1007/s00265-008-0676-3; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Uehara S, 1997, PRIMATES, V38, P193, DOI 10.1007/BF02382009; Uehara Shigeo, 1992, P143; Watts DP, 2013, AM J PRIMATOL, V75, P927, DOI 10.1002/ajp.22157; Watts DP, 2002, INT J PRIMATOL, V23, P1, DOI 10.1023/A:1013270606320; WHITE LJT, 1994, J ANIM ECOL, V63, P499, DOI 10.2307/5217; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; Wittig RM, 2003, BEHAV ECOL SOCIOBIOL, V54, P491, DOI 10.1007/s00265-003-0654-8; Woolfenden GE, 1984, FLORIDA SCRUB JAY DE, V20; Wrangham R. W., 1975, THESIS; Yamagiwa J, 1999, PRIMATES, V40, P87, DOI 10.1007/BF02557704; Yamamoto S, 2015, BEHAVIOUR, V152, P335, DOI 10.1163/1568539X-00003257	79	28	28	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178065	10.1371/journal.pone.0178065	http://dx.doi.org/10.1371/journal.pone.0178065			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636646	gold, Green Published			2022-12-26	WOS:000404118300008
J	Kurata, R; Futaki, S; Nakano, I; Fujita, F; Tanemura, A; Murota, H; Katayama, I; Okada, F; Sekiguchi, K				Kurata, Ryuichiro; Futaki, Sugiko; Nakano, Itsuko; Fujita, Fumitaka; Tanemura, Atsushi; Murota, Hiroyuki; Katayama, Ichiro; Okada, Fumihiro; Sekiguchi, Kiyotoshi			Three-dimensional cell shapes and arrangements in human sweat glands as revealed by whole-mount immunostaining	PLOS ONE			English	Article							STEM-CELLS; MYOEPITHELIAL CELLS; MOUSE-BRAIN; RECONSTRUCTION; IDENTIFICATION; INNERVATION; EXPRESSION; DISORDERS; CULTURE; NICHES	Because sweat secretion is facilitated by mechanical contraction of sweat gland structures, understanding their structure-function relationship could lead to more effective treatments for patients with sweat gland disorders such as heat stroke. Conventional histological studies have shown that sweat glands are three-dimensionally coiled tubular structures consisting of ducts and secretory portions, although their detailed structural anatomy remains unclear. To better understand the details of the three-dimensional (3D) coiled structures of sweat glands, a whole-mount staining method was employed to visualize 3D coiled gland structures with sweat gland markers for ductal luminal, ductal basal, secretory luminal, and myoepithelial cells. Imaging the 3D coiled gland structures demonstrated that the ducts and secretory portions were comprised of distinct tubular structures. Ductal tubules were occasionally bent, while secretory tubules were frequently bent and formed a self-entangled coiled structure. Whole-mount staining of complex coiled gland structures also revealed the detailed 3D cellular arrangements in the individual sweat gland compartments. Ducts were composed of regularly arranged cuboidal shaped cells, while secretory portions were surrounded by myoepithelial cells longitudinally elongated along entangled secretory tubules. Whole-mount staining was also used to visualize the spatial arrangement of blood vessels and nerve fibers, both of which facilitate sweat secretion. The blood vessels ran longitudinally parallel to the sweat gland tubules, while nerve fibers wrapped around secretory tubules, but not ductal tubules. Taken together, whole-mount staining of sweat glands revealed the 3D cell shapes and arrangements of complex coiled gland structures and provides insights into the mechanical contraction of coiled gland structures during sweat secretion.	[Kurata, Ryuichiro; Fujita, Fumitaka; Okada, Fumihiro] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Adv Cosmet Sci, Suita, Osaka, Japan; [Kurata, Ryuichiro; Fujita, Fumitaka; Okada, Fumihiro] Mandom Corp, Fundamental Res Inst, Osaka, Osaka, Japan; [Kurata, Ryuichiro; Futaki, Sugiko; Nakano, Itsuko; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Div Matrixome Res & Applicat, Suita, Osaka, Japan; [Tanemura, Atsushi; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka, Japan; [Futaki, Sugiko] Osaka Med Coll, Dept Anat & Cell Biol, Takatsuki, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka Medical College	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, Div Matrixome Res & Applicat, Suita, Osaka, Japan.	sekiguch@protein.osaka-u.ac.jp		yi lang, pian shan/0000-0002-3270-1085	Japan Society for the Promotion of Science [16K19721]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-inAid for Scientific Research (16K19721) from the Japan Society for the Promotion of Science. Mandom Corporation provided support in the form of salaries to some authors [R.K., F.F., and F.O.], but did not have any role in the study design, data collection andanalysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	BRAYDEN DJ, 1995, PHARM RES-DORDR, V12, P171, DOI 10.1023/A:1016275728879; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; COUGHLIN MD, 1975, DEV BIOL, V43, P123, DOI 10.1016/0012-1606(75)90136-0; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gibbons CH, 2009, NEUROLOGY, V72, P1479, DOI 10.1212/WNL.0b013e3181a2e8b8; HALL PA, 1989, DEVELOPMENT, V106, P619; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; HOLYOKE JB, 1952, J INVEST DERMATOL, V18, P147, DOI 10.1038/jid.1952.18; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Kuno Y., 1956, AM LECT SER, V285; Kurata R, 2016, H PC TODAY, V11, P39; Kurata R, 2014, CELL STRUCT FUNCT, V39, P101, DOI 10.1247/csf.14009; Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x; LINZELL JL, 1971, PHYSIOL REV, V51, P564, DOI 10.1152/physrev.1971.51.3.564; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; MOLL I, 1992, J INVEST DERMATOL, V98, P777, DOI 10.1111/1523-1747.ep12499950; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; QUINTON PM, 1983, ANNU REV MED, V34, P429, DOI 10.1146/annurev.me.34.020183.002241; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Rittie L, 2013, AM J PATHOL, V182, P163, DOI 10.1016/j.ajpath.2012.09.019; SATO K, 1977, EXPERIENTIA, V33, P631, DOI 10.1007/BF01946542; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schon M, 1999, J CELL SCI, V112, P1925; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Turner MD, 2007, J AM DENT ASSOC, V138, p15S, DOI 10.14219/jada.archive.2007.0358; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Zhu L, 2013, J DERMATOL SCI, V70, P211, DOI 10.1016/j.jdermsci.2013.03.002	34	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178709	10.1371/journal.pone.0178709	http://dx.doi.org/10.1371/journal.pone.0178709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636607	gold, Green Published, Green Submitted			2022-12-26	WOS:000404118300015
J	Si, Q; Luo, JY; Hu, Z; Zhang, W; Zhou, CF				Si, Qin; Luo, Juan-Yan; Hu, Ze; Zhang, Wei; Zhou, Chang-Fa			De novo transcriptome of the mayfly Cloeon viridulum and transcriptional signatures of Prometabola	PLOS ONE			English	Article							BOMBYX-MORI; INSECT METAMORPHOSIS; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; TRIBOLIUM-CASTANEUM; GENOME SEQUENCE; BROAD-COMPLEX; RNA-SEQ; EVOLUTION; KRUPPEL-HOMOLOG-1	Mayflies (Ephemeroptera) display many primitive characters and a unique type of metamorphosis (Prometabola). However, information on the genomes and transcriptomes of this insect group is limited. The RNA sequencing study presented here generated the first de novo transcriptome assembly of Cloeon viridulum (Ephemeroptera: Baetidae), and compared gene expression signatures among the young larva (YL), mature larva (ML), subimago (SI), and imago (IM) stages of this mayfly. The transcriptome, based on 88 Gb of sequence data, comprised a set of 81,185 high quality transcripts. The number of differentially expressed genes (DEGs) in YL vs. ML, ML vs. SI, and SI vs. IM, was 4,825, 1,584, and 1,278, respectively, according to the reads per kilobase of transcript per million mapped reads analysis, assuming a false discovery rate <0.05 and a fold change >2. Gene enrichment analysis revealed that these DEGs were enriched in the "chitin metabolic process", "germ cell development", "steroid hormone biosynthesis", and "cutin, suberine, and wax biosynthesis "pathways. Finally, the expression pattern of a selected group of candidate signature genes for Prometabola, including vestigial, methoprene-tolerant, wingless, and broadcomplex were confirmed by quantitative real time-PCR analysis. The Q-PCR analysis of larval, subimaginal, and imaginal stages of C. viridulum suggests that the development of mayflies more closely resembles hemimetamorphosis than holometamorphosis.	[Si, Qin; Luo, Juan-Yan; Hu, Ze; Zhang, Wei; Zhou, Chang-Fa] Nanjing Normal Univ, Coll Life Sci, Key Lab Jiangsu Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Zhou, CF (corresponding author), Nanjing Normal Univ, Coll Life Sci, Key Lab Jiangsu Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	zhouchangfa@njnu.edu.cn			National Natural Science Foundation of China [31172124, 31472023]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Sciencet echnology basic condition platform from The Ministry of Science and Technology of the People's Republic of China [2005DKA21402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Sciencet echnology basic condition platform from The Ministry of Science and Technology of the People's Republic of China	This work was supported by the National Natural Science Foundation of China (Grant 31172124and31472023), Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and project supported by key project of Sciencet echnology basic condition platform fromThe Ministry of Science and Technology of the People's Republic of China (Grant No.2005DKA21402).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Certel K, 2000, DEVELOPMENT, V127, P3173; Chauhan P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-808; Chen S. H., 1955, Acta Entomologica Sinica, V5, P1; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COUSO JP, 1994, DEVELOPMENT, V120, P621; EDMUNDS GF, 1988, ANNU REV ENTOMOL, V33, P509; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Goodisman MAD, 2005, EVOLUTION, V59, P858, DOI 10.1111/j.0014-3820.2005.tb01759.x; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grossmann D, 2009, DEV GENES EVOL, V219, P469, DOI 10.1007/s00427-009-0310-z; Gu J, 2013, INSECT BIOCHEM MOLEC, V43, P794, DOI 10.1016/j.ibmb.2013.06.001; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Hevia CF, 2013, DEV BIOL, V377, P138, DOI 10.1016/j.ydbio.2013.02.004; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang JH, 2013, BBA-GEN SUBJECTS, V1830, P2178, DOI 10.1016/j.bbagen.2012.09.025; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; Johnston DM, 2011, MOL CELL, V44, P51, DOI 10.1016/j.molcel.2011.07.033; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Kukalova-Peck J., 1991, P141; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Arguelles DB, 2010, STEROIDS, V75, P467, DOI 10.1016/j.steroids.2010.02.004; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nijhout H.F., 1994, INSECT HORMONES; Ou J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-820; Palli SR, 1997, DEV GENET, V20, P36, DOI 10.1002/(SICI)1520-6408(1997)20:1&lt;36::AID-DVG5&gt;3.0.CO;2-A; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; RIDDIFORD LM, 1978, GEN COMP ENDOCR, V34, P438, DOI 10.1016/0016-6480(78)90284-8; SCHAEFER CW, 1975, ANN ENTOMOL SOC AM, V68, P183, DOI 10.1093/aesa/68.1.183; Shanku AG, 2013, G3-GENES GENOM GENET, V3, P763, DOI 10.1534/g3.113.005637; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tan J.-j., 1980, Acta Zootaxonomica Sinica, V5, P1; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Togawa T, 2004, INSECT BIOCHEM MOLEC, V34, P1059, DOI 10.1016/j.ibmb.2004.06.008; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Yang P, 2015, SCI REP-UK, V5, DOI 10.1038/srep08141; Zabza Andrzej, 1994, Acta Biochimica Polonica, V41, P375; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479	54	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179083	10.1371/journal.pone.0179083	http://dx.doi.org/10.1371/journal.pone.0179083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636618	gold, Green Submitted, Green Published			2022-12-26	WOS:000404118300024
J	Fuchs, H; Rossmann, N; Schmid, MB; Hoenig, M; Thome, U; Mayer, B; Klotz, D; Hummler, HD				Fuchs, Hans; Rossmann, Nicola; Schmid, Manuel B.; Hoenig, Manfred; Thome, Ulrich; Mayer, Benjamin; Klotz, Daniel; Hummler, Helmut D.			Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; LUNG INJURY; THERAPEUTIC HYPERCAPNIA; VENTILATED PATIENTS; 6 ML/KG; ACIDOSIS; MORTALITY; PULMONARY; STRATEGY; OUTCOMES	Background Controlled hypoventilation while accepting hypercapnia has been advocated to reduce ventilator-induced lung injury. The aim of the study was to analyze outcomes of a cohort of immunocompromised children with acute respiratory distress syndrome (ARDS) ventilated with a strategy of stepwise increasing PCO2 targets up to 140 mm Hg. Methods Retrospective analysis of outcomes of a cohort of children with oncologic disease or after stem cell transplantation and severe respiratory failure in comparison with a historical control cohort. Results Out of 150 episodes of admission to the PICU 88 children underwent invasive mechanical ventilation for >24h (overall survival 75%). In a subgroup of 38 children with high ventilator requirements the PCO2 target ranges were increased stepwise. Fifteen children survived and were discharged from the PICU. Severe pulmonary hypertension was seen in two patients and no case of cerebral edema was observed. Long term outcome was available in 15 patients and 10 of these patients survived without adverse neurological sequelae. With introduction of this strategy survival of immunocompromised children undergoing mechanical ventilation for >24h increased to 48% compared to 32% prior to introduction historical cohort). Conclusions A ventilation strategy incorporating very high carbon dioxide levels to allow for low tidal volumes and limited inspiratory pressures is feasible in children. Even severe hypercapnia may be well tolerated. No severe side effects associated with hypercapnia were observed. This strategy could potentially increase survival in immunocompromised children with severe ARDS.	[Fuchs, Hans; Klotz, Daniel] Albert Ludwig Univ Freiburg, Fac Med, Med Ctr, Ctr Pediat,Dept Neonatol & Pediat Intens Care, Freiburg, Germany; [Rossmann, Nicola; Hummler, Helmut D.] Ulm Univ, Dept Pediat & Adolescent Med, Div Neonatol & Pediat Crit Care, Ulm, Germany; [Schmid, Manuel B.] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Zurich, Switzerland; [Hoenig, Manfred] Ulm Univ, Dept Pediat & Adolescent Med, Oncol & Stem Cell Transplantat, Ulm, Germany; [Thome, Ulrich] Univ Hosp Leipzig, Div Neonatol, Leipzig, Germany; [Mayer, Benjamin] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany	University of Freiburg; Ulm University; University of Zurich; University Zurich Hospital; Ulm University; Leipzig University; Ulm University	Fuchs, H (corresponding author), Albert Ludwig Univ Freiburg, Fac Med, Med Ctr, Ctr Pediat,Dept Neonatol & Pediat Intens Care, Freiburg, Germany.	hans.fuchs@uniklinik-freiburg.de	Hummler, Helmut/AAN-7297-2021; Klotz, Daniel/AAB-2585-2022	Klotz, Daniel/0000-0003-2347-3866; Bryant, Manuel/0000-0002-5981-1006				Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; [Anonymous], 2014, J INTENSIVE CARE MED, V29, P31, DOI 10.1177/0885066612457343; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Briva A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001238; Broccard AF, 2001, AM J RESP CRIT CARE, V164, P802, DOI 10.1164/ajrccm.164.5.2007060; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carvalho CRR, 1997, AM J RESP CRIT CARE, V156, P1458, DOI 10.1164/ajrccm.156.5.9604081; Chima RS, 2012, PEDIATR CRIT CARE ME, V13, pE336, DOI 10.1097/PCC.0b013e318253c945; Chonghaile MN, 2008, CRIT CARE MED, V36, P3135, DOI 10.1097/CCM.0b013e31818f0d13; Costello J, 2009, CRIT CARE MED, V37, P2412, DOI 10.1097/CCM.0b013e3181a385d3; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; Fuchs H, 2015, KLIN PADIATR, V227, P322, DOI 10.1055/s-0034-1395692; Fuchs H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023816; Galluccio Steven T, 2008, Crit Care Resusc, V10, P235; Gates Khalilah L, 2013, Am J Respir Cell Mol Biol, V49, P821, DOI 10.1165/rcmb.2012-0487OC; Hummler HD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147807; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Joyce Ryan R, 2011, J Med Case Rep, V5, P192, DOI 10.1186/1752-1947-5-192; Ketabchi F, 2009, AM J PHYSIOL-LUNG C, V297, pL977, DOI 10.1152/ajplung.00074.2009; Komori M, 2007, CRIT CARE MED, V35, P2171, DOI 10.1097/01.ccm.0000281445.77223.31; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Laffey JG, 2003, AM J RESP CRIT CARE, V168, P1383, DOI 10.1164/rccm.2108078; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Lheritier G, 2013, INTENS CARE MED, V39, P1734, DOI 10.1007/s00134-013-3017-6; Nichol AD, 2009, CRIT CARE MED, V37, P2953, DOI 10.1097/CCM.0b013e3181b028ce; Nin N, 2017, INTENS CARE MED, V43, P200, DOI 10.1007/s00134-016-4611-1; O'Croinin DF, 2008, CRIT CARE MED, V36, P2128, DOI 10.1097/CCM.0b013e31817d1b59; O'Toole D, 2009, THORAX, V64, P976, DOI 10.1136/thx.2008.110304; Peltekova V, 2010, INTENS CARE MED, V36, P869, DOI 10.1007/s00134-010-1787-7; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Santschi M, 2013, PEDIATR CRIT CARE ME, V14, pE332, DOI 10.1097/PCC.0b013e31828a89a2; Sinclair SE, 2002, AM J RESP CRIT CARE, V166, P403, DOI 10.1164/rccm.200112-117OC; Stubs CCM, 2013, MICROVASC RES, V90, P180, DOI 10.1016/j.mvr.2013.07.008; Tamburro RF, 2008, PEDIATR CRIT CARE ME, V9, P270, DOI 10.1097/PCC.0b013e31816c7260; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; van Gestel JPJ, 2008, CRIT CARE MED, V36, P2898, DOI 10.1097/CCM.0b013e318186a34a; van Gestel JRJ, 2008, BIOL BLOOD MARROW TR, V14, P1385, DOI 10.1016/j.bbmt.2008.09.020; Zabrocki LA, 2011, CRIT CARE MED, V39, P364, DOI 10.1097/CCM.0b013e3181fb7b35	41	6	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179974	10.1371/journal.pone.0179974	http://dx.doi.org/10.1371/journal.pone.0179974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632754	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000404046100055
J	Lee, YB; Rhiu, S; Lee, JY; Choi, MY; Paik, HJ; Lim, KH; Choi, DG				Lee, Young Bok; Rhiu, Soolienah; Lee, Joo Yeon; Choi, Mi Young; Paik, Hae Jung; Lim, Key Hwan; Choi, Dong Gyu			Effect of horizontal rectus surgery for the correction of intermittent exotropia on sub-A or sub-V pattern	PLOS ONE			English	Article							OCULAR TORSION; MUSCLES; DISPLACEMENT; STRABISMUS; DIAGNOSIS	We evaluated effect of horizontal rectus surgery on sub-A or sub-V pattern intermittent exotropia. We enrolled patients with sub-A or sub-V pattern intermittent exotropia. The sub-A pattern was diagnosed when the eyes diverged less than 10 prism diopters (PD) from upgaze to downgaze, and sub-V pattern when the divergence was 14 PD or less from downgaze to upgaze. Patients had undergone horizontal rectus surgery without vertical transposition of horizontal rectus muscle or oblique muscle weakening. The patients were divided into two groups: sub-A pattern (group A) and sub-V pattern (group V). The outcome measures were change of amount of pattern and rate of collapse of pattern postoperatively. The amount of pattern (vertical incomitance) was amount of difference in exodeviation between upgaze and downgaze. Collapse of pattern was defined as disappearance of difference in exodeviation between upgaze and downgaze. In groups A and V, preoperative amounts of pattern were 4.9 PD and 6.8 PD, respectively. A significant reduction in amount of pattern was observed in both groups throughout the follow-up period (p<0.05). At postoperative 6 months, the amounts of pattern were 1.0 PD and 1.2 PD and the extents of reduction in amount of pattern were 4.4 PD and 5.9 PD. The rates of collapse of pattern at postoperative 6 months were 77.8 and 60.0%, respectively. In the patients with sub-A or sub-V pattern exotropia, horizontal rectus surgery without vertical transposition or oblique muscle weakening can successfully collapse the pattern.	[Lee, Young Bok; Choi, Dong Gyu] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Rhiu, Soolienah] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Ophthalmol, Dongtan, South Korea; [Lee, Joo Yeon] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Ophthalmol, Anyang, South Korea; [Choi, Mi Young] Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Ophthalmol, Cheongju, South Korea; [Paik, Hae Jung] Gachon Univ, Sch Med, Gil Med Ctr, Dept Ophthalmol, Incheon, South Korea; [Lim, Key Hwan] Ewha Womans Univ, Sch Med, Dept Ophthalmol, Mokdong Hosp, Seoul, South Korea	Hallym University; Hallym University; Hallym University; Chungbuk National University; Chungbuk National University Hospital; Gachon University; Ewha Womans University	Choi, DG (corresponding author), Hallym Univ, Kangnam Sacred Heart Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea.	eyechoi@dreamwiz.com						BILLET E, 1969, ARCH OPHTHALMOL-CHIC, V82, P21; BREININ G M, 1964, Trans Am Acad Ophthalmol Otolaryngol, V68, P363; BREININ GM, 1957, ARCH OPHTHALMOL-CHIC, V58, P375; BURIAN H M, 1964, Trans Am Acad Ophthalmol Otolaryngol, V68, P375; Clark RA, 1999, J AAPOS, V3, P18, DOI 10.1016/S1091-8531(99)70090-X; GOLDSTEIN JH, 1967, AM J OPHTHALMOL, V64, P265, DOI 10.1016/0002-9394(67)92521-4; Jampolsky A, 1965, J PEDIATR OPHTHALMOL, V2, P31; Kekunnaya R, 2015, EYE, V29, P184, DOI 10.1038/eye.2014.270; KNAPP PHILIP, 1959, TRANSL AMER CPHTHALMOL SOC, V57, P666; Kushner BJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P712, DOI 10.1001/archophthalmol.2010.88; Lee HJ, 2011, J KOREAN OPHTHALMOL, V52, P846; MILLER JE, 1960, ARCH OPHTHALMOL-CHIC, V64, P175; MILLER MM, 1994, J PEDIATR OPHTHALMOL, V31, P220; Parks MM, 2000, DUANES CLIN OPHTHALM, P12; SCOTT AB, 1973, INVEST OPHTH VISUAL, V12, P232; SCOTT AB, 1968, AM J OPHTHALMOL, V65, P12, DOI 10.1016/0002-9394(68)91021-0; Shin KH, 2013, AM J OPHTHALMOL, V155, P177, DOI 10.1016/j.ajo.2012.07.011; URIST MJ, 1951, AMA ARCH OPHTHALMOL, V46, P245; URIST MJ, 1958, AM J OPHTHALMOL, V46, P835, DOI 10.1016/0002-9394(58)90995-4; URIST MJ, 1968, AM J OPHTHALMOL, V65, P769, DOI 10.1016/0002-9394(68)94396-1; VONNOORD.GK, 1965, AM J OPHTHALMOL, V60, P434, DOI 10.1016/0002-9394(65)90707-5	21	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179626	10.1371/journal.pone.0179626	http://dx.doi.org/10.1371/journal.pone.0179626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628645	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100041
J	Mazzocco, P; Bernard, S; Pujo-Menjouet, L				Mazzocco, Pauline; Bernard, Samuel; Pujo-Menjouet, Laurent			Estimates and impact of lymphocyte division parameters from CFSE data using mathematical modelling	PLOS ONE			English	Article							T-CELL RESPONSES; IN-VIVO; LABELING EXPERIMENTS; DEATH RATES; CYCLE; PROLIFERATION; KINETICS; TURNOVER; DYNAMICS; IMMUNITY	Carboxyfluorescein diacetate succinimidyl ester (CFSE) labelling has been widely used to track and study cell proliferation. Here we use mathematical modelling to describe the kinetics of immune cell proliferation after an in vitro polyclonal stimulation tracked with CFSE. This approach allows us to estimate a set of key parameters, including ones related to cell death and proliferation. We develop a three-phase model that distinguishes a latency phase, accounting for non-divided cell behaviour, a resting phase and the active phase of the division process. Parameter estimates are derived from model results, and numerical simulations are then compared to the dynamics of in vitro experiments, with different biological assumptions tested. Our model allows us to compare the dynamics of CD4+ and CD8+ cells, and to highlight their kinetic differences. Finally we perform a sensitivity analysis to quantify the impact of each parameter on proliferation kinetics. Interestingly, we find that parameter sensitivity varies with time and with cell generation. Our approach can help biologists to understand cell proliferation mechanisms and to identify potential pathological division processes.	[Mazzocco, Pauline] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, UMR 5558,Lab Biometrie & Biol Evolut, Villeurbanne, France; [Mazzocco, Pauline; Bernard, Samuel; Pujo-Menjouet, Laurent] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, UMR 5208,Inst Camille Jordan, Villeurbanne, France; [Mazzocco, Pauline; Bernard, Samuel; Pujo-Menjouet, Laurent] Inria Grenoble Rhone Alpes Ctr, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet	Pujo-Menjouet, L (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, UMR 5208,Inst Camille Jordan, Villeurbanne, France.	pujo@math.univ-lyon1.fr	Bernard, Samuel/A-5623-2009	Bernard, Samuel/0000-0002-8442-9968				Akaike H., 1992, 2 INT S INF THEOR, V1, P610; Asquith B, 2006, P R SOC B, V273, P1165, DOI 10.1098/rspb.2005.3432; Banks HT, 2012, MATH BIOSCI ENG, V9, P699, DOI 10.3934/mbe.2012.9.699; Banks HT, 2011, J IMMUNOL METHODS, V373, P143, DOI 10.1016/j.jim.2011.08.014; Banks HT, 2009, TEXTB MATH, P1; Bernard S, 2003, BIOPHYS J, V84, P3414, DOI 10.1016/S0006-3495(03)70063-0; Bocharov G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00264; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; De Boer RJ, 2005, J COMPUT APPL MATH, V184, P140, DOI 10.1016/j.cam.2004.08.020; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2013, J THEOR BIOL, V29, P997; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Dowling MR, 2014, P NATL ACAD SCI USA, V111, P6377, DOI 10.1073/pnas.1322420111; Ganusov VV, 2005, J IMMUNOL METHODS, V298, P183, DOI 10.1016/j.jim.2005.01.011; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hyrien O, 2008, J AM STAT ASSOC, V103, P222, DOI 10.1198/016214507000000194; Hyrien O, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-41; Iooss B, UNCERTAINTY MANAGEME, P101, DOI [10.1007/978-1-4899-7547-8, DOI 10.1007/978-1-4899-7547-8]; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Liu DC, 2006, J IMMUNOL METHODS, V312, P126, DOI 10.1016/j.jim.2006.03.010; Luzyanina T, 2013, J MATH BIOL, P1547; Luzyanina T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-26; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Oostendorp RAJ, 2000, BLOOD, V95, P855, DOI 10.1182/blood.V95.3.855.003k41_855_862; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Pilyugin SS, 2003, J THEOR BIOL, V225, P275, DOI 10.1016/S0022-5193(03)00245-5; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; Whitmire JK, 2000, CURR OPIN IMMUNOL, V12, P448, DOI 10.1016/S0952-7915(00)00119-9	34	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179768	10.1371/journal.pone.0179768	http://dx.doi.org/10.1371/journal.pone.0179768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622387	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300050
J	Masini, M; Marselli, L; Himpe, E; Martino, L; Bugliani, M; Suleiman, M; Boggi, U; Filipponi, F; Occhipinti, M; Bouwens, L; De Tata, V; Marchetti, P				Masini, Matilde; Marselli, Lorella; Himpe, Eddy; Martino, Luisa; Bugliani, Marco; Suleiman, Mara; Boggi, Ugo; Filipponi, Franco; Occhipinti, Margherita; Bouwens, Luc; De Tata, Vincenzo; Marchetti, Piero			Co-localization of acinar markers and insulin in pancreatic cells of subjects with type 2 diabetes	PLOS ONE			English	Article							BETA-CELLS; IMMUNOHISTOCHEMICAL LOCALIZATION; ENDOCRINE PANCREAS; EXOCRINE ENZYMES; ISLETS; REGENERATION; CONVERSION; MASS; RAT	To search for clues suggesting that beta cells may generate by transdifferentiation in humans, we assessed the presence of cells double positive for exocrine (amylase, carboxypeptidase A) and endocrine (insulin) markers in the pancreas of non-diabetic individuals (ND) and patients with type 2 diabetes (T2D). Samples from twelve ND and twelve matched T2D multiorgan donors were studied by electron microscopy, including amylase and insulin immunogold labeling; carboxypeptidase A immunofluorescence light microscopy assessment was also performed. In the pancreas from four T2D donors, cells containing both zymogen-like and insulin-like granules were observed, scattered in the exocrine compartment. Nature of granules was confirmed by immunogold labeling for amylase and insulin. Double positive cells ranged from 0.82 to 1.74 per mm(2), corresponding to 0.26 +/- 0.045% of the counted exocrine cells. Intriguingly, cells of the innate immune systems (mast cells and/or macrophages) were adjacent to 33.3 +/- 13.6% of these hybrid cells. No cells showing colocalization of amylase and insulin were found in ND samples by electron microscopy. Similarly, cells containing both carboxypeptidase A and insulin were more frequently observed in the diabetic pancreata. These results demonstrate more abundant presence of cells containing both acinar markers and insulin in the pancreas of T2D subjects, which suggests possible conversion from one cellular type to the other and specific association with the diseased condition.	[Masini, Matilde; Martino, Luisa; Boggi, Ugo; Filipponi, Franco; De Tata, Vincenzo] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Marselli, Lorella; Bugliani, Marco; Suleiman, Mara; Occhipinti, Margherita; Marchetti, Piero] Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, Pisa, Italy; [Himpe, Eddy; Bouwens, Luc] VUB, Cell Differentiat Lab, Brussels, Belgium	University of Pisa; University of Pisa; Vrije Universiteit Brussel	Marchetti, P (corresponding author), Univ Pisa, Islet Cell Lab, Dept Clin & Expt Med, Pisa, Italy.	piero.marchetti@med.unipi.it	Occhipinti, Margherita/AAC-1545-2019; Suleiman, Mara/AAB-9841-2019; Occhipinti, Margherita/AAC-4636-2022; Bugliani, Marco/I-3168-2019	Occhipinti, Margherita/0000-0003-4848-334X; Suleiman, Mara/0000-0002-2478-8782; Bugliani, Marco/0000-0002-1744-1561; Marselli, Lorella/0000-0002-6698-2962; Bouwens, Luc/0000-0001-5767-7002; Himpe, Eddy/0000-0001-6624-5877	European Union's Horizon research and innovation programme, project T2DSystems [667191]	European Union's Horizon research and innovation programme, project T2DSystems	This work was supported by the European Union's Horizon 2020 research and innovation programme, project T2DSystems, under grant agreement No 667191.; This work was supported by the European Union's Horizon 2020 research and innovation programme, project T2DSystems, under grant agreement No 667191. Piero Marchetti is the guarantor of this manuscript.	Bader E, 2016, NATURE, V535, P430, DOI 10.1038/nature18624; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Banaei-Bouchareb L, 2006, J ENDOCRINOL, V188, P467, DOI 10.1677/joe.1.06225; BENDAYAN M, 1982, J HISTOCHEM CYTOCHEM, V30, P81, DOI 10.1177/30.1.6172469; BENDAYAN M, 1979, J HISTOCHEM CYTOCHEM, V27, P1029, DOI 10.1177/27.6.110872; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; COSSEL L, 1983, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V128, P147; COSSEL L, 1986, VIRCHOWS ARCH B, V52, P283, DOI 10.1007/BF02889969; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Delaspre F, 2015, DIABETES, V64, P3499, DOI 10.2337/db15-0153; Desgraz R, 2011, TRENDS ENDOCRIN MET, V22, P34, DOI 10.1016/j.tem.2010.09.004; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; El-Gohary Y, 2016, ENDOCRINOLOGY, V157, P166, DOI 10.1210/en.2015-1175; Forbes SJ, 2014, NAT MED, V20, P857, DOI 10.1038/nm.3653; Gianani R, 2011, SEMIN IMMUNOPATHOL, V33, P23, DOI 10.1007/s00281-010-0235-7; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Halban PA, 2010, J CLIN ENDOCR METAB, V95, P1034, DOI 10.1210/jc.2009-1819; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; HANSEN LJ, 1981, J HISTOCHEM CYTOCHEM, V29, P309, DOI 10.1177/29.2.6166657; Johnston NR, 2016, CELL METAB; Klein D, 2015, DIABETES, V64, P4123, DOI 10.2337/db15-0688; Lemper M, 2015, CELL DEATH DIFFER, V22, P1117, DOI 10.1038/cdd.2014.193; Marchetti P., 2015, INT TXB DIABETES MEL, P354; Marchetti P, 2016, DIABETOLOGIA, V59, P668, DOI 10.1007/s00125-016-3875-x; Marselli L, 2014, DIABETOLOGIA, V57, P362, DOI 10.1007/s00125-013-3098-3; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Martino L, 2015, DIABETOLOGIA, V58, P2554, DOI 10.1007/s00125-015-3734-1; Martino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036188; Mezza T, 2014, DIABETES, V63, P994, DOI 10.2337/db13-1013; Mfopou JK, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150259; Moritoh Y, 2003, DIABETES, V52, P1163, DOI 10.2337/diabetes.52.5.1163; Morris DL, 2015, MOL ENDOCRINOL, V29, P946, DOI 10.1210/me.2014-1393; Pictet R, 1967, Diabetologia, V3, P188, DOI 10.1007/BF01222197; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Sato S, 2015, DIABETES, V64, P2915, DOI 10.2337/db15-0151; SEEMAYER TA, 1982, AM J PATHOL, V106, P237; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; STURROCK RR, 1979, J ANAT, V129, P31; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067454; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	44	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179398	10.1371/journal.pone.0179398	http://dx.doi.org/10.1371/journal.pone.0179398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617859	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600035
J	Saunders-Hastings, P; Hayes, BQ; Smith, R; Krewski, D				Saunders-Hastings, Patrick; Hayes, Bryson Quinn; Smith, Robert; Krewski, Daniel			Modelling community-control strategies to protect hospital resources during an influenza pandemic in Ottawa, Canada	PLOS ONE			English	Article							IMMUNIZATION PRACTICES ACIP; A H1N1; MITIGATION STRATEGIES; ADVISORY-COMMITTEE; COST-EFFECTIVENESS; AGE-GROUPS; TRANSMISSION; PREVENTION; INFECTION; IMPACT	Background A novel influenza virus has emerged to produce a global pandemic four times in the past one hundred years, resulting in millions of infections, hospitalizations and deaths. There is substantial uncertainty about when, where and how the next influenza pandemic will occur. Methods We developed a novel mathematical model to chart the evolution of an influenza pandemic. We estimate the likely burden of future influenza pandemics through health and economic endpoints. An important component of this is the adequacy of existing hospital-resource capacity. Using a simulated population reflective of Ottawa, Canada, we model the potential impact of a future influenza pandemic under different combinations of pharmaceutical and non-pharmaceutical interventions. Results There was substantial variation in projected pandemic impact and outcomes across intervention scenarios. In a population of 1.2 million, the illness attack rate ranged from 8.4% (all interventions) to 54.5% (no interventions); peak acute care hospital capacity ranged from 0.2% (all interventions) to 13.8% (no interventions); peak ICU capacity ranged from 1.1% (all interventions) to 90.2% (no interventions); and mortality ranged from 11 (all interventions) to 363 deaths (no interventions). Associated estimates of economic burden ranged from CAD $ 115 million to over $ 2 billion when extended mass school closure was implemented. Discussion Children accounted for a disproportionate number of pandemic infections, particularly in household settings. Pharmaceutical interventions effectively reduced peak and total pandemic burden without affecting timing, while non-pharmaceutical measures delayed and attenuated pandemic wave progression. The timely implementation of a layered intervention bundle appeared likely to protect hospital resource adequacy in Ottawa. The adaptable nature of this model provides value in informing pandemic preparedness policy planning in situations of uncertainty, as scenarios can be updated in real time as more data become available. However D given the inherent uncertainties of model assumptions D results should be interpreted with caution.	[Saunders-Hastings, Patrick; Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, 850 Peter Morand Crescent, Ottawa, ON, Canada; [Saunders-Hastings, Patrick; Smith, Robert; Krewski, Daniel] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada; [Hayes, Bryson Quinn; Smith, Robert] Univ Ottawa, Dept Math, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Saunders-Hastings, P (corresponding author), Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, 850 Peter Morand Crescent, Ottawa, ON, Canada.; Saunders-Hastings, P (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Fac Med, Ottawa, ON, Canada.	patrick.saundershastings@gmail.com		Smith?, Stacey/0000-0002-6529-3321	Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-G SST) [005-709-285]; Natural Sciences and Engineering Council of Canada Chair in Risk Science at the University of Ottawa; NSERC	Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-G SST); Natural Sciences and Engineering Council of Canada Chair in Risk Science at the University of Ottawa; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	PSH currently holds the Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-G SST, grant number 005-709-285, http://www.uottawa.ca/graduatestudies/ students/awards/queen-elizabeth-II-graduate-scholarships). DK is the Natural Sciences and Engineering Council of Canada Chair in Risk Science at the University of Ottawa. DK and RS? both hold an NSERC Discovery Grant (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGPPSIGP_eng.asp). DK is the Chief Executive Officer at Risk Sciences International, but no specific funding was allocated for this study. The funders identified above had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andradottir S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S1; Arino J, 2008, J THEOR BIOL, V253, P118, DOI 10.1016/j.jtbi.2008.02.026; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bondy SJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-488; Borse RH, 2011, CLIN INFECT DIS, V52, pS168, DOI 10.1093/cid/ciq033; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Burgess D, 2010, DISCOUNT RATES EVALU; Carrasco LR, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-3; Chao DL, 2011, AM J EPIDEMIOL, V173, P1121, DOI 10.1093/aje/kwq497; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; Chowell G, 2006, J THEOR BIOL, V241, P193, DOI 10.1016/j.jtbi.2005.11.026; Chowell G, 2016, PHYS LIFE REV; CIHI, 2016, NUMB HOSP BEDS STAFF; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Daly P., 2007, BC MED J, V49, P240; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Del Valle SY, 2013, MATH BIOSCI ENG, V10, P1475, DOI 10.3934/mbe.2013.10.1475; Deng Ying, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P1075; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; FLAHAULT A, 1994, EUR J EPIDEMIOL, V10, P471, DOI 10.1007/BF01719679; Flahault A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-129; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garfors G, 100000 FLIGHTS DAY 2; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Godoy P, 2012, PREV MED, V54, P434, DOI 10.1016/j.ypmed.2012.04.009; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Greer AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067253; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Haber MJ, 2007, EMERG INFECT DIS, V13, P581, DOI 10.3201/eid1304.060828; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; House T, 2011, P ROY SOC B-BIOL SCI, V278, P2753, DOI 10.1098/rspb.2010.2688; Humphries MO, 2014, WAR HIST, V21, P55, DOI 10.1177/0968344513504525; Jaeger JL, 2009, INFECT CONT HOSP EP, V2011, P1149, DOI DOI 10.1086/662709; Jefferson T, 2014, COCHRANE DATABASE SY; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Kelso JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-211; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; Kim CO, 2012, INFLUENZA OTHER RESP, V6, P313, DOI 10.1111/j.1750-2659.2011.00318.x; Kuszewski K, 2000, BIOMED PHARMACOTHER, V54, P188, DOI 10.1016/S0753-3322(00)89025-3; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; Lee J, 2015, J THEOR BIOL, V380, P60, DOI 10.1016/j.jtbi.2015.05.008; Li TG, 2011, J CLIN VIROL, V50, P235, DOI 10.1016/j.jcv.2010.11.012; Liu Wen-ting, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P509; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Madhav Nita., 2013, MSP H AIRCURRENTS MO; Merk H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-509; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Public Health Agency of Canada, VACC COV AD CAN RES; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Remschmidt C, 2013, INFLUENZA OTHER RESP, V7, P418, DOI 10.1111/j.1750-2659.2012.00407.x; Reperant L. A., 2013, PANDEMIC INFLUENZA, P31; Sander B, 2010, VACCINE, V28, P6210, DOI 10.1016/j.vaccine.2010.07.010; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Schanzer DL, 2013, INFLUENZA OTHER RESP, V7, P799, DOI 10.1111/irv.12011; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Sertsou G, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-38; Simonsen L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001558; Smith K, 2007, NATURE, V445, P237, DOI 10.1038/445237a; SSSQ, I LEG ENT 2016; StatsCan, EARN AV WEEKL PROV T; Stroud PD, 2006, MATH BIOSCI, V203, P301, DOI 10.1016/j.mbs.2006.01.007; Suess T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-26; Thompson M. G., 2010, MMWR-MORBID MORTAL W, V59, P1057; Tooher R, 2013, INFLUENZA OTHER RESP, V7, P1316, DOI 10.1111/irv.12103; Torner N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1890-3; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15; Winquist E, 2012, VALUE HEALTH, V15, P982, DOI 10.1016/j.jval.2012.06.009; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yin JK, 2012, VACCINE, V30, P3209, DOI 10.1016/j.vaccine.2012.02.048; Zambon MC, 1999, J ANTIMICROB CHEMOTH, V44, P3, DOI 10.1093/jac/44.suppl_2.3; Zhang QX, 2015, INT J ENV RES PUB HE, V12, P9750, DOI 10.3390/ijerph120809750; Zhang Y, 2013, INFLUENZA OTHER RESP, V7, P466, DOI 10.1111/irv.12025	98	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179315	10.1371/journal.pone.0179315	http://dx.doi.org/10.1371/journal.pone.0179315			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614365	Green Submitted, Green Published, gold			2022-12-26	WOS:000403280900042
J	Marchal, J; Cumming, SG; McIntire, EJB				Marchal, Jean; Cumming, Steve G.; McIntire, Eliot J. B.			Land cover, more than monthly fire weather, drives fire-size distribution in Southern Quebec forests: Implications for fire risk management	PLOS ONE			English	Article							CLIMATE-CHANGE; BOREAL FOREST; POWER-LAW; WILDFIRE; MODELS; MIXEDWOOD; REGIMES; MOISTURE; BEHAVIOR; IMPACTS	Fire activity in North American forests is expected to increase substantially with climate change. This would represent a growing risk to human settlements and industrial infrastructure proximal to forests, and to the forest products industry. We modelled fire size distributions in southern Quebec as functions of fire weather and land cover, thus explicitly integrating some of the biotic interactions and feedbacks in a forest-wildfire system. We found that, contrary to expectations, land-cover and not fire weather was the primary driver of fire size in our study region. Fires were highly selective on fuel-type under a wide range of fire weather conditions: specifically, deciduous forest, lakes and to a lesser extent recently burned areas decreased the expected fire size in their vicinity compared to conifer forest. This has large implications for fire risk management in that fuels management could reduce fire risk over the long term. Our results imply, for example, that if 30% of a conifer-dominated landscape were converted to hardwoods, the probability of a given fire, occurring in that landscape under mean fire weather conditions, exceeding 100,000 ha would be reduced by a factor of 21. A similarly marked but slightly smaller effect size would be expected under extreme fire weather conditions. We attribute the decrease in expected fire size that occurs in recently burned areas to fuel availability limitations on fires spread. Because regenerating burned conifer stands often pass through a deciduous stage, this would also act as a negative biotic feedback whereby the occurrence of fires limits the size of nearby future for some period of time. Our parameter estimates imply that changes in vegetation flammability or fuel availability after fires would tend to counteract shifts in the fire size distribution favoring larger fires that are expected under climate warming. Ecological forecasts from models neglecting these feedbacks may markedly overestimate the consequences of climate warming on fire activity, and could be misleading. Assessments of vulnerability to climate change, and subsequent adaptation strategies, are directly dependent on integrated ecological forecasts. Thus, we stress the need to explicitly incorporate land-cover's direct effects and feedbacks in simulation models of coupled climate-fire-fuels systems.	[Marchal, Jean; Cumming, Steve G.; McIntire, Eliot J. B.] Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price, Quebec City, PQ, Canada; [McIntire, Eliot J. B.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada	Laval University; Natural Resources Canada; Canadian Forest Service	Marchal, J (corresponding author), Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price, Quebec City, PQ, Canada.	jean.d.marchal@gmail.com		Marchal, Jean/0000-0002-0059-3446	Ouranos Consortium; Fonds vert du gouvernement du Quebec; National Sciences and Engineering Research Council of Canada Discovery Grants program; Canada Research Chair program	Ouranos Consortium; Fonds vert du gouvernement du Quebec; National Sciences and Engineering Research Council of Canada Discovery Grants program; Canada Research Chair program(Canada Research Chairs)	Financial support came from the Ouranos Consortium, the Fonds vert du gouvernement du Quebec, the National Sciences and Engineering Research Council of Canada Discovery Grants program (SGC) and the Canada Research Chair program (SGC and EJBM).r Financial support came from the Ouranos Consortium, the Fonds vert du gouvernement du Quebec, the National Sciences and Engineering Research Council of Canada Discovery Grants program (SGC) and the Canada Research Chair program (SGC and EJBM). We thank T. Logan from the Ouranos Consortium for providing the weather data.	AHMAD MI, 1988, WATER RESOUR RES, V24, P1323, DOI 10.1029/WR024i008p01323; Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; Barros A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096672; Bergeron Y, 2010, INT J WILDLAND FIRE, V19, P1127, DOI 10.1071/WF09092; Beverly JL, 2007, INT J WILDLAND FIRE, V16, P161, DOI 10.1071/WF06072; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Burnham K. P., 2002, MODEL SELECTION AND; Comite permanent de la stratification (CPSF), 2013, NORM STRAT INV EC QU; Cui W, 2008, INT J WILDLAND FIRE, V17, P234, DOI 10.1071/WF06145; Cumming SG, 2001, CAN J FOREST RES, V31, P1297, DOI 10.1139/cjfr-31-8-1297; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Girardin MP, 2015, CLIMATIC CHANGE, V130, P587, DOI 10.1007/s10584-015-1373-7; Girardin MP, 2009, J APPL METEOROL CLIM, V48, P517, DOI 10.1175/2008JAMC1996.1; Gouvernement du Quebec, CLIM QUEB; Gralewicz NJ, 2012, FOREST ECOL MANAG, V265, P20, DOI 10.1016/j.foreco.2011.10.031; Hantson S, 2016, INT J WILDLAND FIRE, V25, P403, DOI 10.1071/WF15108; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hely C, 2001, CAN J FOREST RES, V31, P430, DOI 10.1139/cjfr-31-3-430; Hirsch K, 2004, 22 TALL TIMB FIR EC, P175; Kagan Y.Y., 2001, J APPL PROBAB, V38, P158, DOI [DOI 10.1239/jap/1085496599, 10.1017/s0021900200112756, DOI 10.1017/S0021900200112756]; Krawchuk MA, 2014, ENVIRONMETRICS, V25, P472, DOI 10.1002/env.2287; Krawchuk MA, 2011, ECOL APPL, V21, P122, DOI 10.1890/09-2004.1; Liu ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066666, 10.1371/journal.pone.0055618]; Marchal J, 2016, ECOGRAPHY; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Moritz MA, 2011, ECOL STUD-ANAL SYNTH, V213, P51, DOI 10.1007/978-94-007-0301-8_3; Mullen KM, 2011, J STAT SOFTW, V40, P1; O'Donnell AJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00145.1; Parisien MA, 2014, ECOL APPL, V24, P1341, DOI 10.1890/13-1477.1; Parks SA, 2015, ECOL APPL, V25, P1478, DOI 10.1890/14-1430.1; Pausas JG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1074, DOI 10.1111/j.1466-8238.2012.00769.x; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Podur JJ, 2009, ECOL APPL, V19, P1246, DOI 10.1890/08-0790.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reed WJ, 2002, ECOL MODEL, V150, P239, DOI 10.1016/S0304-3800(01)00483-5; Schoenberg FP, 2012, EUR PHYS J-SPEC TOP, V205, P159, DOI 10.1140/epjst/e2012-01568-4; Societe de protection des contre le feu, 2014, RAPP ANN 2014; STRAUSS D, 1989, FOREST SCI, V35, P319; Terrier A, 2013, ECOL APPL, V23, P21, DOI 10.1890/12-0425.1; Wang XL, 2014, GLOBAL CHANGE BIOL, V20, P2518, DOI 10.1111/gcb.12590; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Williams RJ, 2008, INT J WILDLAND FIRE, V17, P685, DOI 10.1071/WF07155; Zhu K, 2014, GLOBAL CHANGE BIOL, V20, P251, DOI 10.1111/gcb.12382; Zinck RD, 2011, AM NAT, V178, pE149, DOI 10.1086/662675	51	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179294	10.1371/journal.pone.0179294	http://dx.doi.org/10.1371/journal.pone.0179294			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609467	Green Submitted, gold, Green Published			2022-12-26	WOS:000403274700026
J	Khokhar, JS; Sareen, S; Tyagi, BS; Singh, G; Chowdhury, AK; Dhar, T; Singh, V; King, IP; Young, SD; Broadley, MR				Khokhar, Jaswant S.; Sareen, Sindhu; Tyagi, Bhudeva S.; Singh, Gyanendra; Chowdhury, Apurba K.; Dhar, Tapamay; Singh, Vinod; King, Ian P.; Young, Scott D.; Broadley, Martin R.			Characterising variation in wheat traits under hostile soil conditions in India	PLOS ONE			English	Article							SALT TOLERANCE; SALINITY TOLERANCE; ALUMINUM RESISTANCE; DURUM-WHEAT; STRESS; ACIDITY; YIELD; GROWTH; PLANTS; STRATEGIES	Intensive crop breeding has increased wheat yields and production in India. Wheat improvement in India typically involves selecting yield and component traits under non-hostile soil conditions at regional scales. The aim of this study is to quantify G*E interactions on yield and component traits to further explore site-specific trait selection for hostile soils. Field experiments were conducted at six sites (pH range 4.5-9.5) in 2013-14 and 2014-15, in three agro-climatic regions of India. At each site, yield and component traits were measured on 36 genotypes, representing elite varieties from a wide genetic background developed for different regions. Mean grain yields ranged from 1.0 to 5.5 t ha(-1) at hostile and non-hostile sites, respectively. Site (E) had the largest effect on yield and component traits, however, interactions between genotype and site (G*E) affected most traits to a greater extent than genotype alone. Within each agro-climatic region, yield and component traits correlated positively between hostile and non-hostile sites. However, some genotypes performed better under hostile soils, with site-specific relationships between yield and component traits, which supports the value of ongoing site-specific selection activities.	[Khokhar, Jaswant S.; King, Ian P.; Young, Scott D.; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Sareen, Sindhu; Tyagi, Bhudeva S.; Singh, Gyanendra] Indian Inst Wheat & Barley Res, Aggarsain Marg, Karnal, Haryana, India; [Chowdhury, Apurba K.; Dhar, Tapamay] Uttar Banga Krishi Viswavidyalaya, Pundibari, W Bengal, India; [Singh, Vinod] Narendra Deva Univ Agr & Technol, Faizabad, Uttar Pradesh, India	University of Nottingham; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research	Broadley, MR (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	martin.broadley@nottingham.ac.uk	broadley, martin r/E-9081-2011; Khokhar, Jaswant/ABG-8288-2020; Broadley, Martin/AAW-4638-2021; Tyagi, Bhudeva/AAR-8225-2021; Sareen, Sindhu/A-8465-2012	broadley, martin r/0000-0003-3964-7226; Khokhar, Jaswant/0000-0003-4870-6208; Broadley, Martin/0000-0003-3964-7226; Sareen, Sindhu/0000-0003-2944-0395	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Crop Production Research for International Development (SCPRID) [BB/J011827/1]; BBSRC [BB/J011827/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Crop Production Research for International Development (SCPRID); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Crop Production Research for International Development (SCPRID) scheme award to IK (reference BB/J011827/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarpour OA, 2015, CROP PASTURE SCI, V66, P770, DOI 10.1071/CP14286; [Anonymous], 2014, OPEN T GEOSCI, DOI DOI 10.15764/GEOS.2014.01003; Ashraf M, 2008, ADV AGRON, V97, P45, DOI 10.1016/S0065-2113(07)00002-8; Asli DE, 2014, ANN BOT, V3, P165; Bian M, 2013, CROP J, V1, P91, DOI 10.1016/j.cj.2013.08.002; BOWER CA, 1952, SOIL SCI, V73, P251, DOI 10.1097/00010694-195204000-00001; Brown TT, 2008, SOIL SCI SOC AM J, V72, P634, DOI 10.2136/sssaj2007.0061; Chamekh Z, 2016, PLANT SCI, V251, P44, DOI 10.1016/j.plantsci.2016.07.005; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chuan MC, 1996, WATER AIR SOIL POLL, V90, P543, DOI 10.1007/BF00282668; DELHAIZE E, 1993, PLANT PHYSIOL, V103, P695, DOI 10.1104/pp.103.3.695; Dey P, 2011, SALINITY MANAGEMENT; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Genc Y, 2016, NEW PHYTOL, V210, P145, DOI 10.1111/nph.13757; Gholizadeha A., 2014, Agricultural Advances, V3, P103; Haling RE, 2011, PLANT CELL ENVIRON, V34, P444, DOI 10.1111/j.1365-3040.2010.02254.x; Intshar-Ul-Haq Javed, 2003, International Journal of Agriculture and Biology, V5, P233; James RA, 2008, FUNCT PLANT BIOL, V35, P111, DOI 10.1071/FP07234; Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Krishnamurthy SL, 2016, FIELD CROP RES, V190, P26, DOI 10.1016/j.fcr.2016.02.018; Lenis JM, 2011, J AGRON CROP SCI, V197, P302, DOI 10.1111/j.1439-037X.2011.00466.x; MAAS EV, 1990, CROP SCI, V30, P1309, DOI 10.2135/cropsci1990.0011183X003000060031x; McDonald GK, 2012, CROP PASTURE SCI, V63, P1043, DOI 10.1071/CP12244; Merino-Gergichevich C, 2010, J SOIL SCI PLANT NUT, V10, P217, DOI 10.4067/S0718-95162010000100003; Mondal AK, 2010, CENTRAL SOIL SALINIT, P28; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2015, NEW PHYTOL, V208, P668, DOI 10.1111/nph.13519; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Osundwa M. A., 2013, American Journal of Experimental Agriculture, V3, P806; Rahman M. A., 2013, Bangladesh Journal of Agricultural Research, V38, P97; Ranjbar G. H., 2010, American-Eurasian Journal of Agricultural and Environmental Science, V8, P50; Ryan PR, 2009, PLANT PHYSIOL, V149, P340, DOI 10.1104/pp.108.129155; Sadat Noori S. A., 2010, IRANIAN J PLANT PHYS, V1, P108; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Setter TL, 2016, FIELD CROP RES, V194, P31, DOI 10.1016/j.fcr.2016.04.034; Sharma KL, 2012, RESOURCE MANAGEMENT, pCh 08; Sharma PC, 2010, CSSRI AT A GLANCE; Sharma R. K., 2007, J WHEAT RES, V1, P97; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Singh G, 2009, LAND DEGRAD DEV, V20, P367, DOI 10.1002/ldr.933; Singh G, 2010, J ENVIRON QUAL, V39, P5, DOI 10.2134/jeq2009.0032; Singh N., 1997, J PUNJAB STUD, V12, P285; Singh NT, 2005, IRRIGATION SOIL SALI; Tang C, 2003, AUST J AGR RES, V54, P445, DOI 10.1071/AR02116; Tang C, 2002, FIELD CROP RES, V78, P93, DOI 10.1016/S0378-4290(02)00105-3; Turki N, 2012, J ARID LAND STUD, V22-1, P311; Wright D, 2000, PLANT SOIL, V223, P279, DOI 10.1023/A:1004882523013; Zhang XX, 2016, FOOD CHEM, V197, P516, DOI 10.1016/j.foodchem.2015.11.008; Zhu M, 2016, J AGRON CROP SCI, V202, P115, DOI 10.1111/jac.12122	51	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179208	10.1371/journal.pone.0179208	http://dx.doi.org/10.1371/journal.pone.0179208			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604800	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400036
J	Menezes, MBC; Kim, S; Huang, RB				Menezes, Mozart B. C.; Kim, Seokjin; Huang, Rongbing			Constructing a Watts-Strogatz network from a small-world network with symmetric degree distribution	PLOS ONE			English	Article								Though the small-world phenomenon is widespread in many real networks, it is still challenging to replicate a large network at the full scale for further study on its structure and dynamics when sufficient data are not readily available. We propose a method to construct a Watts-Strogatz network using a sample from a small-world network with symmetric degree distribution. Our method yields an estimated degree distribution which fits closely with that of a Watts-Strogatz network and leads into accurate estimates of network metrics such as clustering coefficient and degree of separation. We observe that the accuracy of our method increases as network size increases.	[Menezes, Mozart B. C.] Kedge Business Sch Bordeaux, Operat Management Dept, 680 Cours Liberat, F-33405 Talence, France; [Kim, Seokjin] Suffolk Univ, Dept Informat Syst & Operat Management, Sawyer Business Sch, 120 Tremont St, Boston, MA 02108 USA; [Huang, Rongbing] York Univ, Sch Adm Studies, 4700 Keele St, Toronto, ON M3J 1P3, Canada	Suffolk University; York University - Canada	Kim, S (corresponding author), Suffolk Univ, Dept Informat Syst & Operat Management, Sawyer Business Sch, 120 Tremont St, Boston, MA 02108 USA.	kim@suffolk.edu	B.C. Menezes, Mozart/F-3015-2015	B.C. Menezes, Mozart/0000-0002-5815-7639				Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; KILLWORTH PD, 1990, SOC NETWORKS, V12, P289, DOI 10.1016/0378-8733(90)90012-X; Maltiel R, 2015, ANN APPL STAT, V9, P1247, DOI 10.1214/15-AOAS827; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Schnettler S, 2009, SOC NETWORKS, V31, P165, DOI 10.1016/j.socnet.2008.12.004; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	11	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179120	10.1371/journal.pone.0179120	http://dx.doi.org/10.1371/journal.pone.0179120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604809	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400027
J	Izawa, KP; Shibata, A; Ishii, K; Miyawaki, R; Oka, K				Izawa, Kazuhiro P.; Shibata, Ai; Ishii, Kaori; Miyawaki, Rina; Oka, Koichiro			Associations of low-intensity light physical activity with physical performance in community-dwelling elderly Japanese: A cross-sectional study	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; LOWER-EXTREMITY FUNCTION; CLINICAL CHARACTERISTICS; NUTRITIONAL-STATUS; OLDER-ADULTS; MUSCLE MASS; GAIT SPEED; DISABILITY; BIOMARKERS; FITNESS	Background Physical activity and physical performance relate to quality of life, mortality, and morbidity in elderly people. However, little is known about differences in physical performance related to low-intensity light physical activity (LLPA), high-intensity light physical activity (HLPA), and moderate-intensity physical activity (MPA) and how they are separated by sex in elderly populations. Aims This study aimed to determine differences in LLPA, HLPA, MPA, and physical performance, and associations between these measures in community-dwelling elderly men and women. Methods Physical activity and physical performance such as timed-up-and-go test, one-leg standing time, and maximum gait speed were measured in 181 community-dwelling elderly men (mean age, 75.1 +/- 5.3 years) and 109 women (mean age, 73.4 +/- 4.8 years) in 2013. Physical activity was classified as LLPA (1.6 +/- 1.9 METs of physical activity), HLPA (2.0 similar to 2.9 METs of physical activity), and MPA (over 3 METs of physical activity). The association between the values of these three intensities of physical activity in the participants was assessed by Pearson's correlation coefficients. Multiple linear regression analyses were used to assess the association of physical performance values with the three groups defined by accelerometer- measured physical activity intensity adjusted for sociographic, behavioral, and multiple diseases in the participants. Results MPA was beneficially associated with all physical performance indicators in the men (all P < 0.05) and women (all P < 0.05). Only HLPA showed significant associations with the timed-up-and-go test (P = 0.001) and maximum gait speed (P = 0.006) in women. Discussion These results may support the notion that not only HLPA in women but MPA in both sexes appears to improve physical performance in elderly populations. Conclusion The present study findings provide novel epidemiological evidence for the potential benefits of HLPA in women and also reinforce the potential benefits of MPA in both sexes, which is the mainstay of public health recommendations.	[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Shibata, Ai] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Ishii, Kaori; Miyawaki, Rina; Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Kobe University; University of Tsukuba; Waseda University	Oka, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	koka@waseda.jp	Oka, Koichiro/K-3297-2019	Oka, Koichiro/0000-0001-5571-042X	Ministry of Education, Culture, Sports, Science, and Technology-Supported Program for the Strategic Research Foundation at Private Universities [S1511017]	Ministry of Education, Culture, Sports, Science, and Technology-Supported Program for the Strategic Research Foundation at Private Universities	This study was supported by the Ministry of Education, Culture, Sports, Science, and Technology-Supported Program for the Strategic Research Foundation at Private Universities (S1511017).	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Budtz-Jorgensen E, 2001, BEST PRACT RES CL GA, V15, P885, DOI 10.1053/bega.2001.0247; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Furuna T, 1998, J Jpn Phys Ther Assoc, V1, P1, DOI 10.1298/jjpta.1.1; Gardner Andrew W, 2008, Clin Med Geriatr, V1, P1; Gonzales JU, 2015, J AGING PHYS ACTIV, V23, P395, DOI 10.1123/japa.2014-0049; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haider S, 2016, QUAL LIFE RES, V25, P3129, DOI 10.1007/s11136-016-1349-8; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hirota C, 2010, GERIATR GERONTOL INT, V10, P40, DOI 10.1111/j.1447-0594.2009.00557.x; Howard B, 2015, MED SCI SPORT EXER, V47, P2093, DOI 10.1249/MSS.0000000000000631; Inui A, 2016, CLIN INTERV AGING, V11, P873, DOI 10.2147/CIA.S108498; Izawa KP, 2008, J REHABIL MED, V40, P225, DOI 10.2340/16501977-0156; Izawa KP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000623; Izawa KP, 2015, GERIATR GERONTOL INT, V15, P189, DOI 10.1111/ggi.12257; Katsura Y, 2010, EUR J APPL PHYSIOL, V108, P957, DOI 10.1007/s00421-009-1306-0; Moriya S, 2009, INT DENT J, V59, P369, DOI 10.1922/IDJ_2323Moriya07; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ohkawara K, 2011, BRIT J NUTR, V105, P1681, DOI 10.1017/S0007114510005441; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Sadeghi M, 2012, J RES MED SCI, V17, P787; Sahyoun NR, 2003, J AM DIET ASSOC, V103, P61, DOI 10.1053/jada.2003.50003; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Shimada H, 2011, ARCH GERONTOL GERIAT, V53, P131, DOI 10.1016/j.archger.2010.11.003; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Takata Y, 2004, ORAL DIS, V10, P44, DOI 10.1046/j.1354-523X.2003.00972.x; Tsuchihashi M, 2000, JPN CIRC J, V64, P953, DOI 10.1253/jcj.64.953; Visser M, 1998, J GERONTOL A-BIOL, V53, pM214, DOI 10.1093/gerona/53A.3.M214	31	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178654	10.1371/journal.pone.0178654	http://dx.doi.org/10.1371/journal.pone.0178654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX1NV	28598993	Green Submitted, Green Published, gold			2022-12-26	WOS:000402992000008
J	Lukic, A; Larssen, P; Fauland, A; Samuelsson, B; Wheelock, CE; Gabrielsson, S; Radmark, O				Lukic, Ana; Larssen, Pia; Fauland, Alexander; Samuelsson, Bengt; Wheelock, Craig E.; Gabrielsson, Susanne; Radmark, Olof			GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures	FASEB JOURNAL			English	Article						eicosanoid; M1; M2; leukotriene; lipoxin	ALTERNATIVELY ACTIVATED MACROPHAGES; COLONY-STIMULATING FACTORS; LEUKOTRIENE BIOSYNTHESIS; ANTIINFLAMMATORY ACTIONS; CYSTEINYL-LEUKOTRIENES; HUMAN MONOCYTES; RESOLUTION; POLARIZATION; CELLS; 5-LIPOXYGENASE	M1 and M2 activated macrophages (M phi s) have different roles in inflammation. Because pathogens may first encounter resting cells, we investigated lipid mediator profiles prior to full activation. Human monocytes were differentiated with granulocyte M phi colony-stimulating factor (GM-CSF) or M phi colony-stimulating factor (M-CSF), which are known to prime toward M1 or M2 phenotypes, respectively. Lipid mediators released during resting conditions and produced in response to bacterial stimuli (LPS/N-formylmethionyl-leucyl-phenylalanine or peptidoglycan) were quantified by liquid chromatography-mass spectrometry. In resting conditions, both M phi phenotypes released primarily proresolving lipid mediators (prostaglandin E-2 metabolite, lipoxin A(4), and 18-hydroxyeicosapentaenoic acid). A striking shift toward proinflammatory eicosanoids was observed when the same cells were exposed (30 min) to bacterial stimuli: M-CSF M phi s produced considerably more 5-lipoxygenase products, particularly leukotriene C-4, potentially linked to M2 functions in asthma. Prostaglandins were formed by both M phi types. In the M-CSF cells, there was also an enhanced release of arachidonic acid and activation of cytosolic phospholipase A(2). However, GM-CSF cells expressed higher levels of 5-lipoxygenase and 5-lipoxygenase-activating protein, and in ionophore incubations these cells also produced the highest levels of 5-hydroxyeicosatetraenoic acid. In summary, GM-CSF and M-CSF M phi s displayed similar proresolving lipid mediator formation in resting conditions but shifted toward different proinflammatory eicosanoids upon bacterial stimuli. This demonstrates that preference for specific eicosanoid pathways is primed by CSFs before full M1/M2 activation.-Lukic, A., Larssen, P., Fauland, A., Samuelsson, B., Wheelock, C. E., Gabrielsson, S., Radmark, O. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.	[Lukic, Ana; Fauland, Alexander; Samuelsson, Bengt; Wheelock, Craig E.; Radmark, Olof] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden; [Larssen, Pia; Gabrielsson, Susanne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Radmark, O (corresponding author), Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	olof.radmark@ki.se	Gabrielsson, S./E-4145-2014	Gabrielsson, S./0000-0003-1771-1346	Swedish Medical Research Council; Swedish Cancer Foundation; Cancer Research Foundations of Radiumhemmet; Stockholm County Council; Swedish Heart-Lung Foundation; Center for Allergy Research; Cancer and Allergy Foundation; AstraZeneca Joint Research Program in Translational Science (ChAMP); Hesselman Foundation; Karolinska Institute (Stockholm, Sweden); Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden); Swedish Heart Lung Foundation [HLF 20150640]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Foundation; Cancer Research Foundations of Radiumhemmet; Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Center for Allergy Research; Cancer and Allergy Foundation; AstraZeneca Joint Research Program in Translational Science (ChAMP); Hesselman Foundation; Karolinska Institute (Stockholm, Sweden)(Karolinska Institutet); Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation)	The authors thank Johan Kolmert (Department of Environmental Medicine, Karolinska Institutet) for kind help and discussions. This work was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Foundation, the Cancer Research Foundations of Radiumhemmet, the Stockholm County Council, the Swedish Heart-Lung Foundation, the Center for Allergy Research, the Cancer and Allergy Foundation, the AstraZeneca Joint Research Program in Translational Science (ChAMP), and the Hesselman Foundation, and from the Karolinska Institute (all in Stockholm, Sweden). A.F. was funded by the Karin and Sten Mortstedt Initiative on Anaphylaxis (Stockholm, Sweden). C.E.W. was supported by the Swedish Heart Lung Foundation (HLF 20150640). The authors declare no conflicts of interest.	Allen IC, 2006, AM J PHYSIOL-LUNG C, V290, pL526, DOI 10.1152/ajplung.00340.2005; Balgoma D, 2016, EUR RESPIR J, V47, P1645, DOI 10.1183/13993003.01080-2015; Bosse Y, 2008, CLIN EXP ALLERGY, V38, P113, DOI 10.1111/j.1365-2222.2007.02873.x; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Cabrero A, 2003, METABOLISM, V52, P652, DOI 10.1053/meta.2003.50100; Dai MY, 2015, J CELL PHYSIOL, V230, P2108, DOI 10.1002/jcp.24939; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Draijer C, 2016, J LEUKOCYTE BIOL, V100, P95, DOI 10.1189/jlb.3MAB1115-505R; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Endo J, 2014, J EXP MED, V211, P1673, DOI 10.1084/jem.20132011; Esser J, 2011, FASEB J, V25, P1417, DOI 10.1096/fj.10-175828; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; FU JY, 1990, J BIOL CHEM, V265, P16737; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; Jiang ZL, 2016, J ASTHMA ALLERGY, V9, P101, DOI 10.2147/JAA.S104508; Kita Y, 2005, BIOCHEM BIOPH RES CO, V330, P898, DOI 10.1016/j.bbrc.2005.03.055; Kolaczkowska E, 2002, INFLAMMATION, V26, P61, DOI 10.1023/A:1014837110735; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lehmann C, 2015, FASEB J, V29, P5029, DOI 10.1096/fj.15-275487; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Lukic A, 2016, J LIPID RES, V57, P1659, DOI 10.1194/jlr.M066910; Lundstrom SL, 2013, J LIPID RES, V54, P116, DOI 10.1194/jlr.M030171; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Namgaladze D, 2014, BBA-MOL CELL BIOL L, V1841, P1329, DOI 10.1016/j.bbalip.2014.06.007; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; Poczobutt JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079633; Poulin S, 2011, CLIN EXP ALLERGY, V41, P204, DOI 10.1111/j.1365-2222.2010.03653.x; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rossi A, 2014, PHARMACOL RES, V87, P1, DOI 10.1016/j.phrs.2014.05.011; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sokolowska M, 2014, J BIOL CHEM, V289, P4470, DOI 10.1074/jbc.M113.515106; Surette ME, 1998, FASEB J, V12, P1521, DOI 10.1096/fasebj.12.14.1521; Thompson C, 2008, AM J RESP CELL MOL, V39, P227, DOI 10.1165/rcmb.2007-0293OC; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Varin A, 2015, ARTERIOSCL THROM VAS, V35, P1357, DOI 10.1161/ATVBAHA.115.305539; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959; Zhang YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157035	54	41	41	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4370	4381		10.1096/fj.201700319R	http://dx.doi.org/10.1096/fj.201700319R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28637652				2022-12-26	WOS:000413397400016
J	Dong, XH; Li, JY; He, LQQ; Gu, C; Jia, WS; Yue, YY; Li, J; Zhang, QX; Chu, LL; Zhao, QS				Dong, Xiaohua; Li, Jingyun; He, Luqingqing; Gu, Chun; Jia, Wenshuang; Yue, Yunyun; Li, Jun; Zhang, Qinxin; Chu, Lele; Zhao, Qingshun			Zebrafish Znfl1 proteins control the expression of hoxb1b gene in the posterior neuroectoderm by acting upstream of pou5f3 and sall4 genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; homeobox; neurodevelopment; transcription factor; zebrafish; zinc finger	RETINOIC ACID; DISTINCT ROLES; HINDBRAIN SEGMENTATION; EMBRYONIC-DEVELOPMENT; NEURAL DEVELOPMENT; MAMMALIAN OCT4; DEFAULT MODEL; INDUCTION; SPIEL-OHNE-GRENZEN/POU2; XENOPUS	Transcription factors play crucial roles in patterning posterior neuroectoderm. Previously, zinc finger transcription factor znfl1 was reported to be expressed in the posterior neuroectoderm of zebrafish embryos. However, its roles remain unknown. Here, we report that there are 13 copies of znfl1 in the zebrafish genome, and all the paralogues share highly identical protein sequences and cDNA sequences. When znfl1s are knocked down using a morpholino to inhibit their translation or dCas9-Eve to inhibit their transcription, the zebrafish gastrula displays reduced expression of hoxb1b, the marker gene for the posterior neuroectoderm. Further analyses reveal that diminishing znfl1s produces the decreased expressions of pou5f3, whereas overexpression of pou5f3 effectively rescues the reduced expression of hoxb1b in the posterior neuroectoderm. Additionally, knocking down znfl1s causes the reduced expression of sall4, a direct regulator of pou5f3, in the posterior neuroectoderm, and overexpression of sall4 rescues the expression of pou5f3 in the knockdown embryos. In contrast, knocking down either pou5f3 or sall4 does not affect the expressions of znfl1s. Taken together, our results demonstrate that zebrafish znfl1s control the expression of hoxb1b in the posterior neuroectoderm by acting upstream of pou5f3 and sall4.	[Dong, Xiaohua; He, Luqingqing; Gu, Chun; Jia, Wenshuang; Yue, Yunyun; Zhang, Qinxin; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study,, Nanjing 210061, Jiangsu, Peoples R China; [Li, Jingyun; Li, Jun] Nanjing Med Univ, Obstet & Gynecol Hosp, Dept Plast & Cosmet Surg, Maternal & Child Hlth Med Inst, Nanjing 210004, Jiangsu, Peoples R China; [Dong, Xiaohua; Chu, Lele] Nanjing YSY Biotech Co, Inst Genome Editing, Nanjing 211812, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Zhao, QS (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			National Natural Science Foundation of China [31471355, 31271569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grants 31471355 and 31271569. The authors declare that they have no conflicts of interest with the contents of this article.	Belting HG, 2001, DEVELOPMENT, V128, P4165; Burgess S, 2002, DEVELOPMENT, V129, P905; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cruz C, 2010, P NATL ACAD SCI USA, V107, P3564, DOI 10.1073/pnas.1000389107; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Harvey SA, 2006, DEVELOPMENT, V133, P1165, DOI 10.1242/dev.02259; Hauptmann G, 2002, DEVELOPMENT, V129, P1645; Ishioka A, 2011, DEV BIOL, V350, P154, DOI 10.1016/j.ydbio.2010.10.011; Kam MKM, 2015, DEV GROWTH DIFFER, V57, P158, DOI 10.1111/dgd.12199; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klymkowsky MW, 2010, CELL ADHES MIGR, V4, P595, DOI 10.4161/cam.4.4.12962; Kudoh T, 2002, DEVELOPMENT, V129, P4335; Li JY, 2014, DEV DYNAM, V243, P1544, DOI 10.1002/dvdy.24181; Li JY, 2012, ANAT REC, V295, P268, DOI 10.1002/ar.21520; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lippmann ES, 2015, STEM CELL REP, V4, P632, DOI 10.1016/j.stemcr.2015.02.018; Long LJ, 2015, CELL RES, V25, P638, DOI 10.1038/cr.2015.35; Lunde K, 2004, CURR BIOL, V14, P48, DOI 10.1016/j.cub.2003.11.022; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Paik EJ, 2013, STEM CELL REP, V1, P425, DOI 10.1016/j.stemcr.2013.10.001; Parker HJ, 2016, BIOESSAYS, V38, P526, DOI 10.1002/bies.201600010; Parvin MS, 2008, DEV DYNAM, V237, P1373, DOI 10.1002/dvdy.21539; Reim G, 2002, DEVELOPMENT, V129, P917; Robles V, 2011, ZEBRAFISH, V8, P57, DOI 10.1089/zeb.2010.0684; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Tallafuss A, 2001, DEVELOPMENT, V128, P4021; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Xu S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1038-5; Yoda H, 2003, DIFFERENTIATION, V71, P152, DOI 10.1046/j.1432-0436.2003.710206.x; Young JJ, 2014, DEVELOPMENT, V141, P1683, DOI 10.1242/dev.099374; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zigman M, 2014, DEVELOPMENT, V141, P639, DOI 10.1242/dev.098731	38	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					13045	13055		10.1074/jbc.M117.777094	http://dx.doi.org/10.1074/jbc.M117.777094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28623229	hybrid, Green Published			2022-12-26	WOS:000407220100031
J	Piechotta, A; Parthier, C; Kleinschmidt, M; Gnoth, K; Pillot, T; Lues, I; Demuth, HU; Schilling, S; Rahfeld, JU; Stubbs, MT				Piechotta, Anke; Parthier, Christoph; Kleinschmidt, Martin; Gnoth, Kathrin; Pillot, Thierry; Lues, Inge; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich; Stubbs, Milton T.			Structural and functional analyses of pyroglutamate-amyloid--specific antibodies as a basis for Alzheimer immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); crystal structure; drug development; monoclonal antibody; thermodynamics; ligand binding	A-BETA OLIGOMERS; STRUCTURE REVEALS; DISEASE; PEPTIDE; PROTEIN; MOUSE; BAPINEUZUMAB; DEPOSITION; PLAQUES; MODEL	Alzheimer disease is associated with deposition of the amyloidogenic peptide A in the brain. Passive immunization using A-specific antibodies has been demonstrated to reduce amyloid deposition both in vitro and in vivo. Because N-terminally truncated pyroglutamate (pE)-modified A species (A(pE3)) exhibit enhanced aggregation potential and propensity to form toxic oligomers, they represent particularly attractive targets for antibody therapy. Here we present three separate monoclonal antibodies that specifically recognize A(pE3) with affinities of 1-10 nm and inhibit A(pE3) fibril formation in vitro. In vivo application of one of these resulted in improved memory in A(pE3) oligomer-treated mice. Crystal structures of F-ab-A(pE3) complexes revealed two distinct binding modes for the peptide. Juxtaposition of pyroglutamate pE3 and the F4 side chain (the pEF head) confers a pronounced bulky hydrophobic nature to the A(pE3) N terminus that might explain the enhanced aggregation properties of the modified peptide. The deep burial of the pEF head by two of the antibodies explains their high target specificity and low cross-reactivity, making them promising candidates for the development of clinical antibodies.	[Piechotta, Anke; Kleinschmidt, Martin; Gnoth, Kathrin; Lues, Inge; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich] Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany; [Piechotta, Anke; Parthier, Christoph; Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Inst Biotechnol, D-06108 Halle, Germany; [Piechotta, Anke; Kleinschmidt, Martin; Gnoth, Kathrin; Demuth, Hans-Ulrich; Schilling, Stephan; Rahfeld, Jens-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Biochem & Therapy, Weinbergweg 22, D-06120 Halle, Germany; [Pillot, Thierry] SynAging SAS, F-54518 Vandoeuvre Les Nancy, France	Vivoryon Therapeutics; Martin Luther University Halle Wittenberg; Fraunhofer Gesellschaft	Rahfeld, JU (corresponding author), Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Saale, Germany.	jens-ulrich.rahfeld@probiodrug.de; stubbs@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013	Deutsche Forschungsgemeinschaft [GRK1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by funds from the Deutsche Forschungsgemeinschaft GRK1026 Conformational Transitions in Macromolecular Interactions (to M. T. S.). M. K., H.-U. D., S. S., and J.-U. R. are consultants and former employees of Probiodrug. I. L. and H.-U. D. are shareholders and I. L. is chief development officer of Probiodrug.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Antonyuk SV, 2011, P NATL ACAD SCI USA, V108, P15780, DOI 10.1073/pnas.1109051108; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Bibl M, 2012, PROTEOM CLIN APPL, V6, P163, DOI 10.1002/prca.201100082; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bouter Y, 2015, ACTA NEUROPATHOL, V130, P713, DOI 10.1007/s00401-015-1489-x; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Bussiere T., 2014, Patent, Patent No. [WO2014089500, 2014089500]; Dammers C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139710; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; ELMORE MA, 1990, NEUROPEPTIDES, V15, P31, DOI 10.1016/0143-4179(90)90157-T; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feinberg H, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt261; Frost JL, 2015, NEUROBIOL AGING, V36, P3187, DOI 10.1016/j.neurobiolaging.2015.08.021; Frost JL, 2012, NEURODEGENER DIS, V10, P265, DOI 10.1159/000335913; Garcia P, 2010, J NEUROSCI, V30, P7516, DOI 10.1523/JNEUROSCI.4182-09.2010; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Lannfelt L, 2014, J INTERN MED, V275, P284, DOI 10.1111/joim.12168; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lemere CA, 1996, NAT MED, V2, P1146, DOI 10.1038/nm1096-1146; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles LA, 2008, J MOL BIOL, V377, P181, DOI 10.1016/j.jmb.2007.12.036; Miles LA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01302; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Puzzo D, 2013, J ALZHEIMERS DIS, V33, pS111, DOI 10.3233/JAD-2012-129033; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sergeant N, 2003, J NEUROCHEM, V85, P1581, DOI 10.1046/j.1471-4159.2003.01818.x; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Williams LK, 2012, J MED CHEM, V55, P10177, DOI 10.1021/jm301273u; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wu GX, 2014, NEURODEGENER DIS, V14, P53, DOI 10.1159/000353634; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005	58	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	2017	292	30					12713	12724		10.1074/jbc.M117.777839	http://dx.doi.org/10.1074/jbc.M117.777839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC1ZM	28623233	hybrid, Green Published			2022-12-26	WOS:000406636900034
J	van Riel, ACMJ; Systrom, DM; Oliveira, RKF; Landzberg, MJ; Mulder, BJM; Bouma, BJ; Maron, BA; Shah, AM; Waxman, AB; Opotowsky, AR				van Riel, Annelieke C. M. J.; Systrom, David M.; Oliveira, Rudolf K. F.; Landzberg, Michael J.; Mulder, Barbara J. M.; Bouma, Berto J.; Maron, Bradley A.; Shah, Amil M.; Waxman, Aaron B.; Opotowsky, Alexander R.			Hemodynamic and metabolic characteristics associated with development of a right ventricular outflow tract pressure gradient during upright exercise	PLOS ONE			English	Article							PULMONARY ARTERIAL-PRESSURE; CONGENITAL HEART-DISEASE; SYSTEMIC-SCLEROSIS; HYPERTROPHIC CARDIOMYOPATHY; STRESS ECHOCARDIOGRAPHY; VASCULAR-RESISTANCE; HYPERTENSION; OBSTRUCTION; FAILURE; PATIENT	Background We recently reported a novel observation that many patients with equal resting supine right ventricular(RV) and pulmonary artery(PA) systolic pressures develop an RV outflow tract (RVOT) pressure gradient during upright exercise. The current work details the characteristics of patients who develop such an RVOT gradient. Methods We studied 294 patients (59.7 +/- 15.5 years-old, 49% male) referred for clinical invasive cardiopulmonary exercise testing, who did not have a resting RVOT pressure gradient defined by the simultaneously measured peak-to-peak difference between RV and PA systolic pressures. Results The magnitude of RVOT gradient did not correspond to clinical or hemodynamic findings suggestive of right heart failure; rather, higher gradients were associated with favorable exercise findings. The presence of a high peak RVOT gradient (90th percentile, >= 33mmHg) was associated with male sex (70 vs. 46%, p = 0.01), younger age (43.6 +/- 17.7 vs. 61.8 +/- 13.9 years, p<0.001), lower peak right atrial pressure (5 [3-7] vs. 8 [4-12] mmHg, p<0.001), higher peak heart rate (159 +/- 19 vs. 124 +/- 26 beats per minute, p<0.001), and higher peak cardiac index (8.3 +/- 2.3 vs. 5.7 +/- 1.9 L/min/m(2), p<0.001). These associations persisted when treating peak RVOT as a continuous variable and after age and sex adjustment. At peak exercise, patients with a high exercise RVOT gradient had both higher RV systolic pressure (78 +/- 11 vs. 66 +/- 17 mmHg, p<0.001) and lower PA systolic pressure (34 +/- 8 vs. 50 +/- 19 mmHg, p<0.001). Conclusions Development of a systolic RV-PA pressure gradient during upright exercise is not associated with an adverse hemodynamic exercise response and may represent a normal physiologic finding in aerobically fit young people.	[van Riel, Annelieke C. M. J.; Mulder, Barbara J. M.; Bouma, Berto J.] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [van Riel, Annelieke C. M. J.; Mulder, Barbara J. M.] Netherlands Heart Inst, Utrecht, Netherlands; [Systrom, David M.; Oliveira, Rudolf K. F.; Waxman, Aaron B.] Brigham & Womens Hosp, Dept Med, Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Systrom, David M.; Oliveira, Rudolf K. F.; Landzberg, Michael J.; Maron, Bradley A.; Shah, Amil M.; Waxman, Aaron B.; Opotowsky, Alexander R.] Harvard Med Sch, Boston, MA USA; [Oliveira, Rudolf K. F.] Fed Univ Sao Paulo UNIFESP, Dept Med, Div Resp Dis, Sao Paulo, SP, Brazil; [Landzberg, Michael J.; Opotowsky, Alexander R.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Landzberg, Michael J.; Maron, Bradley A.; Shah, Amil M.; Opotowsky, Alexander R.] Brigham & Womens Hosp, Dept Med, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Opotowsky, AR (corresponding author), Harvard Med Sch, Boston, MA USA.; Opotowsky, AR (corresponding author), Boston Childrens Hosp, Dept Cardiol, Boston, MA USA.; Opotowsky, AR (corresponding author), Brigham & Womens Hosp, Dept Med, Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	alexander.opotowsky@cardio.chboston.org	Waxman, Aaron/L-7450-2019; Oliveira, Rudolf/A-8409-2013; Waxman, Aaron/I-8659-2019; van Riel, Annelieke/GRO-1553-2022; Opotowsky, Alexander/AAL-1481-2020	Oliveira, Rudolf/0000-0002-2252-8119; Waxman, Aaron/0000-0001-7797-0361; Opotowsky, Alexander/0000-0002-6107-2281; Bouma, Berto/0000-0002-1433-9692	Netherlands Heart Institute; ZON-MW; Dunlevie Family Fund; Sao Paulo Research Foundation (FAPESP) [2014/12212-5]; Brazilian National Council for Scientific and Techological Development (CNPq) [232643/2014-8]; National Institutes of Health [U01HL125215, K08HL116792, 1K08HL11207-01A1]; American Heart Association [14CRP20380422, AHA15GRNT25080016]; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund	Netherlands Heart Institute; ZON-MW(Netherlands Organization for Health Research and Development); Dunlevie Family Fund; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Techological Development (CNPq); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund	The work in this study was supported by a fellowship grant provided by Netherlands Heart Institute (ACMJ van Riel) and a travel grant provided by ZON-MW (ACM Jvan Riel). AR Opotowsky and MJ Landzberg are supported by the Dunlevie Family Fund.RKF Oliveira received funds from the Sao Paulo Research Foundation (FAPESP), grant#2014/12212-5 and from the Brazilian National Council for Scientific and Techological Development (CNPq), grant #232643/2014-8. ABW axman and DM Systrom are supported by grant funding from the National Institutes of Health (U01HL125215). AM Shahis supported by the National Institutes of Health (K08HL116792) and the American Heart Association (14CRP20380422). BA Maronis supported by the National Institutes of Health (1K08HL11207-01A1), American Heart Association (AHA15GRNT25080016), Pulmonary Hypertension Association, and the Cardiovascular Medical Research and Education Fund.The funders had no role in study design,data collection and analysis,decision to publish,or preparation of the manuscript.	Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Argiento P, 2010, EUR RESPIR J, V35, P1273, DOI 10.1183/09031936.00076009; Bae S, 2012, ANN RHEUM DIS, V71, P1335, DOI 10.1136/annrheumdis-2011-200546; Berry NC, 2015, PULM CIRC, V5, P610, DOI 10.1086/683815; Canivet Jean-Luc, 2008, J Intensive Care Med, V23, P281, DOI 10.1177/0885066608318662; Claessen G, 2015, JACC CARDIOVASC IMAG; D'Alto M, 2011, HEART, V97, P112, DOI 10.1136/hrt.2010.203471; DELLITALIA LJ, 1991, CURR PROB CARDIOLOGY, V16, P659; Denault AY, 2006, J THORAC CARDIOV SUR, V132, P43, DOI 10.1016/j.jtcvs.2006.03.014; El Mahmoud R, 2008, AM HEART J, V156, P543, DOI 10.1016/j.ahj.2008.05.002; Geva T, 1998, CIRCULATION, V98, P339, DOI 10.1161/01.CIR.98.4.339; Gorcsan J 3rd, 1993, J Am Soc Echocardiogr, V6, P324; Ha JW, 2009, HEART, V95, P490, DOI 10.1136/hrt.2007.139295; HAMILTON DR, 1994, CIRCULATION, V90, P2492, DOI 10.1161/01.CIR.90.5.2492; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; Humbert M, 2012, EUR RESPIR REV, V21, P306, DOI 10.1183/09059180.00005112; KAPLAN JD, 1994, AM HEART J, V127, P1572, DOI 10.1016/0002-8703(94)90388-3; KEITH A, 1924, LANCET, V204, P1267; Kirshbom PM, 1996, CHEST, V109, P575, DOI 10.1378/chest.109.2.575; Kovacs G, 2009, EUR RESPIR J, V34, P888, DOI 10.1183/09031936.00145608; Kovacs G, 2010, CHEST, V138, P270, DOI 10.1378/chest.09-2099; Kovacs G, 2009, AM J RESP CRIT CARE, V180, P881, DOI 10.1164/rccm.200904-0563OC; Lau EMT, 2015, NAT REV CARDIOL, V12, P143, DOI 10.1038/nrcardio.2014.191; MARCH HW, 1962, AM J MED, V32, P835, DOI 10.1016/0002-9343(62)90030-X; Maron BJ, 2009, J AM COLL CARDIOL, V54, P191, DOI 10.1016/j.jacc.2008.11.069; Maron BA, 2016, CIRCULATION, V133, P1240, DOI 10.1161/CIRCULATIONAHA.115.020207; Mingo S, 2006, INT J CARDIOL, V112, P393, DOI 10.1016/j.ijcard.2005.07.075; MOLS P, 1993, CHEST, V103, P1381, DOI 10.1378/chest.103.5.1381; Oldham WM, 2016, PULM CIRC, V6, P55, DOI 10.1086/685054; Oliveira RK, 2015, EUR RESP J; Opotowsky AR, 2013, AM J CARDIOL, V112, P873, DOI 10.1016/j.amjcard.2013.05.016; Pignone A, 2007, ANN NY ACAD SCI, V1108, P291, DOI 10.1196/annals.1422.031; RAINES RA, 1976, AM J PHYSIOL, V231, P1395, DOI 10.1152/ajplegacy.1976.231.5.1395; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Saggar R, 2012, ARTHRITIS RHEUM-US, V64, P4072, DOI 10.1002/art.34614; STIERLE U, 1987, JPN HEART J, V28, P115; THADANI U, 1978, AM J CARDIOL, V41, P52, DOI 10.1016/0002-9149(78)90131-5; TOBIN JR, 1965, CIRC RES, V16, P162, DOI 10.1161/01.RES.16.2.162; Tolle JJ, 2008, CIRCULATION, V118, P2183, DOI 10.1161/CIRCULATIONAHA.108.787101; Turhan H, 2007, INT J CARDIOL, V118, P124, DOI 10.1016/j.ijcard.2006.06.035; Valerio CJ, 2013, ARTHRITIS RHEUM-US, V65, P1074, DOI 10.1002/art.37838; Van De Bruaene A, 2011, CIRC-CARDIOVASC IMAG, V4, P237, DOI 10.1161/CIRCIMAGING.110.962571; van Riel ACMJ, 2017, J AM COLL CARDIOL, V69, P595, DOI 10.1016/j.jacc.2016.11.039; van Riel ACMJ, 2015, INT J CARDIOL, V197, P312, DOI 10.1016/j.ijcard.2015.06.062	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179053	10.1371/journal.pone.0179053	http://dx.doi.org/10.1371/journal.pone.0179053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636647	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300023
J	Chang, CC; Lee, WS; Hsieh, HG; Chuang, CL; Huang, HC; Lee, FY; Lee, SD				Chang, Ching-Chih; Lee, Wen-Shin; Hsieh, Hsian-Guey; Chuang, Chiao-Lin; Huang, Hui-Chun; Lee, Fa-Yauh; Lee, Shou-Dong			Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats	PLOS ONE			English	Article							PORTAL-HYPERTENSIVE-RATS; NITRIC-OXIDE; TUMOR ANGIOGENESIS; LIVER; INDOMETHACIN; MODEL; CELECOXIB; BLOCKADE; HEMODYNAMICS; PROSTACYCLIN	Objective Hepatopulmonary syndrome (HPS) is characterized by hypoxia in patients with chronic liver disease. The mechanism of HPS includes pulmonary vasodilatation, inflammation, and angiogenesis. Prostaglandins synthesized by cyclooxygenases (COX) participate in vascular responsiveness, inflammation and angiogenesis, which can be modulated by COX inhibitors. We therefore evaluated the impact of COX inhibition in rats with common bile duct ligation (CBDL)-induced liver cirrhosis and HPS. Methods Cirrhotic rats were randomly allocated to receive non-selective COX inhibitor (indomethacin), selective COX-1 inhibitor (SC-560), or COX-2 inhibitor (celecoxib) for 14 days. After that, hemodynamic parameters, severity of hypoxia and intrapulmonary shunts, liver and renal biochemistry parameters, histological finding and protein expressions were evaluated. Results Non-selective COX inhibition by indomethacin improved hepatic fibrosis and pulmonary inflammation in cirrhotic rats with HPS. It also decreased mean arterial blood pressure, portal pressure, and alleviated hypoxia and intrapulmonary shunts. However, indomethacin increased mortality rate. In contrast, selective COX inhibitors neither affected hemodynamics nor increased mortality rate. Hypoxia was improved by SC-560 and celecoxib. In addition, SC-560 decreased intrapulmonary shunts, attenuated pulmonary inflammation and angiogenesis through down-regulating COX-, NF kappa B-and VEGF-mediated pathways. Conclusion Selective COX-1 inhibitor ameliorated HPS by mitigating hypoxia and intrapulmonary shunts, which are related to anti-inflammation and anti-angiogenesis.	[Chang, Ching-Chih; Lee, Wen-Shin; Chuang, Chiao-Lin; Huang, Hui-Chun] Taipei Vet Gen Hosp, Div Gen Med, Dept Med, Taipei, Taiwan; [Chang, Ching-Chih; Lee, Wen-Shin; Chuang, Chiao-Lin; Huang, Hui-Chun; Lee, Fa-Yauh; Lee, Shou-Dong] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hsieh, Hsian-Guey] Taipei Vet Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital	Huang, HC (corresponding author), Taipei Vet Gen Hosp, Div Gen Med, Dept Med, Taipei, Taiwan.; Huang, HC; Lee, FY (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Lee, FY (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.	hchuang2@vghtpe.gov.tw; fylee@vghtpe.gov.tw			Ministry of Science and Technology, R.O.C. [NSC 101-2314 B-075-016-MY2]; Szu-Zuan Research Foundation of Internal Medicine, Taipei, R.O.C.	Ministry of Science and Technology, R.O.C.; Szu-Zuan Research Foundation of Internal Medicine, Taipei, R.O.C.	This work was supported by a grant from Ministry of Science and Technology, R.O.C. (NSC 101-2314 B-075-016-MY2) and Szu-Zuan Research Foundation of Internal Medicine, Taipei, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIVET P, 1993, CHEST, V103, P500, DOI 10.1378/chest.103.2.500; Arellanes-Robledo J, 2006, ANTICANCER RES, V26, P1271; Bolego C, 2009, FASEB J, V23, P605, DOI 10.1096/fj.08-106591; BRUIX J, 1985, GASTROENTEROLOGY, V88, P430, DOI 10.1016/0016-5085(85)90503-7; Chang CC, 2015, CLIN SCI, V129, P449, DOI 10.1042/CS20140622; Chang CC, 2013, J CHIN MED ASSOC, V76, P557, DOI 10.1016/j.jcma.2013.06.006; Chang CC, 2013, CLIN SCI, V124, P457, DOI 10.1042/CS20120052; Chang CC, 2011, EUR J PHARMACOL, V666, P226, DOI 10.1016/j.ejphar.2011.04.060; Fallon MB, 2000, HEPATOLOGY, V32, P859, DOI 10.1053/jhep.2000.7519; Fallon MB, 1997, AM J PHYSIOL-GASTR L, V272, pG779, DOI 10.1152/ajpgi.1997.272.4.G779; Fernandez M, 1996, GASTROENTEROLOGY, V110, P1529, DOI 10.1053/gast.1996.v110.pm8613060; Fernandez-Martinez A, 2004, J HEPATOL, V40, P963, DOI 10.1016/j.jhep.2004.02.019; FRANCO D, 1979, ARCH SURG-CHICAGO, V114, P1064; Gao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069309; Gately S, 2003, PROG EXP TUMOR RES, V37, P179; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Grilo-Bensusan I, 2016, WORLD J GASTROENTERO, V22, P5728, DOI 10.3748/wjg.v22.i25.5728; Hsia HC, 1995, SCAND J GASTROENTERO, V30, P1194, DOI 10.3109/00365529509101630; Huang HC, 2006, SCAND J GASTROENTERO, V41, P1440, DOI 10.1080/00365520600735696; Huang Hui-Chun, 2007, J Chin Med Assoc, V70, P521, DOI 10.1016/S1726-4901(08)70054-6; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; LANGE PA, 1995, ANN INTERN MED, V122, P521, DOI 10.7326/0003-4819-122-7-199504010-00008; Lee FY, 2001, EUR J CLIN INVEST, V31, P145, DOI 10.1046/j.1365-2362.2001.00764.x; LEE HB, 1985, J NUCL MED, V26, P72; Li W, 2014, INT J MOL SCI, V15, P19265, DOI 10.3390/ijms151019265; Liu L, 2012, LIVER INT, V32, P1018, DOI 10.1111/j.1478-3231.2012.02821.x; OBERTI F, 1993, HEPATOLOGY, V18, P621, DOI 10.1002/hep.1840180322; Rheinlaender C, 2009, ACTA PAEDIATR, V98, P36, DOI 10.1111/j.1651-2227.2008.01007.x; SIKULER E, 1985, AM J PHYSIOL, V248, pG618, DOI 10.1152/ajpgi.1985.248.6.G618; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Song JY, 1996, PEDIATRICS, V97, P917; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; THORNELL E, 1991, ACTA CHIR-EUR J SURG, V157, P127; Washino Y, 2010, BIOL PHARM BULL, V33, P707, DOI 10.1248/bpb.33.707; Wen SL, 2014, J GASTROEN HEPATOL, V29, P1932, DOI 10.1111/jgh.12641; WU YP, 1993, HEPATOLOGY, V18, P1416, DOI 10.1002/hep.1840180621; Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3; Zhang JL, 2009, GASTROENTEROLOGY, V136, P1070, DOI 10.1053/j.gastro.2008.12.001	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179809	10.1371/journal.pone.0179809	http://dx.doi.org/10.1371/journal.pone.0179809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632747	Green Submitted, gold, Green Published			2022-12-26	WOS:000404046100049
J	Gao, B; Yu, T; Xue, DB; Sun, BS; Shao, Q; Choudhry, H; Marcus, V; Ragoussis, J; Zhang, YG; Zhang, WH; Gao, ZH				Gao, Bo; Yu, Tian; Xue, Dongbo; Sun, Boshi; Shao, Qin; Choudhry, Hani; Marcus, Victoria; Ragoussis, Jiannis; Zhang, Yuguo; Zhang, Weihui; Gao, Zu-hua			A multidimensional integration analysis reveals potential bridging targets in the process of colorectal cancer liver metastasis	PLOS ONE			English	Article							LONG-NONCODING RNA; EPITHELIAL-MESENCHYMAL-TRANSITION; HEPATOCELLULAR-CARCINOMA; COLON-CANCER; POOR-PROGNOSIS; GASTRIC-CANCER; INVASION; CELLS; PROGRESSION; EXPRESSION	Approximately 9% of cancer-related deaths are caused by colorectal cancer. Liver metastasis is a major factor for the high colorectal cancer mortality rate. However, the molecular mechanism underlying colorectal cancer liver metastasis remains unclear. Using a global and multidimensional integration approach, we studied sequencing data, protein-protein interactions, and regulation of transcription factor and non-coding RNAs in primary tumor samples and liver metastasis samples to unveil the potential bridging molecules and the regulators that functionally link different stages of colorectal cancer liver metastasis. Primary tumor samples and liver metastasis samples had modules with significant overlap and crosstalk from which we identified several bridging genes (e.g. KNG1 and COX5B), transcription factors (e.g. E2F4 and CDX2), microRNAs (e.g. miR-590-3p and miR-203) and lncRNAs (e.g. lincIRX5 and lincFOXF1) that may play an important role in the process of colorectal cancer liver metastasis. This study enhances our understanding of the genetic alterations and transcriptional regulation that drive the metastatic process, but also provides the methodology to guide the studies on other metastatic cancers.	[Gao, Bo; Xue, Dongbo; Zhang, Weihui] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Peoples R China; [Gao, Bo; Shao, Qin; Marcus, Victoria; Gao, Zu-hua] McGill Univ, Hlth Ctr, Res Inst, Dept Pathol, Montreal, PQ, Canada; [Yu, Tian] Univ Aberdeen, Inst Med Sci, Sch Med & Dent, Sect Immun Infect & Inflammat,Div Appl Med, Aberdeen, Scotland; [Sun, Boshi] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China; [Choudhry, Hani] King Abdulaziz Univ, Ctr Innovat Personalized Med, King Fahd Ctr Med Res, Dept Biochem,Fac Sci,Canc & Mutagenesis Unit, Jeddah, Saudi Arabia; [Ragoussis, Jiannis] McGill Univ, Montreal, PQ, Canada; [Ragoussis, Jiannis] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Zhang, Yuguo] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Shijiazhuang, Peoples R China	Harbin Medical University; McGill University; University of Aberdeen; Harbin Medical University; King Abdulaziz University; McGill University; Hebei Medical University	Gao, ZH (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Dept Pathol, Montreal, PQ, Canada.	zu-hua.gao@mcgill.ca	Ragoussis, Ioannis/AAD-9790-2022	Ragoussis, Ioannis/0000-0002-8515-0934; Choudhry, Hani/0000-0003-0401-6619	Harbin Medical University Postgraduate Innovative Research Projects [YJSCX2015-19HYD]	Harbin Medical University Postgraduate Innovative Research Projects	Harbin Medical University Postgraduate Innovative Research Projects, YJSCX2015-19HYD, Dr Bo Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai FY, 2015, ONCOTARGET, V6, P5412, DOI 10.18632/oncotarget.3027; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Chang WH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150355; Chen P, 2014, ASIAN PAC J CANCER P, V15, P9185, DOI 10.7314/APJCP.2014.15.21.9185; Choi K, 2009, J BIOL CHEM, V284, P17766, DOI 10.1074/jbc.M109.003111; Chowdhury S, 2013, J SURG RES, V184, P755, DOI 10.1016/j.jss.2013.03.035; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gao B, 2014, ONCOL REP, V32, P309, DOI 10.3892/or.2014.3217; Gao SP, 2015, ONCOTARGET, V6, P43363, DOI 10.18632/oncotarget.6222; Ge X., 2016, ONCOTARGET; Guan X, 2015, ONCOTARGET, V6, P37609, DOI 10.18632/oncotarget.6067; Ho GH, 2001, BREAST CANCER RES TR, V69, P115, DOI 10.1023/A:1012230115173; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Huang XP, 2015, FEBS J, V282, P579, DOI 10.1111/febs.13167; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Ji HK, 2013, P NATL ACAD SCI USA, V110, P6789, DOI 10.1073/pnas.1204398110; Ji K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-723; Kan JY, 2015, J CELL PHYSIOL, V230, P1883, DOI 10.1002/jcp.24918; Li RX, 2014, MOL CELL BIOCHEM, V396, P295, DOI 10.1007/s11010-014-2164-6; Lin YN, 2015, ONCOTARGET, V6, P18577, DOI 10.18632/oncotarget.4094; Liu FY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.46; Liu Y, 2016, CANCER LETT, V376, P226, DOI 10.1016/j.canlet.2016.03.031; Ma H, 2014, SCI WORLD J, DOI 10.1155/2014/230835; Mao C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08065; Mayevsky A, 2009, MITOCHONDRION, V9, P165, DOI 10.1016/j.mito.2009.01.009; Migliore C, 2012, CLIN CANCER RES, V18, P737, DOI 10.1158/1078-0432.CCR-11-1699; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Ming J, 2009, EUR J CANCER, V45, P866, DOI 10.1016/j.ejca.2008.12.006; Osumi H, 2016, INTERNATIONAL JOURNA; Pancione M, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-297; Pang HY, 2015, BIOCHEM BIOPH RES CO, V468, P739, DOI 10.1016/j.bbrc.2015.11.025; Pasetto LM, 2005, ANTICANCER RES, V25, P563; Pils D, 2014, EUR J CANCER, V50, P99, DOI 10.1016/j.ejca.2013.09.011; Roudier MP, 2016, PROSTATE, V76, P810, DOI 10.1002/pros.23171; Sakamoto S, 2002, ANTICANCER RES, V22, P339; Samantarrai D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09742; Shariat SF, 2006, HUM PATHOL, V37, P1568, DOI 10.1016/j.humpath.2006.05.017; Shi YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122679; Sottnik JL, 2011, CLIN EXP METASTAS, V28, P865, DOI 10.1007/s10585-011-9417-5; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun HP, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0750-z; Sun JF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0786-z; Tian Y, 2014, J BIOL CHEM, V289, P36101, DOI 10.1074/jbc.M114.598383; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Vinay DS, 2015, SEMIN CANCER BIOL, V35, pS185, DOI 10.1016/j.semcancer.2015.03.004; Wan DW, 2016, ANTI-CANCER AGENT ME, V16, P414, DOI 10.2174/1871520615666150716105955; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Wang YL, 2015, CANCER LETT, V367, P122, DOI 10.1016/j.canlet.2015.03.027; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Wu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1097, DOI 10.1152/ajpgi.00216.2003; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Yan B, 2016, MITOCHONDRION, V26, P86, DOI 10.1016/j.mito.2015.12.007; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yao DB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-432; Yu DD, 2015, ONCOTARGET, V6, P42687, DOI 10.18632/oncotarget.5883; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zheng JB, 2011, PATHOL ONCOL RES, V17, P743, DOI 10.1007/s12253-011-9380-0; Zhong G, 2015, INT J CLIN EXP PATHO, V8, P2809; Zhu Dexiang, 2014, Zhonghua Wei Chang Wai Ke Za Zhi, V17, P525	60	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178760	10.1371/journal.pone.0178760	http://dx.doi.org/10.1371/journal.pone.0178760			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628609	gold, Green Published, Green Submitted			2022-12-26	WOS:000404043100007
J	Lundberg, M; Lindqvist, A; Wierup, N; Krogvold, L; Dahl-Jorgensen, K; Skog, O				Lundberg, Marcus; Lindqvist, Andreas; Wierup, Nils; Krogvold, Lars; Dahl-Jorgensen, Knut; Skog, Oskar			The density of parasympathetic axons is reduced in the exocrine pancreas of individuals recently diagnosed with type 1 diabetes	PLOS ONE			English	Article							ADULT PATIENTS; SECRETION; VIP; INNERVATION; INSULITIS; NEURONS; BIOPSY; ONSET	To elucidate the etiology of type 1 diabetes, the affected pancreas needs to be thoroughly characterized. Pancreatic innervation has been suggested to be involved in the pathology of the disease and a reduction of sympathetic innervation of the islets was recently reported. In the present study, we hypothesized that parasympathetic innervation would be altered in the type 1 diabetes pancreas. Human pancreatic specimens were obtained from a unique cohort of individuals with recent onset or long standing type 1 diabetes. Density of parasympathetic axons was assessed by immunofluorescence and morphometry. Our main finding was a reduced density of parasympathetic axons in the exocrine, but not endocrine compartment of the pancreas in individuals with recent onset type 1 diabetes. The reduced density of parasympathetic axons in the exocrine compartment could have functional implications, e.g. be related to the exocrine insufficiency reported in type 1 diabetes patients. Further studies are needed to understand whether reduced parasympathetic innervation is a cause or consequence of type 1 diabetes.	[Lundberg, Marcus; Skog, Oskar] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Lindqvist, Andreas; Wierup, Nils] Lund Univ, Diabet Ctr, Malmo, Sweden; [Krogvold, Lars; Dahl-Jorgensen, Knut] Oslo Univ Hosp, Div Paediat & Adolescent Med, Oslo, Norway; [Krogvold, Lars; Dahl-Jorgensen, Knut] Univ Oslo, Fac Med, Oslo, Norway	Uppsala University; Lund University; University of Oslo; University of Oslo	Lundberg, M (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	marcus.lundberg@igp.uu.se		Skog, Oskar/0000-0001-9713-722X; Lundberg, Marcus/0000-0001-7916-2237	South-Eastern Norway Regional Health Authority; Novo Nordisk Foundation, through the PEVNET Study Group; European Union's Seventh Framework Programme [FP7] [261441 PEVNET]; Barndiabetesfonden (Swedish Child Diabetes Foundation); Swedish Medical Research Council [65X-12219-15-6, K2015-54X-12219-19-4, 2008-4216, 521-2012-2119]; Diabetes Wellness Sweden; Swedish Diabetes Foundation; Family Ernfors Fund; Magnus Bergvalls Stiftelse; Gillbergska stiftelsen; Tore Nilsson Fund for Medical Research	South-Eastern Norway Regional Health Authority; Novo Nordisk Foundation, through the PEVNET Study Group; European Union's Seventh Framework Programme [FP7]; Barndiabetesfonden (Swedish Child Diabetes Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Diabetes Wellness Sweden; Swedish Diabetes Foundation; Family Ernfors Fund; Magnus Bergvalls Stiftelse; Gillbergska stiftelsen; Tore Nilsson Fund for Medical Research	The project was funded by South-Eastern Norway Regional Health Authority (Grant to KDJ), The Novo Nordisk Foundation (Grant to KDJ), through the PEVNET Study Group funded by the European Union's Seventh Framework Programme [FP7/2007-2013] under grant agreement no 261441 PEVNET (http://www.uta.fi/med/pevnet/publications.html), Barndiabetesfonden (Swedish Child Diabetes Foundation), the Swedish Medical Research Council (65X-12219-15-6, K2015-54X-12219-19-4, 2008-4216, 521-2012-2119), Diabetes Wellness Sweden, the Swedish Diabetes Foundation, Tore Nilsson Fund for Medical Research, the Ake Wiberg foundation, the Family Ernfors Fund, Gillbergska stiftelsen, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322; Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Battaglia M, 2015, DIABETES, V64, P1081, DOI 10.2337/db14-1208; BISHOP AE, 1980, DIABETOLOGIA, V18, P73, DOI 10.1007/BF01228307; BUCHLER M, 1992, PANCREAS, V7, P183; Campbell-Thompson M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0653-y; Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048; Chandra R, 2013, CURR OPIN GASTROEN, V29, P517, DOI 10.1097/MOG.0b013e3283639326; Del Carro U, 2007, DIABETES CARE, V30, P3063, DOI 10.2337/dc07-0206; Fahrenkrug J, 2004, PEPTIDES, V25, P393, DOI 10.1016/j.peptides.2004.01.010; FAHRENKRUG J, 1987, REGUL PEPTIDES, V18, P51, DOI 10.1016/0167-0115(87)90050-4; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; GILBEAU JP, 1992, AM J ROENTGENOL, V159, P527, DOI 10.2214/ajr.159.3.1503017; KOHLER H, 1987, DIGESTION, V37, P149, DOI 10.1159/000199492; Korsgren S, 2012, AM J PATHOL, V181, P1735, DOI 10.1016/j.ajpath.2012.07.022; Krogvold L, 2016, DIABETOLOGIA, V59, P492, DOI 10.1007/s00125-015-3820-4; Krogvold L, 2014, DIABETOLOGIA, V57, P841, DOI 10.1007/s00125-013-3155-y; Love JA, 2007, AUTON NEUROSCI-BASIC, V133, P19, DOI 10.1016/j.autneu.2006.10.001; Lundberg M, 2017, DIABETOLOGIA, V60, P346, DOI 10.1007/s00125-016-4140-z; LUZI L, 1992, DIABETES, V41, P1632, DOI 10.2337/diabetes.41.12.1632; Mundinger TO, 2016, DIABETES; Razavi R, 2006, CELL, V127, P1123, DOI 10.1016/j.cell.2006.10.038; ROBERTSON R P, 1991, Diabetologia, V34, pS57, DOI 10.1007/BF00587621; Rodriguez-Diaz R, 2011, CELL METAB, V14, P45, DOI 10.1016/j.cmet.2011.05.008; SCHWARTZ TW, 1978, J CLIN INVEST, V61, P781, DOI 10.1172/JCI108992; SHIMOSEGAWA T, 1993, PANCREAS, V8, P403, DOI 10.1097/00006676-199307000-00001; Skog O, 2013, CURR OPIN ENDOCRINOL, V20, P118, DOI 10.1097/MED.0b013e32835edb89; Williams AJK, 2012, J CLIN ENDOCR METAB, V97, pE2109, DOI 10.1210/jc.2012-1815	29	5	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179911	10.1371/journal.pone.0179911	http://dx.doi.org/10.1371/journal.pone.0179911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628651	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100049
J	Alyami, H; Dahmash, E; Bowen, J; Mohammed, AR				Alyami, Hamad; Dahmash, Eman; Bowen, James; Mohammed, Afzal R.			An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug	PLOS ONE			English	Article							DRY POWDER INHALERS; PHARMACEUTICAL POWDERS; GRANULAR-MATERIALS; SEGREGATION; ADHESION; TABLETS; FLOW	Powder blend homogeneity is a critical attribute in formulation development of low dose and potent active pharmaceutical ingredients (API) yet a complex process with multiple contributing factors. Excipient characteristics play key role in efficient blending process and final product quality. In this work the effect of excipient type and properties, blending technique and processing time on content uniformity was investigated. Powder characteristics for three commonly used excipients (starch, pregelatinised starch and microcrystalline cellulose) were initially explored using laser diffraction particle size analyser, angle of repose for flowability, followed by thorough evaluations of surface topography employing scanning electron microscopy and interferometry. Blend homogeneity was evaluated based on content uniformity analysis of the model API, ergocalciferol, using a validated analytical technique. Flowability of powders were directly related to particle size and shape, while surface topography results revealed the relationship between surface roughness and ability of excipient with high surface roughness to lodge fine API particles within surface groves resulting in superior uniformity of content. Of the two blending techniques, geometric blending confirmed the ability to produce homogeneous blends at low dilution when processed for longer durations, whereas manual ordered blending failed to achieve compendial requirement for content uniformity despite mixing for 32 minutes. Employing the novel dry powder hybrid mixer device, developed at Aston University laboratory, results revealed the superiority of the device and enabled the production of homogenous blend irrespective of excipient type and particle size. Lower dilutions of the API (1% and 0.5% w/w) were examined using non-sieved excipients and the dry powder hybrid mixing device enabled the development of successful blends within compendial requirements and low relative standard deviation.	[Alyami, Hamad; Dahmash, Eman; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England; [Bowen, James] Open Univ, Dept Engn & Innovat, Milton Keynes, Bucks, England; [Dahmash, Eman] Aston Univ, Aston Particle Technol Ltd, Birmingham, W Midlands, England	Aston University; Open University - UK; Aston University	Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England.	a.u.r.mohammed@aston.ac.uk	Bowen, James/B-9874-2011	Bowen, James/0000-0002-8452-0139; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040; Dahmash, Eman/0000-0002-9815-3720; Alyami, Hamad/0000-0003-3513-4976	Saudi Arabian Government; Aston Particle Technologies Ltd	Saudi Arabian Government; Aston Particle Technologies Ltd	The work in this paper was supported by Research grant from Saudi Arabian Government, in particular Najran University. Author Eman Dahmash is currently employed by Aston Particle Technologies Ltd. Aston Particle Technologies Ltd provided support in the form of salary for author Eman Dahmash, but did not have any role in study design, data collection and the decision to publish. The specific role of this author is articulated in the 'author contributions' section.	Al-Khattawi A, 2014, CURR DRUG DELIV, V11, P486, DOI 10.2174/1567201811666140323201650; Alchikh-Sulaiman B, 2016, PARTICUOLOGY, V25, P133, DOI 10.1016/j.partic.2015.05.006; [Anonymous], 2005, INT C HARMONISATION, VQ2; Aulton M., 2002, PHARMACEUTICS SCI DO, V2, P24; BP, 2012, BRIT PHARMACOPOEIA, P2012; Bridgwater J, 2012, PARTICUOLOGY, V10, P397, DOI 10.1016/j.partic.2012.06.002; Builders PF, 2010, INT J PHARMACEUT, V388, P159, DOI 10.1016/j.ijpharm.2009.12.056; Chaudhuri B, 2006, POWDER TECHNOL, V165, P105, DOI 10.1016/j.powtec.2006.04.001; Dahmash EZ, 2015, EXPERT OPIN DRUG DEL, V12, P1867, DOI 10.1517/17425247.2015.1071351; Deveswaran R., 2009, RES J PHARM TECHNOL, V2, P245; Flament MP, 2004, INT J PHARMACEUT, V275, P201, DOI 10.1016/j.ijpharm.2004.02.002; Harnby, 2000, Pharm Sci Technol Today, V3, P303, DOI 10.1016/S1461-5347(00)00283-2; HERSEY JA, 1975, POWDER TECHNOL, V11, P41, DOI 10.1016/0032-5910(75)80021-0; Hirani JJ, 2009, TROP J PHARM RES, V8, P161; ISHIZAKA T, 1989, J PHARM PHARMACOL, V41, P361, DOI 10.1111/j.2042-7158.1989.tb06478.x; Jallo LJ, 2012, INT J PHARMACEUT, V423, P213, DOI 10.1016/j.ijpharm.2011.12.012; Kaye B.H., 1997, POWDER MIXING; Kornchankul W, 2002, PHARMAZIE, V57, P49; Kukkar V, 2008, THAI J PHARM SCI, V32, P43; Leach R., 2008, MEASUREMENT GOOD PRA; Leach R.K, 2014, GOOD PRACTICE GUIDE; Liam Blunt, 2003, SURFSTAND; Liu LX, 2008, INT J PHARM, V362, P109, DOI 10.1016/j.ijpharm.2008.06.023; Lohrmann M, 2007, EUR J PHARM BIOPHARM, V67, P579, DOI 10.1016/j.ejpb.2007.02.011; Maynard EP, MIXING BLENDING US 2; Muselik J, 2014, ACTA PHARMACEUT, V64, P355, DOI 10.2478/acph-2014-0022; Muzzio FJ, 2002, POWDER TECHNOL, V124, P1, DOI 10.1016/S0032-5910(01)00482-X; Newman AW, 1996, STARCHES STARCH DERI, P22; Ottino JM, 2000, ANNU REV FLUID MECH, V32, P55, DOI 10.1146/annurev.fluid.32.1.55; Parkash V, 2011, J ADV PHARM TECHNOL, V2, P223, DOI 10.4103/2231-4040.90877; Pawar Shiwaji, 2002, Paediatr Drugs, V4, P371, DOI 10.2165/00128072-200204060-00004; Pingali K, 2011, DRUG DEV IND PHARM, V37, P428, DOI 10.3109/03639045.2010.521160; Portillo PM., 2008, J PHARM INNOV, V3, P258, DOI [10.1007/s12247-008-9048-9, DOI 10.1007/S12247-008-9048-9]; Rohrs BR, 2006, J PHARM SCI-US, V95, P1049, DOI 10.1002/jps.20587; Saharan V.A., 2008, ASIAN J PHARM SCI, V3, P240, DOI DOI 10.1002/JPS.3080030220; Shah RB, 2008, AAPS PHARMSCITECH, V9, P250, DOI 10.1208/s12249-008-9046-8; Siddiqui MD, 2011, ADV BIOL RES, V5, P291; Tang P, 2004, PARTICUL SCI TECHNOL, V22, P321, DOI 10.1080/02726350490501420; USP D, 2003, ANTIDEPRESSANTS, V26, P296; USP-29, 2006, USP 29 NF 24 AUTH US; Zhang Y, 1997, INT J PHARM, V154, P179, DOI 10.1016/S0378-5173(97)00134-8; Zheng J., 2009, FORMULATION ANAL DEV	42	36	38	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178772	10.1371/journal.pone.0178772	http://dx.doi.org/10.1371/journal.pone.0178772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609454	Green Accepted, Green Published, gold			2022-12-26	WOS:000403274700013
J	Brennan, A; Cross, PC; Portacci, K; Scurlock, BM; Edwards, WH				Brennan, Angela; Cross, Paul C.; Portacci, Katie; Scurlock, Brandon M.; Edwards, William H.			Shifting brucellosis risk in livestock coincides with spreading seroprevalence in elk	PLOS ONE			English	Article							MANAGEMENT; REGRESSION; TRANSMISSION; EVENTS	Tracking and preventing the spillover of disease from wildlife to livestock can be difficult when rare outbreaks occur across large landscapes. In these cases, broad scale ecological studies could help identify risk factors and patterns of risk to inform management and reduce incidence of disease. Between 2002 and 2014, 21 livestock herds in the Greater Yellow-stone Area (GYA) were affected by brucellosis, a bacterial disease caused by Brucella abortus, while no affected herds were detected between 1990 and 2001. Using a Bayesian analysis, we examined several ecological covariates that may be associated with affected livestock herds across the region. We showed that livestock risk has been increasing over time and expanding outward from the historical nexus of brucellosis in wild elk on Wyoming's feeding grounds where elk are supplementally fed during the winter. Although elk were the presumed source of cattle infections, occurrences of affected livestock herds were only weakly associated with the density of seropositive elk across the GYA. However, the shift in livestock risk did coincide with recent increases in brucellosis seroprevalence in unfed elk populations. As increasing brucellosis in unfed elk likely stemmed from high levels of the disease in fed elk, disease-related costs of feeding elk have probably been incurred across the entire GYA, rather than solely around the feeding grounds. Our results suggest that focused disease mitigation in areas where seroprevalence in unfed elk is high could reduce the spillover of brucellosis to livestock. We also highlight the need to better understand the epidemiology of spillover events with detailed histories of disease testing, calving, and movement of infected livestock. Finally, we recommend using case-control studies to investigate local factors important to livestock risk.	[Brennan, Angela] Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA; [Brennan, Angela; Cross, Paul C.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT 59717 USA; [Portacci, Katie] Anim & Plant Hlth Inspect Serv, USDA, Ctr Epidemiol & Anim Hlth, Ft Collins, CO USA; [Scurlock, Brandon M.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Edwards, William H.] Wyoming Game & Fish Dept, Laramie, WY USA	University of Wyoming; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Brennan, A (corresponding author), Univ Wyoming, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY 82071 USA.; Brennan, A (corresponding author), US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT 59717 USA.	abrenna5@uwyo.edu		Brennan, Angela/0000-0003-4360-0738				[Anonymous], 2014, R LANG ENV STAT COMP; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Barbknecht AE, 2011, J WILDLIFE MANAGE, V75, P646, DOI 10.1002/jwmg.100; Beja-Pereira A, 2009, J WILDLIFE DIS, V45, P1174, DOI 10.7589/0090-3558-45.4.1174; Boroff K, 2016, PREV VET MED, V134, P39, DOI 10.1016/j.prevetmed.2016.09.025; Brennan A, 2015, J APPL ECOL, V52, P1656, DOI 10.1111/1365-2664.12514; Brennan A, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00181.1; Brennan A, 2013, ECOL APPL, V23, P643, DOI 10.1890/12-0959.1; Chen JD, 2013, EMERG INFECT DIS, V19, P817, DOI 10.3201/eid1905.120146; Cheville NF, 1998, BRUCELLOSIS GREATER; Christianson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102330; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross PC, 2015, J WILDLIFE MANAGE, V79, P739, DOI 10.1002/jwmg.883; Cross PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010322; Gelman A., 2007, DATA ANAL USING REGR; Gower CN, 2009, TERR ECOL SER, V3, P401, DOI 10.1016/S1936-7961(08)00219-4; Haggerty JH, 2006, GEOFORUM, V37, P816, DOI 10.1016/j.geoforum.2005.12.004; Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448; Kery M., 2010, INTRO WINBUGS ECOLOG; Maichak E, 2009, J WILDLIFE MANAGE, V45, P1; MORTON JK, 1981, J WILDLIFE DIS, V17, P23, DOI 10.7589/0090-3558-17.1.23; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; PARKER KL, 1984, J WILDLIFE MANAGE, V48, P474, DOI 10.2307/3801180; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Proffitt KM, 2015, J WILDLIFE MANAGE, V79, P373, DOI 10.1002/jwmg.860; Proffitt KM, 2011, J APPL ECOL, V48, P471, DOI 10.1111/j.1365-2664.2010.01928.x; Rhyan JC, 2013, EMERG INFECT DIS, V19, P1992, DOI 10.3201/eid1912.130167; Roberts TW, 2012, PREV VET MED, V107, P187, DOI 10.1016/j.prevetmed.2012.06.008; Schumaker Brant A., 2012, Human-Wildlife Interactions, V6, P48; Schumaker BA, 2010, J WILDLIFE DIS, V46, P87, DOI 10.7589/0090-3558-46.1.87; Scurlock B. M., 2010, USING TEST SLAUGHTER; Scurlock BM, 2010, J WILDLIFE DIS, V46, P442, DOI 10.7589/0090-3558-46.2.442; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Smith BL, 2001, J WILDLIFE MANAGE, V65, P173, DOI 10.2307/3802896; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; THORNE ET, 1978, J WILDLIFE DIS, V14, P74, DOI 10.7589/0090-3558-14.1.74; THORNE ET, 1978, J WILDLIFE DIS, V14, P280, DOI 10.7589/0090-3558-14.3.280; USDA-Animal and Plant Health Inspection Service Veterinary Services, 2009, FED PEST REC PROGR H, P1; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; White PJ, 2012, AM MIDL NAT, V167, P174, DOI 10.1674/0003-0031-167.1.174; White PJ, 2010, J MAMMAL, V91, P827, DOI 10.1644/08-MAMM-A-252.1; Wyoming Game and Fish Department, 2014, WYOM GAM FISH DEP AN; [No title captured]	43	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178780	10.1371/journal.pone.0178780	http://dx.doi.org/10.1371/journal.pone.0178780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609437	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700014
J	Dhimal, M; Karki, KB; Aryal, KK; Dhimal, B; Joshi, HD; Puri, S; Pandey, AR; Dhakal, P; Sharma, AK; Raya, GB; Ansari, I; Groneberg, DA; Muller, R; Kuch, U				Dhimal, Meghnath; Karki, Khem Bahadur; Aryal, Krishna Kumar; Dhimal, Bimala; Joshi, Hari Datt; Puri, Sajan; Pandey, Achyut Raj; Dhakal, Purushotam; Sharma, Arun Kumar; Raya, Ganendra Bhakta; Ansari, Imran; Groneberg, David A.; Mueller, Ruth; Kuch, Ulrich			High blood levels of lead in children aged 6-36 months in Kathmandu Valley, Nepal: A cross-sectional study of associated factors	PLOS ONE			English	Article							CHITWAN VALLEY; BIRTH COHORT; CAPILLARY; TOXICITY; EXPOSURE; SAMPLES	Young children are at greatest risk of exposure to lead and its effects. Although lead is one of the most widely used elements with known health hazard, there is little data on the blood lead level (BLL) of children in the Kathmandu Valley. Thus, this study aimed to assess factors associated with high BLL in children who were 6-36 months of age and resided in the Kathmandu Valley. In this hospital-based cross-sectional study 6-36 month-old children visiting the Paediatrics Outpatient Department of Tribhuvan University Teaching Hospital, Patan Hospital, and Siddhi Memorial Hospital were enrolled. All three hospitals are located in different areas inside the Kathmandu Valley. Written informed consent was obtained from the parents, and exposure data were collected using a structured questionnaire. Portable Anodic Stripping Voltammetry (ASV) was used to determine BLLs in children. Data were analyzed using SPSS version 16. Of 312 children enrolled in the study, 64.4% had BLLs >= 5 mu gdl. A significant association was found between BLL and exposure to enamel paints in the household in the form of painting materials used in different parts of the house like walls, windows and doors (p = 0.001). Furthermore, multivariate analyses showed that BLLs were 4.5 times higher in children playing with dirt and dust (p = 0.006) and that children belonging to the community of lower casteethnicity groups had significantly higher BLLs compared to those from the upper caste groups (p = 0.02). Our study demonstrated that children living in households that have used enamel paints, children belonging to lower casteethnic groups, and children frequently playing with dirt and dust had significantly higher BLLs. The results of this study highlight the importance of policy decisions to limit environmental lead contamination, and to roll out awareness building measures designed to limit lead exposure and break the poverty cycle associated with chronic lead poisoning.	[Dhimal, Meghnath; Karki, Khem Bahadur; Aryal, Krishna Kumar; Dhimal, Bimala; Joshi, Hari Datt; Puri, Sajan; Pandey, Achyut Raj; Dhakal, Purushotam] Nepal Hlth Res Council, Kathmandu, Nepal; [Sharma, Arun Kumar] Tribhuvan Univ, Teaching Hosp, Dept Pediat, Kathmandu, Nepal; [Raya, Ganendra Bhakta] Siddhi Mem Hosp, Bhaktapur, Nepal; [Ansari, Imran] Patan Acad Hlth Sci, Dept Pediat, Lalitpur, Nepal; [Groneberg, David A.; Mueller, Ruth; Kuch, Ulrich] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany	Tribhuvan University; Institute of Medicine (IoM) - Nepal; Goethe University Frankfurt	Dhimal, M (corresponding author), Nepal Hlth Res Council, Kathmandu, Nepal.	meghdhimal@gmail.com	Muller, Ruth/GXA-1300-2022; Karki, Khem/AAM-8242-2021; Groneberg, David/A-5132-2018; Dhimal, Meghnath/AAD-7261-2021; Muller, Ruth/D-2551-2009	Groneberg, David/0000-0001-8551-6556; Dhimal, Meghnath/0000-0001-7176-7821; Dhakal, Purushottam/0000-0002-9882-6892; Shrestha, Dhruba/0000-0003-0218-5152; Muller, Ruth/0000-0003-3909-3876; Karki, Khem/0000-0002-4318-1126	WHO Country Office, Nepal	WHO Country Office, Nepal	The Nepal Health Research Council (NHRC) received technical and financial support from WHO Country Office, Nepal for conduction of this study.	[Anonymous], 1988, NAT EXT LEAD POIS CH; [Anonymous], 2006, IN ORG LEAD COMP; Ashoka C, 2016, INDIAN J CHILD HLTH, V3; Bornschein RL, 1986, EXTERIOR SURGACE DUS; Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848; Cao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113297; CDC, 2017, BLOOD LEAD LEV CHILD; CEPHED, 2013, NAT REP LEAD NEP NEW; EPA (Environmental Protection Agency). Air quality criteria for lead. Research Triangle Park (NC): Office of Health and Environmental Assessment, 1986, EPA600883028AF OFF H; Gottesfeld P, 2011, J OCCUP ENVIRON HYG, V8, P520, DOI 10.1080/15459624.2011.601710; Hanna-Attisha M, 2016, AM J PUBLIC HEALTH, V106, P283, DOI 10.2105/AJPH.2015.303003; Krleza JL, 2015, BIOCHEM MEDICA, V25, P335, DOI 10.11613/BM.2015.034; Lanphear BP, 2005, PUBLIC HEALTH REP, V120, P305, DOI 10.1177/003335490512000315; Levallois P, 2014, J EXPO SCI ENV EPID, V24, P185, DOI 10.1038/jes.2012.129; Li YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111707; Liu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065230; NAT'L CTR. ON ADDICTION & SUBSTANCE ABUSE COLUMBIA UNIV, 2012, NTP MON HLTH EFF LOW; Parajuli RP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120992; Parajuli RP, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-56; Parajuli RP, 2013, ENVIRON RES, V121, P45, DOI 10.1016/j.envres.2012.10.010; Qiu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122710; Ragan Patti, 2009, JAAPA, V22, P40; Roy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625; SCHLENKER TL, 1994, JAMA-J AM MED ASSOC, V271, P1346, DOI 10.1001/jama.271.17.1346; SCHONFELD DJ, 1994, PEDIATRICS, V94, P174; Sherchand O, 2014, NEPAL J I MED, V36; Shrestha A., 2017, J PATHOL NEPAL, V7, P4, DOI [10.3126/jpn.v7i1.16943, DOI 10.3126/JPN.V7I1.16943]; Stanton NV, 2007, AM J IND MED, V50, P1018, DOI 10.1002/ajim.20525; Tong S, 2000, B WORLD HEALTH ORGAN, V78, P1068; UNICEF, 1999, IMCI HOUS SURV QUEST; Van Belle G., 2008, STAT RULES THUMB; White BM, 2016, J RACIAL ETHN HEALTH, V3, P145, DOI 10.1007/s40615-015-0124-9; WHO (World Health Organization), 2016, LEAD GEN WORLD HLTH; Wu XY, 2016, ENVIRON SCI POLLUT R, V23, P8244, DOI 10.1007/s11356-016-6333-x	34	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179233	10.1371/journal.pone.0179233	http://dx.doi.org/10.1371/journal.pone.0179233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604801	gold, Green Submitted, Green Published			2022-12-26	WOS:000403088400041
J	Ryan, CG; Vijayaraman, A; Denny, V; Ogier, A; Ells, L; Wellburn, S; Cooper, L; Martin, DJ; Atkinson, G				Ryan, Cormac G.; Vijayaraman, Arutchelvam; Denny, Victoria; Ogier, Alison; Ells, Louisa; Wellburn, Shaun; Cooper, Lesley; Martin, Denis J.; Atkinson, Greg			The association between baseline persistent pain and weight change in patients attending a specialist weight management service	PLOS ONE			English	Article							LOW-BACK-PAIN; GENERAL-POPULATION; OBESITY; SF-36; OSTEOARTHRITIS; QUESTIONNAIRE; SCALE; LIFE	Objective To quantify the influence of baseline pain levels on weight change at one-year follow-up in patients attending a National Health Service specialist weight management programme. Methods We compared one-year follow-up weight (body mass) change between patient sub-groups of none-to-mild, moderate, and severe pain at baseline. A mean sub-group difference in weight change of >= 5kg was considered clinically relevant. Results Of the 141 complete cases, n = 43 (30.5%) reported none-to-mild pain, n = 44 (31.2%) reported moderate pain, and n = 54 (38.3%) reported severe pain. Covariate-adjusted mean weight loss (95% CI) was similar for those with none-to-mild (8.1kg (4.2 to 12.0kg)) and moderate pain (8.3kg (4.9 to 11.7kg). The mean weight loss of 3.0kg (-0.4 to 6.4kg) for the severe pain group was 5.1kg (-0.6 to 10.7, p = 0.08) lower than the none-to-mild pain group and 5.3kg (0.4 to 10.2kg, p = 0.03) lower than the moderate pain group. Conclusions Patients with severe pain upon entry to a specialist weight management service in England achieve a smaller mean weight loss at one-year follow-up than those with none-to-moderate pain. The magnitude of the difference in mean weight loss was clinically relevant, highlighting the importance of addressing severe persistent pain in obese patients undertaking weight management programmes.	[Ryan, Cormac G.; Ells, Louisa; Wellburn, Shaun; Cooper, Lesley; Martin, Denis J.; Atkinson, Greg] Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Vijayaraman, Arutchelvam; Denny, Victoria; Ogier, Alison] South Tees Hosp NHS Fdn Trust, Specialist Weight Management Serv, NHS, Middlesbrough, Cleveland, England	University of Teesside	Ryan, CG (corresponding author), Teesside Univ, Hlth & Social Care Inst, Middlesbrough, Cleveland, England.	c.ryan@tees.ac.uk	Atkinson, Greg/ABA-2278-2021	Ryan, Cormac/0000-0001-5864-4325; Ells, Louisa/0000-0003-0559-4832; Atkinson, Greg/0000-0002-5459-9042	Teesside University	Teesside University	This work was funded by Teesside University under the University's research fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 2017, SPORTS MED, V25, P1; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BOMBARDIER C, 1995, MED CARE, V33, pAS131; Bonakdar RA, 2013, J FAM PRACTICE, V62, P22; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Dixon KJL, 2012, J PUBLIC HEALTH-UK, V34, P555, DOI 10.1093/pubmed/fds034; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Health & Social Care Information Centre, STAT OB PHYS ACT DIE; Hitt HC, 2007, J PAIN, V8, P430, DOI 10.1016/j.jpain.2006.12.003; Janke EA, 2007, J REHABIL RES DEV, V44, P245, DOI 10.1682/JRRD.2006.06.0060; Janke EA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-621; Janke EA, 2012, OBESITY, V20, P2027, DOI 10.1038/oby.2012.39; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Magnusson K, 2014, EUR J PAIN, V18, P120, DOI 10.1002/j.1532-2149.2013.00338.x; Masheb RM, 2015, OBESITY, V23, P1778, DOI 10.1002/oby.21160; Mauro M, 2008, EUR J INTERN MED, V19, P173, DOI 10.1016/j.ejim.2007.09.011; McCarthy LH, 2009, J AM GERIATR SOC, V57, P115, DOI 10.1111/j.1532-5415.2008.02089.x; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; McVinnie DS, 2013, BRIT J PAIN, V7, P163, DOI 10.1177/2049463713484296; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Ray L, 2011, PAIN, V152, P53, DOI 10.1016/j.pain.2010.08.043; Ryan CG, 2009, AUST J PHYSIOTHER, V55, P53, DOI 10.1016/S0004-9514(09)70061-3; Saito E, 2012, J OBES WEIGHT LOSS T, V2, P126; Somers TJ, 2012, PAIN, V153, P1199, DOI 10.1016/j.pain.2012.02.023; Stone AA, 2012, OBESITY, V20, P1491, DOI 10.1038/oby.2011.397; Urquhart DM, 2011, SPINE, V36, P1320, DOI 10.1097/BRS.0b013e3181f9fb66; Wachholtz A, 2010, INT J BEHAV MED, V17, P118, DOI 10.1007/s12529-010-9088-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright LJ, 2010, J PAIN, V11, P628, DOI 10.1016/j.jpain.2009.10.004; Zelman DC, 2003, PAIN, V106, P35, DOI 10.1016/S0304-3959(03)00274-4	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179227	10.1371/journal.pone.0179227	http://dx.doi.org/10.1371/journal.pone.0179227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX2VR	28604789	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000403088400040
J	Toor, GS; Occhipinti, ML; Yang, YY; Majcherek, T; Haver, D; Oki, L				Toor, Gurpal S.; Occhipinti, Marti L.; Yang, Yun-Ya; Majcherek, Tammy; Haver, Darren; Oki, Lorence			Managing urban runoff in residential neighborhoods: Nitrogen and phosphorus in lawn irrigation driven runoff	PLOS ONE			English	Article							WATER-QUALITY; STORMWATER RUNOFF; RECLAIMED WATER; LAND-USE; NITRATE; CATCHMENTS; RETENTION; EXPORT; EUTROPHICATION; ECOSYSTEMS	Sources and mechanisms of nutrient transport in lawn irrigation driven surface runoff are largely unknown. We investigated the transport of nitrogen (N) and phosphorus (P) in lawn irrigation driven surface runoff from a residential neighborhood (28 ha) of 56% impervious and 44% pervious areas. Pervious areas encompassing turfgrass (lawns) in the neighborhood were irrigated with the reclaimed water in common areas during the evening to late night and with the municipal water in homeowner's lawns during the morning. The stormwater outlet pipe draining the residential neighborhood was instrumented with a flow meter and Hach autosampler. Water samples were collected every 1-h and triple composite samples were obtained at 3-h intervals during an intensive sampling period of 1-week. Mean concentrations, over 56 sampling events, of total N (TN) and total P (TP) in surface runoff at the outlet pipe were 10.9 +/- 6.34 and 1.3 +/- 1.03 mg L-1, respectively. Of TN, the proportion of nitrate-N was 58% and other-N was 42%, whereas of TP, orthophosphate-P was 75% and other-P was 25%. Flow and nutrient (N and P) concentrations were lowest from 6:00 a.m. to noon, which corresponded with the use of municipal water and highest from 6:00 p.m. to midnight, which corresponded with the use of reclaimed water. This data suggests that N and P originating in lawn irrigation driven surface runoff from residential catchments is an important contributor of nutrients in surface waters.	[Toor, Gurpal S.; Occhipinti, Marti L.; Yang, Yun-Ya] Univ Florida, Soil & Water Qual Lab, Gulf Coast Res & Educ Ctr, Inst Food & Agr Sci, Wimauma, FL 33598 USA; [Majcherek, Tammy; Haver, Darren] Univ Calif Cooperat Extens, South Coast Res & Extens Ctr, 7601 Irvine Blvd, Irvine, CA USA; [Oki, Lorence] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Toor, Gurpal S.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA	State University System of Florida; University of Florida; University of California System; University of California System; University of California Davis; University System of Maryland; University of Maryland College Park	Toor, GS (corresponding author), Univ Florida, Soil & Water Qual Lab, Gulf Coast Res & Educ Ctr, Inst Food & Agr Sci, Wimauma, FL 33598 USA.; Toor, GS (corresponding author), Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA.	gstoor@umd.edu	Yang, Yun-Ya/I-6722-2019	Yang, Yun-Ya/0000-0002-9919-2457				Andrews G., 1998, GARDENING WATER QUAL; Asano T, 1987, MUNICIPAL WASTEWATER; Badruzzaman M, 2012, J ENVIRON MANAGE, V109, P80, DOI 10.1016/j.jenvman.2012.04.040; Baker LA, 2001, ECOSYSTEMS, V4, P582, DOI 10.1007/s10021-001-0031-2; Beckert KA, 2011, WATER AIR SOIL POLL, V221, P255, DOI 10.1007/s11270-011-0788-7; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Brion G, 2011, RIVER RES APPL, V27, P772, DOI 10.1002/rra.1394; Bureau USC, 2012, CAL QUICK FACTS; Caccia VG, 2007, MAR POLLUT BULL, V54, P994, DOI 10.1016/j.marpolbul.2007.02.009; Candela L, 2007, SCI TOTAL ENVIRON, V374, P26, DOI 10.1016/j.scitotenv.2006.12.028; CDM, 2009, US ARMY CORPS ENGINE, V2; Chua LHC, 2009, J ENVIRON MANAGE, V90, P3635, DOI 10.1016/j.jenvman.2009.07.001; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Conley DJ, 1999, HYDROBIOLOGIA, V410, P87, DOI 10.1023/A:1003784504005; Crompton C., 2006, HYDROLOGIC DATA REPO; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; District MNW., 2011, WATER USE DATA; Divers MT, 2014, ENVIRON SCI TECHNOL, V48, P10580, DOI 10.1021/es404880j; Dodd R. C., 1992, WATERSHED PLANNING A; Endreny TA, 2005, INT J RIVER BASIN MA, V3, P53, DOI 10.1080/15715124.2005.9635245; Evanylo G, 2010, WATER-SUI, V2, P685, DOI 10.3390/w2030685; FORSBERG C, 1994, MAR POLLUT BULL, V29, P409, DOI 10.1016/0025-326X(94)90663-7; Gaddis EJB, 2007, ENVIRON MODELL SOFTW, V22, P619, DOI 10.1016/j.envsoft.2005.12.027; Garcia-Pintado J, 2007, SCI TOTAL ENVIRON, V373, P220, DOI 10.1016/j.scitotenv.2006.10.046; Gin KYH, 2011, J ENVIRON ENG-ASCE, V137, P913, DOI 10.1061/(ASCE)EE.1943-7870.0000397; Golterman H. L., 1991, Handbook of Environmental Chemistry, V5, P79; Goonetilleke A, 2005, J ENVIRON MANAGE, V74, P31, DOI 10.1016/j.jenvman.2004.08.006; Grant DM, 1997, ISCO OPEN CHANNEL FL; Graves GA, 2004, J AM WATER RESOUR AS, V40, P1405, DOI 10.1111/j.1752-1688.2004.tb01595.x; Gray L, 2004, HYDROBIOLOGIA, V518, P33, DOI 10.1023/B:HYDR.0000025055.15164.40; Groffman PM, 2004, ECOSYSTEMS, V7, P393, DOI 10.1007/s10021-003-0039-x; Haver D., 2011, ALISO VIEJO SITE DAT; Johannesson KM, 2011, HYDROBIOLOGIA, V674, P179, DOI 10.1007/s10750-011-0728-y; Kaushal SS, 2008, ENVIRON SCI TECHNOL, V42, P5872, DOI 10.1021/es800264f; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kim G, 2007, J ENVIRON MANAGE, V85, P9, DOI 10.1016/j.jenvman.2006.07.009; Lado M, 2009, SOIL TILL RES, V106, P152, DOI 10.1016/j.still.2009.04.011; Lee SW, 2009, LANDSCAPE URBAN PLAN, V92, P80, DOI 10.1016/j.landurbplan.2009.02.008; Lewis DB, 2007, ECOL APPL, V17, P2347, DOI 10.1890/06-0031.1; Lim HS, 2003, HYDROBIOLOGIA, V494, P57, DOI 10.1023/A:1025429307708; Line DE, 2002, WATER ENVIRON RES, V74, P100, DOI 10.2175/106143002X139794; Ma J, 2010, J ENVIRON ENG, V136, P1197, DOI 10.1061/(ASCE)EE.1943-7870.0000263; Manning R., 1891, T I CIVIL ENG IRELAN, V20, P161; McPherson TN, 2005, J AM WATER RESOUR AS, V41, P959, DOI 10.1111/j.1752-1688.2005.tb03780.x; Metcalf E, 1916, AM SEWERAGE PRACTICE; Miguntanna NP, 2013, J ENVIRON MANAGE, V120, P61, DOI 10.1016/j.jenvman.2013.02.027; Miguntanna NP, 2010, J ENVIRON SCI-CHINA, V22, P806, DOI 10.1016/S1001-0742(09)60181-9; Nyenje PM, 2010, SCI TOTAL ENVIRON, V408, P447, DOI 10.1016/j.scitotenv.2009.10.020; Obermann M, 2007, J HYDROL, V334, P99, DOI 10.1016/j.jhydrol.2006.09.029; Parsons LR, 2010, HORTSCIENCE, V45, P1626, DOI 10.21273/HORTSCI.45.11.1626; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Pfeifer LR, 2011, URBAN ECOSYST, V14, P485, DOI 10.1007/s11252-011-0160-0; RAST W, 1983, J ENVIRON ENG-ASCE, V109, P502, DOI 10.1061/(ASCE)0733-9372(1983)109:2(502); Song K, 2015, BIOGEOCHEMISTRY, V125, P1, DOI 10.1007/s10533-015-0114-3; Steele M. K., 2010, AGRONOMY MONOGRAPH, V55, P297, DOI DOI 10.2134/AGRONMONOGR55.C15; Stein ED, 2007, J AM WATER RESOUR AS, V43, P398, DOI 10.1111/j.1752-1688.2007.00031.x; U.S. EPA, 1983, CHEM METH EX WAT WAS; US Environmental Protection Agency, 1983, FIN REP; Uusitalo R, 2000, WATER RES, V34, P2477, DOI 10.1016/S0043-1354(99)00419-4; Vadeboncoeur MA, 2010, ESTUAR COAST, V33, P1113, DOI 10.1007/s12237-010-9320-3; Vaze J, 2002, URBAN WATER, V4, P379, DOI [10.1016/S1462-0758(02)00027-4, DOI 10.1016/S1462-0758(02)00027-4]; Watersheds OC, 2012, 2012 AL CREEK WAT WO; Wollheim WM, 2005, ECOSYSTEMS, V8, P871, DOI 10.1007/s10021-005-0178-3; Wu JL, 2015, ENVIRON SCI POLLUT R, V22, P15788, DOI 10.1007/s11356-015-4743-9; Yang YY, 2017, WATER RES, V112, P176, DOI 10.1016/j.watres.2017.01.039; Yang YY, 2016, ENVIRON SCI TECHNOL, V50, P2881, DOI 10.1021/acs.est.5b05353; Yu S, 2012, RIVER RES APPL, V28, P1135, DOI 10.1002/rra.1501	68	30	30	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179151	10.1371/journal.pone.0179151	http://dx.doi.org/10.1371/journal.pone.0179151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604811	gold, Green Published, Green Submitted			2022-12-26	WOS:000403088400032
J	Wang, M; Xue, H; Feng, ZW; Cheng, BF; Yang, HJ				Wang, Mian; Xue, Han; Feng, Zhiwei; Cheng, Binfeng; Yang, Haijie			Increase of tensile strength and toughness of bio-based diglycidyl ether of bisphenol A with chitin nanowhiskers	PLOS ONE			English	Article							EPOXY/CLAY NANOCOMPOSITES; MECHANICAL-PROPERTIES; CHITOSAN; COMPOSITES; NANOFIBERS; SYSTEM; SLURRY	It is challenging to reinforce and toughen thermoset epoxy resins. We describe a slurry-compounding technique to transfer a uniform dispersion of chitin nanowhiskers (CW) in ethanol into an epoxy matrix. The incorporation of the hydrophilic CW reinforces the oil-soluble diglycidyl ether of bisphenol A (DGEBA). The resultant CW/epoxy bionanocomposites were transparent and showed considerably enhanced thermal and mechanical properties with tensile strength, modulus, toughness, and elongation at break being increased by 49%, 16%, 457%, and 250%, with only 2.5 wt.% CW. This improvement in strength and toughness is rare for thermoset epoxy/rigid nanofiller systems. We hypothesize that CW with many free amine groups could function not only as a nanofiller but also as a macromolecular polyamine hardener that participates in epoxy curing. The strong covalent interaction between the filler and the matrix allowed for efficient load transfer across the interfaces, which accounted for the greater strength and toughness.	[Wang, Mian; Xue, Han; Feng, Zhiwei; Cheng, Binfeng; Yang, Haijie] Xinxiang Med Univ, Sch Life Sci & Technol, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Peoples R China	Xinxiang Medical University	Cheng, BF; Yang, HJ (corresponding author), Xinxiang Med Univ, Sch Life Sci & Technol, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Xinxiang, Peoples R China.	chengbinfeng@xxmu.edu.cn; 18238760185@163.com			Xinxiang Medical University; Henan science and technology project [162102210314];  [505046];  [505047]	Xinxiang Medical University; Henan science and technology project; ; 	We thank Xinxiang Medical University for financial support for this work. M.Wang (Fund No; 505046); H.J.Yang (Fund No: 505047); (Henan science and technology project 162102210314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER A, 1992, INT J BIOL MACROMOL, V14, P166, DOI 10.1016/S0141-8130(05)80007-8; Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8; Cao YM, 2003, J APPL POLYM SCI, V90, P3384, DOI 10.1002/app.13007; Cestari AR, 2012, J HAZARD MATER, V213, P109, DOI 10.1016/j.jhazmat.2012.01.068; Chang PR, 2010, CARBOHYD POLYM, V80, P420, DOI 10.1016/j.carbpol.2009.11.041; GAILL F, 1992, J STRUCT BIOL, V109, P116, DOI 10.1016/1047-8477(92)90043-A; Ifuku S, 2013, CARBOHYD POLYM, V98, P1198, DOI 10.1016/j.carbpol.2013.07.033; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Illy N, 2014, POLYM INT, V63, P420, DOI 10.1002/pi.4516; Kim IY, 2002, J APPL POLYM SCI, V85, P2661, DOI 10.1002/app.10626; Kiuchi H, 2008, J APPL POLYM SCI, V107, P3823, DOI 10.1002/app.27546; Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567; Lertwattanaseri T, 2009, CHEM LETT, V38, P798, DOI 10.1246/cl.2009.798; Malucelli G, 2007, POLYMER, V48, P7000, DOI 10.1016/j.polymer.2007.10.008; Miyagawa H, 2004, J POLYM SCI POL PHYS, V42, P4384, DOI 10.1002/polb.20288; Mohan P, 2013, POLYM-PLAST TECHNOL, V52, P107, DOI 10.1080/03602559.2012.727057; Muzzarelli RAA, 2007, CARBOHYD POLYM, V70, P274, DOI 10.1016/j.carbpol.2007.04.008; Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H; Prasanna K, 2012, J APPL POLYM SCI, V124, P3264, DOI 10.1002/app.35262; Qin AW, 2015, J MEMBRANE SCI, V480, P1, DOI 10.1016/j.memsci.2015.01.035; Raabe D, 2005, ACTA MATER, V53, P4281, DOI 10.1016/j.actamat.2005.05.027; Riyajan SA, 2013, MAT SCI ENG C-MATER, V33, P1041, DOI 10.1016/j.msec.2012.11.012; Saba N, 2014, POLYMERS-BASEL, V6, P2247, DOI 10.3390/polym6082247; Salaberria AM, 2014, CHEM ENG J, V256, P356, DOI 10.1016/j.cej.2014.07.009; Satheesh B, 2014, J COMPOSITES; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Sriupayo J, 2005, CARBOHYD POLYM, V62, P130, DOI 10.1016/j.carbpol.2005.07.013; STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P177, DOI 10.1002/app.1987.070330115; Uddin AJ, 2012, POLYM INT, V61, P1010, DOI 10.1002/pi.4174; Varley RJ, 2001, POLYMER, V42, P3847, DOI 10.1016/S0032-3861(00)00491-2; Wang K, 2005, LANGMUIR, V21, P3613, DOI 10.1021/la047709u; Wang M, 2015, POLYMER, V58, P43, DOI 10.1016/j.polymer.2014.12.042; Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004; Zilg C, 1999, MACROMOL CHEM PHYSIC, V200, P661, DOI 10.1002/(SICI)1521-3935(19990301)200:3<661::AID-MACP661>3.0.CO;2-4	34	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0177673	10.1371/journal.pone.0177673	http://dx.doi.org/10.1371/journal.pone.0177673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604774	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400007
J	Garzon, J; Rodriguez, R; Kong, Z; Chabes, A; Rodriguez-Acebes, S; Mendez, J; Moreno, S; Garcia-Higuera, I				Garzon, J.; Rodriguez, R.; Kong, Z.; Chabes, A.; Rodriguez-Acebes, S.; Mendez, J.; Moreno, S.; Garcia-Higuera, I.			Shortage of dNTPs underlies altered replication dynamics and DNA breakage in the absence of the APC/C cofactor Cdh1	ONCOGENE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE CONTROL; RIBONUCLEOTIDE REDUCTASE; FORK PROGRESSION; GENOMIC INSTABILITY; UBIQUITIN LIGASES; TUMOR SUPPRESSION; MAMMALIAN-CELLS; DORMANT ORIGINS; EXCESS MCM2-7	The APC/C-Cdh1 ubiquitin-ligase complex targets cell cycle regulators for proteosomal degradation and helps prevent tumor development and accumulation of chromosomal aberrations. Replication stress has been proposed to be the main driver of genomic instability in the absence of Cdh1, but the real contribution of APC/C-Cdh1 to efficient replication, especially in normal cells, remains unclear. Here we show that, in primary MEFs, acute depletion or permanent ablation of Cdh1 slowed down replication fork movement and increased origin activity. Partial inhibition of origin firing does not accelerate replication forks, suggesting that fork progression is intrinsically limited in the absence of Cdh1. Moreover, exogenous supply of nucleotide precursors, or ectopic overexpression of RRM2, the regulatory subunit of Ribonucleotide Reductase, restore replication efficiency, indicating that dNTP availability could be impaired upon Cdh1 loss. Indeed, we found reduced dNTP levels in Cdh1-deficient MEFs. Importantly, DNA breakage is also significantly alleviated by increasing intracellular dNTP pools, strongly suggesting that genomic instability is the result of aberrant replication. These observations highlight the relevance of APC/C-Cdh1 activity during G1 to ensure an adequate supply of dNTPs to the replisome, prevent replication stress and the resulting chromosomal breaks and, ultimately, suppress tumorigenesis.	[Garzon, J.; Rodriguez, R.; Moreno, S.; Garcia-Higuera, I.] Univ Salamanca, CSIC, IBFG, C Zacarias Gonzalez 2, Salamanca 37007, Spain; [Kong, Z.; Chabes, A.] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Rodriguez-Acebes, S.; Mendez, J.] Spanish Natl Canc Res Ctr CNIO, DNA Replicat Grp, Madrid, Spain; [Moreno, S.; Garcia-Higuera, I.] Salamanca Univ, Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Garzon, J.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Umea University; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Salamanca; University of Aberdeen	Moreno, S; Garcia-Higuera, I (corresponding author), Univ Salamanca, CSIC, IBFG, C Zacarias Gonzalez 2, Salamanca 37007, Spain.	smo@usal.es; igh@usal.es	Garcia-Higuera, Irene/L-5004-2014; Moreno, Sergio/K-3671-2014; Rodriguez, Sara/AAA-8972-2019; Mendez, Juan/K-8001-2014	Garcia-Higuera, Irene/0000-0001-6331-075X; Moreno, Sergio/0000-0002-8039-1413; Rodriguez, Sara/0000-0002-9867-7591; Mendez, Juan/0000-0002-3235-2559; Chabes, Andrei/0000-0003-1708-8259	Spanish Ministry of Economy and Competitiveness MINECO [CSD2007-0015, BFU2011-28274, BFU2014-55439]; Junta de Castilla y Leon [CSI151U13, CSI084U16]; Swedish Cancer Society; Knut and Alice Wallenberg Foundation; Swedish Research Council; Fundacion Cientifica de la Asociacion Espanola contra el Cancer (AECC); CSIC JAE predoctoral fellowship (MINECO); CSIC FPU predoctoral fellowship (MINECO)	Spanish Ministry of Economy and Competitiveness MINECO(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Swedish Cancer Society(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Fundacion Cientifica de la Asociacion Espanola contra el Cancer (AECC); CSIC JAE predoctoral fellowship (MINECO); CSIC FPU predoctoral fellowship (MINECO)	This research was funded by grants from the Spanish Ministry of Economy and Competitiveness MINECO (CSD2007-0015, BFU2011-28274 and BFU2014-55439) and Junta de Castilla y Leon (CSI151U13 and CSI084U16), the Swedish Cancer Society, the Knut and Alice Wallenberg Foundation and the Swedish Research Council (AC). IGH is supported by Fundacion Cientifica de la Asociacion Espanola contra el Cancer (AECC). JG and RR were recipients of CSIC JAE and FPU predoctoral fellowships (MINECO).	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Ayuda-Duran P, 2014, NUCLEIC ACIDS RES, V42, P7057, DOI 10.1093/nar/gku313; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Choudhury R, 2016, CELL REP, V16, P3359, DOI 10.1016/j.celrep.2016.08.058; Craney A, 2013, CURR OPIN CELL BIOL, V25, P704, DOI 10.1016/j.ceb.2013.07.004; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Delgado-Esteban M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3879; Eguren M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3880; Eguren M, 2011, SEMIN CELL DEV BIOL, V22, P572, DOI 10.1016/j.semcdb.2011.03.010; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Gelot C, 2015, GENES-BASEL, V6, P267, DOI 10.3390/genes6020267; Greil C, 2016, ONCOGENE, V35, P3062, DOI 10.1038/onc.2015.367; Guarino E, 2014, SEMIN CELL DEV BIOL, V30, P97, DOI 10.1016/j.semcdb.2014.03.030; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Labib K, 2011, PHILOS T R SOC B, V366, P3554, DOI 10.1098/rstb.2011.0071; Lopez-Contreras AJ, 2015, GENE DEV, V29, P690, DOI 10.1101/gad.256958.114; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Munoz S, 2017, CHROMOSOMA, V126, P1, DOI 10.1007/s00412-016-0573-x; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Poli J, 2012, EMBO J, V31, P883, DOI 10.1038/emboj.2011.470; Pu X, 2015, CURR PROTOC TOXICOL, V65; Ruiz S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9036; Ruzankina Y, 2008, MECH AGEING DEV, V129, P460, DOI 10.1016/j.mad.2008.03.009; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Stillman B, 2013, P NATL ACAD SCI USA, V110, P14120, DOI 10.1073/pnas.1312901110; Teixeira LK, 2015, CURR BIOL, V25, P1327, DOI 10.1016/j.cub.2015.03.022; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wilhelm T, 2014, P NATL ACAD SCI USA, V111, P763, DOI 10.1073/pnas.1311520111; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yokochi T, 2007, CURR PROTOC CELL BIO, P10; Yuan X, 2014, MOL BIOL CELL, V25, P441, DOI 10.1091/mbc.E13-08-0480; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhang JF, 2014, BBA-REV CANCER, V1845, P277, DOI 10.1016/j.bbcan.2014.02.001; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	50	15	15	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5808	5818		10.1038/onc.2017.186	http://dx.doi.org/10.1038/onc.2017.186			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28604743	Green Submitted			2022-12-26	WOS:000413292900003
J	Kiyohara, MH; Dillard, C; Tsui, J; Kim, SR; Lu, J; Sachdev, D; Goodglick, L; Tong, M; Torous, VF; Aryasomayajula, C; Wang, W; Najafzadeh, P; Gordon, LK; Braun, J; McDermott, S; Wicha, MS; Wadehra, M				Kiyohara, M. H.; Dillard, C.; Tsui, J.; Kim, S. R.; Lu, J.; Sachdev, D.; Goodglick, L.; Tong, M.; Torous, V. F.; Aryasomayajula, C.; Wang, W.; Najafzadeh, P.; Gordon, L. K.; Braun, J.; McDermott, S.; Wicha, M. S.; Wadehra, M.			EMP2 is a novel therapeutic target for endometrial cancer stem cells	ONCOGENE			English	Article							EPITHELIAL MEMBRANE PROTEIN-2; EXPRESSION; RESISTANCE; CHEMOTHERAPY; ASSOCIATION; NICHE; TUMORIGENESIS; METASTASIS; INHIBITION; PREDICTOR	Previous studies have suggested that overexpression of the oncogenic protein epithelial membrane protein-2 (EMP2) correlates with endometrial carcinoma progression and ultimately poor survival from disease. To understand the role of EMP2 in the etiology of disease, gene analysis was performed to show transcripts that are reciprocally regulated by EMP2 levels. In particular, EMP2 expression correlates with and helps regulate the expression of several cancer stem cell associated markers including aldehyde dehydrogenase 1 (ALDH1). ALDH expression significantly promotes tumor initiation and correlates with the levels of EMP2 expression in both patient samples and tumor cell lines. As therapy against cancer stem cells in endometrial cancer is lacking, the ability of anti-EMP2 IgG1 therapy to reduce primary and secondary tumor formation using xenograft HEC1A models was determined. Anti-EMP2 IgG1 reduced the expression and activity of ALDH and correspondingly reduced both primary and secondary tumor load. Our results collectively suggest that anti-EMP2 therapy may be a novel method of reducing endometrial cancer stem cells.	[Kiyohara, M. H.; Dillard, C.; Tsui, J.; Goodglick, L.; Tong, M.; Aryasomayajula, C.; Najafzadeh, P.; Braun, J.; Wadehra, M.] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, 675 Charles Young Dr South,Box 951732, Los Angeles, CA 90095 USA; [Lu, J.; Wadehra, M.] Charles Drew Univ, Ctr Eliminate Canc Hlth Dispar, Los Angeles, CA USA; [Sachdev, D.; Goodglick, L.; Braun, J.; Wadehra, M.] UCLA, David Geffen Sch Med, Dept Internal Med, Los Angeles, CA USA; [Torous, V. F.] Beth Israel Deaconess Med Ctr, Dept Pathol & Lab Med, Boston, MA USA; [Wang, W.; Gordon, L. K.] UCLA, Dept Ophthalmol, David Geffen Sch Med, Los Angeles, CA USA; [McDermott, S.; Wicha, M. S.] Univ Michigan, Med Oncol, Ann Arbor, MI USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Charles R. Drew University of Medicine & Science; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan	Wadehra, M (corresponding author), UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, 675 Charles Young Dr South,Box 951732, Los Angeles, CA 90095 USA.	mwadehra@mednet.ucla.edu	Wicha, Max/AAE-7268-2019	Braun, Jonathan/0000-0003-1646-2974	Early Detection Research Network [NCI CA-86366, CA016042]; Charles Drew University/UCLA NIH [U54-CA-143931]; NIH/National Center for Advancing Translational Sciences (NCATS) [UL1TR000124]; NCI [R01 CA163971]; NATIONAL CANCER INSTITUTE [U24CA086366, P30CA016042, U54CA143931, R01CA163971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	Early Detection Research Network; Charles Drew University/UCLA NIH; NIH/National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was generously supported by the Early Detection Research Network NCI CA-86366 (L Goodglick), CA016042 (University of California at Los Angeles Jonsson Comprehensive Cancer Center Flow Cytometry Core), Charles Drew University/UCLA NIH U54-CA-143931 (JL and MW), the NIH/National Center for Advancing Translational Sciences (NCATS) UL1TR000124, and NCI R01 CA163971 (MW).	Alam M, 2013, J BIOL CHEM, V288, P30892, DOI 10.1074/jbc.M113.477158; Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Ayhan A, 2001, GYNECOL ONCOL, V80, P355, DOI 10.1006/gyno.2000.6014; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Daoud SA, 2013, J AM SCI, V9, P900; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dossus L, 2011, INT J CANCER, V129, P2032, DOI 10.1002/ijc.25840; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Fu M, 2014, MOL CANCER THER, V13, P902, DOI 10.1158/1535-7163.MCT-13-0199; Fu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019945; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Glinsky GV, 2007, STEM CELL REV, V3, P79, DOI 10.1007/s12015-007-0011-9; Gordon LK, 2013, ONCOGENE, V32, P5369, DOI 10.1038/onc.2012.622; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Habeeb O, 2010, CANCER-AM CANCER SOC, V116, P4718, DOI 10.1002/cncr.25259; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hubbard SA, 2009, CANCER RES, V69, P8241, DOI 10.1158/0008-5472.CAN-08-4808; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim RJ, 2013, CANCER LETT, V333, P18, DOI 10.1016/j.canlet.2012.11.026; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kurebayashi J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-568; Kyo S, 2013, CURR OBSTET GYNECOL, V2, P1, DOI 10.1007/s13669-012-0030-7; Leblanc M, 2001, VIRCHOWS ARCH, V438, P78, DOI 10.1007/s004280000269; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liang DM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-201; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Mamat Suhana, 2011, Genes Cancer, V2, P979, DOI 10.1177/1947601911436009; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mendez O, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-133; Mirantes C, 2013, HUM PATHOL, V44, P1973, DOI 10.1016/j.humpath.2013.04.009; Morales SA, 2007, EXP EYE RES, V85, P790, DOI 10.1016/j.exer.2007.08.014; Nandy SB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-644; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Plaks V, 2015, CELL STEM CELL, V16, P225, DOI 10.1016/j.stem.2015.02.015; Rahadiani N, 2011, CANCER SCI, V102, P903, DOI 10.1111/j.1349-7006.2011.01864.x; Rutella S, 2009, CLIN CANCER RES, V15, P4299, DOI 10.1158/1078-0432.CCR-08-1883; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soltysova A, 2005, NEOPLASMA, V52, P435; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tirino Virginia, 2012, Methods Mol Biol, V879, P513, DOI 10.1007/978-1-61779-815-3_32; Wadehra M, 2006, DEV BIOL, V292, P430, DOI 10.1016/j.ydbio.2006.01.015; Wadehra M, 2005, DEV BIOL, V287, P336, DOI 10.1016/j.ydbio.2005.09.003; Wadehra M, 2006, CANCER-AM CANCER SOC, V107, P90, DOI 10.1002/cncr.21957; Wang MY, 2006, CANCER RES, V66, P7864, DOI 10.1158/0008-5472.CAN-04-4392; Whitcomb BP, 2008, SURG CLIN N AM, V88, P301, DOI 10.1016/j.suc.2008.01.004; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Ye J, 2014, TUMOR BIOL, V35, P3945, DOI 10.1007/s13277-013-1561-x	66	25	25	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 19	2017	36	42					5793	5807		10.1038/onc.2017.142	http://dx.doi.org/10.1038/onc.2017.142			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK2DN	28604744	Green Accepted			2022-12-26	WOS:000413292900002
J	Valigurova, A; Vaskovicova, N; Diakin, A; Paskerova, GG; Simdyanov, TG; Kovacikova, M				Valigurova, Andrea; Vaskovicova, Nadezda; Diakin, Andrei; Paskerova, Gita G.; Simdyanov, Timur G.; Kovacikova, Magdalena			Motility in blastogregarines (Apicomplexa): Native and drug-induced organisation of Siedleckia nematoides cytoskeletal elements	PLOS ONE			English	Article							FINE-STRUCTURE; MOLECULAR PHYLOGENY; GLIDING MOTILITY; FREEZE-FRACTURE; SUBPELLICULAR MICROTUBULES; GREGARINES APICOMPLEXA; TOXOPLASMA-GONDII; ACTIN; PARASITE; HOST	Recent studies on motility of Apicomplexa concur with the so-called glideosome concept applied for apicomplexan zoites, describing a unique mechanism of substrate-dependent gliding motility facilitated by a conserved form of actomyosin motor and subpellicular micro-tubules. In contrast, the gregarines and blastogregarines exhibit different modes and mechanisms of motility, correlating with diverse modifications of their cortex. This study focuses on the motility and cytoskeleton of the blastogregarine Siedleckia nematoides Caullery et Mesnil, 1898 parasitising the polychaete Scoloplos cf. armiger (Muller, 1776). The blastogregarine moves independently on a solid substrate without any signs of gliding motility; the motility in a liquid environment (in both the attached and detached forms) rather resembles a sequence of pendular, twisting, undulation, and sometimes spasmodic movements. Despite the presence of key glideosome components such as pellicle consisting of the plasma membrane and the inner membrane complex, actin, myosin, subpellicular microtubules, micronemes and glycocalyx layer, the motility mechanism of S. nematoides differs from the glideosome machinery. Nevertheless, experimental assays using cytoskeletal probes proved that the polymerised forms of actin and tubulin play an essential role in the S. nematoides movement. Similar to Selenidium archigregarines, the subpellicular microtubules organised in several layers seem to be the leading motor structures in blastogregarine motility. The majority of the detected actin was stabilised in a polymerised form and appeared to be located beneath the inner membrane complex. The experimental data suggest the subpellicular microtubules to be associated with filamentous structures (=cross-linking protein complexes), presumably of actin nature.	[Valigurova, Andrea; Diakin, Andrei; Kovacikova, Magdalena] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic; [Vaskovicova, Nadezda] Inst Sci Instruments CAS, Vvi, Kralovopolska 147, Brno, Czech Republic; [Paskerova, Gita G.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, Univ Skaya Emb 7-9, St Petersburg, Russia; [Simdyanov, Timur G.] Lomonosov Moscow State Univ, Dept Invertebrate Zool, Fac Biol, Leninskiye Gory 1-12, Moscow, Russia	Masaryk University Brno; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Saint Petersburg State University; Lomonosov Moscow State University	Valigurova, A (corresponding author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, Brno, Czech Republic.	andreav@sci.muni.cz	Paskerova, Gita G./H-3805-2014; Simdyanov, Timur G/H-8279-2012; Vaškovicová, Naděžda/G-1456-2014; Valigurová, Andrea/B-4522-2012	Paskerova, Gita G./0000-0002-1026-4216; Simdyanov, Timur G/0000-0003-2478-9301; Vaškovicová, Naděžda/0000-0003-4325-8565; Valigurová, Andrea/0000-0001-8313-1580	Czech Science Foundation [GBP505/12/G112]; Department of Botany and Zoology, Faculty of Science, Masaryk University; MEYS CR [L01212]; EC [CZ.1.05/2.1.00/01.0017]; Council of President of the Russian Federation [NSh-7770.2016.4]; Russian Foundation of Basic Researches [15-29-02601]; Czech-Biolmaging large RI project (MEYS CR) [LM2015062]	Czech Science Foundation(Grant Agency of the Czech Republic); Department of Botany and Zoology, Faculty of Science, Masaryk University; MEYS CR; EC(European CommissionEuropean Commission Joint Research Centre); Council of President of the Russian Federation; Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Czech-Biolmaging large RI project (MEYS CR)	AV, AD and MK were funded from the project from Czech Science Foundation No. GBP505/12/G112 (ECIP - Centre of excellence) and acknowledge support from the Department of Botany and Zoology, Faculty of Science, Masaryk University, towards the preparation of this manuscript. NV was supported by MEYS CR (L01212) and its infrastructure by MEYS CR and EC (CZ.1.05/2.1.00/01.0017). TGS was supported by the grants from the Council of President of the Russian Federation NSh-7770.2016.4 and from the Russian Foundation of Basic Researches 15-29-02601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the White Sea Biological Station of Lomonosov Moscow State University (WSBS MSU) and the Marine Biological Station of St. Petersburg State University (MBS SPbSU) for providing facilities for field sampling and material processing, as well as their kind and friendly approach. The authors are greatly indebted to the Laboratory of Electron Microscopy, Biology Centre CAS, supported by the Czech-Biolmaging large RI project (LM2015062 funded by MEYS CR) for their support and technical assistance with obtaining of EM data presented in this paper. The present study also utilised equipment of core facility centres 'Culturing of microorganisms', 'Observatory of Environmental Safety' and 'Development of molecular and cell technologies' of St. Petersburg State University. Many thanks to Prof. Dominique Soldati-Favre (University of Geneva) for kindly providing the monoclonal anti-actin antibody.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; BAINES I, 1989, CELL BIOL INT REP, V13, P679, DOI 10.1016/0309-1651(89)90044-1; BEAMS HW, 1959, J PROTOZOOL, V6, P136, DOI 10.1111/j.1550-7408.1959.tb03940.x; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Boucher LE, 2015, J STRUCT BIOL, V190, P93, DOI 10.1016/j.jsb.2015.02.008; BRANTON D, 1975, SCIENCE, V190, P54, DOI 10.1126/science.1166299; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Caullery, 1898, Compte Rendu des Seances de la Societe de Biologie, Vv, P1093; Chatton E, 1936, CR HEBD ACAD SCI, V203, P505; CHATTON EDOUARD, 1929, ARCH ANAT MICROSC [PARIS], V25, P530; Chatton F, 1929, B ZOOL SOC FR, V54, P28; Chen WJ, 2001, J EUKARYOT MICROBIOL, V48, P537, DOI 10.1111/j.1550-7408.2001.tb00189.x; Crawley H., 1905, P ACAD NAT SCI PHILA, V57, P89; Daher W, 2009, CURR OPIN MICROBIOL, V12, P408, DOI 10.1016/j.mib.2009.06.008; DALLAI R, 1983, Bollettino di Zoologia, V50, P235; Desportes I., 2013, GREGARINES; Diakin A, 2016, PROTIST, V167, P279, DOI 10.1016/j.protis.2016.05.001; Dostal V, 2014, PROTOPLASMA, V251, P991, DOI 10.1007/s00709-014-0633-0; DUBREMETZ JF, 1978, J ULTRA MOL STRUCT R, V62, P94, DOI 10.1016/S0022-5320(78)90012-6; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Fowell R. R., 1936, Journal of the Royal Microscopical Society (3), V58, P12; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; GHAZALI M, 1993, J EUKARYOT MICROBIOL, V40, P345, DOI 10.1111/j.1550-7408.1993.tb04927.x; GHAZALI M, 1989, BIOL CELL, V67, P173, DOI 10.1016/0248-4900(89)90052-X; Gould SB, 2008, MOL BIOL EVOL, V25, P1219, DOI 10.1093/molbev/msn070; Guha-Niyogi A, 2001, GLYCOBIOLOGY, V11, p45R, DOI 10.1093/glycob/11.4.45R; GUNDERSON J, 1986, J PARASITOL, V72, P107, DOI 10.2307/3281801; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harding CR, 2014, CELL MICROBIOL, V16, P632, DOI 10.1111/cmi.12285; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Heintzelman MB, 2008, J PARASITOL, V94, P158, DOI 10.1645/GE-1339.1; Heintzelman MB, 2004, CELL MOTIL CYTOSKEL, V58, P83, DOI 10.1002/cm.10178; HILDEBRAND HF, 1980, Z PARASITENKD, V64, P29, DOI 10.1007/BF00927055; Hliscs M, 2015, CELL MICROBIOL, V17, P207, DOI 10.1111/cmi.12359; KING CA, 1982, EXPERIENTIA, V38, P1051, DOI 10.1007/BF01955361; KING CA, 1981, CELL BIOL INT REP, V5, P297, DOI 10.1016/0309-1651(81)90228-9; KOBAYASHI H, 1988, PROTOPLASMA, V143, P29, DOI 10.1007/BF01282956; Kuhni-Boghenbor K, 2012, CELL MICROBIOL, V14, P1867, DOI 10.1111/cmi.12006; Kumpula EP, 2015, ACTA CRYSTALLOGR F, V71, P500, DOI 10.1107/S2053230X1500391X; Landers SC, 2001, SYST PARASITOL, V48, P55, DOI 10.1023/A:1026572223364; Leander BS, 2007, ZOOL SCR, V36, P213, DOI 10.1111/j.1463-6409.2007.00272.x; Leander BS, 2006, MAR BIOL RES, V2, P178, DOI 10.1080/17451000600724395; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; MACGREGO.HC, 1965, J PROTOZOOL, V12, P438, DOI 10.1111/j.1550-7408.1965.tb03239.x; MACKENZIE C, 1983, J PROTOZOOL, V30, P3, DOI 10.1111/j.1550-7408.1983.tb01024.x; MACMILLAN WG, 1973, J PROTOZOOL, V20, P267, DOI 10.1111/j.1550-7408.1973.tb00874.x; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MCLAREN DJ, 1979, PARASITOLOGY, V79, P125, DOI 10.1017/S0031182000052021; MELLOR JS, 1980, J EXP BIOL, V87, P149; Menard R, 2001, CELL MICROBIOL, V3, P63, DOI 10.1046/j.1462-5822.2001.00097.x; MILES H B, 1968, Revista Iberica de Parasitologia, V28, P455; MILES H. R., 1966, REV IBERICA PARASITOL, V26, P361; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Morrissette NS, 2004, MOL BIOL CELL, V15, P1960, DOI 10.1091/mbc.E03-07-0530; Morrissette NS, 2002, J CELL SCI, V115, P1017; Raibaud A, 2001, J STRUCT BIOL, V135, P47, DOI 10.1006/jsbi.2001.4396; RICHTER IE, 1959, PROTOPLASMA, V51, P197, DOI 10.1007/BF01252489; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Santos JM, 2009, INT J PARASITOL, V39, P153, DOI 10.1016/j.ijpara.2008.10.007; SCHREVEL J, 1974, CR ACAD SCI D NAT, V278, P2201; SCHREVEL J, 1971, Protistologica, V7, P101; SCHREVEL J, 1971, J PROTOZOOL, V18, P448, DOI 10.1111/j.1550-7408.1971.tb03355.x; SCHREVEL J, 1983, J CELL SCI, V61, P151; Schrevel J, 2016, PROTIST, V167, P339, DOI 10.1016/j.protis.2016.06.001; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Simdyanov TG, 2007, EUR J PROTISTOL, V43, P17, DOI 10.1016/j.ejop.2006.09.003; STEBBING.H, 1974, CELL TISSUE RES, V148, P331; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; Tran JQ, 2012, EUKARYOT CELL, V11, P206, DOI 10.1128/EC.05161-11; Valigurova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125063; Valigurova A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-57; Valigurova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042606; Valigurova A, 2009, INT J PARASITOL, V39, P1235, DOI 10.1016/j.ijpara.2009.04.009; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; VIVIER E, 1964, J MICROSC-PARIS, V3, P651; Wakeman KC, 2014, PROTIST, V165, P493, DOI 10.1016/j.protis.2014.05.007; WALKER MH, 1984, J ULTRA MOL STRUCT R, V88, P66, DOI 10.1016/S0022-5320(84)90182-5; WARNER FD, 1968, J PROTOZOOL, V15, P59, DOI 10.1111/j.1550-7408.1968.tb02090.x; Whitelaw JA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0343-5	79	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179709	10.1371/journal.pone.0179709	http://dx.doi.org/10.1371/journal.pone.0179709			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640849	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800054
J	Graham, C; Chooniedass, R; Stefura, WP; Becker, AB; Sears, MR; Turvey, SE; Mandhane, PJ; Subbarao, P; HayGlass, KT				Graham, Caroline; Chooniedass, Rishma; Stefura, William P.; Becker, Allan B.; Sears, Malcolm R.; Turvey, Stuart E.; Mandhane, Piush J.; Subbarao, Padmaja; HayGlass, Kent T.		CHILD Study Investigator	In vivo immune signatures of healthy human pregnancy: Inherently inflammatory or antiinflammatory?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDUCIBLE PROTEIN-10; IL-10 PRODUCTION; PRETERM BIRTH; WOMEN; INTERLEUKIN-6; CYTOKINE; GAMMA; ACTIVATION; MARKERS	Changes in maternal innate immunity during healthy human pregnancy are not well understood. Whether basal immune status in vivo is largely unaffected by pregnancy, is constitutively biased towards an inflammatory phenotype (transiently enhancing host defense) or exhibits anti-inflammatory bias (reducing potential responsiveness to the fetus) is unclear. Here, in a longitudinal study of healthy women who gave birth to healthy infants following uncomplicated pregnancies within the Canadian Healthy Infant Longitudinal Development (CHILD) cohort, we test the hypothesis that a progressively altered bias in resting innate immune status develops. Women were examined during pregnancy and again, one and/or three years postpartum. Most pro-inflammatory cytokine expression, including CCL2, CXCL10, IL-18 and TNF alpha, was reduced in vivo during pregnancy (20'-57%, p<0.0001). Antiinflammatory biomarkers (sTNF-RI, sTNF-RII, and IL-1Ra) were elevated by similar to 50-100% (p<0.0001). Systemic IL-10 levels were unaltered during vs. post-pregnancy. Kinetic studies demonstrate that while decreased pro-inflammatory biomarker expression (CCL2, CXCL10, IL-18, and TNFa) was constant, anti-inflammatory expression increased progressively with increasing gestational age (p<0.0001). We conclude that healthy resting maternal immune status is characterized by an increasingly pronounced bias towards a systemic anti-inflammatory innate phenotype during the last two trimesters of pregnancy. This is resolved by one year postpartum in the absence of repeat pregnancy. The findings provide enhanced understanding of immunological changes that occur in vivo during healthy human pregnancy.	[Graham, Caroline; Stefura, William P.; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Chooniedass, Rishma; Becker, Allan B.; HayGlass, Kent T.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Becker, Allan B.; HayGlass, Kent T.] Childrens Hosp Res, Inst Manitoba, Winnipeg, MB, Canada; [Sears, Malcolm R.] McMaster Univ, Dept Med, de Groote Sch Med, Hamilton, ON, Canada; [Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC, Canada; [Turvey, Stuart E.] Univ British Columbia, BC Childrens Hosp, Vancouver, BC, Canada; [Mandhane, Piush J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Subbarao, Padmaja] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [CHILD Study Investigator] McMaster Univ, CHILD Canadian Hlth Infant Longitudinal Dev St, Hamilton, ON, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; Child & Family Research Institute; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of Alberta; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	HayGlass, KT (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.; HayGlass, KT (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.; HayGlass, KT (corresponding author), Childrens Hosp Res, Inst Manitoba, Winnipeg, MB, Canada.	kent.hayglass@umanitoba.ca	Turvey, Stuart/HGV-1191-2022; Scott, James A/AAN-4011-2021; Befus, Dean/C-5561-2009; Scott, James A/A-8598-2011; Brauer, Michael/Y-2810-2019	Scott, James A/0000-0002-5073-0832; Befus, Dean/0000-0002-1611-2897; Scott, James A/0000-0002-5073-0832; Brauer, Michael/0000-0002-9103-9343; Hegele, Richard/0000-0003-1073-8044; Larche, Mark/0000-0002-1439-7593; HayGlass, Kent/0000-0002-4621-7737; Turvey, Stuart/0000-0003-1599-1065; Laprise, Catherine/0000-0001-5526-9945; Subbarao, Padmaja/0000-0003-0394-1933; Ratjen, Felix/0000-0003-4057-6592; Dell, Sharon/0000-0003-2169-9407	Canadian Institutes of Health Research (CIHR); Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence; Canada Research Chairs; Children's Hospital Research Foundation of Manitoba	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence; Canada Research Chairs(Canada Research ChairsCGIAR); Children's Hospital Research Foundation of Manitoba	The Canadian Institutes of Health Research (CIHR) and the Allergy, Genes and Environment (AllerGen) Network of Centres of Excellence provided core funding for the CHILD Study. Support for this work has also been provided by Canada Research Chairs, Children's Hospital Research Foundation of Manitoba. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Aagaard-Tillery KM, 2006, SEMIN FETAL NEONAT M, V11, P279, DOI 10.1016/j.siny.2006.04.003; Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Aye ILMH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116186; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Banchereau R, 2017, ANN REV IMMUNOL; Baxter AE, 2016, NAT IMMUNOL, V17, P476, DOI 10.1038/ni.3436; Baylis F, 2010, NATURE, V465, P689, DOI 10.1038/465689a; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; Bjorkander S, 2012, CYTOKINE, V59, P392, DOI 10.1016/j.cyto.2012.04.046; Blank V, 2008, PLACENTA S, pAS102; Campbell J. Darren, 2004, FASEB Journal, V18, P329; Campbell JD, 2001, HUM IMMUNOL, V62, P668, DOI 10.1016/S0198-8859(01)00260-9; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Catalano PM, 2011, SCI VIS WORKSH PREGN; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chaouat G, 1997, AM J REPROD IMMUNOL, V37, P427; CHAOUAT G, 1995, J IMMUNOL, V154, P4261; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Chawes BLK, 2015, J ALLERGY CLIN IMMUN, V135, P1450, DOI 10.1016/j.jaci.2014.11.020; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Dubinski Andrzej, 2007, Pol Merkur Lekarski, V22, P291; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Foulkes MA, 2011, J WOMENS HEALTH, V20, P1429, DOI 10.1089/jwh.2011.3118; Friis CM, 2013, OBESITY, V21, pE124, DOI 10.1002/oby.20120; Gabrysova L, 2014, CURR TOP MICROBIOL I; Gado K, 2000, CELL BIOL INT, V24, P195, DOI 10.1006/cbir.2000.0497; Gonzalez-Perez G, 2016, J IMMUNOL, V196, P3768, DOI 10.4049/jimmunol.1502322; Green WD, 2017, CURR OPIN IMMUNOL, P461; Hamidzadeh K, 2017, ANNU REV PHYSIOL, V79, P567, DOI 10.1146/annurev-physiol-022516-034348; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hedges JC, 2000, AM J RESP CELL MOL, V23, P86, DOI 10.1165/ajrcmb.23.1.4014; Hosoki K, 2016, CURR OPIN ALLERGY CL, V16, P45, DOI 10.1097/ACI.0000000000000231; Huang E, 2014, J IMMUNOL, V193, P13, DOI 10.4049/jimmunol.1303410; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ito Y, 2015, ENDOCR METAB IMMUNE, V15, P206, DOI 10.2174/1871530315666150316123657; JOHNSTONE FD, 1994, OBSTET GYNECOL, V83, P941, DOI 10.1097/00006250-199406000-00008; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kutteh WH, 1996, REPROD IMMUNOLOGY; Lam VC, 2016, CURR OPIN IMMUNOL, P4443; Liu Z, 2010, INT J EXP PATHOL, V91, P420, DOI 10.1111/j.1365-2613.2010.00715.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MALEFYT RD, 1991, J EXP MED, V174, P1209; McDade TW, 2016, J NUTR, V146, P353, DOI 10.3945/jn.115.224279; Mendola P, 2016, J ALLERGY CLIN IMMUN, V138, P432, DOI 10.1016/j.jaci.2015.12.1309; Miller EM, 2009, AM J HUM BIOL, V21, P401, DOI 10.1002/ajhb.20882; Moore KW, 2001, ANNU REV IMMUNOL, P19683; Moraes TJ, 2015, PAEDIATR PERINAT EP, V29, P84, DOI 10.1111/ppe.12161; Mosser DM, 2008, IMMUNOL REV; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NICHD, 2013, PREGN RES HLTH CAR P; Nishimoto N, 2006, CURR OPIN RHEUMATOL, V18, P277, DOI 10.1097/01.bor.0000218949.19860.d1; O'Connor T, 2015, ENDOCR METAB IMMUNE, V15, P105, DOI 10.2174/1871530315666150316120920; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Pendeloski KPT, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12674; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Perucci LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138475; Pestka S, 2004, ANNU REV IMMUNOL, P22929; PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131; Rebelo F, 2013, J HYPERTENS, V31, P16, DOI 10.1097/HJH.0b013e32835b0556; ROMEM Y, 1985, AM J OBSTET GYNECOL, V151, P380, DOI 10.1016/0002-9378(85)90307-2; Sacks G, 1999, IMMUNOL TODAY, V20, P114, DOI 10.1016/S0167-5699(98)01393-0; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Simavli S, 2014, J MATERN-FETAL NEO M, V27, P75, DOI 10.3109/14767058.2013.804054; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; St Louis D, 2016, J IMMUNOL, V196, P1044, DOI 10.4049/jimmunol.1501962; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Subbarao P, 2015, THORAX, V70, P998, DOI 10.1136/thoraxjnl-2015-207246; Sutinen EM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-199; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Szarka A, 2010, BMC IMMUNOL, P1159; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; Tan SY, 2016, CURR OPIN IMMUNOL, P4434; Thaxton JE, 2010, AM J REPROD IMMUNOL, V63, P482, DOI 10.1111/j.1600-0897.2010.00810.x; Tyrrell J, 2016, JAMA-J AM MED ASSOC, V315, P1129, DOI 10.1001/jama.2016.1975; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; von Mutius E, 2016, JAMA-J AM MED ASSOC, V315, P347, DOI 10.1001/jama.2015.18963; Ware Carl F., 1998, P549; Wei MX, 2001, CYTOKINE, V15, P223, DOI 10.1006/cyto.2001.0920; Willrich MAV, 2015, TRANSL RES, V165, P270, DOI 10.1016/j.trsl.2014.09.006; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365	93	34	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0177813	10.1371/journal.pone.0177813	http://dx.doi.org/10.1371/journal.pone.0177813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636613	Green Published, gold, Green Accepted			2022-12-26	WOS:000404118300006
J	Ai, CZ; Liu, Y; Li, W; Chen, DM; Zhu, XX; Yan, YW; Chen, DC; Jiang, YZ				Ai, Chun-Zhi; Liu, Yong; Li, Wei; Chen, De-Meng; Zhu, Xin-Xing; Yan, Ya-Wei; Chen, Du-Chu; Jiang, Yi-Zhou			Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib	PLOS ONE			English	Article							CELL LUNG-CANCER; COMPOUND-I; LIVER-MICROSOMES; DRUG-METABOLISM; HYDROXYLATION; THERAPY; SELECTIVITY; GEFITINIB; TOXICITY; ENZYMES	EGFR inhibitors, even with therapeutics superiorities in anticancer, can cause idiosyncratic pulmonary and hepatic toxicities that are associated with the reactive electrophile bioactivated by Cytochrome P450s (P450s). Until now, neither has the electrophilic intermediate been caught experimentally, nor has the subtle mechanism been declared. Herein, the underlying mechanism of bioactivation mediated by P450s was explored by DFT calculations for a case of EGFR inhibitor, Erlotinib. Based on the calculation and analysis, we suggest that with other metabolites, reactive electrophiles of Erlotinib: epoxide and quinineimine, can be generated by several steps along the oxidative reaction pathway. The generation of epoxide needs two steps: (1) the addition of Erlotinib to Compound I (Cpd I) and (2) the rearrangement of protons. Whereas, quinine-imine needs a further oxidation step (3) via which quinone is generated and ultimately turns into quinine-imine. Although both reactive electrophiles can be produced for either face-on or side-on pose of Erlotinib, the analysis of energy barriers indicates that the side-on path is preferred in solvent environment. In the rate-determining step, e.g. the addition of Erlotinib to the porphyrin, the reaction barrier for side-on conformation is decreased in aqueous and protein environment compared with gas phase, whereas, the barrier for face-on pose is increased in solvent environment. The simulated mechanism is in good agreement with the speculation in previous experiment. The understanding of the subtle mechanism of bioactivation of Erlotinib will provide theoretical support for toxicological mechanism of EGFR inhibitors.	[Ai, Chun-Zhi; Chen, De-Meng; Zhu, Xin-Xing; Yan, Ya-Wei; Chen, Du-Chu; Jiang, Yi-Zhou] Shenzhen Univ, Inst Adv Study, Shenzhen, Guangdong, Peoples R China; [Ai, Chun-Zhi; Zhu, Xin-Xing; Yan, Ya-Wei; Chen, Du-Chu] Shenzhen Univ, Coll Optoelect Engn, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen, Guangdong, Peoples R China; [Liu, Yong] Dalian Univ Technol, Sch Life Sci & Med, Panjin, Liaoning, Peoples R China; [Li, Wei] Yangzhou Univ, Coll Med, Yangzhou, Jiangsu, Peoples R China; [Chen, De-Meng] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA USA	Shenzhen University; Shenzhen University; Dalian University of Technology; Yangzhou University; University of California System; University of California Los Angeles	Jiang, YZ (corresponding author), Shenzhen Univ, Inst Adv Study, Shenzhen, Guangdong, Peoples R China.	jiangyz@szu.edu.cn	Liu, Yong/A-1289-2011	Liu, Yong/0000-0002-6173-8186; Ai, Chun-Zhi/0000-0002-4194-6690	National Nature Science Foundation of China [81173124]; Shenzhen Science Foundation [JCYJ20160308104109234]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science Foundation	The work was funded by the National Nature Science Foundation of China (grant no.81173124 to C.-Z.A, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list&81500354 to Y.-Z.J, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list) and Shenzhen Science Foundation (grant no. JCYJ20160308104109234 to YZ Jiang).	Amacher DE, 2012, EXPERT OPIN DRUG MET, V8, P335, DOI 10.1517/17425255.2012.658041; Argikar UA, 2011, CURR TOP MED CHEM, V11, P419; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Bathelt CM, 2004, ORG BIOMOL CHEM, V2, P2998, DOI 10.1039/b410729b; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bell SR, 2009, J AM CHEM SOC, V131, P9640, DOI 10.1021/ja903394s; Chen Q, 2006, DRUG METAB DISPOS, V34, P145, DOI 10.1124/dmd.105.004341; Cohen S, 2006, J AM CHEM SOC, V128, P11028, DOI 10.1021/ja063269c; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; de Visser SP, 2003, J AM CHEM SOC, V125, P7413, DOI 10.1021/ja034142f; Frisch MJea, 2009, GAUSSIAN; GUENGERICH FP, 1994, TOXICOL LETT, V70, P133; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Harris D, 2001, J INORG BIOCHEM, V83, P309, DOI 10.1016/S0162-0134(00)00177-X; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Iverson SL, 1996, CHEM RES TOXICOL, V9, P492, DOI 10.1021/tx950178c; Kalgutkar AS, 2005, CURR DRUG METAB, V6, P161, DOI 10.2174/1389200054021799; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kumar D, 2005, CHEM-EUR J, V11, P2825, DOI 10.1002/chem.200401044; Li XH, 2010, DRUG METAB DISPOS, V38, P1238, DOI 10.1124/dmd.109.030361; Li XH, 2009, CHEM RES TOXICOL, V22, P1736, DOI 10.1021/tx900256y; Lind JSW, 2008, J THORAC ONCOL, V3, P1050, DOI 10.1097/JTO.0b013e318183a9f5; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Lonsdale R, 2011, J AM CHEM SOC, V133, P15464, DOI 10.1021/ja203157u; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Olah J, 2011, P NATL ACAD SCI USA, V108, P6050, DOI 10.1073/pnas.1010194108; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Palazzo A, 2010, CURR CANCER DRUG TAR, V10, P433, DOI 10.2174/156800910791517145; PARK GL, 1988, PHYS REV B, V38, P13200, DOI 10.1103/PhysRevB.38.13200; Pellegrinotti M, 2009, ANN PHARMACOTHER, V43, P542, DOI 10.1345/aph.1L468; Ramanarayanan Jeyanthi, 2008, Clin Adv Hematol Oncol, V6, P200; Ricciardi S, 2009, CLIN LUNG CANCER, V10, P28, DOI 10.3816/CLC.2009.n.004; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Schoneboom JC, 2002, J AM CHEM SOC, V124, P8142, DOI 10.1021/ja026279w; Schyman P, 2011, J AM CHEM SOC, V133, P7977, DOI 10.1021/ja201665x; Su Z, 2012, CHEM-EUR J, V18, P2472, DOI 10.1002/chem.201103170; Takano T, 2004, LUNG CANCER, V45, P93, DOI 10.1016/j.lungcan.2004.01.010; Wang Y, 2006, J PHYS CHEM B, V110, P6154, DOI 10.1021/jp060033m; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Zhang T, 2012, MOL INFORM, V31, P53, DOI 10.1002/minf.201100052; Zuniga FI, 2012, EXPERT OPIN DRUG MET, V8, P467, DOI 10.1517/17425255.2012.668528	42	2	2	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179333	10.1371/journal.pone.0179333	http://dx.doi.org/10.1371/journal.pone.0179333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628631	gold, Green Published, Green Submitted			2022-12-26	WOS:000404043100029
J	Pereira, ENGD; Silvares, RR; Flores, EEI; Rodrigues, KL; Ramos, IP; da Silva, IJ; Machado, MP; Miranda, RA; Pazos-Moura, CC; Goncalves-de-Albuquerque, CF; Faria-Neto, HCD; Tibirica, E; Daliry, A				Goulart da Silva Pereira, Evelyn Nunes; Silvares, Raquel Rangel; Ilaquita Flores, Edgar Eduardo; Rodrigues, Karine Lino; Ramos, Isalira Peroba; da Silva, Igor Josea; Machado, Marcelo Pelajo; Miranda, Rosiane Aparecida; Pazos-Moura, Carmen Cabanelas; Goncalves-de-Albuquerque, Cassiano F.; de Castro Faria-Neto, Hugo Caire; Tibirica, Eduardo; Daliry, Anissa			Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease	PLOS ONE			English	Article							METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; INFLAMMATORY RESPONSE; ELEVATED LEVELS; MICROCIRCULATION; STEATOHEPATITIS; PROGRESSION; MODEL; PATHOGENESIS	Background This study aimed to investigate the pathophysiology of hepatic microcirculatory dysfunction in non-alcoholic fatty liver disease (NAFLD). Methods In Wistar rats, NAFLD model was induced by 20 weeks of high-fat diet (HFD) feeding. Rolling and adhesion of leukocytes and tissue perfusion in hepatic microcirculation were examined using in vivo microscopic and laser speckle contrast imaging (LSCI), respectively. Oxidative stress and inflamatory parameters were analysed by TBARs, catalase enzyme activity, RT-PCR and ELISA. The participation of advanced glycation end-products (AGE) and its receptor RAGE was evaluated by the measurement of gene and protein expression of RAGE by RT-PCR and Western-blot, respectively and by liver and serum quantification of fluorescent AGEs. Results Wistar rats fed high-fat diet (HFD) showed increase in epididymal and abdominal fat content, systolic arterial blood pressure, fasting blood glucose levels, hepatic triglycerides and cholesterol, and impairment of glucose and insulin metabolisms. Liver histology confirmed the presence of steatosis and ultrasound analysis revealed increased liver size and parenchymal echogenicity in HFD-fed rats. HFD causes significant increases in leukocyte rolling and adhesion on hepatic microcirculation and decrease in liver microvascular blood flow. Liver tissue presented increase in oxidative stress and inflammtion. At 20 weeks, there was a significantly increase in AGE content in the liver and serum of HFD-fed rats and an increase in RAGE gene expression in the liver. Conclusion The increase in liver AGE levels and microcirculatory disturbances could play a role in the pathogenesis of liver injury and are key components of NAFLD.	[Goulart da Silva Pereira, Evelyn Nunes; Silvares, Raquel Rangel; Ilaquita Flores, Edgar Eduardo; Rodrigues, Karine Lino; Tibirica, Eduardo; Daliry, Anissa] Oswaldo Cruz Inst, Lab Cardiovasc Invest, Rio De Janeiro, RJ, Brazil; [Ramos, Isalira Peroba] Univ Fed Rio de Janeiro, Lab Celular & Mol Cardiol, Rio De Janeiro, RJ, Brazil; [Ramos, Isalira Peroba] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, RJ, Brazil; [da Silva, Igor Josea; Machado, Marcelo Pelajo] Oswaldo Cruz Inst, Lab Pathol, Rio De Janeiro, RJ, Brazil; [Miranda, Rosiane Aparecida; Pazos-Moura, Carmen Cabanelas] Univ Fed Rio de Janeiro, Lab Mol Endocrinol, Rio De Janeiro, RJ, Brazil; [Goncalves-de-Albuquerque, Cassiano F.; de Castro Faria-Neto, Hugo Caire] Oswaldo Cruz Inst, Lab Immunopharmacol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Daliry, A (corresponding author), Oswaldo Cruz Inst, Lab Cardiovasc Invest, Rio De Janeiro, RJ, Brazil.	daliry@gmail.com	Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020; Machado, Marcelo Pelajo/I-5359-2012; Daliry, Anissa/F-6256-2014; Miranda, Rosiane Aparecida/C-1688-2019; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Nunes Goulart Pereira, Evelyn/AEA-8222-2022; PEREIRA, EVELYN NUNES GOULART DA SILVA/AAG-2711-2021	Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Miranda, Rosiane Aparecida/0000-0003-0978-7949; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; PEREIRA, EVELYN NUNES GOULART DA SILVA/0000-0001-5511-7036; Pelajo Machado, Marcelo/0000-0002-7295-7018; Peroba Rezende Ramos, Isalira/0000-0003-3577-0403				AEBI H, 1984, METHOD ENZYMOL, V105, P121; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Basta G, 2011, LIVER TRANSPLANT, V17, P633, DOI 10.1002/lt.22306; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Choi M, 2015, PHYSIOLOGY, V30, P40, DOI 10.1152/physiol.00019.2014; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Farrell GC, 2008, ANAT REC, V291, P684, DOI 10.1002/ar.20715; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Gaens KHJ, 2012, J HEPATOL, V56, P647, DOI 10.1016/j.jhep.2011.07.028; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; HIJIOKA T, 1991, BIOCHEM PHARMACOL, V41, P1551, DOI 10.1016/0006-2952(91)90153-V; Horiuchi S, 2002, J HEPATOL, V36, P123, DOI 10.1016/S0168-8278(01)00293-8; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1112, DOI 10.1111/j.1440-1746.2007.04943.x; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Leung C, 2016, WORLD J GASTROENTERO, V22, P8026, DOI 10.3748/wjg.v22.i35.8026; Leung C, 2014, J HEPATOL, V60, P832, DOI 10.1016/j.jhep.2013.11.033; Li CH, 2017, MICROVASC RES, V110, P14, DOI 10.1016/j.mvr.2016.11.004; Marques PE, 2015, J HEPATOL, V63, P733, DOI 10.1016/j.jhep.2015.05.027; McClain CJ, 2004, AM J PHYSIOL-GASTR L, V287, pG497, DOI 10.1152/ajpgi.00171.2004; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; MCCUSKEY RS, 1995, J GASTROEN HEPATOL, V10, pS18, DOI 10.1111/j.1440-1746.1995.tb01790.x; McDonald B, 2008, J EXP MED, V205, P915, DOI 10.1084/jem.20071765; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; NAKAYAMA H, 1993, DIABETES, V42, P345, DOI 10.2337/diabetes.42.2.345; Nascimento AR, 2013, OBESITY, V21, P2046, DOI 10.1002/oby.20358; Ouadda ABD, 2009, BIOSCIENCE REP, V29, P283, DOI 10.1042/BSR20080141; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035143; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rockey DC, 1998, GASTROENTEROLOGY, V114, P344, DOI 10.1016/S0016-5085(98)70487-1; Sayej WN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7867852; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebekova K, 2002, J HEPATOL, V36, P66, DOI 10.1016/S0168-8278(01)00232-X; Seifalian AM, 1998, LIVER TRANSPLANT SUR, V4, P71, DOI 10.1002/lt.500040110; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Song F, 2014, DIABETES, V63, P1948, DOI 10.2337/db13-1636; Song JS, 2016, TOXICOL APPL PHARM, V307, P138, DOI 10.1016/j.taap.2016.08.003; Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882; Sun CK, 2001, TRANSPLANTATION, V72, P1625, DOI 10.1097/00007890-200111270-00008; Svistounov D, 2004, J HEPATOL, V41, P1038, DOI 10.1016/j.jhep.2004.10.004; TERAMOTO K, 1993, TRANSPLANTATION, V56, P1076, DOI 10.1097/00007890-199311000-00005; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Wanless IR, 2004, SEMIN LIVER DIS, V24, P99; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Wu Y, 2015, MICROVASC RES, V97, P137, DOI 10.1016/j.mvr.2014.10.006; Yagmur E, 2006, CLIN BIOCHEM, V39, P39, DOI 10.1016/j.clinbiochem.2005.07.016; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4	55	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179654	10.1371/journal.pone.0179654	http://dx.doi.org/10.1371/journal.pone.0179654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628674	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100043
J	Wang, LX; Li, RZ; Xu, CH; Zhang, H; Ruan, YZ; Chen, MT; Wang, DM; Dirlikov, E; Du, X; Zhao, J; Yanlin, ZL; Wang, SF; Liu, YH; Li, L; Falzon, D; Sun, YN; Wang, Y; Schwartlander, B; Scano, F				Wang, Lixia; Li, Renzhong; Xu, Caihong; Zhang, Hui; Ruan, Yunzhou; Chen, Mingting; Wang, Dongmei; Dirlikov, Emilio; Du, Xin; Zhao, Jin; Zhao, Yanlin; Wang, ShengFen; Liu, Yuhong; Li, Liang; Falzon, Dennis; Sun, Yanni; Wang, Yu; Schwartlander, Bernhard; Scano, Fabio			The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership	PLOS ONE			English	Article							PREVALENCE; CARE	China has the world's second largest burden of multidrug-resistant tuberculosis (MDR-TB; resistance to at least isoniazid and rifampicin), with an estimated 57,000 cases (range, 48,000-67,000) among notified pulmonary TB patients in 2015. During October 1, 2006 June 30, 2014, China expanded MDR-TB care through a partnership with the Global Fund to Fight AIDS, Tuberculosis, and Malaria (Global Fund). We analyzed data on site expansion, patient enrolment, treatment outcomes, cost per patient, and overall programme expenditure. China expanded MDR-TB diagnostic and treatment services from 2 prefectures in 2006 to 92 prefectures, covering 921 of the country's 3,000 counties by June 2014. A total of 130,910 patients were tested for MDR-TB, resulting in 13,744 laboratory-confirmed cases, and 9,183 patients started on MDR-TB treatment. Treatment success was 48.4% (2011 cohort). The partnership between China and the Global Fund resulted in enormous gains. However, changes to health system TB delivery and financing coincided with the completion of the Global Fund Programme, and could potentially impact TB and MDR-TB control. Transition to full country financial ownership is proving difficult, with a decline in enrollment and insufficient financial coverage. Given needed improvement to the current treatment success rates, these factors jeopardise investments made for MDR-TB control and care. China now has a chance to cement its status in TB control by strengthening future financing and ensuring ongoing commitment to quality service delivery.	[Wang, Lixia; Li, Renzhong; Xu, Caihong; Zhang, Hui; Ruan, Yunzhou; Chen, Mingting; Wang, Dongmei; Du, Xin; Zhao, Jin; Zhao, Yanlin; Wang, ShengFen; Wang, Yu] Chinese Ctr Dis Prevent & Control, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Dirlikov, Emilio] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Liu, Yuhong; Li, Liang] Beijing Chest Hosp, Chinese Ctr Dis Prevent & Control, Clin Ctr TB, Beijing, Peoples R China; [Falzon, Dennis] WHO, Global TB Programme, Geneva, Switzerland; [Sun, Yanni; Schwartlander, Bernhard; Scano, Fabio] WHO, China Country Off, Beijing, Peoples R China; [Li, Renzhong; Xu, Caihong; Zhang, Hui; Ruan, Yunzhou; Chen, Mingting; Wang, Dongmei] Chinese Ctr Dis Prevent & Control, Beijing, Peoples R China; [Schwartlander, Bernhard; Scano, Fabio] WHO, 401 Dongwai Diplomat Off Bldg, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; McGill University; Capital Medical University; Chinese Center for Disease Control & Prevention; World Health Organization; World Health Organization; Chinese Center for Disease Control & Prevention; World Health Organization	Wang, Y (corresponding author), Chinese Ctr Dis Prevent & Control, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	wangyu@chinacdc.cn		Dirlikov, Emilio/0000-0003-4631-2643	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; [Anonymous], 2009, GGPLOT2 ELEGANT GRAP; Du J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111945; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Li RZ, 2015, LANCET GLOB HEALTH, V3, pE217, DOI 10.1016/S2214-109X(15)70021-5; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; MOH of the PRC, 2011, 5 NAT SURV EP TUB 20; Organization WH, 2016, GLOBAL TUBERCULOSIS; *R PROJ, 2013, R LANG ENV STAT COMP; Wan LY, 2007, B WORLD HEALTH ORGAN, V85, P401, DOI 10.2471/BLT.06.036376; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wei XL, 2009, INT J TUBERC LUNG D, V13, P514; Wei XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090596; WHO, 2009, WHOHTMSTB2009420; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2006, WHOHTM2006361; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789	20	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0177536	10.1371/journal.pone.0177536	http://dx.doi.org/10.1371/journal.pone.0177536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628669	Green Published, Green Submitted, gold			2022-12-26	WOS:000404043100002
J	Blicharski, T; Tomaszewska, E; Dobrowolski, P; Hulas-Stasiak, M; Muszynski, S				Blicharski, Tomasz; Tomaszewska, Ewa; Dobrowolski, Piotr; Hulas-Stasiak, Monika; Muszynski, Siemowit			A metabolite of leucine (beta-hydroxy-beta-methylbutyrate) given to sows during pregnancy alters bone development of their newborn offspring by hormonal modulation	PLOS ONE			English	Article							SCANNING CALORIMETRIC EXAMINATION; DIETARY SUPPLEMENTATION; GROWTH-PLATE; ALPHA-KETOISOCAPROATE; STRUCTURAL-PROPERTIES; HMB SUPPLEMENTATION; ARTICULAR-CARTILAGE; 2-OXOGLUTARIC ACID; HYALINE CARTILAGE; CANCELLOUS BONE	The effects of dietary beta-hydroxy-beta-methylbutyrate (HMB) supplementation during gestation on bone, growth plate, and articular cartilage in newborns were determined. Thermal analysis of articular cartilage was performed to examine the structural changes in collagen. At day 70 of gestation, a total of 12 sows (Large White Polish breed, at the second parity) were randomly assigned to two groups, with each group receiving either a basal diet or the same diet supplemented with 0.2 g/day HMB until the 90 th day. Maternal HMB supplementation enhanced body weight, bone length, and diameter in males. It also improved geometric and mechanical properties contributing to increased bone morphology and endurance. In turn, alteration of the length was only observed in females. The positive effects were mediated by increased serum concentrations of insulin-like growth factor-1 and leptin. HMB-treatment enhanced the concentration of FSH, LH, estradiol, and testosterone. Serum TAP was enhanced by the HMB-treatment by 34% in females and 138% in males. Beneficial effects of the HMB-treatment on trabecular bone and content of proteoglycans in articular cartilage were shown. The HMB-treatment significantly changed the collagen structure in cartilages, especially in the females, which was demonstrated by the PSR analysis. Differences between the HMB-supplemented and the control females in the calorimetric peak temperatures were presumably related to different collagen fibril density in the articular cartilage structure. In summary, maternal HMB supplementation in the mid-gestation period significantly improved general growth and mechanical endurance of long bones by the influence on the somatotropic and pituitary-gonadal axes in the offspring.	[Blicharski, Tomasz] Med Univ Lublin, Chair & Dept Rehabil & Orthopaed, Lublin, Poland; [Tomaszewska, Ewa] Univ Life Sci Lublin, Dept Anim Physiol, Fac Vet Med, Lublin, Poland; [Dobrowolski, Piotr; Hulas-Stasiak, Monika] Marie Curie Sklodowska Univ, Dept Comparat Anat & Anthropol, Lublin, Poland; [Muszynski, Siemowit] Univ Life Sci Lublin, Fac Prod Engn, Dept Phys, Lublin, Poland	Medical University of Lublin; University of Life Sciences in Lublin; Maria Curie-Sklodowska University; University of Life Sciences in Lublin	Blicharski, T (corresponding author), Med Univ Lublin, Chair & Dept Rehabil & Orthopaed, Lublin, Poland.; Tomaszewska, E (corresponding author), Univ Life Sci Lublin, Dept Anim Physiol, Fac Vet Med, Lublin, Poland.	blicharski@vp.pl; ewaRST@interia.pl	Dobrowolski, Piotr Jerzy/R-7917-2019; Tomaszewska, Ewa/U-5490-2018; Muszyński, Siemowit/U-4945-2018	Dobrowolski, Piotr Jerzy/0000-0001-5873-9666; Tomaszewska, Ewa/0000-0002-7574-2653; Muszyński, Siemowit/0000-0002-4118-6302; Hulas-Stasiak, Monika/0000-0002-5039-009X; Blicharski, Tomasz/0000-0001-9747-8817	Statutory Research of Chair and Department of Rehabilitation and Orthopaedics of Medical University in Lublin [DS 338/16]; Statutory Research of Department of Animal Physiology University of Life Sciences in Lublin [WKF/DS/5]; Statutory Research of Department of Comparative Anatomy and Anthropology of Maria Curie-Skfodowska University [BS-01-1200-0000]	Statutory Research of Chair and Department of Rehabilitation and Orthopaedics of Medical University in Lublin; Statutory Research of Department of Animal Physiology University of Life Sciences in Lublin; Statutory Research of Department of Comparative Anatomy and Anthropology of Maria Curie-Skfodowska University	This work was partly financed by: 1) Statutory Research of Chair and Department of Rehabilitation and Orthopaedics of Medical University in Lublin No. DS 338/16; 2) Statutory Research of Department of Animal Physiology University of Life Sciences in Lublin No. WKF/DS/5; and 3) Statutory Research of Department of Comparative Anatomy and Anthropology of Maria Curie-Skfodowska University No. BS-01-1200-0000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medical University in Lublin: www.umlub.pI/en/. University of Life Sciences in Lublin: www.up.lublin.pl/english/. Maria Curie-Skfodowska University: www.umcs.pli en/.	Bertram CE, 2002, REPRODUCTION, V124, P459, DOI 10.1530/rep.0.1240459; CAMPLEJOHN KL, 1988, HISTOCHEMISTRY, V89, P185, DOI 10.1007/BF00489922; Christou H, 2001, J CLIN ENDOCR METAB, V86, P935, DOI 10.1210/jc.86.2.935; Dobrowolski P, 2016, EXP BIOL MED, V241, P14, DOI 10.1177/1535370215595466; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; FERRETTI JL, 1993, BONE, V14, P265, DOI 10.1016/8756-3282(93)90150-9; Giannini S, 2008, INT ORTHOP, V32, P145, DOI 10.1007/s00264-006-0297-2; Holemans K, 1998, EUR J OBSTET GYN R B, V81, P149, DOI 10.1016/S0301-2115(98)00180-8; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S, DOI 10.1093/ajcn/71.5.1249s; KIJOWSKI J, 1993, INT J FOOD SCI TECH, V28, P587; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Lingas R, 1999, BRAIN RES, V846, P236, DOI 10.1016/S0006-8993(99)02058-2; McArdle HJ, 2006, PLACENTA, V27, pS56, DOI 10.1016/j.placenta.2006.01.014; Molfino A, 2013, AMINO ACIDS, V45, P1273, DOI 10.1007/s00726-013-1592-z; Muszynski S., 2016, Electronic Journal of Polish Agricultural Universities, V19; Muszynski S, 2017, POULTRY SCI, V96, P491, DOI 10.3382/ps/pew301; Nissen S, 1996, J APPL PHYSIOL, V81, P2095, DOI 10.1152/jappl.1996.81.5.2095; Nissen S, 2000, J NUTR, V130, P1937, DOI 10.1093/jn/130.8.1937; Nissen SL, 1997, J NUTR BIOCHEM, V8, P300, DOI 10.1016/S0955-2863(97)00048-X; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Regmi P, 2016, POULTRY SCI, V95, P198, DOI 10.3382/ps/pev209; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; SABOURIN PJ, 1983, METABOLISM, V32, P160, DOI 10.1016/0026-0495(83)90223-8; Sayer AA, 2005, EARLY HUM DEV, V81, P735, DOI 10.1016/j.earlhumdev.2005.07.003; Sliwa E, 2005, B VET I PULAWY, V49, P117; Sliwa E, 2007, J PRECLINICAL CLIN R, V1, P112; Smith N.H., 2006, REV GYNAECOL PERINAT, V6, P211, DOI DOI 10.1016/J.RIGAPP.2006.03.002; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Suvara SK., 2013, BANCROFTS THEORY PRA, V7th ed; Swietlicka I, 2016, ARCH ORAL BIOL, V70, P24, DOI 10.1016/j.archoralbio.2016.06.001; Szabo I, 2006, THERMOCHIM ACTA, V445, P179, DOI 10.1016/j.tca.2005.10.011; Szczesniak KA, 2015, J ANIM PHYSIOL AN N, V99, P405, DOI 10.1111/jpn.12234; Tatara MR, 2007, BONE, V40, P1615, DOI 10.1016/j.bone.2007.02.018; Than P, 2003, THERMOCHIM ACTA, V404, P149, DOI 10.1016/S0040-6031(03)00146-1; Than P, 2000, THERMOCHIM ACTA, V346, P147, DOI 10.1016/S0040-6031(99)00392-5; Tomaszewska E, 2014, J PHYSIOL PHARMACOL, V65, P107; Tomaszewska E, 2013, J ANIM PHYSIOL AN N, V97, P785, DOI 10.1111/j.1439-0396.2012.01319.x; Tomaszewska E, 2012, J PHYSIOL PHARMACOL, V63, P547; Tomaszewska E, 2017, J ANIM PHYS IN PRESS; Tomaszewska E, 2017, J TRACE ELEM MED BIO, V42, P103, DOI 10.1016/j.jtemb.2017.05.002; Tomaszewska E, 2017, BIOL TRACE ELEM RES, V178, P54, DOI 10.1007/s12011-016-0894-x; Tomaszewska E, 2016, J VET MED SCI, V78, P563, DOI 10.1292/jvms.15-0385; Tomaszewska E, 2015, B VET I PULAWY, V59, P563, DOI 10.1515/bvip-2015-0084; Tomaszewska E, 2015, CONNECT TISSUE RES, V56, P483, DOI 10.3109/03008207.2015.1069822; Tomaszewska E, 2012, B VET I PULAWY, V56, P247, DOI 10.2478/v10213-012-0044-y; Tomaszewska E, 2012, LIVEST SCI, V146, P175, DOI 10.1016/j.livsci.2012.03.008; VANKOEVERING M, 1992, AM J PHYSIOL, V262, pE27, DOI 10.1152/ajpendo.1992.262.1.E27; Wan HF, 2016, REPROD DOMEST ANIM, V51, P135, DOI 10.1111/rda.12657; Wan HF, 2016, BRIT J NUTR, V115, P1360, DOI 10.1017/S0007114516000465; Wiegand N, 2013, THERMOCHIM ACTA, V568, P171, DOI 10.1016/j.tca.2013.06.018; Wilson JM, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-18; Zanchi NE, 2011, AMINO ACIDS, V40, P1015, DOI 10.1007/s00726-010-0678-0	53	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179693	10.1371/journal.pone.0179693	http://dx.doi.org/10.1371/journal.pone.0179693			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617846	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600056
J	Miura, T; Minamisawa, M; Ueki, Y; Abe, N; Nishimura, H; Hashizume, N; Mochidome, T; Harada, M; Oguchi, Y; Yoshie, K; Shoin, W; Saigusa, T; Ebisawa, S; Motoki, H; Koyama, J; Ikeda, U; Kuwahara, K				Miura, Takashi; Minamisawa, Masatoshi; Ueki, Yasushi; Abe, Naoyuki; Nishimura, Hitoshi; Hashizume, Naoto; Mochidome, Tomoaki; Harada, Mikiko; Oguchi, Yasutaka; Yoshie, Koji; Shoin, Wataru; Saigusa, Tatsuya; Ebisawa, Soichiro; Motoki, Hirohiko; Koyama, Jun; Ikeda, Uichi; Kuwahara, Koichiro			Impressive predictive value of ankle-brachial index for very long-term outcomes in patients with cardiovascular disease: IMPACT-ABI study	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ATHEROSCLEROSIS RISK; MORTALITY; ASSOCIATION; HEMODIALYSIS; COMMUNITIES; MANAGEMENT; STROKE	Background The ankle-brachial index (ABI) is a marker of generalized atherosclerosis and is predictive of future cardiovascular events. However, few studies have assessed its relation to long-term future cardiovascular events, especially in patients with borderline ABI. We therefore evaluated the relationship between long-term future cardiovascular events and ABI. Methods In the IMPACT-ABI study, a single-center, retrospective cohort study, we enrolled 3131 consecutive patients (67 +/- 13 years; 82% male) hospitalized for cardiovascular disease and measured ABI between January 2005 and December 2012. After excluding patients with an ABI > 1.4, the remaining 3056 patients were categorized as having low ABI (<= 0.9), borderline ABI (0.91-0.99), or normal ABI (1.00-1.40). The primary endpoint was MACE (cardiovascular death, myocardial infarction [MI] and stroke). The secondary endpoints were cardiovascular death, MI, stroke, admission due to heart failure, and major bleeding. Results During a 4.8-year mean follow-up period, the incidences of MACE (low vs. borderline vs. normal: 32.9% vs. 25.0% vs. 14.6%, P<0.0001) and cardiovascular death (26.2% vs. 18.7% vs. 8.9%, P<0.0001) differed significantly across ABIs. The incidences of stroke (9.1% vs. 8.6% vs. 4.8%, P<0.0001) and heart failure (25.7% vs. 20.8% vs. 8.9%, P<0.0001) were significantly higher in the low and borderline ABI groups than in the normal ABI group. But the incidences of MI and major bleeding were similar in the borderline and normal ABI groups. The hazard ratios for MACE adjusted for traditional atherosclerosis risk factors were significantly higher in patients with low and borderline ABI than those with normal ABI (HR, 1.93; 95%CI: 1.44-2.59, P < 0.0001, HR, 1.54; 95% CI: 1.03-2.29, P = 0.035). Conclusions The incidence of long-term adverse events was markedly higher among patients with low or borderline ABI than among those with normal ABI. This suggests that more attention should be paid to patients with borderline ABIs, especially with regard to cardiovascular death, stroke, and heart failure.	[Miura, Takashi; Minamisawa, Masatoshi; Ueki, Yasushi; Abe, Naoyuki; Nishimura, Hitoshi; Hashizume, Naoto; Mochidome, Tomoaki; Harada, Mikiko; Oguchi, Yasutaka; Yoshie, Koji; Shoin, Wataru; Saigusa, Tatsuya; Ebisawa, Soichiro; Motoki, Hirohiko; Koyama, Jun; Ikeda, Uichi; Kuwahara, Koichiro] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan	Shinshu University	Miura, T (corresponding author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan.	miuramen10miuramen@yahoo.co.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170	Grants-in-Aid for Scientific Research [16K15442] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aisu H, 2016, HYPERTENS RES; Alahdab F, 2015, J VASC SURG, V61, p42S, DOI 10.1016/j.jvs.2014.12.008; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chirakarnjanakorn S, 2017, INT J CARDIOL, V232, P12, DOI 10.1016/j.ijcard.2017.01.015; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Greenland P, 2000, CIRCULATION, V101, P723; Gupta DK, 2014, JACC-HEART FAIL, V2, P447, DOI 10.1016/j.jchf.2014.05.008; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Koene RJ, 2014, J CARD FAIL, V20, P800, DOI 10.1016/j.cardfail.2014.08.010; Kojima I, 2014, J ATHEROSCLER THROMB, V21, P966, DOI 10.5551/jat.22608; McDermott Mary McGrae, 2006, Cleve Clin J Med, V73 Suppl 4, pS2; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Natsuaki C, 2014, ATHEROSCLEROSIS, V234, P360, DOI 10.1016/j.atherosclerosis.2014.03.018; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Ovbiagele B, 2009, J NEUROL SCI, V276, P14, DOI 10.1016/j.jns.2008.08.016; Rac-Albu Marius, 2014, Maedica (Bucur), V9, P295; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Suominen V, 2010, EUR J VASC ENDOVASC, V39, P316, DOI 10.1016/j.ejvs.2009.12.003; Tanaka S, 2016, ATHEROSCLEROSIS, V250, P69, DOI 10.1016/j.atherosclerosis.2016.05.014; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9	23	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0177609	10.1371/journal.pone.0177609	http://dx.doi.org/10.1371/journal.pone.0177609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617815	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600002
J	Choi, BH; Young, HS; Quan, YH; Rho, J; Eo, JS; Han, KN; Choi, YH; Koo, KH				Choi, Byeong Hyeon; Young, Hwan Seok; Quan, Yu Hua; Rho, Jiyun; Eo, Jae Seon; Han, Kook Nam; Choi, Young Ho; Koo, Kim Hyun			Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit	PLOS ONE			English	Article							COOLED-TIP-ELECTRODE; RADIOFREQUENCY ABLATION; PULMONARY NODULE; LOCALIZATION; RESECTION; CANCER; INTRAPULMONARY; ERADICATION; PROPAGATION	Preclinical studies of lung cancer require suitable large-animal models to allow evaluation and development of surgical and interventional techniques. We assessed the feasibility and safety of a novel rabbit lung cancer model of solitary tumors, in which real-time computed tomography fluoroscopy is used to guide inoculation of VX2 carcinoma single-cell suspensions. Thirty-eight rabbits were divided into four groups according to the volume of the VX2 tissue or cell suspension, the volume of lipiodol, the volume of Matrigel, and the injection needle size. The mixtures were percutaneously injected into rabbit lungs under real-time computed tomography fluoroscopy guidance. Two weeks later, VX2 lung carcinomas were confirmed via positron emission tomography/computed tomography, necropsy, and histology. Real-time computed tomography fluoroscopy allowed the precise inoculation of the tumor cell suspensions containing lipiodol, while the use of Matrigel and a small needle prevented leakage of the suspensions into the lung parenchyma. Solitary lung tumors were successfully established in rabbits (n = 22) inoculated with single-cell suspensions (150 mu L), lipiodol (150 mu L), and Matrigel (150 mu L) using a 26-gauge needle. This combination was determined to be optimal. Pneumothorax was observed in only two of the 38 rabbits (5.3%), both of which survived to the end of the study without any intervention. Real-time computed tomography fluoroscopy-guided inoculation of VX2 single-cell suspensions with lipiodol and Matrigel using a small needle is an easy and safe method to establish solitary lung tumors in rabbits.	[Choi, Byeong Hyeon; Quan, Yu Hua; Rho, Jiyun; Koo, Kim Hyun] Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Choi, Byeong Hyeon; Quan, Yu Hua; Rho, Jiyun; Han, Kook Nam; Choi, Young Ho; Koo, Kim Hyun] Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea; [Young, Hwan Seok] Korea Univ, Guro Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Eo, Jae Seon] Korea Univ, Guro Hosp, Dept Nucl Med, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Koo, KH (corresponding author), Korea Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea.; Koo, KH (corresponding author), Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.	kimhyunkoo@korea.ac.kr	Han, Kook Nam/GSJ-1109-2022; Han, Kook Nam/D-6036-2012; Han, Kooknam/AAB-6677-2020	Han, Kook Nam/0000-0002-1508-0125; Han, Kooknam/0000-0002-1508-0125; Kim, Hyun Koo/0000-0001-7604-4729; Eo, Jae Seon/0000-0003-3273-5661; Jeon, Ok Hwa/0000-0002-6620-1388	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121074]; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology [NFR-2015R1A2A2A04005760]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology(National Research Foundation of Korea)	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No: A121074), a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (NFR-2015R1A2A2A04005760). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anayama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067355; BREM SS, 1990, AM J PATHOL, V137, P1121; Chen YR, 2007, J FORMOS MED ASSOC, V106, P911, DOI 10.1016/S0929-6646(08)60061-3; Doo KW, 2015, ANN SURG ONCOL, V22, P331, DOI 10.1245/s10434-014-3884-2; Goldberg SN, 1996, ACAD RADIOL, V3, P929; Huang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085326; Kang DY, 2011, EUR RESPIR J, V37, P13, DOI 10.1183/09031936.00021410; Kim HK, 2008, ANN THORAC SURG, V86, P1098, DOI 10.1016/j.athoracsur.2008.06.021; Kim HK, 2016, EUR J CARDIO-THORAC, V49, P1497, DOI 10.1093/ejcts/ezv367; Ko YH, 2001, CANCER LETT, V173, P83, DOI 10.1016/S0304-3835(01)00667-X; Lee JM, 2003, INVEST RADIOL, V38, P129; Mayo JR, 2009, RADIOLOGY, V250, P576, DOI 10.1148/radiol.2502080442; MCLEMORE TL, 1988, CANCER RES, V48, P2880; MCLEMORE TL, 1987, CANCER RES, V47, P5132; Miao Y, 2001, J SURG RES, V99, P265, DOI 10.1006/jsre.2001.6208; Miao Y, 2001, ANN SURG ONCOL, V8, P651, DOI 10.1245/aso.2001.8.8.651; Ng CSH, 2016, THORAC CARDIOV SURG, V64, P348, DOI 10.1055/s-0034-1396789; Nomori H, 2002, ANN THORAC SURG, V74, P170, DOI 10.1016/S0003-4975(02)03615-9; Oh Y, 2015, J SURG RES, V199, P287, DOI 10.1016/j.jss.2015.05.009; Okuma T, 2006, J NUCL MED, V47, P1351; Okusanya OT, 2015, J THORAC CARDIOV SUR, V150, P28, DOI 10.1016/j.jtcvs.2015.05.014; Parekh K, 2001, ANN SURG ONCOL, V8, P175, DOI 10.1007/s10434-001-0175-5; Rami-Porta R, 2015, J THORAC ONCOL, V10, P990, DOI 10.1097/JTO.0000000000000559; Shomura Yuzo, 2003, Jpn J Thorac Cardiovasc Surg, V51, P337, DOI 10.1007/BF02719464; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sugi K, 2003, CHEST, V124, P155, DOI 10.1378/chest.124.1.155	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179220	10.1371/journal.pone.0179220	http://dx.doi.org/10.1371/journal.pone.0179220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609443	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700025
J	Cui, HH; Bansal, V; Grunert, M; Malecova, B; Dall'Agnese, A; Latella, L; Gatto, S; Ryan, T; Schulz, K; Chen, W; Dorn, C; Puri, PL; Sperling, SR				Cui, Huanhuan; Bansal, Vikas; Grunert, Marcel; Malecova, Barbora; Dall'Agnese, Alessandra; Latella, Lucia; Gatto, Sole; Ryan, Tammy; Schulz, Kerstin; Chen, Wei; Dorn, Cornelia; Puri, Pier Lorenzo; Sperling, Silke R.			Muscle-relevant genes marked by stable H3K4me2/3 profiles and enriched MyoD binding during myogenic differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE; HISTONE MODIFICATIONS; CELL-DIFFERENTIATION; H3K4 METHYLATION; EXPRESSION; TRANSCRIPTION; GENOME; CHROMATIN; ACTIVATION; LINEAGE	Post-translational modifications of histones play a key role in the regulation of gene expression during development and differentiation. Numerous studies have shown the dynamics of combinatorial regulation by transcription factors and histone modifications, in the sense that different combinations lead to distinct expression outcomes. Here, we investigated gene regulation by stable enrichment patterns of histone marks H3K4me2 and H3K4me3 in combination with the chromatin binding of the muscle tissue-specific transcription factor MyoD during myogenic differentiation of C2C12 cells. Using k-means clustering, we found that specific combinations of H3K4me2/3 profiles over and towards the gene body impact on gene expression and marks a subset of genes important for muscle development and differentiation. By further analysis, we found that the muscle key regulator MyoD was significantly enriched on this subset of genes and played a repressive role during myogenic differentiation. Among these genes, we identified the pluripotency gene Patz1, which is repressed during myogenic differentiation through direct binding of MyoD to promoter elements. These results point to the importance of integrating histone modifications and MyoD chromatin binding for coordinated gene activation and repression during myogenic differentiation.	[Cui, Huanhuan; Bansal, Vikas; Grunert, Marcel; Schulz, Kerstin; Dorn, Cornelia; Sperling, Silke R.] Charite Univ Med Berlin, Expt & Clin Res Ctr, Dept Cardiovasc Genet, Berlin, Germany; [Cui, Huanhuan; Sperling, Silke R.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Cui, Huanhuan; Sperling, Silke R.] BIH, Berlin, Germany; [Bansal, Vikas] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Malecova, Barbora; Dall'Agnese, Alessandra; Gatto, Sole; Ryan, Tammy; Puri, Pier Lorenzo] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA USA; [Latella, Lucia; Puri, Pier Lorenzo] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, Epigenet & Regenerat Med, Rome, Italy; [Chen, Wei] Berlin Inst Med Syst Biol, Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany; [Ryan, Tammy] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Chen, Wei] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Chen, Wei] Southern Univ Sci & Technol, SUSTech Acad Adv Interdisciplinary Studies, MediX Inst, Shenzhen, Guangdong, Peoples R China	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Berlin Institute of Health; Free University of Berlin; Sanford Burnham Prebys Medical Discovery Institute; IRCCS Santa Lucia; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Guelph; Southern University of Science & Technology; Southern University of Science & Technology	Sperling, SR (corresponding author), Charite Univ Med Berlin, Expt & Clin Res Ctr, Dept Cardiovasc Genet, Berlin, Germany.; Sperling, SR (corresponding author), Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany.; Sperling, SR (corresponding author), BIH, Berlin, Germany.	silke.sperling@charite.de	Latella, Lucia/K-7834-2016; chen, wei/AFV-4999-2022	LATELLA, LUCIA/0000-0003-1317-9233; Grunert, Marcel/0000-0002-2375-6404; Ryan, Tammy/0000-0002-0428-8932; Rickert-Sperling, Silke/0000-0002-7135-3298; Cui, Huanhuan/0000-0002-6190-6135; Bansal, Vikas/0000-0002-0944-7226	Berlin Institute of Health [BIH-CRG2-ConDi]; European Community's Seventh Framework [People-2011-ITN-289600]; China Scholarship Council (CSC); Marie Curie PhD fellowship; National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR056712, R01AR052779, P30 AR061303]; EPIGEN; Muscular Dystrophy Association (MDA); California Institute for Regenerative Medicine (CIRM) [TG2-01162]; American-Italian Cancer Foundation (AICF); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052779, R01AR056712] Funding Source: NIH RePORTER	Berlin Institute of Health; European Community's Seventh Framework(European Commission); China Scholarship Council (CSC)(China Scholarship Council); Marie Curie PhD fellowship(European Commission); National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); EPIGEN; Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American-Italian Cancer Foundation (AICF); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Berlin Institute of Health (BIH-CRG2-ConDi to SRS), the European Community's Seventh Framework ("CardioNet" People-2011-ITN-289600 to SRS), a PhD scholarship to HC from the China Scholarship Council (CSC) and a Marie Curie PhD fellowship to VB. PLP was supported by R01AR056712, R01AR052779 and P30 AR061303 from the National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), EPIGEN, Muscular Dystrophy Association (MDA). BM (TG2-01162) was supported by the California Institute for Regenerative Medicine (CIRM) training fellowships. SG was supported by the American-Italian Cancer Foundation (AICF).	Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; Buckingham M, 2014, DEV CELL, V28, P225, DOI 10.1016/j.devcel.2013.12.020; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chandran R, 2007, AM J PHYSIOL-CELL PH, V293, pC267, DOI 10.1152/ajpcell.00594.2006; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; Chu C, 1997, J BIOL CHEM, V272, P3145, DOI 10.1074/jbc.272.6.3145; Conerly ML, 2016, DEV CELL, V36, P375, DOI 10.1016/j.devcel.2016.01.021; Consalvi S, 2011, MOL MED, V17, P457, DOI 10.2119/molmed.2011.00049; Cui HH, 2016, NUCLEIC ACIDS RES, V44, P2538, DOI 10.1093/nar/gkv1244; Etzioni S, 2005, J BIOL CHEM, V280, P26805, DOI 10.1074/jbc.M500820200; Fischer JJ, 2008, GENOMICS, V91, P41, DOI 10.1016/j.ygeno.2007.08.010; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Himeda CL, 2010, MOL CELL BIOL, V30, P3430, DOI 10.1128/MCB.00302-10; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JC, 2005, MOL CELL BIOL, V25, P10111, DOI 10.1128/MCB.25.22.10111-10121.2005; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Neguembor MV, 2010, EPIGENOMICS-UK, V2, P271, DOI [10.2217/epi.10.8, 10.2217/EPI.10.8]; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Ow JR, 2014, STEM CELLS DEV, V23, P1062, DOI 10.1089/scd.2013.0430; Pekowska A, 2010, GENOME RES, V20, P1493, DOI 10.1101/gr.109389.110; Relaix F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003425; ROCKEY DC, 1993, J CLIN INVEST, V92, P1795, DOI 10.1172/JCI116769; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Sebastian S, 2009, P NATL ACAD SCI USA, V106, P4719, DOI 10.1073/pnas.0807136106; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; Takubo T, 2003, EUR J HISTOCHEM, V47, P345; Tao YZ, 2011, J CELL BIOL, V194, P551, DOI 10.1083/jcb.201010090; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TROUCHE D, 1993, NATURE, V363, P79, DOI 10.1038/363079a0; Valentino T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.500; Valentino T, 2013, J CELL PHYSIOL, V228, P646, DOI 10.1002/jcp.24174; Vinals F, 1997, J BIOL CHEM, V272, P12913, DOI 10.1074/jbc.272.20.12913; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S5; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	58	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179464	10.1371/journal.pone.0179464	http://dx.doi.org/10.1371/journal.pone.0179464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609469	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000403274700040
J	Freitas, SH; Doria, RGS; Bueno, RS; Rocha, WB; Filho, JRE; Moraes, JRE; Vidane, AS; Ambrosio, CE				Freitas, Silvio Henrique; Doria, Renata G. S.; Bueno, Rachel S.; Rocha, William B.; Filho, Jair R. E.; Moraes, Julieta R. E.; Vidane, Atanasio Serafin; Ambrosio, Carlos E.			Evaluation of potential changes in liver and lung tissue of rats in an ischemia-reperfusion injury model (modified pringle maneuver)	PLOS ONE			English	Article							HEPATIC ISCHEMIA; APOPTOSIS; NECROSIS; HEPATOCYTE; OCCLUSION; DAMAGE; CELL	In surgical procedures involving the liver, such as transplantation, resection, and trauma, a temporary occlusion of hepatic vessels may be required. This study was designed to analyze the lesions promoted by ischemia and reperfusion injury of the hepatic pedicle, in the liver and lung, using histopathological and immunohistochemical techniques. In total, 39 Wistar rats were divided into four groups: control group (C n = 3) and ischemia groups subjected to 10, 20, and 30 minutes of hepatic pedicle clamping (I10, n = 12; I20, n = 12; I30, n = 12). Each ischemia group was subdivided into four subgroups of reperfusion (R15, n = 3; R30, n = 3; R60, n = 3; R120, n = 3), after 15, 30, 60, and 120 minutes of reperfusion, respectively. Significant differences were observed in the liver parenchyma (P < 0.05) between the values of microvesicles and hydropic degeneration at different times of ischemia and reperfusion. However, the values of vascular congestion, necrosis, and pyknotic nuclei showed no significant differences (P > 0.05). In the lung parenchyma, a significant difference was observed (P < 0.05) between the values of alveolar septal wall thickening and inflammatory infiltration at different times of ischemia and reperfusion. However, there was no significant difference (P < 0.05) between the values of vascular congestion, bronchial epithelial degeneration, interstitial edema, and hemorrhage. The positive immunoreactivity of caspase-3 protein in the liver parenchyma (indication of ongoing apoptosis), showed no significant differences (P > 0.05) at different times of ischemia and reperfusion. In the pulmonary parenchyma, the immunoreactivity was not specific, and was not quantified. This study demonstrated that the longer the duration of ischemia and reperfusion, the greater are the morphological lesions found in the hepatic and pulmonary parenchyma.	[Freitas, Silvio Henrique] Univ Cuiaba, Fac Vet Med, Cuiaba, Mato Grosso, Brazil; [Freitas, Silvio Henrique; Doria, Renata G. S.; Ambrosio, Carlos E.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Bueno, Rachel S.] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Basic Sci, Pirassununga, SP, Brazil; [Rocha, William B.] Univ Cuiaba, Fac Vet Med, Cuiaba, Mato Grosso, Brazil; [Filho, Jair R. E.] Pontificia Univ Catolica Parana PUCPR, Sch Agr Sci & Vet Med, Grad Program Anim Sci, Sao Jose Dos Pinhais, Parana, Brazil; [Moraes, Julieta R. E.] Sao Paulo State Univ Julio de Mesquita Filho, Fac Agr & Vet Sci, Dept Pathol, Jaboticabal, SP, Brazil; [Vidane, Atanasio Serafin] Eduardo Mondlane Univ, Vet Fac, Maputo, Mozambique	Universidade de Cuiaba; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Cuiaba; Universidade Estadual Paulista; Eduardo Mondlane University	Ambrosio, CE (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	ceambrosio@usp.br	de Freitas, Silvio Henrique/O-6034-2016; MORAES, JULIETA/AAC-3365-2019; Ambrosio, Carlos Eduardo/F-3402-2010; Bueno, Rachel S/F-4483-2012; Dória, Renata/J-2948-2013; FILHO, JAIR R ENGRACIA/C-6546-2012; Moraes, Julieta R. E./L-8484-2017	MORAES, JULIETA/0000-0002-8384-8781; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Dória, Renata/0000-0002-4275-0358; FILHO, JAIR R ENGRACIA/0000-0002-2043-0652; Moraes, Julieta R. E./0000-0002-8384-8781; Santos Bueno Carvalho, Rachel/0000-0002-0555-1480	Foundation for Research Support of Mato Grosso State (FAPEMAT)	Foundation for Research Support of Mato Grosso State (FAPEMAT)	Foundation for Research Support of Mato Grosso State (FAPEMAT).	Anwar S, 2004, ARCH PATHOL LAB MED, V128, P649; ASAKAWA H, 1989, EUR SURG RES, V21, P42, DOI 10.1159/000129002; Ferraz AAB, 2011, ABCD-ARQ BRAS CIR DI, V24, P20, DOI 10.1590/S0102-67202011000100005; Brasileiro José Lacerda, 2007, J. vasc. bras., V6, P50, DOI 10.1590/S1677-54492007000100008; Camargo LM, 2003, ACTA CIR BRAS, V18, P509, DOI DOI 10.1590/S0102-86502003000600005>; Campos EBP, 2004, J VASC BRAS, V3, P357; Castro e Silva Jr O, 2002, ACTA CIR BRAS, V17, P96, DOI DOI 10.1590/S0102-86502002000900020; [常磊 Chang Lei], 2014, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V14, P743; Motta Vicente Paulo da, 2009, Rev. Col. Bras. Cir., V36, P223; Daemen MARC, 2002, TRANSPLANTATION, V73, P1693; Araújo Júnior Francisco Alves de, 2005, Acta Cir. Bras., V20, P93, DOI 10.1590/S0102-86502005000100013; Dello SAWG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030539; Eum HA, 2007, BIOCHEM BIOPH RES CO, V358, P500, DOI 10.1016/j.bbrc.2007.04.153; Fernandez L, 2003, TRANSPLANTATION, V76, P282, DOI 10.1097/01.TP.0000067529.82245.4E; Teixeira ARF, 2009, ACTA CIR BRAS, V24, P52, DOI 10.1590/S0102-86502009000100011; Francisco Neto Acacio, 2005, Acta Cir. Bras., V20, P134, DOI 10.1590/S0102-86502005000200006; FREDERIKS WM, 1982, EXP PATHOL-JENA, V22, P245, DOI 10.1016/S0232-1513(82)80015-7; Freitas SH, 2009, ARQ BRAS MED VET ZOO, V61, P1314, DOI 10.1590/S0102-09352009000600010; Freitas SH, 2009, CIENC ANIM BRAS, V10, P1218; Glantzounis GK, 2005, LIVER TRANSPLANT, V11, P1031, DOI 10.1002/lt.20504; GONCE ME, 1995, SHOCK, V3, P440; HARDY KJ, 1995, BRIT J SURG, V82, P833, DOI 10.1002/bjs.1800820636; Inouyea LA, 2014, UNICIENCIAS, p[18103, 26]; ISOZAKI H, 1995, EUR SURG RES, V27, P313, DOI 10.1159/000129415; Kohli V, 1999, TRANSPLANTATION, V67, P1099, DOI 10.1097/00007890-199904270-00003; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; MARUYAMA H, 1995, J SURG RES, V58, P290, DOI 10.1006/jsre.1995.1045; Massip-Salcedo M, 2007, LIVER INT, V27, P6, DOI 10.1111/j.1478-3231.2006.01390.x; Miranda Luiz Eduardo C., 2004, Acta Cir. Bras., V19, P1, DOI 10.1590/S0102-86502004000100001; Montero EFS, 2005, TRANSPLANT P, V37, P425, DOI 10.1016/j.transproceed.2004.12.194; Nomi T, 2015, ANN SURG ONCOL, V22, P852, DOI 10.1245/s10434-014-4088-5; Peralta C, 2002, TRANSPLANTATION, V73, P1203, DOI 10.1097/00007890-200204270-00004; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Quireze C, 2006, J INVEST SURG, V19, P229, DOI 10.1080/08941930600778206; Ramalho Fernando Silva, 2006, Acta Cir. Bras., V21, P48, DOI 10.1590/S0102-86502006000700012; Rocha AB., 2007, REV BRAS CANCEROL, V53, P335, DOI DOI 10.1590/S0102-311X2003000200031; Sebe AA, 2000, ACTA CIR BRAS, V15, P4; Silva FN, 2006, REV COL BRAS CIR, V33, P393; TOLEDOPEREYRA LH, 1994, J AM COLL SURGEONS, V179, P758	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178665	10.1371/journal.pone.0178665	http://dx.doi.org/10.1371/journal.pone.0178665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604841	Green Submitted, gold, Green Published			2022-12-26	WOS:000403088400016
J	Loebel, M; Eckey, M; Sotzny, F; Hahn, E; Bauer, S; Grabowski, P; Zerweck, J; Holenya, P; Hanitsch, LG; Wittke, K; Borchmann, P; Ruffer, JU; Hiepe, F; Ruprecht, K; Behrends, U; Meindl, C; Volk, HD; Reimer, U; Scheibenbogen, C				Loebel, Madlen; Eckey, Maren; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Zerweck, Johannes; Holenya, Pavlo; Hanitsch, Leif G.; Wittke, Kirsten; Borchmann, Peter; Rueffer, Jens-Ulrich; Hiepe, Falk; Ruprecht, Klemens; Behrends, Uta; Meindl, Carola; Volk, Hans-Dieter; Reimer, Ulf; Scheibenbogen, Carmen			Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CELLS IN-VIVO; EPITHELIAL-CELLS; ANTIBODY-RESPONSES; LYMPHOPROLIFERATIVE DISORDERS; NASOPHARYNGEAL CARCINOMA; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD	Background Epstein-Barr-Virus (EBV) plays an important role as trigger or cofactor for various autoimmune diseases. In a subset of patients with Chronic Fatigue Syndrome (CFS) disease starts with infectious mononucleosis as late primary EBV-infection, whereby altered levels of EBV-specific antibodies can be observed in another subset of patients. Methods We performed a comprehensive mapping of the IgG response against EBV comparing 50 healthy controls with 92 CFS patients using a microarray platform. Patients with multiple sclerosis (MS), systemic lupus erythematosus (SLE) and cancer-related fatigue served as controls. 3054 overlapping peptides were synthesised as 15-mers from 14 different EBV proteins. Array data was validated by ELISA for selected peptides. Prevalence of EBV sero-types was determined by qPCR from throat washing samples. Results EBV type 1 infections were found in patients and controls. EBV seroarray profiles between healthy controls and CFS were less divergent than that observed for MS or SLE. We found significantly enhanced IgG responses to several EBNA-6 peptides containing a repeat sequence in CFS patients compared to controls. EBNA-6 peptide IgG responses correlated well with EBNA-6 protein responses. The EBNA-6 repeat region showed sequence homologies to various human proteins. Conclusion Patients with CFS had a quite similar EBV IgG antibody response pattern as healthy controls. Enhanced IgG reactivity against an EBNA-6 repeat sequence and against EBNA-6 protein is found in CFS patients. Homologous sequences of various human proteins with this EBNA-6 repeat sequence might be potential targets for antigenic mimicry.	[Loebel, Madlen; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Hanitsch, Leif G.; Wittke, Kirsten; Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite Univ Med Berlin, Inst Med Immunol, Campus Virchow, Berlin, Germany; [Eckey, Maren; Zerweck, Johannes; Holenya, Pavlo; Reimer, Ulf] JPT Peptide Technol GmbH, Berlin, Germany; [Borchmann, Peter] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Borchmann, Peter] GHSG, Cologne, Germany; [Rueffer, Jens-Ulrich] German Fatigue Soc eV DFaG, Cologne, Germany; [Hiepe, Falk] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Ruprecht, Klemens] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Ruprecht, Klemens] Charite Univ Med Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Behrends, Uta; Meindl, Carola] TUM, Childrens Hosp Schwabing, Munich, Germany; [Behrends, Uta; Meindl, Carola] Helmholtz Ctr Munich HMGU, Dept Gene Vectors, Munich, Germany; [Behrends, Uta] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Volk, Hans-Dieter; Scheibenbogen, Carmen] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; German Center for Infection Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scheibenbogen, C (corresponding author), Charite Univ Med Berlin, Inst Med Immunol, Campus Virchow, Berlin, Germany.; Scheibenbogen, C (corresponding author), Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.	carmen.scheibenbogen@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Hanitsch, Leif G./0000-0002-8181-0093; Scheibenbogen, Carmen/0000-0002-8554-9638; Reimer, Ulf/0000-0002-3375-6889; Sotzny, Franziska/0000-0003-1593-8563; Hahn, Elisabeth/0000-0001-7168-1403; Hiepe, Falk/0000-0003-3584-5292	"Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union grant "Investition in Ihre Zukunft" [10158447]; Lost Voices Foundation e.V.; flex fund grant from German Center for Infection Research [07-905]; JPT Peptide Technologies GmbH	"Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union grant "Investition in Ihre Zukunft"; Lost Voices Foundation e.V.; flex fund grant from German Center for Infection Research; JPT Peptide Technologies GmbH	This work was supported by a grant 10158447 from the "Europaischen Fonds fur regionale Entwicklung (EFRE)" of the European Union grant "Investition in Ihre Zukunft". The funder provided support in the form of salaries for authors PH, EM, UR, JZ and ML, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The work was further supported by the Lost Voices Foundation e.V., and by a flex fund grant (07-905) from the German Center for Infection Research. The authors ME, JZ, PH and UR are employed by a commercial company, JPT Peptide Technologies GmbH, and received support in the form of salaries. JPT Peptide Technologies is not the funder of this study, but the recipient of the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almehdar HA, 2015, CURR PROTEIN PEPT SC, V16, P352, DOI 10.2174/1389203716666150316114956; Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Ascherio A, 2015, CURR TOP MICROBIOL, V390, P365, DOI 10.1007/978-3-319-22822-8_15; Babcock GJ, 1998, IMMUNITY, V9, P395, DOI 10.1016/S1074-7613(00)80622-6; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; Bansal AS, 2012, BRAIN BEHAV IMMUN, V26, P24, DOI 10.1016/j.bbi.2011.06.016; Blaschke S, 2000, J RHEUMATOL, V27, P866; BORNKAMM GW, 1980, J VIROL, V35, P603, DOI 10.1128/JVI.35.3.603-618.1980; Brenu EW, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-81; BUCHWALD D, 1987, JAMA-J AM MED ASSOC, V257, P2303, DOI 10.1001/jama.257.17.2303; Cameron B, 2010, J MED VIROL, V82, P1684, DOI 10.1002/jmv.21873; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Castellazzi M, 2010, MULT SCLER J, V16, P883, DOI 10.1177/1352458510368051; CELLO J, 1993, J CLIN MICROBIOL, V31, P911, DOI 10.1128/JCM.31.4.911-916.1993; Cheng WZ, 2012, FRONT BIOSCI-LANDMRK, V17, P1648, DOI 10.2741/4010; Christley Y, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0353-8; Cohen JI, 1999, CURR OPIN IMMUNOL, V11, P365, DOI 10.1016/S0952-7915(99)80062-4; Conacher M, 2005, J VIROL, V79, P11128, DOI 10.1128/JVI.79.17.11128-11134.2005; Csuka D, 2012, EUR J NEUROL, V19, P842, DOI 10.1111/j.1468-1331.2011.03636.x; Draborg AH, 2012, SCAND J RHEUMATOL, V41, P280, DOI 10.3109/03009742.2012.665944; DUBOIS RE, 1984, SOUTHERN MED J, V77, P1376, DOI 10.1097/00007611-198411000-00007; Esen BA, 2012, RHEUMATOL INT, V32, P79, DOI 10.1007/s00296-010-1573-4; Fachiroh J, 2004, J INFECT DIS, V190, P53, DOI 10.1086/421245; Fattal I, 2014, IMMUNOLOGY, V141, P276, DOI 10.1111/imm.12200; Fluge O, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.89376; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Gabibov AG, 2011, FASEB J, V25, P4211, DOI 10.1096/fj.11-190769; Garcia-Cosio M, 2008, HISTOL HISTOPATHOL, V23, P209, DOI 10.14670/HH-23.209; Gorzer I, 2006, VIRUS RES, V118, P105, DOI 10.1016/j.virusres.2005.11.020; GREENSPAN JS, 1985, NEW ENGL J MED, V313, P1564, DOI 10.1056/NEJM198512193132502; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; HELLINGER WC, 1988, JAMA-J AM MED ASSOC, V260, P971; HENLE W, 1987, P NATL ACAD SCI USA, V84, P570, DOI 10.1073/pnas.84.2.570; Herrmann K, 2002, J GEN VIROL, V83, P2995, DOI 10.1099/0022-1317-83-12-2995; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; Hudnall S., 2014, VIRUSES HUMAN CANC; Ibrahim HAH, 2010, EUR J HAEMATOL, V85, P227, DOI 10.1111/j.1600-0609.2010.01460.x; Jason LA, 2002, BIOL PSYCHOL, V59, P15, DOI 10.1016/S0301-0511(01)00120-X; Jason LA, 2000, J CLIN PSYCHOL, V56, P1497, DOI 10.1002/1097-4679(200012)56:12<1497::AID-2>3.0.CO;2-Z; JONES JF, 1988, ARCH INTERN MED, V148, P1957, DOI 10.1001/archinte.148.9.1957; Kang I, 2004, J IMMUNOL, V172, P1287, DOI 10.4049/jimmunol.172.2.1287; KAWAI K, 1992, INTERNAL MED, V31, P313, DOI 10.2169/internalmedicine.31.313; Klein G, 2010, BIOCHEM BIOPH RES CO, V396, P67, DOI 10.1016/j.bbrc.2010.02.146; KOMAROFF AL, 1987, HOSP PRACT, V22, P71; Larsen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002328; Lerner AM, 2007, IN VIVO, V21, P707; Lerner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047891; Lerner AM, 2004, IN VIVO, V18, P101; Loebel M, 2016, BRAIN BEHAV IMMUN, V52, P32, DOI 10.1016/j.bbi.2015.09.013; Loebel M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085387; Lucchesi W, 2008, J VIROL, V82, P7456, DOI 10.1128/JVI.00223-08; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; MILLER G, 1985, NEW ENGL J MED, V312, P750, DOI 10.1056/NEJM198503213121204; Montoya JG, 2013, J MED VIROL, V85, P2101, DOI 10.1002/jmv.23713; NILSSON K, 1971, INT J CANCER, V8, P443, DOI 10.1002/ijc.2910080312; Ostdal H, 2000, J AGR FOOD CHEM, V48, P3939, DOI 10.1021/jf991378n; Pasoto SG, 2013, RHEUMATOL INT, V33, P1149, DOI 10.1007/s00296-012-2504-3; Pender MP, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.25; Poole BD, 2008, J AUTOIMMUN, V31, P362, DOI 10.1016/j.jaut.2008.08.007; Rajnavolgyi E, 2000, INT IMMUNOL, V12, P281, DOI 10.1093/intimm/12.3.281; Rezk SA, 2007, HUM PATHOL, V38, P1293, DOI 10.1016/j.humpath.2007.05.020; Ruprecht K, 2014, JOURNAL OF NEUROIMMU; Sairenji T, 1995, INTERVIROLOGY, V38, P269, DOI 10.1159/000150450; SAMPLE J, 1990, J VIROL, V64, P4084, DOI 10.1128/JVI.64.9.4084-4092.1990; Scheibenbogen C, 2014, INTERNISTISCHE PRAXI, V54, P335; Shepherd C, 2002, BRIT MED J, V324, P914, DOI 10.1136/bmj.324.7342.914; SIXBEY JW, 1984, NEW ENGL J MED, V310, P1225, DOI 10.1056/NEJM198405103101905; STRAUS SE, 1988, NEW ENGL J MED, V319, P1692, DOI 10.1056/NEJM198812293192602; STRAUS SE, 1985, ANN INTERN MED, V102, P7, DOI 10.7326/0003-4819-102-1-7; Tanaka Yoshihide, 2012, Nihon Rinsho, V70, P880; THOMAS EL, 1978, INFECT IMMUN, V20, P456, DOI 10.1128/IAI.20.2.456-463.1978; Tsurumi T, 2005, REV MED VIROL, V15, P3, DOI 10.1002/rmv.441; Wallace HL, 1999, CLIN DIAGN LAB IMMUN, V6, P216, DOI 10.1128/CDLI.6.2.216-223.1999; Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992; WHELTON CL, 1992, J RHEUMATOL, V19, P939; Yamano E, 2016, SCI REP-UK, V6, DOI 10.1038/srep34990; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YIP TTC, 1994, CANCER, V74, P2414, DOI 10.1002/1097-0142(19941101)74:9<2414::AID-CNCR2820740905>3.0.CO;2-8; Zerweck J, 2016, METHODS MOL BIOL, V1352, P19, DOI 10.1007/978-1-4939-3037-1_2; Zivadinov R, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000190	84	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179124	10.1371/journal.pone.0179124	http://dx.doi.org/10.1371/journal.pone.0179124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604802	Green Submitted, gold, Green Published			2022-12-26	WOS:000403088400028
J	Aoki, Y; Kitazawa, K; Kobayashi, H; Senda, M; Arahata, Y; Homma, R; Watanabe, Y; Honda, A				Aoki, Yoshihiro; Kitazawa, Katsuhiko; Kobayashi, Hironobu; Senda, Masayoshi; Arahata, Yukie; Homma, Riu; Watanabe, Yudai; Honda, Akihito			Clinical features of children with nontyphoidal Salmonella bacteremia: A single institution survey in rural Japan	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; ANTIMICROBIAL RESISTANCE; GASTROENTERITIS; EPIDEMIOLOGY; INFECTIONS; SEROTYPE; AGE	Nontyphoidal Salmonella (NTS) can cause bacterial enterocolitis. Although some children with NTS infection develop bacteremia, its clinical manifestations have not been discussed adequately. Therefore, we examined children with NTS bacteremia. We retrospectively examined the medical records of 15 patients aged less than 15 years. Salmonella spp. were detected in the blood cultures of these patients between 1991 and 2014. We divided an additional sample group of 34 patients diagnosed with an NTS infection between 2005 and 2014, into 2 groups. Group bacteremia (B) included patients in whose blood cultures Salmonella spp. were detected, and group non-bacteremia (NB) included patients in whom Salmonella infection was not detected. We compared each group using Wilcoxon test and Fisher's exact test. The number of patients with fever, diarrhea, or abdominal pain was 15 (100%), 13 (87%), and 9 (60%), respectively, in the first sample of patients. However, vomiting and bloody stool were observed in only 5 patients (33%). More than 70% of patients exhibited a reduced white blood cell count, while C-reactive protein levels were variable in the patients. Salmonella spp. were detected via stool culture in 10 patients (67%). Diarrhea persisted for more than 4 days more frequently in group B than group NB (p = 0.004). The number of patients whose fever persisted for more than 4 days was significantly higher in group B than group NB (p = 0.030). Therefore, if NTS bacteremia is suspected, blood cultures should be collected and antibiotics should be initiated in cases with diarrhea or fever for more than 4 days. Furthermore, a negative stool culture result does not preclude the possibility of NTS bacteremia.	[Aoki, Yoshihiro; Kitazawa, Katsuhiko; Kobayashi, Hironobu; Senda, Masayoshi; Arahata, Yukie; Homma, Riu; Honda, Akihito] Asahi Gen Hosp, Dept Pediat, Chiba, Japan; [Watanabe, Yudai] Asahi Gen Hosp, Dept Clin Lab, Chiba, Japan		Aoki, Y (corresponding author), Asahi Gen Hosp, Dept Pediat, Chiba, Japan.	yaoki-hki@umin.ac.jp	Aoki, Yoshihiro/U-4541-2019	Aoki, Yoshihiro/0000-0003-2011-485X				[Anonymous], 2015, RED BOOK 2015 REPORT; Asmar BI, 2016, INFECT DIS-NOR, V48, P147, DOI 10.3109/23744235.2015.1094823; Bar-Meir M, 2005, CLIN MICROBIOL INFEC, V11, P651, DOI 10.1111/j.1469-0691.2005.01200.x; Bula-Rudas Fernando J, 2015, Adv Pediatr, V62, P29, DOI 10.1016/j.yapd.2015.04.005; CDC. gov, 2012 NARMS ANN HUM I; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Finlay B B, 1994, Curr Top Microbiol Immunol, V192, P163; FINLAY BB, 1988, BIOCHIMIE, V70, P1089, DOI 10.1016/0300-9084(88)90271-4; Haeusler GM, 2013, ADV EXP MED BIOL, V764, P13, DOI 10.1007/978-1-4614-4726-9_2; Hara-Kudo Y, 2013, FOOD ADDIT CONTAM A, V30, P1450, DOI 10.1080/19440049.2012.745097; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Huang IF, 2012, PEDIATR NEONATOL, V53, P193, DOI 10.1016/j.pedneo.2012.04.007; HYAMS JS, 1980, J PEDIATR-US, V96, P57, DOI 10.1016/S0022-3476(80)80325-8; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; MANDAL BK, 1988, BRIT MED J, V297, P1242, DOI 10.1136/bmj.297.6658.1242; MEADOW WL, 1985, J INFECT DIS, V152, P185, DOI 10.1093/infdis/152.1.185; Murphy D, 2015, ARCH DIS CHILD, V100, P364, DOI 10.1136/archdischild-2014-306134; Shimoni Z, 1999, CLIN INFECT DIS, V28, P822, DOI 10.1086/515186; Standards Unit, 2013, UK STAND MICR INV, VB37; Suez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058449; Taneja N, 2014, J MED MICROBIOL, V63, P66, DOI 10.1099/jmm.0.061416-0; Tasaka Keiji, 2015, Kansenshogaku Zasshi, V89, P727; TAYLOR DN, 1982, J INFECT DIS, V146, P322, DOI 10.1093/infdis/146.3.322	23	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0176990	10.1371/journal.pone.0176990	http://dx.doi.org/10.1371/journal.pone.0176990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28599007	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000002
J	Rahman, T; Liu, X; Hussain, S; Ahmed, S; Chen, GP; Yang, F; Chen, LL; Du, JB; Liu, WG; Yang, WY				Rahman, Tanzeelur; Liu, Xin; Hussain, Sajad; Ahmed, Shoaib; Chen, Guopeng; Yang, Feng; Chen, Lilian; Du, Junbo; Liu, Weiguo; Yang, Wenyu			Water use efficiency and evapotranspiration in maize-soybean relay strip intercrop systems as affected by planting geometries	PLOS ONE			English	Article							NORTHWESTERN CHINA; ACTIVE RADIATION; CROP COEFFICIENT; WINTER-WHEAT; ARID REGION; YIELD; GROWTH; IRRIGATION; NITROGEN; RATIO	Optimum planting geometries have been shown to increase crop yields in maize-soybean intercrop systems. However, little is known about whether changes in planting geometry improve the seasonal water use of maize and soybean intercrops. We conducted two different field experiments in 2013 and 2014 to investigate the effects of changes in planting geometry on water use efficiency (WUE) and evapotranspiration (ETc) of maize (Zea mays L.) and soybean [Glycine max (L.) Merr.] relay strip intercrop systems. Our results showed that the leaf area index of maize for both years where intercropping occurred was notably greater compared to sole maize, thus the soil water content (SWC), soil evaporation (E), and throughfall followed a decreasing trend in the following order: central row of maize strip (CRM) < adjacent row between maize and soybean strip (AR) < central row of soybean strip (CRS). When intercropped, the highest grain yield for maize and total yields were recorded for the 40: 120 cm and 40: 160 cm planting geometries using 160 cm and 200 cm bandwidth, respectively. By contrast, the highest grain yield of intercropped soybean was appeared for the 20: 140 cm and 20: 180 cm planting geometries. The largest land equivalent ratios were 1.62 for the 40: 120 cm planting geometry and 1.79 for the 40: 160 cm planting geometry, indicating that both intercropping strategies were advantageous. Changes in planting geometries did not show any significant effect on the ETc of the maize and soybean intercrops. WUEs in the different planting geometries of intercrop systems were lower compared to sole cropping. However, the highest group WUEs of 23.06 and 26.21 kg ha(-1) mm(-1) for the 40: 120 cm and 40: 160 cm planting geometries, respectively, were 39% and 23% higher than those for sole cropping. Moreover, the highest water equivalent ratio values of 1.66 and 1.76 also appeared for the 40: 120 cm and 40: 160 cm planting geometries. We therefore suggest that an optimum planting geometry of 40: 160 cm and bandwidth of 200 cm could be a viable planting pattern management method for attaining high group WUE in maize-soybean intercrop systems.	[Rahman, Tanzeelur; Liu, Xin; Hussain, Sajad; Ahmed, Shoaib; Chen, Guopeng; Yang, Feng; Du, Junbo; Liu, Weiguo; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Yang, Feng; Du, Junbo; Liu, Weiguo; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China; [Chen, Lilian] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.; Yang, WY (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China.	mssiyangwy@sicau.edu.cn	Hussain, Sajad/GZL-5573-2022; Hussain, Sajad/S-4261-2019	Hussain, Sajad/0000-0001-9100-360X	National Key Research and Development Program of China [2016YFD0300209, 2016YFD0300602]; National Nature Science Foundation [31571615]; Program on Industrial Technology System of National Soybean [CARS-04-PS19]	National Key Research and Development Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Program on Industrial Technology System of National Soybean	The research was supported by the National Key Research and Development Program of China (grant numbers 2016YFD0300209, 2016YFD0300602), the National Nature Science Foundation (grant number 31571615), and Program on Industrial Technology System of National Soybean (grant number CARS-04-PS19).	AGGARWAL GC, 1988, FIELD CROP RES, V18, P177, DOI 10.1016/0378-4290(88)90007-X; Brooker RW, 2015, NEW PHYTOL, V206, P107, DOI 10.1111/nph.13132; Chen SY, 2010, AGR WATER MANAGE, V97, P1126, DOI 10.1016/j.agwat.2009.09.005; Coll L, 2012, FIELD CROP RES, V134, P105, DOI 10.1016/j.fcr.2012.05.005; [崔亮 Cui Liang], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P1489; Deng XiaoYan, 2013, Acta Agronomica Sinica, V39, P1891, DOI 10.3724/SP.J.1006.2013.01891; Dong WanLin, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P127; Echarte L, 2011, FIELD CROP RES, V121, P423, DOI 10.1016/j.fcr.2011.01.011; Fereres E, 2007, J EXP BOT, V58, P147, DOI 10.1093/jxb/erl165; GAMO M, 1999, J ARID LAND STUD, V9, P17; Gao Y, 2010, AGRON J, V102, P1149, DOI 10.2134/agronj2009.0409; Gao Yang, 2009, Yingyong Shengtai Xuebao, V20, P307; Gao Y, 2009, FIELD CROP RES, V111, P65, DOI 10.1016/j.fcr.2008.10.007; Gao Y, 2014, FIELD CROP RES, V167, P19, DOI 10.1016/j.fcr.2014.07.003; GREMA AK, 1994, AGR WATER MANAGE, V26, P169, DOI 10.1016/0378-3774(94)90056-6; Guo Y. J., 2002, J GANSU AGR SCI TECH, V4, P34; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Kendy E, 2003, HYDROL PROCESS, V17, P2011, DOI 10.1002/hyp.1240; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Lithourgidis AS, 2011, AUST J CROP SCI, V5, P396; Lv Y, 2014, CROP SCI, V54, P914, DOI 10.2135/cropsci2013.06.0403; Martello M, 2015, WATER-SUI, V7, P2254, DOI 10.3390/w7052254; MEAD R, 1980, EXP AGR, V16, P217, DOI 10.1017/S0014479700010978; MORRIS RA, 1993, FIELD CROP RES, V34, P303, DOI 10.1016/0378-4290(93)90119-8; Ouda SA, 2010, AUST J BASIC APPL SC, V1, P578; Raji JA, 2007, AFR J BIOTECHNOL, V6, P1885; Ren YY, 2016, EUR J AGRON, V72, P70, DOI 10.1016/j.eja.2015.10.001; Riahinia S., 2008, Journal of Biological Sciences, V8, P954; Saren BK, 1999, INDIAN J AGR SCI, V69, P317; Seran T. H., 2010, Journal of Agronomy, V9, P135, DOI 10.3923/ja.2010.135.145; Soil Conservation Service, 1972, NAT ENG HDB; Tang L. S., 2005, J ARID ZONE RES, V22, P90; Thorsted MD, 2006, J APPL ECOL, V43, P237, DOI 10.1111/j.1365-2664.2006.01131.x; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Walker S, 2003, PHYS CHEM EARTH, V28, P919, DOI 10.1016/j.pce.2003.08.018; Wallace JS, 1999, AGR FOREST METEOROL, V94, P189, DOI 10.1016/S0168-1923(99)00009-X; Wang ZK, 2015, AGR WATER MANAGE, V161, P77, DOI 10.1016/j.agwat.2015.07.012; WOLFF XY, 1990, J AM SOC HORTIC SCI, V115, P175, DOI 10.21273/JASHS.115.1.175; Yang CH, 2011, FIELD CROP RES, V124, P426, DOI 10.1016/j.fcr.2011.07.013; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; [杨峰 Yang Feng], 2013, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V19, P781; Zhang Feng-yun, 2012, Yingyong Shengtai Xuebao, V23, P1400; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006; Zhang HP, 1998, PLANT SOIL, V201, P295, DOI 10.1023/A:1004328004860; ZHANG J, 1990, PLANT CELL ENVIRON, V13, P277, DOI 10.1111/j.1365-3040.1990.tb01312.x; ZHANG J, 1987, J EXP BOT, V38, P2015, DOI 10.1093/jxb/38.12.2015; Zhang L, 2007, FIELD CROP RES, V103, P178, DOI 10.1016/j.fcr.2007.06.002	49	35	36	8	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2017	12	6							e0178332	10.1371/journal.pone.0178332	http://dx.doi.org/10.1371/journal.pone.0178332			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX1NV	28598974	Green Published, Green Submitted, gold			2022-12-26	WOS:000402992000006
J	Sengupta, B; Sahihi, M; Dehkhodaei, M; Kelly, D; Arany, I				Sengupta, Bidisha; Sahihi, Mehdi; Dehkhodaei, Monireh; Kelly, Darrian; Arany, Istvan			Differential roles of 3-Hydroxyflavone and 7-Hydroxyflavone against nicotine-induced oxidative stress in rat renal proximal tubule cells	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; PARTICLE MESH EWALD; BETA-LACTOGLOBULIN; TRANSCRIPTIONAL ACTIVATION; FLAVONOID ANTIOXIDANTS; SUPEROXIDE-DISMUTASE; SIGNALING PATHWAY; BINDING; INJURY; SMOKING	Plant flavonoids are well known as antioxidants against oxidative stress induced by exposure to external pollutants. Nicotine (NIC) is one of those agents which increases renal oxidative stress, an important factor in the pathogenesis of renal epithelial injury in smokers. Although several studies had been conducted on flavonoids and oxidative stress, the mechanism of the protective pathways are not fully understood. Here, we present studies on antioxidant properties of two mono-hydroxyflavone isomers, 3-hydroxyflanove (3HF)- and 7-hydroxyflavone (7HF), against nicotine-associated oxidative stress and injury in cultured renal proximal tubule cells and correlate their antioxidant properties with their chemical structure. Our data clearly demonstrates, for the first time, that while both 3HF and 7HF protect renal cells from NIC-associated cytotoxicity, the mechanism of their action is different: 3HF elicits protective activity via the PKA/CREB/MnSOD pathway while 7HF does so via the ERK/Nrf2/HO-1 pathway. Molecular docking and dynamics simulations with two major signaling pathway proteins showed significant differences in the binding energies of 3HF (-5.67 and -7.39 kcal.mol(-1)) compared to 7HF (-5.41 and -8.55 kcal.mol(-1)) in the matrices of CREB and Keap1-Nrf2 proteins respectively, which corroborate with the observed differences in their protective properties in the renal cells. The implications of this novel explorative study is likely to promote the understanding of the mechanisms of the antioxidative functions of different flavones.	[Sengupta, Bidisha; Kelly, Darrian] Tougaloo Coll, Dept Chem, Tougaloo, MS 39174 USA; [Sahihi, Mehdi; Dehkhodaei, Monireh] Univ Isfahan, Dept Chem, Esfahan, Iran; [Arany, Istvan] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA	Tougaloo College; University of Isfahan; University of Mississippi; University of Mississippi Medical Center	Sengupta, B (corresponding author), Tougaloo Coll, Dept Chem, Tougaloo, MS 39174 USA.	bsengupta@tougaloo.edu	Sahihi, Mehdi/AAY-1571-2020	Sahihi, Mehdi/0000-0003-2923-1833; Sengupta, Bidisha/0000-0003-4624-9998	Mississippi I NBRE - Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103476]; NSF MS-EPSCoR at Tougaloo College [EPS-0903787]; Department of Pediatrics; Bower Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Mississippi I NBRE - Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NSF MS-EPSCoR at Tougaloo College; Department of Pediatrics; Bower Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mississippi I NBRE, funded by an Institutional Development Award (I DeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant No. P20GM103476. BS also acknowledges financial and research support from NSF MS-EPSCoR Grant No. EPS-0903787 at Tougaloo College. This work was also supported by a grant from the Department of Pediatrics and the Bower Foundation (to IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Mississippi INBRE, funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under Grant No. P20GM103476. BS also acknowledges financial and research support from NSF MS-EPSCoR Grant No. EPS-0903787 at Tougaloo College. This work was also supported by a grant from the Department of Pediatrics and the Bower Foundation (to IA).	Akhlaghi M, 2009, J MOL CELL CARDIOL, V46, P309, DOI 10.1016/j.yjmcc.2008.12.003; Al-Malki AL, 2013, TOXICOL IND HEALTH, V29, P202, DOI 10.1177/0748233711430976; Alam J, 2003, CURR PHARM DESIGN, V9, P2499, DOI 10.2174/1381612033453730; Arany I, 2005, KIDNEY INT, V68, P1573, DOI 10.1111/j.1523-1755.2005.00569.x; Arany I, 2004, KIDNEY INT, V65, P1231, DOI 10.1111/j.1523-1755.2004.00500.x; Arany I, 2017, APOPTOSIS, V22, P220, DOI 10.1007/s10495-016-1309-3; Arany I, 2016, MOL MED REP, V14, P2771, DOI 10.3892/mmr.2016.5543; Arany I, 2013, NEPHROL DIAL TRANSPL, V28, P1417, DOI 10.1093/ndt/gfs596; Arany I, 2011, AM J PHYSIOL-RENAL, V301, pF125, DOI 10.1152/ajprenal.00041.2011; Arany I, 2010, AM J PHYSIOL-RENAL, V298, pF1214, DOI 10.1152/ajprenal.00639.2009; Baeza-Loya S, 2014, B MENNINGER CLIN, V78, P243, DOI 10.1521/bumc.2014.78.3.243; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Ben Mansour H, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-32; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dinkova-Kostova AT, 2008, MOL NUTR FOOD RES, V52, pS128, DOI 10.1002/mnfr.200700195; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Gunsteren WV, 2001, MOL DYNAMICS SIMULAT, V55, P856; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Huang XS, 2014, MOL CELL BIOCHEM, V385, P33, DOI 10.1007/s11010-013-1812-6; Ibrahim ZS, 2016, MOL MED REP, V13, P3017, DOI 10.3892/mmr.2016.4922; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Ji LL, 2015, FREE RADICAL BIO MED, V85, P12, DOI 10.1016/j.freeradbiomed.2015.03.035; Khosravi I, 2016, J MOL STRUCT, V1119, P373, DOI 10.1016/j.molstruc.2016.04.094; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Korkmaz A, 2010, J SURG RES, V164, P309, DOI 10.1016/j.jss.2009.03.022; Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007; Lamson D W, 2000, Altern Med Rev, V5, P196; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lo Presti R, 2007, NUTRITION, V23, P598, DOI 10.1016/j.nut.2007.04.012; Mohammadi F, 2015, SPECTROCHIM ACTA A, V140, P274, DOI 10.1016/j.saa.2014.12.032; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mulligan AA, 2007, EUR J CLIN NUTR, V61, P248, DOI 10.1038/sj.ejcn.1602509; Orth SR, 2008, CLIN J AM SOC NEPHRO, V3, P226, DOI 10.2215/CJN.03740907; Pahari B, 2012, CHEM PHYS LIPIDS, V165, P488, DOI 10.1016/j.chemphyslip.2011.10.006; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Rice-Evans C, 2001, CURR MED CHEM, V8, P797, DOI 10.2174/0929867013373011; Sahihi M, 2014, COMPUT BIOL MED, V51, P44, DOI 10.1016/j.compbiomed.2014.04.022; Sahihi M, 2014, CHEM PAP, V68, P1601, DOI 10.2478/s11696-014-0598-7; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schumacher MA, 2000, J BIOL CHEM, V275, P35242, DOI 10.1074/jbc.M007293200; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; Singh AK, 2013, NEUROMOL MED, V15, P570, DOI 10.1007/s12017-013-8243-0; Snijman PW, 2009, J AGR FOOD CHEM, V57, P6678, DOI 10.1021/jf901417k; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tsuji PA, 2013, NUTR CANCER, V65, P1014, DOI 10.1080/01635581.2013.809127; Zhou J, 2016, CLIN NUTR, V35, P117, DOI 10.1016/j.clnu.2015.03.012	53	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179777	10.1371/journal.pone.0179777	http://dx.doi.org/10.1371/journal.pone.0179777			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640852	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800063
J	van Hoof, RHM; Hermeling, E; Sluimer, JC; Salzmann, J; Hoeks, APG; Roussel, J; Daemen, MJAP; Struijker-Boudier, H; Wildberger, JE; Heeneman, S; Kooi, ME				van Hoof, Raf H. M.; Hermeling, Evelien; Sluimer, Judith C.; Salzmann, Julie; Hoeks, Arnold P. G.; Roussel, Jerome; Daemen, Mat J. A. P.; Struijker-Boudier, Harry; Wildberger, Joachim E.; Heeneman, Sylvia; Kooi, M. Eline			Heart rate lowering treatment leads to a reduction in vulnerable plaque features in atherosclerotic rabbits	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; DCE-MRI; NONINVASIVE ASSESSMENT; ARTERIAL STIFFNESS; BRADYCARDIAC AGENT; RATE REACTIVITY; ANIMAL-MODELS; MOUSE MODELS; RISK-FACTOR; PET-CT	Objective To investigate the effect of a heart rate (HR) lowering agent (Ivabradine) on features of atherosclerotic plaque vulnerability with magnetic resonance imaging (MRI), ultrasound imaging, and histology. Approach and results Atherosclerosis was induced in the abdominal aorta of 19 rabbits. Nine rabbits were treated with Ivabradine (17 mg/kg/day) during the entire study period. At week 14, imaging was performed. Plaque size was quantified on contrast-enhanced T1-weighted MR images. Microvascular flow, density, and permeability was studied with dynamic contrast-enhanced MRI. Plaque biomechanics was studied by measuring the aortic distension with ultrasound. After, animals were sacrificed and histology was performed. HR was reduced by 16% (p = 0.026) in Ivabradine-treated animals. No differences in absolute and relative vessel wall beat-to-beat distension were found, but due to the reduction in HR, the frequency of the biomechanical load on the plaque was reduced. Plaque size (MR and histology) was similar between groups. Although microvessel density (histology) was similar between groups, AUC and K-trans, indicative for plaque microvasculature flow, density, and permeability, were decreased by 24% (p = 0.029) and 32% (p = 0.037), respectively. Macrophage content (relative RAM11 positive area) was reduced by 44% (p<0.001) on histology in Ivabradine-treated animals. Conclusions HR lowering treatment with Ivabradine in an atherosclerotic rabbit model is associated with a reduction in vulnerable plaque features. The current study suggests that HR reduction may be beneficial for inducing or maintaining a more stable plaque phenotype.	[van Hoof, Raf H. M.; Hermeling, Evelien; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [van Hoof, Raf H. M.; Hermeling, Evelien; Sluimer, Judith C.; Hoeks, Arnold P. G.; Struijker-Boudier, Harry; Wildberger, Joachim E.; Heeneman, Sylvia; Kooi, M. Eline] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Sluimer, Judith C.; Heeneman, Sylvia] Maastricht Univ, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Salzmann, Julie; Roussel, Jerome] Inst Rech Int Servier, Suresnes, France; [Hoeks, Arnold P. G.] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Daemen, Mat J. A. P.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Struijker-Boudier, Harry] Maastricht Univ, Dept Pharmacol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Servier; Institut de Recherches Internationales Servier; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University	Kooi, ME (corresponding author), Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands.; Kooi, ME (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.	eline.kooi@mumc.nl	Kooi, M. Eline/D-3848-2016; Sluimer, Judith c/D-5277-2012	Kooi, M. Eline/0000-0001-7562-5724; Sluimer, Judith c/0000-0002-0269-4582; Wildberger, Joachim/0000-0002-4810-6854; Daemen, Mat/0000-0003-1076-199X	project PARISk [01C-202]; Dutch Heart Foundation; Netherlands Organization for Scientific Research [015.008.047]; Stichting de Weijerhorst; Servier	project PARISk; Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Stichting de Weijerhorst; Servier(Servier)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. M.E. Kooi is supported by Aspasia Grant 015.008.047 from the Netherlands Organization for Scientific Research. J.E. Wildberger and M.E. Kooi are supported by Stichting de Weijerhorst. This research was supported by a research grant of Servier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo P, 2003, J VASC RES, V40, P320, DOI 10.1159/000072696; Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Bassiouny HS, 2002, J CARDIOVASC RISK, V9, P331, DOI 10.1097/00043798-200212000-00006; BEERE PA, 1984, SCIENCE, V226, P180, DOI 10.1126/science.6484569; BEERE PA, 1992, ARTERIOSCLER THROMB, V12, P1245, DOI 10.1161/01.ATV.12.11.1245; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; Brands PJ, 1997, ULTRASOUND MED BIOL, V23, P911, DOI 10.1016/S0301-5629(97)00021-5; Calcagno C, 2008, ARTERIOSCL THROM VAS, V28, P1311, DOI 10.1161/ATVBAHA.108.166173; Calcagno C, 2015, NMR BIOMED, V28, P1304, DOI 10.1002/nbm.3369; Calcagno C, 2013, EUR J NUCL MED MOL I, V40, P1884, DOI 10.1007/s00259-013-2518-4; Calcagno C, 2010, J MAGN RESON IMAGING, V32, P191, DOI 10.1002/jmri.22225; Chirinos JA, 2012, J CARDIOVASC TRANSL, V5, P243, DOI 10.1007/s12265-012-9359-6; Custodis F, 2008, CIRCULATION, V117, P2377, DOI 10.1161/CIRCULATIONAHA.107.746537; DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003; Dominguez-Rodriguez A, 2011, WORLD J CARDIOL, V3, P101, DOI 10.4330/wjc.v3.i4.101; Epstein FH, 2007, NMR BIOMED, V20, P238, DOI 10.1002/nbm.1152; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Fox K, 2014, NEW ENGL J MED, V371, P1091, DOI 10.1056/NEJMoa1406430; Gaens ME, 2013, RADIOLOGY, V266, P271, DOI 10.1148/radiol.12120499; GARDINER SM, 1995, BRIT J PHARMACOL, V115, P579, DOI 10.1111/j.1476-5381.1995.tb14971.x; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Grant Edward G, 2003, Ultrasound Q, V19, P190, DOI 10.1097/00013644-200312000-00005; HOEKS APG, 1990, ULTRASOUND MED BIOL, V16, P121, DOI 10.1016/0301-5629(90)90139-4; Jaspers K, 2010, MED PHYS, V37, P5746, DOI 10.1118/1.3484057; KAPLAN JR, 1987, CIRCULATION, V76, P1364, DOI 10.1161/01.CIR.76.6.1364; Kapourchali FR, 2014, WORLD J CLIN CASES, V2, P126, DOI 10.12998/wjcc.v2.i5.126; Kerwin W, 2003, CIRCULATION, V107, P851, DOI 10.1161/01.CIR.0000048145.52309.31; Kerwin WS, 2006, RADIOLOGY, V241, P459, DOI 10.1148/radiol.2412051336; Kwee RM, 2008, NEUROLOGY, V70, P2401, DOI 10.1212/01.wnl.0000314697.76580.cb; Lees-Miller JP, 2015, J MOL CELL CARDIOL, V85, P71, DOI 10.1016/j.yjmcc.2015.05.009; Levy S, 2006, THERAPIE, V61, P115, DOI 10.2515/therapie:2006033; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Lobbes MBI, 2009, RADIOLOGY, V250, P682, DOI 10.1148/radiol.2503080875; MANUCK SB, 1988, AM HEART J, V116, P328, DOI 10.1016/0002-8703(88)90110-X; Manuck SB, 1997, ARTERIOSCL THROM VAS, V17, P1774, DOI 10.1161/01.ATV.17.9.1774; Meinders JM, 2001, ULTRASONIC IMAGING, V23, P199, DOI 10.1177/016173460102300401; Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054; Millon A, 2014, VASCULAR, V22, P221, DOI 10.1177/1708538113478758; Moreno PR, 2006, CIRCULATION, V113, P2245, DOI 10.1161/CIRCULATIONAHA.105.578955; Nawarskas JJ, 2015, CARDIOL REV, V23, P201, DOI 10.1097/CRD.0000000000000070; Niccoli G, 2017, INTERNATIONAL JOURNA; Oliphant CS, 2016, AM J CARDIOVASC DRUG, V16, P337, DOI 10.1007/s40256-016-0178-z; Palatini P, 2007, DRUGS, V67, P3, DOI 10.2165/00003495-200767002-00002; Pei X, 2014, JACC-CARDIOVASC IMAG, V7, P738, DOI 10.1016/j.jcmg.2014.01.019; Phinikaridou A, 2010, CIRC-CARDIOVASC IMAG, V3, P323, DOI 10.1161/CIRCIMAGING.109.918524; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Sun J, 2016, ARTERIOSCL THROM VAS, V36, P743, DOI 10.1161/ATVBAHA.115.307043; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Tardif JC, 2009, BRIT MED BULL, V90, P71, DOI 10.1093/bmb/ldp016; Truijman MTB, 2013, STROKE, V44, P3568, DOI 10.1161/STROKEAHA.113.003140; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Versluis A, 2006, J BIOMECH, V39, P339, DOI 10.1016/j.jbiomech.2004.10.041; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Vucic E, 2012, JACC-CARDIOVASC IMAG, V5, P819, DOI 10.1016/j.jcmg.2011.11.025; Vucic E, 2011, JACC-CARDIOVASC IMAG, V4, P1100, DOI 10.1016/j.jcmg.2011.04.020; Wang J, 2014, STROKE, V45, P1842, DOI 10.1161/STROKEAHA.114.005147; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013; Zuurbier CJ, 2002, AM J PHYSIOL-HEART C, V282, pH2099, DOI 10.1152/ajpheart.01002.2001	58	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179024	10.1371/journal.pone.0179024	http://dx.doi.org/10.1371/journal.pone.0179024			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640847	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800015
J	Borgo, F; Riva, A; Benetti, A; Casiraghi, MC; Bertelli, S; Garbossa, S; Anselmetti, S; Scarone, S; Pontiroli, AE; Morace, G; Borghi, E				Borgo, Francesca; Riva, Alessandra; Benetti, Alberto; Casiraghi, Maria Cristina; Bertelli, Sara; Garbossa, Stefania; Anselmetti, Simona; Scarone, Silvio; Pontiroli, Antonio E.; Morace, Giulia; Borghi, Elisa			Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; EATING-DISORDERS; ANXIETY DISORDERS; INTESTINAL MICROBIOTA; WEIGHT-GAIN; BUTYRATE; ACID; DEPRESSION; OBESITY; SYSTEM	Anorexia nervosa (AN) is a psychiatric disease with devastating physical consequences, with a pathophysiological mechanism still to be elucidated. Metagenomic studies on anorexia nervosa have revealed profound gut microbiome perturbations as a possible environmental factor involved in the disease. In this study we performed a comprehensive analysis integrating data on gut microbiota with clinical, anthropometric and psychological traits to gain new insight in the pathophysiology of AN. Fifteen AN women were compared with fifteen age-, sex- and ethnicity-matched healthy controls. AN diet was characterized by a significant lower energy intake, but macronutrient analysis highlighted a restriction only in fats and carbohydrates consumption. Next generation sequencing showed that AN intestinal microbiota was significantly affected at every taxonomic level, showing a significant increase of Enterobacteriaceae, and of the archeon Methanobrevibactersmithiicompared with healthy controls. On the contrary, the genera Roseburia, Ruminococcus and Clostridium, were depleted, in line with the observed reduction in AN of total short chain fatty acids, butyrate, and propionate. Butyrate concentrations inversely correlated with anxiety levels, whereas propionate directly correlated with insulin levels and with the relative abundance of Roseburia inulinivorans, a known propionate producer. BMI represented the best predictive value for gut dysbiosis and metabolic alterations, showing a negative correlation with Bacteroides uniformis (microbiota), with alanine aminotransferase (liver function), and with psychopathological scores (obsession-compulsion, anxiety, and depression), and a positive correlation with white blood cells count. In conclusion, our findings corroborate the hypothesis that the gut dysbiosis could take part in the AN neurobiology, in particular in sustaining the persistence of alterations that eventually result in relapses after renourishment and psychological therapy, but causality still needs to be proven.	[Borgo, Francesca; Riva, Alessandra; Garbossa, Stefania; Scarone, Silvio; Pontiroli, Antonio E.; Morace, Giulia; Borghi, Elisa] Univ Milan, Dept Hlth Sci, Milan, Italy; [Benetti, Alberto; Bertelli, Sara; Garbossa, Stefania; Anselmetti, Simona; Scarone, Silvio; Pontiroli, Antonio E.] ASST St Paolo & Carlo, Milan, Italy; [Casiraghi, Maria Cristina] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy	University of Milan; University of Milan	Borghi, E (corresponding author), Univ Milan, Dept Hlth Sci, Milan, Italy.	elisa.borghi@unimi.it	Riva, Alessandra/AAA-4038-2020; pontiroli, antonio e/AAI-5575-2020; BORGO, FRANCESCA CLAUDIA/AAM-7200-2020; Borghi, Elisa/I-8811-2012; Casiraghi, Maria Cristina/L-3103-2017	BORGO, FRANCESCA CLAUDIA/0000-0001-9685-1069; Borghi, Elisa/0000-0002-1893-0455; Riva, Alessandra/0000-0002-5724-7616; scarone, silvio/0000-0001-7187-3747; Morace, Giulia/0000-0003-1696-1183; Casiraghi, Maria Cristina/0000-0001-9875-8087	Universita degli Studi di Milano	Universita degli Studi di Milano	This study was supported by the Universita degli Studi di Milano. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2001, EUR NEUROPSYCHOPHARM, V11, P483, DOI 10.1016/S0924-977X(01)00125-0; Alcock J, 2014, BIOESSAYS, V36, P940, DOI 10.1002/bies.201400071; [Anonymous], 2017, BRAIN BEHAV IMMUN; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Beck AT., 1996, MANUAL BECK DEPRESSI; Belmonte L, 2016, SCI REP-UK, V6, DOI 10.1038/srep35813; Breton J, 2016, INT J EAT DISORDER, V49, P805, DOI 10.1002/eat.22531; BRIGHENTI F, 1991, EUR J CLIN NUTR, V45, P221; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Derogatis L.R., 1994, USE PSYCHOL TESTING, P217; DEURENBERG P, 1991, BRIT J NUTR, V65, P105, DOI 10.1079/BJN19910073; DSM-5, 2013, DIAGNOSTIC STAT MANU; Fernandez-Aranda F, 2007, AUST NZ J PSYCHIAT, V41, P24, DOI 10.1080/00048670601057718; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Gkolfakis P, 2015, HEPATOB PANCREAT DIS, V14, P572, DOI 10.1016/S1499-3872(15)60026-1; Godart NT, 2002, INT J EAT DISORDER, V32, P253, DOI 10.1002/eat.10096; Goh KHR, 2015, SINGAP MED J, V56, P488, DOI 10.11622/smedj.2015132; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Imhann F., 2016, GUT; Jesus P, 2014, CLIN NUTR, V33, P1046, DOI 10.1016/j.clnu.2013.11.006; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaplan AS, 2009, PSYCHOL MED, V39, P1037, DOI 10.1017/S003329170800442X; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Klump KL, 2009, INT J EAT DISORDER, V42, P97, DOI 10.1002/eat.20589; Ktsoyan ZA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00776; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; Mack I, 2016, SCI REP-UK, V6, DOI 10.1038/srep26752; Mehler PS, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0040-8; Mercader JM, 2012, GENE, V497, P181, DOI 10.1016/j.gene.2012.01.057; Million M, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.28; Misra M, 2014, LANCET DIABETES ENDO, V2, P581, DOI 10.1016/S2213-8587(13)70180-3; Montagnese C, 2007, INT J EAT DISORDER, V40, P746, DOI 10.1002/eat.20432; Morita C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145274; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Pfleiderer A, 2013, EUR J CLIN MICROBIOL, V32, P1471, DOI 10.1007/s10096-013-1900-2; Pingitore A, 2017, DIABETES OBES METAB, V19, P257, DOI 10.1111/dom.12811; Puertollano E, 2014, CURR OPIN CLIN NUTR, V17, P139, DOI 10.1097/MCO.0000000000000025; Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185; Rosen E, 2015, INT J EAT DISORDER, P151; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Seiler N, 2007, CRIT REV CL LAB SCI, V44, P365, DOI 10.1080/10408360701250016; Spielberger C., 1983, MAN STATE TRAIT ANXI, P4; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Tamanai-Shacoori Z, 2017, FUTURE MICROBIOL, V12, P157, DOI 10.2217/fmb-2016-0130; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Waldecker M, 2008, NUTRITION, V24, P366, DOI 10.1016/j.nut.2007.12.013; Weaver GA, 1997, J NUTR, V127, P717, DOI 10.1093/jn/127.5.717; Wildes JE, 2017, INT J EAT DISORDER, V50, P389, DOI 10.1002/eat.22651; Winter SE, 2014, GUT MICROBES, V5, P71, DOI 10.4161/gmic.27129	68	112	115	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179739	10.1371/journal.pone.0179739	http://dx.doi.org/10.1371/journal.pone.0179739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636668	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300053
J	Gugsa, S; Potter, K; Tweya, H; Phiri, S; Sande, O; Sikwese, P; Chikonda, J; O'Malley, G				Gugsa, Salem; Potter, Katy; Tweya, Hannock; Phiri, Sam; Sande, Odala; Sikwese, Pascal; Chikonda, Janet; O'Malley, Gabrielle			Exploring factors associated with ART adherence and retention in care under Option B plus strategy in Malawi: A qualitative study	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ADULT HIV PATIENTS; ANTIRETROVIRAL THERAPY; PMTCT PROGRAM; FOLLOW-UP; PREVENTION; BARRIERS; WOMEN; FACILITATORS; INVOLVEMENT	Although several studies have documented challenges related to inadequate adherence to antiretroviral therapy (ART) and high loss to follow-up (LTFU) among Option B+ women, there is limited understanding of why these challenges occur and how to address them. This qualitative study examines women's experiences with ART adherence and retention in care. Between July and October 2015, in-depth interviews were conducted with 39 pregnant and lactating women who initiated ART at Bwaila Hospital in Lilongwe, Malawi. Study participants included 14 in care and 25 out of care women, according to facility records. Data were analyzed using an inductive, open-coding approach to thematic analysis. Ten of the respondents (7 out of care, 3 in-care) had stopped and re-started treatment before the interview date. One of the most important factors influencing adherence and retention was the strength of women's support systems. In contrast to women in-care, most out-of-care women lacked emotional and financial support from male partners, received minimal counseling from providers at initiation, lacked designated guardians to assist with medication refills or clinic appointments, and were highly mobile. Mobility led to difficulties in accessing treatment in new settings. The most common reasons women re-started treatment following interruptions were due to providers' counseling and encouragement and the mother's desire to be healthy. Improved counseling at initiation, active follow-up counseling, women's economic empowerment interventions, promotion of peer counseling schemes and meaningful engagement of male partners can help in addressing the identified barriers and promoting sustained retention of Option B+ women.	[Gugsa, Salem; Tweya, Hannock; Phiri, Sam; Sande, Odala; Sikwese, Pascal] Lighthouse Trust, Lilongwe, Malawi; [Gugsa, Salem; Potter, Katy; O'Malley, Gabrielle] Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA; [Tweya, Hannock] Int Union TB & Lung Dis, Paris, France; [Phiri, Sam] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Phiri, Sam] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Dept Publ Hlth, Lilongwe, Malawi; [Chikonda, Janet] Minist Hlth, Dist Hlth Off, Lilongwe, Malawi	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Malawi	Gugsa, S (corresponding author), Lighthouse Trust, Lilongwe, Malawi.; Gugsa, S (corresponding author), Univ Washington, Dept Global Hlth, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA.	salemtg@uw.edu		O&apos;Malley, Gabrielle/0000-0002-7514-8240; Gugsa, Salem/0000-0003-3545-3117	National Institute of Allergy and Infectious Diseases [5U01-A1069924]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, grant 5U01-A1069924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio A, 2016, J ACQUIR IMMUNE DEFI, V1; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Busza J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.4.17373; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Dunlap J, 2014, CURR HIV-AIDS REP, V11, P109, DOI 10.1007/s11904-014-0200-5; Ebuy H, 2015, INT J INFECT DIS, V33, P123, DOI 10.1016/j.ijid.2014.12.026; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Goudge J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-75; Gourlay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106325; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Haas AD, 2016, CLIN INFECT DIS, DOI [10.1093/cid/ciw500, DOI 10.1093/CID/CIW500]; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kalembo FW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066517; Katirayi L, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20919; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Loccoh E, 2014, WJA, V04, P446; MacLachlan EW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153042; Malawi Ministry of Health, 2016, INT HIV PROGR REP; Mitiku I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20662; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Nam SL, 2008, SOC SCI MED, V67, P301, DOI 10.1016/j.socscimed.2008.03.042; Napua M, 2016, JAIDS-J ACQ IMM DEF, V72, pS181, DOI 10.1097/QAI.0000000000001061; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th; Rogers AJ, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21224; Roy M, 2016, CURR HIV-AIDS REP, V13, P177, DOI 10.1007/s11904-016-0317-9; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Schnack A, 2016, AIDS PATIENT CARE ST, V30, P110, DOI 10.1089/apc.2015.0318; Skovdal M, 2011, INT J HEALTH PLAN M, V26, P296, DOI 10.1002/hpm.1082; Stinson K, 2012, AJAR-AFR J AIDS RES, V11, P65, DOI 10.2989/16085906.2012.671263; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2016, FAST TRACK AIDS FREE; Wachira J, 2014, INT J QUAL HEALTH C, V26, P190, DOI 10.1093/intqhc/mzu004; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Watt MH, 2009, SOC SCI MED, V68, P1793, DOI 10.1016/j.socscimed.2009.02.037; Zhou A, 2016, SOC SCI MED, V158, P52, DOI 10.1016/j.socscimed.2016.04.013	44	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179838	10.1371/journal.pone.0179838	http://dx.doi.org/10.1371/journal.pone.0179838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636669	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300058
J	Rausch, D; Dekker, A; Rettenberger, M				Rausch, Diana; Dekker, Arne; Rettenberger, Martin			The construct of sexual openness for females in steady intimate relationships	PLOS ONE			English	Article							GENDER-DIFFERENCES; FIT INDEXES; MASS-MEDIA; SATISFACTION; WOMEN; ASSOCIATIONS; PORNOGRAPHY; ATTITUDES; AROUSAL; TELEVISION	The analysis of open-minded attitudes towards sexuality in general requires a construct based on attitudinal dimensions. Although several existing studies involve sexual attitudes, they differ substantially and standardized conceptual work is missing. Thus, the authors introduce the latent variable sexual openness to develop a construct based on self-oriented attitudes towards different sexual topics. Available survey data of female German students in a steady relationship allowed providing a first empirical test for the applicability of this construct. Five subdimensions are acknowledged central for sexual openness: sexual practices, masturbation, bisexuality, permissiveness, and pornography consumption. Confirmatory factor analysis and correlations confirmed the idea of an underlying mechanism with an impact on all five variables. Though further validation of the construct of sexual openness is required, the findings strongly support the notion of an overarching latent attitude variable, which influences the individual relation to everything sexual. The results were compared to other studies and potential approaches for future analyses were proposed.	[Rausch, Diana; Rettenberger, Martin] Johannes Gutenberg Univ Mainz JGU, Dept Psychol, Mainz, Germany; [Dekker, Arne] Univ Med Ctr Hamburg Eppendorf, Inst Sex Res & Forens Psychiat, Hamburg, Germany; [Rettenberger, Martin] Ctr Criminol, Wiesbaden, Germany	Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rettenberger, M (corresponding author), Johannes Gutenberg Univ Mainz JGU, Dept Psychol, Mainz, Germany.; Rettenberger, M (corresponding author), Ctr Criminol, Wiesbaden, Germany.	m.rettenberger@krimz.de			Gerrnan Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [MA5351/1-1]	Gerrnan Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The project was funded by the Gerrnan Research Foundation (Deutsche Forschungsgemeinschaft, DFG);funding number MA5351/1-1 (recipient: AD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EA, 2012, AM SOCIOL REV, V77, P435, DOI 10.1177/0003122412445802; Arrington R, 2004, QUAL LIFE RES, V13, P1643, DOI 10.1007/s11136-004-7625-z; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brown JD, 2006, PEDIATRICS, V117, P1018, DOI 10.1542/peds.2005-1406; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Busing S, 2001, PSYCHOTHER PSYCH MED, V51, P68, DOI 10.1055/s-2001-10757; Byers ES, 2005, J SEX RES, V42, P113, DOI 10.1080/00224490509552264; Byrne BM., 2001, STRUCTURAL EQUATION, V1; Carpenter LM, 2009, ARCH SEX BEHAV, V38, P87, DOI 10.1007/s10508-007-9215-y; Carvalho J, 2013, ARCH SEX BEHAV, V42, P1011, DOI 10.1007/s10508-013-0076-2; Carvalho J, 2012, ARCH SEX BEHAV, V41, P907, DOI 10.1007/s10508-011-9865-7; Castellanos-Torres E, 2013, ANN EPIDEMIOL, V23, P150, DOI 10.1016/j.annepidem.2012.12.010; Collins RL, 2004, PEDIATRICS, V114, pE280, DOI 10.1542/peds.2003-1065-L; Conley TD, 2013, PERS SOC PSYCHOL REV, V17, P124, DOI 10.1177/1088868312467087; Curran P. J., 1994, ROBUSTNESS CONFIRMAT; Olvera FJD, 2013, REV INT ANDROL, V11, P9, DOI 10.1016/j.androl.2012.09.003; DeLamater J, 2002, J SEX RES, V39, P10, DOI 10.1080/00224490209552113; Doring N., 2013, FRAUEN NETZ, P275; Draganic J., 2013, SEXUAL FLUIDITY WOME; Fahs B, 2011, ARCH SEX BEHAV, V40, P903, DOI 10.1007/s10508-010-9681-5; Fallis EE, 2011, HDB SEXUALITY RELATE, P228; Fisher TD, 2011, HDB SEXUALITY RELATE, DOI 10.4324/9781315881089; Fisher W., 1998, HDB SEXUALITY RELATE, P213; FISHER WA, 1988, J SEX RES, V25, P123, DOI 10.1080/00224498809551448; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Gerressu M, 2008, ARCH SEX BEHAV, V37, P266, DOI 10.1007/s10508-006-9123-6; Ghazzawi L, 2014, REV SOCIOL, V43, P133; Giraldi A, 2013, J SEX MED, V10, P58, DOI 10.1111/j.1743-6109.2012.02820.x; Grov C, 2011, ARCH SEX BEHAV, V40, P429, DOI 10.1007/s10508-010-9598-z; Guerra VM, 2007, PSICOL-REFLEX CRIT, V20, P43, DOI 10.1590/S0102-79722007000100007; Guerra VM, 2012, ARCH SEX BEHAV, V41, P1027, DOI 10.1007/s10508-012-9936-4; Hald GM, 2008, ARCH SEX BEHAV, V37, P614, DOI 10.1007/s10508-007-9212-1; Hannon R, 2011, HDB SEXUALITY RELATE, P68; Hartmann U, 2004, MENOPAUSE, V11, P726, DOI 10.1097/01.GME.0000143705.42486.33; Heiman JR, 2002, J SEX RES, V39, P73, DOI 10.1080/00224490209552124; Hendrick C, 2006, J SEX RES, V43, P76, DOI 10.1080/00224490609552301; Hendrick S, 1987, J SEX RES, V23, P502, DOI [10.1080/00224498709551387, DOI 10.1080/00224498709551387]; HENDRICK SS, 1995, PERS RELATIONSHIP, V2, P55, DOI 10.1111/j.1475-6811.1995.tb00077.x; Hess JA, 2012, J SEX RES, V49, P603, DOI 10.1080/00224499.2011.619282; Hill A, 2011, PSYCHOTHERAPEUT, V56, P475, DOI 10.1007/s00278-011-0866-8; Hinchliff S, 2012, ARCH SEX BEHAV, V41, P1253, DOI 10.1007/s10508-012-9903-0; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; HUDSON WW, 1983, J SEX RES, V19, P258, DOI 10.1080/00224498309551186; Kaestle CE, 2011, ARCH SEX BEHAV, V40, P983, DOI 10.1007/s10508-010-9722-0; Kliem S, 2012, Z KL PSYCH PSYCHOTH, V41, P81, DOI 10.1026/1616-3443/a000135; Klusmann D, 2002, ARCH SEX BEHAV, V31, P275, DOI 10.1023/A:1015205020769; L'Engle KL, 2006, J ADOLESCENT HEALTH, V38, P186, DOI 10.1016/j.jadohealth.2005.03.020; Laier C, 2014, ARCH SEX BEHAV, V43, P473, DOI 10.1007/s10508-013-0119-8; Le Gall A, 2002, J SEX RES, V39, P207, DOI 10.1080/00224490209552143; Ledermann T, 2010, FAM RELAT, V59, P195, DOI 10.1111/j.1741-3729.2010.00595.x; Lehmann A., 2007, PSYCHOSOZIALE EINFLU; Macapagal KR, 2011, PERS INDIV DIFFER, V51, P699, DOI 10.1016/j.paid.2011.06.008; Maddox AM, 2011, ARCH SEX BEHAV, V40, P441, DOI 10.1007/s10508-009-9585-4; Matthiesen S., 2013, PROFAMILIA MAGAZIN, V3, P4; Matthiesen S, 2011, Z SEXUALFORSCH, V24, P326, DOI 10.1055/s-0031-1283839; Montesi JL, 2013, ARCH SEX BEHAV, V42, P81, DOI 10.1007/s10508-012-9929-3; Muise A, 2010, ARCH SEX BEHAV, V39, P915, DOI 10.1007/s10508-009-9492-8; Nelson AL, 2011, ARCH SEX BEHAV, V40, P395, DOI 10.1007/s10508-010-9693-1; Nobre PJ, 2004, J SEX RES, V41, P363, DOI 10.1080/00224490409552243; Parish WL, 2007, ARCH SEX BEHAV, V36, P5, DOI 10.1007/s10508-006-9082-y; Parvez ZF, 2006, GENDER SOC, V20, P605, DOI 10.1177/0891243206291109; PETERSON RA, 1994, J CONSUM RES, V21, P381, DOI 10.1086/209405; Poulsen FO, 2013, J SEX RES, V50, P72, DOI 10.1080/00224499.2011.648027; Pronier C, 2014, J GENDER STUD, V23, P69, DOI 10.1080/09589236.2012.752347; Purnine DM, 1996, BEHAV RES THER, V34, P375, DOI 10.1016/0005-7967(96)00002-2; Rehman US, 2011, J SEX MED, V8, P3108, DOI 10.1111/j.1743-6109.2011.02439.x; Richter D, 2012, Z SEXUALFORSCH, V25, P93, DOI 10.1055/s-0031-1284040; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Rye B. J., 2012, CAN J HUM SEX, V21, P91; Sanders SA, 2008, ARCH SEX BEHAV, V37, P241, DOI 10.1007/s10508-007-9235-7; Santos-Iglesias P, 2013, ARCH SEX BEHAV, V42, P1043, DOI 10.1007/s10508-012-9998-3; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schmidt G, 1998, SCANDINAVIAN J SEXOL, V1, P157; Schmidt G, 2006, SPATMODERNE BEZIEHUN; Schmidt G, 2011, Z SEXUALFORSCH, V24, P353, DOI 10.1055/s-0031-1283840; Schmidt R., 2003, LEBENSTHEMA SEXUALIT; Schonbucher V, 2007, SEXUELLE ZUFRIEDENHE, V20, P21; Seal BN, 2009, ARCH SEX BEHAV, V38, P866, DOI 10.1007/s10508-008-9467-1; Smith CV, 2007, J SOC PERS RELAT, V24, P69, DOI 10.1177/0265407507072589; Staley C, 2013, ARCH SEX BEHAV, V42, P615, DOI 10.1007/s10508-012-0034-4; StataCorp LP, 2011, STAT STRUCT EQ MOD R; Stephenson K. R., 2011, CANADIAN J HUMAN SEX, V20, P31; Stephenson K. R., 2009, CANADIAN J HUMAN SEX, V18, P89; Taylor LD, 2005, J SEX RES, V42, P130, DOI 10.1080/00224490509552266; Thompson AE, 2012, ARCH SEX BEHAV, V41, P949, DOI 10.1007/s10508-011-9794-5; Trueblood K, 1998, M SOC SCI STUD SEX W; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; UKE, 2014, FORSCH STUD SEX WAND; Ullman JB, 2006, J PERS ASSESS, V87, P35, DOI 10.1207/s15327752jpa8701_03; von Irmer J, 2008, ZEITSCHRIFT FAM, P3; West S., 2012, HDB STRUCTURAL EQUAT, P209, DOI DOI 10.1016/J.SURFCOAT.2015.05.023; Wiederman MW, 1998, J SEX RES, V35, P88, DOI 10.1080/00224499809551919; Wright PJ, 2013, ARCH SEX BEHAV, V42, P1131, DOI 10.1007/s10508-013-0116-y; Wright PJ, 2012, J MEDIA PSYCHOL-GER, V24, P67, DOI 10.1027/1864-1105/a000063; Wright PJ, 2011, COMM YEARB, V35, P343; Zimmer-Gembeck MJ, 2011, ARCH SEX BEHAV, V40, P927, DOI 10.1007/s10508-011-9751-3	101	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0172274	10.1371/journal.pone.0172274	http://dx.doi.org/10.1371/journal.pone.0172274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636608	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300001
J	Matsumoto, K; Ichimura, M; Tsuneyama, K; Moritoki, Y; Tsunashima, H; Omagari, K; Hara, M; Yasuda, I; Miyakawa, H; Kikuchi, K				Matsumoto, Kotaro; Ichimura, Mayuko; Tsuneyama, Koichi; Moritoki, Yuki; Tsunashima, Hiromichi; Omagari, Katsuhisa; Hara, Masumi; Yasuda, Ichiro; Miyakawa, Hiroshi; Kikuchi, Kentaro			Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HEPATIC STEATOSIS; GUT MICROBIOTA; PERMEABILITY; ENDOTOXEMIA; CELLS; NASH; DIET	Impairments in intestinal barrier function, epithelial mucins, and tight junction proteins have been reported to be associated with nonalcoholic steatohepatitis. Prebiotic fructo-oligosaccharides restore balance in the gastrointestinal microbiome. This study was conducted to determine the effects of dietary fructo-oligosaccharides on intestinal barrier function and steatohepatitis in methionine-choline-deficient mice. Three groups of 12-week-old male C57BL/6J mice were studied for 3 weeks; specifically, mice were fed a methionine-choline-deficient diet, a methionine-choline-deficient diet plus 5% fructo-oligosaccharides in water, or a normal control diet. Fecal bacteria, short-chain fatty acids, and immunoglobulin A (IgA) levels were investigated. Histological and immunohistochemical examinations were performed using mice livers for CD14 and Toll-like receptor-4 (TLR4) expression and intestinal tissue samples for IgA and zonula occludens-1 expression in epithelial tight junctions. The methionine-choline-deficient mice administered 5% fructo-oligosaccharides maintained a normal gastrointestinal microbiome, whereas methionine-choline-deficient mice without prebiotic supplementation displayed increases in Clostridium cluster XI and subcluster XIVa populations and a reduction in Lactobacillales spp. counts. Methionine-choline-deficient mice given 5% fructo-oligosaccharides exhibited significantly decreased hepatic steatosis (p = 0.003), decreased liver inflammation (p = 0.005), a decreased proportion of CD14-positive Kupffer cells (p = 0.01), decreased expression of TLR4 (p = 0.04), and increases in fecal short-chain fatty acid and IgA concentrations (p < 0.04) compared with the findings in methionine-choline-deficient mice that were not administered this prebiotic. This study illustrated that in the methionine-choline-deficient mouse model, dietary fructo-oligosaccharides can restore normal gastrointestinal microflora and normal intestinal epithelial barrier function, and decrease steatohepatitis. The findings support the role of prebiotics, such as fructo-oligosaccharides, in maintaining a normal gastrointestinal microbiome; they also support the need for further studies on preventing or treating nonalcoholic steatohepatitis using dietary fructo-oligosaccharides.	[Matsumoto, Kotaro; Tsunashima, Hiromichi; Yasuda, Ichiro] Teikyo Univ, Dept Gastroenterol, Mizonokuchi Hosp, Takatsu Ku, Kawasaki, Kanagawa, Japan; [Ichimura, Mayuko] Nara Womens Univ, Dept Food Sci & Nutr, Kita Uoya Nishimachi, Nara, Nara, Japan; [Tsuneyama, Koichi] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Pathol & Lab Med, Tokushima, Tokushima, Japan; [Moritoki, Yuki] Akita Univ, Grad Sch Med, Dept Gen Med, Akita, Akita, Japan; [Moritoki, Yuki] Akita Univ, Grad Sch Med, Lab Diagnost Med, Akita, Akita, Japan; [Omagari, Katsuhisa] Univ Nagasaki, Fac Nursing & Nutr, Dept Nutr, Nagayo Cho, Nagasaki, Japan; [Hara, Masumi; Miyakawa, Hiroshi; Kikuchi, Kentaro] Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med 4, Takatsu Ku, Kawasaki, Kanagawa, Japan	Teikyo University; Nara Womens University; Tokushima University; Akita University; Akita University; Nagasaki University; Teikyo University	Kikuchi, K (corresponding author), Teikyo Univ, Mizonokuchi Hosp, Dept Internal Med 4, Takatsu Ku, Kawasaki, Kanagawa, Japan.	kentaro@med.teikyo-u.ac.jp		Tsuneyama, Koichi/0000-0002-0670-9868	Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [26460174]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan and JSPS KAKENHI Grant-in-Aid for Scientific Research (C) Number 26460174. https//kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26460174/. The funder had no role in this study.	Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130; Dai X, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/287348; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hashimoto E, 2005, HEPATOL RES, V33, P72, DOI 10.1016/j.hepres.2005.09.007; Hashimoto E, 2013, J GASTROEN HEPATOL, V28, P64, DOI 10.1111/jgh.12271; HIDAKA H, 1990, ADV EXP MED BIOL, V270, P105; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Jha P, 2014, HEPATOLOGY, V59, P858, DOI 10.1002/hep.26732; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Masahata K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4704; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Nakamura Y, 2004, CLIN EXP IMMUNOL, V137, P52, DOI 10.1111/j.1365-2249.2004.02487.x; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Okubo H, 2013, AM J PHYSIOL-GASTR L, V305, pG911, DOI 10.1152/ajpgi.00225.2013; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Alonso VR, 2013, BRIT J NUTR, V109, pS21, DOI 10.1017/S0007114512005235; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	33	38	38	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0175406	10.1371/journal.pone.0175406	http://dx.doi.org/10.1371/journal.pone.0175406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632732	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100001
J	Li, X; Xu, ZH; Pang, XQ; Huang, YB; Yang, BX; Yang, YY; Chen, KX; Liu, XQ; Mao, P; Li, YM				Li, Xi; Xu, Zhiheng; Pang, Xiaoqing; Huang, Yongbo; Yang, Baoxin; Yang, Yuanyuan; Chen, Kangxie; Liu, Xiaoqing; Mao, Pu; Li, Yimin			Interleukin-10/lymphocyte ratio predicts mortality in severe septic patients	PLOS ONE			English	Article							INTENSIVE-CARE; SEVERE SEPSIS; T-CELLS; LYMPHOPENIA; RESPONSES; SHOCK; IMMUNOSUPPRESSION; PATHOGENESIS; SURVIVAL	Background Immunosuppression is common even in the early stage of severe sepsis. Interleukin-10 (IL-10) secretion and lymphocyte exhaustion are the main features of sepsis-induced immuno-suppression. However, the relationship between IL-10 and the lymphocyte is still unclear. We investigated if IL-10/lymphocyte ratio (IL10LCR) were associated with mortality in severe septic patients. Methods Adult patients with severe sepsis admitted to ICU of the First Affiliated Hospital of Guangzhou Medical University were identified from October 2012 to August 2013. Within 24 hours of ICU admission, peripheral whole blood was collected for the measurement of IL-10 using commercial multiplex bead-based assay kits and determination of lymphocyte count from laboratory data. The primary outcome was 28-day mortality. Results A total of 63 severe sepsis patients were identified. There were 20 (32%) patients died within 28 days. IL10LCR in non-survival patients was significantly higher than survival patients (median (IQR) 36.78 (12.34-79.63) ng/ml(2) versus 11.01(5.41-27.50) ng/ml(2), P = 0.002). Correlation analysis showed that IL10LCR was significantly correlated with APACHE II score (Spearman's rho = 0.424, P<0.001). The receiver operating characteristic (ROC) curves showed the area under the curve was 0.749 for IL10LCR level to predict 28-day mortality with sensitivity and specificity at 70.0% and 74.4%, respectively. At an optimal cutoff of 23.39ng/ml(2), Kaplan-Meier curve showed survival in patients with IL10LCR level above 23.39ng/ml(2) was significantly lower than in patients with IL10LCR level less than 23.39ng/ml(2) (P = 0.001 by log-rank test). Conclusion IL10LCR level is significantly associated with the severity and outcome of severe septic patients. It may serve as a biomarker for sepsis-induced immunosuppression.	[Li, Xi; Xu, Zhiheng; Huang, Yongbo; Yang, Baoxin; Yang, Yuanyuan; Chen, Kangxie; Li, Yimin] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Xi] Peoples Hosp Leshan, Intens Care Unit, Leshan, Sichuan, Peoples R China; [Xu, Zhiheng; Pang, Xiaoqing; Liu, Xiaoqing; Li, Yimin] Guangzhou Med Univ, Affiliated Hosp 1, Intens Care Unit, Guangzhou, Guangdong, Peoples R China; [Mao, Pu] Guangzhou Med Univ, Dept Infect Control, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University	Li, YM (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.; Li, YM (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Intens Care Unit, Guangzhou, Guangdong, Peoples R China.; Mao, P (corresponding author), Guangzhou Med Univ, Dept Infect Control, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	maopu1981@126.com; dryiminli@vip.163.com			National Natural Science Foundation of China [81400060, 81490534]; Natural Science Foundation of Guangdong Province, China [2015A030313480, 2015A030313456]; Guangzhou Healthcare Collaborative Innovation Major Project [201400000002]; Science and Technology Program of Guangzhou, China [2014Y-00065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Guangzhou Healthcare Collaborative Innovation Major Project; Science and Technology Program of Guangzhou, China	This study was supported by National Natural Science Foundation of China (Grant No. 81400060 to YH and 81490534 to YL); Natural Science Foundation of Guangdong Province, China (Grant No. 2015A030313480 to YL and 2015A030313456 to XQL); Guangzhou Healthcare Collaborative Innovation Major Project (Grant No. 201400000002 to YL) and Science and Technology Program of Guangzhou, China (Grant No. 2014Y-00065 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the medical doctors and nurses of the ICU of the First Affiliated Hospital of Guangzhou Medical University for their careful and generous collaboration while doing this work. This study was supported by National Natural Science Foundation of China (Grant No. 81400060 to YH and 81490534 to YL); Natural Science Foundation of Guangdong Province, China (Grant No. 2015A030313480 to YL and 2015A030313456 to X.Q. L); Guangzhou Healthcare Collaborative Innovation Major Project (Grant No. 201400000002 to YL) and Science and Technology Program of Guangzhou, China (Grant No. 2014Y-00065 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2008, J SURG RES, V147, P1, DOI 10.1016/j.jss.2007.07.009; Asner S, 2012, J CYST FIBROS, V11, P433, DOI 10.1016/j.jcf.2012.04.006; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cross AS, 2003, ANN INTERN MED, V138, P502, DOI 10.7326/0003-4819-138-6-200303180-00016; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Hein F, 2010, CRIT CARE, V14, DOI 10.1186/cc8876; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MARCHANT A, 1995, J CLIN IMMUNOL, V15, P266, DOI 10.1007/BF01540884; Monserrat J, 2013, CRIT CARE, V17, DOI 10.1186/cc12750; Monserrat J, 2009, CRIT CARE, V13, DOI 10.1186/cc7731; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; OBERHOLZER A, 2002, CRIT CARE MED S1, V30, pS58; Rajan G, 1997, INTENS CARE MED, V23, P1187, DOI 10.1007/s001340050482; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Scumpia PO, 2005, CRIT CARE MED, V33, pS468, DOI 10.1097/01.CCM.0000186268.53799.67; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; TAGA K, 1992, J IMMUNOL, V148, P1143; Tamayo E, 2011, EUR CYTOKINE NETW, V22, P82, DOI 10.1684/ecn.2011.0281; Torgersen C, 2009, ANESTH ANALG, V108, P1841, DOI 10.1213/ane.0b013e318195e11d; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335	34	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179050	10.1371/journal.pone.0179050	http://dx.doi.org/10.1371/journal.pone.0179050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628675	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100014
J	Xu, QY; Bai, F; Chen, N; Bai, G				Xu, Qingyang; Bai, Fang; Chen, Ning; Bai, Gang			Gene modification of the acetate biosynthesis pathway in Escherichia coli and implementation of the cell recycling technology to increase L-tryptophan production	PLOS ONE			English	Article							TRANSPORT-SYSTEM; ACETYL-COENZYME; IMPACT; GROWTH; ACCUMULATION; OPTIMIZATION; METABOLISM	The implementation of a novel cell recycling technology based on a special disk centrifuge during microbial fermentation process can continuously separate the product and harmful intermediates, while maintaining the cell viability owing to the installed cooling system. Acetate accumulation is an often encountered problem in L-tryptophan fermentation by Escherichia colt. To extend our previous studies, the current study deleted the key genes underlying acetate biosynthesis to improve L-tryptophan production. The deletion of the phosphotransacetylase (pta) acetate kinase (ackA) pathway in a gltB (encoding glutamate synthase) mutant of E. colt TRTHB, led to the highest production of L-tryptophan (47.18 g/L) and glucose conversion rate (17.83%), with a marked reduction in acetate accumulation (1.22 g/L). This strain, TRTHBPA, was then used to investigate the effects of the cell recycling process on L-tryptophan fermentation. Four different strategies were developed concerning two issues, the volume ratio of the concentrated cell solution and clear solution and the cell recycling period. With strategy I (concentrated cell solution: clear solution, 1: 1; cell recycling within 24-30 h), L-tryptophan production and the glucose conversion rate increased to 55.12 g/L and 19.75%, respectively, 17.55% and 10.77% higher than those without the cell recycling. In addition, the biomass increased by 13.52% and the fermentation period was shortened from 40 h to 32 h. These results indicated that the cell recycling technology significantly improved L-tryptophan production by E. colt.	[Xu, Qingyang; Bai, Fang; Bai, Gang] Nankai Univ, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Xu, Qingyang; Bai, Fang; Bai, Gang] Nankai Univ, Tianjin Key Lab Mol Drug Res, Coll Pharm, Tianjin, Peoples R China; [Chen, Ning] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin, Peoples R China	Nankai University; Nankai University; Tianjin University Science & Technology	Bai, G (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China.; Bai, G (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Coll Pharm, Tianjin, Peoples R China.	gangbai@nankai.edu.cn			Key Technologies R & D Program of Tianjin [14ZCZDSY00015]; Tianjin Science and Technology Commissioner Project [15JCTPJC57000]	Key Technologies R & D Program of Tianjin; Tianjin Science and Technology Commissioner Project	This work was supported by the Key Technologies R & D Program of Tianjin (Grant No. 14ZCZDSY00015) and Tianjin Science and Technology Commissioner Project (Grant No. 15JCTPJC57000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baez-Viveros JL, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-30; Castano-Cerezo S, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-54; Chang DE, 1999, J BACTERIOL, V181, P6656, DOI 10.1128/JB.181.21.6656-6663.1999; Cheng HC, 2008, BIOCHEM ENG J, V41, P258, DOI 10.1016/j.bej.2008.05.004; Cheng LK, 2012, ANN MICROBIOL, V62, P1625, DOI 10.1007/s13213-012-0419-6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Anda R, 2006, METAB ENG, V8, P281, DOI 10.1016/j.ymben.2006.01.002; De Mey M, 2007, BIOTECHNOL PROGR, V23, P1053, DOI 10.1021/bp070170g; Dodge TC, 2002, J CHEM TECHNOL BIOT, V77, P1238, DOI 10.1002/jctb.698; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Hesslinger C, 1998, MOL MICROBIOL, V27, P477, DOI 10.1046/j.1365-2958.1998.00696.x; Jin MJ, 2012, ENERG ENVIRON SCI, V5, P7168, DOI 10.1039/c2ee03058f; Kumar R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-8; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Liu Q, 2012, BIORESOURCE TECHNOL, V114, P549, DOI 10.1016/j.biortech.2012.02.088; Martinez-Gomez K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-46; Newmaster SG, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-2; Phue JN, 2005, METAB ENG, V7, P353, DOI 10.1016/j.ymben.2005.06.003; Sarks C, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-73; SPIRA WM, 1983, APPL ENVIRON MICROB, V46, P704, DOI 10.1128/AEM.46.3.704-709.1983; Wang FS, 2010, IND ENG CHEM RES, V49, P2306, DOI 10.1021/ie901066a; Wang J, 2013, APPL MICROBIOL BIOT, V97, P7587, DOI 10.1007/s00253-013-5026-3; [赵春光 Zhao Chunguang], 2016, [食品与发酵工业, Food and Fermentation Industries], V42, P8; Zhao CG, 2016, ANN MICROBIOL, V66, P843, DOI 10.1007/s13213-015-1172-4; Zhao CG, 2016, ANN MICROBIOL, V66, P261, DOI 10.1007/s13213-015-1103-4	25	5	6	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179240	10.1371/journal.pone.0179240	http://dx.doi.org/10.1371/journal.pone.0179240			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622378	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300016
J	Azcona-Gutierrez, JM; de Lucio, A; Hernandez-de-Mingo, M; Garcia-Garcia, C; Soria-Blanco, LM; Morales, L; Aguilera, M; Fuentes, I; Carmena, D				Manuel Azcona-Gutierrez, Jose; de Lucio, Aida; Hernandez-de-Mingo, Marta; Garcia-Garcia, Concepcion; Miguel Soria-Blanco, Luis; Morales, Lucia; Aguilera, Maria; Fuentes, Isabel; Carmena, David			Molecular diversity and frequency of the diarrheagenic enteric protozoan Giardia duodenalis and Cryptosporidium spp. in a hospital setting in Northern Spain	PLOS ONE			English	Article							PEDIATRIC-PATIENT; GENETIC EXCHANGE; 1ST REPORT; IDENTIFICATION; CHILDREN; TRANSMISSION; GENOTYPES; HUMANS; RECOMBINATION; EPIDEMIOLOGY	Background Human giardiosis and cryptosporidiosis are caused by the enteric protozoan parasites Giardia duodenalis and Cryptosporidium spp. Both pathogens are major contributors to the global burden of diarrhoeal disease, affecting primarily children and immunodebilitated individuals in resource-poor settings. Giardiosis and cryptosporidiosis also represent an important, often underestimate, public health threat in developed countries. In Spain only limited information is currently available on the epidemiology of these infections. Molecular data on the diversity, frequency, geographical distribution, and seasonality of G. duodenalis assemblages/sub-assemblages and Cryptosporidium species/sub-genotypes are particularly scarce. Methods A longitudinal molecular epidemiological survey was conducted between July 2015 to September 2016 in patients referred to or attended at the Hospital San Pedro (La Rioja, Northern Spain) that tested positive for G. duodenalis (N = 106) or Cryptosporidium spp. (N = 103) by direct microscopy and/or a rapid lateral flow immunochromatographic assay. G. duodenalis infections were subsequently confirmed by real-time PCR and positive isolates assessed by multi-locus sequence genotyping of the glutamate dehydrogenase and beta-giardin genes of the parasite. Cryptosporidium species and sub-genotypes were investigated at the 60 kDa glycoprotein or the small subunit ribosomal RNA genes of the parasite. Sociode-mographic and clinical parameters of infected patients were also gathered and analysed. Principal findings Out of 90 G. duodenalis-positive isolates by real-time PCR a total of 16 isolates were successfully typed. AII (44%, 7/16) was the most prevalent sub-assemblage found, followed by BIV (31%, 5/16) and BIII (19%, 3/ 16). A discordant genotype result AII/AIII was identified in an additional (6%, 1/16) isolate. No mixed infections A+B were detected. Similarly, a total of 81 Cryptosporidium spp. isolates were successfully typed, revealing the presence of C. hominis (81%, 66/81) and C. parvum (19%, 15/81). Obtained GP60 sequences were assigned to subtype families Ib (73%, 59/81) within C. hominis, and IIa (7%, 6/81) and IId (2%, 2/81) within C. parvum. A marked inter-annual variation in Cryptosporidium cases was observed. Conclusions Human giardiasis and cryptosporidiosis are commonly identified in patients seeking medical care in Northern Spain and represent a more important health concern than initially thought. Assemblage A within G. duodenalis and sub-genotype IbA10G2 within C. hominis were the genetic variants of these parasite species more frequently found circulating in the population under study. Molecular data presented here seem to suggest that G. duodenalis and Cryptosporidium infections arise through anthroponotic rather than zoonotic transmission in this Spanish region.	[Manuel Azcona-Gutierrez, Jose; Miguel Soria-Blanco, Luis] Hosp San Pedro, Dept Biomed Diagnost, Logrono, La Rioja, Spain; [de Lucio, Aida; Hernandez-de-Mingo, Marta; Morales, Lucia; Aguilera, Maria; Fuentes, Isabel; Carmena, David] Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain; [Garcia-Garcia, Concepcion] Hosp San Pedro, Dept Infect Dis, Logrono, La Rioja, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Carmena, D (corresponding author), Natl Ctr Microbiol, Parasitol Serv, Madrid, Spain.	dacarmena@isciii.es	Carmena, David/S-4049-2019; Azcona-Gutierrez, Jose Manuel/L-2260-2015; García-García, Concepción/H-5456-2017	Carmena, David/0000-0002-4015-8553; Azcona-Gutierrez, Jose Manuel/0000-0002-0932-9596; García-García, Concepción/0000-0003-1606-8141	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain [CP12/03081, PI13/01106]	Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain	This project was funded by Research project CP12/03081 (DC), Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain. It was also supported by Research project PI13/01106 (IF), Carlos III Health Institute, Ministry of Economy and Competitiveness, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal-Fabeiro JL, 2015, EPIDEMIOL INFECT, V143, P3022, DOI 10.1017/S0950268815000163; Blanco MA, 2016, ENFERM INFEC MICR CL, V34, P142, DOI 10.1016/j.eimc.2015.05.010; Caccio SM, 2016, CLIN MICROBIOL INFEC, V22, P471, DOI 10.1016/j.cmi.2016.04.021; Cardona GA, 2011, SCI TOTAL ENVIRON, V412, P101, DOI 10.1016/j.scitotenv.2011.09.076; Carmena D., 2012, WORLD J CLIN INFECT, V2, P1, DOI DOI 10.5495/WJCID.V2.I1.1; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Cieloszyk J, 2012, ENFERM INFEC MICR CL, V30, P549, DOI 10.1016/j.eimc.2012.04.011; Cobo F, 2016, J IMMIGR MINOR HEALT, V18, P8, DOI 10.1007/s10903-014-0141-5; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; de Lucio A, 2017, ACTA TROP, V170, P48, DOI 10.1016/j.actatropica.2017.02.024; de Lucio A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159992; de Lucio A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143981; de Lucio A, 2016, INFECT GENET EVOL, V37, P49, DOI 10.1016/j.meegid.2015.10.026; Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2014, J CLIN MICROBIOL, V52, P524, DOI 10.1128/JCM.02973-13; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Fournet N, 2012, EUROSURVEILLANCE, V17, P18; Gabin-Garcia LB, 2017, INFECT GENET EVOL, V48, P131, DOI 10.1016/j.meegid.2016.12.014; Garcia LS, 2003, J CLIN MICROBIOL, V41, P209, DOI 10.1128/JCM.41.1.209-212.2003; Goni P, 2010, ENFERM INFEC MICR CL, V28, P710, DOI 10.1016/j.eimc.2010.04.010; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Gutierrez JM, 2013, TRAVEL MED INFECT DI, V11, P126, DOI 10.1016/j.tmaid.2012.10.004; Halliez MCM, 2013, WORLD J GASTROENTERO, V19, P8974, DOI 10.3748/wjg.v19.i47.8974; Ignatius R, 2014, CLIN MICROBIOL INFEC, V20, pO783, DOI 10.1111/1469-0691.12596; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031883; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lasek-Nesselquist E, 2009, J EUKARYOT MICROBIOL, V56, P504, DOI 10.1111/j.1550-7408.2009.00443.x; Lebbad M, 2008, ACTA TROP, V106, P44, DOI 10.1016/j.actatropica.2008.01.004; Li N, 2013, EMERG INFECT DIS, V19, P1573, DOI 10.3201/eid1910.121361; Majowicz SE, 2001, CAN J PUBLIC HEALTH, V92, P62, DOI 10.1007/BF03404847; Manser M, 2014, CLIN MICROBIOL INFEC, V20, pO65, DOI 10.1111/1469-0691.12297; Martinez-Ruiz R, 2016, ENFERM INFEC MICR CL, V34, P532, DOI 10.1016/j.eimc.2015.11.012; Mateo M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000075; Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762; Navarro-i-Martinez L, 2013, ENFERM INFEC MICR CL, V31, P506, DOI 10.1016/j.eimc.2012.11.005; Navarro-i-Martinez L, 2011, ENFERM INFEC MICR CL, V29, P135, DOI 10.1016/j.eimc.2010.12.002; Paulos S, 2016, J MICROBIOL METH, V127, P68, DOI 10.1016/j.mimet.2016.05.020; Quilez J, 2008, APPL ENVIRON MICROB, V74, P6026, DOI 10.1128/AEM.00606-08; Ramo A, 2015, INFECT GENET EVOL, V31, P190, DOI 10.1016/j.meegid.2015.01.023; Ramo A, 2014, VET PARASITOL, V205, P466, DOI 10.1016/j.vetpar.2014.08.025; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Robertson LJ, 2013, GIARDIA FOODBORNE PA, P13; Roelfsema JH, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1397-5; Roellig DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169915; Ryan U, 2014, PARASITOLOGY, V141, P1667, DOI 10.1017/S0031182014001085; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Segura R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121753; Siripattanapipong S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-206; Soriano JM, 2011, TROP BIOMED, V28, P557; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Takumi K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-168; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Llorent MT, 2007, PARASITOL INT, V56, P201, DOI 10.1016/j.parint.2007.02.003; Tiangtip R, 2002, TROP MED INT HEALTH, V7, P357, DOI 10.1046/j.1365-3156.2002.00855.x; Verweij JJ, 2003, MOL CELL PROBE, V17, P223, DOI 10.1016/S0890-8508(03)00057-4; Xiao LH, 2008, FEMS IMMUNOL MED MIC, V52, P309, DOI 10.1111/j.1574-695X.2008.00377.x; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	63	32	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178575	10.1371/journal.pone.0178575	http://dx.doi.org/10.1371/journal.pone.0178575			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617836	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600011
J	Cheng, ST; Tang, H; Ren, JH; Chen, X; Huang, AL; Chen, J				Cheng, Sheng-Tao; Tang, Hua; Ren, Ji-Hua; Chen, Xiang; Huang, Ai-Long; Chen, Juan			Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo	PLOS ONE			English	Article							X PROTEIN; IL-34; INFECTION; TRANSCRIPTION; MACROPHAGES; CSF-1; CELLS	Background The hepatitis B virus (HBV) infection could activate the immune system and induce extensive inflammatory response. As the most important inflammatory factor, interleukins are critical for anti-viral immunity. Here we investigated whether interleukin-34 (IL-34) play a role in HBV infection. Methodology/Principal findings In this study, we first found that both serum IL-34 and IL-34 mRNA in PBMCs in chronic HBV patients was significantly decreased compared to the healthy controls. Furthermore, both IL-34 protein and mRNA levels were declined hepatoma cells expressing HBV. In addition, the clinical parameters analysis found that serum IL-34 was significantly associated with HBV DNA (P = 0.0066), ALT (P = 0.0327), AST (P = 0.0435), TB (P = 0.0406), DB (P = 0.0368) and AFP (P = 0.0225). Correlation analysis also found that serum IL-34 negatively correlated with HBV DNA copies, ALT and AST. In vitro studies found that IL-34 treatment in HepAD38 and HepG2.2.15 cells markedly inhibited HBV DNA, total RNA, 3.5kb mRNA and HBc protein. In vivo studies further demonstrated IL-34 treatment in HBV transgenic mice exhibited greater inhibition on HBV DNA, total RNA, 3.5kb mRNA and HBc protein, suggesting the effect to IL-34 on HBV is likely due to host innate or adaptive immune response. Conclusions/Significance Our study identified a novel interleukin, IL-34, which has anti-viral activity in HBV replication in hepatocytes in vitro and in vivo. These data suggest a rationale for the use of IL-34 in the HBV treatment.	[Cheng, Sheng-Tao; Tang, Hua; Ren, Ji-Hua; Huang, Ai-Long; Chen, Juan] Chongqing Med Univ, Inst Viral Hepatitis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Dept Infe, Chongqing, Peoples R China; [Chen, Xiang] Zhuzhou Cent Hosp, Dept Clin Lab, Zhuzhou, Peoples R China; [Huang, Ai-Long] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chongqing Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Huang, AL; Chen, J (corresponding author), Chongqing Med Univ, Inst Viral Hepatitis, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis,Minist Educ,Dept Infe, Chongqing, Peoples R China.; Huang, AL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ahuang1964@163.com; yixin_xinyuan@163.com			National Natural Science Foundation of China [81672012]; Chongqing Natural Science Foundation [cstc2016jcyjA0183]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundation of China (81672012, JC) and Chongqing Natural Science Foundation (cstc2016jcyjA0183, JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoro S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8562; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Bao S, 2016, CLIN RES HEPATOLOGY; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Braum O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070281; Busca A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-22; Chen L, 2016, ANN RHEUMATIC DIS; Chen RD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40783; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018689; Dandri M, 2016, CLIN INFECT DIS, V62, pS281, DOI 10.1093/cid/ciw023; Darrieutort-Laffite C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/241840; Edwards Jessica K, 2015, Nat Rev Nephrol, V11, P504, DOI 10.1038/nrneph.2015.116; Fan Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep39324; Garceau V, 2010, J LEUKOCYTE BIOL, V87, P753, DOI 10.1189/jlb.0909624; Gerngross L, 2015, J NEUROVIROL, V21, P249, DOI 10.1007/s13365-014-0270-6; Ivanov S, 2013, J VIROL, V87, P6911, DOI 10.1128/JVI.02943-12; Lin CL, 2016, LIVER INT, V36, P85, DOI 10.1111/liv.13003; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Lucifora J, 2011, J HEPATOL, V55, P996, DOI 10.1016/j.jhep.2011.02.015; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Peng YZ, 2016, DIAGN MICR INFEC DIS, V85, P154, DOI 10.1016/j.diagmicrobio.2015.09.017; Pham Edward A, 2016, Curr Hepatol Rep, V15, P237, DOI 10.1007/s11901-016-0315-9; Pollicino T, 2015, WORLD J HEPATOL, V7, P819, DOI 10.4254/wjh.v7.i6.819; Preisser L, 2014, HEPATOLOGY, V60, P1879, DOI 10.1002/hep.27328; Ren JH, 2014, J VIROL, V88, P2442, DOI 10.1128/JVI.02861-13; Roh EY, 2017, ANN HEPATOL, V16, P63, DOI 10.5604/16652681.1226816; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; van de Klundert MAA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100281; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yu GZ, 2015, AM J MED SCI, V349, P145, DOI 10.1097/MAJ.0000000000000373; Zepp JA, 2011, J IMMUNOL, V186, P4110, DOI 10.4049/jimmunol.1000081; Zhou SL, 2016, HEPATOLOGY, V63, P1560, DOI 10.1002/hep.28445; Zwicker S, 2015, CLIN SCI, V129, P281, DOI 10.1042/CS20150176	36	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179605	10.1371/journal.pone.0179605	http://dx.doi.org/10.1371/journal.pone.0179605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614380	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900065
J	Pan, YL; Liu, DW; Deng, L				Pan, Yuliang; Liu, Diwei; Deng, Lei			Accurate prediction of functional effects for variants by combining gradient tree boosting with optimal neighborhood properties	PLOS ONE			English	Article							AMINO-ACID; FEATURE-SELECTION; PHENYLALANINE-HYDROXYLASE; PROTEIN-STRUCTURE; GENOME SEQUENCE; MUTATIONS; DATABASE; IDENTIFICATION; INFORMATION; RESOURCE	Single amino acid variations (SAVs) potentially alter biological functions, including causing diseases or natural differences between individuals. Identifying the relationship between a SAV and certain disease provides the starting point for understanding the underlying mechanisms of specific associations, and can help further prevention and diagnosis of inherited disease. We propose PredSAV, a computational method that can effectively predict how likely SAVs are to be associated with disease by incorporating gradient tree boosting (GTB) algorithm and optimally selected neighborhood features. A two-step feature selection approach is used to explore the most relevant and informative neighborhood properties that contribute to the prediction of disease association of SAVs across a wide range of sequence and structural features, especially some novel structural neighborhood features. In crossvalidation experiments on the benchmark dataset, PredSAV achieves promising performances with an AUC score of 0.908 and a specificity of 0.838, which are significantly better than that of the other existing methods. Furthermore, we validate the capability of our proposed method by an independent test and gain a competitive advantage as a result. PredSAV, which combines gradient tree boosting with optimally selected neighborhood features, can return reliable predictions in distinguishing between disease-associated and neutral variants. Compared with existing methods, PredSAV shows improved specificity as well as increased overall performance.	[Pan, Yuliang; Liu, Diwei; Deng, Lei] Cent South Univ, Sch Software, Changsha, Hunan, Peoples R China; [Deng, Lei] Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China	Central South University	Deng, L (corresponding author), Cent South Univ, Sch Software, Changsha, Hunan, Peoples R China.; Deng, L (corresponding author), Shanghai Key Lab Intelligent Informat Proc, Shanghai, Peoples R China.	leideng@csu.edu.cn		Pan, Yuliang/0000-0002-4551-6057	National Natural Science Foundation of China [61672541, 61309010]; China Postdoctoral Science Foundation [2015T80886]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130162120073]; Shanghai Key Laboratory of Intelligent Information Processing [IIPL-2014-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Key Laboratory of Intelligent Information Processing	This work was supported by National Natural Science Foundation of China under grants No. 61672541 and No. 61309010, China Postdoctoral Science Foundation under grant no. 2015T80886, Specialized Research Fund for the Doctoral Program of Higher Education of China under grant no. 20130162120073 and Shanghai Key Laboratory of Intelligent Information Processing under grant no. IIPL-2014-002.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andersen OA, 2001, J MOL BIOL, V314, P279, DOI 10.1006/jmbi.2001.5061; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; BAKER CH, 1995, BIOCHEM BIOPH RES CO, V213, P154, DOI 10.1006/bbrc.1995.2110; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chakrabarty B, 2016, NUCLEIC ACIDS RES; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Chen XX, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1654623; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cline MS, 2011, BIOINFORMATICS, V27, P441, DOI 10.1093/bioinformatics/btq695; David A, 2015, J MOL BIOL, V427, P2886, DOI 10.1016/j.jmb.2015.07.004; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Deng L, 2014, NUCLEIC ACIDS RES, V42, pW290, DOI 10.1093/nar/gku437; Deng L, 2013, J COMPUT BIOL, V20, P878, DOI 10.1089/cmb.2013.0083; Deng L, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-426; Ding H, 2014, MOL BIOSYST, V10, P2229, DOI 10.1039/c4mb00316k; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Du PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086879; Du PF, 2012, J THEOR BIOL, V313, P61, DOI 10.1016/j.jtbi.2012.08.016; Fan C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0851-2; Flicek P, 2011, NUCLEIC ACIDS RES; Flydal MI, 2013, IUBMB LIFE, V65, P341, DOI 10.1002/iub.1150; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Garzon JI, 2016, ELIFE, V5, DOI 10.7554/eLife.18715; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hardin C, 2002, CURR OPIN STRUC BIOL, V12, P176, DOI 10.1016/S0959-440X(02)00306-8; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hubbard SJ, 1993, NACCESS COMPUTER PRO, V2; Jiao YS, 2016, J THEOR BIOL, V391, P35, DOI 10.1016/j.jtbi.2015.11.009; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Liang SD, 2004, PROTEINS, V54, P271, DOI 10.1002/prot.10560; Liang SD, 2009, PROTEINS, V75, P397, DOI 10.1002/prot.22252; Liang ZY, 2017, BIOINFORMATICS, V33, P467, DOI 10.1093/bioinformatics/btw630; Lin H, 2019, IEEE ACM T COMPUT BI, V16, P1316, DOI 10.1109/TCBB.2017.2666141; Lin H, 2011, J MICROBIOL METH, V84, P67, DOI 10.1016/j.mimet.2010.10.013; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Sunyaev SR, 1999, PROTEIN ENG, V12, P387, DOI 10.1093/protein/12.5.387; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043847; Wei LY, 2017, J PROTEOME RES, V16, P2044, DOI 10.1021/acs.jproteome.7b00019; WEI LY, IEEE ACM TRANSACTION, V16, P1264; Yang H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5413903; Yates CM, 2014, J MOL BIOL, V426, P2692, DOI 10.1016/j.jmb.2014.04.026; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zhang CJ, 2016, ONCOTARGET, V7, P69783, DOI 10.18632/oncotarget.11975; Zhao YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34817; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	82	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179314	10.1371/journal.pone.0179314	http://dx.doi.org/10.1371/journal.pone.0179314			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614374	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900041
J	Zhu, HF; Li, XF; Zhai, W; Liu, Y; Gao, QQ; Liu, JP; Ren, L; Chen, HY; Zhu, YY				Zhu, Hongfang; Li, Xiaofeng; Zhai, Wen; Liu, Yang; Gao, Qianqian; Liu, Jinping; Ren, Li; Chen, Huoying; Zhu, Yuying			Effects of low light on photosynthetic properties, antioxidant enzyme activity, and anthocyanin accumulation in purple pak-choi (Brassica campestris ssp Chinensis Makino)	PLOS ONE			English	Article							LOW-TEMPERATURE; STRESS; EXPRESSION; GENES; BIOSYNTHESIS; LEAVES; INTENSITY; QUALITY; SHADE; PIGMENTATION	Anthocyanins are secondary metabolites that contribute to red, blue, and purple colors in plants and are affected by light, but the effects of low light on the physiological responses of purple pak-choi plant leaves are still unclear. In this study, purple pak-choi seedlings were exposed to low light by shading with white gauze and black shading in a phytotron. The responses in terms of photosynthetic properties, carbohydrate metabolism, antioxidant enzyme activity, anthocyanin biosynthetic enzyme activity, and the relative chlorophyll and anthocyanin content of leaves were measured. The results showed that chlorophyll b, intracellular CO2 content, stomatal conductance and antioxidant activities of guaiacol peroxidase, catalase and superoxide dismutase transiently increased in the shade treatments at 5 d. The malondialdehyde content also increased under low light stress, which damages plant cells. With the extension of shading time (at 15 d), the relative chlorophyll a, anthocyanin and soluble protein contents, net photosynthetic rate, transpiration rate, stomata conductance, antioxidant enzyme activities, and activities of four anthocyanin biosynthetic enzymes decreased significantly. Thus, at the early stage of low light treatment, the chlorophyll b content increased to improve photosynthesis. When the low light treatment was extended, antioxidant enzyme activity and the activity of anthocyanin biosynthesis enzymes were inhibited, causing the purple pak-choi seedlings to fade from purple to green. This study provides valuable information for further deciphering genetic mechanisms and improving agronomic traits in purple pak-choi under optimal light requirements.	[Zhu, Hongfang; Liu, Yang; Ren, Li; Chen, Huoying] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Zhu, Hongfang; Li, Xiaofeng; Zhai, Wen; Gao, Qianqian; Zhu, Yuying] Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China; [Gao, Qianqian; Liu, Jinping] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Academy of Agricultural Sciences; Nanjing Agricultural University	Chen, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.; Zhu, YY (corresponding author), Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.	chhy@sjtu.edu.cn; yy5@saas.sh.cn	Wen, Zhai/AAF-3410-2019; li, xiaofeng/GXF-9442-2022		Shanghai green vegetable industry system; SAAS Program for Excellent Research Team (SPERT)	Shanghai green vegetable industry system; SAAS Program for Excellent Research Team (SPERT)	This work was supported by the Shanghai green vegetable industry system, and SAAS Program for Excellent Research Team (SPERT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert NW, 2009, J EXP BOT, V60, P2191, DOI 10.1093/jxb/erp097; Almeselmani M, 2006, PLANT SCI, V171, P382, DOI 10.1016/j.plantsci.2006.04.009; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Amirjani M. R., 2010, AM J PLANT PHYSL, V5, P350, DOI [DOI 10.3923/ajpp.2010.350.360, DOI 10.3923/AJPP.2010.350.360]; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; BATSCHAUER A, 1991, PLANT MOL BIOL, V16, P175, DOI 10.1007/BF00020550; Bell GE, 1999, CROP SCI, V39, P1142, DOI 10.2135/cropsci1999.0011183X003900040032x; Berenschot AS, 2014, PHYSIOL MOL BIOL PLA, V20, P1, DOI 10.1007/s12298-013-0212-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Callejon-Ferre AJ, 2009, SPAN J AGRIC RES, V7, P41, DOI 10.5424/sjar/2009071-396; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; COCKSHULL KE, 1992, J HORTIC SCI, V67, P11, DOI 10.1080/00221589.1992.11516215; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; CROOKSTON RK, 1975, CROP SCI, V15, P412, DOI 10.2135/cropsci1975.0011183X001500030039x; Dai AH, 2012, ENVIRON EXP BOT, V79, P1, DOI 10.1016/j.envexpbot.2012.01.003; Durner J, 1996, J BIOL CHEM, V271, P28492, DOI 10.1074/jbc.271.45.28492; Fay PA, 1998, INT J PLANT SCI, V159, P805, DOI 10.1086/297600; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Gong ZZ, 1997, PLANT MOL BIOL, V35, P915, DOI 10.1023/A:1005959203396; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Guo J, 2010, PLANT GROWTH REGUL, V62, P1, DOI 10.1007/s10725-010-9472-y; Guo N, 2014, BMC GENOMICS, V487, P135; Holmgren M, 2000, OIKOS, V90, P67, DOI 10.1034/j.1600-0706.2000.900107.x; Huang ZA, 2012, J GENET GENOMICS, V39, P149, DOI 10.1016/j.jgg.2012.01.007; ISHIDA K, 1989, J JPN SOC HORTIC SCI, V58, P657, DOI 10.2503/jjshs.58.657; JANARDHAN KV, 1980, INDIAN J PLANT PHYSI, V23, P156; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jiao DM, 2001, PHOTOSYNTHETICA, V39, P167, DOI 10.1023/A:1013758504857; Johnson WA, 2016, J ENTOMOLOGICAL SCI, V47, P327; Koblet W, 1996, BOT HELV, V106, P73; KOES RE, 1994, BIOESSAYS, V16, P123, DOI 10.1002/bies.950160209; Lakshmi Praba M., 2011, INT RICE RES NOTES, V29; LANGE H, 1971, PLANT PHYSIOL, V47, P649, DOI 10.1104/pp.47.5.649; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lee J, 2008, FOOD CHEM, V110, P782, DOI 10.1016/j.foodchem.2008.03.010; Li YC, 2015, S AFR J BOT, V99, P122, DOI 10.1016/j.sajb.2015.04.001; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; LIPPHARDT S, 1988, EMBO J, V7, P4027, DOI 10.1002/j.1460-2075.1988.tb03296.x; Liu QH, 2014, RICE SCI, V21, P243, DOI 10.1016/S1672-6308(13)60192-4; Lopez L, 2012, PLANT CELL ENVIRON, V35, P994, DOI 10.1111/j.1365-3040.2011.02467.x; Ma ZQ, 2010, HORTSCIENCE, V45, P863, DOI 10.21273/HORTSCI.45.6.863; Meir S, 2010, ACTA HORTIC, V877, P1735, DOI 10.17660/ActaHortic.2010.877.238; [孟雷 Meng Lei], 2002, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V33, P87; Meng XC, 2004, PLANT GROWTH REGUL, V44, P243, DOI 10.1007/s10725-004-4454-6; Miki S, 2015, J PLANT PHYSIOL, V175, P157, DOI 10.1016/j.jplph.2014.12.002; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moyano E, 1998, PLANT PHYSIOL, V117, P711, DOI 10.1104/pp.117.2.711; Mushtaq MA, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00311; Nagy F, 2006, PHOTOMORPHOGENESIS P; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NEUHAUS G, 1993, CELL, V73, P937, DOI 10.1016/0092-8674(93)90272-R; Nielsen SL, 2011, PHOTOSYNTHETICA, V49, P346, DOI 10.1007/s11099-011-0042-y; Niu SS, 2010, PLANTA, V231, P887, DOI 10.1007/s00425-009-1095-z; PATTEN KD, 1986, J AM SOC HORTIC SCI, V111, P360; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Pompelli MF, 2010, J PLANT PHYSIOL, V167, P1052, DOI 10.1016/j.jplph.2010.03.001; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Sato K, 1980, JPN J CROP SCI; Shimada N, 2003, PLANT PHYSIOL, V131, P941, DOI 10.1104/pp.004820; SINGH V P, 1988, Indian Journal of Plant Physiology, V31, P84; Siringam K, 2011, AFR J BIOTECHNOL, V10, P1340; Steyn WJ, 2009, PHYSIOL PLANTARUM, V136, P461, DOI 10.1111/j.1399-3054.2009.01246.x; Sukwattanasinit T, 2007, PLANTA MED, V73, P1517, DOI 10.1055/s-2007-990262; Takos AM, 2006, PLANT PHYSIOL, V142, P1216, DOI 10.1104/pp.106.088104; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Tsuda T, 2004, J AM SOC HORTIC SCI, V129, P857, DOI 10.21273/JASHS.129.6.0857; Vale AP, 2015, FOOD CHEM, V178, P292, DOI 10.1016/j.foodchem.2015.01.064; Verheul MJ, 2012, ACTA HORTIC, V956, P365; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang L, 2012, PLOS ONE, V8; [杨东 Yang Dong], 2011, [中国生态农业学报, Chinese Journal of Eco-Agriculture], V19, P347, DOI 10.3724/SP.J.1011.2011.00347; Yang Feng-Jian, 2007, Bulletin of Botanical Research, V27, P556; Zhang XL, 2011, SCI HORTIC-AMSTERDAM, V129, P656, DOI 10.1016/j.scienta.2011.05.009; Zhao DL, 1998, J PLANT NUTR, V21, P1681, DOI 10.1080/01904169809365513; [周卫霞 Zhou Weixia], 2013, [生态学报, Acta Ecologica Sinica], V33, P4315; Zhu Ping, 2008, Acta Agronomica Sinica, V34, P2003	80	52	58	12	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179305	10.1371/journal.pone.0179305	http://dx.doi.org/10.1371/journal.pone.0179305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609452	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700027
J	Rossmann, C; McCrackin, MA; Armeson, KE; Haemmerich, D				Rossmann, Christian; McCrackin, M. A.; Armeson, Kent E.; Haemmerich, Dieter			Temperature sensitive liposomes combined with thermal ablation: Effects of duration and timing of heating in mathematical models and in vivo	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; PROLONGED CIRCULATION TIME; TARGETED DRUG-DELIVERY; RADIOFREQUENCY ABLATION; THERMOSENSITIVE LIPOSOMES; HEPATOCELLULAR-CARCINOMA; DOXORUBICIN RELEASE; MILD HYPERTHERMIA; LIVER-CANCER; PHASE-I	Background Temperature sensitive liposomes (TSL) are nanoparticles that rapidly release the contained drug at hyperthermic temperatures, typically above similar to 40 degrees C. TSL have been combined with various heating modalities, but there is no consensus on required hyperthermia duration or ideal timing of heating relative to TSL administration. The goal of this study was to determine changes in drug uptake when heating duration and timing are varied when combining TSL with radiofrequency ablation (RF) heating. Methods We used computer models to simulate both RF tissue heating and TSL drug delivery, to calculate spatial drug concentration maps. We simulated heating for 5, 12 and 30 min for a single RF electrode, as well as three sequential 12 min ablations for 3 electrodes placed in a triangular array. To support simulation results, we performed porcine in vivo studies in normal liver, where TSL filled with doxorubicin (TSL-Dox) at a dose of 30 mg was infused over 30 min. Following infusion, RF heating was performed in separate liver locations for either 5 min (n = 2) or 12 min (n = 2). After ablation, the animal was euthanized, and liver extracted and frozen. Liver samples were cut orthogonal to the electrode axis, and fluorescence imaging was used to visualize tissue doxorubicin distribution. Results Both in vivo studies and computer models demonstrate a ring-shaped drug deposition within similar to 1 cm of the visibly coagulated tissue. Drug uptake directly correlated with heating duration. In computer simulations, drug concentration increased by a factor of 2.2x and 4.3x when heating duration was extended from 5 to either 12, or 30 minutes, respectively. In vivo, drug concentration was by a factor of 2.4x higher at 12 vs 5 min heating duration (7.1 mu g/g to 3.0 mu g/g). The computer models suggest that heating should be timed to maximize area under the curve of systemic plasma concentration of encapsulated drug. Conclusions Both computer models and in vivo study demonstrate that tissue drug uptake directly correlates with heating duration for TSL based delivery. Computational models were able to predict the spatial drug delivery profile, and may serve as a valuable tool in understanding and optimizing drug delivery systems.	[Rossmann, Christian; Haemmerich, Dieter] Med Univ South Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA; [McCrackin, M. A.] Med Univ South Carolina, Dept Comparat Med, Charleston, SC 29425 USA; [McCrackin, M. A.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA; [Armeson, Kent E.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; [Haemmerich, Dieter] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Clemson University	Haemmerich, D (corresponding author), Med Univ South Carolina, Dept Pediat, 171 Ashley Ave, Charleston, SC 29425 USA.; Haemmerich, D (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.	haemmer@musc.edu		Haemmerich, Dieter/0000-0003-1127-7024	National Institutes of Health (National Cancer Institute) [R01CA181664]; Extramural Research Facilities Program of the National Center for Research Resources (National Institutes of Health) [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA181664] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Extramural Research Facilities Program of the National Center for Research Resources (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	National Institutes of Health (National Cancer Institute) R01CA181664 (DH). Part of this research was conducted in a facility supported by grant C06 RR018823 from the Extramural Research Facilities Program of the National Center for Research Resources (National Institutes of Health).	Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Andriyanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092555; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; GABIZON A, 1994, CANCER RES, V54, P987; Gasselhuber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047453; Gasselhuber A, 2012, INT J HYPERTHER, V28, P337, DOI 10.3109/02656736.2012.677930; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Gillams AM, 2005, BRIT J CANCER, V92, P1825, DOI 10.1038/sj.bjc.6602582; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; Gustafson DL, 2002, J PHARM SCI, V91, P1488, DOI 10.1002/jps.10161; Haemmerich D, 2003, 2003 P 25 ANN INT C; Haemmerich Dieter, 2010, Critical Reviews in Biomedical Engineering, V38, P53, DOI 10.1615/CritRevBiomedEng.v38.i1.50; Hauck ML, 2006, CLIN CANCER RES, V12, P4004, DOI 10.1158/1078-0432.CCR-06-0226; Hilmer SN, 2004, DRUG METAB DISPOS, V32, P794, DOI 10.1124/dmd.32.8.794; Jacques S, 1991, THERMAL COAGULATION; Li L, 2013, J CONTROL RELEASE, V168, P142, DOI 10.1016/j.jconrel.2013.03.011; Lindner LH, 2004, CLIN CANCER RES, V10, P2168, DOI 10.1158/1078-0432.CCR-03-0035; Livraghi T, 2001, Eur J Ultrasound, V13, P159, DOI 10.1016/S0929-8266(01)00128-8; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; Machi J, 2001, J GASTROINTEST SURG, V5, P477, DOI 10.1016/S1091-255X(01)80085-8; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Manzoor AA, 2012, CANCER RES, V72, P5566, DOI 10.1158/0008-5472.CAN-12-1683; Mertyna P, 2007, J VASC INTERV RADIOL, V18, P647, DOI 10.1016/j.jvir.2007.02.033; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Needham D, 2000, CANCER RES, V60, P1197; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Poon RTP, 2011, FUTURE ONCOL, V7, P937, DOI [10.2217/fon.11.73, 10.2217/FON.11.73]; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Prakash P, 2013, INT J HYPERTHER, V29, P296, DOI 10.3109/02656736.2013.800998; Reddy G, 2013, INT J HYPERTHER, V29, P318, DOI 10.3109/02656736.2013.792125; Rossmann C, 2015, CRIT REV BI IN PRESS; Solbiati L, 2001, RADIOLOGY, V221, P159, DOI 10.1148/radiol.2211001624; Staruch RM, 2015, INT J HYPERTHER, P1; Staruch RM, 2012, INT J HYPERTHER, V28, P776, DOI 10.3109/02656736.2012.736670; Swenson CE, 2015, PLOS ONE UNPUB; Team RC, 2016, R LANG ENV STAT COMP; van Duijnhoven FH, 2006, ANN SURG ONCOL, V13, P651, DOI 10.1245/ASO.2006.08.014; Willerding L, 2016, J CONTROL RELEASE, V222, P47, DOI 10.1016/j.jconrel.2015.12.004; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018	40	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179131	10.1371/journal.pone.0179131	http://dx.doi.org/10.1371/journal.pone.0179131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604815	gold, Green Published			2022-12-26	WOS:000403088400030
J	Stoll, JS; Fuller, E; Crona, BI				Stoll, Joshua S.; Fuller, Emma; Crona, Beatrice I.			Uneven adaptive capacity among fishers in a sea of change	PLOS ONE			English	Article							DIVERSIFICATION; MANAGEMENT; IMPACTS	Fishers worldwide operate in an environment of uncertainty and constant change. Their ability to manage risk associated with such uncertainty and subsequently adapt to change is largely a function of individual circumstances, including their access to different fisheries. However, explicit attention to the heterogeneity of fishers' connections to fisheries at the level of the individual has been largely ignored. We illustrate the ubiquitous nature of these connections by constructing a typology of commercial fishers in the state of Maine based on the different fisheries that fishers rely on to sustain their livelihoods and find that there are over 600 combinations. We evaluate the adaptive potential of each strategy, using a set of attributes identified by fisheries experts in the state, and find that only 12% of fishers can be classified as being well positioned to adapt in the face of changing socioeconomic and ecological conditions. Sensitivity to the uneven and heterogeneous capacity of fishers to manage risk and adapt to change is critical to devising effective management strategies that broadly support fishers. This will require greater attention to the social-ecological connectivity of fishers across different jurisdictions.	[Stoll, Joshua S.] Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; [Stoll, Joshua S.] Maine Ctr Coastal Fisheries, Stonington, ME 04681 USA; [Fuller, Emma] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ USA; [Crona, Beatrice I.] Royal Swedish Acad Sci, Global Econ Dynam & Biosphere, Stockholm, Sweden; [Crona, Beatrice I.] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden	University of Maine System; University of Maine Orono; Princeton University; Royal Swedish Academy of Sciences; Global Economic Dynamics & Biosphere - The Erling-Persson Family Academy Program; Stockholm University	Stoll, JS (corresponding author), Univ Maine, Sch Marine Sci, Orono, ME 04469 USA.; Stoll, JS (corresponding author), Maine Ctr Coastal Fisheries, Stonington, ME 04681 USA.	joshua.stoll@maine.edu	Crona, Beatrice/HHZ-3183-2022	Crona, Beatrice/0000-0003-1617-4067	Robert and Patricia Switzer Foundation; Senator George J. Mitchell Center for Sustainability Solutions; National Fish and Wildlife Foundation; Erling-Persson Foundation through Global Economic Dynamics; Biosphere Program at the Royal Swedish Academy of Sciences; MISTRA; National Science Foundation (GRFP) [GEO-1211972]	Robert and Patricia Switzer Foundation; Senator George J. Mitchell Center for Sustainability Solutions; National Fish and Wildlife Foundation; Erling-Persson Foundation through Global Economic Dynamics; Biosphere Program at the Royal Swedish Academy of Sciences; MISTRA; National Science Foundation (GRFP)(National Science Foundation (NSF))	Funding to support JSS was provided by the Robert and Patricia Switzer Foundation, Senator George J. Mitchell Center for Sustainability Solutions, and the National Fish and Wildlife Foundation. Contribution by BC was made possible by funding from the Erling-Persson Foundation through the Global Economic Dynamics and the Biosphere Program at the Royal Swedish Academy of Sciences, and by MISTRA through a core grant to the Stockholm Resilience Center, Stockholm University. EF was supported by funding from the National Science Foundation (GRFP, GEO-1211972).	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Bennett NJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06315-190205; Biggs R, 2010, ECOL SOC, V15, DOI 10.5751/ES-03411-150209; Chapin III F., 1999, TRENDS ECOL EVOL, V25, P241; Chollett I, 2014, ECOL ECON, V102, P118, DOI 10.1016/j.ecolecon.2014.03.010; Cinner J, 2005, E S, P1; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Coulthard S, 2008, GLOBAL ENVIRON CHANG, V18, P479, DOI 10.1016/j.gloenvcha.2008.04.003; Coulthard S, 2015, SOCIOL RURALIS, V55, P275, DOI 10.1111/soru.12093; Crona BI, 2015, GLOBAL ENVIRON CHANG, V35, P162, DOI 10.1016/j.gloenvcha.2015.07.006; Crona BI, 2016, MAR POLICY, V65, P1, DOI 10.1016/j.marpol.2015.11.016; Finkbeiner EM, 2015, GLOBAL ENVIRON CHANG, V32, P139, DOI 10.1016/j.gloenvcha.2015.03.009; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Gunnrd, 2006, 0615 EMAX, V6, P1; Hentati-Sundberg J, 2015, ECOSYSTEMS, V18, P45, DOI 10.1007/s10021-014-9811-3; Husson F., 2010, PRINCIPAL COMPONENT, P1; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; ME DMR, 2016, PRELIMINARY 2015 COM, P1; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Rodriguez-Manas L, 2013, J GERONTOL A-BIOL, V68, P62, DOI 10.1093/gerona/gls119; Schindler DE, 2015, SCIENCE, V347, P953, DOI 10.1126/science.1261824; Stoll JS, 2016, GLOBAL ENVIRON CHANG, V37, P79, DOI 10.1016/j.gloenvcha.2016.01.005; Stoll JS, 2015, OCEAN COAST MANAGE, V116, P185, DOI 10.1016/j.ocecoaman.2015.07.019; United States Department of Agriculture (USDA), 2016, GLOB AGR TRAD SYST; US Department of Commerce, 2015, SALM POP TREND SUMM; Villasante S, 2013, AMBIO, V42, P923, DOI 10.1007/s13280-013-0448-9; Westley FR, 2013, ECOL SOC, V18, DOI 10.5751/ES-05072-180327; WILSON JA, 1994, MAR POLICY, V18, P291, DOI 10.1016/0308-597X(94)90044-2	29	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178266	10.1371/journal.pone.0178266	http://dx.doi.org/10.1371/journal.pone.0178266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX2VR	28604775	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400013
J	Zhang, JQ; Ma, RJ; Li, L; Wang, LN; Hou, XJ; Han, LS; Ge, J; Li, M; Wang, Q				Zhang, Jiaqi; Ma, Rujun; Li, Ling; Wang, Lina; Hou, Xiaojing; Han, Longsen; Ge, Juan; Li, Mo; Wang, Qiang			Intersectin 2 controls actin cap formation and meiotic division in mouse oocytes through the Cdc42 pathway	FASEB JOURNAL			English	Article						meiosis; spindle; chromosome; polarization; cytokinesis	POLARITY ESTABLISHMENT; RHO GTPASES; N-WASP; SPINDLE; PROTEIN; ACTIVATION; DYNAMIN; ENDOCYTOSIS; ORGANIZATION; PROTRUSION	Intersectins (ITSNs), an evolutionarily conserved adaptor protein family, have been implicated in multiple biologic processes; however, their functions in mammalian oocytes have not been addressed. Here, we report delayed meiotic resumption and defective cytokinesis upon specific depletion of ITSN2 in mouse oocytes. In particular, abnormal spindle, misaligned chromosomes, and loss of cortical actin cap are readily observed in ITSN2-depleted oocytes. Similarly, a small molecule that targets the Cdc42-ITSN interaction also disrupts oocyte maturation and actin polymerization. Moreover, we find that ITSN2 depletion reduces the activity of Cdc42 in oocytes and, of note, that forced expression of the dominant-positive mutant of Cdc42, in part, prevents the effects of ITSN2 knockdown on actin cap formation. In addition, the localization of WASP and Arp2, the downstream effector proteins of Cdc42, is altered in ITSN2-depleted oocytes accordingly. In summary, our data support a model in which ITSN2 depletion induces the inactivation of Cdc42, which, in turn, influences the distribution and function of Arp2/3 and WASP, consequently disrupting oocyte polarity establishment and meiotic division.-Zhang, J., Ma, R., Li, L., Wang, L., Hou, X., Han, L., Ge, J., Li, M., Wang, Q. Intersectin 2 controls actin cap formation and meiotic division in mouse oocytes through the Cdc42 pathway.	[Zhang, Jiaqi; Li, Ling; Hou, Xiaojing; Han, Longsen; Ge, Juan; Wang, Qiang] Nanjing Med Univ, State Key Lab Reprod Med, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Ma, Rujun] Nanjing Univ, Jinling Hosp, Ctr Reprod Med, Sch Med, Nanjing, Jiangsu, Peoples R China; [Wang, Lina] Natl Hlth & Family Planning Commiss, Key Lab Birth Defects Prevent, Zhengzhou, Henan, Peoples R China; [Li, Mo] Peking Univ, Ctr Reprod Med, Hosp 3, Beijing, Peoples R China	Nanjing Medical University; Nanjing University; Peking University	Wang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	qwang2012@njmu.edu.cn			National Natural Science Foundation of China [31571543]; National Key Scientific Research Projects of China [2014CB943200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Research Projects of China	This work was supported by the National Natural Science Foundation of China (31571543) and National Key Scientific Research Projects of China (2014CB943200). The authors declare no conflicts of interest.	Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Cannon JL, 2001, IMMUNITY, V15, P249, DOI 10.1016/S1074-7613(01)00178-9; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Friesland A, 2013, P NATL ACAD SCI USA, V110, P1261, DOI 10.1073/pnas.1116051110; Gryaznova T, 2015, CELL SIGNAL, V27, P1499, DOI 10.1016/j.cellsig.2015.03.006; Guipponi M, 1998, GENOMICS, V53, P369, DOI 10.1006/geno.1998.5521; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Li L, 2016, ONCOTARGET, V7, P50927, DOI 10.18632/oncotarget.10815; Ma CQ, 2006, CURR BIOL, V16, P214, DOI 10.1016/j.cub.2005.11.067; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; Mohney RP, 2003, J BIOL CHEM, V278, P47038, DOI 10.1074/jbc.M303895200; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Novokhatska O, 2011, BIOCHEM BIOPH RES CO, V408, P663, DOI 10.1016/j.bbrc.2011.04.081; Okamoto M, 1999, J BIOL CHEM, V274, P18446, DOI 10.1074/jbc.274.26.18446; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pucharcos C, 2001, BBA-GENE STRUCT EXPR, V1521, P1, DOI 10.1016/S0167-4781(01)00276-7; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Shao XW, 2015, BIOL OPEN, V4, P1569, DOI 10.1242/bio.013649; Smith WJ, 2005, BIOCHEMISTRY-US, V44, P13282, DOI 10.1021/bi050591b; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Sun QY, 2009, CELL CYCLE, V8, P2741, DOI 10.4161/cc.8.17.9471; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang QC, 2014, BIOL CELL, V106, P193, DOI 10.1111/boc.201400007; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Yi KX, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0002; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang X, 2008, DEV CELL, V15, P386, DOI 10.1016/j.devcel.2008.07.005	38	12	12	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2017	31	10					4277	4285		10.1096/fj.201700179R	http://dx.doi.org/10.1096/fj.201700179R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PF	28626024				2022-12-26	WOS:000413397400008
J	Upadhyay, AS; Stehling, O; Panayiotou, C; Rosser, R; Lill, R; Overby, AK				Upadhyay, Arunkumar S.; Stehling, Oliver; Panayiotou, Christakis; Roesser, Ralf; Lill, Roland; Overby, Anna K.			Cellular requirements for iron-sulfur cluster insertion into the antiviral radical SAM protein viperin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMPHIPATHIC ALPHA-HELIX; HEPATITIS-C VIRUS; WEST NILE VIRUS; DNA METABOLISM; BIOGENESIS; REPLICATION; MMS19; IDENTIFICATION; MATURATION; INHIBIT	Viperin (RSAD2) is an interferon-stimulated antiviral protein that belongs to the radical S-adenosylmethionine (SAM) enzyme family. Viperin's iron-sulfur (Fe/S) cluster is critical for its antiviral activity against many different viruses. CIA1 (CIAO1), an essential component of the cytosolic iron-sulfur protein assembly (CIA) machinery, is crucial for Fe/S cluster insertion into viperin and hence for viperin's antiviral activity. In the CIA pathway, CIA1 cooperates with CIA2A, CIA2B, and MMS19 targeting factors to form various complexes that mediate the dedicated maturation of specific Fe/S recipient proteins. To date, however, the mechanisms of how viperin acquires its radical SAM Fe/S cluster to gain antiviral activity are poorly understood. Using co-immunoprecipitation and Fe-55-radiolabeling experiments, we therefore studied the roles of CIA2A, CIA2B, and MMS19 for Fe/S cluster insertion. CIA2B and MMS19 physically interacted with the C terminus of viperin and used CIA1 as the primary viperin-interacting protein. In contrast, CIA2A bound to viperin's N terminus in a CIA1-, CIA2B-, and MMS19-independent fashion. Of note, the observed interaction of both CIA2 isoforms with a single Fe/S target protein is unprecedented in the CIA pathway. Fe-55-radiolabeling experiments with human cells depleted of CIA1, CIA2A, CIA2B, or MMS19 revealed that CIA1, but none of the other CIA factors, is predominantly required for (55F)e/S cluster incorporation into viperin. Collectively, viperin maturation represents a novel CIA pathway with a minimal requirement of the CIA-targeting factors and represents a new paradigm for the insertion of the Fe/S cofactor into a radical SAM protein.	[Upadhyay, Arunkumar S.; Panayiotou, Christakis; Overby, Anna K.] Umea Univ, Dept Clin Microbiol, Virol, Bldg 6F, S-90185 Umea, Sweden; [Upadhyay, Arunkumar S.; Panayiotou, Christakis; Overby, Anna K.] Umea Univ, Lab Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Stehling, Oliver; Roesser, Ralf; Lill, Roland] Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany; [Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, Hans Meerwein Str, D-35043 Marburg, Germany	Umea University; Umea University; Philipps University Marburg	Overby, AK (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Bldg 6F, S-90185 Umea, Sweden.; Lill, R (corresponding author), Philipps Univ Marburg, Inst Zytobiol & Zytopathol, Robert Koch Str 6, D-35032 Marburg, Germany.	lill@staff.uni-marburg.de; anna.overby@umu.se		Lill, Roland/0000-0002-8345-6518; Overby Wernstedt, Anna/0000-0001-6553-0940	Laboratory for Molecular Medicine Sweden (MIMS); Umea Center for Microbial Research (UCMR); Swedish Research Council [2011-2795]; Swedish Foundation for Strategic Research [ICA10-0059, FFL12-0089]; EMBO Short Term Fellowship [ASTF444-2015]; Deutsche Forschungsgemeinschaft [LI 415/6, SPP 1710, SPP 1927]	Laboratory for Molecular Medicine Sweden (MIMS); Umea Center for Microbial Research (UCMR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EMBO Short Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Laboratory for Molecular Medicine Sweden (MIMS), the Umea Center for Microbial Research (UCMR), Swedish Research Council Grant 2011-2795, Swedish Foundation for Strategic Research Grants ICA10-0059 and FFL12-0089 (to A. K. O.), and EMBO Short Term Fellowship ASTF444-2015) (to A. S. U.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Deutsche Forschungsgemeinschaft Grants LI 415/6, SPP 1710, and SPP 1927. To whom correspondence may be addressed: Institut fur Zytobiologie und Zytopathologie, Philipps-Universitat Marburg, Robert-Kochstr. 6, 35032 Marburg, Germany. Tel.: 49-6421-2866483; Fax: 49-6421-2866449; E-mail: lill@staff.uni-marburg.de.	Balk J, 2005, BIOCHEM SOC T, V33, P86, DOI 10.1042/BST0330086; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Seki M, 2013, J BIOL CHEM, V288, P16680, DOI 10.1074/jbc.M112.416602; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; van Wietmarschen N, 2012, J BIOL CHEM, V287, P43351, DOI 10.1074/jbc.M112.431270; Vashisht AA, 2015, J BIOL CHEM, V290, P14218, DOI 10.1074/jbc.M115.650762; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	39	22	24	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 18	2017	292	33					13879	13889		10.1074/jbc.M117.780122	http://dx.doi.org/10.1074/jbc.M117.780122			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE0XG	28615450	hybrid, Green Published			2022-12-26	WOS:000407942400029
J	Kokabu, S; Nakatomi, C; Matsubara, T; Ono, Y; Addison, WN; Lowery, JW; Urata, M; Hudnall, AM; Hitomi, S; Nakatomi, M; Sato, T; Osawa, K; Yoda, T; Rosen, V; Jimi, E				Kokabu, Shoichiro; Nakatomi, Chihiro; Matsubara, Takuma; Ono, Yusuke; Addison, William N.; Lowery, Jonathan W.; Urata, Mariko; Hudnall, Aaron M.; Hitomi, Suzuro; Nakatomi, Mitsushiro; Sato, Tsuyoshi; Osawa, Kenji; Yoda, Tetsuya; Rosen, Vicki; Jimi, Eijiro			The transcriptional co-repressor TLE3 regulates myogenic differentiation by repressing the activity of the MyoD transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						basic helix-loop-helix (bHLH) transcription factor; mesenchymal stem cells (MSCs); MyoD; myogenesis; skeletal muscle; TLE	MUSCLE SATELLITE CELL; MARROW STROMAL CELLS; GROUCHO-RELATED GENE; STEM-CELLS; EXPRESSION; FAMILY; DOMAIN; PROTEINS; ENHANCER; MEMBER	Satellite cells are skeletal muscle stem cells that provide myonuclei for postnatal muscle growth, maintenance, and repair/regeneration in adults. Normally, satellite cells are mitotically quiescent, but they are activated in response to muscle injury, in which case they proliferate extensively and exhibit up-regulated expression of the transcription factor MyoD, a master regulator of myogenesis. MyoD forms a heterodimer with E proteins through their basic helix-loop-helix domain, binds to E boxes in the genome and thereby activates transcription at muscle-specific promoters. The central role of MyoD in muscle differentiation has increased interest in finding potential MyoD regulators. Here we identified transducin-like enhancer of split (TLE3), one of the Groucho/TLE family members, as a regulator of MyoD function during myogenesis. TLE3 was expressed in activated and proliferative satellite cells in which increased TLE3 levels suppressed myogenic differentiation, and, conversely, reduced TLE3 levels promoted myogenesis with a concomitant increase in proliferation. We found that, via its glutamine- and serine/proline-rich domains, TLE3 interferes with MyoD function by disrupting the association between the basic helix-loop-helix domain of MyoD and E proteins. Our findings indicate that TLE3 participates in skeletal muscle homeostasis by dampening satellite cell differentiation via repression of MyoD transcriptional activity.	[Kokabu, Shoichiro; Nakatomi, Chihiro; Matsubara, Takuma; Urata, Mariko; Jimi, Eijiro] Kyushu Dent Univ, Div Mol Signaling & Biochem, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Hitomi, Suzuro] Kyushu Dent Univ, Div Physiol, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Nakatomi, Mitsushiro] Kyushu Dent Univ, Div Anat, Dept Hlth Promot, Kitakyushu, Fukuoka 8038580, Japan; [Osawa, Kenji] Kyushu Dent Univ, Div Oral Med, Dept Sci Phys Funct, Kitakyushu, Fukuoka 8038580, Japan; [Kokabu, Shoichiro; Sato, Tsuyoshi; Yoda, Tetsuya] Saitama Med Univ, Fac Med, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Kokabu, Shoichiro; Rosen, Vicki] Harvard Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Ono, Yusuke] Nagasaki Univ, Musculoskeletal Mol Biol Res Grp, Grad Sch Biomed Sci, Nagasaki 8528102, Japan; [Addison, William N.] McGill Univ, Shriners Hosp Children, Dept Human Genet, Res Unit, Montreal, PQ H4A 0A9, Canada; [Lowery, Jonathan W.; Hudnall, Aaron M.] Marian Univ, Coll Osteopath Med, Div Biomed Sci, Indianapolis, IN 46222 USA; [Jimi, Eijiro] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Oral Hlth Brain Hlth Total Hlth, Fukuoka 8128582, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Saitama Medical University; Harvard University; Harvard School of Dental Medicine; Nagasaki University; McGill University; Kyushu University	Kokabu, S (corresponding author), Kyushu Dent Univ, Div Mol Signaling & Biochem, Dept Hlth Promot, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	r14kokabu@fa.kyu-dent.ac.jp	Matsubara, Takuma/B-5031-2019; Nakatomi, Chihiro/AAV-5575-2021	Matsubara, Takuma/0000-0002-8505-0431; Nakatomi, Chihiro/0000-0003-2049-6624; Addison, William/0000-0002-8587-8028; Kokabu, Shoichiro/0000-0002-6663-4327; Ono, Yusuke/0000-0002-4802-7507	Ministry of Education, Culture, Sports, Science and Technology of Japan [26870543]; Fukuoka Foundation for Sound Health	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fukuoka Foundation for Sound Health(Fukuoka Foundation for Sound Health)	This work was supported by a grant obtained from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant 26870543 to S. K.). This work was also supported by the Fukuoka Foundation for Sound Health (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1992, SCIENCE, V256, P1027, DOI 10.1126/science.1317057; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Goldman LA, 1996, BIOTECHNIQUES, V21, P1013; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Harvey N, 2010, NAT REV RHEUMATOL, V6, P99, DOI 10.1038/nrrheum.2009.260; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Kokabu S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3753581; Kokabu S, 2015, BIOCHEM BIOPH RES CO, V468, P568, DOI 10.1016/j.bbrc.2015.10.142; Kokabu S, 2014, FEBS LETT, V588, P614, DOI 10.1016/j.febslet.2013.12.031; Kokabu S, 2013, BIOCHEM BIOPH RES CO, V438, P205, DOI 10.1016/j.bbrc.2013.07.054; Kokabu S, 2011, MOL ENDOCRINOL, V25, P474, DOI 10.1210/me.2010-0305; Kokabu S, 2010, J BONE MINER RES, V25, P653, DOI 10.1359/jbmr.090736; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MIYASAKA H, 1993, J BIOL CHEM, V268, P22695; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; NEUHOLD LA, 1993, CELL, V74, P1033, DOI 10.1016/0092-8674(93)90725-6; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Parkhurst SM, 1998, TRENDS GENET, V14, P130, DOI 10.1016/S0168-9525(98)01407-3; Pickles LM, 2002, STRUCTURE, V10, P751, DOI 10.1016/S0969-2126(02)00768-2; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; STIFANI S, 1992, NAT GENET, V2, P343, DOI 10.1038/ng1292-343a; Tada Y, 2014, ONCOTARGET, V5, P12317, DOI 10.18632/oncotarget.2640; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tsuka S, 2015, BIOCHEM BIOPH RES CO, V459, P437, DOI 10.1016/j.bbrc.2015.02.123; Villanueva CJ, 2013, CELL METAB, V17, P423, DOI 10.1016/j.cmet.2013.01.016; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Wang YK, 1997, DEVELOPMENT, V124, P2507; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhang P, 2013, BIOCHEM BIOPH RES CO, V440, P454, DOI 10.1016/j.bbrc.2013.09.128; Zhu ZM, 1997, DEV DYNAM, V209, P233, DOI 10.1002/(SICI)1097-0177(199706)209:2<233::AID-AJA9>3.3.CO;2-D	52	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	2017	292	31					12885	12894		10.1074/jbc.M116.774570	http://dx.doi.org/10.1074/jbc.M116.774570			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD0HJ	28607151	Green Published, hybrid			2022-12-26	WOS:000407220100018
J	Buehring, GC; Shen, HM; Schwartz, DA; Lawson, JS				Buehring, Gertrude C.; Shen, HuaMin; Schwartz, Daniel A.; Lawson, James S.			Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development	PLOS ONE			English	Article							DNA; PATTERNS; RISK	Bovine leukemia virus (BLV), a common virus of cattle globally, was believed for decades not to infect humans. More recent techniques (in situ PCR and DNA sequencing) enabled detection of BLV in human breast tissue, and determination of its significant association with breast cancer in a US population. Using similar techniques to study 96 Australian women, we report here detection of retrotranscribed BLV DNA in breast tissue of 40/50(80%) of women with breast cancer versus 19/46(41%) of women with no history of breast cancer, indicating an age-adjusted odds ratio and confidence interval of 4.72(1.71-13.05). These results corroborate the findings of the previous study of US women with an even higher odds ratio for the Australian population. For 48 of the subjects, paired breast tissue samples, removed 3-10 years apart in two unrelated procedures, were available. For 23/31 (74%) of these, in which the first specimen was diagnosed as nonmalignant (benign or premalignant) and the second as malignant, BLV was already present in benign breast tissue years 3-10 years before the malignancy was diagnosed. This is consistent with the supposition of a causative temporal relationship between BLV infection and subsequent development of cancer.	[Buehring, Gertrude C.; Shen, HuaMin; Schwartz, Daniel A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Lawson, James S.] Univ New South Wales, Dept Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of California System; University of California Berkeley; University of New South Wales Sydney	Buehring, GC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	buehring@berkeley.edu		, Gertrude/0000-0002-8868-7390	University of California, Berkeley; James and Margaret Lawson Research Fund	University of California, Berkeley(University of California System); James and Margaret Lawson Research Fund	This research was supported by a Research Enabling Grant from the University of California, Berkeley and the James and Margaret Lawson Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2004, BREAST CANCER RES, V6, P229, DOI 10.1186/bcr932; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Chartsbin, 2007, CURR WORLDW TOL MILK; Cooper JK, 2007, IN VITRO CELL DEV-AN, V43, P344, DOI 10.1007/s11626-007-9060-2; Dairy Australia, 2012, DAIRY AUSTR; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Gardner SN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-668; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Giovanna M, 2013, OPEN J MED MICROBIOL; Globcan, 2012, EST AG STAND BREAST; GRAVES DC, 1976, CANCER RES, V36, P4152; Jaisamrarn U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079260; McGirr KM, 2006, VIRUS GENES, V32, P229, DOI 10.1007/s11262-005-6907-z; Nuovo GJ, 1996, PCR SITU HYBRIDIZATI, P193; Parkin DM, 2006, BREAST J, V12, pS70, DOI 10.1111/j.1075-122X.2006.00205.x; Robinson LA, 2016, BRIT J CANCER, V115, P497, DOI 10.1038/bjc.2016.213; Ryan D, 2012, FLOCK HERD CASE NOTE; Smit E, 1999, J AM DIET ASSOC, V99, P813, DOI 10.1016/S0002-8223(99)00193-5; StataCorp, 2015, STAT 14 BAS REF MAN; Van Der Maaten M J, 1975, Bibl Haematol, P360; Vedham V, 2015, CANCER MED-US, V4, P1908, DOI 10.1002/cam4.538; ZIEGLER RG, 1993, JNCI-J NATL CANCER I, V85, P1819, DOI 10.1093/jnci/85.22.1819	24	47	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179367	10.1371/journal.pone.0179367	http://dx.doi.org/10.1371/journal.pone.0179367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640828	Green Submitted, gold, Green Published			2022-12-26	WOS:000404135800031
J	Nishikawa, E; Oakley, L; Seed, PT; Doyle, P; Oteng-Ntim, E				Nishikawa, Erin; Oakley, Laura; Seed, Paul T.; Doyle, Pat; Oteng-Ntim, Eugene			Maternal BMI and diabetes in pregnancy: Investigating variations between ethnic groups using routine maternity data from London, UK	PLOS ONE			English	Article							BODY-MASS INDEX; RACIAL ORIGIN; OBESITY; INTERRELATIONSHIP; COMPLICATIONS; PREVALENCE; MELLITUS; POINTS; RISK	Objective To investigate the ethnicity-specific association between body mass index (BMI) and diabetes in pregnancy, with a focus on the appropriateness of using BMI cut-offs to identify pregnant women at risk of diabetes. Study design Analysis of routinely-collected data from a maternity unit in London, UK. Data were available on 53 264 women delivering between 2004 and 2012. Logistic regression was used to explore the association between diabetes in pregnancy and BMI among women of different ethnicities, and adjusted probability estimates were used to derive risk equivalent cut-offs. ROC curve analysis was used to assess the performance of BMI as a predictor of diabetes in pregnancy. Results The prevalence of diabetes in pregnancy was 2.3% overall; highest in South and East Asian women (4.6% and 3.7%). In adjusted analysis, BMI category was strongly associated with diabetes in all ethnic groups. Modelled as a continuous variable with a quadratic term, BMI was an acceptable predictor of diabetes according to ROC curve analysis. Applying a BMI cut-off of 30 kg/m(2) would identify just over half of Black women with diabetes in pregnancy, a third of White (32%) and South Asian (35%) women, but only 13% of East Asian women. The 'risk equivalent' (comparable to 30 kg/m(2) in White women) threshold for South Asian and East Asian women was approximately 21 kg/m(2), and 27.5 kg/m(2) for Black women. Conclusions This study suggests that current BMI thresholds are likely to be ineffective for diabetes screening in South and East Asian women, as many cases of diabetes will occur at low BMI levels. Our results suggest that East Asian women appear to face a similarly high risk of diabetes to South Asian women. Current UK guidelines recommend diabetes screening should be offered to all pregnant South Asian women; extending this recommendation to include women of East Asian ethnicity may be appropriate.	[Nishikawa, Erin; Oakley, Laura; Doyle, Pat] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Seed, Paul T.] Kings Coll London, Womens Hlth Acad Ctr, London, England; [Oteng-Ntim, Eugene] Guys & St Thomas NHS Fdn Trust, Dept Womens Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Oakley, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	laura.oakley@lshtm.ac.uk	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; /0000-0002-4697-4316	Tommy's [1060508]; CLAHRC South London (NIHR)	Tommy's; CLAHRC South London (NIHR)	Paul T Seed is partly funded by Tommy's (Registered charity no. 1060508) and by CLAHRC South London (NIHR).	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bryant M, 2014, INT J OBESITY, V38, P444, DOI 10.1038/ijo.2013.117; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Chong YS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-345; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Department of Communities and Local Government, 2010, ENGL IND DEPR; Hedderson M, 2012, DIABETES CARE, V35, P1492, DOI 10.2337/dc11-2267; Heslehurst N, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-156; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Khalil A, 2013, ULTRASOUND OBST GYN, V41, P278, DOI 10.1002/uog.12313; Kim SY, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110249; Makgoba M, 2012, BJOG-INT J OBSTET GY, V119, P276, DOI 10.1111/j.1471-0528.2011.03156.x; McDonald R, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/297420; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Misra A, 2009, J Assoc Physicians India, V57, P163; Mitanchez D, 2015, WORLD J DIABETES, V6, P734, DOI 10.4239/wjd.v6.i5.734; Mpondo BCT, 2015, J DIABETES METABOLIC, V14, P1; National Collaborating Centre for Women's and Children's Health (UK), 2015, DIAB PREGN MAN DIAB; National Institute for Health and Care Excellence (NICE), 2013, BMI PREV ILL HLTH PR; NHS Digital, 2017, HOSP EP STAT WWW DOC; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ramos GA, 2005, AM J OBSTET GYNECOL, V193, P1089, DOI 10.1016/j.ajog.2005.06.040; Retnakaran R, 2006, J CLIN ENDOCR METAB, V91, P93, DOI 10.1210/jc.2005-1253; Royal College of Obstetricians and Gynaecologists, 2011, DIAGN TREATM GEST DI; Shah A, 2011, AM J PERINAT, V28, P515, DOI 10.1055/s-0031-1272968	25	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179332	10.1371/journal.pone.0179332	http://dx.doi.org/10.1371/journal.pone.0179332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640854	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000404135800028
J	Popova, EY; Salzberg, AC; Yang, C; Zhang, SSM; Barnstable, CJ				Popova, Evgenya Y.; Salzberg, Anna C.; Yang, Chen; Zhang, Samuel Shao-Min; Barnstable, Colin J.			Identification and prediction of alternative transcription start sites that generate rod photoreceptor-specific transcripts from ubiquitously expressed genes	PLOS ONE			English	Article							RECEPTOR-BETA; RETINAL DEGENERATION; PROMOTER USAGE; MOUSE RETINA; DIVERSITY; SEQUENCE; ISOFORM; SUBUNIT; BRAIN; CHIP	Transcriptome complexity is substantially increased by the use of multiple transcription start sites for a given gene. By utilizing a rod photoreceptor-specific chromatin signature, and the RefSeq database of established transcription start sites, we have identified essentially all known rod photoreceptor genes as well as a group of novel genes that have a high probability of being expressed in rod photoreceptors. Approximately half of these novel rod genes are transcribed into multiple mRNA and/or protein isoforms through alternative transcriptional start sites (ATSS), only one of which has a rod-specific epigenetic signature and gives rise to a rod transcript. This suggests that, during retina development, some genes use ATSS to regulate cell type and temporal specificity, effectively generating a rod transcript from otherwise ubiquitously expressed genes. Biological confirmation of the relationship between epigenetic signatures and gene expression, as well as comparison of our genome-wide chromatin signature maps with available data sets for retina, namely a ChIP-on-Chip study of Polymerase-II (Pol-II) binding sites, ChIP-Seq studies for NRL- and CRX-binding sites and DHS (University of Washington data, available on UCSC mouse Genome Browser as a part of ENCODE project) fully support our hypothesis and together accurately identify and predict an array of new rod transcripts. The same approach was used to identify a number of TSS that are not currently in RefSeq. Biological conformation of the use of some of these TSS suggests that this method will be valuable for exploring the range of transcriptional complexity in many tissues. Comparison of mouse and human genome-wide data indicates that most of these alternate TSS appear to be present in both species, indicating that our approach can be useful for identification of regulatory regions that might play a role in human retinal disease.	[Popova, Evgenya Y.; Yang, Chen; Zhang, Samuel Shao-Min; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 16801 USA; [Popova, Evgenya Y.; Zhang, Samuel Shao-Min; Barnstable, Colin J.] Penn State Hershey Eye Ctr, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Univ, Coll Med, Bioinformat Core, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Barnstable, CJ (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 16801 USA.; Barnstable, CJ (corresponding author), Penn State Hershey Eye Ctr, Hershey, PA 17033 USA.	cbarnstable@psu.edu	Barnstable, Colin/GLU-9219-2022; Barnstable, Colin/ABB-4822-2021	Barnstable, Colin/0000-0002-7011-4068; Popova, Evgenya/0000-0001-6164-262X	Macula Vision Foundation for CJB	Macula Vision Foundation for CJB	Support was provided by Macula Vision Foundation for CJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Batut P, 2013, GENOME RES, V23, P169, DOI 10.1101/gr.139618.112; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Brooks MJ, 2011, MOL VIS, V17, P3034; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dorrell MI, 2004, INVEST OPHTH VIS SCI, V45, P1009, DOI 10.1167/iovs.03-0806; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farjo R, 2002, VISION RES, V42, P463, DOI 10.1016/S0042-6989(01)00219-X; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fu YL, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.605774; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gamsiz ED, 2012, GENOMICS, V99, P44, DOI 10.1016/j.ygeno.2011.09.003; Geisert EE, 2009, MOL VIS, V15, P1730; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hao H, 2012, PLOS GENET, V8, P380, DOI 10.1371/journal.pgen.1002649; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Kim JW, 2016, CELL REP, V17, P2460, DOI 10.1016/j.celrep.2016.10.074; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Liu H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2793; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Loeffen J, 1998, BIOCHEM BIOPH RES CO, V247, P751, DOI 10.1006/bbrc.1998.8882; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Matsumoto K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku600; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mo A, 2016, ELIFE, V5, DOI 10.7554/eLife.11613; Mortazavi A, 2013, GENOME RES, V23, P2136, DOI 10.1101/gr.158261.113; Mu XQ, 2001, NUCLEIC ACIDS RES, V29, P4983, DOI 10.1093/nar/29.24.4983; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Natarajan A, 2012, GENOME RES, V22, P1711, DOI 10.1101/gr.135129.111; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Popova EY, 2016, MOL NEUROBIOL, V53, P4563, DOI 10.1007/s12035-015-9395-8; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ruzycki PA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0732-z; Sergouniotis PI, 2011, AM J HUM GENET, V89, P782, DOI 10.1016/j.ajhg.2011.11.004; Shabalina SA, 2014, NUCLEIC ACIDS RES, V42, P7132, DOI 10.1093/nar/gku342; Shafit-Zagardo B, 1998, MOL NEUROBIOL, V16, P149, DOI 10.1007/BF02740642; Sharon D, 2002, P NATL ACAD SCI USA, V99, P315, DOI 10.1073/pnas.012582799; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Stohr H, 2002, BBA-GENE STRUCT EXPR, V1579, P18, DOI 10.1016/S0167-4781(02)00499-2; Sun H, 2011, NUCLEIC ACIDS RES, V39, P190, DOI 10.1093/nar/gkq775; Suzuki A, 2015, NUCLEIC ACIDS RES, V43, pD87, DOI 10.1093/nar/gku1080; Tamarkin-Ben-Harush A, 2017, ELIFE, P6, DOI DOI 10.7554/ELIFE.21907270.E10; Tummala P, 2010, MOL VIS, V16, P252; Wang X, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166941; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wilken MS, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-8; Wong P, 2011, BLOOD, V118, pE128, DOI 10.1182/blood-2011-03-341404; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yasuda M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-982; Zhang JH, 2000, J NEUROCHEM, V75, P393, DOI 10.1046/j.1471-4159.2000.0750393.x; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-40; Zhang XC, 2016, CELL, V166, P1147, DOI 10.1016/j.cell.2016.07.025	63	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179230	10.1371/journal.pone.0179230	http://dx.doi.org/10.1371/journal.pone.0179230			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640837	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800023
J	Torche, PC; Muller, V; Westerlund, F; Ambjornsson, T				Torche, Paola C.; Muller, Vilhelm; Westerlund, Fredrik; Ambjornsson, Tobias			Noise reduction in single time frame optical DNA maps	PLOS ONE			English	Article							STRUCTURAL VARIATION; HYBRIDIZATION	In optical DNA mapping technologies sequence-specific intensity variations (DNA barcodes) along stretched and stained DNA molecules are produced. These "fingerprints" of the underlying DNA sequence have a resolution of the order one kilobasepairs and the stretching of the DNA molecules are performed by surface adsorption or nano-channel setups. A post-processing challenge for nano-channel based methods, due to local and global random movement of the DNA molecule during imaging, is how to align different time frames in order to produce reproducible time-averaged DNA barcodes. The current solutions to this challenge are computationally rather slow. With high-throughput applications in mind, we here introduce a parameter-free method for filtering a single time frame noisy barcode (snap-shot optical map), measured in a fraction of a second. By using only a single time frame barcode we circumvent the need for post-processing alignment. We demonstrate that our method is successful at providing filtered barcodes which are less noisy and more similar to time averaged barcodes. The method is based on the application of a low-pass filter on a single noisy barcode using the width of the Point Spread Function of the system as a unique, and known, filtering parameter. We find that after applying our method, the Pearson correlation coefficient (a real number in the range from -1 to 1) between the single time-frame barcode and the time average of the aligned kymograph increases significantly, roughly by 0.2 on average. By comparing to a database of more than 3000 theoretical plasmid barcodes we show that the capabilities to identify plasmids is improved by filtering single time-frame barcodes compared to the unfiltered analogues. Since snap-shot experiments and computational time using our method both are less than a second, this study opens up for high throughput optical DNA mapping with improved reproducibility.	[Torche, Paola C.; Ambjornsson, Tobias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden; [Muller, Vilhelm; Westerlund, Fredrik] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden	Lund University; Chalmers University of Technology	Ambjornsson, T (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	tobias.ambjornsson@thep.lu.se		Muller, Vilhelm/0000-0002-4554-2124; Ambjornsson, Tobias/0000-0002-6439-8842	EU Horizon 2020 program [634890]; EuroNanoMed2 (project NanoDiaBac); Torsten Soderbergs Stiftelse; Swedish Research Council [2014-4305]	EU Horizon 2020 program; EuroNanoMed2 (project NanoDiaBac); Torsten Soderbergs Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	FW and TA acknowledge the EU Horizon 2020 program (Grant 634890, BeyondSeq, https://ec.europa.eu/programmes/horizon2020/). FW acknowledges the EuroNanoMed2 (project NanoDiaBac, http://www.euronanomed.net/) and Torsten Soderbergs Stiftelse (http://www.torstensoderbergsstiftelse.se/) for funding. TA acknowledges the Swedish Research Council (grant number 2014-4305, http://www.vr.se/) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Lena Nyberg is acknowledged for assisting with some of the experiments. The plasmids where a kind gift from Assoc. Prof. Linus Sandegren at Uppsala University. FW and TA acknowledges the EU Horizon 2020 program (Grant 634890, BeyondSeq). FW is grateful to the EuroNanoMed2 project NanoDiaBac and Torsten Soderbergs Stiftelse. TA acknowledges the Swedish Research Council (grant number 2014-4305) for funding.	Aitman T, 2005, NATURE; Alvarez L, 1992, SIAM J NUMERICAL ANA; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Chamala S, 2014, SCIENCE; Chambolle A., 2004, J MATH IMAGING VISIO; Chapleau R, 2015, J CLIN DIAGNOSTIC RE; Chen Q, 2006, MICROBIOL-SGM, V152, P1041, DOI 10.1099/mic.0.28648-0; Conrad D, 2009, NATURE; Dong Y, 2012, NATURE BIOTECHNOLOGY; Easton Jr R.L., 2010, FOURIER METHODS IMAG; Faraji H, 2006, IEEE T IMAGE PROCESS, V15, P2676, DOI 10.1109/TIP.2006.877363; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiore L, 1996, J NEUROSCIENCE METHO; Grunwald A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv563; Haider S, 2016, SCI REPORTS; Howe K, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0052-y; Iarko V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062701; Jackson SA, 2012, APPL ENVIRON MICROB, V78, P1601, DOI 10.1128/AEM.07464-11; Jo K, 2009, METHODS MOL BIOL, V544, P29, DOI 10.1007/978-1-59745-483-4_3; Kervrann C, 2007, LECT NOTES COMPUT SC, V4485, P520; Kervrann C, 2006, IEEE T IMAGE PROCESS, V15, P2866, DOI 10.1109/TIP.2006.877529; Lacroix J, 2016, SMALL; Lavigne JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034294; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Lim A, 2001, GENOME RES; Loudon R., 2000, QUANTUM THEORY LIGHT; Meng X, 1995, NATURE GENETICS; Mrazek P, 2003, INT J COMPUTER VISIO; Muller V, 2016, SCI REPORTS, P6; Muller V, 2016, ACS INFECT DIS; Muller V, 2017, LAB CHIP, V17, P579, DOI 10.1039/c6lc01439a; NAGARAJAN N, 2008, BIOINFORMATICS; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Nilsson AN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku556; Noble C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121905; Nyberg L, 2011, BIOCH BIOPHYSICAL RE; Nyberg L, 2016, NATURE; Okada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157595; Ostergaard P, 2015, J MICROMECHANICS MIC; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pedersen J, 2013, BIOPHYSICAL J; Phelippeau H, 2008, INT C SIGN PROC; Pitas I, 1992, P IEEE; Pizurica A, 2003, IEEE T MED IMAGING, V22, P323, DOI 10.1109/TMI.2003.809588; Ponomarev VI, 1996, MMET'96 - VITH INTERNATIONAL CONFERENCE ON MATHEMATICAL METHODS IN ELECTROMAGNETIC THEORY, PROCEEDINGS, P211, DOI 10.1109/MMET.1996.565693; Ramirez MS, 2011, ANTIMICROB AGENTS CH, V55, P1520, DOI 10.1128/AAC.01595-10; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; Richards B, 1959, P ROYAL SOC LONDON; Schwan WR, 2010, MICROBIOL-SGM, V156, P2124, DOI 10.1099/mic.0.033977-0; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shearer LA, 2014, G3-GENES GENOM GENET, V4, P1395, DOI 10.1534/g3.114.011197; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Stallinga S, 2010, OPTICS EXPRESS; Teague B, 2010, P NATL ACAD SCI USA, V107, P10848, DOI 10.1073/pnas.0914638107; Teo ASM, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0106-1; Vranken C, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1406; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Zhou S, 2009, PLOS GENETICS	61	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179041	10.1371/journal.pone.0179041	http://dx.doi.org/10.1371/journal.pone.0179041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640821	Green Published, gold, Green Submitted			2022-12-26	WOS:000404135800016
J	Assfalg, R; Alupei, MC; Wagner, M; Koch, S; Gonzalez, OG; Schelling, A; Scharffetter-Kochanek, K; Iben, S				Assfalg, Robin; Alupei, Marius Costel; Wagner, Maximilian; Koch, Sylvia; Gonzalez, Omar Garcia; Schelling, Adrian; Scharffetter-Kochanek, Karin; Iben, Sebastian			Cellular sensitivity to UV-irradiation is mediated by RNA polymerase I transcription	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN L11; COCKAYNE-SYNDROME; DNA-DAMAGE; P53; APOPTOSIS; INHIBITION; ACTIVATION; DISRUPTION; ELONGATION; PATHWAY	The nucleolus has long been considered to be a pure ribosome factory. However, over the last two decades it became clear that the nucleolus is involved in numerous other functions besides ribosome biogenesis. Our experiments indicate that the activity of RNA polymerase I (Pol l) transcription monitors the integrity of the DNA and influences the response to nucleolar stress as well as the rate of survival. Cells with a repressed ribosomal DNA (rDNA) transcription activity showed an increased and prolonged p53 stabilisation after UVC-irradiation. Furthermore, p53 stabilisation after inhibition and especially after UVC-irradiation might be due to abrogation of the HDM2-p53 degradation pathway by ribosomal proteins (RPs). Apoptosis mediated by highly activated p53 is a typical hallmark of Cockayne syndrome cells and transcriptional abnormalities and the following activation of the RP-HDM2-p53 pathway would be a possible explanation.	[Assfalg, Robin; Alupei, Marius Costel; Wagner, Maximilian; Koch, Sylvia; Gonzalez, Omar Garcia; Schelling, Adrian; Scharffetter-Kochanek, Karin; Iben, Sebastian] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Assfalg, Robin] Helmholtz Ctr Munich, Inst Diabet Res, Neuherberg, Germany	Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Assfalg, R (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	sebastian.iben@uni-ulm.de	Assfalg, Robin/O-8495-2016	Assfalg, Robin/0000-0003-1277-716X; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	German Research Foundation DFG [KFO 142, IB 83-3/1, 11383 2-2, IB 83 3/3]; DFG	German Research Foundation DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was funded by grants of the German Research Foundation DFG (KFO 142, IB 83-3/1,11383 2-2, IB 83 3/3) to Dr Sebastian Iben, by the DFG funded CEMMA (cellular and molecular mechanisms in aging) program to Marius Alupei, and Perspektivfoerderung des Landes Baden-Wuertemberg to Dr Sebastian Iben. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assfalg R, 2012, NUCLEIC ACIDS RES, V40, P650, DOI 10.1093/nar/gkr746; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Brooks PJ, 2013, DNA REPAIR, V12, P656, DOI 10.1016/j.dnarep.2013.04.018; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; HADJIOLOVA KV, 1995, EUR J BIOCHEM, V228, P605, DOI 10.1111/j.1432-1033.1995.tb20300.x; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Iben S, 2002, CELL, V109, P297, DOI 10.1016/S0092-8674(02)00729-8; Kalita K, 2008, J NEUROCHEM, V105, P2286, DOI 10.1111/j.1471-4159.2008.05316.x; Koch S, 2014, CELL CYCLE, V13, P2029, DOI 10.4161/cc.29018; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Larsen DH, 2014, NAT CELL BIOL, V16, P792, DOI 10.1038/ncb3007; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Lebedev A, 2008, J MOL BIOL, V382, P266, DOI 10.1016/j.jmb.2008.07.018; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Miyahara H, 2015, NEUROPATHOLOGY, V35, P266, DOI 10.1111/neup.12183; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Parlato R, 2008, J NEUROSCI, V28, P12759, DOI 10.1523/JNEUROSCI.2439-08.2008; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Tremblay M, 2014, NUCLEIC ACIDS RES, V42, P380, DOI 10.1093/nar/gkt871; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	26	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179843	10.1371/journal.pone.0179843	http://dx.doi.org/10.1371/journal.pone.0179843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636660	Green Published, Green Submitted, gold			2022-12-26	WOS:000404118300059
J	Huang, CT; Ruan, SY; Tsai, YJ; Ho, CC; Yu, CJ				Huang, Chun-Ta; Ruan, Sheng-Yuan; Tsai, Yi-Ju; Ho, Chao-Chi; Yu, Chong-Jen			Experience improves the performance of endobronchial ultrasound-guided transbronchial biopsy for peripheral pulmonary lesions: A learning curve at a medical centre	PLOS ONE			English	Article							DIAGNOSTIC YIELD; LUNG-CANCER; THIN BRONCHOSCOPE; AMERICAN-COLLEGE; ULTRASONOGRAPHY; NODULES; SHEATH	Background Endobronchial ultrasound(EBUS)-guided transbronchial biopsy(TBB) is the preferred diagnostic tool for peripheral pulmonary lesions(PPLs) and mastering this procedure is an important task in the training of chest physicians. Little has been published about the learning experience of physicians with this technique, particularly at an institutional level. We aimed to establish a learning curve for EBUS-guided TBB for PPLs at a medical center. Methods Between 2008 and 2015, consecutive patients with PPLs referred for EBUS-guided TBB at National Taiwan University Hospital were enrolled. To build the learning curve, the diagnostic yield of TBB (plus brushings and washings) was calculated and compared. Meanwhile, lesion characteristics, and procedure-related features and complications were obtained to analyze associations with TBB yield and safety profile. Results A total of 2144 patients were included and EBUS-guided TBB was diagnostic for 1547 (72%). The TBB yield was 64% in 2008 and reached a plateau of 72% after 2010. It took approximately 400 EBUS-guided procedures to achieve stable proficiency. Further analysis showed that improvement in diagnostic yield over time was mainly observed in PPLs, in cases in which the diameter was <= 2 cm or the EBUS probe could not be positioned within. Complication rates were low, with 1.8% and 0.5% for pneumothorax and hemorrhage, respectively. Conclusions Even though EBUS-guided TBB is an easy-to-learn technique, it takes 3 years or around 400 procedures for a medical center to achieve a better and stable performance. In particular, the diagnostic yield for lesions without the probe within or those sized <= 2 cm could improve with time.	[Huang, Chun-Ta; Ruan, Sheng-Yuan; Ho, Chao-Chi; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Huang, Chun-Ta] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Tsai, Yi-Ju] Fu Jen Catholic Univ, Coll Med, Grad Inst Biomed & Pharmaceut Sci, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Fu Jen Catholic University	Ho, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	ccho1203@ntu.edu.tw		Yu, Chong-Jen/0000-0001-5664-9392; HO, CHAO-CHI/0000-0002-8156-2413; RUAN, SHENG-YUAN/0000-0002-7949-7253; HUANG, CHUN-TA/0000-0002-5234-4986				Asano F, 2006, CHEST, V130, P559, DOI 10.1378/chest.130.2.559; Bolliger CT, 2002, EUR RESPIR J, V19, P356, DOI 10.1183/09031936.02.00204602; Chung YH, 2007, RESP MED, V101, P738, DOI 10.1016/j.rmed.2006.08.014; Dooms CA, 2007, J THORAC ONCOL, V2, P121, DOI 10.1097/JTO.0b013e31802fbc96; Eberhardt R, 2009, EUR RESPIR J, V34, P1284, DOI 10.1183/09031936.00166708; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Ernst A, 2003, CHEST, V123, P1693, DOI 10.1378/chest.123.5.1693; Gildea TR, 2006, AM J RESP CRIT CARE, V174, P982, DOI 10.1164/rccm.200603-344OC; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Gupta S, 2005, RADIOLOGY, V234, P631, DOI 10.1148/radiol.2342031423; Henschke CI, 2004, RADIOLOGY, V231, P164, DOI 10.1148/radiol.2311030634; Herth FJF, 2002, EUR RESPIR J, V20, P972, DOI 10.1183/09031936.02.00032001; Heyer CM, 2008, ACAD RADIOL, V15, P1017, DOI 10.1016/j.acra.2008.02.018; Huang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049125; Huang CT, 2012, RESPIRATION, V84, P128, DOI 10.1159/000339412; Huang CT, 2009, RESPIROLOGY, V14, P859, DOI 10.1111/j.1440-1843.2009.01585.x; Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Oki M, 2008, EUR RESPIR J, V32, P465, DOI 10.1183/09031936.00169107; Oki M, 2015, AM J RESP CRIT CARE, V192, P468, DOI 10.1164/rccm.201502-0205OC; Oki M, 2009, J THORAC ONCOL, V4, P1274, DOI 10.1097/JTO.0b013e3181b623e1; Ost DE, 2016, AM J RESP CRIT CARE, V193, P68, DOI 10.1164/rccm.201507-1332OC; Paone G, 2005, CHEST, V128, P3551, DOI 10.1378/chest.128.5.3551; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Steinfort DP, 2011, EUR RESPIR J, V37, P902, DOI 10.1183/09031936.00075310; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Wahidi MM, 2007, CHEST, V132, p94S, DOI DOI 10.1378/CHEST.07-1352; Yang MC, 2004, J FORMOS MED ASSOC, V103, P124; Yoshikawa M, 2007, CHEST, V131, P1788, DOI 10.1378/chest.06-2506	30	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179719	10.1371/journal.pone.0179719	http://dx.doi.org/10.1371/journal.pone.0179719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632761	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100045
J	Meyer, A; Dinh, TX; Nhu, TV; Pham, LT; Newman, S; Nguyen, TTT; Pfeiffer, DU; Vergne, T				Meyer, Anne; Tung Xuan Dinh; Thu Van Nhu; Long Thanh Pham; Scott Newman; Thuy Thi Thanh Nguyen; Pfeiffer, Dirk Udo; Vergne, Timothee			Movement and contact patterns of long-distance free-grazing ducks and avian influenza persistence in Vietnam	PLOS ONE			English	Article							RISK-FACTORS; RIVER DELTA; WILD BIRDS; H5N1 VIRUS; HONG-KONG; POULTRY; SURVEILLANCE; INFECTION; OUTBREAKS; AFRICA	Presence of ducks, and in particular of free-grazing ducks, has consistently been shown to be one of the most important risk factors for highly pathogenic avian influenza outbreaks which has compromised poultry production in South-East Asia since the early 2000s and continues to threaten public health, farmers' livelihood and food security. Although free-grazing duck production has been practised for decades in South-East Asia, there are few published studies describing this production system, which is suspected to play an important role in the maintenance of avian influenza viruses. This study aimed at describing quantitatively the long-distance free-grazing duck production system in South Vietnam, characterising the movement and contact patterns of the duck flocks, and identifying potential associations between farming practices, movement and contact patterns and the circulation of avian influenza viruses. We conducted interviews among stakeholders involved in the free-grazing duck production system (duck farmers, transporters and rice paddy owners) in combination with a virological cross-sectional survey in South Vietnam. Results show that both direct and indirect contacts between free-grazing duck flocks were frequent and diverse. The flocks were transported extensively across district and province boundaries, mainly by boat but also by truck or on foot. A third of the investigated flocks had a positive influenza A virology test, indicating current circulation of avian influenza viruses, but none were positive for H5 subtypes. The age and size of the flock as well as its location at the time of sampling were associated with the risk of influenza A circulation in the flocks. These findings should be considered when developing risk assessment models of influenza virus spread aimed at informing the development of improved biosecurity practices leading to enhanced animal health, sustainable animal production and reliable income for farmers.	[Meyer, Anne; Pfeiffer, Dirk Udo; Vergne, Timothee] Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, London, England; [Tung Xuan Dinh; Thu Van Nhu] Natl Inst Anim Sci, Hanoi, Vietnam; [Long Thanh Pham] Minist Agr & Rural Dev, Dept Anim Hlth, Hanoi, Vietnam; [Scott Newman; Thuy Thi Thanh Nguyen] Food & Agr Org United Nations, Emergency Ctr Transboundary Anim Dis, Hanoi, Vietnam; [Pfeiffer, Dirk Udo] City Univ Hong Kong, Sch Vet Med, Kowloon, Hong Kong, Peoples R China; [Vergne, Timothee] Univ Montpellier 2, CNRS 5290, MIVEGEC Malad Infect & Vecteurs Ecol Genet Evolut, Inst Rech Dev,IRD 224, Montpellier, France	University of London; University of London Royal Veterinary College; Food & Agriculture Organization of the United Nations (FAO); City University of Hong Kong; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Meyer, A (corresponding author), Royal Vet Coll, Vet Epidemiol Econ & Publ Hlth Grp, London, England.	ameyer@rvc.ac.uk	Vergne, Timothée/ABH-4185-2020; Pfeiffer, Dirk U/C-5002-2009; Meyer, Anne/AAG-5471-2020; Pham, Long/GNP-6477-2022	Vergne, Timothée/0000-0002-1146-9256; Pfeiffer, Dirk U/0000-0001-7000-0530; Meyer, Anne/0000-0003-0105-0926; PHAM, Long Thanh/0000-0001-7093-7032	British Council Institutional Links grant under Newton Fund [172711836]; United States Agency for International Development; technical cooperation of the Food and Agriculture Organization of the United Nations [LOA. FAVIE.2015.45- OSRO/VIE/402/USA]; The British Council [172711836] Funding Source: researchfish	British Council Institutional Links grant under Newton Fund; United States Agency for International Development(United States Agency for International Development (USAID)); technical cooperation of the Food and Agriculture Organization of the United Nations; The British Council	This work was supported by a British Council Institutional Links grant under the Newton Fund (Grant ID: 172711836), which is administered through the UK Department for Business Innovation and Skills. The laboratory testing was partially supported by the United States Agency for International Development with the technical cooperation of the Food and Agriculture Organization of the United Nations (LOA. FAVIE.2015.45- OSRO/VIE/402/USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzitey F., 2011, J WORLDS POULT RES, V1, P7; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; [Anonymous], 2016, WORLD AN HLTH INF SY; Beaudoin AL, 2014, TRANSBOUND EMERG DIS, V61, P362, DOI 10.1111/tbed.12043; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Bui XM, 2010, DUCK FARMING SYSTEMS; Burnham K. P., 1998, MODEL SELECTION INFE; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Desvaux S, 2008, GEN REV DESCRIPTION; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; ESRI, 2011, ARCGIS DESKT REL 10; Fasina FO, 2011, PREV VET MED, V98, P204, DOI 10.1016/j.prevetmed.2010.11.007; Fournie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037986; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Gilbert M, 2012, SPAT SPATIO-TEMPORAL, V3, P173, DOI 10.1016/j.sste.2012.01.002; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; GSO, 2011, AGR FISHERY CENSUS; Henning J, 2013, EPIDEMIOL INFECT, V141, P390, DOI 10.1017/S0950268812001100; Henning J, 2009, 12 S INT SOC VET EPI, P30; Henning J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152123; Henning J, 2013, TROP ANIM HEALTH PRO, V45, P837, DOI 10.1007/s11250-012-0296-9; Henning J, 2011, PREV VET MED, V101, P229, DOI 10.1016/j.prevetmed.2010.05.016; Henning KA, 2009, PREV VET MED, V91, P179, DOI 10.1016/j.prevetmed.2009.05.027; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Le HP, 2010, POULTRY WASTE MANAGE; Merial, 2012, H5N1 REASS AV INFL V; Minh PQ, 2010, PREV VET MED, V94, P101, DOI 10.1016/j.prevetmed.2009.11.011; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Minh PQ, 2010, EPIDEMIOLOGICAL STUD; Montgomery D.C., 2015, INTRO LINEAR REGRESS; NAVETCO, 2016, VACC MAN NAV POULTR; Nguyen LV, 2014, TRANSBOUND EMERG DIS, V61, P511, DOI 10.1111/tbed.12055; Nguyen TTT, 2012, FOOD AGR ORG UNITED; Nguyen V, 2013, EPIDEMIOLOGY AVIAN I; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; R Core Team, 2021, R LANGUAGE ENV STAT; Rich KM, 2011, PREV VET MED, V101, P133, DOI 10.1016/j.prevetmed.2010.08.002; Ripley B., 2022, PACKAGE MASS; Savill NJ, 2006, NATURE, V442, P757, DOI 10.1038/442757a; Siengsanan J, 2009, J WILDLIFE DIS, V45, P740, DOI 10.7589/0090-3558-45.3.740; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Tai Chein, 2001, Journal of Poultry Science, V38, P99; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Vergne T, 2014, PREV VET MED, V114, P28, DOI 10.1016/j.prevetmed.2014.01.011; Vergne T, 2012, EMERG INFECT DIS, V18, P2076, DOI 10.3201/eid1812.120616; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Wei K, 2015, TRANSBOUND EMERG DIS, V62, P315, DOI 10.1111/tbed.12147; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014	54	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0178241	10.1371/journal.pone.0178241	http://dx.doi.org/10.1371/journal.pone.0178241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632789	Green Published, gold, Green Submitted			2022-12-26	WOS:000404046100004
J	Micalizzi, EW; Mack, JN; White, GP; Avis, TJ; Smith, ML				Micalizzi, Emma W.; Mack, Jonathan N.; White, George P.; Avis, Tyler J.; Smith, Myron L.			Microbial inhibitors of the fungus Pseudogymnoascus destructans, the causal agent of white-nose syndrome in bats	PLOS ONE			English	Article							GEOMYCES-DESTRUCTANS; MYOTIS-LUCIFUGUS; SOIL; PCR; TRANSMISSION; PATHOGENS; VOLATILES; EPIDEMIC; BACTERIA; YEASTS	Pseudogymnoascus destructans, the fungus that causes white-nose syndrome in hibernating bats, has spread across eastern North America over the past decade and decimated bat populations. The saprotrophic growth of P. destructans may help to perpetuate the white-nose syndrome epidemic, and recent model predictions suggest that sufficiently reducing the environmental growth of P. destructans could help mitigate or prevent white-nose syndrome-associated bat colony collapse. In this study, we screened 301 microbes from diverse environmental samples for their ability to inhibit the growth of P. destructans. We identified 145 antagonistic isolates, 53 of which completely or nearly completely inhibited the growth of P. destructans in co-culture. Further analysis of our best antagonists indicated that these microbes have different modes of action and may have some specificity in inhibiting P. destructans. The results suggest that naturally-occurring microbes and/or their metabolites may be considered further as candidates to ameliorate bat colony collapse due to P. destructans.	[Micalizzi, Emma W.; Mack, Jonathan N.; Smith, Myron L.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [White, George P.] RIFDS Inc, Ottawa, ON, Canada; [Avis, Tyler J.] Carleton Univ, Dept Chem, Ottawa, ON, Canada	Carleton University; Carleton University	Micalizzi, EW (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.	EmmaMicalizzi@cmail.carleton.ca		Smith, Myron/0000-0001-6274-0053; Avis, Tyler/0000-0003-1890-3307	Natural Sciences and Engineering Research Council of Canada [RGPIN 2014-05436]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada grants to Emma W. Micalizzi (CGSM) and Myron L. Smith (RGPIN 2014-05436). GPW has a commercial affiliation with his business RIFDS Inc. The funder provided support in the form of salary for author G.P.W, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Biella S, 2002, P ROY SOC B-BIOL SCI, V269, P2269, DOI 10.1098/rspb.2002.2148; Boire N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148473; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; BRAGULAT MR, 1991, APPL ENVIRON MICROB, V57, P2777, DOI 10.1128/AEM.57.9.2777-2780.1991; Braun G, 2012, INT J MOL SCI, V13, P15848, DOI 10.3390/ijms131215848; Chaturvedi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017032; Cornelison CT, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0246-y; Cornelison CT, 2014, MYCOPATHOLOGIA, V177, P1, DOI 10.1007/s11046-013-9716-2; Cruz AF, 2012, PHYTOCHEMISTRY, V78, P72, DOI 10.1016/j.phytochem.2012.03.003; Dionne A, 2012, CAN J PLANT PATHOL, V34, P51, DOI 10.1080/07060661.2012.660195; EGGER KN, 1995, CAN J BOT, V73, pS1415, DOI 10.1139/b95-405; Farh ME, 2015, ARCH MICROBIOL, V197, P439, DOI 10.1007/s00203-014-1075-y; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Fuller NW, 2011, ECOHEALTH, V8, P154, DOI 10.1007/s10393-011-0705-y; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hosoe T, 1999, CHEM PHARM BULL, V47, P1591, DOI 10.1248/cpb.47.1591; Hoyt JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121329; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Johnson L, 2010, J OCCUP ENVIRON HYG, V7, P585, DOI 10.1080/15459624.2010.508951; Jurjevic Z, 2008, PHYTOPATHOL MEDITERR, V47, P266; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kone SB, 2010, BIOL CONTROL, V52, P167, DOI 10.1016/j.biocontrol.2009.10.018; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; Lutz MC, 2011, ACTA HORTIC, V909, P761, DOI 10.17660/ActaHortic.2011.909.95; Meteyer CU, 2012, VIRULENCE, V3, P583, DOI 10.4161/viru.22330; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; Meyer AD, 2016, J THEOR BIOL, V409, P60, DOI 10.1016/j.jtbi.2016.08.033; Murphy N, 2012, INTERNET J MICROBIOL, V10, P2; O'Regan SM, 2015, ECOL APPL, V25, P621, DOI 10.1890/14-0417.1; Providenti MA, 2009, CAN J MICROBIOL, V55, P1166, DOI [10.1139/W09-071, 10.1139/w09-071]; Raudabaugh DB, 2015, MYCOPATHOLOGIA, V180, P325, DOI 10.1007/s11046-015-9921-2; Reynolds HT, 2015, J WILDLIFE DIS, V51, P318, DOI 10.7589/2014-06-157; Reynolds HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086437; Sanchez-Ortiz BL, 2016, J APPL MICROBIOL, V120, P1313, DOI 10.1111/jam.13101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; U. S. Fish and Wildlife Service, WHIT NOS ORG COORD R; Verant Michelle L., 2014, BMC Physiology, V14, P10, DOI 10.1186/s12899-014-0010-4; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vogel VH, 1956, MICROB GENET B, V13, P42; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Yun J, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow089; Zhang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141316; Zukal J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19829; Zunino MP, 2015, J AGR FOOD CHEM, V63, P7743, DOI 10.1021/acs.jafc.5b02315	51	20	21	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179770	10.1371/journal.pone.0179770	http://dx.doi.org/10.1371/journal.pone.0179770			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632782	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100047
J	Bethea, CL; Mueller, K; Reddy, AP; Kohama, SG; Urbanski, HF				Bethea, Cynthia L.; Mueller, Kevin; Reddy, Arubala P.; Kohama, Steven G.; Urbanski, Henryk F.			Effects of obesogenic diet and estradiol on dorsal raphe gene expression in old female macaques	PLOS ONE			English	Article							HORMONE REPLACEMENT THERAPY; ALPHA-SYNUCLEIN AGGREGATION; OVARIAN-STEROID REGULATION; ESTROGEN-RECEPTOR-BETA; FACTOR-KAPPA-B; SEROTONIN NEURONS; DNA-REPAIR; METABOLIC SYNDROME; NEURODEGENERATIVE DISEASES; INSULIN-RESISTANCE	The beneficial effects of bioidentical ovarian steroid hormone therapy (HT) during the perimenopause are gaining recognition. However, the positive effects of estrogen (E) plus or minus progesterone (P) administration to ovariectomized (Ovx) lab animals were recognized in multiple systems for years before clinical trials could adequately duplicate the results. Moreover, very large numbers of women are often needed to find statistically significant results in clinical trials of HT; and there are still opposing results being published, especially in neural and cardiovascular systems. One of the obvious differences between human and animal studies is diet. Laboratory animals are fed a diet that is low in fat and refined sugar, but high in micronutrients. In the US, a large portion of the population eats what is known as a "western style diet" or WSD that provides calories from 36% fat, 44% carbohydrates (includes 18.5% sugars) and 18% protein. Unfortunately, obesity and diabetes have reached epidemic proportions and the percentage of obese women in clinical trials may be overlooked. We questioned whether WSD and obesity could decrease the positive neural effects of estradiol (E) in the serotonin system of old macaques that were surgically menopausal. Old ovo-hysterectomized female monkeys were fed WSD for 2.5 years, and treated with placebo, Immediate E (ImE) or Delayed E (DE). Compared to old Ovx macaques on primate chow and treated with placebo or E, the WSD-fed monkeys exhibited greater individual variance and blunted responses to E-treatment in the expression of genes related to serotonin neurotransmission, CRH components in the midbrain, synapse assembly, DNA repair, protein folding, ubiquitylation, transport and neurodegeneration. For many of the genes examined, transcript abundance was lower in WSD-fed than chow-fed monkeys. In summary, an obesogenic diet for 2.5 years in old surgically menopausal macaques blunted or increased variability in E-induced gene expression in the dorsal raphe. These results suggest that with regard to function and viability in the dorsal raphe, HT may not be as beneficial for obese women as normal weight women.	[Bethea, Cynthia L.; Mueller, Kevin] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA; [Bethea, Cynthia L.; Kohama, Steven G.; Urbanski, Henryk F.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; [Bethea, Cynthia L.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Reddy, Arubala P.] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Internal Med, Lubbock, TX 79430 USA; [Urbanski, Henryk F.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Oregon Health & Science University	Bethea, CL (corresponding author), Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR 97006 USA.; Bethea, CL (corresponding author), Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA.; Bethea, CL (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA.	betheac@ohsu.edu			NIH [MH62677, R24 0D11895, P51 OD011092]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants: MH62677 and R24 0D11895 to CLB; and P51 OD011092 for the operation of ONPRC.	Abdouh M, 2001, J BIOL CHEM, V276, P4382, DOI 10.1074/jbc.M004559200; Adams JH, 2005, AM J MED GENET B, V132B, P90, DOI 10.1002/ajmg.b.30084; Bethea CL, 2015, MOL PSYCHIATR, V20, P1565, DOI 10.1038/mp.2014.178; Bethea CL, 2010, MOL PSYCHIATR, V15, P1034, DOI 10.1038/mp.2009.78; Bethea C L, 2000, Novartis Found Symp, V230, P112, DOI 10.1002/0470870818.ch9; Bethea CL, 2006, J PSYCHIATR NEUROSCI, V31, P105; Bethea CL, 2005, FERTIL STERIL, V83, P148, DOI 10.1016/j.fertnstert.2004.06.051; Bethea CL, 2002, FRONT NEUROENDOCRIN, V23, P41, DOI 10.1006/frne.2001.0225; Bethea CL, 2016, NEUROBIOL AGING, V37, P179, DOI 10.1016/j.neurobiolaging.2015.10.004; Bethea CL, 2015, PROG NEURO-PSYCHOPH, V58, P71, DOI 10.1016/j.pnpbp.2014.11.008; Bethea CL, 2012, J NEUROSCI RES, V90, P1324, DOI 10.1002/jnr.23004; Bethea CL, 2009, FRONT NEUROENDOCRIN, V30, P212, DOI 10.1016/j.yfrne.2009.04.003; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chadderdon SM, 2014, CIRCULATION, V129, P471, DOI 10.1161/CIRCULATIONAHA.113.003645; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Christianson MS, 2015, MATURITAS, V80, P133, DOI 10.1016/j.maturitas.2014.11.013; Chu YP, 2011, NEUROBIOL DIS, V41, P71, DOI 10.1016/j.nbd.2010.08.022; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Debnath M, 2016, OBES RES CLIN PRACT, V10, P103, DOI 10.1016/j.orcp.2015.10.012; Divella R, 2016, J CANCER, V7, P2346, DOI 10.7150/jca.16884; Dobos N, 2010, BIOL PSYCHIAT, V67, P503, DOI 10.1016/j.biopsych.2010.01.023; Duncan JE, 2006, PLOS GENET, V2, P1275, DOI 10.1371/journal.pgen.0020124; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Engelmann F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149045; Epperson CN, 2012, PSYCHONEUROENDOCRINO, V37, P372, DOI 10.1016/j.psyneuen.2011.07.007; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Everson-Rose SA, 2009, PSYCHOSOM MED, V71, P410, DOI 10.1097/PSY.0b013e3181a20c9c; Foster RH, 1997, DRUG AGING, V11, P309, DOI 10.2165/00002512-199711040-00006; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Gardner A, 2011, PROG NEURO-PSYCHOPH, V35, P730, DOI 10.1016/j.pnpbp.2010.07.030; Gentil BJ, 2015, CELL TISSUE RES, V360, P609, DOI 10.1007/s00441-014-2082-7; Ghosh S., 2012, ISRN MOL BIOL, V2012; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Goldbacher EM, 2009, PSYCHOSOM MED, V71, P266, DOI 10.1097/PSY.0b013e318197a4d5; Gray J, 2007, INT J OBESITY, V31, P359, DOI 10.1038/sj.ijo.0803390; Grilli M, 1999, BIOCHEM PHARMACOL, V57, P1, DOI 10.1016/S0006-2952(98)00214-7; Gundlah C, 2001, MOL BRAIN RES, V91, P14, DOI 10.1016/S0169-328X(01)00108-5; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris RA, 2016, SCI REP-UK, V6, DOI 10.1038/srep36123; Henderson VW, 2016, NEUROLOGY, V87, P699, DOI 10.1212/WNL.0000000000002980; Henderson VW, 2006, NEUROSCIENCE, V138, P1031, DOI 10.1016/j.neuroscience.2005.06.017; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Himmerich H, 2006, BIOL PSYCHIAT, V60, P882, DOI 10.1016/j.biopsych.2006.03.075; Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241; Hurley LL, 2013, NEUROTOX RES, V23, P131, DOI 10.1007/s12640-012-9348-1; Jull J, 2014, J OBES, V2014, DOI 10.1155/2014/824310; Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70; Kloiber S, 2010, MOL PSYCHIATR, V15, P736, DOI 10.1038/mp.2008.142; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Lee MW, 2001, BIOCHEM BIOPH RES CO, V284, P261, DOI 10.1006/bbrc.2001.4938; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Lu NZ, 2002, NEUROPSYCHOPHARMACOL, V27, P12, DOI 10.1016/S0893-133X(01)00423-7; Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Miller AP, 2003, HYPERTENSION, V42, P657, DOI 10.1161/01.HYP.0000085560.02979.0C; Nam SY, 2016, GUT LIVER; Nigro SC, 2013, CURR MED RES OPIN, V29, P839, DOI 10.1185/03007995.2013.794776; Nosalski R, 2017, BR J PHARM; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Pecins-Thompson M, 1999, NEUROSCIENCE, V89, P267, DOI 10.1016/S0306-4522(98)00326-1; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Quanz M, 2012, J BIOL CHEM, V287, P8803, DOI 10.1074/jbc.M111.320887; Reyes TM, 2014, BRAIN BEHAV IMMUN, V42, P6, DOI 10.1016/j.bbi.2014.08.006; Ribases M, 2005, EUR J HUM GENET, V13, P428, DOI 10.1038/sj.ejhg.5201351; Rivera HM, 2012, NEUROSCIENCE, V208, P27, DOI 10.1016/j.neuroscience.2012.02.002; Rocha DM, 2017, SAO PAULO MED J; Sanchez RL, 2010, NEUROSCIENCE, V171, P893, DOI 10.1016/j.neuroscience.2010.08.059; Schmidt PJ, 2009, ANN NY ACAD SCI, V1179, P70, DOI 10.1111/j.1749-6632.2009.04982.x; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Shanmugan S, 2014, HUM BRAIN MAPP, V35, P847, DOI 10.1002/hbm.22218; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Stipic I, 2012, REJUV RES, V15, P596, DOI 10.1089/rej.2012.1337; Stroud FC, 2006, J AM ASSOC LAB ANIM, V45, P20; Tsatsanis C, 2015, HORM-INT J ENDOCRINO, V14, P549, DOI 10.14310/horm.2002.1649; van der Burg B, 1996, MOL HUM REPROD, V2, P433, DOI 10.1093/molehr/2.6.433; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANITALLIE TB, 1994, PHARMACOECONOMICS, V5, P1, DOI 10.2165/00019053-199400051-00003; Ventura T, 2014, NUTRITION, V30, P252, DOI 10.1016/j.nut.2013.06.010; Wang TT, 2017, CURR DRUG TARGETS; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; WURTMAN JJ, 1988, J CLIN PSYCHIAT, V49, P37; Wurtman RJ, 1995, OBES RES, V3, pS477, DOI 10.1002/j.1550-8528.1995.tb00215.x; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	91	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178788	10.1371/journal.pone.0178788	http://dx.doi.org/10.1371/journal.pone.0178788			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628658	gold, Green Published, Green Submitted			2022-12-26	WOS:000404043100010
J	Jang, MA; Chung, JW; Yeon, JY; Kim, JS; Hong, SC; Bang, OY; Ki, CS				Jang, Mi-Ae; Chung, Jong-Won; Yeon, Je Young; Kim, Jong-Soo; Hong, Seung Chyul; Bang, Oh Young; Ki, Chang-Seok			Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease	PLOS ONE			English	Article							GENE; ANGIOGENESIS; POPULATION; LEADS	Purpose Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by stenosis of the internal carotid arteries with compensatory development of collateral vessels. Although a founder variant of RNF213, p.Arg4810Lys (c.14429G>A, rs112735431), is a major genetic risk factor for MMD in East Asians, the frequency and disease susceptibility of other variants in this gene remain largely unknown. In the present study, we investigated the association of RNF213 variants with MMD in Korean patients and population controls. Methods For all RNF213 variants listed in the Human Gene Mutation Database (HGMD) as disease-causing or likely disease-causing mutations for MMD, genotyping was performed using matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. Genetic data from 264 adult patients with MMD were analyzed and compared with two control populations comprised of 622 and 1,100 Korean individuals, respectively. Results Among the 30 RNF213 variants that were listed in the HGMD, p.Arg4810Lys was identified in 67.4% (178/264) of patients with MMD and showed a significantly higher allele frequency than in the controls, giving an odds ratio of 63.29 (95% confidence interval, 33.11-120.98) for the 622 controls and 48.55 (95% confidence interval, 31.00-76.03) for the 1100 controls. One additional variant, p.Ala5021Val (c.15062C>T, rs138130613), was identified in 0.8% (2/264) of patients; however, the allele frequencies were not significantly different from those in the controls. Conclusions These results suggest that, in our cohort of Korean patients, the p.Arg4810Lys is the only variant that is strongly associated with MMD among the 30 RNF213 variants listed in the HGMD.	[Jang, Mi-Ae] Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Lab Med & Genet, Bucheon, South Korea; [Chung, Jong-Won; Bang, Oh Young] Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Yeon, Je Young; Kim, Jong-Soo; Hong, Seung Chyul] Sungkyunkwan Univ, Dept Neurosurg, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Ki, Chang-Seok] Sungkyunkwan Univ, Dept Lab Med & Genet, Samsung Med Ctr, Sch Med, Seoul, South Korea	Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Dept Neurol, Samsung Med Ctr, Sch Med, Seoul, South Korea.; Ki, CS (corresponding author), Sungkyunkwan Univ, Dept Lab Med & Genet, Samsung Med Ctr, Sch Med, Seoul, South Korea.	ohyoung.bang@samsung.com; changski@skku.edu	Ki, Chang-Seok/G-7559-2014; ki, cs/O-5931-2014; Jang, Mi-Ae/P-1228-2019	Ki, Chang-Seok/0000-0001-7679-8731; Yeon, Je Young/0000-0003-4603-8103; Chung, Jong-Won/0000-0002-9200-8899				Ahn IM, 2014, STROKE, V45, P1090, DOI 10.1161/STROKEAHA.113.004273; Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Dai DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102382; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Herve D, 2014, AM J HUM GENET, V94, P385, DOI 10.1016/j.ajhg.2014.01.018; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Ito A, 2015, BRAIN RES, V1594, P310, DOI 10.1016/j.brainres.2014.11.014; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lee MJ, 2015, J NEUROL SCI, V353, P161, DOI 10.1016/j.jns.2015.04.019; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Ma JP, 2013, NEUROL INDIA, V61, P35, DOI 10.4103/0028-3886.107927; Mineharu Y, 2013, CEREBROVASC DIS, V36, P155, DOI 10.1159/000352065; Miskinyte S, 2011, AM J HUM GENET, V88, P718, DOI 10.1016/j.ajhg.2011.04.017; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Moteki Y, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001862; Rafat N, 2009, STROKE, V40, P432, DOI 10.1161/STROKEAHA.108.529420; Ryoo S, 2014, STROKE, V45, P2457, DOI 10.1161/STROKEAHA.114.004761; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Wu ZG, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/896458; Yonekawa Y, 1997, CLIN NEUROL NEUROSUR, V99, pS58, DOI 10.1016/S0303-8467(97)00042-5	24	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179689	10.1371/journal.pone.0179689	http://dx.doi.org/10.1371/journal.pone.0179689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617845	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600055
J	Liang, Y; Song, DZ; Liang, S; Zhang, ZF; Gao, LX; Fan, XH				Liang, Ying; Song, De-Zhi; Liang, Shuang; Zhang, Zeng-Feng; Gao, Ling-Xi; Fan, Xiao-Hui			The hemagglutinin-neuramidinase protein of Newcastle disease virus upregulates expression of the TRAIL gene in murine natural killer cells through the activation of Syk and NF-kappa B	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INTERFERON-ALPHA; TUMORICIDAL ACTIVITY; ONCOLYTIC VIRUSES; TUMOR-CELLS; FOLLOW-UP; INDUCTION; MELANOMA; RECEPTOR; CYTOTOXICITY	Newcastle disease virus (NDV) is responsible for tumoricidal activity in vitro and in vivo. However, the mechanisms that lead to this activity are unclear. Natural killer cells are able to induce apoptosis of tumor cells through multiple pathways, including the tumor necrosis factor- related apoptosis-inducing ligand-death receptor pathway. We previously showed that exposure of NK and T cells to NDV resulted in enhanced tumoricidal activity that was mediated by upregulated expression of the TRAIL gene, via an interferon gamma -dependent pathway. Other pathways involved in the upregulated expression of TRAIL are yet to be identified. In the current study, we used mice in which the IFN-gamma receptor one gene was inactivated functionally. We identified an IFN-gamma -independent TRAIL pathway in the NDV-stimulated NK cells. Hemagglutinin-neuramidinase induced expression of the TRAIL gene in IFN-R1 -/-NK cells by binding to the NKp46 receptor. This upregulation was inhibited by pretreatment of NDV with a neutralizing monoclonal antibody against HN, or desialylation of NK cells. Phosphorylation of spleen tryosine kinases and I.Ba was increased in HN-induced IFN-R1 -/-NK cells. Treatment with the HN neutralizing monoclonal antibody, pharmacological disialylation, or a Syk inhibitor decreased Syk and I.Ba phosphorylation levels. We concluded that killer activation receptors pathway is involved in the IFN-gamma.-independent TRAIL expression of NDV-stimulated NK cells, and these are activated by Syk and NF-kappa B.	[Liang, Ying; Song, De-Zhi; Zhang, Zeng-Feng; Gao, Ling-Xi; Fan, Xiao-Hui] Guangxi Med Univ, Sch Preclin Med, Dept Microbiol, Nanning, Peoples R China; [Liang, Shuang] Trading Ctr Guangxi Publ Resources, Dept Pharmaceut & Med Equipment, Nanning, Peoples R China	Guangxi Medical University	Fan, XH (corresponding author), Guangxi Med Univ, Sch Preclin Med, Dept Microbiol, Nanning, Peoples R China.	fanxiaohui63@163.com	Song, Dezhi/AAL-9799-2020	Song, Dezhi/0000-0001-9431-5182	National Natural Science Foundation of China [81460437]; Natural Science Foundation of Guangxi, China [2014GXNSFAA118244]; Innovating Project of Guangxi Graduate Education; Guangxi Education Department [YCBZ2012014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi, China(National Natural Science Foundation of Guangxi Province); Innovating Project of Guangxi Graduate Education; Guangxi Education Department	This study was supported by a grant from National Natural Science Foundation of China (Grant No. 81460437), Natural Science Foundation of Guangxi, China (Grant No. 2014GXNSFAA118244), Innovating Project of Guangxi Graduate Education and YCBZ2012014 from Guangxi Education Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batliwalla FM, 1998, MOL MED, V4, P783, DOI 10.1007/BF03401771; Brando C, 2005, J LEUKOCYTE BIOL, V78, P359, DOI 10.1189/jlb.0604360; Brumbaugh KM, 1997, J EXP MED, V186, P1965, DOI 10.1084/jem.186.12.1965; CASSEL WA, 1992, MED ONCOL TUMOR PHAR, V9, P169; Ch'ng WC, 2013, J INTERF CYTOK RES, V33, P346, DOI 10.1089/jir.2012.0095; Choi EA, 2003, CANCER RES, V63, P5299; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Csatary L, 1992, CANC DETECTION PREVE, V17, P619; Cuadrado-Castano S, 2015, MOL CANCER THER, V14, P1247, DOI 10.1158/1535-7163.MCT-14-0913; Fanger NA, 1999, J EXP MED, V190, P1155, DOI 10.1084/jem.190.8.1155; Fournier Philippe, 2013, Biology (Basel), V2, P936, DOI 10.3390/biology2030936; Fulda S, 2002, ONCOGENE, V21, P2295, DOI 10.1038/sj.onc.1205255; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Ivanov VN, 2011, APOPTOSIS, V16, P1268, DOI 10.1007/s10495-011-0649-2; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kirshner JR, 2005, J VIROL, V79, P9320, DOI 10.1128/JVI.79.14.9320-9324.2005; Knowlton JJ, J VIROLOGY, V86, P1650; Kumar S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.122; Lam HY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4529437; Lam HY, 2014, INT J MED SCI, V11, P1240, DOI 10.7150/ijms.8170; Lamb A., 1996, FIELDS VIROLOGY; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Lorence RM, 2007, CURR CANCER DRUG TAR, V7, P157, DOI 10.2174/156800907780058853; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Miura Y, 2006, ANTICANCER RES, V26, P4115; Nguyen A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00145; Oykhman P, 2013, INFECT IMMUN, V81, P3912, DOI 10.1128/IAI.00533-13; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V424, P41, DOI 10.1016/S0014-5793(98)00135-5; PAULSON JC, 1982, J BIOL CHEM, V257, P2734; Plante MK, 2013, PROSTATE CANCER P D, V16, P16, DOI 10.1038/pcan.2012.37; Schirrmacher V, 2000, INT J ONCOL, V16, P363; Schirrmacher V, 1999, GENE THER, V6, P63, DOI 10.1038/sj.gt.3300787; Schulze T, 2009, CANCER IMMUNOL IMMUN, V58, P61, DOI 10.1007/s00262-008-0526-1; Song DZ, 2013, ANAT REC, V296, P1552, DOI 10.1002/ar.22768; Song KY, 2010, J MOL MED, V88, P589, DOI 10.1007/s00109-010-0605-6; Tai LH, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00217; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Tong AW, 2012, CURR PHARM BIOTECHNO, V13, P1750; Trotta R, 1998, J IMMUNOL, V161, P6648; Umansky V, 1996, INT IMMUNOL, V8, P491, DOI 10.1093/intimm/8.4.491; Vigil A, 2008, MOL THER, V16, P1883, DOI 10.1038/mt.2008.181; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Washburn B, 2003, J IMMUNOL, V170, P1814, DOI 10.4049/jimmunol.170.4.1814; WERTZ K, 1994, VET MICROBIOL, V39, P299, DOI 10.1016/0378-1135(94)90166-X; Yanase N, 2005, EXP CELL RES, V310, P10, DOI 10.1016/j.yexcr.2005.06.021; Zamarin D, 2009, GENE THER, V16, P796, DOI 10.1038/gt.2009.14; Zeng JY, 2002, VIROLOGY, V297, P19, DOI 10.1006/viro.2002.1413; ZORN U, 1994, CANCER BIOTHERAPY, V9, P225, DOI 10.1089/cbr.1994.9.225	52	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0178746	10.1371/journal.pone.0178746	http://dx.doi.org/10.1371/journal.pone.0178746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614370	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900021
J	Miao, Q; Deng, P; Saha, S; Jenkins, JN; Hsu, CY; Abdurakhmonov, IY; Buriev, ZT; Pepper, A; Ma, DP				Miao, Qing; Deng, Peng; Saha, Sukumar; Jenkins, Johnie N.; Hsu, Chuan-Yu; Abdurakhmonov, Ibrokhim Y.; Buriev, Zabardast T.; Pepper, Alan; Ma, Din-Pow			Genome-wide identification and characterization of microRNAs differentially expressed in fibers in a cotton phytochrome A1 RNAi line	PLOS ONE			English	Article							TRANSFER PROTEIN GENE; IN-VITRO; PLANT; SEQUENCE; MIRNA; TARGETS; BIOSYNTHESIS; ELONGATION; EVOLUTION; REVEAL	Cotton fiber is an important commodity throughout the world. Fiber property determines fiber quality and commercial values. Previous studies showed that silencing phytochrome A1 gene (PHYA1) by RNA interference in Upland cotton (Gossypium hirsutum L. cv. Coker 312) had generated PHYA1 RNAi lines with simultaneous improvements in fiber quality (longer, stronger and finer fiber) and other key agronomic traits. Characterization of the altered molecular processes in these RNAi genotypes and its wild-type controls is a great interest to better understand the PHYA1 RNAi phenotypes. In this study, a total of 77 conserved miRNAs belonging to 61 families were examined in a PHYA1 RNAi line and its parental Coker 312 genotype by using multiplex sequencing. Of these miRNAs, seven (miR7503, miR7514, miR399c, miR399d, miR160, miR169b, and miR2950) were found to be differentially expressed in PHYA1 RNAi cotton. The target genes of these differentially expressed miRNAs were involved in the metabolism and signaling pathways of phytohormones, which included Gibberellin, Auxin and Abscisic Acid. The expression of several MYB transcription factors was also affected by miRNAs in RNAi cotton. In addition, 35 novel miRNAs (novel miR1-novel miR35) were identified in fibers for the first time in this study. Target genes of vast majority of these novel miRNAs were also predicted. Of these, nine novel miRNAs (novel-miR1, 2, 16, 19, 26, 27, 28, 31 and 32) were targeted to cytochrome P450-like TATA box binding protein (TBP). The qRT-PCR confirmed expression levels of several differentially regulated miRNAs. Expression patterns of four miRNAs-targets pairs were also examined via RNA deep sequencing. Together, the results imply that the regulation of miRNA expression might confer to the phenotype of the PHYA1 RNAi line(s) with improved fiber quality.	[Miao, Qing; Ma, Din-Pow] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Deng, Peng] Cornell Univ, Dept Pharmacol, Weill Cornell Med Coll, New York, NY 10021 USA; [Saha, Sukumar; Jenkins, Johnie N.] USDA ARS, Crop Sci Res Lab, Mississippi State, MS 39762 USA; [Hsu, Chuan-Yu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Abdurakhmonov, Ibrokhim Y.; Buriev, Zabardast T.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan; [Pepper, Alan] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Mississippi State University; Cornell University; Mississippi State University; United States Department of Agriculture (USDA); Mississippi State University; Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics; Texas A&M University System; Texas A&M University College Station	Ma, DP (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	dma@bch.msstate.edu	Abdurakhmonov, Ibrokhim Y./F-5588-2015; Deng, Peng/P-1874-2017; Buriev, Zabardast/AAE-2579-2021	Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Deng, Peng/0000-0001-5781-090X; Buriev, Zabardast/0000-0001-7737-9168	Mississippi Agricultural and Forestry Experiment Station; Cotton Incorporated	Mississippi Agricultural and Forestry Experiment Station; Cotton Incorporated(Cotton R&D Corp)	This research was funded by the Mississippi Agricultural and Forestry Experiment Station and the Cotton Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00202; Abdurakhmonov IY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4062; Abdurakhmonov IY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-93; Abdurakhmonov IY, 2001, MOL CLONING CHARACTE; Akdogan G, 2016, FUNCT INTEGR GENOMIC, V16, P221, DOI 10.1007/s10142-015-0452-1; An WY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2071-6; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Burke JM, 2014, NUCL ACIDS RES; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Eren H, 2015, ANN APPL BIOL, V167, P208, DOI 10.1111/aab.12219; Fang L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-838; Gao S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19736; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Guan XY, 2014, TRENDS PLANT SCI, V19, P516, DOI 10.1016/j.tplants.2014.04.007; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Jensen K, 2011, ACS CHEM BIOL, V6, P533, DOI 10.1021/cb100393j; Kasperbauer MJ, 2000, CROP SCI, V40, P1673, DOI 10.2135/cropsci2000.4061673x; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kushanov FN, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0448-4; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lester DR, 1997, PLANT CELL, V9, P1435, DOI 10.1105/tpc.9.8.1435; Li C, 2017, SPINAL CORD, V55, P135, DOI 10.1038/sc.2016.166; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Li ZX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002461; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA DP, 1995, BBA-LIPID LIPID MET, V1257, P81, DOI 10.1016/0005-2760(95)00077-P; Ma DP, 1997, BBA-LIPID LIPID MET, V1344, P111, DOI 10.1016/S0005-2760(96)00166-X; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naoumkina M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2715-1; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849; Qiu CX, 2007, GENE, V395, P49, DOI 10.1016/j.gene.2007.01.034; Ramamoorthy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028069; Ruan MB, 2009, GENOMICS, V94, P263, DOI 10.1016/j.ygeno.2009.07.002; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; 't Hoen PAC, 2013, NAT BIOTECHNOL, V31, P1015, DOI 10.1038/nbt.2702; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang Q, 2013, MOL PLANT, V6, P5, DOI 10.1093/mp/sss102; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Xie FL, 2015, PLANT BIOTECHNOL J, V13, P355, DOI 10.1111/pbi.12296; Xie FL, 2015, PLANT BIOTECHNOL J, V13, P421, DOI 10.1111/pbi.12295; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang YJ, 2015, INT J MOL SCI, V16, P14749, DOI 10.3390/ijms160714749; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	71	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179381	10.1371/journal.pone.0179381	http://dx.doi.org/10.1371/journal.pone.0179381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614407	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900046
J	Carlson, S; Borrell, LN; Eng, C; Nguyen, M; Thyne, S; LeNoir, MA; Burke-Harris, N; Burchard, EG; Thakur, N				Carlson, Sonia; Borrell, Luisa N.; Eng, Celeste; Myngoc Nguyen; Thyne, Shannon; LeNoir, Michael A.; Burke-Harris, Nadine; Burchard, Esteban G.; Thakur, Neeta			Self-reported racial/ethnic discrimination and bronchodilator response in African American youth with asthma	PLOS ONE			English	Article							LUNG-FUNCTION; SOCIOECONOMIC-STATUS; AIRWAY INFLAMMATION; RACIAL DISPARITIES; CHILDREN; STRESS; HEALTH; ASSOCIATION; MANAGEMENT; RISKS	Importance Asthma is a multifactorial disease composed of endotypes with varying risk profiles and outcomes. African Americans experience a high burden of asthma and of psychosocial stress, including racial discrimination. It is unknown which endotypes of asthma are vulnerable to racial/ethnic discrimination. Objective We examined the association between self-reported racial/ethnic discrimination and bronchodilator response (BDR) among African American youth with asthma ages 8 to 21 years (n = 576) and whether this association varies with tumor necrosis factor alpha (TNF-alpha) level. Materials and methods Self-reported racial/ethnic discrimination was assessed by a modified Experiences of Discrimination questionnaire as none or any. Using spirometry, BDR was specified as the mean percentage change in forced expiratory volume in one second before and after albuterol administration. TNF-alpha was specified as high/low levels based on our study population mean. Linear regression was used to examine the association between self-reported racial/ethnic discrimination and BDR adjusted for selected characteristics. An interaction term between TNF-alpha levels and self-reported racial/ethnic discrimination was tested in the final model. Results Almost half of participants (48.8%) reported racial/ethnic discrimination. The mean percent BDR was higher among participants reporting racial/ethnic discrimination than among those who did not (10.8 versus 8.9, p = 0.006). After adjustment, participants reporting racial/ethnic discrimination had a 1.7 (95% CI: 0.36-3.03) higher BDR mean than those not reporting racial/ethnic discrimination. However, we found heterogeneity of this association according to TNF-alpha levels (p-interaction = 0.040): Among individuals with TNF-alpha high level only, we observed a 2.78 higher BDR mean among those reporting racial/ethnic discrimination compared with those not reporting racial/ethnic discrimination ( 95% CI: 0.79-4.77). Conclusions We found BDR to be increased in participants reporting racial/ethnic discrimination and this association was limited to African American youth with TNF-alpha high asthma, an endotype thought to be resistant to traditional asthma medications. These results support screening for racial/ethnic discrimination in those with asthma as it may reclassify disease pathogenesis.	[Carlson, Sonia] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Borrell, Luisa N.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Eng, Celeste; Burchard, Esteban G.; Thakur, Neeta] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Myngoc Nguyen] Kaiser Permanente, Dept Allergy & Immunol, Oakland Med Ctr, Oakland, CA USA; [Thyne, Shannon] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Burke-Harris, Nadine] Ctr Youth Wellness, San Francisco, CA USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; City University of New York (CUNY) System; University of California System; University of California San Francisco; Kaiser Permanente; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Borrell, LN (corresponding author), CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.	Luisa.Borrell@sph.cuny.edu	Borrell, Luisa N./G-8753-2018	Borrell, Luisa N./0000-0002-0560-4853; Thakur, Neeta/0000-0001-6126-6601	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; Center for Youth Wellness, National Institutes of Health [1R01HL117004, R01 ES015794, R01HD085993]; National Institute of Health and Environmental Health Sciences [R21ES24844]; National Institute on Minority Health and Health Disparities [1P60 MD006902, 1R01MD010443]; Tobacco-Related Disease Research Program [24RT-0025]; Department of Defense [PR141896]; NHLBI [K12-HL119997, K23-HL125551-01A1]; Parker B. Francis Fellowship Program; American Thoracic Society; UCSF PROF-PATH program from the NIMHD [R25MD006832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD085993] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL125551, R01HL117004, K12HL119997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024844, R01ES015794] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD010443, R25MD006832, P60MD006902] Funding Source: NIH RePORTER	Sandler Family Foundation; American Asthma Foundation; RWJF Amos Medical Faculty Development Program; Center for Youth Wellness, National Institutes of Health; National Institute of Health and Environmental Health Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Tobacco-Related Disease Research Program(University of California System); Department of Defense(United States Department of Defense); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parker B. Francis Fellowship Program; American Thoracic Society; UCSF PROF-PATH program from the NIMHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by the Sandler Family Foundation, the American Asthma Foundation, the RWJF Amos Medical Faculty Development Program, Harry Wm. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences II, Center for Youth Wellness, National Institutes of Health 1R01HL117004, R01 ES015794, R01HD085993, National Institute of Health and Environmental Health Sciences R21ES24844, the National Institute on Minority Health and Health Disparities 1P60 MD006902 and 1R01MD010443; Tobacco-Related Disease Research Program under Award Number 24RT-0025; Department of Defense (PR141896); N.T. was supported by career development awards from the NHLBI (K12-HL119997 and K23-HL125551-01A1), Parker B. Francis Fellowship Program, and the American Thoracic Society. S.C. was supported through the UCSF PROF-PATH program by R25MD006832 from the NIMHD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2012, NCHS Data Brief, P1; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Anderson GP, 2008, LANCET, V372, P1107, DOI 10.1016/S0140-6736(08)61452-X; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bailey MT, 2009, J IMMUNOL, V182, P7888, DOI 10.4049/jimmunol.0800891; Brehm JM, 2015, AM J RESP CRIT CARE, V192, P47, DOI 10.1164/rccm.201501-0037OC; Brody GH, DISCRIMINATION RACIA; Brown SD, 2015, J ALLERGY CLIN IMMUN, V135, P1651, DOI 10.1016/j.jaci.2014.08.054; Coutinho MT, 2013, J CHILD HEALTH CARE, V17, P138, DOI 10.1177/1367493512456109; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Dubow EF, 2009, MERRILL PALMER QUART, V55, P224; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauthier M, 2015, AM J RESP CRIT CARE, V192, P660, DOI 10.1164/rccm.201504-0763PP; Gurrola-Diaz CM, 2009, J CLIN LAB ANAL, V23, P51, DOI 10.1002/jcla.20289; Haczku A, 2010, J ALLERGY CLIN IMMUN, V125, P550, DOI 10.1016/j.jaci.2009.11.005; Hosnijeh FS, 2010, BIOMARKERS, V15, P140, DOI 10.3109/13547500903340570; KERSTJENS HAM, 1993, THORAX, V48, P722, DOI 10.1136/thx.48.7.722; Koinis-Mitchell D, 2007, J PEDIATR PSYCHOL, V32, P582, DOI 10.1093/jpepsy/jsl050; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Kuczmarski R J, 2000, Adv Data, P1; Kumar R, 2010, NEW ENGL J MED, V363, P321, DOI 10.1056/NEJMoa0907897; Lee A, 2016, J ALLERGY CLIN IMMUN, V138, P740, DOI 10.1016/j.jaci.2016.01.014; Lu YX, 2015, J ALLERGY CLIN IMMUN, V135, P1061, DOI 10.1016/j.jaci.2014.10.036; McCormick SP, 2014, CHRON RESP DIS, V11, P15, DOI 10.1177/1479972313516878; National Heart Lung and BI, 2007, GUID DIAGN MAN ASTHM; Ogden CL, 2005, NCHS DATA BRIEF, V127; Oh SS, 2012, J ALLERGY CLIN IMMUN, V129, P1478, DOI 10.1016/j.jaci.2012.03.017; Pachter LM, 2010, HEALTH SOC WORK, V35, P61, DOI 10.1093/hsw/35.1.61; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031; R Development Core Team, 2016, R LANG ENV STAT COMP; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Tantisira KG, 2006, J ALLERGY CLIN IMMUN, V117, P1264, DOI 10.1016/j.jaci.2006.01.050; Thakur N, 2016, CHEST; Thakur N, 2014, J ASTHMA, V51, P720, DOI 10.3109/02770903.2014.905593; Tillie-Leblond I, 1999, AM J RESP CRIT CARE, V159, P487, DOI 10.1164/ajrccm.159.2.9805115; van Gent R, 2008, J ASTHMA, V45, P807, DOI 10.1080/02770900802311477; Walker TJ, 2014, J ASTHMA, V51, P808, DOI 10.3109/02770903.2014.920875; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wesolowska-Andersen A, 2015, CURR OPIN ALLERGY CL, V15, P163, DOI 10.1097/ACI.0000000000000148; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Yonas MA, 2012, CURR OPIN ALLERGY CL, V12, P202, DOI 10.1097/ACI.0b013e32835090c9	47	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179091	10.1371/journal.pone.0179091	http://dx.doi.org/10.1371/journal.pone.0179091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5IQ	28609485	Green Published, gold			2022-12-26	WOS:000403274700020
J	Chen, X; Zhang, M; Tan, J; Huang, SP; Wang, CL; Zhang, HY; Tan, TM				Chen, Xia; Zhang, Min; Tan, Jie; Huang, Shuping; Wang, Chunli; Zhang, Hongyuan; Tan, Taiming			Comparative transcriptome analysis provides insights into molecular mechanisms for parthenocarpic fruit development in eggplant (Solanum melongena L.)	PLOS ONE			English	Article							CONSTANS-LIKE GENE; PIN PHOSPHORYLATION; AUXIN; EXPRESSION; TOMATO; GROWTH; BIOSYNTHESIS; REGULATORS; SEQUENCE; DISTINCT	Genetic control of parthenocarpy, a desirable trait in edible fruit with hard seeds, has been extensively studied. However, the molecular mechanism of parthenocarpic fruit development in eggplant (Solanum melongena L.) is still unclear. To provide insights into eggplant parthenocarpy, the transcriptomic profiles of a natural parthenocarpic (PP05) and two non-parthenocarpic (PnP05 and GnP05) eggplant lines were analyzed using RNA-sequencing (RNA-seq) technology. These sequences were assembled into 38925 unigenes, of which 22683 had an annotated function and 3419 were predicted as novel genes or from alternative splicing. 4864 and 1592 unigenes that were identified as DEGs between comparison groups PP05 vs PnP05 and PP05 vs GnP05, respectively. 506 common DEGs were found contained in both comparison groups, including 258 up-regulated and 248 down-regulated genes. Functional enrichment analyses identified many common or specific biological processes and gene set potentially associated with plant development. The most pronounced findings are that differentially regulated genes potentially-related with auxin signaling between parthenocarpic and non-parthenocarpic eggplants, e.g. calcium-binding protein PBP1 and transcription factor E2FB, which mediate the auxin distribution and auxin-dependent cell division, respectively, are up-regulated in the PP05; whereas homologs of GH3.1 and AUX/IAA, which are involved in inactivation of IAA and interference of auxin signaling, respectively, are down-regulated in PP05. Furthermore, gibberellin and cytokinin signaling genes and genes related to flower development were found differentially regulated between these eggplant lines. The present study provides comprehensive transcriptomic profiles of eggplants with or without parthenocarpic capacity. The information will deepen our understanding of the molecular mechanisms of eggplant parthenocarpy. The DEGs, especially these filtered from PP05 vs PnP05 + GnP05, will be valuable for further investigation of key genes involved in the parthenocarpic fruit development and genomics-assisted breeding.	[Chen, Xia; Zhang, Min; Tan, Jie; Huang, Shuping; Wang, Chunli; Zhang, Hongyuan; Tan, Taiming] Wuhan Acad Agr Sci & Technol, Wuhan Vegetable Res Inst, Wuhan, Hubei, Peoples R China		Tan, TM (corresponding author), Wuhan Acad Agr Sci & Technol, Wuhan Vegetable Res Inst, Wuhan, Hubei, Peoples R China.	tantaiming_001@126.com			National Science and Technology Support Program during the Twelfth Five-Year-Plan Period of China [2012BAD02B02]; Science and Technology Support Program of Hubei Province [2015BBA202]; Excellent Talents Support Program of Wuhan Academy of Agricultural Science and Technology [CX201606-05]	National Science and Technology Support Program during the Twelfth Five-Year-Plan Period of China; Science and Technology Support Program of Hubei Province; Excellent Talents Support Program of Wuhan Academy of Agricultural Science and Technology	the National Science and Technology Support Program during the Twelfth Five-Year-Plan Period of China (2012BAD02B02); This work was supported by the Science and Technology Support Program of Hubei Province (2015BBA202); the Excellent Talents Support Program of Wuhan Academy of Agricultural Science and Technology (CX201606-05).	Abraham Z, 2012, J PLANT GROWTH REGUL, V31, P11, DOI 10.1007/s00344-011-9215-y; Acciarri Nazzareno, 2002, BMC Biotechnol, V2, P4, DOI 10.1186/1472-6750-2-4; Alcantara TP, 1996, J HERED, V87, P239, DOI 10.1093/oxfordjournals.jhered.a022992; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamins R, 2003, PLANT PHYSIOL, V132, P1623, DOI 10.1104/pp.103.019943; Calderon-Villalobos LI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005546; Carmi N, 2003, PLANTA, V217, P726, DOI 10.1007/s00425-003-1052-1; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Choudhury SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044361; Dai MQ, 2012, PLANT CELL, V24, P2497, DOI 10.1105/tpc.112.098905; Ding JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070080; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Ficcadenti N, 1999, MOL BREEDING, V5, P463, DOI 10.1023/A:1009665409959; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fos M, 2001, PHYSIOL PLANTARUM, V111, P545, DOI 10.1034/j.1399-3054.2001.1110416.x; Fu J, 2011, PLANT SIGNAL BEHAV, V6, P570, DOI 10.4161/psb.6.4.14947; GARCIAMARTINEZ JL, 1980, PLANTA, V147, P451, DOI 10.1007/BF00380187; George W. L. Jr., 1984, Horticultural Reviews, V6, P65, DOI 10.1002/9781118060797.ch2; Gustafson Felix G., 1942, BOT REV, V8, P599, DOI 10.1007/BF02881046; Hirakawa H, 2014, DNA RES, V21, P649, DOI 10.1093/dnares/dsu027; Ikeda T, 1999, SCI HORTIC-AMSTERDAM, V79, P143, DOI 10.1016/S0304-4238(98)00210-6; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SK, 2008, PLANTA, V228, P355, DOI 10.1007/s00425-008-0742-0; Kumar R, 2014, J EXP BOT, V65, P4561, DOI 10.1093/jxb/eru277; Li X.-M., 2012, NANOSCI NANOTECHNOL, V1, P14; Liu FuZhong, 2008, Acta Horticulturae Sinica, V35, P1305; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magyar Z, 2005, PLANT CELL, V17, P2527, DOI 10.1105/tpc.105.033761; Matsuo S, 2012, J EXP BOT, V63, P5569, DOI 10.1093/jxb/ers207; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Miyatake K, 2012, THEOR APPL GENET, V124, P1403, DOI 10.1007/s00122-012-1796-8; Molesini B, 2009, PLANT PHYSIOL, V149, P534, DOI 10.1104/pp.108.131367; Molesini Barbara, 2009, BMC Res Notes, V2, P143, DOI 10.1186/1756-0500-2-143; NOTHMANN J, 1975, J HORTIC SCI, V50, P23, DOI 10.1080/00221589.1975.11514599; Ofori K, 2005, SCI HORTIC-AMSTERDAM, V105, P305, DOI 10.1016/j.scienta.2005.02.003; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pandolfini Tiziana, 2002, BMC Biotechnology, V2, P1, DOI 10.1186/1472-6750-2-1; Pandolfini T, 2009, NUTRIENTS, V1, P168, DOI 10.3390/nu1020168; Pecaut J., 1978, REP TOM GENET COOP, V28, P12; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Rebers M, 1999, PLANT J, V17, P241, DOI 10.1046/j.1365-313X.1999.00366.x; Rogg LE, 2001, DEV CELL, V1, P595, DOI 10.1016/S1534-5807(01)00077-6; Rotino GL, 1997, NAT BIOTECHNOL, V15, P1398, DOI 10.1038/nbt1297-1398; Saito T, 2009, JARQ-JPN AGR RES Q, V43, P123, DOI 10.6090/jarq.43.123; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Shimomura Katsumi, 2010, Horticultural Research (Japan), V9, P13, DOI 10.2503/hrj.9.13; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Sudheesh S, 1999, PHYTOTHER RES, V13, P393, DOI 10.1002/(SICI)1099-1573(199908/09)13:5&lt;393::AID-PTR474&gt;3.0.CO;2-8; Sugiyama K, 2000, SCI HORTIC-AMSTERDAM, V84, P255, DOI 10.1016/S0304-4238(99)00104-1; Takei K, 2004, J BIOL CHEM, V279, P41866, DOI 10.1074/jbc.M406337200; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125355; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; Yamauchi D, 2002, PLANTA, V215, P319, DOI 10.1007/s00425-002-0740-6; Yasui Y, 2012, PLANT CELL, V24, P3248, DOI 10.1105/tpc.112.101915; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang J, 2010, P NATL ACAD SCI USA, V107, P918, DOI 10.1073/pnas.0909460107; Zhang Ying, 2011, Scientia Agricultura Sinica, V44, P3368; Zhou YaJun, 2010, Acta Horticulturae Sinica, V37, P1944	67	10	13	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179491	10.1371/journal.pone.0179491	http://dx.doi.org/10.1371/journal.pone.0179491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604820	Green Submitted, Green Published, gold			2022-12-26	WOS:000403088400052
J	Huang, JY; Yu, ZX; Gao, HJ; Yan, XM; Chang, J; Wang, CM; Hu, JW; Zhang, LG				Huang, Jieying; Yu, Zixuan; Gao, Hongjian; Yan, Xiaoming; Chang, Jiang; Wang, Chengming; Hu, Jingwei; Zhang, Ligan			Chemical structures and characteristics of animal manures and composts during composting and assessment of maturity indices	PLOS ONE			English	Article							ORGANIC-MATTER; NMR-SPECTROSCOPY; STABILITY PARAMETERS; CATTLE MANURE; C-13 NMR; WASTES; DECOMPOSITION; TRANSFORMATIONS; FRACTION; LITTER	Changes in physicochemical characteristics, chemical structures and maturity of swine, cattle and chicken manures and composts during 70-day composting without addition of bulking agents were investigated. Physicochemical characteristics were measured by routine analyses and chemical structures by solid-state C-13 NMR and FT-IR. Three manures were of distinct properties. Their changes in physicochemical characteristics, chemical structures, and maturity were different not only from each other but also from those with addition of bulking agents during composting. Aromaticity in chicken manure composts decreased at first, and then increased whereas that in cattle and swine manure composts increased. Enhanced ammonia volatilization occurred without addition of bulking agents. NMR structural information indicated that cattle and chicken composts were relatively stable at day 36 and 56, respectively, but swine manure composts were not mature up to day 70. Finally, the days required for three manures to reach the threshold values of different maturity indices were different.	[Huang, Jieying; Yu, Zixuan; Gao, Hongjian; Chang, Jiang; Hu, Jingwei; Zhang, Ligan] Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China; [Huang, Jieying; Gao, Hongjian; Zhang, Ligan] Anhui Prov Key Lab Farmland Ecol Conservat & Poll, Hefei, Anhui, Peoples R China; [Yan, Xiaoming] Anhui Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Hefei, Anhui, Peoples R China; [Wang, Chengming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, LG (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei, Anhui, Peoples R China.; Zhang, LG (corresponding author), Anhui Prov Key Lab Farmland Ecol Conservat & Poll, Hefei, Anhui, Peoples R China.	zhligan@ahau.edu.cn	Wang, Chengming/A-1710-2015; wang, meng/GWZ-9558-2022	Wang, Chengming/0000-0001-5430-8949; 	Science and technology support program [2012BAD14B13, 2013BAD07B08]; National Natural Science Foundation of China [31328020]; State Key Special Program of China [2016YFD0200107, 2016YFD0300801, 2016YFD0300900]; Project of the Introduction of the Leading Talent Team in Colleges and Universities of Anhui Province of China [gxljtdzd201607]	Science and technology support program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Special Program of China; Project of the Introduction of the Leading Talent Team in Colleges and Universities of Anhui Province of China	This work was supported by the Science and technology support program (ID: 2012BAD14B13 and 2013BAD07B08 ZLG AND YXM), the National Natural Science Foundation of China (31328020 GHJ), the State Key Special Program of China (2016YFD0200107, 2016YFD0300801, 2016YFD0300900 GHJ), and the Project of the Introduction of the Leading Talent Team in Colleges and Universities of Anhui Province of China (gxljtdzd201607 GHJ).	Albrecht R, 2008, EUR J SOIL SCI, V59, P445, DOI 10.1111/j.1365-2389.2007.00993.x; Antil RS, 2013, WASTE BIOMASS VALORI, V4, P95, DOI 10.1007/s12649-012-9141-7; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bernal MP, 1998, BIORESOURCE TECHNOL, V63, P91, DOI 10.1016/S0960-8524(97)00084-9; Brito LM, 2012, WASTE MANAGE, V32, P1332, DOI 10.1016/j.wasman.2012.03.013; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; Erickson MC, 2009, COMPOST SCI UTIL, V17, P229; Gomez X, 2007, CHEMOSPHERE, V68, P1889, DOI 10.1016/j.chemosphere.2007.02.065; He XS, 2013, MICROCHEM J, V106, P160, DOI 10.1016/j.microc.2012.06.004; HOITINK HAJ, 1986, ANNU REV PHYTOPATHOL, V24, P93, DOI 10.1146/annurev.py.24.090186.000521; Hsu JH, 1999, ENVIRON POLLUT, V104, P189, DOI 10.1016/S0269-7491(98)00193-6; Hue N. V., 1995, Compost Science and Utilization, V3, P8; KEENEY DR, 1982, METHODS SOIL ANAL 2, P672; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Kumar DS, 2013, J AGR FOOD CHEM, V61, P11326, DOI 10.1021/jf4034943; Leenheer JA, 20045276 US GEOL SUR; Mao JD, 2004, ENVIRON SCI TECHNOL, V38, P2680, DOI 10.1021/es034770x; Mao JD, 2008, J AGR FOOD CHEM, V56, P2131, DOI 10.1021/jf071588x; Mao JD, 2012, ENVIRON SCI TECHNOL, V46, P5806, DOI 10.1021/es300521e; Mao JD, 2011, GEOCHIM COSMOCHIM AC, V75, P7864, DOI 10.1016/j.gca.2011.09.044; Marche T, 2003, GEODERMA, V116, P345, DOI 10.1016/S0016-7061(03)00108-3; MATHUR SP, 1993, BIOL AGRIC HORTIC, V10, P65, DOI 10.1080/01448765.1993.9754655; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Paredes C, 2015, COMMUN SOIL SCI PLAN, V46, P238, DOI 10.1080/00103624.2014.989022; Satisha GC, 2007, WASTE MANAGE, V27, P1083, DOI 10.1016/j.wasman.2006.04.020; Spaccini R, 2007, J AGR FOOD CHEM, V55, P2303, DOI 10.1021/jf0625407; Tang JC, 2006, PROCESS BIOCHEM, V41, P380, DOI 10.1016/j.procbio.2005.06.022; Tiquia SM, 2010, CHEMOSPHERE, V79, P506, DOI 10.1016/j.chemosphere.2010.02.040; Tiquia SM, 1997, ENVIRON POLLUT, V98, P97, DOI 10.1016/S0269-7491(97)00116-4; Tiquia SM, 2002, PROCESS BIOCHEM, V37, P869, DOI 10.1016/S0032-9592(01)00274-6; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Veeken AHM, 2001, J ENVIRON QUAL, V30, P1675, DOI 10.2134/jeq2001.3051675x; Wang K, 2015, J HAZARD MATER, V300, P745, DOI 10.1016/j.jhazmat.2015.08.016; ZUCCONI F, 1981, BIOCYCLE, V22, P54; Zucconi F., 1987, COMPOST PRODUCTION Q, P30	36	40	43	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178110	10.1371/journal.pone.0178110	http://dx.doi.org/10.1371/journal.pone.0178110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604783	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400010
J	Arredondo, LT; Perez, CA				Arredondo, Luis T.; Perez, Claudio A.			Spatially coincident vibrotactile noise improves subthreshold stimulus detection	PLOS ONE			English	Article							STOCHASTIC RESONANCE; UNCERTAINTY; SIGNALS	Stochastic Resonance (SR) is a phenomenon, mainly present in nonlinear detection systems, in which the addition of certain amount of noise, called optimal noise, has proven to enhance detection performance of subthreshold stimuli. When added noise is present only during the stimulus, an additional enhancement can be reached. This phenomenon was called time Coincidence Enhanced Stochastic Resonance (CESR). The aim of this study was to study the effect of spatially distributed vibrotactile noise in subthreshold stimuli detection. The correct response rates from two different stimuli conditions were compared, using four tactile stimulator systems to excite four different spatial locations on the fingertip. Under two different conditions, the stimuli were present in only one randomly chosen stimulator. For the first condition, all stimulators contain optimal noise level. In the second condition, the optimal noise was present only at the stimulator with the stimulus. SR threshold principle should not produce different correct response rates between the two conditions, since in both cases the noise enables the subthreshold stimulus to go above threshold. The stimulus signal used was a rectangular displacement controlled pulse that lasted 300ms within a 1.5s attention interval, applied to the exploratory zone of the index finger of 13 human subjects. For all subjects it was found that detection rates were better (p<0.0003) when noise was spatially coincident with the stimulus, compared to the condition in which noise was present simultaneously in all the stimulators. According to our literature review this is the first report of SR being influenced by the spatial location of the noise. These results were not found previously reported, so represent the discovery of a new phenomenon. We call this phenomenon Spatial-Coincidence-Enhanced Stochastic Resonance (SCESR). As results show, the optimal noise level is dependent on the relative position between stimulus and noise.	[Arredondo, Luis T.] Univ Chile, Dept Elect Engn, Santiago, Chile; [Perez, Claudio A.] Univ Chile, Dept Elect Engn, Santiago, Chile; [Perez, Claudio A.] Univ Chile, Adv Min Technol Ctr, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile	Arredondo, LT (corresponding author), Univ Chile, Dept Elect Engn, Santiago, Chile.	togo.arredondo@uv.cl	Arredondo, Juan/L-2404-2013; Perez, Claudio A/F-3560-2015	Arredondo, Juan/0000-0002-6784-0990; Perez, Claudio A/0000-0002-5484-4159; , Sara/0000-0001-6048-624X	Fondecyt [1080593]; Department of Electrical Engineering, Universidad de Chile	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Department of Electrical Engineering, Universidad de Chile	This research was funded in part by Fondecyt grant No. 1080593 and by the Department of Electrical Engineering, Universidad de Chile.	COHN TE, 1974, J OPT SOC AM, V64, P1715, DOI 10.1364/JOSA.64.001715; Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923; Dickerson K., 2015, J VIS, V15, P1; Ehrenstein W. H, 1999, PSYCHOPHYSICAL METHO, P1211, DOI [DOI 10.1007/978-3-642-58552-4_43, 10.1007/978-3-642-58552- 4_43, DOI 10.1007/978-3-642-58552-4, 10.1007/978-3-642-58552-4]; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gescheider GA, 2004, BEHAV BRAIN RES, V148, P35, DOI 10.1016/S0166-4328(03)00177-3; Green D. M., 1974, SIGNAL DETECTION THE; Kay KN, 2015, CURR BIOL, V25, P595, DOI 10.1016/j.cub.2014.12.050; Klein SA, 2001, PERCEPT PSYCHOPHYS, V63, P1421, DOI 10.3758/BF03194552; Klein SA, 2009, J OPT SOC AM A, V26, pB110, DOI 10.1364/JOSAA.26.00B110; Kurita Y, 2011, IEEE T HUMAN MACHINE; Liu W, 2002, ARCH PHYS MED REHAB, V83, P171, DOI 10.1053/apmr.2002.28025; Manjarrez E, 2003, J NEUROSCI, V23, P1997; Manjarrez E, 2002, NEUROSCI LETT, V324, P213, DOI 10.1016/S0304-3940(02)00212-4; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; NEVIN JA, 1969, J EXP ANAL BEHAV, V12, P875, DOI 10.1901/jeab.1969.12-875; Ohka M, 2012, INT J SOC ROBOT, V4, P65, DOI 10.1007/s12369-011-0095-x; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Perez CA, 2007, NEUROSCI LETT, V424, P31, DOI 10.1016/j.neulet.2007.07.014; Perez-Garcia C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-109; Phu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150922; Sasaki H, 2008, NEUROSCI LETT, V436, P255, DOI 10.1016/j.neulet.2008.03.036; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; Sueda Y, 2013, IEEE ENG MED BIO, P4601, DOI 10.1109/EMBC.2013.6610572; TANNER WP, 1961, ANN NY ACAD SCI, V89, P752, DOI 10.1111/j.1749-6632.1961.tb20176.x; VERRILLO RT, 1968, SKIN SENSES, P135; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/jourrial.pone.0186932	http://dx.doi.org/10.1371/jourrial.pone.0186932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	28617826				2022-12-26	WOS:000414229700035
J	Dilley, KA; Voorhies, AA; Luthra, P; Puri, V; Stockwell, TB; Lorenzi, H; Basler, CF; Shabman, RS				Dilley, Kari A.; Voorhies, Alexander A.; Luthra, Priya; Puri, Vinita; Stockwell, Timothy B.; Lorenzi, Hernan; Basler, Christopher F.; Shabman, Reed S.			The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEFECTIVE INTERFERING PARTICLES; RIG-I; IMMUNE EVASION; 5'-TRIPHOSPHATE RNA; IRF-3 ACTIVATION; ANTAGONISM; INFECTION; SURVEILLANCE; GENERATION	Ebola virus and Marburg virus are members of the Filovirdae family and causative agents of hemorrhagic fever with high fatality rates in humans. Filovirus virulence is partially attributed to the VP35 protein, a well-characterized inhibitor of the RIG-I-like receptor pathway that triggers the antiviral interferon (IFN) response. Prior work demonstrates the ability of VP35 to block potent RIG-I activators, such as Sendai virus (SeV), and this IFN-antagonist activity is directly correlated with its ability to bind RNA. Several structural studies demonstrate that VP35 binds short synthetic dsRNAs; yet, there are no data that identify viral immunostimulatory RNAs (isRNA) or host RNAs bound to VP35 in cells. Utilizing a SeV infection model, we demonstrate that both viral isRNA and host RNAs are bound to Ebola and Marburg VP35s in cells. By deep sequencing the purified VP35-bound RNA, we identified the SeV copyback defective interfering (DI) RNA, previously identified as a robust RIG-I activator, as the isRNA bound by multiple filovirus VP35 proteins, including the VP35 protein from the West African outbreak strain (Makona EBOV). Moreover, RNAs isolated from a VP35 RNA-binding mutant were not immunostimulatory and did not include the SeV DI RNA. Strikingly, an analysis of host RNAs bound by wild-type, but not mutant, VP35 revealed that select host RNAs are preferentially bound by VP35 in cell culture. Taken together, these data support a model in which VP35 sequesters isRNA in virus-infected cells to avert RIG-I like receptor (RLR) activation.	[Dilley, Kari A.; Puri, Vinita; Stockwell, Timothy B.; Shabman, Reed S.] J Craig Venter Inst, Virol Grp, Rockville, MD 20850 USA; [Voorhies, Alexander A.; Lorenzi, Hernan] J Craig Venter Inst, Infect Dis Grp, Rockville, MD USA; [Luthra, Priya; Basler, Christopher F.] Georgia State Univ, Ctr Microbial Pathogenesis, Atlanta, GA 30303 USA; [Stockwell, Timothy B.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD USA	J. Craig Venter Institute; J. Craig Venter Institute; University System of Georgia; Georgia State University	Dilley, KA; Shabman, RS (corresponding author), J Craig Venter Inst, Virol Grp, Rockville, MD 20850 USA.	kdilley@jcvi.org; rshabman@jcvi.org		Basler, Christopher/0000-0003-4195-425X; Lorenzi, Hernan/0000-0003-0910-7894; Stockwell, Timothy/0000-0002-3595-4539	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [U19AI110819]; NIH [AI109945]; Department of the Defense, Defense Threat Reduction Agency [HDTRA1-12-1-0051]; JCV [9260]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110819, U19AI109945] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); JCV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in whole or part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under Award Number U19AI110819.This work was also supported NIH grant AI109945 and Department of the Defense, Defense Threat Reduction Agency grant HDTRA1-12-1-0051 to CFB. RS Sand KD were also supported by JCV Iinternal funding (9260).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anthony SM, 2015, VIRUSES-BASEL, V7, P5172, DOI 10.3390/v7102867; Bai YH, 2016, BRIEF BIOINFORM, V17, P63, DOI 10.1093/bib/bbv026; Basler CF, 2000, P NATL ACAD SCI USA, V97, P12289, DOI 10.1073/pnas.220398297; Basler CF, 2003, J VIROL, V77, P7945, DOI 10.1128/JVI.77.14.7945-7956.2003; Basler CF, 2015, VIROLOGY, V479, P122, DOI 10.1016/j.virol.2015.03.030; Basler CF, 2013, EXPERT REV ANTI-INFE, V11, P475, DOI [10.1586/eri.13.30, 10.1586/ERI.13.30]; Basler CF, 2009, J INTERF CYTOK RES, V29, P511, DOI 10.1089/jir.2009.0076; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Binning JM, 2013, BIOCHEMISTRY-US, V52, P8406, DOI 10.1021/bi400704d; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown CS, 2014, J MOL BIOL, V426, P2045, DOI 10.1016/j.jmb.2014.01.010; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Cannas V, 2015, J INFECT DIS, V212, pS277, DOI 10.1093/infdis/jiv214; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Dunham EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9000; Edwards MR, 2016, CELL REP, V14, P1632, DOI 10.1016/j.celrep.2016.01.049; Ekins Sean, 2014, F1000Res, V3, P277, DOI 10.12688/f1000research.5741.1; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hartman AL, 2008, J VIROL, V82, P2699, DOI 10.1128/JVI.02344-07; Hartman AL, 2006, J VIROL, V80, P6430, DOI 10.1128/JVI.00044-06; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Johnson RF, 2006, J VIROL, V80, P5135, DOI 10.1128/JVI.01857-05; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859; Leung DW, 2010, NAT STRUCT MOL BIOL, V17, P165, DOI 10.1038/nsmb.1765; Leung DW, 2009, ACTA CRYSTALLOGR F, V65, P163, DOI 10.1107/S1744309108044187; Lopez CB, 2006, J VIROL, V80, P4538, DOI 10.1128/JVI.80.9.4538-4545.2006; Luthra P, 2013, CELL HOST MICROBE, V14, P74, DOI 10.1016/j.chom.2013.06.010; Martinez-Romero C, 2015, VIRUS RES, V209, P4, DOI 10.1016/j.virusres.2015.05.025; Messaoudi I, 2015, NAT REV MICROBIOL, V13, P663, DOI 10.1038/nrmicro3524; Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Patel JR, 2014, CYTOKINE GROWTH F R, V25, P513, DOI 10.1016/j.cytogfr.2014.08.005; Perrault J, 1981, Curr Top Microbiol Immunol, V93, P151; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins KC, 2010, J VIROL, V84, P3004, DOI 10.1128/JVI.02459-09; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Spiropoulou CF, 2009, VIROLOGY, V392, P11, DOI 10.1016/j.virol.2009.06.032; St Reid P, 2005, VIROLOGY, V341, P179, DOI 10.1016/j.virol.2005.06.044; Sun Y, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005122; Team RC, 2015, LANG ENV STAT COMP; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valmas C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000721; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Xue Q, 2014, BIOPOLYMERS, V101, P849, DOI 10.1002/bip.22463; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Zhang HX, 2013, P NATL ACAD SCI USA, V110, P6459, DOI 10.1073/pnas.1304432110	56	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178717	10.1371/journal.pone.0178717	http://dx.doi.org/10.1371/journal.pone.0178717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636653	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300016
J	Mitrega, KA; Spalek, AM; Nozynski, J; Porc, M; Stankiewicz, M; Krzeminski, TF				Mitrega, Katarzyna A.; Spalek, Adrianna M.; Nozynski, Jerzy; Porc, Maurycy; Stankiewicz, Magdalena; Krzeminski, Tadeusz F.			Cardiomyopathy development protection after myocardial infarction in rats: Successful competition for major dihydropyridines' common metabolite against captopril	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CARDIOVASCULAR EVENTS; CALCIUM-ANTAGONIST; HEART-FAILURE; TNF-ALPHA; INHIBITION; SIZE; ARRHYTHMIAS; EXPRESSION; REDUCTION	During the last 25 years angiotensin-converting enzyme inhibitors spectacularly conquered the field of cardiovascular diseases therapy. Nevertheless, lack of new studies concerning side effects associated with their chronic administration seems to be rather confusing. In our previous research, we proved that the main furnidipines' metabolite (M-2) possess multiple cardioprotective actions. Currently, we compared effects of post-infarction long-term oral treatment with M-2 and captopril on hemodynamic parameters and ''ischemic cardiomyopathy'' development in rats. Myocardial infarction was evoked by permanent left anterior descending coronary artery occlusion for 35 days. Surviving rats were treated with captopril (2 x 25 mg/kg) or M-2 (4 mg/kg) from 6(th) -35(th) day. At 35(th) day rats' hearts were tested on working heart setup, where following parameters were measured: heart rate, preload pressure, aortic systolic and diastolic pressures, aortic maximum rise and fall, aortic and coronary flow, myocardial oxygen consumption and oximetry in perfusate. Subsequently, heart tissue specimens were assessed during morphological estimation. Captopril caused significant heart rate increase and markedly diminished preload pressure in comparison to M-2. Both drugs evoked essential aortic pressure increase. Aortic flow was significantly decreased after M-2, whereas captopril increased this parameter in comparison to M-2. Both agents caused marked coronary flow increase. Morphologic examination in captopril revealed cardiomyopathic process in 70% of hearts, whereas in M-2 this value reached 30%. Neovascularization of post-infarcted myocardium was visible only after M-2 therapy. Concluding, M-2 presented itself as more attractive agent in long-term post-infarction treatment by preventing cardiomyopathy development, angiogenesis stimulation and preserving cardiac performance.	[Mitrega, Katarzyna A.; Nozynski, Jerzy] Silesian Ctr Heart Dis, Zabrze, Poland; [Spalek, Adrianna M.; Porc, Maurycy; Stankiewicz, Magdalena; Krzeminski, Tadeusz F.] Med Univ Silesia, Chair & Dept Pharmacol, Zabrze, Poland	Silesian Center for Heart Diseases; Medical University Silesia	Spalek, AM (corresponding author), Med Univ Silesia, Chair & Dept Pharmacol, Zabrze, Poland.	adrianna.spalek@gmail.com		Porc, Maurycy Pawel/0000-0001-8914-1173; Stankiewicz, Magdalena/0000-0002-2608-1959; Spalek, Adrianna/0000-0001-9314-6292; Krzeminski, Tadeusz/0000-0003-3663-4518				Bergmeyer H. U., 1983, METHODS ENZYMATIC AN; Bonarjee VVS, 1996, DRUGS, V51, P347, DOI 10.2165/00003495-199651030-00001; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; BUDDEN R, 1980, RAT ELECTROCARDIOGRA; CARLSSON L, 1989, EUR J PHARMACOL, V166, P157, DOI 10.1016/0014-2999(89)90055-1; Cleland JGF, 1997, EUR HEART J, V18, P41; CROME R, 1986, J CARDIOVASC PHARM, V8, P1249, DOI 10.1097/00005344-198611000-00023; CROTTOGINI AJ, 1985, AM HEART J, V110, P753, DOI 10.1016/0002-8703(85)90453-3; Deck CC, 1996, J CARDIOVASC PHARM, V28, P167, DOI 10.1097/00005344-199607000-00024; Dembinska-Kiec A, 1998, ADV EXPT MED BIOL, P163; ELLRODT G, 1980, CIRCULATION, V62, P669, DOI 10.1161/01.CIR.62.4.669; ERTL G, 1983, BASIC RES CARDIOL, V78, P518, DOI 10.1007/BF01906463; ERTL G, 1988, EUR HEART J, V9, P716, DOI 10.1093/eurheartj/9.7.716; ERTL G, 1982, CIRCULATION, V65, P40, DOI 10.1161/01.CIR.65.1.40; FERRARI R, 1994, CARDIOVASC DRUG THER, V8, P565, DOI 10.1007/BF00877225; Fox KM, 2003, LANCET, V362, P782; Fryer RM, 2000, J PHARMACOL EXP THER, V294, P451; Gerol M, 1998, COMP BIOCHEM PHYS C, V120, P397, DOI 10.1016/S0742-8413(98)10064-6; GUENDJEV Z, 1977, ARZNEIMITTELFORSCH, V27-2, P1576; HAMM CW, 1983, CIRC RES, V52, P129; Heba G, 2001, J PHYSIOL PHARMACOL, V52, P39; Heba G, 2001, J VASC RES, V38, P288, DOI 10.1159/000051057; HIRSCH AT, 1991, CIRC RES, V69, P475, DOI 10.1161/01.RES.69.2.475; Jin H, 2001, CIRCULATION, V103, P736; JOHNSTON CI, 1991, CLIN EXP PHARMACOL P, V18, P107, DOI 10.1111/j.1440-1681.1991.tb01417.x; KEMNITZ J, 1987, AM J SURG PATHOL, V11, P503, DOI 10.1097/00000478-198707000-00002; Kleinman L, 1986, HARVARD APPARATUS BI, P25; KREHER P, 1995, J CARDIOVASC PHARM, V25, P75, DOI 10.1097/00005344-199501000-00012; Krzeminski TF, 2008, VASC PHARMACOL, V49, P91, DOI 10.1016/j.vph.2008.06.005; Krzeminski TF, 2006, EUR J PHARMACOL, V549, P91, DOI 10.1016/j.ejphar.2006.08.002; Krzeminski TF, 2011, J CARDIOVASC PHARM, V57, P183, DOI 10.1097/FJC.0b013e318202e2ea; Krzeminski TF, 2005, VASC PHARMACOL, V43, P164, DOI 10.1016/j.vph.2005.06.003; Krzeminski TF, 1995, 9 FREIB FOC BIOM PHA, P128; Langendorff O., 1898, PFLUGERS ARCH, V70, P473; Letelier CS, 2002, US 477 Patent, Patent No. [US 6,482,841B1, 6482841]; Luscher T F, 1993, Drugs, V46 Suppl 2, P121; MARTORANA PA, 1990, EUR J PHARMACOL, V182, P395, DOI 10.1016/0014-2999(90)90301-L; MCDONALD KM, 1990, T ASSOC AM PHYSICIAN, V103, P229; MELIN JA, 1984, CIRCULATION, V69, P131, DOI 10.1161/01.CIR.69.1.131; Mitrega KA, 2013, J CLIN EXP CARDIOLOG, V4, P281; Mitrega KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089477; NEELY JR, 1967, AM J PHYSIOL, V212, P804; OLSEN EGJ, 1986, COR VASA, V28, P241; OLSEN EGJ, 1984, AM J CARDIOL, V53, P654, DOI 10.1016/0002-9149(84)90064-X; Opie LH, 2000, PROG CARDIOVASC DIS, V43, P171, DOI 10.1053/pcad.2000.7010; PFEFFER MA, 1988, NEW ENGL J MED, V319, P80, DOI 10.1056/NEJM198807143190204; PFEFFER MA, 1985, CIRCULATION, V72, P406, DOI 10.1161/01.CIR.72.2.406; Roden DM, 2003, J CARDIOVASC ELECTR, V14, P1389, DOI 10.1046/j.1540-8167.2003.03441.x; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rouleau JL, 2008, CIRCULATION, V117, P24, DOI 10.1161/CIRCULATIONAHA.106.685073; Russ U, 1996, PFLUG ARCH EUR J PHY, V432, P75, DOI 10.1007/s004240050107; SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Stormont MF, 1930, J PHARMACOL EXP THER, V39, P165; Thandroyen FT, 1981, AM J CARDIOL, V47, P15; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TUMAS J, 1985, J CARDIOVASC PHARM, V7, P361, DOI 10.1097/00005344-198503000-00023; VANGILST WH, 1986, J CARDIOVASC PHARM, V8, P722; WEATHERALL JAC, 1960, BRIT J PHARM CHEMOTH, V15, P454, DOI 10.1111/j.1476-5381.1960.tb01272.x; WESTLIN W, 1988, CIRCULATION, V77, P30; Wilkens H, 1970, SHOCK BIOCH PHARM CL, P201; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zander B, 1967, MEASUREMENT OXYGEN, P271; Zdrojewski T., 1994, European Heart Journal, V15, P118; ZUGHAIB ME, 1993, BASIC RES CARDIOL, V88, P155; Zwieten PA, 1966, CARDIOVASC DRUG THER, V10, P693	66	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179633	10.1371/journal.pone.0179633	http://dx.doi.org/10.1371/journal.pone.0179633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636634	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300045
J	Sikic, D; Keck, B; Wach, S; Taubert, H; Wullich, B; Goebell, PJ; Kahlmeyer, A; Olbert, P; Isfort, P; Nimphius, W; Hartmann, A; Giedl, J				Sikic, Danijel; Keck, Bastian; Wach, Sven; Taubert, Helge; Wullich, Bernd; Goebell, Peter J.; Kahlmeyer, Andreas; Olbert, Peter; Isfort, Philipp; Nimphius, Wilhelm; Hartmann, Arndt; Giedl, Johannes		Bridge Consortium	Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis	PLOS ONE			English	Article							INVASIVE BLADDER-CANCER; LUMINAL SUBTYPES; CELL-CARCINOMA; BASAL; CHEMOTHERAPY; RECURRENCE; THERAPY	Purpose Genome-wide analyses revealed basal and luminal subtypes of urothelial carcinomas of the bladder. It is unknown if this subtyping can also be applied to upper tract urothelial carcinomas. Materials and methods Tumor samples from 222 patients with upper tract urothelial carcinomas who were treated with radical nephroureterectomy were analyzed for the expression of seven basal/luminal immunohistochemical markers (CK5, EGFR, CD44, CK20, p63, GATA3, FOXA1). Results Hierarchical clustering revealed a basal-like subtype (enrichment of CK5, EGFR and CD44) in 23.9% and a luminal-like subtype (enrichment of CK20, GATA3, p63 and FOXA1) in 13.1% of the patients. In 60.8%, little to no markers were expressed, whereas markers of both subtypes were expressed in 2.2%. By using CK5 and CK20 as surrogate markers for the basal and luminal subtypes, we defined four subtypes of upper tract urothelial carcinomas: (i) exclusively CK20 positive and CK5 negative (CK20+/CK5-), (ii) exclusively CK5 positive and CK20 negative (CK20-/CK5+), (iii) both markers positive (CK20+/CK5+) and (iv) both markers negative (CK20-/CK5-). A receiver-operator analysis provided the optimal cut-off values for this discrimination. An immunoreactive score > 1 for CK5 and > 6 for CK20 were defined as positive. In multivariate Cox's regression analysis, the CK20+/CK5-subtype was an independent negative prognostic marker with a 3.83-fold increased risk of cancer-specific death (p = 0.02) compared to the other three subtypes. Conclusions Immunohistochemical subgrouping of upper tract urothelial carcinomas by analyzing CK5 and CK20 expression can be performed in a routine setting and can identify tumors with a significantly worse cancer-specific survival prognosis.	[Sikic, Danijel; Keck, Bastian; Wach, Sven; Taubert, Helge; Wullich, Bernd; Goebell, Peter J.; Kahlmeyer, Andreas] Univ Hosp Erlangen, Dept Urol & Pediat Urol, Erlangen, Germany; [Olbert, Peter; Isfort, Philipp] Philipps Univ Marburg, Dept Urol & Pediat Urol, Marburg, Germany; [Nimphius, Wilhelm] Philipps Univ Marburg, Inst Pathol, Marburg, Germany; [Hartmann, Arndt; Giedl, Johannes] Univ Hosp Erlangen, Inst Pathol, Erlangen, Germany	University of Erlangen Nuremberg; Philipps University Marburg; Philipps University Marburg; University of Erlangen Nuremberg	Sikic, D (corresponding author), Univ Hosp Erlangen, Dept Urol & Pediat Urol, Erlangen, Germany.	danijel.sikic@uk-erlangen.de						Bing ZY, 2012, AM J CLIN PATHOL, V138, P382, DOI 10.1309/AJCPUXAP6P2GVBTI; Carballido EM, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0404-2; Carneiro BA, 2015, CANCER TREAT REV, V41, P170, DOI 10.1016/j.ctrv.2014.11.003; Choi W, 2014, NAT REV UROL, V11, P400, DOI 10.1038/nrurol.2014.129; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Goebell PJ, 2010, UROL ONCOL-SEMIN ORI, V28, P409, DOI 10.1016/j.urolonc.2010.04.003; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Hartmann A, 2002, CANCER RES, V62, P6796; Hedegaard J, 2016, CANC CELL; Kim J, 2015, CLIN CANCER RES, V21, P4514, DOI 10.1158/1078-0432.CCR-14-1215; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Leow JJ, 2014, EUR UROL, V66, P529, DOI 10.1016/j.eururo.2014.03.003; Mai KT, 2016, APPL IMMUNOHISTO M M, V24, P575, DOI 10.1097/PAI.0000000000000224; Mai KT, 2015, PATHOL RES PRACT, V211, P610, DOI 10.1016/j.prp.2015.05.005; Marquis L, 2012, CANCER BIOL THER, V13, P477, DOI 10.4161/cbt.19590; Patschan O, 2015, EUR UROL, V68, P824, DOI 10.1016/j.eururo.2015.02.021; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raman JD, 2016, UROLOGY; REMMELE W, 1987, PATHOLOGE, V8, P138; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Roupret M, 2015, EUR UROL, V68, P868, DOI 10.1016/j.eururo.2015.06.044; Roupret M, 2008, EUR UROL, V54, P1226, DOI 10.1016/j.eururo.2008.08.008; Seiler R, 2017, EUR UROL; Sfakianos JP, 2015, EUR UROL, V68, P970, DOI 10.1016/j.eururo.2015.07.039; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Terakawa T, 2014, UROL INT, V92, P180, DOI 10.1159/000354149; Volkmer JP, 2012, P NATL ACAD SCI USA, V109, P2078, DOI 10.1073/pnas.1120605109; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wezel F, 2016, UROL INT	31	19	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179602	10.1371/journal.pone.0179602	http://dx.doi.org/10.1371/journal.pone.0179602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632777	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100041
J	Phillippe, M; Adeli, S				Phillippe, Mark; Adeli, Sharareh			Cell-free DNA release by mouse placental explants	PLOS ONE			English	Article							FREE FETAL DNA; MATERNAL CIRCULATION; INDUCED APOPTOSIS; SEX DETERMINATION; OXIDATIVE STRESS; PLASMA; TELOMERES; QUANTIFICATION; PREGNANCY; KINETICS	Although suggested that "fetal" cell-free DNA (cfDNA) is derived from trophoblast cells, the exact origin is unclear. The studies in this report sought to demonstrate that placental tissue releases cfDNA in parallel with cell death, that the size range of cfDNA is similar to that found in maternal plasma, and that the cfDNA fragments are able to stimulate a proinflammatory cytokine response. Placentas were harvested from near term pregnant CD-1 mice and cultured in DMEM/Ham's F12/FBS media in 8% or 21% O-2. After centrifugation to remove cells and cellular debris, the cfDNA was extracted from the media and quantified by DNA spectrophotometry. The cfDNA fragments were sized using a 1.5% TAE gel. Cell death was quantified by lactate dehydrogenase assay; and tissue homogenates were used to quantify caspase activity and BAX expression. Cultured RAW-264.7 macrophage cells were used to determine IL6 stimulation by cfDNA. The cfDNA levels released in 8% O2 (placental normoxia) were not significantly different from explants cultured in 21% O2 (placental hyperoxia). The cfDNA fragments ranged in size from < 100 -< 400 bp. The cfDNA release increased when cultured with LPS, whereas it decreased with trolox (vitamin E analog). Explant release of cfDNA increased in parallel with cell death. The cfDNA release and cell death of trophoblast appears to involve components of the apoptosis signaling pathway as suggested by LPS enhancement of placental caspase activity, suppression of cfDNA release by a pan-caspase inhibitor and the trend toward increased Bax protein expression. Studies with cultured macrophage cells confirmed the ability of cfDNA to stimulate an IL6 response. In summary, these studies have confirmed the ability of placental tissue to release significant amounts of cfDNA, a phenomenon that appears to be mediated, at least in part, by apoptosis; and that the cfDNA released by the placental explants is able to stimulate a significant proinflammatory response. Thus, these studies provide support for the hypothesis that cell-free fetal DNA released by placental tissue potentially plays a mechanistically important role during the events leading to the onset of parturition.	[Phillippe, Mark; Adeli, Sharareh] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Phillippe, M (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	mphillippe@mgh.harvard.edu			Burroughs Welcome Fund Preterm Birth Initiative	Burroughs Welcome Fund Preterm Birth Initiative	This work was funded by the Burroughs Welcome Fund 2015 Preterm Birth Initiative. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ariga H, 2001, TRANSFUSION, V41, P1524, DOI 10.1046/j.1537-2995.2001.41121524.x; Baritaud M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.120; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Bischoff FZ, 2005, HUM REPROD UPDATE, V11, P59, DOI 10.1093/humupd/dmh053; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chen BS, 2012, AM J PHYSIOL-ENDOC M, V302, pE1142, DOI 10.1152/ajpendo.00003.2012; Depoix C, 2013, MOL HUM REPROD, V19, P29, DOI 10.1093/molehr/gas042; Goldfarb I, 2017, REPROD SCI; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Guilbert LJ, 2010, PLACENTA, V31, P982, DOI 10.1016/j.placenta.2010.08.012; Gursel I, 2003, J IMMUNOL, V171, P1393, DOI 10.4049/jimmunol.171.3.1393; Jimenez DF, 2003, PEDIATR RES, V53, P18, DOI 10.1203/01.PDR.0000039837.34834.65; Kadivar A, 2013, THERIOGENOLOGY, V79, P995, DOI 10.1016/j.theriogenology.2013.01.027; Kakinuma C, 1997, OBSTET GYNECOL, V90, P117, DOI 10.1016/S0029-7844(97)00176-2; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Khosrotehrani K, 2004, HUM REPROD, V19, P2460, DOI 10.1093/humrep/deh445; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Luo GY, 2010, REPROD SCI, V17, P532, DOI 10.1177/1933719110363618; Majer S, 2007, PRENATAL DIAG, V27, P1219, DOI 10.1002/pd.1875; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Mitsunaga F, 2010, EXP ANIM TOKYO, V59, P255, DOI 10.1538/expanim.59.255; de Leon PMM, 2012, THERIOGENOLOGY, V77, P694, DOI 10.1016/j.theriogenology.2011.09.005; Phillippe M, 2015, REPROD SCI, V22, P1186, DOI 10.1177/1933719115592714; Phillippe M, 2014, NEW ENGL J MED, V370, P2534, DOI 10.1056/NEJMcibr1404324; Reddy A, 2008, PLACENTA, V29, P942, DOI 10.1016/j.placenta.2008.08.018; Taglauer ES, 2013, PLACENTA; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119; Wang GL, 2010, J REPROD DEVELOP, V56, P639, DOI 10.1262/jrd.10-010T; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; Zhang X, 2006, J SOC GYNECOL INVEST, V13, P451, DOI 10.1016/j.jsgi.2006.05.005; Zhong XY, 2002, MOL HUM REPROD, V8, P864, DOI 10.1093/molehr/8.9.864	35	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0178845	10.1371/journal.pone.0178845	http://dx.doi.org/10.1371/journal.pone.0178845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622381	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300010
J	Wen, SY; Tamilselvi, S; Shen, CY; Day, CH; Chun, LC; Cheng, LY; Ou, HC; Chen, RJ; Viswanadha, VP; Kuo, WW; Huang, CY				Wen, Su-Ying; Tamilselvi, Shanmugam; Shen, Chia-Yao; Day, Cecilia Hsuan; Chun, Li-Chin; Cheng, Li-Yi; Ou, Hsiu-Chung; Chen, Ray-Jade; Viswanadha, Vijaya Padma; Kuo, Wei-Wen; Huang, Chih-Yang			Protective effect of HDL on NADPH oxidase-derived super oxide anion mediates hypoxia-induced cardiomyocyte apoptosis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; N-TERMINAL KINASES; NEUTROPHIL RESPIRATORY BURST; ACTIVATED PROTEIN-KINASES; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; HEART-FAILURE; HIF-1-ALPHA; MYOCARDIN; OXYGEN	Cardiovascular diseases are the leading cause of death of death in Taiwan. Atherosclerosis can lead to serious problems, including heart attack, stroke, or even death. Coronary heart disease (CHD) occurs when plaque builds up in the coronary arteries to cause the ischemic heart disease which will enhance myocardial remodeling and also induce myocardial hypoxia. High density lipoprotein (HDL) has been proposed to have cardio-protective effects. Under hypoxic conditions (1%O-2 for 24hr), in H9c2 cells, reactive oxygen species (ROS) is induced which leads to cardiomyocyte apoptosis and cardiac dysfunction. Therefore, the present study described the protective effect of HDL on hypoxia-induced cardiomyocyte damage. We investigated the NADPH oxidase-produced ROS-related signaling pathways and apoptosis in cardiomyocytes under hypoxia conditions. Results showed that the ROS mediated cardiac damage might occur via AT1 and PKC activation. Furthermore, hypoxia downregulated the survival protein (p-AKT(ser473)) and anti-apoptotic protein (BCL2), whereas pro-apoptotic protein, Bax and caspase 3 were upregulated. These detrimental effects by ROS and apoptosis were prevented by HDL pretreatment. Our findings revealed the underlying molecular mechanism by which HDL suppresses the hypoxia-induced cardiomyocyte dysfunction. Further, we elucidated the role of HDL on preventing hypoxia induced cardiomyocyte apoptosis is mediated through the inhibition of NADPH oxidase-derived ROS.	[Wen, Su-Ying] Taipei City Hosp, Renai Branch, Dept Dermatol, Taipei, Taiwan; [Wen, Su-Ying] Mackay Jr Coll Med Nursing & Management, Ctr Gen Educ, Taipei, Taiwan; [Tamilselvi, Shanmugam; Ou, Hsiu-Chung; Huang, Chih-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Shen, Chia-Yao; Day, Cecilia Hsuan] MeiHo Univ, Dept Nursing, Pingtung, Taiwan; [Chun, Li-Chin] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Tainan County, Taiwan; [Cheng, Li-Yi; Huang, Chih-Yang] Asia Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Chen, Ray-Jade] Taipei Med Univ, Dept Surg, Sch Med, Coll Med, Taipei, Taiwan; [Viswanadha, Vijaya Padma] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India; [Kuo, Wei-Wen] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Huang, Chih-Yang] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan	Taipei City Hospital; Mackay Junior College of Medicine, Nursing & Management; China Medical University Taiwan; Chia Nan University of Pharmacy & Science; Asia University Taiwan; Taipei Medical University; Bharathiar University; China Medical University Taiwan; China Medical University Taiwan	Huang, CY (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Huang, CY (corresponding author), Asia Univ, Dept Biol Sci & Technol, Taichung, Taiwan.; Huang, CY (corresponding author), China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan.	cyhuang@mail.cmu.edu.tw	Tamilselvi, Shanmugam/AAB-8134-2020; Ou, Hsiu-Chung/AAQ-2489-2020; Viswanadha, Vijaya Padma/ABG-4936-2020; Chen, Ray/GRJ-6736-2022	Ou, Hsiu-Chung/0000-0001-6794-3431; Viswanadha, Vijaya Padma/0000-0001-9154-027X; Huang, Chih-Yang/0000-0003-2347-0411; Tamilselvi, Shanmugam/0000-0001-9339-5598	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW106-TDU-B-212-113004]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence MOHW106-TDU-B-212-113004. There was no additional external funding received for this study.	Bogoyevitch MA, 1996, CIRC RES, V79, P162, DOI 10.1161/01.RES.79.2.162; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Chroni A, 2011, J LIPIDS, V2011, DOI 10.1155/2011/160104; COMBADIERE C, 1993, BLOOD, V82, P2890; Cook SA, 1999, J MOL CELL CARDIOL, V31, P1429, DOI 10.1006/jmcc.1999.0979; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; ElBenna J, 1996, J BIOL CHEM, V271, P6374; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2; Halterman MW, 1999, EXP NEUROL, V159, P65, DOI 10.1006/exnr.1999.7160; Hsieh SR, 2014, BIOMEDICINE-TAIWAN, V4, P7, DOI 10.7603/s40681-014-0023-0; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kim JH, 2003, ELEC SOC S, V2003, P1; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964; Lin CJ, 2015, BIOMEDICINE-TAIWAN, V5, P1, DOI 10.7603/s40681-015-0007-8; MCPHAIL LC, 1995, P NATL ACAD SCI USA, V92, P7931, DOI 10.1073/pnas.92.17.7931; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Nakano A, 2000, CIRC RES, V86, P144, DOI 10.1161/01.RES.86.2.144; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.102618; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sugano M, 2000, BIOCHEM BIOPH RES CO, V272, P872, DOI 10.1006/bbrc.2000.2877; Sugden PH, 1998, CIRC RES, V83, P345, DOI 10.1161/01.RES.83.4.345; Vaisar T, 2010, CLIN CHIM ACTA, V411, P972, DOI 10.1016/j.cca.2010.03.023; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; WOLFSON M, 1985, J IMMUNOL, V135, P2057; Zeng QH, 2010, AM J PHYSIOL-HEART C, V299, pH1109, DOI 10.1152/ajpheart.00067.2010; Zewinger S, 2015, EUR HEART J, V36, P3007, DOI 10.1093/eurheartj/ehv352; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179492	10.1371/journal.pone.0179492	http://dx.doi.org/10.1371/journal.pone.0179492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617849	gold, Green Published, Green Submitted			2022-12-26	WOS:000403364600042
J	Bai, AP; Mao, CG; Jenkins, RW; Szulc, ZM; Bielawska, A; Hannun, YA				Bai, Aiping; Mao, Cungui; Jenkins, Russell W.; Szulc, Zdzislaw M.; Bielawska, Alicja; Hannun, Yusuf A.			Anticancer actions of lysosomally targeted inhibitor, LCL521, of acid ceramidase	PLOS ONE			English	Article							TUMOR-GROWTH; CELL-DEATH; CANCER; ANALOGS; B13; EXPRESSION; RESISTANCE; APOPTOSIS; SPHINGOLIPIDS; SPHINGOSINE	Acid ceramidase, which catalyzes ceramide hydrolysis to sphingosine and free fatty acid mainly in the lysosome, is being recognized as a potential therapeutic target for cancer. B13 is an effective and selective acid ceramidase inhibitor in vitro, but not as effective in cells due to poor access to the lysosomal compartment. In order to achieve targeting of B13 to the lysosome, we designed lysosomotropic N, N-dimethyl glycine (DMG)-conjugated B13 prodrug LCL521 (1,3-di-DMG-B13). Our previous results indicated the efficient delivery of B13 to the lysosome resulted in augmented effects of LCL521 on cellular acid ceramidase as evaluated by effects on substrate/product levels. Our current studies indicate that functionally, this translated into enhanced inhibition of cell proliferation. Moreover, there were greater synergistic effects of LCL521 with either ionizing radiation or Tamoxifen. Taken together, these results clearly indicate that compartmental targeting for the inhibition of acid ceramidase is an efficient and valuable therapeutic strategy.	[Bai, Aiping; Jenkins, Russell W.; Szulc, Zdzislaw M.; Bielawska, Alicja] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Bai, Aiping; Jenkins, Russell W.; Szulc, Zdzislaw M.; Bielawska, Alicja] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Mao, Cungui; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Mao, Cungui; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Jenkins, Russell W.] Dana Farber Canc Inst, Internal Med, Boston, MA 02115 USA	Medical University of South Carolina; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Dana-Farber Cancer Institute	Bai, AP (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Bai, AP (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	baia@musc.edu		, Aiping/0000-0002-7762-7835	National Cancer Institute (NCI) [P01 CA097132]; National Institute of General Medical Sciences (NIGMS) [P30 GM103339]; South Carolina Clinical & Translational Research (SCTR) Institute; MUSC/HCC Cancer Center Support Grant [P30 GM103339]; NCI [P01-CA097132]; NIH/NCATS [UL1TR000062]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103339] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); South Carolina Clinical & Translational Research (SCTR) Institute; MUSC/HCC Cancer Center Support Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: 1. National Cancer Institute (NCI) Grant P01 CA097132 (YAH), http//www.cancer.gov/. 2. National Institute of General Medical Sciences (NIGMS) Grant P30 GM103339 (AB), https://www. nigms.nih.gov/. 3. South Carolina Clinical & Translational Research (SCTR) Institute, with an academic home at the Medical University of South Carolina CTSA, NIH/NCATS grant number UL1TR000062, http://academicdepartments.musc. edu/sctr/index.htm.; We acknowledge MUSC Flow Cytometry and cell sorting facility for cell cycle analysis, and Lipidomics Shared Resources for sphingolipids analysis (MUSC/HCC Cancer Center Support Grant P30 GM103339); Special acknowledgement goes to Dr. Jacek Bielawski at the Lipidomics Shared Resources MUSC for the excellent lipid analysis. Financial support was provided by NCI Grant #P01-CA097132 (YH). We also thank NIH/NCATS grant # UL1TR000062 Voucher Pilot Program for several key reagents purchase (APB).	Bai AP, 2014, BIOORGAN MED CHEM, V22, P6933, DOI 10.1016/j.bmc.2014.10.025; Bai AP, 2009, BIOORGAN MED CHEM, V17, P1840, DOI 10.1016/j.bmc.2009.01.057; Bedia C, 2011, J BIOL CHEM, V286, P28200, DOI 10.1074/jbc.M110.216382; BIELAWSKA A, 1992, J BIOL CHEM, V267, P18493; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Dorssers LCJ, 2001, DRUGS, V61, P1721, DOI 10.2165/00003495-200161120-00004; Eliyahu E, 2011, J BIOL CHEM, V286, P35624, DOI 10.1074/jbc.M111.260372; Elojeimy S, 2007, MOL THER, V15, P1259, DOI 10.1038/sj.mt.6300167; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; HOFFMAN RM, 1991, J CLIN LAB ANAL, V5, P133, DOI 10.1002/jcla.1860050211; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Kitatani K, 2015, MOL CELLS, V38, P482, DOI 10.14348/molcells.2015.0118; Liu FY, 2016, ONCOTARGET, V7, P83907, DOI 10.18632/oncotarget.13438; Morales A, 2007, ONCOGENE, V26, P905, DOI 10.1038/sj.onc.1209834; Nahas Z, 2009, BEHAV BRAIN RES, V197, P41, DOI 10.1016/j.bbr.2008.07.040; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; Raisova M, 2002, FEBS LETT, V516, P47, DOI 10.1016/S0014-5793(02)02472-9; Roh JL, 2016, EUR J CANCER, V52, P163, DOI 10.1016/j.ejca.2015.10.056; Samsel L, 2004, PROSTATE, V58, P382, DOI 10.1002/pros.10350; Selzner M, 2001, CANCER RES, V61, P1233; Separovic D, 2011, BIOCHEM BIOPH RES CO, V409, P372, DOI 10.1016/j.bbrc.2011.04.091; Szulc ZM, 2008, BIOORGAN MED CHEM, V16, P1015, DOI 10.1016/j.bmc.2007.08.033; Takabe K, 2014, J LIPID RES, V55, P1839, DOI 10.1194/jlr.R046656; Xu RJ, 2010, FASEB J, V24, P2507, DOI 10.1096/fj.09-153635	28	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							0177805	10.1371/journal.pone.0177805	http://dx.doi.org/10.1371/journal.pone.0177805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614356	Green Submitted, gold, Green Published			2022-12-26	WOS:000403280900007
J	Li, YM; Wang, L; Jia, M; Guo, JH; Wang, HJ; Wang, MW				Li, Yanmin; Wang, Lin; Jia, Meng; Guo, Jihong; Wang, Huijun; Wang, Mingwei			The effects of high-frequency rTMS over the left DLPFC on cognitive control in young healthy participants	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; STROOP TASK-PERFORMANCE; EVENT-RELATED POTENTIALS; MAJOR DEPRESSION; RESPONSE CONFLICT; HF-RTMS; CORTICAL EXCITABILITY; BRAIN-STIMULATION	A large body of evidence suggests that repetitive transcranial magnetic stimulation (rTMS) is clinically effective in treating neuropsychiatric disorders and multiple sessions are commonly used. However, it is unknown whether multiple sessions of rTMS improve cognitive control, which is a function of the neural circuitry of the left dorsolateral prefrontal cortex (DLPFC)-cingulate cortex in healthy individuals. In addition, it is still unclear which stages of neural processing are altered by rTMS. In this study, we investigated the effects of high-frequency rTMS on cognitive control and explored the time course changes of cognitive processing after rTMS using event-related potentials (ERPs). For seven consecutive days, 25 young healthy participants underwent one 10-Hz rTMS session per day in which stimulation was applied over the left DLPFC, and a homogeneous participant group of 25 individuals received a sham rTMS treatment. A Stroop task was performed, and an electroencephalogram (EEG) was recorded. The results revealed that multiple sessions of rTMS can decrease reaction time (RTs) under both congruent and incongruent conditions and also increased the amplitudes of both N2 and N450 compared with sham rTMS. The negative correlations between the mean amplitudes of both N2 and N450 and the RTs were found, however, the latter correlation were restricted to incongruent trials and the correlation was enhanced significantly by rTMS. This observation supports the view that high-frequency rTMS over the left DLPFC can not only recruit more neural resources from the prefrontal cortex by inducing an electrophysiologically excitatory effect but also enhance efficiency of resources to deploy for conflict resolution during multiple stages of cognitive control processing in healthy young people.	[Li, Yanmin; Wang, Lin; Jia, Meng; Wang, Mingwei] Hebei Med Univ, Dept Neurol, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China; [Li, Yanmin; Wang, Mingwei] Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Hebei Province, Peoples R China; [Guo, Jihong; Wang, Huijun] Hebei Med Univ, Hosp 1, Dept Neural Electrophysiol, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University	Wang, MW (corresponding author), Hebei Med Univ, Dept Neurol, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China.; Wang, MW (corresponding author), Brain Aging & Cognit Neurosci Lab Hebei Prov, Shijiazhuang, Hebei Province, Peoples R China.	mwwang2015@163.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		National Basic Research Program of China [2010CB535005]; Key medical Program of Hebei Province [zd2013079]; Hebei Medical University [XH201705]	National Basic Research Program of China(National Basic Research Program of China); Key medical Program of Hebei Province; Hebei Medical University	This work was supported by the Project of Special Foundation for National Basic Research Program of China (2010CB535005), Key medical Program of Hebei Province (zd2013079) and Spark Program for Young Scholar of The First Hospital of Hebei Medical University (XH201705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Project of Special Foundation for National Basic Research Program of China (2010CB535005), Key medical Program of Hebei Province (zd2013079) and Spark Program for Young Scholar of The First Hospital of Hebei Medical University (XH201705). The authors wish to thank doctor J Shi in the First Hospital of Hebei Medical University for the assistance throughout the experiment.	Ahmed MA, 2012, J NEUROL, V259, P83, DOI 10.1007/s00415-011-6128-4; Anand S, 2002, BRAIN COGNITION, V50, P366, DOI 10.1016/S0278-2626(02)00512-2; Baeken C, 2010, PROG NEURO-PSYCHOPH, V34, P684, DOI 10.1016/j.pnpbp.2010.03.021; Baeken C, 2015, BRAIN STIMUL, V8, P808, DOI 10.1016/j.brs.2015.01.415; BARKER AT, 1991, J CLIN NEUROPHYSIOL, V8, P26, DOI 10.1097/00004691-199101000-00005; Bartholow BD, 2005, PSYCHOPHYSIOLOGY, V42, P33, DOI 10.1111/j.1469-8986.2005.00258.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chouiter L, 2014, BRAIN TOPOGR, V27, P279, DOI 10.1007/s10548-013-0303-0; Cotelli M, 2011, J NEUROL NEUROSUR PS, V82, P794, DOI 10.1136/jnnp.2009.197848; Dall'Agnol L, 2014, J PAIN, V15, P845, DOI 10.1016/j.jpain.2014.05.001; DALRYMPLEALFORD EC, 1966, PERCEPT MOTOR SKILL, V23, P1211, DOI 10.2466/pms.1966.23.3f.1211; De Raedt R, 2010, BIOL PSYCHOL, V85, P487, DOI 10.1016/j.biopsycho.2010.09.015; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Eliasova I, 2014, J NEUROL SCI, V346, P318, DOI 10.1016/j.jns.2014.08.036; Esslinger C, 2014, HUM BRAIN MAPP, V35, P140, DOI 10.1002/hbm.22165; Evers S, 2001, NEUROREPORT, V12, P2915, DOI 10.1097/00001756-200109170-00032; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox P, 1997, NEUROREPORT, V8, P2787, DOI 10.1097/00001756-199708180-00027; Gajewski PD, 2015, BRAIN COGNITION, V98, P87, DOI 10.1016/j.bandc.2015.06.004; Goldfarb L, 2007, J EXP PSYCHOL HUMAN, V33, P1170, DOI 10.1037/0096-1523.33.5.1170; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Haghighi M, 2015, J PSYCHIATR RES, V68, P238, DOI 10.1016/j.jpsychires.2015.06.020; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Haraldsson HM, 2004, SCHIZOPHR RES, V71, P1, DOI 10.1016/j.schres.2003.10.006; Harrison BJ, 2005, NEUROIMAGE, V24, P181, DOI 10.1016/j.neuroimage.2004.08.033; Hoeppner J, 2010, EUR ARCH PSY CLIN N, V260, P197, DOI 10.1007/s00406-009-0039-8; Holmes AJ, 2008, NEUROPSYCHOLOGIA, V46, P2904, DOI 10.1016/j.neuropsychologia.2008.05.028; Huang CC, 2004, J PSYCHIATR RES, V38, P513, DOI 10.1016/j.jpsychires.2004.01.006; Hwang JH, 2010, BRAIN RES, V1329, P152, DOI 10.1016/j.brainres.2010.03.013; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kim SH, 2012, NEUROSCI RES, V74, P256, DOI 10.1016/j.neures.2012.08.008; Krompinger JW, 2011, BIOL PSYCHOL, V86, P239, DOI 10.1016/j.biopsycho.2010.12.004; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Little JT, 2000, NEUROPSY NEUROPSY BE, V13, P119; Lucci G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056566; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Martis B, 2003, CLIN NEUROPHYSIOL, V114, P1125, DOI 10.1016/S1388-2457(03)00046-4; Millner AJ, 2012, NEUROIMAGE, V63, P742, DOI 10.1016/j.neuroimage.2012.07.032; Minzenberg MJ, 2014, PSYCHIAT RES-NEUROIM, V221, P114, DOI 10.1016/j.pscychresns.2013.11.003; Mir-Moghtadaei A, 2015, BRAIN STIMUL, V8, P965, DOI 10.1016/j.brs.2015.05.008; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Padberg F, 1999, PSYCHIAT RES, V88, P163, DOI 10.1016/S0165-1781(99)00092-X; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Rektor I, 2010, NEURODEGENER DIS, V7, P160, DOI 10.1159/000289228; Rektorova I, 2005, J NEUROL SCI, V229, P157, DOI 10.1016/j.jns.2004.11.021; REN CY, 1995, IEEE T BIO-MED ENG, V42, P918, DOI 10.1109/10.412658; Rollnik JD, 2004, CLIN NEUROPHYSIOL, V115, P145, DOI 10.1016/j.clinph.2003.05.001; Rossi S, 2004, TRENDS COGN SCI, V8, P273, DOI 10.1016/j.tics.2004.04.012; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Scherr M, 2016, J NEUROINTERV SURG, V8, DOI 10.1136/neurintsurg-2014-011612; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takahashi S, 2015, NEUROCASE, V21, P339, DOI 10.1080/13554794.2014.893000; Van den Eynde F, 2011, EAT WEIGHT DISORD-ST, V16, pE45; van den Heuvel OA, 2013, HUM BRAIN MAPP, V34, P347, DOI 10.1002/hbm.21443; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vanderhasselt MA, 2006, EXP BRAIN RES, V169, P279, DOI 10.1007/s00221-005-0344-z; Vanderhasselt MA, 2007, BRAIN RES, V1137, P111, DOI 10.1016/j.brainres.2006.12.050; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; Yang HY, 2015, BEHAV BRAIN RES, V281, P149, DOI 10.1016/j.bbr.2014.12.037; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009	74	22	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179430	10.1371/journal.pone.0179430	http://dx.doi.org/10.1371/journal.pone.0179430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614399	Green Submitted, gold, Green Published			2022-12-26	WOS:000403280900052
J	Qiu, SG; Fan, XL; Yang, YY; Dong, PP; Zhou, W; Xu, YL; Zhou, YH; Guo, FK; Zheng, Y; Yang, JQ				Qiu, Sugan; Fan, Xiaolin; Yang, Yingying; Dong, Panpan; Zhou, Wei; Xu, Yongliang; Zhou, Yonghua; Guo, Fukun; Zheng, Yi; Yang, Jun-Qi			Schistosoma japonicum infection downregulates house dust mite-induced allergic airway inflammation in mice	PLOS ONE			English	Article							T-CELLS; TH17 CELLS; ASTHMA; TH2; EXPOSURE; HYGIENE; DIFFERENTIATION; LUNG	The "hygiene hypothesis" is a theory try to explain the dramatic increases in the prevalence of autoimmune and allergic diseases over the past two to three decades in developed countries. According to this theory, reduced exposure to parasites and microorganisms in childhood is the main cause for the increased incidences of both T helper 1 (Th1)-mediated autoimmunity and Th2-mediated allergy. In this study, we investigated the impact of Schistosoma japonicum infection on the allergic airway inflammation induced by repeated intracheal inoculations of house dust mites (HDM), which is a Th17 and neutrophils dominant murine asthma model, mimicking severe asthma. We found that S. japonicum infection downregulated airway hyperresponsiveness. The infiltrating cells, Th17 and Th2 effector cytokines in the bronchoalveolar lavage (BAL) fluids and lungs were significantly reduced in the infected mice. Our findings indicated that S. japonicum infection was able to effectively inhibit host's allergic airway inflammation, which may be related to the upregulated Treg cells upon infection. To our knowledge, it is the first study to reveal the impact of S. japonicum infection on house dust mite induced severe asthma. More in depth investigation is need to elucidate the underlying mechanisms.	[Qiu, Sugan; Fan, Xiaolin; Yang, Yingying; Dong, Panpan; Zhou, Wei; Xu, Yongliang; Zhou, Yonghua; Yang, Jun-Qi] Jiangnan Univ, Key Lab Natl Hlth & Family Planning Commiss Paras, Jiangsu Prov Key Lab Parasite & Vector Control, Jiangsu Inst Parasit Dis, Wuxi, Jiangsu, Peoples R China; [Qiu, Sugan; Fan, Xiaolin; Yang, Yingying; Dong, Panpan; Zhou, Wei; Xu, Yongliang; Zhou, Yonghua; Yang, Jun-Qi] Jiangnan Univ, Publ Hlth Res Ctr, Wuxi, Jiangsu, Peoples R China; [Guo, Fukun; Zheng, Yi; Yang, Jun-Qi] Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	Jiangnan University; Jiangnan University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Yang, JQ (corresponding author), Jiangnan Univ, Key Lab Natl Hlth & Family Planning Commiss Paras, Jiangsu Prov Key Lab Parasite & Vector Control, Jiangsu Inst Parasit Dis, Wuxi, Jiangsu, Peoples R China.; Yang, JQ (corresponding author), Jiangnan Univ, Publ Hlth Res Ctr, Wuxi, Jiangsu, Peoples R China.; Yang, JQ (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	Junqi.Yang@cchmc.org		Yang, Jun-Qi/0000-0002-4510-8117	National Natural Science Foundation of China [81373116]; Research Capacity-strengthening Project from the Jiangsu Science and Technology Department, China [BM2015024]; National Institutes of Health, United States [GM 108661, CA198358, CA193350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Capacity-strengthening Project from the Jiangsu Science and Technology Department, China; National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work has been supported by grants from the National Natural Science Foundation of China (81373116 to J. Q.Y), the Research Capacity-strengthening Project from the Jiangsu Science and Technology Department, China (BM2015024 to J.Q.Y), and the National Institutes of Health, United States (GM 108661 and CA198358 to F.G.; CA193350 to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Busse PJ, 2005, J ALLERGY CLIN IMMUN, V116, P1256, DOI 10.1016/j.jaci.2005.08.059; Carvalho EM, 2006, PARASITE IMMUNOL, V28, P525, DOI 10.1111/j.1365-3024.2006.00894.x; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Conroy DM, 2001, RESP RES, V2, P150, DOI 10.1186/rr52; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Finkelman FD, 1999, INT IMMUNOL, V11, P1811, DOI 10.1093/intimm/11.11.1811; Gavino AC, 2016, ALLERGY, V71, P1684, DOI 10.1111/all.12937; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; Harnett W, 2014, MOL BIOCHEM PARASIT, V195, P130, DOI 10.1016/j.molbiopara.2014.03.007; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; LUKACS NW, 1993, CLIN IMMUNOL IMMUNOP, V68, P57, DOI 10.1006/clin.1993.1095; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Mangan NE, 2006, J IMMUNOL, V176, P138, DOI 10.4049/jimmunol.176.1.138; McGee HS, 2010, AM J RESP CELL MOL, V43, P520, DOI 10.1165/rcmb.2009-0241OC; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mo HM, 2008, PARASITOL RES, V103, P1183, DOI 10.1007/s00436-008-1114-1; Norimoto A, 2014, AM J RESP CELL MOL, V51, P201, DOI 10.1165/rcmb.2013-0522OC; Osada Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/743758; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Pineda MA, 2014, CLIN EXP IMMUNOL, V177, P13, DOI 10.1111/cei.12252; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Stelmaszczyk-Emmel A, 2015, RESP PHYSIOL NEUROBI, V209, P59, DOI 10.1016/j.resp.2014.11.010; Stiemsma LT, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-016-0173-6; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Umetsu DT, 2012, CELL RES, V22, P1210, DOI 10.1038/cr.2012.65; Wen XY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001399; Wilson MS, 2004, CLIN REV ALLERG IMMU, V26, P35, DOI 10.1385/CRIAI:26:1:35; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wong CK, 2009, IMMUNOL INVEST, V38, P652, DOI 10.1080/08820130903062756; Yang JH, 2007, IMMUNOLOGY, V120, P8, DOI 10.1111/j.1365-2567.2006.02472.x; Yang JQ, 1999, J PARASITOL, V85, P257, DOI 10.2307/3285629; Yang JQ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2395645; Yang JQ, 2016, J ALLERGY CLIN IMMUN, V137, P231, DOI 10.1016/j.jaci.2015.05.004; Yang JQ, 2010, EMBO J, V29, P3421, DOI 10.1038/emboj.2010.214; Yang JQ, 2009, P NATL ACAD SCI USA, V106, P1099, DOI 10.1073/pnas.0805907106; Zhao SS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1614-2	44	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179565	10.1371/journal.pone.0179565	http://dx.doi.org/10.1371/journal.pone.0179565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614408	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900062
J	Yamaguchi, T; Suzuki, A; Hokkirigawa, K				Yamaguchi, Takeshi; Suzuki, Akito; Hokkirigawa, Kazuo			Required coefficient of friction in the anteroposterior and mediolateral direction during turning at different walking speeds	PLOS ONE			English	Article							CENTER-OF-MASS; LEVEL WALKING; KINEMATICS; PATH; STRATEGIES; FALLS; GAIT; STABILITY; INJURIES; SLIP	This study investigated the required coefficient of friction (RCOF) and the tangent of center of mass (COM)-center of pressure (COP) angle in the mediolateral (ML) and anteroposterior (AP) directions during turning at different walking speeds. Sixteen healthy young adults (8 males and 8 females) participated in this study. The participants were instructed to conduct trials of straight walking and 90 degrees step and spin turns to the right at each of three self-selected speeds (slow, normal, and fast). The ML and AP directions during turning gait were defined using the orientation of the pelvis to construct a body-fixed reference frame. The RCOF values and COM-COP angle tangent in the ML direction during turning at weight acceptance phase were higher than those during straight walking, and those values increased with increasing walking speed. The ML component of the RCOF and COM-COP tangent values during weight acceptance for step turns were higher than those for spin turns. The mean centripetal force during turning tended to increase with an increase in walking speed and had a strong positive correlation with the RCOF values in the ML direction (R = 0.97 during the weight acceptance phase; R = 0.95 during the push-off phase). Therefore, turning, particularly step turn, is likely to cause lateral slip at weight acceptance because of the increased centripetal force compared with straight walking. Future work should test at-risk population and compare with the present results.	[Yamaguchi, Takeshi; Suzuki, Akito; Hokkirigawa, Kazuo] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan; [Yamaguchi, Takeshi] Tohoku Univ, Grad Sch Bioengn, Sendai, Miyagi, Japan	Tohoku University; Tohoku University	Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Engn, Sendai, Miyagi, Japan.; Yamaguchi, T (corresponding author), Tohoku Univ, Grad Sch Bioengn, Sendai, Miyagi, Japan.	yamatake@gdl.mech.tohoku.ac.jp	YAMAGUCHI, Takeshi/ABF-8367-2021; Yamaguchi, Takeshi T/D-3550-2017	Yamaguchi, Takeshi T/0000-0002-5063-9924	 [25420080]; Grants-in-Aid for Scientific Research [16K06038] Funding Source: KAKEN	; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research (C) (25420080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by a Grant-in-Aid for Scientific Research (C) (25420080).	Akram SB, 2010, GAIT POSTURE, V31, P23, DOI 10.1016/j.gaitpost.2009.08.238; Burnfield JM, 2007, J FORENSIC SCI, V52, P1328, DOI 10.1111/j.1556-4029.2007.00549.x; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Chang WR, 2013, SAFETY SCI, V58, P49, DOI 10.1016/j.ssci.2013.03.014; Chang WR, 2012, ERGONOMICS, V55, P308, DOI 10.1080/00140139.2011.642008; Chang WR, 2012, SAFETY SCI, V50, P240, DOI 10.1016/j.ssci.2011.08.056; Courtine G, 2003, EUR J NEUROSCI, V18, P177, DOI 10.1046/j.1460-9568.2003.02736.x; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; DTI, 1997, 19 ANN REP HOM ACC S; Fino P, 2014, J BIOMECH, V47, P1395, DOI 10.1016/j.jbiomech.2014.01.032; Fino PC, 2015, J BIOMECH, V48, P104, DOI 10.1016/j.jbiomech.2014.10.034; Glaister BC, 2007, J BIOMECH, V40, P3527, DOI 10.1016/j.jbiomech.2007.05.014; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; HAGEMAN PA, 1986, PHYS THER, V66, P1382, DOI 10.1093/ptj/66.9.1382; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kim S, 2005, SAFETY SCI, V43, P425, DOI 10.1016/j.ssci.2005.08.004; Koepp GA, 2015, ERGONOMICS, V58, P674, DOI 10.1080/00140139.2014.985260; Maki B E, 1999, IEEE Trans Rehabil Eng, V7, P80, DOI 10.1109/86.750556; Maki Brian E., 1999, Physiotherapy Theory and Practice, V15, P69, DOI 10.1080/095939899307784; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Orendurff MS, 2006, GAIT POSTURE, V23, P106, DOI 10.1016/j.gaitpost.2004.12.008; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Redfern M. S., 1984, P 1984 INT C OCC ERG, VI, P573; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; Sedgman R., 1994, P IN C FAC HLTH SCI; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Yamaguchi T, 2008, TRIBOL ONLINE, V3, DOI [10.2474/trol.3.59, DOI 10.2474/TROL.3.59]; Yamaguchi T., 2016, BIOTRIBOLOGY, V5, P16, DOI [DOI 10.1016/J.BIOTRI.2015.12.002, 10.1016/j.biotri.2015.12.002]; Yamaguchi T, 2008, IND HEALTH, V46, P23, DOI 10.2486/indhealth.46.23; Yamaguchi T, 2013, GAIT POSTURE, V38, P209, DOI 10.1016/j.gaitpost.2012.11.007; Yamaguchi T, 2012, J BIOMECH, V45, P2624, DOI 10.1016/j.jbiomech.2012.08.006	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0179817	10.1371/journal.pone.0179817	http://dx.doi.org/10.1371/journal.pone.0179817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6ZV	28640853	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800069
J	Devis-Devis, J; Lizandra, J; Valencia-Peris, A; Perez-Gimeno, E; Garcia-Masso, X; Peiro-Velert, C				Devis-Devis, Jose; Lizandra, Jorge; Valencia-Peris, Alexandra; Perez-Gimeno, Esther; Garcia-Masso, Xavier; Peiro-Velert, Carmen			Longitudinal changes in physical activity, sedentary behavior and body mass index in adolescence: Migrations towards different weight cluster	PLOS ONE			English	Article							SCREEN MEDIA TIME; OBESITY; OVERWEIGHT; ASSOCIATIONS; TELEVISION; CHILDREN; BMI; PREVALENCE; EXERCISE; NUMBER	This study examined longitudinal changes in physical activity, sedentary behavior and body mass index in adolescents, specifically their migrations towards a different weight cluster. A cohort of 755 adolescents participated in a three-year study. A clustering Self-Organized Maps Analysis was performed to visualize changes in subjects' characteristics between the first and second assessment, and how adolescents were grouped. Also a classification tree was used to identify the behavioral characteristics of the groups that changed their weight cluster. Results indicated that boys were more active and less sedentary than girls. Boys were especially keen to technological-based activities while girls preferred social-based activities. A moderate competing effect between sedentary behaviors and physical activities was observed, especially in girls. Overweight and obesity were negatively associated with physical activity, although a small group of overweight/obese adolescents showed a positive relationship with vigorous physical activity. Cluster migrations indicated that 22.66% of adolescents changed their weight cluster to a lower category and none of them moved in the opposite direction. The behavioral characteristics of these adolescents did not support the hypothesis that the change to a lower weight cluster was a consequence of an increase in time devoted to physical activity or a decrease in time spent on sedentary behavior. Physical activity and sedentary behavior does not exert a substantial effect on overweight and obesity. Therefore, there are other ways of changing to a lower-weight status in adolescents apart from those in which physical activity and sedentary behavior are involved.	[Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Lizandra, Jorge; Valencia-Peris, Alexandra; Perez-Gimeno, Esther; Garcia-Masso, Xavier; Peiro-Velert, Carmen] Univ Valencia, Dept Didact Expressio Mus Plast & Corporal, Valencia, Spain	University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Lizandra, Jorge/O-6916-2015; Valencia-Peris, Alexandra/ABE-5860-2020; Devis-Devis, Jose/G-8758-2015; García-Massó, Xavier/L-8222-2014; Valencia-Peris, Alexandra/L-2260-2014; Peiró-Velert, Carmen/N-6056-2015	Lizandra, Jorge/0000-0001-5599-133X; Valencia-Peris, Alexandra/0000-0002-2031-9743; Devis-Devis, Jose/0000-0003-4599-3782; Peiró-Velert, Carmen/0000-0003-4794-6541; Garcia-Masso, Xavier/0000-0002-5925-4537	Ministry of Science and Innovation (Spain) [EDU2009-13664]; Generalitat Valenciana (Spain) [ACIF/2013/214]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF))	This work was partially funded by the Ministry of Science and Innovation (Spain) (EDU2009-13664), as well as the Generalitat Valenciana (Spain) which supported this work by the VALi+d predoctoral contract to JL (ACIF/2013/214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron DJ, 2002, ARCH PEDIAT ADOL MED, V156, P1075, DOI 10.1001/archpedi.156.11.1075; Aires L, 2010, INT J SPORTS MED, V31, P133, DOI 10.1055/s-0029-1243255; Belanger M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0237-x; Bickham DS, 2013, PEDIATRICS, V131, P935, DOI 10.1542/peds.2012-1197; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Boreham Colin, 2004, Int J Behav Nutr Phys Act, V1, P14, DOI 10.1186/1479-5868-1-14; Camhi SM, 2011, J SCHOOL HEALTH, V81, P409, DOI 10.1111/j.1746-1561.2011.00609.x; Carrascosa A, 2010, REV ESP ENDOCRINOL P, V2, P59, DOI 10.3266; Cleland V, 2008, INT J OBESITY, V32, P1685, DOI 10.1038/ijo.2008.171; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Collings PJ, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0222-4; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Devis-Devis J, 2009, J ADOLESCENCE, V32, P213, DOI 10.1016/j.adolescence.2008.04.004; Elgar FJ, 2005, PUBLIC HEALTH, V119, P518, DOI 10.1016/j.puhe.2004.10.011; Fang J, 2003, AM J PREV MED, V25, P283, DOI 10.1016/S0749-3797(03)00207-1; Fisher A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018576; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gebremariam MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-104; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Laurson K, 2008, ACTA PAEDIATR, V97, P795, DOI 10.1111/j.1651-2227.2008.00713.x; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Maher C, 2012, ACTA PAEDIATR, V101, P1170, DOI 10.1111/j.1651-2227.2012.02804.x; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Mcmurray RG, 2004, MED SCI SPORT EXER, V36, P2135; Melkevik O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1810-6; Mitchell JA, 2013, OBESITY, V21, P572, DOI 10.1002/oby.20157; Mitchell JA, 2012, MED SCI SPORT EXER, V44, P1081, DOI 10.1249/MSS.0b013e3182446c65; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Nelson TF, 2011, CURR SPORT MED REP, V10, P360, DOI 10.1249/JSR.0b013e318237bf74; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Peiro-Velert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099478; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rosenberg DE, 2007, J ADOLESCENT HEALTH, V41, P472, DOI 10.1016/j.jadohealth.2007.05.018; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Schoeller DA, 2009, NUTR REV, V67, P249, DOI 10.1111/j.1753-4887.2009.00197.x; Sisson SB, 2011, J PHYS ACT HEALTH, V8, pS188, DOI 10.1123/jpah.8.s2.s188; Sundblad GB, 2008, PAIN, V136, P239, DOI 10.1016/j.pain.2007.06.032; te Velde SJ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-16; Thompson AM, 2005, MED SCI SPORT EXER, V37, P1902, DOI 10.1249/01.mss.0000176306.11134.23; Timperio A, 2017, HEALTH PLACE, V43, P121, DOI 10.1016/j.healthplace.2016.10.004; Trang NHHD, 2013, AM J PREV MED, V44, P223, DOI 10.1016/j.amepre.2012.10.021; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2003, INT J OBESITY, V27, P1100, DOI 10.1038/sj.ijo.0802376; Valencia-Peris A, 2016, J PHYS ACT HEALTH, V13, P579, DOI 10.1123/jpah.2015-0407; Vesanto Juha, 1999, P MATLAB DSP C, V99, P35	51	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179502	10.1371/journal.pone.0179502	http://dx.doi.org/10.1371/journal.pone.0179502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY6UH	28636644	gold, Green Submitted, Green Published			2022-12-26	WOS:000404118300039
J	Elsherif, O; Bannan, C; Keating, S; McKiernan, S; Bergin, C; Norris, S				Elsherif, Omar; Bannan, Ciaran; Keating, Shay; McKiernan, Susan; Bergin, Colm; Norris, Suzanne			Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; ANTIVIRAL TREATMENT; HCV TREATMENT; SOFOSBUVIR; RIBAVIRIN; ABT-450/R-OMBITASVIR; EPIDEMIOLOGY; METAANALYSIS; REINFECTION; DASABUVIR	Background and aims People who inject drugs (PWID) are historically viewed as having "difficult to treat" hepatitis C disease, with perceived inferior treatment adherence and outcomes, and concerns regarding reinfection risk. We evaluated for differences in treatment adherence and response to Peginterferon-alfa-2a/Ribavirin (Peg-IFN alpha/RBV) in a large urban cohort with and without a history of remote or recent injection drug use. Methods Patient data was retrospectively reviewed for 1000 consecutive patients D 608 former (no injecting drug use for 6 months of therapy), 85 recent (injecting drug use within 6 months) PWID, and 307 non-drug users who were treated for chronic hepatitis C with Peg-IFN alpha/RBV. The groups were compared for baseline characteristics, treatment adherence, and outcome. Results There was no significant difference in treatment non-adherence between the groups (8.4% in PWID vs 6.8% in non-PWIDs; RR = 1.23, CI 0.76-1.99). The overall SVR rate in PWID (64.2%) was not different from non-PWIDs (60.9%) [RR = 1.05, 95% CI 0.95-1.17]. There was no significant difference in SVR rates between the groups controlling for genotype (48.4% vs 48.4% for genotype 1; 74.9 vs 73.3% for genotype 3). Former and recent PWID had similar adherence rates. Conclusions PWID have comparable treatment adherence and SVR rates when compared to non-drug users treated with Peg-IFNa/RBV. These data support a public health strategy of HCV treatment and eradication in PWID in the DAA era.	[Elsherif, Omar; McKiernan, Susan; Norris, Suzanne] St James Hosp, Dept Hepatol, Dublin, Ireland; [Bannan, Ciaran; Bergin, Colm] St James Hosp, Dept Genito Urinary Med & Infect Dis, Dublin, Ireland; [Keating, Shay] Drug Treatment Ctr Board, Dublin, Ireland; [McKiernan, Susan; Bergin, Colm; Norris, Suzanne] Trinity Coll Dublin, Sch Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin	Elsherif, O (corresponding author), St James Hosp, Dept Hepatol, Dublin, Ireland.	elsherio@tcd.ie						Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Alavi M, 2014, LIVER INT, V34, P1198, DOI 10.1111/liv.12370; [Anonymous], 1999, J Hepatol, V30, P956; [Anonymous], 1997, HEPATOLOGY S, V26, p71S; Backmund M, 2001, HEPATOLOGY, V34, P188, DOI 10.1053/jhep.2001.25882; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Cescon A, 2014, AIDS, V28, P121, DOI 10.1097/QAD.0000000000000020; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Gazdik F, 2009, BRATISL MED J, V110, P77; Goldberg D, 2008, EURO SURVEILL, P13; Grady BP, 2013, CLIN INFECT DIS, V57, pS105, DOI 10.1093/cid/cit301; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Hellard ME, 2012, MED J AUSTRALIA, V196, P638, DOI 10.5694/mja11.10981; Iversen J, 2013, J VIRAL HEPATITUS, DOI [DOI 10.1111/JVH.12129, 10.1111/jvh.12129]; Martin NK, 2015, J VIRAL HEPATITIS, V22, P399, DOI 10.1111/jvh.12338; Martin NK, 2016, J HEPATOL, V65, P17, DOI 10.1016/j.jhep.2016.02.007; McDonald SA, 2014, J VIRAL HEPATITIS, V21, P366, DOI 10.1111/jvh.12153; Melin P, 2010, EUR J GASTROEN HEPAT, V22, P1050, DOI 10.1097/MEG.0b013e328338d9aa; Monga HK, 2001, CLIN INFECT DIS, V33, P240, DOI 10.1086/321819; Moussalli J, 2010, GASTROENTEROL RES PR, V2010; Myles A, 2011, CAN J GASTROENTEROL, V25, P135, DOI 10.1155/2011/810108; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Robaeys G, 2006, EUR J GASTROEN HEPAT, V18, P159, DOI 10.1097/00042737-200602000-00008; Scottish Executive Health Department (SEND), 2006, HEP C ACT PLAN SCOTL; Simmons B, 2016, CLIN INFECT DIS, V62, P683, DOI 10.1093/cid/civ948; Skipper C, 2003, GUT, V52, P1500, DOI 10.1136/gut.52.10.1500; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sylvestre DL, 2004, J URBAN HEALTH, V81, P719, DOI 10.1093/jurban/jth153; 2009, HEPATOLOGY, V49, P1335, DOI DOI 10.1002/HEP.22759	36	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178398	10.1371/journal.pone.0178398	http://dx.doi.org/10.1371/journal.pone.0178398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636638	Green Published, gold, Green Submitted			2022-12-26	WOS:000404118300011
J	Kolosenko, I; Yu, Y; Busker, S; Dyczynski, M; Liu, JP; Haraldsson, M; Apergi, CP; Helleday, T; Tamm, KP; Page, BDG; Grander, D				Kolosenko, Iryna; Yu, Yasmin; Busker, Sander; Dyczynski, Matheus; Liu, Jianping; Haraldsson, Martin; Apergi, Caroline Palm; Helleday, Thomas; Tamm, Katja Pokrovskaja; Page, Brent D. G.; Grander, Dan			Identification of novel small molecules that inhibit STAT3-dependent transcription and function	PLOS ONE			English	Article							STAT3 ACTIVATION; SIGNAL TRANSDUCER; KINASE INHIBITOR; GROWTH-FACTOR; HUMAN BREAST; PHASE-I; INTERLEUKIN-6; PATHWAY; ASSAY; IL-6	Activation of Signal Transducer and Activator of Transcription 3 (STAT3) has been linked to several processes that are critical for oncogenic transformation, cancer progression, cancer cell proliferation, survival, drug resistance and metastasis. Inhibition of STAT3 signaling has shown a striking ability to inhibit cancer cell growth and therefore, STAT3 has become a promising target for anti-cancer drug development. The aim of this study was to identify novel inhibitors of STAT-dependent gene transcription. A cellular reporter-based system for monitoring STAT3 transcriptional activity was developed which was suitable for high-throughput screening (Z' = 0,8). This system was used to screen a library of 28,000 compounds (the ENAMINE Drug-Like Diversity Set). Following counter-screenings and toxicity studies, we identified four hit compounds that were subjected to detailed biological characterization. Of the four hits, KI16 stood out as the most promising compound, inhibiting STAT3 phosphorylation and transcriptional activity in response to IL6 stimulation. In silico docking studies showed that KI16 had favorable interactions with the STAT3 SH2 domain, however, no inhibitory activity could be observed in the STAT3 fluorescence polarization assay. KI16 inhibited cell viability preferentially in STAT3-dependent cell lines. Taken together, using a targeted, cell-based approach, novel inhibitors of STAT-driven transcriptional activity were discovered which are interesting leads to pursue further for the development of anti-cancer therapeutic agents.	[Kolosenko, Iryna; Yu, Yasmin; Busker, Sander; Dyczynski, Matheus; Apergi, Caroline Palm; Tamm, Katja Pokrovskaja; Grander, Dan] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden; [Liu, Jianping] Karolinska Inst, Div Funct Gen, Dept Med Biochem & Biophys, Karolinska High Throughput Ctr, Stockholm, Sweden; [Haraldsson, Martin] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Chem Biol Consortium Sweden, Stockholm, Sweden; [Helleday, Thomas; Page, Brent D. G.] Karolinska Inst, Sci Life Lab, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Kolosenko, I; Grander, D (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden.	Iryna.Kolosenko@ki.se; Dan.Grander@ki.se		Dyczynski, Matheus/0000-0002-7650-3574; Helleday, Thomas/0000-0002-7384-092X; Yu, Yasmin/0000-0002-0560-5012; Pokrovskaja Tamm, Katja/0000-0001-6359-1256; Liu, Jianping/0000-0002-7336-3895; Palm Apergi, Caroline/0000-0003-2236-2099	The Swedish Research Council [521-2012-2037]; The Swedish Cancer Foundation [150768]; Radiumhemmet Research Foundation [144063]; Ruthand Rickard Julins Fond [46442]	The Swedish Research Council(Swedish Research Council); The Swedish Cancer Foundation; Radiumhemmet Research Foundation; Ruthand Rickard Julins Fond	Support was provided by The Swedish Research Council; 521-2012-2037 [www.vr.se] (DG) The Swedish Cancer Foundation; 150768 [www.cancerfonden.se] (DG); Radiumhemmet Research Foundation; 144063 [www.rahfo.se] (DG); Ruthand Rickard Julins Fond; 2016 juli 46442, managed by Karolinska Institutet Funds [www.fonder.ki.se] (IK); Robert Lund bergs Memmorial Fund; 2015 lund 45360, managed by Karolinska Institutet Funds [fonder.ki.se] (IK); Jakob Linder's Memorial Foundation, [www. carls onlinder.se] (IK); Swedish Society for Medical Research (SSMF), [www.ssmf.se] (BDGP);The David and Astrid Hagele An Foundation; managed by Karolinska Institutet Funds [fonder.ki.se] (BDGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2016, CHEMMEDCHEM, V11, P850, DOI 10.1002/cmdc.201600021; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Chen KF, 2012, EUR J MED CHEM, V55, P220, DOI 10.1016/j.ejmech.2012.07.023; Chen SH, 2008, CANCER BIOL THER, V7, P1994, DOI 10.4161/cbt.7.12.6967; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Duarte CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029653; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gao D, 2016, BIOORG MED CHEM; Garske AL, 2011, P NATL ACAD SCI USA, V108, P15046, DOI 10.1073/pnas.1111239108; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang M, 2016, BIOORG MED CHEM LETT, V26, P5172, DOI 10.1016/j.bmcl.2016.09.073; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094226; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Khodarev NN, 2004, P NATL ACAD SCI USA, V101, P1714, DOI 10.1073/pnas.0308102100; Kim EJ, 2002, J CELL BIOCHEM, V85, P369, DOI 10.1002/jcb.10142; Kolosenko I, 2014, INT J CANC; Lai PS, 2015, EXPERT OPIN THER PAT, V25, P1397, DOI 10.1517/13543776.2015.1086749; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Noolvi Malleshappa N, 2010, J Basic Clin Pharm, V1, P153; Ogura M, 2015, CANCER SCI, V106, P896, DOI 10.1111/cas.12683; Oh DY, 2015, CANCER RES TREAT, V47, P607, DOI 10.4143/crt.2014.249; Pedranzini L, 2006, CANCER RES, V66, P9714, DOI 10.1158/0008-5472.CAN-05-4280; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Ren ZY, 2003, BIOORG MED CHEM LETT, V13, P633, DOI 10.1016/S0960-894X(02)01050-8; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Schiavone D, 2011, FEBS LETT, V585, P2455, DOI 10.1016/j.febslet.2011.06.020; Schust J, 2004, ANAL BIOCHEM, V330, P114, DOI 10.1016/j.ab.2004.03.024; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wang HL, 2000, CARCINOGENESIS, V21, P1313, DOI 10.1093/carcin/21.7.1313; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; WANG Y, 1994, MOL BIOL CELL, V5, P819, DOI 10.1091/mbc.5.7.819; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yang E, 2003, J BIOL CHEM, V278, P15794, DOI 10.1074/jbc.M213073200; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Yang JB, 2010, P NATL ACAD SCI USA, V107, P21499, DOI 10.1073/pnas.1016147107; Zeng Y, 2015, SCI PROGRAMMING-NETH, V2015, DOI 10.1155/2015/910281; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang L, 2006, MOL CELL BIOCHEM, V288, P179, DOI 10.1007/s11010-006-9137-3; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	54	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0178844	10.1371/journal.pone.0178844	http://dx.doi.org/10.1371/journal.pone.0178844			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636670	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000404118300018
J	Pedersen, GA; Jensen, HH; Schelde, ASB; Toft, C; Pedersen, HN; Ulrichsen, M; Login, FH; Amieva, MR; Nejsum, LN				Pedersen, Gitte A.; Jensen, Helene H.; Schelde, Anne-Sofie B.; Toft, Charlotte; Pedersen, Hans N.; Ulrichsen, Maj; Login, Frederic H.; Amieva, Manuel R.; Nejsum, Lene N.			The basolateral vesicle sorting machinery and basolateral proteins are recruited to the site of enteropathogenic E-coli microcolony growth at the apical membrane	PLOS ONE			English	Article							TRANSLOCATED INTIMIN RECEPTOR; VESICULAR STOMATITIS-VIRUS; ACTIN PEDESTAL FORMATION; EPITHELIAL-CELLS; TIGHT JUNCTIONS; BARRIER FUNCTION; PLASMA-MEMBRANE; EFFECTOR; TIR; ADHESION	Foodborne Enteropathogenic Escherichia coli (EPEC) infections of the small intestine cause diarrhea especially in children and are a major cause of childhood death in developing countries. EPEC infects the apical membrane of the epithelium of the small intestine by attaching, effacing the microvilli under the bacteria and then forming microcolonies on the cell surface. We first asked the question where on epithelial cells EPEC attaches and grows. Using models of polarized epithelial monolayers, we evaluated the sites of initial EPEC attachment to the apical membrane and found that EPEC preferentially attached over the cell-cell junctions and formed microcolonies preferentially where three cells come together at tricellular tight junctions. The ability of EPEC to adhere increased when host cell polarity was compromised yielding EPEC access to basolateral proteins. EPEC pedestals contain basolateral cytoskeletal proteins. Thus, we asked if attached EPEC causes reorganization the protein composition of the host cell plasma membrane at sites of microcolony formation. We found that EPEC microcolony growth at the apical membrane resulted in a local accumulation of basolateral plasma membrane proteins surrounding the microcolony. Basolateral marker protein aquaporin-3 localized to forming EPEC microcolonies. Components of the basolateral vesicle targeting machinery were re-routed. The Exocyst (Exo70) was recruited to individual EPEC as was the basolateral vesicle SNARE VAMP-3. Moreover, several Rab variants were also recruited to the infection site, and their dominant-negative equivalents were not. To quantitatively study the recruitment of basolateral proteins, we created a pulse of the temperature sensitive basolateral VSVG, VSVG3-SP-GFP, from the trans-Golgi Network. We found that after release from the TGN, significantly more VSVG3SP-GFP accumulated at the site of microcolony growth than on equivalent membrane regions of uninfected cells. This suggests that trafficking of vesicles destined for the basolateral membrane are redirected to the apical site of microcolony growth. Thus, in addition to disrupting host cell fence function, local host cell plasma membrane protein composition is changed by altered protein trafficking and recruitment of basolateral proteins to the apical microcolony. This may aid EPEC attachment and subsequent microcolony growth.	[Pedersen, Gitte A.; Jensen, Helene H.; Schelde, Anne-Sofie B.; Login, Frederic H.; Nejsum, Lene N.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Jensen, Helene H.; Schelde, Anne-Sofie B.; Toft, Charlotte; Pedersen, Hans N.; Ulrichsen, Maj] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Amieva, Manuel R.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Amieva, Manuel R.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Aarhus University; Aarhus University; Stanford University; Stanford University	Nejsum, LN (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	nejsum@clin.au.dk	Jensen, Helene H/V-5038-2018; Amieva, Manuel/U-2581-2017; Jensen, Helene/GZK-5914-2022	Jensen, Helene H/0000-0002-8426-9802; Amieva, Manuel/0000-0002-5601-4490; Nejsum, Lene Niemann/0000-0003-4368-8821	Lund beck Junior Group Leader Fellowship; Lund beck Foundation; Carlsberg Foundation; MEMBRANES; PhD fellowship from the Graduate School of Science and Technology, Aarhus University, Denmark	Lund beck Junior Group Leader Fellowship; Lund beck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); MEMBRANES; PhD fellowship from the Graduate School of Science and Technology, Aarhus University, Denmark	This work was supported bya Lund beck Junior Group Leader Fellowship to LNN from the Lund beck Foundation(http://www. lundbeckfonden.com).The Nikon microscopes were funded by the Lundbeck Foundation(http:// www.lundbeckfonden.com),the Carlsberg Foundation (http://www.carlsbergfondet.dk/en)and MEMBRANES (http://membranes.au.dk)Aarhus University,Denmark) and a PhD fellowship from the Graduate School of Science and Technology, Aarhus University, Denmark, to Helene H.Jensen.	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Arnspang EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073977; Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; BALCAROVASTANDER J, 1984, EMBO J, V3, P2687, DOI 10.1002/j.1460-2075.1984.tb02194.x; Benjamin JM, 2010, J CELL BIOL, V189, P339, DOI 10.1083/jcb.200910041; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004; Cantarelli VV, 2001, CELL MICROBIOL, V3, P745, DOI 10.1046/j.1462-5822.2001.00156.x; Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Clements A, 2012, GUT MICROBES, V3, P71, DOI 10.4161/gmic.19182; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Courtneidge SA, 2012, BIOCHEM SOC T, V40, P129, DOI 10.1042/BST20110685; Crane JK, 2001, CELL MICROBIOL, V3, P197, DOI 10.1046/j.1462-5822.2001.00103.x; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; Ducharme NA, 2006, MOL BIOL CELL, V17, P3625, DOI 10.1091/mbc.E05-08-0736; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Frankel G, 1996, J BIOL CHEM, V271, P20359, DOI 10.1074/jbc.271.34.20359; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V47, P307, DOI 10.1002/1097-0169(200012)47:4<307::AID-CM5>3.0.CO;2-Q; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856; Guttman JA, 2006, INFECT IMMUN, V74, P6075, DOI 10.1128/IAI.00721-06; Guttman JA, 2007, CELL MICROBIOL, V9, P131, DOI 10.1111/j.1462-5822.2006.00773.x; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Hertzog M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052627; Huang L, 2002, CELL MOTIL CYTOSKEL, V52, P255, DOI 10.1002/cm.10050; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Iizumi Y, 2007, CELL HOST MICROBE, V2, P383, DOI 10.1016/j.chom.2007.09.012; Jensen HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141871; Kalman D, 1999, NAT CELL BIOL, V1, P389, DOI 10.1038/14087; Kazmierczak BI, 2001, CELL MICROBIOL, V3, P85, DOI 10.1046/j.1462-5822.2001.00091.x; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kierbel A, 2007, J CELL BIOL, V177, P21, DOI 10.1083/jcb.200605142; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kovbasnjuk O, 1998, P NATL ACAD SCI USA, V95, P6526, DOI 10.1073/pnas.95.11.6526; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; LOUVARD D, 1980, P NATL ACAD SCI-BIOL, V77, P4132, DOI 10.1073/pnas.77.7.4132; Marlar S, 2014, AM J PHYSIOL-CELL PH, V306, pC598, DOI 10.1152/ajpcell.00132.2013; McNeil E, 2006, MOL BIOL CELL, V17, P1922, DOI 10.1091/mbc.E05-07-0650; Muza-Moons MM, 2003, INFECT IMMUN, V71, P7069, DOI 10.1128/IAI.71.12.7069-7078.2003; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nougayrede JP, 2004, CELL MICROBIOL, V6, P1097, DOI 10.1111/j.1462-5822.2004.00421.x; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Ojakian GK, 1997, J CELL SCI, V110, P2781; Oztan A, 2007, MOL BIOL CELL, V18, P3978, DOI 10.1091/mbc.E07-02-0097; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; PFEIFFER S, 1985, J CELL BIOL, V101, P470, DOI 10.1083/jcb.101.2.470; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Simonovic I, 2000, CELL MICROBIOL, V2, P305, DOI 10.1046/j.1462-5822.2000.00055.x; Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093; Tan S, PLOS PATHOG, V7; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; VAN MEER G, 1987, J CELL BIOL, V105, P1623, DOI 10.1083/jcb.105.4.1623; Vogelmann R, 2004, CURR OPIN CELL BIOL, V16, P86, DOI 10.1016/j.ceb.2003.12.002; Wong ARC, 2012, CELL MICROBIOL, V14, P1051, DOI 10.1111/j.1462-5822.2012.01778.x; Wu ZY, 2000, CELL MICROBIOL, V2, P11, DOI 10.1046/j.1462-5822.2000.00025.x; Xia P, 1998, BIOPHYS J, V74, P3302, DOI 10.1016/S0006-3495(98)78037-3; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73	75	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2017	12	6							e0179122	10.1371/journal.pone.0179122	http://dx.doi.org/10.1371/journal.pone.0179122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6UH	28636623	Green Submitted, Green Published, gold			2022-12-26	WOS:000404118300025
J	van der Schaft, N; Brahimaj, A; Wen, KX; Franco, OH; Dehghan, A				van der Schaft, Niels; Brahimaj, Adela; Wen, Ke-xin; Franco, Oscar H.; Dehghan, Abbas			The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: The Rotterdam Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; RISK; METABOLISM	Background Limited evidence is available about the association between serum uric acid and sub-stages of the spectrum from normoglycaemia to type 2 diabetes mellitus. We aimed to investigate the association between serum uric acid and risk of prediabetes and type 2 diabetes mellitus. Methods Eligible participants of the Rotterdam Study (n = 8,367) were classified into mutually exclusive subgroups of normoglycaemia (n = 7,030) and prediabetes (n = 1,337) at baseline. These subgroups were followed up for incident prediabetes (n = 1,071) and incident type 2 diabetes mellitus (n = 407), respectively. We used Cox proportional hazard models to determine hazard ratios (HRs) for incident prediabetes among individuals with normoglycaemia and incident type 2 diabetes mellitus among individuals with prediabetes. Results The mean duration of follow-up was 7.5 years for incident prediabetes and 7.2 years for incident type 2 diabetes mellitus. A standard deviation increment in serum uric acid was significantly associated with incident prediabetes among individuals with normoglycaemia (HR 1.10, 95% confidence interval (CI) 1.01; 1.18), but not with incident type 2 diabetes mellitus among individuals with prediabetes (HR 1.07, 95% CI 0.94; 1.21). Exclusion of individuals who used diuretics or individuals with hypertension did not change our results. Serum uric acid was significantly associated with incident prediabetes among normoglycaemic women (HR 1.13, 95% CI 1.02; 1.25) but not among normoglycaemic men (HR 1.08, 95% CI 0.96; 1.21). In contrast, serum uric acid was significantly associated with incident type 2 diabetes mellitus among prediabetic men (HR 1.23, 95% CI 1.01; 1.48) but not among prediabetic women (HR 1.00, 95% CI 0.84; 1.19). Conclusions Our findings agree with the notion that serum uric acid is more closely related to early-phase mechanisms in the development of type 2 diabetes mellitus than late-phase mechanisms.	[van der Schaft, Niels; Brahimaj, Adela; Wen, Ke-xin; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dehghan, A (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	a.dehghan@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Dehghan, Abbas/ABE-7377-2020; Dehghan, Abbas/B-9896-2008	Franco, Óscar H/0000-0002-4606-4929; Dehghan, Abbas/0000-0001-6403-016X	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE; part of ZonMw); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; European Commission (DG XII); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission; Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; AXA Research Fund; Ministry of Health, Welfare and Sports	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE; part of ZonMw); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Erasmus Mundus Western Balkans (ERAWEB); European Commission(European CommissionEuropean Commission Joint Research Centre); Nestle Nutrition (Nestec Ltd.)(Nestle SA); Metagenics Inc.; AXA Research Fund(AXA Research Fund); Ministry of Health, Welfare and Sports	The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl/en); the Netherlands Organisation for Health Research and Development (ZonMw; https://www.zonmw.nl/ nl/); the Research Institute for Diseases in the Elderly (RIDE; part of ZonMw); the Netherlands Genomics Initiative (NGI; http://www.genomics.nl/, stopped in 2013); the Ministry of Education, Culture and Science, the Ministry of Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. AB is financially supported by Erasmus Mundus Western Balkans (ERAWEB), a project funded by the European Commission. OHF and KXW work at ErasmusAGE, a center for aging research across the life course funded by Nestle Nutrition (Nestec Ltd.); Metagenics Inc.; and the AXA Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Jia ZT, 2013, DIABETES RES CLIN PR, V101, P88, DOI 10.1016/j.diabres.2013.03.026; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kawamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065886; Kivity S, 2013, J WOMENS HEALTH, V22, P782, DOI 10.1089/jwh.2012.4043; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Kramer CK, 2009, DIABETES CARE, V32, P1272, DOI 10.2337/dc09-0275; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ligthart S, 2016, LANCET DIABETES ENDO, V4, P44, DOI 10.1016/S2213-8587(15)00362-9; Liu YH, 2013, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2013-8; Lv Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056864; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; NEELEY WE, 1972, CLIN CHEM, V18, P509; Peng T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/735056; Shimodaira M, 2014, HORM METAB RES, V46, P950, DOI 10.1055/s-0034-1389996; Tang W, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/709691; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; WHO/IDF, 2006, DEF DIAGN DIAB MELL, P3; Wu AH, 2016, INT J CARDIOL, V213, P4, DOI 10.1016/j.ijcard.2015.08.110; Yamada T, 2011, DIABETES METAB, V37, P252, DOI 10.1016/j.diabet.2010.10.009	27	56	56	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2017	12	6							e0179482	10.1371/journal.pone.0179482	http://dx.doi.org/10.1371/journal.pone.0179482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5UN	28632742	Green Published, Green Submitted, gold			2022-12-26	WOS:000404046100029
J	Bernardinelli, E; Costa, R; Scantamburlo, G; To, J; Morabito, R; Nofziger, C; Doerrier, C; Krumschnabel, G; Paulmichl, M; Dossena, S				Bernardinelli, Emanuele; Costa, Roberta; Scantamburlo, Giada; To, Janet; Morabito, Rossana; Nofziger, Charity; Doerrier, Carolina; Krumschnabel, Gerhard; Paulmichl, Markus; Dossena, Silvia			Mis-targeting of the mitochondrial protein LIPT2 leads to apoptotic cell death	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; VOLUME REGULATION; ION CHANNELS; B-MYC; MECHANISMS; PROLIFERATION; DEFICIENCY; DISEASE; DEHYDROGENASE; METABOLISM	Lipoyl(Octanoyl) Transferase 2 (LIPT2) is a protein involved in the post-translational modification of key energy metabolism enzymes in humans. Defects of lipoic acid synthesis and transfer start to emerge as causes of fatal or severe early-onset disease. We show that the first 31 amino acids of the N-terminus of LIPT2 represent a mitochondrial targeting sequence and inhibition of the transit of LIPT2 to the mitochondrion results in apoptotic cell death associated with activation of the apoptotic volume decrease (AVD) current in normotonic conditions, as well as over-activation of the swelling-activated chloride current (IClswell), mitochondrial membrane potential collapse, caspase-3 cleavage and nuclear DNA fragmentation. The findings presented here may help elucidate the molecular mechanisms underlying derangements of lipoic acid biosynthesis.	[Bernardinelli, Emanuele; Costa, Roberta; Scantamburlo, Giada; Nofziger, Charity; Dossena, Silvia] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria; [To, Janet] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Morabito, Rossana] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Doerrier, Carolina; Krumschnabel, Gerhard] Oroboros Instruments, Innsbruck, Austria; [Paulmichl, Markus] Austrian Inst Technol, Ctr Hlth & Bioresources, Vienna, Austria	Paracelsus Private Medical University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Messina; Austrian Institute of Technology (AIT)	Dossena, S (corresponding author), Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria.	silvia.dossena@pmu.ac.at	Doerrier, Carolina/AAH-3969-2021; Bernardinelli, Emanuele/AAD-7213-2022; Dossena, Silvia/G-1437-2018; Morabito, Rossana/AFP-6914-2022	Doerrier, Carolina/0000-0002-7969-6762; Krumschnabel, Gerhard/0000-0003-0804-1248; BERNARDINELLI, EMANUELE/0000-0002-6119-3067; Dossena, Silvia/0000-0002-6694-9249				Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P641; ASKER CE, 1995, ONCOGENE, V11, P1963; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHEN BPC, 1994, GENE, V139, P73, DOI 10.1016/0378-1119(94)90525-8; Cosentino K, 2016, TRENDS CELL BIOL; DiCiommo DP, 2004, INVEST OPHTH VIS SCI, V45, P3320, DOI 10.1167/iovs.04-0140; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Dossena S, 2013, CELL PHYSIOL BIOCHEM, V32, P41, DOI 10.1159/000356623; Dossena S, 2011, J BIOL CHEM, V286, P40659, DOI 10.1074/jbc.M111.260430; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Gandini R, 2008, CELL PHYSIOL BIOCHEM, V22, P579, DOI 10.1159/000185542; Grancara S, 2016, AMINO ACIDS, V48, P2313, DOI 10.1007/s00726-016-2323-z; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gregory MA, 2000, ONCOGENE, V19, P4886, DOI 10.1038/sj.onc.1203851; Habarou F, 2015, J INHERIT METAB DIS, V38, pS48; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Kastaniotis AJ, 2017, BBA-MOL CELL BIOL L, V1862, P39, DOI 10.1016/j.bbalip.2016.08.011; Kossler S, 2012, TOXICOLOGY, V292, P123, DOI 10.1016/j.tox.2011.12.002; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 1998, CELL PHYSIOL BIOCHEM, V8, P285, DOI 10.1159/000016290; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Marvin ME, 2001, FEMS MICROBIOL LETT, V199, P131, DOI 10.1016/S0378-1097(01)00170-7; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011; Meyer G, 2004, FEBS LETT, V559, P45, DOI 10.1016/S0014-5793(04)00020-1; Model MA, 2014, AM J PHYSIOL-CELL PH, V306, pC417, DOI 10.1152/ajpcell.00328.2013; MORGAN RA, 1992, NUCLEIC ACIDS RES, V20, P1293, DOI 10.1093/nar/20.6.1293; MORRIS TW, 1995, J BACTERIOL, V177, P1; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Pasantes-Morales H, 2016, MOL PHARMACOL, V90, P358, DOI 10.1124/mol.116.104158; REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; Soreze Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-192; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Tache A V, 2016, CASE REP OBSTET GYNE, V2016; Tamma G, 2011, CELL PHYSIOL BIOCHEM, V28, P1191, DOI 10.1159/000335851; Tort F, 2016, J INHERIT METAB DIS, V39, P781, DOI 10.1007/s10545-016-9975-4; Tort F, 2014, HUM MOL GENET, V23, P1907, DOI 10.1093/hmg/ddt585; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang YJ, 2014, J INVEST DERMATOL, V134, P183, DOI 10.1038/jid.2013.268	52	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179591	10.1371/journal.pone.0179591	http://dx.doi.org/10.1371/journal.pone.0179591			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628643	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100040
J	Ludena-Choez, J; Quispe-Soncco, R; Gallardo-Antolin, A				Ludena-Choez, Jimmy; Quispe-Soncco, Raisa; Gallardo-Antolin, Ascension			Bird sound spectrogram decomposition through Non-Negative Matrix Factorization for the acoustic classification of bird species	PLOS ONE			English	Article								Feature extraction for Acoustic Bird Species Classification (ABSC) tasks has traditionally been based on parametric representations that were specifically developed for speech signals, such as Mel Frequency Cepstral Coefficients (MFCC). However, the discrimination capabilities of these features for ABSC could be enhanced by accounting for the vocal production mechanisms of birds, and, in particular, the spectro-temporal structure of bird sounds. In this paper, a new front-end for ABSC is proposed that incorporates this specific information through the non-negative decomposition of bird sound spectrograms. It consists of the following two different stages: short-time feature extraction and temporal feature integration. In the first stage, which aims at providing a better spectral representation of bird sounds on a frame-by-frame basis, two methods are evaluated. In the first method, cepstrallike features (NMF_CC) are extracted by using a filter bank that is automatically learned by means of the application of Non-Negative Matrix Factorization (NMF) on bird audio spectrograms. In the second method, the features are directly derived from the activation coefficients of the spectrogram decomposition as performed through NMF (H_CC). The second stage summarizes the most relevant information contained in the short-time features by computing several statistical measures over long segments. The experiments show that the use of NMF_CC and H_CC in conjunction with temporal integration significantly improves the performance of a Support Vector Machine (SVM)-based ABSC system with respect to conventional MFCC.	[Ludena-Choez, Jimmy; Quispe-Soncco, Raisa] Univ Catolica San Pablo, CIET, Fac Ingn Comp, Grp Invest Ciencia & Tecnol Mat CITEM, Arequipa, Peru; [Ludena-Choez, Jimmy; Gallardo-Antolin, Ascension] Univ Carlos III Madrid, Dept Signal Theory & Commun, Madrid, Spain	Universidad Catolica San Pablo; Universidad Carlos III de Madrid	Ludena-Choez, J (corresponding author), Univ Catolica San Pablo, CIET, Fac Ingn Comp, Grp Invest Ciencia & Tecnol Mat CITEM, Arequipa, Peru.; Ludena-Choez, J (corresponding author), Univ Carlos III Madrid, Dept Signal Theory & Commun, Madrid, Spain.	jludenac@ucsp.edu.pe	Choez, Jimmy Diestin Ludeña/I-2378-2019; Choez, Jimmy Diestin Ludeña/C-6188-2014; GALLARDO-ANTOLÍN, ASCENSIÓN/L-4152-2014	Choez, Jimmy Diestin Ludeña/0000-0002-2891-183X; Choez, Jimmy Diestin Ludeña/0000-0002-2891-183X; GALLARDO-ANTOLÍN, ASCENSIÓN/0000-0002-9322-3128	Spanish Government grant [TEC2014-53390-P]	Spanish Government grant(Spanish Government)	This work was supported by the Spanish Government grant TEC2014-53390-P. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckers G., 2006, ENCY LANGUAGE LINGUI, P454; Bertrand A, 2008, INT CONF ACOUST SPEE, P4713, DOI 10.1109/ICASSP.2008.4518709; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Brookes M., 2006, VOICEBOX SPEECH PROC; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen Z, 2006, INT C COMMUN CIRCUIT, P893; Damon C, 2013, INT CONF ACOUST SPEE, P1177, DOI 10.1109/ICASSP.2013.6637836; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Evangelista TLF, 2014, 2014 IEEE INTERNATIONAL SYMPOSIUM ON MULTIMEDIA (ISM), P223, DOI 10.1109/ISM.2014.46; Fagerlund S, 2007, EURASIP J ADV SIG PR, DOI 10.1155/2007/38637; Harma A, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P545; International BirdLife and NatureServe, 2015, BIRD SPEC DISTR MAPS; Joder C., 2012, SPEECH COMMUN, P1; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Kwan C, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P289; Lee C., 2006, J INFORM TECHNOLOGY, V1, P17; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lu E, 2016, SJSTATS STAT FUNCTIO; Meng A, 2007, IEEE T AUDIO SPEECH, V15, P1654, DOI 10.1109/TASL.2007.899293; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Qian K, 2015, 2015 IEEE GLOBAL CONFERENCE ON SIGNAL AND INFORMATION PROCESSING (GLOBALSIP), P1317, DOI 10.1109/GlobalSIP.2015.7418412; R Core Team, 2021, R LANGUAGE ENV STAT; Rigoll G., 2013, 2013 IEEE WORKSHOP A, P1, DOI DOI 10.1109/WASPAA.2013.6701857; Ryosuke O, 2014, PLOS ONE, V9; Sandler R, 2011, IEEE T PATTERN ANAL, V33, P1590, DOI 10.1109/TPAMI.2011.18; Schuller B, 2010, INT CONF ACOUST SPEE, P4562, DOI 10.1109/ICASSP.2010.5495567; Somervuo P, 2006, IEEE T AUDIO SPEECH, V14, P2252, DOI 10.1109/TASL.2006.872624; Tsai H, 2013, MULT EXP ICME IEEE I; Ventura TM, 2015, EXPERT SYST APPL, V42, P8463, DOI 10.1016/j.eswa.2015.07.002; Wilson KW, 2008, INT CONF ACOUST SPEE, P4029, DOI 10.1109/ICASSP.2008.4518538; Winter B., ARXIV13085499; Xu W, 2003, P 26 ANN INT ACM SIG, P267, DOI [10.1145/860435.860485, DOI 10.1145/860435.860485]; Zhang YB, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P349; Zhang ZX, 2012, INT CONF ACOUST SPEE, P333, DOI 10.1109/ICASSP.2012.6287884	36	14	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179403	10.1371/journal.pone.0179403	http://dx.doi.org/10.1371/journal.pone.0179403			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628630	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100030
J	Zhao, Z; Xie, L; Bourne, PE				Zhao, Zheng; Xie, Lei; Bourne, Philip E.			Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome	PLOS ONE			English	Article							PROTEIN-KINASE; P-LOOP; SITE; DYNAMICS; CHARMM	Protein kinases are critical drug targets for treating a large variety of human diseases. Type-III kinase inhibitors have attracted increasing attention as highly selective therapeutics. Thus, understanding the binding mechanism of existing type-III kinase inhibitors provides useful insights into designing new type-III kinase inhibitors. In this work, we have systematically studied the binding mode of MEK-targeted type-III inhibitors using structural systems pharmacology and molecular dynamics simulation. Our studies provide detailed sequence, structure, interaction-fingerprint, pharmacophore and binding-site information on the binding characteristics of MEK type-III kinase inhibitors. We hypothesize that the helix-folding activation loop is a hallmark allosteric binding site for type-III inhibitors. Subsequently, we screened and predicted allosteric binding sites across the human kinome, suggesting other kinases as potential targets suitable for type-III inhibitors.	[Zhao, Zheng; Bourne, Philip E.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Xie, Lei] CUNY, Hunter Coll, Dept Comp Sci, New York, NY 10021 USA; [Xie, Lei] CUNY, Grad Ctr, New York, NY 10031 USA; [Bourne, Philip E.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Zhao, Zheng; Bourne, Philip E.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; National Institutes of Health (NIH) - USA; University of Virginia	Bourne, PE (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.; Xie, L (corresponding author), CUNY, Hunter Coll, Dept Comp Sci, New York, NY 10021 USA.; Xie, L (corresponding author), CUNY, Grad Ctr, New York, NY 10031 USA.; Bourne, PE (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.; Bourne, PE (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.	lei.xie@hunter.cuny.edu; peb6a@virginia.edu	Bourne, Philip/ABG-8967-2021; zhao, zheng/S-7147-2016	Bourne, Philip/0000-0002-7618-7292; zhao, zheng/0000-0003-1453-3230	Intramural Research Program of the National Library of Medicine, National Institutes of Health; National Library of Medicine, National Institutes of Health [R01LM011986]; National Institute on Minority Health and Health Disparities, National Institutes of Health [G12MD007599]; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011986] Funding Source: NIH RePORTER	Intramural Research Program of the National Library of Medicine, National Institutes of Health; National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute on Minority Health and Health Disparities, National Institutes of Health; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The Intramural Research Program of the National Library of Medicine, National Institutes of Health (Z.Z. and P.E.B.), the National Library of Medicine, National Institutes of Health under Award R01LM011986 (L.X.), and the National Institute on Minority Health and Health Disparities, National Institutes of Health, under Award G12MD007599 (L.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by: (i) the Intramural Research Program of the National Library of Medicine, National Institutes of Health (Z.Z. and P.E.B.); (ii) the National Library of Medicine, National Institutes of Health under Award R01LM011986 (L.X.); and (iii) the National Institute on Minority Health and Health Disparities, National Institutes of Health, under Award G12MD007599 (L.X.).	Abramson R., 2016, OVERVIEW TARGETED TH; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; [Anonymous], 2016, SCHR REL 2016 2 MAES; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Bourne PE, 2017, ANN REV PHARM TOXICO, V57; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; Deyrup AT, 1998, J BIOL CHEM, V273, P9450, DOI 10.1074/jbc.273.16.9450; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Garnock-Jones KP, 2015, DRUGS, V75, P1645, DOI 10.1007/s40265-015-0463-1; Gharwan H, 2016, NAT REV CLIN ONCOL, V13, P209, DOI 10.1038/nrclinonc.2015.213; Gushwa NN, 2012, J AM CHEM SOC, V134, P20214, DOI 10.1021/ja310659j; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Klebl B, 2011, PROTEIN KINASE DRUG; Kooistra AJ, 2016, NUCLEIC ACIDS RES, V44, pD365, DOI 10.1093/nar/gkv1082; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lee CC, 2010, BIOCHEM J, V430, P425, DOI 10.1042/BJ20100609; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsumoto T, 2010, BIOCHEM BIOPH RES CO, V400, P369, DOI 10.1016/j.bbrc.2010.08.071; Mazanetz MP, 2014, MOLECULES, V19, P9134, DOI 10.3390/molecules19079134; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Muller S, 2015, NAT CHEM BIOL, V11, P818, DOI 10.1038/nchembio.1938; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Radifar M, 2013, BIOINFORMATION, V9, P325, DOI 10.6026/97320630009325; Rask-Andersen M, 2014, TRENDS PHARMACOL SCI, V35, P60, DOI 10.1016/j.tips.2014.09.007; Rice KD, 2012, ACS MED CHEM LETT, V3, P416, DOI 10.1021/ml300049d; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Sebolt-Leopold J.S., 2009, KINASE INHIBITOR DRU, P205; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Wu P, 2015, PHARMACOL THERAPEUT, V156, P59, DOI 10.1016/j.pharmthera.2015.10.002; Wu P, 2016, DRUG DISCOV TODAY, V21, P5, DOI 10.1016/j.drudis.2015.07.008; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Xie L, 2008, P NATL ACAD SCI USA, V105, P5441, DOI 10.1073/pnas.0704422105; Xie L, 2009, BIOINFORMATICS, V25, pI305, DOI 10.1093/bioinformatics/btp220; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhao Z, 2016, J MED CHEM, V59, P4326, DOI 10.1021/acs.jmedchem.5b02041; Zhao Z, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0941-9; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	49	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179936	10.1371/journal.pone.0179936	http://dx.doi.org/10.1371/journal.pone.0179936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628649	Green Published, gold, Green Submitted			2022-12-26	WOS:000404043100050
J	Kretschmer, S; Zieske, K; Schwille, P				Kretschmer, Simon; Zieske, Katja; Schwille, Petra			Large-scale modulation of reconstituted Min protein patterns and gradients by defined mutations in MinE's membrane targeting sequence	PLOS ONE			English	Article							BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; IN-VITRO; TOPOLOGICAL REGULATION; POLE OSCILLATION; INHIBITOR MINC; WAVES; LOCALIZATION; DYNAMICS; BIOLOGY	The E. coli MinDE oscillator is a paradigm for protein self-organization and gradient formation. Previously, we reconstituted Min protein wave patterns on flat membranes as well as gradient-forming pole-to-pole oscillations in cell-shaped PDMS microcompartments. These oscillations appeared to require direct membrane interaction of the ATPase activating protein MinE. However, it remained unclear how exactly Min protein dynamics are regulated by MinE membrane binding. Here, we dissect the role of MinE's membrane targeting sequence (MTS) by reconstituting various MinE mutants in 2D and 3D geometries. We demonstrate that the MTS defines the lower limit of the concentration-dependent wavelength of Min protein patterns while restraining MinE's ability to stimulate MinD's ATPase activity. Strikingly, a markedly reduced length scale obtainable even by single mutations is associated with a rich variety of multistable dynamic modes in cell-shaped compartments. This dramatic remodeling in response to biochemical changes reveals a remarkable trade-off between robustness and versatility of the Min oscillator.	[Kretschmer, Simon; Zieske, Katja; Schwille, Petra] Max Planck Inst Biochem, Dept Cellular & Mol Biophys, Martinsried, Germany; [Kretschmer, Simon] Ludwig Maximilians Univ Munchen, Grad Sch Quantitat Biosci, Munich, Germany; [Zieske, Katja; Schwille, Petra] UCSF, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Max Planck Society; University of Munich; University of California System; University of California San Francisco	Schwille, P (corresponding author), Max Planck Inst Biochem, Dept Cellular & Mol Biophys, Martinsried, Germany.; Schwille, P (corresponding author), UCSF, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	schwille@biochem.mpg.de	Schwille, Petra/A-4983-2010	Schwille, Petra/0000-0002-6106-4847; Kretschmer, Simon/0000-0002-0825-174X	German Research Foundation [1032]; MaxSynBio consortium; Federal Ministry of Education and Research of Germany; Max Planck Society	German Research Foundation(German Research Foundation (DFG)); MaxSynBio consortium; Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck Society)	PS and SK were supported by the collaborative research project 1032 "Nanoagents for the spatiotemporal control of molecular and cellular reactions" of the German Research Foundation (http://www.sfb1032.physik.uni-muenchen.de/). SK is a student of the Graduate School of Quantitative Biosciences of the Ludwig Maximilians University (http://www.qbm.genzentrum.lmu.de/). PS is supported by the MaxSynBio consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society (https://www.maxsynbio.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiranashvili A, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/9/093049; Bement WM, 2015, NAT CELL BIOL, V17, P1471, DOI 10.1038/ncb3251; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; Camazine S, 2001, SELF ORG BIOL SYSTEM, Vviii; Caspi Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19271; Coyle SM, 2016, ELIFE, V5, DOI 10.7554/eLife.12435; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Halatek J, 2014, P NATL ACAD SCI USA, V111, pE1817, DOI 10.1073/pnas.1220971111; Halatek J, 2012, CELL REP, V1, P741, DOI 10.1016/j.celrep.2012.04.005; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; JAKUBITH S, 1990, PHYS REV LETT, V65, P3013, DOI 10.1103/PhysRevLett.65.3013; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kretschmer S, 2016, CURR OPIN CELL BIOL, V38, P52, DOI 10.1016/j.ceb.2016.02.005; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Martos A, 2015, BIOPHYS J, V108, P2371, DOI 10.1016/j.bpj.2015.03.031; Martos A, 2013, ENVIRON MICROBIOL, V15, P3319, DOI 10.1111/1462-2920.12295; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Rivas G, 2014, CURR OPIN CHEM BIOL, V22, P18, DOI 10.1016/j.cbpa.2014.07.018; Schweizer J, 2012, P NATL ACAD SCI USA, V109, P15283, DOI 10.1073/pnas.1206953109; Schwille P, 2009, CRIT REV BIOCHEM MOL, V44, P223, DOI 10.1080/10409230903074549; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Vecchiarelli AG, 2014, MOL MICROBIOL, V93, P453, DOI 10.1111/mmi.12669; Wu FB, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156724; Wu FB, 2015, NAT NANOTECHNOL, V10, P719, DOI [10.1038/NNANO.2015.126, 10.1038/nnano.2015.126]; Zieske K, 2016, ANGEW CHEM INT EDIT, V55, P13455, DOI 10.1002/anie.201606069; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2014, FEBS LETT, V588, P2545, DOI 10.1016/j.febslet.2014.06.026; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	43	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179582	10.1371/journal.pone.0179582	http://dx.doi.org/10.1371/journal.pone.0179582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622374				2022-12-26	WOS:000403506300041
J	Do, MT; Chai, TF; Casey, PJ; Wang, M				Do, M. T.; Chai, T. F.; Casey, P. J.; Wang, M.			Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin beta 3 recycling, cell migration and cancer metastasis	ONCOGENE			English	Article							GDP DISSOCIATION INHIBITOR; PROSTATE-CANCER; TUMOR-GROWTH; RAB GTPASES; ALPHA-V-BETA-3 INTEGRIN; EPITHELIAL-CELLS; EARLY ENDOSOMES; BREAST-CANCER; PHASE-II; K-RAS	Isoprenylcysteine carboxylmethyltransferase (ICMT) catalyzes the post-translational modification of RAB GTPases that contain C-terminal CXC motifs. However, the functional impact of this modification on RAB proteins has not been actively explored. We found that inhibition of ICMT significantly reduced cell migration in vitro and cancer invasion and metastasis in vivo. This role of ICMT was found to be mediated by RAB4A, an essential regulator of the fast recycling of integrin beta 3. Integrin beta 3 regulates cell polarity and migration when localized appropriately to the plasma membrane, thereby having an essential role in cancer metastasis. ICMT catalyzed carboxylmethylation is critical for RAB4A activation and interaction with effectors, its localization to endosomes and recycling vesicles, and hence important for RAB4A-dependent integrin beta 3 recycling to plasma membrane. These findings bring attention to the effects of C-terminal carboxylmethylation on RAB GTPases and provide a rationale for targeting ICMT in the treatment of metastatic cancer.	[Do, M. T.; Chai, T. F.; Casey, P. J.; Wang, M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Casey, P. J.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Wang, M.] Natl Univ Singapore, Dept Biochem, Singapore, Singapore	National University of Singapore; Duke University; National University of Singapore	Wang, M (corresponding author), Duke NUS Med Sch, Program Canc Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	mei.wang@duke-nus.edu.sg		Casey, Patrick/0000-0002-7366-9309; Do, Minh Truong/0000-0002-2319-0287	Ministry of Health through CSA scheme; Ministry of Health through Tier II scheme	Ministry of Health through CSA scheme; Ministry of Health through Tier II scheme	This work is supported by Singapore Ministries of Education and Ministry of Health for funding of this project through their Tier II and CSA schemes, respectively. We are grateful for the help on CAM assays by Dr Suhail Ahmed Kabeer Rasheed of Duke-NUS. The authors confirm that neither the submitted manuscript nor any similar manuscript, in whole or in part, is under consideration, in press, or reported elsewhere.	ARAKI S, 1990, J BIOL CHEM, V265, P13007; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Beekman KW, 2006, CLIN GENITOURIN CANC, V4, P299, DOI 10.3816/CGC.2006.n.012; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2000, J BIOL CHEM, V275, P17605, DOI 10.1074/jbc.C000079200; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; D'Souza RS, 2014, CURR BIOL, V24, P1187, DOI 10.1016/j.cub.2014.04.003; Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Gruber G, 2005, BRIT J CANCER, V92, P41, DOI 10.1038/sj.bjc.6602278; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hanker AB, 2010, ONCOGENE, V29, P380, DOI 10.1038/onc.2009.336; Hosotani Ryo, 2002, Pancreas, V25, pe30, DOI 10.1097/00006676-200208000-00021; Ignatev A, 2008, J BIOL CHEM, V283, P18377, DOI 10.1074/jbc.M709718200; Knight JB, 2000, ENDOCRINOLOGY, V141, P208, DOI 10.1210/en.141.1.208; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lau HY, 2014, CANCER BIOL THER, V15, P1280, DOI 10.4161/cbt.29692; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Legler DF, 2001, J CELL SCI, V114, P1545; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; LI GP, 1993, ARCH BIOCHEM BIOPHYS, V304, P471, DOI 10.1006/abbi.1993.1377; Manu KA, 2017, MOL CANCER THER, V16, P914, DOI 10.1158/1535-7163.MCT-16-0703; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Paul NR, 2015, CURR BIOL, V25, pR1092, DOI 10.1016/j.cub.2015.09.049; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Ratajczak MZ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-95; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; SMELAND TE, 1994, P NATL ACAD SCI USA, V91, P10712, DOI 10.1073/pnas.91.22.10712; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Teh JT, 2015, ONCOGENE, V34, P3296, DOI 10.1038/onc.2014.260; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; Wang M, 2010, ONCOGENE, V29, P4959, DOI 10.1038/onc.2010.247; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267; Zhu WL, 2011, J BIOL CHEM, V286, P35291, DOI 10.1074/jbc.M111.280990; Zijlstra A, 2002, CANCER RES, V62, P7083	52	18	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 12	2017	36	41					5757	5767		10.1038/onc.2017.183	http://dx.doi.org/10.1038/onc.2017.183			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FJ6DJ	28604748	Green Published, hybrid			2022-12-26	WOS:000412843900009
J	Bilova, T; Paudel, G; Shilyaev, N; Schmidt, R; Brauch, D; Tarakhovskaya, E; Milrud, S; Smolikova, G; Tissier, A; Vogt, T; Sinz, A; Brandt, W; Birkemeyer, C; Wessjohann, LA; Frolov, A				Bilova, Tatiana; Paudel, Gagan; Shilyaev, Nikita; Schmidt, Rico; Brauch, Dominic; Tarakhovskaya, Elena; Milrud, Svetlana; Smolikova, Galina; Tissier, Alain; Vogt, Thomas; Sinz, Andrea; Brandt, Wolfgang; Birkemeyer, Claudia; Wessjohann, Ludger A.; Frolov, Andrej			Global proteomic analysis of advanced glycation end products in the Arabidopsis proteome provides evidence for age-related glycation hot spots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOXIDATIVE GLYCOSYLATION; GLUCOSE AUTOXIDATION; CARBONYLATION SITES; FAMILIES DATABASE; PROTEINS; METHYLGLYOXAL; PEPTIDES; IDENTIFICATION; ENDPRODUCTS; PREDICTION	Glycation is a post-translational modification resulting from the interaction of protein amino and guanidino groups with carbonyl compounds. Initially, amino groups react with reducing carbohydrates, yielding Amadori and Heyns compounds. Their further degradation results in formation of advanced glycation end products (AGEs), also originating from alpha-dicarbonyl products of monosaccharide autoxidation and primary metabolism. In mammals, AGEs are continuously formed during the life of the organism, accumulate in tissues, are well-known markers of aging, and impact age-related tissue stiffening and atherosclerotic changes. However, the role of AGEs in age-related molecular alterations in plants is still unknown. To fill this gap, we present here a comprehensive study of the age-related changes in the Arabidopsis thaliana glycated proteome, including the proteins affected and specific glycation sites therein. We also consider the qualitative and quantitative changes in glycation patterns in terms of the general metabolic background, pathways of AGE formation, and the status of plant anti-oxidative/ anti-glycative defense. Although the patterns of glycated proteins were only minimally influenced by plant age, the abundance of 96 AGE sites in 71 proteins was significantly affected in an age-dependent manner and clearly indicated the existence of age-related glycation hot spots in the plant proteome. Homology modeling revealed glutamyl and aspartyl residues in close proximity (less than 5 angstrom) to these sites in three aging-specific and eight differentially glycated proteins, four of which were modified in catalytic domains. Thus, the sites of glycation hot spots might be defined by protein structure that indicates, at least partly, site-specific character of glycation.	[Bilova, Tatiana; Paudel, Gagan; Brandt, Wolfgang; Wessjohann, Ludger A.; Frolov, Andrej] Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany; [Tissier, Alain; Vogt, Thomas] Leibniz Inst Plant Biochem IPB, Dept Cell & Metab Biol, D-06120 Halle, Saale, Germany; [Bilova, Tatiana; Paudel, Gagan; Brauch, Dominic; Birkemeyer, Claudia; Frolov, Andrej] Univ Leipzig, Fac Chem & Mineral, D-04103 Leipzig, Germany; [Bilova, Tatiana; Tarakhovskaya, Elena; Milrud, Svetlana; Smolikova, Galina] St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, Univ Skaya Emb 7-9, St Petersburg 199034, Russia; [Shilyaev, Nikita; Milrud, Svetlana] St Petersburg State Univ, Fac Biol, Dept Biochem, St Petersburg 199034, Russia; [Schmidt, Rico; Sinz, Andrea] Martin Luther Univ Halle Wittenberg, Inst Pharm, D-06099 Halle, Saale, Germany; [Brauch, Dominic] Leibniz Inst Plant Genet & Crop Plant Res IPK, D-06466 Stadt Seeland, Germany	Leibniz Institut fur Pflanzenbiochemie; Leibniz Institut fur Pflanzenbiochemie; Leipzig University; Saint Petersburg State University; Saint Petersburg State University; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Frolov, A (corresponding author), Leibniz Inst Plant Biochem IPB, Dept Bioorgan Chem, Weinberg 3, D-06120 Halle, Saale, Germany.; Bilova, T (corresponding author), St Petersburg State Univ, Fac Biol, Dept Plant Physiol & Biochem, Univ Skaya Emb 7-9, St Petersburg 199034, Russia.	bilova.tatiana@gmail.com; afrolov@ipb-halle.de	Tissier, Alain F/B-2108-2017; Smolikova, Galina/H-6269-2013; Frolov, Andrej A/V-5550-2018; Bilova, Tatiana E./M-2405-2015; Wessjohann, Ludger/AAZ-3838-2021; Tarakhovskaya, Elena R./I-7458-2013; Tarakhovskaya, Elena/Y-8165-2019; Birkemeyer, Claudia/L-8687-2015	Tissier, Alain F/0000-0002-9406-4245; Smolikova, Galina/0000-0001-5238-1851; Bilova, Tatiana E./0000-0002-6024-3667; Tarakhovskaya, Elena R./0000-0002-5341-2813; Tarakhovskaya, Elena/0000-0002-5341-2813; Wessjohann, Ludger A./0000-0003-2060-8235; Birkemeyer, Claudia/0000-0002-8538-8838				Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P1; [Anonymous], 2017, MOL OP ENV MOE 2013; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Barnaby OS, 2011, CLIN CHIM ACTA, V412, P277, DOI 10.1016/j.cca.2010.10.018; Baynes J W, 1989, Prog Clin Biol Res, V304, P43; Bechtold U, 2009, PLANT J, V59, P661, DOI 10.1111/j.1365-313X.2009.03898.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilova T, 2016, J BIOL CHEM, V291, P7621, DOI 10.1074/jbc.M115.678581; Bollineni RC, 2011, J PROTEOMICS, V74, P2338, DOI 10.1016/j.jprot.2011.07.002; Bollineni RC, 2014, FREE RADICAL BIO MED, V68, P186, DOI 10.1016/j.freeradbiomed.2013.11.030; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dammann P, 2012, J GERONTOL A-BIOL, V67, P573, DOI 10.1093/gerona/glr208; Deshmukh S, 2015, J CHROMATOGR A, V1388, P1, DOI 10.1016/j.chroma.2015.01.093; DiMario RJ, 2016, PLANT PHYSIOL, V171, P280, DOI 10.1104/pp.15.01990; Ehrlich H, 2010, J BIOMED MATER RES B, V92B, P542, DOI 10.1002/jbm.b.31551; Ehrlich H, 2009, INT J BIOL MACROMOL, V44, P51, DOI 10.1016/j.ijbiomac.2008.10.001; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fittinghoff K, 2006, PLANT J, V47, P577, DOI 10.1111/j.1365-313X.2006.02812.x; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Frolov A, 2008, ANN NY ACAD SCI, V1126, P253, DOI 10.1196/annals.1433.060; Frolov A, 2006, J MASS SPECTROM, V41, P1459, DOI 10.1002/jms.1117; Frolov A, 2017, J PLANT PHYSIOL, V208, P70, DOI 10.1016/j.jplph.2016.09.013; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Frolov A, 2014, J AGR FOOD CHEM, V62, P3626, DOI 10.1021/jf4050183; Fuentealba D, 2009, PHOTOCHEM PHOTOBIOL, V85, P185, DOI 10.1111/j.1751-1097.2008.00415.x; Glomb MA, 2001, J AGR FOOD CHEM, V49, P1493, DOI 10.1021/jf001082d; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Greifenhagen U, 2015, AMINO ACIDS, V47, P1065, DOI 10.1007/s00726-015-1940-2; Greifenhagen U, 2015, J PROTEOME RES, V14, P768, DOI 10.1021/pr500799m; HENLE T, 1994, Z LEBENSM UNTERS FOR, V199, P55, DOI 10.1007/BF01192954; HEYNS K, 1970, CHEM BER-RECL, V103, P2873, DOI 10.1002/cber.19701030925; HODGE JE, 1955, ADV CARBOHYD CHEM, V10, P169, DOI 10.1016/S0096-5332(08)60392-6; Hu H, 2015, DIABETES-METAB RES, V31, P127, DOI 10.1002/dmrr.2560; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; Johansen MB, 2006, GLYCOBIOLOGY, V16, P844, DOI 10.1093/glycob/cwl009; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laubinger S, 2004, PLANT CELL, V16, P2293, DOI 10.1105/tpc.104.024216; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Milkovska-Stamenova S, 2015, J AGR FOOD CHEM, V63, P5911, DOI 10.1021/jf505757m; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Paudel G, 2016, J EXP BOT, V67, P6283, DOI 10.1093/jxb/erw395; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Poulsen MW, 2013, FOOD CHEM TOXICOL, V60, P10, DOI 10.1016/j.fct.2013.06.052; Richards SL, 2015, J EXP BOT, V66, P37, DOI 10.1093/jxb/eru398; Saenz-Suarez H, 2016, TURK J BIOL, V40, P12, DOI 10.3906/biy-1501-71; Saito R, 2013, BIOSCI BIOTECH BIOCH, V77, P2038, DOI 10.1271/bbb.130353; Schmidt R, 2015, J MASS SPECTROM, V50, P613, DOI 10.1002/jms.3569; Schneider A, 2007, BIOL CHEM, V388, P1099, DOI 10.1515/BC.2007.114; Schwarzenbolz U., 1997, Z LEBENSM UNTERS FOR, DOI [10.1007/s002170050137, DOI 10.1007/S002170050137]; Sebekova K, 2001, EUR J NUTR, V40, P275, DOI 10.1007/s394-001-8356-3; Shimakawa G, 2014, BIOCHEM SOC T, V42, P543, DOI 10.1042/BST20130273; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Takagi D, 2014, PLANT CELL PHYSIOL, V55, P333, DOI 10.1093/pcp/pcu007; Usui T, 2007, BIOSCI BIOTECH BIOCH, V71, P442, DOI 10.1271/bbb.60497; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Wessjohann LA, 2008, ADV SYNTH CATAL, V350, P107, DOI 10.1002/adsc.200600491; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Yadav SK, 2007, PROTEIN EXPRES PURIF, V51, P126, DOI 10.1016/j.pep.2006.07.007; Zhang B, 2008, ANAL CHEM, V80, P2379, DOI 10.1021/ac701810q; Zhang QB, 2011, J PROTEOME RES, V10, P3076, DOI 10.1021/pr200040j	74	33	34	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15758	15776		10.1074/jbc.M117.794537	http://dx.doi.org/10.1074/jbc.M117.794537			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28611063	hybrid, Green Published			2022-12-26	WOS:000411512200015
J	Yang, XN; Zhang, Q; Chen, ZY; Liu, HX; Li, PW				Yang, Xiaona; Zhang, Qi; Chen, Zhi-Yuan; Liu, Hongxia; Li, Peiwu			Investigation of Pseudomonas fluorescens strain 3JW1 on preventing and reducing aflatoxin contaminations in peanuts	PLOS ONE			English	Article							ATOXIGENIC ASPERGILLUS-FLAVUS; HEPATOCELLULAR-CARCINOMA; BIOLOGICAL-CONTROL; INHIBITS GROWTH; BIOCONTROL; DEGRADATION; MAIZE; SOIL	Pseudomonas fluorescens strain 3JW1, which has a broad-spectrum antimicrobial activity, was studied to investigate whether it affects the amounts of aflatoxin B-1 (AFB(1)) produced by Aspergillus flavus. It was found that the bacterium reduced the amounts of AFB(1) in potato dextrose broth (PDB) and peanut medium by 97.8% and 99.4%, respectively. It also reduced AFB(1) by similar to 183 mu g/kg (55.8%) when applied onto peanut kernels. This strain reduced AFB(1) via three mechanisms. First, it significantly inhibited A. flavus growth; second, our data showed that strain 3JW1 inhibits aflatoxin biosynthesis by A. flavus; and third, P. fluorescens strain 3JW1 is capable of degrading AFB(1) at a rate as high as 88.3% in 96 hours. This is the first report demonstrating that Pseudomonas fluorescens can reduce toxin contamination caused by A. flavus on peanut kernels. Our findings indicate that P. fluorescens strain 3JW1 had multiple effects including reducing A. flavus infection and aflatoxin contamination. And the results also highlight the potential applications of the strain 3JW1 for the biological control of aflatoxin contamination in peanuts and other susceptible crops.	[Yang, Xiaona; Liu, Hongxia] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Yang, Xiaona; Liu, Hongxia] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China; [Zhang, Qi; Li, Peiwu] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China; [Zhang, Qi; Li, Peiwu] Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China; [Chen, Zhi-Yuan] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Nanjing Agricultural University; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University	Liu, HX (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.; Liu, HX (corresponding author), Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China.; Li, PW (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Key Lab Detect Mycotoxins, Wuhan, Peoples R China.; Li, PW (corresponding author), Minist Agr, Lab Risk Assessment Oilseeds Prod Wuhan, Wuhan, Peoples R China.	hxliu@njau.edu.cn; peiwuli@oilcrops.cn			Special Fund for Agri-food-scientific Research in the Public Interest [201303088, 201513006]; National Key Project for Agro-product Quality & Safety Risk Assessment, PRC [GJFP2017001]; International Science & Technology Cooperation Program of China [2016YFE0112900]	Special Fund for Agri-food-scientific Research in the Public Interest; National Key Project for Agro-product Quality & Safety Risk Assessment, PRC; International Science & Technology Cooperation Program of China	This work was supported by the Special Fund for Agri-food-scientific Research in the Public Interest (201303088, 201513006), the National Key Project for Agro-product Quality & Safety Risk Assessment, PRC (GJFP2017001) and the International Science & Technology Cooperation Program of China (2016YFE0112900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Special Fund for Agri-food-scientific Research in the Public Interest (201303088, 201513006), the National Key Project for Agro-product Quality & Safety Risk Assessment, PRC (GJFP2017001) and the International Science & Technology Cooperation Program of China (2016YFE0112900).	Atehnkeng J, 2008, FOOD ADDIT CONTAM A, V25, P1264, DOI 10.1080/02652030802112635; Bock CH, 1999, BIOCONTROL SCI TECHN, V9, P529, DOI 10.1080/09583159929497; Chen R, 2014, FOOD CHEM, V146, P284, DOI 10.1016/j.foodchem.2013.09.059; Cho KM, 2009, FOOD CONTROL, V20, P402, DOI 10.1016/j.foodcont.2008.07.010; COTTY PJ, 1990, PLANT DIS, V74, P233, DOI 10.1094/PD-74-0233; Dharmaputra OS, 2003, BIOTROPIA SE ASIAN J, P21; EATON DL, 1994, ANNU REV PHARMACOL, V34, P135, DOI 10.1146/annurev.pa.34.040194.001031; Egmond HPV, 2004, TOXIN REV, V119, P92; Farombi EO, 2006, AFR J BIOTECHNOL, V5, P1; Farzaneh M, 2012, FOOD CONTROL, V23, P100, DOI 10.1016/j.foodcont.2011.06.018; Groopman JD, 2011, CURR CANCER RES, P113, DOI 10.1007/978-1-61737-995-6_6; Hedayati MT, 2007, MICROBIOL-SGM, V153, P1677, DOI 10.1099/mic.0.2007/007641-0; Henry SH, 2002, ADV EXP MED BIOL, V504, P229; Horn BW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146169; Horn BW, 2009, BIOCONTROL SCI TECHN, V19, P249, DOI 10.1080/09583150802696541; Hua SST, 2014, MYCOTOXIN RES, V30, P71, DOI 10.1007/s12550-014-0189-z; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kong Q, 2010, INT J FOOD MICROBIOL, V139, P31, DOI 10.1016/j.ijfoodmicro.2010.01.036; Kumar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106041; Kumar V, 2008, CROP PROT, V27, P891, DOI 10.1016/j.cropro.2007.12.011; Liang ZhiHong, 2008, Agricultural Sciences in China, V7, P1433, DOI 10.1016/S1671-2927(08)60399-5; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Mishra HN, 2003, CRIT REV FOOD SCI, V43, P245, DOI 10.1080/10408690390826518; Moore GG, 2009, MOL ECOL, V18, P4870, DOI 10.1111/j.1365-294X.2009.04414.x; Nyikal J., 2004, Morbidity and Mortality Weekly Report, V53, P790; Palumbo JD, 2007, J FOOD PROTECT, V70, P1615, DOI 10.4315/0362-028X-70.7.1615; Payne GA, 1998, ANNU REV PHYTOPATHOL, V36, P329, DOI 10.1146/annurev.phyto.36.1.329; Probst C, 2011, PLANT DIS, V95, P212, DOI 10.1094/PDIS-06-10-0438; Reddy KRN, 2010, AFR J BIOTECHNOL, V9, P4247; Samuel MS, 2014, INT BIODETER BIODEGR, V86, P202, DOI 10.1016/j.ibiod.2013.08.026; Sangmanee P, 2014, FOOD CONTROL, V40, P224, DOI 10.1016/j.foodcont.2013.12.005; Sindhu S, 2011, FOOD CHEM TOXICOL, V49, P1188, DOI 10.1016/j.fct.2011.02.014; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wu F, 2010, FOOD ADDIT CONTAM A, V27, P496, DOI 10.1080/19440040903437865; Yang W.T., 2011, THESIS; Yazdanpanah H, 2005, FOOD CHEM TOXICOL, V43, P1135, DOI 10.1016/j.fct.2005.03.004	36	14	17	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0178810	10.1371/journal.pone.0178810	http://dx.doi.org/10.1371/journal.pone.0178810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640833	Green Submitted, Green Published, gold			2022-12-26	WOS:000404135800010
J	Reis, MND; Bello, G; Guimaraes, ML; Stefani, MMA				da Guarda Reis, Monica Nogueira; Bello, Gonzalo; Guimaraes, Monick Lindenmeyer; Araujo Stefani, Mariane Martins			Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central West, North and Northeast Brazilian regions	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; CIRCULATING RECOMBINANT FORMS; TYPE-1 SUBTYPE C; GENETIC DIVERSITY; PREGNANT-WOMEN; MOLECULAR EPIDEMIOLOGY; MODERATE PREVALENCE; STATE; IDENTIFICATION; SURVEILLANCE	The Brazilian AIDS epidemic has been characterized by an increasing rate of BF1 recombinants and so far eight circulating recombinant forms/CRFs_BF1 have been described countrywide. In this study, pol sequences (protease/PR, reverse transcriptase/RT) of 87 BF1 mosaic isolates identified among 828 patients living in six Brazilian States from three geographic regions (Central West, North, Northeast) were analyzed. Phylogenetic and boot-scan analyses were performed to investigate the evolutionary relationship and mosaic structure of BF1 isolates. Those analyses showed that 20.7% of mosaics (18 out of 87) were CRFs-like isolates, mostly represented by CRF28/CRF29_BF-like viruses (14 out of 18). We also identified five highly supported clusters that together comprise 42 out of 87 (48.3%) BF1 sequences, each cluster containing at least five sequences sharing a similar mosaic structure, suggesting possible new unidentified CRFs_BF1. The divergence time of these five potential new CRFs_BF1 clusters was estimated using a Bayesian approach and indicate that they probably originated between the middle 1980s and the middle 1990s. DNA was extracted from whole blood and four overlapping fragments were amplified by PCR providing full/near full length genomes (FLG/NFLG) and partial genomes. Eleven HIV-1 isolates from Cluster # 5 identified in epidemiologically unlinked individuals living in Central West and North regions provided FLG/NFLG/partial genome sequences with identical mosaic structure. These viruses differ from any known CRF_BF1 reported to date and were named CRF90_BF1 by the Los Alamos National Laboratory. This is the 9th CRF_BF1 described in Brazil and the first one identified in Central West and North regions. Our results highlight the importance of continued molecular screening and surveillance studies, especially of full genome sequences to understand the evolutionary dynamics of the HIV-1 epidemic in a country of continental dimensions as Brazil.	[da Guarda Reis, Monica Nogueira; Araujo Stefani, Mariane Martins] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunol AIDS & Hanseniase, Goiania, Go, Brazil; [Bello, Gonzalo; Guimaraes, Monick Lindenmeyer] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil	Universidade Federal de Goias; Fundacao Oswaldo Cruz	Stefani, MMA (corresponding author), Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Imunol AIDS & Hanseniase, Goiania, Go, Brazil.	mmastefani@gmail.com	Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Programa de Apoio a Nucleos de Excelencia/PRONEX; Fundacao de Amparo a Pesquisa do Estado de Goias/FAPEG; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq [201210267000801]; Conselho Nacional de DesenvolvimentoCientifico e Tecnologico/CNPq Universal [481208/2012-7]; FAPEG [201410267000598]; fellowship from CNPq [308381/2015-7]	Programa de Apoio a Nucleos de Excelencia/PRONEX; Fundacao de Amparo a Pesquisa do Estado de Goias/FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de DesenvolvimentoCientifico e Tecnologico/CNPq Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); fellowship from CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by the "Programa de Apoio a Nucleos de Excelencia/PRONEX; Fundacao de Amparo a Pesquisa do Estado de Goias/FAPEG; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/ CNPq (grant number:201210267000801 to MMAS) and by the "Conselho Nacional de DesenvolvimentoCientifico e Tecnologico/CNPq Universal grant number: 481208/2012-7 to MMAS). MNGR was supported by a scholarship from FAPEG (grant number:201410267000598). MMAS is a recipient of a fellowship from CNPq (grant number 308381/2015-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Passaes CPB, 2009, INFECT GENET EVOL, V9, P474, DOI 10.1016/j.meegid.2009.01.008; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Carvalho BC, 2011, AIDS RES HUM RETROV, V27, P1081, DOI [10.1089/aid.2010.0334, 10.1089/AID.2010.0334]; da Costa CM, 2016, AIDS RES HUM RETROV, V32, P918, DOI [10.1089/aid.2016.0044, 10.1089/AID.2016.0044]; da Costa ZB, 2013, AIDS PATIENT CARE ST, V27, P439, DOI 10.1089/apc.2012.0448; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; de Sa DJ, 2009, AIDS RES HUM RETROV, V25, P925, DOI 10.1089/aid.2009.0073; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ferreira AS, 2011, J MED VIROL, V83, P1301, DOI 10.1002/jmv.22128; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Guimaraes ML, 2010, INFECT GENET EVOL, V10, P1094, DOI 10.1016/j.meegid.2010.07.001; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Monteiro-Cunha JP, 2011, AIDS RES HUM RETROV, V27, P623, DOI [10.1089/AID.2010.0126, 10.1089/aid.2010.0126]; Najera R, 2002, GENETIC RECOMBINATIO, V4, pS3; Nei M, 2002, MOL PHYLOGENET EVOL, V3, P567; Pessoa R, 2014, GENOME ANNOUNC, V2; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Pessoa R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112674; Prellwitz IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069033; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Lima YAR, 2016, J MED VIROL, V88, P1936, DOI 10.1002/jmv.24540; Ristic N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017485; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; Sanabani SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062552; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Santos LA, 2011, J MED VIROL, V83, P2066, DOI 10.1002/jmv.22170; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Silveira AA, 2012, RES HUM RETROVIRUSES, V28, P304; Silveira J, 2012, J CLIN VIROL, V54, P36, DOI 10.1016/j.jcv.2012.01.017; Moura MES, 2015, J MED VIROL, V87, P798, DOI 10.1002/jmv.24087; Moura MES, 2015, AIDS RES HUM RETROV, V31, P250, DOI 10.1089/aid.2014.0261; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson MM, 2005, AIDS REV, V7, P210; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Cardoso LPV, 2011, AIDS RES HUM RETROV, V27, P1349, DOI 10.1089/aid.2011.0153; Cardoso LPV, 2010, J MED VIROL, V82, P351, DOI 10.1002/jmv.21722; Cardoso LPV, 2009, AIDS RES HUM RETROV, V25, P943, DOI 10.1089/aid.2009.0060; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	59	15	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0178578	10.1371/journal.pone.0178578	http://dx.doi.org/10.1371/journal.pone.0178578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628667	Green Submitted, Green Published, gold			2022-12-26	WOS:000404043100005
J	Long, XW; Wu, XG; Zhao, L; Ye, HH; Cheng, YX; Zeng, CS				Long, Xiaowen; Wu, Xugan; Zhao, Lei; Ye, Haihui; Cheng, Yongxu; Zeng, Chaoshu			Effects of salinity on gonadal development, osmoregulation and metabolism of adult male Chinese mitten crab, Eriocheir sinensis	PLOS ONE			English	Article							NA+/K+-ATPASE ACTIVITY; FREE AMINO-ACIDS; FRESH-WATER; SEAWATER ACCLIMATION; LITOPENAEUS-VANNAMEI; IONIC REGULATION; CARCINUS-MAENAS; ANIMAL-TISSUES; K+-ATPASE; GILLS	As a catadromous species, salinity is a key parameter that affects gonadal development of Chinese mitten crab Eriocheir sinensis during reproductive migration. It is however unclear the effects of salinity on the gonadal development of male E. sinensis as well as their physiological responses to salinity during reproductive migration. This study investigated the effects of four salinities (0 %, 6 %, 12 % and 18 %) on gonadal development, osmoregulation and metabolism of adult male E. sinensis over a 40-day period. The results showed that elevating salinity promote gonadal development, increase hemolymph osmolality and K+ and Mg2+ concentrations (P < 0.05). The 12 % salinity resulted in the highest contents of taurine and arginine in the hemolymph while the highest contents of threonine, phenylalanine, lysine, beta-alanine, tryptophan, ornithine and total free amino acids were found for 0 % treatment (P < 0.05). A decreasing trend was detected for the Na+/K+-ATPase activity and its mRNA expression level in the posterior gills with salinity (P < 0.05). Total saturated fatty acids in the anterior gills decreased with increasing salinity (P < 0.05); the 0 % treatment had the highest total polyunsaturated fatty acids in the posterior gills while total n-6 polyunsaturated fatty acids increased with salinity (P < 0.05). The hemolymph glucose and uric acid showed a decreasing trend as salinity while an increasing trend was found for the hemolymph triglyceride and high-density lipoprotein cholesterol (P < 0.05). The 12 % treatment had the highest levels of hemolymph malonaldehyde and hepatopancreatic gamma-gluta-myltranspeptidase (P < 0.05). In conclusion, these results suggested that the brackish water promote gonadal development of male E. sinensis, and increase osmolality and ionic concentrations in hemolymph while reduced the activity of Na+/K+-ATPase and its mRNA expression in the posterior gills as well as metabolism.	[Long, Xiaowen; Ye, Haihui; Zeng, Chaoshu] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Wu, Xugan; Zhao, Lei; Cheng, Yongxu; Zeng, Chaoshu] Shanghai Ocean Univ, Ctr Res Environm Ecol & Fish Nutr, Minist Agr, Shanghai, Peoples R China; [Wu, Xugan; Cheng, Yongxu] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Wu, Xugan; Cheng, Yongxu] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Zeng, Chaoshu] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia	Xiamen University; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; James Cook University	Zeng, CS (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China.; Wu, XG; Zeng, CS (corresponding author), Shanghai Ocean Univ, Ctr Res Environm Ecol & Fish Nutr, Minist Agr, Shanghai, Peoples R China.; Wu, XG (corresponding author), Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.; Wu, XG (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Zeng, CS (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	wuxugan@hotmail.com; chaoshu.zeng@jcu.edu.cu	Zeng, Chaoshu/A-9758-2012	Zeng, Chaoshu/0000-0001-9022-6588	Shanghai Municipal Science and Technology Commission [13320502100, 13231203504]; Chinese mainland and Taiwan from Ministry of Science and Technology of China [2014DFT30270]; Shanghai Universities First-class Disciplines project of fisheries from Shanghai Municipal Education Committee [2015-62-0908]; Shanghai Agriculture Committee [2015-1-7]; Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission [16DZ2281200, 13DZ2280500]	Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese mainland and Taiwan from Ministry of Science and Technology of China; Shanghai Universities First-class Disciplines project of fisheries from Shanghai Municipal Education Committee; Shanghai Agriculture Committee; Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission	This study was supported by the two projects (13320502100 and 13231203504) from Shanghai Municipal Science and Technology Commission to XGW, and the Scientific and Technological Cooperation Project (2014DFT30270) between Chinese mainland and Taiwan from Ministry of Science and Technology of China to YXC. Infrastructure costs were supported by the Shanghai Universities First-class Disciplines project of fisheries (2015-62-0908) from Shanghai Municipal Education Committee to YXC, the extension project (2015-1-7) from Shanghai Agriculture Committee and the Capacity Promotion Projects (16DZ2281200, 13DZ2280500) of Shanghai Engineering and Technology Center from Shanghai Municipal Science and Technology Commission to YXC.	Abe H, 1999, FISHERIES SCI, V65, P949, DOI 10.2331/fishsci.65.949; Al-Azhary D.B., 2008, PAK J PHYSL, V4, P1; Bas CC, 2000, J CRUSTACEAN BIOL, V20, P647, DOI 10.1651/0278-0372(2000)020[0647:EOSOEO]2.0.CO;2; Bentley MG, 2011, INVAD NAT SPRING SER, V6, P107, DOI 10.1007/978-94-007-0591-3_3; Bindhuja M. D., 2013, J AQUACULTURE TROPIC, V28, P11; Chang EWY, 2007, J EXP ZOOL PART A, V307A, P708, DOI 10.1002/jez.a.424; CHAPELLE S, 1984, COMP BIOCHEM PHYS B, V78, P363, DOI 10.1016/0305-0491(84)90044-0; Chen JC, 1995, AQUACULTURE, V136, P243, DOI 10.1016/0044-8486(95)01060-2; Chen JC, 1997, COMP BIOCHEM PHYS A, V117, P239, DOI 10.1016/S0300-9629(96)00237-X; Cheng Yong-xu, 2001, Journal of Fishery Sciences of China, V7, P104; Cheng YX, 2008, REV FISH SCI, V16, P377, DOI 10.1080/10641260701681698; Chew SF, 1999, MAR BIOL, V134, P735, DOI 10.1007/s002270050590; Deng JM, 2011, FISH PHYSIOL BIOCHEM, V37, P959, DOI 10.1007/s10695-011-9493-0; Feng Guang-peng, 2013, Marine Fisheries, V35, P468; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gelin A, 2001, J CRUSTACEAN BIOL, V21, P905, DOI 10.1651/0278-0372(2001)021[0905:CSCARS]2.0.CO;2; Genovese G, 2004, MAR BIOL, V144, P111, DOI 10.1007/s00227-003-1169-6; Guo ZH, 2013, AQUACULTURE, V402, P58, DOI 10.1016/j.aquaculture.2013.03.033; HAINES TH, 1994, FEBS LETT, V346, P115, DOI 10.1016/0014-5793(94)00470-6; Henry RP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00431; Henry RP, 2003, COMP BIOCHEM PHYS A, V136, P243, DOI 10.1016/S1095-6433(03)00113-2; Herborg LM, 2003, HYDROBIOLOGIA, V503, P21, DOI 10.1023/B:HYDR.0000008483.63314.3c; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Jia XiaoYan, 2012, Journal of Fisheries of China, V36, P91; Lai, 1994, FISH WORLD, V6, P33; Lee WC, 2003, J EXP MAR BIOL ECOL, V288, P39, DOI 10.1016/S0022-0981(02)00597-X; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Li Yuquan, 2015, Acta Ecologica Sinica, V35, P7229; Limdi JK, 2003, POSTGRAD MED J, V79, P307, DOI 10.1136/pmj.79.932.307; Lorenzon S, 1997, GEN COMP ENDOCR, V108, P395, DOI 10.1006/gcen.1997.6986; Lu Jun, 2011, Marine Fisheries, V33, P39; Lucu C, 2008, COMP BIOCHEM PHYS A, V149, P362, DOI 10.1016/j.cbpa.2008.01.026; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Lv Fu, 2004, Transactions of Oceanology and Limnology, V3, P47; Mo JL, 2003, J CRUSTACEAN BIOL, V23, P505; MORRISON WR, 1964, J LIPID RES, V5, P600; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Palacios E, 2004, AQUACULTURE, V234, P497, DOI 10.1016/j.aquaculture.2003.12.001; PEQUEUX A, 1988, COMP BIOCHEM PHYS A, V89, P163, DOI 10.1016/0300-9629(88)91074-2; Pinoni SA, 2005, J EXP MAR BIOL ECOL, V326, P217, DOI 10.1016/j.jembe.2005.06.004; Qi Lei, 2013, Marine Sciences (Beijing), V37, P56; Qiu RJ, 2011, AQUACULT INT, V19, P283, DOI 10.1007/s10499-010-9390-z; Rathmayer M, 2001, J COMP PHYSIOL B, V171, P271, DOI 10.1007/s003600100173; REGNAULT M, 1992, J EXP ZOOL, V264, P372, DOI 10.1002/jez.1402640403; Rocatta IS, 2000, J WORLD AQUACULTURE, V29, P351; Romano N, 2014, MAR BIOL RES, V10, P460, DOI 10.1080/17451000.2013.819981; Romano N, 2012, AQUACULTURE, V334, P12, DOI 10.1016/j.aquaculture.2011.12.035; Romano N, 2010, COMP BIOCHEM PHYS C, V151, P222, DOI 10.1016/j.cbpc.2009.10.011; Ross SW, 2001, COMP BIOCHEM PHYS C, V130, P289, DOI 10.1016/S1532-0456(01)00243-5; Sui LY, 2009, MAR BIOL, V156, P1573, DOI 10.1007/s00227-009-1193-2; Torres G, 2007, COMP BIOCHEM PHYS A, V147, P460, DOI 10.1016/j.cbpa.2007.01.020; VINCENTM.C, 1970, COMP BIOCHEM PHYSIOL, V35, P479, DOI 10.1016/0010-406X(70)90611-0; Wang Qun, 2004, Oceanologia et Limnologia Sinica, V35, P351; Wang RF, 2012, CRUSTACEANA, V85, P1431, DOI 10.1163/15685403-00003125; Wang S.C., 2003, J HUAINAN TEACHERS C, V5, P24, DOI [10.3969/j.issn.1009-9530.2003.03.010, DOI 10.3969/J.ISSN.1009-9530.2003.03.010]; Wei Wei, 2007, Journal of Fishery Sciences of China, V14, P275; Weihrauch D, 2004, J EXP BIOL, V207, P4491, DOI 10.1242/jeb.01308; Wen Wei, 2005, Journal of Fisheries of China, V29, P862; [温小波 Wen Xiaobo], 2002, [华东师范大学学报. 自然科学版, Journal of East China Normal University], V0, P105; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; WINKLER A, 1986, MAR BIOL, V92, P537, DOI 10.1007/BF00392513; Yen PT, 2008, AQUACULTURE, V280, P124, DOI 10.1016/j.aquaculture.2008.04.035; Zhang L.S., 1973, AQUATIC SCI TECHNOLO, V1, P5; Zhang LS, 2002, AQUACULTURE TECHNOLO; Zhang Shuo, 1999, Journal of Fisheries of China, V23, P144; Zhang TL, 2001, J FRESHWATER ECOL, V16, P633, DOI 10.1080/02705060.2001.9663855; ZhangK, 2013, OIL GEOPHYSICAL PROS, V48, P409, DOI [10.13810/j.cnki.issn.1000.7210, DOI 10.13810/J.CNKI.ISSN.1000.7210, DOI 10.13859/J.CJZ.2013.04.008]; [赵磊 Zhao Lei], 2016, [水生生物学报, Acta Hydrobiologica Sinica], V40, P27	68	46	52	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179036	10.1371/journal.pone.0179036	http://dx.doi.org/10.1371/journal.pone.0179036			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628611	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000404043100013
J	Kajonius, P; Mac Giolla, E				Kajonius, Petri; Mac Giolla, Erik			Personality traits across countries: Support for similarities rather than differences	PLOS ONE			English	Article							BIG 5; ITEM POOL; PROFILES; UNIVERSAL; INVENTORY; GEOGRAPHY; PATTERNS; MODEL; SIZE	In the current climate of migration and globalization, personality characteristics of individuals from different countries have received a growing interest. Previous research has established reliable differences in personality traits across countries. The present study extends this research by examining 30 personality traits in 22 countries, based on an online survey in English with large national samples (N-Total 130,602). The instrument used was a comprehensive, open-source measure of the Five Factor Model (FFM) (IPIP-NEO-120). We postulated that differences in personality traits between countries would be small, labeling this a Similarities Hypothesis. We found support for this in three stages. First, similarities across countries were observed for model fits for each of the five personality trait structures. Second, within-country sex differences for the five personality traits showed similar patterns across countries. Finally, the overall the contribution to personality traits from countries was less than 2%. In other words, the relationship between a country and an individual's personality traits, however interesting, are small. We conclude that the most parsimonious explanation for the current and past findings is a cross-country personality Similarities Hypothesis.	[Kajonius, Petri; Mac Giolla, Erik] Univ Gothenburg, Dept Psychol, Gothenburg, Sweden; [Kajonius, Petri] Univ West, Dept Behav Sci, Trollhattan, Sweden; [Kajonius, Petri] Univ Skovde, Dept Cognit Neurosci & Philosophy, Skovde, Sweden	University of Gothenburg; University West - Sweden; University of Skovde	Kajonius, P (corresponding author), Univ Gothenburg, Dept Psychol, Gothenburg, Sweden.; Kajonius, P (corresponding author), Univ West, Dept Behav Sci, Trollhattan, Sweden.; Kajonius, P (corresponding author), Univ Skovde, Dept Cognit Neurosci & Philosophy, Skovde, Sweden.	petri.kajonius@hv.se		Mac Giolla, Erik/0000-0002-5285-5321				Allik J, 2004, J CROSS CULT PSYCHOL, V35, P13, DOI 10.1177/0022022103260382; Anderson CJ, 2016, SCIENCE, V351, DOI 10.1126/science.aad9163; Bartram D, 2013, J CROSS CULT PSYCHOL, V44, P61, DOI 10.1177/0022022111430258; Briley DA, 2014, PSYCHOL BULL, V140, P1303, DOI 10.1037/a0037091; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Church AT, 2011, J PERS SOC PSYCHOL, V101, P1068, DOI 10.1037/a0025290; Cohen E. H., 2014, B METHODOLOGIE SOCIO, V122, P63, DOI [10.1177/0759106314521971, DOI 10.1177/0759106314521971]; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; De Raad B, 2014, EUR J PERSONALITY, V28, P497, DOI 10.1002/per.1953; De Raad B, 2010, J PERS SOC PSYCHOL, V98, P160, DOI 10.1037/a0017184; Eigenhuis A, 2015, J CROSS CULT PSYCHOL, V46, P549, DOI 10.1177/0022022115570671; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gurven M, 2013, J PERS SOC PSYCHOL, V104, P354, DOI 10.1037/a0030841; Hirschfeld G, 2014, J RES PERS, V53, P54, DOI 10.1016/j.jrp.2014.08.003; Hopwood CJ, 2010, PERS SOC PSYCHOL REV, V14, P332, DOI 10.1177/1088868310361240; Johnson JA, 2014, J RES PERS, V51, P78, DOI 10.1016/j.jrp.2014.05.003; Kajonius PJ., 2017, INT J PERSONALITY PS, V3, P1; Lockenhoff CE, 2014, J CROSS CULT PSYCHOL, V45, P675, DOI 10.1177/0022022113520075; Maples JL, 2014, PSYCHOL ASSESSMENT, V26, P1070, DOI 10.1037/pas0000004; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; McCrae RR, 2002, INT CUL PSY, P105; Meisenberg G., 2015, MANKIND QUART, V55, P360, DOI [10.46469/mq.2015.55.4.7, DOI 10.46469/MQ.2015.55.4.7]; Mottus R, 2017, J PERS SOC PSYCHOL, V112, P474, DOI 10.1037/pspp0000100; Rentfrow PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122245; Rentfrow PJ, 2013, J PERS SOC PSYCHOL, V105, P996, DOI 10.1037/a0034434; Rentfrow PJ, 2010, AM PSYCHOL, V65, P548, DOI 10.1037/a0018194; Saucier G., 2014, JOURNAL OF PERSONALI, V82, P1, DOI [DOI 10.1111/J0PY.12028), DOI 10.1111/J0PY.12028]; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; Thalmayer AG, 2014, EUR J PERSONALITY, V28, P482, DOI 10.1002/per.1969; Vedel A, 2016, PERS INDIV DIFFER, V92, P1, DOI 10.1016/j.paid.2015.12.011; Yamagata S, 2006, J PERS SOC PSYCHOL, V90, P987, DOI 10.1037/0022-3514.90.6.987	34	44	46	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179646	10.1371/journal.pone.0179646	http://dx.doi.org/10.1371/journal.pone.0179646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX8NF	28622380	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300045
J	Nganso, BT; Fombong, AT; Yusuf, AA; Pirk, CWW; Stuhl, C; Torto, B				Nganso, Beatrice T.; Fombong, Ayuka T.; Yusuf, Abdullahi A.; Pirk, Christian W. W.; Stuhl, Charles; Torto, Baldwyn			Hygienic and grooming behaviors in African and European honeybees-New damage categories in Varroa destructor	PLOS ONE			English	Article							APIS-MELLIFERA-SCUTELLATA; APIDAE COLONIES; BEE COLONIES; JACOBSONI; MITE; INFESTATION; RESISTANCE; HYMENOPTERA; HEALTH; DEBRIS	Varroa destructor is an ectoparasitic pest of honeybees, and a threat to the survival of the apiculture industry. Several studies have shown that unlike European honeybees, African honeybee populations appear to be minimally affected when attacked by this mite. However, little is known about the underlying drivers contributing to survival of African honeybee populations against the mite. We hypothesized that resistant behavioral defenses are responsible for the survival of African honeybees against the ectoparasite. We tested this hypothesis by comparing grooming and hygienic behaviors in the African savannah honeybee Apis mellifera scutellata in Kenya and A. mellifera hybrids of European origin in Florida, USA against the mite. Grooming behavior was assessed by determining adult mite infestation levels, daily mite fall per colony and percentage mite damage (as an indicator of adult grooming rate), while hygienic behavior was assessed by determining the brood removal rate after freeze killing a section of the brood. Our results identified two additional undescribed damaged mite categories along with the six previously known damage categories associated with the grooming behavior of both honeybee subspecies. Adult mite infestation level was approximately three-fold higher in A. mellifera hybrids of European origin than in A. m. scutellata, however, brood removal rate, adult grooming rate and daily natural mite fall were similar in both honeybee subspecies. Unlike A. mellifera hybrids of European origin, adult grooming rate and brood removal rate did not correlate with mite infestation levels on adult worker honeybee of A. m. scutellata though they were more aggressive towards the mites than their European counterparts. Our results provide valuable insights into the tolerance mechanisms that contribute to the survival of A. m. scutellata against the mite.	[Nganso, Beatrice T.; Fombong, Ayuka T.; Torto, Baldwyn] ICIPE, Nairobi, Kenya; [Nganso, Beatrice T.; Yusuf, Abdullahi A.; Pirk, Christian W. W.; Torto, Baldwyn] Univ Pretoria, Dept Zool & Entomol, Social Insects Res Grp, Pretoria, South Africa; [Stuhl, Charles] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	International Centre of Insect Physiology & Ecology (ICIPE); University of Pretoria; United States Department of Agriculture (USDA)	Torto, B (corresponding author), ICIPE, Nairobi, Kenya.; Torto, B (corresponding author), Univ Pretoria, Dept Zool & Entomol, Social Insects Res Grp, Pretoria, South Africa.	btorto@icipe.org	Pirk, Christian/E-4180-2010; Yusuf, Abdullahi Ahmed/E-4701-2011	Pirk, Christian/0000-0001-6821-7044; Yusuf, Abdullahi Ahmed/0000-0002-8625-6490; Torto, Baldwyn/0000-0002-5080-9903	United States Department of Agriculture (USDA)/ARS [58-6615-3-011-f]; UK aid from the UK government; Swedish International Development Cooperation Agency (SIDA); Swiss Agency for Development and Cooperation (SDC); Kenyan government; German Academic Exchange Service In-Region Scholarship; Office of International Research Programs at USDA-ARS	United States Department of Agriculture (USDA)/ARS(United States Department of Agriculture (USDA)); UK aid from the UK government(CGIAR); Swedish International Development Cooperation Agency (SIDA); Swiss Agency for Development and Cooperation (SDC); Kenyan government; German Academic Exchange Service In-Region Scholarship; Office of International Research Programs at USDA-ARS	We gratefully acknowledge the financial support for this research by the following organizations and agencies: United States Department of Agriculture (USDA)/ARS- grant # 58-6615-3-011-f; UK aid from the UK government; Swedish International Development Cooperation Agency (SIDA); the Swiss Agency for Development and Cooperation (SDC); and the Kenyan government. The views expressed herein do not necessarily reflect the official opinion of the donors. Immense gratitude to the German Academic Exchange Service In-Region Scholarship for funding the PhD research work and studies of Beatrice T. Nganso at the International Centre of Insect Physiology and Ecology (ICIPE) and the Office of International Research Programs at USDA-ARS for providing the financial support needed for the research conducted in the USA.	Allsopp MH, 2006, THESIS; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bienefeld K, 1999, APIDOLOGIE, V30, P249, DOI 10.1051/apido:19990401; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; Correa-Marques MH, 2000, AM BEE J, V140, P820; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Fazier M, 2010, APIDOLOGIE, V41, P463, DOI 10.1051/apido/2009073; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Guzman-Novoa E, 2012, J INVERTEBR PATHOL, V110, P314, DOI 10.1016/j.jip.2012.03.020; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hepburn H., 1988, HONEYBEES AFRICA; Hepburn HR, 2011, HONEYBEES OF ASIA, P1, DOI 10.1007/978-3-642-16422-4; Hood M., 2000, ENTOMOL INSECT INF S, V12, P1; Ibrahim A, 2006, APIDOLOGIE, V37, P31, DOI 10.1051/apido:2005052; Invernizzi C, 2016, J APICULT RES, V54, P321, DOI 10.1080/00218839.2016.1159055; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Lee KV, 2010, J ECON ENTOMOL, V103, P1039, DOI 10.1603/EC10037; Locke B., 2015, APIDOLOGIE, P1; Locke B., 2012, THESIS; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Lodesani M, 1996, J APICULT RES, V35, P49, DOI 10.1080/00218839.1996.11100912; Masterman R, 2000, J INSECT BEHAV, V13, P87, DOI 10.1023/A:1007767626594; Meixner MD, 2015, CURR OPIN INSECT SCI, V10, P177, DOI 10.1016/j.cois.2015.05.010; Mondragon L, 2005, APIDOLOGIE, V36, P345, DOI 10.1051/apido:2005022; MORITZ RFA, 1985, J HERED, V76, P267, DOI 10.1093/oxfordjournals.jhered.a110090; MORITZ RFA, 1990, APIDOLOGIE, V21, P53, DOI 10.1051/apido:19900107; Mortensen AN, 2016, EXP APPL ACAROL, V68, P509, DOI 10.1007/s10493-015-9999-8; Muli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094459; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nazzi F, 2016, ANNU REV ENTOMOL, V61, P417, DOI 10.1146/annurev-ento-010715-023731; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; Pirk CWW, 2016, APIDOLOGIE, V47, P276, DOI 10.1007/s13592-015-0406-6; Raina S. K., 2005, International Journal of Tropical Insect Science, V25, P281; Ramsey SD, 2017, P AM BEE RES C 2017; Rath W, 1999, APIDOLOGIE, V30, P97, DOI 10.1051/apido:19990202; Rinderer TE, 1986, AM BEE J, V98-100, P128; RITTER W, 1981, BEE WORLD, V62, P141, DOI 10.1080/0005772X.1981.11097838; Rosenkranz P, 1997, APIDOLOGIE, V28, P427, DOI 10.1051/apido:19970609; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; RUTTNER F, 1992, APIDOLOGIE, V23, P173, DOI 10.1051/apido:19920210; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Spivak M, 1998, APIDOLOGIE, V29, P291, DOI 10.1051/apido:19980308; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; Strauss U, 2016, PARASITOLOGY, V143, P374, DOI 10.1017/S0031182015001754; Strauss U, 2015, EXP APPL ACAROL, V65, P89, DOI 10.1007/s10493-014-9842-7; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Traynor KS, 2016, APIDOLOGIE, V47, P325, DOI 10.1007/s13592-016-0431-0	52	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179329	10.1371/journal.pone.0179329	http://dx.doi.org/10.1371/journal.pone.0179329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622341	Green Published, gold, Green Submitted			2022-12-26	WOS:000403506300024
J	Frola, C; Guelfand, L; Blugerman, G; Szyld, E; Kaufman, S; Cahn, P; Sued, O; Perez, H				Frola, Claudia; Guelfand, Liliana; Blugerman, Gabriela; Szyld, Edgardo; Kaufman, Sara; Cahn, Pedro; Sued, Omar; Perez, Hector			Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay	PLOS ONE			English	Article							ANTIGEN; MENINGITIS; SERUM; DETERMINANTS; POSITIVITY; MORTALITY; UPDATE; COHORT; AIDS	Background Globally, Latin America ranks third among regions with most cases of AIDS related cryptococcal meningitis. In 2009, a lateral flow immunoassay (LFA) for the detection of cryptococcal antigen (CrAg) was developed as a potential point-of-care test for diagnosis of cryptococcal infection. In 2011 World Health Organizations recommended on CrAg screening for HIV positive persons with CD4 below 100 cells/mu L, followed by preemptive fluconazole treatment. However, in Argentina no formal recommendations for CrAg screening have been issued. Methods HIV positive patients > = 18 years with advanced immunosuppression (CD4 counts <= 100 cells/mu L within 3 months or WHO stage III/IV), who visited the hospital between April 1, 2014 and January 31, 2015, were included. The LFA was performed according to the manufacturer's instructions on all serum samples. When CrAg detection was positive, a lumbar puncture was performed to rule out cryptococcal meningitis. Patients without evidence of meningeal involvement were treated with preemptive oral fluconazole in ambulatory care. Results We included 123 patients. Prevalence of CrAg-positivity was 8.1%. Among the 10 CrAg-positive patients, 6 had meningeal involvement detected through the CSF analysis (CSF India-ink testing, CSF CrAg and culture). The remaining 4 patients with positive CrAg received targeted preemptive treatment with oral fluconazole and were free of cryptococcal disease during the follow-up period. None of the 113 patients with a negative CrAg test result developed cryptococcal disease. Conclusions This is the first study in Argentina, to our knowledge, describing the prevalence of cryptococcosis and usefulness of CrAg screening. LFA provided early diagnosis to determine a high prevalence of CrAg in our hospital, and that screening for subclinical infection with preemptive antifungal treatment, prevented a substantial proportion of meningeal disease.	[Frola, Claudia; Blugerman, Gabriela; Perez, Hector] Juan A Fernandez Hosp, Infect Dis Serv, Buenos Aires, DF, Argentina; [Frola, Claudia; Szyld, Edgardo; Cahn, Pedro; Sued, Omar] Fdn Huesped, Dept Clin Res, Buenos Aires, DF, Argentina; [Guelfand, Liliana; Szyld, Edgardo; Kaufman, Sara] Juan A Fernandez Hosp, Microbiol Lab, Buenos Aires, DF, Argentina; [Szyld, Edgardo] Oklahoma Univ, Hlth Sci Ctr, Oklahoma City, OK USA	University of Buenos Aires; University of Buenos Aires; University of Oklahoma System; University of Oklahoma Health Sciences Center	Frola, C (corresponding author), Juan A Fernandez Hosp, Infect Dis Serv, Buenos Aires, DF, Argentina.; Frola, C (corresponding author), Fdn Huesped, Dept Clin Res, Buenos Aires, DF, Argentina.	claudia.frola@huesped.org.ar	PEREZ, HECTOR M./S-9366-2019; Sued, Omar/GRJ-3964-2022		Fundacion Florencio Fiorini grant	Fundacion Florencio Fiorini grant	This work is supported by Fundacion Florencio Fiorini grant year 2014 (http://www.fff.org.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to express our sincere acknowledgment to all the participants and to all the staff, including nurses and residents of Juan A. Fernandez Hospital. We tank Paul Kerston for their critical reading and English review of this manuscript. This work was supported by a Fundacion Florencio Fiorini Grant number 2014.	[Anonymous], 2015, B VIH SIDA ITS ARGEN; Antinori S., 2013, REV ARTIC NEW; AYATS J, 2011, ENFERM INFECC MICROB, V29; Bava Amadeo Javier, 1997, Revista Iberoamericana de Micologia, V14, P111; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Dhana A, 2013, CASE REP MED, V2013, DOI 10.1155/2013/640216; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Feldmesser M, 1996, CLIN INFECT DIS, V23, P827, DOI 10.1093/clinids/23.4.827; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Group WHOCGW, 2011, RAP ADV DIAGN PREV M; Haddow LJ, 2010, LANCET INFECT DIS, V10, P791, DOI 10.1016/S1473-3099(10)70170-5; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Lawn SD, 2011, EXPERT REV ANTI-INFE, V9, P415, DOI [10.1586/eri.11.21, 10.1586/ERI.11.21]; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; McKenney J, 2015, CLIN INFECT DIS, V60, P959, DOI 10.1093/cid/ciu937; Metta H. A., 2002, Revista Argentina de Microbiologia, V34, P117; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pongsai P, 2010, J INFECTION, V60, P474, DOI 10.1016/j.jinf.2010.03.015; Rajasingham Radha, 2012, J Acquir Immune Defic Syndr, V59, pe85, DOI 10.1097/QAI.0b013e31824c837e; Vidal JE, 2013, BRAZ J INFECT DIS, V17, P353, DOI 10.1016/j.bjid.2012.10.020; Warkentien T, 2010, INT J STD AIDS, V21, P679, DOI 10.1258/ijsa.2010.010182; Williams DA, 2015, CLIN INFECT DIS, V61, P464, DOI 10.1093/cid/civ263	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0178721	10.1371/journal.pone.0178721	http://dx.doi.org/10.1371/journal.pone.0178721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617817	Green Published, Green Submitted, gold			2022-12-26	WOS:000403364600014
J	Joly, P; Vignaud, H; Di Martino, J; Ruiz, M; Garin, R; Restier, L; Belmalih, A; Marchal, C; Cullin, C; Arveiler, B; Fergelot, P; Gitler, AD; Lachaux, A; Couthouis, J; Bouchecareilh, M				Joly, Philippe; Vignaud, Helene; Di Martino, Julie; Ruiz, Mathias; Garin, Roman; Restier, Lioara; Belmalih, Abdelouahed; Marchal, Christelle; Cullin, Christophe; Arveiler, Benoit; Fergelot, Patricia; Gitler, Aaron D.; Lachaux, Alain; Couthouis, Julien; Bouchecareilh, Marion			ERAD defects and the HFE-H63D variant are associated with increased risk of liver damages in Alpha 1-Antitrypsin Deficiency	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MUTANT ALPHA-1-ANTITRYPSIN; MISFOLDED PROTEINS; ALPHA-SYNUCLEIN; YEAST-CELLS; DISEASE; HERP; DEGRADATION; STRESS; GENOME	Background The most common and severe disease causing allele of Alpha 1-Antitrypsin Deficiency (1ATD) is Z-1AT. This protein aggregates in the endoplasmic reticulum, which is the main cause of liver disease in childhood. Based on recent evidences and on the frequency of liver disease occurrence in Z-1AT patients, it seems that liver disease progression is linked to still unknown genetic factors. Methods We used an innovative approach combining yeast genetic screens with next generation exome sequencing to identify and functionally characterize the genes involved in 1ATD associated liver disease. Results Using yeast genetic screens, we identified HRD1, an Endoplasmic Reticulum Associated Degradation (ERAD) associated protein, as an inducer of Z-mediated toxicity. Whole exome sequencing of 1ATD patients resulted in the identification of two variants associated with liver damages in Z-1AT homozygous cases: HFE H63D and HERPUD1 R50H. Functional characterization in Z-1AT model cell lines demonstrated that impairment of the ERAD machinery combined with the HFE H63D variant expression decreased both cell proliferation and cell viability, while Unfolded Protein Response (UPR)-mediated cell death was hyperstimulated. Conclusion This powerful experimental pipeline allowed us to identify and functionally validate two genes involved in Z-1AT-mediated severe liver toxicity. This pilot study moves forward our understanding on genetic modifiers involved in 1ATD and highlights the UPR pathway as a target for the treatment of liver diseases associated with 1ATD. Finally, these findings support a larger scale screening for HERPUD1 R50H and HFE H63D variants in the sub-group of 1ATD patients developing significant chronic hepatic injuries (hepatomegaly, chronic cholestasis, elevated liver enzymes) and at risk developing liver cirrhosis.	[Joly, Philippe] Univ Claude Bernard Lyon 1, EA 7424, Interuniv Lab Human Movement Sci, Villeurbanne, France; [Joly, Philippe] Hosp Civils Lyon, Hop Edouard Herriot, Lab Biochim & Biol Mol Grand Est, Lyon, France; [Vignaud, Helene; Di Martino, Julie; Marchal, Christelle; Cullin, Christophe; Bouchecareilh, Marion] Univ Bordeaux, CNRS, UMR5095, Inst Biochim & Genet Cellulaires, Bordeaux, France; [Di Martino, Julie; Bouchecareilh, Marion] Univ Bordeaux, INSERM, UMR1053, Bordeaux Res Translat Oncol,BaRITOn, Bordeaux, France; [Ruiz, Mathias; Garin, Roman; Restier, Lioara; Belmalih, Abdelouahed; Lachaux, Alain] Childrens Hosp Lyon, Dept Paediat Gastroenterol Hepatol & Nutr, Lyon, France; [Arveiler, Benoit; Fergelot, Patricia] Univ Bordeaux, INSERM U1211, Lab Malad Rares Genet & Metab MRGM, Bordeaux, France; [Gitler, Aaron D.; Couthouis, Julien] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Stanford University	Bouchecareilh, M (corresponding author), Univ Bordeaux, CNRS, UMR5095, Inst Biochim & Genet Cellulaires, Bordeaux, France.; Bouchecareilh, M (corresponding author), Univ Bordeaux, INSERM, UMR1053, Bordeaux Res Translat Oncol,BaRITOn, Bordeaux, France.	marionb@ibgc.cnrs.fr	cullin, christophe/AAM-2179-2020; COUTHOUIS, Julien/G-3895-2012; di Martino, Julie Sandra/AAD-1430-2020	cullin, christophe/0000-0003-4110-4677; COUTHOUIS, Julien/0000-0002-2378-4595; di Martino, Julie Sandra/0000-0002-2163-0736; Gitler, Aaron/0000-0001-8603-1526; alain, lachaux/0000-0003-3852-788X	ADAAT Alpha1-France; Ligue contre le cancer; Inserm - ITM 0 BCDE; CNRS	ADAAT Alpha1-France; Ligue contre le cancer(Ligue nationale contre le cancer); Inserm - ITM 0 BCDE; CNRS(Centre National de la Recherche Scientifique (CNRS))	Our work was funded by ADAAT Alpha1-France, Ligue contre le cancer, Inserm - ITM 0 BCDE and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Bouchecareilh Marion, 2010, Proc Am Thorac Soc, V7, P415, DOI 10.1513/pats.201001-016AW; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chappell S, 2009, HEPATOLOGY, V50, P1315, DOI 10.1002/hep.23170; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Couthouis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004539; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Feng LJ, 2017, AUTOPHAGY, V13, P686, DOI 10.1080/15548627.2017.1280207; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Ghouse R, 2014, DIS MODEL MECH, V7, P411, DOI 10.1242/dmm.014092; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Greene CM, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.51; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Hutt DM, 2017, METHODS MOL BIOL, V1510, P77, DOI 10.1007/978-1-4939-6527-4_6; Hutt DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106224; Johnston M, 2000, CURR OPIN GENET DEV, V10, P617, DOI 10.1016/S0959-437X(00)00145-3; Joly P, 2015, REV MAL RESPIR, V32, P759, DOI 10.1016/j.rmr.2015.06.010; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lam M, 2010, MODERN PATHOL, V23, P637, DOI 10.1038/modpathol.2010.42; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200; MCCRACKEN AA, 1993, MOL BIOL CELL, V4, P729, DOI 10.1091/mbc.4.7.729; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pan SJ, 2009, HEPATOLOGY, V50, P275, DOI 10.1002/hep.22974; Pastore N, 2017, HEPATOLOGY; Perlmutter DH, 2007, HEPATOLOGY, V45, P1313, DOI 10.1002/hep.21628; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Peters SL, 2016, HUM MOL GENET, V25, P976, DOI 10.1093/hmg/ddv630; Pinto JP, 2007, BLOOD CELL MOL DIS, V39, P75, DOI 10.1016/j.bcmd.2007.01.005; Powell LW, 2016, LANCET, V388, P706, DOI 10.1016/S0140-6736(15)01315-X; Pratap U, 2010, RESPIROLOGY, V15, P141, DOI 10.1111/j.1440-1843.2009.01649.x; Ruiz M, 2015, J PEDIATR GASTR NUTR, V61, pE25, DOI 10.1097/MPG.0000000000000932; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Smith SE, 2011, J BIOL CHEM, V286, P41563, DOI 10.1074/jbc.M111.280073; Stockley RA, 2001, NOVART FDN SYMP, V234, P189; SWFaJL Brodsky, 2013, ENTRY INTO THE ENDOP; Tafaleng EN, 2015, HEPATOLOGY, V62, P147, DOI 10.1002/hep.27753; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; van Laar T, 2000, FEBS LETT, P469; Vignaud H, 2015, REV MAL RESPIR, V32, P1059, DOI 10.1016/j.rmr.2015.05.013; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H.-H., 2011, J NANOMATER, V2011, P1, DOI [DOI 10.1007/S11010-010-0600-9, DOI 10.1007/S11105-010-]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Winzeler EA, 1999, PARASITOLOGY, V118, pS73, DOI 10.1017/S0031182099004047; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yan L, 2014, J CELL SCI, V127, P1417, DOI 10.1242/jcs.135293	60	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179369	10.1371/journal.pone.0179369	http://dx.doi.org/10.1371/journal.pone.0179369			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617828	Green Submitted, Green Published, gold			2022-12-26	WOS:000403364600034
J	Salomao, PMA; de Oliveira, FA; Rodrigues, PD; Al-Ahj, LP; Gasque, KCD; Jeggle, P; Buzalaf, MAR; de Oliveira, RC; Edwardson, JM; Magalhaes, AC				Aranda Salomao, Priscila Maria; de Oliveira, Flavia Amadeu; Rodrigues, Paula Danielle; Al-Ahj, Luana Polioni; da Silva Gasque, Kellen Cristina; Jeggle, Pia; Rabelo Buzalaf, Marilia Afonso; de Oliveira, Rodrigo Cardoso; Edwardson, John Michael; Magalhaes, Ana Carolina			The cytotoxic effect of TiF4 and NaF on fibroblasts is influenced by the experimental model, fluoride concentration and exposure time	PLOS ONE			English	Article							TITANIUM TETRAFLUORIDE; SODIUM-FLUORIDE; HUMAN-ENAMEL; IN-VITRO; EROSION PROGRESSION; CARIES PREVENTION; INDUCED APOPTOSIS; DENTAL EROSION; CYTO-TOXICITY; CELL-DEATH	Objective Titanium tetrafluoride (TiF4) has shown promising effect in preventing tooth lesions. Therefore, we compared the cytotoxicity of TiF4 with sodium fluoride (NaF) (already applied in Dentistry) considering different fluoride concentrations, pH values and experimental models. Materials and methods Step 1) NIH/3T3 fibroblasts were exposed to mediums containing NaF or TiF4 (from 0.15 to 2.45% F), both at native and adjusted pH, for 6 h. Step 2) NIH/3T3 were exposed to NaF or TiF4 varnishes with 0.95, 1.95 or 2.45% F (native pH), for 6, 12 or 24 h. We applied MTT (1st and 2nd steps) and Hoescht/PI stain (2nd step) assays. Step 3) NIH/3T3 were exposed to NaF or TiF4 varnish (2.45% F), at native pH, for 6 or 12 h. The cell stiffness was measured by atomic force microscopy (AFM). Results Step 1) All cells exposed to NaF or TiF4 mediums died, regardless of the F concentration and pH. Step 2) Both varnishes, at 1.90 and 2.45% F, reduced cell viability by similar extents (33-86% at 6 h, 35-93% at 12 h, and 87-98% at 24 h) compared with control, regardless of the type of fluoride. Varnishes with 0.95% F did not differ from control. Step 3) TiF4 and NaF reduced cell stiffness to a similar extent, but only TiF4 differed from control at 6 h. Conclusions Based on the results of the 3 experimental steps, we conclude that TiF4 and NaF have similar cytotoxicity. The cytotoxicity was dependent on F concentration and exposure time. This result gives support for testing the effect of TiF4 varnish in vivo.	[Aranda Salomao, Priscila Maria; de Oliveira, Flavia Amadeu; Rodrigues, Paula Danielle; Al-Ahj, Luana Polioni; da Silva Gasque, Kellen Cristina; Rabelo Buzalaf, Marilia Afonso; de Oliveira, Rodrigo Cardoso; Magalhaes, Ana Carolina] Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Sao Paulo, Brazil; [Jeggle, Pia; Edwardson, John Michael] Univ Cambridge, Dept Pharmacol, Cambridge, England	Universidade de Sao Paulo; University of Cambridge	Magalhaes, AC (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Biol Sci, Sao Paulo, Brazil.	acm@fob.usp.br	Amadeu de Oliveira, Flavia/M-9680-2013; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021; Magalhães, Ana Carolina/C-5203-2012; Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Salomao, Priscila/E-4663-2013; de Oliveira, Rodrigo Cardoso/E-2551-2012; Gasque, Kellen Cristina da Silva/I-7155-2016	Amadeu de Oliveira, Flavia/0000-0003-3063-6694; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Magalhães, Ana Carolina/0000-0002-6413-5348; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; de Oliveira, Rodrigo Cardoso/0000-0003-3070-5960; Gasque, Kellen Cristina da Silva/0000-0003-2015-2717	FAPESP [09/17360-4, 10/14984-4, 13/20372-0, 13/13484-6, 14/16415-8, 15/05009-1]; Kidney Research UK; Kidney Research UK [RP17/2012] Funding Source: researchfish	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Kidney Research UK(Kidney Research UK (KRUK)); Kidney Research UK(Kidney Research UK (KRUK))	This work was supported by FAPESP [Grant numbers: 09/17360-4, 10/14984-4, 13/20372-0, 13/13484-6, 14/16415-8 and 15/05009-1]; and Kidney Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buyukyilmaz T, 1997, EUR J ORAL SCI, V105, P473, DOI 10.1111/j.1600-0722.1997.tb00233.x; BUYUKYILMAZ T, 1994, AM J ORTHOD DENTOFAC, V105, P293, DOI 10.1016/S0889-5406(94)70124-5; Comar LP, 2012, EUR J ORAL SCI, V120, P342, DOI 10.1111/j.1600-0722.2012.00968.x; Comar LP, 2014, J APPL ORAL SCI, V22, P138, DOI 10.1590/1678-775720130574; Divaris K, 2013, CARIES RES, V47, P78, DOI 10.1159/000344015; Eakle WS, 2004, COMMUNITY DENT ORAL, V32, P462, DOI 10.1111/j.1600-0528.2004.00185.x; Ganss C, 2004, CARIES RES, V38, P561, DOI 10.1159/000080587; Ganss C, 2007, ARCH ORAL BIOL, V52, P9, DOI 10.1016/j.archoralbio.2006.07.004; Hashimoto Y, 2003, EUR J CANCER, V39, P2239, DOI 10.1016/S0959-8049(03)00599-9; Hermanowicz P, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4881683; Hove LH, 2011, CARIES RES, V45, P64, DOI 10.1159/000324155; Inkielewicz-Stepniak I, 2014, INT J NANOMED, V9, P1677, DOI 10.2147/IJN.S59172; Jeng JH, 1998, CELL BIOL TOXICOL, V14, P383, DOI 10.1023/A:1007591426267; Olympio KPK, 2009, J APPL ORAL SCI, V17, P179, DOI 10.1590/S1678-77572009000300009; Kansu G, 2014, J DENT SCI, V9, P381, DOI 10.1016/j.jds.2013.01.008; Karube H, 2009, J DENT RES, V88, P461, DOI 10.1177/0022034509334771; Korostoff J, 1998, INFECT IMMUN, V66, P4474; Lee GJ, 2010, MICRON, V41, P220, DOI 10.1016/j.micron.2009.10.012; Lee JH, 2008, TOXICOLOGY, V243, P340, DOI 10.1016/j.tox.2007.10.026; Lee YJ, 2013, MICRON, V49, P54, DOI 10.1016/j.micron.2013.02.014; Magalhaes AC, 2008, CARIES RES, V42, P269, DOI 10.1159/000135672; Magalhaes AC, 2008, J DENT, V36, P158, DOI 10.1016/j.jdent.2007.12.001; Magalhaes AC, 2013, CARIES RES, V47, P515; Magalhaes AC, 2011, MONOGR ORAL SCI, V22, P158, DOI 10.1159/000325167; Marinho VCC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002279.pub2; Matsui H, 2007, TOXICOL IN VITRO, V21, P1113, DOI 10.1016/j.tiv.2007.04.006; Acra AM, 2012, IN VIVO, V26, P657; Moron BM, 2013, CARIES RES, V47, P162, DOI 10.1159/000345362; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nishida M, 2016, J BIOMED MATER RES A, V104, P2029, DOI 10.1002/jbm.a.35737; Otsuki S, 2005, J DENT RES, V84, P919, DOI 10.1177/154405910508401009; Otsuki S, 2011, TOXICOLOGY, V287, P131, DOI 10.1016/j.tox.2011.06.007; Pessan JP, 2011, MONOGR ORAL SCI, V22, P115, DOI 10.1159/000325154; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Radmacher M, 2002, METHOD CELL BIOL, V68, P67; Rejinold NS, 2010, INT J BIOL MACROMOL, V47, P37, DOI 10.1016/j.ijbiomac.2010.03.023; SAXEGAARD E, 1988, SCAND J DENT RES, V96, P523; Schlueter N, 2007, CARIES RES, V41, P141, DOI 10.1159/000098048; Sen BH, 1998, ORAL SURG ORAL MED O, V86, P341; Seppa L, 2004, MED PRIN PRACT, V13, P307, DOI 10.1159/000080466; SHRESTHA BM, 1972, J DENT RES, V51, P1561, DOI 10.1177/00220345720510060901; Sirghi L, 2010, MICROSCOPY SCI TECHN, P433; Subbiah R, 2015, INT J NANOMED, V10, P191, DOI 10.2147/IJN.S88508; TAVES DR, 1968, TALANTA, V15, P969, DOI 10.1016/0039-9140(68)80097-9; ten Cate JM, 2004, CARIES RES, V38, P254, DOI 10.1159/000077763; tenCate JM, 1997, EUR J ORAL SCI, V105, P461; TSUTSUI T, 1984, MUTAT RES, V139, P193, DOI 10.1016/0165-7992(84)90127-1; Twetman S, 1999, ACTA ODONTOL SCAND, V57, P263, DOI 10.1080/000163599428670; Vieira AM, 2011, CARIES RES, V45, P142, DOI 10.1159/000324805; Wang YB, 2011, J BIOMED MATER RES B, V96B, P34, DOI 10.1002/jbm.b.31725; Whitford GM, 1996, MONOGR ORAL SCI, V16, P1; Wiegand A, 2009, CARIES RES, V43, P269, DOI 10.1159/000217859; Wiegand Annette, 2003, Oral Health Prev Dent, V1, P245; Wiegand A, 2010, ARCH ORAL BIOL, V55, P223, DOI 10.1016/j.archoralbio.2009.11.007	54	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179471	10.1371/journal.pone.0179471	http://dx.doi.org/10.1371/journal.pone.0179471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614381	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900056
J	Fan, ZX; Miao, Y; Qu, Q; Xiao, SN; Wang, J; Du, LJ; Liu, BC; Hu, ZQ				Fan, Zhexiang; Miao, Yong; Qu, Qian; Xiao, Shune; Wang, Jin; Du, Lijuan; Liu, Bingcheng; Hu, Zhiqi			Unlocking the vital role of host cells in hair follicle reconstruction by semi-permeable capsules	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; DISSOCIATED CELLS; IN-VITRO; REGENERATION; SKIN; MORPHOGENESIS; MICROENVIRONMENT; RECONSTITUTION; MICROTISSUES; CULTURE	Organ regeneration is becoming a promising choice for many patients; however, many details about the mechanisms underlying organ regeneration remain unknown. As regenerative organs, hair follicles offer a good model to study the mechanisms associated with regenerative medicine. The relevant studies have mainly focused on donor cells, and there are no systematic studies involving the effect of host factors on hair follicle reconstruction. Thus, we intend to explore the effect of host cells on hair follicle reconstruction. Epidermal and dermal cells from red fluorescent protein (RFP) transgenic newborn mice were injected into green fluorescent protein (GFP) transgenic mice. In addition, we wrapped the mixed dermal and epidermal cells from GFP transgenic and RFP transgenic mice by the Cell-in-a-Box kit to form "capsules," so that the cells within would be isolated from host cells. These capsules were cultured in vitro and transplanted in vivo. Fully developed reconstructed hair follicles were observed after the injection of mixed cells. These reconstructed follicles mainly consisted of donor cells, as well as a small number of host cells. The encapsulated cells gradually aggregated into cell spheres in vitro without apparent differentiation towards hair follicles. With respect to the transplanted capsules, concentric circle structures were observed, but no hair follicles or hair shafts formed. When the concentric circle structures were transplanted in vivo, mature hair follicles were observed 30 days later. Host cells were found in the reconstructed hair follicles. Thus, we conclude that host cells participate in the process of hair follicle reconstruction, and they play a vital role in the process, especially for the maturation of reconstructed hair follicles. Furthermore, we established a special hair follicle reconstruction system with the help of capsules: transplant cells were isolated from host, but other factors from host could exchange with cells inside.	[Fan, Zhexiang; Miao, Yong; Qu, Qian; Xiao, Shune; Wang, Jin; Du, Lijuan; Liu, Bingcheng; Hu, Zhiqi] Southern Med Univ, Nan Fang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Hu, ZQ (corresponding author), Southern Med Univ, Nan Fang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China.	huzhiqidr@163.com	Hu, Zhi/AAD-1479-2020	Du, Lijuan/0000-0003-4944-190X	Natural Science Foundation of China [81471900]; Natural Science Foundation of Guangdong Province [2015A030311001]; Science and Technology Program of Guangzhou [201508020262]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou	This work was supported by the Natural Science Foundation of China (81471900), the Natural Science Foundation of Guangdong Province (2015A030311001), Science and Technology Program of Guangzhou (201508020262).	Asakawa K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00424; Bolton EM, 2015, REGEN MED, V10, P287, DOI [10.2217/rme.15.11, 10.2217/RME.15.11]; Bruneau BG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008292; Ellis JA, 2008, DRUG DISCOV TODAY, V13, P791, DOI 10.1016/j.drudis.2008.05.010; Fiegel HC, 2008, J CELL MOL MED, V12, P56, DOI 10.1111/j.1582-4934.2007.00162.x; Hazeltine LB, 2013, BIOTECHNOL ADV, V31, P1002, DOI 10.1016/j.biotechadv.2013.03.002; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Huang CY, 2016, WOUND REPAIR REGEN, V24, P759, DOI 10.1111/wrr.12451; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kloepper JE, 2015, J INVEST DERMATOL, V135, P679, DOI 10.1038/jid.2014.475; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin BJ, 2016, ACS APPL MATER INTER, V8, P5906, DOI 10.1021/acsami.6b00202; Lohr M, 2001, LANCET, V357, P1591, DOI 10.1016/S0140-6736(00)04749-8; Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112; Miao Y, 2014, TISSUE ENG PT A, V20, P2329, DOI [10.1089/ten.tea.2013.0547, 10.1089/ten.TEA.2013.0547]; Miao Y, 2013, DERMATOL SURG, V39, P1868, DOI 10.1111/dsu.12292; Ohyama M, 2013, J DERMATOL SCI, V70, P78, DOI 10.1016/j.jdermsci.2013.02.004; Qiao J, 2008, EXP DERMATOL, V17, P512, DOI 10.1111/j.1600-0625.2007.00661.x; Qiao JZ, 2008, REGEN MED, V3, P683, DOI 10.2217/17460751.3.5.683; Salmons B, 2010, ADV EXP MED BIOL, V670, P92; Schormann W, 2008, HISTOCHEM CELL BIOL, V130, P329, DOI 10.1007/s00418-008-0428-5; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Su YS, 2015, CLIN EXP DERMATOL, V40, P653, DOI 10.1111/ced.12563; Thane K, 2014, TRANSL RES, V163, P363, DOI 10.1016/j.trsl.2013.11.010; Toyoshima K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1784; Wang XS, 2012, STEM CELLS DEV, V21, P7, DOI 10.1089/scd.2011.0230; Woo WM, 2013, JOVE-J VIS EXP, DOI 10.3791/4344; Xiao SN, 2016, J TISSUE ENG REGEN M, V10, pE286, DOI 10.1002/term.1802; Yen CM, 2010, BIOMATERIALS, V31, P4341, DOI 10.1016/j.biomaterials.2010.02.014; Yu BD, 2008, HUM MOL GENET, V17, pR54, DOI 10.1093/hmg/ddn086; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Zheng Y, 2010, DEV DYNAM, V239, P2619, DOI 10.1002/dvdy.22398	34	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179279	10.1371/journal.pone.0179279	http://dx.doi.org/10.1371/journal.pone.0179279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614369	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900039
J	Harvey, ND; Craigon, PJ; Blythe, SA; England, GCW; Asher, L				Harvey, Naomi D.; Craigon, Peter J.; Blythe, Simon A.; England, Gary C. W.; Asher, Lucy			An evidence-based decision assistance model for predicting training outcome in juvenile guide dogs	PLOS ONE			English	Article							BEHAVIOR TEST; BREED DIFFERENCES; COMPANION DOGS; SERVICE DOGS; PERSONALITY; TEMPERAMENT; TRAITS; VALIDITY; QUESTIONNAIRE; ENVIRONMENT	Working dog organisations, such as Guide Dogs, need to regularly assess the behaviour of the dogs they train. In this study we developed a questionnaire-style behaviour assessment completed by training supervisors of juvenile guide dogs aged 5, 8 and 12 months old (n = 1,401), and evaluated aspects of its reliability and validity. Specifically, internal reliability, temporal consistency, construct validity, predictive criterion validity (comparing against later training outcome) and concurrent criterion validity (comparing against a standardised behaviour test) were evaluated. Thirty-nine questions were sourced either from previously published literature or created to meet requirements identified via Guide Dogs staff surveys and staff feedback. Internal reliability analyses revealed seven reliable and interpretable trait scales named according to the questions within them as: Adaptability; Body Sensitivity; Distractibility; Excitability; General Anxiety; Trainability and Stair Anxiety. Intra-individual temporal consistency of the scale scores between 5-8, 8-12 and 5-12 months was high. All scales excepting Body Sensitivity showed some degree of concurrent criterion validity. Predictive criterion validity was supported for all seven scales, since associations were found with training outcome, at at-least one age. Thresholds of z-scores on the scales were identified that were able to distinguish later training outcome by identifying 8.4% of all dogs withdrawn for behaviour and 8.5% of all qualified dogs, with 84% and 85% specificity. The questionnaire assessment was reliable and could detect traits that are consistent within individuals over time, despite juvenile dogs undergoing development during the study period. By applying thresholds to scores produced from the questionnaire this assessment could prove to be a highly valuable decision-making tool for Guide Dogs. This is the first question-naire- style assessment of juvenile dogs that has shown value in predicting the training outcome of individual working dogs.	[Harvey, Naomi D.; Craigon, Peter J.; Blythe, Simon A.; England, Gary C. W.; Asher, Lucy] Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Leicester, Leics, England; [Blythe, Simon A.] Guide Dogs Blind Assoc, Reading, Berks, England; [Asher, Lucy] Newcastle Univ, Ctr Behav & Evolut, Henry Wellcome Bldg, Newcastle Upon Tyne, Tyne & Wear, England	University of Nottingham; Newcastle University - UK	Harvey, ND (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton Bonington Campus, Leicester, Leics, England.	Naomi.Harvey@nottingham.ac.uk	England, Gary C.W./G-5432-2011; Harvey, Naomi D./H-6435-2019	Harvey, Naomi D./0000-0002-9208-7734; Asher, Lucy/0000-0001-9729-7856; England, Gary/0000-0001-5800-3106	Guide Dogs, UK [CR2009-01a]; The University of Nottingham	Guide Dogs, UK; The University of Nottingham	This work was funded by Guide Dogs, UK (grant number CR2009-01a http://guidedogs.org.uk) and The University of Nottingham as part of a 6-year longitudinal study. Guide Dogs approved of the study design, granted access to their IT systems to allow implementation of the data collection system and access to their training staff members who completed the assessments. The funders had no role in data analysis or preparation of the manuscript but have given their approval to publish the manuscript.	Arata S, 2010, J VET MED SCI, V72, P539, DOI 10.1292/jvms.09-0512; Asher L, 2013, J VET BEHAV, V8, P431, DOI 10.1016/j.jveb.2013.08.004; Asher L, 2009, J R SOC INTERFACE, V6, P1103, DOI 10.1098/rsif.2009.0221; Barnard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149831; Beerda B, 1997, APPL ANIM BEHAV SCI, V52, P307, DOI 10.1016/S0168-1591(96)01131-8; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Belshaw Z, 2015, VET J, V206, P203, DOI 10.1016/j.tvjl.2015.07.016; Brooks A, 2010, VET REC, V166, P778, DOI 10.1136/vr.b4855; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Caron-Lormier G, 2016, SCI REP-UK, V6, DOI 10.1038/srep23860; Carrier LO, 2013, APPL ANIM BEHAV SCI, V146, P96, DOI 10.1016/j.applanim.2013.04.002; Carter AJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P153, DOI 10.1007/s00265-011-1263-6; Crone EA, 2009, DEVELOPMENTAL SCI, V12, P825, DOI 10.1111/j.1467-7687.2009.00918.x; De Meester RH, 2008, J VET BEHAV, V3, P161, DOI 10.1016/j.jveb.2007.10.005; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Freeman H, 2011, DEV PRIMATOL-PROG PR, P17, DOI 10.1007/978-1-4614-0176-6_2; Funder DC, 2001, ANNU REV PSYCHOL, V52, P197, DOI 10.1146/annurev.psych.52.1.197; GODDARD ME, 1983, APPL ANIM ETHOL, V9, P299, DOI 10.1016/0304-3762(83)90010-X; GODDARD ME, 1986, APPL ANIM BEHAV SCI, V15, P247, DOI 10.1016/0168-1591(86)90095-X; Gore JS, 2013, AM J PSYCHOL, V126, P81, DOI 10.5406/amerjpsyc.126.1.0081; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2003, J PERS SOC PSYCHOL, V85, P1161, DOI 10.1037/0022-3514.85.6.1161; Harvey ND, 2016, J VET BEHAV, V16, P13, DOI 10.1016/j.jveb.2016.03.004; Harvey ND, 2016, J VET BEHAV, V11, P65, DOI 10.1016/j.jveb.2015.09.005; Highfill L, 2010, ZOO BIOL, V29, P509, DOI 10.1002/zoo.20279; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; King JE, 2011, DEV PRIMATOL-PROG PR, P77, DOI 10.1007/978-1-4614-0176-6_4; Konok V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118375; Konok V, 2011, APPL ANIM BEHAV SCI, V135, P300, DOI 10.1016/j.applanim.2011.10.011; Kubinyi E, 2015, ACTA BIOL HUNG, V66, P27, DOI 10.1556/ABiol.66.2015.1.3; McGarrity ME, 2016, APPL ANIM BEHAV SCI, V179, P82, DOI 10.1016/j.applanim.2016.03.013; Miklosi A., 2011, DOG BEHAV EVOLUTION; Mischel W, 2006, PIECES PERSONALITY P; Moxon R, 2016, VET REC, V178, DOI 10.1136/vr.103433; Nagasawa M, 2011, ANIM COGN, V14, P525, DOI 10.1007/s10071-011-0386-5; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Serpell JA, 2001, APPL ANIM BEHAV SCI, V72, P347, DOI 10.1016/S0168-1591(00)00210-0; Sinn DL, 2010, APPL ANIM BEHAV SCI, V127, P51, DOI 10.1016/j.applanim.2010.08.007; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Slabbert JM, 1999, APPL ANIM BEHAV SCI, V64, P269, DOI 10.1016/S0168-1591(99)00038-6; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Taylor KD, 2006, J VET BEHAV, V1, P94, DOI 10.1016/j.jveb.2006.09.002; Uher J, 2008, J RES PERS, V42, P821, DOI 10.1016/j.jrp.2007.10.004; Uher J, 2011, DEV PRIMATOL-PROG PR, P41, DOI 10.1007/978-1-4614-0176-6_3; Valsecchi P, 2011, J VET BEHAV, V6, P161, DOI 10.1016/j.jveb.2011.01.002; van den Berg SM, 2010, APPL ANIM BEHAV SCI, V124, P136, DOI 10.1016/j.applanim.2010.02.005; Wilsson E, 1997, APPL ANIM BEHAV SCI, V53, P279, DOI 10.1016/S0168-1591(96)01174-4; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012	51	23	23	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0174261	10.1371/journal.pone.0174261	http://dx.doi.org/10.1371/journal.pone.0174261			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614347	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900001
J	Murray, RL; Herridge, EJ; Ness, RW; Bussiere, LF				Murray, Rosalind L.; Herridge, Elizabeth J.; Ness, Rob W.; Bussiere, Luc F.			Are sex ratio distorting endosymbionts responsible for mating system variation among dance flies (Diptera: Empidinae)?	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; BACTERIAL SYMBIONTS; ROLE REVERSAL; WOLBACHIA; FLY; INFECTIONS; EVOLUTION; PHYLOGENY; SELECTION; INSECT	Maternally inherited bacterial endosymbionts are common in many arthropod species. Some endosymbionts cause female-biased sex ratio distortion in their hosts that can result in profound changes to a host's mating behaviour and reproductive biology. Dance flies (Diptera: Empidinae) are well known for their unusual reproductive biology, including species with female-specific ornamentation and female-biased lek-like swarming behaviour. The cause of the repeated evolution of female ornaments in these flies remains unknown, but is probably associated with female-biased sex ratios in individual species. In this study we assessed whether dance flies harbour sex ratio distorting endosymbionts that might have driven these mating system evolutionary changes. We measured the incidence and prevalence of infection by three endosymbionts that are known to cause female-biased sex ratios in other insect hosts (Wolbachia, Rickettsia and Spiroplasma) across 20 species of dance flies. We found evidence of widespread infection by all three symbionts and variation in sex-specific prevalence across the taxa sampled. However, there was no relationship between infection prevalence and adult sex ratio measures and no evidence that female ornaments are associated with high prevalences of sex-biased symbiont infections. We conclude that the current distribution of endosymbiont infections is unlikely to explain the diversity in mating systems among dance fly species.	[Murray, Rosalind L.; Ness, Rob W.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada; [Murray, Rosalind L.] Univ Toronto, Ecol & Evolutionary Biol, Toronto, ON, Canada; [Murray, Rosalind L.; Herridge, Elizabeth J.; Bussiere, Luc F.] Univ Stirling, Biol & Environm Sci, Stirling, Scotland	University of Toronto; University Toronto Mississauga; University of Toronto; University of Stirling	Murray, RL (corresponding author), Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada.; Murray, RL (corresponding author), Univ Toronto, Ecol & Evolutionary Biol, Toronto, ON, Canada.; Murray, RL (corresponding author), Univ Stirling, Biol & Environm Sci, Stirling, Scotland.	rosalind.murray@utoronto.ca	Bussiere, Luc/T-2134-2018	Bussiere, Luc/0000-0001-8937-8381	Royal Society; University of Stirling; Natural Environment Research Council [NBAF010001] Funding Source: researchfish; NERC [NBAF010001] Funding Source: UKRI	Royal Society(Royal Society of London); University of Stirling; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a grant from the Royal Society to LFB, Scholarships from the University of Stirling to RLM and EJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2003, BEHAV ECOLOGY; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; [Anonymous], 2004, BMC GENETICS, V5; Arnqvist Goran, 2005, pUnpaginated; Bates D, 2014, ARXIV14065823; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bussiere LF, 2008, J EVOLUTION BIOL, V21, P1683, DOI 10.1111/j.1420-9101.2008.01580.x; Charlat S, 2007, CURR BIOL, V17, P273, DOI 10.1016/j.cub.2006.11.068; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; Collin JE, 1961, BRIT FLIES 2; Corbin C, 2017, HEREDITY, V118, P10, DOI 10.1038/hdy.2016.71; CUMMING JM, 1994, CAN ENTOMOL, V126, P907, DOI 10.4039/Ent126907-3; De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x; DOWNES JA, 1969, AM ZOOL, V9, P566; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Engelstadter J, 2009, AM NAT, V173, pE159, DOI 10.1086/597375; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fromhage L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12517; Funk DH, 2000, ANIM BEHAV, V59, P411, DOI 10.1006/anbe.1999.1310; Goodacre Sara L., 2012, Insects, V3, P246, DOI 10.3390/insects3010246; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Gwynne DT, 2002, BEHAVIOUR, V139, P1425, DOI 10.1163/15685390260514690; Herridge EJ., 2016, ENCY EVOL BIOL, V2, P453, DOI [10.1016/B978-0-12-800049-6.00154-2, DOI 10.1016/B978-0-12-800049-6.00154-2]; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hurst GDD, 1999, PARASITOLOGY, V118, P125, DOI 10.1017/S0031182098003655; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Hurst GDD, 2015, COLD SPRING HARBOR P, V7, P1, DOI DOI 10.1101/CSHPERSPECT.A017699); Jiggins FM, 2000, P ROY SOC B-BIOL SCI, V267, P69, DOI 10.1098/rspb.2000.0968; Konecka E, 2015, MICROBIOL-SGM, V161, P1561, DOI 10.1099/mic.0.000114; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; LeBas NR, 2005, CURR BIOL, V15, P64, DOI 10.1016/j.cub.2004.12.043; Lefebvre V, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0742; Majerus MEN, 1997, ENTOMOPHAGA, V42, P13, DOI 10.1007/BF02769875; MARDEN JH, 1989, ECOLOGY, V70, P496, DOI 10.2307/1937553; Martin OY, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.4701; Martin OY, 2013, INFECT GENET EVOL, V13, P317, DOI 10.1016/j.meegid.2012.11.005; Martin OY, 2012, INFECT GENET EVOL, V12, P315, DOI 10.1016/j.meegid.2011.11.012; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; Murray RL, 2015, ECOLOGY EVOLUTION FE; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; R Core Development Team, 2014, R LANG ENV STAT COMP; Schulenburg JHGV, 2001, APPL ENVIRON MICROB, V67, P270, DOI 10.1128/AEM.67.1.270-277.2001; Shoemaker DD, 2002, P ROY SOC B-BIOL SCI, V269, P2257, DOI 10.1098/rspb.2002.2100; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; SVENSSON BG, 1987, ANN ZOOL FENN, V24, P323; Svensson BG, 1997, J INSECT BEHAV, V10, P783, DOI 10.1023/B:JOIR.0000010413.20596.28; Svensson BG, 2000, J INSECT BEHAV, V13, P785, DOI 10.1023/A:1007826715423; VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	57	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0178364	10.1371/journal.pone.0178364	http://dx.doi.org/10.1371/journal.pone.0178364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609446	Green Published, gold			2022-12-26	WOS:000403274700007
J	Maas, F; Arends, S; Wink, FR; Bos, R; Bootsma, H; Brouwer, E; Spoorenberg, A				Maas, Fiona; Arends, Suzanne; Wink, Freke R.; Bos, Reinhard; Bootsma, Hendrika; Brouwer, Elisabeth; Spoorenberg, Anneke			Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-a inhibitors	PLOS ONE			English	Article							BODY-MASS INDEX; AXIAL SPONDYLOARTHRITIS; DISEASE-ACTIVITY; DAMAGE; SYNDESMOPHYTES; PREDICTORS; SMOKING; SMOKERS; OBESITY; COHORT	Objective To investigate the influence of patient characteristics on the course of spinal radiographic progression in a large prospective longitudinal cohort study of ankylosing spondylitis (AS) patients treated long-term with TNF-a inhibitors. Methods Consecutive patients from the Groningen Leeuwarden AS (GLAS) cohort starting TNF-a inhibitors with spinal radiographs at least available at baseline and 6 years of follow-up were included. Radiographs were scored using mSASSS by two independent readers. Generalized estimating equations (GEE) were used to explore the associations between baseline characteristics and spinal radiographic progression. The course of radiographic progression in patients with and without risk factors for poor radiographic outcome was investigated using different time models (linear and non-linear). Single linear imputation was used in case of missing radiographic data at the intermediate (2 or 4 years) follow-up visits. Results 80 AS patients were included with mean baseline mSASSS 8.7 +/- 13.3. Baseline syndesmophytes, male gender, older age, longer symptom duration, smoking, and higher BMI were significantly associated with more radiographic damage over time. GEE analysis in patients with these risk factors revealed that radiographic progression followed a non-linear course with mean mSASSS progression rates reducing from max. 2.8 units over 0-2 years to min. 0.9 units over 4-6 years. The GEE model revealed a linear course with overall very low progression (<= 1 mSASSS units/2yrs) in patients without risk factors. Complete case analysis in 53 patients showed similar results. Conclusion AS patients at risk of poor radiographic outcome showed the highest but diminishing spinal radiographic progression during long-term treatment with TNF-a inhibitors.	[Maas, Fiona; Arends, Suzanne; Bootsma, Hendrika; Brouwer, Elisabeth; Spoorenberg, Anneke] Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands; [Arends, Suzanne; Wink, Freke R.; Bos, Reinhard; Spoorenberg, Anneke] Med Ctr Leeuwarden, Rheumatol, Leeuwarden, Netherlands	University of Groningen; Medical Center Leeuwarden	Maas, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands.	f.maas@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015; Bos, Reinhard/AAS-1726-2020; Arends, Suzanne/M-5436-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; Arends, Suzanne/0000-0002-4422-7640; Bos, Reinhard/0000-0003-1094-5596	Pfizer	Pfizer(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer. Pfizer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Chung HY, 2012, ANN RHEUM DIS, V71, P809, DOI 10.1136/annrheumdis-2011-200180; Durcan L, 2012, J RHEUMATOL, V39, P2310, DOI 10.3899/jrheum.120595; Glintborg B, 2016, RHEUMATOLOGY, V55, P659, DOI 10.1093/rheumatology/kev392; Gremese E, 2014, RHEUMATOLOGY, V53, P875, DOI 10.1093/rheumatology/ket433; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jacques P, 2014, ANN RHEUM DIS, V73, P437, DOI 10.1136/annrheumdis-2013-203643; Jeong H, 2015, JOINT BONE SPINE, V82, P473, DOI 10.1016/j.jbspin.2014.11.009; Kaan U, 2005, RHEUMATOL INT, V25, P357, DOI 10.1007/s00296-004-0451-3; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Maas F, 2016, ARTHRITIS CARE RES; Maas F, 2016, J RHEUMATOL, V43, P383, DOI 10.3899/jrheum.150648; Maas F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122693; Ottaviani S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3841; Poddubnyy D, 2016, ANN RHEUM DIS; Poddubnyy D, 2012, CURR OPIN RHEUMATOL, V24, P363, DOI 10.1097/BOR.0b013e328352b7bd; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Poddubnyy D, 2011, ANN RHEUM DIS, V70, P1369, DOI 10.1136/ard.2010.145995; Ramiro S, 2015, ANN RHEUM DIS, V74, P52, DOI 10.1136/annrheumdis-2013-204055; Ramiro S, 2014, ANN RHEUM DIS, V73, P1455, DOI 10.1136/annrheumdis-2014-205178; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; US Department of Health and Human Services, HLTH CONS SMOK 50 YE; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	27	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2017	12	6							e0177231	10.1371/journal.pone.0177231	http://dx.doi.org/10.1371/journal.pone.0177231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY6ZV	28640818	Green Published, Green Submitted, gold			2022-12-26	WOS:000404135800003
J	de la Fuente, A; Rojas, M; Mac Lean, C				de la Fuente, Alberto; Rojas, Maisa; Mac Lean, Claudia			A human-scale perspective on global warming: Zero emission year and personal quotas	PLOS ONE			English	Article							CLIMATE-CHANGE; CO2 EMISSIONS; VALUES; TARGETS	This article builds on the premise that human consumption of goods, food and transport are the ultimate drivers of climate change. However, the nature of the climate change problem (well described as a tragedy of the commons) makes it difficult for individuals to recognise their personal duty to implement behavioural changes to reduce greenhouse gas emissions. Consequently, this article aims to analyse the climate change issue from a human-scale perspective, in which each of us has a clearly defined personal quota of CO2 emissions that limits our activity and there is a finite time during which CO2 emissions must be eliminated to achieve the "well below 2 degrees C" warming limit set by the Paris Agreement of 2015 (COP21). Thus, this work's primary contribution is to connect an equal per capita fairness approach to a global carbon budget, linking personal levels with planetary levels. Here, we show that a personal quota of 5.0 tons of CO2 yr(-1) p(-1) is a representative value for both past and future emissions; for this level of a constant per-capita emissions and without considering any mitigation, the global accumulated emissions compatible with the "well below 2 degrees C" and 2 degrees C targets will be exhausted by 2030 and 2050, respectively. These are references years that provide an order of magnitude of the time that is left to reverse the global warming trend. More realistic scenarios that consider a smooth transition toward a zero-emission world show that the global accumulated emissions compatible with the "well below 2 degrees C" and 2 degrees C targets will be exhausted by 2040 and 2080, respectively. Implications of this paper include a return to personal responsibility following equity principles among individuals, and a definition of boundaries to the personal emissions of CO2.	[de la Fuente, Alberto] Univ Chile, Civil Engn Dept, Santiago, Chile; [Rojas, Maisa] Univ Chile, Geophys Dept, Santiago, Chile; [Rojas, Maisa] Univ Chile, Ctr Climate & Resilience Res, Santiago, Chile; [Mac Lean, Claudia] Univ Chile, Off Engn Sustainable Dev, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	de la Fuente, A (corresponding author), Univ Chile, Civil Engn Dept, Santiago, Chile.	aldelafu@ing.uchile.cl	de la Fuente Stranger, Alberto/G-7018-2016; Rojas, Maisa/A-7229-2013	de la Fuente Stranger, Alberto/0000-0001-5415-9816; Rojas, Maisa/0000-0002-5985-1905	scientific proyects from Comision Nacional de Investigacion Cientifica y Tecnologica [Fondecyt 1140821, Fondecyt 1131055, Fondecyt 1171773, Fondap-Conicyt 15110009]; Ministerio de Economia, Fomento y Turismo, Iniciativa Cientifica Milenio [NC120066]	scientific proyects from Comision Nacional de Investigacion Cientifica y Tecnologica; Ministerio de Economia, Fomento y Turismo, Iniciativa Cientifica Milenio	This article was financied by scientific proyects from Comision Nacional de Investigacion Cientifica y Tecnologica: Fondecyt 1140821 (Alberto de la Fuente), Fondecyt 1131055, Fondecyt 1171773, and Fondap-Conicyt 15110009 (Maisa Rojas); and Ministerio de Economia, Fomento y Turismo, Iniciativa Cientifica Milenio NC120066 (Maisa Rojas).	Agarwal A, GLOBAL WARMING UNEQU; [Anonymous], 1992, UN C ENV DEV RIO DE, P351, DOI [10.1007/s11671-008-9208-3, DOI 10.1007/S11671-008-9208-3]; Baer P, 2000, SCIENCE, V289, P2287, DOI 10.1126/science.289.5488.2287; Baer P, 2013, WIRES CLIM CHANGE, V4, P61, DOI 10.1002/wcc.201; Berners- Lee M, 2010, CARBON FOOTPRINT EVE; Blennow K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050182; Broomell SB, 2015, GLOBAL ENVIRON CHANG, V32, P67, DOI 10.1016/j.gloenvcha.2015.03.001; Chakravarty S, 2009, P NATL ACAD SCI USA, V106, P11884, DOI 10.1073/pnas.0905232106; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Corner A, 2015, WIRES CLIM CHANGE, V6, P523, DOI 10.1002/wcc.353; Eggleston H.S., 2006, 2006 IPCC GUIDELINES, DOI DOI 10.11-10.89; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Friedlingstein P, 2014, NAT GEOSCI, V7, P709, DOI [10.1038/NGEO2248, 10.1038/ngeo2248]; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hoekstra AY, 2014, SCIENCE, V344, P1114, DOI 10.1126/science.1248365; Howell RA, 2013, GLOBAL ENVIRON CHANG, V23, P281, DOI 10.1016/j.gloenvcha.2012.10.015; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Kintisch E, 2009, SCIENCE, V326, P1465, DOI 10.1126/science.326.5959.1465; Knutti R, 2015, CLIMATIC CHANGE, V133, P361, DOI 10.1007/s10584-015-1340-3; Kronrod A, 2012, J MARKETING, V76, P95, DOI 10.1509/jm.10.0416; Le Quere C, 2016, EARTH SYST SCI DATA, V8, P605, DOI 10.5194/essd-8-605-2016; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Matthews HD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032388; Matthews HD, 2016, NAT CLIM CHANGE, V6, P60, DOI [10.1038/NCLIMATE2774, 10.1038/nclimate2774]; Max-neet M a, 1991, HUMAN SCALE DEV CONC, V1; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2015, NAT CLIM CHANGE, V5, P1098, DOI [10.1038/nclimate2826, 10.1038/NCLIMATE2826]; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Mottet, 2013, TACKLING CLIMATE CHA; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Palmer C, 2014, ETHICS INT AFF, V28, P343, DOI 10.1017/S0892679414000410; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Rogelj J, 2016, NAT CLIM CHANGE, V6, P245, DOI 10.1038/NCLIMATE2868; Rogelj J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/10/105007; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Schuppert F, 2015, CLIMATIC CHANGE, V133, P397, DOI 10.1007/s10584-015-1409-z; Steg L, 2016, ANNU REV ENV RESOUR, V41, P277, DOI 10.1146/annurev-environ-110615-085947; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tebaldi C, 2007, PHILOS T R SOC LON A, P365; UNFCCC, 2015, C PART COP PAR AGR P, V21932, P32; United Nations, 2015, ESAPWP241 UN, DOI DOI 10.1007/S13398-014-0173-7.2; van Renssen S, 2015, NAT CLIM CHANGE, V5, P513, DOI 10.1038/nclimate2661; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; WBGU, 2009, SPECIAL REPORT	46	4	4	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179705	10.1371/journal.pone.0179705	http://dx.doi.org/10.1371/journal.pone.0179705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY5TN	28628676	gold, Green Published, Green Submitted			2022-12-26	WOS:000404043100046
J	Hurem, S; Martin, LM; Brede, DA; Skjerve, E; Nourizadeh-Lillabadi, R; Lind, OC; Christensen, T; Berg, V; Teien, HC; Salbu, B; Oughton, DH; Alestrom, P; Lyche, JL				Hurem, Selma; Martin, Leonardo Martin; Brede, Dag Anders; Skjerve, Eystein; Nourizadeh-Lillabadi, Rasoul; Lind, Ole Christian; Christensen, Terje; Berg, Vidar; Teien, Hans-Christian; Salbu, Brit; Oughton, Deborah Helen; Alestrom, Peter; Lyche, Jan Ludvig			Dose-dependent effects of gamma radiation on the early zebrafish development and gene expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BINDING PROTEIN ALPHA; IONIZING-RADIATION; DNA-DAMAGE; OXIDATIVE STRESS; TGF-BETA; DIFFERENTIAL EXPRESSION; UKRAINIAN PATIENTS; C/EBP-ALPHA; P53	Ionizing radiation from natural sources or anthropogenic activity has the potential to cause oxidative stress or genetic damage in living organisms, through the ionization and excitation of molecules and the subsequent production of free radicals and reactive oxygen species (ROS). The present work focuses on radiation-induced biological effects using the zebrafish (Danio rerio) vertebrate model. Changes in developmental traits and gene expression in zebrafish were assessed after continuous external gamma irradiation (0.4, 3.9, 15 and 38 mGy/h) with corresponding controls, starting at 2.5 hours post fertilization (hpf) and lasting through embryogenesis and the early larval stage. The lowest dose rate corresponded to recommended benchmarks at which adverse effects are not expected to occur in aquatic ecosystems (2-10 mGy/day). The survival observed at 96 hours post fertilization (hpf) in the 38 mGy/h group was significantly lower, while other groups showed no significant difference compared to controls. The total hatching was significantly lower from controls in the 15 mGy/h group and a delay in hatching onset in the 0.4 mGy/h group was observed. The deformity frequency was significantly increased by prolonged exposure duration at dose rates-0.4 mGy/h. Molecular responses analyzed by RNA-seq at gastrulation (5.5 hpf transcriptome) indicate that the radiation induced adverse effects occurred during the earliest stages of development. A dose-response relationship was found in the numbers of differentially regulated genes in exposure groups compared to controls at a total dose as low as 1.62 mGy. Ingenuity Pathway Analysis identified retinoic acid receptor activation, apoptosis, and glutathione mediated detoxification signaling as the most affected pathways in the lower dose rate (0.54 mGy/h), while eif2 and mTOR, i.e., involved in the modulation of angiogenesis, were most affected in higher dose rates (5.4 and 10.9 mGy/h). By comparing gene expression data, myc was found to be the most significant upstream regulator, followed by tp53, TNF, hnf4a, TGFb1 and cebpa, while crabp2b and vegfab were identified as most frequent downstream target genes. These genes are associated with various developmental processes. The present findings show that continuous gamma irradiation (>= 0.54 mGy/h) during early gastrula causes gene expression changes that are linked to developmental defects in zebrafish embryos.	[Hurem, Selma; Martin, Leonardo Martin; Skjerve, Eystein; Nourizadeh-Lillabadi, Rasoul; Berg, Vidar; Alestrom, Peter; Lyche, Jan Ludvig] Norwegian Univ Life Sci NMBU, CERAD CoE, Fac Vet Med & Biosci, Oslo, Norway; [Martin, Leonardo Martin] Univ Camaguey Ignacio Agramonte y Loynaz UC, Fac Agr Sci, Camaguey, Cuba; [Brede, Dag Anders; Lind, Ole Christian; Teien, Hans-Christian; Salbu, Brit; Oughton, Deborah Helen] Norwegian Univ Life Sci NMBU, CERAD CoE, Fac Environm Sci & Nat Resource Management, N-1433 As, Norway; [Christensen, Terje] Norwegian Radiat Protect Author, CERAD CoE, Osteras, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Hurem, S (corresponding author), Norwegian Univ Life Sci NMBU, CERAD CoE, Fac Vet Med & Biosci, Oslo, Norway.	selma.hurem@nmbu.no	Skjerve, Eystein/D-7491-2014; Hurem, Selma/AAC-3141-2019; Lind, Ole Christian/J-1529-2015	Skjerve, Eystein/0000-0001-9652-6952; Lind, Ole Christian/0000-0001-9074-8028; Hurem, Selma/0000-0001-5379-3305; Berg, Vidar/0000-0002-4613-5627	Norwegian Research Council - Centre of Excellence CERAD - Centre for Environmental Radioactivity [223268/F50]	Norwegian Research Council - Centre of Excellence CERAD - Centre for Environmental Radioactivity	This work was supported by the Norwegian Research Council funded through the Centre of Excellence CERAD - Centre for Environmental Radioactivity (project 223268/F50).	Aanes H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-331; Aktas C, 2013, TURK J HEMATOL, V30, P371, DOI 10.4274/Tjh.2012.0142; Andrews S, FASTQC QUALITY CONTR; Andrews SS mapped sequence analysis tool, 2012, BABR BIOINF SEQM MAP; Avraham-Davidi I, 2012, NAT MED, V18, P967, DOI 10.1038/nm.2759; Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; BECKMAN L, 1988, HUM HERED, V38, P56, DOI 10.1159/000153756; Bergonie A J, 1906, YALE J BIOL MED, V76, P181; Bjerke H, 2014, CELL DEATH DIS MACMI; Bladen CL, 2007, NEUROSCI LETT, V422, P97, DOI 10.1016/j.neulet.2007.05.045; Bladen CL, 2012, RADIAT RES, V178, P499, DOI 10.1667/RR3042.2; Blomhoff R, 2003, TEMA NORD, V2003, P502; Cai AQ, 2012, DEVELOPMENT, V139, P2150, DOI 10.1242/dev.077065; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Crichton RR, 2002, J INORG BIOCHEM, V91, P9, DOI 10.1016/S0162-0134(02)00461-0; Dancea Horatiu C, 2009, Mol Cell Pharmacol, V1, P44; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Duffy KT, 2007, CANCER BIOL THER, V6, P675, DOI 10.4161/cbt.6.5.3956; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Feinendegen LE, 2007, EXP HEMATOL, V35, P37, DOI 10.1016/j.exphem.2007.01.011; Feinendegen Ludwig E, 2004, Nonlinearity Biol Toxicol Med, V2, P143, DOI 10.1080/15401420490507431; Ferrari G, 2009, J CELL PHYSIOL, V219, P449, DOI 10.1002/jcp.21706; Fleenor CJ, 2015, STEM CELLS, V33, P1345, DOI 10.1002/stem.1936; Fraenkel PG, 2009, BLOOD, V113, P2843, DOI 10.1182/blood-2008-06-165340; Freeman JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00268; Gagnaire B, 2015, AQUAT TOXICOL, V169, P69, DOI 10.1016/j.aquatox.2015.10.005; Garnier-Laplace J, 2010, J RADIOL PROT, V30, P215, DOI 10.1088/0952-4746/30/2/S02; Goishi K, 2004, CURR TOP DEV BIOL, V62, P127; Guo L, 2013, ONCOGENE, V32, P4009, DOI 10.1038/onc.2012.409; Gutierrez-Mazariegos J, 2011, SEMIN CELL DEV BIOL, V22, P603, DOI 10.1016/j.semcdb.2011.06.001; Haberle V, 2014, NATURE, V507, P381, DOI 10.1038/nature12974; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hu WT, 2014, RNA BIOL, V11, P1189, DOI 10.4161/rna.34345; Huang R, 2011, FASEB J, V25, P4138, DOI 10.1096/fj.11-185033; Hudson D, 2011, AGING-US, V3, P609, DOI 10.18632/aging.100340; Ilnytskyy Y, 2011, MUTAT RES-FUND MOL M, V714, P113, DOI 10.1016/j.mrfmmm.2011.06.014; Jaafar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069445; Jacot JL, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/589813; Jacquet P, 2004, J BIOL REG HOMEOS AG, V18, P106; Jarvis RB, 2003, MUTAT RES-GEN TOX EN, V541, P63, DOI 10.1016/S1383-5718(03)00182-7; KANE DA, 1993, DEVELOPMENT, V119, P447; Karkanitsa LV, 1997, STEM CELLS, V15, P95; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Li CI, 2010, CANCER RES, V70, P7187, DOI 10.1158/0008-5472.CAN-10-0276; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McAleer MF, 2005, INT J RADIAT ONCOL, V61, P10, DOI 10.1016/j.ijrobp.2004.09.046; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Mezentsev A, 2011, RADIAT RES, V175, P677, DOI 10.1667/RR2483.1; Miao L, 2014, ANTIOXID REDOX SIGN, V20, P1481, DOI 10.1089/ars.2013.5637; Nylund R, 2014, J RADIAT RES, V55, P674, DOI 10.1093/jrr/rru007; OECD/ OCDE, 2013, EXPT STUDY RAD EFFEC; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pereira S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092974; Pereira S, 2011, ENVIRON TOXICOL CHEM, V30, P2831, DOI 10.1002/etc.695; Rajesh K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.554; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rojo I, 2007, FISH SHELLFISH IMMUN, V23, P1285, DOI 10.1016/j.fsi.2007.07.002; Savli H., 2012, Experimental Oncology, V34, P57; Savli H, 2016, TURK J HEMATOL, V33, P8, DOI 10.4274/tjh.2014.0190; Seo M, 2014, J MOL BIOL, V426, P830, DOI 10.1016/j.jmb.2013.11.021; Sharlow ER, 2016, ACS CHEM BIOL; Sharma MK, 2005, GENE EXPR PATTERNS, V5, P371, DOI 10.1016/j.modgep.2004.09.010; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Shoji H, 2014, ACTA PAEDIATR, V103, P22, DOI 10.1111/apa.12436; Simon O, 2011, J ENVIRON RADIOACTIV, V102, P1039, DOI 10.1016/j.jenvrad.2011.06.004; Skinner MK, 2011, BIRTH DEFECTS RES C, V93, P51, DOI 10.1002/bdrc.20199; Stalmans I, 2005, Verh K Acad Geneeskd Belg, V67, P229; Streffer C, 2004, MUTAT RES-FUND MOL M, V568, P79, DOI 10.1016/j.mrfmmm.2004.07.014; Tawana K, 2016, DEREGULATED LEVELS N; Tedgren AC, 2014, BRACHYTHERAPY, V13, P420, DOI 10.1016/j.brachy.2014.01.002; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UNSCEAR, 1996, UN SCI COMM EFF AT R; WARGA RM, 1990, DEVELOPMENT, V108, P569; Wegert J, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-136; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Williams RD, 2015, ONCOTARGET, V6, P7232, DOI 10.18632/oncotarget.3377; Xie F., 2012, PLANT MOL BIOL; Xu JK, 2013, J BIOL CHEM, V288, P34799, DOI 10.1074/jbc.M113.495580; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; YAMAMOTO T, 2014, NAT COMMUN, V5; Yamane K, 2003, J IMMUNOL, V171, P3855, DOI 10.4049/jimmunol.171.7.3855; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024; Yuan H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15838	88	28	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2017	12	6							e0179259	10.1371/journal.pone.0179259	http://dx.doi.org/10.1371/journal.pone.0179259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY5TN	28628668	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000404043100020
J	Chui, APY; Ang, P				Chui, Apple Pui Yi; Ang, Put, Jr.			High tolerance to temperature and salinity change should enable scleractinian coral Platygyra acuta from marginal environments to persist under future climate change	PLOS ONE			English	Article							LIFE-HISTORY STAGES; ELEVATED-TEMPERATURE; LARVAL DEVELOPMENT; OCEAN ACIDIFICATION; PORITES-ASTREOIDES; DIPLORIA-STRIGOSA; CARIBBEAN CORAL; ACROPORA SPP.; RANGE SHIFTS; REEF CORALS	With projected changes in the marine environment under global climate change, the effects of single stressors on corals have been relatively well studied. However, more focus should be placed on the interactive effects of multiple stressors if their impacts upon corals are to be assessed more realistically. Elevation of sea surface temperature is projected under global climate change, and future increases in precipitation extremes related to the monsoon are also expected. Thus, the lowering of salinity could become a more common phenomenon and its impact on corals could be significant as extreme precipitation usually occurs during the coral spawning season. Here, we investigated the interactive effects of temperature [24, 27 (ambient), 30, 32 degrees C] and salinity [33 psu (ambient), 30, 26, 22, 18, 14 psu] on larval settlement, post-settlement survival and early growth of the dominant coral Platygyra acuta from Hong Kong, a marginal environment for coral growth. The results indicate that elevated temperatures (+3 degrees C and +5 degrees C above ambient) did not have any significant effects on larval settlement success and post-settlement survival for up to 56 days of prolonged exposure. Such thermal tolerance was markedly higher than that reported in the literature for other coral species. Moreover, there was a positive effect of these elevated temperatures in reducing the negative effects of lowered salinity (26 psu) on settlement success. The enhanced settlement success brought about by elevated temperatures, together with the high post-settlement survival recorded up to 44 and 8 days of exposure under +3 degrees C and +5 degrees C ambient respectively, resulted in the overall positive effects of elevated temperatures on recruitment success. These results suggest that projected elevation in temperature over the next century should not pose any major problem for the recruitment success of P. acuta. The combined effects of higher temperatures and lowered salinity (26 psu) could even be beneficial. Therefore, corals that are currently present in marginal environments like Hong Kong, as exemplified by the dominant P. acuta, are likely to persist in a warmer and intermittently less saline, future ocean.	[Chui, Apple Pui Yi; Ang, Put, Jr.] Chinese Univ Hong Kong, Sch Life Sci, Marine Sci Lab, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Ang, P (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Marine Sci Lab, Shatin, Hong Kong, Peoples R China.	put-ang@cuhk.edu.hk	Ang, Put/AAO-5490-2021		Hong Kong Research Grant Council General Research Fund [460013, 14122215]	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council)	This work was supported by Hong Kong Research Grant Council General Research Fund No. 460013 and No. 14122215, https://cerg1.ugc.edu.hk/cergprod/scrrm00541.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANG PO, 2005, STATUS CORAL REEFS E, P121; BABCOCK RC, 1986, CORAL REEFS, V5, P111, DOI 10.1007/BF00298178; Baird AH, 2012, CORAL REEFS, V31, P1063, DOI 10.1007/s00338-012-0928-6; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Berkelmans R, 2012, CORAL REEFS, V31, P1103, DOI 10.1007/s00338-012-0930-z; Brown BE, 2000, NATURE, V404, P142, DOI 10.1038/35004657; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Chui APY, 2015, CORAL REEFS, V34, P461, DOI 10.1007/s00338-014-1247-x; Chui Apple Pui Yi, 2014, Journal of Marine Biology, P953587; Chui APY, 2016, REG STUD MAR SCI; Coles S.L., 1992, P147; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Descombes P, 2015, GLOBAL CHANGE BIOL, V21, P2479, DOI 10.1111/gcb.12868; Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224; Edmunds PJ, 2001, MAR BIOL, V139, P981; Granados-Cifuentes C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-228; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Hedouin L, 2015, MAR ENVIRON RES, V104, P1, DOI 10.1016/j.marenvres.2014.12.001; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2014, CURR OPIN ENV SUST, V7, P127, DOI 10.1016/j.cosust.2014.01.005; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; JOHNSON CR, 1992, P 7 INT COR REEF S G, V1, P606; Keshavmurthy S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05633; Kwok CK, 2016, CORAL REEFS, V35, P827, DOI 10.1007/s00338-016-1432-1; Kwok CK, 2013, MAR POLLUT BULL, V74, P264, DOI 10.1016/j.marpolbul.2013.06.048; Lam EKY, 2015, CORAL REEFS, V34, P837, DOI 10.1007/s00338-015-1317-8; Lee TC, 2011, ACTA METEOROL SIN, V25, P691, DOI 10.1007/s13351-011-0601-y; Marshall DJ, 2003, MAR ECOL PROG SER, V246, P153, DOI 10.3354/meps246153; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Nozawa Y, 2000, 9 INT COR REEF S, P409; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Olsen K, 2015, B MAR SCI, V91, P255, DOI 10.5343/bms.2014.1050; Olsen K, 2014, MAR ECOL PROG SER, V509, P181, DOI 10.3354/meps10880; Omori M., 2014, METHODS FARMING SEXU, P1; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Randall CJ, 2009, BIOL BULL-US, V217, P269, DOI 10.1086/BBLv217n3p269; RICHMOND RH, 1993, AM ZOOL, V33, P524; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Rosic N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1052; Ross C, 2013, CORAL REEFS, V32, P71, DOI 10.1007/s00338-012-0956-2; Scott A, 2013, MAR ENVIRON RES, V92, P10, DOI 10.1016/j.marenvres.2013.08.001; SHLESINGER Y, 1991, HYDROBIOLOGIA, V216, P101, DOI 10.1007/BF00026449; Stocker TF, 2013, INT PAN CLIM CHANG 2; Tam TW, 2008, AQUAT CONSERV, V18, P1005, DOI 10.1002/aqc.922; True JD, 2012, 12 INT COR REEF S 20, P9; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448; Woolsey ES, 2015, CORAL REEFS, V34, P471, DOI 10.1007/s00338-014-1253-z; Woolsey ES, 2013, MAR ECOL PROG SER, V493, P179, DOI 10.3354/meps10499; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	58	10	10	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179423	10.1371/journal.pone.0179423	http://dx.doi.org/10.1371/journal.pone.0179423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622371	gold, Green Published, Green Submitted			2022-12-26	WOS:000403506300031
J	Wang, B; Xu, M; Li, WJ; Li, XL; Zheng, QS; Niu, XL				Wang, Bin; Xu, Ming; Li, Wenju; Li, Xiaoli; Zheng, Qiangsun; Niu, Xiaolin			Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via beta 3-AR-nNOS-NO activation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; HUMAN FAILING MYOCARDIUM; HEART-FAILURE; OXIDATIVE STRESS; BETA(3)-ADRENOCEPTOR STIMULATION; CARDIOVASCULAR-SYSTEM; KINASE-II; RECEPTOR; RAT	Aerobic exercise confers sustainable protection against cardiac hypertrophy and heart failure (HF). Nitric oxide synthase (NOS) and nitric oxide (NO) are known to play an important role in exercise-mediated cardioprotection, but the mechanism of NOS/NO stimulation during exercise remains unclear. The aim of this study is to determine the role of beta 3-adrenergic receptors (beta 3-ARs), NOS activation, and NO metabolites (nitrite and nitrosothiols) in the sustained cardioprotective effects of aerobic exercise. An HF model was constructed by transverse aortic constriction (TAC). Animals were treated with either moderate aerobic exercise by swimming for 9 weeks and/or the beta 3-AR-specific inhibitor SR59230A at 0.1 mg/kg/hour one day after TAC operation. Myocardial fibrosis, myocyte size, plasma catecholamine (CA) level, cardiac function and geometry were assessed using Masson's trichrome staining, FITC-labeled wheat germ agglutinin staining, enzyme-linked immuno sorbent assay (ELISA) and echocardiography, respectively. Western blot analysis was performed to elucidate the expression of target proteins. The concentration of myocardial NO production was evaluated using the nitrate reductase method. Myocardial oxidative stress was assessed by detecting the concentration of myocardial super oxidative dismutase (SOD), malonyldialdehyde (MDA), and reactive oxygen species (ROS). Aerobic exercise training improved dilated left ventricular function and partially attenuated the degree of cardiac hypertrophy and fibrosis in TAC mice. Moreover, the increased expression of beta 3-AR, activation of neuronal NOS (nNOS), and production of NO were detected after aerobic exercise training in TAC mice. However, selective inhibition of beta 3-AR by SR59230A abolished the upregulation and activation of nNOS induced NO production. Furthermore, aerobic exercise training decreased the myocardial ROS and MDA contents and increased myocardial levels of SOD; both effects were partially attenuated by SR59230A. Our study suggested that aerobic exercise training could improve cardiac systolic function and alleviate LV chamber dilation, cardiac fibrosis and hypertrophy in HF mice. The mechanism responsible for the protective effects of aerobic exercise is associated with the activation of the beta 3-AR-nNOS-NO pathway.	[Wang, Bin; Li, Wenju; Li, Xiaoli; Zheng, Qiangsun; Niu, Xiaolin] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian, Peoples R China; [Xu, Ming] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Physiol, Shanghai, Peoples R China; [Zheng, Qiangsun] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian, Peoples R China	Air Force Military Medical University; Shanghai University of Traditional Chinese Medicine; Xi'an Jiaotong University	Zheng, QS; Niu, XL (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian, Peoples R China.; Zheng, QS (corresponding author), Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 2, Xian, Peoples R China.	qiangsunzheng@gmail.com; xiaolinniu@163.com	Li, Xiaoli/GYQ-7384-2022	niu, xiaolin/0000-0002-8320-5516; Li, Wenju/0000-0001-8576-2271; xu, ming/0000-0001-5234-2203	National Natural Science Foundation of China [81570227]; Young Science and Technology Star Foundation of Shaanxi Province [2015KJKK-52]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Science and Technology Star Foundation of Shaanxi Province	This work was supported by National Natural Science Foundation of China NO. 81570227 (To Dr Niu) (http://www.nsfc.gov.cn/); and Young Science and Technology Star Foundation of Shaanxi Province NO. 2015KJKK-52 (To Dr Niu) (http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon JP, 2011, J AM COLL CARDIOL, V58, P2683, DOI 10.1016/j.jacc.2011.09.033; Aydin C, 2007, CELL BIOCHEM FUNCT, V25, P129, DOI 10.1002/cbf.1279; Balci SS, 2012, CHINESE J PHYSIOL, V55, P236, DOI 10.4077/CJP.2012.BAA021; Balligand JL, 2009, J AM COLL CARDIOL, V53, P1539, DOI 10.1016/j.jacc.2009.01.048; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Bisognano JD, 2000, J MOL CELL CARDIOL, V32, P817, DOI 10.1006/jmcc.2000.1123; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1993, J CLIN INVEST, V92, P2737, DOI 10.1172/JCI116891; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Brown DA, 2005, J PHYSIOL-LONDON, V569, P913, DOI 10.1113/jphysiol.2005.095729; Calvert JW, 2011, CIRC RES, V108, P1448, DOI 10.1161/CIRCRESAHA.111.241117; Carnicer R, 2013, ANTIOXID REDOX SIGN, V18, P1078, DOI 10.1089/ars.2012.4824; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097810; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Ferrari R, 1996, HEART, V76, P50, DOI 10.1136/hrt.76.1.50; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Giallauria F, 2013, EUR J NUCL MED MOL I, V40, P315, DOI 10.1007/s00259-012-2302-x; Ha TZ, 2006, AM J PHYSIOL-HEART C, V290, pH985, DOI 10.1152/ajpheart.00720.2005; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Husain K, 2004, BIOCHEM BIOPH RES CO, V320, P1169, DOI 10.1016/j.bbrc.2004.06.058; Kanter M., 2016, EXP CLIN ENDOCRINOL; KAYE DM, 1995, J AM COLL CARDIOL, V26, P1257, DOI 10.1016/0735-1097(95)00332-0; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Kompa AR, 1999, J MOL CELL CARDIOL, V31, P1185, DOI 10.1006/jmcc.1999.0951; Kumral ZNO, 2016, J PHYSIOL PHARMACOL, V67, P45; Lennon SL, 2004, J APPL PHYSIOL, V96, P1299, DOI 10.1152/japplphysiol.00920.2003; Lymperopoulos A, 2007, TRENDS MOL MED, V13, P503, DOI 10.1016/j.molmed.2007.10.005; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mishra OP, 2009, NEUROSCI LETT, V462, P64, DOI 10.1016/j.neulet.2009.06.075; Moens AL, 2010, J MOL CELL CARDIOL, V48, P1088, DOI 10.1016/j.yjmcc.2010.02.011; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Napp A, 2009, J CARD FAIL, V15, P57, DOI 10.1016/j.cardfail.2008.08.006; Niu XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098713; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Orso F, 2016, HDB EXP PHARM; Paolillo S, 2013, DIABETES CARE, V36, P2395, DOI 10.2337/dc12-2147; Piepoli MF, 2004, BMJ-BRIT MED J, V328, P189, DOI 10.1136/bmj.37938.645220.EE; Rameau GA, 2003, NEUROBIOL AGING, V24, P1123, DOI 10.1016/j.neurobiolaging.2003.07.002; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Rengo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052952; Rengo G, 2010, AM J PHYSIOL-HEART C, V298, pH2032, DOI 10.1152/ajpheart.00702.2009; Roof SR, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0332-6; Rozec B, 2003, ARCH MAL COEUR VAISS, V96, P905; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Schlaich MP, 2004, HYPERTENSION, V43, P169, DOI 10.1161/01.HYP.0000103160.35395.9E; Sucharov CC, 2006, AM J PHYSIOL-HEART C, V291, pH1299, DOI 10.1152/ajpheart.00017.2006; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; Venditti P, 1997, INT J SPORTS MED, V18, P497, DOI 10.1055/s-2007-972671; Wei LF, 2016, TURK NEUROSURG, V26, P384, DOI 10.5137/1019-5149.JTN.8265-13.1; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098179; Zheng H, 2016, AM J PHYSIOL-HEART C, V311, pH337, DOI 10.1152/ajpheart.00999.2015; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	57	14	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2017	12	6							e0179648	10.1371/journal.pone.0179648	http://dx.doi.org/10.1371/journal.pone.0179648			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX8NF	28622359	Green Published, Green Submitted, gold			2022-12-26	WOS:000403506300046
J	Thomason, RT; Pettiglio, MA; Herrera, C; Kao, C; Gitlin, JD; Bartnikas, TB				Thomason, Rebecca T.; Pettiglio, Michael A.; Herrera, Carolina; Kao, Clara; Gitlin, Jonathan D.; Bartnikas, Thomas B.			Characterization of trace metal content in the developing zebrafish embryo	PLOS ONE			English	Article							COPPER-METABOLISM; DANIO-RERIO; MANGANESE; ZINC; DEFICIENCY; SLC39A8; GLYCOSYLATION; MODEL	Trace metals are essential for health but toxic when present in excess. The maintenance of trace metals at physiologic levels reflects both import and export by cells and absorption and excretion by organs. The mechanism by which this maintenance is achieved in vertebrate organisms is incompletely understood. To explore this, we chose zebrafish as our model organism, as they are amenable to both pharmacologic and genetic manipulation and comprise an ideal system for genetic screens and toxicological studies. To characterize trace metal content in developing zebrafish, we measured levels of three trace elements, copper, zinc, and manganese, from the oocyte stage to 30 days post-fertilization using inductively coupled plasma mass spectrometry. Our results indicate that metal levels are stable until zebrafish can acquire metals from the environment and imply that the early embryo relies on maternal contribution of metals to the oocyte. We also measured metal levels in bodies and yolks of embryos reared in presence and absence of the copper chelator neocuproine. All three metals exhibited different relative abundances between yolks and bodies of embryos. While neocuproine treatment led to an expected phenotype of copper deficiency, total copper levels were unaffected, indicating that measurement of total metal levels does not equate with measurement of biologically active metal levels. Overall, our data not only can be used in the design and execution of genetic, physiologic, and toxicologic studies but also has implications for the understanding of vertebrate metal homeostasis.	[Thomason, Rebecca T.] Univ Virginia, Charlottesville, VA USA; [Pettiglio, Michael A.; Herrera, Carolina; Bartnikas, Thomas B.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Kao, Clara; Gitlin, Jonathan D.] Eugene Bell Ctr, Marine Biol Lab, Woods Hole, MA USA	University of Virginia; Brown University; Marine Biological Laboratory - Woods Hole	Bartnikas, TB (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	thomas_bartnikas@brown.edu		Latimer, Rebecca Thomason/0000-0002-0254-6803	National Institutes of Health [R00 DK84122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, R00 DK84122. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakthavatsalam S, 2014, DIS MODEL MECH, V7, P1239, DOI 10.1242/dmm.016683; Bourassa D, 2014, METALLOMICS, V6, P1648, DOI 10.1039/c4mt00121d; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Collins J.F., 2017, MOL GENETIC NUTR ASP; Dai YJ, 2014, ENVIRON TOXICOL CHEM, V33, P11, DOI 10.1002/etc.2406; Herna Andez PP, 2008, AM J CLIN NUTR, V88, p835S; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Kaler SG, 2013, HAND CLINIC, V113, P1745, DOI 10.1016/B978-0-444-59565-2.00045-9; Kambe T, 2015, J NUTR SCI VITAMINOL, V61, pS44, DOI 10.3177/jnsv.61.S44; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Maret W, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010066; Mendelsohn BA, 2006, CELL METAB, V4, P155, DOI 10.1016/j.cmet.2006.05.001; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Riggio M, 2003, COMP BIOCHEM PHYS C, V135, P191, DOI 10.1016/S1532-0456(03)00107-8; Riley LG, 2017, J INHERIT METAB DIS, V40, P261, DOI 10.1007/s10545-016-0010-6; Tuschl K., 1993, GENEREVIEWS; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Yan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042939	20	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2017	12	6							e0179318	10.1371/journal.pone.0179318	http://dx.doi.org/10.1371/journal.pone.0179318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX6PQ	28617866	Green Published, gold, Green Submitted			2022-12-26	WOS:000403364600030
J	Chen, WY; Chen, LY; Liu, HC; Wu, CS; Yang, SY; Pan, CH; Tsai, SY; Chen, CC; Kuo, CJ				Chen, Wen-Yin; Chen, Lian-Yu; Liu, Hsing-Cheng; Wu, Chi-Shin; Yang, Shu-Yu; Pan, Chun-Hung; Tsai, Shang-Ying; Chen, Chiao-Chicy; Kuo, Chian-Jue			Antipsychotic medications and stroke in schizophrenia: A case-crossover study	PLOS ONE			English	Article							CEREBROVASCULAR EVENTS; RISK-FACTORS; MORTALITY; COMORBIDITIES; METAANALYSIS; ASSOCIATION; PNEUMONIA; HISTAMINE; PEOPLE; COHORT	Background The association between antipsychotic use and the risk of stroke in schizophrenic patients is controversial. We sought to study the association in a nationwide cohort with schizophrenia. Methods Using a retrospective cohort of patients with schizophrenia (N = 31,976) derived from the Taiwan National Health Insurance Research Database, 802 new-onset cases of stroke were identified within 10 years of follow-up (from 2000 through 2010). We designed a case-crossover study using 14-day windows to explore the risk factors of stroke and the association between antipsychotic drugs and the risk of stroke. We analyzed the risks of individual antipsychotics on various subgroups of stroke including ischemic, hemorrhagic, and other strokes, and the risks based on the antipsychotic receptor-binding profile of each drug. Results Use of any second-generation antipsychotic was associated with an increased risk of stroke (adjusted risk ratio = 1.45, P = .009) within 14 days while the use of any first-generation antipsychotic was not. Intriguingly, the use of any second-generation antipsychotic was associated with ischemic stroke but not hemorrhagic stroke. The antipsychotic receptor-binding profile analysis showed that the antihistamine 1 receptor was significantly associated with ischemic stroke (adjusted risk ratio = 1.72, P = .037), and the sensitivity analysis based on the 7-day window of exposure validated the association (adjusted risk ratio = 1.87, P = .015). Conclusions Use of second-generation antipsychotic drugs appeared to be associated with an increased risk of ischemic stroke in the patients studied, possibly mediated by high affinity for hista-mine-1 receptor blockade. Further research regarding the underlying biological mechanism and drug safety is suggested.	[Chen, Wen-Yin; Chen, Lian-Yu; Liu, Hsing-Cheng; Yang, Shu-Yu; Pan, Chun-Hung; Kuo, Chian-Jue] Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chen, Wen-Yin] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chen, Lian-Yu] Natl Cheng Kung Univ, Dept Psychiat, Tainan, Taiwan; [Liu, Hsing-Cheng; Tsai, Shang-Ying; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ, Dept Psychiat, Sch Med, Taipei, Taiwan; [Liu, Hsing-Cheng; Tsai, Shang-Ying; Chen, Chiao-Chicy; Kuo, Chian-Jue] Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan; [Wu, Chi-Shin] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Yang, Shu-Yu] Kaohsiung Med Univ, Grad Inst Clin Pharm, Coll Pharm, Kaohsiung, Taiwan; [Pan, Chun-Hung] Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan; [Chen, Chiao-Chicy] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Chiao-Chicy] Mackay Med Coll, Dept Psychiat, Taipei, Taiwan	Taipei City Hospital; National Taiwan University; National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; National Chengchi University; Mackay Memorial Hospital; Mackay Medical College	Kuo, CJ (corresponding author), Taipei City Hosp, Taipei City Psychiat Ctr, Taipei, Taiwan.; Kuo, CJ (corresponding author), Taipei Med Univ, Dept Psychiat, Sch Med, Taipei, Taiwan.; Kuo, CJ (corresponding author), Taipei Med Univ Hosp, Psychiat Res Ctr, Taipei, Taiwan.	tcpckuo@seed.net.tw	Wu, Chi-Shin/GQP-4970-2022	WU, CHI-SHIN/0000-0003-2762-7295; Pan, Chun-Hung/0000-0002-8542-558X; Chen, Lian-Yu/0000-0001-9241-1613	National Science Council, Taiwan [MOST 105-2314-B-532-006-MY3]; Taipei City Hospital [10401=62=013, 10501=62=015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei City Hospital	This research was supported by grants from the National Science Council, Taiwan (MOST 105-2314-B-532-006-MY3) and Taipei City Hospital (10401=62=013; 10501=62=015).	Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Arsava EM, 2010, NEUROLOGY, V75, P1277, DOI 10.1212/WNL.0b013e3181f612ce; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Chuang YC, 2012, EPILEPSIA, V53, P120, DOI 10.1111/j.1528-1167.2011.03316.x; Crump C, 2013, AM J PSYCHIAT, V170, P324, DOI 10.1176/appi.ajp.2012.12050599; Douglas IJ, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1227; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Greenland S, 2008, MODERN EPIDEMIOLOGY, P125; Hsieh PH, 2013, J CLIN PSYCHOPHARM, V33, P299, DOI 10.1097/JCP.0b013e3182900dfe; HU HH, 1992, STROKE, V23, P1237, DOI 10.1161/01.STR.23.9.1237; KELLY PT, 1983, BRAIN RES, V258, P338, DOI 10.1016/0006-8993(83)91162-9; Kleijer BC, 2009, J PSYCHOPHARMACOL, V23, P909, DOI 10.1177/0269881108093583; Kuo CJ, 2013, SCHIZOPHRENIA BULL, V39, P648, DOI 10.1093/schbul/sbr202; Laredo L, 2011, J AM GERIATR SOC, V59, P1182, DOI 10.1111/j.1532-5415.2011.03479.x; Lazar RM, 2002, STROKE, V33, P283, DOI 10.1161/hs0102.101222; Li M, 2014, INT J CARDIOL, V173, P588, DOI 10.1016/j.ijcard.2014.03.101; Liao CH, 2011, SCHIZOPHR RES, V126, P110, DOI 10.1016/j.schres.2010.12.007; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Nanau RM, 2013, CLIN BIOCHEM, V46, P1323, DOI 10.1016/j.clinbiochem.2013.06.012; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenbaum PR, 1983, BIOMETRIKA, V79, P516; ROSENBLUM WI, 1990, STROKE, V21, P305, DOI 10.1161/01.STR.21.2.305; Roth BL, 2004, PHARMACOL THERAPEUT, V102, P99, DOI 10.1016/j.pharmthera.2004.03.004; Sacchetti E, 2010, DRUG SAFETY, V33, P273, DOI 10.2165/11319120-000000000-00000; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Stahl SM, 2013, STAHLS ESSENTIAL PSY; STANIMIROVIC DB, 1994, METAB BRAIN DIS, V9, P275, DOI 10.1007/BF01991201; Szklo M, 2014, EPIDEMIOLOGY BASICS, P32; Wu CS, 2013, BIOL PSYCHIAT, V73, P414, DOI 10.1016/j.biopsych.2012.07.006; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Yang SY, 2013, J CLIN PSYCHIAT, V74, pE79, DOI 10.4088/JCP.12m07938	32	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179424	10.1371/journal.pone.0179424	http://dx.doi.org/10.1371/journal.pone.0179424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614417	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900051
J	Gennet, S; Spotswood, E; Hammond, M; Bartolome, JW				Gennet, Sasha; Spotswood, Erica; Hammond, Michele; Bartolome, James W.			Livestock grazing supports native plants and songbirds in a California annual grassland	PLOS ONE			English	Article							NORTH-AMERICAN GRASSLAND; BREEDING BIRD SURVEY; VEGETATION STRUCTURE; NESTING SUCCESS; HABITAT SELECTION; PATCH SIZE; ABUNDANCE; FIRE; HETEROGENEITY; CONSERVATION	Over eight years we measured the effects of plant community composition, vegetation structure, and livestock grazing on occurrence of three grassland bird species-Western Meadowlark (Sturnella neglecta), Horned Lark (Eremophila alpestris), and Grasshopper Sparrow (Ammodramus savannarum)-at sites in central California during breeding season. In California's Mediterranean-type climatic region, coastal and inland grassland vegetation is dominated by exotic annual grasses with occasional patches of native bunchgrass and forbs. Livestock grazing, primarily with beef cattle, is the most widely used management tool. Compared with ungrazed plots, grazed plots had higher bare ground, native plant cover, and vertically heterogeneous vegetation. Grazed plots also had less plant litter and shorter vegetation. Higher native plant cover, which is predominantly composed of bunchgrasses in our study area, was associated with livestock grazing and north-facing aspects. Using an information theoretic approach, we found that all three bird species had positive associations with native plant abundance and neutral (Western Meadowlark, Grasshopper Sparrow) or positive (Horned Lark) association with livestock grazing. All species favored flatter areas. Horned Larks and Western Meadowlark occurred more often where there were patches of bare ground. Western Meadowlarks and Grasshopper Sparrows were most common on north-facing slopes, suggesting that these species may be at risk from projected climate change. These findings demonstrate that livestock grazing is compatible with or supports grassland bird conservation in Mediterranean-type grasslands, including areas with high levels of exotic annual grass invasion, in part because grazing supports the persistence of native plants and heterogeneity in vegetation structure. However, conservation of low-lying grasslands with high native species presence, and active management to increase the abundance of native plant species are also likely to be important for sustaining grassland birds long-term.	[Gennet, Sasha] Nature Conservancy, San Francisco, CA 94105 USA; [Spotswood, Erica] San Francisco Estuary Inst, Richmond, CA USA; [Hammond, Michele] East Bay Reg Pk Dist, Oakland, CA USA; [Bartolome, James W.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Nature Conservancy; University of California System; University of California Berkeley	Gennet, S (corresponding author), Nature Conservancy, San Francisco, CA 94105 USA.	sgennet@tnc.org		Gennet, Sasha/0000-0002-6338-5337	East Bay Regional Park District	East Bay Regional Park District	East Bay Regional Park District (http://www.abparks.org/) provided support to the University of California, Berkeley, Rangeland Ecology Lab, led by Dr. Bartolome, for 2000-2010 field sampling. The project was developed to assess the effects of livestock grazing on natural resources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christine Gaber, Peter Hopkinson, Luke Macaulay, Devii Rao, and Andrew Scavullo from the Rangeland Ecology Laboratory at the University of California, Berkeley for assistance with field work, and David Amme, Douglas Bell and Joseph DiDonato at the East Bay Regional Park District for support and project funding.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Allen B., 2000, POINT REYES BIRD OBS; Askins Robert A., 2007, Ornithological Monographs, V64, pi; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Bartolome J., 2006, GUIDELINES RESIDUAL, P8092; Bartolome JW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P367; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; BISWELL H. H., 1956, JOUR RANGE MANAGEMENT, V9, P19, DOI 10.2307/3894645; BOCK CE, 1992, SOUTHWEST NAT, V37, P73, DOI 10.2307/3672149; Bock CE, 1999, STUD AVIAN BIOL-SER, P131; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bush L, 2006, GRAZING HDB GUIDE RE; CALLAWAY RM, 1993, ECOLOGY, V74, P1567, DOI 10.2307/1940084; Cameron DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103468; CANNINGS R J, 1981, Murrelet, V62, P21, DOI 10.2307/3534447; CHURCHWELL R. T., 2005, THESIS; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; CODY ML, 1968, AM NAT, V102, P107, DOI 10.1086/282531; Collier CL, 1994, THESIS; Collins SL, 2006, ECOLOGY, V87, P2058, DOI 10.1890/0012-9658(2006)87[2058:SIOFAG]2.0.CO;2; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Crawley M.J., 2007, R BOOK; D'Antonio C, 2003, ECOLOGY RESTORATION; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis S., 2008, BIRDS N AM; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Davis SK, 2004, AUK, V121, P1130, DOI 10.1642/0004-8038(2004)121[1130:ASIGPE]2.0.CO;2; Dennis P, 1998, ECOL ENTOMOL, V23, P253, DOI 10.1046/j.1365-2311.1998.00135.x; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; Dyer AR, 1999, ECOLOGY, V80, P2697, DOI 10.1890/0012-9658(1999)080[2697:EOCORA]2.0.CO;2; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Flanders AA, 2006, AUK, V123, P171, DOI 10.1642/0004-8038(2006)123[0171:EOIEGO]2.0.CO;2; Fletcher RJ, 2002, J WILDLIFE MANAGE, V66, P1011, DOI 10.2307/3802933; Fritcher SC, 2004, J RANGE MANAGE, V57, P351, DOI 10.2307/4003858; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2004, J APPL ECOL, V41, P604, DOI 10.1111/j.0021-8901.2004.00937.x; Gelbard JL, 2003, ECOL APPL, V13, P404, DOI 10.1890/1051-0761(2003)013[0404:RHARFN]2.0.CO;2; Goerrissen J, 2005, THESIS; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; Hayes GF, 2003, CONSERV BIOL, V17, P1694, DOI 10.1111/j.1523-1739.2003.00281.x; HEADY HAROLD F., 1959, JOUR RANGE MANAGEMENT, V12, P180, DOI 10.2307/3894848; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; Herkert JR, 2003, CONSERV BIOL, V17, P587, DOI 10.1046/j.1523-1739.2003.01418.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; JACKSON LE, 1986, ACTA OECOL-OEC PLANT, V7, P191; Jackson RD, 2002, PLANT ECOL, V162, P49, DOI 10.1023/A:1020363603900; Johnson DH, 2001, AUK, V118, P24, DOI 10.1642/0004-8038(2001)118[0024:AROGBA]2.0.CO;2; Jones MM, 2011, GLOBAL ECOL BIOGEOGR, V20, P558, DOI 10.1111/j.1466-8238.2010.00627.x; Kennedy PL, 2009, RESTOR ECOL, V17, P515, DOI 10.1111/j.1526-100X.2008.00402.x; Kercher SM, 2003, J VEG SCI, V14, P899, DOI 10.1111/j.1654-1103.2003.tb02223.x; Knopf Fritz L., 1994, Studies in Avian Biology, V15, P247; Leonard S, 2010, J APPL ECOL, V47, P876, DOI 10.1111/j.1365-2664.2010.01840.x; Litt AR, 2010, BIOL INVASIONS, V12, P3449, DOI 10.1007/s10530-010-9743-6; Lloyd JD, 2005, CONDOR, V107, P363, DOI 10.1650/7701; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maggini R, 2006, J BIOGEOGR, V33, P1729, DOI 10.1111/j.1365-2699.2006.01465.x; Marzluff John M., 2001, P19; MCNAUGHTON SJ, 1968, ECOLOGY, V49, P962, DOI 10.2307/1936547; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; MILLER EH, 1947, AM MIDL NAT, V37, P379, DOI 10.2307/2421661; Myers N, 2003, BIOSCIENCE, V53, P916; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nobel PS, 1997, ANN BOT-LONDON, V80, P731, DOI 10.1006/anbo.1997.0508; Noss R.F., 1995, ENDANGERED ECOSYSTEM; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Patten MA, 2006, ECOL APPL, V16, P687, DOI 10.1890/1051-0761(2006)016[0687:HELMAR]2.0.CO;2; Patterson MP, 1996, AM MIDL NAT, V135, P153, DOI 10.2307/2426881; Peterjohn BG, 1999, STUD AVIAN BIOL, P27; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2020, R LANG ENV STAT COMP; Ralph JC, 1993, HDB FIELD METHODS MO; Rao D, 2006, 6 S OAK WOODL TOD CH; Reino L, 2010, AGR ECOSYST ENVIRON, V138, P27, DOI 10.1016/j.agee.2010.03.013; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; REYNOLDS RT, 1980, CONDOR, V82, P309, DOI 10.2307/1367399; Rosenstock SS, 2002, AUK, V119, P46, DOI 10.1642/0004-8038(2002)119[0046:LCTCPA]2.0.CO;2; ROTENBERRY JT, 1980, ECOLOGY, V61, P1228, DOI 10.2307/1936840; Rotenberry JT, 1999, STUD AVIAN BIOL, P95; SALA OE, 1986, VEGETATIO, V67, P27; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Scheiman DM, 2003, J WILDLIFE MANAGE, V67, P115, DOI 10.2307/3803067; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Sebastia MT, 2004, BASIC APPL ECOL, V5, P331, DOI 10.1016/j.baae.2003.10.001; Serrano D, 2005, BIOL CONSERV, V125, P391, DOI 10.1016/j.biocon.2005.04.010; Sisk TD, 2002, STUD AVIAN BIOL-SER, P30; Stahlheber KA, 2013, BIOL CONSERV, V157, P300, DOI 10.1016/j.biocon.2012.09.008; Stohlgren TJ, 1998, J RANGE MANAGE, V51, P164, DOI 10.2307/4003202; Stromberg MR., 2007, CALIFORNIA GRASSLAND; Sutter GC, 2000, J FIELD ORNITHOL, V71, P110, DOI 10.1648/0273-8570-71.1.110; Swengel SR, 2001, BIRD CONSERV INT, V11, P113; Turner MD, 1999, J ARID ENVIRON, V41, P277, DOI 10.1006/jare.1998.0485; Vickery J., 1996, BIRDS N AM; Vickery PD, 2000, P 3 PARTN FLIGHT WOR; Vogiatzakis IN, 2003, GLOBAL ECOL BIOGEOGR, V12, P131, DOI 10.1046/j.1466-822X.2003.00021.x; WHITMORE RC, 1981, J WILDLIFE MANAGE, V45, P811, DOI 10.2307/3808729; WHITMORE RC, 1979, AUK, V96, P621; Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; WIENS JA, 1973, ECOLOGY, V54, P877, DOI 10.2307/1935683; WIENS JA, 1979, OECOLOGIA, V42, P253, DOI 10.1007/BF00346594; WIENS JA, 1973, ECOL MONOGR, V43, P237, DOI 10.2307/1942196; WILSON SD, 1989, CONSERV BIOL, V3, P39, DOI 10.1111/j.1523-1739.1989.tb00222.x; Winter M, 2006, J WILDLIFE MANAGE, V70, P158, DOI 10.2193/0022-541X(2006)70[158:PSALEO]2.0.CO;2; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; WITH KA, 1993, CONDOR, V95, P401, DOI 10.2307/1369363; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zuur Alain F., 2009, P1	114	12	13	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0176367	10.1371/journal.pone.0176367	http://dx.doi.org/10.1371/journal.pone.0176367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614358	gold, Green Published, Green Submitted			2022-12-26	WOS:000403280900002
J	Miranda, I; Sousa, V; Ferreira, J; Pereira, H				Miranda, Isabel; Sousa, Vicelina; Ferreira, Joana; Pereira, Helena			Chemical characterization and extractives composition of heartwood and sapwood from Quercus faginea	PLOS ONE			English	Article							AMERICAN OAK WOODS; WEIGHT PHENOLIC-COMPOUNDS; ANTIOXIDANT CAPACITY; GEOGRAPHICAL ORIGIN; DENSITY COMPONENTS; RING WIDTH; SPANISH; ELLAGITANNINS; PORTUGUESE; EVOLUTION	Heartwood and sapwood of Quercus faginea were evaluated in relation to summative chemical composition and non-polar and polar extracts composition, including an assessment of antioxidant properties (DPPH and FRAP). Twenty trees from two sites in Portugal were analysed. Heartwood had approximately two times more solvent extractible compounds than sapwood (on average 19.0% and 9.5%). The lipophilic extractible compounds were below 1%, and most of them were polar e.g. ethanol-soluble compounds corresponded to 65% of total extractives in heartwood and 43% in sapwood. Lignin content was similar in sapwood and heartwood (28.1% and 28.6% of extractive-free wood respectively) as well as the sugar composition. Site did not influence the chemical composition. The lipophilic extractible compounds from both sapwood and heartwood included mainly saturated fatty acids (23.0% and 36.9% respectively) and aromatic compounds were also abundant in sapwood (22.9%). The ethanol-water extractibles had a high content of phenolic substances (558.0 and 319.4 mg GAE/g extract, respectively of heartwood and sapwood). The polyphenolic composition was similar in heartwood and sapwood with higher content of ellagitannins (168.9 and 153.5 mg tannic acid/g of extract in sapwood and heartwood respectively) and very low content of condensed tannins. The antioxidant activity was very high with IC50 of 2.6 mu g/ml and 3.3 mu g/ml for sapwood and heartwood respectively, as compared to standard antioxidants (IC50 of 3.8 mu g/ml for Trolox). The ferric reducing ability was 2.8 and 2.0 mMol Trolox equivalents/g extract of heartwood and sapwood respectively. The variability between trees was low and no differences between the two sites were found. Q. faginea showed a very good potential for cooperage and other applications for which a source of compounds with antioxidant properties is desirable.	[Miranda, Isabel; Sousa, Vicelina; Ferreira, Joana; Pereira, Helena] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal	Universidade de Lisboa	Ferreira, J (corresponding author), Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal.	jpferreira@isa.ulisboa.pt	Ferreira, Joana/I-6369-2019; Pereira, Helena/V-5236-2019; Sousa, Vicelina/B-3067-2016	Ferreira, Joana/0000-0002-7637-3466; Pereira, Helena/0000-0002-5393-4443; Sousa, Vicelina/0000-0003-4221-0041; Miranda, Isabel/0000-0003-0280-5219	Portuguese Science Foundation (FCT) [PTDC/AGR-AAM/69077/2006]; FCT [UID/AGR/00239/2013, SFRH/BPD/97970/2013]	Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The sampling for this research was supported by the Portuguese Project OAKWOODS (PTDC/AGR-AAM/69077/2006) from the Portuguese Science Foundation (FCT) and we thank Jose L. Louzada for providing the samples from Site 1 and Sofia Knapic for project management. We also thank Joaquina Silva and Lidia Silva for help with the chemical analysis. Centro de Estudos Florestais is a research unit funded by FCT under UID/AGR/00239/2013. The second author acknowledges a post-doc scholarship by FCT (SFRH/BPD/97970/2013).	Abdalla S, 2014, BIORESOURCES, V9, P3396; Alanon ME, 2011, FOOD CHEM, V129, P1584, DOI 10.1016/j.foodchem.2011.06.013; Alanon ME, 2011, FOOD CHEM, V128, P997, DOI 10.1016/j.foodchem.2011.04.005; [Anonymous], 2013, IFN6 AR US SOL ESP F; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Blanchette R.A., 1992, DEFENSE MECH WOODY P; Cadahia E, 2003, J AGR FOOD CHEM, V51, P5923, DOI 10.1021/jf0302456; Cadahia E, 2001, J AGR FOOD CHEM, V49, P1790, DOI 10.1021/jf0006168; Cadahia E, 2001, J AGR FOOD CHEM, V49, P3677, DOI 10.1021/jf010288r; Canas S, 2000, HOLZFORSCHUNG, V54, P255, DOI 10.1515/HF.2000.043; Castro-Vazquez L, 2013, EUR FOOD RES TECHNOL, V237, P367, DOI 10.1007/s00217-013-1999-5; de Simon BF, 1999, J AGR FOOD CHEM, V47, P1687, DOI 10.1021/jf9805855; de Simon BF, 1999, HOLZFORSCHUNG, V53, P147, DOI 10.1515/HF.1999.024; De Simon BF, 2006, J AGR FOOD CHEM, V54, P8314, DOI 10.1021/jf061546t; deSimon BF, 1996, J AGR FOOD CHEM, V44, P1507, DOI 10.1021/jf9502461; EGLINTON G, 1968, PHYTOCHEMISTRY, V7, P313, DOI 10.1016/S0031-9422(00)86330-X; EKMAN R, 1979, Acta Academiae Aboensis Ser B Mathematica et Physica, V39, P1; Fries A, 2000, CAN J FOREST RES, V30, P1707, DOI 10.1139/cjfr-30-11-1707; Hernandez RB, 2005, CIENCIA FORESTAL MEX, V30, P25; Jordao AM, 2007, HOLZFORSCHUNG, V61, P155, DOI 10.1515/HF.2007.028; Knapic S, 2007, ANN FOREST SCI, V64, P211, DOI 10.1051/forest:2006105; Knapic S, 2011, CAN J FOREST RES, V41, P1212, DOI [10.1139/X11-038, 10.1139/x11-038]; KOLATTUKUDY PE, 1974, LIPIDS, V9, P682, DOI 10.1007/BF02532176; Lourenco A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01612; Lourenco A, 2008, J WOOD SCI, V54, P464, DOI 10.1007/s10086-008-0972-6; MILLER DP, 1992, AM J ENOL VITICULT, V43, P333; Miranda I, 2006, CAN J FOREST RES, V36, P2675, DOI 10.1139/X06-130; Miranda I, 2011, J WOOD SCI, V57, P171, DOI 10.1007/s10086-010-1164-8; Morais MC, 2012, WOOD SCI TECHNOL, V46, P709, DOI 10.1007/s00226-011-0438-7; Pereira H, 2003, WOOD QUALITY ITS BIO, P53; Reboredo F, 2014, J FORESTRY RES, V25, P249, DOI 10.1007/s11676-014-0456-z; Ruiz-Aquino F, 2015, IND CROP PROD, V65, P90, DOI 10.1016/j.indcrop.2014.11.024; Salem MZM, 2014, BIORESOURCES, V9, P2382; Sanz M, 2012, ANAL CHIM ACTA, V732, P33, DOI 10.1016/j.aca.2011.12.012; SCALBERT A, 1988, PHYTOCHEMISTRY, V27, P3483, DOI 10.1016/0031-9422(88)80753-2; SEIKEL MK, 1971, PHYTOCHEMISTRY, V10, P2249, DOI 10.1016/S0031-9422(00)97238-8; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Sousa VB, 2013, WOOD FIBER SCI, V45, P405; Sousa VB, 2015, IFOREST, V8, DOI 10.3832/ifor1346-008; Sousa VB, 2014, IAWA J, V35, P293, DOI 10.1163/22941932-00000067; Willis RB, 1998, ANALYST, V123, P435, DOI 10.1039/a706862j; Zhang B, 2015, INT J MOL SCI, V16, P6978, DOI 10.3390/ijms16046978	44	37	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179268	10.1371/journal.pone.0179268	http://dx.doi.org/10.1371/journal.pone.0179268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614371	Green Published, gold, Green Submitted			2022-12-26	WOS:000403280900038
J	Qiao, XM; Yin, FY; Ji, YY; Li, YX; Yan, P; Lai, JH				Qiao, Xiaomeng; Yin, Fangyuan; Ji, Yuanyuan; Li, Yunxiao; Yan, Peng; Lai, Jianghua			5-Aza-2'-deoxycytidine in the medial prefrontal cortex regulates alcohol-related behavior and Ntf3-TrkC expression in rats	PLOS ONE			English	Article							DNA METHYLATION INHIBITORS; SIGNALING PATHWAYS; NEUROTROPHIN-3; COCAINE; BRAIN; MICE; METHYLTRANSFERASES; DECITABINE; PLASTICITY; DEPENDENCE	Recent studies have indicated that DNA methylation plays an important role in the development of alcohol abuse. 5-Aza-2'-deoxycytidine (5-Aza-dc), an inhibitor of DNA methyltransferases, was FDA approved for myelodysplastic syndrome treatment. However, it is unclear whether 5-Aza-dc is involved in alcohol abuse. In this study, using a chronic alcohol exposure model in rats, 5-Aza-dc was injected into the medial prefrontal cortex (mPFC). Alcohol-drinking behavior and the anxiety related behavior were evaluated by two-bottle choice and open field test. We found that 5-Aza-dc injection into the mPFC significantly decreased alcohol consumption and alcohol preference in alcohol-exposure rats, corresponding to the reduced blood alcohol levels. Although 5-Aza-dc potentiated the anxiety-like behavior of alcohol-exposure rats, it had no effect on the locomotor activity. Moreover, both of the mRNA and protein levels of DNA Methyltransferase 3A (DNMT3A) and DNMT3B in the mPFC were upregulated after 35 days of alcohol exposure and this upregulation could be reversed by 5-Aza-dc treatment. Additionally, 5-Aza-dc reversed the alcohol-induced down-regulation of neurotrophin-3 (Ntf3), correspondingly the expression of its receptor-TrkC was reduced. These findings identified a functional role of 5-Aza-dc in alcohol-related behavioral phenotypes and one of the potential target genes, Ntf3. We also provide novel evidence for DNA methyltransferases as potential therapeutic targets in alcohol abuse.	[Qiao, Xiaomeng; Yin, Fangyuan; Ji, Yuanyuan; Li, Yunxiao; Yan, Peng; Lai, Jianghua] Xi An Jiao Tong Univ, Sch Med, Coll Forens Sci, Xian, Shaanxi, Peoples R China; [Lai, Jianghua] Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Lai, JH (corresponding author), Xi An Jiao Tong Univ, Sch Med, Coll Forens Sci, Xian, Shaanxi, Peoples R China.; Lai, JH (corresponding author), Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	laijh1011@163.com			National Science Foundation of China [81373247]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation of China (81373247; http://www.nsfa.gov.cn) to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 2001, MOL PSYCHIATR, V6, P593, DOI 10.1038/sj.mp.4000897; Alvarado S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7513; [Anonymous], [No title captured]; Barbier E, 2015, J NEUROSCI, V35, P6153, DOI 10.1523/JNEUROSCI.4571-14.2015; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Boerngen-Lacerda R, 2000, PHARMACOL BIOCHEM BE, V67, P225, DOI 10.1016/S0091-3057(00)00360-9; Chang JY, 1998, J NEUROSCI, V18, P3098; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Elliott E, 2016, J NEUROSCI, V36, P730, DOI 10.1523/JNEUROSCI.0971-15.2016; Fonteneau M, 2017, GENES BRAIN BEHAV, V16, P313, DOI 10.1111/gbb.12354; Han J, 2010, EUR J PHARMACOL, V642, P93, DOI 10.1016/j.ejphar.2010.05.050; Han KA, 2016, J NEUROSCI, V36, P4816, DOI 10.1523/JNEUROSCI.4024-15.2016; Harlaar N, 2013, DRUG ALCOHOL DEPEN, V133, P305, DOI 10.1016/j.drugalcdep.2013.07.026; Helms Christa M, 2012, Front Endocrinol (Lausanne), V3, P10, DOI 10.3389/fendo.2012.00010; Higuchi F, 2011, J PSYCHIATR RES, V45, P1295, DOI 10.1016/j.jpsychires.2011.04.008; Kalsi G, 2009, TRENDS GENET, V25, P49, DOI 10.1016/j.tig.2008.10.005; Kantarjian HM, 2005, SEMIN HEMATOL, V42, pS17, DOI 10.1053/j.seminhematol.2005.05.006; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Keil KP, 2014, DEV BIOL, V396, P237, DOI 10.1016/j.ydbio.2014.10.006; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Kutay H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041949; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Liu P, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00050; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Moore DB, 2004, J NEUROBIOL, V60, P101, DOI 10.1002/neu.20009; Muschler MAN, 2010, J NEURAL TRANSM, V117, P513, DOI 10.1007/s00702-010-0378-7; Oliveira AMM, 2012, NAT NEUROSCI, V15, P1111, DOI 10.1038/nn.3151; de Almeidaa WAO, 2014, SLEEP SCI, V7, P203, DOI 10.1016/j.slsci.2014.10.003; Park BY, 2011, PSYCHIAT INVEST, V8, P130, DOI 10.4306/pi.2011.8.2.130; Paxinos G., 2005, STEREOTAXIC COORDINA, V7th; Pierce RC, 1999, J NEUROSCI, V19, P8685; Ramos-Languren LE, 2013, EUR J NEUROSCI, V37, P1248, DOI 10.1111/ejn.12141; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sales AJ, 2011, BRIT J PHARMACOL, V164, P1711, DOI 10.1111/j.1476-5381.2011.01489.x; Sales AJ, 2016, ACTA NEUROPSYCHIATR, V28, P11, DOI 10.1017/neu.2015.40; Sayapina N V, 2015, Dokl Biol Sci, V464, P223, DOI 10.1134/S0012496615050026; Somkuwar SS, 2016, BRAIN STRUCT FUNCT, V221, P4319, DOI 10.1007/s00429-015-1163-z; Song X., 2017, DNA RES INT J RAPID; STODULKA J, 1991, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V131, P39; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; Tzschentke TM, 2000, AMINO ACIDS, V19, P211, DOI 10.1007/s007260070051; Umriukhin P E, 2015, Ross Fiziol Zh Im I M Sechenova, V101, P1366; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Warnault V, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.4; White AM, 2003, ALCOHOL RES HEALTH, V27, P186; Xing B, 2014, NEUROSCI LETT, V574, P11, DOI 10.1016/j.neulet.2014.04.050; Zhu Y., 2013, EURASIP J ADV SIG PR, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0054930	51	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2017	12	6							e0179469	10.1371/journal.pone.0179469	http://dx.doi.org/10.1371/journal.pone.0179469			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5KN	28614398	Green Published, Green Submitted, gold			2022-12-26	WOS:000403280900055
J	Cai, YY; Liu, YT; Culhane, KJ; DeVree, BT; Yang, Y; Sunahara, RK; Yan, ECY				Cai, Yingying; Liu, Yuting; Culhane, Kelly J.; DeVree, Brian T.; Yang, Yang; Sunahara, Roger K.; Yan, Elsa C. Y.			Purification of family B G protein-coupled receptors using nanodiscs: Application to human glucagon-like peptide-1 receptor	PLOS ONE			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; HIGH-LEVEL EXPRESSION; LIGAND-BINDING; GLP-1 RECEPTOR; PARATHYROID-HORMONE; CRYSTAL-STRUCTURE; SECRETIN FAMILY; IN-VITRO; RHODOPSIN; ACTIVATION	Family B G protein-coupled receptors (GPCRs) play vital roles in hormone-regulated homeostasis. They are drug targets for metabolic diseases, including type 2 diabetes and osteoporosis. Despite their importance, the signaling mechanisms for family B GPCRs at the molecular level remain largely unexplored due to the challenges in purification of functional receptors in sufficient amount for biophysical characterization. Here, we purified the family B GPCR human glucagon-like peptide-1 (GLP-1) receptor (GLP1R), whose agonists, e.g. exendin-4, are used for the treatment of type 2 diabetes mellitus. The receptor was expressed in HEK293S GnTl -cells using our recently developed protocol. The protocol incorporates the receptor into the native-like lipid environment of reconstituted high density lipoprotein (rHDL) particles, also known as nanodiscs, immediately after the membrane solubilization step followed by chromatographic purification, minimizing detergent contact with the target receptor to reduce denaturation and prolonging stabilization of receptor in lipid bilayers without extra steps of reconstitution. This method yielded purified GLP1R in nanodiscs that could bind to GLP-1 and exendin-4 and activate G(s) protein. This nanodisc purification method can potentially be a general strategy to routinely obtain purified family B GPCRs in the 10s of microgram amounts useful for spectroscopic analysis of receptor functions and activation mechanisms.	[Cai, Yingying; Liu, Yuting; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Culhane, Kelly J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [DeVree, Brian T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Yang, Yang] Yale Univ, Nanobiol Inst, New Haven, CT USA; [Yang, Yang] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Sunahara, Roger K.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Yale University; Yale University; University of Michigan System; University of Michigan; Yale University; Yale University; University of California System; University of California San Diego	Yan, ECY (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	elsa.yan@yale.edu	DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020	Yan, Elsa/0000-0002-3583-1627; DeVree, Brian/0000-0003-0582-8125	Yale Setup fund; National Institute of Health Biophysics Training Grant [T32 GM008283-27]; National Institute of General Medical Sciences [R01-GM083118, R01-GM068603]; Molecular Biophysics Training Grant [T32GM008270]; National Institute of Health Director's New Innovator Award [DP2-GM114830]; NIH Biophysics Training Grant [T32 GM008283-27]; NIH Director's New Innovator Award [DP2-GM114830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM114830, T32GM008270, R01GM083118, T32GM008283, R01GM068603] Funding Source: NIH RePORTER	Yale Setup fund; National Institute of Health Biophysics Training Grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Molecular Biophysics Training Grant; National Institute of Health Director's New Innovator Award; NIH Biophysics Training Grant; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was partially supported by the Yale Setup fund (to EY), the National Institute of Health Biophysics Training Grant T32 GM008283-27 (to KC), the National Institute of General Medical Sciences Grants R01-GM083118 and R01-GM068603 (to RKS), Molecular Biophysics Training Grant T32GM008270 (to BTD) and the National Institute of Health Director's New Innovator Award DP2-GM114830 (to support YY and to maintain the TEM facility). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Victor S. Batista for providing the schematic figure of a receptor incorporated nanodisc. We also thank Prof. Chenxiang Lin for the access to the transmission electron spectroscope facility. The work was partially supported by the Yale Setup fund (to EY), the NIH Biophysics Training Grant T32 GM008283-27 (to KC), the National Institute of General Medical Sciences Grants RO1-GM083118 and RO1-GM068603 (to RKS), Molecular Biophysics Training Grant T32GM008270 (to BTD) and the NIH Director's New Innovator Award DP2-GM114830 (to support YY and to maintain the TEM facility).	Aaboe K, 2008, DIABETES OBES METAB, V10, P994, DOI 10.1111/j.1463-1326.2008.00853.x; Al-Sabah S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106890; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Bradley SJ, 2016, ANNU REV PHARMACOL, V56, P535, DOI 10.1146/annurev-pharmtox-011613-140012; Breivogel CS, 1998, J BIOL CHEM, V273, P16865, DOI 10.1074/jbc.273.27.16865; BROWN PJ, 1993, J BIOL CHEM, V268, P6668; Bueno AB, 2016, J BIOL CHEM, V291, P10700, DOI 10.1074/jbc.M115.696039; Buteau J, 2008, DIABETES METAB, V34, pS73, DOI 10.1016/S1262-3636(08)73398-6; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; Christ E, 2010, ENDOCRIN METAB CLIN, V39, P791, DOI 10.1016/j.ecl.2010.09.003; Chung KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054942; Corin K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00172; Culhane KJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00264; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2016, NAT STRUCT MOL BIOL, V23, P481, DOI 10.1038/nsmb.3195; Deupi X, 2007, ADV PROTEIN CHEM, V74, P137, DOI 10.1016/S0065-3231(07)74004-4; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; GOKE R, 1993, J BIOL CHEM, V268, P19650; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; GROMADA J, 1995, FEBS LETT, V373, P182, DOI 10.1016/0014-5793(95)01070-U; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huber T, 2013, METHOD ENZYMOL, V520, P281, DOI 10.1016/B978-0-12-391861-1.00013-7; Kieffer TJ, 1996, ENDOCRINOLOGY, V137, P5119, DOI 10.1210/en.137.11.5119; Kim H, 2009, BIOCHEMISTRY-US, V48, P10976, DOI 10.1021/bi901291c; Kumari P, 2015, TRENDS MOL MED, V21, P687, DOI 10.1016/j.molmed.2015.09.002; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; LAZARENO S, 1993, LIFE SCI, V52, P449, DOI 10.1016/0024-3205(93)90301-I; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Liu YT, 2015, CHEM COMMUN, V51, P6157, DOI 10.1039/c5cc00301f; Mak PJ, 2011, J AM CHEM SOC, V133, P1357, DOI 10.1021/ja105869p; Mann RJ, 2010, BRIT J PHARMACOL, V160, P1973, DOI 10.1111/j.1476-5381.2010.00834.x; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; Mitra N, 2013, ACS CHEM BIOL, V8, P617, DOI 10.1021/cb300466n; Mooney V, 2015, J AM CHEM SOC, V137, P307, DOI 10.1021/ja510553f; Nadkarni P, 2014, PROG MOL BIOL TRANSL, V121, P23, DOI 10.1016/B978-0-12-800101-1.00002-8; Naganathan S, 2013, BIOCHEMISTRY-US, V52, P1028, DOI 10.1021/bi301292h; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nimchinsky EA, 1997, J BIOL CHEM, V272, P29229, DOI 10.1074/jbc.272.46.29229; Ohtaki T, 1998, J BIOL CHEM, V273, P15464, DOI 10.1074/jbc.273.25.15464; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Park M, 2015, CHEM BIOL, V22, P1431, DOI 10.1016/j.chembiol.2015.09.014; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Poyner DR, 2012, BRIT J PHARMACOL, V166, P1, DOI 10.1111/j.1476-5381.2011.01810.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rath A, 2013, ANAL BIOCHEM, V434, P67, DOI 10.1016/j.ab.2012.11.007; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Schmied WH, 2014, J AM CHEM SOC, V136, P15577, DOI 10.1021/ja5069728; Schroder-Tittmann K, 2010, BIOCHEMISTRY-US, V49, P7956, DOI 10.1021/bi101159s; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Shimada M, 2002, J BIOL CHEM, V277, P31774, DOI 10.1074/jbc.M204166200; Singh Awadhesh Kumar, 2015, Indian J Endocrinol Metab, V19, P182, DOI 10.4103/2230-8210.146881; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Soubias O, 2012, BBA-BIOMEMBRANES, V1818, P234, DOI 10.1016/j.bbamem.2011.08.034; Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Szekeres PG, 1997, J PHARMACOL EXP THER, V283, P1276; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tian H, 2014, CHEMBIOCHEM, V15, P1820, DOI 10.1002/cbic.201402193; TIAN WN, 1994, MOL PHARMACOL, V45, P524; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Valentin-Hansen L, 2014, J BIOL CHEM, V289, P18045, DOI 10.1074/jbc.M113.527085; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wang X., 2015, INT J ENDOCRINOL, V2015; Willard Francis S, 2012, Exp Diabetes Res, V2012, P709893, DOI 10.1155/2012/709893; Yamamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/315848; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620; Zocher M, 2012, ACS NANO, V6, P961, DOI 10.1021/nn204624p	90	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179568	10.1371/journal.pone.0179568	http://dx.doi.org/10.1371/journal.pone.0179568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609478	Green Published, Green Submitted, gold			2022-12-26	WOS:000403274700042
J	Cheng, N; Alshammari, F; Hughes, E; Khanbabaei, M; Rho, JM				Cheng, Ning; Alshammari, Fawaz; Hughes, Elizabeth; Khanbabaei, Maryam; Rho, Jong M.			Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism	PLOS ONE			English	Article							T PLUS TF/J; SYNAPTIC PLASTICITY; CORPUS-CALLOSUM; PROGENITOR PROLIFERATION; CORTICAL DEVELOPMENT; SPECTRUM DISORDERS; HEAD CIRCUMFERENCE; SOCIAL-INTERACTION; BASAL DENDRITES; NEURON NUMBER	Autism spectrum disorder (hereafter referred to as " (ASD") is a heterogeneous neurodevelopmental condition characterized by impaired social communication and interactions, and restricted, repetitive activities or interests. Alterations in network connectivity and memory function are frequently observed in autism patients, often involving the hippocampus. However, specific changes during early brain development leading to disrupted functioning remain largely unclear. Here, we investigated the development of dendritic arbor of hippocampal CA1 pyramidal neurons in the BTBR T+tf/J (BTBR) mouse model of autism. BTBR mice display the defining behavioural features of autism, and also exhibit impaired learning and memory. We found that compared to control C57BL/6J (B6) animals, the lengths of both apical and basal dendrites were significantly greater in neonatal BTBR animals. Further, basal dendrites in the BTBR mice had higher branching complexity. In contrast, crosssectional area of the soma was unchanged. In addition, we observed a similar density of CA1 pyramidal neurons and thickness of the neuronal layer between the two strains. Thus, there was a specific, compartmentalized overgrowth of dendrites during early development in the BTBR animals. Biochemical analysis further showed that the extracellular signal-regulated kinases (ERK) pathway was up-regulated in the hippocampus of neonatal BTBR animals. Since dendritic structure is critical for information integration and relay, our data suggest that altered development of dendrites could potentially contribute to impaired hippocampal function and behavior observed in the BTBR model, and that this might be related to increased activation of the ERK pathway.	[Cheng, Ning; Hughes, Elizabeth; Khanbabaei, Maryam] Univ Calgary, Cumming Sch Med, ACHRI, Dev Neurosci Res Program, Calgary, AB, Canada; [Alshammari, Fawaz] Univ Calgary, Cumming Sch Med, OBrien Ctr Bachelor Hlth Sci, Calgary, AB, Canada; [Rho, Jong M.] Univ Calgary, Cumming Sch Med, ACHRI, Dept Pediat, Calgary, AB, Canada; [Rho, Jong M.] Univ Calgary, Cumming Sch Med, ACHRI, Dept Clin Neurosci, Calgary, AB, Canada; [Rho, Jong M.] Univ Calgary, Cumming Sch Med, ACHRI, Dept Physiol, Calgary, AB, Canada; [Rho, Jong M.] Univ Calgary, Cumming Sch Med, ACHRI, Dept Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Cheng, N (corresponding author), Univ Calgary, Cumming Sch Med, ACHRI, Dev Neurosci Res Program, Calgary, AB, Canada.	ncheng@ucalgary.ca			Alberta Children's Hospital Foundation	Alberta Children's Hospital Foundation	This work was supported by Alberta Children's Hospital Foundation, http://www.childrenshospital.ab.ca/site/PageServer? pagename=home_template. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Amodeo DA, 2012, BEHAV BRAIN RES, V227, P64, DOI 10.1016/j.bbr.2011.10.032; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; Blizinsky KD, 2016, P NATL ACAD SCI USA, V113, P8520, DOI 10.1073/pnas.1607014113; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Casanova MF, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-67; Casanova MF, 2002, J CHILD NEUROL, V17, P515, DOI 10.1177/088307380201700708; Cheng N, 2017, AUTISM RES, V10, P212, DOI 10.1002/aur.1687; Cheng N, 2013, J NEUROSCI, V33, P12208, DOI 10.1523/JNEUROSCI.0291-13.2013; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Cochoy DM, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0020-5; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Crowell B, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0046-15.2015; Davis S, 2006, GENES BRAIN BEHAV, V5, P61, DOI 10.1111/j.1601-183X.2006.00230.x; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Dodero L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076655; Ellegood J, 2015, NEUROTHERAPEUTICS, V12, P521, DOI 10.1007/s13311-015-0360-z; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Fang WQ, 2014, CELL REP, V9, P1635, DOI 10.1016/j.celrep.2014.11.003; Faridar A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-57; Feliciano DM, 2013, INT J DEV NEUROSCI, V31, P667, DOI 10.1016/j.ijdevneu.2013.02.008; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Gkogkas CG, 2013, NATURE, V493, P371, DOI 10.1038/nature11628; Goh S, 2012, DEV MED CHILD NEUROL, V54, P208, DOI 10.1111/j.1469-8749.2011.04153.x; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Ha S, 2008, DEV NEUROBIOL, V68, P1565, DOI 10.1002/dneu.20682; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jasien Joan M, 2014, Front Aging Neurosci, V6, P225, DOI 10.3389/fnagi.2014.00225; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Koldewyn K, 2008, BRAIN IMAGING BEHAV, V2, P105, DOI 10.1007/s11682-008-9020-9; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lanz TA, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-45; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Llaneza DC, 2010, PHYSIOL BEHAV, V100, P268, DOI 10.1016/j.physbeh.2010.01.003; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; MacPherson P, 2008, BRAIN RES, V1210, P179, DOI 10.1016/j.brainres.2008.03.008; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Maximo JO, 2014, NEUROPSYCHOL REV, V24, P16, DOI 10.1007/s11065-014-9250-0; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Meyza KZ, 2013, BEHAV BRAIN RES, V251, P25, DOI 10.1016/j.bbr.2012.07.021; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Niblock MM, 2000, J NEUROSCI, V20, P4165; Oblak AL, 2011, AUTISM RES, V4, P200, DOI 10.1002/aur.188; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pucilowska J, 2015, J NEUROSCI, V35, P3190, DOI 10.1523/JNEUROSCI.4864-13.2015; Pucilowska J, 2012, J NEUROSCI, V32, P8663, DOI 10.1523/JNEUROSCI.1107-12.2012; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Raymond GV, 1996, ACTA NEUROPATHOL, V91, P117; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Ribeiro AS, 2013, BEHAV BRAIN RES, V245, P145, DOI 10.1016/j.bbr.2013.02.021; Roelink H, 2000, CURR BIOL, V10, pR279, DOI 10.1016/S0960-9822(00)00407-3; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Scattoni ML, 2013, BEHAV BRAIN RES, V251, P35, DOI 10.1016/j.bbr.2012.12.028; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Sforazzini F, 2016, BRAIN STRUCT FUNCT, V221, P941, DOI 10.1007/s00429-014-0948-9; Shpyleva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113712; Simon R, 2012, EMBO J, V31, P2922, DOI 10.1038/emboj.2012.142; Snow WM, 2008, DEV PSYCHOBIOL, V50, P633, DOI 10.1002/dev.20337; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Srivastava DP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001350; Stephenson DT, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-7; Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tolwani RJ, 2002, NEUROSCIENCE, V114, P795, DOI 10.1016/S0306-4522(02)00301-9; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; Uddin LQ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00458; Urbanska M, 2012, J BIOL CHEM, V287, P30240, DOI 10.1074/jbc.M112.374405; Vaccarino FM, 2009, J AUTISM DEV DISORD, V39, P511, DOI 10.1007/s10803-008-0653-8; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Vithayathil J, 2015, J NEUROSCI, V35, P6836, DOI 10.1523/JNEUROSCI.4196-14.2015; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Waltes R, 2014, J NEURAL TRANSM, V121, P1107, DOI 10.1007/s00702-014-1230-2; Wang JM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00297; Weber JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11380; Wegiel J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0141-7; Wen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153329; Wolff JJ, 2015, BRAIN, V138, P2046, DOI 10.1093/brain/awv118; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Yang H, 2015, ENDOCRINOL METAB, V30, P98, DOI 10.3803/EnM.2015.30.1.98; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Zhang LB, 2016, NEUROSCI LETT, V612, P43, DOI 10.1016/j.neulet.2015.11.038; Zhang LB, 2014, NEURON, V84, P78, DOI 10.1016/j.neuron.2014.09.009; Zhou WL, 2008, EUR J NEUROSCI, V27, P923, DOI 10.1111/j.1460-9568.2008.06075.x	102	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179409	10.1371/journal.pone.0179409	http://dx.doi.org/10.1371/journal.pone.0179409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EX5IQ	28609458	gold, Green Published, Green Submitted			2022-12-26	WOS:000403274700034
J	Hajjar, D; Kremb, S; Sioud, S; Emwas, AH; Voolstra, CR; Ravasi, T				Hajjar, Dina; Kremb, Stephan; Sioud, Salim; Emwas, Abdul-Hamid; Voolstra, Christian R.; Ravasi, Timothy			Anti-cancer agents in Saudi Arabian herbals revealed by automated high-content imaging	PLOS ONE			English	Article							IN-VITRO ACTIVITY; DNA-DAMAGE; CELL-CYCLE; CITRULLUS-COLOCYNTHIS; HISTONE H2AX; PHOSPHORYLATION; PURIFICATION; ACTIVATION; NMR; 2,4-DI-TERT-BUTYLPHENOL	Natural products have been used for medical applications since ancient times. Commonly, natural products are structurally complex chemical compounds that efficiently interact with their biological targets, making them useful drug candidates in cancer therapy. Here, we used cell-based phenotypic profiling and image-based high-content screening to study the mode of action and potential cellular targets of plants historically used in Saudi Arabia's traditional medicine. We compared the cytological profiles of fractions taken from Juniperus phoenicea (Arar), Anastatica hierochuntica (Kaff Maryam), and Citrullus colocynthis (Hanzal) with a set of reference compounds with established modes of action. Cluster analyses of the cytological profiles of the tested compounds suggested that these plants contain possible topoisomerase inhibitors that could be effective in cancer treatment. Using histone H2AX phosphorylation as a marker for DNA damage, we discovered that some of the compounds induced double-strand DNA breaks. Furthermore, chemical analysis of the active fraction isolated from Juniperus phoenicea revealed possible anti-cancer compounds. Our results demonstrate the usefulness of cell-based phenotypic screening of natural products to reveal their biological activities.	[Hajjar, Dina; Ravasi, Timothy] King Abdullah Univ Sci & Technol, KAUST Environm Epigenet Program, Thuwal, Saudi Arabia; [Kremb, Stephan; Voolstra, Christian R.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sioud, Salim] King Abdullah Univ Sci & Technol, Analyt Core Lab, Thuwal, Saudi Arabia; [Emwas, Abdul-Hamid] King Abdullah Univ Sci & Technol, NMR Core Lab, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Ravasi, T (corresponding author), King Abdullah Univ Sci & Technol, KAUST Environm Epigenet Program, Thuwal, Saudi Arabia.; Voolstra, CR (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	christian.voolstra@kaust.edu.sa; timothy.ravasi@kaust.edu.sa	Emwas, Abdul-Hamid/AAG-5382-2020; Hajjar, Dina/AAH-1612-2020; Ravasi, Timothy/B-8777-2008; Voolstra, Christian R/H-7158-2014	Hajjar, Dina/0000-0003-3901-1172; Voolstra, Christian R/0000-0003-4555-3795; Ravasi, Timothy/0000-0002-9950-465X	King Abdullah of Science and Technology (KAUST)	King Abdullah of Science and Technology (KAUST)	The project was funded by: King Abdullah of Science and Technology (KAUST).	Agoramoorthy G, 2007, BRAZ J MICROBIOL, V38, P739, DOI 10.1590/S1517-83822007000400028; Ahn EH, 2006, ANTICANCER RES, V26, P121; Al-Talla ZA, 2011, INT J CLIN PHARM TH, V49, P469, DOI 10.5414/CP201478; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bailly C, 2012, CHEM REV, V112, P3611, DOI 10.1021/cr200325f; Beesley J, 1993, EICOSANOIDS OTHER BI, P573; Ben Ali MJ, 2015, BIOL PHARM BULL, V38, P1738, DOI 10.1248/bpb.b15-00412; BioMagResBank A, REP DAT NMR SPECTR P; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; CAIRNES DA, 1980, J NAT PROD, V43, P495, DOI 10.1021/np50010a010; Cancer IAfRo, 2014, WORLD CANC REPORT 20; Dharni S, 2014, J AGR FOOD CHEM, V62, P6138, DOI 10.1021/jf5001138; Diercks T, 2001, CURR OPIN CHEM BIOL, V5, P285, DOI 10.1016/S1367-5931(00)00204-0; Duke JA, 1986, PLANTS INDIGENOUS ME, P70; EKLUND EA, 1990, J BIOL CHEM, V265, P8426; El-Ghazali GE, 2010, J MED PLANTS RES, V4, P2680; Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P75, DOI 10.1007/978-1-4939-2377-9_7; Emwas Abdul-Hamid M, 2015, Methods Mol Biol, V1277, P91, DOI 10.1007/978-1-4939-2377-9_8; Ge Q, 2010, J FOOD BIOCHEM, V34, P1205, DOI 10.1111/j.1745-4514.2010.00359.x; Ghosh RN, 2004, ASSAY DRUG DEV TECHN, V2, P473, DOI 10.1089/adt.2004.2.473; Giuliano KA, 1997, J BIOMOL SCREEN, V2, P249, DOI 10.1177/108705719700200410; Hail N, 2005, APOPTOSIS, V10, P687, DOI 10.1007/s10495-005-0792-8; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Huang X, 2003, CELL CYCLE, V2, P614, DOI 10.4161/cc.2.6.565; Hussain AI, 2014, J ETHNOPHARMACOL, V155, P54, DOI 10.1016/j.jep.2014.06.011; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Kalt FR, 2014, PHARMACOGN MAG, V10, pS37, DOI 10.4103/0973-1296.127338; Keifer PA, 2000, PROG DRUG RES, V55, P137; Khorshid F, 2015, BRIT J MED MED RES; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Kremb S, 2017, SCI REPORTS, P7; Kuete V, 2011, J ETHNOPHARMACOL, V137, P752, DOI 10.1016/j.jep.2011.06.035; LC-NMR Urban S., 2006, CHEM AUSTR, V73, P15; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Macomber R. S. A., 1998, COMPLETE INTRO MODER; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Malek SNA, 2009, MOLECULES, V14, P1713, DOI 10.3390/molecules14051713; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Messina F, 2015, JOURNAL OF NATURAL P; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Negritto M, 2010, NAT ED, V3, P26; Nichols A., 2006, HIGH CONTENT SCREENI, P379; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Quan C, 1996, BIOPHYS J, V70, P194, DOI 10.1016/S0006-3495(96)79563-2; Rashad AE, 2011, EUR J MED CHEM, V46, P1019, DOI 10.1016/j.ejmech.2011.01.013; Rausch O, 2006, CURR OPIN CHEM BIOL, V10, P316, DOI 10.1016/j.cbpa.2006.06.004; Roberts JD, 2000, ABCS OF FT NMR; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanders JK, 1994, ANGEW CHEM ENGLISH E, V33, P1992; Sani H. L., 2015, Pharmacognosy Journal, V7, P89, DOI 10.5530/pj.2015.2.2; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; Seidel V, 2004, INT J ANTIMICROB AG, V23, P613, DOI 10.1016/j.ijantimicag.2003.11.008; Separovic, 2005, FRONT DRUG DES DISCO, V1, P113, DOI 10.2174/1574088054583273; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Simpson JH, 2012, ORGANIC STRUCTURE DETERMINATION USING 2-D NMR SPECTROSCOPY: A PROBLEM-BASED APPROACH, 2ND EDITION, P1; Sordet Olivier, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P271, DOI 10.2174/1568011033482378; Sudha T, GC MS ANAL BIOACTIVE; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Tavakoli J, 2012, IRAN J CANCER PREV, V5, P144; Taylor DL, 2006, HIGH CONTENT SCREENI, P3; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; Vorobiof DA, 2007, SAMJ S AFR MED J, V97, P937; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; Wu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112220; Yin Y, 2011, FOOD CHEM TOXICOL, V49, P3046, DOI 10.1016/j.fct.2011.10.001; Yoon MA, 2006, BIOL PHARM BULL, V29, P735, DOI 10.1248/bpb.29.735; Young DW, 2008, NAT CHEM BIOL, V4, P59, DOI 10.1038/nchembio.2007.53; Yurdakok B, 2014, DRUG CHEM TOXICOL, V37, P459, DOI 10.3109/01480545.2014.884112; Zhang F, 2007, ANAL CHEM, V79, P7748, DOI 10.1021/ac0711586; ZON G, 1983, CARBOHYD RES, V114, P103, DOI 10.1016/0008-6215(83)88177-4	75	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0177316	10.1371/journal.pone.0177316	http://dx.doi.org/10.1371/journal.pone.0177316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609451	Green Published, gold, Green Submitted			2022-12-26	WOS:000403274700002
J	Nguyen, CD; Amatoury, J; Carberry, JC; Eckert, DJ				Nguyen, Chinh D.; Amatoury, Jason; Carberry, Jayne C.; Eckert, Danny J.			An automated and reliable method for breath detection during variable mask pressures in awake and sleeping humans	PLOS ONE			English	Article							AIRWAY; MECHANISMS; SYNCHRONIZATION; TRAITS	Accurate breath detection is crucial in sleep and respiratory physiology research and in several clinical settings. However, this process is technically challenging due to measurement and physiological artifacts and other factors such as variable leaks in the breathing circuit. Recently developed techniques to quantify the multiple causes of obstructive sleep apnea, require intermittent changes in airway pressure applied to a breathing mask. This presents an additional unique challenge for breath detection. Traditional algorithms often require drift correction. However, this is an empirical operation potentially prone to human error. This paper presents a new algorithm for breath detection during variable mask pressures in awake and sleeping humans based on physiological landmarks detected in the airflow or epiglottic pressure signal (Pepi). The algorithms were validated using simulated data from a mathematical model and against the standard visual detection approach in 4 healthy individuals and 6 patients with sleep apnea during variable mask pressure conditions. Using the flow signal, the algorithm correctly identified 97.6% of breaths with a mean difference +/- SD in the onsets of respiratory phase compared to expert visual detection of 23 +/- 89ms for inspiration and 6 +/- 56ms for expiration during wakefulness and 10 +/- 74ms for inspiration and 3 +/- 28 ms for expiration with variable mask pressures during sleep. Using the Pepi signal, the algorithm correctly identified 89% of the breaths with accuracy of 31 +/- 156ms for inspiration and 9 +/- 147ms for expiration compared to expert visual detection during variable mask pressures asleep. The algorithm had excellent performance in response to baseline drifts and noise during variable mask pressure conditions. This new algorithm can be used for accurate breath detection including during variable mask pressure conditions which represents a major advance over existing time-consuming manual approaches.	[Nguyen, Chinh D.; Amatoury, Jason; Carberry, Jayne C.; Eckert, Danny J.] Neurosci Res Australia NeuRA, Randwick, NSW, Australia; [Nguyen, Chinh D.] Univ Sydney, Woolcock Inst Med Res, Glebe, NSW, Australia; [Nguyen, Chinh D.] Univ Sydney, Sydney Med Sch, Glebe, NSW, Australia; [Amatoury, Jason; Carberry, Jayne C.; Eckert, Danny J.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia	Neuroscience Research Australia; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of New South Wales Sydney	Nguyen, CD (corresponding author), Neurosci Res Australia NeuRA, Randwick, NSW, Australia.; Nguyen, CD (corresponding author), Univ Sydney, Woolcock Inst Med Res, Glebe, NSW, Australia.; Nguyen, CD (corresponding author), Univ Sydney, Sydney Med Sch, Glebe, NSW, Australia.	c.nguyen@neura.edu.au	Eckert, Danny/A-6145-2012	Eckert, Danny/0000-0003-3503-2363; Carberry, Jayne/0000-0003-4634-4047	National Health and Medical Research Council (NHMRC) of Australia NeuroSleep Centre of Research Excellence Fellowship [1060992]; NHMRC RD Wright Fellowship [1049814]	National Health and Medical Research Council (NHMRC) of Australia NeuroSleep Centre of Research Excellence Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	C. Nguyen, J. Amatoury and J. Carberry received support from a National Health and Medical Research Council (NHMRC) of Australia NeuroSleep Centre of Research Excellence Fellowship (1060992). D. Eckert has received support from a NHMRC RD Wright Fellowship, 1049814 (https://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. Nguyen, J. Amatoury and J. Carberry received support from a National Health and Medical Research Council (NHMRC) of Australia NeuroSleep Centre of Research Excellence Fellowship (1060992). D. Eckert has received support from a NHMRC RD Wright Fellowship (1049814). C. Nguyen is grateful for the implementation of fractal trends provided by Dr. Cindy Thamrin.	Azarbarzin A, 2016, SLEEP; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; Bates JHT, 2000, EUR RESPIR J, V16, P1180, DOI 10.1034/j.1399-3003.2000.16f26.x; Nguyen CD, 2012, IEEE T BIO-MED ENG, V59, P946, DOI 10.1109/TBME.2011.2179937; DAVIES RB, 1987, BIOMETRIKA, V74, P95, DOI 10.2307/2336024; Eckert DJ, 2013, AM J RESP CRIT CARE, V188, P996, DOI 10.1164/rccm.201303-0448OC; Eckert DJ, 2011, J APPL PHYSIOL, V111, P1644, DOI 10.1152/japplphysiol.00653.2011; Eckert DJ, 2016, SLEEP IN PRESS  1213; Eckert DJ, 2015, SLEEP APNOEA EUROPEA, P9; Henke KG, 1998, J APPL PHYSIOL, V84, P486, DOI 10.1152/jappl.1998.84.2.486; Nguyen CD, 2016, SLEEP, V39, P541, DOI 10.5665/sleep.5522; Nguyen CD, 2012, SLEEP, V35, P1643, DOI 10.5665/sleep.2236; Sa RC, 2002, IEEE T BIO-MED ENG, V49, P1130, DOI 10.1109/TBME.2002.803514; Saboisky JP, 2007, J APPL PHYSIOL, V102, P772, DOI 10.1152/japplphysiol.00683.2006; Schafer C, 1999, PHYS REV E, V60, P857, DOI 10.1103/PhysRevE.60.857; Schmidt M, 1998, COMPUT BIOMED RES, V31, P413, DOI 10.1006/cbmr.1998.1493; Verin E, 2000, RESP PHYSIOL, V124, P35, DOI 10.1016/S0034-5687(00)00189-4; Wellman A, 2013, J APPL PHYSIOL, V114, P911, DOI 10.1152/japplphysiol.00747.2012; Wellman A, 2011, J APPL PHYSIOL, V110, P1627, DOI 10.1152/japplphysiol.00972.2010; Younes M, 2004, AM J RESP CRIT CARE, V169, P623, DOI 10.1164/rccm.200307-1023OC; Younes M, 2003, AM J RESP CRIT CARE, V168, P645, DOI 10.1164/rccm.200302-201OC; Younes M, 2007, J APPL PHYSIOL, V103, P1929, DOI 10.1152/japplphysiol.00561.2007; Younes M, 2012, J APPL PHYSIOL, V112, P249, DOI 10.1152/japplphysiol.00312.2011	23	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2017	12	6							e0179030	10.1371/journal.pone.0179030	http://dx.doi.org/10.1371/journal.pone.0179030			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX5IQ	28609480	Green Published, Green Submitted, gold			2022-12-26	WOS:000403274700019
J	Kamimura, K; Yokoo, T; Kamimura, H; Sakamaki, A; Abe, S; Tsuchiya, A; Takamura, M; Kawai, H; Yamagiwa, S; Terai, S				Kamimura, Kenya; Yokoo, Takeshi; Kamimura, Hiroteru; Sakamaki, Akira; Abe, Satoshi; Tsuchiya, Atsunori; Takamura, Masaaki; Kawai, Hirokazu; Yamagiwa, Satoshi; Terai, Shuji			Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses	PLOS ONE			English	Article							CHOLESTASIS; AGONIST	Background and aim Among various symptoms accompanied with chronic liver disease, pruritus affects the quality of life of patients, causing physical and mental stress, and worsens hepatic function. Recently, kappa-opioid receptor agonist, nalfurafine hydrochloride was approved to treat central pruritus in patients with liver disease in Japan. This study aimed to assess the long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients. Methods A patient-reported outcome using questionnaire-based methods was used for 41 liver disease patients with or without pruritus symptoms. Nalfurafine hydrochloride (2.5 mu g/day) was orally administered to 18 patients suffering from pruritus symptoms and whose current treatment was not effective. The same questionnaires and visual analogue scales (VAS) were repeatedly followed up for the patients for the entire follow-up period, and biochemical analyses were performed to evaluate the safety of the treatment. Results Pruritus completely disappeared in seven of 18 cases, and VAS scores showed a decreasing trend over time from the start of nalfurafine hydrochloride administration in all patients who received the medication. Among 11 patients who were followed up for more than 12 weeks, nine patients showed continuous improvement of symptoms, and this progress was still apparent at >= 20 weeks after starting administration (p < 0.0001). The medication was discontinued in four patients because of progression of primary disease, high cost, oral dryness, and anemia. No significant toxicity was observed on the serum biochemical analyses. Conclusions Nalfurafine hydrochloride contributed to long-term suppression of pruritus without significant safety problems.	[Kamimura, Kenya; Yokoo, Takeshi; Kamimura, Hiroteru; Sakamaki, Akira; Abe, Satoshi; Tsuchiya, Atsunori; Takamura, Masaaki; Kawai, Hirokazu; Yamagiwa, Satoshi; Terai, Shuji] Niigata Univ, Div Gastroenterol & Hepatol, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Niigata, Japan	Niigata University	Kamimura, K (corresponding author), Niigata Univ, Div Gastroenterol & Hepatol, Grad Sch Med & Dent Sci, Chuo Ku, Niigata, Niigata, Japan.	kenya-k@med.niigata-u.ac.jp	Kamimura, Hiroteru/AGS-1352-2022; Kamimura, Kenya/U-6797-2019	Kamimura, Hiroteru/0000-0002-9135-3092; Yokoo, Takeshi/0000-0001-7138-1785; Kamimura, Kenya/0000-0001-7182-4400				Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3; Beuers U, 2014, HEPATOLOGY, V60, P399, DOI 10.1002/hep.26909; GILLESPIE DA, 1993, J GASTROEN HEPATOL, V8, P168, DOI 10.1111/j.1440-1746.1993.tb01510.x; JONES EA, 1990, HEPATOLOGY, V11, P884, DOI 10.1002/hep.1840110526; Jones EA, 1999, HEPATOLOGY, V29, P1003, DOI 10.1002/hep.510290450; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kumada H, 2016, HEPATOL RES; Kumagai H, 2004, BAS CLIN DERMATOL, V27, P279; Kumagai H, 2012, AM J NEPHROL, V36, P175, DOI 10.1159/000341268; Kumagai H, 2010, NEPHROL DIAL TRANSPL, V25, P1251, DOI 10.1093/ndt/gfp588; Suzuki K, 2014, WORLD J GASTROENTERO, V20, P17877, DOI 10.3748/wjg.v20.i47.17877; Umeuchi H, 2003, EUR J PHARMACOL, V477, P29, DOI 10.1016/j.ejphar.2003.08.007; WAHLGREN CF, 1989, ACTA DERM-VENEREOL, V69, P185	13	36	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0178991	10.1371/journal.pone.0178991	http://dx.doi.org/10.1371/journal.pone.0178991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604788	Green Published, gold, Green Submitted			2022-12-26	WOS:000403088400024
J	Kim, BJ; Kim, GN; Kim, BR; Shim, TS; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Shim, Tae-Sun; Kook, Yoon-Hoh; Kim, Bum-Joon			Phylogenetic analysis of Mycobacterium massiliense strains having recombinant rpoB gene laterally transferred from Mycobacterium abscessus	PLOS ONE			English	Article							SEQUENCE TYPING SCHEME; NONTUBERCULOUS MYCOBACTERIA; SUBSP ABSCESSUS; CYSTIC-FIBROSIS; II GENOTYPE; BOLLETII; GENOME; DIFFERENTIATION; CLARITHROMYCIN; COHORT	Recent multi locus sequence typing (MLST) and genome based studies indicate that lateral gene transfer (LGT) events in the rpoB gene are prevalent between Mycobacterium abscessus complex strains. To check the prevalence of the M. massiliense strains subject to rpoB LGT (Rec-mas), we applied rpoB typing (711 bp) to 106 Korean strains of M. massiliense infection that had already been identified by hsp65 sequence analysis (603 bp). The analysis indicated 6 smooth strains in M. massiliense Type I (10.0%, 6/60) genotypes but no strains in M. massiliense Type II genotypes (0%, 0/46), showing a discrepancy between the 2 typing methods. Further MLST analysis based on the partial sequencing of seven housekeeping genes, argH, cya, glpK, gnd, murC, pta and purH, as well as erm(41) PCR proved that these 6 Rec-mas strains consisted of two distinct genotypes belonging to M. massiliense and not M. abscessus. The complete rpoB sequencing analysis showed that these 6 Rec-mas strains have an identical hybrid rpoB gene, of which a 478 bp partial rpoB fragment may be laterally transferred from M. abscessus. Notably, five of the 6 Rec-mas strains showed complete identical sequences in a total of nine genes, including the seven MLST genes, hsp65, and rpoB, suggesting their clonal propagation in South Korea. In conclusion, we identified 6 M. massiliense smooth strains of 2 phylogenetically distinct genotypes with a specific hybrid rpoB gene laterally transferred from M. abscessus from Korean patients. Their clinical relevance and bacteriological traits remain to be elucidated.	[Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Liver Res Inst, Dept Microbiol & Immunol,Biomed Sci, Seoul, South Korea; [Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Shim, Tae-Sun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Dept Microbiol & Immunol,Biomed Sci, Seoul, South Korea.; Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	National Research Foundation of Korea (NRF) [NRF-2016R1A2B4011847]; BK21-plus education program by the National Research Foundation of Korea	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); BK21-plus education program by the National Research Foundation of Korea	This work was supported by the National Research Foundation of Korea (NRF), Grant no., NRF-2016R1A2B4011847 (http://ernd.nrf.re.kr). Bo-Ram Kim received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Choi WS, 2011, CLIN MICROBIOL INFEC, V17, P1084, DOI 10.1111/j.1469-0691.2010.03395.x; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Kim B.H., 2012, PLOS ONE, V7; Kim BJ, 2013, GENOME ANNOUNC, V1; Kim BJ, 2015, APMIS, V123, P895, DOI 10.1111/apm.12436; Kim BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-890; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Kim K, 2015, J CLIN MICROBIOL, V53, P1403, DOI 10.1128/JCM.03424-14; Kim SY, 2013, DIAGN MICR INFEC DIS, V77, P143, DOI 10.1016/j.diagmicrobio.2013.06.023; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Krzywinska E, 2004, MICROBIOL-SGM, V150, P1707, DOI 10.1099/mic.0.27088-0; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Machado GE, 2014, J CLIN MICROBIOL, V52, P2881, DOI 10.1128/JCM.00688-14; Macheras E, 2014, RES MICROBIOL, V165, P82, DOI 10.1016/j.resmic.2013.12.003; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Macheras E, 2009, J CLIN MICROBIOL, V47, P2596, DOI 10.1128/JCM.00037-09; Martin D, 2015, VIRUS EVOL, V1; Maurer FP, 2012, J ANTIMICROB CHEMOTH, V67, P2606, DOI 10.1093/jac/dks279; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Morschhauser J, 2000, PHILOS T R SOC B, V355, P695, DOI 10.1098/rstb.2000.0609; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nie WJ, 2014, INT J INFECT DIS, V25, P170, DOI 10.1016/j.ijid.2014.02.014; O'Driscoll C, 2016, J CYST FIBROS, V15, P179, DOI 10.1016/j.jcf.2015.05.007; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Raz Y, 2010, GENETICS, V185, P327, DOI 10.1534/genetics.109.113613; Reva O, 2015, BMC EVOL BIOL, V15, DOI 10.1186/1471-2148-15-S1-S2; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sapriel G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2448-1; Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Tortoli E, 2016, INT J SYST EVOL MICR, V66, P4471, DOI 10.1099/ijsem.0.001376; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	47	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2017	12	6							e0179237	10.1371/journal.pone.0179237	http://dx.doi.org/10.1371/journal.pone.0179237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EX2VR	28604829	Green Published, Green Submitted, gold			2022-12-26	WOS:000403088400042
